data_2jwy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jwy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 31' ' ' ILE . 14.6 pt-20 . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 120.949 0.404 . . . . 73.319999999999993 110.842 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -60.02 -34.3 73.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 111.543 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.78 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.948 0.404 . . . . 75.019999999999996 110.713 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -62.3 -36.2 81.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 74.319999999999993 111.163 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.8 mt -62.04 -48.01 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.08 0.467 . . . . 74.239999999999995 110.798 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -60.11 -35.29 74.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.282 0.563 . . . . 75.310000000000002 110.932 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.622 ' HG3' HD13 ' A' ' 108' ' ' ILE . 35.1 tt0 -68.37 -43.35 77.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.176 -0.465 . . . . 64.109999999999999 110.653 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 -55.76 29.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.013 -0.54 . . . . 72.129999999999995 110.684 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -54.15 -47.38 71.99 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.182 0.438 . . . . 72.340000000000003 112.182 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -62.29 -48.21 80.91 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.965 0.357 . . . . 75.319999999999993 111.965 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.7 -33.57 75.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.211 0.529 . . . . 72.340000000000003 111.026 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -56.04 -48.96 75.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.856 -0.611 . . . . 71.510000000000005 110.628 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.75 -32.3 72.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.942 -0.572 . . . . 71.409999999999997 111.683 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.45 -10.46 59.41 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.007 0.373 . . . . 71.400000000000006 112.007 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 43.2 t -87.13 132.45 33.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 111.871 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.0 p -103.36 -24.82 13.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 75.400000000000006 110.781 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t -100.53 93.48 5.64 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.175 -0.466 . . . . 62.340000000000003 110.918 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.64 -160.18 47.65 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.198 0.439 . . . . 70.310000000000002 114.198 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -116.6 144.92 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.3 0.481 . . . . 73.209999999999994 112.3 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.461 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 16.1 m-85 -83.3 113.75 20.92 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.407 -0.361 . . . . 72.230000000000004 111.898 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 86.9 mt -103.9 94.26 5.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.182 0.515 . . . . 72.400000000000006 110.304 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.72 120.67 82.42 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.543 -0.299 . . . . 72.409999999999997 110.818 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.593 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.7 Cg_endo -57.17 -22.2 47.01 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.827 2.352 . . . . 74.409999999999997 112.888 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.49 -21.39 60.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.34 -0.457 . . . . 61.020000000000003 113.061 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.97 -40.62 10.02 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.845 0.355 . . . . 44.130000000000003 111.164 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.9 mttm 62.88 2.48 1.0 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.69 0.626 . . . . 75.219999999999999 112.69 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 p -70.76 151.06 95.31 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 113.02 0.748 . . . . 73.519999999999996 113.02 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 65' ' ' ARG . 73.8 Cg_endo -72.89 136.33 24.95 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.843 2.362 . . . . 72.439999999999998 112.467 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.51 140.58 51.24 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.737 0.304 . . . . 71.310000000000002 111.604 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -92.71 127.43 38.21 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.999 0.428 . . . . 75.109999999999999 111.738 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.648 ' HB3' ' HE1' ' A' ' 66' ' ' MET . 32.2 tp -131.13 127.19 37.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.119 0.485 . . . . 63.32 111.369 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.02 97.7 11.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.127 0.489 . . . . 73.219999999999999 110.715 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -93.55 -177.18 4.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.275 0.56 . . . . 72.109999999999999 112.262 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -67.5 -32.41 73.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.021 -0.536 . . . . 72.230000000000004 112.032 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 pt -84.45 -30.0 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 111.883 0.327 . . . . 75.329999999999998 111.883 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.58 -177.69 37.76 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.396 -0.43 . . . . 62.219999999999999 112.895 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.5 m -85.18 109.01 17.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.039 0.447 . . . . 74.329999999999998 111.446 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.728 HD11 ' SD ' ' A' ' 66' ' ' MET . 0.6 OUTLIER -116.57 171.71 7.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.011 0.434 . . . . 73.409999999999997 111.897 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 30.6 ttm180 -140.64 114.04 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.258 -0.428 . . . . 72.129999999999995 111.101 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.728 ' SD ' HD11 ' A' ' 64' ' ' LEU . 3.2 mpp? -103.59 158.55 16.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.5 0.555 . . . . 63.310000000000002 112.5 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 p -156.67 157.85 35.93 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.793 -0.64 . . . . 70.340000000000003 111.237 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.491 HD22 HD12 ' A' ' 80' ' ' LEU . 76.3 mt -112.37 117.67 33.1 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.896 0.332 . . . . 73.329999999999998 111.896 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.435 HG22 HD21 ' A' ' 70' ' ' ASN . 22.5 m -135.74 165.06 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.657 0.265 . . . . 72.420000000000002 111.555 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.435 HD21 HG22 ' A' ' 69' ' ' VAL . 44.4 m-80 57.7 40.08 26.77 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.118 0.485 . . . . 54.32 111.907 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.466 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 40.5 mt -69.86 112.18 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.2 -0.454 . . . . 73.140000000000001 111.217 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -137.23 151.31 71.39 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-O 120.772 0.32 . . . . 75.519999999999996 111.83 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.92 146.76 83.77 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.887 2.391 . . . . 60.240000000000002 113.186 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.726 ' HB2' HG23 ' A' ' 79' ' ' THR . 19.6 t70 -115.02 169.86 8.78 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.258 -0.428 . . . . 73.150000000000006 111.043 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.63 72.48 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.866 0.321 . . . . 74.010000000000005 111.866 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.21 -45.68 3.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.517 -0.31 . . . . 63.229999999999997 111.465 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.425 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -130.6 -110.07 1.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.754 -0.736 . . . . 61.439999999999998 113.893 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -146.97 127.83 14.43 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.104 0.409 . . . . 54.229999999999997 112.104 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.726 HG23 ' HB2' ' A' ' 74' ' ' ASP . 75.7 p -98.93 120.81 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.767 0.317 . . . . 72.219999999999999 111.752 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -137.15 151.06 48.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.823 0.344 . . . . 62.130000000000003 111.197 175.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 m -83.3 113.45 20.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.006 0.431 . . . . 75.25 111.846 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.42 109.39 20.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.92 -0.582 . . . . 71.099999999999994 109.969 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 66' ' ' MET . 73.7 mtm180 -101.15 123.07 44.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.861 0.319 . . . . 63.210000000000001 111.861 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 84' ' ' ILE . 3.7 mp -102.2 102.42 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.034 0.445 . . . . 73.200000000000003 110.593 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -100.9 134.51 43.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.433 -0.349 . . . . 73.519999999999996 111.188 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.56 122.52 5.81 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.075 -0.583 . . . . 62.119999999999997 113.446 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.0 -27.81 62.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.428 0.632 . . . . 65.439999999999998 110.498 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -85.89 -175.24 5.5 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.774 -0.648 . . . . 54.420000000000002 111.44 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.41 5.63 39.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.397 -0.365 . . . . 63.240000000000002 111.458 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.09 152.98 38.01 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.196 0.443 . . . . 62.0 112.196 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 73.2 Cg_endo -74.27 138.18 24.59 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.773 2.315 . . . . 74.340000000000003 112.79 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.17 122.07 55.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 O-C-N 122.142 -0.349 . . . . 70.340000000000003 111.848 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.27 170.88 14.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.607 2.205 . . . . 37.880000000000003 112.866 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.6 131.48 50.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.307 0.484 . . . . 44.439999999999998 112.307 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -146.79 154.85 41.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.261 0.553 . . . . 73.200000000000003 112.225 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.9 p -118.87 151.23 38.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.898 -0.592 . . . . 73.430000000000007 110.438 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 154' ' ' ASP . . . -141.18 150.24 21.67 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.771 -0.728 . . . . 37.880000000000003 113.83 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 154' ' ' ASP . 61.3 m -100.06 110.0 22.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.771 0.319 . . . . 70.409999999999997 110.819 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.1 p -102.28 117.88 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.433 0.531 . . . . 75.540000000000006 112.433 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HG2' ' CD2' ' A' ' 153' ' ' HIS . 32.8 mm-40 -83.98 147.26 27.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.901 -0.407 . . . . 75.420000000000002 109.901 174.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -155.12 133.71 11.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.066 0.46 . . . . 70.420000000000002 111.654 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.85 -147.67 5.48 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.952 -0.567 . . . . 63.219999999999999 112.951 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.432 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 87.4 mt-30 -123.36 150.71 43.33 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.333 0.587 . . . . 63.140000000000001 112.565 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.3 mt -116.26 104.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.978 -0.556 . . . . 54.43 110.657 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.498 ' NE2' HD11 ' A' ' 114' ' ' ILE . 4.0 pt20 -89.19 -17.41 29.18 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.398 0.518 . . . . 64.019999999999996 112.398 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -90.37 -159.23 35.36 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.026 -0.607 . . . . 52.100000000000001 113.963 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 51.8 p -114.25 -178.44 3.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.806 0.443 . . . . 72.510000000000005 110.967 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.622 HD13 ' HG3' ' A' ' 33' ' ' GLN . 48.0 mm -66.81 -30.92 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 60.020000000000003 110.709 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.92 -39.28 72.8 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.097 -0.501 . . . . 74.209999999999994 111.163 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.59 108.87 2.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.164 -0.471 . . . . 75.150000000000006 111.191 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.608 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 36.9 p90 -125.99 139.49 53.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.89 0.376 . . . . 75.239999999999995 111.743 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -108.78 123.23 48.69 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.244 -0.434 . . . . 75.519999999999996 111.443 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -74.66 100.48 3.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.718 0.294 . . . . 64.030000000000001 110.798 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.498 HD11 ' NE2' ' A' ' 105' ' ' GLN . 50.6 pt -109.63 157.46 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 111.812 0.301 . . . . 63.219999999999999 111.812 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 56.73 31.38 19.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.18 0.514 . . . . 71.129999999999995 111.502 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -97.08 132.91 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.385 0.612 . . . . 50.149999999999999 112.583 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -142.11 178.18 7.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.723 -0.672 . . . . 70.519999999999996 109.656 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 11.3 p30 -127.85 172.91 10.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.949 1.092 . . . . 71.430000000000007 113.949 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -153.1 156.34 38.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.872 -1.058 . . . . 72.230000000000004 109.921 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.54 111.48 23.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.258 0.466 . . . . 74.109999999999999 112.258 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.2 pt -96.11 101.17 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.325 0.583 . . . . 55.299999999999997 110.989 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.89 108.93 20.48 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.436 -0.347 . . . . 63.130000000000003 111.185 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.57 38.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.513 -0.312 . . . . 70.140000000000001 111.599 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.83 179.69 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.67 2.247 . . . . 64.540000000000006 113.553 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.89 108.09 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.023 0.439 . . . . 73.239999999999995 111.299 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 15.3 m -80.77 96.66 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 73.439999999999998 111.203 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 127' ' ' VAL . 12.2 t -86.71 7.98 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 121.081 0.467 . . . . 73.530000000000001 111.609 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.637 ' H ' HD21 ' A' ' 128' ' ' LEU . 2.1 pt? -105.52 147.0 28.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.186 0.517 . . . . 65.439999999999998 111.925 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.39 127.37 22.44 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.098 -0.501 . . . . 72.099999999999994 111.015 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.18 155.14 91.81 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.836 -1.318 . . . . 74.299999999999997 113.086 -0.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.612 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 48.5 t -88.64 121.27 30.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.652 0.612 . . . . 70.430000000000007 112.652 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -138.79 130.72 27.95 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.085 0.469 . . . . 74.5 110.948 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.35 149.72 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.802 0.334 . . . . 54.329999999999998 111.563 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -132.76 125.38 30.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.027 0.441 . . . . 73.319999999999993 110.737 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 pt -130.74 137.88 31.77 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 120.814 0.34 . . . . 71.319999999999993 111.472 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.71 120.21 7.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.302 2.001 . . . . 75.409999999999997 112.777 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.31 97.41 8.48 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.023 -0.535 . . . . 71.109999999999999 109.782 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.444 ' HG3' HG21 ' A' ' 79' ' ' THR . 63.0 tt0 -87.83 83.36 7.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 53.450000000000003 111.297 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 65.9 mt -62.86 145.75 54.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 111.072 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -116.81 147.57 41.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.136 0.494 . . . . 71.329999999999998 112.073 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.19 -49.98 3.88 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.066 -0.516 . . . . 71.420000000000002 114.03 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.557 HD13 HD22 ' A' ' 147' ' ' LEU . 20.9 tt -87.64 138.47 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.261 0.553 . . . . 74.219999999999999 112.24 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.6 m -92.79 149.69 21.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.183 -0.462 . . . . 72.439999999999998 111.519 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -53.25 -42.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.379 0.511 . . . . 73.140000000000001 112.379 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.75 -23.65 65.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.199 0.523 . . . . 73.329999999999998 111.289 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.432 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.1 mm-40 -103.03 7.81 38.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 74.109999999999999 112.089 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.593 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 14.0 mt -72.85 124.36 25.24 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.279 0.474 . . . . 74.329999999999998 112.279 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.67 -57.59 0.82 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.203 -0.523 . . . . 44.130000000000003 112.886 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -145.0 146.34 31.87 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.333 -0.51 . . . . 72.230000000000004 111.9 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' A' ' 68' ' ' LEU . 62.1 t -124.54 100.19 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.068 -0.514 . . . . 74.099999999999994 109.917 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -100.53 114.47 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.736 0.643 . . . . 75.430000000000007 112.736 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.49 123.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.797 -0.638 . . . . 51.43 110.988 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.465 ' CD2' ' HG2' ' A' ' 100' ' ' GLU . 10.2 p80 -152.88 178.44 9.66 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.574 0.226 . . . . 75.430000000000007 111.082 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.456 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 33.1 t70 54.53 73.63 0.39 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.376 0.607 . . . . 73.439999999999998 111.197 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 115.29 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.843 -0.617 . . . . 45.240000000000002 110.695 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.52 140.07 36.72 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.095 0.405 . . . . 74.420000000000002 112.095 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.91 146.77 42.68 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.635 2.224 . . . . 75.420000000000002 112.538 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 113.047 0.758 . . . . 75.200000000000003 113.047 -176.056 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.57 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.571 0.224 . . . . 71.420000000000002 111.067 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.2 m -59.62 -50.05 75.36 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.224 0.535 . . . . 64.450000000000003 111.164 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.12 -35.29 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.475 0.655 . . . . 75.109999999999999 110.657 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.597 ' HE3' HD11 ' A' ' 48' ' ' LEU . 23.7 tptt -70.3 -35.95 74.02 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.623 -0.717 . . . . 74.140000000000001 110.754 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 27' ' ' GLU . 89.2 mt -60.48 -42.91 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.412 0.625 . . . . 72.519999999999996 110.322 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -57.4 -44.76 84.81 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.838 -0.619 . . . . 71.540000000000006 110.551 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HG3' HD12 ' A' ' 108' ' ' ILE . 31.6 tt0 -60.91 -40.03 91.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.934 -0.576 . . . . 74.230000000000004 111.12 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -55.47 34.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.938 -0.574 . . . . 70.340000000000003 111.535 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -60.71 -39.05 87.1 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 111.893 0.331 . . . . 73.340000000000003 111.893 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.08 -54.57 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.425 0.528 . . . . 74.549999999999997 112.425 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.61 -41.64 77.39 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.064 0.459 . . . . 64.329999999999998 110.919 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.8 -46.02 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 111.343 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.81 63.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 64.219999999999999 112.561 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.701 ' HB3' ' HZ1' ' A' ' 40' ' ' LYS . 8.1 mtpm? -94.42 -12.41 27.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.892 0.33 . . . . 75.219999999999999 111.892 178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.2 t -85.7 142.47 29.0 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.669 0.271 . . . . 73.420000000000002 111.336 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.2 p -84.0 -42.32 16.34 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.099 -0.375 . . . . 72.109999999999999 111.517 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 m -148.08 87.79 1.63 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 65.430000000000007 111.377 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.4 153.35 6.08 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.244 -0.503 . . . . 42.210000000000001 112.405 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 152' ' ' ILE . 25.8 m -106.41 146.12 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.315 0.579 . . . . 60.210000000000001 112.449 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -106.22 102.9 12.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.807 -0.633 . . . . 73.219999999999999 110.884 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -92.58 116.02 28.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.897 0.379 . . . . 74.5 111.221 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.597 HD11 ' HE3' ' A' ' 30' ' ' LYS . 3.8 mm? -86.93 117.46 68.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.578 -0.283 . . . . 54.119999999999997 110.717 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.602 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 78.5 Cg_exo -51.11 -36.36 54.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.102 2.534 . . . . 73.430000000000007 113.768 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.84 99.79 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.954 -0.641 . . . . 61.100000000000001 112.548 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 30' ' ' LYS . . . -86.88 93.61 9.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.731 0.301 . . . . 75.140000000000001 111.487 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.568 ' HE3' HD11 ' A' ' 71' ' ' ILE . 43.6 mmtm -67.52 77.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.878 0.37 . . . . 73.549999999999997 110.251 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 p -140.48 149.97 59.16 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 112.841 0.682 . . . . 75.140000000000001 112.841 -175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.596 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 92.9 Cg_endo -80.48 154.19 21.04 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.393 2.728 . . . . 64.219999999999999 113.242 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.46 137.93 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.67 0.272 . . . . 63.43 111.456 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' CZ ' HG21 ' A' ' 63' ' ' THR . 37.6 ttt85 -79.22 133.69 36.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.853 0.359 . . . . 72.299999999999997 111.901 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 64' ' ' LEU . 56.2 tp -138.14 120.58 16.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.497 0.554 . . . . 75.420000000000002 112.497 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.47 121.63 26.51 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.726 -0.67 . . . . 61.43 110.401 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 p -123.68 -179.33 4.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.534 . . . . 64.209999999999994 111.808 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.498 HE22 ' HB3' ' A' ' 156' ' ' GLN . 46.3 mt-30 -67.72 -19.12 65.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 72.099999999999994 112.146 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 pt -100.26 -25.71 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.971 0.415 . . . . 73.439999999999998 111.891 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.76 32.54 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.415 -0.421 . . . . 65.310000000000002 112.243 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.535 HG21 ' CZ ' ' A' ' 56' ' ' ARG . 39.0 m -94.48 127.19 40.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.176 0.513 . . . . 72.140000000000001 111.709 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.8 170.13 13.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.03 -0.532 . . . . 72.319999999999993 110.71 175.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.596 ' HG2' ' HB2' ' A' ' 54' ' ' PRO . 17.2 ttp180 -133.44 105.59 7.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.835 0.35 . . . . 74.349999999999994 110.924 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.759 ' SD ' HG23 ' A' ' 152' ' ' ILE . 66.9 mtt -95.77 148.99 21.99 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.224 0.453 . . . . 73.400000000000006 112.224 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.1 p -145.08 148.89 34.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.793 0.33 . . . . 63.030000000000001 111.742 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 80' ' ' LEU . 95.6 mt -96.68 114.0 25.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.177 -0.465 . . . . 54.130000000000003 111.557 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.637 HG22 HD21 ' A' ' 70' ' ' ASN . 28.3 m -134.37 162.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.625 0.232 . . . . 71.030000000000001 111.625 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.637 HD21 HG22 ' A' ' 69' ' ' VAL . 44.5 m-80 61.96 33.89 17.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.776 0.43 . . . . 70.409999999999997 111.794 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.568 HD11 ' HE3' ' A' ' 52' ' ' LYS . 38.8 mt -71.33 106.9 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 73.030000000000001 111.421 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 21.9 p -140.67 158.72 65.01 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 111.891 0.33 . . . . 70.010000000000005 111.891 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 22.6 Cg_endo -60.17 153.76 56.59 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.73 2.287 . . . . 61.149999999999999 113.517 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.656 ' HB2' HG22 ' A' ' 79' ' ' THR . 26.0 t70 -129.96 172.62 11.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.156 -0.475 . . . . 72.239999999999995 111.679 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -53.58 -46.63 70.38 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.306 0.484 . . . . 72.439999999999998 112.306 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -110.14 -21.39 12.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.55 0.574 . . . . 75.530000000000001 112.55 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -157.49 -103.7 0.2 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.154 -1.022 . . . . 74.040000000000006 114.144 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.2 m -150.1 129.27 12.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.711 0.291 . . . . 74.25 111.636 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 74' ' ' ASP . 82.5 p -97.59 123.56 41.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.87 0.367 . . . . 54.329999999999998 111.405 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.537 HD11 ' O ' ' A' ' 80' ' ' LEU . 2.6 pp -135.73 137.96 42.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.19 0.519 . . . . 75.409999999999997 111.352 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.0 m -83.66 107.35 16.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.155 0.502 . . . . 71.25 111.354 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.41 HD23 HD22 ' A' ' 68' ' ' LEU . 3.0 tm? -82.75 109.98 17.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.914 -0.585 . . . . 71.530000000000001 110.366 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 66' ' ' MET . 48.3 mtm180 -93.7 112.47 24.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.76 0.282 . . . . 73.340000000000003 111.76 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mp -92.18 93.94 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.04 0.448 . . . . 75.349999999999994 110.611 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -94.22 104.03 16.04 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 71.319999999999993 110.799 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.46 145.13 40.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.822 -0.704 . . . . 52.25 113.353 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.92 -45.05 95.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.418 0.628 . . . . 71.329999999999998 110.439 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 m -80.68 115.2 20.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.869 -0.605 . . . . 62.509999999999998 110.699 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -61.26 -27.22 68.3 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.89 0.376 . . . . 65.129999999999995 111.39 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 141.22 49.95 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.765 -0.652 . . . . 71.409999999999997 112.0 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.82 106.96 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.144 2.563 . . . . 72.019999999999996 113.508 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.6 148.91 63.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.238 -0.437 . . . . 72.299999999999997 111.643 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.7 179.81 4.88 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.594 2.196 . . . . 52.43 113.153 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 139.5 36.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.07 0.462 . . . . 62.009999999999998 111.687 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 42.5 p90 -141.59 176.11 9.15 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.564 0.697 . . . . 73.150000000000006 112.475 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 p -152.73 168.69 24.84 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.536 -0.757 . . . . 73.510000000000005 111.077 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.55 -177.79 44.87 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.819 -0.705 . . . . 52.140000000000001 113.605 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 m -113.13 119.06 36.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.689 0.28 . . . . 74.340000000000003 111.308 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.09 115.81 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.103 0.478 . . . . 62.240000000000002 111.235 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 53.1 mt-10 -106.56 113.64 27.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.987 0.422 . . . . 74.540000000000006 111.158 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.428 ' CE1' HD23 ' A' ' 139' ' ' LEU . 17.0 p90 -116.95 129.02 55.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.044 0.45 . . . . 74.019999999999996 111.648 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.97 -146.71 4.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.186 -0.53 . . . . 72.409999999999997 113.189 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.615 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 92.9 mt-30 -128.58 152.87 47.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.169 0.509 . . . . 65.129999999999995 111.8 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.474 HG22 ' HB2' ' A' ' 111' ' ' PHE . 57.9 mt -114.74 126.15 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.977 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.448 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -112.7 17.23 19.27 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.862 0.319 . . . . 75.129999999999995 111.862 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -132.99 -165.0 11.05 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.915 -0.659 . . . . 65.439999999999998 113.908 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.8 p -102.82 176.01 5.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.978 0.418 . . . . 74.5 111.558 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.479 HD12 ' HG3' ' A' ' 33' ' ' GLN . 49.2 mm -58.67 -38.23 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.085 0.469 . . . . 73.310000000000002 110.613 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.28 -47.91 59.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.899 -0.591 . . . . 64.510000000000005 110.995 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.41 91.69 2.57 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 64.230000000000004 111.826 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.612 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.9 p90 -115.41 127.89 55.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.178 0.513 . . . . 73.329999999999998 112.209 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.96 124.39 40.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 70.120000000000005 110.827 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.91 105.59 17.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.858 -0.61 . . . . 73.219999999999999 111.195 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.448 HD13 ' NE2' ' A' ' 105' ' ' GLN . 41.0 pt -109.28 156.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.63 -0.259 . . . . 63.130000000000003 111.652 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 56.66 39.36 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.945 0.402 . . . . 72.319999999999993 111.881 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 p -96.72 116.43 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.472 0.653 . . . . 72.010000000000005 112.454 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.02 147.37 27.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.98 -0.554 . . . . 62.130000000000003 110.341 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.426 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 7.4 p30 -112.68 136.47 52.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.346 0.593 . . . . 54.119999999999997 111.931 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -127.45 157.74 39.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.956 -0.565 . . . . 73.310000000000002 110.217 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.5 122.02 37.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.11 0.411 . . . . 75.450000000000003 112.11 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.813 HG21 HD23 ' A' ' 137' ' ' LEU . 20.0 pt -100.95 105.64 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.163 0.506 . . . . 73.430000000000007 111.539 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -110.38 119.14 38.27 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.338 -0.392 . . . . 55.149999999999999 110.193 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -114.28 133.29 22.45 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 111.858 0.318 . . . . 65.299999999999997 111.858 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 24.5 Cg_exo -64.28 159.99 40.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.174 2.583 . . . . 74.0 113.22 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.14 147.63 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.128 0.418 . . . . 53.25 112.128 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 t -87.39 124.54 33.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.342 -0.39 . . . . 61.200000000000003 110.541 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.4 -34.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.887 0.375 . . . . 72.0 111.722 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.09 -169.1 1.95 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.892 0.377 . . . . 74.439999999999998 111.655 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.47 149.73 53.1 Favored Pre-proline 0 N--CA 1.472 0.658 0 CA-C-N 116.508 -0.314 . . . . 38.619999999999997 111.358 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.54 147.2 63.5 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.0 -1.25 . . . . 73.329999999999998 113.306 -1.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m -65.89 82.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.356 0.598 . . . . 75.219999999999999 112.145 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.57 93.35 4.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.498 -0.774 . . . . 71.239999999999995 109.285 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.94 105.66 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.51 -0.313 . . . . 62.439999999999998 111.803 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.521 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.5 p-10 -96.97 142.9 28.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.992 0.425 . . . . 62.399999999999999 111.581 175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.471 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 18.0 pt -135.85 135.82 22.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 116.314 -0.403 . . . . 75.129999999999995 111.346 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.0 Cg_exo -75.63 117.1 4.65 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 75.129999999999995 113.0 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.813 HD23 HG21 ' A' ' 121' ' ' ILE . 38.4 mt -97.1 112.33 24.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.185 0.439 . . . . 62.439999999999998 112.185 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -91.02 90.73 7.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.105 0.479 . . . . 62.439999999999998 110.023 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.428 HD23 ' CE1' ' A' ' 101' ' ' TYR . 66.3 mt -76.72 137.71 39.51 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.319 -0.4 . . . . 63.439999999999998 111.252 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.8 135.82 48.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.226 0.454 . . . . 71.129999999999995 112.226 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.62 17.03 79.51 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 114.581 0.592 . . . . 61.109999999999999 114.581 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.2 tt -147.55 129.57 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 117.273 0.537 . . . . 63.100000000000001 111.628 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -92.48 156.75 16.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.975 0.416 . . . . 72.150000000000006 111.818 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.75 -33.79 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.964 -0.562 . . . . 75.239999999999995 111.727 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -31.63 72.95 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.966 0.413 . . . . 51.329999999999998 111.726 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.615 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 87.5 mm-40 -110.53 18.36 19.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.286 -0.415 . . . . 74.140000000000001 111.852 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -82.55 106.53 14.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.925 0.393 . . . . 71.030000000000001 110.832 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -83.78 -67.4 1.45 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.178 -0.534 . . . . 60.049999999999997 113.462 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -140.58 157.36 45.59 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.42 -0.459 . . . . 73.439999999999998 111.784 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.8 t -128.09 103.14 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.958 -0.565 . . . . 75.239999999999995 110.662 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -93.32 114.97 27.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.27 0.47 . . . . 71.120000000000005 112.27 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.759 HG23 ' SD ' ' A' ' 66' ' ' MET . 42.7 mm -96.14 130.78 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.105 -0.498 . . . . 73.140000000000001 111.118 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -165.39 -175.32 3.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.596 0.236 . . . . 75.450000000000003 111.632 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 64.22 24.47 13.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.117 0.567 . . . . 61.530000000000001 112.0 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.74 104.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.541 0.686 . . . . 75.340000000000003 111.538 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.498 ' HB3' HE22 ' A' ' 60' ' ' GLN . 8.0 pt20 -132.75 142.95 46.64 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.423 -0.808 . . . . 72.340000000000003 111.159 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 95' ' ' PHE . 62.5 Cg_endo -72.07 151.53 55.8 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.296 1.997 . . . . 75.209999999999994 112.692 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.619 -0.264 . . . . 73.420000000000002 110.812 178.132 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.392 0.615 . . . . 75.329999999999998 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 m -66.01 -31.08 71.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.829 -0.623 . . . . 72.530000000000001 111.049 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.79 -45.15 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.36 -0.382 . . . . 71.340000000000003 110.89 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.51 -48.33 77.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.142 0.496 . . . . 74.439999999999998 110.732 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -55.81 -51.22 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.904 -0.589 . . . . 75.519999999999996 111.41 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.1 m -58.36 -44.65 88.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.278 -0.419 . . . . 70.319999999999993 111.557 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.38 -44.05 96.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.447 -0.342 . . . . 74.549999999999997 111.209 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -56.79 -50.87 71.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.403 -0.362 . . . . 75.409999999999997 111.449 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -58.12 -43.8 87.4 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.859 0.361 . . . . 71.310000000000002 111.726 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -63.64 -48.23 78.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.729 0.3 . . . . 74.340000000000003 111.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.23 -33.82 76.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.333 0.587 . . . . 75.519999999999996 110.549 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.46 HD22 ' HB ' ' A' ' 45' ' ' VAL . 6.9 t-20 -63.6 -41.47 98.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.834 -0.621 . . . . 71.019999999999996 110.509 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.47 65.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.048 -0.524 . . . . 65.140000000000001 111.654 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HE3' HG23 ' A' ' 108' ' ' ILE . 66.7 mttm -82.21 -7.97 59.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.835 0.309 . . . . 51.119999999999997 111.835 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -55.97 117.57 3.83 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.648 0.61 . . . . 71.310000000000002 112.648 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 t -71.12 -36.87 72.3 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.081 -0.509 . . . . 73.230000000000004 111.691 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 m -151.99 121.54 6.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.714 0.292 . . . . 73.120000000000005 110.723 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.79 -153.59 22.08 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.221 -0.514 . . . . 42.100000000000001 112.547 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.46 ' HB ' HD22 ' A' ' 38' ' ' ASN . 17.7 m -136.29 148.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.14 0.47 . . . . 72.400000000000006 111.918 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -95.92 130.11 42.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.411 . . . . 75.409999999999997 112.069 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -125.06 143.89 50.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.858 -0.61 . . . . 74.420000000000002 109.868 172.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.5 mt -114.12 136.36 22.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.837 0.351 . . . . 63.329999999999998 111.721 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 36.8 Cg_exo -61.53 -14.0 32.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.922 2.415 . . . . 75.150000000000006 113.406 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.35 6.43 26.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.212 -0.518 . . . . 72.540000000000006 113.145 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.88 103.12 11.86 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.043 0.449 . . . . 71.299999999999997 111.125 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -80.65 60.55 4.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.513 0.673 . . . . 74.510000000000005 111.231 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 p -146.01 150.65 42.89 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-N 115.826 -0.624 . . . . 70.209999999999994 112.123 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.69 170.85 13.84 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.024 2.483 . . . . 72.420000000000002 114.396 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.38 157.03 44.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.738 -0.665 . . . . 72.420000000000002 110.076 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -113.59 119.36 37.23 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.46 0.648 . . . . 73.310000000000002 112.17 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.95 126.16 53.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.839 -0.618 . . . . 75.019999999999996 112.284 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.0 tt0 -86.78 108.33 18.66 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.741 -0.466 . . . . 61.32 109.741 172.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.472 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 82.6 p -113.04 -177.5 3.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.234 0.54 . . . . 71.129999999999995 112.338 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 50.1 mt-30 -67.66 -19.82 65.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.945 -0.57 . . . . 71.430000000000007 112.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 pt -95.19 -6.55 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.986 0.422 . . . . 73.120000000000005 111.073 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.54 -179.46 16.3 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.382 -0.437 . . . . 71.109999999999999 112.89 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 60.3 m -79.81 131.69 35.95 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.454 -0.439 . . . . 72.319999999999993 111.34 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.96 175.18 10.03 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.127 0.489 . . . . 64.230000000000004 112.246 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -124.34 123.35 40.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 74.420000000000002 110.664 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.559 ' SD ' HG22 ' A' ' 152' ' ' ILE . 63.0 mtt -118.0 156.16 29.04 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.873 0.368 . . . . 74.310000000000002 111.896 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.9 t -158.79 170.47 22.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.905 0.383 . . . . 70.200000000000003 111.908 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 71' ' ' ILE . 99.2 mt -116.29 106.18 13.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.29 -0.414 . . . . 71.340000000000003 111.996 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' HB ' ' A' ' 81' ' ' THR . 33.0 m -113.36 162.19 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.238 -0.288 . . . . 65.200000000000003 111.064 176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 63.83 31.2 14.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.039 0.447 . . . . 74.329999999999998 112.095 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 68' ' ' LEU . 45.3 mt -73.08 103.93 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.17 0.433 . . . . 52.100000000000001 112.17 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 p -137.78 152.49 72.56 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 120.861 0.362 . . . . 75.450000000000003 111.562 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.11 168.88 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.737 2.291 . . . . 51.43 113.495 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.635 ' HB2' HG21 ' A' ' 79' ' ' THR . 31.5 t70 -143.82 170.54 15.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.773 -0.649 . . . . 72.530000000000001 110.749 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.25 94.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.692 0.282 . . . . 70.120000000000005 111.692 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.15 -34.27 24.09 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.525 -0.307 . . . . 61.310000000000002 111.736 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.54 -100.83 0.14 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.36 -0.924 . . . . 64.439999999999998 114.149 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -146.03 131.28 18.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.832 0.349 . . . . 73.150000000000006 111.586 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 74' ' ' ASP . 79.0 p -109.56 137.7 47.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.895 0.379 . . . . 74.319999999999993 111.604 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 pp -149.41 -179.57 7.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.898 0.38 . . . . 55.240000000000002 111.272 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.655 ' HB ' HG23 ' A' ' 69' ' ' VAL . 21.7 m -124.13 117.77 25.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.894 0.378 . . . . 64.439999999999998 111.258 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.2 113.54 20.73 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.238 -0.437 . . . . 72.129999999999995 109.946 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 66' ' ' MET . 69.7 mtt180 -96.29 136.57 36.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.822 0.344 . . . . 75.420000000000002 111.09 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.507 HG12 ' HG2' ' A' ' 66' ' ' MET . 42.1 mt -131.63 133.97 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 74.140000000000001 111.529 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -142.51 124.79 15.51 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.737 -0.21 . . . . 73.150000000000006 110.689 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 92' ' ' LEU . . . -75.86 146.08 33.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.843 -0.694 . . . . 74.140000000000001 113.933 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.41 -39.48 83.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.753 0.787 . . . . 75.200000000000003 109.927 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -93.81 112.18 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 74.099999999999994 109.671 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -64.35 -7.71 10.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.46 0.541 . . . . 75.230000000000004 112.46 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.97 156.29 80.77 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.881 0.473 . . . . 71.150000000000006 111.572 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.82 123.38 11.51 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.094 2.529 . . . . 61.210000000000001 113.824 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 126' ' ' SER . 95.9 mt -100.19 147.98 34.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.099 -0.501 . . . . 73.409999999999997 111.332 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.13 172.79 15.28 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.471 2.114 . . . . 65.319999999999993 112.991 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.48 43.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 64.450000000000003 111.032 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -146.35 162.27 38.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.351 0.596 . . . . 72.329999999999998 112.282 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.4 m -146.9 151.54 37.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.932 -0.577 . . . . 53.219999999999999 110.309 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.738 ' HA3' HD11 ' A' ' 155' ' ' ILE . . . -150.25 170.61 30.22 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.411 -0.899 . . . . 55.409999999999997 113.762 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.1 m -105.32 132.04 52.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 75.129999999999995 110.999 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.75 130.39 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.955 0.407 . . . . 75.349999999999994 111.6 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 40.4 mm-40 -97.83 111.92 24.03 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 74.140000000000001 110.818 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -122.75 120.95 35.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.237 0.542 . . . . 75.349999999999994 111.844 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -161.65 -149.18 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.837 -0.62 . . . . 55.409999999999997 113.23 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -125.06 157.19 36.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.222 0.534 . . . . 61.32 112.043 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.36 121.16 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.205 -0.452 . . . . 75.209999999999994 111.354 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 114' ' ' ILE . 4.1 pt20 -105.08 5.95 32.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.872 0.367 . . . . 73.319999999999993 111.658 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -113.69 -177.89 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.233 -0.508 . . . . 73.430000000000007 113.19 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -90.44 179.41 5.87 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.611 -0.346 . . . . 52.43 111.223 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.565 HG23 ' HE3' ' A' ' 40' ' ' LYS . 48.8 mm -68.73 -27.56 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.521 . . . . 74.329999999999998 110.605 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.54 -32.34 58.16 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.975 -0.557 . . . . 74.319999999999993 111.384 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.39 90.57 1.67 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.285 0.564 . . . . 61.340000000000003 111.14 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -96.3 117.23 30.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.413 0.625 . . . . 74.219999999999999 112.05 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -86.59 111.98 21.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.081 -0.508 . . . . 71.519999999999996 110.633 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.77 104.08 11.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.951 0.405 . . . . 72.340000000000003 111.053 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.427 HD12 ' NE2' ' A' ' 105' ' ' GLN . 41.5 pt -113.39 151.65 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.475 -0.33 . . . . 63.350000000000001 111.687 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 58.14 34.44 24.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.078 0.465 . . . . 55.109999999999999 111.802 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.432 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 3.7 p -91.14 116.74 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.339 0.59 . . . . 73.409999999999997 112.331 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.66 171.79 7.68 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.268 -0.424 . . . . 63.439999999999998 111.011 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.12 143.47 50.87 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.14 0.495 . . . . 73.319999999999993 111.872 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -144.76 147.69 33.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.36 -0.382 . . . . 72.230000000000004 111.17 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.88 125.47 37.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.076 0.465 . . . . 74.530000000000001 112.216 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.2 pt -101.96 120.62 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.978 0.418 . . . . 72.540000000000006 111.043 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.32 122.31 46.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.869 0.366 . . . . 71.140000000000001 111.491 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -119.08 138.19 25.93 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 120.732 0.301 . . . . 54.520000000000003 111.546 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 170.34 20.26 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.725 2.283 . . . . 72.510000000000005 113.396 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.53 117.59 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.161 -0.472 . . . . 43.049999999999997 112.061 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 25.1 m -79.56 63.81 4.25 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.954 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.31 -11.66 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.451 0.908 . . . . 72.0 113.451 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.45 120.67 40.91 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.034 -0.416 . . . . 73.519999999999996 111.411 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.64 139.16 31.42 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 111.733 0.272 . . . . 74.510000000000005 111.733 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.74 145.63 82.15 Favored 'Cis proline' 0 C--N 1.356 0.922 0 C-N-CA 124.116 -1.202 . . . . 74.209999999999994 113.431 0.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 p -83.86 95.53 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.991 0.737 . . . . 62.310000000000002 112.991 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.24 127.02 20.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.003 -0.544 . . . . 54.229999999999997 110.739 171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -132.59 139.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 72.540000000000006 111.712 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 18.1 p-10 -114.67 133.39 55.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.256 0.551 . . . . 64.519999999999996 110.95 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.501 HD13 ' HB1' ' A' ' 123' ' ' ALA . 25.3 pt -130.5 140.18 37.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.482 -0.327 . . . . 72.150000000000006 111.509 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.24 156.2 62.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.418 2.079 . . . . 72.510000000000005 112.439 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -145.44 116.69 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.493 -0.321 . . . . 75.019999999999996 110.158 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -103.25 96.95 7.11 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.197 0.523 . . . . 74.140000000000001 111.814 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.8 129.86 35.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.842 0.354 . . . . 74.230000000000004 110.248 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -116.11 139.45 50.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.917 0.389 . . . . 45.240000000000002 111.809 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 20.21 61.26 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.326 -0.397 . . . . 70.420000000000002 113.815 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -160.29 124.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 117.334 0.567 . . . . 73.219999999999999 112.299 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.5 m -86.45 146.69 26.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.193 -0.317 . . . . 72.019999999999996 111.602 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.92 -35.64 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.749 0.648 . . . . 74.349999999999994 112.749 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.64 -23.15 66.73 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.159 0.504 . . . . 64.030000000000001 111.481 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -109.21 8.86 26.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.062 -0.517 . . . . 75.430000000000007 111.525 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 1.1 tt -91.63 126.05 36.57 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.913 0.387 . . . . 75.450000000000003 110.894 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.19 -62.35 1.22 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.297 -0.478 . . . . 73.129999999999995 113.72 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.39 160.35 40.31 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.563 0.579 . . . . 65.510000000000005 112.563 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.92 101.48 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.644 -0.707 . . . . 51.210000000000001 110.342 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 45.2 ttp180 -98.03 116.77 30.93 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.029 -0.419 . . . . 61.350000000000001 112.055 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.559 HG22 ' SD ' ' A' ' 66' ' ' MET . 22.3 mm -85.46 130.32 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.435 -0.348 . . . . 64.400000000000006 111.191 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -158.67 179.52 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.292 -0.255 . . . . 72.340000000000003 111.585 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.43 30.92 20.17 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.763 0.653 . . . . 74.129999999999995 112.763 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.738 HD11 ' HA3' ' A' ' 97' ' ' GLY . 49.9 mm -71.79 106.43 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.365 0.602 . . . . 71.549999999999997 110.691 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.7 pt20 -129.71 149.39 72.83 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.711 -0.677 . . . . 73.530000000000001 111.859 -174.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 156' ' ' GLN . 9.4 Cg_exo -71.23 136.93 30.24 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.627 2.218 . . . . 74.530000000000001 112.65 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 120.8 0.333 . . . . 72.540000000000006 110.748 177.154 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.433 ' O ' HG13 ' A' ' 31' ' ' ILE . 34.4 tt0 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.799 0.333 . . . . 70.120000000000005 111.522 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.403 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.0 m -56.27 -41.16 75.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.963 0.411 . . . . 51.200000000000003 111.302 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.32 -36.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 74.239999999999995 111.32 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' HE3' HD12 ' A' ' 48' ' ' LEU . 52.3 tptt -66.96 -38.37 85.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.123 -0.49 . . . . 62.5 110.437 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.489 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 84.7 mt -60.22 -48.57 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.13 0.491 . . . . 63.049999999999997 110.755 174.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.6 m -56.05 -41.79 75.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.115 -0.493 . . . . 72.150000000000006 110.783 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HG3' HD12 ' A' ' 108' ' ' ILE . 34.3 tt0 -59.09 -46.37 88.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.169 -0.469 . . . . 74.140000000000001 111.157 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.71 -52.92 63.1 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.994 0.368 . . . . 70.420000000000002 111.994 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.69 -42.87 84.56 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.819 0.342 . . . . 75.420000000000002 111.608 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.1 -34.56 76.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.929 0.344 . . . . 72.439999999999998 111.929 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.9 mt -68.1 -37.7 81.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.929 0.395 . . . . 64.230000000000004 110.829 174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.76 -44.06 85.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.006 0.431 . . . . 53.439999999999998 110.751 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.91 81.91 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.211 -0.45 . . . . 74.040000000000006 111.647 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.79 -2.08 58.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.93 0.395 . . . . 74.409999999999997 111.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -78.0 150.86 33.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.075 0.464 . . . . 73.430000000000007 111.863 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 m -122.01 -31.63 3.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.821 -0.627 . . . . 74.239999999999995 110.868 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -112.19 85.47 2.16 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.194 0.521 . . . . 74.409999999999997 111.438 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 80.92 -146.25 26.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.214 -0.517 . . . . 51.240000000000002 113.833 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 57' ' ' LEU . 33.5 m -123.74 140.6 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.472 0.545 . . . . 64.519999999999996 112.472 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.419 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 65.5 m-85 -87.04 107.63 18.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.436 -0.347 . . . . 74.329999999999998 110.895 172.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.64 128.26 44.21 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 71.319999999999993 110.499 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.542 HD12 ' HE3' ' A' ' 30' ' ' LYS . 72.1 mt -108.63 133.62 20.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.629 0.252 . . . . 63.520000000000003 111.471 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.41 -45.76 38.7 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.003 2.468 . . . . 72.530000000000001 113.251 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -71.38 -25.67 74.92 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.926 -0.654 . . . . 64.140000000000001 113.001 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . . . -91.93 63.2 4.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.051 0.453 . . . . 63.130000000000003 111.429 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -64.56 75.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.409 0.623 . . . . 63.350000000000001 111.541 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -141.65 151.47 60.4 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.132 -0.486 . . . . 72.510000000000005 111.946 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.655 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 74.5 Cg_endo -73.67 128.11 12.28 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.875 2.383 . . . . 75.450000000000003 113.958 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.96 139.9 50.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.348 -0.387 . . . . 73.420000000000002 110.703 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -89.39 133.18 34.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.063 0.458 . . . . 63.240000000000002 111.282 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.488 HD12 HG11 ' A' ' 45' ' ' VAL . 40.9 tp -132.89 129.67 38.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.132 -0.485 . . . . 71.230000000000004 111.374 -177.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.71 137.97 32.02 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.003 -0.369 . . . . 71.420000000000002 110.003 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.4 p -126.11 177.94 6.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.213 0.53 . . . . 70.340000000000003 111.287 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.0 0.75 23.21 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.178 -0.465 . . . . 74.519999999999996 111.869 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 pt -118.46 -4.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.737 0.303 . . . . 44.119999999999997 111.762 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.11 -177.94 20.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.53 -0.367 . . . . 42.039999999999999 112.993 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -88.39 132.32 34.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.207 -0.584 . . . . 73.519999999999996 111.716 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.03 -177.59 4.96 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.001 0.429 . . . . 75.120000000000005 111.706 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.655 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 66.7 ttp85 -135.41 140.77 45.2 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.477 -0.329 . . . . 74.400000000000006 111.088 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.659 ' SD ' HG23 ' A' ' 152' ' ' ILE . 64.8 mtt -129.36 152.23 49.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 61.43 111.854 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.1 p -152.38 152.65 32.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.906 0.384 . . . . 72.420000000000002 111.626 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 HD13 ' A' ' 80' ' ' LEU . 71.1 mt -100.81 111.06 23.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.323 -0.399 . . . . 73.450000000000003 111.349 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.62 HG21 ' HD2' ' A' ' 83' ' ' ARG . 33.7 m -128.12 159.35 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.626 0.25 . . . . 71.299999999999997 110.997 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.501 HD21 HG22 ' A' ' 69' ' ' VAL . 28.7 m-80 51.71 69.03 0.71 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.955 0.407 . . . . 74.519999999999996 111.113 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.6 mt -100.43 102.13 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.247 -0.433 . . . . 72.420000000000002 110.732 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -121.65 144.86 41.57 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 112.672 0.619 . . . . 74.519999999999996 112.672 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.27 129.67 15.29 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.766 2.311 . . . . 73.230000000000004 112.104 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HB2' HG21 ' A' ' 79' ' ' THR . 26.9 t70 -110.46 164.95 12.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.159 -0.473 . . . . 54.200000000000003 111.708 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.01 76.93 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 71.109999999999999 112.489 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -96.47 -12.29 24.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.912 0.338 . . . . 71.209999999999994 111.912 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . 171.51 -102.51 0.18 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.988 -0.625 . . . . 73.319999999999993 113.48 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -147.81 130.45 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.492 -0.417 . . . . 71.510000000000005 111.775 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 39.4 p -106.78 120.41 41.93 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.831 0.348 . . . . 73.329999999999998 111.485 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.503 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -130.13 159.13 37.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.691 0.282 . . . . 74.299999999999997 110.875 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -101.92 108.21 19.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.973 0.415 . . . . 74.299999999999997 111.867 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.567 HD12 HD12 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -84.07 106.63 15.87 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.499 -0.556 . . . . 65.219999999999999 109.499 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.62 ' HD2' HG21 ' A' ' 69' ' ' VAL . 20.2 mtp180 -96.11 125.76 40.87 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.192 -0.318 . . . . 74.310000000000002 111.247 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 82' ' ' LEU . 3.9 mp -115.93 103.3 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.917 0.389 . . . . 74.310000000000002 111.381 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -106.5 134.7 49.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.382 . . . . 73.340000000000003 110.722 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 142.47 32.61 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.957 -0.64 . . . . 65.010000000000005 113.324 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -62.15 -35.76 79.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.385 0.612 . . . . 62.539999999999999 110.749 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.8 m -99.82 149.83 22.97 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.794 -0.639 . . . . 60.329999999999998 110.718 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.71 -17.35 64.05 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.178 0.513 . . . . 74.510000000000005 111.342 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.15 136.33 58.69 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.622 -0.717 . . . . 72.409999999999997 112.052 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.75 117.01 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.456 2.104 . . . . 73.040000000000006 113.053 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -85.2 148.16 49.43 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.391 -0.368 . . . . 72.120000000000005 111.837 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.61 176.22 9.64 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.622 2.215 . . . . 64.120000000000005 113.007 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 125' ' ' ALA . . . -75.14 140.46 43.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.927 0.394 . . . . 74.319999999999993 111.741 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.86 168.67 19.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.529 0.68 . . . . 72.530000000000001 112.368 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 93.8 p -146.6 145.16 29.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.522 -0.763 . . . . 64.129999999999995 110.255 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -143.49 157.12 26.88 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.556 -0.83 . . . . 72.109999999999999 113.448 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.9 m -99.94 104.99 16.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.981 0.42 . . . . 74.519999999999996 110.784 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.407 HG13 HG21 ' A' ' 152' ' ' ILE . 20.1 m -91.06 125.3 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.007 0.432 . . . . 74.049999999999997 111.391 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.8 mt-10 -108.41 112.69 25.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.198 0.523 . . . . 70.129999999999995 110.831 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -115.97 141.28 48.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.953 -0.567 . . . . 74.420000000000002 111.641 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.27 -146.48 4.85 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.283 -0.484 . . . . 64.319999999999993 112.81 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.697 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 mt-30 -128.22 144.17 51.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.254 0.464 . . . . 70.340000000000003 112.254 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.2 mt -114.14 103.89 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.409 -0.359 . . . . 74.25 110.78 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.438 ' NE2' HD11 ' A' ' 114' ' ' ILE . 4.1 pt20 -92.83 15.03 15.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.043 0.386 . . . . 72.450000000000003 112.043 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -123.29 -170.26 13.4 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.884 -0.674 . . . . 72.349999999999994 113.872 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 49.9 p -102.63 -178.1 3.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.804 0.441 . . . . 62.340000000000003 111.644 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' A' ' 33' ' ' GLN . 46.7 mm -63.42 -30.83 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.461 0.648 . . . . 70.209999999999994 110.668 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.82 -56.13 5.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.685 -0.689 . . . . 75.209999999999994 110.848 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.31 98.26 4.83 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.196 0.522 . . . . 72.150000000000006 111.567 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.539 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 32.2 p90 -113.8 132.37 55.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.082 0.468 . . . . 72.420000000000002 111.537 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -107.32 115.94 31.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.219 -0.446 . . . . 62.25 111.492 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.8 97.46 3.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.888 0.375 . . . . 70.510000000000005 110.615 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.438 HD11 ' NE2' ' A' ' 105' ' ' GLN . 36.3 pt -108.73 156.81 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.491 -0.322 . . . . 75.230000000000004 111.288 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 56.86 36.32 27.56 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.119 0.485 . . . . 73.219999999999999 111.546 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.31 116.37 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.96 0.726 . . . . 72.109999999999999 112.96 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.527 ' H ' ' NE2' ' A' ' 117' ' ' GLN . 0.8 OUTLIER -124.89 156.88 37.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.711 -0.677 . . . . 71.129999999999995 110.972 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.476 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.3 p-10 -102.42 166.9 10.29 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.361 0.875 . . . . 73.510000000000005 113.361 -172.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.411 ' NE2' HD23 ' A' ' 139' ' ' LEU . 8.4 tt0 -152.9 152.83 31.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.413 -0.812 . . . . 74.219999999999999 110.087 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.39 133.46 35.86 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.019 0.438 . . . . 73.349999999999994 112.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.87 HG23 HD23 ' A' ' 137' ' ' LEU . 39.4 pt -109.98 106.21 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.199 0.523 . . . . 74.430000000000007 110.758 173.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.82 101.72 12.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.903 0.382 . . . . 73.200000000000003 111.031 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 140.87 21.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.073 0.398 . . . . 64.540000000000006 112.073 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.68 168.58 22.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.819 2.346 . . . . 75.25 113.216 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -82.94 139.57 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.288 -0.415 . . . . 64.019999999999996 111.856 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.8 m -78.01 93.07 4.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 75.030000000000001 110.655 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.94 -36.92 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.264 0.554 . . . . 54.229999999999997 111.034 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.15 145.11 39.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.925 -0.58 . . . . 70.129999999999995 111.148 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.73 45.54 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.483 -0.326 . . . . 63.240000000000002 110.963 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -82.33 170.85 56.71 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.007 -1.247 . . . . 73.230000000000004 113.872 1.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -79.82 74.12 6.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.324 -0.398 . . . . 75.209999999999994 112.035 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.4 103.11 12.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.262 -0.426 . . . . 65.310000000000002 111.289 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.7 t -122.38 108.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.234 0.214 . . . . 71.230000000000004 111.429 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -117.87 128.28 54.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.028 0.442 . . . . 64.349999999999994 111.701 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 19.4 pt -126.12 144.33 48.58 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.185 -0.461 . . . . 65.329999999999998 112.145 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 8.2 Cg_exo -73.74 158.39 46.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.884 2.389 . . . . 72.540000000000006 112.852 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.87 HD23 HG23 ' A' ' 121' ' ' ILE . 31.7 mt -139.72 103.97 4.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.459 0.54 . . . . 75.530000000000001 112.459 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -82.78 95.11 7.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.342 0.591 . . . . 65.25 110.557 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.493 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 40.9 mt -80.19 114.79 19.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 72.409999999999997 109.803 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -95.58 134.5 38.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.006 0.431 . . . . 74.340000000000003 112.056 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.68 15.47 58.15 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.253 -0.499 . . . . 43.409999999999997 113.696 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.42 HD12 HD22 ' A' ' 147' ' ' LEU . 20.7 tt -152.54 134.93 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 117.229 0.514 . . . . 70.129999999999995 111.528 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -94.83 156.23 16.45 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.915 0.388 . . . . 71.430000000000007 111.847 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.98 -43.76 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.874 0.694 . . . . 75.010000000000005 112.874 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.02 -13.53 62.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 63.539999999999999 111.042 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.427 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.6 mm-40 -106.18 5.82 30.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.5 . . . . 75.549999999999997 111.979 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.42 HD22 HD12 ' A' ' 142' ' ' ILE . 40.2 mt -80.14 109.6 14.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.251 0.548 . . . . 74.430000000000007 111.485 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -87.65 -45.24 5.26 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.847 -0.615 . . . . 70.310000000000002 112.904 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -156.13 151.99 27.4 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.167 0.508 . . . . 70.219999999999999 111.748 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.38 93.23 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.881 -0.599 . . . . 71.310000000000002 109.745 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 18.5 ttp85 -88.27 109.1 19.68 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.274 0.559 . . . . 75.430000000000007 112.249 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.659 HG23 ' SD ' ' A' ' 66' ' ' MET . 13.4 mm -90.51 129.69 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.748 -0.66 . . . . 75.209999999999994 111.083 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.537 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 14.8 p80 -167.25 -178.13 3.96 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.237 0.458 . . . . 70.219999999999999 112.237 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 t70 66.32 31.59 8.31 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.53 -0.759 . . . . 74.400000000000006 111.174 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.458 HD13 ' HA3' ' A' ' 97' ' ' GLY . 43.0 mm -68.04 94.02 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.87 -0.604 . . . . 74.439999999999998 111.154 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -112.83 145.07 32.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.813 -0.631 . . . . 73.109999999999999 111.702 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.44 140.8 37.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.487 2.125 . . . . 42.009999999999998 112.962 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.554 0.692 . . . . 63.32 111.111 177.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.8 pt-20 . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.115 0.483 . . . . 62.420000000000002 110.726 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 7.1 m -69.01 -26.02 64.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.063 -0.517 . . . . 73.519999999999996 111.612 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.15 -47.9 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.005 0.431 . . . . 72.310000000000002 110.56 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.87 -39.07 92.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.359 -0.382 . . . . 75.329999999999998 111.004 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 27' ' ' GLU . 84.4 mt -58.97 -46.43 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.994 0.426 . . . . 61.409999999999997 110.832 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -56.29 -49.54 73.98 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.246 0.546 . . . . 70.140000000000001 110.611 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.761 ' HG3' HD13 ' A' ' 108' ' ' ILE . 60.2 tt0 -54.89 -43.75 73.5 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.724 -0.671 . . . . 74.329999999999998 111.228 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -60.53 -51.81 67.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.111 -0.495 . . . . 55.009999999999998 111.868 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -57.46 -40.4 78.45 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.19 0.441 . . . . 55.149999999999999 112.19 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -65.01 -47.67 76.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.696 0.284 . . . . 71.430000000000007 111.643 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.44 -39.35 91.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.312 0.577 . . . . 70.310000000000002 110.757 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.51 HD22 ' HB ' ' A' ' 45' ' ' VAL . 3.3 t-20 -60.23 -38.22 82.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.583 -0.735 . . . . 53.5 111.072 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.54 -25.83 35.55 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.301 0.482 . . . . 72.099999999999994 112.301 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 55.9 mttm -69.3 -30.9 69.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.803 0.297 . . . . 74.439999999999998 111.803 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.422 ' HB2' ' HE1' ' A' ' 46' ' ' TYR . 48.2 t -71.4 130.19 40.71 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.358 0.503 . . . . 61.240000000000002 112.358 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.7 m -83.11 -13.86 54.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.068 -0.515 . . . . 73.319999999999993 111.686 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -160.78 102.9 1.33 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.863 0.363 . . . . 71.420000000000002 111.394 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.07 137.61 6.16 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.17 -0.538 . . . . 52.329999999999998 112.896 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 38' ' ' ASN . 27.4 m -89.49 138.3 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.383 0.512 . . . . 55.210000000000001 112.383 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HE1' ' HB2' ' A' ' 41' ' ' SER . 30.2 m-85 -90.01 114.11 25.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.835 -0.62 . . . . 74.340000000000003 110.783 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -108.58 133.48 52.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 110.493 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 51' ' ' ALA . 74.3 mt -110.4 126.97 27.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.762 -0.199 . . . . 71.349999999999994 111.071 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -33.41 68.65 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.539 2.159 . . . . 55.450000000000003 112.727 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.29 -36.37 50.53 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.235 -0.439 . . . . 61.140000000000001 112.883 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . . . -92.43 71.88 5.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.154 0.502 . . . . 62.43 111.187 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -66.84 77.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.159 0.504 . . . . 71.239999999999995 111.429 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -144.02 151.37 52.19 Favored Pre-proline 0 N--CA 1.47 0.546 0 CA-C-N 116.215 -0.448 . . . . 73.200000000000003 111.812 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.38 152.05 65.88 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.881 2.387 . . . . 74.430000000000007 113.406 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -135.66 140.72 44.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.323 -0.399 . . . . 74.019999999999996 111.385 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 56' ' ' ARG . 17.1 ttm180 -83.83 132.22 34.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.83 0.347 . . . . 72.219999999999999 111.822 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.48 ' HB3' HD21 ' A' ' 64' ' ' LEU . 53.6 tp -130.29 129.9 43.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.8 0.44 . . . . 71.519999999999996 111.359 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.26 115.87 30.14 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.296 -0.631 . . . . 73.219999999999999 109.296 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.7 p -137.27 -178.9 5.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.735 0.779 . . . . 71.310000000000002 112.903 -171.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -66.29 -20.12 66.01 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.196 -0.911 . . . . 73.150000000000006 112.563 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 95' ' ' PHE . 36.6 pt -90.68 -18.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.851 0.357 . . . . 72.439999999999998 111.247 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.43 -164.71 25.1 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.141 -0.482 . . . . 44.039999999999999 112.433 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.6 m -95.01 107.3 19.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.231 0.539 . . . . 72.209999999999994 111.34 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.711 ' H ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.6 -176.47 2.91 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.212 0.53 . . . . 75.409999999999997 111.74 -178.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 31.3 ttp180 -150.94 107.51 3.5 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.941 0.4 . . . . 72.129999999999995 110.888 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.853 ' SD ' HG23 ' A' ' 152' ' ' ILE . 65.7 mtt -104.11 161.29 14.14 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.732 0.642 . . . . 51.140000000000001 112.732 -173.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 t -153.52 158.89 41.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.101 -0.5 . . . . 52.329999999999998 111.793 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 71' ' ' ILE . 96.2 mt -106.27 110.19 22.36 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.418 -0.356 . . . . 74.140000000000001 111.71 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.541 HG22 HD21 ' A' ' 70' ' ' ASN . 20.4 m -130.04 165.9 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.702 0.287 . . . . 71.409999999999997 111.753 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.541 HD21 HG22 ' A' ' 69' ' ' VAL . 37.7 m-80 59.22 29.29 18.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.988 0.515 . . . . 73.230000000000004 112.323 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 35.2 mt -68.09 107.35 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.901 0.382 . . . . 63.32 111.464 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.63 153.07 78.76 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.185 0.439 . . . . 70.030000000000001 112.185 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.28 150.34 81.37 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.824 2.35 . . . . 53.439999999999998 113.268 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -140.9 167.46 22.14 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.141 -0.482 . . . . 54.030000000000001 111.546 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.47 72.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.961 0.41 . . . . 62.149999999999999 111.911 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 6.6 m-20 -76.01 -26.77 57.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.801 0.334 . . . . 72.439999999999998 110.994 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.34 -93.32 0.1 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-N 116.022 -0.535 . . . . 63.409999999999997 112.97 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -147.84 126.5 12.54 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.549 -0.383 . . . . 73.430000000000007 111.466 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -104.77 129.89 52.94 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.705 0.288 . . . . 73.209999999999994 111.658 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 pp -141.1 152.65 44.94 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.976 0.417 . . . . 73.409999999999997 111.501 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.439 ' HB ' HG22 ' A' ' 69' ' ' VAL . 60.1 m -89.87 109.04 20.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.965 0.412 . . . . 52.299999999999997 111.113 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.419 HD11 HD12 ' A' ' 84' ' ' ILE . 2.6 tm? -86.5 109.37 19.04 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.716 -0.475 . . . . 65.140000000000001 109.716 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -99.24 130.32 45.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.811 0.339 . . . . 71.530000000000001 111.207 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.451 HG12 ' HE3' ' A' ' 66' ' ' MET . 4.1 mp -111.62 102.85 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 73.349999999999994 111.294 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 72.430000000000007 110.695 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.74 153.43 17.54 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.006 -0.616 . . . . 70.519999999999996 112.172 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -45.33 91.56 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.349 0.575 . . . . 73.510000000000005 110.736 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -85.15 176.39 8.4 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.093 -0.503 . . . . 61.130000000000003 111.655 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 89' ' ' ASN . 0.8 OUTLIER -89.26 -37.11 15.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.403 -0.362 . . . . 62.109999999999999 111.67 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.93 145.71 99.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.666 0.27 . . . . 73.540000000000006 111.5 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.75 145.94 82.4 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.236 2.624 . . . . 71.230000000000004 114.99 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.42 152.92 44.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.661 -0.7 . . . . 74.239999999999995 111.393 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.23 -171.55 1.19 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.678 2.252 . . . . 73.150000000000006 113.104 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 157' ' ' PRO . . . -74.62 151.33 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.749 0.309 . . . . 60.310000000000002 111.469 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' HB3' HG21 ' A' ' 61' ' ' ILE . 36.4 p90 -154.69 149.63 26.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.599 0.714 . . . . 74.030000000000001 112.669 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 91.1 p -130.55 136.75 49.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.287 -0.869 . . . . 65.340000000000003 109.8 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.686 ' HA3' HD11 ' A' ' 155' ' ' ILE . . . -145.36 175.54 24.87 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.332 -0.937 . . . . 63.329999999999998 113.598 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.9 m -111.13 122.19 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.010000000000005 111.547 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.11 133.74 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.187 -0.461 . . . . 63.140000000000001 111.131 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 41.3 mt-10 -122.76 126.23 47.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.958 0.409 . . . . 75.340000000000003 111.024 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -134.18 133.13 40.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.803 0.335 . . . . 75.049999999999997 111.741 -171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.31 -157.43 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.242 -0.504 . . . . 72.019999999999996 113.28 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HB2' HG13 ' A' ' 114' ' ' ILE . 87.5 mt-30 -117.39 151.43 37.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.068 0.461 . . . . 74.230000000000004 112.049 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.556 HG21 ' H ' ' A' ' 106' ' ' GLY . 60.7 mt -109.28 122.46 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.192 -0.458 . . . . 72.319999999999993 111.266 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -106.88 23.64 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.837 0.31 . . . . 75.450000000000003 111.837 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -146.09 -170.43 14.75 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.006 -0.616 . . . . 37.049999999999997 113.678 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 44.7 p -97.31 -173.55 2.69 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.935 0.398 . . . . 73.150000000000006 111.522 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.761 HD13 ' HG3' ' A' ' 33' ' ' GLN . 31.8 mm -67.9 -36.45 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.037 0.446 . . . . 72.099999999999994 111.397 174.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.05 -37.66 58.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 111.312 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -144.93 111.87 5.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 111.44 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.1 p90 -139.1 145.81 39.93 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.451 0.643 . . . . 74.310000000000002 112.365 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -117.01 144.73 44.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.59 -0.732 . . . . 72.319999999999993 110.495 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.19 119.57 37.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.04 0.448 . . . . 72.329999999999998 111.489 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.554 HG13 ' HB2' ' A' ' 103' ' ' GLN . 33.6 pt -123.07 149.52 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.53 -0.305 . . . . 74.329999999999998 111.429 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.89 39.28 31.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.362 0.601 . . . . 73.200000000000003 111.445 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.05 127.19 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 61.130000000000003 112.203 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.27 167.78 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.977 -0.556 . . . . 71.400000000000006 111.058 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.7 p-10 -112.94 178.48 4.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.056 0.762 . . . . 43.109999999999999 113.056 -172.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -167.75 159.78 12.05 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.482 -0.781 . . . . 74.349999999999994 110.251 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.05 133.92 44.84 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 122.01 -0.431 . . . . 54.130000000000003 112.033 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 121' ' ' ILE . 28.4 pt -111.79 106.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.208 0.527 . . . . 74.010000000000005 111.165 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.51 100.84 10.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.259 -0.428 . . . . 75.150000000000006 110.635 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.72 152.48 37.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.926 0.393 . . . . 75.219999999999999 112.047 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.51 174.43 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.801 2.334 . . . . 55.450000000000003 113.0 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.83 156.82 20.4 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.218 0.532 . . . . 73.25 112.023 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.9 m -100.95 118.27 36.64 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.094 -0.503 . . . . 74.519999999999996 109.983 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.3 -51.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.851 0.358 . . . . 73.430000000000007 111.664 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -119.95 164.42 16.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.014 0.435 . . . . 62.119999999999997 111.338 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.29 91.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 116.33 -0.395 . . . . 73.099999999999994 111.973 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -91.74 166.75 26.92 Favored 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.193 -1.17 . . . . 74.209999999999994 113.344 -1.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 55.1 m -66.93 95.46 0.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.928 0.394 . . . . 74.329999999999998 111.852 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -148.47 112.71 5.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.899 -0.591 . . . . 74.230000000000004 109.946 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.86 110.15 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.648 0.261 . . . . 75.430000000000007 111.323 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.11 118.75 35.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 73.5 111.222 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.3 pt -126.41 133.1 24.63 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 120.902 0.382 . . . . 71.540000000000006 111.898 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.92 118.3 5.5 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.254 1.969 . . . . 54.329999999999998 112.144 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.35 123.54 50.51 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.064 -0.516 . . . . 62.530000000000001 110.89 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -105.39 106.59 17.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.035 0.445 . . . . 72.430000000000007 111.625 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 mt -83.17 124.21 30.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.483 -0.326 . . . . 51.229999999999997 110.535 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 35.3 mtmm -105.87 128.63 53.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.319999999999993 111.928 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.9 7.09 57.76 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.258 -0.428 . . . . 60.340000000000003 113.811 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.2 tt -145.08 137.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.173 -0.604 . . . . 74.409999999999997 111.774 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.9 m -98.3 148.99 23.08 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.459 -0.337 . . . . 73.120000000000005 111.744 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.27 -49.54 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.941 0.719 . . . . 64.140000000000001 112.941 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.79 -26.94 68.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.017 0.437 . . . . 64.439999999999998 111.803 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -100.31 14.57 30.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.273 -0.421 . . . . 64.450000000000003 111.772 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.83 121.63 34.39 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 50.329999999999998 110.708 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.22 -61.75 0.97 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.162 -0.542 . . . . 52.43 113.646 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HE2' ' HD3' ' A' ' 151' ' ' ARG . 49.4 p90 -136.06 155.49 50.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.024 0.44 . . . . 75.439999999999998 112.096 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.32 138.4 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.888 -0.596 . . . . 64.219999999999999 110.575 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.647 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 21.3 mtp180 -123.55 113.07 18.22 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.962 0.505 . . . . 72.230000000000004 111.72 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.853 HG23 ' SD ' ' A' ' 66' ' ' MET . 9.7 mm -106.25 115.16 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 122.413 -0.179 . . . . 74.310000000000002 111.221 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -151.17 179.44 8.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.266 0.469 . . . . 74.409999999999997 112.266 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 63.12 24.98 14.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.221 0.608 . . . . 63.140000000000001 112.589 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.686 HD11 ' HA3' ' A' ' 97' ' ' GLY . 49.7 mm -63.05 105.72 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.174 0.512 . . . . 75.530000000000001 110.879 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -125.1 143.76 45.18 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.979 -0.555 . . . . 74.329999999999998 111.447 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -67.51 107.94 1.52 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.538 2.159 . . . . 74.409999999999997 113.42 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 121.202 0.525 . . . . 72.010000000000005 110.953 177.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.1 tt0 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.013 0.435 . . . . 70.349999999999994 110.733 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' HA ' HD12 ' A' ' 31' ' ' ILE . 89.1 m -59.58 -33.3 71.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.243 -0.435 . . . . 72.109999999999999 111.393 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.98 -45.87 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.952 0.406 . . . . 73.230000000000004 110.873 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.367 -0.379 . . . . 75.040000000000006 111.343 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 28' ' ' THR . 85.5 mt -62.09 -48.58 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.164 0.507 . . . . 74.439999999999998 110.786 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.5 m -58.5 -42.33 87.39 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.151 0.501 . . . . 73.010000000000005 110.658 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.606 HE21 HD11 ' A' ' 108' ' ' ILE . 30.8 tt0 -56.38 -50.19 72.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.615 -0.72 . . . . 72.109999999999999 111.061 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.2 -48.83 75.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.036 -0.529 . . . . 73.239999999999995 111.927 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -61.41 -46.9 88.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.891 0.33 . . . . 65.209999999999994 111.891 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.2 -36.49 84.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.005 0.372 . . . . 74.049999999999997 112.005 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.48 -38.28 89.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.07 0.462 . . . . 73.25 110.4 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.51 -33.27 75.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.097 -0.501 . . . . 74.219999999999999 110.925 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.46 98.87 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.927 0.394 . . . . 51.530000000000001 111.625 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -74.89 -25.86 59.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.999 0.428 . . . . 72.319999999999993 111.183 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.467 ' HB2' ' HE2' ' A' ' 46' ' ' TYR . 47.8 t -69.54 125.81 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.95 0.405 . . . . 63.43 111.915 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 92.9 p -117.98 9.35 12.76 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.499 -0.319 . . . . 54.25 111.353 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 m -135.73 32.33 3.01 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.593 0.59 . . . . 73.049999999999997 112.593 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.65 -164.9 25.14 Favored Glycine 0 N--CA 1.463 0.467 0 C-N-CA 120.859 -0.686 . . . . 53.350000000000001 113.314 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.455 HG12 HD13 ' A' ' 57' ' ' LEU . 27.6 m -115.69 136.33 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.085 0.469 . . . . 64.209999999999994 112.135 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.467 ' HE2' ' HB2' ' A' ' 41' ' ' SER . 55.0 m-85 -89.69 103.82 16.44 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.313 -0.403 . . . . 73.010000000000005 111.242 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.12 102.14 14.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.91 0.386 . . . . 73.549999999999997 110.789 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.7 119.1 73.86 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.605 -0.27 . . . . 74.25 110.924 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -58.24 -18.97 40.04 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.263 1.975 . . . . 75.109999999999999 112.961 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.62 64.67 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.433 -0.413 . . . . 65.530000000000001 113.167 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.96 89.37 2.97 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.118 0.485 . . . . 51.109999999999999 111.117 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.39 83.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.174 0.511 . . . . 73.120000000000005 110.689 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -158.59 153.35 20.99 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 115.895 -0.593 . . . . 74.219999999999999 111.903 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 66.5 Cg_endo -88.12 146.13 6.42 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.054 2.503 . . . . 73.319999999999993 112.942 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.21 136.08 53.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.796 0.332 . . . . 72.219999999999999 111.479 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -86.75 127.21 34.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.898 0.38 . . . . 72.329999999999998 111.367 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.455 HD13 HG12 ' A' ' 45' ' ' VAL . 53.5 tp -120.95 118.34 29.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.016 0.436 . . . . 65.340000000000003 111.225 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.9 100.13 12.65 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.186 0.517 . . . . 63.229999999999997 110.437 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.439 ' OG ' HG12 ' A' ' 61' ' ' ILE . 73.8 p -99.22 -167.96 1.55 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.306 0.574 . . . . 72.140000000000001 112.51 -171.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -76.0 -25.92 56.21 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.638 . . . . 74.040000000000006 111.718 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 157' ' ' PRO . 33.9 pt -84.96 -24.8 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.158 0.504 . . . . 73.030000000000001 111.101 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -164.35 28.65 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.811 -0.632 . . . . 73.129999999999995 112.336 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -91.8 124.81 36.21 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.556 -0.379 . . . . 73.340000000000003 111.953 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -135.51 175.5 9.53 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 111.69 176.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -131.54 119.18 21.16 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.477 -0.328 . . . . 72.239999999999995 111.298 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.567 ' SD ' HG23 ' A' ' 152' ' ' ILE . 63.3 mtt -112.16 154.99 24.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 73.540000000000006 112.315 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 24.2 t -160.89 169.77 21.98 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 111.234 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 80' ' ' LEU . 94.4 mt -114.66 124.32 51.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.243 0.46 . . . . 74.239999999999995 112.243 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 81' ' ' THR . 29.1 m -133.04 164.53 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.413 -0.358 . . . . 72.310000000000002 111.096 174.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 62.61 28.32 16.59 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.54 0.57 . . . . 71.319999999999993 112.54 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 mt -67.94 104.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 74.120000000000005 111.416 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 p -139.1 152.69 70.43 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 112.299 0.481 . . . . 73.019999999999996 112.299 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.52 159.89 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.328 2.685 . . . . 74.219999999999999 113.873 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.548 ' HB2' HG22 ' A' ' 79' ' ' THR . 14.0 t70 -150.11 160.33 43.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.931 -0.577 . . . . 72.049999999999997 111.141 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.07 90.08 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.089 0.403 . . . . 75.230000000000004 112.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -82.49 -31.0 29.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.767 0.317 . . . . 71.129999999999995 111.552 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -174.65 -97.67 0.11 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.697 -0.763 . . . . 52.25 113.649 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.2 m -144.84 125.87 14.53 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.929 0.395 . . . . 64.230000000000004 111.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 74' ' ' ASP . 46.6 p -96.55 137.17 36.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.908 0.385 . . . . 71.099999999999994 111.825 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 HD11 HD22 ' A' ' 68' ' ' LEU . 3.3 pp -144.96 155.4 43.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 74.040000000000006 111.1 174.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.687 ' HB ' HG22 ' A' ' 69' ' ' VAL . 26.5 m -95.55 111.88 23.71 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.977 0.418 . . . . 73.519999999999996 111.117 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.93 109.86 18.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.547 -0.538 . . . . 72.209999999999994 109.547 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtt-85 -97.18 127.58 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.819 0.342 . . . . 73.219999999999999 111.849 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.6 mp -113.83 98.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 70.319999999999993 111.529 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.91 -178.54 6.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.952 -0.388 . . . . 73.019999999999996 109.952 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.19 135.3 5.95 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.19 -1.005 . . . . 71.310000000000002 113.973 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -59.05 -23.82 62.34 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.884 0.373 . . . . 70.019999999999996 111.559 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 88.9 p -83.47 136.26 34.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.299 0.571 . . . . 61.520000000000003 111.614 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -68.99 -37.73 78.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.524 0.678 . . . . 70.540000000000006 109.53 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.1 147.72 93.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.119 -0.946 . . . . 75.310000000000002 111.108 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HD3' ' HB1' ' A' ' 129' ' ' ALA . 55.5 Cg_endo -67.85 162.71 38.45 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.423 2.082 . . . . 73.439999999999998 113.477 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.96 145.79 38.75 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.951 -0.568 . . . . 63.409999999999997 111.154 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.36 179.91 4.63 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.671 2.248 . . . . 54.450000000000003 112.99 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -73.09 153.89 40.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.128 0.49 . . . . 73.510000000000005 111.619 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.25 164.97 37.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.194 0.521 . . . . 71.510000000000005 111.632 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.8 m -150.88 156.07 40.47 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.16 -0.473 . . . . 41.240000000000002 110.372 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 155' ' ' ILE . . . -165.25 178.9 40.04 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.271 -0.966 . . . . 74.340000000000003 113.893 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 m -104.38 135.36 45.97 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.895 0.379 . . . . 73.219999999999999 111.08 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 26.7 m -110.47 134.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 52.310000000000002 111.592 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.777 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.9 mm-40 -103.74 120.08 40.21 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.956 -0.565 . . . . 53.109999999999999 110.151 177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.427 ' CG ' HD23 ' A' ' 139' ' ' LEU . 10.2 p90 -133.7 130.22 37.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.265 0.555 . . . . 74.030000000000001 112.149 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.41 -156.38 12.41 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.519 -0.764 . . . . 72.120000000000005 112.635 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 114' ' ' ILE . 52.9 mt-30 -111.02 151.3 28.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.775 0.321 . . . . 74.219999999999999 111.505 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -114.59 106.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 73.450000000000003 110.824 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.493 ' NE2' HD11 ' A' ' 114' ' ' ILE . 3.6 pt20 -94.39 -6.74 43.48 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.832 0.679 . . . . 71.140000000000001 112.832 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -102.26 -170.04 27.03 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.949 -0.643 . . . . 75.239999999999995 113.499 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.3 p -96.31 173.26 7.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.84 0.352 . . . . 71.340000000000003 111.014 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.606 HD11 HE21 ' A' ' 33' ' ' GLN . 30.9 mm -63.79 -25.94 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.127 0.489 . . . . 74.209999999999994 111.023 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.56 -41.63 19.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.777 -0.647 . . . . 74.549999999999997 110.518 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -139.45 97.94 3.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.177 0.513 . . . . 71.239999999999995 111.53 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.677 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.0 p90 -115.99 151.07 36.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.558 0.577 . . . . 63.219999999999999 112.558 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -127.51 120.53 28.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.753 -0.658 . . . . 73.140000000000001 110.46 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.31 104.53 8.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.827 0.346 . . . . 64.120000000000005 110.8 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.493 HD11 ' NE2' ' A' ' 105' ' ' GLN . 44.6 pt -105.26 153.21 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.64 -0.254 . . . . 74.209999999999994 111.631 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 57.32 28.29 15.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.213 0.53 . . . . 70.140000000000001 111.045 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.9 137.13 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.926 -0.579 . . . . 52.119999999999997 111.942 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.11 171.09 14.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 72.129999999999995 110.746 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 3.1 p-10 -108.5 169.96 8.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.335 0.588 . . . . 62.009999999999998 112.44 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -163.54 149.39 11.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.683 -0.69 . . . . 52.350000000000001 110.966 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -93.03 126.62 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.005 0.372 . . . . 64.040000000000006 112.005 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.9 pt -111.6 140.03 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.714 0.293 . . . . 64.129999999999995 111.427 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -124.91 131.11 53.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.596 0.236 . . . . 74.530000000000001 111.01 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -124.69 135.35 26.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 111.808 0.299 . . . . 71.519999999999996 111.808 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 15.0 Cg_exo -69.32 167.84 22.71 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.999 2.466 . . . . 65.420000000000002 113.272 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.15 130.56 34.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.15 0.426 . . . . 62.039999999999999 112.15 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 74.2 m -79.5 100.88 7.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.908 0.385 . . . . 75.0 110.717 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.647 HG11 ' HG ' ' A' ' 128' ' ' LEU . 8.5 p -71.96 -26.47 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.299 0.481 . . . . 55.329999999999998 112.299 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.647 ' HG ' HG11 ' A' ' 127' ' ' VAL . 98.4 mt -119.7 165.17 14.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.06 0.457 . . . . 72.340000000000003 112.139 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.575 ' HB1' ' HD3' ' A' ' 91' ' ' PRO . . . -106.28 153.64 40.25 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.042 -0.526 . . . . 72.310000000000002 111.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.75 175.15 37.27 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.241 -1.149 . . . . 70.400000000000006 113.686 0.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.7 m -75.31 97.08 3.49 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.639 0.607 . . . . 64.540000000000006 112.639 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.36 122.94 22.13 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.908 -0.587 . . . . 72.010000000000005 110.182 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 134' ' ' ASP . 26.4 t -133.96 159.61 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.395 0.278 . . . . 44.450000000000003 111.323 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.43 ' N ' HG13 ' A' ' 133' ' ' VAL . 2.7 p30 -147.14 143.11 28.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.818 0.342 . . . . 70.140000000000001 110.94 170.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 pt -140.26 147.94 52.13 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 72.120000000000005 111.729 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.7 144.24 21.96 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.704 2.269 . . . . 72.519999999999996 112.676 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.61 108.87 6.44 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.182 -0.324 . . . . 72.519999999999996 110.859 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -95.14 97.82 10.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.131 0.491 . . . . 73.230000000000004 111.625 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.438 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 55.4 mt -74.13 128.75 36.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.327 -0.397 . . . . 50.32 110.739 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.06 141.97 35.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.202 0.445 . . . . 62.350000000000001 112.202 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.87 34.79 88.26 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.066 -0.515 . . . . 42.25 113.878 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.96 125.96 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.07 0.462 . . . . 75.25 111.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.1 m -88.59 155.04 19.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.897 0.379 . . . . 51.420000000000002 111.358 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.49 -39.27 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.08 0.77 . . . . 65.420000000000002 113.08 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.81 -27.64 66.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.076 0.465 . . . . 75.439999999999998 111.258 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.467 ' HB3' HE21 ' A' ' 103' ' ' GLN . 15.3 mm100 -81.74 -4.14 55.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.273 -0.421 . . . . 71.349999999999994 111.752 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.589 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 28.5 mt -71.75 121.56 19.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.088 0.47 . . . . 75.129999999999995 112.265 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.98 -47.81 1.22 Allowed Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.098 -0.501 . . . . 62.530000000000001 112.632 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -150.97 161.69 42.25 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.75 0.31 . . . . 73.329999999999998 111.442 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.46 93.76 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.36 0.6 . . . . 62.229999999999997 110.462 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 47.2 ttp180 -86.99 107.41 18.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.952 0.406 . . . . 73.129999999999995 112.007 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.567 HG23 ' SD ' ' A' ' 66' ' ' MET . 23.3 mm -85.93 135.0 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.535 -0.302 . . . . 72.430000000000007 111.432 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.36 179.25 8.44 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.07 0.396 . . . . 74.349999999999994 112.07 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 64.97 22.5 12.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.193 0.597 . . . . 72.030000000000001 112.425 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.469 HD11 ' HA3' ' A' ' 97' ' ' GLY . 51.5 mm -64.53 97.33 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.42 0.629 . . . . 72.040000000000006 111.454 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -114.8 150.67 44.46 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.586 -0.734 . . . . 75.310000000000002 111.139 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.456 ' HB3' HG23 ' A' ' 61' ' ' ILE . 61.1 Cg_endo -72.69 148.32 46.75 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.324 2.016 . . . . 60.210000000000001 113.806 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 3.4 p . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 115.841 -0.618 . . . . 53.539999999999999 110.27 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 31' ' ' ILE . 28.6 tt0 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.969 0.414 . . . . 61.420000000000002 110.65 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -59.14 -35.4 73.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 73.329999999999998 111.471 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.54 -42.84 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.971 0.415 . . . . 74.140000000000001 110.597 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.567 ' HE3' HD23 ' A' ' 48' ' ' LEU . 44.5 tptt -66.61 -38.15 86.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.176 -0.466 . . . . 63.229999999999997 110.781 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.1 mt -59.74 -46.87 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.329 0.585 . . . . 72.25 110.47 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -58.89 -44.85 91.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.702 -0.681 . . . . 74.510000000000005 111.057 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.534 ' HG3' HD13 ' A' ' 108' ' ' ILE . 63.1 tt0 -59.21 -45.23 91.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.346 0.593 . . . . 75.299999999999997 110.809 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.5 -54.07 50.99 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.31 -0.859 . . . . 74.329999999999998 111.188 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -66.31 -30.8 71.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.462 0.541 . . . . 70.549999999999997 112.462 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.43 -49.66 68.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.893 0.377 . . . . 74.530000000000001 110.673 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -38.35 87.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.116 0.484 . . . . 53.539999999999999 110.732 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.475 HD22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 t-20 -56.68 -42.38 78.94 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.782 -0.645 . . . . 73.030000000000001 111.031 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -43.4 68.85 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.195 -0.457 . . . . 73.010000000000005 112.022 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.94 -7.13 53.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.03 0.381 . . . . 71.430000000000007 112.03 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.408 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 37.1 t -61.89 126.29 26.84 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.106 0.41 . . . . 73.299999999999997 112.106 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 t -93.73 -4.04 51.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.272 -0.422 . . . . 73.049999999999997 111.132 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -142.41 96.87 3.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.992 0.425 . . . . 73.209999999999994 111.364 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 66.84 -149.17 51.14 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.316 -0.469 . . . . 60.43 113.616 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 38' ' ' ASN . 31.6 m -114.51 152.84 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.069 0.461 . . . . 64.150000000000006 112.091 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 33.6 m-85 -101.31 114.42 28.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.329 -0.396 . . . . 72.120000000000005 111.571 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.58 104.12 14.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.905 0.383 . . . . 73.150000000000006 110.749 173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.567 HD23 ' HE3' ' A' ' 30' ' ' LYS . 9.5 mp -82.18 111.83 30.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 122.312 -0.243 . . . . 74.430000000000007 110.682 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.6 Cg_endo -57.47 -23.47 56.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.848 2.365 . . . . 41.109999999999999 113.461 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.37 -17.67 59.88 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.96 -0.638 . . . . 55.039999999999999 113.16 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.67 101.09 5.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.547 0.339 . . . . 72.5 111.26 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.43 88.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.055 0.455 . . . . 52.109999999999999 110.438 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -135.93 148.76 66.34 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.713 0.634 . . . . 71.430000000000007 112.713 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.24 131.56 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.24 2.627 . . . . 72.409999999999997 113.24 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.04 134.0 55.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.323 -0.399 . . . . 55.25 110.679 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -84.87 109.87 18.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.192 0.52 . . . . 70.450000000000003 111.855 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.425 HD13 HG11 ' A' ' 45' ' ' VAL . 44.3 tp -105.65 124.01 48.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.106 -0.497 . . . . 72.310000000000002 111.655 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -75.86 132.02 40.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.355 -0.384 . . . . 62.450000000000003 110.39 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -126.13 -178.71 4.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.337 0.589 . . . . 74.540000000000006 111.701 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.23 0.87 54.69 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.936 -0.574 . . . . 70.409999999999997 111.675 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.9 pt -111.16 -28.88 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.009 0.433 . . . . 72.409999999999997 111.016 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.26 151.1 5.83 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.16 -0.473 . . . . 73.109999999999999 112.607 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.7 m -55.28 126.47 25.08 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.955 0.378 . . . . 72.430000000000007 111.482 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.74 174.5 10.51 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.446 0.641 . . . . 62.210000000000001 112.4 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -127.61 125.67 40.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.991 -0.55 . . . . 64.019999999999996 111.087 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.792 ' SD ' HG23 ' A' ' 152' ' ' ILE . 62.3 mtt -117.14 144.1 45.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.837 0.351 . . . . 54.350000000000001 111.776 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -143.66 143.48 31.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.942 0.401 . . . . 71.340000000000003 111.413 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.565 HD22 HD23 ' A' ' 82' ' ' LEU . 92.6 mt -90.17 107.01 18.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.349 -0.387 . . . . 72.120000000000005 111.429 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.543 HG22 HD21 ' A' ' 70' ' ' ASN . 27.5 m -122.61 161.48 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.186 -0.321 . . . . 73.549999999999997 111.7 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.543 HD21 HG22 ' A' ' 69' ' ' VAL . 35.5 m-80 59.03 41.19 21.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.083 0.401 . . . . 75.239999999999995 112.083 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 57.7 mt -73.13 111.44 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.939 0.4 . . . . 73.310000000000002 111.55 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -136.82 156.5 75.96 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.413 -0.358 . . . . 74.120000000000005 111.907 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.64 151.34 52.2 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.856 2.37 . . . . 72.019999999999996 113.023 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.655 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.6 t70 -134.12 164.7 26.76 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.975 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -49.2 77.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 42.450000000000003 111.711 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.1 -36.41 35.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.55 -0.295 . . . . 73.019999999999996 111.628 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.41 -97.38 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.316 -0.945 . . . . 65.239999999999995 114.344 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.3 m -141.03 130.9 24.37 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.209 0.448 . . . . 73.200000000000003 112.209 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.655 HG23 ' HB2' ' A' ' 74' ' ' ASP . 30.4 p -107.04 116.87 32.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.917 0.389 . . . . 73.129999999999995 111.572 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.0 pp -137.52 147.26 45.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.864 0.364 . . . . 73.319999999999993 111.472 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -89.32 114.82 26.27 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.91 0.386 . . . . 74.019999999999996 111.188 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD23 HD22 ' A' ' 68' ' ' LEU . 3.2 tm? -90.56 113.65 25.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.922 -0.399 . . . . 64.010000000000005 109.922 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 mtt-85 -102.1 114.48 28.65 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.872 0.693 . . . . 74.310000000000002 112.872 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' H ' HD11 ' A' ' 84' ' ' ILE . 3.8 mp -92.39 147.86 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.886 -0.597 . . . . 72.209999999999994 110.716 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.1 118.45 7.86 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.296 -0.261 . . . . 62.450000000000003 110.296 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 137.75 28.56 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.99 -0.624 . . . . 72.450000000000003 113.3 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.04 68.47 4.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.421 0.629 . . . . 53.409999999999997 110.479 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -170.32 179.82 3.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.859 -0.609 . . . . 75.120000000000005 111.131 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -100.15 -3.82 30.95 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.854 0.316 . . . . 70.129999999999995 111.854 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.486 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.2 p30 -112.2 166.45 10.93 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.577 0.584 . . . . 63.32 112.577 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.578 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 72.6 Cg_endo -74.07 171.37 18.08 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.02 2.48 . . . . 75.439999999999998 114.332 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.92 152.05 76.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.066 -0.515 . . . . 71.340000000000003 111.126 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.12 172.96 15.18 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.381 2.054 . . . . 75.319999999999993 113.124 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.82 149.28 48.08 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.741 0.305 . . . . 65.109999999999999 111.662 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.72 163.04 39.53 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.613 0.721 . . . . 74.219999999999999 112.583 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.1 p -133.99 167.13 21.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.385 -0.825 . . . . 75.439999999999998 109.917 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -165.63 163.98 37.02 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.046 -1.073 . . . . 55.520000000000003 114.005 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.594 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 91.1 m -103.8 108.5 19.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.463 0.305 . . . . 73.150000000000006 110.804 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 27.9 m -98.28 130.23 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.951 0.405 . . . . 74.299999999999997 111.812 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -107.52 111.81 24.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.904 0.383 . . . . 75.319999999999993 111.016 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.485 ' CD1' HD22 ' A' ' 139' ' ' LEU . 40.9 p90 -115.71 140.41 49.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.714 0.292 . . . . 73.510000000000005 111.361 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -179.0 -150.34 8.84 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.141 -0.552 . . . . 72.129999999999995 113.168 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.498 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.2 mt-30 -119.9 166.14 13.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.198 0.523 . . . . 65.430000000000007 112.034 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.547 HG21 ' H ' ' A' ' 106' ' ' GLY . 71.0 mt -126.01 124.99 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.939 -0.573 . . . . 73.25 110.62 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.546 HE21 HG23 ' A' ' 114' ' ' ILE . 6.3 pt20 -98.88 17.04 20.48 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.813 0.671 . . . . 75.140000000000001 112.813 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.547 ' H ' HG21 ' A' ' 104' ' ' ILE . . . -145.13 -173.1 16.07 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.373 -0.918 . . . . 64.239999999999995 114.141 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 72.2 p -101.01 178.93 4.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.839 0.456 . . . . 74.329999999999998 111.667 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.534 HD13 ' HG3' ' A' ' 33' ' ' GLN . 45.1 mm -54.94 -38.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 71.310000000000002 111.845 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.64 -45.7 43.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.407 -0.361 . . . . 71.140000000000001 111.945 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -134.8 102.54 5.29 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.144 0.497 . . . . 70.5 111.57 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.1 p90 -132.25 150.57 52.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 111.898 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -134.55 130.59 36.8 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.05 -0.523 . . . . 74.109999999999999 110.856 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.38 113.95 18.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.012 -0.54 . . . . 74.439999999999998 111.197 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.546 HG23 HE21 ' A' ' 105' ' ' GLN . 36.0 pt -119.18 158.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.724 0.297 . . . . 62.420000000000002 111.478 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 58.75 26.79 15.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 73.140000000000001 110.826 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.36 144.67 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.538 -0.756 . . . . 62.340000000000003 112.237 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.37 161.4 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.666 -0.697 . . . . 65.450000000000003 110.5 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 2.6 p-10 -106.78 153.87 21.82 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.938 0.718 . . . . 62.219999999999999 112.938 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -139.97 148.71 42.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.704 -0.68 . . . . 55.100000000000001 110.553 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.19 119.87 29.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.8 0.333 . . . . 72.239999999999995 111.419 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.6 pt -98.09 141.66 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.465 -0.334 . . . . 62.549999999999997 110.863 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.24 114.82 18.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.863 0.364 . . . . 73.530000000000001 111.173 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.736 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -110.61 129.7 23.67 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.537 -0.301 . . . . 72.239999999999995 111.641 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.49 164.45 35.23 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.641 2.227 . . . . 73.299999999999997 113.158 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -77.49 121.88 24.45 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.304 0.483 . . . . 73.430000000000007 112.304 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.1 m -92.97 96.87 10.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.429 -0.351 . . . . 71.329999999999998 110.782 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -78.37 -21.31 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.331 0.586 . . . . 64.329999999999998 111.104 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.543 ' H ' HD21 ' A' ' 128' ' ' LEU . 2.0 pt? -77.41 152.95 34.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.931 -0.577 . . . . 61.049999999999997 111.283 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.85 139.91 26.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.574 -0.285 . . . . 74.409999999999997 111.685 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.76 156.75 95.35 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.748 -1.355 . . . . 64.019999999999996 112.635 -3.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.578 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 38.7 t -72.12 99.0 2.22 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.079 0.77 . . . . 73.219999999999999 113.079 -173.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.88 143.0 44.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.716 0.293 . . . . 63.329999999999998 110.428 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.736 HG11 ' HB1' ' A' ' 123' ' ' ALA . 36.5 t -133.64 121.21 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.694 0.283 . . . . 74.420000000000002 111.03 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.35 101.72 10.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.102 0.477 . . . . 64.209999999999994 111.289 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.403 HG23 HG13 ' A' ' 133' ' ' VAL . 18.8 pt -112.5 129.06 24.74 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.369 0.507 . . . . 75.109999999999999 112.369 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.92 121.07 7.28 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.449 2.1 . . . . 53.310000000000002 112.12 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.98 107.64 15.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.108 -0.496 . . . . 63.43 111.02 -174.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.99 99.17 11.85 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.162 0.506 . . . . 75.310000000000002 111.502 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.485 HD22 ' CD1' ' A' ' 101' ' ' TYR . 46.2 mt -77.71 123.8 27.14 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.226 -0.443 . . . . 60.140000000000001 110.506 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -99.62 148.31 24.46 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.849 0.357 . . . . 60.450000000000003 111.877 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.54 -10.09 74.71 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 114.395 0.518 . . . . 50.109999999999999 114.395 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.576 HD11 HD22 ' A' ' 147' ' ' LEU . 19.4 tt -138.8 119.03 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 117.881 0.84 . . . . 75.239999999999995 112.589 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.6 m -75.01 156.58 36.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.246 -0.434 . . . . 63.240000000000002 111.286 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.76 -46.28 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.057 0.762 . . . . 73.400000000000006 113.057 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.01 -14.87 63.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.14 0.495 . . . . 74.549999999999997 111.797 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -92.21 -5.35 52.65 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.539 -0.3 . . . . 64.510000000000005 111.645 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.576 HD22 HD11 ' A' ' 142' ' ' ILE . 50.6 mt -73.39 113.33 10.36 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.743 0.645 . . . . 73.200000000000003 112.743 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.57 -36.54 6.12 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.941 -0.572 . . . . 72.109999999999999 112.68 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.98 160.51 27.8 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.8 0.333 . . . . 73.420000000000002 111.334 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.53 100.82 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.008 0.433 . . . . 75.040000000000006 110.418 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -86.54 119.93 27.32 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.771 0.32 . . . . 73.430000000000007 111.803 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.792 HG23 ' SD ' ' A' ' 66' ' ' MET . 20.7 mm -104.59 125.76 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.309 -0.244 . . . . 74.430000000000007 111.136 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.46 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 13.3 p80 -164.85 -175.17 3.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.955 0.354 . . . . 71.010000000000005 111.955 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.594 ' HB3' ' H ' ' A' ' 98' ' ' THR . 13.9 t70 67.29 22.38 9.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.332 0.586 . . . . 65.400000000000006 111.367 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.521 HD12 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -66.91 110.52 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.283 0.563 . . . . 75.530000000000001 112.165 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.78 144.49 53.13 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.917 -0.583 . . . . 54.130000000000003 111.106 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.82 155.73 67.8 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.411 2.074 . . . . 72.409999999999997 113.148 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.844 0.354 . . . . 75.299999999999997 110.984 177.242 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 52.310000000000002 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -60.55 -30.35 69.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 111.351 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.62 -47.56 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 64.219999999999999 110.364 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.08 80.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.181 -0.463 . . . . 70.120000000000005 111.274 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 53' ' ' THR . 69.7 mt -56.85 -48.19 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.349 0.595 . . . . 71.409999999999997 111.084 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -62.0 -41.07 97.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.788 -0.642 . . . . 75.439999999999998 111.059 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.749 ' HG3' HD11 ' A' ' 108' ' ' ILE . 44.0 tt0 -65.15 -38.07 89.42 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.091 -0.504 . . . . 62.210000000000001 111.482 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.8 -57.52 12.41 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.528 -0.305 . . . . 70.340000000000003 110.566 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -52.02 -45.23 64.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.419 0.526 . . . . 50.130000000000003 112.419 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.401 ' HB2' HD13 ' A' ' 108' ' ' ILE . 99.1 mtt180 -66.51 -48.84 68.5 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.326 0.491 . . . . 71.409999999999997 112.326 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.97 -45.92 91.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.309 0.576 . . . . 75.230000000000004 110.845 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.488 ' OD1' ' HA ' ' A' ' 45' ' ' VAL . 65.7 t30 -66.08 -28.89 69.17 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.884 -0.598 . . . . 70.519999999999996 111.142 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.733 0.301 . . . . 72.409999999999997 111.184 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.66 -21.93 54.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.848 0.356 . . . . 62.439999999999998 111.285 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.426 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 41.1 t -63.72 123.63 19.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.259 0.466 . . . . 74.209999999999994 112.259 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 m -108.11 -0.08 21.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.775 0.287 . . . . 73.200000000000003 111.775 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 t -148.1 77.62 1.41 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.075 0.464 . . . . 73.319999999999993 111.825 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.71 -166.89 12.21 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.512 -0.375 . . . . 65.420000000000002 112.926 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.488 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 29.1 m -130.9 149.9 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.761 0.652 . . . . 74.230000000000004 112.761 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 41' ' ' SER . 72.9 m-85 -99.95 112.1 24.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.039 -0.528 . . . . 74.430000000000007 111.42 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -104.16 106.1 16.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.075 0.464 . . . . 74.400000000000006 110.792 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.1 mt -83.17 128.88 63.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.619 -0.264 . . . . 61.340000000000003 111.241 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.07 -29.17 82.08 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 122.697 2.265 . . . . 65.540000000000006 113.187 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.41 9.91 76.12 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.21 -0.519 . . . . 75.230000000000004 113.234 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.62 86.36 2.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.02 0.438 . . . . 75.420000000000002 111.651 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.47 80.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.156 0.503 . . . . 74.129999999999995 111.113 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.667 HG22 HG21 ' A' ' 31' ' ' ILE . 3.8 p -138.49 150.81 67.59 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 112.84 0.682 . . . . 54.509999999999998 112.84 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.84 127.74 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.277 2.652 . . . . 73.120000000000005 113.01 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -108.73 132.68 53.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.976 0.417 . . . . 64.099999999999994 111.293 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -90.97 125.89 35.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.31 -0.405 . . . . 72.299999999999997 110.771 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.99 121.11 22.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.905 0.383 . . . . 75.450000000000003 111.698 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -86.5 111.1 20.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.065 0.459 . . . . 73.430000000000007 110.1 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -112.39 -173.02 2.16 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.17 0.509 . . . . 74.540000000000006 112.343 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.435 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 47.0 mt-30 -74.25 -24.09 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.777 -0.647 . . . . 74.129999999999995 111.819 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.49 -29.4 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.99 0.424 . . . . 63.329999999999998 111.196 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.94 -173.22 33.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.218 -0.515 . . . . 63.43 112.955 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -82.85 112.79 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.557 -0.378 . . . . 75.219999999999999 110.712 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -119.9 171.91 8.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.521 0.677 . . . . 71.340000000000003 112.408 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -132.95 111.95 11.46 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.587 -0.733 . . . . 74.25 110.716 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.67 ' SD ' HG22 ' A' ' 152' ' ' ILE . 64.2 mtt -107.35 148.0 29.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.281 0.474 . . . . 74.430000000000007 112.281 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.2 t -154.66 157.22 37.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.948 0.404 . . . . 73.200000000000003 111.645 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.53 HD22 HD12 ' A' ' 80' ' ' LEU . 95.0 mt -102.97 114.04 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.307 -0.406 . . . . 63.530000000000001 111.579 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 81' ' ' THR . 28.6 m -128.06 161.6 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.69 0.281 . . . . 65.099999999999994 111.667 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 54.29 30.71 12.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.318 0.488 . . . . 72.120000000000005 112.318 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.2 mt -59.22 104.13 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.007 0.432 . . . . 70.239999999999995 111.399 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -125.69 149.53 65.63 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 112.343 0.497 . . . . 71.510000000000005 112.343 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.98 129.24 14.0 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.758 2.305 . . . . 72.430000000000007 113.375 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.729 ' HB2' HG22 ' A' ' 79' ' ' THR . 29.4 t70 -91.65 166.74 12.64 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.289 -0.414 . . . . 64.510000000000005 110.62 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.44 69.13 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.134 0.42 . . . . 74.349999999999994 112.134 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -115.64 -9.78 11.93 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.51 0.559 . . . . 74.030000000000001 112.51 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -167.35 -113.78 0.29 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.259 -0.972 . . . . 71.120000000000005 114.021 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -146.89 127.12 13.84 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.028 0.381 . . . . 73.239999999999995 112.028 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 74' ' ' ASP . 41.4 p -104.6 114.83 29.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.566 -0.288 . . . . 73.230000000000004 111.104 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.53 HD12 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -126.81 148.46 49.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.883 0.373 . . . . 72.530000000000001 111.657 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' HG22 ' A' ' 69' ' ' VAL . 62.2 m -92.0 107.92 19.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.123 0.487 . . . . 75.349999999999994 111.566 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.38 108.91 19.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.034 -0.53 . . . . 71.430000000000007 110.053 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' MET . 9.7 mtp-105 -93.66 122.96 36.65 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.3 -0.25 . . . . 74.150000000000006 111.609 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.438 HD11 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -107.16 91.29 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.535 -0.302 . . . . 73.040000000000006 110.758 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -88.19 122.79 32.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.706 0.288 . . . . 74.120000000000005 111.021 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.33 132.0 11.35 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.709 -0.757 . . . . 62.409999999999997 113.154 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -69.16 -43.56 74.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.282 0.563 . . . . 61.299999999999997 109.898 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 m -79.42 109.08 13.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.1 -0.704 . . . . 71.439999999999998 109.1 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -73.35 1.58 9.3 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.341 0.867 . . . . 73.299999999999997 113.341 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.7 p30 -74.09 156.87 87.48 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.681 0.276 . . . . 73.519999999999996 111.59 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 11.6 Cg_endo -54.03 114.24 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.021 2.481 . . . . 53.350000000000001 113.716 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.88 145.15 29.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.132 -0.485 . . . . 63.130000000000003 111.533 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.78 169.01 23.12 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.58 2.186 . . . . 72.040000000000006 112.618 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 147.9 49.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.542 -0.299 . . . . 71.049999999999997 110.949 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -144.95 160.61 41.06 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.82 0.674 . . . . 74.0 112.82 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -137.75 140.63 40.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.334 -0.848 . . . . 72.209999999999994 110.325 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.492 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -148.09 171.33 28.58 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.811 -0.709 . . . . 73.0 113.097 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.0 m -103.18 134.98 45.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.714 -0.286 . . . . 60.119999999999997 111.016 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 119' ' ' GLN . 7.2 p -117.36 122.67 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 74.420000000000002 112.015 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 27.5 mm-40 -90.16 105.12 17.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.871 -0.604 . . . . 74.400000000000006 110.372 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -114.99 117.81 31.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.356 0.598 . . . . 65.150000000000006 111.497 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -163.13 -149.27 5.65 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.961 -0.563 . . . . 63.210000000000001 112.866 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -121.23 157.14 30.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.076 0.465 . . . . 75.099999999999994 111.972 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -123.0 122.07 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.14 -0.482 . . . . 75.200000000000003 111.196 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 3.8 pt20 -104.34 90.71 3.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.457 0.646 . . . . 72.409999999999997 111.159 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 160.39 -152.18 22.89 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.140000000000001 113.672 175.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -120.72 -171.66 2.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.876 0.47 . . . . 64.010000000000005 111.113 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 ' HG3' ' A' ' 33' ' ' GLN . 29.7 mm -62.77 -34.43 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.266 0.555 . . . . 74.540000000000006 110.844 172.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.98 -49.51 8.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.664 -0.698 . . . . 73.140000000000001 112.138 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -129.65 105.53 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.08 0.467 . . . . 75.329999999999998 111.647 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.516 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.4 p90 -139.97 160.41 39.98 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.097 0.475 . . . . 73.120000000000005 112.18 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -134.51 134.76 41.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.074 -0.512 . . . . 62.539999999999999 110.768 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.19 123.12 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.484 -0.326 . . . . 63.310000000000002 110.884 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.38 154.71 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.047 0.388 . . . . 71.219999999999999 112.047 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 53.46 39.2 29.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.071 0.463 . . . . 73.129999999999995 111.751 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.469 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 5.6 p -97.6 126.18 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.318 0.58 . . . . 74.230000000000004 111.978 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -114.9 153.12 31.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.052 -0.522 . . . . 73.120000000000005 110.6 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.22 133.72 53.35 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.166 0.508 . . . . 71.150000000000006 111.85 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.503 ' O ' HG11 ' A' ' 99' ' ' VAL . 8.8 tt0 -129.03 149.26 50.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.149 -0.478 . . . . 72.450000000000003 110.02 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.8 mt -92.11 118.63 31.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.119 0.485 . . . . 72.150000000000006 111.885 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.692 HG21 HD23 ' A' ' 137' ' ' LEU . 30.4 pt -92.78 99.37 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 72.319999999999993 111.371 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -101.46 114.57 28.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.293 -0.412 . . . . 65.230000000000004 110.96 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -111.67 147.26 36.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.053 0.39 . . . . 70.049999999999997 112.053 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.98 164.91 34.19 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.886 2.391 . . . . 62.020000000000003 113.733 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.38 125.98 29.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.869 -0.605 . . . . 73.340000000000003 112.121 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 71.1 m -90.6 79.44 6.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.962 0.41 . . . . 61.240000000000002 110.614 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.37 -10.65 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.149 -0.478 . . . . 64.430000000000007 111.875 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.84 129.89 53.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.845 0.355 . . . . 74.239999999999995 111.58 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.16 139.39 23.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.359 -0.382 . . . . 72.439999999999998 111.233 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 148.48 92.25 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.103 -1.207 . . . . 73.239999999999995 113.541 2.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.9 p -89.05 125.24 34.92 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.5 0.667 . . . . 64.109999999999999 112.608 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.73 143.39 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.581 -0.736 . . . . 64.0 110.366 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.02 157.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 61.119999999999997 110.973 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.402 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.2 p30 -146.76 111.91 5.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.306 0.574 . . . . 75.120000000000005 110.866 170.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 pt -117.05 142.71 30.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.007 -0.542 . . . . 73.120000000000005 111.915 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.24 130.92 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.907 2.405 . . . . 37.390000000000001 112.636 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.692 HD23 HG21 ' A' ' 121' ' ' ILE . 62.9 mt -111.43 111.85 23.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 73.129999999999995 111.656 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -91.35 89.57 7.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.239 0.542 . . . . 73.219999999999999 110.625 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.497 HD23 ' NE2' ' A' ' 119' ' ' GLN . 26.2 mt -81.67 110.75 17.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 73.209999999999994 110.016 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -98.47 139.15 34.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.973 0.416 . . . . 74.030000000000001 111.76 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.98 63.72 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.079 -0.509 . . . . 61.100000000000001 113.28 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 147' ' ' LEU . 18.4 tt -134.33 123.61 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 122.401 -0.47 . . . . 72.140000000000001 111.774 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -85.41 147.53 26.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.094 0.405 . . . . 74.140000000000001 112.094 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -47.66 -51.4 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 113.192 0.812 . . . . 60.420000000000002 113.192 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.2 -38.13 82.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.094 0.473 . . . . 74.140000000000001 111.61 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -87.54 7.64 28.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.194 0.442 . . . . 71.319999999999993 112.194 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.508 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.2 tt -82.35 126.86 32.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.749 0.309 . . . . 73.430000000000007 110.257 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.42 -58.51 1.36 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.09 -0.576 . . . . 53.210000000000001 113.452 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -147.34 148.83 31.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.369 -0.489 . . . . 74.400000000000006 112.305 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.6 t -116.79 99.33 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.72 -0.673 . . . . 60.509999999999998 109.833 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -102.55 114.1 28.03 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.091 0.472 . . . . 75.219999999999999 111.74 -171.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.67 HG22 ' SD ' ' A' ' 66' ' ' MET . 38.2 mm -90.59 140.19 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 111.842 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -165.67 179.33 6.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 111.908 0.336 . . . . 75.420000000000002 111.908 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 61.87 22.57 13.13 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.417 0.895 . . . . 63.130000000000003 113.417 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.492 HD12 ' HA3' ' A' ' 97' ' ' GLY . 50.8 mm -63.86 94.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.313 0.578 . . . . 74.519999999999996 111.741 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.435 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 8.0 pt20 -125.66 144.8 49.31 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.556 -0.747 . . . . 72.319999999999993 111.179 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 146.27 51.14 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.49 2.127 . . . . 70.420000000000002 113.654 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 116.261 -0.427 . . . . 64.310000000000002 110.451 175.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.906 0.384 . . . . 73.209999999999994 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -56.55 -37.14 70.11 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.141 -0.481 . . . . 75.230000000000004 111.044 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.16 -47.14 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.356 -0.384 . . . . 73.209999999999994 111.065 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 48' ' ' LEU . 21.0 tptm -62.24 -43.3 99.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.98 0.419 . . . . 65.409999999999997 111.176 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -49.31 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.031 0.443 . . . . 63.0 111.185 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -56.55 -38.78 72.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.965 0.412 . . . . 63.520000000000003 110.906 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.462 ' HG3' HD12 ' A' ' 108' ' ' ILE . 62.8 tt0 -59.71 -42.04 92.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.024 -0.534 . . . . 72.420000000000002 111.073 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -62.52 -52.42 63.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.479 -0.328 . . . . 75.420000000000002 111.072 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -52.99 -42.96 66.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.88 0.371 . . . . 75.019999999999996 111.209 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -57.29 -45.92 83.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.994 0.426 . . . . 65.329999999999998 111.567 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.47 -31.18 72.11 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.833 0.349 . . . . 71.019999999999996 111.26 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -67.8 -30.48 69.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.938 0.399 . . . . 73.099999999999994 110.971 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.89 66.48 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.14 0.495 . . . . 74.239999999999995 111.083 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.43 1.05 47.22 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.284 -0.416 . . . . 54.32 111.788 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 t -65.77 120.48 13.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.274 0.472 . . . . 75.299999999999997 112.274 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -126.48 -13.97 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.37 -0.377 . . . . 72.310000000000002 111.695 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.3 p -129.39 25.51 5.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.377 0.51 . . . . 64.209999999999994 112.377 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.39 161.75 11.35 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.048 -0.596 . . . . 71.400000000000006 112.763 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.78 135.34 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.542 0.687 . . . . 64.25 112.823 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.96 109.41 20.75 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.453 -0.794 . . . . 72.409999999999997 110.746 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.3 131.98 47.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.793 0.33 . . . . 72.329999999999998 110.676 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 84.8 mt -117.17 120.29 33.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 111.903 0.334 . . . . 72.400000000000006 111.903 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HG3' HD23 ' A' ' 147' ' ' LEU . 11.5 Cg_endo -55.42 139.23 81.72 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.339 2.026 . . . . 73.150000000000006 111.666 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.82 -36.67 3.82 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.9 -0.667 . . . . 72.400000000000006 111.923 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.7 93.47 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.096 0.474 . . . . 74.450000000000003 110.057 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -79.61 27.29 0.28 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.265 0.555 . . . . 63.520000000000003 111.959 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 p -97.35 142.59 24.78 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 121.129 0.49 . . . . 64.450000000000003 112.132 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 73.9 Cg_endo -73.57 163.8 36.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.116 2.544 . . . . 63.009999999999998 113.597 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.86 140.66 45.99 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 111.117 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -86.78 123.53 32.03 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.115 0.483 . . . . 72.549999999999997 112.046 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.3 tp -125.45 123.28 38.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.187 -0.46 . . . . 74.5 111.187 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -85.11 96.91 9.59 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 61.240000000000002 110.21 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.7 p -86.58 -174.85 5.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.265 0.555 . . . . 74.540000000000006 111.737 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.45 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 43.4 mt-30 -83.56 -4.71 58.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.998 -0.546 . . . . 74.319999999999993 111.605 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 pt -106.59 -28.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.92 0.391 . . . . 73.230000000000004 111.253 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.62 175.54 31.74 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.128 -0.558 . . . . 61.32 113.188 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.4 m -72.76 112.05 8.45 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.056 0.455 . . . . 71.239999999999995 111.119 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 pp -121.84 155.95 34.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.329 0.585 . . . . 64.319999999999993 112.076 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 32.4 ttt180 -118.17 107.05 13.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.6 -0.727 . . . . 64.549999999999997 110.854 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.745 ' SD ' HG23 ' A' ' 152' ' ' ILE . 64.5 mtt -104.41 156.06 18.26 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.079 0.466 . . . . 55.409999999999997 112.09 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 26.1 t -158.07 160.82 37.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.779 0.324 . . . . 74.400000000000006 111.582 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.592 HD23 HD12 ' A' ' 80' ' ' LEU . 79.3 mt -105.29 113.13 26.53 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.275 -0.421 . . . . 75.439999999999998 111.478 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.638 HG22 HD21 ' A' ' 70' ' ' ASN . 27.2 m -130.58 166.27 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.327 -0.233 . . . . 73.540000000000006 111.194 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.638 HD21 HG22 ' A' ' 69' ' ' VAL . 45.5 m-80 61.16 28.1 17.79 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.012 0.434 . . . . 61.340000000000003 111.618 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.8 mt -64.03 96.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.141 0.496 . . . . 74.019999999999996 111.319 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 p -131.26 150.88 77.73 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.102 -0.499 . . . . 74.019999999999996 112.089 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.66 156.97 61.1 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.737 2.291 . . . . 72.230000000000004 113.568 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 79' ' ' THR . 22.9 t70 -133.36 168.8 17.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.875 -0.602 . . . . 74.420000000000002 110.65 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.83 68.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 71.409999999999997 111.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.56 -31.9 32.44 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.184 0.438 . . . . 74.430000000000007 112.184 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.96 -99.1 0.13 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.233 -0.984 . . . . 63.32 113.759 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -147.2 134.01 20.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.834 0.35 . . . . 71.120000000000005 111.539 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 36.2 p -110.72 127.55 55.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.569 -0.287 . . . . 74.519999999999996 111.627 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.592 HD12 HD23 ' A' ' 68' ' ' LEU . 2.9 pp -134.35 145.16 48.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.018 0.437 . . . . 53.399999999999999 111.208 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.5 m -84.37 101.78 12.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.11 0.481 . . . . 73.329999999999998 111.405 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.1 107.28 12.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.031 -0.531 . . . . 73.420000000000002 109.971 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 69' ' ' VAL . 14.9 mtp180 -95.66 113.13 24.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.791 0.329 . . . . 54.100000000000001 111.614 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.529 ' H ' HD11 ' A' ' 84' ' ' ILE . 3.2 mp -88.53 88.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.133 0.492 . . . . 70.219999999999999 110.09 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 63.2 tt0 -94.03 95.18 8.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.133 0.492 . . . . 73.430000000000007 110.78 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.45 131.51 41.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.401 -0.428 . . . . 43.43 113.462 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.19 -5.98 58.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.112 0.482 . . . . 70.219999999999999 111.352 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.5 p -91.65 147.84 22.7 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.136 -0.484 . . . . 63.399999999999999 110.872 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.481 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 28.1 t-20 -79.5 -24.77 42.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.957 0.408 . . . . 70.329999999999998 110.639 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.3 134.46 95.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.289 -0.414 . . . . 74.319999999999993 111.802 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.57 102.74 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.648 2.232 . . . . 61.340000000000003 112.576 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.88 141.87 92.85 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 112.251 0.463 . . . . 72.019999999999996 112.251 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.93 177.07 6.8 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.665 2.243 . . . . 74.310000000000002 113.33 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 125' ' ' ALA . . . -63.19 135.01 56.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.939 0.4 . . . . 65.540000000000006 111.339 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.94 154.28 46.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.43 0.633 . . . . 75.530000000000001 112.56 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 90.1 p -131.04 -179.93 5.62 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.626 -0.716 . . . . 72.019999999999996 110.498 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.66 175.12 46.21 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.727 -0.749 . . . . 52.439999999999998 113.095 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.9 m -111.61 131.96 54.9 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.239 0.216 . . . . 74.319999999999993 110.5 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 m -118.79 133.93 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.199 0.523 . . . . 64.150000000000006 111.987 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 8.6 mm-40 -99.13 106.65 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.851 -0.613 . . . . 71.409999999999997 110.557 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.448 ' HE1' ' HB2' ' A' ' 119' ' ' GLN . 48.5 p90 -116.65 122.56 44.92 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.391 0.615 . . . . 70.530000000000001 111.831 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.54 -144.71 4.36 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.68 -0.691 . . . . 61.119999999999997 112.811 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.471 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.9 mt-30 -127.03 158.42 37.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.104 0.478 . . . . 63.240000000000002 111.687 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.418 HG21 ' H ' ' A' ' 106' ' ' GLY . 67.8 mt -119.17 117.07 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.347 -0.388 . . . . 71.239999999999995 111.332 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -92.25 41.81 1.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.086 0.47 . . . . 73.200000000000003 111.167 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.418 ' H ' HG21 ' A' ' 104' ' ' ILE . . . -162.35 -158.95 9.91 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.975 -0.631 . . . . 51.020000000000003 113.676 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.5 p -125.78 -175.92 3.48 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.911 0.386 . . . . 71.519999999999996 111.59 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.462 HD12 ' HG3' ' A' ' 33' ' ' GLN . 45.9 mm -56.75 -38.57 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.031 0.443 . . . . 73.439999999999998 111.454 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.63 -42.63 77.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 111.234 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -139.32 87.59 2.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.293 0.568 . . . . 72.239999999999995 111.996 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -98.0 129.86 44.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.079 0.466 . . . . 74.420000000000002 111.065 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -123.68 120.17 31.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.059 -0.519 . . . . 63.109999999999999 110.838 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.08 118.71 19.11 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.976 0.417 . . . . 74.540000000000006 111.937 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.5 pt -130.57 155.11 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.444 -0.343 . . . . 72.200000000000003 110.96 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 54.67 32.08 16.55 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.463 0.649 . . . . 70.530000000000001 111.279 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.41 117.77 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.752 -0.658 . . . . 70.129999999999995 112.226 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -102.42 145.77 29.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.035 -0.529 . . . . 73.140000000000001 110.178 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -103.72 117.73 35.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.003 0.43 . . . . 71.420000000000002 111.324 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.448 ' HB2' ' HE1' ' A' ' 101' ' ' TYR . 8.9 tt0 -109.68 147.57 32.89 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 75.340000000000003 110.889 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.02 115.16 29.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.848 0.356 . . . . 73.430000000000007 111.05 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 121' ' ' ILE . 46.7 pt -94.8 116.38 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.108 0.48 . . . . 64.420000000000002 111.756 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.439 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.9 OUTLIER -109.74 109.4 20.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.984 -0.376 . . . . 72.140000000000001 109.984 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.84 147.63 34.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 112.201 0.445 . . . . 41.530000000000001 112.201 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.45 151.46 84.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.826 2.35 . . . . 43.020000000000003 113.168 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.507 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . . . -67.7 140.0 56.75 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.033 0.444 . . . . 74.310000000000002 112.041 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -83.7 77.37 9.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.118 -0.326 . . . . 74.420000000000002 110.118 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.417 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -67.94 -21.71 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.066 0.46 . . . . 73.530000000000001 111.925 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.417 ' HG ' HG23 ' A' ' 127' ' ' VAL . 93.1 mt -105.1 152.42 22.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 75.200000000000003 111.039 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 89' ' ' ASN . . . -115.15 140.05 25.18 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.525 -0.307 . . . . 63.43 111.644 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.74 173.83 56.15 Favored 'Cis proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.78 -1.342 . . . . 53.350000000000001 113.496 0.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -73.67 111.09 8.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.327 0.491 . . . . 73.25 112.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -141.94 115.57 9.09 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.326 0.584 . . . . 72.319999999999993 111.056 172.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.82 155.34 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 116.403 -0.362 . . . . 71.140000000000001 110.932 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 9.0 p-10 -143.97 121.34 11.64 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.142 0.496 . . . . 73.200000000000003 111.303 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.1 pt -119.91 138.52 27.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 112.182 0.438 . . . . 72.219999999999999 112.182 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.8 Cg_exo -78.14 123.33 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.015 2.477 . . . . 74.340000000000003 112.819 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 79' ' ' THR . 76.1 mt -100.89 106.46 17.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.89 0.376 . . . . 64.040000000000006 111.945 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.403 ' HA ' HG23 ' A' ' 79' ' ' THR . 35.4 tt0 -84.05 88.37 7.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.401 0.62 . . . . 71.120000000000005 110.228 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.44 116.74 21.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 71.239999999999995 110.013 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -99.68 141.82 31.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 73.409999999999997 112.055 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.2 41.29 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.297 -0.478 . . . . 44.140000000000001 113.154 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 147' ' ' LEU . 16.9 tt -161.51 127.12 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.039 0.447 . . . . 63.109999999999999 111.191 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.4 m -84.65 145.78 27.81 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.007 0.373 . . . . 71.200000000000003 112.007 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.84 -43.03 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.741 0.645 . . . . 73.239999999999995 112.741 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.54 -30.3 64.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.096 0.474 . . . . 74.140000000000001 111.471 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.458 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 29.7 mm-40 -90.88 -4.16 56.77 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.079 0.4 . . . . 60.329999999999998 112.079 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.466 HD23 ' HG3' ' A' ' 49' ' ' PRO . 1.6 tt -61.26 117.94 6.25 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.859 0.361 . . . . 74.439999999999998 110.304 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.98 -62.45 1.36 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.278 -0.487 . . . . 41.210000000000001 113.457 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.438 ' HD2' ' HG3' ' A' ' 151' ' ' ARG . 37.4 p90 -142.63 155.55 44.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.383 0.512 . . . . 72.099999999999994 112.383 -174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.9 t -131.49 104.02 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.196 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 77.5 mtp180 -96.09 115.28 27.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.933 0.397 . . . . 74.329999999999998 112.01 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.745 HG23 ' SD ' ' A' ' 66' ' ' MET . 21.4 mm -93.69 121.91 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.071 -0.513 . . . . 73.239999999999995 110.741 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -154.34 172.94 16.88 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.245 0.461 . . . . 70.319999999999993 112.245 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 63.6 23.8 13.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.889 0.7 . . . . 73.140000000000001 112.889 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.3 mm -64.23 109.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.18 0.514 . . . . 73.239999999999995 111.293 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.45 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.2 pt20 -133.86 147.11 62.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.84 -0.618 . . . . 74.439999999999998 111.9 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.44 124.1 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.253 1.968 . . . . 54.049999999999997 112.339 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 112.424 0.527 . . . . 75.310000000000002 112.424 -177.026 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 31' ' ' ILE . 42.8 tt0 . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.004 0.431 . . . . 75.5 110.149 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 m -61.32 -33.2 73.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.212 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.66 -54.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.322 0.582 . . . . 73.420000000000002 110.973 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -64.72 -34.69 78.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.59 -0.732 . . . . 73.409999999999997 111.777 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 27' ' ' GLU . 77.1 mt -64.9 -46.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.871 0.367 . . . . 74.439999999999998 111.314 174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.4 m -64.56 -38.97 92.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.781 0.324 . . . . 73.209999999999994 111.201 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -60.16 -45.33 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.825 0.345 . . . . 70.400000000000006 110.489 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -57.24 10.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.073 -0.512 . . . . 71.430000000000007 110.573 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -55.17 -46.27 75.76 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.459 0.54 . . . . 63.109999999999999 112.459 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.71 -48.6 76.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.132 0.419 . . . . 73.519999999999996 112.132 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.173 0.511 . . . . 75.120000000000005 110.8 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -59.25 -44.01 92.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.78 -0.645 . . . . 74.25 110.386 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.6 97.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.034 -0.53 . . . . 71.019999999999996 111.945 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -68.81 -23.24 64.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.832 0.349 . . . . 72.329999999999998 111.855 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -63.87 115.47 4.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.88 0.371 . . . . 74.450000000000003 111.75 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 m -64.42 -47.72 78.08 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.174 0.511 . . . . 65.239999999999995 111.4 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.2 p -129.64 117.75 20.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.176 -0.465 . . . . 71.530000000000001 111.143 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 99.85 169.51 29.81 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.154 -0.546 . . . . 44.310000000000002 113.727 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.44 HG12 HD12 ' A' ' 57' ' ' LEU . 31.1 m -113.19 153.99 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.113 0.483 . . . . 71.319999999999993 111.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -101.95 126.8 48.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.258 -0.428 . . . . 71.310000000000002 111.421 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.83 112.28 19.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.397 -0.365 . . . . 74.530000000000001 110.749 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.88 135.01 27.92 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.718 -0.219 . . . . 73.310000000000002 111.265 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -56.62 -32.5 90.64 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.685 2.257 . . . . 63.43 113.274 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.73 15.23 61.01 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.256 -0.497 . . . . 64.310000000000002 113.131 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.03 84.2 2.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.164 0.506 . . . . 73.019999999999996 111.607 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.75 81.98 0.44 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.45 0.643 . . . . 71.230000000000004 111.301 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.425 HG21 HG23 ' A' ' 31' ' ' ILE . 5.2 p -137.43 152.07 72.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.98 -0.555 . . . . 51.25 112.246 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.62 ' HB3' HH11 ' A' ' 65' ' ' ARG . 92.8 Cg_endo -81.5 132.4 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.959 2.439 . . . . 62.5 112.717 171.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.11 130.16 55.58 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.813 0.34 . . . . 71.420000000000002 111.14 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.705 ' HD3' HG21 ' A' ' 63' ' ' THR . 1.6 tmm_? -86.28 108.52 18.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.96 0.409 . . . . 74.239999999999995 110.137 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.44 HD12 HG12 ' A' ' 45' ' ' VAL . 40.2 tp -101.77 131.42 48.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.454 0.645 . . . . 54.409999999999997 112.595 -174.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.32 106.21 15.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.277 -0.874 . . . . 73.120000000000005 109.817 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -110.41 -178.71 3.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.168 0.509 . . . . 74.430000000000007 111.927 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 47.7 mt-30 -87.64 -2.96 58.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.075 -0.512 . . . . 74.340000000000003 111.747 177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 157' ' ' PRO . 31.8 pt -104.18 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.839 0.352 . . . . 75.430000000000007 111.175 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -162.43 29.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.425 -0.417 . . . . 38.219999999999999 113.318 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.705 HG21 ' HD3' ' A' ' 56' ' ' ARG . 77.8 m -87.46 118.72 27.11 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.58 -0.365 . . . . 51.310000000000002 111.012 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.45 169.36 17.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.63 0.604 . . . . 74.120000000000005 112.63 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.62 HH11 ' HB3' ' A' ' 54' ' ' PRO . 35.1 ttp85 -118.09 136.42 53.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.704 -0.68 . . . . 74.049999999999997 110.844 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.618 ' SD ' HG23 ' A' ' 152' ' ' ILE . 62.2 mtt -130.39 157.4 42.69 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.768 0.318 . . . . 71.239999999999995 111.545 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -164.5 165.11 21.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.905 0.383 . . . . 64.129999999999995 111.682 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 80' ' ' LEU . 94.4 mt -109.5 117.69 34.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 71.109999999999999 111.588 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 70' ' ' ASN . 35.3 m -128.01 162.99 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 72.310000000000002 111.51 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 69' ' ' VAL . 51.1 m-80 58.41 29.58 18.43 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.463 0.542 . . . . 72.329999999999998 112.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.28 106.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.915 0.388 . . . . 73.109999999999999 110.935 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -138.22 151.25 69.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.183 -0.462 . . . . 75.439999999999998 112.122 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.06 162.3 38.84 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.9 2.4 . . . . 72.329999999999998 113.147 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.56 ' HB2' HG23 ' A' ' 79' ' ' THR . 20.5 t70 -147.16 158.46 43.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.246 -0.433 . . . . 75.209999999999994 111.478 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.58 84.34 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.17 0.433 . . . . 71.120000000000005 112.17 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -88.26 -32.85 18.3 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.707 0.289 . . . . 71.420000000000002 111.269 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -172.43 -96.19 0.1 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.692 -0.766 . . . . 74.040000000000006 113.763 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -150.72 129.35 12.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.562 -0.375 . . . . 75.5 111.498 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.56 HG23 ' HB2' ' A' ' 74' ' ' ASP . 60.3 p -104.36 125.76 50.87 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.187 -0.321 . . . . 71.239999999999995 111.525 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.435 HD12 HD23 ' A' ' 68' ' ' LEU . 3.1 pp -138.61 151.37 47.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.038 0.447 . . . . 75.439999999999998 111.44 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.521 ' HB ' HG22 ' A' ' 69' ' ' VAL . 32.7 m -94.79 110.02 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 71.329999999999998 111.422 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.36 111.58 19.56 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.663 -0.495 . . . . 72.140000000000001 109.663 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HE ' ' HB3' ' A' ' 134' ' ' ASP . 38.0 mtp180 -105.28 126.51 52.18 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.239 0.459 . . . . 75.349999999999994 112.239 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.402 HG12 ' HE3' ' A' ' 66' ' ' MET . 3.2 mp -110.96 141.13 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.824 -0.626 . . . . 75.400000000000006 110.201 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -139.64 148.05 41.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 65.140000000000001 111.055 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.15 124.61 6.5 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.884 -0.674 . . . . 71.120000000000005 113.567 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HG3' HG22 ' A' ' 63' ' ' THR . 19.3 mm-40 -70.76 -3.32 18.19 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.966 0.413 . . . . 64.430000000000007 111.264 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -116.34 161.93 18.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.305 -0.407 . . . . 72.140000000000001 110.826 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -81.6 24.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.723 0.297 . . . . 55.119999999999997 111.741 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.86 146.74 34.42 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.704 0.402 . . . . 62.329999999999998 111.293 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 59.9 Cg_endo -72.64 112.06 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.633 2.222 . . . . 54.409999999999997 112.988 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.46 143.38 98.19 Favored Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 112.529 0.566 . . . . 63.240000000000002 112.529 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.89 -165.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.793 2.329 . . . . 71.420000000000002 112.675 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 138.39 31.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.937 0.399 . . . . 71.219999999999999 111.502 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.86 162.88 38.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.144 0.497 . . . . 74.329999999999998 112.148 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 95.5 p -140.76 151.0 44.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 110.973 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.677 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -153.01 170.64 32.02 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.527 -0.844 . . . . 74.209999999999994 113.839 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -100.93 124.34 46.48 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.744 0.307 . . . . 61.130000000000003 111.388 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.47 130.75 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 75.450000000000003 111.194 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.04 126.36 52.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.977 0.418 . . . . 64.150000000000006 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.407 ' CE1' HD23 ' A' ' 139' ' ' LEU . 10.4 p90 -127.95 121.14 29.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 74.219999999999999 111.193 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.92 -159.29 9.57 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.092 -0.575 . . . . 62.030000000000001 113.085 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HB2' HG13 ' A' ' 114' ' ' ILE . 77.2 mt-30 -119.22 156.53 29.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.007 0.432 . . . . 45.219999999999999 111.896 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.2 mt -112.96 129.39 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.125 -0.489 . . . . 73.239999999999995 110.998 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.505 HE21 HD12 ' A' ' 114' ' ' ILE . 4.1 pt20 -114.14 30.09 7.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.055 0.391 . . . . 74.530000000000001 112.055 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.495 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -151.83 -157.86 8.12 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.652 -0.785 . . . . 73.349999999999994 113.461 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.3 p -105.77 -164.47 1.02 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.529 0.332 . . . . 73.129999999999995 111.613 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.18 -40.57 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.877 0.695 . . . . 72.450000000000003 112.877 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -94.09 -42.7 8.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.311 0.486 . . . . 73.409999999999997 112.311 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.76 99.81 7.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.332 0.587 . . . . 73.409999999999997 111.807 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.89 148.11 26.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.902 -0.59 . . . . 72.340000000000003 111.493 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -113.69 136.9 52.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.907 0.384 . . . . 63.240000000000002 110.912 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.49 103.91 13.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.194 0.521 . . . . 74.439999999999998 111.189 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.505 HD12 HE21 ' A' ' 105' ' ' GLN . 45.2 pt -109.28 155.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 116.447 -0.342 . . . . 50.140000000000001 111.889 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 51.89 39.32 25.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.187 0.517 . . . . 72.230000000000004 111.837 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.32 123.66 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.175 0.512 . . . . 74.200000000000003 111.904 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -112.15 160.31 17.69 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.087 -0.506 . . . . 75.239999999999995 110.442 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.31 145.01 51.19 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.251 0.463 . . . . 64.120000000000005 112.251 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -140.91 166.32 25.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.204 -0.453 . . . . 75.420000000000002 110.959 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -107.64 121.79 45.38 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.814 0.34 . . . . 73.25 111.791 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.551 HG23 HD22 ' A' ' 137' ' ' LEU . 32.2 pt -95.05 107.58 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.203 0.525 . . . . 73.340000000000003 111.369 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.53 101.88 13.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.881 0.372 . . . . 73.420000000000002 111.004 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.11 140.73 21.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.862 0.319 . . . . 54.5 111.862 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.41 168.47 21.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.832 2.355 . . . . 75.510000000000005 113.466 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.29 146.11 31.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.225 0.454 . . . . 65.109999999999999 112.225 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.0 m -93.34 155.81 17.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.138 0.495 . . . . 74.319999999999993 112.02 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.0 t -105.51 -47.45 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.958 -0.565 . . . . 44.409999999999997 111.682 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.35 173.5 6.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.352 0.596 . . . . 72.349999999999994 112.165 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.96 142.34 45.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.741 -0.663 . . . . 74.329999999999998 111.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.87 162.93 90.34 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 123.809 -1.33 . . . . 74.510000000000005 112.931 -1.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 38.6 m -100.59 108.39 20.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.181 0.438 . . . . 74.400000000000006 112.181 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.78 93.09 4.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.579 0.351 . . . . 72.310000000000002 110.209 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.57 111.28 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.354 0.261 . . . . 71.329999999999998 111.341 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.459 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -117.01 143.69 45.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.287 0.565 . . . . 74.340000000000003 112.047 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.7 pt -137.63 136.35 20.11 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.707 -0.679 . . . . 73.340000000000003 111.608 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.97 137.28 19.45 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.694 2.263 . . . . 65.140000000000001 113.382 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.551 HD22 HG23 ' A' ' 121' ' ' ILE . 20.4 mt -120.54 114.83 22.33 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.125 0.417 . . . . 73.319999999999993 112.125 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -91.66 93.73 9.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.963 0.411 . . . . 74.049999999999997 110.245 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.435 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 46.7 mt -74.33 120.89 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 63.109999999999999 110.053 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.2 mtmt -102.33 141.47 35.11 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.396 0.517 . . . . 64.319999999999993 112.396 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.29 10.43 86.01 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.211 -0.519 . . . . 61.43 113.885 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.5 tt -143.63 122.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.346 0.593 . . . . 73.239999999999995 111.847 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -76.77 155.54 33.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.395 -0.366 . . . . 73.340000000000003 111.416 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.4 -40.1 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.117 0.484 . . . . 73.239999999999995 111.407 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.53 -23.39 66.86 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.057 0.456 . . . . 72.510000000000005 111.47 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -89.47 1.13 56.29 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.226 0.454 . . . . 53.119999999999997 112.226 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.3 mt -81.43 125.83 30.91 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.237 0.541 . . . . 74.310000000000002 111.872 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.82 -54.28 0.68 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.652 -0.704 . . . . 70.120000000000005 112.284 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.13 150.02 37.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.752 0.31 . . . . 70.400000000000006 111.332 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.8 102.97 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.519999999999996 110.546 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -91.53 116.31 28.75 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.004 0.372 . . . . 61.200000000000003 112.004 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.618 HG23 ' SD ' ' A' ' 66' ' ' MET . 11.2 mm -100.48 119.63 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 110.045 -0.354 . . . . 73.519999999999996 110.045 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 15.5 p80 -143.78 177.94 8.17 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.729 1.011 . . . . 75.040000000000006 113.729 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 74.64 -74.66 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.771 -1.104 . . . . 71.310000000000002 111.769 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.677 HD13 ' HA3' ' A' ' 97' ' ' GLY . 46.7 mm 39.83 82.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.602 0.715 . . . . 70.099999999999994 112.376 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.421 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.6 pt20 -110.09 150.54 41.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.451 -0.795 . . . . 60.219999999999999 111.557 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HG3' HG22 ' A' ' 61' ' ' ILE . 8.4 Cg_exo -71.23 128.19 14.38 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.51 2.14 . . . . 43.240000000000002 112.715 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.808 0.813 . . . . 72.530000000000001 111.081 176.369 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.015 0.436 . . . . 73.329999999999998 110.711 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.3 m -59.85 -31.96 70.24 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.082 -0.508 . . . . 72.239999999999995 110.982 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.54 -50.35 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.709 -0.223 . . . . 74.140000000000001 110.935 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -55.47 -47.24 76.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.017 0.437 . . . . 64.200000000000003 110.854 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.406 HG22 HG21 ' A' ' 53' ' ' THR . 73.7 mt -55.17 -53.64 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.337 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.7 m -56.65 -47.82 78.91 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.258 -0.428 . . . . 73.329999999999998 111.625 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -58.83 -39.92 82.64 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.984 -0.553 . . . . 70.200000000000003 111.363 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.89 -47.66 85.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.722 0.296 . . . . 74.310000000000002 111.181 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -57.87 -41.69 82.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.931 0.396 . . . . 70.409999999999997 111.148 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 3.4 mmp_? -60.57 -54.55 44.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.949 0.404 . . . . 74.329999999999998 111.568 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.88 -36.05 83.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.991 0.424 . . . . 73.239999999999995 111.683 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.45 ' ND2' ' HB1' ' A' ' 55' ' ' ALA . 20.0 t-20 -63.95 -35.18 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.843 0.354 . . . . 73.439999999999998 111.043 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.05 60.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.949 0.404 . . . . 71.230000000000004 111.362 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.626 ' HE3' HG23 ' A' ' 108' ' ' ILE . 62.5 mttm -90.69 -3.9 57.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 73.030000000000001 111.572 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 108.63 4.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.145 0.498 . . . . 64.019999999999996 112.061 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.5 p -91.98 -1.33 57.31 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.162 -0.472 . . . . 73.219999999999999 111.696 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.6 p -153.71 102.9 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.783 0.325 . . . . 75.319999999999993 111.23 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 -145.47 28.0 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.941 -0.647 . . . . 64.340000000000003 112.692 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.491 HG12 HD12 ' A' ' 57' ' ' LEU . 17.9 m -134.29 139.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.336 -0.508 . . . . 75.530000000000001 112.333 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.55 106.91 18.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.924 -0.58 . . . . 72.530000000000001 111.455 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.54 148.78 23.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.989 -0.375 . . . . 63.100000000000001 109.989 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.78 130.79 23.48 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.369 . . . . 73.040000000000006 111.466 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 66.2 Cg_endo -72.2 28.36 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.208 2.605 . . . . 54.439999999999998 113.805 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.35 12.93 2.05 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.493 -0.384 . . . . 70.329999999999998 112.3 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.13 115.72 18.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 73.140000000000001 111.551 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -69.07 8.66 0.52 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.675 0.621 . . . . 72.120000000000005 112.675 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.406 HG21 HG22 ' A' ' 31' ' ' ILE . 1.5 p -90.81 145.25 31.62 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.584 0.587 . . . . 72.140000000000001 112.584 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.483 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 75.1 Cg_endo -81.97 -178.28 4.03 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.168 2.578 . . . . 45.420000000000002 114.029 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.45 ' HB1' ' ND2' ' A' ' 38' ' ' ASN . . . -147.31 145.64 29.42 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.811 -0.631 . . . . 74.150000000000006 111.389 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -80.83 112.25 18.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.415 -0.357 . . . . 71.450000000000003 111.185 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.491 HD12 HG12 ' A' ' 45' ' ' VAL . 56.1 tp -117.95 120.64 38.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.296 0.569 . . . . 73.200000000000003 111.534 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -83.85 115.09 22.09 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.615 . . . . 72.340000000000003 110.701 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -114.08 179.14 4.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.124 0.487 . . . . 64.349999999999994 111.512 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.19 0.12 29.66 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.197 0.443 . . . . 73.530000000000001 112.197 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.463 HD12 ' HB3' ' A' ' 92' ' ' LEU . 37.5 pt -109.61 5.27 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.231 0.539 . . . . 62.240000000000002 110.551 171.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.13 -171.35 13.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.99 -0.55 . . . . 62.219999999999999 112.731 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -77.87 134.33 37.97 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.485 -0.421 . . . . 73.340000000000003 111.257 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.48 152.96 48.76 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.333 0.587 . . . . 65.310000000000002 111.427 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HD2' ' OE1' ' A' ' 85' ' ' GLN . 39.8 ttm180 -109.63 107.1 17.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.957 -0.565 . . . . 74.129999999999995 111.325 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.618 ' SD ' HG22 ' A' ' 152' ' ' ILE . 63.0 mtt -98.96 138.07 36.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.76 0.314 . . . . 63.509999999999998 111.785 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 42.3 t -139.15 161.77 36.59 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.392 -0.367 . . . . 70.0 111.614 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.651 HD22 HD12 ' A' ' 80' ' ' LEU . 89.8 mt -113.79 108.95 17.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.951 0.405 . . . . 75.409999999999997 111.768 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.587 HG22 ' HB ' ' A' ' 81' ' ' THR . 35.6 m -117.25 161.53 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.7 0.286 . . . . 74.510000000000005 111.284 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 65.14 22.76 12.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.488 0.551 . . . . 74.329999999999998 112.488 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.4 mt -61.84 114.78 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 111.948 0.351 . . . . 74.099999999999994 111.948 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -145.09 154.49 54.49 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 112.32 0.489 . . . . 74.340000000000003 112.32 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.68 136.62 33.67 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.503 2.135 . . . . 72.5 112.67 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.493 ' HB2' HG21 ' A' ' 79' ' ' THR . 34.7 t70 -107.69 159.06 16.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 111.123 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.93 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.068 0.461 . . . . 53.329999999999998 111.647 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -86.95 -55.06 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.297 0.57 . . . . 73.329999999999998 110.131 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.21 -94.42 0.16 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.116 -0.564 . . . . 54.509999999999998 113.343 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -149.21 136.19 19.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.375 -0.486 . . . . 51.140000000000001 111.702 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 74' ' ' ASP . 32.4 p -116.08 129.97 56.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.288 0.566 . . . . 74.219999999999999 111.939 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.651 HD12 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -142.34 150.75 41.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.006 -0.543 . . . . 72.530000000000001 111.236 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.587 ' HB ' HG22 ' A' ' 69' ' ' VAL . 30.9 m -92.89 112.16 24.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.871 0.367 . . . . 74.129999999999995 111.687 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.3 112.97 22.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.773 -0.454 . . . . 64.510000000000005 109.773 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 66' ' ' MET . 83.6 mtt180 -110.64 133.82 52.98 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.144 0.424 . . . . 73.030000000000001 112.144 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.433 HG13 ' HG2' ' A' ' 66' ' ' MET . 4.0 mp -113.66 109.36 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.072 -0.513 . . . . 75.5 111.175 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.484 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 97.6 mt-30 -93.25 143.61 26.1 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.927 0.394 . . . . 63.009999999999998 111.193 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.13 146.85 23.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.28 -0.486 . . . . 75.310000000000002 114.013 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.8 -46.02 59.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.664 0.386 . . . . 72.140000000000001 111.969 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -102.45 179.9 4.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.307 0.575 . . . . 71.140000000000001 112.222 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.87 10.19 12.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.789 -0.641 . . . . 73.120000000000005 111.223 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.96 145.75 31.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 110.864 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.73 131.54 14.75 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.461 2.107 . . . . 72.299999999999997 112.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.463 ' HB3' HD12 ' A' ' 61' ' ' ILE . 94.3 mt -79.75 147.63 67.26 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.681 0.277 . . . . 71.230000000000004 111.534 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 16.3 Cg_exo -69.83 -178.13 2.22 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.891 2.394 . . . . 72.430000000000007 113.07 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HB3' ' HB1' ' A' ' 125' ' ' ALA . . . -78.14 132.34 37.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.568 -0.287 . . . . 72.109999999999999 111.412 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.56 170.24 16.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 75.239999999999995 112.342 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.3 p -153.65 157.02 38.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.041 -0.527 . . . . 74.5 110.516 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.611 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -161.64 -173.67 30.58 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.717 -0.754 . . . . 75.040000000000006 113.787 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -120.59 142.94 48.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.76 0.315 . . . . 74.209999999999994 110.806 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.0 128.83 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.053 0.454 . . . . 74.040000000000006 112.034 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 11.1 mm-40 -95.82 113.04 24.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.011 -0.54 . . . . 75.239999999999995 110.039 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 44.6 p90 -124.31 127.9 48.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.874 -0.516 . . . . 71.409999999999997 111.965 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.59 -154.26 9.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.075 -0.583 . . . . 70.430000000000007 113.263 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -113.31 152.12 30.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.202 0.525 . . . . 74.219999999999999 111.944 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 111' ' ' PHE . 66.3 mt -108.45 106.82 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.008 -0.542 . . . . 73.329999999999998 111.037 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -92.64 22.53 4.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.039 0.385 . . . . 75.310000000000002 112.039 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -136.66 -165.38 10.49 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.894 -0.67 . . . . 63.210000000000001 113.446 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 11.2 p -87.69 -161.72 0.74 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.703 0.287 . . . . 71.329999999999998 111.035 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.626 HG23 ' HE3' ' A' ' 40' ' ' LYS . 51.4 mm -85.67 -28.64 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.878 0.371 . . . . 64.340000000000003 111.087 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -91.49 -40.84 11.17 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.02 0.378 . . . . 75.430000000000007 112.02 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -127.47 96.89 4.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.444 0.64 . . . . 73.430000000000007 110.881 175.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.636 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.5 p90 -118.93 144.94 46.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.906 -0.588 . . . . 72.510000000000005 111.912 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -115.27 131.44 56.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.923 -0.58 . . . . 61.310000000000002 110.244 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -96.57 113.6 25.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.983 0.421 . . . . 74.340000000000003 111.822 -174.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.9 pt -121.1 164.64 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.406 -0.361 . . . . 64.219999999999999 111.365 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.07 29.06 11.76 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.984 0.421 . . . . 70.120000000000005 111.526 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 4.8 p -94.04 124.64 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.275 0.56 . . . . 75.299999999999997 112.218 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.19 155.7 24.56 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.884 -0.598 . . . . 73.549999999999997 110.758 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -104.78 139.88 38.91 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.154 -0.476 . . . . 62.210000000000001 111.202 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -138.58 146.48 41.87 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.708 0.289 . . . . 52.219999999999999 111.464 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.93 116.71 27.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.032 0.444 . . . . 74.349999999999994 111.825 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 121' ' ' ILE . 23.5 pt -106.7 105.06 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 71.439999999999998 111.15 176.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.98 132.61 51.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.281 -0.418 . . . . 61.539999999999999 111.065 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.521 ' HB3' HG11 ' A' ' 133' ' ' VAL . . . -121.51 145.78 43.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.75 0.31 . . . . 72.310000000000002 111.828 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.6 174.79 12.26 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.655 2.237 . . . . 64.219999999999999 113.001 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 94' ' ' ALA . . . -80.82 135.77 36.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.015 0.436 . . . . 63.32 111.872 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.2 m -70.69 126.35 29.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.332 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.602 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -97.91 -35.78 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.104 0.779 . . . . 63.549999999999997 113.104 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 127' ' ' VAL . 92.5 mt -125.62 120.36 30.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.726 0.298 . . . . 75.319999999999993 110.93 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.95 68.71 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 112.52 0.563 . . . . 63.340000000000003 112.52 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.98 167.52 78.41 Favored 'Cis proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.243 -1.149 . . . . 74.109999999999999 112.93 -1.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 49.2 m -75.62 133.73 40.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 111.773 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.47 31.37 1.9 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.996 -0.547 . . . . 75.049999999999997 111.239 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 123' ' ' ALA . 59.3 t -52.1 115.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.699 0.629 . . . . 71.420000000000002 112.699 -174.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.81 114.57 28.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.197 0.523 . . . . 72.109999999999999 111.733 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.1 pt -122.87 136.68 27.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.973 0.416 . . . . 61.32 112.094 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.14 135.84 14.07 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.744 2.296 . . . . 74.319999999999993 112.942 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.2 113.02 20.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.383 -0.371 . . . . 74.310000000000002 110.495 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -103.04 118.9 37.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.219 0.533 . . . . 71.230000000000004 112.114 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.2 mt -99.93 142.84 30.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.859 0.464 . . . . 74.439999999999998 110.692 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -102.9 144.01 31.75 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.581 0.585 . . . . 74.519999999999996 112.581 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.91 -43.27 1.92 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.971 0.749 . . . . 61.329999999999998 114.971 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.442 HD12 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -88.83 122.91 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.565 0.698 . . . . 74.120000000000005 111.993 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.6 m -82.04 154.97 25.36 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.984 -0.553 . . . . 74.5 111.205 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.557 ' HA ' HD11 ' A' ' 147' ' ' LEU . 9.0 p -57.23 -36.73 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.898 0.38 . . . . 65.099999999999994 111.733 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.6 -27.62 68.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.222 0.534 . . . . 52.009999999999998 111.208 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -94.32 0.14 55.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.243 0.461 . . . . 64.109999999999999 112.243 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.609 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.2 mt -78.73 142.1 37.33 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.101 0.477 . . . . 75.120000000000005 112.211 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.88 -56.61 0.29 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.989 -0.55 . . . . 54.039999999999999 113.129 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.48 ' HB3' HD11 ' A' ' 104' ' ' ILE . 38.7 p90 -139.33 159.3 42.48 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.323 -0.516 . . . . 71.510000000000005 112.103 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 67.4 t -134.19 96.4 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.9 -0.591 . . . . 65.319999999999993 110.415 175.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 20.4 ttm180 -93.39 112.77 24.77 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.123 -0.361 . . . . 72.510000000000005 111.969 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.618 HG22 ' SD ' ' A' ' 66' ' ' MET . 37.0 mm -89.71 138.11 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 122.205 -0.31 . . . . 74.150000000000006 111.296 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -163.58 -177.22 5.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.871 0.323 . . . . 62.229999999999997 111.871 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 65.2 20.64 11.98 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.924 0.712 . . . . 74.0 112.924 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.611 HD12 ' HA3' ' A' ' 97' ' ' GLY . 47.4 mm -69.9 103.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.393 0.616 . . . . 53.130000000000003 111.927 -177.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -136.38 153.95 76.66 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.831 -0.622 . . . . 75.420000000000002 111.149 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.79 153.81 70.16 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.635 2.224 . . . . 74.140000000000001 113.329 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.979 0.418 . . . . 63.200000000000003 111.878 179.226 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 120.998 0.428 . . . . 73.430000000000007 111.005 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -64.68 -29.94 70.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.266 -0.424 . . . . 73.120000000000005 111.331 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.05 -46.73 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.533 -0.303 . . . . 62.149999999999999 110.619 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -63.02 -38.81 92.69 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.408 -0.36 . . . . 73.439999999999998 111.504 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.19 -48.94 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.329 0.585 . . . . 73.400000000000006 110.742 173.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.3 m -62.79 -39.47 94.34 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.932 -0.577 . . . . 74.150000000000006 110.991 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.47 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 62.8 tt0 -63.29 -45.08 93.05 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.139 -0.482 . . . . 73.040000000000006 110.919 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.3 tt0 -58.63 -50.84 72.35 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.849 0.315 . . . . 72.430000000000007 111.849 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -58.8 -43.51 90.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.86 0.362 . . . . 70.010000000000005 111.798 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -68.87 -43.49 75.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.623 0.249 . . . . 70.109999999999999 111.571 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 33' ' ' GLN . 56.3 mt -65.84 -32.84 74.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.984 0.421 . . . . 72.319999999999993 110.657 175.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.406 ' ND2' HG13 ' A' ' 45' ' ' VAL . 3.3 t-20 -61.65 -30.64 70.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.148 -0.478 . . . . 73.409999999999997 110.556 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.29 -36.25 61.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.226 -0.443 . . . . 75.239999999999995 111.756 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.88 -32.81 63.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.337 0.495 . . . . 54.399999999999999 112.337 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -55.5 105.68 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.888 0.699 . . . . 73.5 112.888 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -79.6 -22.72 43.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.176 -0.466 . . . . 63.119999999999997 111.18 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.519 ' HB3' HH21 ' A' ' 151' ' ' ARG . 30.5 t -124.98 99.15 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 73.340000000000003 111.13 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 79.59 -143.38 25.68 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.973 -0.558 . . . . 75.439999999999998 113.916 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 28.3 m -140.52 144.96 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.993 0.425 . . . . 75.299999999999997 111.873 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 73.5 m-85 -89.89 99.1 12.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.529 -0.305 . . . . 72.0 111.172 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.4 110.08 20.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.885 0.374 . . . . 70.200000000000003 110.628 173.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.01 115.79 63.83 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 122.278 -0.264 . . . . 75.510000000000005 110.965 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 30.5 Cg_endo -64.24 -7.1 12.95 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.523 2.149 . . . . 72.340000000000003 113.281 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 -2.31 55.72 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.455 -0.403 . . . . 65.340000000000003 112.666 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.72 115.72 30.72 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.683 -0.304 . . . . 72.140000000000001 111.09 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -79.21 61.54 3.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.316 0.579 . . . . 64.400000000000006 110.659 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -155.45 151.56 22.72 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 115.798 -0.637 . . . . 73.200000000000003 111.662 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 63.6 Cg_endo -85.85 -178.61 2.98 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.128 2.552 . . . . 72.019999999999996 113.858 178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.05 138.98 18.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.873 -0.603 . . . . 63.140000000000001 110.959 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -89.14 131.74 35.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.242 0.544 . . . . 75.239999999999995 112.459 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.7 135.81 40.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.779 -0.646 . . . . 74.430000000000007 110.738 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 49.0 tt0 -93.18 128.55 39.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.947 -0.471 . . . . 63.329999999999998 111.262 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.8 p -97.13 179.81 4.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.356 -0.384 . . . . 64.109999999999999 110.58 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.644 HE21 ' HB3' ' A' ' 156' ' ' GLN . 38.2 mt-30 -83.24 -1.79 53.98 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.144 -0.348 . . . . 62.329999999999998 111.778 178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.462 HG22 ' HD3' ' A' ' 157' ' ' PRO . 38.1 pt -103.94 -32.44 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.713 0.292 . . . . 74.239999999999995 110.979 171.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.23 172.9 39.17 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.52 -0.371 . . . . 51.43 112.946 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 95.6 m -78.6 138.26 38.26 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.318 -0.519 . . . . 74.450000000000003 111.402 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.91 171.73 13.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.187 0.518 . . . . 63.009999999999998 111.775 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.91 120.73 25.34 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.296 -0.411 . . . . 74.450000000000003 110.919 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.524 ' SD ' HG23 ' A' ' 152' ' ' ILE . 62.3 mtt -105.42 152.36 23.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.967 0.413 . . . . 37.960000000000001 112.094 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 84.5 p -149.29 143.29 25.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.364 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.452 HD21 HD23 ' A' ' 82' ' ' LEU . 91.6 mt -96.78 100.45 11.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.934 0.397 . . . . 71.299999999999997 111.285 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.405 HG23 HD21 ' A' ' 70' ' ' ASN . 27.5 m -120.41 152.75 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.667 0.27 . . . . 74.040000000000006 111.013 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 19.2 m-80 57.13 76.47 0.31 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.0 0.429 . . . . 74.209999999999994 111.166 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mt -109.36 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.513 -0.312 . . . . 72.209999999999994 111.402 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 p -129.89 152.54 80.08 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 73.109999999999999 111.714 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 165.57 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.833 2.355 . . . . 72.409999999999997 113.804 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.619 ' HB2' HG21 ' A' ' 79' ' ' THR . 33.3 t70 -139.66 170.35 16.05 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.862 -0.608 . . . . 73.230000000000004 110.673 -178.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.84 -44.63 91.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.883 0.327 . . . . 64.430000000000007 111.883 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -91.03 -31.92 16.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.183 0.438 . . . . 74.329999999999998 112.183 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.51 0.15 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.586 -0.816 . . . . 64.239999999999995 113.901 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -144.9 135.82 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.061 0.457 . . . . 75.239999999999995 111.903 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.619 HG21 ' HB2' ' A' ' 74' ' ' ASP . 46.3 p -110.24 132.88 53.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.344 -0.389 . . . . 75.439999999999998 111.167 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 2.8 pp -142.41 160.06 41.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.003 0.43 . . . . 73.200000000000003 112.052 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 m -97.96 113.44 25.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 65.120000000000005 111.469 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.452 HD23 HD21 ' A' ' 68' ' ' LEU . 3.0 tm? -92.78 109.53 20.96 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.137 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 90.2 mtt180 -99.04 121.85 41.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.461 0.541 . . . . 74.239999999999995 112.461 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 84' ' ' ILE . 3.6 mp -104.97 117.4 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.709 -0.678 . . . . 74.239999999999995 111.387 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -112.04 117.51 32.87 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.693 0.282 . . . . 74.150000000000006 110.415 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.14 142.64 29.71 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.254 -0.498 . . . . 54.310000000000002 113.707 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.91 -44.63 84.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.289 0.566 . . . . 74.340000000000003 109.909 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -67.88 124.26 22.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.892 -0.595 . . . . 41.450000000000003 110.858 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 21.5 m-80 -68.89 -15.8 63.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.4 . . . . 72.299999999999997 111.475 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.18 154.55 63.55 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 111.872 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD3' ' HB1' ' A' ' 129' ' ' ALA . 41.3 Cg_endo -65.4 130.85 26.32 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.022 2.481 . . . . 74.340000000000003 114.233 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.4 mt -103.43 151.61 38.66 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.046 -0.525 . . . . 73.540000000000006 111.357 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 174.93 11.94 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.514 2.143 . . . . 74.230000000000004 113.226 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.57 134.34 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.069 0.461 . . . . 37.960000000000001 112.029 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -132.32 155.48 48.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.409 0.623 . . . . 70.5 111.993 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -147.15 170.64 16.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.81 -0.632 . . . . 75.439999999999998 110.603 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.501 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -176.91 -175.17 44.0 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.252 -0.975 . . . . 44.539999999999999 113.69 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.9 m -103.05 139.09 39.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.956 0.408 . . . . 61.200000000000003 111.087 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.58 129.8 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.215 0.531 . . . . 75.25 111.787 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.2 mm-40 -90.87 139.43 30.75 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.882 -0.599 . . . . 74.030000000000001 109.692 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.467 ' CG ' HD23 ' A' ' 139' ' ' LEU . 28.5 p90 -146.04 122.96 11.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 71.25 111.695 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.79 -146.9 5.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.574 -0.739 . . . . 52.200000000000003 112.894 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.577 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 89.8 mt-30 -123.74 151.01 43.69 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.134 0.492 . . . . 74.239999999999995 111.981 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.2 133.69 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.106 -0.497 . . . . 75.409999999999997 111.252 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 4.0 pt20 -121.7 98.87 6.16 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.525 0.679 . . . . 75.209999999999994 110.982 171.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 151.21 -162.82 29.63 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.123 -0.56 . . . . 43.229999999999997 113.675 176.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.6 p -108.0 -169.86 1.59 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.068 0.547 . . . . 74.420000000000002 111.657 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.67 -47.04 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.1 0.476 . . . . 75.040000000000006 111.518 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -71.46 -48.07 51.63 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.195 0.443 . . . . 60.219999999999999 112.195 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.53 110.9 12.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.567 0.699 . . . . 72.049999999999997 112.627 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -140.48 154.5 46.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.735 -0.666 . . . . 73.230000000000004 111.157 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -122.86 134.37 54.39 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.135 0.493 . . . . 74.329999999999998 111.806 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -87.43 104.78 16.77 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.839 -0.619 . . . . 72.439999999999998 111.095 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.0 pt -113.93 162.67 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.18 0.192 . . . . 71.140000000000001 111.205 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 54.01 30.27 11.53 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.905 0.383 . . . . 62.549999999999997 111.973 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.84 124.34 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.313 0.578 . . . . 71.530000000000001 112.308 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -113.55 163.12 15.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.105 -0.498 . . . . 64.030000000000001 110.728 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -111.72 140.11 46.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 64.420000000000002 111.601 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -140.33 160.3 40.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.888 0.375 . . . . 61.240000000000002 111.272 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.83 136.75 41.14 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.026 -0.421 . . . . 75.409999999999997 111.712 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.27 141.05 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.578 -0.283 . . . . 74.099999999999994 110.886 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.28 115.94 17.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.806 0.336 . . . . 62.539999999999999 111.163 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.49 137.2 20.63 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.019 0.377 . . . . 64.200000000000003 112.019 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.85 165.24 31.75 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.585 2.19 . . . . 51.119999999999997 113.255 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.82 24.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.843 0.683 . . . . 72.219999999999999 112.843 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 m -93.61 112.04 23.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.086 -0.507 . . . . 72.019999999999996 110.53 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.33 -48.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.072 0.463 . . . . 73.200000000000003 111.23 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.01 151.52 25.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 73.129999999999995 110.852 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 91' ' ' PRO . . . -77.31 149.35 78.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.391 -0.368 . . . . 61.420000000000002 111.565 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.27 179.33 25.87 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.956 -1.268 . . . . 73.439999999999998 113.158 -0.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.2 m -87.59 86.75 7.24 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.465 -0.334 . . . . 74.349999999999994 111.655 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 22.2 p-10 -130.54 114.78 15.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.708 0.766 . . . . 73.540000000000006 111.567 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 134' ' ' ASP . 21.9 t -126.44 162.62 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.88 -0.6 . . . . 73.510000000000005 110.458 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 2.8 p-10 -142.53 137.24 30.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.03 0.443 . . . . 72.540000000000006 111.101 172.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.4 pt -131.06 131.98 23.53 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 120.801 0.334 . . . . 73.019999999999996 111.722 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.64 110.28 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.129 1.886 . . . . 73.420000000000002 112.56 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -92.57 127.47 38.07 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.47 -0.786 . . . . 75.420000000000002 110.387 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -103.72 101.11 10.94 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.983 0.42 . . . . 75.109999999999999 111.546 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.467 HD23 ' CG ' ' A' ' 101' ' ' TYR . 68.1 mt -85.97 128.1 34.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.085 -0.339 . . . . 72.549999999999997 110.085 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -119.22 141.22 49.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.104 0.478 . . . . 74.400000000000006 112.059 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.16 19.31 50.89 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.183 -0.462 . . . . 72.430000000000007 113.394 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.581 HD13 HD23 ' A' ' 147' ' ' LEU . 21.2 tt -155.71 134.07 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.08 0.467 . . . . 75.209999999999994 112.06 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m -78.75 154.18 30.2 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.296 -0.411 . . . . 73.310000000000002 111.93 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.41 -46.07 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.574 0.583 . . . . 64.219999999999999 112.574 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.57 -17.28 60.1 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.198 0.523 . . . . 75.120000000000005 110.927 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.456 ' HB3' HE21 ' A' ' 103' ' ' GLN . 87.3 mm-40 -93.31 7.37 44.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.368 -0.378 . . . . 61.43 111.642 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.581 HD23 HD13 ' A' ' 142' ' ' ILE . 29.6 mt -75.95 111.53 11.42 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.207 0.527 . . . . 73.430000000000007 111.357 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -86.45 -47.74 4.78 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.225 -0.512 . . . . 71.439999999999998 112.946 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.95 151.43 25.42 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.131 0.491 . . . . 72.209999999999994 112.223 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.35 97.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.808 -0.633 . . . . 54.329999999999998 109.738 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.792 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 ttt180 -94.87 99.41 11.46 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.309 0.485 . . . . 70.109999999999999 112.309 -172.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.543 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 11.9 mm -79.78 139.97 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 64.439999999999998 111.014 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -162.17 166.58 25.41 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.824 0.676 . . . . 73.530000000000001 112.824 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.84 37.11 15.65 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.962 0.727 . . . . 73.549999999999997 112.962 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.501 HD12 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -73.11 113.5 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.405 0.621 . . . . 74.340000000000003 111.283 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.644 ' HB3' HE21 ' A' ' 60' ' ' GLN . 10.6 pt20 -138.69 164.0 42.82 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.506 -0.77 . . . . 73.540000000000006 111.172 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.462 ' HD3' HG22 ' A' ' 61' ' ' ILE . 29.8 Cg_endo -63.03 146.18 94.54 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.01 1.807 . . . . 73.25 112.652 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 112.494 0.553 . . . . 55.119999999999997 112.494 -178.119 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.16 0.505 . . . . 65.010000000000005 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.514 ' HA ' HD13 ' A' ' 31' ' ' ILE . 25.2 m -69.05 -28.69 66.77 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 72.329999999999998 111.548 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.21 -44.32 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.061 0.457 . . . . 71.140000000000001 110.674 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.574 ' HE3' HD23 ' A' ' 48' ' ' LEU . 48.1 tptt -63.4 -41.72 98.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.391 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 28' ' ' THR . 87.3 mt -56.55 -49.0 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.028 -0.533 . . . . 73.420000000000002 110.869 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 60.7 m -58.71 -42.53 88.88 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.057 -0.52 . . . . 53.229999999999997 110.944 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.737 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -57.28 -46.22 83.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.886 0.374 . . . . 64.109999999999999 110.913 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.6 tt0 -58.47 -50.02 75.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.26 0.552 . . . . 74.239999999999995 111.379 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.57 -27.33 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.852 -0.613 . . . . 73.25 112.037 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 32' ' ' THR . 99.2 mtt180 -74.31 -41.29 61.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.03 -0.419 . . . . 73.239999999999995 111.146 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 48' ' ' LEU . 85.3 mt -65.57 -35.36 80.6 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.404 0.621 . . . . 70.319999999999993 110.469 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.508 ' ND2' HG13 ' A' ' 45' ' ' VAL . 26.2 t-20 -59.3 -37.35 77.51 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.604 -0.725 . . . . 74.129999999999995 110.809 172.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.2 96.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.933 0.396 . . . . 65.420000000000002 111.84 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -72.32 -22.18 61.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.14 0.422 . . . . 53.219999999999999 112.14 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -92.94 139.09 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.99 0.424 . . . . 73.299999999999997 111.626 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.8 m -75.02 -83.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.669 0.618 . . . . 43.420000000000002 112.669 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.0 m -97.54 -36.18 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.113 0.412 . . . . 64.439999999999998 112.113 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.0 177.49 53.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.113 -0.565 . . . . 70.450000000000003 112.802 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG13 ' ND2' ' A' ' 38' ' ' ASN . 27.6 m -135.83 152.19 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.535 0.683 . . . . 65.120000000000005 112.692 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.3 m-85 -98.42 102.53 14.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.667 -0.697 . . . . 74.409999999999997 110.255 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.2 mt -86.41 113.48 22.4 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.116 0.484 . . . . 74.239999999999995 111.115 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 8.8 mp -89.46 114.85 62.04 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.222 -0.444 . . . . 74.230000000000004 111.145 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.637 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 36.9 Cg_endo -64.48 11.47 0.11 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.224 2.616 . . . . 73.340000000000003 114.378 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.84 -10.58 26.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.205 -0.522 . . . . 62.450000000000003 112.683 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.66 127.74 53.93 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 70.019999999999996 111.546 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -79.23 17.46 0.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.813 0.34 . . . . 73.420000000000002 111.763 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -99.95 147.06 32.94 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 112.988 0.736 . . . . 73.109999999999999 112.988 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 66.8 Cg_endo -85.66 165.0 10.59 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.143 2.562 . . . . 74.230000000000004 113.25 174.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.6 133.94 29.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.487 -0.324 . . . . 37.549999999999997 110.984 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -97.02 122.82 40.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.381 . . . . 72.420000000000002 111.057 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.43 ' HB3' HG12 ' A' ' 45' ' ' VAL . 3.4 pp -120.69 159.57 25.09 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.932 0.396 . . . . 61.200000000000003 111.047 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.88 106.54 18.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.047 0.451 . . . . 60.109999999999999 110.823 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.1 p -99.69 178.47 4.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.094 -0.503 . . . . 72.010000000000005 111.046 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.587 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 50.2 mt-30 -76.89 0.58 20.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.373 -0.376 . . . . 73.0 111.94 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.02 -13.91 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.926 0.393 . . . . 73.409999999999997 111.16 171.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.75 -158.89 23.49 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.473 -0.394 . . . . 72.510000000000005 113.005 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 p -76.09 129.65 37.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.372 -0.487 . . . . 71.540000000000006 112.177 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 155' ' ' ILE . 3.1 pp -140.77 138.5 34.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.586 0.708 . . . . 74.420000000000002 110.889 170.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HB3' ' HB3' ' A' ' 85' ' ' GLN . 1.6 ttp180 -98.87 115.33 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.192 -0.913 . . . . 75.400000000000006 110.951 -175.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.612 ' SD ' HG22 ' A' ' 152' ' ' ILE . 58.6 mtt -110.17 154.54 23.2 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.928 0.394 . . . . 72.329999999999998 111.608 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 28.1 t -159.58 155.84 26.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.415 -0.357 . . . . 75.230000000000004 111.096 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.57 HD21 HD11 ' A' ' 80' ' ' LEU . 89.0 mt -107.35 105.8 15.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.883 0.373 . . . . 74.230000000000004 111.387 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' A' ' 81' ' ' THR . 31.8 m -115.97 162.76 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.573 -0.285 . . . . 62.219999999999999 111.312 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 60.62 34.14 20.22 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.121 0.486 . . . . 72.040000000000006 111.911 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.84 108.29 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.099 0.476 . . . . 71.540000000000006 111.855 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.47 150.62 74.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.129 0.418 . . . . 75.319999999999993 112.129 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.36 146.83 81.8 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.86 2.373 . . . . 64.129999999999995 113.231 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.621 ' HB2' HG21 ' A' ' 79' ' ' THR . 25.5 t70 -115.38 170.47 8.38 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 110.92 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.86 40.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.858 0.361 . . . . 37.549999999999997 111.478 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.66 -45.92 11.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.884 0.373 . . . . 64.120000000000005 111.488 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.01 -111.34 0.93 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.029 -0.605 . . . . 51.43 113.586 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -145.7 136.62 24.55 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.476 -0.426 . . . . 73.540000000000006 111.788 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.621 HG21 ' HB2' ' A' ' 74' ' ' ASP . 54.0 p -107.98 124.48 50.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.701 0.286 . . . . 62.399999999999999 111.581 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.57 HD11 HD21 ' A' ' 68' ' ' LEU . 3.2 pp -133.66 167.84 19.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.722 0.296 . . . . 75.409999999999997 111.298 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.504 ' HB ' HG22 ' A' ' 69' ' ' VAL . 26.4 m -113.14 116.63 30.14 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 111.729 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.431 HD12 ' SD ' ' A' ' 66' ' ' MET . 3.1 tm? -93.61 110.51 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.236 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -100.12 115.63 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.337 0.495 . . . . 72.299999999999997 112.337 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 84' ' ' ILE . 3.3 mp -95.38 147.45 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.853 0.461 . . . . 71.239999999999995 111.384 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 65' ' ' ARG . 64.9 tt0 -146.02 106.61 4.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.482 0.313 . . . . 72.230000000000004 110.335 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.34 27.54 0.84 Allowed Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.257 0.863 . . . . 53.200000000000003 115.257 -171.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 59.98 -68.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 74.150000000000006 112.097 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 m -61.87 144.66 54.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.757 0.423 . . . . 75.430000000000007 111.83 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 43.6 m-80 -74.36 -26.57 60.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.613 -0.267 . . . . 73.319999999999993 111.654 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.96 131.62 79.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 112.162 0.43 . . . . 73.310000000000002 112.162 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 26.1 Cg_endo -60.8 115.77 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.009 2.473 . . . . 74.200000000000003 113.308 -176.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.64 151.98 42.92 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.285 -0.416 . . . . 75.430000000000007 111.537 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.66 176.38 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.998 . . . . 74.230000000000004 112.536 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 158' ' ' VAL . . . -68.15 163.25 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.698 0.285 . . . . 61.340000000000003 111.382 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -158.33 148.73 20.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.555 0.693 . . . . 72.400000000000006 112.282 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.3 p -127.51 168.64 14.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.417 -0.811 . . . . 74.329999999999998 110.726 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.67 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -173.04 167.6 40.44 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.214 -0.994 . . . . 72.109999999999999 114.183 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -99.26 116.88 32.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.478 0.311 . . . . 74.010000000000005 111.05 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 119' ' ' GLN . 34.0 m -109.79 113.08 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.436 0.636 . . . . 73.239999999999995 111.364 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.2 mt-10 -97.03 110.82 23.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.94 0.4 . . . . 75.219999999999999 111.353 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -106.74 138.45 42.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.443 -0.344 . . . . 74.319999999999993 111.134 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.15 -164.59 27.11 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.839 -0.696 . . . . 73.219999999999999 113.514 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.583 ' HB2' HG13 ' A' ' 114' ' ' ILE . 52.7 mt-30 -105.79 157.42 17.47 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.909 0.385 . . . . 73.319999999999993 110.9 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.72 142.68 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.714 0.293 . . . . 45.409999999999997 111.233 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 4.1 pt20 -138.9 103.1 4.72 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.362 0.601 . . . . 73.340000000000003 110.577 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.43 -162.79 31.27 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.197 -0.525 . . . . 72.0 113.51 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.8 p -105.82 -178.37 3.63 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.871 0.367 . . . . 63.130000000000003 111.213 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.737 HD11 ' HG3' ' A' ' 33' ' ' GLN . 30.2 mm -62.72 -27.78 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.174 0.511 . . . . 55.43 111.013 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -81.72 -55.95 4.31 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.991 -0.55 . . . . 73.030000000000001 110.895 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -117.8 84.39 2.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.389 0.614 . . . . 74.140000000000001 112.003 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 107' ' ' THR . 31.0 p90 -107.86 123.74 49.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.079 -0.51 . . . . 72.340000000000003 110.697 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -94.58 117.8 30.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.982 0.42 . . . . 74.310000000000002 111.525 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.67 101.87 5.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.008 -0.542 . . . . 75.420000000000002 110.386 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.583 HG13 ' HB2' ' A' ' 103' ' ' GLN . 36.2 pt -112.61 150.91 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.732 0.301 . . . . 64.519999999999996 111.807 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 54.38 34.49 20.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.958 0.409 . . . . 63.109999999999999 112.069 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.4 130.13 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.23 0.538 . . . . 74.5 112.13 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.55 156.8 48.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.791 -0.64 . . . . 52.200000000000003 110.269 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 8.9 p30 -103.3 153.63 20.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.46 0.911 . . . . 73.530000000000001 113.46 -171.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.405 ' O ' HG21 ' A' ' 99' ' ' VAL . 8.4 tt0 -133.05 150.59 52.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.296 -0.865 . . . . 71.109999999999999 109.921 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -94.84 123.13 38.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.018 0.437 . . . . 72.319999999999993 111.954 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.689 HG23 HD21 ' A' ' 137' ' ' LEU . 41.6 pt -100.53 138.9 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 70.540000000000006 111.409 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.92 105.23 6.64 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.419 -0.355 . . . . 75.040000000000006 111.103 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.27 139.48 22.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.61 -0.268 . . . . 62.039999999999999 111.461 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.44 ' HD2' HG11 ' A' ' 133' ' ' VAL . 38.3 Cg_exo -61.17 158.7 33.61 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.008 2.472 . . . . 64.409999999999997 113.85 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.83 130.73 41.79 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.987 -0.551 . . . . 62.109999999999999 111.703 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.1 m -91.95 101.12 13.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.87 0.366 . . . . 70.430000000000007 110.993 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 p -89.0 -21.28 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.188 0.518 . . . . 72.310000000000002 110.925 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.7 mt -101.6 165.36 11.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.181 0.515 . . . . 74.25 111.649 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -114.65 147.41 38.08 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 62.350000000000001 111.105 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 84.3 Cg_endo -83.48 169.94 54.96 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.837 -1.318 . . . . 64.329999999999998 113.529 -1.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 m -83.56 83.07 8.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.478 0.547 . . . . 71.420000000000002 112.478 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.422 ' OD1' ' HG2' ' A' ' 130' ' ' PRO . 4.6 p-10 -136.57 118.23 14.97 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.482 0.658 . . . . 72.349999999999994 111.244 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.44 HG11 ' HD2' ' A' ' 124' ' ' PRO . 46.5 t -122.23 150.74 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.0 -0.546 . . . . 74.219999999999999 111.385 -173.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -124.4 110.2 14.26 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.359 0.6 . . . . 74.439999999999998 111.557 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.0 pt -112.62 136.35 21.54 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 112.23 0.456 . . . . 73.040000000000006 112.23 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.85 146.34 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.836 2.358 . . . . 60.43 113.416 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.689 HD21 HG23 ' A' ' 121' ' ' ILE . 63.0 mt -132.14 117.17 17.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.191 -0.459 . . . . 72.5 112.101 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -96.37 94.43 7.43 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.189 0.519 . . . . 74.319999999999993 110.206 171.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.7 110.05 10.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.346 0.593 . . . . 75.510000000000005 110.207 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.688 ' HB2' ' HZ3' ' A' ' 140' ' ' LYS . 10.5 mtmp? -83.94 150.4 25.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.612 -0.722 . . . . 70.239999999999995 112.39 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.61 13.81 74.77 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.722 0.649 . . . . 44.119999999999997 114.722 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 147' ' ' LEU . 19.7 tt -144.5 128.43 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.03 0.915 . . . . 72.439999999999998 112.4 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.6 m -84.17 146.24 27.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.165 -0.47 . . . . 62.130000000000003 111.302 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' A' ' 147' ' ' LEU . 8.0 p -56.88 -34.77 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.524 0.564 . . . . 74.540000000000006 112.524 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.58 -32.95 70.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.161 0.505 . . . . 72.340000000000003 111.082 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.454 ' HB3' HE21 ' A' ' 103' ' ' GLN . 32.0 mm-40 -97.38 5.08 50.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.317 0.488 . . . . 73.430000000000007 112.317 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.637 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 17.1 mt -69.99 96.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.266 0.555 . . . . 72.230000000000004 111.156 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.32 -41.22 11.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.863 -0.608 . . . . 73.409999999999997 113.193 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.89 157.02 23.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.186 0.517 . . . . 71.430000000000007 111.998 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.21 101.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.773 -0.649 . . . . 74.030000000000001 109.82 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 51.5 ttt180 -83.97 105.04 14.54 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.151 -0.477 . . . . 74.430000000000007 111.928 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.612 HG22 ' SD ' ' A' ' 66' ' ' MET . 21.8 mm -90.72 121.4 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 116.535 -0.302 . . . . 72.129999999999995 111.639 -177.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -159.24 178.24 10.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.322 0.49 . . . . 74.430000000000007 112.322 176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.77 18.54 11.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.883 0.697 . . . . 70.430000000000007 112.883 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.67 HD13 ' HA3' ' A' ' 97' ' ' GLY . 36.2 mm -63.19 113.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.021 0.439 . . . . 72.530000000000001 111.317 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.587 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 8.9 pt20 -136.2 153.83 76.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.007 0.523 . . . . 75.150000000000006 111.831 -173.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.87 135.05 22.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.605 2.203 . . . . 73.439999999999998 113.754 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 6.0 p . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.119 0.485 . . . . 75.239999999999995 110.942 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.061 0.458 . . . . 72.349999999999994 111.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.4 m -68.53 -28.23 66.8 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.248 -0.433 . . . . 73.450000000000003 111.326 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.93 -48.98 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.711 0.291 . . . . 73.420000000000002 111.164 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 14.4 mptt -59.83 -47.69 84.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.923 0.392 . . . . 65.519999999999996 111.19 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.18 -49.45 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.936 0.398 . . . . 74.319999999999993 111.382 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.7 m -57.27 -43.49 83.11 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.995 0.426 . . . . 75.540000000000006 111.136 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.676 ' HG3' HD12 ' A' ' 108' ' ' ILE . 63.8 tt0 -59.06 -44.63 91.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.27 -0.423 . . . . 74.150000000000006 111.394 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.29 -44.17 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.376 . . . . 74.099999999999994 111.256 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -63.31 -36.8 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.827 0.306 . . . . 71.519999999999996 111.827 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.99 -50.13 67.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.947 0.403 . . . . 74.140000000000001 110.914 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.62 -40.01 95.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.071 0.463 . . . . 71.329999999999998 111.32 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.29 -39.22 89.62 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.196 -0.456 . . . . 61.109999999999999 110.814 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.99 74.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.302 -0.408 . . . . 37.960000000000001 111.588 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.32 0.83 57.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.039 0.447 . . . . 71.099999999999994 111.794 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 46' ' ' TYR . 25.3 t -77.63 103.43 7.57 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.965 0.412 . . . . 74.340000000000003 111.112 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 t -88.28 -23.05 23.58 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.961 0.41 . . . . 61.450000000000003 111.743 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.4 p -131.27 104.45 7.05 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.261 -0.427 . . . . 61.119999999999997 111.054 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.93 -162.03 35.24 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.288 -0.482 . . . . 40.509999999999998 112.89 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.9 145.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.478 -0.425 . . . . 74.219999999999999 111.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.54 ' HD2' ' HB2' ' A' ' 41' ' ' SER . 46.7 m-85 -97.06 120.6 37.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.847 0.356 . . . . 75.420000000000002 111.909 176.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.55 136.08 52.51 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.991 -0.549 . . . . 65.25 109.814 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . 63.8 mt -107.1 130.15 23.29 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 122.17 -0.332 . . . . 74.349999999999994 111.351 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 26.4 Cg_endo -60.3 -30.11 90.36 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.528 2.152 . . . . 64.519999999999996 112.807 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.64 -12.95 80.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.337 -0.458 . . . . 73.120000000000005 112.985 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . . . -120.83 76.66 1.22 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.067 0.46 . . . . 64.209999999999994 111.116 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.54 80.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.292 -0.413 . . . . 72.319999999999993 111.789 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 p -136.22 152.59 75.51 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 112.091 0.404 . . . . 73.340000000000003 112.091 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 59.9 Cg_endo -71.02 146.61 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.099 2.533 . . . . 73.299999999999997 114.151 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.81 32.96 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.83 -0.623 . . . . 53.0 110.78 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -85.9 139.93 30.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.014 0.435 . . . . 63.219999999999999 111.949 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -144.3 129.78 18.97 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.989 -0.55 . . . . 64.049999999999997 111.026 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -83.23 139.82 32.89 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.325 0.583 . . . . 72.120000000000005 110.761 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.1 p -124.32 -174.89 3.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 74.420000000000002 111.369 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.528 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.3 mt-30 -90.81 11.52 22.22 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 53.329999999999998 111.353 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.4 pt -121.67 -4.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.884 0.373 . . . . 75.329999999999998 111.179 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.34 -167.83 24.84 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.288 -0.415 . . . . 71.299999999999997 112.459 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.8 m -93.95 122.12 36.11 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.19 -0.594 . . . . 73.349999999999994 111.301 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -123.41 -176.4 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.919 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -151.7 104.93 3.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.208 0.528 . . . . 73.239999999999995 110.709 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.842 ' HE2' HD13 ' A' ' 82' ' ' LEU . 86.5 mtp -101.33 165.67 11.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.66 0.615 . . . . 74.140000000000001 112.66 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 46.5 t -162.77 167.03 23.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.046 0.451 . . . . 63.039999999999999 111.793 178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 80' ' ' LEU . 90.5 mt -117.73 123.27 45.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.062 -0.517 . . . . 62.130000000000003 111.688 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.689 HG22 HD21 ' A' ' 70' ' ' ASN . 27.6 m -138.1 171.41 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 116.64 -0.255 . . . . 63.340000000000003 111.359 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.689 HD21 HG22 ' A' ' 69' ' ' VAL . 46.7 m-80 56.49 33.08 21.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.614 0.598 . . . . 63.439999999999998 112.614 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.3 mt -71.79 109.17 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.023 0.44 . . . . 75.329999999999998 111.901 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -134.79 152.7 77.98 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 116.24 -0.436 . . . . 64.439999999999998 112.026 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 136.99 34.16 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.65 2.234 . . . . 41.219999999999999 112.358 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' HG21 ' A' ' 79' ' ' THR . 33.9 t70 -113.72 156.58 23.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.737 0.303 . . . . 75.109999999999999 111.44 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.37 69.02 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.358 0.503 . . . . 55.240000000000002 112.358 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -101.15 -29.56 12.05 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.975 0.416 . . . . 74.349999999999994 111.412 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.44 -102.06 0.16 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.05 -0.595 . . . . 50.549999999999997 113.104 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.3 m -151.62 128.19 10.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.567 -0.373 . . . . 63.43 110.815 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 138' ' ' GLN . 35.3 p -107.49 132.66 52.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.154 0.502 . . . . 75.439999999999998 111.824 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 68' ' ' LEU . 3.5 pp -148.31 143.22 26.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.135 -0.484 . . . . 71.140000000000001 110.996 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.586 ' HB ' HG22 ' A' ' 69' ' ' VAL . 56.0 m -81.54 116.49 21.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 70.010000000000005 111.358 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.842 HD13 ' HE2' ' A' ' 66' ' ' MET . 3.5 tm? -88.35 116.91 26.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.931 -0.577 . . . . 41.310000000000002 109.814 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -98.55 137.36 37.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.768 0.318 . . . . 73.120000000000005 111.336 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -117.93 90.53 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.887 0.375 . . . . 70.310000000000002 110.921 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 120.86 24.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 73.299999999999997 110.164 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.16 122.67 6.26 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.327 -0.94 . . . . 61.130000000000003 112.786 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -51.0 -39.83 56.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.467 0.651 . . . . 74.349999999999994 109.869 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 m -74.54 117.03 15.9 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.171 -0.922 . . . . 72.120000000000005 110.35 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -60.44 -31.68 70.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.016 0.436 . . . . 65.319999999999993 111.38 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.15 149.02 98.17 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.763 -0.653 . . . . 61.439999999999998 111.898 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 19.2 Cg_endo -58.31 124.38 15.75 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.146 2.564 . . . . 72.030000000000001 114.172 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.8 mt -84.1 149.02 54.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.518 -0.31 . . . . 72.439999999999998 111.33 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.06 173.95 13.63 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.422 2.082 . . . . 62.399999999999999 113.098 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 125' ' ' ALA . . . -72.35 141.94 48.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 52.530000000000001 111.725 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.38 161.51 41.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.169 0.509 . . . . 73.209999999999994 112.291 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 81.1 p -125.09 151.69 45.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.862 -0.608 . . . . 71.140000000000001 109.992 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -144.9 154.67 26.03 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.429 -0.891 . . . . 54.340000000000003 113.904 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.2 m -97.99 106.56 18.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.414 0.285 . . . . 72.439999999999998 110.965 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.466 HG13 HD11 ' A' ' 152' ' ' ILE . 15.9 m -95.58 136.07 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.975 0.416 . . . . 70.150000000000006 111.159 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 151' ' ' ARG . 50.6 mt-10 -115.17 114.37 25.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.25 -0.432 . . . . 73.450000000000003 111.092 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -121.47 123.63 42.51 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.975 0.417 . . . . 63.439999999999998 111.645 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.24 -146.9 4.95 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.324 -0.465 . . . . 37.960000000000001 113.234 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.481 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 97.0 mt-30 -126.98 155.98 42.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.494 0.664 . . . . 72.329999999999998 112.333 -176.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.36 131.48 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.836 -0.62 . . . . 61.409999999999997 110.329 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -102.08 -2.9 28.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.268 0.84 . . . . 71.530000000000001 113.268 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.34 -158.99 9.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.274 -0.965 . . . . 64.120000000000005 114.619 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.5 p -99.27 -176.76 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.074 0.464 . . . . 62.240000000000002 111.831 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.676 HD12 ' HG3' ' A' ' 33' ' ' GLN . 44.4 mm -70.4 -24.92 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.188 0.518 . . . . 73.219999999999999 111.157 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.81 -43.06 14.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.346 -0.388 . . . . 72.420000000000002 111.695 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.81 115.91 8.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.24 0.543 . . . . 65.230000000000004 111.588 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.36 163.07 36.72 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.138 0.494 . . . . 72.030000000000001 111.978 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -132.82 129.34 38.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.978 -0.555 . . . . 73.409999999999997 110.35 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 2.4 mp0 -81.08 105.9 12.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.36 -0.382 . . . . 74.450000000000003 111.166 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.3 pt -111.11 160.37 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.292 0.478 . . . . 61.32 112.292 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.89 21.12 8.77 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.871 0.693 . . . . 52.149999999999999 112.871 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.07 137.92 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.79 0.663 . . . . 74.549999999999997 112.79 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -117.92 161.13 20.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.728 -0.669 . . . . 73.549999999999997 110.804 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -110.68 151.62 27.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.349 -0.387 . . . . 63.109999999999999 111.282 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.15 145.07 28.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.526 -0.306 . . . . 74.319999999999993 110.403 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.72 112.07 24.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.675 0.274 . . . . 75.430000000000007 111.556 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 96' ' ' SER . 38.8 pt -94.56 116.94 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.089 0.471 . . . . 73.420000000000002 111.195 177.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.21 105.68 16.39 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.977 0.417 . . . . 72.140000000000001 111.067 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.9 146.69 35.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.488 -0.324 . . . . 42.009999999999998 111.847 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 169.79 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.947 2.431 . . . . 54.539999999999999 113.287 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.47 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . . . -89.1 127.76 35.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.476 -0.329 . . . . 73.329999999999998 111.798 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -86.25 135.06 33.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.091 0.472 . . . . 73.109999999999999 111.388 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.564 HG21 ' HG ' ' A' ' 128' ' ' LEU . 35.9 m -117.78 4.08 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 111.871 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.564 ' HG ' HG21 ' A' ' 127' ' ' VAL . 96.3 mt -136.59 170.36 16.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.281 0.562 . . . . 74.549999999999997 111.941 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.58 145.47 47.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.97 -0.559 . . . . 55.32 111.174 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 156.08 97.49 Favored 'Cis proline' 0 C--N 1.355 0.889 0 C-N-CA 124.164 -1.181 . . . . 55.329999999999998 113.354 0.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 31.7 t -95.35 83.74 3.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.644 0.609 . . . . 72.340000000000003 112.644 -176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -119.93 108.68 14.63 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.289 0.566 . . . . 65.25 110.179 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.47 144.07 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.413 0.524 . . . . 73.349999999999994 112.413 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.56 121.36 41.52 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.755 0.312 . . . . 71.219999999999999 111.584 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.1 pt -132.44 125.81 19.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 120.799 0.333 . . . . 65.439999999999998 111.559 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.69 115.6 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.312 2.008 . . . . 62.229999999999997 112.876 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.81 111.01 22.37 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.973 -0.558 . . . . 63.32 109.986 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.498 ' HG3' HG22 ' A' ' 79' ' ' THR . 7.6 tt0 -101.33 101.36 12.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.103 0.477 . . . . 74.209999999999994 111.365 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.3 mt -89.06 149.13 23.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.394 -0.367 . . . . 64.109999999999999 111.767 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.86 150.53 41.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.961 0.41 . . . . 74.040000000000006 111.764 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.1 29.01 73.7 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.461 0.545 . . . . 61.409999999999997 114.461 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -158.73 135.15 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 122.394 -0.474 . . . . 74.239999999999995 111.474 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.3 m -101.39 148.92 24.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 111.673 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -52.49 -51.93 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 113.317 0.858 . . . . 72.239999999999995 113.317 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.97 -17.49 62.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.157 0.503 . . . . 75.239999999999995 111.094 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -98.54 -1.65 40.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.097 -0.501 . . . . 72.030000000000001 111.739 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.559 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 1.5 tt -79.53 129.36 34.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.916 0.389 . . . . 73.030000000000001 110.486 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.66 -58.07 1.37 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.313 -0.47 . . . . 62.109999999999999 113.655 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 113' ' ' GLU . 22.6 p90 -146.39 157.52 43.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.106 0.479 . . . . 74.340000000000003 112.211 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.1 t -130.47 100.09 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.942 -0.572 . . . . 75.420000000000002 110.374 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 100' ' ' GLU . 35.4 ttm180 -94.68 125.41 39.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.19 -0.319 . . . . 73.25 111.404 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.488 HG21 ' HE1' ' A' ' 66' ' ' MET . 19.0 mm -105.35 140.25 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 65.409999999999997 111.491 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -168.93 173.87 6.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.989 0.366 . . . . 74.5 111.989 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.26 40.62 17.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.62 0.6 . . . . 72.120000000000005 112.62 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.469 HG21 HD22 ' A' ' 64' ' ' LEU . 42.5 mm -73.57 104.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.04 0.447 . . . . 75.420000000000002 110.221 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.528 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.0 pt20 -123.98 146.3 50.62 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 116.277 -0.419 . . . . 74.430000000000007 111.962 -171.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.71 141.4 37.59 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.415 2.077 . . . . 73.209999999999994 112.981 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.539 0.547 0 O-C-N 122.275 -0.265 . . . . 73.510000000000005 110.749 176.647 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.357 0.599 . . . . 72.109999999999999 110.978 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -65.88 -21.06 66.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.948 -0.569 . . . . 73.099999999999994 111.827 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.99 -47.76 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.973 0.416 . . . . 75.430000000000007 110.409 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HE2' HD23 ' A' ' 48' ' ' LEU . 17.3 tptm -63.29 -36.93 85.31 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.19 0.519 . . . . 74.5 109.958 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.2 mt -59.56 -50.41 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.172 -0.467 . . . . 61.539999999999999 111.292 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.3 m -54.42 -41.7 69.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.958 0.409 . . . . 75.129999999999995 111.082 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.662 ' HG3' HD12 ' A' ' 108' ' ' ILE . 62.8 tt0 -61.89 -44.43 96.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.441 -0.345 . . . . 72.450000000000003 110.892 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.497 ' NE2' ' HG1' ' A' ' 53' ' ' THR . 28.9 tt0 -56.85 -40.89 76.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.435 -0.348 . . . . 71.329999999999998 111.459 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.6 -50.28 73.65 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.103 0.477 . . . . 75.400000000000006 111.335 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.29 -41.72 99.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.164 -0.471 . . . . 74.340000000000003 111.325 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.895 0.378 . . . . 73.299999999999997 111.005 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.56 -29.18 70.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.088 0.471 . . . . 71.420000000000002 110.693 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.13 70.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.218 -0.446 . . . . 71.209999999999994 111.245 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -95.01 12.23 29.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.362 0.505 . . . . 75.010000000000005 112.362 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -67.35 88.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.949 0.404 . . . . 73.120000000000005 111.551 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -66.99 -56.76 8.73 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.195 0.443 . . . . 71.219999999999999 112.195 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.2 p -138.23 105.06 5.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.164 0.507 . . . . 72.010000000000005 111.226 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 92.12 142.97 11.48 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.176 -0.535 . . . . 38.740000000000002 112.956 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 27.2 m -86.35 148.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 112.472 0.545 . . . . 71.120000000000005 112.472 -173.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -95.25 114.26 26.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.007 -0.542 . . . . 65.340000000000003 112.031 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.02 103.72 13.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.895 0.378 . . . . 74.439999999999998 110.727 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.419 HD13 ' HG3' ' A' ' 34' ' ' GLN . 7.2 mp -82.37 121.96 78.76 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 122.306 -0.246 . . . . 74.519999999999996 111.035 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 52.9 Cg_exo -54.94 -32.57 78.95 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.918 2.412 . . . . 71.549999999999997 113.726 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.17 11.37 63.12 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.113 -0.565 . . . . 65.450000000000003 113.415 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.44 129.6 56.27 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.012 0.434 . . . . 73.519999999999996 111.794 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 85.8 tttt -84.85 32.32 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.487 0.661 . . . . 71.239999999999995 111.253 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.497 ' HG1' ' NE2' ' A' ' 34' ' ' GLN . 1.3 p -128.13 133.88 25.62 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 113.445 0.906 . . . . 73.319999999999993 113.445 -176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.29 179.06 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.431 2.754 . . . . 64.219999999999999 113.066 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.76 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.062 0.458 . . . . 73.120000000000005 111.801 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -91.77 124.89 36.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.96 0.409 . . . . 72.219999999999999 111.015 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.8 tp -120.59 138.33 53.94 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.464 0.542 . . . . 75.340000000000003 112.464 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.5 117.13 22.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.945 -0.57 . . . . 72.129999999999995 110.229 172.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -118.14 173.92 6.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.935 0.398 . . . . 75.140000000000001 111.488 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 48.0 mt-30 -79.24 1.41 24.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.194 0.442 . . . . 74.450000000000003 112.194 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 157' ' ' PRO . 38.5 pt -105.37 -34.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.983 0.42 . . . . 72.530000000000001 110.693 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.46 -156.5 28.32 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.108 -0.496 . . . . 72.430000000000007 112.428 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.9 m -98.36 124.33 42.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.951 0.405 . . . . 72.329999999999998 110.994 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.99 170.75 15.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.809 0.337 . . . . 63.43 111.905 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -134.25 116.1 14.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.471 0.309 . . . . 71.540000000000006 110.526 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.733 ' SD ' HG23 ' A' ' 152' ' ' ILE . 65.1 mtt -107.4 155.32 20.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.685 0.624 . . . . 53.020000000000003 112.685 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.8 p -154.78 157.76 38.45 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.083 -0.508 . . . . 64.5 111.357 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.59 125.93 50.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.556 -0.293 . . . . 64.340000000000003 111.677 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.58 HG22 HD21 ' A' ' 70' ' ' ASN . 23.9 m -137.6 169.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.65 0.262 . . . . 62.5 111.416 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.58 HD21 HG22 ' A' ' 69' ' ' VAL . 40.9 m-80 55.54 26.72 9.37 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.543 0.571 . . . . 75.319999999999993 112.543 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.451 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 53.5 mt -60.67 111.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.819 0.342 . . . . 71.109999999999999 111.426 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 151.8 77.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.464 0.542 . . . . 72.010000000000005 112.464 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.61 118.8 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.888 2.392 . . . . 73.129999999999995 112.521 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.414 ' HB2' HG23 ' A' ' 79' ' ' THR . 28.6 t70 -100.37 164.61 11.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.398 -0.365 . . . . 73.310000000000002 111.603 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.57 92.28 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 72.120000000000005 111.828 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.85 -41.36 15.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.939 0.4 . . . . 74.540000000000006 111.404 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.21 -94.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.439 -0.886 . . . . 72.340000000000003 114.07 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.5 m -143.71 120.36 11.13 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.562 -0.375 . . . . 73.530000000000001 112.002 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' HB2' ' A' ' 74' ' ' ASP . 8.0 p -96.83 118.71 33.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 62.310000000000002 111.127 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.1 pp -132.9 -172.47 2.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.38 -0.373 . . . . 64.439999999999998 111.261 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.557 ' HB ' HG22 ' A' ' 69' ' ' VAL . 31.2 m -130.12 111.1 12.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.88 0.371 . . . . 64.510000000000005 110.661 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.7 112.88 20.46 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 60.140000000000001 110.04 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtm180 -93.96 124.72 38.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.526 -0.306 . . . . 75.420000000000002 111.61 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -110.34 97.3 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.473 -0.33 . . . . 71.340000000000003 111.05 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.22 108.09 20.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.582 -0.525 . . . . 71.140000000000001 109.582 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.22 140.16 29.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.887 -0.673 . . . . 73.5 113.261 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.83 -21.33 57.38 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.384 0.611 . . . . 72.299999999999997 110.075 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -64.83 118.46 9.03 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.27 -0.877 . . . . 73.109999999999999 111.994 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -71.88 -14.03 61.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.202 0.525 . . . . 72.430000000000007 110.905 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -97.86 149.42 35.7 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.837 -0.62 . . . . 71.439999999999998 110.913 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -65.68 137.36 49.65 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.606 2.204 . . . . 72.430000000000007 113.365 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.17 158.42 31.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.418 -0.356 . . . . 72.420000000000002 111.296 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.55 -165.14 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.205 1.937 . . . . 61.210000000000001 112.43 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.92 156.13 22.51 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.278 -0.264 . . . . 53.119999999999997 110.81 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -150.19 162.86 39.63 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.585 0.707 . . . . 74.25 112.681 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 p -157.74 154.36 28.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.216 -0.902 . . . . 72.239999999999995 110.492 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.614 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -164.39 -175.23 35.0 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.278 -0.963 . . . . 70.200000000000003 114.039 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 m -111.23 145.43 38.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.494 0.318 . . . . 73.120000000000005 110.852 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.0 p -124.13 128.84 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.253 0.464 . . . . 75.25 112.253 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 29.8 mm-40 -98.2 110.37 22.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.248 -0.433 . . . . 73.150000000000006 110.325 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.462 ' HD2' HG23 ' A' ' 142' ' ' ILE . 12.4 p90 -121.7 118.24 28.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.287 0.565 . . . . 75.120000000000005 112.064 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.18 -153.43 6.75 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.714 -0.675 . . . . 50.240000000000002 113.01 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 77.3 mt-30 -119.29 145.77 45.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.089 0.471 . . . . 71.400000000000006 112.27 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.96 104.69 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 75.230000000000004 110.606 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.585 HE21 HD12 ' A' ' 114' ' ' ILE . 8.8 pt20 -89.36 -11.89 42.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.839 0.681 . . . . 74.319999999999993 112.839 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.11 -168.64 15.69 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.86 -0.686 . . . . 43.310000000000002 114.025 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 45.8 p -92.12 -176.66 4.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.703 0.401 . . . . 64.25 111.387 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.662 HD12 ' HG3' ' A' ' 33' ' ' GLN . 50.8 mm -74.36 -26.89 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.255 0.55 . . . . 44.539999999999999 110.622 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.9 -35.99 56.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.911 -0.586 . . . . 61.450000000000003 110.851 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.66 97.43 2.97 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.124 0.488 . . . . 75.340000000000003 111.908 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -122.64 151.27 41.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.277 0.56 . . . . 73.430000000000007 111.606 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -132.36 117.81 18.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.876 -0.602 . . . . 64.319999999999993 110.402 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.99 108.16 5.75 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.918 0.389 . . . . 71.010000000000005 111.091 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.585 HD12 HE21 ' A' ' 105' ' ' GLN . 34.6 pt -113.41 152.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.418 -0.356 . . . . 74.420000000000002 111.041 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 57.6 32.89 22.53 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.957 0.408 . . . . 71.019999999999996 111.297 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.96 124.72 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.375 0.607 . . . . 74.230000000000004 112.127 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -114.88 157.51 23.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.029 -0.532 . . . . 71.430000000000007 110.524 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 7.0 p30 -112.22 153.74 26.64 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.807 0.337 . . . . 72.129999999999995 111.139 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -153.39 154.05 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.691 0.282 . . . . 75.530000000000001 111.456 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -92.18 122.86 35.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.084 0.401 . . . . 73.430000000000007 112.084 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.9 pt -112.73 120.83 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.088 0.47 . . . . 73.450000000000003 111.516 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -118.03 139.73 50.77 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.259 -0.275 . . . . 72.230000000000004 111.13 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.87 149.69 73.04 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.182 0.438 . . . . 74.030000000000001 112.182 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.11 164.21 20.38 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.351 2.701 . . . . 74.219999999999999 113.988 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.35 26.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.976 -0.556 . . . . 74.439999999999998 111.979 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.2 m -83.3 55.01 2.99 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.891 0.377 . . . . 62.520000000000003 111.413 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.29 -2.39 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.473 0.916 . . . . 55.340000000000003 113.473 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.01 124.27 30.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.164 -0.335 . . . . 74.140000000000001 111.226 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.36 56.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.651 -0.249 . . . . 64.040000000000006 111.379 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.14 156.84 94.29 Favored 'Cis proline' 0 C--N 1.355 0.901 0 C-N-CA 123.863 -1.307 . . . . 65.299999999999997 112.972 -0.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 p -80.43 57.25 2.78 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.129 0.49 . . . . 74.319999999999993 112.17 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.11 89.92 8.18 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.087 0.47 . . . . 75.129999999999995 110.084 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.66 154.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.268 -0.424 . . . . 74.230000000000004 111.714 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -142.89 144.79 32.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.791 0.329 . . . . 75.340000000000003 110.982 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.1 128.39 11.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.651 0.262 . . . . 74.120000000000005 111.705 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.71 142.06 47.15 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.286 1.991 . . . . 71.239999999999995 112.009 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.48 123.28 20.0 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.625 -0.261 . . . . 73.010000000000005 111.212 -172.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -102.1 102.91 13.44 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.121 0.486 . . . . 63.130000000000003 111.309 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 71.9 mt -83.55 128.22 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.573 -0.285 . . . . 62.329999999999998 110.267 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -103.47 142.93 33.4 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.609 0.596 . . . . 74.530000000000001 112.609 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.75 80.44 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.863 -0.608 . . . . 61.409999999999997 114.136 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.462 HG23 ' HD2' ' A' ' 101' ' ' TYR . 16.1 tt -149.51 114.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 117.485 0.643 . . . . 74.310000000000002 112.042 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 64.6 m -80.47 155.03 27.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.078 0.466 . . . . 70.010000000000005 112.214 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.05 -47.99 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 113.372 0.879 . . . . 74.430000000000007 113.372 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.91 -16.52 64.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.134 0.492 . . . . 73.120000000000005 111.341 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.526 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 29.7 mm-40 -108.66 11.56 26.43 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.334 -0.394 . . . . 74.030000000000001 111.68 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -88.94 108.18 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.071 0.462 . . . . 63.43 110.246 178.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.98 -55.43 3.13 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.125 -0.56 . . . . 63.329999999999998 113.661 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -145.09 152.53 40.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.973 0.416 . . . . 74.120000000000005 111.831 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.63 94.09 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.885 -0.598 . . . . 64.510000000000005 110.31 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 68.7 ttt180 -89.05 107.2 18.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.755 0.422 . . . . 71.540000000000006 111.974 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.733 HG23 ' SD ' ' A' ' 66' ' ' MET . 35.9 mm -89.12 126.44 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.468 -0.333 . . . . 74.349999999999994 111.432 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.567 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.9 p80 -154.96 177.56 11.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.156 0.428 . . . . 72.400000000000006 112.156 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 64.4 23.14 12.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.092 0.557 . . . . 72.329999999999998 112.414 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.614 HD12 ' HA3' ' A' ' 97' ' ' GLY . 51.0 mm -67.57 95.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.643 0.735 . . . . 74.299999999999997 112.073 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 60' ' ' GLN . 9.0 pt20 -116.78 151.56 47.42 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.266 -0.879 . . . . 72.239999999999995 111.449 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HB3' HG21 ' A' ' 61' ' ' ILE . 58.2 Cg_endo -70.47 128.62 15.63 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 72.329999999999998 113.786 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.545 0.788 0 CA-C-O 121.849 0.833 . . . . 71.439999999999998 110.886 176.271 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 31' ' ' ILE . 40.5 tt0 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 121.236 0.541 . . . . 71.129999999999995 109.91 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.713 ' HA ' HD13 ' A' ' 31' ' ' ILE . 18.6 m -62.1 -37.51 85.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.876 -0.602 . . . . 73.400000000000006 111.389 176.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.07 -40.64 86.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.138 0.494 . . . . 74.510000000000005 110.753 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.623 ' HE3' HD12 ' A' ' 48' ' ' LEU . 43.5 tptt -64.34 -37.15 86.47 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.065 -0.516 . . . . 71.129999999999995 110.35 175.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.713 HD13 ' HA ' ' A' ' 28' ' ' THR . 91.1 mt -57.71 -44.24 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.981 -0.554 . . . . 73.109999999999999 111.19 173.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.8 m -58.68 -43.38 89.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.204 -0.453 . . . . 51.32 110.805 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.631 ' HG3' HD11 ' A' ' 108' ' ' ILE . 55.9 tt0 -57.79 -48.49 79.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.234 -0.439 . . . . 72.409999999999997 111.14 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -51.57 -53.06 42.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.183 -0.462 . . . . 63.210000000000001 111.499 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.599 0.592 . . . . 72.530000000000001 112.599 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.441 ' HD2' HG21 ' A' ' 108' ' ' ILE . 20.9 mtm180 -78.6 -38.27 40.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.068 -0.395 . . . . 74.329999999999998 111.052 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.27 -46.45 83.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.127 0.489 . . . . 72.239999999999995 110.693 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 46' ' ' TYR . 3.8 m-20 -58.36 -38.66 77.69 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.973 -0.558 . . . . 63.350000000000001 111.492 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.58 -38.1 80.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.902 0.382 . . . . 75.310000000000002 111.411 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.75 -32.86 58.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.936 0.347 . . . . 60.140000000000001 111.936 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -94.27 103.39 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.761 0.652 . . . . 43.149999999999999 112.761 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -96.01 27.72 3.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.381 0.61 . . . . 52.119999999999997 110.684 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -139.73 38.76 2.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.025 -0.534 . . . . 70.319999999999993 110.584 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 129.49 158.01 9.36 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.142 -0.481 . . . . 75.040000000000006 112.799 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 57' ' ' LEU . 35.1 m -100.85 147.06 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.295 0.48 . . . . 74.140000000000001 112.295 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.448 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 31.8 m-85 -93.31 139.5 30.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.084 0.469 . . . . 75.299999999999997 110.962 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.82 119.99 29.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 74.129999999999995 109.756 172.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.623 HD12 ' HE3' ' A' ' 30' ' ' LYS . 79.0 mt -97.46 134.24 22.81 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 111.851 0.315 . . . . 72.329999999999998 111.851 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 32.0 Cg_endo -62.79 -24.64 74.56 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.577 2.184 . . . . 71.140000000000001 112.876 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.01 18.54 55.88 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.078 -0.51 . . . . 53.0 112.825 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.431 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -144.3 106.75 4.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.954 0.407 . . . . 60.219999999999999 110.915 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -74.42 11.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.623 0.601 . . . . 71.230000000000004 112.623 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -85.7 141.99 36.64 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 112.987 0.736 . . . . 53.149999999999999 112.987 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.56 -178.03 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.151 2.568 . . . . 74.530000000000001 113.516 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.18 137.03 28.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.71 -0.677 . . . . 63.130000000000003 110.785 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -82.48 97.93 8.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.023 0.439 . . . . 64.209999999999994 111.268 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 45' ' ' VAL . 61.0 tp -104.87 122.75 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.031 0.444 . . . . 75.129999999999995 111.153 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.3 tt0 -95.86 108.55 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.109999999999999 110.543 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.9 p -96.89 -178.18 4.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.567 0.58 . . . . 71.409999999999997 112.567 -172.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -76.32 -4.88 44.47 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.857 -0.61 . . . . 71.030000000000001 112.02 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 92' ' ' LEU . 39.5 pt -108.48 -34.03 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.794 0.33 . . . . 73.209999999999994 111.173 175.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.69 172.27 36.1 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.234 -0.508 . . . . 44.119999999999997 112.885 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 33.8 m -77.46 124.77 28.34 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.501 -0.411 . . . . 71.299999999999997 111.327 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 155' ' ' ILE . 2.4 pp -129.98 165.03 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.49 0.662 . . . . 63.229999999999997 111.909 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -129.82 100.19 5.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.659 -0.7 . . . . 74.219999999999999 110.863 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.687 ' SD ' HG22 ' A' ' 152' ' ' ILE . 65.3 mtt -102.73 148.93 24.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.68 0.622 . . . . 70.340000000000003 112.68 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -148.42 161.03 42.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.818 0.342 . . . . 71.0 111.563 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 80' ' ' LEU . 93.2 mt -105.44 119.32 38.8 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.797 0.332 . . . . 72.25 111.199 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.588 HG21 HD21 ' A' ' 70' ' ' ASN . 21.9 m -135.65 161.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.618 0.247 . . . . 75.150000000000006 111.655 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.588 HD21 HG21 ' A' ' 69' ' ' VAL . 31.4 m-80 60.85 34.49 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.175 0.512 . . . . 75.150000000000006 111.672 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.79 114.52 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.446 . . . . 73.519999999999996 111.742 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -138.46 150.74 67.37 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.371 . . . . 73.409999999999997 111.895 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.47 155.36 70.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.809 2.339 . . . . 64.209999999999994 113.165 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' HB2' HG22 ' A' ' 79' ' ' THR . 29.0 t70 -142.05 162.99 34.09 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.476 . . . . 75.420000000000002 111.214 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.37 -43.39 97.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 64.400000000000006 111.863 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -81.91 -25.05 35.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.623 0.249 . . . . 61.020000000000003 111.615 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.73 -99.95 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.955 -0.64 . . . . 61.43 113.52 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.1 m -145.89 125.75 13.53 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.002 0.43 . . . . 73.25 111.565 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 74' ' ' ASP . 39.9 p -97.0 123.07 40.63 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 111.716 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD11 HD21 ' A' ' 68' ' ' LEU . 3.1 pp -138.39 165.79 25.9 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.102 0.477 . . . . 71.5 111.712 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.5 m -107.91 123.44 48.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.257 -0.429 . . . . 74.120000000000005 111.274 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -99.75 109.58 22.02 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.309 -0.405 . . . . 74.439999999999998 110.193 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 66' ' ' MET . 49.5 mtm180 -89.45 128.27 35.93 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.663 -0.244 . . . . 53.039999999999999 110.92 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.486 HD12 HG12 ' A' ' 135' ' ' ILE . 3.4 mp -113.02 91.11 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.86 0.362 . . . . 71.140000000000001 110.538 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -92.75 106.49 18.45 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.84 -0.43 . . . . 71.430000000000007 109.84 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.474 ' HA3' ' OG ' ' A' ' 131' ' ' SER . . . -66.1 123.25 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.919 -0.658 . . . . 53.509999999999998 113.091 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.33 -25.6 66.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.513 0.673 . . . . 73.099999999999994 110.443 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -88.47 119.93 29.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.325 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.42 -22.86 63.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.949 0.404 . . . . 54.43 111.678 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -65.9 135.08 95.23 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.319 -0.4 . . . . 65.209999999999994 111.583 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.83 120.19 7.84 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.894 2.396 . . . . 72.109999999999999 113.097 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.6 mt -88.67 149.61 44.37 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.551 -0.295 . . . . 74.120000000000005 111.255 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.01 176.07 10.01 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.399 2.066 . . . . 61.340000000000003 113.167 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.24 47.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.827 0.346 . . . . 52.299999999999997 111.434 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.95 159.14 42.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.535 0.684 . . . . 75.549999999999997 112.638 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.7 p -141.38 163.94 31.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.495 -0.775 . . . . 63.210000000000001 110.141 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.625 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.31 169.68 38.48 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.278 -0.963 . . . . 53.25 114.005 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.2 m -99.9 129.39 45.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.699 0.4 . . . . 73.319999999999993 110.727 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 24.5 m -112.53 117.01 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.103 0.477 . . . . 72.340000000000003 111.57 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 43.7 mt-10 -92.82 103.61 15.94 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.574 -0.285 . . . . 75.409999999999997 110.787 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -112.91 137.05 51.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.009 0.433 . . . . 72.140000000000001 111.61 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.04 -145.96 4.91 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.004 -0.544 . . . . 37.43 112.957 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -130.39 145.8 51.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.995 0.426 . . . . 72.200000000000003 111.95 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.0 mt -105.4 120.99 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.225 -0.443 . . . . 74.329999999999998 110.478 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.08 3.36 54.9 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.402 0.89 . . . . 73.439999999999998 113.402 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.04 -162.67 9.3 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.077 -1.059 . . . . 65.219999999999999 114.724 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -88.34 -161.96 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.031 0.532 . . . . 75.310000000000002 111.585 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.5 mm -83.72 -21.97 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.409 0.624 . . . . 54.340000000000003 110.421 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.25 -37.12 12.85 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 111.337 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.47 106.6 5.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.19 0.519 . . . . 71.140000000000001 111.377 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -154.07 153.47 31.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.158 0.504 . . . . 73.140000000000001 112.235 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -125.77 146.91 49.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.965 -0.561 . . . . 74.219999999999999 110.766 173.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.32 105.62 17.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.161 -0.472 . . . . 74.430000000000007 110.882 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.416 HG13 ' HB2' ' A' ' 103' ' ' GLN . 35.6 pt -110.72 157.54 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.498 -0.319 . . . . 74.120000000000005 111.446 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 56.28 29.24 14.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.075 0.464 . . . . 72.310000000000002 111.666 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.78 131.58 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.256 0.55 . . . . 71.150000000000006 112.321 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.45 164.99 28.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.906 -0.588 . . . . 73.340000000000003 110.258 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.6 p-10 -115.01 142.09 47.11 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.956 0.724 . . . . 74.239999999999995 112.956 -173.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.42 154.91 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.666 -0.697 . . . . 65.439999999999998 110.283 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.72 122.59 42.14 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.983 0.364 . . . . 73.510000000000005 111.983 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.7 pt -102.1 143.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.503 -0.317 . . . . 75.120000000000005 111.063 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.44 119.58 19.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.972 0.415 . . . . 73.519999999999996 111.673 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.57 144.04 31.72 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 111.776 0.287 . . . . 75.340000000000003 111.776 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.28 163.3 36.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.65 2.233 . . . . 74.519999999999996 113.602 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.17 138.77 40.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.117 0.484 . . . . 75.209999999999994 112.233 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -81.55 119.1 23.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.325 -0.398 . . . . 71.329999999999998 110.772 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.606 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.9 m -93.78 -28.89 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.931 0.396 . . . . 72.349999999999994 111.228 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.606 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.0 mt -117.89 -178.5 3.51 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.987 0.423 . . . . 71.510000000000005 111.163 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -118.82 151.68 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 111.793 0.294 . . . . 62.149999999999999 111.793 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.49 -177.44 20.12 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.1 -1.209 . . . . 73.349999999999994 113.392 -2.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.474 ' OG ' ' HA3' ' A' ' 86' ' ' GLY . 53.9 p -90.2 40.62 1.01 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.101 0.477 . . . . 74.540000000000006 112.008 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -84.12 99.7 10.66 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.39 0.614 . . . . 62.130000000000003 111.423 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.36 134.11 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.215 -0.448 . . . . 65.349999999999994 111.301 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -114.78 127.09 55.54 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.241 -0.287 . . . . 64.430000000000007 111.174 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.486 HG12 HD12 ' A' ' 84' ' ' ILE . 33.1 pt -131.09 146.4 61.92 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.181 0.437 . . . . 74.109999999999999 112.181 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.9 161.99 20.99 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.552 2.168 . . . . 73.129999999999995 112.496 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.93 125.37 10.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.804 0.335 . . . . 63.229999999999997 110.51 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -108.59 106.38 16.43 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.049 0.452 . . . . 65.239999999999995 111.512 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.92 135.18 33.78 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.65 -0.25 . . . . 74.239999999999995 110.772 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -109.68 149.83 29.17 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.312 0.486 . . . . 71.340000000000003 112.312 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.92 83.06 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.153 -0.476 . . . . 71.150000000000006 113.873 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 147' ' ' LEU . 17.1 tt -143.68 135.17 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.026 0.441 . . . . 75.209999999999994 111.401 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.2 m -101.71 147.52 26.35 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.61 -0.268 . . . . 60.240000000000002 111.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.61 -43.83 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.744 0.646 . . . . 55.240000000000002 112.744 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.46 -28.27 69.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.001 0.429 . . . . 70.5 111.675 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -108.11 13.13 26.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.166 -0.47 . . . . 65.109999999999999 111.664 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.596 ' HA ' HD12 ' A' ' 142' ' ' ILE . 1.4 tt -81.0 120.8 25.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 110.407 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.27 -59.0 1.32 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.971 -0.633 . . . . 53.219999999999999 113.333 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.51 153.52 35.98 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.4 . . . . 73.099999999999994 111.911 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 65.9 t -125.99 107.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.01 -0.541 . . . . 63.210000000000001 110.046 170.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 38.5 ttt180 -96.22 110.94 23.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.823 0.344 . . . . 72.239999999999995 111.683 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.687 HG22 ' SD ' ' A' ' 66' ' ' MET . 18.0 mm -90.48 124.23 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.513 -0.312 . . . . 72.140000000000001 111.331 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.566 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 1.8 p80 -159.55 -176.75 5.94 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.372 0.508 . . . . 71.140000000000001 112.372 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 63.15 17.87 10.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.695 0.628 . . . . 63.140000000000001 112.695 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.625 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.5 mm -61.54 103.49 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.471 0.653 . . . . 73.140000000000001 111.097 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -136.52 158.3 73.57 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.762 -0.654 . . . . 71.209999999999994 111.451 -174.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.43 132.37 23.72 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.366 2.044 . . . . 62.340000000000003 112.665 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.895 0.379 . . . . 63.340000000000003 111.783 -178.828 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 120.968 0.413 . . . . 74.299999999999997 110.4 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -65.36 -34.81 79.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.062 0.458 . . . . 75.239999999999995 110.785 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.86 -38.66 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.307 -0.406 . . . . 60.409999999999997 110.854 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -30.64 69.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.44 -0.346 . . . . 75.450000000000003 111.664 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.6 mt -61.44 -51.38 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.025 0.44 . . . . 75.219999999999999 110.496 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.4 m -58.92 -45.37 90.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.04 0.447 . . . . 74.010000000000005 110.832 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.623 HE21 HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -55.85 -45.58 78.4 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.794 -0.639 . . . . 71.439999999999998 111.256 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -63.17 -54.39 38.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.946 -0.57 . . . . 74.540000000000006 111.578 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.49 -35.86 74.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.351 -0.386 . . . . 73.349999999999994 112.033 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -64.89 -48.57 73.76 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.275 -0.265 . . . . 74.519999999999996 111.251 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.07 -41.64 88.48 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.251 0.548 . . . . 72.239999999999995 110.79 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.11 -43.52 82.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.661 -0.7 . . . . 72.439999999999998 111.401 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -33.69 64.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.31 0.485 . . . . 73.349999999999994 112.31 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -84.2 -7.79 59.25 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.272 0.471 . . . . 75.25 112.272 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.6 t -107.44 119.17 38.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.248 0.547 . . . . 75.400000000000006 111.946 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.6 p -83.6 -45.77 13.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.127 -0.488 . . . . 62.229999999999997 110.839 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.7 m -73.64 81.72 1.53 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.182 -0.463 . . . . 70.439999999999998 111.708 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 89.29 -171.72 38.84 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 113.848 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 57' ' ' LEU . 35.8 m -121.02 142.81 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 44.32 111.846 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.69 133.44 37.04 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.934 0.397 . . . . 74.310000000000002 111.946 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.75 138.44 52.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.854 -0.612 . . . . 53.100000000000001 110.187 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 74.8 mt -112.64 137.55 21.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 112.076 0.399 . . . . 72.209999999999994 112.076 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 16.0 Cg_exo -66.55 -30.81 42.61 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.724 2.283 . . . . 72.120000000000005 113.022 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.96 -8.04 67.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 114.314 0.486 . . . . 41.399999999999999 114.314 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.68 97.28 2.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.51 0.655 . . . . 74.519999999999996 111.901 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.87 88.88 0.11 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.847 0.832 . . . . 70.230000000000004 111.418 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -137.02 151.43 72.05 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 112.633 0.605 . . . . 74.120000000000005 112.633 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 89.2 Cg_endo -80.74 159.66 21.65 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.116 2.544 . . . . 73.25 114.06 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.19 144.8 27.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.986 -0.552 . . . . 63.329999999999998 110.632 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -83.69 119.56 24.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.943 0.401 . . . . 73.540000000000006 111.67 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 45' ' ' VAL . 46.5 tp -113.83 119.45 37.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.335 0.588 . . . . 53.439999999999998 110.658 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.52 110.77 22.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.963 -0.562 . . . . 72.140000000000001 110.348 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.4 p -115.72 -174.32 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.505 0.669 . . . . 74.519999999999996 112.751 -170.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -72.65 -24.68 61.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.583 -0.735 . . . . 74.430000000000007 112.196 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.8 pt -91.37 -7.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.795 0.331 . . . . 72.540000000000006 111.499 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.62 -167.75 23.8 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.366 -0.445 . . . . 62.530000000000001 113.056 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 m -91.7 123.08 34.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.865 0.364 . . . . 63.109999999999999 111.069 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.45 164.2 28.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.108 0.48 . . . . 75.439999999999998 111.625 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -124.04 114.63 19.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.279 -0.419 . . . . 74.510000000000005 110.916 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.66 ' SD ' HG23 ' A' ' 152' ' ' ILE . 63.4 mtt -98.56 143.39 29.02 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.929 0.395 . . . . 44.399999999999999 111.936 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 33.3 p -141.07 142.77 34.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.128 0.49 . . . . 74.019999999999996 111.848 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.51 HD22 HD12 ' A' ' 80' ' ' LEU . 82.4 mt -97.9 122.14 40.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 111.411 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 81' ' ' THR . 23.2 m -132.68 163.06 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.647 -0.251 . . . . 74.230000000000004 110.941 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 60.28 33.55 20.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.193 0.521 . . . . 74.519999999999996 111.939 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 68' ' ' LEU . 46.5 mt -71.9 106.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.192 -0.458 . . . . 64.310000000000002 111.677 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 p -135.17 149.85 71.21 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 112.419 0.526 . . . . 62.450000000000003 112.419 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.47 148.87 55.12 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.84 2.36 . . . . 63.32 113.099 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.4 -175.44 3.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.234 -0.439 . . . . 72.040000000000006 110.359 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.96 -45.86 39.44 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.993 -0.442 . . . . 64.200000000000003 111.998 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.432 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 2.1 p30 -92.36 -24.31 18.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.395 0.517 . . . . 72.409999999999997 112.395 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -164.97 -118.98 0.46 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.567 -0.825 . . . . 72.530000000000001 114.047 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.1 m -139.78 132.13 28.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.607 -0.349 . . . . 75.530000000000001 111.588 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.3 p -108.59 123.44 48.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.055 0.455 . . . . 72.430000000000007 111.502 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.51 HD12 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -139.09 151.91 47.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 73.450000000000003 111.079 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.693 ' HB ' HG22 ' A' ' 69' ' ' VAL . 27.3 m -90.35 111.05 22.13 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.301 -0.249 . . . . 61.200000000000003 110.936 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.58 108.41 19.05 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.543 -0.54 . . . . 73.25 109.543 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 66' ' ' MET . 23.9 mtp-105 -98.64 131.58 44.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.781 0.324 . . . . 53.009999999999998 111.627 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.2 mp -114.04 96.48 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.657 -0.247 . . . . 63.530000000000001 111.051 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.4 103.73 15.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.654 0.264 . . . . 71.400000000000006 110.623 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.87 131.77 26.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.72 -0.753 . . . . 53.530000000000001 112.876 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -68.56 -25.49 64.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.234 0.54 . . . . 72.230000000000004 110.593 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.5 m -79.11 117.26 19.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.868 -0.605 . . . . 54.310000000000002 110.223 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -80.02 41.05 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.355 0.598 . . . . 75.5 112.131 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.59 154.18 80.83 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.1 0.56 . . . . 64.439999999999998 110.215 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.451 ' HD3' ' HB1' ' A' ' 129' ' ' ALA . 19.7 Cg_endo -59.14 109.0 0.47 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.492 2.128 . . . . 45.210000000000001 112.681 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.77 151.03 57.45 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.079 -0.509 . . . . 50.140000000000001 112.152 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.88 159.73 41.4 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.467 2.111 . . . . 61.229999999999997 112.841 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.55 136.76 56.79 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.983 0.421 . . . . 73.430000000000007 111.641 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -133.76 163.31 29.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.417 0.627 . . . . 74.230000000000004 112.575 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.4 p -134.73 132.94 39.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.421 -0.809 . . . . 74.530000000000001 110.564 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.76 ' HA3' HD11 ' A' ' 155' ' ' ILE . . . -133.98 166.01 24.13 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.731 -0.747 . . . . 64.150000000000006 113.195 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.4 m -108.61 124.85 51.14 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.669 -0.313 . . . . 71.099999999999994 110.917 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.5 p -106.2 118.4 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.044 0.449 . . . . 72.299999999999997 112.144 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.6 mm-40 -89.32 113.18 24.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 74.349999999999994 110.041 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -122.81 128.7 50.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.158 0.504 . . . . 73.420000000000002 111.746 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.54 4.44 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.907 -0.588 . . . . 51.009999999999998 112.636 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.624 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.3 mt-30 -128.12 156.34 43.0 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.217 0.532 . . . . 73.420000000000002 112.213 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.42 120.91 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.17 -0.468 . . . . 51.439999999999998 111.211 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -93.19 -30.99 14.93 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.538 0.57 . . . . 71.209999999999994 112.538 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -93.25 -157.67 33.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.027 -0.606 . . . . 72.030000000000001 114.175 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.7 p -92.97 -173.69 3.36 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.933 0.397 . . . . 51.509999999999998 111.425 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.623 HD11 HE21 ' A' ' 33' ' ' GLN . 36.5 mm -82.58 -3.26 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.348 0.594 . . . . 74.230000000000004 111.213 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -109.04 -39.19 5.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.233 0.54 . . . . 73.109999999999999 110.791 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -134.9 102.37 5.21 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.864 -0.607 . . . . 61.109999999999999 111.344 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 107' ' ' THR . 34.8 p90 -141.8 148.67 39.27 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.101 0.477 . . . . 75.239999999999995 111.801 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -109.44 126.03 53.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.001 -0.545 . . . . 74.219999999999999 110.703 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.8 105.28 4.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.27 -0.423 . . . . 75.010000000000005 110.91 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 pt -110.12 152.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 111.759 0.281 . . . . 62.100000000000001 111.759 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 57.68 29.6 17.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.967 0.413 . . . . 72.209999999999994 111.842 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -95.1 115.55 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.883 0.697 . . . . 73.209999999999994 112.883 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.518 ' H ' ' NE2' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -117.73 170.98 8.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.985 -0.552 . . . . 64.319999999999993 110.154 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 22.9 p30 -123.87 162.62 22.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.341 0.867 . . . . 74.230000000000004 113.341 -171.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -144.18 152.24 40.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.313 -0.858 . . . . 74.349999999999994 110.366 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.52 117.16 28.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.892 0.377 . . . . 52.200000000000003 111.301 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 121' ' ' ILE . 30.0 pt -102.86 103.13 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.523 0.678 . . . . 72.329999999999998 111.368 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.05 114.87 29.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.115 -0.493 . . . . 70.420000000000002 111.348 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -95.05 139.37 22.05 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.543 -0.299 . . . . 71.299999999999997 111.287 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 32.5 Cg_exo -62.07 170.65 5.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.879 2.386 . . . . 75.140000000000001 113.397 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.56 10.83 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.052 0.453 . . . . 41.530000000000001 111.556 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -77.54 69.01 3.74 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.222 0.534 . . . . 64.439999999999998 111.281 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.55 -19.39 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.073 0.463 . . . . 53.009999999999998 111.734 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.7 mt -85.86 136.89 33.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.345 -0.389 . . . . 74.310000000000002 111.675 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.451 ' HB1' ' HD3' ' A' ' 91' ' ' PRO . . . -122.18 127.7 25.8 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.31 -0.405 . . . . 53.119999999999997 111.199 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.72 154.53 97.7 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.074 -1.219 . . . . 74.510000000000005 113.331 1.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.9 m -87.91 92.64 9.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.002 0.742 . . . . 54.310000000000002 113.002 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 8.3 p-10 -117.96 100.54 7.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.401 0.62 . . . . 62.399999999999999 110.158 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' ARG . 32.2 t -87.12 144.12 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.012 0.745 . . . . 72.319999999999993 113.012 -170.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.11 115.48 26.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.887 -0.597 . . . . 75.239999999999995 110.622 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.8 pt -125.95 126.53 24.83 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 120.904 0.383 . . . . 73.430000000000007 111.964 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.83 111.63 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.935 2.423 . . . . 43.340000000000003 112.274 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -103.81 115.4 30.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.267 -0.424 . . . . 65.239999999999995 110.523 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -105.92 103.28 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.3 0.571 . . . . 72.329999999999998 111.347 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.507 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 81.1 mt -78.76 138.76 38.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.17 -0.468 . . . . 74.400000000000006 109.911 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -116.23 135.76 53.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.427 0.529 . . . . 73.430000000000007 112.427 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.51 40.28 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.091 -0.504 . . . . 44.329999999999998 113.094 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 147' ' ' LEU . 20.6 tt -115.19 126.86 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.202 0.525 . . . . 73.340000000000003 111.659 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.2 m -94.73 149.17 21.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.805 0.298 . . . . 71.099999999999994 111.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 p -50.37 -44.42 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.793 1.034 . . . . 73.439999999999998 113.793 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.56 -31.8 71.27 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.885 -0.509 . . . . 73.140000000000001 111.018 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -95.52 9.05 41.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.205 -0.452 . . . . 54.229999999999997 111.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.542 ' HA ' HD13 ' A' ' 142' ' ' ILE . 1.9 tt -85.45 115.84 23.41 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.097 0.475 . . . . 51.539999999999999 110.406 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.624 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -81.68 -59.55 2.33 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.326 -0.464 . . . . 72.5 113.203 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.76 149.1 31.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.086 0.47 . . . . 71.519999999999996 112.16 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.9 106.71 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.694 -0.685 . . . . 64.299999999999997 109.713 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.4 ttt180 -107.58 106.33 16.63 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.09 0.404 . . . . 75.230000000000004 112.09 -172.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.66 HG23 ' SD ' ' A' ' 66' ' ' MET . 25.6 mm -89.6 134.32 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.657 -0.247 . . . . 74.510000000000005 111.293 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.406 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.2 p80 -164.61 174.83 10.39 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.655 0.264 . . . . 73.409999999999997 111.664 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 62.72 32.75 15.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.327 0.492 . . . . 73.409999999999997 112.327 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.76 HD11 ' HA3' ' A' ' 97' ' ' GLY . 49.2 mm -66.71 99.48 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.257 -0.429 . . . . 61.32 110.804 175.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.51 151.58 67.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.264 -0.425 . . . . 72.439999999999998 111.196 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.7 149.55 89.47 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.801 2.334 . . . . 74.129999999999995 113.797 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.841 175.729 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.06 0.457 . . . . 73.310000000000002 110.594 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.5 m -59.02 -33.63 70.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.077 -0.51 . . . . 70.329999999999998 111.329 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -45.31 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.602 -0.272 . . . . 74.400000000000006 111.169 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -62.49 -44.44 96.37 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.53 0.205 . . . . 75.109999999999999 111.175 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.423 HG22 HG21 ' A' ' 53' ' ' THR . 75.7 mt -54.26 -55.66 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.414 0.626 . . . . 75.219999999999999 110.831 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 89.5 m -56.0 -44.05 78.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.623 -0.717 . . . . 73.420000000000002 111.148 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.81 -44.5 90.84 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.591 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.6 -42.65 93.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.832 0.348 . . . . 74.230000000000004 111.167 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -60.95 -45.27 95.38 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.109 0.48 . . . . 74.030000000000001 111.199 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 32' ' ' THR . 70.9 mtp180 -65.19 -42.54 93.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.11 -0.495 . . . . 73.219999999999999 111.412 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.19 -37.63 86.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.885 0.374 . . . . 75.439999999999998 110.998 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.013 0.435 . . . . 74.230000000000004 110.686 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.54 66.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.292 -0.413 . . . . 50.450000000000003 111.941 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.507 ' NZ ' ' HA ' ' A' ' 109' ' ' ASP . 85.5 mttt -82.84 -18.74 39.35 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.634 0.605 . . . . 73.030000000000001 112.634 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -59.12 115.61 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.867 0.365 . . . . 73.319999999999993 111.97 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -92.07 -27.68 17.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.591 -0.277 . . . . 63.240000000000002 111.55 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 m -117.21 86.39 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.892 0.377 . . . . 71.510000000000005 111.374 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 83.77 -132.95 11.44 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.174 -0.536 . . . . 43.409999999999997 113.359 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.401 HG13 HD13 ' A' ' 57' ' ' LEU . 30.9 m -139.66 154.09 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.171 0.51 . . . . 63.43 111.916 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.42 101.29 10.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.067 -0.515 . . . . 75.030000000000001 111.268 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.534 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 87.1 mt -85.27 133.98 34.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 73.430000000000007 110.815 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.7 mt -107.15 108.55 62.08 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 120.722 0.296 . . . . 65.209999999999994 111.211 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.1 Cg_endo -57.03 -22.92 49.41 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.014 2.476 . . . . 72.25 113.654 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.75 -26.35 71.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.133 -0.556 . . . . 63.420000000000002 113.238 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.66 112.99 17.43 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.697 -0.296 . . . . 71.299999999999997 111.584 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -74.62 75.71 2.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.699 0.762 . . . . 71.310000000000002 111.019 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.423 HG21 HG22 ' A' ' 31' ' ' ILE . 4.4 p -133.05 145.19 55.94 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.751 -0.659 . . . . 72.209999999999994 111.732 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 145.22 33.19 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.008 2.472 . . . . 74.109999999999999 113.711 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.86 153.02 40.18 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.885 -0.598 . . . . 64.439999999999998 110.558 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ttm105 -95.78 117.8 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.925 0.393 . . . . 74.540000000000006 111.463 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD13 HG13 ' A' ' 45' ' ' VAL . 45.7 tp -118.3 124.69 48.41 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.296 0.569 . . . . 75.120000000000005 112.172 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.51 102.44 14.1 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.931 -0.577 . . . . 61.229999999999997 110.584 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 p -94.46 -172.71 2.84 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.222 0.534 . . . . 74.319999999999993 111.792 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.593 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.2 mt-30 -91.99 -2.71 56.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.109 -0.496 . . . . 61.539999999999999 111.296 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -105.72 -19.04 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.001 0.429 . . . . 64.430000000000007 110.901 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.8 160.68 9.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.101 -0.499 . . . . 64.340000000000003 112.651 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -62.53 127.57 31.94 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.152 0.476 . . . . 73.450000000000003 110.678 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.45 165.85 26.31 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.137 0.494 . . . . 72.030000000000001 111.728 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -119.15 114.79 23.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.256 -0.429 . . . . 74.450000000000003 110.763 -176.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.652 ' SD ' HG23 ' A' ' 152' ' ' ILE . 61.7 mtt -104.01 150.9 23.83 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.987 0.422 . . . . 75.310000000000002 112.068 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.3 p -151.61 153.32 34.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.324 -0.398 . . . . 64.040000000000006 111.563 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HB3' HD13 ' A' ' 71' ' ' ILE . 97.4 mt -103.33 112.84 25.91 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.266 -0.425 . . . . 75.310000000000002 111.352 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.639 HG22 ' HB ' ' A' ' 81' ' ' THR . 29.8 m -121.22 156.76 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.863 0.364 . . . . 61.310000000000002 111.646 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 59.89 37.13 21.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.123 -0.49 . . . . 70.430000000000007 111.857 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 68' ' ' LEU . 49.8 mt -69.87 101.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.102 -0.499 . . . . 74.230000000000004 111.903 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 18.0 p -121.23 162.95 33.02 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 115.97 -0.559 . . . . 63.350000000000001 111.574 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 57.5 Cg_endo -69.88 166.43 27.79 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.238 1.959 . . . . 53.039999999999999 113.019 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 30.4 t70 -128.22 165.57 20.21 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.116 -0.493 . . . . 74.319999999999993 110.281 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.23 69.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.049 0.452 . . . . 75.319999999999993 111.413 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.2 -47.55 3.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.204 -0.453 . . . . 61.549999999999997 111.316 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.415 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -136.55 -103.6 0.69 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.804 -0.712 . . . . 61.119999999999997 114.129 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.421 HG22 HD13 ' A' ' 147' ' ' LEU . 96.0 m -143.56 130.96 20.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.245 0.461 . . . . 74.340000000000003 112.245 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 40.0 p -104.36 114.22 28.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.679 0.392 . . . . 65.010000000000005 111.626 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 80' ' ' LEU . 3.1 pp -137.24 149.18 46.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.89 0.376 . . . . 74.150000000000006 111.72 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.639 ' HB ' HG22 ' A' ' 69' ' ' VAL . 48.6 m -93.52 113.64 25.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.047 0.451 . . . . 64.209999999999994 111.353 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.46 112.51 24.18 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.024 -0.535 . . . . 75.299999999999997 110.132 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 32.9 mtp180 -97.27 126.6 42.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.016 0.376 . . . . 74.430000000000007 112.016 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.5 107.23 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.189 -0.459 . . . . 74.109999999999999 110.62 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -106.74 106.59 17.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.727 0.299 . . . . 37.670000000000002 111.051 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.48 129.75 49.28 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.095 -0.574 . . . . 74.409999999999997 113.154 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -81.76 58.92 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.428 0.632 . . . . 72.530000000000001 111.137 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -168.49 -166.43 0.68 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.1 -0.5 . . . . 73.329999999999998 110.638 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -112.01 12.57 20.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.048 0.451 . . . . 74.239999999999995 110.628 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.66 136.1 39.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.1 -0.5 . . . . 71.5 111.975 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.39 95.43 1.04 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.242 1.961 . . . . 74.109999999999999 111.635 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.61 139.87 81.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.251 -0.432 . . . . 63.020000000000003 111.996 -176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.03 174.56 12.62 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.584 2.19 . . . . 70.329999999999998 112.901 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.47 138.69 58.52 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.123 0.487 . . . . 44.140000000000001 111.523 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -138.45 171.36 14.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.376 0.607 . . . . 72.030000000000001 112.292 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.4 p -152.92 156.73 39.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.685 -0.689 . . . . 73.439999999999998 110.746 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.5 -178.12 36.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.909 -0.662 . . . . 71.439999999999998 113.072 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.3 m -108.31 127.3 53.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.816 0.341 . . . . 62.409999999999997 111.441 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.95 123.31 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.206 0.527 . . . . 73.230000000000004 111.416 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.8 mt-10 -104.96 107.69 18.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 75.340000000000003 110.601 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -112.5 129.13 56.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 73.340000000000003 111.897 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.97 -145.78 4.53 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.964 -0.562 . . . . 74.109999999999999 112.835 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.652 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.7 mt-30 -125.71 141.14 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.031 0.443 . . . . 64.120000000000005 112.147 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.35 122.71 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.265 -0.425 . . . . 71.209999999999994 111.349 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.537 ' HG3' ' HB2' ' A' ' 112' ' ' GLN . 3.9 pt20 -111.99 99.76 8.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.474 0.654 . . . . 75.310000000000002 110.39 170.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 154.15 -169.17 32.59 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.038 -0.601 . . . . 72.340000000000003 113.852 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -100.43 -165.15 1.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.098 0.475 . . . . 73.230000000000004 111.753 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -72.19 -21.38 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.182 0.515 . . . . 73.329999999999998 111.185 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.507 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 37.6 t70 -105.89 -39.63 5.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 63.420000000000002 111.874 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.49 91.77 3.59 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 75.519999999999996 111.483 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.604 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 40.0 p90 -127.93 143.45 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.964 0.412 . . . . 75.439999999999998 111.751 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.537 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 49.6 mt-30 -118.24 133.69 55.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 73.030000000000001 111.688 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -88.14 109.7 20.1 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.317 -0.401 . . . . 71.510000000000005 110.951 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 pt -123.81 162.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 111.886 0.328 . . . . 70.409999999999997 111.886 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 53.42 28.95 8.1 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.514 0.561 . . . . 72.209999999999994 112.514 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 p -90.17 138.96 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.823 0.675 . . . . 55.520000000000003 112.823 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -124.66 151.8 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.493 -0.776 . . . . 74.439999999999998 110.525 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.29 132.08 54.06 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.337 0.589 . . . . 71.25 111.75 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -129.69 156.27 44.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.035 -0.53 . . . . 61.409999999999997 110.202 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.6 mt -96.83 119.92 36.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 73.310000000000002 111.145 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.71 HG21 HD23 ' A' ' 137' ' ' LEU . 15.4 pt -99.65 100.76 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.337 0.589 . . . . 65.430000000000007 111.732 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.19 131.67 50.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.006 -0.543 . . . . 75.030000000000001 110.268 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.22 148.32 65.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.394 0.516 . . . . 71.340000000000003 112.394 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.2 175.45 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.116 2.544 . . . . 73.209999999999994 113.42 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.04 144.47 29.04 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.803 0.668 . . . . 75.120000000000005 112.803 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.6 m -87.72 102.72 14.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.203 -0.453 . . . . 72.010000000000005 110.374 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.0 m -80.6 -14.04 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.404 0.52 . . . . 71.129999999999995 112.404 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 128' ' ' LEU . 2.0 pt? -138.81 -179.79 6.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.906 0.384 . . . . 64.519999999999996 111.233 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.95 144.52 28.75 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.533 -0.303 . . . . 72.150000000000006 111.469 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.36 170.48 53.79 Favored 'Cis proline' 0 C--N 1.352 0.724 0 C-N-CA 123.932 -1.278 . . . . 70.310000000000002 112.825 -0.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 t -86.58 85.92 7.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 63.030000000000001 111.378 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.56 122.85 48.88 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.859 -0.422 . . . . 75.019999999999996 109.859 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -135.35 112.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.12 -0.362 . . . . 74.019999999999996 111.198 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -112.81 134.79 54.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.321 0.581 . . . . 74.140000000000001 111.96 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -125.31 133.45 24.86 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.813 -0.63 . . . . 73.420000000000002 112.345 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.32 111.81 3.4 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.851 2.367 . . . . 63.539999999999999 112.439 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.71 HD23 HG21 ' A' ' 121' ' ' ILE . 23.6 mt -94.4 141.1 28.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 73.420000000000002 112.63 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.05 92.79 3.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.663 -0.699 . . . . 74.340000000000003 110.21 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.4 mt -77.13 132.16 38.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.125 -0.488 . . . . 64.329999999999998 110.775 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -96.31 145.89 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.536 0.569 . . . . 64.230000000000004 112.536 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 56.98 31.48 61.47 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.064 0.786 . . . . 64.010000000000005 115.064 172.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.1 tt -152.09 127.97 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 117.602 0.701 . . . . 75.420000000000002 111.606 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.4 m -86.83 144.24 27.11 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.306 -0.407 . . . . 50.030000000000001 111.709 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.31 -44.24 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.631 0.604 . . . . 73.319999999999993 112.631 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.56 -21.62 66.45 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.025 0.441 . . . . 75.209999999999994 111.417 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.434 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 81.6 mm-40 -107.1 10.63 30.13 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.084 0.401 . . . . 71.409999999999997 112.084 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.546 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.9 mt -68.84 115.26 7.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.785 0.326 . . . . 74.409999999999997 111.499 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -89.73 -49.39 3.39 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.168 -0.539 . . . . 63.119999999999997 113.298 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.16 157.37 38.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.246 0.546 . . . . 70.329999999999998 112.273 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 60.8 t -124.23 98.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.709 -0.678 . . . . 73.209999999999994 110.1 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.615 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 70.2 ttt180 -90.25 101.28 14.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.305 -0.407 . . . . 73.299999999999997 111.739 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.652 HG23 ' SD ' ' A' ' 66' ' ' MET . 33.2 mm -94.22 132.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 122.273 -0.267 . . . . 53.509999999999998 111.56 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.76 172.36 13.11 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.411 0.523 . . . . 73.319999999999993 112.411 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 65.09 22.23 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.313 0.857 . . . . 74.200000000000003 113.313 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.571 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.8 mm -63.62 101.81 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.112 0.482 . . . . 54.0 111.499 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.593 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 12.1 pt20 -129.17 159.21 70.11 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.071 -0.513 . . . . 75.349999999999994 111.174 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 156' ' ' GLN . 74.0 Cg_endo -73.01 150.96 49.51 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.157 1.905 . . . . 73.349999999999994 113.134 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.545 0.757 0 CA-C-N 116.162 -0.472 . . . . 62.100000000000001 110.889 177.797 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 25.1 tt0 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.851 0.357 . . . . 75.230000000000004 110.861 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -35.07 70.22 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.13 0.49 . . . . 71.430000000000007 110.776 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.9 -44.76 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.205 -0.452 . . . . 71.299999999999997 110.893 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -61.05 -39.84 91.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.657 0.265 . . . . 71.329999999999998 110.969 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.99 -48.19 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.081 0.467 . . . . 73.420000000000002 110.967 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.5 m -57.18 -49.5 75.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.132 0.491 . . . . 73.439999999999998 110.903 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' HG3' HD12 ' A' ' 108' ' ' ILE . 63.6 tt0 -59.49 -43.73 93.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.964 -0.562 . . . . 75.150000000000006 111.337 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.39 -51.97 66.33 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.748 0.419 . . . . 73.439999999999998 111.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -58.95 -44.76 91.49 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.986 0.365 . . . . 63.229999999999997 111.986 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -63.98 -49.3 73.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.61 0.226 . . . . 75.019999999999996 111.61 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 48' ' ' LEU . 73.6 mt -60.58 -41.35 94.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.322 0.582 . . . . 64.219999999999999 110.883 176.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.452 HD22 ' HB ' ' A' ' 45' ' ' VAL . 11.8 t-20 -58.37 -46.22 86.73 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.702 -0.681 . . . . 64.239999999999995 110.846 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.45 -25.6 63.26 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.046 -0.525 . . . . 74.230000000000004 111.965 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -83.37 -14.78 52.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.035 0.383 . . . . 73.239999999999995 112.035 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 44.2 t -64.22 137.0 57.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.343 0.497 . . . . 73.439999999999998 112.343 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -108.93 8.89 26.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.206 -0.452 . . . . 71.049999999999997 111.047 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -160.64 117.86 2.42 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.235 -0.439 . . . . 74.530000000000001 110.903 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.34 -170.46 15.93 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.332 -0.461 . . . . 75.329999999999998 113.661 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.452 ' HB ' HD22 ' A' ' 38' ' ' ASN . 31.6 m -115.87 140.5 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.318 -0.519 . . . . 73.430000000000007 112.104 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 40.9 m-85 -89.75 118.7 29.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.313 -0.403 . . . . 73.349999999999994 111.465 175.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.9 123.4 50.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.908 0.483 . . . . 75.420000000000002 109.937 171.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD13 HD11 ' A' ' 37' ' ' LEU . 68.4 mt -101.66 121.73 50.15 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.279 0.474 . . . . 63.340000000000003 112.279 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -56.66 130.7 41.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.324 2.016 . . . . 73.349999999999994 111.725 173.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . 95.18 19.68 29.98 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.832 -0.622 . . . . 44.140000000000001 112.309 -172.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . . . -142.78 100.26 3.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.461 0.305 . . . . 63.240000000000002 111.584 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.45 76.1 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.12 -0.362 . . . . 71.230000000000004 111.634 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -149.58 137.31 11.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 112.368 0.507 . . . . 75.349999999999994 112.368 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HB2' ' HB3' ' A' ' 65' ' ' ARG . 91.7 Cg_endo -78.36 145.17 21.05 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.165 2.577 . . . . 72.540000000000006 113.639 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -112.51 139.16 48.32 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 54.310000000000002 110.89 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 21.3 ttp85 -81.97 100.37 9.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.846 0.355 . . . . 73.519999999999996 111.486 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 HG12 ' A' ' 45' ' ' VAL . 59.7 tp -96.7 112.16 24.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.274 0.559 . . . . 74.25 111.085 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.89 92.42 9.0 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.86 -0.609 . . . . 74.209999999999994 110.35 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 p -100.41 -175.89 3.05 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.913 0.708 . . . . 64.120000000000005 112.913 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -69.77 -34.6 74.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.523 -0.762 . . . . 74.439999999999998 112.092 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 157' ' ' PRO . 37.0 pt -76.91 -29.06 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.218 0.532 . . . . 53.219999999999999 111.183 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.24 -161.88 31.08 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.566 -0.743 . . . . 40.009999999999998 111.831 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 m -101.93 119.55 38.97 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.374 -0.486 . . . . 71.030000000000001 111.341 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 57' ' ' LEU . 2.2 pp -131.61 152.71 50.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.982 0.42 . . . . 74.5 111.318 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 85.5 mtt180 -116.52 114.49 24.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.884 0.373 . . . . 54.409999999999997 111.218 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.636 ' SD ' HG22 ' A' ' 152' ' ' ILE . 64.1 mtt -99.04 142.19 30.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.277 -0.42 . . . . 71.430000000000007 111.52 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.9 p -136.16 148.32 48.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.119 0.485 . . . . 70.219999999999999 111.963 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.8 mt -99.93 112.24 24.52 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.122 -0.49 . . . . 75.040000000000006 111.671 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 81' ' ' THR . 17.7 m -134.12 164.57 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 122.391 -0.193 . . . . 71.439999999999998 111.099 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.54 HD21 HG22 ' A' ' 69' ' ' VAL . 40.4 m-80 62.84 29.41 16.63 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.899 0.38 . . . . 55.439999999999998 111.675 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.05 110.68 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.803 0.335 . . . . 62.509999999999998 111.309 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -142.85 155.46 62.8 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.539 0.57 . . . . 75.010000000000005 112.539 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.7 157.91 21.93 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.226 2.617 . . . . 61.329999999999998 113.348 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.53 163.88 35.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.085 0.469 . . . . 65.040000000000006 111.905 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.81 70.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.139 -0.482 . . . . 41.340000000000003 111.864 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 8.8 m-20 -71.59 -43.4 66.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.079 0.466 . . . . 61.549999999999997 110.881 175.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.53 -77.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.968 -0.634 . . . . 71.120000000000005 112.911 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.8 m -149.68 138.49 20.99 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.834 0.35 . . . . 75.239999999999995 111.705 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.7 p -122.09 142.48 50.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.989 0.423 . . . . 75.430000000000007 111.401 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.25 152.75 36.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.226 -0.443 . . . . 52.299999999999997 111.549 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.59 ' HB ' HG22 ' A' ' 69' ' ' VAL . 39.0 m -84.34 103.61 13.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.743 0.306 . . . . 73.329999999999998 110.679 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.66 103.06 11.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.636 -0.505 . . . . 62.140000000000001 109.636 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.595 ' HB3' HE22 ' A' ' 85' ' ' GLN . 92.8 mtt-85 -88.83 135.09 33.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.841 0.353 . . . . 64.420000000000002 111.615 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -116.67 99.46 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 74.239999999999995 110.72 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.595 HE22 ' HB3' ' A' ' 83' ' ' ARG . 22.8 mp0 -93.89 109.56 21.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.957 0.408 . . . . 74.430000000000007 111.235 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.31 130.11 37.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.246 -0.502 . . . . 52.030000000000001 112.871 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -73.26 -13.72 61.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.26 0.552 . . . . 61.130000000000003 110.987 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.9 p -107.4 144.79 33.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 110.712 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.27 -17.76 51.26 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.859 0.318 . . . . 75.230000000000004 111.859 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.95 147.39 95.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.349 -0.387 . . . . 73.099999999999994 111.41 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.9 117.21 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.313 2.009 . . . . 72.310000000000002 112.936 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 126' ' ' SER . 93.0 mt -82.0 155.85 69.92 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 120.859 0.361 . . . . 73.439999999999998 111.433 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 -177.45 3.53 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.276 1.984 . . . . 72.129999999999995 112.621 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 158' ' ' VAL . . . -77.99 158.44 29.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.757 0.313 . . . . 72.019999999999996 110.948 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -152.84 149.14 27.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.712 0.768 . . . . 72.420000000000002 112.628 -174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -133.64 162.76 31.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.204 -0.907 . . . . 72.430000000000007 110.238 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.92 -158.26 18.48 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.369 -0.92 . . . . 73.209999999999994 113.591 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.3 m -136.33 145.72 45.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.01 0.434 . . . . 73.230000000000004 111.324 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.68 128.34 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.045 0.45 . . . . 72.120000000000005 112.056 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.796 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 17.6 mm-40 -89.58 110.45 21.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.966 -0.561 . . . . 65.209999999999994 110.246 175.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.404 ' CG ' HD22 ' A' ' 139' ' ' LEU . 31.0 p90 -121.85 124.44 44.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.437 0.637 . . . . 65.510000000000005 111.736 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.66 -140.89 3.05 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.563 -0.744 . . . . 63.200000000000003 112.673 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.564 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 96.5 mt-30 -126.73 163.76 22.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.188 0.518 . . . . 74.150000000000006 111.872 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.77 114.79 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.227 -0.442 . . . . 72.150000000000006 111.107 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -92.48 -9.46 41.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.811 0.3 . . . . 74.129999999999995 111.811 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -91.05 178.59 42.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.09 -0.576 . . . . 36.689999999999998 113.785 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.3 p -85.76 -165.56 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.879 0.371 . . . . 70.329999999999998 111.483 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.482 HD12 ' HG3' ' A' ' 33' ' ' GLN . 41.9 mm -74.25 -31.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.908 0.385 . . . . 74.450000000000003 111.364 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.82 -43.87 8.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.782 0.325 . . . . 72.329999999999998 111.462 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -115.51 96.41 5.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.535 0.683 . . . . 73.239999999999995 111.301 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.684 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 9.3 p90 -121.41 144.1 48.86 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.852 -0.613 . . . . 75.230000000000004 111.899 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -120.09 127.01 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.661 -0.699 . . . . 72.129999999999995 111.114 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.89 99.18 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 55.240000000000002 110.611 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 pt -107.51 150.39 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.424 -0.353 . . . . 53.5 111.501 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 56.63 29.14 15.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.053 0.454 . . . . 44.020000000000003 111.851 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 100' ' ' GLU . 6.0 p -90.57 132.35 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.483 0.549 . . . . 60.200000000000003 112.483 -176.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -116.56 154.41 30.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 73.239999999999995 110.265 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -107.56 132.73 52.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.116 0.484 . . . . 74.209999999999994 112.055 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -122.65 142.13 51.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.413 -0.358 . . . . 74.25 111.281 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.82 102.76 13.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.976 0.417 . . . . 71.25 111.721 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.59 140.21 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.219 0.533 . . . . 70.549999999999997 112.023 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -130.3 148.46 52.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.448 -0.342 . . . . 72.019999999999996 110.812 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.86 144.77 48.02 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 111.935 0.346 . . . . 75.430000000000007 111.935 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -64.81 167.5 15.47 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.143 2.562 . . . . 72.109999999999999 113.648 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.14 128.9 34.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.131 -0.486 . . . . 62.25 112.11 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 66.1 m -79.69 75.73 6.35 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.164 0.507 . . . . 70.109999999999999 110.606 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.29 -30.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.239 0.543 . . . . 74.109999999999999 111.15 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.89 159.58 14.9 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.949 -0.569 . . . . 72.400000000000006 111.086 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.79 146.9 47.03 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.441 -0.345 . . . . 52.340000000000003 111.419 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.95 171.68 58.53 Favored 'Cis proline' 0 C--N 1.353 0.771 0 C-N-CA 124.331 -1.112 . . . . 73.219999999999999 112.753 -1.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 90.73 3.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.156 0.503 . . . . 72.430000000000007 111.477 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.71 84.83 2.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.268 0.556 . . . . 62.420000000000002 109.877 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.8 t -102.34 156.77 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 70.040000000000006 111.893 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 10.3 p-10 -150.13 108.71 3.82 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.192 0.52 . . . . 65.230000000000004 110.699 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.0 pt -113.32 135.27 21.81 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.119 -0.363 . . . . 52.020000000000003 111.821 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.9 119.5 5.9 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.296 1.998 . . . . 60.439999999999998 112.986 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.74 123.33 42.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.101 -0.5 . . . . 72.019999999999996 110.203 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -105.59 105.19 15.11 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.073 0.463 . . . . 64.150000000000006 111.326 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.404 HD22 ' CG ' ' A' ' 101' ' ' TYR . 70.1 mt -91.62 130.08 37.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.383 -0.371 . . . . 75.409999999999997 111.192 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 67.3 mttm -106.64 145.13 32.33 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.122 0.415 . . . . 75.019999999999996 112.122 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.92 27.23 73.7 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.343 -0.456 . . . . 71.439999999999998 113.998 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.4 tt -155.59 122.52 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.472 0.653 . . . . 72.230000000000004 111.802 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.2 m -85.46 148.01 26.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.122 -0.49 . . . . 75.530000000000001 111.283 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.81 -34.79 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.795 0.331 . . . . 72.450000000000003 111.884 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.01 -29.08 66.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.063 0.459 . . . . 64.420000000000002 111.587 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -109.35 10.77 25.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.044 0.387 . . . . 74.019999999999996 112.044 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 3.2 mt -74.01 114.73 12.66 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 71.040000000000006 111.63 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.58 -59.2 1.65 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.241 -0.504 . . . . 36.689999999999998 112.996 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -149.77 157.58 43.34 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.385 0.612 . . . . 75.109999999999999 112.48 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 96.2 t -126.23 107.73 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.261 -0.881 . . . . 75.439999999999998 109.552 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.796 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.8 ttt180 -109.63 108.31 18.68 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.244 0.461 . . . . 74.219999999999999 112.244 -171.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.636 HG22 ' SD ' ' A' ' 66' ' ' MET . 36.0 mm -86.5 132.07 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 111.59 0.219 . . . . 73.230000000000004 111.59 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.62 178.83 8.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.745 0.307 . . . . 70.040000000000006 111.746 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 65.44 19.99 11.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.934 0.716 . . . . 70.129999999999995 112.934 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -65.56 117.74 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.279 0.562 . . . . 75.129999999999995 111.716 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -130.37 153.3 81.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 111.57 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.566 ' HB3' HG21 ' A' ' 61' ' ' ILE . 66.4 Cg_endo -73.66 117.31 5.0 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.553 2.169 . . . . 61.409999999999997 113.385 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 5.7 p . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.353 0.597 . . . . 72.219999999999999 110.997 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.0 tt0 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.87 0.367 . . . . 60.399999999999999 110.485 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.547 ' HA ' HD12 ' A' ' 31' ' ' ILE . 39.7 m -61.21 -30.38 70.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.947 0.403 . . . . 74.439999999999998 111.553 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.2 -47.6 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.788 0.327 . . . . 75.430000000000007 110.839 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -64.54 -30.09 71.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 72.209999999999994 111.335 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 28' ' ' THR . 82.6 mt -62.62 -48.31 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.249 0.547 . . . . 63.200000000000003 110.791 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -64.68 -41.35 96.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.197 0.522 . . . . 74.129999999999995 110.738 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.492 ' HG3' HD11 ' A' ' 108' ' ' ILE . 57.7 tt0 -57.5 -47.59 81.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.797 -0.638 . . . . 73.239999999999995 111.102 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.23 -47.12 75.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 72.25 111.331 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.75 -27.45 68.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.224 -0.444 . . . . 70.109999999999999 111.974 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -77.29 -36.21 54.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.076 -0.39 . . . . 65.340000000000003 111.22 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.0 -36.12 82.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.303 0.573 . . . . 65.400000000000006 110.038 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -57.17 -41.48 79.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.752 -0.658 . . . . 74.25 110.465 172.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.96 76.92 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.283 0.475 . . . . 37.18 112.283 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 109' ' ' ASP . 51.9 mttp -87.67 -9.25 54.71 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.647 0.61 . . . . 74.0 112.647 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.4 t -63.27 123.03 17.63 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.133 0.492 . . . . 74.230000000000004 112.152 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t -88.42 -30.08 19.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.104 0.478 . . . . 73.329999999999998 111.166 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -146.73 107.13 4.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.236 -0.438 . . . . 42.219999999999999 110.854 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 93.3 -143.64 16.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.084 -0.579 . . . . 74.439999999999998 113.104 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.761 HG11 HD12 ' A' ' 57' ' ' LEU . 16.4 m -143.27 153.52 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.34 0.59 . . . . 63.109999999999999 112.198 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -101.25 105.46 16.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.612 -0.722 . . . . 75.230000000000004 110.964 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 98.9 mt -95.23 136.65 35.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.737 0.303 . . . . 73.120000000000005 110.904 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.2 mt -109.81 130.95 22.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.292 -0.255 . . . . 65.140000000000001 111.428 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HB3' HD12 ' A' ' 147' ' ' LEU . 33.0 Cg_endo -62.58 -27.78 76.76 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.604 2.202 . . . . 61.240000000000002 112.714 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.79 -23.54 72.14 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.139 -0.553 . . . . 37.18 112.412 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.23 73.92 1.53 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.149 0.5 . . . . 74.109999999999999 111.314 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -66.6 74.56 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.357 0.599 . . . . 63.350000000000001 110.845 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 p -148.97 159.27 37.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.771 -0.65 . . . . 42.310000000000002 112.38 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.12 149.87 28.88 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.027 2.485 . . . . 72.120000000000005 113.756 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 145.86 49.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.397 -0.365 . . . . 71.450000000000003 111.226 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -82.44 134.93 35.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.446 -0.343 . . . . 72.129999999999995 111.057 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.761 HD12 HG11 ' A' ' 45' ' ' VAL . 37.0 tp -143.53 136.56 27.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.558 0.577 . . . . 75.109999999999999 112.558 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.59 143.15 27.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.91 -0.586 . . . . 71.450000000000003 110.363 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -140.52 170.98 14.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.226 0.536 . . . . 74.5 111.673 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.641 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.0 mt-30 -77.51 5.76 8.37 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.074 -0.512 . . . . 71.329999999999998 112.101 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -112.0 -22.13 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.851 0.358 . . . . 62.200000000000003 110.837 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.03 -160.71 29.24 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.287 -0.415 . . . . 64.319999999999993 112.668 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.6 m -92.91 135.43 34.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.394 -0.474 . . . . 73.540000000000006 110.771 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.2 178.53 7.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.408 0.623 . . . . 37.18 112.619 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -136.29 107.06 6.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.744 -0.662 . . . . 65.040000000000006 111.013 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.707 ' SD ' HG22 ' A' ' 152' ' ' ILE . 58.3 mtt -96.04 170.17 9.47 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.049 -0.407 . . . . 75.140000000000001 111.879 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.6 p -169.08 152.74 5.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.033 0.383 . . . . 54.210000000000001 112.033 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.32 114.81 29.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.155 -0.475 . . . . 75.439999999999998 111.363 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG22 ' HB ' ' A' ' 81' ' ' THR . 26.9 m -128.79 164.09 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.731 0.3 . . . . 75.530000000000001 111.41 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 59.1 42.52 18.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.167 0.508 . . . . 62.43 112.036 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.9 mt -82.45 109.68 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.038 -0.528 . . . . 73.430000000000007 111.782 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 p -131.22 155.16 81.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 120.977 0.418 . . . . 73.200000000000003 112.124 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.49 136.43 33.69 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.767 2.311 . . . . 52.539999999999999 112.757 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.619 ' HB2' HG22 ' A' ' 79' ' ' THR . 32.8 t70 -115.4 164.78 13.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.841 0.456 . . . . 74.530000000000001 111.145 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.94 74.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.098 0.407 . . . . 53.109999999999999 112.098 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.88 -17.6 16.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.137 0.421 . . . . 62.450000000000003 112.137 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.3 -103.02 0.16 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.476 -0.869 . . . . 37.18 114.23 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.4 m -149.73 125.54 10.47 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.565 -0.373 . . . . 73.010000000000005 111.449 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 74' ' ' ASP . 39.4 p -101.66 124.73 47.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.806 0.336 . . . . 75.239999999999995 111.888 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 137' ' ' LEU . 3.4 pp -138.2 177.67 7.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.797 0.332 . . . . 73.109999999999999 111.252 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 69' ' ' VAL . 60.0 m -122.52 126.54 48.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.801 0.334 . . . . 73.120000000000005 111.472 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.6 114.02 25.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.89 -0.411 . . . . 73.209999999999994 109.89 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 97.2 mtt180 -104.53 110.05 22.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.287 0.477 . . . . 63.210000000000001 112.287 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -102.72 112.37 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 64.519999999999996 111.573 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 131' ' ' SER . 34.7 tt0 -98.52 141.8 30.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.568 0.223 . . . . 63.200000000000003 111.026 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.6 144.05 22.94 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.039 -0.6 . . . . 75.030000000000001 113.101 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.09 -40.67 96.62 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.974 0.416 . . . . 75.239999999999995 110.857 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.9 p -96.78 -177.66 3.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.219 0.533 . . . . 51.240000000000002 111.38 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -92.9 6.95 45.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.305 -0.407 . . . . 74.129999999999995 111.248 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.45 135.38 68.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.485 -0.325 . . . . 72.109999999999999 111.784 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 96.68 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.139 1.892 . . . . 64.420000000000002 111.801 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.75 141.3 89.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.33 0.492 . . . . 71.319999999999993 112.33 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.11 177.58 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.663 2.242 . . . . 75.430000000000007 112.929 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.3 134.4 46.75 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.013 0.435 . . . . 62.399999999999999 111.651 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.65 160.95 39.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.138 0.494 . . . . 74.540000000000006 111.954 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 92.3 p -138.71 168.8 19.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.171 -0.468 . . . . 55.340000000000003 111.059 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.616 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.2 165.25 37.08 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.023 -0.608 . . . . 54.200000000000003 113.337 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.6 m -98.98 107.84 20.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.91 0.386 . . . . 64.150000000000006 111.544 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 119' ' ' GLN . 3.2 p -89.83 112.97 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.202 0.525 . . . . 54.329999999999998 111.097 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 117' ' ' GLN . 47.5 mt-10 -102.6 103.56 13.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.277 0.56 . . . . 75.430000000000007 110.956 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' CD1' HD23 ' A' ' 139' ' ' LEU . 19.0 p90 -104.27 137.97 41.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.814 -0.63 . . . . 74.430000000000007 111.579 -175.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.09 -145.5 4.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.697 -0.763 . . . . 52.240000000000002 113.592 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.598 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.5 mt-30 -129.44 161.35 30.59 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.885 0.374 . . . . 64.239999999999995 111.363 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 111' ' ' PHE . 51.9 mt -122.34 140.11 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.073 0.463 . . . . 73.25 112.102 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.741 HE21 HD11 ' A' ' 114' ' ' ILE . 10.9 pt20 -132.03 103.53 6.33 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.489 0.661 . . . . 65.519999999999996 110.79 169.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 157.56 -158.54 29.09 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.156 -0.545 . . . . 62.439999999999998 113.606 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 33.4 p -98.82 -170.71 1.97 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.517 -0.402 . . . . 71.140000000000001 111.073 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 33' ' ' GLN . 34.0 mm -76.12 -15.41 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.31 0.576 . . . . 54.450000000000003 110.766 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.709 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 40.7 m-20 -105.2 -45.94 4.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.104 -0.498 . . . . 74.239999999999995 111.512 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -116.03 92.88 4.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.377 0.608 . . . . 73.010000000000005 111.097 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 104' ' ' ILE . 38.2 p90 -127.33 132.2 50.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.131 0.491 . . . . 74.5 111.809 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -96.49 124.44 40.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.087 -0.506 . . . . 72.319999999999993 111.149 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.82 97.73 11.08 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.138 -0.483 . . . . 72.420000000000002 111.007 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.741 HD11 HE21 ' A' ' 105' ' ' GLN . 36.8 pt -103.53 162.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.126 -0.488 . . . . 72.409999999999997 112.043 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 53.77 22.18 3.07 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 64.420000000000002 112.61 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.57 131.77 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.366 0.603 . . . . 75.310000000000002 112.202 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 34.0 mt-30 -128.15 146.41 50.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.665 -0.698 . . . . 74.530000000000001 110.814 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.03 143.13 28.9 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.263 0.554 . . . . 71.209999999999994 112.267 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.57 ' HB3' HG11 ' A' ' 99' ' ' VAL . 8.4 tt0 -142.23 149.44 39.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.782 -0.645 . . . . 74.019999999999996 110.174 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -100.28 114.41 27.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.138 0.494 . . . . 74.310000000000002 112.231 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.92 121.94 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.113 -0.494 . . . . 65.409999999999997 111.17 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -113.46 135.65 53.65 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.902 0.382 . . . . 73.310000000000002 111.37 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.515 ' HB3' HG13 ' A' ' 133' ' ' VAL . . . -124.1 140.07 34.01 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.234 -0.439 . . . . 72.219999999999999 111.476 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.16 169.66 21.94 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.589 2.193 . . . . 72.019999999999996 113.623 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.13 134.79 34.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 55.210000000000001 111.523 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 m -77.39 124.06 27.36 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.386 -0.37 . . . . 73.239999999999995 111.419 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.28 -42.52 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.103 0.478 . . . . 74.230000000000004 110.973 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -125.81 171.58 10.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 75.150000000000006 111.83 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.11 158.79 31.07 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.263 -0.426 . . . . 71.230000000000004 111.483 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.0 160.14 57.98 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.015 -1.244 . . . . 72.25 113.129 -2.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 58.8 m -86.17 78.07 9.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.494 0.553 . . . . 60.009999999999998 112.494 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.78 79.42 2.23 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.427 -0.583 . . . . 64.349999999999994 109.427 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 135' ' ' ILE . 40.6 t -76.68 99.78 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.402 -0.363 . . . . 75.439999999999998 111.818 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.8 p-10 -91.27 106.84 18.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.033 0.444 . . . . 52.25 110.97 174.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 133' ' ' VAL . 26.9 pt -114.08 131.54 23.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.972 0.36 . . . . 74.310000000000002 111.972 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.58 135.69 54.35 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.722 2.281 . . . . 71.040000000000006 112.381 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.488 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.4 tt -132.42 113.33 13.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.35 -0.386 . . . . 74.200000000000003 110.424 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.61 109.76 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.058 0.456 . . . . 74.209999999999994 111.702 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.472 HD23 ' CD1' ' A' ' 101' ' ' TYR . 80.0 mt -88.57 140.05 29.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.143 -0.317 . . . . 63.520000000000003 110.143 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -129.4 150.69 50.65 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.888 0.375 . . . . 74.5 111.475 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.87 31.14 56.53 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.218 -0.515 . . . . 71.420000000000002 113.068 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 147' ' ' LEU . 17.8 tt -168.51 125.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.916 0.389 . . . . 75.230000000000004 111.487 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.8 m -83.53 144.71 29.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.649 0.261 . . . . 60.329999999999998 111.522 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 p -51.04 -44.77 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 112.391 0.515 . . . . 72.430000000000007 112.391 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -59.74 -38.55 82.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.211 0.529 . . . . 52.310000000000002 111.389 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -93.31 6.16 49.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.346 0.499 . . . . 70.530000000000001 112.346 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 142' ' ' ILE . 1.3 tt -69.68 125.14 25.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.662 0.267 . . . . 73.549999999999997 110.402 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -95.82 -62.16 0.98 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.111 -0.566 . . . . 41.439999999999998 113.602 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -145.44 160.25 41.87 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.272 0.558 . . . . 74.230000000000004 112.008 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 75.5 t -124.86 101.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.696 -0.684 . . . . 64.310000000000002 110.406 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 31.2 ttm180 -88.31 94.37 9.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.874 0.369 . . . . 72.030000000000001 111.636 -176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.707 HG22 ' SD ' ' A' ' 66' ' ' MET . 37.1 mm -85.75 127.58 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.68 -0.237 . . . . 74.519999999999996 110.876 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -164.45 -178.3 5.34 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.405 0.521 . . . . 72.25 112.405 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 66.38 24.56 10.47 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.449 0.7 . . . . 74.310000000000002 112.293 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.616 HD13 ' HA3' ' A' ' 97' ' ' GLY . 41.9 mm -67.15 105.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.187 0.518 . . . . 73.430000000000007 111.701 -177.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.641 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.6 pt20 -137.71 151.72 71.22 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.021 -0.536 . . . . 73.230000000000004 111.42 -175.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.8 133.25 23.27 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.406 2.071 . . . . 43.030000000000001 112.846 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.135 0.493 . . . . 64.310000000000002 111.975 -177.545 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 111.949 0.351 . . . . 73.0 111.949 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.37 -4.95 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.17 0.51 . . . . 74.200000000000003 111.437 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -73.66 79.33 1.52 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.848 -0.615 . . . . 75.140000000000001 111.038 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.04 152.12 20.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.337 -0.392 . . . . 73.030000000000001 111.31 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.9 m -75.38 69.28 2.16 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.167 0.508 . . . . 62.5 110.505 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.37 117.43 29.9 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.176 -0.465 . . . . 61.409999999999997 110.994 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.496 HG23 ' H ' ' A' ' 9' ' ' GLN . 14.9 p -101.98 148.2 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.086 0.469 . . . . 65.239999999999995 112.089 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -101.56 26.13 7.66 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.818 0.342 . . . . 70.450000000000003 111.548 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' H ' HG23 ' A' ' 7' ' ' VAL . 63.7 tt0 -53.8 110.8 0.63 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.183 -0.462 . . . . 62.140000000000001 111.613 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.0 ttm -69.3 93.14 0.61 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.046 0.451 . . . . 64.530000000000001 111.823 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 138.65 31.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.232 -0.44 . . . . 74.400000000000006 110.507 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -73.29 81.96 1.37 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.559 0.695 . . . . 73.099999999999994 111.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 m -148.58 126.19 11.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.792 -0.64 . . . . 73.519999999999996 110.329 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.28 131.86 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.233 0.539 . . . . 72.120000000000005 112.039 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.6 t -136.4 118.25 15.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.014 -0.539 . . . . 73.099999999999994 110.243 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.8 p -87.79 112.23 22.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.965 0.357 . . . . 71.329999999999998 111.965 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -83.31 171.14 13.86 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.869 0.366 . . . . 72.329999999999998 111.086 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.12 152.06 42.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.338 -0.226 . . . . 54.43 110.883 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.32 94.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.669 0.271 . . . . 72.319999999999993 111.677 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.67 135.82 56.31 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.583 -0.28 . . . . 73.030000000000001 110.438 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -72.2 177.27 4.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.801 0.667 . . . . 73.450000000000003 112.801 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -74.16 169.78 16.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.537 0.684 . . . . 65.120000000000005 112.677 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -76.55 179.24 6.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.683 -0.689 . . . . 73.209999999999994 110.8 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp -145.64 150.24 35.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.831 0.348 . . . . 73.209999999999994 111.699 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' OD1' ' HG2' ' A' ' 27' ' ' GLU . 52.4 t-20 -54.3 131.99 42.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.59 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 30.3 mm-40 -50.76 -49.03 59.02 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.316 0.487 . . . . 72.549999999999997 112.316 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 31' ' ' ILE . 14.6 pt-20 -59.68 -45.66 91.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.949 0.404 . . . . 73.319999999999993 110.842 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -60.02 -34.3 73.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 111.543 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 25' ' ' ASN . 98.1 t -62.78 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.948 0.404 . . . . 75.019999999999996 110.713 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 4.9 mptp? -62.3 -36.2 81.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 74.319999999999993 111.163 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.8 mt -62.04 -48.01 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.08 0.467 . . . . 74.239999999999995 110.798 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -60.11 -35.29 74.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.282 0.563 . . . . 75.310000000000002 110.932 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.622 ' HG3' HD13 ' A' ' 108' ' ' ILE . 35.1 tt0 -68.37 -43.35 77.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.176 -0.465 . . . . 64.109999999999999 110.653 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 -55.76 29.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.013 -0.54 . . . . 72.129999999999995 110.684 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -54.15 -47.38 71.99 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.182 0.438 . . . . 72.340000000000003 112.182 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -62.29 -48.21 80.91 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.965 0.357 . . . . 75.319999999999993 111.965 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.7 -33.57 75.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.211 0.529 . . . . 72.340000000000003 111.026 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -56.04 -48.96 75.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.856 -0.611 . . . . 71.510000000000005 110.628 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.75 -32.3 72.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.942 -0.572 . . . . 71.409999999999997 111.683 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.45 -10.46 59.41 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.007 0.373 . . . . 71.400000000000006 112.007 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 43.2 t -87.13 132.45 33.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 111.871 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.0 p -103.36 -24.82 13.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 75.400000000000006 110.781 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t -100.53 93.48 5.64 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.175 -0.466 . . . . 62.340000000000003 110.918 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.64 -160.18 47.65 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.198 0.439 . . . . 70.310000000000002 114.198 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -116.6 144.92 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.3 0.481 . . . . 73.209999999999994 112.3 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.461 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 16.1 m-85 -83.3 113.75 20.92 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.407 -0.361 . . . . 72.230000000000004 111.898 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 86.9 mt -103.9 94.26 5.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.182 0.515 . . . . 72.400000000000006 110.304 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.72 120.67 82.42 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.543 -0.299 . . . . 72.409999999999997 110.818 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.593 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.7 Cg_endo -57.17 -22.2 47.01 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.827 2.352 . . . . 74.409999999999997 112.888 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.49 -21.39 60.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.34 -0.457 . . . . 61.020000000000003 113.061 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.97 -40.62 10.02 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.845 0.355 . . . . 44.130000000000003 111.164 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.9 mttm 62.88 2.48 1.0 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.69 0.626 . . . . 75.219999999999999 112.69 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 p -70.76 151.06 95.31 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 113.02 0.748 . . . . 73.519999999999996 113.02 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 65' ' ' ARG . 73.8 Cg_endo -72.89 136.33 24.95 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.843 2.362 . . . . 72.439999999999998 112.467 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.51 140.58 51.24 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.737 0.304 . . . . 71.310000000000002 111.604 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -92.71 127.43 38.21 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.999 0.428 . . . . 75.109999999999999 111.738 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.648 ' HB3' ' HE1' ' A' ' 66' ' ' MET . 32.2 tp -131.13 127.19 37.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.119 0.485 . . . . 63.32 111.369 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.02 97.7 11.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.127 0.489 . . . . 73.219999999999999 110.715 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -93.55 -177.18 4.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.275 0.56 . . . . 72.109999999999999 112.262 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -67.5 -32.41 73.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.021 -0.536 . . . . 72.230000000000004 112.032 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 pt -84.45 -30.0 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 111.883 0.327 . . . . 75.329999999999998 111.883 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.58 -177.69 37.76 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.396 -0.43 . . . . 62.219999999999999 112.895 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.5 m -85.18 109.01 17.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.039 0.447 . . . . 74.329999999999998 111.446 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.728 HD11 ' SD ' ' A' ' 66' ' ' MET . 0.6 OUTLIER -116.57 171.71 7.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.011 0.434 . . . . 73.409999999999997 111.897 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 30.6 ttm180 -140.64 114.04 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.258 -0.428 . . . . 72.129999999999995 111.101 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.728 ' SD ' HD11 ' A' ' 64' ' ' LEU . 3.2 mpp? -103.59 158.55 16.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.5 0.555 . . . . 63.310000000000002 112.5 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 p -156.67 157.85 35.93 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.793 -0.64 . . . . 70.340000000000003 111.237 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.491 HD22 HD12 ' A' ' 80' ' ' LEU . 76.3 mt -112.37 117.67 33.1 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.896 0.332 . . . . 73.329999999999998 111.896 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.435 HG22 HD21 ' A' ' 70' ' ' ASN . 22.5 m -135.74 165.06 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.657 0.265 . . . . 72.420000000000002 111.555 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.435 HD21 HG22 ' A' ' 69' ' ' VAL . 44.4 m-80 57.7 40.08 26.77 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.118 0.485 . . . . 54.32 111.907 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.466 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 40.5 mt -69.86 112.18 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.2 -0.454 . . . . 73.140000000000001 111.217 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -137.23 151.31 71.39 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-O 120.772 0.32 . . . . 75.519999999999996 111.83 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.92 146.76 83.77 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.887 2.391 . . . . 60.240000000000002 113.186 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.726 ' HB2' HG23 ' A' ' 79' ' ' THR . 19.6 t70 -115.02 169.86 8.78 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.258 -0.428 . . . . 73.150000000000006 111.043 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.63 72.48 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.866 0.321 . . . . 74.010000000000005 111.866 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.21 -45.68 3.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.517 -0.31 . . . . 63.229999999999997 111.465 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -130.6 -110.07 1.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.754 -0.736 . . . . 61.439999999999998 113.893 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -146.97 127.83 14.43 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.104 0.409 . . . . 54.229999999999997 112.104 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.726 HG23 ' HB2' ' A' ' 74' ' ' ASP . 75.7 p -98.93 120.81 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.767 0.317 . . . . 72.219999999999999 111.752 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -137.15 151.06 48.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.823 0.344 . . . . 62.130000000000003 111.197 175.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 m -83.3 113.45 20.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.006 0.431 . . . . 75.25 111.846 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.42 109.39 20.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.92 -0.582 . . . . 71.099999999999994 109.969 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 66' ' ' MET . 73.7 mtm180 -101.15 123.07 44.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.861 0.319 . . . . 63.210000000000001 111.861 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 84' ' ' ILE . 3.7 mp -102.2 102.42 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.034 0.445 . . . . 73.200000000000003 110.593 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -100.9 134.51 43.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.433 -0.349 . . . . 73.519999999999996 111.188 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.56 122.52 5.81 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.075 -0.583 . . . . 62.119999999999997 113.446 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.0 -27.81 62.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.428 0.632 . . . . 65.439999999999998 110.498 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -85.89 -175.24 5.5 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.774 -0.648 . . . . 54.420000000000002 111.44 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.41 5.63 39.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.397 -0.365 . . . . 63.240000000000002 111.458 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.09 152.98 38.01 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.196 0.443 . . . . 62.0 112.196 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 73.2 Cg_endo -74.27 138.18 24.59 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.773 2.315 . . . . 74.340000000000003 112.79 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.17 122.07 55.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 O-C-N 122.142 -0.349 . . . . 70.340000000000003 111.848 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.587 ' HB2' HE22 ' A' ' 160' ' ' GLN . 57.8 Cg_endo -69.27 170.88 14.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.607 2.205 . . . . 37.880000000000003 112.866 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.6 131.48 50.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.307 0.484 . . . . 44.439999999999998 112.307 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -146.79 154.85 41.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.261 0.553 . . . . 73.200000000000003 112.225 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.9 p -118.87 151.23 38.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.898 -0.592 . . . . 73.430000000000007 110.438 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 154' ' ' ASP . . . -141.18 150.24 21.67 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.771 -0.728 . . . . 37.880000000000003 113.83 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 154' ' ' ASP . 61.3 m -100.06 110.0 22.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.771 0.319 . . . . 70.409999999999997 110.819 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.1 p -102.28 117.88 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.433 0.531 . . . . 75.540000000000006 112.433 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HG2' ' CD2' ' A' ' 153' ' ' HIS . 32.8 mm-40 -83.98 147.26 27.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.901 -0.407 . . . . 75.420000000000002 109.901 174.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -155.12 133.71 11.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.066 0.46 . . . . 70.420000000000002 111.654 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.85 -147.67 5.48 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.952 -0.567 . . . . 63.219999999999999 112.951 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.432 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 87.4 mt-30 -123.36 150.71 43.33 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.333 0.587 . . . . 63.140000000000001 112.565 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.3 mt -116.26 104.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.978 -0.556 . . . . 54.43 110.657 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.498 ' NE2' HD11 ' A' ' 114' ' ' ILE . 4.0 pt20 -89.19 -17.41 29.18 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.398 0.518 . . . . 64.019999999999996 112.398 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -90.37 -159.23 35.36 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.026 -0.607 . . . . 52.100000000000001 113.963 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 51.8 p -114.25 -178.44 3.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.806 0.443 . . . . 72.510000000000005 110.967 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.622 HD13 ' HG3' ' A' ' 33' ' ' GLN . 48.0 mm -66.81 -30.92 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 60.020000000000003 110.709 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.92 -39.28 72.8 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.097 -0.501 . . . . 74.209999999999994 111.163 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.59 108.87 2.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.164 -0.471 . . . . 75.150000000000006 111.191 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.608 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 36.9 p90 -125.99 139.49 53.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.89 0.376 . . . . 75.239999999999995 111.743 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -108.78 123.23 48.69 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.244 -0.434 . . . . 75.519999999999996 111.443 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -74.66 100.48 3.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.718 0.294 . . . . 64.030000000000001 110.798 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.498 HD11 ' NE2' ' A' ' 105' ' ' GLN . 50.6 pt -109.63 157.46 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 111.812 0.301 . . . . 63.219999999999999 111.812 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 56.73 31.38 19.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.18 0.514 . . . . 71.129999999999995 111.502 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -97.08 132.91 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.385 0.612 . . . . 50.149999999999999 112.583 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -142.11 178.18 7.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.723 -0.672 . . . . 70.519999999999996 109.656 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 11.3 p30 -127.85 172.91 10.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.949 1.092 . . . . 71.430000000000007 113.949 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -153.1 156.34 38.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.872 -1.058 . . . . 72.230000000000004 109.921 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.54 111.48 23.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.258 0.466 . . . . 74.109999999999999 112.258 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.2 pt -96.11 101.17 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.325 0.583 . . . . 55.299999999999997 110.989 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.89 108.93 20.48 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.436 -0.347 . . . . 63.130000000000003 111.185 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.57 38.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.513 -0.312 . . . . 70.140000000000001 111.599 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.83 179.69 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.67 2.247 . . . . 64.540000000000006 113.553 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.89 108.09 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.023 0.439 . . . . 73.239999999999995 111.299 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 15.3 m -80.77 96.66 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 73.439999999999998 111.203 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 127' ' ' VAL . 12.2 t -86.71 7.98 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 121.081 0.467 . . . . 73.530000000000001 111.609 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.637 ' H ' HD21 ' A' ' 128' ' ' LEU . 2.1 pt? -105.52 147.0 28.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.186 0.517 . . . . 65.439999999999998 111.925 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.39 127.37 22.44 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.098 -0.501 . . . . 72.099999999999994 111.015 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.18 155.14 91.81 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.836 -1.318 . . . . 74.299999999999997 113.086 -0.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.612 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 48.5 t -88.64 121.27 30.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.652 0.612 . . . . 70.430000000000007 112.652 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -138.79 130.72 27.95 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.085 0.469 . . . . 74.5 110.948 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.35 149.72 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.802 0.334 . . . . 54.329999999999998 111.563 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -132.76 125.38 30.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.027 0.441 . . . . 73.319999999999993 110.737 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 pt -130.74 137.88 31.77 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 120.814 0.34 . . . . 71.319999999999993 111.472 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.71 120.21 7.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.302 2.001 . . . . 75.409999999999997 112.777 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.31 97.41 8.48 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.023 -0.535 . . . . 71.109999999999999 109.782 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.444 ' HG3' HG21 ' A' ' 79' ' ' THR . 63.0 tt0 -87.83 83.36 7.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 53.450000000000003 111.297 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 65.9 mt -62.86 145.75 54.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 111.072 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -116.81 147.57 41.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.136 0.494 . . . . 71.329999999999998 112.073 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.19 -49.98 3.88 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.066 -0.516 . . . . 71.420000000000002 114.03 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.557 HD13 HD22 ' A' ' 147' ' ' LEU . 20.9 tt -87.64 138.47 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.261 0.553 . . . . 74.219999999999999 112.24 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.6 m -92.79 149.69 21.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.183 -0.462 . . . . 72.439999999999998 111.519 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -53.25 -42.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.379 0.511 . . . . 73.140000000000001 112.379 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.75 -23.65 65.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.199 0.523 . . . . 73.329999999999998 111.289 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.432 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.1 mm-40 -103.03 7.81 38.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 74.109999999999999 112.089 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.593 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 14.0 mt -72.85 124.36 25.24 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.279 0.474 . . . . 74.329999999999998 112.279 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.67 -57.59 0.82 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.203 -0.523 . . . . 44.130000000000003 112.886 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -145.0 146.34 31.87 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.333 -0.51 . . . . 72.230000000000004 111.9 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' A' ' 68' ' ' LEU . 62.1 t -124.54 100.19 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.068 -0.514 . . . . 74.099999999999994 109.917 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -100.53 114.47 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.736 0.643 . . . . 75.430000000000007 112.736 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.49 123.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.797 -0.638 . . . . 51.43 110.988 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.465 ' CD2' ' HG2' ' A' ' 100' ' ' GLU . 10.2 p80 -152.88 178.44 9.66 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.574 0.226 . . . . 75.430000000000007 111.082 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 33.1 t70 54.53 73.63 0.39 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.376 0.607 . . . . 73.439999999999998 111.197 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 115.29 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.843 -0.617 . . . . 45.240000000000002 110.695 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.52 140.07 36.72 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.095 0.405 . . . . 74.420000000000002 112.095 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.91 146.77 42.68 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.635 2.224 . . . . 75.420000000000002 112.538 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.34 135.56 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.047 0.758 . . . . 75.200000000000003 113.047 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.9 ptt? 37.54 30.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.258 1.577 . . . . 64.219999999999999 115.258 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.587 HE22 ' HB2' ' A' ' 93' ' ' PRO . 2.3 pt20 -107.12 147.85 29.53 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.592 -0.693 . . . . 74.409999999999997 111.488 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.524 HD22 ' H ' ' A' ' 161' ' ' LEU . 2.6 pt? -80.76 148.72 29.95 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.689 0.626 . . . . 75.219999999999999 112.689 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -96.69 172.93 7.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.201 0.524 . . . . 74.439999999999998 110.979 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -106.84 123.96 48.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.497 -0.32 . . . . 63.240000000000002 110.334 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -54.27 112.53 1.0 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.946 0.403 . . . . 73.230000000000004 111.219 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -73.17 76.19 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.405 0.621 . . . . 73.420000000000002 110.591 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -74.29 88.74 2.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.908 -0.587 . . . . 72.319999999999993 111.864 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -97.41 -24.76 15.47 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.095 0.474 . . . . 73.349999999999994 111.015 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.405 -0.807 . . . . 72.540000000000006 110.899 174.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.3 mmm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 110.467 -0.197 . . . . 71.120000000000005 110.467 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.08 143.72 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.172 0.511 . . . . 71.310000000000002 112.183 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -107.18 178.51 4.53 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.038 -0.528 . . . . 75.340000000000003 110.823 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -89.15 131.58 35.22 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.274 -0.266 . . . . 73.349999999999994 111.225 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.3 p -93.94 152.9 18.52 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.11 0.481 . . . . 74.230000000000004 111.88 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.64 -168.26 2.04 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.329999999999998 111.938 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.1 173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.253 -0.43 . . . . 75.409999999999997 111.967 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -126.27 125.48 42.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.023 0.379 . . . . 73.200000000000003 112.023 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -81.0 148.25 29.83 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.141 0.496 . . . . 74.540000000000006 112.303 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.1 mmt -121.79 120.27 34.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.287 -0.415 . . . . 50.520000000000003 110.56 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -113.35 134.63 54.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.906 0.336 . . . . 72.510000000000005 111.906 -172.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -110.72 153.95 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.757 0.313 . . . . 70.099999999999994 111.125 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.5 m -101.75 164.62 11.64 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.872 0.368 . . . . 73.049999999999997 111.841 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 118.32 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.959 0.409 . . . . 72.549999999999997 111.664 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.0 p -170.86 123.14 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 111.862 0.319 . . . . 64.310000000000002 111.862 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 p -111.91 165.76 11.81 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.823 0.344 . . . . 72.099999999999994 111.365 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.36 158.32 16.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.9 0.381 . . . . 74.239999999999995 111.638 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.17 176.47 5.38 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.897 0.38 . . . . 62.039999999999999 111.719 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -105.95 153.91 21.33 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.016 0.436 . . . . 63.530000000000001 111.785 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.18 125.36 35.44 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.031 -0.531 . . . . 75.040000000000006 111.161 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -95.95 -177.7 4.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.036 0.446 . . . . 74.329999999999998 111.944 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -86.65 175.21 8.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.301 -0.409 . . . . 73.319999999999993 111.645 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 26.1 pt20 -67.98 105.38 2.0 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.551 0.691 . . . . 71.349999999999994 112.136 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.686 HD22 HG22 ' A' ' 28' ' ' THR . 19.0 tp -98.78 178.32 5.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.934 -0.576 . . . . 74.430000000000007 109.819 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 32.7 m-20 -45.96 146.17 1.31 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.135 0.493 . . . . 74.140000000000001 112.321 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -56.15 -39.81 72.86 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.443 0.905 . . . . 55.229999999999997 113.443 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.57 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -65.09 -39.69 93.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.378 -0.529 . . . . 71.420000000000002 111.067 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.686 HG22 HD22 ' A' ' 24' ' ' LEU . 94.2 m -59.62 -50.05 75.36 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.224 0.535 . . . . 64.450000000000003 111.164 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.12 -35.29 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.475 0.655 . . . . 75.109999999999999 110.657 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.597 ' HE3' HD11 ' A' ' 48' ' ' LEU . 23.7 tptt -70.3 -35.95 74.02 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.623 -0.717 . . . . 74.140000000000001 110.754 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 27' ' ' GLU . 89.2 mt -60.48 -42.91 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.412 0.625 . . . . 72.519999999999996 110.322 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -57.4 -44.76 84.81 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.838 -0.619 . . . . 71.540000000000006 110.551 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' HG3' HD12 ' A' ' 108' ' ' ILE . 31.6 tt0 -60.91 -40.03 91.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.934 -0.576 . . . . 74.230000000000004 111.12 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -55.47 34.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.938 -0.574 . . . . 70.340000000000003 111.535 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -60.71 -39.05 87.1 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 111.893 0.331 . . . . 73.340000000000003 111.893 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.08 -54.57 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.425 0.528 . . . . 74.549999999999997 112.425 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.61 -41.64 77.39 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.064 0.459 . . . . 64.329999999999998 110.919 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.8 -46.02 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 111.343 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.81 63.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 64.219999999999999 112.561 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.701 ' HB3' ' HZ1' ' A' ' 40' ' ' LYS . 8.1 mtpm? -94.42 -12.41 27.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.892 0.33 . . . . 75.219999999999999 111.892 178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.2 t -85.7 142.47 29.0 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.669 0.271 . . . . 73.420000000000002 111.336 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.2 p -84.0 -42.32 16.34 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.099 -0.375 . . . . 72.109999999999999 111.517 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 m -148.08 87.79 1.63 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 65.430000000000007 111.377 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.4 153.35 6.08 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.244 -0.503 . . . . 42.210000000000001 112.405 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 152' ' ' ILE . 25.8 m -106.41 146.12 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.315 0.579 . . . . 60.210000000000001 112.449 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -106.22 102.9 12.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.807 -0.633 . . . . 73.219999999999999 110.884 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -92.58 116.02 28.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.897 0.379 . . . . 74.5 111.221 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.597 HD11 ' HE3' ' A' ' 30' ' ' LYS . 3.8 mm? -86.93 117.46 68.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.578 -0.283 . . . . 54.119999999999997 110.717 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.602 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 78.5 Cg_exo -51.11 -36.36 54.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.102 2.534 . . . . 73.430000000000007 113.768 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.84 99.79 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.954 -0.641 . . . . 61.100000000000001 112.548 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 30' ' ' LYS . . . -86.88 93.61 9.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.731 0.301 . . . . 75.140000000000001 111.487 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.568 ' HE3' HD11 ' A' ' 71' ' ' ILE . 43.6 mmtm -67.52 77.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.878 0.37 . . . . 73.549999999999997 110.251 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 p -140.48 149.97 59.16 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 112.841 0.682 . . . . 75.140000000000001 112.841 -175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.596 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 92.9 Cg_endo -80.48 154.19 21.04 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.393 2.728 . . . . 64.219999999999999 113.242 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.46 137.93 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.67 0.272 . . . . 63.43 111.456 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' CZ ' HG21 ' A' ' 63' ' ' THR . 37.6 ttt85 -79.22 133.69 36.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.853 0.359 . . . . 72.299999999999997 111.901 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 64' ' ' LEU . 56.2 tp -138.14 120.58 16.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.497 0.554 . . . . 75.420000000000002 112.497 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.47 121.63 26.51 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.726 -0.67 . . . . 61.43 110.401 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 p -123.68 -179.33 4.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.534 . . . . 64.209999999999994 111.808 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.498 HE22 ' HB3' ' A' ' 156' ' ' GLN . 46.3 mt-30 -67.72 -19.12 65.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 72.099999999999994 112.146 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 pt -100.26 -25.71 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.971 0.415 . . . . 73.439999999999998 111.891 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.76 32.54 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.415 -0.421 . . . . 65.310000000000002 112.243 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.535 HG21 ' CZ ' ' A' ' 56' ' ' ARG . 39.0 m -94.48 127.19 40.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.176 0.513 . . . . 72.140000000000001 111.709 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.8 170.13 13.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.03 -0.532 . . . . 72.319999999999993 110.71 175.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.596 ' HG2' ' HB2' ' A' ' 54' ' ' PRO . 17.2 ttp180 -133.44 105.59 7.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.835 0.35 . . . . 74.349999999999994 110.924 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.759 ' SD ' HG23 ' A' ' 152' ' ' ILE . 66.9 mtt -95.77 148.99 21.99 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.224 0.453 . . . . 73.400000000000006 112.224 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.1 p -145.08 148.89 34.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.793 0.33 . . . . 63.030000000000001 111.742 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 80' ' ' LEU . 95.6 mt -96.68 114.0 25.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.177 -0.465 . . . . 54.130000000000003 111.557 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.637 HG22 HD21 ' A' ' 70' ' ' ASN . 28.3 m -134.37 162.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.625 0.232 . . . . 71.030000000000001 111.625 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.637 HD21 HG22 ' A' ' 69' ' ' VAL . 44.5 m-80 61.96 33.89 17.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.776 0.43 . . . . 70.409999999999997 111.794 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.568 HD11 ' HE3' ' A' ' 52' ' ' LYS . 38.8 mt -71.33 106.9 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 73.030000000000001 111.421 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 21.9 p -140.67 158.72 65.01 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 111.891 0.33 . . . . 70.010000000000005 111.891 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 22.6 Cg_endo -60.17 153.76 56.59 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.73 2.287 . . . . 61.149999999999999 113.517 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.656 ' HB2' HG22 ' A' ' 79' ' ' THR . 26.0 t70 -129.96 172.62 11.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.156 -0.475 . . . . 72.239999999999995 111.679 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -53.58 -46.63 70.38 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.306 0.484 . . . . 72.439999999999998 112.306 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -110.14 -21.39 12.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.55 0.574 . . . . 75.530000000000001 112.55 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -157.49 -103.7 0.2 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.154 -1.022 . . . . 74.040000000000006 114.144 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.2 m -150.1 129.27 12.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.711 0.291 . . . . 74.25 111.636 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 74' ' ' ASP . 82.5 p -97.59 123.56 41.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.87 0.367 . . . . 54.329999999999998 111.405 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.537 HD11 ' O ' ' A' ' 80' ' ' LEU . 2.6 pp -135.73 137.96 42.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.19 0.519 . . . . 75.409999999999997 111.352 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.0 m -83.66 107.35 16.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.155 0.502 . . . . 71.25 111.354 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.41 HD23 HD22 ' A' ' 68' ' ' LEU . 3.0 tm? -82.75 109.98 17.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.914 -0.585 . . . . 71.530000000000001 110.366 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 66' ' ' MET . 48.3 mtm180 -93.7 112.47 24.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.76 0.282 . . . . 73.340000000000003 111.76 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mp -92.18 93.94 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.04 0.448 . . . . 75.349999999999994 110.611 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -94.22 104.03 16.04 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 71.319999999999993 110.799 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.46 145.13 40.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.822 -0.704 . . . . 52.25 113.353 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.92 -45.05 95.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.418 0.628 . . . . 71.329999999999998 110.439 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 m -80.68 115.2 20.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.869 -0.605 . . . . 62.509999999999998 110.699 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -61.26 -27.22 68.3 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.89 0.376 . . . . 65.129999999999995 111.39 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 141.22 49.95 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.765 -0.652 . . . . 71.409999999999997 112.0 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.82 106.96 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.144 2.563 . . . . 72.019999999999996 113.508 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.6 148.91 63.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.238 -0.437 . . . . 72.299999999999997 111.643 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.7 179.81 4.88 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.594 2.196 . . . . 52.43 113.153 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 139.5 36.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.07 0.462 . . . . 62.009999999999998 111.687 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 42.5 p90 -141.59 176.11 9.15 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.564 0.697 . . . . 73.150000000000006 112.475 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 p -152.73 168.69 24.84 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.536 -0.757 . . . . 73.510000000000005 111.077 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.55 -177.79 44.87 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.819 -0.705 . . . . 52.140000000000001 113.605 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 m -113.13 119.06 36.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.689 0.28 . . . . 74.340000000000003 111.308 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.09 115.81 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.103 0.478 . . . . 62.240000000000002 111.235 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 53.1 mt-10 -106.56 113.64 27.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.987 0.422 . . . . 74.540000000000006 111.158 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.428 ' CE1' HD23 ' A' ' 139' ' ' LEU . 17.0 p90 -116.95 129.02 55.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.044 0.45 . . . . 74.019999999999996 111.648 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.97 -146.71 4.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.186 -0.53 . . . . 72.409999999999997 113.189 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.615 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 92.9 mt-30 -128.58 152.87 47.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.169 0.509 . . . . 65.129999999999995 111.8 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.474 HG22 ' HB2' ' A' ' 111' ' ' PHE . 57.9 mt -114.74 126.15 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.977 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.448 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -112.7 17.23 19.27 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.862 0.319 . . . . 75.129999999999995 111.862 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -132.99 -165.0 11.05 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.915 -0.659 . . . . 65.439999999999998 113.908 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.8 p -102.82 176.01 5.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.978 0.418 . . . . 74.5 111.558 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.479 HD12 ' HG3' ' A' ' 33' ' ' GLN . 49.2 mm -58.67 -38.23 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.085 0.469 . . . . 73.310000000000002 110.613 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.28 -47.91 59.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.899 -0.591 . . . . 64.510000000000005 110.995 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.41 91.69 2.57 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 64.230000000000004 111.826 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.612 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.9 p90 -115.41 127.89 55.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.178 0.513 . . . . 73.329999999999998 112.209 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.96 124.39 40.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 70.120000000000005 110.827 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.91 105.59 17.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.858 -0.61 . . . . 73.219999999999999 111.195 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.448 HD13 ' NE2' ' A' ' 105' ' ' GLN . 41.0 pt -109.28 156.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.63 -0.259 . . . . 63.130000000000003 111.652 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 56.66 39.36 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.945 0.402 . . . . 72.319999999999993 111.881 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 p -96.72 116.43 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.472 0.653 . . . . 72.010000000000005 112.454 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.02 147.37 27.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.98 -0.554 . . . . 62.130000000000003 110.341 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.426 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 7.4 p30 -112.68 136.47 52.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.346 0.593 . . . . 54.119999999999997 111.931 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -127.45 157.74 39.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.956 -0.565 . . . . 73.310000000000002 110.217 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.5 122.02 37.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.11 0.411 . . . . 75.450000000000003 112.11 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.813 HG21 HD23 ' A' ' 137' ' ' LEU . 20.0 pt -100.95 105.64 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.163 0.506 . . . . 73.430000000000007 111.539 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -110.38 119.14 38.27 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.338 -0.392 . . . . 55.149999999999999 110.193 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -114.28 133.29 22.45 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 111.858 0.318 . . . . 65.299999999999997 111.858 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 24.5 Cg_exo -64.28 159.99 40.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.174 2.583 . . . . 74.0 113.22 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.14 147.63 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.128 0.418 . . . . 53.25 112.128 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 t -87.39 124.54 33.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.342 -0.39 . . . . 61.200000000000003 110.541 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.4 -34.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.887 0.375 . . . . 72.0 111.722 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.09 -169.1 1.95 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.892 0.377 . . . . 74.439999999999998 111.655 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.47 149.73 53.1 Favored Pre-proline 0 N--CA 1.472 0.658 0 CA-C-N 116.508 -0.314 . . . . 38.619999999999997 111.358 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.54 147.2 63.5 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.0 -1.25 . . . . 73.329999999999998 113.306 -1.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m -65.89 82.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.356 0.598 . . . . 75.219999999999999 112.145 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.57 93.35 4.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.498 -0.774 . . . . 71.239999999999995 109.285 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.94 105.66 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.51 -0.313 . . . . 62.439999999999998 111.803 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.521 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.5 p-10 -96.97 142.9 28.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.992 0.425 . . . . 62.399999999999999 111.581 175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.471 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 18.0 pt -135.85 135.82 22.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 116.314 -0.403 . . . . 75.129999999999995 111.346 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.0 Cg_exo -75.63 117.1 4.65 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 75.129999999999995 113.0 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.813 HD23 HG21 ' A' ' 121' ' ' ILE . 38.4 mt -97.1 112.33 24.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.185 0.439 . . . . 62.439999999999998 112.185 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -91.02 90.73 7.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.105 0.479 . . . . 62.439999999999998 110.023 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.428 HD23 ' CE1' ' A' ' 101' ' ' TYR . 66.3 mt -76.72 137.71 39.51 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.319 -0.4 . . . . 63.439999999999998 111.252 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.8 135.82 48.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.226 0.454 . . . . 71.129999999999995 112.226 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.62 17.03 79.51 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 114.581 0.592 . . . . 61.109999999999999 114.581 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.2 tt -147.55 129.57 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 117.273 0.537 . . . . 63.100000000000001 111.628 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -92.48 156.75 16.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.975 0.416 . . . . 72.150000000000006 111.818 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.75 -33.79 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.964 -0.562 . . . . 75.239999999999995 111.727 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -31.63 72.95 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.966 0.413 . . . . 51.329999999999998 111.726 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.615 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 87.5 mm-40 -110.53 18.36 19.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.286 -0.415 . . . . 74.140000000000001 111.852 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -82.55 106.53 14.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.925 0.393 . . . . 71.030000000000001 110.832 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -83.78 -67.4 1.45 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.178 -0.534 . . . . 60.049999999999997 113.462 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -140.58 157.36 45.59 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.42 -0.459 . . . . 73.439999999999998 111.784 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.8 t -128.09 103.14 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.958 -0.565 . . . . 75.239999999999995 110.662 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -93.32 114.97 27.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.27 0.47 . . . . 71.120000000000005 112.27 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.759 HG23 ' SD ' ' A' ' 66' ' ' MET . 42.7 mm -96.14 130.78 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.105 -0.498 . . . . 73.140000000000001 111.118 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -165.39 -175.32 3.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.596 0.236 . . . . 75.450000000000003 111.632 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 64.22 24.47 13.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.117 0.567 . . . . 61.530000000000001 112.0 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.74 104.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.541 0.686 . . . . 75.340000000000003 111.538 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.498 ' HB3' HE22 ' A' ' 60' ' ' GLN . 8.0 pt20 -132.75 142.95 46.64 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.423 -0.808 . . . . 72.340000000000003 111.159 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 95' ' ' PHE . 62.5 Cg_endo -72.07 151.53 55.8 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.296 1.997 . . . . 75.209999999999994 112.692 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.82 143.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.619 -0.264 . . . . 73.420000000000002 110.812 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.6 mtm 70.45 -10.6 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.244 0.618 . . . . 63.520000000000003 112.661 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.21 113.86 21.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.889 0.376 . . . . 62.530000000000001 111.095 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.97 156.87 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.223 0.535 . . . . 72.040000000000006 111.875 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.0 162.66 30.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.288 0.566 . . . . 74.420000000000002 111.856 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -52.87 127.65 24.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.381 -0.827 . . . . 73.120000000000005 112.999 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.91 143.86 41.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.399 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -146.34 146.62 30.74 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 62.43 111.691 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -72.96 168.62 18.61 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.872 0.367 . . . . 74.400000000000006 111.512 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 39.9 m80 69.78 92.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.056 0.761 . . . . 71.150000000000006 113.056 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.6 m170 . . . . . 0 C--O 1.255 1.394 0 CA-C-N 115.105 -0.952 . . . . 75.030000000000001 110.681 169.217 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.733 0.302 . . . . 75.510000000000005 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.88 134.15 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.921 0.391 . . . . 71.319999999999993 111.499 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -125.02 122.73 38.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.56 -0.291 . . . . 73.030000000000001 111.201 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -173.42 145.69 1.28 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.941 0.401 . . . . 75.099999999999994 111.862 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -135.14 -177.33 4.59 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.281 -0.418 . . . . 71.5 110.671 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.31 173.04 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.201 0.445 . . . . 65.239999999999995 112.201 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m -82.07 158.06 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 112.477 0.547 . . . . 71.239999999999995 112.477 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 8' ' ' ARG . 9.7 mmt85 -123.7 123.51 40.69 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.084 0.468 . . . . 75.219999999999999 111.737 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -88.19 146.5 25.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.117 0.414 . . . . 61.100000000000001 112.117 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.5 mmt -129.02 138.35 51.87 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.375 -0.375 . . . . 60.329999999999998 111.228 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.13 129.37 11.95 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.01 0.433 . . . . 65.450000000000003 111.431 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -144.05 123.0 12.76 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.506 -0.315 . . . . 62.409999999999997 111.5 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.2 m -131.53 104.02 6.73 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 72.409999999999997 111.308 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.53 145.29 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.571 -0.286 . . . . 63.509999999999998 110.931 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.7 m -111.21 97.03 6.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.918 0.39 . . . . 75.200000000000003 111.821 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.9 p -91.78 -161.27 0.81 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.439 -0.346 . . . . 70.140000000000001 111.152 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.32 176.98 9.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.232 -0.293 . . . . 74.230000000000004 110.822 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -68.17 77.9 0.24 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.85 0.834 . . . . 74.019999999999996 111.529 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -89.87 162.79 15.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.412 -0.813 . . . . 75.109999999999999 111.808 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -79.66 94.71 5.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.954 -0.566 . . . . 62.210000000000001 110.743 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.688 ' HE2' ' HA ' ' A' ' 21' ' ' MET . 18.3 mmt -101.65 165.58 11.15 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.904 0.383 . . . . 73.010000000000005 111.679 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 p -61.01 -39.12 88.52 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.275 0.56 . . . . 73.150000000000006 111.336 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -109.13 151.07 26.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 63.340000000000003 110.716 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.58 141.05 57.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.319 0.581 . . . . 74.409999999999997 112.149 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -60.36 127.96 34.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.717 -0.674 . . . . 73.219999999999999 110.894 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -60.7 -30.76 70.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.655 0.264 . . . . 74.420000000000002 111.615 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.59 -47.06 85.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.392 0.615 . . . . 75.329999999999998 110.38 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 m -66.01 -31.08 71.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.829 -0.623 . . . . 72.530000000000001 111.049 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.79 -45.15 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.36 -0.382 . . . . 71.340000000000003 110.89 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.51 -48.33 77.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.142 0.496 . . . . 74.439999999999998 110.732 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -55.81 -51.22 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.904 -0.589 . . . . 75.519999999999996 111.41 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.1 m -58.36 -44.65 88.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.278 -0.419 . . . . 70.319999999999993 111.557 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.38 -44.05 96.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.447 -0.342 . . . . 74.549999999999997 111.209 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -56.79 -50.87 71.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.403 -0.362 . . . . 75.409999999999997 111.449 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -58.12 -43.8 87.4 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.859 0.361 . . . . 71.310000000000002 111.726 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -63.64 -48.23 78.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.729 0.3 . . . . 74.340000000000003 111.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.23 -33.82 76.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.333 0.587 . . . . 75.519999999999996 110.549 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.46 HD22 ' HB ' ' A' ' 45' ' ' VAL . 6.9 t-20 -63.6 -41.47 98.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.834 -0.621 . . . . 71.019999999999996 110.509 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.47 65.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.048 -0.524 . . . . 65.140000000000001 111.654 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HE3' HG23 ' A' ' 108' ' ' ILE . 66.7 mttm -82.21 -7.97 59.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.835 0.309 . . . . 51.119999999999997 111.835 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -55.97 117.57 3.83 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.648 0.61 . . . . 71.310000000000002 112.648 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 t -71.12 -36.87 72.3 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.081 -0.509 . . . . 73.230000000000004 111.691 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 m -151.99 121.54 6.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.714 0.292 . . . . 73.120000000000005 110.723 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.79 -153.59 22.08 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.221 -0.514 . . . . 42.100000000000001 112.547 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.46 ' HB ' HD22 ' A' ' 38' ' ' ASN . 17.7 m -136.29 148.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.14 0.47 . . . . 72.400000000000006 111.918 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -95.92 130.11 42.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.411 . . . . 75.409999999999997 112.069 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -125.06 143.89 50.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.858 -0.61 . . . . 74.420000000000002 109.868 172.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.5 mt -114.12 136.36 22.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.837 0.351 . . . . 63.329999999999998 111.721 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 36.8 Cg_exo -61.53 -14.0 32.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.922 2.415 . . . . 75.150000000000006 113.406 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.35 6.43 26.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.212 -0.518 . . . . 72.540000000000006 113.145 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.88 103.12 11.86 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.043 0.449 . . . . 71.299999999999997 111.125 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -80.65 60.55 4.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.513 0.673 . . . . 74.510000000000005 111.231 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 p -146.01 150.65 42.89 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-N 115.826 -0.624 . . . . 70.209999999999994 112.123 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.69 170.85 13.84 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.024 2.483 . . . . 72.420000000000002 114.396 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.38 157.03 44.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.738 -0.665 . . . . 72.420000000000002 110.076 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -113.59 119.36 37.23 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.46 0.648 . . . . 73.310000000000002 112.17 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.95 126.16 53.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.839 -0.618 . . . . 75.019999999999996 112.284 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.0 tt0 -86.78 108.33 18.66 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.741 -0.466 . . . . 61.32 109.741 172.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.472 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 82.6 p -113.04 -177.5 3.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.234 0.54 . . . . 71.129999999999995 112.338 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 50.1 mt-30 -67.66 -19.82 65.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.945 -0.57 . . . . 71.430000000000007 112.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 pt -95.19 -6.55 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.986 0.422 . . . . 73.120000000000005 111.073 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.54 -179.46 16.3 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.382 -0.437 . . . . 71.109999999999999 112.89 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 60.3 m -79.81 131.69 35.95 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.454 -0.439 . . . . 72.319999999999993 111.34 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.96 175.18 10.03 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.127 0.489 . . . . 64.230000000000004 112.246 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -124.34 123.35 40.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 74.420000000000002 110.664 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.559 ' SD ' HG22 ' A' ' 152' ' ' ILE . 63.0 mtt -118.0 156.16 29.04 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.873 0.368 . . . . 74.310000000000002 111.896 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.9 t -158.79 170.47 22.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.905 0.383 . . . . 70.200000000000003 111.908 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 71' ' ' ILE . 99.2 mt -116.29 106.18 13.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.29 -0.414 . . . . 71.340000000000003 111.996 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' HB ' ' A' ' 81' ' ' THR . 33.0 m -113.36 162.19 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.238 -0.288 . . . . 65.200000000000003 111.064 176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 63.83 31.2 14.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.039 0.447 . . . . 74.329999999999998 112.095 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 68' ' ' LEU . 45.3 mt -73.08 103.93 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.17 0.433 . . . . 52.100000000000001 112.17 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 p -137.78 152.49 72.56 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 120.861 0.362 . . . . 75.450000000000003 111.562 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.11 168.88 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.737 2.291 . . . . 51.43 113.495 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.635 ' HB2' HG21 ' A' ' 79' ' ' THR . 31.5 t70 -143.82 170.54 15.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.773 -0.649 . . . . 72.530000000000001 110.749 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.25 94.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.692 0.282 . . . . 70.120000000000005 111.692 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.15 -34.27 24.09 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.525 -0.307 . . . . 61.310000000000002 111.736 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.54 -100.83 0.14 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.36 -0.924 . . . . 64.439999999999998 114.149 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -146.03 131.28 18.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.832 0.349 . . . . 73.150000000000006 111.586 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 74' ' ' ASP . 79.0 p -109.56 137.7 47.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.895 0.379 . . . . 74.319999999999993 111.604 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 pp -149.41 -179.57 7.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.898 0.38 . . . . 55.240000000000002 111.272 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.655 ' HB ' HG23 ' A' ' 69' ' ' VAL . 21.7 m -124.13 117.77 25.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.894 0.378 . . . . 64.439999999999998 111.258 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.2 113.54 20.73 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.238 -0.437 . . . . 72.129999999999995 109.946 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 66' ' ' MET . 69.7 mtt180 -96.29 136.57 36.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.822 0.344 . . . . 75.420000000000002 111.09 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.507 HG12 ' HG2' ' A' ' 66' ' ' MET . 42.1 mt -131.63 133.97 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 74.140000000000001 111.529 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -142.51 124.79 15.51 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.737 -0.21 . . . . 73.150000000000006 110.689 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 92' ' ' LEU . . . -75.86 146.08 33.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.843 -0.694 . . . . 74.140000000000001 113.933 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.41 -39.48 83.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.753 0.787 . . . . 75.200000000000003 109.927 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -93.81 112.18 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 74.099999999999994 109.671 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -64.35 -7.71 10.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.46 0.541 . . . . 75.230000000000004 112.46 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.97 156.29 80.77 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.881 0.473 . . . . 71.150000000000006 111.572 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.82 123.38 11.51 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.094 2.529 . . . . 61.210000000000001 113.824 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 126' ' ' SER . 95.9 mt -100.19 147.98 34.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.099 -0.501 . . . . 73.409999999999997 111.332 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.13 172.79 15.28 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.471 2.114 . . . . 65.319999999999993 112.991 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.48 43.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 64.450000000000003 111.032 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -146.35 162.27 38.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.351 0.596 . . . . 72.329999999999998 112.282 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.4 m -146.9 151.54 37.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.932 -0.577 . . . . 53.219999999999999 110.309 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.738 ' HA3' HD11 ' A' ' 155' ' ' ILE . . . -150.25 170.61 30.22 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.411 -0.899 . . . . 55.409999999999997 113.762 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.1 m -105.32 132.04 52.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 75.129999999999995 110.999 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.75 130.39 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.955 0.407 . . . . 75.349999999999994 111.6 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 40.4 mm-40 -97.83 111.92 24.03 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 74.140000000000001 110.818 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -122.75 120.95 35.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.237 0.542 . . . . 75.349999999999994 111.844 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -161.65 -149.18 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.837 -0.62 . . . . 55.409999999999997 113.23 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -125.06 157.19 36.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.222 0.534 . . . . 61.32 112.043 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.36 121.16 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.205 -0.452 . . . . 75.209999999999994 111.354 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 114' ' ' ILE . 4.1 pt20 -105.08 5.95 32.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.872 0.367 . . . . 73.319999999999993 111.658 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -113.69 -177.89 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.233 -0.508 . . . . 73.430000000000007 113.19 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -90.44 179.41 5.87 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.611 -0.346 . . . . 52.43 111.223 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.565 HG23 ' HE3' ' A' ' 40' ' ' LYS . 48.8 mm -68.73 -27.56 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.521 . . . . 74.329999999999998 110.605 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.54 -32.34 58.16 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.975 -0.557 . . . . 74.319999999999993 111.384 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.39 90.57 1.67 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.285 0.564 . . . . 61.340000000000003 111.14 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -96.3 117.23 30.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.413 0.625 . . . . 74.219999999999999 112.05 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -86.59 111.98 21.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.081 -0.508 . . . . 71.519999999999996 110.633 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.77 104.08 11.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.951 0.405 . . . . 72.340000000000003 111.053 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.427 HD12 ' NE2' ' A' ' 105' ' ' GLN . 41.5 pt -113.39 151.65 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.475 -0.33 . . . . 63.350000000000001 111.687 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 58.14 34.44 24.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.078 0.465 . . . . 55.109999999999999 111.802 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.432 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 3.7 p -91.14 116.74 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.339 0.59 . . . . 73.409999999999997 112.331 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.66 171.79 7.68 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.268 -0.424 . . . . 63.439999999999998 111.011 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.12 143.47 50.87 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.14 0.495 . . . . 73.319999999999993 111.872 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -144.76 147.69 33.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.36 -0.382 . . . . 72.230000000000004 111.17 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.88 125.47 37.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.076 0.465 . . . . 74.530000000000001 112.216 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.2 pt -101.96 120.62 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.978 0.418 . . . . 72.540000000000006 111.043 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.32 122.31 46.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.869 0.366 . . . . 71.140000000000001 111.491 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.501 ' HB1' HD13 ' A' ' 135' ' ' ILE . . . -119.08 138.19 25.93 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 120.732 0.301 . . . . 54.520000000000003 111.546 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 170.34 20.26 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.725 2.283 . . . . 72.510000000000005 113.396 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.53 117.59 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.161 -0.472 . . . . 43.049999999999997 112.061 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 25.1 m -79.56 63.81 4.25 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.954 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.31 -11.66 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.451 0.908 . . . . 72.0 113.451 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.45 120.67 40.91 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.034 -0.416 . . . . 73.519999999999996 111.411 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.64 139.16 31.42 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 111.733 0.272 . . . . 74.510000000000005 111.733 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.74 145.63 82.15 Favored 'Cis proline' 0 C--N 1.356 0.922 0 C-N-CA 124.116 -1.202 . . . . 74.209999999999994 113.431 0.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 p -83.86 95.53 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.991 0.737 . . . . 62.310000000000002 112.991 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.24 127.02 20.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.003 -0.544 . . . . 54.229999999999997 110.739 171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -132.59 139.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 72.540000000000006 111.712 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 18.1 p-10 -114.67 133.39 55.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.256 0.551 . . . . 64.519999999999996 110.95 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.501 HD13 ' HB1' ' A' ' 123' ' ' ALA . 25.3 pt -130.5 140.18 37.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.482 -0.327 . . . . 72.150000000000006 111.509 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.24 156.2 62.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.418 2.079 . . . . 72.510000000000005 112.439 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -145.44 116.69 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.493 -0.321 . . . . 75.019999999999996 110.158 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -103.25 96.95 7.11 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.197 0.523 . . . . 74.140000000000001 111.814 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.8 129.86 35.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.842 0.354 . . . . 74.230000000000004 110.248 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -116.11 139.45 50.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.917 0.389 . . . . 45.240000000000002 111.809 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 20.21 61.26 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.326 -0.397 . . . . 70.420000000000002 113.815 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -160.29 124.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 117.334 0.567 . . . . 73.219999999999999 112.299 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.5 m -86.45 146.69 26.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.193 -0.317 . . . . 72.019999999999996 111.602 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.92 -35.64 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.749 0.648 . . . . 74.349999999999994 112.749 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.64 -23.15 66.73 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.159 0.504 . . . . 64.030000000000001 111.481 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -109.21 8.86 26.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.062 -0.517 . . . . 75.430000000000007 111.525 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 1.1 tt -91.63 126.05 36.57 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.913 0.387 . . . . 75.450000000000003 110.894 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.19 -62.35 1.22 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.297 -0.478 . . . . 73.129999999999995 113.72 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.39 160.35 40.31 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.563 0.579 . . . . 65.510000000000005 112.563 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.92 101.48 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.644 -0.707 . . . . 51.210000000000001 110.342 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 45.2 ttp180 -98.03 116.77 30.93 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.029 -0.419 . . . . 61.350000000000001 112.055 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.559 HG22 ' SD ' ' A' ' 66' ' ' MET . 22.3 mm -85.46 130.32 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.435 -0.348 . . . . 64.400000000000006 111.191 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -158.67 179.52 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.292 -0.255 . . . . 72.340000000000003 111.585 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.43 30.92 20.17 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.763 0.653 . . . . 74.129999999999995 112.763 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.738 HD11 ' HA3' ' A' ' 97' ' ' GLY . 49.9 mm -71.79 106.43 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.365 0.602 . . . . 71.549999999999997 110.691 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.7 pt20 -129.71 149.39 72.83 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.711 -0.677 . . . . 73.530000000000001 111.859 -174.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 156' ' ' GLN . 9.4 Cg_exo -71.23 136.93 30.24 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.627 2.218 . . . . 74.530000000000001 112.65 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.2 153.91 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.8 0.333 . . . . 72.540000000000006 110.748 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.6 ptp -166.89 160.95 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.073 0.463 . . . . 74.010000000000005 111.971 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.75 118.15 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.333 -0.617 . . . . 75.409999999999997 109.333 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.5 tp -58.14 133.2 55.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.188 0.81 . . . . 72.409999999999997 113.188 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -118.42 -178.32 3.5 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.867 -0.606 . . . . 71.530000000000001 111.146 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -123.33 148.61 45.83 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.843 0.354 . . . . 73.129999999999995 111.574 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -147.18 134.97 21.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.489 -0.323 . . . . 74.019999999999996 111.363 -173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -151.46 132.52 14.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.79 0.329 . . . . 71.430000000000007 111.685 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -116.83 161.64 18.97 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.821 0.343 . . . . 64.310000000000002 111.426 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -87.77 -46.72 9.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.824 0.345 . . . . 74.109999999999999 111.818 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.67 -0.681 . . . . 74.409999999999997 111.558 -179.264 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.29 0.567 . . . . 73.400000000000006 111.67 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.87 157.42 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.085 0.469 . . . . 70.450000000000003 111.502 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -138.78 119.01 13.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.162 -0.472 . . . . 45.130000000000003 110.759 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -79.3 94.62 5.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.092 0.472 . . . . 75.349999999999994 111.709 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 150.29 48.78 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.918 -0.583 . . . . 74.409999999999997 111.776 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.3 164.7 12.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.964 0.411 . . . . 71.230000000000004 111.833 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.87 136.41 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.049 0.452 . . . . 63.149999999999999 111.768 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -108.6 149.04 29.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.029 0.442 . . . . 74.129999999999995 111.63 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -108.19 104.35 13.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.099 -0.5 . . . . 75.540000000000006 110.294 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 10' ' ' MET . 3.6 mpp? -76.91 140.4 40.52 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.33 0.586 . . . . 63.399999999999999 112.195 -175.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 8.9 mmpt? -72.19 114.14 9.98 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.899 -0.591 . . . . 64.340000000000003 111.537 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -140.42 169.52 17.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.717 0.294 . . . . 74.150000000000006 111.551 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.9 p -60.23 143.0 53.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.391 -0.368 . . . . 71.099999999999994 111.291 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.33 124.19 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.147 0.499 . . . . 74.230000000000004 111.7 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 m -104.1 22.91 13.85 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.296 0.569 . . . . 73.109999999999999 110.987 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -86.55 176.99 7.53 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.942 -0.572 . . . . 52.119999999999997 112.089 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 162.21 27.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.849 0.357 . . . . 72.349999999999994 111.495 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.64 168.16 19.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.459 0.647 . . . . 74.349999999999994 112.432 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -179.2 3.88 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.946 -0.57 . . . . 74.510000000000005 111.212 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -91.74 -158.15 0.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.27 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 21' ' ' MET . 1.3 mpt? -52.46 136.79 31.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.979 0.419 . . . . 63.329999999999998 111.958 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -88.46 165.97 14.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.12 0.486 . . . . 74.400000000000006 111.778 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -76.88 -173.97 2.89 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.326 0.491 . . . . 74.340000000000003 112.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.5 tp -57.5 152.49 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.997 -0.547 . . . . 74.010000000000005 111.945 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -67.2 147.52 52.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.196 0.443 . . . . 65.310000000000002 112.196 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.316 0.487 . . . . 73.310000000000002 112.316 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.433 ' O ' HG13 ' A' ' 31' ' ' ILE . 34.4 tt0 -54.99 -52.21 63.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.799 0.333 . . . . 70.120000000000005 111.522 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.403 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.0 m -56.27 -41.16 75.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.963 0.411 . . . . 51.200000000000003 111.302 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.32 -36.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 74.239999999999995 111.32 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' HE3' HD12 ' A' ' 48' ' ' LEU . 52.3 tptt -66.96 -38.37 85.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.123 -0.49 . . . . 62.5 110.437 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.489 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 84.7 mt -60.22 -48.57 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.13 0.491 . . . . 63.049999999999997 110.755 174.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.6 m -56.05 -41.79 75.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.115 -0.493 . . . . 72.150000000000006 110.783 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HG3' HD12 ' A' ' 108' ' ' ILE . 34.3 tt0 -59.09 -46.37 88.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.169 -0.469 . . . . 74.140000000000001 111.157 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.71 -52.92 63.1 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.994 0.368 . . . . 70.420000000000002 111.994 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.69 -42.87 84.56 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.819 0.342 . . . . 75.420000000000002 111.608 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.1 -34.56 76.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.929 0.344 . . . . 72.439999999999998 111.929 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.9 mt -68.1 -37.7 81.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.929 0.395 . . . . 64.230000000000004 110.829 174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.76 -44.06 85.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.006 0.431 . . . . 53.439999999999998 110.751 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.91 81.91 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.211 -0.45 . . . . 74.040000000000006 111.647 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.79 -2.08 58.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.93 0.395 . . . . 74.409999999999997 111.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -78.0 150.86 33.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.075 0.464 . . . . 73.430000000000007 111.863 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 m -122.01 -31.63 3.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.821 -0.627 . . . . 74.239999999999995 110.868 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -112.19 85.47 2.16 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.194 0.521 . . . . 74.409999999999997 111.438 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 80.92 -146.25 26.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.214 -0.517 . . . . 51.240000000000002 113.833 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 57' ' ' LEU . 33.5 m -123.74 140.6 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.472 0.545 . . . . 64.519999999999996 112.472 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.419 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 65.5 m-85 -87.04 107.63 18.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.436 -0.347 . . . . 74.329999999999998 110.895 172.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.64 128.26 44.21 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 71.319999999999993 110.499 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.542 HD12 ' HE3' ' A' ' 30' ' ' LYS . 72.1 mt -108.63 133.62 20.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.629 0.252 . . . . 63.520000000000003 111.471 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.41 -45.76 38.7 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.003 2.468 . . . . 72.530000000000001 113.251 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -71.38 -25.67 74.92 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.926 -0.654 . . . . 64.140000000000001 113.001 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . . . -91.93 63.2 4.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.051 0.453 . . . . 63.130000000000003 111.429 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -64.56 75.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.409 0.623 . . . . 63.350000000000001 111.541 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -141.65 151.47 60.4 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.132 -0.486 . . . . 72.510000000000005 111.946 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.655 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 74.5 Cg_endo -73.67 128.11 12.28 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.875 2.383 . . . . 75.450000000000003 113.958 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.96 139.9 50.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.348 -0.387 . . . . 73.420000000000002 110.703 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -89.39 133.18 34.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.063 0.458 . . . . 63.240000000000002 111.282 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.488 HD12 HG11 ' A' ' 45' ' ' VAL . 40.9 tp -132.89 129.67 38.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.132 -0.485 . . . . 71.230000000000004 111.374 -177.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.71 137.97 32.02 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.003 -0.369 . . . . 71.420000000000002 110.003 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.4 p -126.11 177.94 6.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.213 0.53 . . . . 70.340000000000003 111.287 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.0 0.75 23.21 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.178 -0.465 . . . . 74.519999999999996 111.869 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 pt -118.46 -4.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.737 0.303 . . . . 44.119999999999997 111.762 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.11 -177.94 20.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.53 -0.367 . . . . 42.039999999999999 112.993 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -88.39 132.32 34.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.207 -0.584 . . . . 73.519999999999996 111.716 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.03 -177.59 4.96 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.001 0.429 . . . . 75.120000000000005 111.706 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.655 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 66.7 ttp85 -135.41 140.77 45.2 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.477 -0.329 . . . . 74.400000000000006 111.088 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.659 ' SD ' HG23 ' A' ' 152' ' ' ILE . 64.8 mtt -129.36 152.23 49.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 61.43 111.854 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.1 p -152.38 152.65 32.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.906 0.384 . . . . 72.420000000000002 111.626 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 HD13 ' A' ' 80' ' ' LEU . 71.1 mt -100.81 111.06 23.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.323 -0.399 . . . . 73.450000000000003 111.349 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.62 HG21 ' HD2' ' A' ' 83' ' ' ARG . 33.7 m -128.12 159.35 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.626 0.25 . . . . 71.299999999999997 110.997 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.501 HD21 HG22 ' A' ' 69' ' ' VAL . 28.7 m-80 51.71 69.03 0.71 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.955 0.407 . . . . 74.519999999999996 111.113 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.6 mt -100.43 102.13 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.247 -0.433 . . . . 72.420000000000002 110.732 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -121.65 144.86 41.57 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 112.672 0.619 . . . . 74.519999999999996 112.672 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.27 129.67 15.29 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.766 2.311 . . . . 73.230000000000004 112.104 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HB2' HG21 ' A' ' 79' ' ' THR . 26.9 t70 -110.46 164.95 12.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.159 -0.473 . . . . 54.200000000000003 111.708 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.01 76.93 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 71.109999999999999 112.489 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -96.47 -12.29 24.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.912 0.338 . . . . 71.209999999999994 111.912 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . 171.51 -102.51 0.18 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.988 -0.625 . . . . 73.319999999999993 113.48 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -147.81 130.45 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.492 -0.417 . . . . 71.510000000000005 111.775 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 39.4 p -106.78 120.41 41.93 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.831 0.348 . . . . 73.329999999999998 111.485 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.503 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -130.13 159.13 37.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.691 0.282 . . . . 74.299999999999997 110.875 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -101.92 108.21 19.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.973 0.415 . . . . 74.299999999999997 111.867 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.567 HD12 HD12 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -84.07 106.63 15.87 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.499 -0.556 . . . . 65.219999999999999 109.499 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.62 ' HD2' HG21 ' A' ' 69' ' ' VAL . 20.2 mtp180 -96.11 125.76 40.87 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.192 -0.318 . . . . 74.310000000000002 111.247 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 82' ' ' LEU . 3.9 mp -115.93 103.3 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.917 0.389 . . . . 74.310000000000002 111.381 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -106.5 134.7 49.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.382 . . . . 73.340000000000003 110.722 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 142.47 32.61 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.957 -0.64 . . . . 65.010000000000005 113.324 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -62.15 -35.76 79.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.385 0.612 . . . . 62.539999999999999 110.749 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.8 m -99.82 149.83 22.97 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.794 -0.639 . . . . 60.329999999999998 110.718 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.71 -17.35 64.05 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.178 0.513 . . . . 74.510000000000005 111.342 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.15 136.33 58.69 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.622 -0.717 . . . . 72.409999999999997 112.052 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.75 117.01 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.456 2.104 . . . . 73.040000000000006 113.053 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -85.2 148.16 49.43 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.391 -0.368 . . . . 72.120000000000005 111.837 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.61 176.22 9.64 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.622 2.215 . . . . 64.120000000000005 113.007 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 125' ' ' ALA . . . -75.14 140.46 43.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.927 0.394 . . . . 74.319999999999993 111.741 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.86 168.67 19.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.529 0.68 . . . . 72.530000000000001 112.368 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 93.8 p -146.6 145.16 29.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.522 -0.763 . . . . 64.129999999999995 110.255 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -143.49 157.12 26.88 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.556 -0.83 . . . . 72.109999999999999 113.448 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.9 m -99.94 104.99 16.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.981 0.42 . . . . 74.519999999999996 110.784 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.407 HG13 HG21 ' A' ' 152' ' ' ILE . 20.1 m -91.06 125.3 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.007 0.432 . . . . 74.049999999999997 111.391 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.8 mt-10 -108.41 112.69 25.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.198 0.523 . . . . 70.129999999999995 110.831 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -115.97 141.28 48.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.953 -0.567 . . . . 74.420000000000002 111.641 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.27 -146.48 4.85 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.283 -0.484 . . . . 64.319999999999993 112.81 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.697 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 mt-30 -128.22 144.17 51.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.254 0.464 . . . . 70.340000000000003 112.254 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.2 mt -114.14 103.89 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.409 -0.359 . . . . 74.25 110.78 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.438 ' NE2' HD11 ' A' ' 114' ' ' ILE . 4.1 pt20 -92.83 15.03 15.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.043 0.386 . . . . 72.450000000000003 112.043 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -123.29 -170.26 13.4 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.884 -0.674 . . . . 72.349999999999994 113.872 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 49.9 p -102.63 -178.1 3.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.804 0.441 . . . . 62.340000000000003 111.644 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' A' ' 33' ' ' GLN . 46.7 mm -63.42 -30.83 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.461 0.648 . . . . 70.209999999999994 110.668 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.82 -56.13 5.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.685 -0.689 . . . . 75.209999999999994 110.848 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.31 98.26 4.83 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.196 0.522 . . . . 72.150000000000006 111.567 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.539 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 32.2 p90 -113.8 132.37 55.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.082 0.468 . . . . 72.420000000000002 111.537 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -107.32 115.94 31.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.219 -0.446 . . . . 62.25 111.492 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.8 97.46 3.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.888 0.375 . . . . 70.510000000000005 110.615 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.438 HD11 ' NE2' ' A' ' 105' ' ' GLN . 36.3 pt -108.73 156.81 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.491 -0.322 . . . . 75.230000000000004 111.288 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 56.86 36.32 27.56 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.119 0.485 . . . . 73.219999999999999 111.546 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.31 116.37 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.96 0.726 . . . . 72.109999999999999 112.96 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.527 ' H ' ' NE2' ' A' ' 117' ' ' GLN . 0.8 OUTLIER -124.89 156.88 37.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.711 -0.677 . . . . 71.129999999999995 110.972 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.476 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.3 p-10 -102.42 166.9 10.29 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.361 0.875 . . . . 73.510000000000005 113.361 -172.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.411 ' NE2' HD23 ' A' ' 139' ' ' LEU . 8.4 tt0 -152.9 152.83 31.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.413 -0.812 . . . . 74.219999999999999 110.087 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.39 133.46 35.86 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.019 0.438 . . . . 73.349999999999994 112.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.87 HG23 HD23 ' A' ' 137' ' ' LEU . 39.4 pt -109.98 106.21 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.199 0.523 . . . . 74.430000000000007 110.758 173.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.82 101.72 12.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.903 0.382 . . . . 73.200000000000003 111.031 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 140.87 21.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.073 0.398 . . . . 64.540000000000006 112.073 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.68 168.58 22.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.819 2.346 . . . . 75.25 113.216 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -82.94 139.57 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.288 -0.415 . . . . 64.019999999999996 111.856 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.8 m -78.01 93.07 4.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 75.030000000000001 110.655 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.94 -36.92 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.264 0.554 . . . . 54.229999999999997 111.034 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.15 145.11 39.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.925 -0.58 . . . . 70.129999999999995 111.148 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.73 45.54 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.483 -0.326 . . . . 63.240000000000002 110.963 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -82.33 170.85 56.71 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.007 -1.247 . . . . 73.230000000000004 113.872 1.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -79.82 74.12 6.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.324 -0.398 . . . . 75.209999999999994 112.035 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.4 103.11 12.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.262 -0.426 . . . . 65.310000000000002 111.289 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.7 t -122.38 108.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.234 0.214 . . . . 71.230000000000004 111.429 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -117.87 128.28 54.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.028 0.442 . . . . 64.349999999999994 111.701 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 19.4 pt -126.12 144.33 48.58 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.185 -0.461 . . . . 65.329999999999998 112.145 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 8.2 Cg_exo -73.74 158.39 46.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.884 2.389 . . . . 72.540000000000006 112.852 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.87 HD23 HG23 ' A' ' 121' ' ' ILE . 31.7 mt -139.72 103.97 4.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.459 0.54 . . . . 75.530000000000001 112.459 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -82.78 95.11 7.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.342 0.591 . . . . 65.25 110.557 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.493 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 40.9 mt -80.19 114.79 19.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 72.409999999999997 109.803 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -95.58 134.5 38.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.006 0.431 . . . . 74.340000000000003 112.056 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.68 15.47 58.15 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.253 -0.499 . . . . 43.409999999999997 113.696 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.42 HD12 HD22 ' A' ' 147' ' ' LEU . 20.7 tt -152.54 134.93 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 117.229 0.514 . . . . 70.129999999999995 111.528 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -94.83 156.23 16.45 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.915 0.388 . . . . 71.430000000000007 111.847 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.98 -43.76 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.874 0.694 . . . . 75.010000000000005 112.874 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.02 -13.53 62.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 63.539999999999999 111.042 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.427 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.6 mm-40 -106.18 5.82 30.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.5 . . . . 75.549999999999997 111.979 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD22 HD12 ' A' ' 142' ' ' ILE . 40.2 mt -80.14 109.6 14.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.251 0.548 . . . . 74.430000000000007 111.485 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -87.65 -45.24 5.26 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.847 -0.615 . . . . 70.310000000000002 112.904 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -156.13 151.99 27.4 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.167 0.508 . . . . 70.219999999999999 111.748 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.38 93.23 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.881 -0.599 . . . . 71.310000000000002 109.745 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 18.5 ttp85 -88.27 109.1 19.68 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.274 0.559 . . . . 75.430000000000007 112.249 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.659 HG23 ' SD ' ' A' ' 66' ' ' MET . 13.4 mm -90.51 129.69 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.748 -0.66 . . . . 75.209999999999994 111.083 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.537 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 14.8 p80 -167.25 -178.13 3.96 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.237 0.458 . . . . 70.219999999999999 112.237 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 t70 66.32 31.59 8.31 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.53 -0.759 . . . . 74.400000000000006 111.174 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.458 HD13 ' HA3' ' A' ' 97' ' ' GLY . 43.0 mm -68.04 94.02 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.87 -0.604 . . . . 74.439999999999998 111.154 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -112.83 145.07 32.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.813 -0.631 . . . . 73.109999999999999 111.702 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.44 140.8 37.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.487 2.125 . . . . 42.009999999999998 112.962 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.4 m -94.28 26.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.554 0.692 . . . . 63.32 111.111 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 79.0 mtp -125.82 -172.75 2.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.842 -0.617 . . . . 65.140000000000001 110.658 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -76.18 125.94 30.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.685 0.279 . . . . 53.25 111.246 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.6 HD22 ' H ' ' A' ' 161' ' ' LEU . 2.4 pt? -127.03 143.2 51.35 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.906 0.384 . . . . 65.25 111.26 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.32 166.44 10.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.264 0.555 . . . . 74.409999999999997 112.137 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -165.56 94.65 0.61 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.671 -0.695 . . . . 74.200000000000003 110.08 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -72.62 137.76 46.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.946 0.403 . . . . 71.219999999999999 111.817 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -79.84 121.8 25.85 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.865 0.364 . . . . 73.420000000000002 111.883 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -94.98 81.12 3.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.258 0.551 . . . . 73.439999999999998 110.369 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -78.5 -18.39 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.227 -0.442 . . . . 75.129999999999995 111.725 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.2 t60 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.779 -0.629 . . . . 73.239999999999995 111.636 -178.715 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.91 0.386 . . . . 52.32 111.051 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.15 150.2 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.264 0.554 . . . . 73.109999999999999 112.138 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -106.17 137.2 44.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.968 -0.56 . . . . 72.219999999999999 111.248 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -104.55 174.05 6.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.074 0.464 . . . . 64.129999999999995 112.141 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.8 p -58.72 143.5 46.66 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.968 0.729 . . . . 60.32 112.968 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -95.31 98.04 10.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.0 -0.546 . . . . 75.129999999999995 111.377 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.21 142.08 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.926 0.393 . . . . 64.340000000000003 111.771 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.524 ' NH1' ' HA ' ' A' ' 10' ' ' MET . 3.5 tmt_? -141.81 112.33 7.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.398 . . . . 72.409999999999997 110.426 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.98 117.55 10.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.667 0.27 . . . . 74.530000000000001 110.808 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.524 ' HA ' ' NH1' ' A' ' 8' ' ' ARG . 52.6 ttm -94.19 144.1 25.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 70.299999999999997 111.834 -176.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -149.24 118.21 6.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.192 -0.458 . . . . 74.400000000000006 110.768 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -114.97 161.1 18.76 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.169 0.509 . . . . 71.310000000000002 112.167 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -103.23 -172.46 2.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.018 -0.537 . . . . 65.209999999999994 111.096 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.1 p -147.6 138.95 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.363 -0.38 . . . . 73.319999999999993 111.087 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.4 m -128.96 140.75 51.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.843 0.354 . . . . 74.219999999999999 111.538 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -101.53 168.39 9.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.856 0.36 . . . . 73.310000000000002 111.735 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.4 mp -91.72 149.64 21.52 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.976 0.417 . . . . 73.239999999999995 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -98.18 129.06 44.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.854 0.359 . . . . 71.310000000000002 111.668 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -94.06 163.64 13.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.978 0.418 . . . . 55.340000000000003 111.348 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.63 149.24 44.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.064 0.459 . . . . 75.049999999999997 111.465 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.3 mmt -117.7 159.93 22.16 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.287 -0.415 . . . . 74.310000000000002 110.257 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.1 p -60.27 144.31 50.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.622 0.248 . . . . 72.540000000000006 111.069 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -51.24 106.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.203 0.525 . . . . 75.409999999999997 111.543 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.8 tp -86.09 165.0 16.97 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.94 -0.573 . . . . 75.409999999999997 111.717 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.435 ' O ' HG21 ' A' ' 29' ' ' VAL . 1.4 m-20 -49.76 130.66 21.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.196 -0.456 . . . . 62.43 111.506 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -53.52 -41.06 65.97 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.427 0.529 . . . . 65.200000000000003 112.427 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.8 pt-20 -58.4 -49.36 77.53 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.115 0.483 . . . . 62.420000000000002 110.726 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 7.1 m -69.01 -26.02 64.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.063 -0.517 . . . . 73.519999999999996 111.612 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 25' ' ' ASN . 98.2 t -63.15 -47.9 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.005 0.431 . . . . 72.310000000000002 110.56 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.87 -39.07 92.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.359 -0.382 . . . . 75.329999999999998 111.004 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 27' ' ' GLU . 84.4 mt -58.97 -46.43 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.994 0.426 . . . . 61.409999999999997 110.832 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -56.29 -49.54 73.98 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.246 0.546 . . . . 70.140000000000001 110.611 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.761 ' HG3' HD13 ' A' ' 108' ' ' ILE . 60.2 tt0 -54.89 -43.75 73.5 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.724 -0.671 . . . . 74.329999999999998 111.228 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -60.53 -51.81 67.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.111 -0.495 . . . . 55.009999999999998 111.868 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -57.46 -40.4 78.45 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.19 0.441 . . . . 55.149999999999999 112.19 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -65.01 -47.67 76.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.696 0.284 . . . . 71.430000000000007 111.643 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.44 -39.35 91.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.312 0.577 . . . . 70.310000000000002 110.757 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.51 HD22 ' HB ' ' A' ' 45' ' ' VAL . 3.3 t-20 -60.23 -38.22 82.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.583 -0.735 . . . . 53.5 111.072 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.54 -25.83 35.55 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.301 0.482 . . . . 72.099999999999994 112.301 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 55.9 mttm -69.3 -30.9 69.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.803 0.297 . . . . 74.439999999999998 111.803 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.422 ' HB2' ' HE1' ' A' ' 46' ' ' TYR . 48.2 t -71.4 130.19 40.71 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.358 0.503 . . . . 61.240000000000002 112.358 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.7 m -83.11 -13.86 54.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.068 -0.515 . . . . 73.319999999999993 111.686 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -160.78 102.9 1.33 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.863 0.363 . . . . 71.420000000000002 111.394 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.07 137.61 6.16 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.17 -0.538 . . . . 52.329999999999998 112.896 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 38' ' ' ASN . 27.4 m -89.49 138.3 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.383 0.512 . . . . 55.210000000000001 112.383 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HE1' ' HB2' ' A' ' 41' ' ' SER . 30.2 m-85 -90.01 114.11 25.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.835 -0.62 . . . . 74.340000000000003 110.783 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -108.58 133.48 52.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 110.493 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 51' ' ' ALA . 74.3 mt -110.4 126.97 27.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.762 -0.199 . . . . 71.349999999999994 111.071 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -33.41 68.65 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.539 2.159 . . . . 55.450000000000003 112.727 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.29 -36.37 50.53 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.235 -0.439 . . . . 61.140000000000001 112.883 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . . . -92.43 71.88 5.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.154 0.502 . . . . 62.43 111.187 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -66.84 77.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.159 0.504 . . . . 71.239999999999995 111.429 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -144.02 151.37 52.19 Favored Pre-proline 0 N--CA 1.47 0.546 0 CA-C-N 116.215 -0.448 . . . . 73.200000000000003 111.812 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.38 152.05 65.88 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.881 2.387 . . . . 74.430000000000007 113.406 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -135.66 140.72 44.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.323 -0.399 . . . . 74.019999999999996 111.385 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 56' ' ' ARG . 17.1 ttm180 -83.83 132.22 34.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.83 0.347 . . . . 72.219999999999999 111.822 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.48 ' HB3' HD21 ' A' ' 64' ' ' LEU . 53.6 tp -130.29 129.9 43.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.8 0.44 . . . . 71.519999999999996 111.359 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.26 115.87 30.14 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.296 -0.631 . . . . 73.219999999999999 109.296 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.7 p -137.27 -178.9 5.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.735 0.779 . . . . 71.310000000000002 112.903 -171.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -66.29 -20.12 66.01 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.196 -0.911 . . . . 73.150000000000006 112.563 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 95' ' ' PHE . 36.6 pt -90.68 -18.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.851 0.357 . . . . 72.439999999999998 111.247 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.43 -164.71 25.1 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.141 -0.482 . . . . 44.039999999999999 112.433 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.6 m -95.01 107.3 19.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.231 0.539 . . . . 72.209999999999994 111.34 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.711 ' H ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.6 -176.47 2.91 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.212 0.53 . . . . 75.409999999999997 111.74 -178.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 31.3 ttp180 -150.94 107.51 3.5 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.941 0.4 . . . . 72.129999999999995 110.888 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.853 ' SD ' HG23 ' A' ' 152' ' ' ILE . 65.7 mtt -104.11 161.29 14.14 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.732 0.642 . . . . 51.140000000000001 112.732 -173.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 t -153.52 158.89 41.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.101 -0.5 . . . . 52.329999999999998 111.793 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 71' ' ' ILE . 96.2 mt -106.27 110.19 22.36 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.418 -0.356 . . . . 74.140000000000001 111.71 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.541 HG22 HD21 ' A' ' 70' ' ' ASN . 20.4 m -130.04 165.9 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.702 0.287 . . . . 71.409999999999997 111.753 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.541 HD21 HG22 ' A' ' 69' ' ' VAL . 37.7 m-80 59.22 29.29 18.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.988 0.515 . . . . 73.230000000000004 112.323 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 35.2 mt -68.09 107.35 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.901 0.382 . . . . 63.32 111.464 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.63 153.07 78.76 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.185 0.439 . . . . 70.030000000000001 112.185 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.28 150.34 81.37 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.824 2.35 . . . . 53.439999999999998 113.268 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -140.9 167.46 22.14 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.141 -0.482 . . . . 54.030000000000001 111.546 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.47 72.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.961 0.41 . . . . 62.149999999999999 111.911 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 6.6 m-20 -76.01 -26.77 57.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.801 0.334 . . . . 72.439999999999998 110.994 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.34 -93.32 0.1 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-N 116.022 -0.535 . . . . 63.409999999999997 112.97 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -147.84 126.5 12.54 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.549 -0.383 . . . . 73.430000000000007 111.466 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -104.77 129.89 52.94 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.705 0.288 . . . . 73.209999999999994 111.658 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 pp -141.1 152.65 44.94 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.976 0.417 . . . . 73.409999999999997 111.501 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.439 ' HB ' HG22 ' A' ' 69' ' ' VAL . 60.1 m -89.87 109.04 20.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.965 0.412 . . . . 52.299999999999997 111.113 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.419 HD11 HD12 ' A' ' 84' ' ' ILE . 2.6 tm? -86.5 109.37 19.04 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.716 -0.475 . . . . 65.140000000000001 109.716 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -99.24 130.32 45.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.811 0.339 . . . . 71.530000000000001 111.207 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.451 HG12 ' HE3' ' A' ' 66' ' ' MET . 4.1 mp -111.62 102.85 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 73.349999999999994 111.294 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 72.430000000000007 110.695 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.74 153.43 17.54 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.006 -0.616 . . . . 70.519999999999996 112.172 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -45.33 91.56 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.349 0.575 . . . . 73.510000000000005 110.736 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -85.15 176.39 8.4 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.093 -0.503 . . . . 61.130000000000003 111.655 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 89' ' ' ASN . 0.8 OUTLIER -89.26 -37.11 15.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.403 -0.362 . . . . 62.109999999999999 111.67 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.93 145.71 99.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.666 0.27 . . . . 73.540000000000006 111.5 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.75 145.94 82.4 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.236 2.624 . . . . 71.230000000000004 114.99 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.42 152.92 44.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.661 -0.7 . . . . 74.239999999999995 111.393 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.23 -171.55 1.19 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.678 2.252 . . . . 73.150000000000006 113.104 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 157' ' ' PRO . . . -74.62 151.33 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.749 0.309 . . . . 60.310000000000002 111.469 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' HB3' HG21 ' A' ' 61' ' ' ILE . 36.4 p90 -154.69 149.63 26.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.599 0.714 . . . . 74.030000000000001 112.669 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 91.1 p -130.55 136.75 49.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.287 -0.869 . . . . 65.340000000000003 109.8 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.686 ' HA3' HD11 ' A' ' 155' ' ' ILE . . . -145.36 175.54 24.87 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.332 -0.937 . . . . 63.329999999999998 113.598 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.9 m -111.13 122.19 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.010000000000005 111.547 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.11 133.74 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.187 -0.461 . . . . 63.140000000000001 111.131 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 41.3 mt-10 -122.76 126.23 47.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.958 0.409 . . . . 75.340000000000003 111.024 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -134.18 133.13 40.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.803 0.335 . . . . 75.049999999999997 111.741 -171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.31 -157.43 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.242 -0.504 . . . . 72.019999999999996 113.28 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HB2' HG13 ' A' ' 114' ' ' ILE . 87.5 mt-30 -117.39 151.43 37.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.068 0.461 . . . . 74.230000000000004 112.049 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.556 HG21 ' H ' ' A' ' 106' ' ' GLY . 60.7 mt -109.28 122.46 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.192 -0.458 . . . . 72.319999999999993 111.266 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -106.88 23.64 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.837 0.31 . . . . 75.450000000000003 111.837 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -146.09 -170.43 14.75 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.006 -0.616 . . . . 37.049999999999997 113.678 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 44.7 p -97.31 -173.55 2.69 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.935 0.398 . . . . 73.150000000000006 111.522 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.761 HD13 ' HG3' ' A' ' 33' ' ' GLN . 31.8 mm -67.9 -36.45 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.037 0.446 . . . . 72.099999999999994 111.397 174.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.05 -37.66 58.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 111.312 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -144.93 111.87 5.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 111.44 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.1 p90 -139.1 145.81 39.93 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.451 0.643 . . . . 74.310000000000002 112.365 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -117.01 144.73 44.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.59 -0.732 . . . . 72.319999999999993 110.495 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.19 119.57 37.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.04 0.448 . . . . 72.329999999999998 111.489 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.554 HG13 ' HB2' ' A' ' 103' ' ' GLN . 33.6 pt -123.07 149.52 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.53 -0.305 . . . . 74.329999999999998 111.429 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.89 39.28 31.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.362 0.601 . . . . 73.200000000000003 111.445 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.05 127.19 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 61.130000000000003 112.203 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.27 167.78 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.977 -0.556 . . . . 71.400000000000006 111.058 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.7 p-10 -112.94 178.48 4.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.056 0.762 . . . . 43.109999999999999 113.056 -172.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -167.75 159.78 12.05 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.482 -0.781 . . . . 74.349999999999994 110.251 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.05 133.92 44.84 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 122.01 -0.431 . . . . 54.130000000000003 112.033 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 121' ' ' ILE . 28.4 pt -111.79 106.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.208 0.527 . . . . 74.010000000000005 111.165 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.51 100.84 10.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.259 -0.428 . . . . 75.150000000000006 110.635 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.72 152.48 37.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.926 0.393 . . . . 75.219999999999999 112.047 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.51 174.43 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.801 2.334 . . . . 55.450000000000003 113.0 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.83 156.82 20.4 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.218 0.532 . . . . 73.25 112.023 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.9 m -100.95 118.27 36.64 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.094 -0.503 . . . . 74.519999999999996 109.983 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.3 -51.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.851 0.358 . . . . 73.430000000000007 111.664 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -119.95 164.42 16.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.014 0.435 . . . . 62.119999999999997 111.338 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.29 91.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 116.33 -0.395 . . . . 73.099999999999994 111.973 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -91.74 166.75 26.92 Favored 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.193 -1.17 . . . . 74.209999999999994 113.344 -1.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 55.1 m -66.93 95.46 0.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.928 0.394 . . . . 74.329999999999998 111.852 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -148.47 112.71 5.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.899 -0.591 . . . . 74.230000000000004 109.946 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.86 110.15 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.648 0.261 . . . . 75.430000000000007 111.323 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.11 118.75 35.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 73.5 111.222 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.3 pt -126.41 133.1 24.63 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 120.902 0.382 . . . . 71.540000000000006 111.898 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.92 118.3 5.5 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.254 1.969 . . . . 54.329999999999998 112.144 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.35 123.54 50.51 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.064 -0.516 . . . . 62.530000000000001 110.89 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -105.39 106.59 17.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.035 0.445 . . . . 72.430000000000007 111.625 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 mt -83.17 124.21 30.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.483 -0.326 . . . . 51.229999999999997 110.535 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 35.3 mtmm -105.87 128.63 53.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.319999999999993 111.928 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.9 7.09 57.76 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.258 -0.428 . . . . 60.340000000000003 113.811 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.2 tt -145.08 137.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.173 -0.604 . . . . 74.409999999999997 111.774 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.9 m -98.3 148.99 23.08 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.459 -0.337 . . . . 73.120000000000005 111.744 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.27 -49.54 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.941 0.719 . . . . 64.140000000000001 112.941 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.79 -26.94 68.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.017 0.437 . . . . 64.439999999999998 111.803 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -100.31 14.57 30.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.273 -0.421 . . . . 64.450000000000003 111.772 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.83 121.63 34.39 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 50.329999999999998 110.708 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.22 -61.75 0.97 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.162 -0.542 . . . . 52.43 113.646 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HE2' ' HD3' ' A' ' 151' ' ' ARG . 49.4 p90 -136.06 155.49 50.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.024 0.44 . . . . 75.439999999999998 112.096 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.32 138.4 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.888 -0.596 . . . . 64.219999999999999 110.575 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.647 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 21.3 mtp180 -123.55 113.07 18.22 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.962 0.505 . . . . 72.230000000000004 111.72 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.853 HG23 ' SD ' ' A' ' 66' ' ' MET . 9.7 mm -106.25 115.16 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 122.413 -0.179 . . . . 74.310000000000002 111.221 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -151.17 179.44 8.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.266 0.469 . . . . 74.409999999999997 112.266 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 63.12 24.98 14.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.221 0.608 . . . . 63.140000000000001 112.589 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.686 HD11 ' HA3' ' A' ' 97' ' ' GLY . 49.7 mm -63.05 105.72 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.174 0.512 . . . . 75.530000000000001 110.879 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -125.1 143.76 45.18 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.979 -0.555 . . . . 74.329999999999998 111.447 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -67.51 107.94 1.52 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.538 2.159 . . . . 74.409999999999997 113.42 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.03 111.45 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.202 0.525 . . . . 72.010000000000005 110.953 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.8 mtm -130.78 167.53 18.72 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.132 -0.355 . . . . 74.530000000000001 111.877 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -55.6 112.72 1.21 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.139 0.495 . . . . 73.129999999999995 112.099 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.659 ' H ' HD21 ' A' ' 161' ' ' LEU . 2.0 pt? -77.2 97.01 4.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.614 0.721 . . . . 71.409999999999997 111.486 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -87.8 -66.59 0.9 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.948 -0.569 . . . . 75.129999999999995 111.752 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -130.48 137.47 49.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.419 -0.355 . . . . 71.349999999999994 111.404 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -79.15 63.48 3.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.652 0.739 . . . . 72.209999999999994 110.1 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -81.54 92.49 6.52 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.482 -0.781 . . . . 64.530000000000001 111.039 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -115.32 106.52 14.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.257 0.465 . . . . 70.439999999999998 112.257 -175.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.4 t60 74.2 -30.08 0.2 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.773 1.027 . . . . 74.430000000000007 113.773 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.898 -0.572 . . . . 64.129999999999995 111.528 -179.658 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.538 0.209 . . . . 70.439999999999998 110.798 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.9 174.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.033 0.444 . . . . 44.200000000000003 111.811 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -147.89 104.47 3.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.091 0.472 . . . . 74.319999999999993 111.162 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -105.54 100.56 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.907 0.384 . . . . 74.450000000000003 111.294 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 m -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.795 0.331 . . . . 73.230000000000004 110.637 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.09 137.79 41.42 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.869 0.366 . . . . 75.310000000000002 111.832 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -138.07 140.72 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.713 0.405 . . . . 74.420000000000002 110.466 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.525 ' HD3' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -117.95 141.2 48.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.947 0.403 . . . . 63.439999999999998 111.289 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -101.99 121.9 43.04 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.276 -0.42 . . . . 74.549999999999997 111.764 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.8 mmm -99.62 112.49 24.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.551 -0.295 . . . . 72.239999999999995 110.956 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -157.87 124.34 4.84 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.767 0.655 . . . . 75.040000000000006 112.767 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -166.15 98.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.599 -0.728 . . . . 75.230000000000004 110.514 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -116.26 118.66 33.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.214 0.53 . . . . 71.150000000000006 111.774 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.76 132.22 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.028 0.442 . . . . 65.230000000000004 110.743 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.1 p -131.35 101.72 5.66 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.384 0.611 . . . . 70.340000000000003 111.559 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -97.4 110.8 23.28 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.179 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' HD21 ' A' ' 17' ' ' LEU . 3.1 mm? -76.83 113.5 14.57 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.991 0.424 . . . . 72.420000000000002 110.981 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.582 ' HB2' ' HE3' ' A' ' 21' ' ' MET . 18.6 p-10 -80.29 142.01 34.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.229 0.537 . . . . 72.5 112.093 -176.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -88.43 -154.34 0.28 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.902 -0.59 . . . . 74.420000000000002 111.278 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.79 148.39 32.95 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.784 0.326 . . . . 63.229999999999997 111.855 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.582 ' HE3' ' HB2' ' A' ' 18' ' ' ASN . 1.6 mpt? -129.7 174.65 9.5 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.109 0.481 . . . . 73.200000000000003 111.643 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.5 p -84.89 157.9 20.74 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.032 -0.531 . . . . 74.310000000000002 111.57 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.87 86.55 4.1 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.494 0.664 . . . . 70.530000000000001 112.127 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 28' ' ' THR . 55.1 tp -113.5 131.66 55.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.252 -0.431 . . . . 64.510000000000005 110.984 174.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 52.14 109.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.763 -0.653 . . . . 73.510000000000005 112.548 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -50.23 -29.46 9.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.968 0.414 . . . . 63.509999999999998 111.451 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.1 tt0 -58.88 -58.6 7.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.013 0.435 . . . . 70.349999999999994 110.733 171.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' HA ' HD12 ' A' ' 31' ' ' ILE . 89.1 m -59.58 -33.3 71.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.243 -0.435 . . . . 72.109999999999999 111.393 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.98 -45.87 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.952 0.406 . . . . 73.230000000000004 110.873 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.367 -0.379 . . . . 75.040000000000006 111.343 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 28' ' ' THR . 85.5 mt -62.09 -48.58 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.164 0.507 . . . . 74.439999999999998 110.786 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.5 m -58.5 -42.33 87.39 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.151 0.501 . . . . 73.010000000000005 110.658 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.606 HE21 HD11 ' A' ' 108' ' ' ILE . 30.8 tt0 -56.38 -50.19 72.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.615 -0.72 . . . . 72.109999999999999 111.061 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.2 -48.83 75.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.036 -0.529 . . . . 73.239999999999995 111.927 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -61.41 -46.9 88.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.891 0.33 . . . . 65.209999999999994 111.891 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.2 -36.49 84.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.005 0.372 . . . . 74.049999999999997 112.005 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.48 -38.28 89.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.07 0.462 . . . . 73.25 110.4 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.51 -33.27 75.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.097 -0.501 . . . . 74.219999999999999 110.925 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.46 98.87 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.927 0.394 . . . . 51.530000000000001 111.625 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -74.89 -25.86 59.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.999 0.428 . . . . 72.319999999999993 111.183 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.467 ' HB2' ' HE2' ' A' ' 46' ' ' TYR . 47.8 t -69.54 125.81 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.95 0.405 . . . . 63.43 111.915 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 92.9 p -117.98 9.35 12.76 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.499 -0.319 . . . . 54.25 111.353 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 m -135.73 32.33 3.01 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.593 0.59 . . . . 73.049999999999997 112.593 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.65 -164.9 25.14 Favored Glycine 0 N--CA 1.463 0.467 0 C-N-CA 120.859 -0.686 . . . . 53.350000000000001 113.314 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.455 HG12 HD13 ' A' ' 57' ' ' LEU . 27.6 m -115.69 136.33 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.085 0.469 . . . . 64.209999999999994 112.135 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.467 ' HE2' ' HB2' ' A' ' 41' ' ' SER . 55.0 m-85 -89.69 103.82 16.44 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.313 -0.403 . . . . 73.010000000000005 111.242 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.12 102.14 14.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.91 0.386 . . . . 73.549999999999997 110.789 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.7 119.1 73.86 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.605 -0.27 . . . . 74.25 110.924 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -58.24 -18.97 40.04 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.263 1.975 . . . . 75.109999999999999 112.961 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.62 64.67 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.433 -0.413 . . . . 65.530000000000001 113.167 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.96 89.37 2.97 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.118 0.485 . . . . 51.109999999999999 111.117 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.39 83.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.174 0.511 . . . . 73.120000000000005 110.689 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -158.59 153.35 20.99 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 115.895 -0.593 . . . . 74.219999999999999 111.903 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 66.5 Cg_endo -88.12 146.13 6.42 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.054 2.503 . . . . 73.319999999999993 112.942 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.21 136.08 53.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.796 0.332 . . . . 72.219999999999999 111.479 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -86.75 127.21 34.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.898 0.38 . . . . 72.329999999999998 111.367 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.455 HD13 HG12 ' A' ' 45' ' ' VAL . 53.5 tp -120.95 118.34 29.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.016 0.436 . . . . 65.340000000000003 111.225 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.9 100.13 12.65 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.186 0.517 . . . . 63.229999999999997 110.437 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.439 ' OG ' HG12 ' A' ' 61' ' ' ILE . 73.8 p -99.22 -167.96 1.55 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.306 0.574 . . . . 72.140000000000001 112.51 -171.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -76.0 -25.92 56.21 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.638 . . . . 74.040000000000006 111.718 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 157' ' ' PRO . 33.9 pt -84.96 -24.8 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.158 0.504 . . . . 73.030000000000001 111.101 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -164.35 28.65 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.811 -0.632 . . . . 73.129999999999995 112.336 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -91.8 124.81 36.21 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.556 -0.379 . . . . 73.340000000000003 111.953 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -135.51 175.5 9.53 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 111.69 176.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -131.54 119.18 21.16 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.477 -0.328 . . . . 72.239999999999995 111.298 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.567 ' SD ' HG23 ' A' ' 152' ' ' ILE . 63.3 mtt -112.16 154.99 24.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 73.540000000000006 112.315 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 24.2 t -160.89 169.77 21.98 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 111.234 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 80' ' ' LEU . 94.4 mt -114.66 124.32 51.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.243 0.46 . . . . 74.239999999999995 112.243 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 81' ' ' THR . 29.1 m -133.04 164.53 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.413 -0.358 . . . . 72.310000000000002 111.096 174.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 62.61 28.32 16.59 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.54 0.57 . . . . 71.319999999999993 112.54 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 mt -67.94 104.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 74.120000000000005 111.416 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 p -139.1 152.69 70.43 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 112.299 0.481 . . . . 73.019999999999996 112.299 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.52 159.89 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.328 2.685 . . . . 74.219999999999999 113.873 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.548 ' HB2' HG22 ' A' ' 79' ' ' THR . 14.0 t70 -150.11 160.33 43.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.931 -0.577 . . . . 72.049999999999997 111.141 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.07 90.08 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.089 0.403 . . . . 75.230000000000004 112.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -82.49 -31.0 29.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.767 0.317 . . . . 71.129999999999995 111.552 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -174.65 -97.67 0.11 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.697 -0.763 . . . . 52.25 113.649 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.2 m -144.84 125.87 14.53 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.929 0.395 . . . . 64.230000000000004 111.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 74' ' ' ASP . 46.6 p -96.55 137.17 36.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.908 0.385 . . . . 71.099999999999994 111.825 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 HD11 HD22 ' A' ' 68' ' ' LEU . 3.3 pp -144.96 155.4 43.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 74.040000000000006 111.1 174.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.687 ' HB ' HG22 ' A' ' 69' ' ' VAL . 26.5 m -95.55 111.88 23.71 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.977 0.418 . . . . 73.519999999999996 111.117 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.93 109.86 18.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.547 -0.538 . . . . 72.209999999999994 109.547 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtt-85 -97.18 127.58 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.819 0.342 . . . . 73.219999999999999 111.849 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.6 mp -113.83 98.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 70.319999999999993 111.529 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.91 -178.54 6.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.952 -0.388 . . . . 73.019999999999996 109.952 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.19 135.3 5.95 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.19 -1.005 . . . . 71.310000000000002 113.973 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -59.05 -23.82 62.34 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.884 0.373 . . . . 70.019999999999996 111.559 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 88.9 p -83.47 136.26 34.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.299 0.571 . . . . 61.520000000000003 111.614 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -68.99 -37.73 78.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.524 0.678 . . . . 70.540000000000006 109.53 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.1 147.72 93.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.119 -0.946 . . . . 75.310000000000002 111.108 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HD3' ' HB1' ' A' ' 129' ' ' ALA . 55.5 Cg_endo -67.85 162.71 38.45 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.423 2.082 . . . . 73.439999999999998 113.477 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.96 145.79 38.75 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.951 -0.568 . . . . 63.409999999999997 111.154 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.36 179.91 4.63 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.671 2.248 . . . . 54.450000000000003 112.99 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -73.09 153.89 40.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.128 0.49 . . . . 73.510000000000005 111.619 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.25 164.97 37.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.194 0.521 . . . . 71.510000000000005 111.632 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.8 m -150.88 156.07 40.47 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.16 -0.473 . . . . 41.240000000000002 110.372 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 155' ' ' ILE . . . -165.25 178.9 40.04 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.271 -0.966 . . . . 74.340000000000003 113.893 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 m -104.38 135.36 45.97 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.895 0.379 . . . . 73.219999999999999 111.08 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 26.7 m -110.47 134.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 52.310000000000002 111.592 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.777 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.9 mm-40 -103.74 120.08 40.21 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.956 -0.565 . . . . 53.109999999999999 110.151 177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.427 ' CG ' HD23 ' A' ' 139' ' ' LEU . 10.2 p90 -133.7 130.22 37.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.265 0.555 . . . . 74.030000000000001 112.149 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.41 -156.38 12.41 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.519 -0.764 . . . . 72.120000000000005 112.635 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 114' ' ' ILE . 52.9 mt-30 -111.02 151.3 28.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.775 0.321 . . . . 74.219999999999999 111.505 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -114.59 106.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 73.450000000000003 110.824 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.493 ' NE2' HD11 ' A' ' 114' ' ' ILE . 3.6 pt20 -94.39 -6.74 43.48 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.832 0.679 . . . . 71.140000000000001 112.832 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -102.26 -170.04 27.03 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.949 -0.643 . . . . 75.239999999999995 113.499 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.3 p -96.31 173.26 7.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.84 0.352 . . . . 71.340000000000003 111.014 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.606 HD11 HE21 ' A' ' 33' ' ' GLN . 30.9 mm -63.79 -25.94 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.127 0.489 . . . . 74.209999999999994 111.023 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.56 -41.63 19.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.777 -0.647 . . . . 74.549999999999997 110.518 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -139.45 97.94 3.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.177 0.513 . . . . 71.239999999999995 111.53 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.677 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.0 p90 -115.99 151.07 36.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.558 0.577 . . . . 63.219999999999999 112.558 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -127.51 120.53 28.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.753 -0.658 . . . . 73.140000000000001 110.46 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.31 104.53 8.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.827 0.346 . . . . 64.120000000000005 110.8 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.493 HD11 ' NE2' ' A' ' 105' ' ' GLN . 44.6 pt -105.26 153.21 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.64 -0.254 . . . . 74.209999999999994 111.631 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 57.32 28.29 15.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.213 0.53 . . . . 70.140000000000001 111.045 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.9 137.13 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.926 -0.579 . . . . 52.119999999999997 111.942 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.11 171.09 14.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 72.129999999999995 110.746 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 3.1 p-10 -108.5 169.96 8.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.335 0.588 . . . . 62.009999999999998 112.44 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -163.54 149.39 11.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.683 -0.69 . . . . 52.350000000000001 110.966 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -93.03 126.62 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.005 0.372 . . . . 64.040000000000006 112.005 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.9 pt -111.6 140.03 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.714 0.293 . . . . 64.129999999999995 111.427 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -124.91 131.11 53.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.596 0.236 . . . . 74.530000000000001 111.01 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -124.69 135.35 26.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 111.808 0.299 . . . . 71.519999999999996 111.808 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 15.0 Cg_exo -69.32 167.84 22.71 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.999 2.466 . . . . 65.420000000000002 113.272 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.15 130.56 34.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.15 0.426 . . . . 62.039999999999999 112.15 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 74.2 m -79.5 100.88 7.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.908 0.385 . . . . 75.0 110.717 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.647 HG11 ' HG ' ' A' ' 128' ' ' LEU . 8.5 p -71.96 -26.47 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.299 0.481 . . . . 55.329999999999998 112.299 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.647 ' HG ' HG11 ' A' ' 127' ' ' VAL . 98.4 mt -119.7 165.17 14.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.06 0.457 . . . . 72.340000000000003 112.139 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.575 ' HB1' ' HD3' ' A' ' 91' ' ' PRO . . . -106.28 153.64 40.25 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.042 -0.526 . . . . 72.310000000000002 111.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.75 175.15 37.27 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.241 -1.149 . . . . 70.400000000000006 113.686 0.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.7 m -75.31 97.08 3.49 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.639 0.607 . . . . 64.540000000000006 112.639 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.36 122.94 22.13 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.908 -0.587 . . . . 72.010000000000005 110.182 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 134' ' ' ASP . 26.4 t -133.96 159.61 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.395 0.278 . . . . 44.450000000000003 111.323 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.43 ' N ' HG13 ' A' ' 133' ' ' VAL . 2.7 p30 -147.14 143.11 28.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.818 0.342 . . . . 70.140000000000001 110.94 170.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 pt -140.26 147.94 52.13 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 72.120000000000005 111.729 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.7 144.24 21.96 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.704 2.269 . . . . 72.519999999999996 112.676 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.61 108.87 6.44 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.182 -0.324 . . . . 72.519999999999996 110.859 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -95.14 97.82 10.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.131 0.491 . . . . 73.230000000000004 111.625 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.438 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 55.4 mt -74.13 128.75 36.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.327 -0.397 . . . . 50.32 110.739 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.06 141.97 35.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.202 0.445 . . . . 62.350000000000001 112.202 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.87 34.79 88.26 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.066 -0.515 . . . . 42.25 113.878 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.96 125.96 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.07 0.462 . . . . 75.25 111.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.1 m -88.59 155.04 19.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.897 0.379 . . . . 51.420000000000002 111.358 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.49 -39.27 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.08 0.77 . . . . 65.420000000000002 113.08 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.81 -27.64 66.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.076 0.465 . . . . 75.439999999999998 111.258 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.467 ' HB3' HE21 ' A' ' 103' ' ' GLN . 15.3 mm100 -81.74 -4.14 55.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.273 -0.421 . . . . 71.349999999999994 111.752 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.589 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 28.5 mt -71.75 121.56 19.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.088 0.47 . . . . 75.129999999999995 112.265 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.98 -47.81 1.22 Allowed Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.098 -0.501 . . . . 62.530000000000001 112.632 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -150.97 161.69 42.25 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.75 0.31 . . . . 73.329999999999998 111.442 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.46 93.76 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.36 0.6 . . . . 62.229999999999997 110.462 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 47.2 ttp180 -86.99 107.41 18.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.952 0.406 . . . . 73.129999999999995 112.007 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.567 HG23 ' SD ' ' A' ' 66' ' ' MET . 23.3 mm -85.93 135.0 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.535 -0.302 . . . . 72.430000000000007 111.432 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.36 179.25 8.44 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.07 0.396 . . . . 74.349999999999994 112.07 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 64.97 22.5 12.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.193 0.597 . . . . 72.030000000000001 112.425 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.469 HD11 ' HA3' ' A' ' 97' ' ' GLY . 51.5 mm -64.53 97.33 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.42 0.629 . . . . 72.040000000000006 111.454 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -114.8 150.67 44.46 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.586 -0.734 . . . . 75.310000000000002 111.139 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.456 ' HB3' HG23 ' A' ' 61' ' ' ILE . 61.1 Cg_endo -72.69 148.32 46.75 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.324 2.016 . . . . 60.210000000000001 113.806 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 3.4 p -133.8 127.29 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.841 -0.618 . . . . 53.539999999999999 110.27 174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -152.83 -168.52 3.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.105 0.479 . . . . 73.5 112.268 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.473 ' NE2' ' H ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -68.58 156.41 38.13 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 111.41 176.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.63 115.6 15.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.478 -0.328 . . . . 73.019999999999996 111.872 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.54 138.19 53.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.151 0.501 . . . . 74.219999999999999 111.567 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -93.07 139.12 30.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.138 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -123.05 120.62 33.86 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.791 0.293 . . . . 64.430000000000007 111.791 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -86.16 93.67 9.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.996 0.427 . . . . 71.349999999999994 110.125 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 167' ' ' HIS . 18.3 t60 -81.14 130.04 34.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.465 -0.334 . . . . 73.319999999999993 110.451 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 166' ' ' HIS . 32.6 m80 73.94 90.29 0.09 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.235 0.614 . . . . 72.129999999999995 111.824 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.7 p80 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 116.131 -0.486 . . . . 73.349999999999994 111.5 175.732 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 111.992 0.367 . . . . 74.319999999999993 111.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.89 104.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.513 0.673 . . . . 64.400000000000006 112.1 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.54 78.47 4.05 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.257 0.551 . . . . 75.219999999999999 110.566 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.23 134.88 34.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.12 0.486 . . . . 64.430000000000007 111.722 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.0 p -159.57 138.31 10.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.042 -0.526 . . . . 65.340000000000003 111.122 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -101.75 151.19 22.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.851 0.358 . . . . 73.439999999999998 111.324 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.86 142.13 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.156 0.503 . . . . 75.310000000000002 111.53 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.01 102.03 14.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.206 0.527 . . . . 63.350000000000001 111.301 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -109.78 132.91 53.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.053 -0.521 . . . . 75.230000000000004 111.148 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 49.8 tpp -114.2 105.12 12.8 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 73.549999999999997 111.775 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -98.63 150.47 21.71 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.394 -0.366 . . . . 72.400000000000006 110.936 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -168.85 117.77 0.69 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.952 0.406 . . . . 72.319999999999993 111.781 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -158.31 172.68 17.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.365 -0.38 . . . . 73.450000000000003 110.538 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.14 75.81 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.983 0.897 . . . . 64.329999999999998 110.929 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.1 p -90.96 107.29 19.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.861 -0.609 . . . . 63.119999999999997 111.084 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -81.2 100.29 9.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.091 0.472 . . . . 73.439999999999998 111.67 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.767 ' H ' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -95.75 158.27 15.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.415 -0.357 . . . . 73.219999999999999 110.933 176.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -104.75 -164.48 1.05 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 111.914 0.338 . . . . 73.510000000000005 111.914 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -50.05 134.78 21.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.965 0.728 . . . . 75.219999999999999 112.965 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.23 139.62 42.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.473 -0.785 . . . . 63.119999999999997 109.613 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.72 106.68 1.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.63 0.729 . . . . 74.230000000000004 111.065 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -103.74 164.97 11.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.17 -0.923 . . . . 75.129999999999995 112.675 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.42 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.689 0.996 . . . . 74.120000000000005 113.689 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.493 HD23 HG22 ' A' ' 29' ' ' VAL . 38.3 tp -148.01 137.12 22.08 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.002 -0.999 . . . . 73.519999999999996 109.134 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.406 ' O ' HG21 ' A' ' 29' ' ' VAL . 56.4 m-80 -59.55 126.07 26.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.084 0.401 . . . . 75.049999999999997 112.084 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -53.26 -37.57 62.24 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.209 -0.45 . . . . 64.239999999999995 111.788 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 31' ' ' ILE . 28.6 tt0 -58.96 -54.63 44.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.969 0.414 . . . . 61.420000000000002 110.65 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -59.14 -35.4 73.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 73.329999999999998 111.471 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.493 HG22 HD23 ' A' ' 24' ' ' LEU . 89.9 t -64.54 -42.84 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.971 0.415 . . . . 74.140000000000001 110.597 174.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.567 ' HE3' HD23 ' A' ' 48' ' ' LEU . 44.5 tptt -66.61 -38.15 86.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.176 -0.466 . . . . 63.229999999999997 110.781 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.1 mt -59.74 -46.87 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.329 0.585 . . . . 72.25 110.47 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -58.89 -44.85 91.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.702 -0.681 . . . . 74.510000000000005 111.057 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.534 ' HG3' HD13 ' A' ' 108' ' ' ILE . 63.1 tt0 -59.21 -45.23 91.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.346 0.593 . . . . 75.299999999999997 110.809 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.5 -54.07 50.99 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.31 -0.859 . . . . 74.329999999999998 111.188 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -66.31 -30.8 71.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.462 0.541 . . . . 70.549999999999997 112.462 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.43 -49.66 68.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.893 0.377 . . . . 74.530000000000001 110.673 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -38.35 87.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.116 0.484 . . . . 53.539999999999999 110.732 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.475 HD22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 t-20 -56.68 -42.38 78.94 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.782 -0.645 . . . . 73.030000000000001 111.031 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -43.4 68.85 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.195 -0.457 . . . . 73.010000000000005 112.022 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.94 -7.13 53.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.03 0.381 . . . . 71.430000000000007 112.03 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.408 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 37.1 t -61.89 126.29 26.84 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.106 0.41 . . . . 73.299999999999997 112.106 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 t -93.73 -4.04 51.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.272 -0.422 . . . . 73.049999999999997 111.132 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -142.41 96.87 3.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.992 0.425 . . . . 73.209999999999994 111.364 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 66.84 -149.17 51.14 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.316 -0.469 . . . . 60.43 113.616 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 38' ' ' ASN . 31.6 m -114.51 152.84 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.069 0.461 . . . . 64.150000000000006 112.091 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 33.6 m-85 -101.31 114.42 28.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.329 -0.396 . . . . 72.120000000000005 111.571 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.58 104.12 14.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.905 0.383 . . . . 73.150000000000006 110.749 173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 HD23 ' HE3' ' A' ' 30' ' ' LYS . 9.5 mp -82.18 111.83 30.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 122.312 -0.243 . . . . 74.430000000000007 110.682 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.6 Cg_endo -57.47 -23.47 56.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.848 2.365 . . . . 41.109999999999999 113.461 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.37 -17.67 59.88 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.96 -0.638 . . . . 55.039999999999999 113.16 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.67 101.09 5.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.547 0.339 . . . . 72.5 111.26 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.43 88.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.055 0.455 . . . . 52.109999999999999 110.438 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 p -135.93 148.76 66.34 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.713 0.634 . . . . 71.430000000000007 112.713 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.24 131.56 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.24 2.627 . . . . 72.409999999999997 113.24 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.04 134.0 55.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.323 -0.399 . . . . 55.25 110.679 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -84.87 109.87 18.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.192 0.52 . . . . 70.450000000000003 111.855 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.425 HD13 HG11 ' A' ' 45' ' ' VAL . 44.3 tp -105.65 124.01 48.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.106 -0.497 . . . . 72.310000000000002 111.655 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -75.86 132.02 40.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.355 -0.384 . . . . 62.450000000000003 110.39 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -126.13 -178.71 4.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.337 0.589 . . . . 74.540000000000006 111.701 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.23 0.87 54.69 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.936 -0.574 . . . . 70.409999999999997 111.675 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.9 pt -111.16 -28.88 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.009 0.433 . . . . 72.409999999999997 111.016 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.26 151.1 5.83 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.16 -0.473 . . . . 73.109999999999999 112.607 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.7 m -55.28 126.47 25.08 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.955 0.378 . . . . 72.430000000000007 111.482 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.74 174.5 10.51 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.446 0.641 . . . . 62.210000000000001 112.4 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -127.61 125.67 40.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.991 -0.55 . . . . 64.019999999999996 111.087 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.792 ' SD ' HG23 ' A' ' 152' ' ' ILE . 62.3 mtt -117.14 144.1 45.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.837 0.351 . . . . 54.350000000000001 111.776 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -143.66 143.48 31.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.942 0.401 . . . . 71.340000000000003 111.413 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.565 HD22 HD23 ' A' ' 82' ' ' LEU . 92.6 mt -90.17 107.01 18.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.349 -0.387 . . . . 72.120000000000005 111.429 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.543 HG22 HD21 ' A' ' 70' ' ' ASN . 27.5 m -122.61 161.48 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.186 -0.321 . . . . 73.549999999999997 111.7 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.543 HD21 HG22 ' A' ' 69' ' ' VAL . 35.5 m-80 59.03 41.19 21.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.083 0.401 . . . . 75.239999999999995 112.083 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 57.7 mt -73.13 111.44 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.939 0.4 . . . . 73.310000000000002 111.55 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -136.82 156.5 75.96 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.413 -0.358 . . . . 74.120000000000005 111.907 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.64 151.34 52.2 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.856 2.37 . . . . 72.019999999999996 113.023 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.655 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.6 t70 -134.12 164.7 26.76 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.975 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -49.2 77.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 42.450000000000003 111.711 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.1 -36.41 35.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.55 -0.295 . . . . 73.019999999999996 111.628 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.41 -97.38 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.316 -0.945 . . . . 65.239999999999995 114.344 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.3 m -141.03 130.9 24.37 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.209 0.448 . . . . 73.200000000000003 112.209 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.655 HG23 ' HB2' ' A' ' 74' ' ' ASP . 30.4 p -107.04 116.87 32.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.917 0.389 . . . . 73.129999999999995 111.572 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.0 pp -137.52 147.26 45.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.864 0.364 . . . . 73.319999999999993 111.472 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -89.32 114.82 26.27 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.91 0.386 . . . . 74.019999999999996 111.188 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD23 HD22 ' A' ' 68' ' ' LEU . 3.2 tm? -90.56 113.65 25.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.922 -0.399 . . . . 64.010000000000005 109.922 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 mtt-85 -102.1 114.48 28.65 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.872 0.693 . . . . 74.310000000000002 112.872 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' H ' HD11 ' A' ' 84' ' ' ILE . 3.8 mp -92.39 147.86 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.886 -0.597 . . . . 72.209999999999994 110.716 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.1 118.45 7.86 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.296 -0.261 . . . . 62.450000000000003 110.296 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 137.75 28.56 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.99 -0.624 . . . . 72.450000000000003 113.3 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.04 68.47 4.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.421 0.629 . . . . 53.409999999999997 110.479 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -170.32 179.82 3.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.859 -0.609 . . . . 75.120000000000005 111.131 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -100.15 -3.82 30.95 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.854 0.316 . . . . 70.129999999999995 111.854 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.486 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.2 p30 -112.2 166.45 10.93 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.577 0.584 . . . . 63.32 112.577 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.578 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 72.6 Cg_endo -74.07 171.37 18.08 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.02 2.48 . . . . 75.439999999999998 114.332 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.92 152.05 76.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.066 -0.515 . . . . 71.340000000000003 111.126 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.12 172.96 15.18 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.381 2.054 . . . . 75.319999999999993 113.124 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.82 149.28 48.08 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.741 0.305 . . . . 65.109999999999999 111.662 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.72 163.04 39.53 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.613 0.721 . . . . 74.219999999999999 112.583 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.1 p -133.99 167.13 21.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.385 -0.825 . . . . 75.439999999999998 109.917 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -165.63 163.98 37.02 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.046 -1.073 . . . . 55.520000000000003 114.005 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.594 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 91.1 m -103.8 108.5 19.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.463 0.305 . . . . 73.150000000000006 110.804 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 27.9 m -98.28 130.23 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.951 0.405 . . . . 74.299999999999997 111.812 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -107.52 111.81 24.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.904 0.383 . . . . 75.319999999999993 111.016 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.485 ' CD1' HD22 ' A' ' 139' ' ' LEU . 40.9 p90 -115.71 140.41 49.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.714 0.292 . . . . 73.510000000000005 111.361 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -179.0 -150.34 8.84 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.141 -0.552 . . . . 72.129999999999995 113.168 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.498 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.2 mt-30 -119.9 166.14 13.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.198 0.523 . . . . 65.430000000000007 112.034 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.547 HG21 ' H ' ' A' ' 106' ' ' GLY . 71.0 mt -126.01 124.99 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.939 -0.573 . . . . 73.25 110.62 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.546 HE21 HG23 ' A' ' 114' ' ' ILE . 6.3 pt20 -98.88 17.04 20.48 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.813 0.671 . . . . 75.140000000000001 112.813 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.547 ' H ' HG21 ' A' ' 104' ' ' ILE . . . -145.13 -173.1 16.07 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.373 -0.918 . . . . 64.239999999999995 114.141 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 72.2 p -101.01 178.93 4.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.839 0.456 . . . . 74.329999999999998 111.667 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.534 HD13 ' HG3' ' A' ' 33' ' ' GLN . 45.1 mm -54.94 -38.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 71.310000000000002 111.845 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.64 -45.7 43.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.407 -0.361 . . . . 71.140000000000001 111.945 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -134.8 102.54 5.29 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.144 0.497 . . . . 70.5 111.57 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.1 p90 -132.25 150.57 52.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 111.898 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -134.55 130.59 36.8 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.05 -0.523 . . . . 74.109999999999999 110.856 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.38 113.95 18.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.012 -0.54 . . . . 74.439999999999998 111.197 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.546 HG23 HE21 ' A' ' 105' ' ' GLN . 36.0 pt -119.18 158.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.724 0.297 . . . . 62.420000000000002 111.478 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 58.75 26.79 15.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 73.140000000000001 110.826 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.36 144.67 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.538 -0.756 . . . . 62.340000000000003 112.237 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.37 161.4 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.666 -0.697 . . . . 65.450000000000003 110.5 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 2.6 p-10 -106.78 153.87 21.82 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.938 0.718 . . . . 62.219999999999999 112.938 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -139.97 148.71 42.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.704 -0.68 . . . . 55.100000000000001 110.553 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.19 119.87 29.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.8 0.333 . . . . 72.239999999999995 111.419 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.6 pt -98.09 141.66 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.465 -0.334 . . . . 62.549999999999997 110.863 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.24 114.82 18.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.863 0.364 . . . . 73.530000000000001 111.173 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.736 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -110.61 129.7 23.67 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.537 -0.301 . . . . 72.239999999999995 111.641 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.49 164.45 35.23 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.641 2.227 . . . . 73.299999999999997 113.158 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -77.49 121.88 24.45 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.304 0.483 . . . . 73.430000000000007 112.304 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.1 m -92.97 96.87 10.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.429 -0.351 . . . . 71.329999999999998 110.782 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -78.37 -21.31 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.331 0.586 . . . . 64.329999999999998 111.104 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.543 ' H ' HD21 ' A' ' 128' ' ' LEU . 2.0 pt? -77.41 152.95 34.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.931 -0.577 . . . . 61.049999999999997 111.283 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.85 139.91 26.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.574 -0.285 . . . . 74.409999999999997 111.685 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.76 156.75 95.35 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.748 -1.355 . . . . 64.019999999999996 112.635 -3.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.578 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 38.7 t -72.12 99.0 2.22 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.079 0.77 . . . . 73.219999999999999 113.079 -173.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.88 143.0 44.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.716 0.293 . . . . 63.329999999999998 110.428 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.736 HG11 ' HB1' ' A' ' 123' ' ' ALA . 36.5 t -133.64 121.21 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.694 0.283 . . . . 74.420000000000002 111.03 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.35 101.72 10.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.102 0.477 . . . . 64.209999999999994 111.289 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.403 HG23 HG13 ' A' ' 133' ' ' VAL . 18.8 pt -112.5 129.06 24.74 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.369 0.507 . . . . 75.109999999999999 112.369 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.92 121.07 7.28 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.449 2.1 . . . . 53.310000000000002 112.12 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.98 107.64 15.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.108 -0.496 . . . . 63.43 111.02 -174.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.99 99.17 11.85 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.162 0.506 . . . . 75.310000000000002 111.502 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.485 HD22 ' CD1' ' A' ' 101' ' ' TYR . 46.2 mt -77.71 123.8 27.14 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.226 -0.443 . . . . 60.140000000000001 110.506 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -99.62 148.31 24.46 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.849 0.357 . . . . 60.450000000000003 111.877 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.54 -10.09 74.71 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 114.395 0.518 . . . . 50.109999999999999 114.395 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.576 HD11 HD22 ' A' ' 147' ' ' LEU . 19.4 tt -138.8 119.03 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 117.881 0.84 . . . . 75.239999999999995 112.589 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.6 m -75.01 156.58 36.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.246 -0.434 . . . . 63.240000000000002 111.286 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.76 -46.28 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.057 0.762 . . . . 73.400000000000006 113.057 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.01 -14.87 63.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.14 0.495 . . . . 74.549999999999997 111.797 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -92.21 -5.35 52.65 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.539 -0.3 . . . . 64.510000000000005 111.645 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.576 HD22 HD11 ' A' ' 142' ' ' ILE . 50.6 mt -73.39 113.33 10.36 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.743 0.645 . . . . 73.200000000000003 112.743 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.57 -36.54 6.12 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.941 -0.572 . . . . 72.109999999999999 112.68 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.98 160.51 27.8 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.8 0.333 . . . . 73.420000000000002 111.334 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.53 100.82 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.008 0.433 . . . . 75.040000000000006 110.418 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -86.54 119.93 27.32 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.771 0.32 . . . . 73.430000000000007 111.803 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.792 HG23 ' SD ' ' A' ' 66' ' ' MET . 20.7 mm -104.59 125.76 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.309 -0.244 . . . . 74.430000000000007 111.136 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.46 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 13.3 p80 -164.85 -175.17 3.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.955 0.354 . . . . 71.010000000000005 111.955 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.594 ' HB3' ' H ' ' A' ' 98' ' ' THR . 13.9 t70 67.29 22.38 9.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.332 0.586 . . . . 65.400000000000006 111.367 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.521 HD12 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -66.91 110.52 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.283 0.563 . . . . 75.530000000000001 112.165 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.78 144.49 53.13 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.917 -0.583 . . . . 54.130000000000003 111.106 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.82 155.73 67.8 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.411 2.074 . . . . 72.409999999999997 113.148 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.33 150.43 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.844 0.354 . . . . 75.299999999999997 110.984 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.0 ptm -163.03 -173.66 3.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.845 0.355 . . . . 74.349999999999994 111.366 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.14 163.91 16.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.244 -0.435 . . . . 73.540000000000006 111.677 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 80.1 mt -73.13 168.42 19.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.621 0.724 . . . . 70.209999999999994 112.642 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -94.2 160.55 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.436 -0.802 . . . . 64.219999999999999 111.126 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -111.72 25.07 12.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.435 0.531 . . . . 64.209999999999994 112.435 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.9 m80 63.18 69.9 0.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.11 0.481 . . . . 75.140000000000001 111.304 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -75.6 -11.13 59.95 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.55 0.574 . . . . 71.319999999999993 112.55 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 167' ' ' HIS . 55.8 t-80 57.41 57.39 4.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.429 0.529 . . . . 71.439999999999998 112.429 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 166' ' ' HIS . 44.2 t-80 178.82 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.11 0.411 . . . . 74.319999999999993 112.11 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.552 -0.737 . . . . 73.239999999999995 112.055 174.83 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.682 0.277 . . . . 74.400000000000006 111.322 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG13 ' H ' ' A' ' 3' ' ' GLN . 6.9 p -70.58 -56.74 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.763 -0.199 . . . . 73.209999999999994 111.111 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.493 ' H ' HG13 ' A' ' 2' ' ' VAL . 49.6 mt-30 55.95 14.58 1.44 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.379 0.881 . . . . 71.349999999999994 113.379 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -85.25 164.08 18.26 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.098 -0.376 . . . . 65.049999999999997 110.965 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.1 p -64.8 99.23 0.32 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.882 0.327 . . . . 71.409999999999997 111.882 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.14 104.99 2.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.366 0.603 . . . . 62.520000000000003 110.078 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -86.22 160.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.272 0.558 . . . . 64.150000000000006 111.946 -175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' HA ' ' NE ' ' A' ' 8' ' ' ARG . 5.0 mmp_? -100.94 118.62 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 73.030000000000001 110.538 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -59.73 144.33 48.46 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.589 0.588 . . . . 72.219999999999999 112.589 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.477 ' SD ' ' N ' ' A' ' 10' ' ' MET . 1.4 pmm? -77.86 119.57 21.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.217 0.532 . . . . 74.120000000000005 111.217 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.0 104.49 17.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.071 0.462 . . . . 70.340000000000003 110.86 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -143.47 121.5 12.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.467 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.6 p -159.19 125.15 4.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.124 -0.489 . . . . 64.040000000000006 110.901 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -150.8 147.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.934 0.397 . . . . 54.340000000000003 111.838 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.1 m -146.2 94.63 2.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.969 0.414 . . . . 74.030000000000001 111.329 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -126.99 167.95 15.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.906 0.384 . . . . 75.219999999999999 111.525 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -82.01 95.16 7.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.993 0.425 . . . . 75.030000000000001 110.379 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -117.25 -79.36 0.59 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.788 0.328 . . . . 72.329999999999998 111.313 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -167.96 -168.22 0.95 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.995 0.426 . . . . 73.099999999999994 111.333 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.7 152.5 38.97 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.069 -0.514 . . . . 64.140000000000001 111.07 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mmt -76.99 164.25 25.94 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.264 0.554 . . . . 74.319999999999993 112.472 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.486 ' HB ' ' OE1' ' A' ' 23' ' ' GLN . 70.8 p -83.27 -165.95 1.23 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.75 -0.659 . . . . 75.319999999999993 111.689 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.486 ' OE1' ' HB ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -64.19 -175.57 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.553 0.575 . . . . 64.109999999999999 112.553 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.42 HD21 HG22 ' A' ' 29' ' ' VAL . 32.4 tp -54.6 139.17 39.25 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.945 0.72 . . . . 72.329999999999998 112.945 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -122.94 165.14 17.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.971 -0.558 . . . . 72.109999999999999 110.918 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -50.1 71.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.937 0.399 . . . . 65.310000000000002 111.712 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.48 -41.67 90.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 52.310000000000002 111.451 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -60.55 -30.35 69.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 111.351 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.42 HG22 HD21 ' A' ' 24' ' ' LEU . 58.9 t -65.62 -47.56 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 64.219999999999999 110.364 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.08 80.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.181 -0.463 . . . . 70.120000000000005 111.274 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 53' ' ' THR . 69.7 mt -56.85 -48.19 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.349 0.595 . . . . 71.409999999999997 111.084 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -62.0 -41.07 97.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.788 -0.642 . . . . 75.439999999999998 111.059 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.749 ' HG3' HD11 ' A' ' 108' ' ' ILE . 44.0 tt0 -65.15 -38.07 89.42 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.091 -0.504 . . . . 62.210000000000001 111.482 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.8 -57.52 12.41 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.528 -0.305 . . . . 70.340000000000003 110.566 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -52.02 -45.23 64.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.419 0.526 . . . . 50.130000000000003 112.419 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.401 ' HB2' HD13 ' A' ' 108' ' ' ILE . 99.1 mtt180 -66.51 -48.84 68.5 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.326 0.491 . . . . 71.409999999999997 112.326 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.97 -45.92 91.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.309 0.576 . . . . 75.230000000000004 110.845 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.488 ' OD1' ' HA ' ' A' ' 45' ' ' VAL . 65.7 t30 -66.08 -28.89 69.17 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.884 -0.598 . . . . 70.519999999999996 111.142 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.733 0.301 . . . . 72.409999999999997 111.184 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.66 -21.93 54.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.848 0.356 . . . . 62.439999999999998 111.285 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.426 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 41.1 t -63.72 123.63 19.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.259 0.466 . . . . 74.209999999999994 112.259 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 m -108.11 -0.08 21.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.775 0.287 . . . . 73.200000000000003 111.775 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 t -148.1 77.62 1.41 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.075 0.464 . . . . 73.319999999999993 111.825 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.71 -166.89 12.21 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.512 -0.375 . . . . 65.420000000000002 112.926 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.488 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 29.1 m -130.9 149.9 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.761 0.652 . . . . 74.230000000000004 112.761 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 41' ' ' SER . 72.9 m-85 -99.95 112.1 24.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.039 -0.528 . . . . 74.430000000000007 111.42 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -104.16 106.1 16.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.075 0.464 . . . . 74.400000000000006 110.792 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.1 mt -83.17 128.88 63.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.619 -0.264 . . . . 61.340000000000003 111.241 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.07 -29.17 82.08 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 122.697 2.265 . . . . 65.540000000000006 113.187 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.41 9.91 76.12 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.21 -0.519 . . . . 75.230000000000004 113.234 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.62 86.36 2.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.02 0.438 . . . . 75.420000000000002 111.651 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.47 80.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.156 0.503 . . . . 74.129999999999995 111.113 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.667 HG22 HG21 ' A' ' 31' ' ' ILE . 3.8 p -138.49 150.81 67.59 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 112.84 0.682 . . . . 54.509999999999998 112.84 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.84 127.74 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.277 2.652 . . . . 73.120000000000005 113.01 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -108.73 132.68 53.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.976 0.417 . . . . 64.099999999999994 111.293 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -90.97 125.89 35.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.31 -0.405 . . . . 72.299999999999997 110.771 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.99 121.11 22.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.905 0.383 . . . . 75.450000000000003 111.698 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -86.5 111.1 20.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.065 0.459 . . . . 73.430000000000007 110.1 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -112.39 -173.02 2.16 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.17 0.509 . . . . 74.540000000000006 112.343 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.435 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 47.0 mt-30 -74.25 -24.09 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.777 -0.647 . . . . 74.129999999999995 111.819 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.49 -29.4 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.99 0.424 . . . . 63.329999999999998 111.196 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.94 -173.22 33.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.218 -0.515 . . . . 63.43 112.955 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -82.85 112.79 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.557 -0.378 . . . . 75.219999999999999 110.712 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -119.9 171.91 8.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.521 0.677 . . . . 71.340000000000003 112.408 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -132.95 111.95 11.46 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.587 -0.733 . . . . 74.25 110.716 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.67 ' SD ' HG22 ' A' ' 152' ' ' ILE . 64.2 mtt -107.35 148.0 29.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.281 0.474 . . . . 74.430000000000007 112.281 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.2 t -154.66 157.22 37.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.948 0.404 . . . . 73.200000000000003 111.645 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.53 HD22 HD12 ' A' ' 80' ' ' LEU . 95.0 mt -102.97 114.04 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.307 -0.406 . . . . 63.530000000000001 111.579 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 81' ' ' THR . 28.6 m -128.06 161.6 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.69 0.281 . . . . 65.099999999999994 111.667 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 54.29 30.71 12.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.318 0.488 . . . . 72.120000000000005 112.318 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.2 mt -59.22 104.13 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.007 0.432 . . . . 70.239999999999995 111.399 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -125.69 149.53 65.63 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 112.343 0.497 . . . . 71.510000000000005 112.343 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.98 129.24 14.0 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.758 2.305 . . . . 72.430000000000007 113.375 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.729 ' HB2' HG22 ' A' ' 79' ' ' THR . 29.4 t70 -91.65 166.74 12.64 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.289 -0.414 . . . . 64.510000000000005 110.62 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.44 69.13 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.134 0.42 . . . . 74.349999999999994 112.134 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -115.64 -9.78 11.93 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.51 0.559 . . . . 74.030000000000001 112.51 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -167.35 -113.78 0.29 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.259 -0.972 . . . . 71.120000000000005 114.021 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -146.89 127.12 13.84 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.028 0.381 . . . . 73.239999999999995 112.028 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 74' ' ' ASP . 41.4 p -104.6 114.83 29.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.566 -0.288 . . . . 73.230000000000004 111.104 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.53 HD12 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -126.81 148.46 49.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.883 0.373 . . . . 72.530000000000001 111.657 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' HG22 ' A' ' 69' ' ' VAL . 62.2 m -92.0 107.92 19.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.123 0.487 . . . . 75.349999999999994 111.566 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.38 108.91 19.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.034 -0.53 . . . . 71.430000000000007 110.053 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' MET . 9.7 mtp-105 -93.66 122.96 36.65 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.3 -0.25 . . . . 74.150000000000006 111.609 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.438 HD11 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -107.16 91.29 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.535 -0.302 . . . . 73.040000000000006 110.758 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -88.19 122.79 32.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.706 0.288 . . . . 74.120000000000005 111.021 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.33 132.0 11.35 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.709 -0.757 . . . . 62.409999999999997 113.154 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -69.16 -43.56 74.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.282 0.563 . . . . 61.299999999999997 109.898 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 m -79.42 109.08 13.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.1 -0.704 . . . . 71.439999999999998 109.1 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -73.35 1.58 9.3 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.341 0.867 . . . . 73.299999999999997 113.341 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.7 p30 -74.09 156.87 87.48 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.681 0.276 . . . . 73.519999999999996 111.59 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 11.6 Cg_endo -54.03 114.24 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.021 2.481 . . . . 53.350000000000001 113.716 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.88 145.15 29.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.132 -0.485 . . . . 63.130000000000003 111.533 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.78 169.01 23.12 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.58 2.186 . . . . 72.040000000000006 112.618 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 147.9 49.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.542 -0.299 . . . . 71.049999999999997 110.949 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -144.95 160.61 41.06 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.82 0.674 . . . . 74.0 112.82 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -137.75 140.63 40.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.334 -0.848 . . . . 72.209999999999994 110.325 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.492 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -148.09 171.33 28.58 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.811 -0.709 . . . . 73.0 113.097 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.0 m -103.18 134.98 45.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.714 -0.286 . . . . 60.119999999999997 111.016 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 119' ' ' GLN . 7.2 p -117.36 122.67 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 74.420000000000002 112.015 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 27.5 mm-40 -90.16 105.12 17.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.871 -0.604 . . . . 74.400000000000006 110.372 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -114.99 117.81 31.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.356 0.598 . . . . 65.150000000000006 111.497 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -163.13 -149.27 5.65 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.961 -0.563 . . . . 63.210000000000001 112.866 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -121.23 157.14 30.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.076 0.465 . . . . 75.099999999999994 111.972 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -123.0 122.07 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.14 -0.482 . . . . 75.200000000000003 111.196 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 3.8 pt20 -104.34 90.71 3.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.457 0.646 . . . . 72.409999999999997 111.159 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 160.39 -152.18 22.89 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.140000000000001 113.672 175.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -120.72 -171.66 2.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.876 0.47 . . . . 64.010000000000005 111.113 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 ' HG3' ' A' ' 33' ' ' GLN . 29.7 mm -62.77 -34.43 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.266 0.555 . . . . 74.540000000000006 110.844 172.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.98 -49.51 8.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.664 -0.698 . . . . 73.140000000000001 112.138 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -129.65 105.53 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.08 0.467 . . . . 75.329999999999998 111.647 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.516 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.4 p90 -139.97 160.41 39.98 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.097 0.475 . . . . 73.120000000000005 112.18 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -134.51 134.76 41.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.074 -0.512 . . . . 62.539999999999999 110.768 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.19 123.12 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.484 -0.326 . . . . 63.310000000000002 110.884 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.38 154.71 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.047 0.388 . . . . 71.219999999999999 112.047 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 53.46 39.2 29.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.071 0.463 . . . . 73.129999999999995 111.751 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.469 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 5.6 p -97.6 126.18 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.318 0.58 . . . . 74.230000000000004 111.978 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -114.9 153.12 31.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.052 -0.522 . . . . 73.120000000000005 110.6 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.22 133.72 53.35 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.166 0.508 . . . . 71.150000000000006 111.85 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.503 ' O ' HG11 ' A' ' 99' ' ' VAL . 8.8 tt0 -129.03 149.26 50.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.149 -0.478 . . . . 72.450000000000003 110.02 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.8 mt -92.11 118.63 31.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.119 0.485 . . . . 72.150000000000006 111.885 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.692 HG21 HD23 ' A' ' 137' ' ' LEU . 30.4 pt -92.78 99.37 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 72.319999999999993 111.371 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -101.46 114.57 28.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.293 -0.412 . . . . 65.230000000000004 110.96 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -111.67 147.26 36.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.053 0.39 . . . . 70.049999999999997 112.053 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.98 164.91 34.19 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.886 2.391 . . . . 62.020000000000003 113.733 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.38 125.98 29.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.869 -0.605 . . . . 73.340000000000003 112.121 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 71.1 m -90.6 79.44 6.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.962 0.41 . . . . 61.240000000000002 110.614 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.37 -10.65 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.149 -0.478 . . . . 64.430000000000007 111.875 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.84 129.89 53.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.845 0.355 . . . . 74.239999999999995 111.58 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.16 139.39 23.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.359 -0.382 . . . . 72.439999999999998 111.233 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 148.48 92.25 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.103 -1.207 . . . . 73.239999999999995 113.541 2.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.9 p -89.05 125.24 34.92 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.5 0.667 . . . . 64.109999999999999 112.608 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.73 143.39 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.581 -0.736 . . . . 64.0 110.366 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.02 157.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 61.119999999999997 110.973 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.402 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.2 p30 -146.76 111.91 5.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.306 0.574 . . . . 75.120000000000005 110.866 170.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 pt -117.05 142.71 30.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.007 -0.542 . . . . 73.120000000000005 111.915 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.24 130.92 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.907 2.405 . . . . 37.390000000000001 112.636 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.692 HD23 HG21 ' A' ' 121' ' ' ILE . 62.9 mt -111.43 111.85 23.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 73.129999999999995 111.656 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -91.35 89.57 7.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.239 0.542 . . . . 73.219999999999999 110.625 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.497 HD23 ' NE2' ' A' ' 119' ' ' GLN . 26.2 mt -81.67 110.75 17.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 73.209999999999994 110.016 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -98.47 139.15 34.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.973 0.416 . . . . 74.030000000000001 111.76 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.98 63.72 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.079 -0.509 . . . . 61.100000000000001 113.28 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 147' ' ' LEU . 18.4 tt -134.33 123.61 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 122.401 -0.47 . . . . 72.140000000000001 111.774 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -85.41 147.53 26.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.094 0.405 . . . . 74.140000000000001 112.094 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -47.66 -51.4 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 113.192 0.812 . . . . 60.420000000000002 113.192 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.2 -38.13 82.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.094 0.473 . . . . 74.140000000000001 111.61 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -87.54 7.64 28.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.194 0.442 . . . . 71.319999999999993 112.194 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.508 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.2 tt -82.35 126.86 32.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.749 0.309 . . . . 73.430000000000007 110.257 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.42 -58.51 1.36 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.09 -0.576 . . . . 53.210000000000001 113.452 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -147.34 148.83 31.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.369 -0.489 . . . . 74.400000000000006 112.305 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.6 t -116.79 99.33 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.72 -0.673 . . . . 60.509999999999998 109.833 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -102.55 114.1 28.03 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.091 0.472 . . . . 75.219999999999999 111.74 -171.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.67 HG22 ' SD ' ' A' ' 66' ' ' MET . 38.2 mm -90.59 140.19 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 111.842 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -165.67 179.33 6.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 111.908 0.336 . . . . 75.420000000000002 111.908 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 61.87 22.57 13.13 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.417 0.895 . . . . 63.130000000000003 113.417 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.492 HD12 ' HA3' ' A' ' 97' ' ' GLY . 50.8 mm -63.86 94.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.313 0.578 . . . . 74.519999999999996 111.741 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.435 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 8.0 pt20 -125.66 144.8 49.31 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.556 -0.747 . . . . 72.319999999999993 111.179 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 146.27 51.14 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.49 2.127 . . . . 70.420000000000002 113.654 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.83 146.33 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.261 -0.427 . . . . 64.310000000000002 110.451 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -136.16 152.95 51.35 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.115 0.413 . . . . 75.109999999999999 112.115 -175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -75.75 -13.0 60.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.124 -0.489 . . . . 73.400000000000006 111.248 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.67 149.19 32.89 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.381 -0.372 . . . . 74.030000000000001 110.551 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.29 -81.45 0.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.853 0.686 . . . . 74.219999999999999 112.853 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -129.57 141.46 50.96 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.535 0.569 . . . . 74.019999999999996 112.535 -174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -80.24 148.11 30.95 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.038 -0.528 . . . . 74.219999999999999 111.44 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -97.64 178.69 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.083 -0.386 . . . . 73.349999999999994 111.629 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 65.19 87.69 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.093 0.473 . . . . 74.439999999999998 110.994 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -155.63 39.66 0.39 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.469 -0.332 . . . . 75.140000000000001 111.838 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.037 0 N-CA-C 112.605 0.594 . . . . 75.439999999999998 112.605 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.7 mtm . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.77 0.319 . . . . 61.119999999999997 111.658 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -167.61 151.2 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.624 0.25 . . . . 62.450000000000003 110.951 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.89 151.37 39.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.009 0.433 . . . . 74.239999999999995 111.747 176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -134.53 101.99 5.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 73.310000000000002 110.453 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 t -114.49 93.44 4.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.131 0.491 . . . . 74.310000000000002 110.918 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -95.34 93.81 7.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.988 0.423 . . . . 54.520000000000003 110.914 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.73 133.81 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.422 0.629 . . . . 72.129999999999995 112.355 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.578 ' HE ' ' HA ' ' A' ' 8' ' ' ARG . 0.3 OUTLIER -138.12 112.27 8.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.941 -0.572 . . . . 75.439999999999998 110.965 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -81.96 102.92 11.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.916 0.389 . . . . 63.43 111.339 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -153.95 119.44 5.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.397 0.517 . . . . 73.329999999999998 112.397 -177.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -143.52 149.81 38.02 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.235 -0.439 . . . . 73.150000000000006 111.117 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -91.02 -10.08 43.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.993 0.368 . . . . 64.319999999999993 111.993 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -85.9 112.41 21.13 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.856 0.36 . . . . 65.319999999999993 111.335 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.81 119.42 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.397 0.618 . . . . 42.229999999999997 112.147 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.8 t -134.88 154.64 51.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.955 -0.566 . . . . 61.329999999999998 110.638 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -137.38 140.43 41.38 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.216 0.531 . . . . 74.030000000000001 112.154 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.436 ' N ' HD21 ' A' ' 17' ' ' LEU . 2.8 mm? -106.93 164.65 11.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.281 -0.637 . . . . 63.439999999999998 109.281 170.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -51.64 128.12 22.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 121.12 -0.232 . . . . 75.329999999999998 110.924 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -40.06 135.4 1.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.588 0.958 . . . . 74.349999999999994 113.588 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.85 -175.61 0.31 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.587 0.958 . . . . 65.319999999999993 113.587 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.6 mtp -96.51 -172.23 2.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.092 -0.958 . . . . 74.099999999999994 111.632 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 p -95.11 140.92 29.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.191 0.52 . . . . 73.109999999999999 111.804 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -96.44 128.88 43.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.165 -0.47 . . . . 71.400000000000006 110.479 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp -47.82 137.03 10.18 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.361 0.504 . . . . 64.420000000000002 112.361 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.75 137.95 58.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.095 -0.502 . . . . 71.349999999999994 111.714 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.92 -30.87 70.46 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.313 -0.403 . . . . 75.540000000000006 111.267 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.64 -53.93 52.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.906 0.384 . . . . 73.209999999999994 110.797 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -56.55 -37.14 70.11 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.141 -0.481 . . . . 75.230000000000004 111.044 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.16 -47.14 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.356 -0.384 . . . . 73.209999999999994 111.065 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 48' ' ' LEU . 21.0 tptm -62.24 -43.3 99.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.98 0.419 . . . . 65.409999999999997 111.176 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -49.31 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.031 0.443 . . . . 63.0 111.185 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -56.55 -38.78 72.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.965 0.412 . . . . 63.520000000000003 110.906 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.462 ' HG3' HD12 ' A' ' 108' ' ' ILE . 62.8 tt0 -59.71 -42.04 92.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.024 -0.534 . . . . 72.420000000000002 111.073 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -62.52 -52.42 63.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.479 -0.328 . . . . 75.420000000000002 111.072 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -52.99 -42.96 66.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.88 0.371 . . . . 75.019999999999996 111.209 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -57.29 -45.92 83.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.994 0.426 . . . . 65.329999999999998 111.567 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.47 -31.18 72.11 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.833 0.349 . . . . 71.019999999999996 111.26 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -67.8 -30.48 69.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.938 0.399 . . . . 73.099999999999994 110.971 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.89 66.48 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.14 0.495 . . . . 74.239999999999995 111.083 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.43 1.05 47.22 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.284 -0.416 . . . . 54.32 111.788 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 t -65.77 120.48 13.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.274 0.472 . . . . 75.299999999999997 112.274 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -126.48 -13.97 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.37 -0.377 . . . . 72.310000000000002 111.695 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.3 p -129.39 25.51 5.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.377 0.51 . . . . 64.209999999999994 112.377 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.39 161.75 11.35 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.048 -0.596 . . . . 71.400000000000006 112.763 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.78 135.34 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.542 0.687 . . . . 64.25 112.823 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.96 109.41 20.75 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.453 -0.794 . . . . 72.409999999999997 110.746 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.3 131.98 47.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.793 0.33 . . . . 72.329999999999998 110.676 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 84.8 mt -117.17 120.29 33.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 111.903 0.334 . . . . 72.400000000000006 111.903 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HG3' HD23 ' A' ' 147' ' ' LEU . 11.5 Cg_endo -55.42 139.23 81.72 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.339 2.026 . . . . 73.150000000000006 111.666 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.82 -36.67 3.82 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.9 -0.667 . . . . 72.400000000000006 111.923 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.7 93.47 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.096 0.474 . . . . 74.450000000000003 110.057 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -79.61 27.29 0.28 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.265 0.555 . . . . 63.520000000000003 111.959 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 p -97.35 142.59 24.78 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 121.129 0.49 . . . . 64.450000000000003 112.132 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 73.9 Cg_endo -73.57 163.8 36.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.116 2.544 . . . . 63.009999999999998 113.597 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.86 140.66 45.99 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 111.117 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -86.78 123.53 32.03 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.115 0.483 . . . . 72.549999999999997 112.046 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.3 tp -125.45 123.28 38.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.187 -0.46 . . . . 74.5 111.187 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -85.11 96.91 9.59 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 61.240000000000002 110.21 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.7 p -86.58 -174.85 5.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.265 0.555 . . . . 74.540000000000006 111.737 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.45 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 43.4 mt-30 -83.56 -4.71 58.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.998 -0.546 . . . . 74.319999999999993 111.605 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 pt -106.59 -28.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.92 0.391 . . . . 73.230000000000004 111.253 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.62 175.54 31.74 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.128 -0.558 . . . . 61.32 113.188 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.4 m -72.76 112.05 8.45 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.056 0.455 . . . . 71.239999999999995 111.119 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 pp -121.84 155.95 34.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.329 0.585 . . . . 64.319999999999993 112.076 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 32.4 ttt180 -118.17 107.05 13.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.6 -0.727 . . . . 64.549999999999997 110.854 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.745 ' SD ' HG23 ' A' ' 152' ' ' ILE . 64.5 mtt -104.41 156.06 18.26 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.079 0.466 . . . . 55.409999999999997 112.09 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 26.1 t -158.07 160.82 37.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.779 0.324 . . . . 74.400000000000006 111.582 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.592 HD23 HD12 ' A' ' 80' ' ' LEU . 79.3 mt -105.29 113.13 26.53 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.275 -0.421 . . . . 75.439999999999998 111.478 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.638 HG22 HD21 ' A' ' 70' ' ' ASN . 27.2 m -130.58 166.27 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.327 -0.233 . . . . 73.540000000000006 111.194 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.638 HD21 HG22 ' A' ' 69' ' ' VAL . 45.5 m-80 61.16 28.1 17.79 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.012 0.434 . . . . 61.340000000000003 111.618 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.8 mt -64.03 96.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.141 0.496 . . . . 74.019999999999996 111.319 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 p -131.26 150.88 77.73 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.102 -0.499 . . . . 74.019999999999996 112.089 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.66 156.97 61.1 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.737 2.291 . . . . 72.230000000000004 113.568 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 79' ' ' THR . 22.9 t70 -133.36 168.8 17.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.875 -0.602 . . . . 74.420000000000002 110.65 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.83 68.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 71.409999999999997 111.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.56 -31.9 32.44 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.184 0.438 . . . . 74.430000000000007 112.184 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.96 -99.1 0.13 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.233 -0.984 . . . . 63.32 113.759 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -147.2 134.01 20.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.834 0.35 . . . . 71.120000000000005 111.539 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 36.2 p -110.72 127.55 55.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.569 -0.287 . . . . 74.519999999999996 111.627 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.592 HD12 HD23 ' A' ' 68' ' ' LEU . 2.9 pp -134.35 145.16 48.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.018 0.437 . . . . 53.399999999999999 111.208 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.5 m -84.37 101.78 12.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.11 0.481 . . . . 73.329999999999998 111.405 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.1 107.28 12.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.031 -0.531 . . . . 73.420000000000002 109.971 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.479 ' HD2' HG21 ' A' ' 69' ' ' VAL . 14.9 mtp180 -95.66 113.13 24.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.791 0.329 . . . . 54.100000000000001 111.614 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.529 ' H ' HD11 ' A' ' 84' ' ' ILE . 3.2 mp -88.53 88.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.133 0.492 . . . . 70.219999999999999 110.09 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 63.2 tt0 -94.03 95.18 8.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.133 0.492 . . . . 73.430000000000007 110.78 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.45 131.51 41.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.401 -0.428 . . . . 43.43 113.462 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.19 -5.98 58.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.112 0.482 . . . . 70.219999999999999 111.352 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.5 p -91.65 147.84 22.7 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.136 -0.484 . . . . 63.399999999999999 110.872 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.481 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 28.1 t-20 -79.5 -24.77 42.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.957 0.408 . . . . 70.329999999999998 110.639 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.3 134.46 95.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.289 -0.414 . . . . 74.319999999999993 111.802 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.57 102.74 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.648 2.232 . . . . 61.340000000000003 112.576 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.88 141.87 92.85 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 112.251 0.463 . . . . 72.019999999999996 112.251 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.93 177.07 6.8 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.665 2.243 . . . . 74.310000000000002 113.33 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 125' ' ' ALA . . . -63.19 135.01 56.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.939 0.4 . . . . 65.540000000000006 111.339 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.94 154.28 46.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.43 0.633 . . . . 75.530000000000001 112.56 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 90.1 p -131.04 -179.93 5.62 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.626 -0.716 . . . . 72.019999999999996 110.498 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.66 175.12 46.21 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.727 -0.749 . . . . 52.439999999999998 113.095 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.9 m -111.61 131.96 54.9 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.239 0.216 . . . . 74.319999999999993 110.5 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 m -118.79 133.93 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.199 0.523 . . . . 64.150000000000006 111.987 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 8.6 mm-40 -99.13 106.65 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.851 -0.613 . . . . 71.409999999999997 110.557 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.448 ' HE1' ' HB2' ' A' ' 119' ' ' GLN . 48.5 p90 -116.65 122.56 44.92 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.391 0.615 . . . . 70.530000000000001 111.831 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.54 -144.71 4.36 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.68 -0.691 . . . . 61.119999999999997 112.811 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.471 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.9 mt-30 -127.03 158.42 37.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.104 0.478 . . . . 63.240000000000002 111.687 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.418 HG21 ' H ' ' A' ' 106' ' ' GLY . 67.8 mt -119.17 117.07 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.347 -0.388 . . . . 71.239999999999995 111.332 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -92.25 41.81 1.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.086 0.47 . . . . 73.200000000000003 111.167 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.418 ' H ' HG21 ' A' ' 104' ' ' ILE . . . -162.35 -158.95 9.91 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.975 -0.631 . . . . 51.020000000000003 113.676 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.5 p -125.78 -175.92 3.48 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.911 0.386 . . . . 71.519999999999996 111.59 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.462 HD12 ' HG3' ' A' ' 33' ' ' GLN . 45.9 mm -56.75 -38.57 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.031 0.443 . . . . 73.439999999999998 111.454 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.63 -42.63 77.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 111.234 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -139.32 87.59 2.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.293 0.568 . . . . 72.239999999999995 111.996 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -98.0 129.86 44.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.079 0.466 . . . . 74.420000000000002 111.065 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -123.68 120.17 31.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.059 -0.519 . . . . 63.109999999999999 110.838 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.08 118.71 19.11 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.976 0.417 . . . . 74.540000000000006 111.937 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.5 pt -130.57 155.11 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.444 -0.343 . . . . 72.200000000000003 110.96 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 54.67 32.08 16.55 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.463 0.649 . . . . 70.530000000000001 111.279 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.41 117.77 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.752 -0.658 . . . . 70.129999999999995 112.226 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -102.42 145.77 29.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.035 -0.529 . . . . 73.140000000000001 110.178 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -103.72 117.73 35.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.003 0.43 . . . . 71.420000000000002 111.324 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.448 ' HB2' ' HE1' ' A' ' 101' ' ' TYR . 8.9 tt0 -109.68 147.57 32.89 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 75.340000000000003 110.889 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.02 115.16 29.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.848 0.356 . . . . 73.430000000000007 111.05 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 121' ' ' ILE . 46.7 pt -94.8 116.38 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.108 0.48 . . . . 64.420000000000002 111.756 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.439 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.9 OUTLIER -109.74 109.4 20.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.984 -0.376 . . . . 72.140000000000001 109.984 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.84 147.63 34.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 112.201 0.445 . . . . 41.530000000000001 112.201 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.45 151.46 84.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.826 2.35 . . . . 43.020000000000003 113.168 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.507 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . . . -67.7 140.0 56.75 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.033 0.444 . . . . 74.310000000000002 112.041 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -83.7 77.37 9.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.118 -0.326 . . . . 74.420000000000002 110.118 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.417 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -67.94 -21.71 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.066 0.46 . . . . 73.530000000000001 111.925 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.417 ' HG ' HG23 ' A' ' 127' ' ' VAL . 93.1 mt -105.1 152.42 22.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 75.200000000000003 111.039 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 89' ' ' ASN . . . -115.15 140.05 25.18 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.525 -0.307 . . . . 63.43 111.644 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.74 173.83 56.15 Favored 'Cis proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.78 -1.342 . . . . 53.350000000000001 113.496 0.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -73.67 111.09 8.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.327 0.491 . . . . 73.25 112.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -141.94 115.57 9.09 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.326 0.584 . . . . 72.319999999999993 111.056 172.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.82 155.34 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 116.403 -0.362 . . . . 71.140000000000001 110.932 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 9.0 p-10 -143.97 121.34 11.64 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.142 0.496 . . . . 73.200000000000003 111.303 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.1 pt -119.91 138.52 27.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 112.182 0.438 . . . . 72.219999999999999 112.182 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.8 Cg_exo -78.14 123.33 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.015 2.477 . . . . 74.340000000000003 112.819 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 79' ' ' THR . 76.1 mt -100.89 106.46 17.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.89 0.376 . . . . 64.040000000000006 111.945 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.403 ' HA ' HG23 ' A' ' 79' ' ' THR . 35.4 tt0 -84.05 88.37 7.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.401 0.62 . . . . 71.120000000000005 110.228 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.44 116.74 21.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 71.239999999999995 110.013 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -99.68 141.82 31.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 73.409999999999997 112.055 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.2 41.29 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.297 -0.478 . . . . 44.140000000000001 113.154 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 147' ' ' LEU . 16.9 tt -161.51 127.12 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.039 0.447 . . . . 63.109999999999999 111.191 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.4 m -84.65 145.78 27.81 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.007 0.373 . . . . 71.200000000000003 112.007 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.84 -43.03 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.741 0.645 . . . . 73.239999999999995 112.741 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.54 -30.3 64.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.096 0.474 . . . . 74.140000000000001 111.471 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.458 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 29.7 mm-40 -90.88 -4.16 56.77 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.079 0.4 . . . . 60.329999999999998 112.079 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.466 HD23 ' HG3' ' A' ' 49' ' ' PRO . 1.6 tt -61.26 117.94 6.25 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.859 0.361 . . . . 74.439999999999998 110.304 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.98 -62.45 1.36 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.278 -0.487 . . . . 41.210000000000001 113.457 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.438 ' HD2' ' HG3' ' A' ' 151' ' ' ARG . 37.4 p90 -142.63 155.55 44.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.383 0.512 . . . . 72.099999999999994 112.383 -174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.9 t -131.49 104.02 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.196 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 77.5 mtp180 -96.09 115.28 27.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.933 0.397 . . . . 74.329999999999998 112.01 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.745 HG23 ' SD ' ' A' ' 66' ' ' MET . 21.4 mm -93.69 121.91 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.071 -0.513 . . . . 73.239999999999995 110.741 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -154.34 172.94 16.88 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.245 0.461 . . . . 70.319999999999993 112.245 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 63.6 23.8 13.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.889 0.7 . . . . 73.140000000000001 112.889 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.3 mm -64.23 109.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.18 0.514 . . . . 73.239999999999995 111.293 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.45 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.2 pt20 -133.86 147.11 62.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.84 -0.618 . . . . 74.439999999999998 111.9 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.5 ' HB2' ' HG2' ' A' ' 159' ' ' MET . 60.6 Cg_endo -72.44 124.1 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.253 1.968 . . . . 54.049999999999997 112.339 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.24 8.9 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 112.424 0.527 . . . . 75.310000000000002 112.424 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.5 ' HG2' ' HB2' ' A' ' 157' ' ' PRO . 25.3 ptt? -80.0 108.29 13.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.202 0.525 . . . . 55.25 111.447 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -88.05 8.2 27.76 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.312 0.577 . . . . 71.420000000000002 110.936 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.73 9.79 41.7 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.097 0.406 . . . . 73.430000000000007 112.097 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.36 156.73 25.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.31 0.576 . . . . 72.319999999999993 112.331 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -126.11 37.25 4.37 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.102 -0.499 . . . . 74.209999999999994 111.386 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -58.74 -47.86 83.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.235 0.457 . . . . 74.209999999999994 112.235 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -63.82 129.04 38.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.629 0.252 . . . . 73.5 111.173 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -98.74 97.61 8.83 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.212 0.529 . . . . 72.239999999999995 112.392 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -158.53 79.52 0.8 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.36 0.6 . . . . 75.530000000000001 110.612 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 55.0 t60 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.503 -0.771 . . . . 73.019999999999996 110.85 179.518 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.96 0.41 . . . . 72.409999999999997 111.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.35 156.96 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.086 0.469 . . . . 41.0 111.596 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -111.38 151.45 28.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.335 -0.393 . . . . 75.040000000000006 111.071 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -63.99 93.81 0.09 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.68 0.753 . . . . 65.120000000000005 110.773 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.9 m -89.77 132.01 35.44 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.952 -0.567 . . . . 63.140000000000001 112.183 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.93 -175.89 3.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.35 -0.386 . . . . 72.319999999999993 111.366 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.01 155.34 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.577 . . . . 74.219999999999999 111.792 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.54 148.95 24.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.092 -0.504 . . . . 72.400000000000006 110.566 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.2 86.51 1.42 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.553 0.692 . . . . 73.439999999999998 111.441 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 mmt -72.67 147.3 45.85 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.579 -0.737 . . . . 71.519999999999996 110.978 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 3.2 mptp? -87.99 83.7 7.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.913 0.387 . . . . 75.230000000000004 111.548 -171.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -143.28 115.74 8.57 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.573 -0.285 . . . . 72.25 111.022 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -179.48 -170.99 0.18 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.963 0.411 . . . . 74.530000000000001 111.006 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.73 105.57 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.886 0.375 . . . . 74.439999999999998 110.956 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -74.0 99.04 3.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.903 0.383 . . . . 74.340000000000003 111.818 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.6 p -98.38 126.61 43.97 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.01 0.433 . . . . 74.510000000000005 111.329 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.433 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -107.23 142.77 36.44 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.888 0.375 . . . . 73.340000000000003 111.701 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -65.22 143.72 57.65 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.288 -0.415 . . . . 61.229999999999997 111.652 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -95.03 -177.31 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.6 0.714 . . . . 72.409999999999997 112.697 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.13 124.42 24.4 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.312 -0.858 . . . . 75.439999999999998 111.95 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.1 ttm -84.72 157.31 21.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.435 -0.348 . . . . 71.230000000000004 110.843 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -75.5 -167.87 0.74 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.087 0.403 . . . . 74.140000000000001 112.087 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -50.43 141.65 11.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.474 0.546 . . . . 75.310000000000002 112.474 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -126.64 145.58 50.51 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.959 0.409 . . . . 73.519999999999996 111.693 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -91.89 147.91 22.61 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.602 -0.272 . . . . 73.319999999999993 111.375 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -60.3 -39.58 87.48 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.756 0.312 . . . . 73.109999999999999 111.704 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 31' ' ' ILE . 42.8 tt0 -58.79 -48.46 81.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.004 0.431 . . . . 75.5 110.149 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 m -61.32 -33.2 73.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.212 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.66 -54.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.322 0.582 . . . . 73.420000000000002 110.973 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -64.72 -34.69 78.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.59 -0.732 . . . . 73.409999999999997 111.777 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 27' ' ' GLU . 77.1 mt -64.9 -46.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.871 0.367 . . . . 74.439999999999998 111.314 174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.4 m -64.56 -38.97 92.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.781 0.324 . . . . 73.209999999999994 111.201 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -60.16 -45.33 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.825 0.345 . . . . 70.400000000000006 110.489 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -57.24 10.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.073 -0.512 . . . . 71.430000000000007 110.573 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -55.17 -46.27 75.76 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.459 0.54 . . . . 63.109999999999999 112.459 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.71 -48.6 76.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.132 0.419 . . . . 73.519999999999996 112.132 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.173 0.511 . . . . 75.120000000000005 110.8 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -59.25 -44.01 92.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.78 -0.645 . . . . 74.25 110.386 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.6 97.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.034 -0.53 . . . . 71.019999999999996 111.945 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -68.81 -23.24 64.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.832 0.349 . . . . 72.329999999999998 111.855 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -63.87 115.47 4.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.88 0.371 . . . . 74.450000000000003 111.75 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 m -64.42 -47.72 78.08 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.174 0.511 . . . . 65.239999999999995 111.4 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.2 p -129.64 117.75 20.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.176 -0.465 . . . . 71.530000000000001 111.143 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 99.85 169.51 29.81 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.154 -0.546 . . . . 44.310000000000002 113.727 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.44 HG12 HD12 ' A' ' 57' ' ' LEU . 31.1 m -113.19 153.99 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.113 0.483 . . . . 71.319999999999993 111.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -101.95 126.8 48.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.258 -0.428 . . . . 71.310000000000002 111.421 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.83 112.28 19.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.397 -0.365 . . . . 74.530000000000001 110.749 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.88 135.01 27.92 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.718 -0.219 . . . . 73.310000000000002 111.265 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -56.62 -32.5 90.64 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.685 2.257 . . . . 63.43 113.274 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.73 15.23 61.01 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.256 -0.497 . . . . 64.310000000000002 113.131 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.03 84.2 2.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.164 0.506 . . . . 73.019999999999996 111.607 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.75 81.98 0.44 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.45 0.643 . . . . 71.230000000000004 111.301 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.425 HG21 HG23 ' A' ' 31' ' ' ILE . 5.2 p -137.43 152.07 72.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.98 -0.555 . . . . 51.25 112.246 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.62 ' HB3' HH11 ' A' ' 65' ' ' ARG . 92.8 Cg_endo -81.5 132.4 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.959 2.439 . . . . 62.5 112.717 171.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.11 130.16 55.58 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.813 0.34 . . . . 71.420000000000002 111.14 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.705 ' HD3' HG21 ' A' ' 63' ' ' THR . 1.6 tmm_? -86.28 108.52 18.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.96 0.409 . . . . 74.239999999999995 110.137 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.44 HD12 HG12 ' A' ' 45' ' ' VAL . 40.2 tp -101.77 131.42 48.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.454 0.645 . . . . 54.409999999999997 112.595 -174.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.32 106.21 15.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.277 -0.874 . . . . 73.120000000000005 109.817 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -110.41 -178.71 3.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.168 0.509 . . . . 74.430000000000007 111.927 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 47.7 mt-30 -87.64 -2.96 58.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.075 -0.512 . . . . 74.340000000000003 111.747 177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 157' ' ' PRO . 31.8 pt -104.18 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.839 0.352 . . . . 75.430000000000007 111.175 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -162.43 29.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.425 -0.417 . . . . 38.219999999999999 113.318 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.705 HG21 ' HD3' ' A' ' 56' ' ' ARG . 77.8 m -87.46 118.72 27.11 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.58 -0.365 . . . . 51.310000000000002 111.012 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.45 169.36 17.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.63 0.604 . . . . 74.120000000000005 112.63 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.62 HH11 ' HB3' ' A' ' 54' ' ' PRO . 35.1 ttp85 -118.09 136.42 53.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.704 -0.68 . . . . 74.049999999999997 110.844 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.618 ' SD ' HG23 ' A' ' 152' ' ' ILE . 62.2 mtt -130.39 157.4 42.69 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.768 0.318 . . . . 71.239999999999995 111.545 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -164.5 165.11 21.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.905 0.383 . . . . 64.129999999999995 111.682 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 80' ' ' LEU . 94.4 mt -109.5 117.69 34.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 71.109999999999999 111.588 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 70' ' ' ASN . 35.3 m -128.01 162.99 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 72.310000000000002 111.51 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 69' ' ' VAL . 51.1 m-80 58.41 29.58 18.43 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.463 0.542 . . . . 72.329999999999998 112.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.28 106.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.915 0.388 . . . . 73.109999999999999 110.935 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -138.22 151.25 69.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.183 -0.462 . . . . 75.439999999999998 112.122 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.06 162.3 38.84 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.9 2.4 . . . . 72.329999999999998 113.147 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.56 ' HB2' HG23 ' A' ' 79' ' ' THR . 20.5 t70 -147.16 158.46 43.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.246 -0.433 . . . . 75.209999999999994 111.478 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.58 84.34 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.17 0.433 . . . . 71.120000000000005 112.17 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -88.26 -32.85 18.3 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.707 0.289 . . . . 71.420000000000002 111.269 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -172.43 -96.19 0.1 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.692 -0.766 . . . . 74.040000000000006 113.763 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -150.72 129.35 12.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.562 -0.375 . . . . 75.5 111.498 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.56 HG23 ' HB2' ' A' ' 74' ' ' ASP . 60.3 p -104.36 125.76 50.87 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.187 -0.321 . . . . 71.239999999999995 111.525 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.435 HD12 HD23 ' A' ' 68' ' ' LEU . 3.1 pp -138.61 151.37 47.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.038 0.447 . . . . 75.439999999999998 111.44 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.521 ' HB ' HG22 ' A' ' 69' ' ' VAL . 32.7 m -94.79 110.02 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 71.329999999999998 111.422 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.36 111.58 19.56 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.663 -0.495 . . . . 72.140000000000001 109.663 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HE ' ' HB3' ' A' ' 134' ' ' ASP . 38.0 mtp180 -105.28 126.51 52.18 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.239 0.459 . . . . 75.349999999999994 112.239 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.402 HG12 ' HE3' ' A' ' 66' ' ' MET . 3.2 mp -110.96 141.13 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.824 -0.626 . . . . 75.400000000000006 110.201 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -139.64 148.05 41.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 65.140000000000001 111.055 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.15 124.61 6.5 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.884 -0.674 . . . . 71.120000000000005 113.567 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HG3' HG22 ' A' ' 63' ' ' THR . 19.3 mm-40 -70.76 -3.32 18.19 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.966 0.413 . . . . 64.430000000000007 111.264 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -116.34 161.93 18.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.305 -0.407 . . . . 72.140000000000001 110.826 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -81.6 24.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.723 0.297 . . . . 55.119999999999997 111.741 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.86 146.74 34.42 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.704 0.402 . . . . 62.329999999999998 111.293 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 59.9 Cg_endo -72.64 112.06 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.633 2.222 . . . . 54.409999999999997 112.988 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.46 143.38 98.19 Favored Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 112.529 0.566 . . . . 63.240000000000002 112.529 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.89 -165.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.793 2.329 . . . . 71.420000000000002 112.675 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 138.39 31.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.937 0.399 . . . . 71.219999999999999 111.502 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.86 162.88 38.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.144 0.497 . . . . 74.329999999999998 112.148 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 95.5 p -140.76 151.0 44.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 110.973 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.677 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -153.01 170.64 32.02 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.527 -0.844 . . . . 74.209999999999994 113.839 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -100.93 124.34 46.48 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.744 0.307 . . . . 61.130000000000003 111.388 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.47 130.75 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 75.450000000000003 111.194 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.04 126.36 52.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.977 0.418 . . . . 64.150000000000006 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.407 ' CE1' HD23 ' A' ' 139' ' ' LEU . 10.4 p90 -127.95 121.14 29.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 74.219999999999999 111.193 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.92 -159.29 9.57 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.092 -0.575 . . . . 62.030000000000001 113.085 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HB2' HG13 ' A' ' 114' ' ' ILE . 77.2 mt-30 -119.22 156.53 29.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.007 0.432 . . . . 45.219999999999999 111.896 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.2 mt -112.96 129.39 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.125 -0.489 . . . . 73.239999999999995 110.998 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.505 HE21 HD12 ' A' ' 114' ' ' ILE . 4.1 pt20 -114.14 30.09 7.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.055 0.391 . . . . 74.530000000000001 112.055 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.495 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -151.83 -157.86 8.12 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.652 -0.785 . . . . 73.349999999999994 113.461 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.3 p -105.77 -164.47 1.02 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.529 0.332 . . . . 73.129999999999995 111.613 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.18 -40.57 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.877 0.695 . . . . 72.450000000000003 112.877 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -94.09 -42.7 8.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.311 0.486 . . . . 73.409999999999997 112.311 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.76 99.81 7.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.332 0.587 . . . . 73.409999999999997 111.807 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.89 148.11 26.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.902 -0.59 . . . . 72.340000000000003 111.493 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -113.69 136.9 52.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.907 0.384 . . . . 63.240000000000002 110.912 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.49 103.91 13.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.194 0.521 . . . . 74.439999999999998 111.189 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.505 HD12 HE21 ' A' ' 105' ' ' GLN . 45.2 pt -109.28 155.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 116.447 -0.342 . . . . 50.140000000000001 111.889 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 51.89 39.32 25.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.187 0.517 . . . . 72.230000000000004 111.837 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.32 123.66 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.175 0.512 . . . . 74.200000000000003 111.904 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -112.15 160.31 17.69 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.087 -0.506 . . . . 75.239999999999995 110.442 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.31 145.01 51.19 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.251 0.463 . . . . 64.120000000000005 112.251 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -140.91 166.32 25.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.204 -0.453 . . . . 75.420000000000002 110.959 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -107.64 121.79 45.38 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.814 0.34 . . . . 73.25 111.791 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.551 HG23 HD22 ' A' ' 137' ' ' LEU . 32.2 pt -95.05 107.58 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.203 0.525 . . . . 73.340000000000003 111.369 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.53 101.88 13.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.881 0.372 . . . . 73.420000000000002 111.004 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.11 140.73 21.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.862 0.319 . . . . 54.5 111.862 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.41 168.47 21.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.832 2.355 . . . . 75.510000000000005 113.466 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.29 146.11 31.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.225 0.454 . . . . 65.109999999999999 112.225 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.0 m -93.34 155.81 17.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.138 0.495 . . . . 74.319999999999993 112.02 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.0 t -105.51 -47.45 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.958 -0.565 . . . . 44.409999999999997 111.682 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.35 173.5 6.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.352 0.596 . . . . 72.349999999999994 112.165 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.96 142.34 45.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.741 -0.663 . . . . 74.329999999999998 111.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.87 162.93 90.34 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 123.809 -1.33 . . . . 74.510000000000005 112.931 -1.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 38.6 m -100.59 108.39 20.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.181 0.438 . . . . 74.400000000000006 112.181 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.78 93.09 4.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.579 0.351 . . . . 72.310000000000002 110.209 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.57 111.28 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.354 0.261 . . . . 71.329999999999998 111.341 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.459 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -117.01 143.69 45.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.287 0.565 . . . . 74.340000000000003 112.047 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.7 pt -137.63 136.35 20.11 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.707 -0.679 . . . . 73.340000000000003 111.608 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.97 137.28 19.45 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.694 2.263 . . . . 65.140000000000001 113.382 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.551 HD22 HG23 ' A' ' 121' ' ' ILE . 20.4 mt -120.54 114.83 22.33 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.125 0.417 . . . . 73.319999999999993 112.125 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -91.66 93.73 9.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.963 0.411 . . . . 74.049999999999997 110.245 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.435 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 46.7 mt -74.33 120.89 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 63.109999999999999 110.053 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.2 mtmt -102.33 141.47 35.11 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.396 0.517 . . . . 64.319999999999993 112.396 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.29 10.43 86.01 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.211 -0.519 . . . . 61.43 113.885 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.5 tt -143.63 122.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.346 0.593 . . . . 73.239999999999995 111.847 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -76.77 155.54 33.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.395 -0.366 . . . . 73.340000000000003 111.416 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.4 -40.1 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.117 0.484 . . . . 73.239999999999995 111.407 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.53 -23.39 66.86 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.057 0.456 . . . . 72.510000000000005 111.47 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -89.47 1.13 56.29 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.226 0.454 . . . . 53.119999999999997 112.226 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.3 mt -81.43 125.83 30.91 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.237 0.541 . . . . 74.310000000000002 111.872 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.82 -54.28 0.68 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.652 -0.704 . . . . 70.120000000000005 112.284 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.13 150.02 37.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.752 0.31 . . . . 70.400000000000006 111.332 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.8 102.97 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.519999999999996 110.546 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -91.53 116.31 28.75 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.004 0.372 . . . . 61.200000000000003 112.004 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.618 HG23 ' SD ' ' A' ' 66' ' ' MET . 11.2 mm -100.48 119.63 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 110.045 -0.354 . . . . 73.519999999999996 110.045 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 15.5 p80 -143.78 177.94 8.17 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.729 1.011 . . . . 75.040000000000006 113.729 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 74.64 -74.66 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.771 -1.104 . . . . 71.310000000000002 111.769 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.677 HD13 ' HA3' ' A' ' 97' ' ' GLY . 46.7 mm 39.83 82.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.602 0.715 . . . . 70.099999999999994 112.376 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.421 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.6 pt20 -110.09 150.54 41.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.451 -0.795 . . . . 60.219999999999999 111.557 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.509 ' HG3' HG22 ' A' ' 61' ' ' ILE . 8.4 Cg_exo -71.23 128.19 14.38 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.51 2.14 . . . . 43.240000000000002 112.715 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.65 2.95 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.808 0.813 . . . . 72.530000000000001 111.081 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 59.5 mtt -100.98 152.9 20.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.784 -1.098 . . . . 43.299999999999997 110.189 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -69.58 96.38 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.179 0.514 . . . . 73.329999999999998 111.78 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.576 ' H ' HD21 ' A' ' 161' ' ' LEU . 2.4 pt? -71.07 140.13 50.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 74.040000000000006 111.044 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.11 -175.18 5.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.823 0.344 . . . . 63.350000000000001 111.251 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -127.17 160.42 31.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.127 0.489 . . . . 73.519999999999996 111.827 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -134.21 160.76 36.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 111.426 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -137.02 152.7 50.42 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.904 0.335 . . . . 73.510000000000005 111.904 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -153.95 139.76 18.09 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.126 0.417 . . . . 74.239999999999995 112.126 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -81.77 -55.25 4.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.378 0.608 . . . . 74.319999999999993 109.907 170.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.57 -0.728 . . . . 72.129999999999995 110.95 176.491 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.652 0.263 . . . . 75.349999999999994 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -81.24 129.3 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.009 0.433 . . . . 74.450000000000003 111.701 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -104.5 84.03 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.085 0.469 . . . . 54.049999999999997 110.916 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -91.46 -176.32 4.49 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.146 0.498 . . . . 74.540000000000006 111.94 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -76.21 104.79 6.9 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.031 0.443 . . . . 74.450000000000003 112.124 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -117.58 120.04 36.85 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.232 -0.44 . . . . 64.209999999999994 110.671 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.16 150.53 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.363 0.602 . . . . 75.120000000000005 112.525 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -118.56 -170.65 1.94 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.055 -0.521 . . . . 73.430000000000007 111.161 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.69 159.79 33.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.175 0.512 . . . . 74.200000000000003 111.64 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.5 mmt -95.46 140.9 29.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.993 0.425 . . . . 74.519999999999996 111.509 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -111.43 -174.57 2.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.927 0.394 . . . . 61.0 111.09 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -163.21 154.62 17.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.553 -0.294 . . . . 72.120000000000005 111.194 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 t -83.26 -174.72 5.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.814 0.34 . . . . 64.239999999999995 111.321 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.64 118.93 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 121.201 0.524 . . . . 74.109999999999999 111.424 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -100.94 121.18 41.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.337 -0.392 . . . . 74.400000000000006 111.497 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.0 p -136.42 102.35 4.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.594 0.358 . . . . 70.019999999999996 110.836 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.4 mt -78.59 168.61 19.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.072 0.463 . . . . 71.010000000000005 112.113 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -118.24 168.56 10.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.043 0.449 . . . . 74.540000000000006 111.47 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -123.65 135.15 53.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.205 -0.452 . . . . 61.350000000000001 111.155 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.97 121.73 20.56 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.782 0.325 . . . . 72.109999999999999 110.791 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.09 176.96 8.08 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.521 0.563 . . . . 72.510000000000005 112.521 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.0 p -100.29 -158.0 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.879 -0.6 . . . . 54.340000000000003 111.802 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -73.73 -177.89 2.95 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.641 0.734 . . . . 73.219999999999999 112.817 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.12 144.15 33.32 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.495 -0.775 . . . . 75.420000000000002 111.017 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.487 ' O ' HG21 ' A' ' 29' ' ' VAL . 34.8 m-80 -122.23 160.42 25.26 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.74 -0.209 . . . . 63.399999999999999 110.747 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.441 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 16.1 mm100 -57.72 -44.09 85.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.724 0.297 . . . . 65.430000000000007 111.496 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -58.85 -45.36 90.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.015 0.436 . . . . 73.329999999999998 110.711 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.3 m -59.85 -31.96 70.24 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.082 -0.508 . . . . 72.239999999999995 110.982 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 25' ' ' ASN . 87.8 t -64.54 -50.35 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.709 -0.223 . . . . 74.140000000000001 110.935 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 4.7 mptp? -55.47 -47.24 76.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.017 0.437 . . . . 64.200000000000003 110.854 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.406 HG22 HG21 ' A' ' 53' ' ' THR . 73.7 mt -55.17 -53.64 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.337 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.7 m -56.65 -47.82 78.91 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.258 -0.428 . . . . 73.329999999999998 111.625 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -58.83 -39.92 82.64 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.984 -0.553 . . . . 70.200000000000003 111.363 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.89 -47.66 85.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.722 0.296 . . . . 74.310000000000002 111.181 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -57.87 -41.69 82.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.931 0.396 . . . . 70.409999999999997 111.148 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 3.4 mmp_? -60.57 -54.55 44.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.949 0.404 . . . . 74.329999999999998 111.568 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.88 -36.05 83.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.991 0.424 . . . . 73.239999999999995 111.683 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.45 ' ND2' ' HB1' ' A' ' 55' ' ' ALA . 20.0 t-20 -63.95 -35.18 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.843 0.354 . . . . 73.439999999999998 111.043 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.05 60.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.949 0.404 . . . . 71.230000000000004 111.362 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.626 ' HE3' HG23 ' A' ' 108' ' ' ILE . 62.5 mttm -90.69 -3.9 57.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 73.030000000000001 111.572 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 108.63 4.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.145 0.498 . . . . 64.019999999999996 112.061 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.5 p -91.98 -1.33 57.31 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.162 -0.472 . . . . 73.219999999999999 111.696 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.6 p -153.71 102.9 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.783 0.325 . . . . 75.319999999999993 111.23 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 -145.47 28.0 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.941 -0.647 . . . . 64.340000000000003 112.692 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.491 HG12 HD12 ' A' ' 57' ' ' LEU . 17.9 m -134.29 139.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.336 -0.508 . . . . 75.530000000000001 112.333 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.55 106.91 18.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.924 -0.58 . . . . 72.530000000000001 111.455 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.54 148.78 23.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.989 -0.375 . . . . 63.100000000000001 109.989 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.78 130.79 23.48 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.369 . . . . 73.040000000000006 111.466 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 66.2 Cg_endo -72.2 28.36 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.208 2.605 . . . . 54.439999999999998 113.805 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.35 12.93 2.05 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.493 -0.384 . . . . 70.329999999999998 112.3 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.13 115.72 18.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 73.140000000000001 111.551 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -69.07 8.66 0.52 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.675 0.621 . . . . 72.120000000000005 112.675 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.406 HG21 HG22 ' A' ' 31' ' ' ILE . 1.5 p -90.81 145.25 31.62 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.584 0.587 . . . . 72.140000000000001 112.584 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.483 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 75.1 Cg_endo -81.97 -178.28 4.03 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.168 2.578 . . . . 45.420000000000002 114.029 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.45 ' HB1' ' ND2' ' A' ' 38' ' ' ASN . . . -147.31 145.64 29.42 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.811 -0.631 . . . . 74.150000000000006 111.389 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -80.83 112.25 18.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.415 -0.357 . . . . 71.450000000000003 111.185 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.491 HD12 HG12 ' A' ' 45' ' ' VAL . 56.1 tp -117.95 120.64 38.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.296 0.569 . . . . 73.200000000000003 111.534 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -83.85 115.09 22.09 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.615 . . . . 72.340000000000003 110.701 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -114.08 179.14 4.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.124 0.487 . . . . 64.349999999999994 111.512 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.19 0.12 29.66 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.197 0.443 . . . . 73.530000000000001 112.197 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.463 HD12 ' HB3' ' A' ' 92' ' ' LEU . 37.5 pt -109.61 5.27 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.231 0.539 . . . . 62.240000000000002 110.551 171.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.13 -171.35 13.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.99 -0.55 . . . . 62.219999999999999 112.731 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -77.87 134.33 37.97 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.485 -0.421 . . . . 73.340000000000003 111.257 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.48 152.96 48.76 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.333 0.587 . . . . 65.310000000000002 111.427 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HD2' ' OE1' ' A' ' 85' ' ' GLN . 39.8 ttm180 -109.63 107.1 17.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.957 -0.565 . . . . 74.129999999999995 111.325 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.618 ' SD ' HG22 ' A' ' 152' ' ' ILE . 63.0 mtt -98.96 138.07 36.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.76 0.314 . . . . 63.509999999999998 111.785 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 42.3 t -139.15 161.77 36.59 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.392 -0.367 . . . . 70.0 111.614 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.651 HD22 HD12 ' A' ' 80' ' ' LEU . 89.8 mt -113.79 108.95 17.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.951 0.405 . . . . 75.409999999999997 111.768 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.587 HG22 ' HB ' ' A' ' 81' ' ' THR . 35.6 m -117.25 161.53 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.7 0.286 . . . . 74.510000000000005 111.284 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 65.14 22.76 12.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.488 0.551 . . . . 74.329999999999998 112.488 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.4 mt -61.84 114.78 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 111.948 0.351 . . . . 74.099999999999994 111.948 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -145.09 154.49 54.49 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 112.32 0.489 . . . . 74.340000000000003 112.32 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.68 136.62 33.67 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.503 2.135 . . . . 72.5 112.67 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' HB2' HG21 ' A' ' 79' ' ' THR . 34.7 t70 -107.69 159.06 16.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 111.123 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.93 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.068 0.461 . . . . 53.329999999999998 111.647 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -86.95 -55.06 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.297 0.57 . . . . 73.329999999999998 110.131 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.21 -94.42 0.16 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.116 -0.564 . . . . 54.509999999999998 113.343 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -149.21 136.19 19.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.375 -0.486 . . . . 51.140000000000001 111.702 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 74' ' ' ASP . 32.4 p -116.08 129.97 56.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.288 0.566 . . . . 74.219999999999999 111.939 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.651 HD12 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -142.34 150.75 41.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.006 -0.543 . . . . 72.530000000000001 111.236 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.587 ' HB ' HG22 ' A' ' 69' ' ' VAL . 30.9 m -92.89 112.16 24.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.871 0.367 . . . . 74.129999999999995 111.687 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.3 112.97 22.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.773 -0.454 . . . . 64.510000000000005 109.773 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 66' ' ' MET . 83.6 mtt180 -110.64 133.82 52.98 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.144 0.424 . . . . 73.030000000000001 112.144 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.433 HG13 ' HG2' ' A' ' 66' ' ' MET . 4.0 mp -113.66 109.36 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.072 -0.513 . . . . 75.5 111.175 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.484 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 97.6 mt-30 -93.25 143.61 26.1 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.927 0.394 . . . . 63.009999999999998 111.193 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.13 146.85 23.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.28 -0.486 . . . . 75.310000000000002 114.013 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.8 -46.02 59.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.664 0.386 . . . . 72.140000000000001 111.969 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -102.45 179.9 4.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.307 0.575 . . . . 71.140000000000001 112.222 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.87 10.19 12.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.789 -0.641 . . . . 73.120000000000005 111.223 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.96 145.75 31.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 110.864 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.73 131.54 14.75 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.461 2.107 . . . . 72.299999999999997 112.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.463 ' HB3' HD12 ' A' ' 61' ' ' ILE . 94.3 mt -79.75 147.63 67.26 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.681 0.277 . . . . 71.230000000000004 111.534 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 16.3 Cg_exo -69.83 -178.13 2.22 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.891 2.394 . . . . 72.430000000000007 113.07 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HB3' ' HB1' ' A' ' 125' ' ' ALA . . . -78.14 132.34 37.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.568 -0.287 . . . . 72.109999999999999 111.412 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.56 170.24 16.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 75.239999999999995 112.342 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.3 p -153.65 157.02 38.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.041 -0.527 . . . . 74.5 110.516 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.611 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -161.64 -173.67 30.58 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.717 -0.754 . . . . 75.040000000000006 113.787 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -120.59 142.94 48.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.76 0.315 . . . . 74.209999999999994 110.806 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.0 128.83 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.053 0.454 . . . . 74.040000000000006 112.034 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 11.1 mm-40 -95.82 113.04 24.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.011 -0.54 . . . . 75.239999999999995 110.039 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 44.6 p90 -124.31 127.9 48.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.874 -0.516 . . . . 71.409999999999997 111.965 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.59 -154.26 9.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.075 -0.583 . . . . 70.430000000000007 113.263 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -113.31 152.12 30.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.202 0.525 . . . . 74.219999999999999 111.944 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 111' ' ' PHE . 66.3 mt -108.45 106.82 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.008 -0.542 . . . . 73.329999999999998 111.037 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -92.64 22.53 4.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.039 0.385 . . . . 75.310000000000002 112.039 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -136.66 -165.38 10.49 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.894 -0.67 . . . . 63.210000000000001 113.446 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 11.2 p -87.69 -161.72 0.74 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.703 0.287 . . . . 71.329999999999998 111.035 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.626 HG23 ' HE3' ' A' ' 40' ' ' LYS . 51.4 mm -85.67 -28.64 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.878 0.371 . . . . 64.340000000000003 111.087 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -91.49 -40.84 11.17 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.02 0.378 . . . . 75.430000000000007 112.02 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -127.47 96.89 4.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.444 0.64 . . . . 73.430000000000007 110.881 175.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.636 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.5 p90 -118.93 144.94 46.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.906 -0.588 . . . . 72.510000000000005 111.912 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -115.27 131.44 56.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.923 -0.58 . . . . 61.310000000000002 110.244 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -96.57 113.6 25.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.983 0.421 . . . . 74.340000000000003 111.822 -174.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.9 pt -121.1 164.64 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.406 -0.361 . . . . 64.219999999999999 111.365 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.07 29.06 11.76 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.984 0.421 . . . . 70.120000000000005 111.526 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 4.8 p -94.04 124.64 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.275 0.56 . . . . 75.299999999999997 112.218 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.19 155.7 24.56 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.884 -0.598 . . . . 73.549999999999997 110.758 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -104.78 139.88 38.91 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.154 -0.476 . . . . 62.210000000000001 111.202 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -138.58 146.48 41.87 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.708 0.289 . . . . 52.219999999999999 111.464 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.93 116.71 27.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.032 0.444 . . . . 74.349999999999994 111.825 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 121' ' ' ILE . 23.5 pt -106.7 105.06 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 71.439999999999998 111.15 176.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.98 132.61 51.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.281 -0.418 . . . . 61.539999999999999 111.065 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.521 ' HB3' HG11 ' A' ' 133' ' ' VAL . . . -121.51 145.78 43.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.75 0.31 . . . . 72.310000000000002 111.828 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.6 174.79 12.26 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.655 2.237 . . . . 64.219999999999999 113.001 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 94' ' ' ALA . . . -80.82 135.77 36.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.015 0.436 . . . . 63.32 111.872 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.2 m -70.69 126.35 29.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.332 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.602 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -97.91 -35.78 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.104 0.779 . . . . 63.549999999999997 113.104 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 127' ' ' VAL . 92.5 mt -125.62 120.36 30.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.726 0.298 . . . . 75.319999999999993 110.93 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.95 68.71 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 112.52 0.563 . . . . 63.340000000000003 112.52 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.98 167.52 78.41 Favored 'Cis proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.243 -1.149 . . . . 74.109999999999999 112.93 -1.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 49.2 m -75.62 133.73 40.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 111.773 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.47 31.37 1.9 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.996 -0.547 . . . . 75.049999999999997 111.239 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 123' ' ' ALA . 59.3 t -52.1 115.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.699 0.629 . . . . 71.420000000000002 112.699 -174.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.81 114.57 28.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.197 0.523 . . . . 72.109999999999999 111.733 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.1 pt -122.87 136.68 27.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.973 0.416 . . . . 61.32 112.094 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.14 135.84 14.07 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.744 2.296 . . . . 74.319999999999993 112.942 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.2 113.02 20.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.383 -0.371 . . . . 74.310000000000002 110.495 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -103.04 118.9 37.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.219 0.533 . . . . 71.230000000000004 112.114 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.2 mt -99.93 142.84 30.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.859 0.464 . . . . 74.439999999999998 110.692 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -102.9 144.01 31.75 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.581 0.585 . . . . 74.519999999999996 112.581 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.91 -43.27 1.92 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.971 0.749 . . . . 61.329999999999998 114.971 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.442 HD12 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -88.83 122.91 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.565 0.698 . . . . 74.120000000000005 111.993 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.6 m -82.04 154.97 25.36 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.984 -0.553 . . . . 74.5 111.205 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.557 ' HA ' HD11 ' A' ' 147' ' ' LEU . 9.0 p -57.23 -36.73 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.898 0.38 . . . . 65.099999999999994 111.733 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.6 -27.62 68.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.222 0.534 . . . . 52.009999999999998 111.208 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -94.32 0.14 55.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.243 0.461 . . . . 64.109999999999999 112.243 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.609 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.2 mt -78.73 142.1 37.33 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.101 0.477 . . . . 75.120000000000005 112.211 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.88 -56.61 0.29 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.989 -0.55 . . . . 54.039999999999999 113.129 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.48 ' HB3' HD11 ' A' ' 104' ' ' ILE . 38.7 p90 -139.33 159.3 42.48 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.323 -0.516 . . . . 71.510000000000005 112.103 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 67.4 t -134.19 96.4 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.9 -0.591 . . . . 65.319999999999993 110.415 175.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 20.4 ttm180 -93.39 112.77 24.77 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.123 -0.361 . . . . 72.510000000000005 111.969 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.618 HG22 ' SD ' ' A' ' 66' ' ' MET . 37.0 mm -89.71 138.11 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 122.205 -0.31 . . . . 74.150000000000006 111.296 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -163.58 -177.22 5.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.871 0.323 . . . . 62.229999999999997 111.871 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 65.2 20.64 11.98 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.924 0.712 . . . . 74.0 112.924 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.611 HD12 ' HA3' ' A' ' 97' ' ' GLY . 47.4 mm -69.9 103.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.393 0.616 . . . . 53.130000000000003 111.927 -177.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -136.38 153.95 76.66 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.831 -0.622 . . . . 75.420000000000002 111.149 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.79 153.81 70.16 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.635 2.224 . . . . 74.140000000000001 113.329 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.79 -171.56 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.979 0.418 . . . . 63.200000000000003 111.878 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.498 ' N ' ' SD ' ' A' ' 159' ' ' MET . 3.3 mpp? -73.21 83.15 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.081 0.467 . . . . 73.129999999999995 111.455 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -94.79 129.96 41.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 74.25 110.203 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 161' ' ' LEU . 7.0 mp -75.93 106.9 7.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.941 0.4 . . . . 61.409999999999997 111.931 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.49 -173.43 2.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.402 -0.363 . . . . 54.43 110.807 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -125.31 121.44 34.0 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.033 0.444 . . . . 44.219999999999999 110.941 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -83.64 157.32 22.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.584 0.587 . . . . 74.430000000000007 112.584 -170.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -161.08 140.14 10.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 111.652 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -103.02 161.84 13.43 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.833 0.349 . . . . 75.329999999999998 110.604 171.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -137.62 13.17 2.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.869 0.322 . . . . 74.049999999999997 111.869 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 122.834 0.454 . . . . 73.129999999999995 111.985 -176.338 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.714 0.292 . . . . 71.200000000000003 111.503 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.24 147.41 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.652 0.263 . . . . 74.219999999999999 110.786 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.58 161.15 26.82 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.159 0.504 . . . . 75.439999999999998 112.122 -174.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.91 134.13 35.67 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.076 -0.511 . . . . 70.439999999999998 110.712 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 p -96.68 97.95 9.77 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.356 0.598 . . . . 74.299999999999997 111.56 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.57 104.74 17.19 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.209 -0.451 . . . . 72.099999999999994 111.103 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.16 176.24 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.384 0.611 . . . . 44.420000000000002 112.57 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -119.02 149.88 40.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.902 -0.59 . . . . 73.310000000000002 110.936 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -142.12 134.39 27.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.808 0.337 . . . . 71.209999999999994 111.682 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 62.1 mtt -110.42 -172.85 2.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.817 0.341 . . . . 65.200000000000003 111.299 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -99.5 167.61 10.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.22 0.533 . . . . 72.540000000000006 111.967 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -139.15 157.62 45.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.224 -0.444 . . . . 72.420000000000002 111.229 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.8 p -130.87 140.95 50.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.796 0.331 . . . . 63.420000000000002 111.376 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.77 139.81 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 54.240000000000002 111.327 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -132.41 141.56 48.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.324 -0.398 . . . . 65.329999999999998 110.903 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -97.35 101.34 12.86 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 75.530000000000001 111.192 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.62 111.09 22.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.925 0.393 . . . . 71.409999999999997 111.042 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.74 113.72 8.1 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.332 0.587 . . . . 72.420000000000002 111.304 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -140.94 171.92 13.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.753 -0.658 . . . . 51.25 111.308 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.08 142.14 39.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.102 0.477 . . . . 74.209999999999994 110.992 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.2 ttp -125.21 155.65 39.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 72.409999999999997 110.464 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -58.89 140.23 55.6 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.252 -0.277 . . . . 73.129999999999995 110.252 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -53.68 111.48 0.74 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.28 0.562 . . . . 72.099999999999994 111.725 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -60.22 146.16 44.64 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.408 -0.814 . . . . 75.439999999999998 112.163 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' O ' HG21 ' A' ' 29' ' ' VAL . 36.4 m-80 -47.17 125.02 7.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.192 -0.458 . . . . 73.200000000000003 111.338 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -53.89 -33.63 57.07 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.049 0.452 . . . . 74.319999999999993 111.137 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.62 -53.11 62.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.953 -0.567 . . . . 73.430000000000007 111.005 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -64.68 -29.94 70.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.266 -0.424 . . . . 73.120000000000005 111.331 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 25' ' ' ASN . 99.0 t -64.05 -46.73 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.533 -0.303 . . . . 62.149999999999999 110.619 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -63.02 -38.81 92.69 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.408 -0.36 . . . . 73.439999999999998 111.504 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.19 -48.94 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.329 0.585 . . . . 73.400000000000006 110.742 173.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.3 m -62.79 -39.47 94.34 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.932 -0.577 . . . . 74.150000000000006 110.991 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.47 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 62.8 tt0 -63.29 -45.08 93.05 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.139 -0.482 . . . . 73.040000000000006 110.919 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.3 tt0 -58.63 -50.84 72.35 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.849 0.315 . . . . 72.430000000000007 111.849 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -58.8 -43.51 90.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.86 0.362 . . . . 70.010000000000005 111.798 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -68.87 -43.49 75.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.623 0.249 . . . . 70.109999999999999 111.571 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 33' ' ' GLN . 56.3 mt -65.84 -32.84 74.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.984 0.421 . . . . 72.319999999999993 110.657 175.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.406 ' ND2' HG13 ' A' ' 45' ' ' VAL . 3.3 t-20 -61.65 -30.64 70.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.148 -0.478 . . . . 73.409999999999997 110.556 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.29 -36.25 61.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.226 -0.443 . . . . 75.239999999999995 111.756 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.88 -32.81 63.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.337 0.495 . . . . 54.399999999999999 112.337 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -55.5 105.68 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.888 0.699 . . . . 73.5 112.888 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -79.6 -22.72 43.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.176 -0.466 . . . . 63.119999999999997 111.18 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.519 ' HB3' HH21 ' A' ' 151' ' ' ARG . 30.5 t -124.98 99.15 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 73.340000000000003 111.13 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 79.59 -143.38 25.68 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.973 -0.558 . . . . 75.439999999999998 113.916 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 28.3 m -140.52 144.96 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.993 0.425 . . . . 75.299999999999997 111.873 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 73.5 m-85 -89.89 99.1 12.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.529 -0.305 . . . . 72.0 111.172 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.4 110.08 20.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.885 0.374 . . . . 70.200000000000003 110.628 173.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.01 115.79 63.83 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 122.278 -0.264 . . . . 75.510000000000005 110.965 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 30.5 Cg_endo -64.24 -7.1 12.95 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.523 2.149 . . . . 72.340000000000003 113.281 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 -2.31 55.72 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.455 -0.403 . . . . 65.340000000000003 112.666 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.72 115.72 30.72 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.683 -0.304 . . . . 72.140000000000001 111.09 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -79.21 61.54 3.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.316 0.579 . . . . 64.400000000000006 110.659 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -155.45 151.56 22.72 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 115.798 -0.637 . . . . 73.200000000000003 111.662 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 63.6 Cg_endo -85.85 -178.61 2.98 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.128 2.552 . . . . 72.019999999999996 113.858 178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.05 138.98 18.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.873 -0.603 . . . . 63.140000000000001 110.959 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -89.14 131.74 35.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.242 0.544 . . . . 75.239999999999995 112.459 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.7 135.81 40.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.779 -0.646 . . . . 74.430000000000007 110.738 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 49.0 tt0 -93.18 128.55 39.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.947 -0.471 . . . . 63.329999999999998 111.262 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.8 p -97.13 179.81 4.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.356 -0.384 . . . . 64.109999999999999 110.58 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.644 HE21 ' HB3' ' A' ' 156' ' ' GLN . 38.2 mt-30 -83.24 -1.79 53.98 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.144 -0.348 . . . . 62.329999999999998 111.778 178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.462 HG22 ' HD3' ' A' ' 157' ' ' PRO . 38.1 pt -103.94 -32.44 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.713 0.292 . . . . 74.239999999999995 110.979 171.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.23 172.9 39.17 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.52 -0.371 . . . . 51.43 112.946 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 95.6 m -78.6 138.26 38.26 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.318 -0.519 . . . . 74.450000000000003 111.402 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.91 171.73 13.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.187 0.518 . . . . 63.009999999999998 111.775 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.91 120.73 25.34 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.296 -0.411 . . . . 74.450000000000003 110.919 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.524 ' SD ' HG23 ' A' ' 152' ' ' ILE . 62.3 mtt -105.42 152.36 23.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.967 0.413 . . . . 37.960000000000001 112.094 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 84.5 p -149.29 143.29 25.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.364 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.452 HD21 HD23 ' A' ' 82' ' ' LEU . 91.6 mt -96.78 100.45 11.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.934 0.397 . . . . 71.299999999999997 111.285 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.405 HG23 HD21 ' A' ' 70' ' ' ASN . 27.5 m -120.41 152.75 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.667 0.27 . . . . 74.040000000000006 111.013 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 19.2 m-80 57.13 76.47 0.31 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.0 0.429 . . . . 74.209999999999994 111.166 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mt -109.36 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.513 -0.312 . . . . 72.209999999999994 111.402 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 p -129.89 152.54 80.08 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 73.109999999999999 111.714 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 165.57 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.833 2.355 . . . . 72.409999999999997 113.804 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.619 ' HB2' HG21 ' A' ' 79' ' ' THR . 33.3 t70 -139.66 170.35 16.05 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.862 -0.608 . . . . 73.230000000000004 110.673 -178.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.84 -44.63 91.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.883 0.327 . . . . 64.430000000000007 111.883 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -91.03 -31.92 16.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.183 0.438 . . . . 74.329999999999998 112.183 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.51 0.15 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.586 -0.816 . . . . 64.239999999999995 113.901 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -144.9 135.82 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.061 0.457 . . . . 75.239999999999995 111.903 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.619 HG21 ' HB2' ' A' ' 74' ' ' ASP . 46.3 p -110.24 132.88 53.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.344 -0.389 . . . . 75.439999999999998 111.167 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 2.8 pp -142.41 160.06 41.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.003 0.43 . . . . 73.200000000000003 112.052 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 m -97.96 113.44 25.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 65.120000000000005 111.469 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.452 HD23 HD21 ' A' ' 68' ' ' LEU . 3.0 tm? -92.78 109.53 20.96 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.137 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 90.2 mtt180 -99.04 121.85 41.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.461 0.541 . . . . 74.239999999999995 112.461 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 84' ' ' ILE . 3.6 mp -104.97 117.4 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.709 -0.678 . . . . 74.239999999999995 111.387 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -112.04 117.51 32.87 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.693 0.282 . . . . 74.150000000000006 110.415 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.14 142.64 29.71 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.254 -0.498 . . . . 54.310000000000002 113.707 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.91 -44.63 84.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.289 0.566 . . . . 74.340000000000003 109.909 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -67.88 124.26 22.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.892 -0.595 . . . . 41.450000000000003 110.858 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 21.5 m-80 -68.89 -15.8 63.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.4 . . . . 72.299999999999997 111.475 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.18 154.55 63.55 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 111.872 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD3' ' HB1' ' A' ' 129' ' ' ALA . 41.3 Cg_endo -65.4 130.85 26.32 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.022 2.481 . . . . 74.340000000000003 114.233 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.4 mt -103.43 151.61 38.66 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.046 -0.525 . . . . 73.540000000000006 111.357 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 174.93 11.94 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.514 2.143 . . . . 74.230000000000004 113.226 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.57 134.34 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.069 0.461 . . . . 37.960000000000001 112.029 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -132.32 155.48 48.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.409 0.623 . . . . 70.5 111.993 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -147.15 170.64 16.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.81 -0.632 . . . . 75.439999999999998 110.603 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.501 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -176.91 -175.17 44.0 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.252 -0.975 . . . . 44.539999999999999 113.69 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.9 m -103.05 139.09 39.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.956 0.408 . . . . 61.200000000000003 111.087 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.58 129.8 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.215 0.531 . . . . 75.25 111.787 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.2 mm-40 -90.87 139.43 30.75 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.882 -0.599 . . . . 74.030000000000001 109.692 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.467 ' CG ' HD23 ' A' ' 139' ' ' LEU . 28.5 p90 -146.04 122.96 11.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 71.25 111.695 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.79 -146.9 5.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.574 -0.739 . . . . 52.200000000000003 112.894 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.577 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 89.8 mt-30 -123.74 151.01 43.69 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.134 0.492 . . . . 74.239999999999995 111.981 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.2 133.69 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.106 -0.497 . . . . 75.409999999999997 111.252 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 4.0 pt20 -121.7 98.87 6.16 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.525 0.679 . . . . 75.209999999999994 110.982 171.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 151.21 -162.82 29.63 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.123 -0.56 . . . . 43.229999999999997 113.675 176.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.6 p -108.0 -169.86 1.59 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.068 0.547 . . . . 74.420000000000002 111.657 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.67 -47.04 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.1 0.476 . . . . 75.040000000000006 111.518 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -71.46 -48.07 51.63 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.195 0.443 . . . . 60.219999999999999 112.195 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.53 110.9 12.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.567 0.699 . . . . 72.049999999999997 112.627 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -140.48 154.5 46.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.735 -0.666 . . . . 73.230000000000004 111.157 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -122.86 134.37 54.39 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.135 0.493 . . . . 74.329999999999998 111.806 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -87.43 104.78 16.77 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.839 -0.619 . . . . 72.439999999999998 111.095 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.0 pt -113.93 162.67 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.18 0.192 . . . . 71.140000000000001 111.205 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 54.01 30.27 11.53 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.905 0.383 . . . . 62.549999999999997 111.973 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.84 124.34 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.313 0.578 . . . . 71.530000000000001 112.308 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -113.55 163.12 15.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.105 -0.498 . . . . 64.030000000000001 110.728 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -111.72 140.11 46.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 64.420000000000002 111.601 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -140.33 160.3 40.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.888 0.375 . . . . 61.240000000000002 111.272 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.83 136.75 41.14 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.026 -0.421 . . . . 75.409999999999997 111.712 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.27 141.05 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.578 -0.283 . . . . 74.099999999999994 110.886 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.28 115.94 17.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.806 0.336 . . . . 62.539999999999999 111.163 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.49 137.2 20.63 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.019 0.377 . . . . 64.200000000000003 112.019 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.85 165.24 31.75 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.585 2.19 . . . . 51.119999999999997 113.255 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.82 24.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.843 0.683 . . . . 72.219999999999999 112.843 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 m -93.61 112.04 23.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.086 -0.507 . . . . 72.019999999999996 110.53 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.33 -48.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.072 0.463 . . . . 73.200000000000003 111.23 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.01 151.52 25.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 73.129999999999995 110.852 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 91' ' ' PRO . . . -77.31 149.35 78.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.391 -0.368 . . . . 61.420000000000002 111.565 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.27 179.33 25.87 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.956 -1.268 . . . . 73.439999999999998 113.158 -0.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.2 m -87.59 86.75 7.24 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.465 -0.334 . . . . 74.349999999999994 111.655 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 22.2 p-10 -130.54 114.78 15.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.708 0.766 . . . . 73.540000000000006 111.567 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 134' ' ' ASP . 21.9 t -126.44 162.62 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.88 -0.6 . . . . 73.510000000000005 110.458 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 2.8 p-10 -142.53 137.24 30.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.03 0.443 . . . . 72.540000000000006 111.101 172.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.4 pt -131.06 131.98 23.53 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 120.801 0.334 . . . . 73.019999999999996 111.722 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.64 110.28 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.129 1.886 . . . . 73.420000000000002 112.56 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -92.57 127.47 38.07 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.47 -0.786 . . . . 75.420000000000002 110.387 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -103.72 101.11 10.94 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.983 0.42 . . . . 75.109999999999999 111.546 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.467 HD23 ' CG ' ' A' ' 101' ' ' TYR . 68.1 mt -85.97 128.1 34.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.085 -0.339 . . . . 72.549999999999997 110.085 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -119.22 141.22 49.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.104 0.478 . . . . 74.400000000000006 112.059 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.16 19.31 50.89 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.183 -0.462 . . . . 72.430000000000007 113.394 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.581 HD13 HD23 ' A' ' 147' ' ' LEU . 21.2 tt -155.71 134.07 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.08 0.467 . . . . 75.209999999999994 112.06 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m -78.75 154.18 30.2 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.296 -0.411 . . . . 73.310000000000002 111.93 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.41 -46.07 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.574 0.583 . . . . 64.219999999999999 112.574 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.57 -17.28 60.1 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.198 0.523 . . . . 75.120000000000005 110.927 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.456 ' HB3' HE21 ' A' ' 103' ' ' GLN . 87.3 mm-40 -93.31 7.37 44.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.368 -0.378 . . . . 61.43 111.642 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.581 HD23 HD13 ' A' ' 142' ' ' ILE . 29.6 mt -75.95 111.53 11.42 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.207 0.527 . . . . 73.430000000000007 111.357 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -86.45 -47.74 4.78 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.225 -0.512 . . . . 71.439999999999998 112.946 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.95 151.43 25.42 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.131 0.491 . . . . 72.209999999999994 112.223 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.35 97.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.808 -0.633 . . . . 54.329999999999998 109.738 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.792 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 ttt180 -94.87 99.41 11.46 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.309 0.485 . . . . 70.109999999999999 112.309 -172.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.543 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 11.9 mm -79.78 139.97 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 64.439999999999998 111.014 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -162.17 166.58 25.41 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.824 0.676 . . . . 73.530000000000001 112.824 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.84 37.11 15.65 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.962 0.727 . . . . 73.549999999999997 112.962 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.501 HD12 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -73.11 113.5 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.405 0.621 . . . . 74.340000000000003 111.283 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.644 ' HB3' HE21 ' A' ' 60' ' ' GLN . 10.6 pt20 -138.69 164.0 42.82 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.506 -0.77 . . . . 73.540000000000006 111.172 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.462 ' HD3' HG22 ' A' ' 61' ' ' ILE . 29.8 Cg_endo -63.03 146.18 94.54 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.01 1.807 . . . . 73.25 112.652 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.13 19.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 112.494 0.553 . . . . 55.119999999999997 112.494 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 21.6 ptp -145.97 -167.8 2.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.257 0.551 . . . . 75.310000000000002 112.287 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.57 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 10.6 pt20 -71.1 -169.97 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.532 -0.758 . . . . 74.120000000000005 111.731 174.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.57 ' HG ' ' HG3' ' A' ' 160' ' ' GLN . 81.0 mt 63.14 28.82 16.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 112.122 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.35 147.37 53.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.089 0.471 . . . . 65.540000000000006 111.62 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -161.63 114.03 1.81 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.992 -0.549 . . . . 65.439999999999998 110.711 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -72.88 148.35 44.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.99 -0.55 . . . . 75.420000000000002 112.051 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -90.05 -79.51 0.34 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.436 0.532 . . . . 64.209999999999994 112.436 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -128.68 -171.98 2.6 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.467 0.543 . . . . 71.209999999999994 112.467 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 71.0 70.84 0.18 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.36 0.664 . . . . 75.349999999999994 109.834 -169.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 . . . . . 0 C--O 1.255 1.371 0 CA-C-N 115.795 -0.639 . . . . 70.239999999999995 111.605 -178.618 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 tpp . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.973 0.416 . . . . 73.450000000000003 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 125.65 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.029 0.443 . . . . 72.209999999999994 110.896 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.63 137.58 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.075 0.464 . . . . 61.140000000000001 111.567 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.32 176.14 9.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.136 -0.484 . . . . 64.319999999999993 111.207 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 t -171.33 120.92 0.51 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.923 0.392 . . . . 71.25 111.953 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -127.68 -176.21 3.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.123 0.487 . . . . 72.219999999999999 111.63 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.52 166.49 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.351 0.596 . . . . 65.239999999999995 112.408 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -107.47 121.97 45.68 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 74.109999999999999 110.517 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -82.25 165.1 20.71 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.734 0.642 . . . . 64.25 112.734 -174.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.29 -178.83 4.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.852 -0.613 . . . . 64.519999999999996 111.303 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -140.17 153.83 46.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.39 0.515 . . . . 61.240000000000002 112.39 -176.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -125.53 143.51 50.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.121 -0.491 . . . . 75.400000000000006 110.55 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -72.0 -176.18 1.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.156 0.503 . . . . 60.130000000000003 112.202 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.2 p -118.13 146.13 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.977 0.418 . . . . 61.299999999999997 111.658 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -84.86 127.47 34.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.902 0.382 . . . . 72.230000000000004 111.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -95.64 118.32 32.11 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.537 -0.302 . . . . 73.439999999999998 111.773 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.87 153.09 43.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.864 0.364 . . . . 71.219999999999999 111.393 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.45 118.85 25.23 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.263 0.554 . . . . 72.510000000000005 112.447 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -110.04 168.67 9.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.037 -0.529 . . . . 73.040000000000006 111.082 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -53.42 107.2 0.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.2 0.524 . . . . 74.150000000000006 111.965 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.5 ptp -79.9 169.71 17.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.309 0.576 . . . . 64.349999999999994 112.265 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -95.91 -162.37 0.95 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.92 -0.582 . . . . 71.25 111.765 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -70.01 -164.98 0.08 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.244 0.545 . . . . 74.299999999999997 112.328 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 tp -58.43 137.53 57.24 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.209 -0.451 . . . . 72.540000000000006 111.431 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.449 ' O ' HG21 ' A' ' 29' ' ' VAL . 41.2 m-80 -111.67 154.9 24.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.612 -0.267 . . . . 73.150000000000006 111.122 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -54.01 -38.61 65.29 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.327 0.491 . . . . 54.140000000000001 112.327 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.54 -52.8 60.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.16 0.505 . . . . 65.010000000000005 110.93 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.514 ' HA ' HD13 ' A' ' 31' ' ' ILE . 25.2 m -69.05 -28.69 66.77 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 72.329999999999998 111.548 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 25' ' ' ASN . 97.7 t -61.21 -44.32 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.061 0.457 . . . . 71.140000000000001 110.674 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.574 ' HE3' HD23 ' A' ' 48' ' ' LEU . 48.1 tptt -63.4 -41.72 98.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.391 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 28' ' ' THR . 87.3 mt -56.55 -49.0 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.028 -0.533 . . . . 73.420000000000002 110.869 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 60.7 m -58.71 -42.53 88.88 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.057 -0.52 . . . . 53.229999999999997 110.944 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.737 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -57.28 -46.22 83.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.886 0.374 . . . . 64.109999999999999 110.913 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.6 tt0 -58.47 -50.02 75.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.26 0.552 . . . . 74.239999999999995 111.379 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.57 -27.33 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.852 -0.613 . . . . 73.25 112.037 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 32' ' ' THR . 99.2 mtt180 -74.31 -41.29 61.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.03 -0.419 . . . . 73.239999999999995 111.146 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 48' ' ' LEU . 85.3 mt -65.57 -35.36 80.6 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.404 0.621 . . . . 70.319999999999993 110.469 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.508 ' ND2' HG13 ' A' ' 45' ' ' VAL . 26.2 t-20 -59.3 -37.35 77.51 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.604 -0.725 . . . . 74.129999999999995 110.809 172.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.2 96.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.933 0.396 . . . . 65.420000000000002 111.84 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -72.32 -22.18 61.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.14 0.422 . . . . 53.219999999999999 112.14 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -92.94 139.09 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.99 0.424 . . . . 73.299999999999997 111.626 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.8 m -75.02 -83.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.669 0.618 . . . . 43.420000000000002 112.669 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.0 m -97.54 -36.18 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.113 0.412 . . . . 64.439999999999998 112.113 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.0 177.49 53.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.113 -0.565 . . . . 70.450000000000003 112.802 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG13 ' ND2' ' A' ' 38' ' ' ASN . 27.6 m -135.83 152.19 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.535 0.683 . . . . 65.120000000000005 112.692 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.3 m-85 -98.42 102.53 14.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.667 -0.697 . . . . 74.409999999999997 110.255 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.2 mt -86.41 113.48 22.4 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.116 0.484 . . . . 74.239999999999995 111.115 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 8.8 mp -89.46 114.85 62.04 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.222 -0.444 . . . . 74.230000000000004 111.145 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.637 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 36.9 Cg_endo -64.48 11.47 0.11 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.224 2.616 . . . . 73.340000000000003 114.378 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.84 -10.58 26.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.205 -0.522 . . . . 62.450000000000003 112.683 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.66 127.74 53.93 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 70.019999999999996 111.546 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -79.23 17.46 0.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.813 0.34 . . . . 73.420000000000002 111.763 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -99.95 147.06 32.94 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 112.988 0.736 . . . . 73.109999999999999 112.988 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 66.8 Cg_endo -85.66 165.0 10.59 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.143 2.562 . . . . 74.230000000000004 113.25 174.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.6 133.94 29.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.487 -0.324 . . . . 37.549999999999997 110.984 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -97.02 122.82 40.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.381 . . . . 72.420000000000002 111.057 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.43 ' HB3' HG12 ' A' ' 45' ' ' VAL . 3.4 pp -120.69 159.57 25.09 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.932 0.396 . . . . 61.200000000000003 111.047 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.88 106.54 18.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.047 0.451 . . . . 60.109999999999999 110.823 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.1 p -99.69 178.47 4.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.094 -0.503 . . . . 72.010000000000005 111.046 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.587 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 50.2 mt-30 -76.89 0.58 20.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.373 -0.376 . . . . 73.0 111.94 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.02 -13.91 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.926 0.393 . . . . 73.409999999999997 111.16 171.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.75 -158.89 23.49 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.473 -0.394 . . . . 72.510000000000005 113.005 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 p -76.09 129.65 37.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.372 -0.487 . . . . 71.540000000000006 112.177 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 155' ' ' ILE . 3.1 pp -140.77 138.5 34.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.586 0.708 . . . . 74.420000000000002 110.889 170.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HB3' ' HB3' ' A' ' 85' ' ' GLN . 1.6 ttp180 -98.87 115.33 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.192 -0.913 . . . . 75.400000000000006 110.951 -175.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.612 ' SD ' HG22 ' A' ' 152' ' ' ILE . 58.6 mtt -110.17 154.54 23.2 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.928 0.394 . . . . 72.329999999999998 111.608 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 28.1 t -159.58 155.84 26.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.415 -0.357 . . . . 75.230000000000004 111.096 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.57 HD21 HD11 ' A' ' 80' ' ' LEU . 89.0 mt -107.35 105.8 15.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.883 0.373 . . . . 74.230000000000004 111.387 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' A' ' 81' ' ' THR . 31.8 m -115.97 162.76 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.573 -0.285 . . . . 62.219999999999999 111.312 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 60.62 34.14 20.22 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.121 0.486 . . . . 72.040000000000006 111.911 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.84 108.29 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.099 0.476 . . . . 71.540000000000006 111.855 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.47 150.62 74.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.129 0.418 . . . . 75.319999999999993 112.129 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.36 146.83 81.8 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.86 2.373 . . . . 64.129999999999995 113.231 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.621 ' HB2' HG21 ' A' ' 79' ' ' THR . 25.5 t70 -115.38 170.47 8.38 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 110.92 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.86 40.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.858 0.361 . . . . 37.549999999999997 111.478 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.66 -45.92 11.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.884 0.373 . . . . 64.120000000000005 111.488 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.01 -111.34 0.93 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.029 -0.605 . . . . 51.43 113.586 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -145.7 136.62 24.55 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.476 -0.426 . . . . 73.540000000000006 111.788 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.621 HG21 ' HB2' ' A' ' 74' ' ' ASP . 54.0 p -107.98 124.48 50.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.701 0.286 . . . . 62.399999999999999 111.581 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.57 HD11 HD21 ' A' ' 68' ' ' LEU . 3.2 pp -133.66 167.84 19.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.722 0.296 . . . . 75.409999999999997 111.298 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.504 ' HB ' HG22 ' A' ' 69' ' ' VAL . 26.4 m -113.14 116.63 30.14 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 111.729 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.431 HD12 ' SD ' ' A' ' 66' ' ' MET . 3.1 tm? -93.61 110.51 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.236 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -100.12 115.63 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.337 0.495 . . . . 72.299999999999997 112.337 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 84' ' ' ILE . 3.3 mp -95.38 147.45 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.853 0.461 . . . . 71.239999999999995 111.384 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 65' ' ' ARG . 64.9 tt0 -146.02 106.61 4.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.482 0.313 . . . . 72.230000000000004 110.335 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.34 27.54 0.84 Allowed Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.257 0.863 . . . . 53.200000000000003 115.257 -171.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 59.98 -68.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 74.150000000000006 112.097 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 m -61.87 144.66 54.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.757 0.423 . . . . 75.430000000000007 111.83 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 43.6 m-80 -74.36 -26.57 60.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.613 -0.267 . . . . 73.319999999999993 111.654 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.96 131.62 79.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 112.162 0.43 . . . . 73.310000000000002 112.162 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 26.1 Cg_endo -60.8 115.77 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.009 2.473 . . . . 74.200000000000003 113.308 -176.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.64 151.98 42.92 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.285 -0.416 . . . . 75.430000000000007 111.537 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.66 176.38 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.998 . . . . 74.230000000000004 112.536 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 158' ' ' VAL . . . -68.15 163.25 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.698 0.285 . . . . 61.340000000000003 111.382 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -158.33 148.73 20.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.555 0.693 . . . . 72.400000000000006 112.282 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.3 p -127.51 168.64 14.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.417 -0.811 . . . . 74.329999999999998 110.726 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.67 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -173.04 167.6 40.44 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.214 -0.994 . . . . 72.109999999999999 114.183 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -99.26 116.88 32.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.478 0.311 . . . . 74.010000000000005 111.05 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 119' ' ' GLN . 34.0 m -109.79 113.08 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.436 0.636 . . . . 73.239999999999995 111.364 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.2 mt-10 -97.03 110.82 23.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.94 0.4 . . . . 75.219999999999999 111.353 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -106.74 138.45 42.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.443 -0.344 . . . . 74.319999999999993 111.134 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.15 -164.59 27.11 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.839 -0.696 . . . . 73.219999999999999 113.514 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.583 ' HB2' HG13 ' A' ' 114' ' ' ILE . 52.7 mt-30 -105.79 157.42 17.47 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.909 0.385 . . . . 73.319999999999993 110.9 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.72 142.68 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.714 0.293 . . . . 45.409999999999997 111.233 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 4.1 pt20 -138.9 103.1 4.72 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.362 0.601 . . . . 73.340000000000003 110.577 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.43 -162.79 31.27 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.197 -0.525 . . . . 72.0 113.51 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.8 p -105.82 -178.37 3.63 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.871 0.367 . . . . 63.130000000000003 111.213 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.737 HD11 ' HG3' ' A' ' 33' ' ' GLN . 30.2 mm -62.72 -27.78 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.174 0.511 . . . . 55.43 111.013 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -81.72 -55.95 4.31 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.991 -0.55 . . . . 73.030000000000001 110.895 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -117.8 84.39 2.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.389 0.614 . . . . 74.140000000000001 112.003 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 107' ' ' THR . 31.0 p90 -107.86 123.74 49.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.079 -0.51 . . . . 72.340000000000003 110.697 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -94.58 117.8 30.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.982 0.42 . . . . 74.310000000000002 111.525 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.67 101.87 5.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.008 -0.542 . . . . 75.420000000000002 110.386 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.583 HG13 ' HB2' ' A' ' 103' ' ' GLN . 36.2 pt -112.61 150.91 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.732 0.301 . . . . 64.519999999999996 111.807 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 54.38 34.49 20.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.958 0.409 . . . . 63.109999999999999 112.069 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.4 130.13 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.23 0.538 . . . . 74.5 112.13 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.55 156.8 48.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.791 -0.64 . . . . 52.200000000000003 110.269 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 8.9 p30 -103.3 153.63 20.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.46 0.911 . . . . 73.530000000000001 113.46 -171.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.405 ' O ' HG21 ' A' ' 99' ' ' VAL . 8.4 tt0 -133.05 150.59 52.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.296 -0.865 . . . . 71.109999999999999 109.921 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -94.84 123.13 38.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.018 0.437 . . . . 72.319999999999993 111.954 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.689 HG23 HD21 ' A' ' 137' ' ' LEU . 41.6 pt -100.53 138.9 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 70.540000000000006 111.409 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.92 105.23 6.64 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.419 -0.355 . . . . 75.040000000000006 111.103 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.27 139.48 22.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.61 -0.268 . . . . 62.039999999999999 111.461 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.44 ' HD2' HG11 ' A' ' 133' ' ' VAL . 38.3 Cg_exo -61.17 158.7 33.61 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.008 2.472 . . . . 64.409999999999997 113.85 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.83 130.73 41.79 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.987 -0.551 . . . . 62.109999999999999 111.703 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.1 m -91.95 101.12 13.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.87 0.366 . . . . 70.430000000000007 110.993 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 p -89.0 -21.28 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.188 0.518 . . . . 72.310000000000002 110.925 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.7 mt -101.6 165.36 11.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.181 0.515 . . . . 74.25 111.649 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -114.65 147.41 38.08 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 62.350000000000001 111.105 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 84.3 Cg_endo -83.48 169.94 54.96 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.837 -1.318 . . . . 64.329999999999998 113.529 -1.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 m -83.56 83.07 8.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.478 0.547 . . . . 71.420000000000002 112.478 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.422 ' OD1' ' HG2' ' A' ' 130' ' ' PRO . 4.6 p-10 -136.57 118.23 14.97 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.482 0.658 . . . . 72.349999999999994 111.244 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.44 HG11 ' HD2' ' A' ' 124' ' ' PRO . 46.5 t -122.23 150.74 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.0 -0.546 . . . . 74.219999999999999 111.385 -173.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -124.4 110.2 14.26 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.359 0.6 . . . . 74.439999999999998 111.557 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.0 pt -112.62 136.35 21.54 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 112.23 0.456 . . . . 73.040000000000006 112.23 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.85 146.34 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.836 2.358 . . . . 60.43 113.416 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.689 HD21 HG23 ' A' ' 121' ' ' ILE . 63.0 mt -132.14 117.17 17.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.191 -0.459 . . . . 72.5 112.101 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -96.37 94.43 7.43 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.189 0.519 . . . . 74.319999999999993 110.206 171.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.7 110.05 10.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.346 0.593 . . . . 75.510000000000005 110.207 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.688 ' HB2' ' HZ3' ' A' ' 140' ' ' LYS . 10.5 mtmp? -83.94 150.4 25.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.612 -0.722 . . . . 70.239999999999995 112.39 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.61 13.81 74.77 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.722 0.649 . . . . 44.119999999999997 114.722 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 147' ' ' LEU . 19.7 tt -144.5 128.43 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.03 0.915 . . . . 72.439999999999998 112.4 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.6 m -84.17 146.24 27.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.165 -0.47 . . . . 62.130000000000003 111.302 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' A' ' 147' ' ' LEU . 8.0 p -56.88 -34.77 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.524 0.564 . . . . 74.540000000000006 112.524 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.58 -32.95 70.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.161 0.505 . . . . 72.340000000000003 111.082 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.454 ' HB3' HE21 ' A' ' 103' ' ' GLN . 32.0 mm-40 -97.38 5.08 50.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.317 0.488 . . . . 73.430000000000007 112.317 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.637 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 17.1 mt -69.99 96.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.266 0.555 . . . . 72.230000000000004 111.156 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.32 -41.22 11.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.863 -0.608 . . . . 73.409999999999997 113.193 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.89 157.02 23.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.186 0.517 . . . . 71.430000000000007 111.998 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.21 101.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.773 -0.649 . . . . 74.030000000000001 109.82 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 51.5 ttt180 -83.97 105.04 14.54 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.151 -0.477 . . . . 74.430000000000007 111.928 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.612 HG22 ' SD ' ' A' ' 66' ' ' MET . 21.8 mm -90.72 121.4 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 116.535 -0.302 . . . . 72.129999999999995 111.639 -177.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -159.24 178.24 10.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.322 0.49 . . . . 74.430000000000007 112.322 176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.77 18.54 11.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.883 0.697 . . . . 70.430000000000007 112.883 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.67 HD13 ' HA3' ' A' ' 97' ' ' GLY . 36.2 mm -63.19 113.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.021 0.439 . . . . 72.530000000000001 111.317 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.587 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 8.9 pt20 -136.2 153.83 76.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.007 0.523 . . . . 75.150000000000006 111.831 -173.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.87 135.05 22.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.605 2.203 . . . . 73.439999999999998 113.754 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 6.0 p -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.119 0.485 . . . . 75.239999999999995 110.942 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptp -152.54 -165.8 2.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.539 -0.3 . . . . 64.239999999999995 110.751 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -69.2 158.58 34.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.959 0.409 . . . . 71.030000000000001 111.136 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.4 108.48 2.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.778 -0.452 . . . . 63.420000000000002 109.778 173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.02 147.69 12.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.404 0.621 . . . . 52.130000000000003 112.017 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -87.41 59.51 5.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.183 -0.462 . . . . 63.219999999999999 111.828 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.2 p80 39.85 59.08 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.67 . . . . 73.510000000000005 112.645 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -84.45 -25.46 28.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.815 -0.629 . . . . 72.420000000000002 111.917 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -56.37 102.55 0.08 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.081 0.467 . . . . 74.430000000000007 112.256 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 61.36 84.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.837 -0.619 . . . . 75.319999999999993 111.739 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.3 p80 . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.797 -0.62 . . . . 75.310000000000002 111.855 177.088 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.81 0.338 . . . . 73.120000000000005 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.62 113.78 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.7 0.286 . . . . 75.230000000000004 111.288 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -95.49 124.32 39.46 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.846 0.355 . . . . 73.439999999999998 110.44 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.14 119.04 19.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.196 0.522 . . . . 74.430000000000007 112.251 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 p -104.46 86.03 2.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.407 0.622 . . . . 71.040000000000006 110.533 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -79.13 72.81 5.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.921 -0.582 . . . . 64.099999999999994 111.836 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.35 157.79 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.934 -0.575 . . . . 74.340000000000003 111.968 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -125.75 110.51 13.82 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.909 0.337 . . . . 71.329999999999998 111.909 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -94.08 140.53 29.62 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.202 -0.295 . . . . 75.409999999999997 110.202 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -131.14 128.51 40.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 75.540000000000006 111.842 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -152.04 146.62 25.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.269 -0.423 . . . . 74.540000000000006 111.022 174.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -78.32 113.37 16.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 65.530000000000001 111.326 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 t -60.8 123.75 18.44 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.395 -0.366 . . . . 73.140000000000001 111.683 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.1 140.97 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.182 0.515 . . . . 71.430000000000007 112.315 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.5 t -109.35 132.66 53.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.118 -0.492 . . . . 53.420000000000002 110.425 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -134.59 155.62 50.14 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 112.561 0.578 . . . . 72.109999999999999 112.561 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.89 146.52 41.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.055 -0.52 . . . . 42.219999999999999 111.516 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 14.9 m120 -86.01 100.99 12.53 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.015 0.436 . . . . 74.340000000000003 111.497 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -82.91 23.84 0.8 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.904 0.383 . . . . 74.230000000000004 111.426 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 13.1 pt-20 -96.95 179.13 5.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.412 0.523 . . . . 75.200000000000003 112.412 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.23 -169.99 1.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.041 -0.527 . . . . 73.010000000000005 111.914 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -83.46 -163.63 0.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.662 0.615 . . . . 72.340000000000003 112.662 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -42.54 143.26 0.69 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.288 0.847 . . . . 65.540000000000006 113.288 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.6 tp -123.42 145.31 48.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 72.239999999999995 111.425 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -62.5 133.48 55.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.86 0.362 . . . . 73.319999999999993 111.683 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -47.32 -39.53 15.0 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.758 0.651 . . . . 72.439999999999998 112.758 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -51.77 -56.3 14.68 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.061 0.458 . . . . 72.349999999999994 111.444 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.4 m -68.53 -28.23 66.8 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.248 -0.433 . . . . 73.450000000000003 111.326 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.93 -48.98 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.711 0.291 . . . . 73.420000000000002 111.164 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 14.4 mptt -59.83 -47.69 84.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.923 0.392 . . . . 65.519999999999996 111.19 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.18 -49.45 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.936 0.398 . . . . 74.319999999999993 111.382 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.7 m -57.27 -43.49 83.11 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.995 0.426 . . . . 75.540000000000006 111.136 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.676 ' HG3' HD12 ' A' ' 108' ' ' ILE . 63.8 tt0 -59.06 -44.63 91.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.27 -0.423 . . . . 74.150000000000006 111.394 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.29 -44.17 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.376 . . . . 74.099999999999994 111.256 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -63.31 -36.8 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.827 0.306 . . . . 71.519999999999996 111.827 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.99 -50.13 67.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.947 0.403 . . . . 74.140000000000001 110.914 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.62 -40.01 95.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.071 0.463 . . . . 71.329999999999998 111.32 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.29 -39.22 89.62 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.196 -0.456 . . . . 61.109999999999999 110.814 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.99 74.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.302 -0.408 . . . . 37.960000000000001 111.588 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.32 0.83 57.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.039 0.447 . . . . 71.099999999999994 111.794 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 46' ' ' TYR . 25.3 t -77.63 103.43 7.57 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.965 0.412 . . . . 74.340000000000003 111.112 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 t -88.28 -23.05 23.58 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.961 0.41 . . . . 61.450000000000003 111.743 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.4 p -131.27 104.45 7.05 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.261 -0.427 . . . . 61.119999999999997 111.054 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.93 -162.03 35.24 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.288 -0.482 . . . . 40.509999999999998 112.89 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.9 145.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.478 -0.425 . . . . 74.219999999999999 111.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.54 ' HD2' ' HB2' ' A' ' 41' ' ' SER . 46.7 m-85 -97.06 120.6 37.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.847 0.356 . . . . 75.420000000000002 111.909 176.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.55 136.08 52.51 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.991 -0.549 . . . . 65.25 109.814 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . 63.8 mt -107.1 130.15 23.29 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 122.17 -0.332 . . . . 74.349999999999994 111.351 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 26.4 Cg_endo -60.3 -30.11 90.36 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.528 2.152 . . . . 64.519999999999996 112.807 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.64 -12.95 80.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.337 -0.458 . . . . 73.120000000000005 112.985 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . . . -120.83 76.66 1.22 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.067 0.46 . . . . 64.209999999999994 111.116 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.54 80.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.292 -0.413 . . . . 72.319999999999993 111.789 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 p -136.22 152.59 75.51 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 112.091 0.404 . . . . 73.340000000000003 112.091 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 59.9 Cg_endo -71.02 146.61 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.099 2.533 . . . . 73.299999999999997 114.151 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.81 32.96 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.83 -0.623 . . . . 53.0 110.78 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -85.9 139.93 30.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.014 0.435 . . . . 63.219999999999999 111.949 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -144.3 129.78 18.97 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.989 -0.55 . . . . 64.049999999999997 111.026 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -83.23 139.82 32.89 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.325 0.583 . . . . 72.120000000000005 110.761 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.1 p -124.32 -174.89 3.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 74.420000000000002 111.369 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.528 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.3 mt-30 -90.81 11.52 22.22 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 53.329999999999998 111.353 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.4 pt -121.67 -4.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.884 0.373 . . . . 75.329999999999998 111.179 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.34 -167.83 24.84 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.288 -0.415 . . . . 71.299999999999997 112.459 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.8 m -93.95 122.12 36.11 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.19 -0.594 . . . . 73.349999999999994 111.301 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -123.41 -176.4 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.919 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -151.7 104.93 3.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.208 0.528 . . . . 73.239999999999995 110.709 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.842 ' HE2' HD13 ' A' ' 82' ' ' LEU . 86.5 mtp -101.33 165.67 11.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.66 0.615 . . . . 74.140000000000001 112.66 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 46.5 t -162.77 167.03 23.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.046 0.451 . . . . 63.039999999999999 111.793 178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 80' ' ' LEU . 90.5 mt -117.73 123.27 45.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.062 -0.517 . . . . 62.130000000000003 111.688 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.689 HG22 HD21 ' A' ' 70' ' ' ASN . 27.6 m -138.1 171.41 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 116.64 -0.255 . . . . 63.340000000000003 111.359 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.689 HD21 HG22 ' A' ' 69' ' ' VAL . 46.7 m-80 56.49 33.08 21.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.614 0.598 . . . . 63.439999999999998 112.614 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.3 mt -71.79 109.17 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.023 0.44 . . . . 75.329999999999998 111.901 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -134.79 152.7 77.98 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 116.24 -0.436 . . . . 64.439999999999998 112.026 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 136.99 34.16 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.65 2.234 . . . . 41.219999999999999 112.358 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' HG21 ' A' ' 79' ' ' THR . 33.9 t70 -113.72 156.58 23.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.737 0.303 . . . . 75.109999999999999 111.44 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.37 69.02 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.358 0.503 . . . . 55.240000000000002 112.358 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -101.15 -29.56 12.05 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.975 0.416 . . . . 74.349999999999994 111.412 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.44 -102.06 0.16 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.05 -0.595 . . . . 50.549999999999997 113.104 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.3 m -151.62 128.19 10.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.567 -0.373 . . . . 63.43 110.815 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 138' ' ' GLN . 35.3 p -107.49 132.66 52.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.154 0.502 . . . . 75.439999999999998 111.824 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 68' ' ' LEU . 3.5 pp -148.31 143.22 26.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.135 -0.484 . . . . 71.140000000000001 110.996 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.586 ' HB ' HG22 ' A' ' 69' ' ' VAL . 56.0 m -81.54 116.49 21.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 70.010000000000005 111.358 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.842 HD13 ' HE2' ' A' ' 66' ' ' MET . 3.5 tm? -88.35 116.91 26.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.931 -0.577 . . . . 41.310000000000002 109.814 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -98.55 137.36 37.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.768 0.318 . . . . 73.120000000000005 111.336 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -117.93 90.53 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.887 0.375 . . . . 70.310000000000002 110.921 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 120.86 24.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 73.299999999999997 110.164 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.16 122.67 6.26 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.327 -0.94 . . . . 61.130000000000003 112.786 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -51.0 -39.83 56.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.467 0.651 . . . . 74.349999999999994 109.869 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 m -74.54 117.03 15.9 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.171 -0.922 . . . . 72.120000000000005 110.35 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -60.44 -31.68 70.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.016 0.436 . . . . 65.319999999999993 111.38 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.15 149.02 98.17 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.763 -0.653 . . . . 61.439999999999998 111.898 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 19.2 Cg_endo -58.31 124.38 15.75 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.146 2.564 . . . . 72.030000000000001 114.172 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.8 mt -84.1 149.02 54.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.518 -0.31 . . . . 72.439999999999998 111.33 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.06 173.95 13.63 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.422 2.082 . . . . 62.399999999999999 113.098 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 125' ' ' ALA . . . -72.35 141.94 48.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 52.530000000000001 111.725 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.38 161.51 41.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.169 0.509 . . . . 73.209999999999994 112.291 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 81.1 p -125.09 151.69 45.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.862 -0.608 . . . . 71.140000000000001 109.992 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -144.9 154.67 26.03 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.429 -0.891 . . . . 54.340000000000003 113.904 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.2 m -97.99 106.56 18.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.414 0.285 . . . . 72.439999999999998 110.965 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.466 HG13 HD11 ' A' ' 152' ' ' ILE . 15.9 m -95.58 136.07 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.975 0.416 . . . . 70.150000000000006 111.159 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 151' ' ' ARG . 50.6 mt-10 -115.17 114.37 25.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.25 -0.432 . . . . 73.450000000000003 111.092 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -121.47 123.63 42.51 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.975 0.417 . . . . 63.439999999999998 111.645 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.24 -146.9 4.95 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.324 -0.465 . . . . 37.960000000000001 113.234 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 97.0 mt-30 -126.98 155.98 42.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.494 0.664 . . . . 72.329999999999998 112.333 -176.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.36 131.48 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.836 -0.62 . . . . 61.409999999999997 110.329 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -102.08 -2.9 28.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.268 0.84 . . . . 71.530000000000001 113.268 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.34 -158.99 9.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.274 -0.965 . . . . 64.120000000000005 114.619 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.5 p -99.27 -176.76 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.074 0.464 . . . . 62.240000000000002 111.831 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.676 HD12 ' HG3' ' A' ' 33' ' ' GLN . 44.4 mm -70.4 -24.92 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.188 0.518 . . . . 73.219999999999999 111.157 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.81 -43.06 14.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.346 -0.388 . . . . 72.420000000000002 111.695 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.81 115.91 8.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.24 0.543 . . . . 65.230000000000004 111.588 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.36 163.07 36.72 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.138 0.494 . . . . 72.030000000000001 111.978 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -132.82 129.34 38.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.978 -0.555 . . . . 73.409999999999997 110.35 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 2.4 mp0 -81.08 105.9 12.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.36 -0.382 . . . . 74.450000000000003 111.166 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.3 pt -111.11 160.37 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.292 0.478 . . . . 61.32 112.292 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.89 21.12 8.77 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.871 0.693 . . . . 52.149999999999999 112.871 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.07 137.92 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.79 0.663 . . . . 74.549999999999997 112.79 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -117.92 161.13 20.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.728 -0.669 . . . . 73.549999999999997 110.804 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -110.68 151.62 27.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.349 -0.387 . . . . 63.109999999999999 111.282 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.15 145.07 28.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.526 -0.306 . . . . 74.319999999999993 110.403 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.72 112.07 24.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.675 0.274 . . . . 75.430000000000007 111.556 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 96' ' ' SER . 38.8 pt -94.56 116.94 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.089 0.471 . . . . 73.420000000000002 111.195 177.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.21 105.68 16.39 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.977 0.417 . . . . 72.140000000000001 111.067 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.9 146.69 35.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.488 -0.324 . . . . 42.009999999999998 111.847 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 169.79 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.947 2.431 . . . . 54.539999999999999 113.287 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.47 ' HB2' ' HB1' ' A' ' 94' ' ' ALA . . . -89.1 127.76 35.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.476 -0.329 . . . . 73.329999999999998 111.798 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -86.25 135.06 33.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.091 0.472 . . . . 73.109999999999999 111.388 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.564 HG21 ' HG ' ' A' ' 128' ' ' LEU . 35.9 m -117.78 4.08 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 111.871 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.564 ' HG ' HG21 ' A' ' 127' ' ' VAL . 96.3 mt -136.59 170.36 16.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.281 0.562 . . . . 74.549999999999997 111.941 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.58 145.47 47.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.97 -0.559 . . . . 55.32 111.174 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 156.08 97.49 Favored 'Cis proline' 0 C--N 1.355 0.889 0 C-N-CA 124.164 -1.181 . . . . 55.329999999999998 113.354 0.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 31.7 t -95.35 83.74 3.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.644 0.609 . . . . 72.340000000000003 112.644 -176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -119.93 108.68 14.63 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.289 0.566 . . . . 65.25 110.179 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.47 144.07 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.413 0.524 . . . . 73.349999999999994 112.413 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.56 121.36 41.52 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.755 0.312 . . . . 71.219999999999999 111.584 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.1 pt -132.44 125.81 19.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 120.799 0.333 . . . . 65.439999999999998 111.559 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.69 115.6 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.312 2.008 . . . . 62.229999999999997 112.876 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.81 111.01 22.37 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.973 -0.558 . . . . 63.32 109.986 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.498 ' HG3' HG22 ' A' ' 79' ' ' THR . 7.6 tt0 -101.33 101.36 12.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.103 0.477 . . . . 74.209999999999994 111.365 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.3 mt -89.06 149.13 23.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.394 -0.367 . . . . 64.109999999999999 111.767 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.86 150.53 41.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.961 0.41 . . . . 74.040000000000006 111.764 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.1 29.01 73.7 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.461 0.545 . . . . 61.409999999999997 114.461 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -158.73 135.15 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 122.394 -0.474 . . . . 74.239999999999995 111.474 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.3 m -101.39 148.92 24.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 111.673 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -52.49 -51.93 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 113.317 0.858 . . . . 72.239999999999995 113.317 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.97 -17.49 62.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.157 0.503 . . . . 75.239999999999995 111.094 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -98.54 -1.65 40.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.097 -0.501 . . . . 72.030000000000001 111.739 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.559 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 1.5 tt -79.53 129.36 34.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.916 0.389 . . . . 73.030000000000001 110.486 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.66 -58.07 1.37 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.313 -0.47 . . . . 62.109999999999999 113.655 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 113' ' ' GLU . 22.6 p90 -146.39 157.52 43.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.106 0.479 . . . . 74.340000000000003 112.211 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.1 t -130.47 100.09 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.942 -0.572 . . . . 75.420000000000002 110.374 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 100' ' ' GLU . 35.4 ttm180 -94.68 125.41 39.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.19 -0.319 . . . . 73.25 111.404 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.488 HG21 ' HE1' ' A' ' 66' ' ' MET . 19.0 mm -105.35 140.25 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 65.409999999999997 111.491 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -168.93 173.87 6.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.989 0.366 . . . . 74.5 111.989 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.26 40.62 17.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.62 0.6 . . . . 72.120000000000005 112.62 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.469 HG21 HD22 ' A' ' 64' ' ' LEU . 42.5 mm -73.57 104.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.04 0.447 . . . . 75.420000000000002 110.221 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.528 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.0 pt20 -123.98 146.3 50.62 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 116.277 -0.419 . . . . 74.430000000000007 111.962 -171.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.71 141.4 37.59 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.415 2.077 . . . . 73.209999999999994 112.981 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.41 161.41 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.275 -0.265 . . . . 73.510000000000005 110.749 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.8 mtp 61.85 25.12 15.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.221 0.534 . . . . 62.32 111.086 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.23 149.6 42.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.227 0.537 . . . . 55.299999999999997 111.957 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.11 156.86 29.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.434 -0.348 . . . . 51.340000000000003 110.635 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.57 136.98 58.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.253 0.549 . . . . 71.439999999999998 112.345 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -139.79 86.89 2.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.275 0.56 . . . . 74.030000000000001 110.512 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -81.15 132.49 35.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.882 -0.599 . . . . 74.319999999999993 111.256 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.62 126.84 55.72 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.941 0.401 . . . . 63.399999999999999 111.269 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -102.57 139.97 37.47 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.325 -0.398 . . . . 74.120000000000005 111.628 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -76.15 7.93 3.74 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.49 0.552 . . . . 75.140000000000001 112.49 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 29.1 p80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.641 -0.695 . . . . 72.530000000000001 110.928 173.431 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.705 0.288 . . . . 74.439999999999998 110.602 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.21 140.51 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.267 0.556 . . . . 74.25 112.312 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -116.17 137.88 51.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 70.439999999999998 110.84 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -78.4 152.8 32.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.238 0.542 . . . . 75.329999999999998 112.137 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -139.32 143.24 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.038 -0.528 . . . . 38.740000000000002 110.257 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.45 84.89 7.49 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.261 0.553 . . . . 64.219999999999999 111.88 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -91.93 146.58 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.279 -0.419 . . . . 75.209999999999994 110.505 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -90.9 144.92 25.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.978 0.418 . . . . 74.409999999999997 111.657 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -171.43 3.45 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.094 0.473 . . . . 71.439999999999998 112.07 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -142.85 177.65 8.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.066 0.46 . . . . 74.120000000000005 111.803 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.03 177.08 11.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.166 -0.47 . . . . 62.539999999999999 110.787 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -65.51 154.41 38.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.948 0.404 . . . . 74.200000000000003 111.741 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -77.55 155.9 31.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.033 0.444 . . . . 64.530000000000001 111.594 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.01 110.48 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.363 -0.38 . . . . 64.140000000000001 110.698 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 t -71.91 93.9 1.39 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.855 0.36 . . . . 74.430000000000007 110.766 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.8 p -86.02 139.93 30.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.925 0.393 . . . . 74.109999999999999 111.893 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.44 139.05 49.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.889 0.376 . . . . 60.100000000000001 110.915 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -75.23 105.2 6.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.382 0.61 . . . . 70.329999999999998 112.495 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -105.88 87.85 2.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.245 0.545 . . . . 71.439999999999998 111.567 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.32 124.99 37.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.737 -0.665 . . . . 72.540000000000006 109.357 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -97.4 105.19 17.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.805 1.039 . . . . 52.530000000000001 113.805 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p 49.78 -166.97 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.535 1.309 . . . . 73.299999999999997 114.535 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -83.83 164.06 19.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.73 -0.668 . . . . 72.319999999999993 111.648 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -139.21 163.3 32.82 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 63.039999999999999 110.728 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' O ' HG21 ' A' ' 29' ' ' VAL . 2.0 m-20 -49.17 121.73 5.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.262 0.225 . . . . 65.549999999999997 111.137 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -45.26 -47.69 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.84 0.682 . . . . 73.040000000000006 112.84 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.15 -55.05 35.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.357 0.599 . . . . 72.109999999999999 110.978 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -65.88 -21.06 66.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.948 -0.569 . . . . 73.099999999999994 111.827 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 25' ' ' ASN . 73.7 t -67.99 -47.76 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.973 0.416 . . . . 75.430000000000007 110.409 173.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HE2' HD23 ' A' ' 48' ' ' LEU . 17.3 tptm -63.29 -36.93 85.31 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.19 0.519 . . . . 74.5 109.958 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.2 mt -59.56 -50.41 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.172 -0.467 . . . . 61.539999999999999 111.292 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.3 m -54.42 -41.7 69.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.958 0.409 . . . . 75.129999999999995 111.082 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.662 ' HG3' HD12 ' A' ' 108' ' ' ILE . 62.8 tt0 -61.89 -44.43 96.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.441 -0.345 . . . . 72.450000000000003 110.892 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.497 ' NE2' ' HG1' ' A' ' 53' ' ' THR . 28.9 tt0 -56.85 -40.89 76.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.435 -0.348 . . . . 71.329999999999998 111.459 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.6 -50.28 73.65 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.103 0.477 . . . . 75.400000000000006 111.335 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.29 -41.72 99.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.164 -0.471 . . . . 74.340000000000003 111.325 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.895 0.378 . . . . 73.299999999999997 111.005 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.56 -29.18 70.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.088 0.471 . . . . 71.420000000000002 110.693 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.13 70.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.218 -0.446 . . . . 71.209999999999994 111.245 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -95.01 12.23 29.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.362 0.505 . . . . 75.010000000000005 112.362 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -67.35 88.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.949 0.404 . . . . 73.120000000000005 111.551 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -66.99 -56.76 8.73 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.195 0.443 . . . . 71.219999999999999 112.195 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.2 p -138.23 105.06 5.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.164 0.507 . . . . 72.010000000000005 111.226 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 92.12 142.97 11.48 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.176 -0.535 . . . . 38.740000000000002 112.956 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 27.2 m -86.35 148.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 112.472 0.545 . . . . 71.120000000000005 112.472 -173.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -95.25 114.26 26.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.007 -0.542 . . . . 65.340000000000003 112.031 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.02 103.72 13.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.895 0.378 . . . . 74.439999999999998 110.727 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.419 HD13 ' HG3' ' A' ' 34' ' ' GLN . 7.2 mp -82.37 121.96 78.76 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 122.306 -0.246 . . . . 74.519999999999996 111.035 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 52.9 Cg_exo -54.94 -32.57 78.95 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.918 2.412 . . . . 71.549999999999997 113.726 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.17 11.37 63.12 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.113 -0.565 . . . . 65.450000000000003 113.415 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.44 129.6 56.27 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.012 0.434 . . . . 73.519999999999996 111.794 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 85.8 tttt -84.85 32.32 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.487 0.661 . . . . 71.239999999999995 111.253 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.497 ' HG1' ' NE2' ' A' ' 34' ' ' GLN . 1.3 p -128.13 133.88 25.62 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 113.445 0.906 . . . . 73.319999999999993 113.445 -176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.29 179.06 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.431 2.754 . . . . 64.219999999999999 113.066 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.76 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.062 0.458 . . . . 73.120000000000005 111.801 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -91.77 124.89 36.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.96 0.409 . . . . 72.219999999999999 111.015 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.8 tp -120.59 138.33 53.94 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.464 0.542 . . . . 75.340000000000003 112.464 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.5 117.13 22.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.945 -0.57 . . . . 72.129999999999995 110.229 172.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -118.14 173.92 6.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.935 0.398 . . . . 75.140000000000001 111.488 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 48.0 mt-30 -79.24 1.41 24.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.194 0.442 . . . . 74.450000000000003 112.194 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 157' ' ' PRO . 38.5 pt -105.37 -34.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.983 0.42 . . . . 72.530000000000001 110.693 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.46 -156.5 28.32 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.108 -0.496 . . . . 72.430000000000007 112.428 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.9 m -98.36 124.33 42.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.951 0.405 . . . . 72.329999999999998 110.994 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.99 170.75 15.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.809 0.337 . . . . 63.43 111.905 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -134.25 116.1 14.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.471 0.309 . . . . 71.540000000000006 110.526 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.733 ' SD ' HG23 ' A' ' 152' ' ' ILE . 65.1 mtt -107.4 155.32 20.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.685 0.624 . . . . 53.020000000000003 112.685 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.8 p -154.78 157.76 38.45 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.083 -0.508 . . . . 64.5 111.357 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.59 125.93 50.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.556 -0.293 . . . . 64.340000000000003 111.677 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.58 HG22 HD21 ' A' ' 70' ' ' ASN . 23.9 m -137.6 169.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.65 0.262 . . . . 62.5 111.416 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.58 HD21 HG22 ' A' ' 69' ' ' VAL . 40.9 m-80 55.54 26.72 9.37 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.543 0.571 . . . . 75.319999999999993 112.543 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.451 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 53.5 mt -60.67 111.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.819 0.342 . . . . 71.109999999999999 111.426 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 151.8 77.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.464 0.542 . . . . 72.010000000000005 112.464 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.61 118.8 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.888 2.392 . . . . 73.129999999999995 112.521 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.414 ' HB2' HG23 ' A' ' 79' ' ' THR . 28.6 t70 -100.37 164.61 11.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.398 -0.365 . . . . 73.310000000000002 111.603 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.57 92.28 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 72.120000000000005 111.828 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.85 -41.36 15.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.939 0.4 . . . . 74.540000000000006 111.404 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.21 -94.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.439 -0.886 . . . . 72.340000000000003 114.07 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.5 m -143.71 120.36 11.13 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.562 -0.375 . . . . 73.530000000000001 112.002 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' HB2' ' A' ' 74' ' ' ASP . 8.0 p -96.83 118.71 33.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 62.310000000000002 111.127 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.1 pp -132.9 -172.47 2.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.38 -0.373 . . . . 64.439999999999998 111.261 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.557 ' HB ' HG22 ' A' ' 69' ' ' VAL . 31.2 m -130.12 111.1 12.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.88 0.371 . . . . 64.510000000000005 110.661 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.7 112.88 20.46 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 60.140000000000001 110.04 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtm180 -93.96 124.72 38.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.526 -0.306 . . . . 75.420000000000002 111.61 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -110.34 97.3 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.473 -0.33 . . . . 71.340000000000003 111.05 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.22 108.09 20.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.582 -0.525 . . . . 71.140000000000001 109.582 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.22 140.16 29.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.887 -0.673 . . . . 73.5 113.261 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.83 -21.33 57.38 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.384 0.611 . . . . 72.299999999999997 110.075 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -64.83 118.46 9.03 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.27 -0.877 . . . . 73.109999999999999 111.994 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -71.88 -14.03 61.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.202 0.525 . . . . 72.430000000000007 110.905 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -97.86 149.42 35.7 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.837 -0.62 . . . . 71.439999999999998 110.913 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -65.68 137.36 49.65 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.606 2.204 . . . . 72.430000000000007 113.365 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.17 158.42 31.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.418 -0.356 . . . . 72.420000000000002 111.296 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.55 -165.14 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.205 1.937 . . . . 61.210000000000001 112.43 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.92 156.13 22.51 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.278 -0.264 . . . . 53.119999999999997 110.81 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -150.19 162.86 39.63 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.585 0.707 . . . . 74.25 112.681 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 p -157.74 154.36 28.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.216 -0.902 . . . . 72.239999999999995 110.492 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.614 ' HA3' HD12 ' A' ' 155' ' ' ILE . . . -164.39 -175.23 35.0 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.278 -0.963 . . . . 70.200000000000003 114.039 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 m -111.23 145.43 38.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.494 0.318 . . . . 73.120000000000005 110.852 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.0 p -124.13 128.84 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.253 0.464 . . . . 75.25 112.253 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 29.8 mm-40 -98.2 110.37 22.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.248 -0.433 . . . . 73.150000000000006 110.325 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.462 ' HD2' HG23 ' A' ' 142' ' ' ILE . 12.4 p90 -121.7 118.24 28.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.287 0.565 . . . . 75.120000000000005 112.064 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.18 -153.43 6.75 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.714 -0.675 . . . . 50.240000000000002 113.01 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 77.3 mt-30 -119.29 145.77 45.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.089 0.471 . . . . 71.400000000000006 112.27 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.96 104.69 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 75.230000000000004 110.606 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.585 HE21 HD12 ' A' ' 114' ' ' ILE . 8.8 pt20 -89.36 -11.89 42.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.839 0.681 . . . . 74.319999999999993 112.839 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.11 -168.64 15.69 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.86 -0.686 . . . . 43.310000000000002 114.025 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 45.8 p -92.12 -176.66 4.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.703 0.401 . . . . 64.25 111.387 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.662 HD12 ' HG3' ' A' ' 33' ' ' GLN . 50.8 mm -74.36 -26.89 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.255 0.55 . . . . 44.539999999999999 110.622 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.9 -35.99 56.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.911 -0.586 . . . . 61.450000000000003 110.851 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.66 97.43 2.97 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.124 0.488 . . . . 75.340000000000003 111.908 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -122.64 151.27 41.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.277 0.56 . . . . 73.430000000000007 111.606 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -132.36 117.81 18.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.876 -0.602 . . . . 64.319999999999993 110.402 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.99 108.16 5.75 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.918 0.389 . . . . 71.010000000000005 111.091 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.585 HD12 HE21 ' A' ' 105' ' ' GLN . 34.6 pt -113.41 152.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.418 -0.356 . . . . 74.420000000000002 111.041 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 57.6 32.89 22.53 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.957 0.408 . . . . 71.019999999999996 111.297 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.96 124.72 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.375 0.607 . . . . 74.230000000000004 112.127 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -114.88 157.51 23.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.029 -0.532 . . . . 71.430000000000007 110.524 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 7.0 p30 -112.22 153.74 26.64 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.807 0.337 . . . . 72.129999999999995 111.139 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -153.39 154.05 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.691 0.282 . . . . 75.530000000000001 111.456 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -92.18 122.86 35.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.084 0.401 . . . . 73.430000000000007 112.084 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.9 pt -112.73 120.83 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.088 0.47 . . . . 73.450000000000003 111.516 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -118.03 139.73 50.77 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.259 -0.275 . . . . 72.230000000000004 111.13 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.87 149.69 73.04 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.182 0.438 . . . . 74.030000000000001 112.182 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.11 164.21 20.38 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.351 2.701 . . . . 74.219999999999999 113.988 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.35 26.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.976 -0.556 . . . . 74.439999999999998 111.979 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.2 m -83.3 55.01 2.99 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.891 0.377 . . . . 62.520000000000003 111.413 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.29 -2.39 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.473 0.916 . . . . 55.340000000000003 113.473 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.01 124.27 30.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.164 -0.335 . . . . 74.140000000000001 111.226 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.36 56.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.651 -0.249 . . . . 64.040000000000006 111.379 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.14 156.84 94.29 Favored 'Cis proline' 0 C--N 1.355 0.901 0 C-N-CA 123.863 -1.307 . . . . 65.299999999999997 112.972 -0.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 p -80.43 57.25 2.78 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.129 0.49 . . . . 74.319999999999993 112.17 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.11 89.92 8.18 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.087 0.47 . . . . 75.129999999999995 110.084 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.66 154.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.268 -0.424 . . . . 74.230000000000004 111.714 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -142.89 144.79 32.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.791 0.329 . . . . 75.340000000000003 110.982 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.1 128.39 11.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.651 0.262 . . . . 74.120000000000005 111.705 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.71 142.06 47.15 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.286 1.991 . . . . 71.239999999999995 112.009 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.48 123.28 20.0 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.625 -0.261 . . . . 73.010000000000005 111.212 -172.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -102.1 102.91 13.44 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.121 0.486 . . . . 63.130000000000003 111.309 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 71.9 mt -83.55 128.22 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.573 -0.285 . . . . 62.329999999999998 110.267 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -103.47 142.93 33.4 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.609 0.596 . . . . 74.530000000000001 112.609 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.75 80.44 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.863 -0.608 . . . . 61.409999999999997 114.136 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.462 HG23 ' HD2' ' A' ' 101' ' ' TYR . 16.1 tt -149.51 114.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 117.485 0.643 . . . . 74.310000000000002 112.042 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 64.6 m -80.47 155.03 27.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.078 0.466 . . . . 70.010000000000005 112.214 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.05 -47.99 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 113.372 0.879 . . . . 74.430000000000007 113.372 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.91 -16.52 64.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.134 0.492 . . . . 73.120000000000005 111.341 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.526 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 29.7 mm-40 -108.66 11.56 26.43 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.334 -0.394 . . . . 74.030000000000001 111.68 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -88.94 108.18 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.071 0.462 . . . . 63.43 110.246 178.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.98 -55.43 3.13 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.125 -0.56 . . . . 63.329999999999998 113.661 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -145.09 152.53 40.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.973 0.416 . . . . 74.120000000000005 111.831 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.63 94.09 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.885 -0.598 . . . . 64.510000000000005 110.31 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 68.7 ttt180 -89.05 107.2 18.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.755 0.422 . . . . 71.540000000000006 111.974 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.733 HG23 ' SD ' ' A' ' 66' ' ' MET . 35.9 mm -89.12 126.44 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.468 -0.333 . . . . 74.349999999999994 111.432 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.567 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.9 p80 -154.96 177.56 11.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.156 0.428 . . . . 72.400000000000006 112.156 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 64.4 23.14 12.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.092 0.557 . . . . 72.329999999999998 112.414 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.614 HD12 ' HA3' ' A' ' 97' ' ' GLY . 51.0 mm -67.57 95.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.643 0.735 . . . . 74.299999999999997 112.073 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 60' ' ' GLN . 9.0 pt20 -116.78 151.56 47.42 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.266 -0.879 . . . . 72.239999999999995 111.449 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HB3' HG21 ' A' ' 61' ' ' ILE . 58.2 Cg_endo -70.47 128.62 15.63 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 72.329999999999998 113.786 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.28 95.41 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.849 0.833 . . . . 71.439999999999998 110.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 57.8 mtm -106.74 -162.23 0.84 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.524 -0.762 . . . . 60.240000000000002 111.52 -174.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -103.37 -167.92 1.44 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.244 0.461 . . . . 70.319999999999993 112.244 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.41 87.29 1.16 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.12 0.785 . . . . 61.240000000000002 113.12 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.35 149.84 22.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.601 -0.518 . . . . 64.030000000000001 109.601 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -147.14 101.92 3.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.503 0.668 . . . . 73.530000000000001 112.8 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -106.92 105.86 16.1 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.701 -0.682 . . . . 73.519999999999996 110.263 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -91.72 155.12 18.51 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.344 0.592 . . . . 72.040000000000006 112.233 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -58.79 103.42 0.16 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.71 -0.677 . . . . 75.319999999999993 111.726 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -97.09 -39.15 9.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.85 0.357 . . . . 71.019999999999996 111.251 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.885 -0.579 . . . . 64.129999999999995 111.451 179.116 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.766 0.317 . . . . 72.049999999999997 111.375 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t -129.95 122.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.965 0.412 . . . . 61.439999999999998 111.228 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -137.62 122.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.332 -0.395 . . . . 62.119999999999997 110.133 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -149.75 150.22 31.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.098 0.475 . . . . 74.049999999999997 111.946 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.1 t -92.51 145.78 24.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.168 -0.469 . . . . 71.340000000000003 112.104 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.24 147.81 26.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.975 0.417 . . . . 53.409999999999997 111.386 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.6 t -108.93 125.37 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.299 -0.409 . . . . 60.119999999999997 110.6 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -137.79 134.77 35.61 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.826 0.346 . . . . 73.219999999999999 111.646 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -99.57 178.72 4.77 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.363 -0.381 . . . . 64.200000000000003 111.378 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -132.14 148.52 52.48 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.311 -0.404 . . . . 61.210000000000001 111.031 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 5.1 ttmp? -80.0 108.66 13.76 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.885 0.374 . . . . 74.040000000000006 111.596 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -73.02 136.11 45.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.439 -0.346 . . . . 72.519999999999996 110.972 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 t -83.02 114.58 21.37 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.412 -0.358 . . . . 72.129999999999995 111.328 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -100.22 173.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.131 0.491 . . . . 63.219999999999999 112.262 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -164.1 103.41 0.87 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.117 -0.492 . . . . 70.040000000000006 111.202 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.3 p -110.27 -176.9 3.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.952 0.406 . . . . 71.420000000000002 111.755 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.464 HD22 ' HG3' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -145.51 174.09 11.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.437 -0.347 . . . . 64.530000000000001 111.425 -178.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -65.32 109.69 2.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.493 0.553 . . . . 44.350000000000001 112.493 -175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' HG3' HD22 ' A' ' 17' ' ' LEU . 98.1 mt-30 -132.39 179.53 6.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.121 -0.49 . . . . 75.519999999999996 110.835 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -68.84 129.17 39.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.731 0.301 . . . . 74.430000000000007 111.074 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 tpt -70.04 137.09 51.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.727 0.299 . . . . 64.099999999999994 110.457 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -87.22 -160.92 0.64 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.071 0.397 . . . . 73.25 112.071 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -51.63 161.27 0.53 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.212 0.819 . . . . 70.129999999999995 113.212 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 tp -51.56 136.46 26.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.752 -0.658 . . . . 72.400000000000006 112.456 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -94.02 146.85 23.65 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.908 -0.587 . . . . 70.340000000000003 111.905 -177.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.29 -31.01 72.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 72.099999999999994 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 31' ' ' ILE . 40.5 tt0 -60.38 -45.73 92.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.236 0.541 . . . . 71.129999999999995 109.91 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.713 ' HA ' HD13 ' A' ' 31' ' ' ILE . 18.6 m -62.1 -37.51 85.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.876 -0.602 . . . . 73.400000000000006 111.389 176.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.07 -40.64 86.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.138 0.494 . . . . 74.510000000000005 110.753 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.623 ' HE3' HD12 ' A' ' 48' ' ' LEU . 43.5 tptt -64.34 -37.15 86.47 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.065 -0.516 . . . . 71.129999999999995 110.35 175.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.713 HD13 ' HA ' ' A' ' 28' ' ' THR . 91.1 mt -57.71 -44.24 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.981 -0.554 . . . . 73.109999999999999 111.19 173.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.8 m -58.68 -43.38 89.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.204 -0.453 . . . . 51.32 110.805 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.631 ' HG3' HD11 ' A' ' 108' ' ' ILE . 55.9 tt0 -57.79 -48.49 79.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.234 -0.439 . . . . 72.409999999999997 111.14 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -51.57 -53.06 42.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.183 -0.462 . . . . 63.210000000000001 111.499 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.599 0.592 . . . . 72.530000000000001 112.599 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.441 ' HD2' HG21 ' A' ' 108' ' ' ILE . 20.9 mtm180 -78.6 -38.27 40.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.068 -0.395 . . . . 74.329999999999998 111.052 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.27 -46.45 83.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.127 0.489 . . . . 72.239999999999995 110.693 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 46' ' ' TYR . 3.8 m-20 -58.36 -38.66 77.69 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.973 -0.558 . . . . 63.350000000000001 111.492 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.58 -38.1 80.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.902 0.382 . . . . 75.310000000000002 111.411 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.75 -32.86 58.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.936 0.347 . . . . 60.140000000000001 111.936 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -94.27 103.39 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.761 0.652 . . . . 43.149999999999999 112.761 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -96.01 27.72 3.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.381 0.61 . . . . 52.119999999999997 110.684 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -139.73 38.76 2.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.025 -0.534 . . . . 70.319999999999993 110.584 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 129.49 158.01 9.36 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.142 -0.481 . . . . 75.040000000000006 112.799 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 57' ' ' LEU . 35.1 m -100.85 147.06 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.295 0.48 . . . . 74.140000000000001 112.295 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.448 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 31.8 m-85 -93.31 139.5 30.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.084 0.469 . . . . 75.299999999999997 110.962 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.82 119.99 29.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 74.129999999999995 109.756 172.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.623 HD12 ' HE3' ' A' ' 30' ' ' LYS . 79.0 mt -97.46 134.24 22.81 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 111.851 0.315 . . . . 72.329999999999998 111.851 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 32.0 Cg_endo -62.79 -24.64 74.56 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.577 2.184 . . . . 71.140000000000001 112.876 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.01 18.54 55.88 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.078 -0.51 . . . . 53.0 112.825 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.431 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -144.3 106.75 4.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.954 0.407 . . . . 60.219999999999999 110.915 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -74.42 11.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.623 0.601 . . . . 71.230000000000004 112.623 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -85.7 141.99 36.64 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 112.987 0.736 . . . . 53.149999999999999 112.987 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.56 -178.03 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.151 2.568 . . . . 74.530000000000001 113.516 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.18 137.03 28.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.71 -0.677 . . . . 63.130000000000003 110.785 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -82.48 97.93 8.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.023 0.439 . . . . 64.209999999999994 111.268 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 45' ' ' VAL . 61.0 tp -104.87 122.75 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.031 0.444 . . . . 75.129999999999995 111.153 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.3 tt0 -95.86 108.55 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.109999999999999 110.543 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.9 p -96.89 -178.18 4.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.567 0.58 . . . . 71.409999999999997 112.567 -172.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -76.32 -4.88 44.47 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.857 -0.61 . . . . 71.030000000000001 112.02 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 92' ' ' LEU . 39.5 pt -108.48 -34.03 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.794 0.33 . . . . 73.209999999999994 111.173 175.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.69 172.27 36.1 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.234 -0.508 . . . . 44.119999999999997 112.885 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 33.8 m -77.46 124.77 28.34 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.501 -0.411 . . . . 71.299999999999997 111.327 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 155' ' ' ILE . 2.4 pp -129.98 165.03 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.49 0.662 . . . . 63.229999999999997 111.909 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -129.82 100.19 5.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.659 -0.7 . . . . 74.219999999999999 110.863 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.687 ' SD ' HG22 ' A' ' 152' ' ' ILE . 65.3 mtt -102.73 148.93 24.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.68 0.622 . . . . 70.340000000000003 112.68 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -148.42 161.03 42.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.818 0.342 . . . . 71.0 111.563 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 80' ' ' LEU . 93.2 mt -105.44 119.32 38.8 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.797 0.332 . . . . 72.25 111.199 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.588 HG21 HD21 ' A' ' 70' ' ' ASN . 21.9 m -135.65 161.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.618 0.247 . . . . 75.150000000000006 111.655 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.588 HD21 HG21 ' A' ' 69' ' ' VAL . 31.4 m-80 60.85 34.49 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.175 0.512 . . . . 75.150000000000006 111.672 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.79 114.52 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.446 . . . . 73.519999999999996 111.742 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -138.46 150.74 67.37 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.371 . . . . 73.409999999999997 111.895 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.47 155.36 70.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.809 2.339 . . . . 64.209999999999994 113.165 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' HB2' HG22 ' A' ' 79' ' ' THR . 29.0 t70 -142.05 162.99 34.09 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.476 . . . . 75.420000000000002 111.214 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.37 -43.39 97.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 64.400000000000006 111.863 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -81.91 -25.05 35.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.623 0.249 . . . . 61.020000000000003 111.615 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.73 -99.95 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.955 -0.64 . . . . 61.43 113.52 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.1 m -145.89 125.75 13.53 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.002 0.43 . . . . 73.25 111.565 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 74' ' ' ASP . 39.9 p -97.0 123.07 40.63 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 111.716 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD11 HD21 ' A' ' 68' ' ' LEU . 3.1 pp -138.39 165.79 25.9 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.102 0.477 . . . . 71.5 111.712 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.5 m -107.91 123.44 48.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.257 -0.429 . . . . 74.120000000000005 111.274 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -99.75 109.58 22.02 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.309 -0.405 . . . . 74.439999999999998 110.193 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 66' ' ' MET . 49.5 mtm180 -89.45 128.27 35.93 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.663 -0.244 . . . . 53.039999999999999 110.92 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.486 HD12 HG12 ' A' ' 135' ' ' ILE . 3.4 mp -113.02 91.11 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.86 0.362 . . . . 71.140000000000001 110.538 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -92.75 106.49 18.45 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.84 -0.43 . . . . 71.430000000000007 109.84 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.474 ' HA3' ' OG ' ' A' ' 131' ' ' SER . . . -66.1 123.25 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.919 -0.658 . . . . 53.509999999999998 113.091 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.33 -25.6 66.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.513 0.673 . . . . 73.099999999999994 110.443 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -88.47 119.93 29.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.325 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.42 -22.86 63.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.949 0.404 . . . . 54.43 111.678 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -65.9 135.08 95.23 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.319 -0.4 . . . . 65.209999999999994 111.583 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.83 120.19 7.84 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.894 2.396 . . . . 72.109999999999999 113.097 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.6 mt -88.67 149.61 44.37 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.551 -0.295 . . . . 74.120000000000005 111.255 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.01 176.07 10.01 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.399 2.066 . . . . 61.340000000000003 113.167 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.24 47.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.827 0.346 . . . . 52.299999999999997 111.434 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.95 159.14 42.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.535 0.684 . . . . 75.549999999999997 112.638 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.7 p -141.38 163.94 31.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.495 -0.775 . . . . 63.210000000000001 110.141 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.625 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.31 169.68 38.48 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.278 -0.963 . . . . 53.25 114.005 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.2 m -99.9 129.39 45.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.699 0.4 . . . . 73.319999999999993 110.727 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 24.5 m -112.53 117.01 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.103 0.477 . . . . 72.340000000000003 111.57 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 43.7 mt-10 -92.82 103.61 15.94 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.574 -0.285 . . . . 75.409999999999997 110.787 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -112.91 137.05 51.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.009 0.433 . . . . 72.140000000000001 111.61 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.04 -145.96 4.91 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.004 -0.544 . . . . 37.43 112.957 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -130.39 145.8 51.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.995 0.426 . . . . 72.200000000000003 111.95 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.0 mt -105.4 120.99 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.225 -0.443 . . . . 74.329999999999998 110.478 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.08 3.36 54.9 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.402 0.89 . . . . 73.439999999999998 113.402 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.04 -162.67 9.3 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.077 -1.059 . . . . 65.219999999999999 114.724 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -88.34 -161.96 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.031 0.532 . . . . 75.310000000000002 111.585 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.5 mm -83.72 -21.97 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.409 0.624 . . . . 54.340000000000003 110.421 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.25 -37.12 12.85 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 111.337 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.47 106.6 5.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.19 0.519 . . . . 71.140000000000001 111.377 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -154.07 153.47 31.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.158 0.504 . . . . 73.140000000000001 112.235 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -125.77 146.91 49.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.965 -0.561 . . . . 74.219999999999999 110.766 173.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.32 105.62 17.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.161 -0.472 . . . . 74.430000000000007 110.882 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.416 HG13 ' HB2' ' A' ' 103' ' ' GLN . 35.6 pt -110.72 157.54 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.498 -0.319 . . . . 74.120000000000005 111.446 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 56.28 29.24 14.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.075 0.464 . . . . 72.310000000000002 111.666 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.78 131.58 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.256 0.55 . . . . 71.150000000000006 112.321 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.45 164.99 28.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.906 -0.588 . . . . 73.340000000000003 110.258 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.6 p-10 -115.01 142.09 47.11 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.956 0.724 . . . . 74.239999999999995 112.956 -173.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.42 154.91 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.666 -0.697 . . . . 65.439999999999998 110.283 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.72 122.59 42.14 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.983 0.364 . . . . 73.510000000000005 111.983 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.7 pt -102.1 143.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.503 -0.317 . . . . 75.120000000000005 111.063 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.44 119.58 19.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.972 0.415 . . . . 73.519999999999996 111.673 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.57 144.04 31.72 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 111.776 0.287 . . . . 75.340000000000003 111.776 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.28 163.3 36.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.65 2.233 . . . . 74.519999999999996 113.602 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.17 138.77 40.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.117 0.484 . . . . 75.209999999999994 112.233 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -81.55 119.1 23.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.325 -0.398 . . . . 71.329999999999998 110.772 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.606 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.9 m -93.78 -28.89 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.931 0.396 . . . . 72.349999999999994 111.228 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.606 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.0 mt -117.89 -178.5 3.51 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.987 0.423 . . . . 71.510000000000005 111.163 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -118.82 151.68 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 111.793 0.294 . . . . 62.149999999999999 111.793 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.49 -177.44 20.12 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.1 -1.209 . . . . 73.349999999999994 113.392 -2.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.474 ' OG ' ' HA3' ' A' ' 86' ' ' GLY . 53.9 p -90.2 40.62 1.01 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.101 0.477 . . . . 74.540000000000006 112.008 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -84.12 99.7 10.66 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.39 0.614 . . . . 62.130000000000003 111.423 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.36 134.11 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.215 -0.448 . . . . 65.349999999999994 111.301 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -114.78 127.09 55.54 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.241 -0.287 . . . . 64.430000000000007 111.174 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.486 HG12 HD12 ' A' ' 84' ' ' ILE . 33.1 pt -131.09 146.4 61.92 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.181 0.437 . . . . 74.109999999999999 112.181 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.9 161.99 20.99 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.552 2.168 . . . . 73.129999999999995 112.496 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.93 125.37 10.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.804 0.335 . . . . 63.229999999999997 110.51 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -108.59 106.38 16.43 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.049 0.452 . . . . 65.239999999999995 111.512 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.92 135.18 33.78 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.65 -0.25 . . . . 74.239999999999995 110.772 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -109.68 149.83 29.17 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.312 0.486 . . . . 71.340000000000003 112.312 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.92 83.06 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.153 -0.476 . . . . 71.150000000000006 113.873 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 147' ' ' LEU . 17.1 tt -143.68 135.17 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.026 0.441 . . . . 75.209999999999994 111.401 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.2 m -101.71 147.52 26.35 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.61 -0.268 . . . . 60.240000000000002 111.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.61 -43.83 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.744 0.646 . . . . 55.240000000000002 112.744 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.46 -28.27 69.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.001 0.429 . . . . 70.5 111.675 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -108.11 13.13 26.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.166 -0.47 . . . . 65.109999999999999 111.664 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.596 ' HA ' HD12 ' A' ' 142' ' ' ILE . 1.4 tt -81.0 120.8 25.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 110.407 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.27 -59.0 1.32 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.971 -0.633 . . . . 53.219999999999999 113.333 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.51 153.52 35.98 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.4 . . . . 73.099999999999994 111.911 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 65.9 t -125.99 107.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.01 -0.541 . . . . 63.210000000000001 110.046 170.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 38.5 ttt180 -96.22 110.94 23.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.823 0.344 . . . . 72.239999999999995 111.683 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.687 HG22 ' SD ' ' A' ' 66' ' ' MET . 18.0 mm -90.48 124.23 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.513 -0.312 . . . . 72.140000000000001 111.331 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.566 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 1.8 p80 -159.55 -176.75 5.94 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.372 0.508 . . . . 71.140000000000001 112.372 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 63.15 17.87 10.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.695 0.628 . . . . 63.140000000000001 112.695 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.625 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.5 mm -61.54 103.49 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.471 0.653 . . . . 73.140000000000001 111.097 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -136.52 158.3 73.57 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.762 -0.654 . . . . 71.209999999999994 111.451 -174.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.43 132.37 23.72 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.366 2.044 . . . . 62.340000000000003 112.665 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.56 170.11 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.895 0.379 . . . . 63.340000000000003 111.783 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mtm 63.1 23.12 13.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 112.016 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 157.8 37.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.199 0.523 . . . . 71.140000000000001 111.696 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.478 HD11 ' N ' ' A' ' 161' ' ' LEU . 4.9 mp -97.67 144.04 27.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.136 -0.484 . . . . 72.349999999999994 111.155 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.17 113.42 20.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.865 0.364 . . . . 75.219999999999999 111.527 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -79.99 75.28 6.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.357 0.598 . . . . 72.230000000000004 110.277 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -61.43 133.47 55.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.631 -0.713 . . . . 72.209999999999994 112.237 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -145.26 172.4 13.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.194 -0.457 . . . . 54.509999999999998 111.036 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -113.93 115.42 27.65 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.365 0.876 . . . . 70.549999999999997 113.365 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 70.19 92.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.278 0.631 . . . . 75.25 112.647 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 119.01 -0.519 . . . . 73.0 110.93 170.877 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.453 0.168 . . . . 63.200000000000003 110.783 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t -131.24 110.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.651 0.262 . . . . 63.5 111.256 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.38 177.96 5.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.876 0.369 . . . . 73.540000000000006 111.551 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.24 162.59 36.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.955 0.407 . . . . 71.349999999999994 111.322 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.4 p -133.02 142.64 48.92 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.995 0.426 . . . . 72.450000000000003 111.284 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -90.4 -174.42 4.14 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.433 0.635 . . . . 74.409999999999997 112.304 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.21 95.65 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.585 -0.734 . . . . 63.420000000000002 110.093 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -91.33 -170.18 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.898 -0.592 . . . . 64.310000000000002 111.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.46 85.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.136 0.493 . . . . 72.329999999999998 111.95 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.6 mtp -109.22 135.45 50.3 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.221 -0.445 . . . . 63.119999999999997 110.848 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.93 102.1 1.51 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.12 0.415 . . . . 72.030000000000001 112.12 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -101.18 86.06 2.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.718 0.294 . . . . 74.430000000000007 110.673 174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.8 t 55.4 75.28 0.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.306 -0.406 . . . . 70.430000000000007 111.289 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.65 113.06 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.191 0.52 . . . . 44.140000000000001 112.369 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.4 m -145.47 108.54 4.57 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.754 -0.657 . . . . 72.510000000000005 109.557 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -144.43 174.59 10.79 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.246 0.546 . . . . 72.319999999999993 112.345 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 17' ' ' LEU . 1.3 mm? -95.96 -169.22 1.89 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.919 -0.582 . . . . 72.530000000000001 111.392 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -74.8 90.37 2.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.149 0.5 . . . . 62.520000000000003 110.636 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -110.02 -166.31 1.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.226 -0.443 . . . . 50.229999999999997 111.828 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -49.8 152.17 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.186 0.439 . . . . 72.420000000000002 112.186 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.5 mtt -51.35 126.92 18.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.15 -0.477 . . . . 75.230000000000004 112.166 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -77.08 -175.32 3.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.13 0.491 . . . . 73.219999999999999 111.855 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -69.94 164.66 23.38 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 63.329999999999998 112.013 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.12 142.33 31.32 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.27 -0.423 . . . . 71.450000000000003 111.429 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.03 140.37 50.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.805 0.336 . . . . 75.430000000000007 111.354 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -60.71 -31.63 70.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.778 0.659 . . . . 73.439999999999998 112.778 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.14 -44.98 96.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.968 0.413 . . . . 74.299999999999997 110.4 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -65.36 -34.81 79.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.062 0.458 . . . . 75.239999999999995 110.785 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.86 -38.66 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.307 -0.406 . . . . 60.409999999999997 110.854 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -30.64 69.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.44 -0.346 . . . . 75.450000000000003 111.664 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.6 mt -61.44 -51.38 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.025 0.44 . . . . 75.219999999999999 110.496 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.4 m -58.92 -45.37 90.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.04 0.447 . . . . 74.010000000000005 110.832 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.623 HE21 HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -55.85 -45.58 78.4 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.794 -0.639 . . . . 71.439999999999998 111.256 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -63.17 -54.39 38.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.946 -0.57 . . . . 74.540000000000006 111.578 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.49 -35.86 74.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.351 -0.386 . . . . 73.349999999999994 112.033 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -64.89 -48.57 73.76 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.275 -0.265 . . . . 74.519999999999996 111.251 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.07 -41.64 88.48 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.251 0.548 . . . . 72.239999999999995 110.79 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.11 -43.52 82.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.661 -0.7 . . . . 72.439999999999998 111.401 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -33.69 64.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.31 0.485 . . . . 73.349999999999994 112.31 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -84.2 -7.79 59.25 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.272 0.471 . . . . 75.25 112.272 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.6 t -107.44 119.17 38.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.248 0.547 . . . . 75.400000000000006 111.946 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.6 p -83.6 -45.77 13.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.127 -0.488 . . . . 62.229999999999997 110.839 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.7 m -73.64 81.72 1.53 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.182 -0.463 . . . . 70.439999999999998 111.708 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 89.29 -171.72 38.84 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 113.848 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 57' ' ' LEU . 35.8 m -121.02 142.81 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 44.32 111.846 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.69 133.44 37.04 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.934 0.397 . . . . 74.310000000000002 111.946 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.75 138.44 52.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.854 -0.612 . . . . 53.100000000000001 110.187 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 74.8 mt -112.64 137.55 21.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 112.076 0.399 . . . . 72.209999999999994 112.076 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 16.0 Cg_exo -66.55 -30.81 42.61 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.724 2.283 . . . . 72.120000000000005 113.022 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.96 -8.04 67.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 114.314 0.486 . . . . 41.399999999999999 114.314 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.68 97.28 2.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.51 0.655 . . . . 74.519999999999996 111.901 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.87 88.88 0.11 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.847 0.832 . . . . 70.230000000000004 111.418 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -137.02 151.43 72.05 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 112.633 0.605 . . . . 74.120000000000005 112.633 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 89.2 Cg_endo -80.74 159.66 21.65 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.116 2.544 . . . . 73.25 114.06 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.19 144.8 27.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.986 -0.552 . . . . 63.329999999999998 110.632 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -83.69 119.56 24.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.943 0.401 . . . . 73.540000000000006 111.67 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 45' ' ' VAL . 46.5 tp -113.83 119.45 37.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.335 0.588 . . . . 53.439999999999998 110.658 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.52 110.77 22.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.963 -0.562 . . . . 72.140000000000001 110.348 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.4 p -115.72 -174.32 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.505 0.669 . . . . 74.519999999999996 112.751 -170.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -72.65 -24.68 61.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.583 -0.735 . . . . 74.430000000000007 112.196 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.8 pt -91.37 -7.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.795 0.331 . . . . 72.540000000000006 111.499 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.62 -167.75 23.8 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.366 -0.445 . . . . 62.530000000000001 113.056 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 m -91.7 123.08 34.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.865 0.364 . . . . 63.109999999999999 111.069 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.45 164.2 28.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.108 0.48 . . . . 75.439999999999998 111.625 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -124.04 114.63 19.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.279 -0.419 . . . . 74.510000000000005 110.916 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.66 ' SD ' HG23 ' A' ' 152' ' ' ILE . 63.4 mtt -98.56 143.39 29.02 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.929 0.395 . . . . 44.399999999999999 111.936 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 33.3 p -141.07 142.77 34.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.128 0.49 . . . . 74.019999999999996 111.848 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.51 HD22 HD12 ' A' ' 80' ' ' LEU . 82.4 mt -97.9 122.14 40.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 111.411 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 81' ' ' THR . 23.2 m -132.68 163.06 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.647 -0.251 . . . . 74.230000000000004 110.941 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 60.28 33.55 20.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.193 0.521 . . . . 74.519999999999996 111.939 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 68' ' ' LEU . 46.5 mt -71.9 106.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.192 -0.458 . . . . 64.310000000000002 111.677 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 p -135.17 149.85 71.21 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 112.419 0.526 . . . . 62.450000000000003 112.419 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.47 148.87 55.12 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.84 2.36 . . . . 63.32 113.099 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.4 -175.44 3.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.234 -0.439 . . . . 72.040000000000006 110.359 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.96 -45.86 39.44 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.993 -0.442 . . . . 64.200000000000003 111.998 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.432 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 2.1 p30 -92.36 -24.31 18.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.395 0.517 . . . . 72.409999999999997 112.395 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -164.97 -118.98 0.46 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.567 -0.825 . . . . 72.530000000000001 114.047 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.1 m -139.78 132.13 28.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.607 -0.349 . . . . 75.530000000000001 111.588 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.3 p -108.59 123.44 48.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.055 0.455 . . . . 72.430000000000007 111.502 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.51 HD12 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -139.09 151.91 47.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 73.450000000000003 111.079 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.693 ' HB ' HG22 ' A' ' 69' ' ' VAL . 27.3 m -90.35 111.05 22.13 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.301 -0.249 . . . . 61.200000000000003 110.936 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.58 108.41 19.05 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.543 -0.54 . . . . 73.25 109.543 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 66' ' ' MET . 23.9 mtp-105 -98.64 131.58 44.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.781 0.324 . . . . 53.009999999999998 111.627 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.2 mp -114.04 96.48 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.657 -0.247 . . . . 63.530000000000001 111.051 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.4 103.73 15.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.654 0.264 . . . . 71.400000000000006 110.623 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.87 131.77 26.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.72 -0.753 . . . . 53.530000000000001 112.876 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -68.56 -25.49 64.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.234 0.54 . . . . 72.230000000000004 110.593 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.5 m -79.11 117.26 19.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.868 -0.605 . . . . 54.310000000000002 110.223 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -80.02 41.05 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.355 0.598 . . . . 75.5 112.131 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.59 154.18 80.83 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.1 0.56 . . . . 64.439999999999998 110.215 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.451 ' HD3' ' HB1' ' A' ' 129' ' ' ALA . 19.7 Cg_endo -59.14 109.0 0.47 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.492 2.128 . . . . 45.210000000000001 112.681 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.77 151.03 57.45 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.079 -0.509 . . . . 50.140000000000001 112.152 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.88 159.73 41.4 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.467 2.111 . . . . 61.229999999999997 112.841 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.55 136.76 56.79 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.983 0.421 . . . . 73.430000000000007 111.641 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -133.76 163.31 29.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.417 0.627 . . . . 74.230000000000004 112.575 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.4 p -134.73 132.94 39.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.421 -0.809 . . . . 74.530000000000001 110.564 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.76 ' HA3' HD11 ' A' ' 155' ' ' ILE . . . -133.98 166.01 24.13 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.731 -0.747 . . . . 64.150000000000006 113.195 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.4 m -108.61 124.85 51.14 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.669 -0.313 . . . . 71.099999999999994 110.917 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.5 p -106.2 118.4 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.044 0.449 . . . . 72.299999999999997 112.144 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.6 mm-40 -89.32 113.18 24.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 74.349999999999994 110.041 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -122.81 128.7 50.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.158 0.504 . . . . 73.420000000000002 111.746 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.54 4.44 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.907 -0.588 . . . . 51.009999999999998 112.636 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.624 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.3 mt-30 -128.12 156.34 43.0 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.217 0.532 . . . . 73.420000000000002 112.213 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.42 120.91 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.17 -0.468 . . . . 51.439999999999998 111.211 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -93.19 -30.99 14.93 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.538 0.57 . . . . 71.209999999999994 112.538 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -93.25 -157.67 33.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.027 -0.606 . . . . 72.030000000000001 114.175 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.7 p -92.97 -173.69 3.36 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.933 0.397 . . . . 51.509999999999998 111.425 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.623 HD11 HE21 ' A' ' 33' ' ' GLN . 36.5 mm -82.58 -3.26 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.348 0.594 . . . . 74.230000000000004 111.213 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -109.04 -39.19 5.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.233 0.54 . . . . 73.109999999999999 110.791 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -134.9 102.37 5.21 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.864 -0.607 . . . . 61.109999999999999 111.344 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 107' ' ' THR . 34.8 p90 -141.8 148.67 39.27 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.101 0.477 . . . . 75.239999999999995 111.801 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -109.44 126.03 53.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.001 -0.545 . . . . 74.219999999999999 110.703 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.8 105.28 4.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.27 -0.423 . . . . 75.010000000000005 110.91 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 pt -110.12 152.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 111.759 0.281 . . . . 62.100000000000001 111.759 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 57.68 29.6 17.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.967 0.413 . . . . 72.209999999999994 111.842 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -95.1 115.55 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.883 0.697 . . . . 73.209999999999994 112.883 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.518 ' H ' ' NE2' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -117.73 170.98 8.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.985 -0.552 . . . . 64.319999999999993 110.154 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 22.9 p30 -123.87 162.62 22.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.341 0.867 . . . . 74.230000000000004 113.341 -171.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -144.18 152.24 40.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.313 -0.858 . . . . 74.349999999999994 110.366 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.52 117.16 28.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.892 0.377 . . . . 52.200000000000003 111.301 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 121' ' ' ILE . 30.0 pt -102.86 103.13 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.523 0.678 . . . . 72.329999999999998 111.368 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.05 114.87 29.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.115 -0.493 . . . . 70.420000000000002 111.348 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -95.05 139.37 22.05 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.543 -0.299 . . . . 71.299999999999997 111.287 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 32.5 Cg_exo -62.07 170.65 5.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.879 2.386 . . . . 75.140000000000001 113.397 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.56 10.83 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.052 0.453 . . . . 41.530000000000001 111.556 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -77.54 69.01 3.74 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.222 0.534 . . . . 64.439999999999998 111.281 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.55 -19.39 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.073 0.463 . . . . 53.009999999999998 111.734 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.7 mt -85.86 136.89 33.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.345 -0.389 . . . . 74.310000000000002 111.675 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.451 ' HB1' ' HD3' ' A' ' 91' ' ' PRO . . . -122.18 127.7 25.8 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.31 -0.405 . . . . 53.119999999999997 111.199 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.72 154.53 97.7 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.074 -1.219 . . . . 74.510000000000005 113.331 1.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.9 m -87.91 92.64 9.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.002 0.742 . . . . 54.310000000000002 113.002 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 8.3 p-10 -117.96 100.54 7.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.401 0.62 . . . . 62.399999999999999 110.158 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' ARG . 32.2 t -87.12 144.12 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.012 0.745 . . . . 72.319999999999993 113.012 -170.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.11 115.48 26.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.887 -0.597 . . . . 75.239999999999995 110.622 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.8 pt -125.95 126.53 24.83 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 120.904 0.383 . . . . 73.430000000000007 111.964 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.83 111.63 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.935 2.423 . . . . 43.340000000000003 112.274 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -103.81 115.4 30.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.267 -0.424 . . . . 65.239999999999995 110.523 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -105.92 103.28 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.3 0.571 . . . . 72.329999999999998 111.347 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.507 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 81.1 mt -78.76 138.76 38.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.17 -0.468 . . . . 74.400000000000006 109.911 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -116.23 135.76 53.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.427 0.529 . . . . 73.430000000000007 112.427 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.51 40.28 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.091 -0.504 . . . . 44.329999999999998 113.094 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 147' ' ' LEU . 20.6 tt -115.19 126.86 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.202 0.525 . . . . 73.340000000000003 111.659 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.2 m -94.73 149.17 21.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.805 0.298 . . . . 71.099999999999994 111.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 p -50.37 -44.42 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.793 1.034 . . . . 73.439999999999998 113.793 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.56 -31.8 71.27 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.885 -0.509 . . . . 73.140000000000001 111.018 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -95.52 9.05 41.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.205 -0.452 . . . . 54.229999999999997 111.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.542 ' HA ' HD13 ' A' ' 142' ' ' ILE . 1.9 tt -85.45 115.84 23.41 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.097 0.475 . . . . 51.539999999999999 110.406 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.624 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -81.68 -59.55 2.33 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.326 -0.464 . . . . 72.5 113.203 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.76 149.1 31.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.086 0.47 . . . . 71.519999999999996 112.16 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.9 106.71 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.694 -0.685 . . . . 64.299999999999997 109.713 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.4 ttt180 -107.58 106.33 16.63 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.09 0.404 . . . . 75.230000000000004 112.09 -172.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.66 HG23 ' SD ' ' A' ' 66' ' ' MET . 25.6 mm -89.6 134.32 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.657 -0.247 . . . . 74.510000000000005 111.293 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.406 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.2 p80 -164.61 174.83 10.39 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.655 0.264 . . . . 73.409999999999997 111.664 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 62.72 32.75 15.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.327 0.492 . . . . 73.409999999999997 112.327 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.76 HD11 ' HA3' ' A' ' 97' ' ' GLY . 49.2 mm -66.71 99.48 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.257 -0.429 . . . . 61.32 110.804 175.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.51 151.58 67.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.264 -0.425 . . . . 72.439999999999998 111.196 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.7 149.55 89.47 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.801 2.334 . . . . 74.129999999999995 113.797 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.63 -155.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.841 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.2 ptp -46.23 103.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.66 0.615 . . . . 73.540000000000006 112.66 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -130.2 117.36 19.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 70.430000000000007 111.193 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 161' ' ' LEU . 6.4 mp -100.78 120.16 39.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.954 0.407 . . . . 73.129999999999995 110.698 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.08 163.19 31.37 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.515 -0.311 . . . . 74.129999999999995 111.221 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -52.71 115.55 1.86 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 74.299999999999997 111.437 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -73.74 122.61 22.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.373 -0.376 . . . . 72.510000000000005 111.707 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -100.67 148.71 24.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.423 -0.353 . . . . 73.400000000000006 110.868 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -73.24 171.75 12.43 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.9 0.704 . . . . 74.230000000000004 112.9 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -136.8 -42.41 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.437 -0.801 . . . . 75.420000000000002 110.054 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.862 -0.608 . . . . 71.519999999999996 111.07 175.076 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.964 0.412 . . . . 64.409999999999997 111.262 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.76 129.85 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.845 0.355 . . . . 74.019999999999996 111.583 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.37 137.66 47.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.466 -0.334 . . . . 62.43 110.752 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.55 158.93 27.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.375 0.607 . . . . 74.319999999999993 112.432 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -165.16 142.15 5.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.573 -0.74 . . . . 43.310000000000002 110.299 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.47 177.37 10.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.954 0.406 . . . . 70.430000000000007 111.951 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -159.23 157.33 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 116.117 -0.492 . . . . 73.010000000000005 110.611 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -161.76 129.68 4.14 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.305 -0.247 . . . . 74.120000000000005 110.801 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -128.9 167.19 17.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.467 0.651 . . . . 72.049999999999997 112.467 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.9 156.36 43.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.314 -0.857 . . . . 73.430000000000007 109.679 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -147.38 100.64 3.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.823 0.675 . . . . 71.140000000000001 112.823 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -150.08 133.32 16.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.65 -0.704 . . . . 74.439999999999998 110.277 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.5 p -96.12 105.96 18.08 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.011 0.434 . . . . 73.310000000000002 111.235 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.47 118.57 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.974 0.416 . . . . 70.310000000000002 111.495 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.3 m -115.78 18.62 15.62 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.479 -0.328 . . . . 64.510000000000005 111.377 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -61.32 143.46 55.66 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.547 0.573 . . . . 75.0 112.547 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.8 mt -93.63 135.0 35.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.166 -0.47 . . . . 74.519999999999996 112.179 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -138.17 -91.29 0.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.294 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -138.67 164.73 28.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.043 0.449 . . . . 64.209999999999994 110.929 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -145.81 123.56 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.313 -0.403 . . . . 74.510000000000005 110.189 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -92.53 177.76 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.289 0.566 . . . . 70.340000000000003 112.356 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -83.02 -176.29 6.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.818 -0.628 . . . . 70.319999999999993 111.875 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -105.22 168.95 8.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.2 -0.455 . . . . 71.540000000000006 111.905 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.66 152.83 51.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.283 -0.417 . . . . 73.010000000000005 111.09 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' O ' HG21 ' A' ' 29' ' ' VAL . 25.8 t-20 -61.65 131.29 49.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.602 0.239 . . . . 74.430000000000007 111.2 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.416 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 1.6 mp0 -56.86 -44.57 82.3 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.269 0.47 . . . . 61.450000000000003 112.269 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 39.4 tt0 -58.35 -47.31 84.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.06 0.457 . . . . 73.310000000000002 110.594 176.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.5 m -59.02 -33.63 70.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.077 -0.51 . . . . 70.329999999999998 111.329 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 25' ' ' ASN . 89.6 t -64.49 -45.31 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.602 -0.272 . . . . 74.400000000000006 111.169 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 1.3 mptm? -62.49 -44.44 96.37 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.53 0.205 . . . . 75.109999999999999 111.175 176.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.423 HG22 HG21 ' A' ' 53' ' ' THR . 75.7 mt -54.26 -55.66 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.414 0.626 . . . . 75.219999999999999 110.831 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 89.5 m -56.0 -44.05 78.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.623 -0.717 . . . . 73.420000000000002 111.148 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.81 -44.5 90.84 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.591 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.6 -42.65 93.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.832 0.348 . . . . 74.230000000000004 111.167 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -60.95 -45.27 95.38 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.109 0.48 . . . . 74.030000000000001 111.199 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 32' ' ' THR . 70.9 mtp180 -65.19 -42.54 93.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.11 -0.495 . . . . 73.219999999999999 111.412 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.19 -37.63 86.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.885 0.374 . . . . 75.439999999999998 110.998 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.013 0.435 . . . . 74.230000000000004 110.686 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.54 66.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.292 -0.413 . . . . 50.450000000000003 111.941 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.507 ' NZ ' ' HA ' ' A' ' 109' ' ' ASP . 85.5 mttt -82.84 -18.74 39.35 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.634 0.605 . . . . 73.030000000000001 112.634 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -59.12 115.61 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.867 0.365 . . . . 73.319999999999993 111.97 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -92.07 -27.68 17.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.591 -0.277 . . . . 63.240000000000002 111.55 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 m -117.21 86.39 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.892 0.377 . . . . 71.510000000000005 111.374 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 83.77 -132.95 11.44 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.174 -0.536 . . . . 43.409999999999997 113.359 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.401 HG13 HD13 ' A' ' 57' ' ' LEU . 30.9 m -139.66 154.09 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.171 0.51 . . . . 63.43 111.916 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.42 101.29 10.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.067 -0.515 . . . . 75.030000000000001 111.268 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.534 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 87.1 mt -85.27 133.98 34.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 73.430000000000007 110.815 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.7 mt -107.15 108.55 62.08 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 120.722 0.296 . . . . 65.209999999999994 111.211 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.1 Cg_endo -57.03 -22.92 49.41 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.014 2.476 . . . . 72.25 113.654 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.75 -26.35 71.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.133 -0.556 . . . . 63.420000000000002 113.238 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.66 112.99 17.43 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.697 -0.296 . . . . 71.299999999999997 111.584 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -74.62 75.71 2.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.699 0.762 . . . . 71.310000000000002 111.019 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.423 HG21 HG22 ' A' ' 31' ' ' ILE . 4.4 p -133.05 145.19 55.94 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.751 -0.659 . . . . 72.209999999999994 111.732 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 145.22 33.19 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.008 2.472 . . . . 74.109999999999999 113.711 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.86 153.02 40.18 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.885 -0.598 . . . . 64.439999999999998 110.558 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ttm105 -95.78 117.8 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.925 0.393 . . . . 74.540000000000006 111.463 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD13 HG13 ' A' ' 45' ' ' VAL . 45.7 tp -118.3 124.69 48.41 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.296 0.569 . . . . 75.120000000000005 112.172 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.51 102.44 14.1 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.931 -0.577 . . . . 61.229999999999997 110.584 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 p -94.46 -172.71 2.84 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.222 0.534 . . . . 74.319999999999993 111.792 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.593 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.2 mt-30 -91.99 -2.71 56.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.109 -0.496 . . . . 61.539999999999999 111.296 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -105.72 -19.04 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.001 0.429 . . . . 64.430000000000007 110.901 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.8 160.68 9.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.101 -0.499 . . . . 64.340000000000003 112.651 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -62.53 127.57 31.94 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.152 0.476 . . . . 73.450000000000003 110.678 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.45 165.85 26.31 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.137 0.494 . . . . 72.030000000000001 111.728 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -119.15 114.79 23.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.256 -0.429 . . . . 74.450000000000003 110.763 -176.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.652 ' SD ' HG23 ' A' ' 152' ' ' ILE . 61.7 mtt -104.01 150.9 23.83 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.987 0.422 . . . . 75.310000000000002 112.068 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.3 p -151.61 153.32 34.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.324 -0.398 . . . . 64.040000000000006 111.563 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HB3' HD13 ' A' ' 71' ' ' ILE . 97.4 mt -103.33 112.84 25.91 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.266 -0.425 . . . . 75.310000000000002 111.352 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.639 HG22 ' HB ' ' A' ' 81' ' ' THR . 29.8 m -121.22 156.76 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.863 0.364 . . . . 61.310000000000002 111.646 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 59.89 37.13 21.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.123 -0.49 . . . . 70.430000000000007 111.857 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 68' ' ' LEU . 49.8 mt -69.87 101.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.102 -0.499 . . . . 74.230000000000004 111.903 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 18.0 p -121.23 162.95 33.02 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 115.97 -0.559 . . . . 63.350000000000001 111.574 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 57.5 Cg_endo -69.88 166.43 27.79 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.238 1.959 . . . . 53.039999999999999 113.019 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 30.4 t70 -128.22 165.57 20.21 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.116 -0.493 . . . . 74.319999999999993 110.281 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.23 69.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.049 0.452 . . . . 75.319999999999993 111.413 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.2 -47.55 3.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.204 -0.453 . . . . 61.549999999999997 111.316 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.415 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -136.55 -103.6 0.69 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.804 -0.712 . . . . 61.119999999999997 114.129 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.421 HG22 HD13 ' A' ' 147' ' ' LEU . 96.0 m -143.56 130.96 20.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.245 0.461 . . . . 74.340000000000003 112.245 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 40.0 p -104.36 114.22 28.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.679 0.392 . . . . 65.010000000000005 111.626 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 80' ' ' LEU . 3.1 pp -137.24 149.18 46.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.89 0.376 . . . . 74.150000000000006 111.72 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.639 ' HB ' HG22 ' A' ' 69' ' ' VAL . 48.6 m -93.52 113.64 25.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.047 0.451 . . . . 64.209999999999994 111.353 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.46 112.51 24.18 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.024 -0.535 . . . . 75.299999999999997 110.132 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 32.9 mtp180 -97.27 126.6 42.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.016 0.376 . . . . 74.430000000000007 112.016 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.5 107.23 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.189 -0.459 . . . . 74.109999999999999 110.62 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -106.74 106.59 17.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.727 0.299 . . . . 37.670000000000002 111.051 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.48 129.75 49.28 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.095 -0.574 . . . . 74.409999999999997 113.154 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -81.76 58.92 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.428 0.632 . . . . 72.530000000000001 111.137 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -168.49 -166.43 0.68 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.1 -0.5 . . . . 73.329999999999998 110.638 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -112.01 12.57 20.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.048 0.451 . . . . 74.239999999999995 110.628 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.66 136.1 39.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.1 -0.5 . . . . 71.5 111.975 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.39 95.43 1.04 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.242 1.961 . . . . 74.109999999999999 111.635 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.61 139.87 81.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.251 -0.432 . . . . 63.020000000000003 111.996 -176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.03 174.56 12.62 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.584 2.19 . . . . 70.329999999999998 112.901 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.47 138.69 58.52 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.123 0.487 . . . . 44.140000000000001 111.523 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -138.45 171.36 14.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.376 0.607 . . . . 72.030000000000001 112.292 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.4 p -152.92 156.73 39.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.685 -0.689 . . . . 73.439999999999998 110.746 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.5 -178.12 36.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.909 -0.662 . . . . 71.439999999999998 113.072 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.3 m -108.31 127.3 53.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.816 0.341 . . . . 62.409999999999997 111.441 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.95 123.31 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.206 0.527 . . . . 73.230000000000004 111.416 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.8 mt-10 -104.96 107.69 18.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 75.340000000000003 110.601 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -112.5 129.13 56.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 73.340000000000003 111.897 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.97 -145.78 4.53 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.964 -0.562 . . . . 74.109999999999999 112.835 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.652 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.7 mt-30 -125.71 141.14 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.031 0.443 . . . . 64.120000000000005 112.147 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.35 122.71 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.265 -0.425 . . . . 71.209999999999994 111.349 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.537 ' HG3' ' HB2' ' A' ' 112' ' ' GLN . 3.9 pt20 -111.99 99.76 8.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.474 0.654 . . . . 75.310000000000002 110.39 170.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 154.15 -169.17 32.59 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.038 -0.601 . . . . 72.340000000000003 113.852 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -100.43 -165.15 1.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.098 0.475 . . . . 73.230000000000004 111.753 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -72.19 -21.38 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.182 0.515 . . . . 73.329999999999998 111.185 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.507 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 37.6 t70 -105.89 -39.63 5.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 63.420000000000002 111.874 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.49 91.77 3.59 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 75.519999999999996 111.483 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.604 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 40.0 p90 -127.93 143.45 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.964 0.412 . . . . 75.439999999999998 111.751 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.537 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 49.6 mt-30 -118.24 133.69 55.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 73.030000000000001 111.688 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -88.14 109.7 20.1 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.317 -0.401 . . . . 71.510000000000005 110.951 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 pt -123.81 162.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 111.886 0.328 . . . . 70.409999999999997 111.886 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 53.42 28.95 8.1 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.514 0.561 . . . . 72.209999999999994 112.514 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 p -90.17 138.96 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.823 0.675 . . . . 55.520000000000003 112.823 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -124.66 151.8 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.493 -0.776 . . . . 74.439999999999998 110.525 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.29 132.08 54.06 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.337 0.589 . . . . 71.25 111.75 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -129.69 156.27 44.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.035 -0.53 . . . . 61.409999999999997 110.202 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.6 mt -96.83 119.92 36.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 73.310000000000002 111.145 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.71 HG21 HD23 ' A' ' 137' ' ' LEU . 15.4 pt -99.65 100.76 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.337 0.589 . . . . 65.430000000000007 111.732 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.19 131.67 50.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.006 -0.543 . . . . 75.030000000000001 110.268 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.22 148.32 65.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.394 0.516 . . . . 71.340000000000003 112.394 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.2 175.45 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.116 2.544 . . . . 73.209999999999994 113.42 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.04 144.47 29.04 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.803 0.668 . . . . 75.120000000000005 112.803 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.6 m -87.72 102.72 14.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.203 -0.453 . . . . 72.010000000000005 110.374 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.0 m -80.6 -14.04 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.404 0.52 . . . . 71.129999999999995 112.404 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 128' ' ' LEU . 2.0 pt? -138.81 -179.79 6.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.906 0.384 . . . . 64.519999999999996 111.233 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.95 144.52 28.75 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.533 -0.303 . . . . 72.150000000000006 111.469 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.36 170.48 53.79 Favored 'Cis proline' 0 C--N 1.352 0.724 0 C-N-CA 123.932 -1.278 . . . . 70.310000000000002 112.825 -0.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 t -86.58 85.92 7.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 63.030000000000001 111.378 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.56 122.85 48.88 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.859 -0.422 . . . . 75.019999999999996 109.859 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -135.35 112.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.12 -0.362 . . . . 74.019999999999996 111.198 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -112.81 134.79 54.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.321 0.581 . . . . 74.140000000000001 111.96 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -125.31 133.45 24.86 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.813 -0.63 . . . . 73.420000000000002 112.345 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.32 111.81 3.4 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.851 2.367 . . . . 63.539999999999999 112.439 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.71 HD23 HG21 ' A' ' 121' ' ' ILE . 23.6 mt -94.4 141.1 28.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 73.420000000000002 112.63 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.05 92.79 3.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.663 -0.699 . . . . 74.340000000000003 110.21 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.4 mt -77.13 132.16 38.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.125 -0.488 . . . . 64.329999999999998 110.775 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -96.31 145.89 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.536 0.569 . . . . 64.230000000000004 112.536 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 56.98 31.48 61.47 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.064 0.786 . . . . 64.010000000000005 115.064 172.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.1 tt -152.09 127.97 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 117.602 0.701 . . . . 75.420000000000002 111.606 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.4 m -86.83 144.24 27.11 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.306 -0.407 . . . . 50.030000000000001 111.709 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.31 -44.24 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.631 0.604 . . . . 73.319999999999993 112.631 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.56 -21.62 66.45 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.025 0.441 . . . . 75.209999999999994 111.417 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.434 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 81.6 mm-40 -107.1 10.63 30.13 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.084 0.401 . . . . 71.409999999999997 112.084 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.546 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.9 mt -68.84 115.26 7.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.785 0.326 . . . . 74.409999999999997 111.499 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -89.73 -49.39 3.39 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.168 -0.539 . . . . 63.119999999999997 113.298 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.16 157.37 38.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.246 0.546 . . . . 70.329999999999998 112.273 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 60.8 t -124.23 98.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.709 -0.678 . . . . 73.209999999999994 110.1 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.615 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 70.2 ttt180 -90.25 101.28 14.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.305 -0.407 . . . . 73.299999999999997 111.739 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.652 HG23 ' SD ' ' A' ' 66' ' ' MET . 33.2 mm -94.22 132.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 122.273 -0.267 . . . . 53.509999999999998 111.56 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.76 172.36 13.11 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.411 0.523 . . . . 73.319999999999993 112.411 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 65.09 22.23 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.313 0.857 . . . . 74.200000000000003 113.313 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.571 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.8 mm -63.62 101.81 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.112 0.482 . . . . 54.0 111.499 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.593 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 12.1 pt20 -129.17 159.21 70.11 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.071 -0.513 . . . . 75.349999999999994 111.174 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 156' ' ' GLN . 74.0 Cg_endo -73.01 150.96 49.51 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.157 1.905 . . . . 73.349999999999994 113.134 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.46 -153.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 116.162 -0.472 . . . . 62.100000000000001 110.889 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -50.87 94.17 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.466 0.65 . . . . 63.310000000000002 111.732 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.74 153.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.022 -0.536 . . . . 74.349999999999994 111.255 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.42 ' N ' HD22 ' A' ' 161' ' ' LEU . 3.1 mm? -71.83 132.48 44.49 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.984 0.421 . . . . 72.510000000000005 111.847 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.78 142.65 57.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.161 0.505 . . . . 62.5 112.161 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -116.75 82.42 1.79 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.168 -0.469 . . . . 71.420000000000002 110.322 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -85.23 115.7 23.16 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.842 0.682 . . . . 71.349999999999994 112.842 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -115.67 140.52 49.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.044 -0.525 . . . . 73.010000000000005 110.531 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -66.21 90.61 0.15 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.862 0.69 . . . . 74.030000000000001 112.862 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -126.01 28.21 6.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.056 -0.52 . . . . 75.109999999999999 110.525 170.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.919 -0.562 . . . . 64.200000000000003 111.461 177.689 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.889 0.376 . . . . 74.109999999999999 111.149 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.05 106.06 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.333 -0.394 . . . . 64.239999999999995 110.776 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -108.75 170.43 8.04 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.734 0.302 . . . . 74.409999999999997 110.844 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.88 163.98 39.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.066 0.46 . . . . 74.140000000000001 111.979 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -140.35 133.71 29.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.271 -0.422 . . . . 72.430000000000007 110.987 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -136.64 159.54 41.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.705 0.288 . . . . 64.140000000000001 111.04 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.94 125.43 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.263 0.554 . . . . 72.540000000000006 111.659 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -81.34 142.31 33.17 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.33 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -56.73 148.78 19.42 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.237 0.541 . . . . 64.340000000000003 112.257 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 10' ' ' MET . 1.3 mpt? -65.17 171.38 3.76 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.336 0.865 . . . . 72.150000000000006 113.336 -173.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -73.11 95.38 2.05 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.379 -0.828 . . . . 72.209999999999994 111.323 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -67.79 139.04 56.6 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.189 -0.459 . . . . 63.439999999999998 111.374 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.6 p -70.24 149.16 47.75 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.972 0.415 . . . . 73.450000000000003 111.485 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.67 -178.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.276 0.56 . . . . 73.140000000000001 112.488 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.4 t -134.81 176.42 8.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.907 -0.588 . . . . 73.219999999999999 110.203 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 t -161.08 149.47 15.99 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.978 0.732 . . . . 75.239999999999995 112.978 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt -119.4 116.2 25.67 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.822 -0.626 . . . . 73.099999999999994 109.721 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -81.07 178.69 8.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.477 0.547 . . . . 73.120000000000005 112.477 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -85.03 -172.07 3.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.322 -0.399 . . . . 73.109999999999999 111.91 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HG2' ' N ' ' A' ' 21' ' ' MET . 31.5 tt0 -70.43 159.73 33.67 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.919 0.39 . . . . 73.0 111.655 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.469 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 83.3 mtp -56.12 158.05 4.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.735 0.642 . . . . 74.430000000000007 112.735 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -143.35 -175.28 4.48 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.056 -0.52 . . . . 70.409999999999997 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.02 167.43 19.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.248 0.547 . . . . 75.129999999999995 112.392 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.36 139.76 35.14 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.99 -0.55 . . . . 71.310000000000002 112.341 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -109.16 149.71 28.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.128 -0.487 . . . . 72.230000000000004 110.694 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -59.09 -34.87 72.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.078 0.466 . . . . 74.239999999999995 110.714 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 25.1 tt0 -63.05 -43.22 99.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.088 -0.506 . . . . 75.230000000000004 110.861 173.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -35.07 70.22 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.13 0.49 . . . . 71.430000000000007 110.776 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.9 -44.76 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.205 -0.452 . . . . 71.299999999999997 110.893 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -61.05 -39.84 91.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.657 0.265 . . . . 71.329999999999998 110.969 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.99 -48.19 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.081 0.467 . . . . 73.420000000000002 110.967 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.5 m -57.18 -49.5 75.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.132 0.491 . . . . 73.439999999999998 110.903 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' HG3' HD12 ' A' ' 108' ' ' ILE . 63.6 tt0 -59.49 -43.73 93.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.964 -0.562 . . . . 75.150000000000006 111.337 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.39 -51.97 66.33 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.748 0.419 . . . . 73.439999999999998 111.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -58.95 -44.76 91.49 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.986 0.365 . . . . 63.229999999999997 111.986 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -63.98 -49.3 73.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.61 0.226 . . . . 75.019999999999996 111.61 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 48' ' ' LEU . 73.6 mt -60.58 -41.35 94.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.322 0.582 . . . . 64.219999999999999 110.883 176.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.452 HD22 ' HB ' ' A' ' 45' ' ' VAL . 11.8 t-20 -58.37 -46.22 86.73 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.702 -0.681 . . . . 64.239999999999995 110.846 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.45 -25.6 63.26 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.046 -0.525 . . . . 74.230000000000004 111.965 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -83.37 -14.78 52.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.035 0.383 . . . . 73.239999999999995 112.035 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 44.2 t -64.22 137.0 57.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.343 0.497 . . . . 73.439999999999998 112.343 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -108.93 8.89 26.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.206 -0.452 . . . . 71.049999999999997 111.047 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -160.64 117.86 2.42 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.235 -0.439 . . . . 74.530000000000001 110.903 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.34 -170.46 15.93 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.332 -0.461 . . . . 75.329999999999998 113.661 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.452 ' HB ' HD22 ' A' ' 38' ' ' ASN . 31.6 m -115.87 140.5 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.318 -0.519 . . . . 73.430000000000007 112.104 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 40.9 m-85 -89.75 118.7 29.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.313 -0.403 . . . . 73.349999999999994 111.465 175.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.9 123.4 50.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.908 0.483 . . . . 75.420000000000002 109.937 171.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD13 HD11 ' A' ' 37' ' ' LEU . 68.4 mt -101.66 121.73 50.15 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.279 0.474 . . . . 63.340000000000003 112.279 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -56.66 130.7 41.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.324 2.016 . . . . 73.349999999999994 111.725 173.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . 95.18 19.68 29.98 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.832 -0.622 . . . . 44.140000000000001 112.309 -172.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . . . -142.78 100.26 3.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.461 0.305 . . . . 63.240000000000002 111.584 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.45 76.1 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.12 -0.362 . . . . 71.230000000000004 111.634 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -149.58 137.31 11.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 112.368 0.507 . . . . 75.349999999999994 112.368 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HB2' ' HB3' ' A' ' 65' ' ' ARG . 91.7 Cg_endo -78.36 145.17 21.05 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.165 2.577 . . . . 72.540000000000006 113.639 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -112.51 139.16 48.32 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 54.310000000000002 110.89 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 21.3 ttp85 -81.97 100.37 9.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.846 0.355 . . . . 73.519999999999996 111.486 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 HG12 ' A' ' 45' ' ' VAL . 59.7 tp -96.7 112.16 24.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.274 0.559 . . . . 74.25 111.085 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.89 92.42 9.0 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.86 -0.609 . . . . 74.209999999999994 110.35 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 p -100.41 -175.89 3.05 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.913 0.708 . . . . 64.120000000000005 112.913 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -69.77 -34.6 74.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.523 -0.762 . . . . 74.439999999999998 112.092 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 157' ' ' PRO . 37.0 pt -76.91 -29.06 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.218 0.532 . . . . 53.219999999999999 111.183 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.24 -161.88 31.08 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.566 -0.743 . . . . 40.009999999999998 111.831 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 m -101.93 119.55 38.97 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.374 -0.486 . . . . 71.030000000000001 111.341 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 57' ' ' LEU . 2.2 pp -131.61 152.71 50.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.982 0.42 . . . . 74.5 111.318 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 85.5 mtt180 -116.52 114.49 24.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.884 0.373 . . . . 54.409999999999997 111.218 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.636 ' SD ' HG22 ' A' ' 152' ' ' ILE . 64.1 mtt -99.04 142.19 30.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.277 -0.42 . . . . 71.430000000000007 111.52 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.9 p -136.16 148.32 48.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.119 0.485 . . . . 70.219999999999999 111.963 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.8 mt -99.93 112.24 24.52 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.122 -0.49 . . . . 75.040000000000006 111.671 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 81' ' ' THR . 17.7 m -134.12 164.57 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 122.391 -0.193 . . . . 71.439999999999998 111.099 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.54 HD21 HG22 ' A' ' 69' ' ' VAL . 40.4 m-80 62.84 29.41 16.63 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.899 0.38 . . . . 55.439999999999998 111.675 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.05 110.68 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.803 0.335 . . . . 62.509999999999998 111.309 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -142.85 155.46 62.8 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.539 0.57 . . . . 75.010000000000005 112.539 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.7 157.91 21.93 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.226 2.617 . . . . 61.329999999999998 113.348 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.53 163.88 35.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.085 0.469 . . . . 65.040000000000006 111.905 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.81 70.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.139 -0.482 . . . . 41.340000000000003 111.864 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 8.8 m-20 -71.59 -43.4 66.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.079 0.466 . . . . 61.549999999999997 110.881 175.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.53 -77.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.968 -0.634 . . . . 71.120000000000005 112.911 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.8 m -149.68 138.49 20.99 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.834 0.35 . . . . 75.239999999999995 111.705 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.7 p -122.09 142.48 50.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.989 0.423 . . . . 75.430000000000007 111.401 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.25 152.75 36.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.226 -0.443 . . . . 52.299999999999997 111.549 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.59 ' HB ' HG22 ' A' ' 69' ' ' VAL . 39.0 m -84.34 103.61 13.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.743 0.306 . . . . 73.329999999999998 110.679 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.66 103.06 11.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.636 -0.505 . . . . 62.140000000000001 109.636 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.595 ' HB3' HE22 ' A' ' 85' ' ' GLN . 92.8 mtt-85 -88.83 135.09 33.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.841 0.353 . . . . 64.420000000000002 111.615 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -116.67 99.46 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 74.239999999999995 110.72 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.595 HE22 ' HB3' ' A' ' 83' ' ' ARG . 22.8 mp0 -93.89 109.56 21.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.957 0.408 . . . . 74.430000000000007 111.235 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.31 130.11 37.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.246 -0.502 . . . . 52.030000000000001 112.871 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -73.26 -13.72 61.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.26 0.552 . . . . 61.130000000000003 110.987 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.9 p -107.4 144.79 33.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 110.712 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.27 -17.76 51.26 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.859 0.318 . . . . 75.230000000000004 111.859 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.95 147.39 95.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.349 -0.387 . . . . 73.099999999999994 111.41 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.9 117.21 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.313 2.009 . . . . 72.310000000000002 112.936 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 126' ' ' SER . 93.0 mt -82.0 155.85 69.92 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 120.859 0.361 . . . . 73.439999999999998 111.433 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 -177.45 3.53 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.276 1.984 . . . . 72.129999999999995 112.621 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 158' ' ' VAL . . . -77.99 158.44 29.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.757 0.313 . . . . 72.019999999999996 110.948 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -152.84 149.14 27.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.712 0.768 . . . . 72.420000000000002 112.628 -174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -133.64 162.76 31.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.204 -0.907 . . . . 72.430000000000007 110.238 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.92 -158.26 18.48 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.369 -0.92 . . . . 73.209999999999994 113.591 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.3 m -136.33 145.72 45.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.01 0.434 . . . . 73.230000000000004 111.324 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.68 128.34 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.045 0.45 . . . . 72.120000000000005 112.056 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.796 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 17.6 mm-40 -89.58 110.45 21.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.966 -0.561 . . . . 65.209999999999994 110.246 175.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.404 ' CG ' HD22 ' A' ' 139' ' ' LEU . 31.0 p90 -121.85 124.44 44.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.437 0.637 . . . . 65.510000000000005 111.736 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.66 -140.89 3.05 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.563 -0.744 . . . . 63.200000000000003 112.673 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.564 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 96.5 mt-30 -126.73 163.76 22.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.188 0.518 . . . . 74.150000000000006 111.872 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.77 114.79 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.227 -0.442 . . . . 72.150000000000006 111.107 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -92.48 -9.46 41.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.811 0.3 . . . . 74.129999999999995 111.811 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -91.05 178.59 42.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.09 -0.576 . . . . 36.689999999999998 113.785 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.3 p -85.76 -165.56 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.879 0.371 . . . . 70.329999999999998 111.483 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.482 HD12 ' HG3' ' A' ' 33' ' ' GLN . 41.9 mm -74.25 -31.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.908 0.385 . . . . 74.450000000000003 111.364 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.82 -43.87 8.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.782 0.325 . . . . 72.329999999999998 111.462 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -115.51 96.41 5.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.535 0.683 . . . . 73.239999999999995 111.301 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.684 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 9.3 p90 -121.41 144.1 48.86 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.852 -0.613 . . . . 75.230000000000004 111.899 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -120.09 127.01 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.661 -0.699 . . . . 72.129999999999995 111.114 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.89 99.18 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 55.240000000000002 110.611 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 pt -107.51 150.39 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.424 -0.353 . . . . 53.5 111.501 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 56.63 29.14 15.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.053 0.454 . . . . 44.020000000000003 111.851 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 100' ' ' GLU . 6.0 p -90.57 132.35 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.483 0.549 . . . . 60.200000000000003 112.483 -176.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -116.56 154.41 30.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 73.239999999999995 110.265 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -107.56 132.73 52.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.116 0.484 . . . . 74.209999999999994 112.055 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -122.65 142.13 51.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.413 -0.358 . . . . 74.25 111.281 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.82 102.76 13.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.976 0.417 . . . . 71.25 111.721 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.59 140.21 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.219 0.533 . . . . 70.549999999999997 112.023 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -130.3 148.46 52.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.448 -0.342 . . . . 72.019999999999996 110.812 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.86 144.77 48.02 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 111.935 0.346 . . . . 75.430000000000007 111.935 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -64.81 167.5 15.47 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.143 2.562 . . . . 72.109999999999999 113.648 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.14 128.9 34.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.131 -0.486 . . . . 62.25 112.11 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 66.1 m -79.69 75.73 6.35 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.164 0.507 . . . . 70.109999999999999 110.606 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.29 -30.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.239 0.543 . . . . 74.109999999999999 111.15 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.89 159.58 14.9 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.949 -0.569 . . . . 72.400000000000006 111.086 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.79 146.9 47.03 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.441 -0.345 . . . . 52.340000000000003 111.419 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.95 171.68 58.53 Favored 'Cis proline' 0 C--N 1.353 0.771 0 C-N-CA 124.331 -1.112 . . . . 73.219999999999999 112.753 -1.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 90.73 3.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.156 0.503 . . . . 72.430000000000007 111.477 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.71 84.83 2.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.268 0.556 . . . . 62.420000000000002 109.877 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.8 t -102.34 156.77 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 70.040000000000006 111.893 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 10.3 p-10 -150.13 108.71 3.82 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.192 0.52 . . . . 65.230000000000004 110.699 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.0 pt -113.32 135.27 21.81 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.119 -0.363 . . . . 52.020000000000003 111.821 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.9 119.5 5.9 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.296 1.998 . . . . 60.439999999999998 112.986 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.74 123.33 42.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.101 -0.5 . . . . 72.019999999999996 110.203 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -105.59 105.19 15.11 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.073 0.463 . . . . 64.150000000000006 111.326 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.404 HD22 ' CG ' ' A' ' 101' ' ' TYR . 70.1 mt -91.62 130.08 37.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.383 -0.371 . . . . 75.409999999999997 111.192 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 67.3 mttm -106.64 145.13 32.33 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.122 0.415 . . . . 75.019999999999996 112.122 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.92 27.23 73.7 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.343 -0.456 . . . . 71.439999999999998 113.998 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.4 tt -155.59 122.52 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.472 0.653 . . . . 72.230000000000004 111.802 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.2 m -85.46 148.01 26.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.122 -0.49 . . . . 75.530000000000001 111.283 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.81 -34.79 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.795 0.331 . . . . 72.450000000000003 111.884 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.01 -29.08 66.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.063 0.459 . . . . 64.420000000000002 111.587 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -109.35 10.77 25.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.044 0.387 . . . . 74.019999999999996 112.044 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 3.2 mt -74.01 114.73 12.66 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 71.040000000000006 111.63 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.58 -59.2 1.65 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.241 -0.504 . . . . 36.689999999999998 112.996 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -149.77 157.58 43.34 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.385 0.612 . . . . 75.109999999999999 112.48 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 96.2 t -126.23 107.73 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.261 -0.881 . . . . 75.439999999999998 109.552 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.796 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.8 ttt180 -109.63 108.31 18.68 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.244 0.461 . . . . 74.219999999999999 112.244 -171.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.636 HG22 ' SD ' ' A' ' 66' ' ' MET . 36.0 mm -86.5 132.07 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 111.59 0.219 . . . . 73.230000000000004 111.59 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.62 178.83 8.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.745 0.307 . . . . 70.040000000000006 111.746 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 65.44 19.99 11.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.934 0.716 . . . . 70.129999999999995 112.934 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -65.56 117.74 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.279 0.562 . . . . 75.129999999999995 111.716 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -130.37 153.3 81.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 111.57 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.566 ' HB3' HG21 ' A' ' 61' ' ' ILE . 66.4 Cg_endo -73.66 117.31 5.0 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.553 2.169 . . . . 61.409999999999997 113.385 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 5.7 p -110.55 122.16 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.353 0.597 . . . . 72.219999999999999 110.997 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 21.1 ptp -161.44 177.7 9.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 51.009999999999998 111.358 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -60.49 131.02 49.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.985 0.422 . . . . 73.230000000000004 110.715 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.433 ' N ' HD13 ' A' ' 161' ' ' LEU . 6.7 mp -72.62 87.34 1.22 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.651 0.611 . . . . 74.109999999999999 112.651 -173.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.01 127.13 32.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.653 -0.499 . . . . 63.310000000000002 109.653 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -56.9 115.89 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.178 0.513 . . . . 75.140000000000001 111.649 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -72.18 130.32 40.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.746 -0.661 . . . . 73.510000000000005 111.847 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -105.84 92.72 4.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 72.129999999999995 111.902 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -79.33 126.72 31.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.341 -0.391 . . . . 73.140000000000001 110.11 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 68.41 87.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.992 0.425 . . . . 75.099999999999994 110.913 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.728 -0.653 . . . . 71.120000000000005 111.964 176.378 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.86 0.362 . . . . 64.439999999999998 111.174 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -102.97 154.62 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.865 0.364 . . . . 73.099999999999994 111.613 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -153.65 90.91 1.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.209 0.528 . . . . 74.239999999999995 110.718 175.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.1 154.37 20.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.055 -0.52 . . . . 75.450000000000003 111.106 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -148.34 161.52 41.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.963 0.411 . . . . 61.140000000000001 111.729 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.63 133.66 53.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.202 -0.454 . . . . 62.210000000000001 111.432 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.5 m -100.3 126.91 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.988 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -131.28 151.1 51.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.181 0.515 . . . . 72.230000000000004 112.059 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -78.95 163.65 25.06 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.091 -0.504 . . . . 74.340000000000003 111.732 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.4 mmt -120.33 -175.16 2.94 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.33 0.586 . . . . 71.530000000000001 112.35 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -85.81 156.18 20.68 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.889 -0.596 . . . . 72.120000000000005 112.424 -171.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -133.04 143.71 49.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.015 0.436 . . . . 73.219999999999999 111.467 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -92.12 176.5 6.47 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.155 -0.475 . . . . 54.399999999999999 112.176 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.59 119.13 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.165 0.507 . . . . 73.209999999999994 111.118 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -86.91 141.67 28.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.39 -0.368 . . . . 74.129999999999995 111.718 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.0 p -126.5 179.02 5.52 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.149 0.5 . . . . 75.109999999999999 112.046 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.33 117.91 9.97 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 112.003 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 18' ' ' ASN . 0.9 OUTLIER -89.06 148.75 23.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.134 0.492 . . . . 74.420000000000002 111.274 176.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -99.97 -165.23 1.2 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.908 -0.587 . . . . 72.25 111.628 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.08 92.17 0.17 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.949 0.404 . . . . 75.230000000000004 110.659 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.7 mtt -128.34 -168.16 1.87 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.965 0.412 . . . . 63.32 111.633 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 p -77.44 -172.65 2.59 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.159 0.504 . . . . 73.5 112.036 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.3 126.85 29.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.207 -0.451 . . . . 75.140000000000001 111.056 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -133.32 163.03 30.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.784 0.326 . . . . 55.439999999999998 111.004 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -50.02 124.71 10.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 110.863 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.439 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 29.9 mm-40 -60.81 -18.24 54.33 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.393 0.516 . . . . 75.540000000000006 112.393 -175.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.0 tt0 -58.08 -63.55 1.22 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.87 0.367 . . . . 60.399999999999999 110.485 171.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.547 ' HA ' HD12 ' A' ' 31' ' ' ILE . 39.7 m -61.21 -30.38 70.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.947 0.403 . . . . 74.439999999999998 111.553 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.2 -47.6 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.788 0.327 . . . . 75.430000000000007 110.839 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 6.0 mptp? -64.54 -30.09 71.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 72.209999999999994 111.335 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 28' ' ' THR . 82.6 mt -62.62 -48.31 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.249 0.547 . . . . 63.200000000000003 110.791 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -64.68 -41.35 96.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.197 0.522 . . . . 74.129999999999995 110.738 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.492 ' HG3' HD11 ' A' ' 108' ' ' ILE . 57.7 tt0 -57.5 -47.59 81.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.797 -0.638 . . . . 73.239999999999995 111.102 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.23 -47.12 75.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 72.25 111.331 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.75 -27.45 68.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.224 -0.444 . . . . 70.109999999999999 111.974 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -77.29 -36.21 54.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.076 -0.39 . . . . 65.340000000000003 111.22 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.0 -36.12 82.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.303 0.573 . . . . 65.400000000000006 110.038 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -57.17 -41.48 79.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.752 -0.658 . . . . 74.25 110.465 172.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.96 76.92 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.283 0.475 . . . . 37.18 112.283 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 109' ' ' ASP . 51.9 mttp -87.67 -9.25 54.71 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.647 0.61 . . . . 74.0 112.647 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.4 t -63.27 123.03 17.63 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.133 0.492 . . . . 74.230000000000004 112.152 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t -88.42 -30.08 19.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.104 0.478 . . . . 73.329999999999998 111.166 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -146.73 107.13 4.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.236 -0.438 . . . . 42.219999999999999 110.854 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 93.3 -143.64 16.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.084 -0.579 . . . . 74.439999999999998 113.104 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.761 HG11 HD12 ' A' ' 57' ' ' LEU . 16.4 m -143.27 153.52 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.34 0.59 . . . . 63.109999999999999 112.198 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -101.25 105.46 16.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.612 -0.722 . . . . 75.230000000000004 110.964 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 98.9 mt -95.23 136.65 35.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.737 0.303 . . . . 73.120000000000005 110.904 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.2 mt -109.81 130.95 22.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.292 -0.255 . . . . 65.140000000000001 111.428 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HB3' HD12 ' A' ' 147' ' ' LEU . 33.0 Cg_endo -62.58 -27.78 76.76 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.604 2.202 . . . . 61.240000000000002 112.714 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.79 -23.54 72.14 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.139 -0.553 . . . . 37.18 112.412 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.23 73.92 1.53 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.149 0.5 . . . . 74.109999999999999 111.314 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -66.6 74.56 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.357 0.599 . . . . 63.350000000000001 110.845 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 p -148.97 159.27 37.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.771 -0.65 . . . . 42.310000000000002 112.38 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.12 149.87 28.88 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.027 2.485 . . . . 72.120000000000005 113.756 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 145.86 49.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.397 -0.365 . . . . 71.450000000000003 111.226 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -82.44 134.93 35.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.446 -0.343 . . . . 72.129999999999995 111.057 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.761 HD12 HG11 ' A' ' 45' ' ' VAL . 37.0 tp -143.53 136.56 27.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.558 0.577 . . . . 75.109999999999999 112.558 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.59 143.15 27.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.91 -0.586 . . . . 71.450000000000003 110.363 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -140.52 170.98 14.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.226 0.536 . . . . 74.5 111.673 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.641 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.0 mt-30 -77.51 5.76 8.37 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.074 -0.512 . . . . 71.329999999999998 112.101 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -112.0 -22.13 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.851 0.358 . . . . 62.200000000000003 110.837 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.03 -160.71 29.24 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.287 -0.415 . . . . 64.319999999999993 112.668 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.6 m -92.91 135.43 34.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.394 -0.474 . . . . 73.540000000000006 110.771 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.2 178.53 7.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.408 0.623 . . . . 37.18 112.619 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -136.29 107.06 6.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.744 -0.662 . . . . 65.040000000000006 111.013 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.707 ' SD ' HG22 ' A' ' 152' ' ' ILE . 58.3 mtt -96.04 170.17 9.47 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.049 -0.407 . . . . 75.140000000000001 111.879 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.6 p -169.08 152.74 5.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.033 0.383 . . . . 54.210000000000001 112.033 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.32 114.81 29.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.155 -0.475 . . . . 75.439999999999998 111.363 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG22 ' HB ' ' A' ' 81' ' ' THR . 26.9 m -128.79 164.09 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.731 0.3 . . . . 75.530000000000001 111.41 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 59.1 42.52 18.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.167 0.508 . . . . 62.43 112.036 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.9 mt -82.45 109.68 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.038 -0.528 . . . . 73.430000000000007 111.782 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 p -131.22 155.16 81.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 120.977 0.418 . . . . 73.200000000000003 112.124 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.49 136.43 33.69 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.767 2.311 . . . . 52.539999999999999 112.757 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.619 ' HB2' HG22 ' A' ' 79' ' ' THR . 32.8 t70 -115.4 164.78 13.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.841 0.456 . . . . 74.530000000000001 111.145 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.94 74.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.098 0.407 . . . . 53.109999999999999 112.098 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.88 -17.6 16.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.137 0.421 . . . . 62.450000000000003 112.137 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.3 -103.02 0.16 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.476 -0.869 . . . . 37.18 114.23 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.4 m -149.73 125.54 10.47 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.565 -0.373 . . . . 73.010000000000005 111.449 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 74' ' ' ASP . 39.4 p -101.66 124.73 47.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.806 0.336 . . . . 75.239999999999995 111.888 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 137' ' ' LEU . 3.4 pp -138.2 177.67 7.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.797 0.332 . . . . 73.109999999999999 111.252 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 69' ' ' VAL . 60.0 m -122.52 126.54 48.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.801 0.334 . . . . 73.120000000000005 111.472 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.6 114.02 25.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.89 -0.411 . . . . 73.209999999999994 109.89 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 97.2 mtt180 -104.53 110.05 22.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.287 0.477 . . . . 63.210000000000001 112.287 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -102.72 112.37 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 64.519999999999996 111.573 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 131' ' ' SER . 34.7 tt0 -98.52 141.8 30.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.568 0.223 . . . . 63.200000000000003 111.026 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.6 144.05 22.94 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.039 -0.6 . . . . 75.030000000000001 113.101 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.09 -40.67 96.62 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.974 0.416 . . . . 75.239999999999995 110.857 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.9 p -96.78 -177.66 3.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.219 0.533 . . . . 51.240000000000002 111.38 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -92.9 6.95 45.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.305 -0.407 . . . . 74.129999999999995 111.248 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.45 135.38 68.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.485 -0.325 . . . . 72.109999999999999 111.784 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 96.68 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.139 1.892 . . . . 64.420000000000002 111.801 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.75 141.3 89.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.33 0.492 . . . . 71.319999999999993 112.33 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.11 177.58 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.663 2.242 . . . . 75.430000000000007 112.929 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.3 134.4 46.75 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.013 0.435 . . . . 62.399999999999999 111.651 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.65 160.95 39.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.138 0.494 . . . . 74.540000000000006 111.954 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 92.3 p -138.71 168.8 19.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.171 -0.468 . . . . 55.340000000000003 111.059 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.616 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.2 165.25 37.08 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.023 -0.608 . . . . 54.200000000000003 113.337 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.6 m -98.98 107.84 20.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.91 0.386 . . . . 64.150000000000006 111.544 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 119' ' ' GLN . 3.2 p -89.83 112.97 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.202 0.525 . . . . 54.329999999999998 111.097 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 117' ' ' GLN . 47.5 mt-10 -102.6 103.56 13.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.277 0.56 . . . . 75.430000000000007 110.956 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' CD1' HD23 ' A' ' 139' ' ' LEU . 19.0 p90 -104.27 137.97 41.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.814 -0.63 . . . . 74.430000000000007 111.579 -175.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.09 -145.5 4.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.697 -0.763 . . . . 52.240000000000002 113.592 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.598 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.5 mt-30 -129.44 161.35 30.59 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.885 0.374 . . . . 64.239999999999995 111.363 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 111' ' ' PHE . 51.9 mt -122.34 140.11 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.073 0.463 . . . . 73.25 112.102 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.741 HE21 HD11 ' A' ' 114' ' ' ILE . 10.9 pt20 -132.03 103.53 6.33 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.489 0.661 . . . . 65.519999999999996 110.79 169.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 157.56 -158.54 29.09 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.156 -0.545 . . . . 62.439999999999998 113.606 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 33.4 p -98.82 -170.71 1.97 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.517 -0.402 . . . . 71.140000000000001 111.073 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 33' ' ' GLN . 34.0 mm -76.12 -15.41 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.31 0.576 . . . . 54.450000000000003 110.766 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.709 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 40.7 m-20 -105.2 -45.94 4.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.104 -0.498 . . . . 74.239999999999995 111.512 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -116.03 92.88 4.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.377 0.608 . . . . 73.010000000000005 111.097 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 104' ' ' ILE . 38.2 p90 -127.33 132.2 50.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.131 0.491 . . . . 74.5 111.809 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -96.49 124.44 40.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.087 -0.506 . . . . 72.319999999999993 111.149 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.82 97.73 11.08 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.138 -0.483 . . . . 72.420000000000002 111.007 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.741 HD11 HE21 ' A' ' 105' ' ' GLN . 36.8 pt -103.53 162.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.126 -0.488 . . . . 72.409999999999997 112.043 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 53.77 22.18 3.07 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 64.420000000000002 112.61 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.57 131.77 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.366 0.603 . . . . 75.310000000000002 112.202 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 34.0 mt-30 -128.15 146.41 50.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.665 -0.698 . . . . 74.530000000000001 110.814 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.03 143.13 28.9 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.263 0.554 . . . . 71.209999999999994 112.267 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.57 ' HB3' HG11 ' A' ' 99' ' ' VAL . 8.4 tt0 -142.23 149.44 39.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.782 -0.645 . . . . 74.019999999999996 110.174 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -100.28 114.41 27.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.138 0.494 . . . . 74.310000000000002 112.231 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.92 121.94 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.113 -0.494 . . . . 65.409999999999997 111.17 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -113.46 135.65 53.65 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.902 0.382 . . . . 73.310000000000002 111.37 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.515 ' HB3' HG13 ' A' ' 133' ' ' VAL . . . -124.1 140.07 34.01 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.234 -0.439 . . . . 72.219999999999999 111.476 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.16 169.66 21.94 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.589 2.193 . . . . 72.019999999999996 113.623 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.13 134.79 34.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 55.210000000000001 111.523 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 m -77.39 124.06 27.36 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.386 -0.37 . . . . 73.239999999999995 111.419 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.28 -42.52 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.103 0.478 . . . . 74.230000000000004 110.973 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -125.81 171.58 10.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 75.150000000000006 111.83 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.11 158.79 31.07 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.263 -0.426 . . . . 71.230000000000004 111.483 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.0 160.14 57.98 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.015 -1.244 . . . . 72.25 113.129 -2.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 58.8 m -86.17 78.07 9.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.494 0.553 . . . . 60.009999999999998 112.494 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.78 79.42 2.23 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.427 -0.583 . . . . 64.349999999999994 109.427 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 135' ' ' ILE . 40.6 t -76.68 99.78 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.402 -0.363 . . . . 75.439999999999998 111.818 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.8 p-10 -91.27 106.84 18.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.033 0.444 . . . . 52.25 110.97 174.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 133' ' ' VAL . 26.9 pt -114.08 131.54 23.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.972 0.36 . . . . 74.310000000000002 111.972 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.58 135.69 54.35 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.722 2.281 . . . . 71.040000000000006 112.381 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.488 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.4 tt -132.42 113.33 13.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.35 -0.386 . . . . 74.200000000000003 110.424 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.61 109.76 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.058 0.456 . . . . 74.209999999999994 111.702 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.472 HD23 ' CD1' ' A' ' 101' ' ' TYR . 80.0 mt -88.57 140.05 29.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.143 -0.317 . . . . 63.520000000000003 110.143 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -129.4 150.69 50.65 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.888 0.375 . . . . 74.5 111.475 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.87 31.14 56.53 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.218 -0.515 . . . . 71.420000000000002 113.068 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 147' ' ' LEU . 17.8 tt -168.51 125.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.916 0.389 . . . . 75.230000000000004 111.487 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.8 m -83.53 144.71 29.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.649 0.261 . . . . 60.329999999999998 111.522 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 p -51.04 -44.77 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 112.391 0.515 . . . . 72.430000000000007 112.391 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -59.74 -38.55 82.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.211 0.529 . . . . 52.310000000000002 111.389 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -93.31 6.16 49.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.346 0.499 . . . . 70.530000000000001 112.346 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 142' ' ' ILE . 1.3 tt -69.68 125.14 25.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.662 0.267 . . . . 73.549999999999997 110.402 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -95.82 -62.16 0.98 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.111 -0.566 . . . . 41.439999999999998 113.602 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -145.44 160.25 41.87 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.272 0.558 . . . . 74.230000000000004 112.008 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 75.5 t -124.86 101.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.696 -0.684 . . . . 64.310000000000002 110.406 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 31.2 ttm180 -88.31 94.37 9.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.874 0.369 . . . . 72.030000000000001 111.636 -176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.707 HG22 ' SD ' ' A' ' 66' ' ' MET . 37.1 mm -85.75 127.58 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.68 -0.237 . . . . 74.519999999999996 110.876 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -164.45 -178.3 5.34 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.405 0.521 . . . . 72.25 112.405 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 66.38 24.56 10.47 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.449 0.7 . . . . 74.310000000000002 112.293 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.616 HD13 ' HA3' ' A' ' 97' ' ' GLY . 41.9 mm -67.15 105.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.187 0.518 . . . . 73.430000000000007 111.701 -177.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.641 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.6 pt20 -137.71 151.72 71.22 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.021 -0.536 . . . . 73.230000000000004 111.42 -175.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.645 ' HG2' HD11 ' A' ' 161' ' ' LEU . 57.9 Cg_endo -70.8 133.25 23.27 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.406 2.071 . . . . 43.030000000000001 112.846 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.1 m -85.87 28.92 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.135 0.493 . . . . 64.310000000000002 111.975 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -122.84 -175.02 3.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.924 0.392 . . . . 74.209999999999994 111.362 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -80.09 121.37 25.45 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.948 0.404 . . . . 71.549999999999997 111.835 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' A' ' 157' ' ' PRO . 6.5 mp -100.35 148.15 25.02 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.884 0.373 . . . . 73.439999999999998 111.065 176.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.45 153.46 50.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.033 0.444 . . . . 72.310000000000002 111.446 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -158.5 154.66 27.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.031 -0.532 . . . . 73.099999999999994 110.867 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -137.76 121.85 17.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.28 0.474 . . . . 70.219999999999999 112.28 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -96.19 -173.9 2.93 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.221 0.534 . . . . 75.409999999999997 111.244 175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -133.68 -174.46 3.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.295 -0.412 . . . . 71.230000000000004 110.501 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -75.32 -32.38 60.93 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.148 0.499 . . . . 53.219999999999999 109.818 170.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.747 -0.644 . . . . 74.239999999999995 110.831 174.913 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 31' ' ' ILE . 14.6 pt-20 . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 120.949 0.404 . . . . 73.32 110.842 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -60.02 -34.3 73.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.213 -0.449 . . . . 55.0 111.543 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.78 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.948 0.404 . . . . 75.02 110.713 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -62.3 -36.2 81.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 74.32 111.163 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.8 mt -62.04 -48.01 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.08 0.467 . . . . 74.24 110.798 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -60.11 -35.29 74.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.282 0.563 . . . . 74.51 110.932 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.624 ' HG3' HD11 ' A' ' 108' ' ' ILE . 35.1 tt0 -68.37 -43.35 77.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.176 -0.465 . . . . 64.11 110.653 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 -55.76 29.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.013 -0.54 . . . . 72.13 110.684 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -54.15 -47.38 71.99 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.182 0.438 . . . . 72.34 112.182 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -62.29 -48.21 80.91 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.965 0.357 . . . . 75.32 111.965 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.7 -33.57 75.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.211 0.529 . . . . 72.34 111.026 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -56.04 -48.96 75.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.856 -0.611 . . . . 71.51 110.628 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.75 -32.3 72.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.942 -0.572 . . . . 71.41 111.683 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.45 -10.46 59.41 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.007 0.373 . . . . 71.4 112.007 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.471 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 43.2 t -87.13 132.45 33.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.864 0.364 . . . . 74.34 111.871 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.0 p -103.36 -24.82 13.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 75.4 110.781 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t -100.53 93.48 5.64 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.175 -0.466 . . . . 62.34 110.918 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.64 -160.18 47.65 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.198 0.439 . . . . 70.31 114.198 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -116.6 144.92 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.3 0.481 . . . . 73.21 112.3 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.471 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 16.1 m-85 -83.3 113.75 20.92 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.407 -0.361 . . . . 72.23 111.898 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 86.9 mt -103.9 94.26 5.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.182 0.515 . . . . 72.4 110.304 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.72 120.67 82.42 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.543 -0.299 . . . . 72.41 110.818 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.629 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.7 Cg_endo -57.17 -22.2 47.01 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.827 2.352 . . . . 74.41 112.888 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.49 -21.39 60.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.34 -0.457 . . . . 61.02 113.061 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.97 -40.62 10.02 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.845 0.355 . . . . 44.13 111.164 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.9 mttm 62.88 2.48 1.0 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.69 0.626 . . . . 75.22 112.69 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 p -70.76 151.06 95.31 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 113.02 0.748 . . . . 73.52 113.02 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' A' ' 65' ' ' ARG . 73.8 Cg_endo -72.89 136.33 24.95 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.843 2.362 . . . . 72.44 112.467 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.51 140.58 51.24 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.737 0.304 . . . . 71.31 111.604 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -92.71 127.43 38.21 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.999 0.428 . . . . 75.11 111.738 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.2 tp -131.13 127.19 37.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.119 0.485 . . . . 63.32 111.369 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.02 97.7 11.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.127 0.489 . . . . 73.22 110.715 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -93.55 -177.18 4.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.275 0.56 . . . . 72.11 112.262 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -67.5 -32.41 73.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.021 -0.536 . . . . 72.23 112.032 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 pt -84.45 -30.0 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 111.883 0.327 . . . . 75.33 111.883 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.58 -177.69 37.76 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.396 -0.43 . . . . 62.22 112.895 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.5 m -85.18 109.01 17.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.039 0.447 . . . . 74.33 111.446 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.732 HD13 ' SD ' ' A' ' 66' ' ' MET . 0.6 OUTLIER -116.57 171.71 7.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.011 0.434 . . . . 73.41 111.897 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 30.6 ttm180 -140.64 114.04 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.258 -0.428 . . . . 72.13 111.101 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.732 ' SD ' HD13 ' A' ' 64' ' ' LEU . 3.2 mpp? -103.59 158.55 16.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.5 0.555 . . . . 63.31 112.5 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 p -156.67 157.85 35.93 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.793 -0.64 . . . . 70.34 111.237 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 76.3 mt -112.37 117.67 33.1 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.896 0.332 . . . . 73.33 111.896 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.74 165.06 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.657 0.265 . . . . 72.42 111.555 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 m120 57.7 40.08 26.77 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.118 0.485 . . . . 54.32 111.907 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 40.5 mt -69.86 112.18 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.2 -0.454 . . . . 73.14 111.217 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -137.23 151.31 71.39 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-O 120.772 0.32 . . . . 75.52 111.83 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.92 146.76 83.77 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.887 2.391 . . . . 60.24 113.186 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 19.6 t70 -115.02 169.86 8.78 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.258 -0.428 . . . . 73.15 111.043 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.63 72.48 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.866 0.321 . . . . 74.01 111.866 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.21 -45.68 3.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.517 -0.31 . . . . 63.23 111.465 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -130.6 -110.07 1.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.754 -0.736 . . . . 61.44 113.893 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -146.97 127.83 14.43 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.104 0.409 . . . . 54.23 112.104 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 75.7 p -98.93 120.81 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.767 0.317 . . . . 72.22 111.752 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -137.15 151.06 48.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.823 0.344 . . . . 62.13 111.197 175.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 m -83.3 113.45 20.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.006 0.431 . . . . 73.43 111.846 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.42 109.39 20.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.92 -0.582 . . . . 64.43 109.969 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 66' ' ' MET . 73.7 mtm180 -101.15 123.07 44.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.861 0.319 . . . . 63.21 111.861 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.7 mp -102.2 102.42 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.034 0.445 . . . . 73.2 110.593 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -100.9 134.51 43.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.433 -0.349 . . . . 73.52 111.188 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.56 122.52 5.81 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.075 -0.583 . . . . 62.12 113.446 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.0 -27.81 62.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.428 0.632 . . . . 65.44 110.498 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -85.89 -175.24 5.5 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.774 -0.648 . . . . 32.11 111.44 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.41 5.63 39.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.397 -0.365 . . . . 63.24 111.458 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.09 152.98 38.01 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.196 0.443 . . . . 62.0 112.196 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.678 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 73.2 Cg_endo -74.27 138.18 24.59 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.773 2.315 . . . . 74.34 112.79 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.17 122.07 55.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 O-C-N 122.142 -0.349 . . . . 70.34 111.848 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.27 170.88 14.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.607 2.205 . . . . 32.43 112.866 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.6 131.48 50.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.307 0.484 . . . . 44.44 112.307 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -146.79 154.85 41.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.261 0.553 . . . . 73.2 112.225 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.9 p -118.87 151.23 38.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.898 -0.592 . . . . 73.43 110.438 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 154' ' ' ASP . . . -141.18 150.24 21.67 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.771 -0.728 . . . . 35.44 113.83 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 154' ' ' ASP . 61.3 m -100.06 110.0 22.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.771 0.319 . . . . 70.41 110.819 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.1 p -102.28 117.88 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.433 0.531 . . . . 75.54 112.433 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 153' ' ' HIS . 32.8 mm-40 -83.98 147.26 27.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.901 -0.407 . . . . 75.42 109.901 174.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.412 ' CG ' HD22 ' A' ' 139' ' ' LEU . 32.0 p90 -155.12 133.71 11.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.066 0.46 . . . . 70.42 111.654 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.85 -147.67 5.48 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.952 -0.567 . . . . 63.22 112.951 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 87.4 mt-30 -123.36 150.71 43.33 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.333 0.587 . . . . 63.14 112.565 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.469 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.3 mt -116.26 104.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.978 -0.556 . . . . 54.43 110.657 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -89.19 -17.41 29.18 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.398 0.518 . . . . 64.02 112.398 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -90.37 -159.23 35.36 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.026 -0.607 . . . . 52.1 113.963 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 51.8 p -114.25 -178.44 3.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.806 0.443 . . . . 64.25 110.967 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.624 HD11 ' HG3' ' A' ' 33' ' ' GLN . 48.0 mm -66.81 -30.92 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 60.02 110.709 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.92 -39.28 72.8 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.097 -0.501 . . . . 74.21 111.163 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -154.59 108.87 2.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.164 -0.471 . . . . 75.15 111.191 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.613 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 36.9 p90 -125.99 139.49 53.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.89 0.376 . . . . 75.24 111.743 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -108.78 123.23 48.69 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.244 -0.434 . . . . 75.52 111.443 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -74.66 100.48 3.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.718 0.294 . . . . 64.03 110.798 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.6 pt -109.63 157.46 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 111.812 0.301 . . . . 63.22 111.812 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 56.73 31.38 19.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.18 0.514 . . . . 71.13 111.502 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -97.08 132.91 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.385 0.612 . . . . 50.15 112.583 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -142.11 178.18 7.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.723 -0.672 . . . . 70.52 109.656 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 11.3 p30 -127.85 172.91 10.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.949 1.092 . . . . 64.1 113.949 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -153.1 156.34 38.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.872 -1.058 . . . . 72.23 109.921 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.54 111.48 23.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.258 0.466 . . . . 74.11 112.258 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 121' ' ' ILE . 20.2 pt -96.11 101.17 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.325 0.583 . . . . 55.3 110.989 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.89 108.93 20.48 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.436 -0.347 . . . . 63.13 111.185 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.57 38.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.513 -0.312 . . . . 70.14 111.599 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.83 179.69 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.67 2.247 . . . . 64.54 113.553 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.89 108.09 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.023 0.439 . . . . 73.24 111.299 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 15.3 m -80.77 96.66 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 64.22 111.203 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 127' ' ' VAL . 12.2 t -86.71 7.98 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 121.081 0.467 . . . . 73.53 111.609 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.1 pt? -105.52 147.0 28.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.186 0.517 . . . . 65.44 111.925 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.39 127.37 22.44 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.098 -0.501 . . . . 72.1 111.015 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.18 155.14 91.81 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.836 -1.318 . . . . 74.3 113.086 -0.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.678 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 48.5 t -88.64 121.27 30.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.652 0.612 . . . . 70.43 112.652 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -138.79 130.72 27.95 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.085 0.469 . . . . 74.5 110.948 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.35 149.72 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.802 0.334 . . . . 54.33 111.563 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -132.76 125.38 30.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.027 0.441 . . . . 73.32 110.737 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 pt -130.74 137.88 31.77 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 120.814 0.34 . . . . 71.32 111.472 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.71 120.21 7.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.302 2.001 . . . . 75.41 112.777 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.31 97.41 8.48 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.023 -0.535 . . . . 71.11 109.782 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.456 ' HG3' HG22 ' A' ' 79' ' ' THR . 63.0 tt0 -87.83 83.36 7.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 53.45 111.297 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 101' ' ' TYR . 65.9 mt -62.86 145.75 54.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.072 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -116.81 147.57 41.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.136 0.494 . . . . 71.33 112.073 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.19 -49.98 3.88 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.066 -0.516 . . . . 71.42 114.03 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.604 HD13 HD23 ' A' ' 147' ' ' LEU . 20.9 tt -87.64 138.47 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.261 0.553 . . . . 60.13 112.24 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.6 m -92.79 149.69 21.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.183 -0.462 . . . . 72.44 111.519 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -53.25 -42.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.379 0.511 . . . . 73.14 112.379 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.75 -23.65 65.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.199 0.523 . . . . 73.33 111.289 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.441 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.1 mm-40 -103.03 7.81 38.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 74.11 112.089 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.629 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 14.0 mt -72.85 124.36 25.24 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.279 0.474 . . . . 74.33 112.279 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.67 -57.59 0.82 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.203 -0.523 . . . . 44.13 112.886 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -145.0 146.34 31.87 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.333 -0.51 . . . . 72.23 111.9 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.506 ' HB ' HD11 ' A' ' 68' ' ' LEU . 62.1 t -124.54 100.19 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.068 -0.514 . . . . 74.1 109.917 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -100.53 114.47 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.736 0.643 . . . . 75.43 112.736 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.49 123.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.797 -0.638 . . . . 51.43 110.988 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.479 ' CD2' ' HG2' ' A' ' 100' ' ' GLU . 10.2 p80 -152.88 178.44 9.66 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.574 0.226 . . . . 75.43 111.082 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.463 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 33.1 t70 54.53 73.63 0.39 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.376 0.607 . . . . 73.44 111.197 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 115.29 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.843 -0.617 . . . . 45.24 110.695 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.52 140.07 36.72 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.095 0.405 . . . . 74.42 112.095 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.91 146.77 42.68 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.635 2.224 . . . . 75.42 112.538 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 113.047 0.758 . . . . 75.2 113.047 -176.056 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.571 0.224 . . . . 71.42 111.067 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.2 m -59.62 -50.05 75.36 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.224 0.535 . . . . 63.1 111.164 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.12 -35.29 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.475 0.655 . . . . 74.31 110.657 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.615 ' HE3' HD12 ' A' ' 48' ' ' LEU . 23.7 tptt -70.3 -35.95 74.02 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.623 -0.717 . . . . 74.14 110.754 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 27' ' ' GLU . 89.2 mt -60.48 -42.91 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.412 0.625 . . . . 72.52 110.322 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -57.4 -44.76 84.81 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.838 -0.619 . . . . 71.54 110.551 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HG3' HD11 ' A' ' 108' ' ' ILE . 31.6 tt0 -60.91 -40.03 91.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.934 -0.576 . . . . 74.23 111.12 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -59.03 -55.47 34.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.938 -0.574 . . . . 70.34 111.535 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -60.71 -39.05 87.1 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 111.893 0.331 . . . . 73.34 111.893 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.08 -54.57 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.425 0.528 . . . . 74.55 112.425 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.423 HD12 HD21 ' A' ' 48' ' ' LEU . 97.9 mt -56.61 -41.64 77.39 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.064 0.459 . . . . 64.33 110.919 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.8 -46.02 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.16 -0.473 . . . . 71.01 111.343 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.81 63.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 64.22 112.561 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -94.42 -12.41 27.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.892 0.33 . . . . 75.22 111.892 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.2 t -85.7 142.47 29.0 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.669 0.271 . . . . 73.42 111.336 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.2 p -84.0 -42.32 16.34 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.099 -0.375 . . . . 72.11 111.517 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 m -148.08 87.79 1.63 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 65.43 111.377 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.4 153.35 6.08 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.244 -0.503 . . . . 42.21 112.405 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 152' ' ' ILE . 25.8 m -106.41 146.12 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.315 0.579 . . . . 60.21 112.449 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -106.22 102.9 12.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.807 -0.633 . . . . 73.22 110.884 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -92.58 116.02 28.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.897 0.379 . . . . 73.2 111.221 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.615 HD12 ' HE3' ' A' ' 30' ' ' LYS . 3.8 mm? -86.93 117.46 68.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.578 -0.283 . . . . 45.35 110.717 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 78.5 Cg_exo -51.11 -36.36 54.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.102 2.534 . . . . 73.43 113.768 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.84 99.79 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.954 -0.641 . . . . 61.1 112.548 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . . . -86.88 93.61 9.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.731 0.301 . . . . 75.14 111.487 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HE3' HD12 ' A' ' 71' ' ' ILE . 43.6 mmtm -67.52 77.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.878 0.37 . . . . 73.55 110.251 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 p -140.48 149.97 59.16 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 112.841 0.682 . . . . 75.14 112.841 -175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 92.9 Cg_endo -80.48 154.19 21.04 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.393 2.728 . . . . 64.22 113.242 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.46 137.93 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.67 0.272 . . . . 63.43 111.456 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.543 ' CZ ' HG21 ' A' ' 63' ' ' THR . 37.6 ttt85 -79.22 133.69 36.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.853 0.359 . . . . 72.3 111.901 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HB3' HD22 ' A' ' 64' ' ' LEU . 56.2 tp -138.14 120.58 16.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.497 0.554 . . . . 75.42 112.497 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.47 121.63 26.51 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.726 -0.67 . . . . 61.43 110.401 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 p -123.68 -179.33 4.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.534 . . . . 64.21 111.808 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -67.72 -19.12 65.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 72.1 112.146 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 pt -100.26 -25.71 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.971 0.415 . . . . 73.44 111.891 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.76 32.54 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.415 -0.421 . . . . 65.31 112.243 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.543 HG21 ' CZ ' ' A' ' 56' ' ' ARG . 39.0 m -94.48 127.19 40.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.176 0.513 . . . . 72.14 111.709 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.6 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.8 170.13 13.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.03 -0.532 . . . . 72.32 110.71 175.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.605 ' HG2' ' HB2' ' A' ' 54' ' ' PRO . 17.2 ttp180 -133.44 105.59 7.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.835 0.35 . . . . 74.35 110.924 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.775 ' SD ' HG21 ' A' ' 152' ' ' ILE . 66.9 mtt -95.77 148.99 21.99 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.224 0.453 . . . . 73.4 112.224 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.1 p -145.08 148.89 34.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.793 0.33 . . . . 63.03 111.742 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 80' ' ' LEU . 95.6 mt -96.68 114.0 25.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.177 -0.465 . . . . 54.13 111.557 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -134.37 162.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.625 0.232 . . . . 52.55 111.625 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.4 m120 61.96 33.89 17.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.776 0.43 . . . . 70.41 111.794 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.574 HD12 ' HE3' ' A' ' 52' ' ' LYS . 38.8 mt -71.33 106.9 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 73.03 111.421 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 21.9 p -140.67 158.72 65.01 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 111.891 0.33 . . . . 65.5 111.891 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 22.6 Cg_endo -60.17 153.76 56.59 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.73 2.287 . . . . 61.15 113.517 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.0 t70 -129.96 172.62 11.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.156 -0.475 . . . . 63.11 111.679 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -53.58 -46.63 70.38 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.306 0.484 . . . . 72.44 112.306 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -110.14 -21.39 12.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.55 0.574 . . . . 75.53 112.55 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -157.49 -103.7 0.2 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.154 -1.022 . . . . 74.04 114.144 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.2 m -150.1 129.27 12.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.711 0.291 . . . . 74.25 111.636 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.664 HG23 ' HB2' ' A' ' 74' ' ' ASP . 82.5 p -97.59 123.56 41.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.87 0.367 . . . . 54.33 111.405 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.6 pp -135.73 137.96 42.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.19 0.519 . . . . 75.41 111.352 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.0 m -83.66 107.35 16.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.155 0.502 . . . . 71.25 111.354 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -82.75 109.98 17.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.914 -0.585 . . . . 71.53 110.366 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 66' ' ' MET . 48.3 mtm180 -93.7 112.47 24.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.76 0.282 . . . . 73.34 111.76 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mp -92.18 93.94 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.04 0.448 . . . . 75.35 110.611 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -94.22 104.03 16.04 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 71.32 110.799 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.46 145.13 40.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.822 -0.704 . . . . 52.25 113.353 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.92 -45.05 95.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.418 0.628 . . . . 55.23 110.439 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 m -80.68 115.2 20.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.869 -0.605 . . . . 62.51 110.699 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -61.26 -27.22 68.3 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.89 0.376 . . . . 65.13 111.39 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 141.22 49.95 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.765 -0.652 . . . . 71.41 112.0 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.82 106.96 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.144 2.563 . . . . 72.02 113.508 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.6 148.91 63.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.238 -0.437 . . . . 72.3 111.643 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.7 179.81 4.88 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.594 2.196 . . . . 52.43 113.153 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 139.5 36.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.07 0.462 . . . . 62.01 111.687 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 42.5 p90 -141.59 176.11 9.15 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.564 0.697 . . . . 73.15 112.475 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 p -152.73 168.69 24.84 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.536 -0.757 . . . . 32.44 111.077 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.55 -177.79 44.87 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.819 -0.705 . . . . 52.14 113.605 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 m -113.13 119.06 36.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.689 0.28 . . . . 74.34 111.308 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.09 115.81 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.103 0.478 . . . . 62.24 111.235 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 53.1 mt-10 -106.56 113.64 27.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.987 0.422 . . . . 74.54 111.158 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.434 ' CE1' HD22 ' A' ' 139' ' ' LEU . 17.0 p90 -116.95 129.02 55.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.044 0.45 . . . . 74.02 111.648 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.97 -146.71 4.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.186 -0.53 . . . . 72.41 113.189 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.617 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 92.9 mt-30 -128.58 152.87 47.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.169 0.509 . . . . 55.43 111.8 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 111' ' ' PHE . 57.9 mt -114.74 126.15 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.977 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -112.7 17.23 19.27 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.862 0.319 . . . . 75.13 111.862 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -132.99 -165.0 11.05 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.915 -0.659 . . . . 65.44 113.908 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.8 p -102.82 176.01 5.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.978 0.418 . . . . 74.5 111.558 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.485 HD11 ' HG3' ' A' ' 33' ' ' GLN . 49.2 mm -58.67 -38.23 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.085 0.469 . . . . 72.02 110.613 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.28 -47.91 59.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.899 -0.591 . . . . 64.51 110.995 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.41 91.69 2.57 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 51.01 111.826 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.614 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.9 p90 -115.41 127.89 55.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.178 0.513 . . . . 73.33 112.209 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -96.96 124.39 40.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 70.12 110.827 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.91 105.59 17.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.858 -0.61 . . . . 71.12 111.195 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.28 156.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.63 -0.259 . . . . 63.13 111.652 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 56.66 39.36 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.945 0.402 . . . . 65.44 111.881 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 p -96.72 116.43 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.472 0.653 . . . . 72.01 112.454 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -105.02 147.37 27.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.98 -0.554 . . . . 62.13 110.341 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.451 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 7.4 p30 -112.68 136.47 52.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.346 0.593 . . . . 54.12 111.931 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -127.45 157.74 39.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.956 -0.565 . . . . 73.31 110.217 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.5 122.02 37.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.11 0.411 . . . . 72.34 112.11 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.856 HG22 HD21 ' A' ' 137' ' ' LEU . 20.0 pt -100.95 105.64 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.163 0.506 . . . . 64.54 111.539 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -110.38 119.14 38.27 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.338 -0.392 . . . . 55.15 110.193 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -114.28 133.29 22.45 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 111.858 0.318 . . . . 65.3 111.858 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 24.5 Cg_exo -64.28 159.99 40.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.174 2.583 . . . . 74.0 113.22 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.14 147.63 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.128 0.418 . . . . 53.25 112.128 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 t -87.39 124.54 33.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.342 -0.39 . . . . 61.2 110.541 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.4 -34.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.887 0.375 . . . . 72.0 111.722 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.09 -169.1 1.95 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.892 0.377 . . . . 71.23 111.655 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.47 149.73 53.1 Favored Pre-proline 0 N--CA 1.472 0.658 0 CA-C-N 116.508 -0.314 . . . . 33.21 111.358 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.54 147.2 63.5 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.0 -1.25 . . . . 73.33 113.306 -1.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m -65.89 82.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.356 0.598 . . . . 75.22 112.145 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.57 93.35 4.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.498 -0.774 . . . . 65.31 109.285 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.94 105.66 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.51 -0.313 . . . . 62.44 111.803 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.5 p-10 -96.97 142.9 28.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.992 0.425 . . . . 62.4 111.581 175.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 18.0 pt -135.85 135.82 22.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 116.314 -0.403 . . . . 75.13 111.346 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.0 Cg_exo -75.63 117.1 4.65 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 75.13 113.0 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.856 HD21 HG22 ' A' ' 121' ' ' ILE . 38.4 mt -97.1 112.33 24.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.185 0.439 . . . . 62.44 112.185 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -91.02 90.73 7.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.105 0.479 . . . . 62.44 110.023 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 101' ' ' TYR . 66.3 mt -76.72 137.71 39.51 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.319 -0.4 . . . . 63.44 111.252 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.8 135.82 48.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.226 0.454 . . . . 71.13 112.226 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.62 17.03 79.51 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 114.581 0.592 . . . . 61.11 114.581 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.2 tt -147.55 129.57 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 117.273 0.537 . . . . 63.1 111.628 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -92.48 156.75 16.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.975 0.416 . . . . 72.15 111.818 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.75 -33.79 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.964 -0.562 . . . . 75.24 111.727 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -31.63 72.95 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.966 0.413 . . . . 51.33 111.726 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.617 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 87.5 mm-40 -110.53 18.36 19.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.286 -0.415 . . . . 74.14 111.852 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -82.55 106.53 14.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.925 0.393 . . . . 71.03 110.832 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -83.78 -67.4 1.45 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.178 -0.534 . . . . 60.05 113.462 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -140.58 157.36 45.59 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.42 -0.459 . . . . 64.52 111.784 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.8 t -128.09 103.14 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.958 -0.565 . . . . 75.24 110.662 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -93.32 114.97 27.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.27 0.47 . . . . 71.12 112.27 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.775 HG21 ' SD ' ' A' ' 66' ' ' MET . 42.7 mm -96.14 130.78 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.105 -0.498 . . . . 73.14 111.118 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -165.39 -175.32 3.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.596 0.236 . . . . 75.45 111.632 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 64.22 24.47 13.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.117 0.567 . . . . 61.53 112.0 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.74 104.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.541 0.686 . . . . 75.34 111.538 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -132.75 142.95 46.64 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.423 -0.808 . . . . 72.34 111.159 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 95' ' ' PHE . 62.5 Cg_endo -72.07 151.53 55.8 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.296 1.997 . . . . 75.21 112.692 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.619 -0.264 . . . . 73.42 110.812 178.132 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.392 0.615 . . . . 75.33 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 m -66.01 -31.08 71.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.829 -0.623 . . . . 72.53 111.049 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.79 -45.15 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.36 -0.382 . . . . 65.01 110.89 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.51 -48.33 77.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.142 0.496 . . . . 74.44 110.732 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -55.81 -51.22 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.904 -0.589 . . . . 72.33 111.41 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.1 m -58.36 -44.65 88.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.278 -0.419 . . . . 63.44 111.557 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.38 -44.05 96.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.447 -0.342 . . . . 74.55 111.209 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -56.79 -50.87 71.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.403 -0.362 . . . . 60.51 111.449 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -58.12 -43.8 87.4 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.859 0.361 . . . . 71.31 111.726 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -63.64 -48.23 78.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.729 0.3 . . . . 65.44 111.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.23 -33.82 76.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.333 0.587 . . . . 75.52 110.549 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.6 -41.47 98.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.834 -0.621 . . . . 71.02 110.509 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.47 65.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.048 -0.524 . . . . 65.14 111.654 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.601 ' HE3' HG22 ' A' ' 108' ' ' ILE . 66.7 mttm -82.21 -7.97 59.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.835 0.309 . . . . 51.12 111.835 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -55.97 117.57 3.83 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.648 0.61 . . . . 71.31 112.648 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 t -71.12 -36.87 72.3 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.081 -0.509 . . . . 51.24 111.691 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 m -151.99 121.54 6.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.714 0.292 . . . . 73.12 110.723 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.79 -153.59 22.08 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.221 -0.514 . . . . 42.1 112.547 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.29 148.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.14 0.47 . . . . 72.4 111.918 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -95.92 130.11 42.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.411 . . . . 72.01 112.069 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -125.06 143.89 50.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.858 -0.61 . . . . 74.42 109.868 172.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 76.5 mt -114.12 136.36 22.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.837 0.351 . . . . 63.33 111.721 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 36.8 Cg_exo -61.53 -14.0 32.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.922 2.415 . . . . 75.15 113.406 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.35 6.43 26.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.212 -0.518 . . . . 72.54 113.145 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.88 103.12 11.86 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.043 0.449 . . . . 71.3 111.125 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -80.65 60.55 4.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.513 0.673 . . . . 73.22 111.231 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 p -146.01 150.65 42.89 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-N 115.826 -0.624 . . . . 70.21 112.123 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.69 170.85 13.84 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.024 2.483 . . . . 72.42 114.396 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.38 157.03 44.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.738 -0.665 . . . . 72.42 110.076 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -113.59 119.36 37.23 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.46 0.648 . . . . 73.31 112.17 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.95 126.16 53.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.839 -0.618 . . . . 72.35 112.284 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.0 tt0 -86.78 108.33 18.66 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.741 -0.466 . . . . 61.32 109.741 172.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 82.6 p -113.04 -177.5 3.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.234 0.54 . . . . 71.13 112.338 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -67.66 -19.82 65.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.945 -0.57 . . . . 71.43 112.318 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 pt -95.19 -6.55 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.986 0.422 . . . . 72.4 111.073 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.54 -179.46 16.3 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.382 -0.437 . . . . 71.11 112.89 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 60.3 m -79.81 131.69 35.95 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.454 -0.439 . . . . 72.32 111.34 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.96 175.18 10.03 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.127 0.489 . . . . 63.32 112.246 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -124.34 123.35 40.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 74.42 110.664 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.568 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.0 mtt -118.0 156.16 29.04 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.873 0.368 . . . . 74.31 111.896 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.9 t -158.79 170.47 22.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.905 0.383 . . . . 70.2 111.908 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB3' HD11 ' A' ' 71' ' ' ILE . 99.2 mt -116.29 106.18 13.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.29 -0.414 . . . . 71.34 111.996 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 81' ' ' THR . 33.0 m -113.36 162.19 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.238 -0.288 . . . . 42.31 111.064 176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.8 m120 63.83 31.2 14.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.039 0.447 . . . . 74.33 112.095 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 68' ' ' LEU . 45.3 mt -73.08 103.93 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.17 0.433 . . . . 23.21 112.17 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 p -137.78 152.49 72.56 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 120.861 0.362 . . . . 71.51 111.562 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.11 168.88 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.737 2.291 . . . . 51.43 113.495 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.66 ' HB2' HG23 ' A' ' 79' ' ' THR . 31.5 t70 -143.82 170.54 15.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.773 -0.649 . . . . 72.53 110.749 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.25 94.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.692 0.282 . . . . 70.12 111.692 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.15 -34.27 24.09 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.525 -0.307 . . . . 61.31 111.736 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.54 -100.83 0.14 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.36 -0.924 . . . . 64.44 114.149 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -146.03 131.28 18.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.832 0.349 . . . . 73.15 111.586 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.66 HG23 ' HB2' ' A' ' 74' ' ' ASP . 79.0 p -109.56 137.7 47.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.895 0.379 . . . . 62.52 111.604 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 pp -149.41 -179.57 7.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.898 0.38 . . . . 44.24 111.272 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.691 ' HB ' HG23 ' A' ' 69' ' ' VAL . 21.7 m -124.13 117.77 25.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.894 0.378 . . . . 64.44 111.258 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.2 113.54 20.73 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.238 -0.437 . . . . 70.4 109.946 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 66' ' ' MET . 69.7 mtt180 -96.29 136.57 36.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.822 0.344 . . . . 75.42 111.09 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.536 HG12 ' HG2' ' A' ' 66' ' ' MET . 42.1 mt -131.63 133.97 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 74.14 111.529 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -142.51 124.79 15.51 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.737 -0.21 . . . . 73.15 110.689 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 92' ' ' LEU . . . -75.86 146.08 33.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.843 -0.694 . . . . 74.14 113.933 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.41 -39.48 83.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.753 0.787 . . . . 75.2 109.927 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -93.81 112.18 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 73.12 109.671 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -64.35 -7.71 10.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.46 0.541 . . . . 75.23 112.46 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.97 156.29 80.77 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.881 0.473 . . . . 64.15 111.572 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.82 123.38 11.51 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.094 2.529 . . . . 61.13 113.824 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 126' ' ' SER . 95.9 mt -100.19 147.98 34.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.099 -0.501 . . . . 73.41 111.332 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.13 172.79 15.28 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.471 2.114 . . . . 65.32 112.991 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.48 43.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 64.45 111.032 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -146.35 162.27 38.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.351 0.596 . . . . 72.33 112.282 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.4 m -146.9 151.54 37.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.932 -0.577 . . . . 53.22 110.309 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.763 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -150.25 170.61 30.22 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.411 -0.899 . . . . 55.41 113.762 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.1 m -105.32 132.04 52.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 75.13 110.999 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.75 130.39 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.955 0.407 . . . . 75.35 111.6 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 40.4 mm-40 -97.83 111.92 24.03 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 64.02 110.818 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -122.75 120.95 35.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.237 0.542 . . . . 75.35 111.844 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -161.65 -149.18 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.837 -0.62 . . . . 55.41 113.23 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -125.06 157.19 36.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.222 0.534 . . . . 61.32 112.043 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.36 121.16 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.354 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.08 5.95 32.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.872 0.367 . . . . 73.32 111.658 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -113.69 -177.89 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.233 -0.508 . . . . 73.43 113.19 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -90.44 179.41 5.87 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.611 -0.346 . . . . 52.43 111.223 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.601 HG22 ' HE3' ' A' ' 40' ' ' LYS . 48.8 mm -68.73 -27.56 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.521 . . . . 74.33 110.605 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.54 -32.34 58.16 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.384 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -150.39 90.57 1.67 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.285 0.564 . . . . 61.34 111.14 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -96.3 117.23 30.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.413 0.625 . . . . 70.31 112.05 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -86.59 111.98 21.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.081 -0.508 . . . . 71.52 110.633 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.77 104.08 11.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.951 0.405 . . . . 72.34 111.053 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.5 pt -113.39 151.65 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.475 -0.33 . . . . 63.35 111.687 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 58.14 34.44 24.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.078 0.465 . . . . 55.11 111.802 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.442 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 3.7 p -91.14 116.74 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.339 0.59 . . . . 73.41 112.331 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -99.66 171.79 7.68 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.268 -0.424 . . . . 63.44 111.011 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.12 143.47 50.87 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.14 0.495 . . . . 61.42 111.872 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -144.76 147.69 33.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.36 -0.382 . . . . 72.23 111.17 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.88 125.47 37.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.076 0.465 . . . . 74.53 112.216 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.2 pt -101.96 120.62 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.978 0.418 . . . . 72.15 111.043 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -107.32 122.31 46.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.869 0.366 . . . . 71.14 111.491 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 135' ' ' ILE . . . -119.08 138.19 25.93 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 120.732 0.301 . . . . 54.52 111.546 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 170.34 20.26 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.725 2.283 . . . . 72.51 113.396 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.53 117.59 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.161 -0.472 . . . . 43.05 112.061 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 25.1 m -79.56 63.81 4.25 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.954 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.31 -11.66 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.451 0.908 . . . . 72.0 113.451 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.45 120.67 40.91 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.034 -0.416 . . . . 73.21 111.411 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.64 139.16 31.42 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 111.733 0.272 . . . . 72.22 111.733 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.74 145.63 82.15 Favored 'Cis proline' 0 C--N 1.356 0.922 0 C-N-CA 124.116 -1.202 . . . . 74.21 113.431 0.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 p -83.86 95.53 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.991 0.737 . . . . 62.31 112.991 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.24 127.02 20.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.003 -0.544 . . . . 54.23 110.739 171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -132.59 139.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 72.54 111.712 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.47 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 18.1 p-10 -114.67 133.39 55.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.256 0.551 . . . . 64.52 110.95 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.528 HD13 ' HB2' ' A' ' 123' ' ' ALA . 25.3 pt -130.5 140.18 37.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.482 -0.327 . . . . 72.15 111.509 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.24 156.2 62.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.418 2.079 . . . . 72.51 112.439 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -145.44 116.69 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.493 -0.321 . . . . 75.02 110.158 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -103.25 96.95 7.11 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.197 0.523 . . . . 74.14 111.814 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.8 129.86 35.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.842 0.354 . . . . 74.23 110.248 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -116.11 139.45 50.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.917 0.389 . . . . 45.24 111.809 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 20.21 61.26 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.326 -0.397 . . . . 70.42 113.815 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -160.29 124.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 117.334 0.567 . . . . 73.22 112.299 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.5 m -86.45 146.69 26.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.193 -0.317 . . . . 72.02 111.602 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.92 -35.64 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.749 0.648 . . . . 74.35 112.749 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.64 -23.15 66.73 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.159 0.504 . . . . 64.03 111.481 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -109.21 8.86 26.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.062 -0.517 . . . . 75.43 111.525 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.423 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 1.1 tt -91.63 126.05 36.57 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.913 0.387 . . . . 71.12 110.894 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.19 -62.35 1.22 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.297 -0.478 . . . . 73.13 113.72 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.39 160.35 40.31 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.563 0.579 . . . . 64.34 112.563 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.92 101.48 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.644 -0.707 . . . . 51.21 110.342 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 45.2 ttp180 -98.03 116.77 30.93 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.029 -0.419 . . . . 61.35 112.055 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.568 HG21 ' SD ' ' A' ' 66' ' ' MET . 22.3 mm -85.46 130.32 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.435 -0.348 . . . . 64.4 111.191 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -158.67 179.52 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.292 -0.255 . . . . 72.34 111.585 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.43 30.92 20.17 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.763 0.653 . . . . 74.13 112.763 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.763 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.9 mm -71.79 106.43 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.365 0.602 . . . . 71.55 110.691 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 7.7 pt20 -129.71 149.39 72.83 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.711 -0.677 . . . . 73.53 111.859 -174.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 156' ' ' GLN . 9.4 Cg_exo -71.23 136.93 30.24 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.627 2.218 . . . . 74.53 112.65 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 120.8 0.333 . . . . 55.21 110.748 177.154 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 34.4 tt0 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.799 0.333 . . . . 70.12 111.522 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.0 m -56.27 -41.16 75.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.963 0.411 . . . . 51.2 111.302 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.32 -36.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 74.24 111.32 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HE3' HD13 ' A' ' 48' ' ' LEU . 52.3 tptt -66.96 -38.37 85.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.123 -0.49 . . . . 62.5 110.437 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.448 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 84.7 mt -60.22 -48.57 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.13 0.491 . . . . 63.05 110.755 174.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.6 m -56.05 -41.79 75.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.115 -0.493 . . . . 72.15 110.783 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HG3' HD11 ' A' ' 108' ' ' ILE . 34.3 tt0 -59.09 -46.37 88.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.157 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.71 -52.92 63.1 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.994 0.368 . . . . 70.42 111.994 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.69 -42.87 84.56 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.819 0.342 . . . . 75.42 111.608 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.1 -34.56 76.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.929 0.344 . . . . 60.55 111.929 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.9 mt -68.1 -37.7 81.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.929 0.395 . . . . 64.23 110.829 174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.76 -44.06 85.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.006 0.431 . . . . 53.44 110.751 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.91 81.91 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.647 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.79 -2.08 58.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.93 0.395 . . . . 74.41 111.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -78.0 150.86 33.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.075 0.464 . . . . 73.43 111.863 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 m -122.01 -31.63 3.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.821 -0.627 . . . . 74.24 110.868 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -112.19 85.47 2.16 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.194 0.521 . . . . 74.41 111.438 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 80.92 -146.25 26.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.214 -0.517 . . . . 51.24 113.833 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.502 HG13 HD13 ' A' ' 57' ' ' LEU . 33.5 m -123.74 140.6 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.472 0.545 . . . . 54.34 112.472 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 65.5 m-85 -87.04 107.63 18.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.436 -0.347 . . . . 53.44 110.895 172.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.64 128.26 44.21 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 71.32 110.499 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 72.1 mt -108.63 133.62 20.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.629 0.252 . . . . 63.52 111.471 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.41 -45.76 38.7 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.003 2.468 . . . . 72.53 113.251 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -71.38 -25.67 74.92 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.926 -0.654 . . . . 64.14 113.001 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -91.93 63.2 4.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.051 0.453 . . . . 63.13 111.429 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -64.56 75.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.409 0.623 . . . . 63.35 111.541 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -141.65 151.47 60.4 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.132 -0.486 . . . . 72.51 111.946 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.688 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 74.5 Cg_endo -73.67 128.11 12.28 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.875 2.383 . . . . 75.45 113.958 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.96 139.9 50.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.348 -0.387 . . . . 73.42 110.703 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 56' ' ' ARG . 13.0 ttp180 -89.39 133.18 34.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.063 0.458 . . . . 62.21 111.282 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.502 HD13 HG13 ' A' ' 45' ' ' VAL . 40.9 tp -132.89 129.67 38.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.132 -0.485 . . . . 62.22 111.374 -177.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.71 137.97 32.02 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.003 -0.369 . . . . 71.42 110.003 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.4 p -126.11 177.94 6.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.213 0.53 . . . . 70.34 111.287 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -78.0 0.75 23.21 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.869 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 pt -118.46 -4.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.737 0.303 . . . . 44.12 111.762 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.11 -177.94 20.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.53 -0.367 . . . . 42.04 112.993 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -88.39 132.32 34.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.207 -0.584 . . . . 73.41 111.716 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.03 -177.59 4.96 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.001 0.429 . . . . 75.12 111.706 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.688 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 66.7 ttp85 -135.41 140.77 45.2 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.477 -0.329 . . . . 74.4 111.088 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.676 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.8 mtt -129.36 152.23 49.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 61.43 111.854 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.1 p -152.38 152.65 32.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.906 0.384 . . . . 72.42 111.626 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 71.1 mt -100.81 111.06 23.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.323 -0.399 . . . . 72.14 111.349 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.639 HG21 ' HD2' ' A' ' 83' ' ' ARG . 33.7 m -128.12 159.35 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.626 0.25 . . . . 71.3 110.997 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.7 m120 51.71 69.03 0.71 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.955 0.407 . . . . 74.52 111.113 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.6 mt -100.43 102.13 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.247 -0.433 . . . . 72.42 110.732 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -121.65 144.86 41.57 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 112.672 0.619 . . . . 74.52 112.672 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.27 129.67 15.29 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.766 2.311 . . . . 73.23 112.104 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.9 t70 -110.46 164.95 12.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.159 -0.473 . . . . 54.2 111.708 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.01 76.93 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 71.11 112.489 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -96.47 -12.29 24.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.912 0.338 . . . . 71.21 111.912 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . 171.51 -102.51 0.18 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.988 -0.625 . . . . 73.32 113.48 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -147.81 130.45 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.492 -0.417 . . . . 71.21 111.775 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 39.4 p -106.78 120.41 41.93 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.831 0.348 . . . . 72.42 111.485 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -130.13 159.13 37.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.691 0.282 . . . . 65.23 110.875 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -101.92 108.21 19.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.973 0.415 . . . . 65.21 111.867 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 HD11 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -84.07 106.63 15.87 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.499 -0.556 . . . . 65.22 109.499 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' HD2' HG21 ' A' ' 69' ' ' VAL . 20.2 mtp180 -96.11 125.76 40.87 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.192 -0.318 . . . . 74.31 111.247 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.568 HD11 HD12 ' A' ' 82' ' ' LEU . 3.9 mp -115.93 103.3 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.917 0.389 . . . . 74.31 111.381 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -106.5 134.7 49.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.382 . . . . 73.34 110.722 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 142.47 32.61 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.957 -0.64 . . . . 65.01 113.324 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -62.15 -35.76 79.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.385 0.612 . . . . 62.54 110.749 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.8 m -99.82 149.83 22.97 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.794 -0.639 . . . . 60.33 110.718 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.71 -17.35 64.05 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.178 0.513 . . . . 74.51 111.342 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.15 136.33 58.69 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.622 -0.717 . . . . 72.41 112.052 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.75 117.01 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.456 2.104 . . . . 72.0 113.053 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -85.2 148.16 49.43 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.391 -0.368 . . . . 72.12 111.837 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.61 176.22 9.64 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.622 2.215 . . . . 64.12 113.007 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -75.14 140.46 43.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.927 0.394 . . . . 74.32 111.741 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.86 168.67 19.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.529 0.68 . . . . 72.53 112.368 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 93.8 p -146.6 145.16 29.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.522 -0.763 . . . . 55.23 110.255 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -143.49 157.12 26.88 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.556 -0.83 . . . . 72.11 113.448 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 60.9 m -99.94 104.99 16.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.981 0.42 . . . . 74.52 110.784 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 152' ' ' ILE . 20.1 m -91.06 125.3 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.007 0.432 . . . . 74.05 111.391 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.8 mt-10 -108.41 112.69 25.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.198 0.523 . . . . 70.13 110.831 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -115.97 141.28 48.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.953 -0.567 . . . . 74.42 111.641 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.27 -146.48 4.85 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.283 -0.484 . . . . 64.32 112.81 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.698 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 mt-30 -128.22 144.17 51.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.254 0.464 . . . . 70.34 112.254 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.2 mt -114.14 103.89 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.409 -0.359 . . . . 55.01 110.78 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -92.83 15.03 15.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.043 0.386 . . . . 72.45 112.043 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -123.29 -170.26 13.4 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.884 -0.674 . . . . 72.35 113.872 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 49.9 p -102.63 -178.1 3.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.804 0.441 . . . . 62.34 111.644 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.493 HD11 ' HG3' ' A' ' 33' ' ' GLN . 46.7 mm -63.42 -30.83 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.461 0.648 . . . . 70.21 110.668 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.82 -56.13 5.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.685 -0.689 . . . . 75.21 110.848 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.31 98.26 4.83 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.196 0.522 . . . . 72.15 111.567 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.543 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 32.2 p90 -113.8 132.37 55.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.082 0.468 . . . . 71.34 111.537 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -107.32 115.94 31.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.219 -0.446 . . . . 62.25 111.492 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.8 97.46 3.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.888 0.375 . . . . 63.55 110.615 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.407 HG13 ' HB2' ' A' ' 103' ' ' GLN . 36.3 pt -108.73 156.81 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.491 -0.322 . . . . 75.23 111.288 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 56.86 36.32 27.56 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.119 0.485 . . . . 73.22 111.546 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.31 116.37 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.96 0.726 . . . . 72.11 112.96 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.89 156.88 37.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.711 -0.677 . . . . 71.13 110.972 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.506 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.3 p-10 -102.42 166.9 10.29 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.361 0.875 . . . . 73.51 113.361 -172.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -152.9 152.83 31.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.413 -0.812 . . . . 74.22 110.087 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.39 133.46 35.86 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.019 0.438 . . . . 73.35 112.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.9 HG22 HD21 ' A' ' 137' ' ' LEU . 39.4 pt -109.98 106.21 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.199 0.523 . . . . 74.43 110.758 173.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.82 101.72 12.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.903 0.382 . . . . 73.2 111.031 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 140.87 21.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.073 0.398 . . . . 64.54 112.073 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.68 168.58 22.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.819 2.346 . . . . 75.25 113.216 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -82.94 139.57 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.288 -0.415 . . . . 64.02 111.856 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.8 m -78.01 93.07 4.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 75.03 110.655 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.94 -36.92 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.264 0.554 . . . . 53.14 111.034 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.15 145.11 39.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.925 -0.58 . . . . 63.45 111.148 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.73 45.54 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.483 -0.326 . . . . 63.24 110.963 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -82.33 170.85 56.71 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.007 -1.247 . . . . 73.23 113.872 1.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -79.82 74.12 6.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.324 -0.398 . . . . 75.21 112.035 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.4 103.11 12.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.262 -0.426 . . . . 65.31 111.289 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.7 t -122.38 108.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.234 0.214 . . . . 71.23 111.429 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -117.87 128.28 54.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.028 0.442 . . . . 54.04 111.701 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 pt -126.12 144.33 48.58 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.185 -0.461 . . . . 53.54 112.145 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.74 158.39 46.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.884 2.389 . . . . 72.54 112.852 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.9 HD21 HG22 ' A' ' 121' ' ' ILE . 31.7 mt -139.72 103.97 4.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.459 0.54 . . . . 75.53 112.459 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -82.78 95.11 7.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.342 0.591 . . . . 65.24 110.557 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.495 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 40.9 mt -80.19 114.79 19.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 60.41 109.803 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -95.58 134.5 38.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.006 0.431 . . . . 74.34 112.056 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.68 15.47 58.15 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.253 -0.499 . . . . 43.41 113.696 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -152.54 134.93 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 117.229 0.514 . . . . 70.13 111.528 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -94.83 156.23 16.45 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.915 0.388 . . . . 71.43 111.847 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.98 -43.76 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.874 0.694 . . . . 63.34 112.874 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.02 -13.53 62.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 63.54 111.042 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.432 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.6 mm-40 -106.18 5.82 30.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.5 . . . . 75.55 111.979 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.455 HD23 HD13 ' A' ' 142' ' ' ILE . 40.2 mt -80.14 109.6 14.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.251 0.548 . . . . 74.43 111.485 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.698 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -87.65 -45.24 5.26 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.847 -0.615 . . . . 70.31 112.904 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -156.13 151.99 27.4 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.167 0.508 . . . . 70.22 111.748 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.38 93.23 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.881 -0.599 . . . . 71.31 109.745 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 18.5 ttp85 -88.27 109.1 19.68 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.274 0.559 . . . . 75.43 112.249 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.676 HG21 ' SD ' ' A' ' 66' ' ' MET . 13.4 mm -90.51 129.69 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.748 -0.66 . . . . 72.11 111.083 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.559 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 14.8 p80 -167.25 -178.13 3.96 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.237 0.458 . . . . 61.32 112.237 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 98' ' ' THR . 8.8 t70 66.32 31.59 8.31 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.53 -0.759 . . . . 65.14 111.174 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.478 HD13 ' HA3' ' A' ' 97' ' ' GLY . 43.0 mm -68.04 94.02 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.87 -0.604 . . . . 60.14 111.154 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -112.83 145.07 32.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.813 -0.631 . . . . 73.11 111.702 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.44 140.8 37.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.487 2.125 . . . . 42.01 112.962 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.554 0.692 . . . . 61.43 111.111 177.639 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.8 pt-20 . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.115 0.483 . . . . 62.42 110.726 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.464 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 7.1 m -69.01 -26.02 64.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.063 -0.517 . . . . 73.15 111.612 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.15 -47.9 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.005 0.431 . . . . 72.31 110.56 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.87 -39.07 92.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.359 -0.382 . . . . 75.33 111.004 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 27' ' ' GLU . 84.4 mt -58.97 -46.43 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.994 0.426 . . . . 61.41 110.832 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -56.29 -49.54 73.98 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.246 0.546 . . . . 70.14 110.611 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.791 ' HG3' HD11 ' A' ' 108' ' ' ILE . 60.2 tt0 -54.89 -43.75 73.5 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.724 -0.671 . . . . 74.33 111.228 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 30.3 tt0 -60.53 -51.81 67.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.111 -0.495 . . . . 55.01 111.868 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -57.46 -40.4 78.45 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.19 0.441 . . . . 55.15 112.19 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -65.01 -47.67 76.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.696 0.284 . . . . 71.43 111.643 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.44 -39.35 91.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.312 0.577 . . . . 70.31 110.757 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 1.7 t30 -60.23 -38.22 82.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.583 -0.735 . . . . 53.5 111.072 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.54 -25.83 35.55 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.301 0.482 . . . . 72.1 112.301 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 55.9 mttm -69.3 -30.9 69.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.803 0.297 . . . . 74.44 111.803 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB2' ' HE1' ' A' ' 46' ' ' TYR . 48.2 t -71.4 130.19 40.71 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.358 0.503 . . . . 61.24 112.358 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.7 m -83.11 -13.86 54.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.068 -0.515 . . . . 73.32 111.686 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -160.78 102.9 1.33 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.863 0.363 . . . . 71.42 111.394 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 152' ' ' ILE . . . 116.07 137.61 6.16 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.17 -0.538 . . . . 52.33 112.896 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -89.49 138.3 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.383 0.512 . . . . 55.21 112.383 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HE1' ' HB2' ' A' ' 41' ' ' SER . 30.2 m-85 -90.01 114.11 25.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.835 -0.62 . . . . 72.43 110.783 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -108.58 133.48 52.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.493 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 74.3 mt -110.4 126.97 27.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.762 -0.199 . . . . 71.35 111.071 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -33.41 68.65 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.539 2.159 . . . . 55.45 112.727 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.29 -36.37 50.53 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.235 -0.439 . . . . 61.14 112.883 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -92.43 71.88 5.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.154 0.502 . . . . 62.43 111.187 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -66.84 77.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.159 0.504 . . . . 71.24 111.429 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -144.02 151.37 52.19 Favored Pre-proline 0 N--CA 1.47 0.546 0 CA-C-N 116.215 -0.448 . . . . 52.05 111.812 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 66' ' ' MET . 59.7 Cg_endo -70.38 152.05 65.88 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.881 2.387 . . . . 74.43 113.406 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -135.66 140.72 44.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.323 -0.399 . . . . 53.54 111.385 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HD3' HH11 ' A' ' 56' ' ' ARG . 17.1 ttm180 -83.83 132.22 34.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.83 0.347 . . . . 72.22 111.822 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.47 HD23 HD21 ' A' ' 64' ' ' LEU . 53.6 tp -130.29 129.9 43.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.8 0.44 . . . . 71.52 111.359 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.26 115.87 30.14 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.296 -0.631 . . . . 73.22 109.296 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 79.7 p -137.27 -178.9 5.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.735 0.779 . . . . 71.31 112.903 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -66.29 -20.12 66.01 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.196 -0.911 . . . . 62.43 112.563 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 95' ' ' PHE . 36.6 pt -90.68 -18.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.851 0.357 . . . . 72.44 111.247 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.43 -164.71 25.1 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.141 -0.482 . . . . 44.04 112.433 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.6 m -95.01 107.3 19.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.231 0.539 . . . . 62.04 111.34 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.817 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.6 -176.47 2.91 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.212 0.53 . . . . 75.41 111.74 -178.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 31.3 ttp180 -150.94 107.51 3.5 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.941 0.4 . . . . 72.13 110.888 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.866 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.7 mtt -104.11 161.29 14.14 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.732 0.642 . . . . 51.14 112.732 -173.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 t -153.52 158.89 41.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.101 -0.5 . . . . 52.33 111.793 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 71' ' ' ILE . 96.2 mt -106.27 110.19 22.36 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.418 -0.356 . . . . 74.14 111.71 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' HB ' ' A' ' 81' ' ' THR . 20.4 m -130.04 165.9 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.702 0.287 . . . . 71.41 111.753 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.22 29.29 18.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.988 0.515 . . . . 73.23 112.323 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' A' ' 68' ' ' LEU . 35.2 mt -68.09 107.35 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.901 0.382 . . . . 63.32 111.464 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.63 153.07 78.76 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.185 0.439 . . . . 65.14 112.185 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.28 150.34 81.37 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.824 2.35 . . . . 53.44 113.268 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -140.9 167.46 22.14 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.141 -0.482 . . . . 54.03 111.546 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.47 72.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.961 0.41 . . . . 62.15 111.911 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 6.6 m-20 -76.01 -26.77 57.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.801 0.334 . . . . 72.44 110.994 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.34 -93.32 0.1 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-N 116.022 -0.535 . . . . 63.41 112.97 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -147.84 126.5 12.54 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.549 -0.383 . . . . 73.43 111.466 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -104.77 129.89 52.94 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.705 0.288 . . . . 54.12 111.658 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 pp -141.1 152.65 44.94 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.976 0.417 . . . . 73.41 111.501 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.454 ' HB ' HG23 ' A' ' 69' ' ' VAL . 60.1 m -89.87 109.04 20.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.965 0.412 . . . . 52.3 111.113 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD12 HD11 ' A' ' 84' ' ' ILE . 2.6 tm? -86.5 109.37 19.04 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.716 -0.475 . . . . 65.14 109.716 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -99.24 130.32 45.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.811 0.339 . . . . 71.53 111.207 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.1 mp -111.62 102.85 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 73.35 111.294 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 72.43 110.695 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.74 153.43 17.54 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.006 -0.616 . . . . 70.52 112.172 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -45.33 91.56 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.349 0.575 . . . . 73.51 110.736 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -85.15 176.39 8.4 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.093 -0.503 . . . . 61.13 111.655 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -89.26 -37.11 15.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.403 -0.362 . . . . 62.11 111.67 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.93 145.71 99.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.666 0.27 . . . . 73.54 111.5 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.75 145.94 82.4 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.236 2.624 . . . . 71.23 114.99 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.42 152.92 44.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.661 -0.7 . . . . 74.24 111.393 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.23 -171.55 1.19 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.678 2.252 . . . . 73.15 113.104 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 157' ' ' PRO . . . -74.62 151.33 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.749 0.309 . . . . 33.55 111.469 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' HB3' HG21 ' A' ' 61' ' ' ILE . 36.4 p90 -154.69 149.63 26.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.599 0.714 . . . . 72.43 112.669 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 91.1 p -130.55 136.75 49.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.287 -0.869 . . . . 52.02 109.8 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.705 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -145.36 175.54 24.87 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.332 -0.937 . . . . 63.33 113.598 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.9 m -111.13 122.19 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.01 111.547 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.429 HG12 HD12 ' A' ' 152' ' ' ILE . 20.7 m -104.11 133.74 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.187 -0.461 . . . . 43.1 111.131 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 41.3 mt-10 -122.76 126.23 47.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.958 0.409 . . . . 75.34 111.024 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -134.18 133.13 40.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.803 0.335 . . . . 75.05 111.741 -171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.31 -157.43 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.242 -0.504 . . . . 72.02 113.28 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.582 ' HB2' HG13 ' A' ' 114' ' ' ILE . 87.5 mt-30 -117.39 151.43 37.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.068 0.461 . . . . 74.23 112.049 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 106' ' ' GLY . 60.7 mt -109.28 122.46 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.192 -0.458 . . . . 72.32 111.266 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -106.88 23.64 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.837 0.31 . . . . 75.45 111.837 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -146.09 -170.43 14.75 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.006 -0.616 . . . . 35.13 113.678 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 44.7 p -97.31 -173.55 2.69 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.935 0.398 . . . . 73.15 111.522 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.791 HD11 ' HG3' ' A' ' 33' ' ' GLN . 31.8 mm -67.9 -36.45 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.037 0.446 . . . . 72.1 111.397 174.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.05 -37.66 58.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.182 -0.463 . . . . 72.34 111.312 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -144.93 111.87 5.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.18 -0.464 . . . . 61.23 111.44 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.1 p90 -139.1 145.81 39.93 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.451 0.643 . . . . 73.3 112.365 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -117.01 144.73 44.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.59 -0.732 . . . . 62.31 110.495 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.19 119.57 37.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.04 0.448 . . . . 72.33 111.489 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 103' ' ' GLN . 33.6 pt -123.07 149.52 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.53 -0.305 . . . . 74.33 111.429 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.89 39.28 31.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.362 0.601 . . . . 73.2 111.445 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.05 127.19 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 55.33 112.203 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.27 167.78 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.977 -0.556 . . . . 71.4 111.058 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.7 p-10 -112.94 178.48 4.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.056 0.762 . . . . 43.11 113.056 -172.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -167.75 159.78 12.05 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.482 -0.781 . . . . 74.35 110.251 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.05 133.92 44.84 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 122.01 -0.431 . . . . 54.13 112.033 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.43 ' O ' HG13 ' A' ' 121' ' ' ILE . 28.4 pt -111.79 106.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.208 0.527 . . . . 74.01 111.165 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.51 100.84 10.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.259 -0.428 . . . . 75.15 110.635 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.72 152.48 37.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.926 0.393 . . . . 75.22 112.047 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.51 174.43 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.801 2.334 . . . . 55.45 113.0 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.83 156.82 20.4 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.218 0.532 . . . . 73.25 112.023 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.9 m -100.95 118.27 36.64 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.094 -0.503 . . . . 74.52 109.983 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.3 -51.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.851 0.358 . . . . 73.43 111.664 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -119.95 164.42 16.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.014 0.435 . . . . 50.43 111.338 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.29 91.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 116.33 -0.395 . . . . 73.1 111.973 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -91.74 166.75 26.92 Favored 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.193 -1.17 . . . . 74.21 113.344 -1.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 55.1 m -66.93 95.46 0.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.928 0.394 . . . . 74.33 111.852 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -148.47 112.71 5.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.899 -0.591 . . . . 73.44 109.946 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.86 110.15 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.648 0.261 . . . . 75.43 111.323 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.11 118.75 35.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 73.5 111.222 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.3 pt -126.41 133.1 24.63 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 120.902 0.382 . . . . 71.54 111.898 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.92 118.3 5.5 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.254 1.969 . . . . 54.33 112.144 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.35 123.54 50.51 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.064 -0.516 . . . . 62.53 110.89 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -105.39 106.59 17.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.035 0.445 . . . . 72.43 111.625 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 mt -83.17 124.21 30.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.483 -0.326 . . . . 41.41 110.535 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 35.3 mtmm -105.87 128.63 53.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.32 111.928 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.9 7.09 57.76 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.258 -0.428 . . . . 60.34 113.811 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.2 tt -145.08 137.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.173 -0.604 . . . . 74.41 111.774 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.9 m -98.3 148.99 23.08 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.459 -0.337 . . . . 73.12 111.744 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.27 -49.54 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.941 0.719 . . . . 64.14 112.941 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.79 -26.94 68.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.017 0.437 . . . . 64.44 111.803 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -100.31 14.57 30.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.273 -0.421 . . . . 64.45 111.772 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.83 121.63 34.39 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 50.33 110.708 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.22 -61.75 0.97 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.162 -0.542 . . . . 52.43 113.646 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.479 ' HE2' ' HD3' ' A' ' 151' ' ' ARG . 49.4 p90 -136.06 155.49 50.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.024 0.44 . . . . 75.44 112.096 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.32 138.4 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.888 -0.596 . . . . 64.22 110.575 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.67 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 21.3 mtp180 -123.55 113.07 18.22 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.962 0.505 . . . . 72.23 111.72 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.866 HG21 ' SD ' ' A' ' 66' ' ' MET . 9.7 mm -106.25 115.16 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 122.413 -0.179 . . . . 74.31 111.221 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -151.17 179.44 8.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.266 0.469 . . . . 74.41 112.266 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 63.12 24.98 14.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.221 0.608 . . . . 63.14 112.589 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.705 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.7 mm -63.05 105.72 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.174 0.512 . . . . 75.53 110.879 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -125.1 143.76 45.18 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.979 -0.555 . . . . 74.33 111.447 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -67.51 107.94 1.52 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.538 2.159 . . . . 74.41 113.42 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 121.202 0.525 . . . . 72.01 110.953 177.917 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.1 tt0 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.013 0.435 . . . . 70.35 110.733 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.483 ' HA ' HD12 ' A' ' 31' ' ' ILE . 89.1 m -59.58 -33.3 71.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.243 -0.435 . . . . 72.11 111.393 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.98 -45.87 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.952 0.406 . . . . 72.11 110.873 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.367 -0.379 . . . . 75.04 111.343 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 28' ' ' THR . 85.5 mt -62.09 -48.58 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.164 0.507 . . . . 74.44 110.786 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.5 m -58.5 -42.33 87.39 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.151 0.501 . . . . 72.25 110.658 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.654 HE21 HD11 ' A' ' 108' ' ' ILE . 30.8 tt0 -56.38 -50.19 72.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.615 -0.72 . . . . 64.15 111.061 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.2 -48.83 75.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.036 -0.529 . . . . 73.24 111.927 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -61.41 -46.9 88.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.891 0.33 . . . . 65.21 111.891 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.2 -36.49 84.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.005 0.372 . . . . 74.05 112.005 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.48 -38.28 89.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.07 0.462 . . . . 65.31 110.4 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.51 -33.27 75.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.925 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.46 98.87 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.927 0.394 . . . . 51.53 111.625 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HD2' ' HE1' ' A' ' 111' ' ' PHE . 61.5 mttp -74.89 -25.86 59.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.999 0.428 . . . . 54.51 111.183 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 47.8 t -69.54 125.81 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.95 0.405 . . . . 63.43 111.915 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 92.9 p -117.98 9.35 12.76 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.499 -0.319 . . . . 51.32 111.353 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 m -135.73 32.33 3.01 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.593 0.59 . . . . 65.42 112.593 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.65 -164.9 25.14 Favored Glycine 0 N--CA 1.463 0.467 0 C-N-CA 120.859 -0.686 . . . . 53.35 113.314 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 57' ' ' LEU . 27.6 m -115.69 136.33 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.085 0.469 . . . . 64.21 112.135 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 41' ' ' SER . 55.0 m-85 -89.69 103.82 16.44 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.313 -0.403 . . . . 71.14 111.242 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.12 102.14 14.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.91 0.386 . . . . 73.55 110.789 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.7 119.1 73.86 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.605 -0.27 . . . . 74.25 110.924 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -58.24 -18.97 40.04 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.263 1.975 . . . . 75.11 112.961 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.62 64.67 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.433 -0.413 . . . . 65.53 113.167 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.96 89.37 2.97 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.118 0.485 . . . . 51.11 111.117 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.39 83.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.174 0.511 . . . . 73.12 110.689 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -158.59 153.35 20.99 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 115.895 -0.593 . . . . 73.5 111.903 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.12 146.13 6.42 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.054 2.503 . . . . 73.32 112.942 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.21 136.08 53.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.796 0.332 . . . . 72.22 111.479 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 56' ' ' ARG . 14.1 ttp180 -86.75 127.21 34.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.898 0.38 . . . . 72.33 111.367 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 45' ' ' VAL . 53.5 tp -120.95 118.34 29.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.016 0.436 . . . . 62.45 111.225 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.9 100.13 12.65 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.186 0.517 . . . . 63.23 110.437 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.46 ' OG ' HG12 ' A' ' 61' ' ' ILE . 73.8 p -99.22 -167.96 1.55 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.306 0.574 . . . . 72.14 112.51 -171.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -76.0 -25.92 56.21 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.638 . . . . 74.04 111.718 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' ' 157' ' ' PRO . 33.9 pt -84.96 -24.8 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.158 0.504 . . . . 73.03 111.101 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -164.35 28.65 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.811 -0.632 . . . . 73.13 112.336 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -91.8 124.81 36.21 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.556 -0.379 . . . . 73.34 111.953 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.552 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -135.51 175.5 9.53 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.973 0.416 . . . . 71.42 111.69 176.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -131.54 119.18 21.16 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.477 -0.328 . . . . 72.24 111.298 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.581 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.3 mtt -112.16 154.99 24.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 73.54 112.315 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -160.89 169.77 21.98 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.152 -0.476 . . . . 74.33 111.234 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 80' ' ' LEU . 94.4 mt -114.66 124.32 51.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.243 0.46 . . . . 74.24 112.243 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.698 HG23 ' HB ' ' A' ' 81' ' ' THR . 29.1 m -133.04 164.53 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.413 -0.358 . . . . 72.31 111.096 174.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 62.61 28.32 16.59 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.54 0.57 . . . . 71.32 112.54 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 mt -67.94 104.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 74.12 111.416 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 p -139.1 152.69 70.43 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 112.299 0.481 . . . . 63.43 112.299 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.52 159.89 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.328 2.685 . . . . 74.22 113.873 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.558 ' HB2' HG23 ' A' ' 79' ' ' THR . 14.0 t70 -150.11 160.33 43.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.931 -0.577 . . . . 72.05 111.141 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.07 90.08 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.089 0.403 . . . . 75.23 112.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -82.49 -31.0 29.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.767 0.317 . . . . 71.13 111.552 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -174.65 -97.67 0.11 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.697 -0.763 . . . . 52.25 113.649 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.2 m -144.84 125.87 14.53 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.929 0.395 . . . . 54.12 111.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 74' ' ' ASP . 46.6 p -96.55 137.17 36.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.908 0.385 . . . . 71.1 111.825 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.423 HD13 HD22 ' A' ' 68' ' ' LEU . 3.3 pp -144.96 155.4 43.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 74.04 111.1 174.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.698 ' HB ' HG23 ' A' ' 69' ' ' VAL . 26.5 m -95.55 111.88 23.71 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.977 0.418 . . . . 60.1 111.117 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.93 109.86 18.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.547 -0.538 . . . . 72.21 109.547 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtt-85 -97.18 127.58 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.819 0.342 . . . . 73.22 111.849 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.6 mp -113.83 98.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 63.02 111.529 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.91 -178.54 6.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.952 -0.388 . . . . 73.02 109.952 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.19 135.3 5.95 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.19 -1.005 . . . . 71.31 113.973 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -59.05 -23.82 62.34 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.884 0.373 . . . . 70.02 111.559 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 88.9 p -83.47 136.26 34.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.299 0.571 . . . . 61.52 111.614 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -68.99 -37.73 78.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.524 0.678 . . . . 70.54 109.53 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.1 147.72 93.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.119 -0.946 . . . . 75.31 111.108 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 55.5 Cg_endo -67.85 162.71 38.45 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.423 2.082 . . . . 73.44 113.477 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.96 145.79 38.75 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.951 -0.568 . . . . 63.41 111.154 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.36 179.91 4.63 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.671 2.248 . . . . 54.45 112.99 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -73.09 153.89 40.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.128 0.49 . . . . 73.51 111.619 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.25 164.97 37.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.194 0.521 . . . . 71.51 111.632 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.8 m -150.88 156.07 40.47 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.16 -0.473 . . . . 23.42 110.372 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -165.25 178.9 40.04 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.271 -0.966 . . . . 74.34 113.893 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 61.3 m -104.38 135.36 45.97 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.895 0.379 . . . . 63.33 111.08 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 26.7 m -110.47 134.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 52.31 111.592 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.788 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.9 mm-40 -103.74 120.08 40.21 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.956 -0.565 . . . . 53.11 110.151 177.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.438 ' CG ' HD22 ' A' ' 139' ' ' LEU . 10.2 p90 -133.7 130.22 37.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.265 0.555 . . . . 74.03 112.149 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.41 -156.38 12.41 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.519 -0.764 . . . . 72.12 112.635 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HB2' HG13 ' A' ' 114' ' ' ILE . 10.0 mt-30 -111.02 151.3 28.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.775 0.321 . . . . 74.22 111.505 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -114.59 106.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 60.11 110.824 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -94.39 -6.74 43.48 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.832 0.679 . . . . 71.14 112.832 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -102.26 -170.04 27.03 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.949 -0.643 . . . . 75.24 113.499 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.3 p -96.31 173.26 7.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.84 0.352 . . . . 71.34 111.014 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.654 HD11 HE21 ' A' ' 33' ' ' GLN . 30.9 mm -63.79 -25.94 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.127 0.489 . . . . 74.21 111.023 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.56 -41.63 19.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.777 -0.647 . . . . 74.55 110.518 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -139.45 97.94 3.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.177 0.513 . . . . 71.24 111.53 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.683 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.0 p90 -115.99 151.07 36.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.558 0.577 . . . . 63.22 112.558 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -127.51 120.53 28.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.753 -0.658 . . . . 73.14 110.46 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.31 104.53 8.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.827 0.346 . . . . 64.12 110.8 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.487 HG13 ' HB2' ' A' ' 103' ' ' GLN . 44.6 pt -105.26 153.21 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.64 -0.254 . . . . 74.01 111.631 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.4 m120 57.32 28.29 15.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.213 0.53 . . . . 70.14 111.045 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.9 137.13 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.926 -0.579 . . . . 52.12 111.942 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.11 171.09 14.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 72.13 110.746 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 3.1 p-10 -108.5 169.96 8.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.335 0.588 . . . . 54.34 112.44 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -163.54 149.39 11.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.683 -0.69 . . . . 52.35 110.966 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -93.03 126.62 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.005 0.372 . . . . 64.04 112.005 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.9 pt -111.6 140.03 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.714 0.293 . . . . 64.13 111.427 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -124.91 131.11 53.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.596 0.236 . . . . 64.4 111.01 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -124.69 135.35 26.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 111.808 0.299 . . . . 71.52 111.808 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 15.0 Cg_exo -69.32 167.84 22.71 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.999 2.466 . . . . 65.42 113.272 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.15 130.56 34.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.15 0.426 . . . . 62.04 112.15 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 74.2 m -79.5 100.88 7.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.908 0.385 . . . . 75.0 110.717 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.67 HG13 ' HG ' ' A' ' 128' ' ' LEU . 8.5 p -71.96 -26.47 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.299 0.481 . . . . 55.33 112.299 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.67 ' HG ' HG13 ' A' ' 127' ' ' VAL . 98.4 mt -119.7 165.17 14.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.06 0.457 . . . . 72.34 112.139 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.595 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -106.28 153.64 40.25 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.042 -0.526 . . . . 72.31 111.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.75 175.15 37.27 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.241 -1.149 . . . . 70.4 113.686 0.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.7 m -75.31 97.08 3.49 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.639 0.607 . . . . 52.21 112.639 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.36 122.94 22.13 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.908 -0.587 . . . . 61.23 110.182 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 134' ' ' ASP . 26.4 t -133.96 159.61 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.395 0.278 . . . . 33.4 111.323 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.442 ' N ' HG12 ' A' ' 133' ' ' VAL . 2.7 p30 -147.14 143.11 28.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.818 0.342 . . . . 62.12 110.94 170.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 pt -140.26 147.94 52.13 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 53.11 111.729 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.7 144.24 21.96 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.704 2.269 . . . . 72.52 112.676 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.61 108.87 6.44 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.182 -0.324 . . . . 72.52 110.859 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -95.14 97.82 10.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.131 0.491 . . . . 73.23 111.625 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.438 HD22 ' CG ' ' A' ' 101' ' ' TYR . 55.4 mt -74.13 128.75 36.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.327 -0.397 . . . . 50.32 110.739 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.06 141.97 35.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.202 0.445 . . . . 62.35 112.202 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.87 34.79 88.26 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.066 -0.515 . . . . 42.25 113.878 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.96 125.96 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.07 0.462 . . . . 74.52 111.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.1 m -88.59 155.04 19.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.897 0.379 . . . . 51.42 111.358 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.49 -39.27 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.08 0.77 . . . . 65.42 113.08 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.81 -27.64 66.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.076 0.465 . . . . 54.15 111.258 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 103' ' ' GLN . 29.0 mm-40 -81.74 -4.14 55.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.273 -0.421 . . . . 71.35 111.752 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.632 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 28.5 mt -71.75 121.56 19.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.088 0.47 . . . . 75.13 112.265 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.98 -47.81 1.22 Allowed Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.098 -0.501 . . . . 62.53 112.632 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -150.97 161.69 42.25 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.75 0.31 . . . . 73.33 111.442 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.46 93.76 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.36 0.6 . . . . 62.23 110.462 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.788 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 47.2 ttp180 -86.99 107.41 18.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.952 0.406 . . . . 73.13 112.007 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.581 HG21 ' SD ' ' A' ' 66' ' ' MET . 23.3 mm -85.93 135.0 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.535 -0.302 . . . . 72.43 111.432 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.36 179.25 8.44 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.07 0.396 . . . . 74.35 112.07 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 98' ' ' THR . 75.5 m-20 64.97 22.5 12.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.193 0.597 . . . . 72.03 112.425 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.481 HD13 ' HA3' ' A' ' 97' ' ' GLY . 51.5 mm -64.53 97.33 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.42 0.629 . . . . 72.04 111.454 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -114.8 150.67 44.46 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.586 -0.734 . . . . 75.31 111.139 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.463 ' HB3' HG22 ' A' ' 61' ' ' ILE . 61.1 Cg_endo -72.69 148.32 46.75 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.324 2.016 . . . . 60.21 113.806 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 3.4 p . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 115.841 -0.618 . . . . 53.54 110.27 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . 28.6 tt0 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.969 0.414 . . . . 61.42 110.65 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -59.14 -35.4 73.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 62.12 111.471 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.54 -42.84 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.971 0.415 . . . . 74.14 110.597 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.573 ' HE3' HD23 ' A' ' 48' ' ' LEU . 44.5 tptt -66.61 -38.15 86.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.176 -0.466 . . . . 63.23 110.781 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.1 mt -59.74 -46.87 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.329 0.585 . . . . 61.11 110.47 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -58.89 -44.85 91.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.702 -0.681 . . . . 73.45 111.057 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.565 ' HG3' HD11 ' A' ' 108' ' ' ILE . 63.1 tt0 -59.21 -45.23 91.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.346 0.593 . . . . 75.3 110.809 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.5 -54.07 50.99 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.31 -0.859 . . . . 74.33 111.188 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -66.31 -30.8 71.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.462 0.541 . . . . 70.55 112.462 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.43 -49.66 68.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.893 0.377 . . . . 74.53 110.673 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -38.35 87.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.116 0.484 . . . . 53.54 110.732 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -56.68 -42.38 78.94 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.782 -0.645 . . . . 73.03 111.031 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -43.4 68.85 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.195 -0.457 . . . . 73.01 112.022 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.94 -7.13 53.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.03 0.381 . . . . 71.43 112.03 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 37.1 t -61.89 126.29 26.84 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.106 0.41 . . . . 73.3 112.106 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 t -93.73 -4.04 51.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.272 -0.422 . . . . 73.05 111.132 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -142.41 96.87 3.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.992 0.425 . . . . 73.21 111.364 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 66.84 -149.17 51.14 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.316 -0.469 . . . . 60.43 113.616 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.454 HG13 HD13 ' A' ' 57' ' ' LEU . 31.6 m -114.51 152.84 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.069 0.461 . . . . 63.22 112.091 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 33.6 m-85 -101.31 114.42 28.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.329 -0.396 . . . . 54.41 111.571 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.58 104.12 14.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.905 0.383 . . . . 51.43 110.749 173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.573 HD23 ' HE3' ' A' ' 30' ' ' LYS . 9.5 mp -82.18 111.83 30.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 122.312 -0.243 . . . . 74.32 110.682 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.6 Cg_endo -57.47 -23.47 56.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.848 2.365 . . . . 41.11 113.461 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.37 -17.67 59.88 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.96 -0.638 . . . . 55.04 113.16 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.67 101.09 5.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.547 0.339 . . . . 72.5 111.26 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.43 88.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.055 0.455 . . . . 52.11 110.438 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.425 HG21 HG23 ' A' ' 31' ' ' ILE . 3.3 p -135.93 148.76 66.34 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.713 0.634 . . . . 71.43 112.713 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.24 131.56 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.24 2.627 . . . . 51.22 113.24 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.04 134.0 55.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.323 -0.399 . . . . 55.25 110.679 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -84.87 109.87 18.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.192 0.52 . . . . 70.45 111.855 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 45' ' ' VAL . 44.3 tp -105.65 124.01 48.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.106 -0.497 . . . . 72.31 111.655 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -75.86 132.02 40.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.355 -0.384 . . . . 62.45 110.39 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -126.13 -178.71 4.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.337 0.589 . . . . 74.54 111.701 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.23 0.87 54.69 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.936 -0.574 . . . . 70.41 111.675 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.9 pt -111.16 -28.88 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.009 0.433 . . . . 72.41 111.016 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.26 151.1 5.83 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.16 -0.473 . . . . 73.11 112.607 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.7 m -55.28 126.47 25.08 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.955 0.378 . . . . 65.12 111.482 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.74 174.5 10.51 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.446 0.641 . . . . 62.21 112.4 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -127.61 125.67 40.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.991 -0.55 . . . . 64.02 111.087 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.806 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.3 mtt -117.14 144.1 45.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.837 0.351 . . . . 54.35 111.776 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -143.66 143.48 31.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.942 0.401 . . . . 71.34 111.413 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 82' ' ' LEU . 92.6 mt -90.17 107.01 18.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.349 -0.387 . . . . 72.12 111.429 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.61 161.48 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.186 -0.321 . . . . 73.55 111.7 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.7 m120 59.03 41.19 21.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.083 0.401 . . . . 75.24 112.083 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.414 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 57.7 mt -73.13 111.44 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.939 0.4 . . . . 73.31 111.55 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -136.82 156.5 75.96 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.413 -0.358 . . . . 61.43 111.907 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.64 151.34 52.2 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.856 2.37 . . . . 72.02 113.023 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.6 t70 -134.12 164.7 26.76 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.227 -0.442 . . . . 74.42 110.975 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -49.2 77.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 42.45 111.711 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.1 -36.41 35.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.55 -0.295 . . . . 73.02 111.628 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.41 -97.38 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.316 -0.945 . . . . 65.24 114.344 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.3 m -141.03 130.9 24.37 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.209 0.448 . . . . 53.4 112.209 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.664 HG23 ' HB2' ' A' ' 74' ' ' ASP . 30.4 p -107.04 116.87 32.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.917 0.389 . . . . 73.13 111.572 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.0 pp -137.52 147.26 45.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.864 0.364 . . . . 73.32 111.472 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -89.32 114.82 26.27 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.91 0.386 . . . . 74.02 111.188 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 68' ' ' LEU . 3.2 tm? -90.56 113.65 25.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.922 -0.399 . . . . 64.01 109.922 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 34.0 mtt-85 -102.1 114.48 28.65 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.872 0.693 . . . . 72.43 112.872 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.8 mp -92.39 147.86 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.886 -0.597 . . . . 72.21 110.716 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.1 118.45 7.86 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.296 -0.261 . . . . 62.45 110.296 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 137.75 28.56 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.99 -0.624 . . . . 72.45 113.3 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.04 68.47 4.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.421 0.629 . . . . 53.41 110.479 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -170.32 179.82 3.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.859 -0.609 . . . . 74.11 111.131 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -100.15 -3.82 30.95 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.854 0.316 . . . . 70.13 111.854 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.2 p30 -112.2 166.45 10.93 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.577 0.584 . . . . 63.32 112.577 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.663 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 72.6 Cg_endo -74.07 171.37 18.08 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.02 2.48 . . . . 75.44 114.332 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.92 152.05 76.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.066 -0.515 . . . . 71.34 111.126 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.12 172.96 15.18 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.381 2.054 . . . . 75.32 113.124 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.82 149.28 48.08 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.741 0.305 . . . . 65.11 111.662 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.72 163.04 39.53 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.613 0.721 . . . . 74.22 112.583 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.1 p -133.99 167.13 21.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.385 -0.825 . . . . 75.44 109.917 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.546 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -165.63 163.98 37.02 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.046 -1.073 . . . . 55.52 114.005 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.657 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 91.1 m -103.8 108.5 19.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.463 0.305 . . . . 61.34 110.804 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 27.9 m -98.28 130.23 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.951 0.405 . . . . 54.4 111.812 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 45.4 mt-10 -107.52 111.81 24.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.904 0.383 . . . . 75.32 111.016 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.495 ' CD1' HD22 ' A' ' 139' ' ' LEU . 40.9 p90 -115.71 140.41 49.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.714 0.292 . . . . 73.51 111.361 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -179.0 -150.34 8.84 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.141 -0.552 . . . . 72.13 113.168 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.2 mt-30 -119.9 166.14 13.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.198 0.523 . . . . 65.43 112.034 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 106' ' ' GLY . 71.0 mt -126.01 124.99 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.939 -0.573 . . . . 73.25 110.62 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -98.88 17.04 20.48 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.813 0.671 . . . . 75.14 112.813 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -145.13 -173.1 16.07 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.373 -0.918 . . . . 64.24 114.141 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 72.2 p -101.01 178.93 4.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.839 0.456 . . . . 74.33 111.667 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.565 HD11 ' HG3' ' A' ' 33' ' ' GLN . 45.1 mm -54.94 -38.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 70.35 111.845 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.64 -45.7 43.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.407 -0.361 . . . . 71.14 111.945 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -134.8 102.54 5.29 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.144 0.497 . . . . 70.5 111.57 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.1 p90 -132.25 150.57 52.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 74.43 111.898 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -134.55 130.59 36.8 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.05 -0.523 . . . . 74.11 110.856 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.38 113.95 18.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.012 -0.54 . . . . 74.44 111.197 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.0 pt -119.18 158.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.724 0.297 . . . . 61.32 111.478 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 58.75 26.79 15.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 73.14 110.826 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.36 144.67 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.538 -0.756 . . . . 62.34 112.237 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.37 161.4 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.666 -0.697 . . . . 65.45 110.5 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 2.6 p-10 -106.78 153.87 21.82 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.938 0.718 . . . . 62.22 112.938 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -139.97 148.71 42.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.704 -0.68 . . . . 55.1 110.553 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.19 119.87 29.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.8 0.333 . . . . 72.24 111.419 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.6 pt -98.09 141.66 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.465 -0.334 . . . . 62.55 110.863 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.24 114.82 18.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.863 0.364 . . . . 73.53 111.173 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.739 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -110.61 129.7 23.67 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.537 -0.301 . . . . 72.24 111.641 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.49 164.45 35.23 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.641 2.227 . . . . 73.3 113.158 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -77.49 121.88 24.45 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.304 0.483 . . . . 73.43 112.304 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.1 m -92.97 96.87 10.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.429 -0.351 . . . . 71.33 110.782 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -78.37 -21.31 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.331 0.586 . . . . 64.33 111.104 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -77.41 152.95 34.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.931 -0.577 . . . . 61.05 111.283 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.85 139.91 26.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.574 -0.285 . . . . 74.41 111.685 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.76 156.75 95.35 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.748 -1.355 . . . . 64.02 112.635 -3.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.663 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 38.7 t -72.12 99.0 2.22 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.079 0.77 . . . . 73.22 113.079 -173.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.88 143.0 44.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.716 0.293 . . . . 63.33 110.428 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.739 HG11 ' HB1' ' A' ' 123' ' ' ALA . 36.5 t -133.64 121.21 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.694 0.283 . . . . 74.42 111.03 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.35 101.72 10.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.102 0.477 . . . . 62.23 111.289 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.415 HG23 HG12 ' A' ' 133' ' ' VAL . 18.8 pt -112.5 129.06 24.74 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.369 0.507 . . . . 75.11 112.369 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.92 121.07 7.28 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.449 2.1 . . . . 53.31 112.12 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.98 107.64 15.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.108 -0.496 . . . . 63.43 111.02 -174.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.99 99.17 11.85 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.162 0.506 . . . . 75.31 111.502 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 101' ' ' TYR . 46.2 mt -77.71 123.8 27.14 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.226 -0.443 . . . . 42.24 110.506 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -99.62 148.31 24.46 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.849 0.357 . . . . 60.45 111.877 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.54 -10.09 74.71 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 114.395 0.518 . . . . 50.11 114.395 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 147' ' ' LEU . 19.4 tt -138.8 119.03 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 117.881 0.84 . . . . 75.24 112.589 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.6 m -75.01 156.58 36.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.246 -0.434 . . . . 63.24 111.286 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.76 -46.28 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.057 0.762 . . . . 73.4 113.057 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.01 -14.87 63.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.14 0.495 . . . . 74.55 111.797 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -92.21 -5.35 52.65 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.539 -0.3 . . . . 64.51 111.645 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 50.6 mt -73.39 113.33 10.36 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.743 0.645 . . . . 73.2 112.743 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.57 -36.54 6.12 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.941 -0.572 . . . . 72.11 112.68 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.98 160.51 27.8 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.8 0.333 . . . . 73.42 111.334 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.53 100.82 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.008 0.433 . . . . 75.04 110.418 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 37.6 ttm180 -86.54 119.93 27.32 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.771 0.32 . . . . 73.43 111.803 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.806 HG21 ' SD ' ' A' ' 66' ' ' MET . 20.7 mm -104.59 125.76 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.309 -0.244 . . . . 74.43 111.136 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.486 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 13.3 p80 -164.85 -175.17 3.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.955 0.354 . . . . 71.01 111.955 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.657 ' HB3' ' H ' ' A' ' 98' ' ' THR . 13.9 t70 67.29 22.38 9.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.332 0.586 . . . . 65.4 111.367 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.546 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -66.91 110.52 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.283 0.563 . . . . 75.53 112.165 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.78 144.49 53.13 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.917 -0.583 . . . . 54.13 111.106 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.82 155.73 67.8 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.411 2.074 . . . . 72.41 113.148 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.844 0.354 . . . . 75.3 110.984 177.242 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 52.31 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -60.55 -30.35 69.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.351 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.62 -47.56 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 64.22 110.364 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.08 80.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.181 -0.463 . . . . 70.12 111.274 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.686 HG23 HG21 ' A' ' 53' ' ' THR . 69.7 mt -56.85 -48.19 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.349 0.595 . . . . 71.41 111.084 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -62.0 -41.07 97.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.788 -0.642 . . . . 75.44 111.059 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.782 ' HG3' HD11 ' A' ' 108' ' ' ILE . 44.0 tt0 -65.15 -38.07 89.42 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.091 -0.504 . . . . 62.21 111.482 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.8 -57.52 12.41 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.528 -0.305 . . . . 70.34 110.566 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -52.02 -45.23 64.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.419 0.526 . . . . 41.0 112.419 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.441 ' HB2' HD12 ' A' ' 108' ' ' ILE . 99.1 mtt180 -66.51 -48.84 68.5 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.326 0.491 . . . . 71.41 112.326 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.97 -45.92 91.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.309 0.576 . . . . 64.43 110.845 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 45' ' ' VAL . 65.7 t30 -66.08 -28.89 69.17 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.884 -0.598 . . . . 70.52 111.142 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.733 0.301 . . . . 72.41 111.184 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.66 -21.93 54.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.848 0.356 . . . . 62.44 111.285 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.431 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 41.1 t -63.72 123.63 19.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.259 0.466 . . . . 64.31 112.259 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 m -108.11 -0.08 21.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.775 0.287 . . . . 73.2 111.775 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 t -148.1 77.62 1.41 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.075 0.464 . . . . 73.32 111.825 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.71 -166.89 12.21 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.512 -0.375 . . . . 65.42 112.926 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.471 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 29.1 m -130.9 149.9 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.761 0.652 . . . . 74.23 112.761 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 41' ' ' SER . 72.9 m-85 -99.95 112.1 24.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.039 -0.528 . . . . 74.43 111.42 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -104.16 106.1 16.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.075 0.464 . . . . 74.34 110.792 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 72.1 mt -83.17 128.88 63.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.619 -0.264 . . . . 52.0 111.241 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 47.8 Cg_exo -57.07 -29.17 82.08 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 122.697 2.265 . . . . 65.54 113.187 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.41 9.91 76.12 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.21 -0.519 . . . . 75.23 113.234 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.62 86.36 2.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.02 0.438 . . . . 61.14 111.651 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.47 80.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.156 0.503 . . . . 74.13 111.113 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.686 HG21 HG23 ' A' ' 31' ' ' ILE . 3.8 p -138.49 150.81 67.59 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 112.84 0.682 . . . . 54.51 112.84 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.84 127.74 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.277 2.652 . . . . 73.12 113.01 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -108.73 132.68 53.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.976 0.417 . . . . 64.1 111.293 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 56' ' ' ARG . 12.3 ttm-85 -90.97 125.89 35.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.31 -0.405 . . . . 72.3 110.771 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.99 121.11 22.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.905 0.383 . . . . 75.45 111.698 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -86.5 111.1 20.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.065 0.459 . . . . 73.43 110.1 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -112.39 -173.02 2.16 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.17 0.509 . . . . 74.54 112.343 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.452 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 47.0 mt-30 -74.25 -24.09 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.819 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.49 -29.4 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.99 0.424 . . . . 63.33 111.196 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.94 -173.22 33.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.218 -0.515 . . . . 63.43 112.955 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -82.85 112.79 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.557 -0.378 . . . . 75.22 110.712 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -119.9 171.91 8.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.521 0.677 . . . . 71.34 112.408 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -132.95 111.95 11.46 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.587 -0.733 . . . . 74.25 110.716 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.683 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.2 mtt -107.35 148.0 29.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.281 0.474 . . . . 74.43 112.281 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.2 t -154.66 157.22 37.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.948 0.404 . . . . 73.2 111.645 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 80' ' ' LEU . 95.0 mt -102.97 114.04 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.307 -0.406 . . . . 63.53 111.579 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 81' ' ' THR . 28.6 m -128.06 161.6 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.69 0.281 . . . . 65.1 111.667 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.6 m120 54.29 30.71 12.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.318 0.488 . . . . 72.12 112.318 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 68' ' ' LEU . 52.2 mt -59.22 104.13 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.007 0.432 . . . . 70.24 111.399 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -125.69 149.53 65.63 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 112.343 0.497 . . . . 71.51 112.343 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.98 129.24 14.0 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.758 2.305 . . . . 72.43 113.375 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 29.4 t70 -91.65 166.74 12.64 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.289 -0.414 . . . . 64.51 110.62 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.44 69.13 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.134 0.42 . . . . 74.35 112.134 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -115.64 -9.78 11.93 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.51 0.559 . . . . 74.03 112.51 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -167.35 -113.78 0.29 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.259 -0.972 . . . . 71.12 114.021 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -146.89 127.12 13.84 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.028 0.381 . . . . 73.24 112.028 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 41.4 p -104.6 114.83 29.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.104 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -126.81 148.46 49.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.883 0.373 . . . . 62.34 111.657 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 69' ' ' VAL . 62.2 m -92.0 107.92 19.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.123 0.487 . . . . 73.11 111.566 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.38 108.91 19.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.034 -0.53 . . . . 71.43 110.053 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 66' ' ' MET . 9.7 mtp-105 -93.66 122.96 36.65 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.3 -0.25 . . . . 74.15 111.609 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -107.16 91.29 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.535 -0.302 . . . . 73.04 110.758 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -88.19 122.79 32.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.706 0.288 . . . . 74.12 111.021 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.33 132.0 11.35 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.709 -0.757 . . . . 62.41 113.154 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -69.16 -43.56 74.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.282 0.563 . . . . 61.3 109.898 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 m -79.42 109.08 13.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.1 -0.704 . . . . 71.44 109.1 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -73.35 1.58 9.3 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.341 0.867 . . . . 73.3 113.341 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.7 p30 -74.09 156.87 87.48 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.681 0.276 . . . . 72.4 111.59 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 11.6 Cg_endo -54.03 114.24 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.021 2.481 . . . . 53.35 113.716 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.88 145.15 29.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.132 -0.485 . . . . 63.13 111.533 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.78 169.01 23.12 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.58 2.186 . . . . 72.04 112.618 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 147.9 49.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.542 -0.299 . . . . 54.04 110.949 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -144.95 160.61 41.06 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.82 0.674 . . . . 74.0 112.82 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -137.75 140.63 40.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.334 -0.848 . . . . 64.31 110.325 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -148.09 171.33 28.58 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.811 -0.709 . . . . 73.0 113.097 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 20.0 m -103.18 134.98 45.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.714 -0.286 . . . . 60.12 111.016 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 119' ' ' GLN . 7.2 p -117.36 122.67 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 74.42 112.015 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 27.5 mm-40 -90.16 105.12 17.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.871 -0.604 . . . . 74.4 110.372 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -114.99 117.81 31.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.356 0.598 . . . . 61.14 111.497 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -163.13 -149.27 5.65 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.961 -0.563 . . . . 63.21 112.866 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.414 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -121.23 157.14 30.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.076 0.465 . . . . 75.1 111.972 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -123.0 122.07 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.14 -0.482 . . . . 75.2 111.196 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 3.8 pt20 -104.34 90.71 3.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.457 0.646 . . . . 72.41 111.159 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 160.39 -152.18 22.89 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.14 113.672 175.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -120.72 -171.66 2.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.876 0.47 . . . . 64.01 111.113 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.782 HD11 ' HG3' ' A' ' 33' ' ' GLN . 29.7 mm -62.77 -34.43 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.266 0.555 . . . . 74.54 110.844 172.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.98 -49.51 8.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.664 -0.698 . . . . 71.44 112.138 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -129.65 105.53 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.08 0.467 . . . . 75.33 111.647 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.518 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.4 p90 -139.97 160.41 39.98 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.097 0.475 . . . . 73.12 112.18 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -134.51 134.76 41.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.074 -0.512 . . . . 62.54 110.768 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.19 123.12 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.484 -0.326 . . . . 63.31 110.884 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.38 154.71 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.047 0.388 . . . . 71.22 112.047 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 53.46 39.2 29.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.071 0.463 . . . . 73.13 111.751 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.483 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 5.6 p -97.6 126.18 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.318 0.58 . . . . 74.23 111.978 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -114.9 153.12 31.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.052 -0.522 . . . . 73.12 110.6 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.22 133.72 53.35 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.166 0.508 . . . . 71.15 111.85 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.52 ' O ' HG12 ' A' ' 99' ' ' VAL . 47.4 tt0 -129.03 149.26 50.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.149 -0.478 . . . . 72.45 110.02 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.8 mt -92.11 118.63 31.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.119 0.485 . . . . 71.43 111.885 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.714 HG22 HD21 ' A' ' 137' ' ' LEU . 30.4 pt -92.78 99.37 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 72.32 111.371 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -101.46 114.57 28.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.293 -0.412 . . . . 65.23 110.96 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -111.67 147.26 36.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.053 0.39 . . . . 70.05 112.053 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.98 164.91 34.19 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.886 2.391 . . . . 62.02 113.733 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.38 125.98 29.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.869 -0.605 . . . . 65.2 112.121 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 71.1 m -90.6 79.44 6.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.962 0.41 . . . . 54.41 110.614 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.37 -10.65 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.149 -0.478 . . . . 64.43 111.875 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.84 129.89 53.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.845 0.355 . . . . 74.24 111.58 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.16 139.39 23.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.359 -0.382 . . . . 72.44 111.233 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 148.48 92.25 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.103 -1.207 . . . . 73.24 113.541 2.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.9 p -89.05 125.24 34.92 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.5 0.667 . . . . 64.11 112.608 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.73 143.39 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.581 -0.736 . . . . 64.0 110.366 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.02 157.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 61.12 110.973 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.424 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.2 p30 -146.76 111.91 5.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.306 0.574 . . . . 75.12 110.866 170.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 23.5 pt -117.05 142.71 30.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.007 -0.542 . . . . 73.12 111.915 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 2.5 Cg_endo -81.24 130.92 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.907 2.405 . . . . 33.01 112.636 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 121' ' ' ILE . 62.9 mt -111.43 111.85 23.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 73.13 111.656 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -91.35 89.57 7.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.239 0.542 . . . . 71.21 110.625 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.5 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 26.2 mt -81.67 110.75 17.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 73.21 110.016 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -98.47 139.15 34.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.973 0.416 . . . . 74.03 111.76 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.98 63.72 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.079 -0.509 . . . . 61.1 113.28 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 147' ' ' LEU . 18.4 tt -134.33 123.61 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 122.401 -0.47 . . . . 72.14 111.774 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -85.41 147.53 26.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.094 0.405 . . . . 74.14 112.094 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -47.66 -51.4 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 113.192 0.812 . . . . 55.2 113.192 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.2 -38.13 82.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.094 0.473 . . . . 74.14 111.61 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -87.54 7.64 28.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.194 0.442 . . . . 71.32 112.194 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.517 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.2 tt -82.35 126.86 32.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.749 0.309 . . . . 73.43 110.257 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.42 -58.51 1.36 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.09 -0.576 . . . . 53.21 113.452 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -147.34 148.83 31.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.369 -0.489 . . . . 74.4 112.305 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.6 t -116.79 99.33 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.72 -0.673 . . . . 60.51 109.833 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -102.55 114.1 28.03 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.091 0.472 . . . . 75.22 111.74 -171.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.683 HG21 ' SD ' ' A' ' 66' ' ' MET . 38.2 mm -90.59 140.19 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.842 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -165.67 179.33 6.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 111.908 0.336 . . . . 75.42 111.908 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 98' ' ' THR . 73.2 m-20 61.87 22.57 13.13 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.417 0.895 . . . . 42.22 113.417 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.8 mm -63.86 94.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.313 0.578 . . . . 74.52 111.741 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 8.0 pt20 -125.66 144.8 49.31 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.556 -0.747 . . . . 72.32 111.179 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 146.27 51.14 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.49 2.127 . . . . 70.42 113.654 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 116.261 -0.427 . . . . 64.31 110.451 175.958 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.906 0.384 . . . . 73.21 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -56.55 -37.14 70.11 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.141 -0.481 . . . . 72.43 111.044 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.16 -47.14 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.356 -0.384 . . . . 65.12 111.065 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.636 ' HE2' ' HB3' ' A' ' 48' ' ' LEU . 21.0 tptm -62.24 -43.3 99.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.98 0.419 . . . . 65.41 111.176 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -49.31 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.031 0.443 . . . . 63.0 111.185 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -56.55 -38.78 72.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.965 0.412 . . . . 43.5 110.906 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -59.71 -42.04 92.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.024 -0.534 . . . . 72.42 111.073 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -62.52 -52.42 63.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.479 -0.328 . . . . 75.42 111.072 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -52.99 -42.96 66.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.88 0.371 . . . . 75.02 111.209 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -57.29 -45.92 83.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.994 0.426 . . . . 65.33 111.567 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.47 -31.18 72.11 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.833 0.349 . . . . 71.02 111.26 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -67.8 -30.48 69.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.938 0.399 . . . . 73.1 110.971 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.89 66.48 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.14 0.495 . . . . 74.24 111.083 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.43 1.05 47.22 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.284 -0.416 . . . . 54.32 111.788 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 t -65.77 120.48 13.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.274 0.472 . . . . 75.3 112.274 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -126.48 -13.97 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.37 -0.377 . . . . 72.31 111.695 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.3 p -129.39 25.51 5.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.377 0.51 . . . . 63.22 112.377 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.39 161.75 11.35 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.048 -0.596 . . . . 71.4 112.763 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.78 135.34 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.542 0.687 . . . . 64.25 112.823 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.96 109.41 20.75 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.453 -0.794 . . . . 72.41 110.746 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.3 131.98 47.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.793 0.33 . . . . 64.12 110.676 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.636 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 84.8 mt -117.17 120.29 33.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 111.903 0.334 . . . . 72.4 111.903 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HG3' HD22 ' A' ' 147' ' ' LEU . 11.5 Cg_endo -55.42 139.23 81.72 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.339 2.026 . . . . 73.15 111.666 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.82 -36.67 3.82 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.9 -0.667 . . . . 72.4 111.923 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.7 93.47 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.096 0.474 . . . . 74.45 110.057 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -79.61 27.29 0.28 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.265 0.555 . . . . 63.52 111.959 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 p -97.35 142.59 24.78 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 121.129 0.49 . . . . 64.45 112.132 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HB2' ' HG3' ' A' ' 65' ' ' ARG . 73.9 Cg_endo -73.57 163.8 36.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.116 2.544 . . . . 62.53 113.597 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.86 140.66 45.99 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.094 -0.503 . . . . 73.33 111.117 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -86.78 123.53 32.03 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.115 0.483 . . . . 72.55 112.046 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.3 tp -125.45 123.28 38.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.187 -0.46 . . . . 74.5 111.187 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -85.11 96.91 9.59 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 61.24 110.21 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.7 p -86.58 -174.85 5.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.265 0.555 . . . . 63.34 111.737 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -83.56 -4.71 58.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.998 -0.546 . . . . 74.32 111.605 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 92' ' ' LEU . 31.0 pt -106.59 -28.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.92 0.391 . . . . 73.23 111.253 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.62 175.54 31.74 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.128 -0.558 . . . . 61.32 113.188 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.4 m -72.76 112.05 8.45 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.056 0.455 . . . . 71.24 111.119 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 pp -121.84 155.95 34.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.329 0.585 . . . . 64.32 112.076 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 32.4 ttt180 -118.17 107.05 13.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.6 -0.727 . . . . 64.55 110.854 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.755 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.5 mtt -104.41 156.06 18.26 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.079 0.466 . . . . 55.41 112.09 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.1 t -158.07 160.82 37.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.779 0.324 . . . . 74.4 111.582 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 80' ' ' LEU . 79.3 mt -105.29 113.13 26.53 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.275 -0.421 . . . . 75.44 111.478 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.501 HG21 ' HD2' ' A' ' 83' ' ' ARG . 27.2 m -130.58 166.27 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.327 -0.233 . . . . 73.54 111.194 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.6 m120 61.16 28.1 17.79 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.012 0.434 . . . . 61.34 111.618 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 HG23 ' A' ' 144' ' ' VAL . 51.8 mt -64.03 96.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.141 0.496 . . . . 74.02 111.319 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 p -131.26 150.88 77.73 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.102 -0.499 . . . . 74.02 112.089 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.66 156.97 61.1 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.737 2.291 . . . . 72.23 113.568 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.473 ' HB2' HG23 ' A' ' 79' ' ' THR . 22.9 t70 -133.36 168.8 17.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.875 -0.602 . . . . 74.42 110.65 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.83 68.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 71.41 111.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.56 -31.9 32.44 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.184 0.438 . . . . 74.43 112.184 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.96 -99.1 0.13 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.233 -0.984 . . . . 63.32 113.759 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -147.2 134.01 20.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.834 0.35 . . . . 51.31 111.539 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 36.2 p -110.72 127.55 55.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.569 -0.287 . . . . 72.54 111.627 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -134.35 145.16 48.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.018 0.437 . . . . 53.25 111.208 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.5 m -84.37 101.78 12.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.11 0.481 . . . . 61.42 111.405 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.1 107.28 12.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.031 -0.531 . . . . 73.42 109.971 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HD2' HG21 ' A' ' 69' ' ' VAL . 14.9 mtp180 -95.66 113.13 24.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.791 0.329 . . . . 54.1 111.614 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.571 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.2 mp -88.53 88.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.133 0.492 . . . . 70.22 110.09 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 63.2 tt0 -94.03 95.18 8.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.133 0.492 . . . . 73.43 110.78 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.45 131.51 41.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.401 -0.428 . . . . 43.43 113.462 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.19 -5.98 58.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.112 0.482 . . . . 70.22 111.352 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.5 p -91.65 147.84 22.7 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.136 -0.484 . . . . 63.4 110.872 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.452 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 28.1 t-20 -79.5 -24.77 42.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.957 0.408 . . . . 70.33 110.639 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.3 134.46 95.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.289 -0.414 . . . . 74.32 111.802 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.57 102.74 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.648 2.232 . . . . 61.34 112.576 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.7 mt -68.88 141.87 92.85 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 112.251 0.463 . . . . 72.02 112.251 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.93 177.07 6.8 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.665 2.243 . . . . 74.31 113.33 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -63.19 135.01 56.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.939 0.4 . . . . 65.54 111.339 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.94 154.28 46.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.43 0.633 . . . . 75.53 112.56 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 90.1 p -131.04 -179.93 5.62 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.626 -0.716 . . . . 51.55 110.498 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . 179.66 175.12 46.21 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.727 -0.749 . . . . 52.44 113.095 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.9 m -111.61 131.96 54.9 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.239 0.216 . . . . 74.32 110.5 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 m -118.79 133.93 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.199 0.523 . . . . 64.15 111.987 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 8.6 mm-40 -99.13 106.65 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.851 -0.613 . . . . 71.41 110.557 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.466 ' HE1' ' HB2' ' A' ' 119' ' ' GLN . 48.5 p90 -116.65 122.56 44.92 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.391 0.615 . . . . 70.53 111.831 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.54 -144.71 4.36 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.68 -0.691 . . . . 61.12 112.811 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.483 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.9 mt-30 -127.03 158.42 37.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.104 0.478 . . . . 63.24 111.687 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.8 mt -119.17 117.07 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.347 -0.388 . . . . 71.24 111.332 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.25 41.81 1.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.086 0.47 . . . . 65.22 111.167 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.496 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -162.35 -158.95 9.91 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.975 -0.631 . . . . 51.02 113.676 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.5 p -125.78 -175.92 3.48 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.911 0.386 . . . . 71.52 111.59 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.493 HD11 ' HG3' ' A' ' 33' ' ' GLN . 45.9 mm -56.75 -38.57 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.031 0.443 . . . . 73.44 111.454 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.63 -42.63 77.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.263 -0.426 . . . . 71.33 111.234 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -139.32 87.59 2.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.293 0.568 . . . . 72.24 111.996 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -98.0 129.86 44.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.079 0.466 . . . . 74.42 111.065 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -123.68 120.17 31.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.059 -0.519 . . . . 63.11 110.838 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.08 118.71 19.11 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.976 0.417 . . . . 74.54 111.937 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.5 pt -130.57 155.11 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.444 -0.343 . . . . 72.2 110.96 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 54.67 32.08 16.55 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.463 0.649 . . . . 70.53 111.279 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.41 117.77 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.752 -0.658 . . . . 70.13 112.226 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -102.42 145.77 29.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.035 -0.529 . . . . 73.14 110.178 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -103.72 117.73 35.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.003 0.43 . . . . 71.42 111.324 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.466 ' HB2' ' HE1' ' A' ' 101' ' ' TYR . 52.1 tt0 -109.68 147.57 32.89 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 75.34 110.889 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.02 115.16 29.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.848 0.356 . . . . 73.43 111.05 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 121' ' ' ILE . 46.7 pt -94.8 116.38 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.108 0.48 . . . . 64.42 111.756 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -109.74 109.4 20.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.984 -0.376 . . . . 72.14 109.984 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.84 147.63 34.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 112.201 0.445 . . . . 41.53 112.201 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.45 151.46 84.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.826 2.35 . . . . 43.02 113.168 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -67.7 140.0 56.75 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.033 0.444 . . . . 74.31 112.041 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -83.7 77.37 9.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.118 -0.326 . . . . 73.35 110.118 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.433 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -67.94 -21.71 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.066 0.46 . . . . 73.53 111.925 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.433 ' HG ' HG23 ' A' ' 127' ' ' VAL . 93.1 mt -105.1 152.42 22.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 75.2 111.039 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 89' ' ' ASN . . . -115.15 140.05 25.18 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.525 -0.307 . . . . 50.12 111.644 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.74 173.83 56.15 Favored 'Cis proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.78 -1.342 . . . . 53.35 113.496 0.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -73.67 111.09 8.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.327 0.491 . . . . 73.25 112.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -141.94 115.57 9.09 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.326 0.584 . . . . 72.32 111.056 172.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.82 155.34 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 116.403 -0.362 . . . . 71.14 110.932 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 9.0 p-10 -143.97 121.34 11.64 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.142 0.496 . . . . 73.2 111.303 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.1 pt -119.91 138.52 27.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 112.182 0.438 . . . . 72.22 112.182 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.8 Cg_exo -78.14 123.33 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.015 2.477 . . . . 74.34 112.819 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' THR . 76.1 mt -100.89 106.46 17.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.89 0.376 . . . . 64.04 111.945 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.479 ' HA ' HG22 ' A' ' 79' ' ' THR . 35.4 tt0 -84.05 88.37 7.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.401 0.62 . . . . 71.12 110.228 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.44 116.74 21.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 71.24 110.013 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -99.68 141.82 31.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 73.41 112.055 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.2 41.29 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.297 -0.478 . . . . 44.14 113.154 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 147' ' ' LEU . 16.9 tt -161.51 127.12 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.039 0.447 . . . . 63.11 111.191 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.4 m -84.65 145.78 27.81 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.007 0.373 . . . . 71.2 112.007 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 71' ' ' ILE . 7.2 p -56.84 -43.03 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.741 0.645 . . . . 73.24 112.741 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.54 -30.3 64.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.096 0.474 . . . . 74.14 111.471 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.469 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 29.7 mm-40 -90.88 -4.16 56.77 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.079 0.4 . . . . 55.5 112.079 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.486 HD22 ' HG3' ' A' ' 49' ' ' PRO . 1.6 tt -61.26 117.94 6.25 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.859 0.361 . . . . 72.15 110.304 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.98 -62.45 1.36 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.278 -0.487 . . . . 41.21 113.457 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.436 ' HD2' ' HG3' ' A' ' 151' ' ' ARG . 37.4 p90 -142.63 155.55 44.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.383 0.512 . . . . 72.1 112.383 -174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.9 t -131.49 104.02 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.196 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.597 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 77.5 mtp180 -96.09 115.28 27.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.933 0.397 . . . . 65.53 112.01 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.755 HG21 ' SD ' ' A' ' 66' ' ' MET . 21.4 mm -93.69 121.91 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.071 -0.513 . . . . 73.24 110.741 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -154.34 172.94 16.88 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.245 0.461 . . . . 52.14 112.245 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 63.6 23.8 13.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.889 0.7 . . . . 73.14 112.889 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.409 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.3 mm -64.23 109.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.18 0.514 . . . . 73.24 111.293 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -133.86 147.11 62.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.84 -0.618 . . . . 74.44 111.9 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.44 124.1 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.253 1.968 . . . . 54.05 112.339 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 112.424 0.527 . . . . 75.31 112.424 -177.026 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 31' ' ' ILE . 42.8 tt0 . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.004 0.431 . . . . 75.5 110.149 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 m -61.32 -33.2 73.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.151 -0.477 . . . . 72.12 111.212 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.66 -54.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.322 0.582 . . . . 73.42 110.973 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -64.72 -34.69 78.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.59 -0.732 . . . . 73.41 111.777 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 27' ' ' GLU . 77.1 mt -64.9 -46.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.871 0.367 . . . . 74.35 111.314 174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.4 m -64.56 -38.97 92.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.781 0.324 . . . . 72.44 111.201 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -60.16 -45.33 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.825 0.345 . . . . 70.4 110.489 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -57.24 10.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.073 -0.512 . . . . 62.31 110.573 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -55.17 -46.27 75.76 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.459 0.54 . . . . 63.11 112.459 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.71 -48.6 76.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.132 0.419 . . . . 73.52 112.132 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.173 0.511 . . . . 60.33 110.8 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -59.25 -44.01 92.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.78 -0.645 . . . . 74.25 110.386 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.6 97.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.034 -0.53 . . . . 71.02 111.945 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HE3' HG22 ' A' ' 108' ' ' ILE . 68.7 mttm -68.81 -23.24 64.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.832 0.349 . . . . 72.33 111.855 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -63.87 115.47 4.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.88 0.371 . . . . 74.45 111.75 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 m -64.42 -47.72 78.08 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.174 0.511 . . . . 62.13 111.4 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.2 p -129.64 117.75 20.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.176 -0.465 . . . . 71.53 111.143 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 99.85 169.51 29.81 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.154 -0.546 . . . . 44.31 113.727 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 57' ' ' LEU . 31.1 m -113.19 153.99 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.113 0.483 . . . . 71.32 111.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -101.95 126.8 48.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.258 -0.428 . . . . 71.31 111.421 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.83 112.28 19.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.397 -0.365 . . . . 74.53 110.749 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 9.6 mp -91.88 135.01 27.92 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.718 -0.219 . . . . 73.31 111.265 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 38.5 Cg_exo -56.62 -32.5 90.64 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.685 2.257 . . . . 63.43 113.274 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.73 15.23 61.01 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.256 -0.497 . . . . 64.31 113.131 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.03 84.2 2.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.164 0.506 . . . . 73.02 111.607 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.75 81.98 0.44 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.45 0.643 . . . . 71.23 111.301 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 p -137.43 152.07 72.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.98 -0.555 . . . . 51.05 112.246 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HB3' HH11 ' A' ' 65' ' ' ARG . 92.8 Cg_endo -81.5 132.4 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.959 2.439 . . . . 62.5 112.717 171.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.11 130.16 55.58 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.813 0.34 . . . . 71.42 111.14 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.715 ' HD3' HG23 ' A' ' 63' ' ' THR . 1.6 tmm_? -86.28 108.52 18.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.96 0.409 . . . . 74.24 110.137 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.422 HD13 HG13 ' A' ' 45' ' ' VAL . 40.2 tp -101.77 131.42 48.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.454 0.645 . . . . 54.41 112.595 -174.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.32 106.21 15.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.277 -0.874 . . . . 73.12 109.817 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -110.41 -178.71 3.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.168 0.509 . . . . 72.43 111.927 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 47.7 mt-30 -87.64 -2.96 58.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.075 -0.512 . . . . 74.34 111.747 177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 157' ' ' PRO . 31.8 pt -104.18 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.839 0.352 . . . . 75.43 111.175 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -162.43 29.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.425 -0.417 . . . . 33.14 113.318 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.715 HG23 ' HD3' ' A' ' 56' ' ' ARG . 77.8 m -87.46 118.72 27.11 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.58 -0.365 . . . . 45.21 111.012 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.45 169.36 17.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.63 0.604 . . . . 74.12 112.63 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.678 HH11 ' HB3' ' A' ' 54' ' ' PRO . 35.1 ttp85 -118.09 136.42 53.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.704 -0.68 . . . . 74.05 110.844 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.639 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.2 mtt -130.39 157.4 42.69 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.768 0.318 . . . . 63.44 111.545 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -164.5 165.11 21.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.905 0.383 . . . . 64.13 111.682 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 80' ' ' LEU . 94.4 mt -109.5 117.69 34.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 61.42 111.588 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 81' ' ' THR . 35.3 m -128.01 162.99 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 72.31 111.51 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.7 m120 58.41 29.58 18.43 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.463 0.542 . . . . 72.33 112.463 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.28 106.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.915 0.388 . . . . 73.11 110.935 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -138.22 151.25 69.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.183 -0.462 . . . . 75.44 112.122 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.06 162.3 38.84 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.9 2.4 . . . . 72.33 113.147 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 79' ' ' THR . 20.5 t70 -147.16 158.46 43.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.246 -0.433 . . . . 75.21 111.478 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.58 84.34 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.17 0.433 . . . . 71.12 112.17 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -88.26 -32.85 18.3 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.707 0.289 . . . . 71.42 111.269 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -172.43 -96.19 0.1 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.692 -0.766 . . . . 74.04 113.763 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -150.72 129.35 12.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.562 -0.375 . . . . 65.43 111.498 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.566 HG23 ' HB2' ' A' ' 74' ' ' ASP . 60.3 p -104.36 125.76 50.87 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.187 -0.321 . . . . 71.24 111.525 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.45 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -138.61 151.37 47.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.038 0.447 . . . . 75.44 111.44 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.496 ' HB ' HG23 ' A' ' 69' ' ' VAL . 32.7 m -94.79 110.02 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 71.33 111.422 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.36 111.58 19.56 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.663 -0.495 . . . . 72.14 109.663 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HE ' ' HB3' ' A' ' 134' ' ' ASP . 38.0 mtp180 -105.28 126.51 52.18 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.239 0.459 . . . . 75.35 112.239 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.2 mp -110.96 141.13 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.824 -0.626 . . . . 75.4 110.201 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -139.64 148.05 41.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 65.14 111.055 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.15 124.61 6.5 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.884 -0.674 . . . . 71.12 113.567 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 63' ' ' THR . 19.3 mm-40 -70.76 -3.32 18.19 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.966 0.413 . . . . 64.43 111.264 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -116.34 161.93 18.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.305 -0.407 . . . . 54.43 110.826 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -81.6 24.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.723 0.297 . . . . 55.12 111.741 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.86 146.74 34.42 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.704 0.402 . . . . 62.33 111.293 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 59.9 Cg_endo -72.64 112.06 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.633 2.222 . . . . 54.41 112.988 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.46 143.38 98.19 Favored Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 112.529 0.566 . . . . 63.24 112.529 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.89 -165.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.793 2.329 . . . . 71.42 112.675 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 138.39 31.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.937 0.399 . . . . 71.22 111.502 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.86 162.88 38.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.144 0.497 . . . . 74.33 112.148 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 95.5 p -140.76 151.0 44.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.973 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.689 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -153.01 170.64 32.02 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.527 -0.844 . . . . 74.21 113.839 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -100.93 124.34 46.48 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.744 0.307 . . . . 61.13 111.388 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.47 130.75 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 75.41 111.194 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.04 126.36 52.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.977 0.418 . . . . 64.15 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 139' ' ' LEU . 10.4 p90 -127.95 121.14 29.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 63.14 111.193 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.92 -159.29 9.57 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.092 -0.575 . . . . 62.03 113.085 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB2' HG13 ' A' ' 114' ' ' ILE . 77.2 mt-30 -119.22 156.53 29.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.007 0.432 . . . . 45.22 111.896 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.2 mt -112.96 129.39 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.125 -0.489 . . . . 73.24 110.998 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -114.14 30.09 7.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.055 0.391 . . . . 74.53 112.055 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -151.83 -157.86 8.12 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.652 -0.785 . . . . 73.35 113.461 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.3 p -105.77 -164.47 1.02 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.529 0.332 . . . . 73.13 111.613 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.416 HG22 ' HE3' ' A' ' 40' ' ' LYS . 50.0 mm -66.18 -40.57 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.877 0.695 . . . . 72.45 112.877 -175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -94.09 -42.7 8.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.311 0.486 . . . . 73.41 112.311 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.76 99.81 7.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.332 0.587 . . . . 73.41 111.807 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.89 148.11 26.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.902 -0.59 . . . . 72.34 111.493 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -113.69 136.9 52.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.907 0.384 . . . . 63.24 110.912 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.49 103.91 13.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.194 0.521 . . . . 74.44 111.189 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.473 HG13 ' HB2' ' A' ' 103' ' ' GLN . 45.2 pt -109.28 155.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 116.447 -0.342 . . . . 50.14 111.889 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 51.89 39.32 25.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.187 0.517 . . . . 72.23 111.837 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.32 123.66 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.175 0.512 . . . . 74.2 111.904 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.15 160.31 17.69 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.087 -0.506 . . . . 65.21 110.442 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.31 145.01 51.19 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.251 0.463 . . . . 64.12 112.251 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -140.91 166.32 25.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.959 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -107.64 121.79 45.38 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.814 0.34 . . . . 73.25 111.791 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.559 HG22 HD21 ' A' ' 137' ' ' LEU . 32.2 pt -95.05 107.58 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.203 0.525 . . . . 73.34 111.369 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.53 101.88 13.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.881 0.372 . . . . 73.42 111.004 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.11 140.73 21.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.862 0.319 . . . . 54.5 111.862 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.41 168.47 21.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.832 2.355 . . . . 75.51 113.466 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.29 146.11 31.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.225 0.454 . . . . 61.44 112.225 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.0 m -93.34 155.81 17.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.138 0.495 . . . . 74.32 112.02 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.0 t -105.51 -47.45 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.958 -0.565 . . . . 44.41 111.682 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.35 173.5 6.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.352 0.596 . . . . 72.35 112.165 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.96 142.34 45.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.741 -0.663 . . . . 74.33 111.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.87 162.93 90.34 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 123.809 -1.33 . . . . 74.51 112.931 -1.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 38.6 m -100.59 108.39 20.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.181 0.438 . . . . 74.4 112.181 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.78 93.09 4.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.579 0.351 . . . . 72.31 110.209 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.57 111.28 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.354 0.261 . . . . 71.33 111.341 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.501 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -117.01 143.69 45.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.287 0.565 . . . . 74.34 112.047 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.7 pt -137.63 136.35 20.11 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.707 -0.679 . . . . 73.34 111.608 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.97 137.28 19.45 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.694 2.263 . . . . 65.14 113.382 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.559 HD21 HG22 ' A' ' 121' ' ' ILE . 20.4 mt -120.54 114.83 22.33 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.125 0.417 . . . . 73.32 112.125 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -91.66 93.73 9.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.963 0.411 . . . . 74.05 110.245 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 46.7 mt -74.33 120.89 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 63.11 110.053 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.2 mtmt -102.33 141.47 35.11 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.396 0.517 . . . . 64.32 112.396 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.29 10.43 86.01 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.211 -0.519 . . . . 61.43 113.885 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.5 tt -143.63 122.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.346 0.593 . . . . 71.0 111.847 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -76.77 155.54 33.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.395 -0.366 . . . . 73.34 111.416 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.4 -40.1 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.117 0.484 . . . . 73.24 111.407 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.53 -23.39 66.86 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.057 0.456 . . . . 72.51 111.47 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -89.47 1.13 56.29 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.226 0.454 . . . . 53.12 112.226 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.3 mt -81.43 125.83 30.91 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.237 0.541 . . . . 74.31 111.872 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.82 -54.28 0.68 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.652 -0.704 . . . . 70.12 112.284 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.13 150.02 37.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.752 0.31 . . . . 70.4 111.332 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.8 102.97 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.1 110.546 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -91.53 116.31 28.75 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.004 0.372 . . . . 61.2 112.004 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.639 HG21 ' SD ' ' A' ' 66' ' ' MET . 11.2 mm -100.48 119.63 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 110.045 -0.354 . . . . 73.52 110.045 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.513 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 15.5 p80 -143.78 177.94 8.17 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.729 1.011 . . . . 74.13 113.729 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 74.64 -74.66 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.771 -1.104 . . . . 71.31 111.769 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.689 HD13 ' HA3' ' A' ' 97' ' ' GLY . 46.7 mm 39.83 82.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.602 0.715 . . . . 70.1 112.376 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.431 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.6 pt20 -110.09 150.54 41.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.451 -0.795 . . . . 60.22 111.557 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.504 ' HG3' HG22 ' A' ' 61' ' ' ILE . 8.4 Cg_exo -71.23 128.19 14.38 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.51 2.14 . . . . 43.24 112.715 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.808 0.813 . . . . 72.53 111.081 176.369 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.015 0.436 . . . . 73.33 110.711 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.3 m -59.85 -31.96 70.24 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.082 -0.508 . . . . 72.24 110.982 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.54 -50.35 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.709 -0.223 . . . . 74.14 110.935 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -55.47 -47.24 76.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.017 0.437 . . . . 62.3 110.854 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 53' ' ' THR . 73.7 mt -55.17 -53.64 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.131 -0.486 . . . . 75.45 111.337 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.7 m -56.65 -47.82 78.91 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.258 -0.428 . . . . 73.33 111.625 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -58.83 -39.92 82.64 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.984 -0.553 . . . . 70.2 111.363 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.89 -47.66 85.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.722 0.296 . . . . 74.31 111.181 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -57.87 -41.69 82.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.931 0.396 . . . . 70.41 111.148 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.4 mmp_? -60.57 -54.55 44.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.949 0.404 . . . . 74.33 111.568 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.88 -36.05 83.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.991 0.424 . . . . 73.24 111.683 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.95 -35.18 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.843 0.354 . . . . 73.44 111.043 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.05 60.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.949 0.404 . . . . 71.23 111.362 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HE3' HG22 ' A' ' 108' ' ' ILE . 62.5 mttm -90.69 -3.9 57.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 73.03 111.572 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 108.63 4.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.145 0.498 . . . . 55.41 112.061 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.5 p -91.98 -1.33 57.31 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.162 -0.472 . . . . 73.22 111.696 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.6 p -153.71 102.9 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.783 0.325 . . . . 75.32 111.23 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 -145.47 28.0 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.941 -0.647 . . . . 64.34 112.692 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 57' ' ' LEU . 17.9 m -134.29 139.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.336 -0.508 . . . . 72.31 112.333 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.55 106.91 18.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.924 -0.58 . . . . 71.43 111.455 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.54 148.78 23.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.989 -0.375 . . . . 63.1 109.989 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.78 130.79 23.48 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.369 . . . . 63.41 111.466 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.645 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 66.2 Cg_endo -72.2 28.36 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.208 2.605 . . . . 54.44 113.805 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.35 12.93 2.05 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.493 -0.384 . . . . 70.33 112.3 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.13 115.72 18.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 73.14 111.551 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -69.07 8.66 0.52 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.675 0.621 . . . . 72.12 112.675 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.435 HG21 HG23 ' A' ' 31' ' ' ILE . 1.5 p -90.81 145.25 31.62 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.584 0.587 . . . . 72.14 112.584 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 75.1 Cg_endo -81.97 -178.28 4.03 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.168 2.578 . . . . 45.42 114.029 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.31 145.64 29.42 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.811 -0.631 . . . . 72.52 111.389 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -80.83 112.25 18.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.415 -0.357 . . . . 71.45 111.185 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.495 HD13 HG13 ' A' ' 45' ' ' VAL . 56.1 tp -117.95 120.64 38.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.296 0.569 . . . . 73.2 111.534 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -83.85 115.09 22.09 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.615 . . . . 72.34 110.701 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -114.08 179.14 4.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.124 0.487 . . . . 64.35 111.512 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -79.19 0.12 29.66 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.197 0.443 . . . . 73.53 112.197 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 92' ' ' LEU . 37.5 pt -109.61 5.27 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.231 0.539 . . . . 62.24 110.551 171.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.13 -171.35 13.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.99 -0.55 . . . . 62.22 112.731 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -77.87 134.33 37.97 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.485 -0.421 . . . . 43.45 111.257 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.48 152.96 48.76 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.333 0.587 . . . . 65.31 111.427 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HD2' ' OE1' ' A' ' 85' ' ' GLN . 39.8 ttm180 -109.63 107.1 17.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.957 -0.565 . . . . 74.13 111.325 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.0 mtt -98.96 138.07 36.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.76 0.314 . . . . 63.51 111.785 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 42.3 t -139.15 161.77 36.59 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.392 -0.367 . . . . 70.0 111.614 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 80' ' ' LEU . 89.8 mt -113.79 108.95 17.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.951 0.405 . . . . 75.41 111.768 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 81' ' ' THR . 35.6 m -117.25 161.53 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.7 0.286 . . . . 74.51 111.284 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 65.14 22.76 12.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.488 0.551 . . . . 74.33 112.488 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 49' ' ' PRO . 51.4 mt -61.84 114.78 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 111.948 0.351 . . . . 73.04 111.948 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -145.09 154.49 54.49 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 112.32 0.489 . . . . 74.34 112.32 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.68 136.62 33.67 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.503 2.135 . . . . 72.5 112.67 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.499 ' HB2' HG23 ' A' ' 79' ' ' THR . 34.7 t70 -107.69 159.06 16.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.826 0.346 . . . . 72.21 111.123 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.93 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.068 0.461 . . . . 53.33 111.647 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -86.95 -55.06 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.297 0.57 . . . . 72.12 110.131 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.21 -94.42 0.16 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.116 -0.564 . . . . 54.51 113.343 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -149.21 136.19 19.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.375 -0.486 . . . . 51.14 111.702 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 74' ' ' ASP . 32.4 p -116.08 129.97 56.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.288 0.566 . . . . 74.22 111.939 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.666 HD13 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -142.34 150.75 41.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.006 -0.543 . . . . 72.53 111.236 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.596 ' HB ' HG23 ' A' ' 69' ' ' VAL . 30.9 m -92.89 112.16 24.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.871 0.367 . . . . 71.42 111.687 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.3 112.97 22.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.773 -0.454 . . . . 64.51 109.773 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' MET . 83.6 mtt180 -110.64 133.82 52.98 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.144 0.424 . . . . 73.03 112.144 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.457 HG13 ' HG2' ' A' ' 66' ' ' MET . 4.0 mp -113.66 109.36 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.072 -0.513 . . . . 75.5 111.175 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 97.6 mt-30 -93.25 143.61 26.1 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.927 0.394 . . . . 63.01 111.193 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.13 146.85 23.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.28 -0.486 . . . . 75.31 114.013 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.8 -46.02 59.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.664 0.386 . . . . 72.14 111.969 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -102.45 179.9 4.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.307 0.575 . . . . 71.14 112.222 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -84.87 10.19 12.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.789 -0.641 . . . . 73.12 111.223 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.96 145.75 31.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.078 -0.51 . . . . 74.51 110.864 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.73 131.54 14.75 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.461 2.107 . . . . 72.3 112.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.479 ' HB3' HD12 ' A' ' 61' ' ' ILE . 94.3 mt -79.75 147.63 67.26 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.681 0.277 . . . . 62.31 111.534 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 16.3 Cg_exo -69.83 -178.13 2.22 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.891 2.394 . . . . 72.43 113.07 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -78.14 132.34 37.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.568 -0.287 . . . . 72.11 111.412 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.56 170.24 16.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 75.24 112.342 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.3 p -153.65 157.02 38.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.041 -0.527 . . . . 74.5 110.516 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.609 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -161.64 -173.67 30.58 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.717 -0.754 . . . . 75.04 113.787 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -120.59 142.94 48.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.76 0.315 . . . . 53.53 110.806 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.0 128.83 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.053 0.454 . . . . 54.1 112.034 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 11.1 mm-40 -95.82 113.04 24.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.011 -0.54 . . . . 75.24 110.039 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 44.6 p90 -124.31 127.9 48.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.874 -0.516 . . . . 53.3 111.965 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.59 -154.26 9.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.075 -0.583 . . . . 70.43 113.263 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -113.31 152.12 30.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.202 0.525 . . . . 74.22 111.944 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.565 HG23 ' HB2' ' A' ' 111' ' ' PHE . 66.3 mt -108.45 106.82 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.008 -0.542 . . . . 73.33 111.037 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -92.64 22.53 4.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.039 0.385 . . . . 75.31 112.039 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -136.66 -165.38 10.49 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.894 -0.67 . . . . 63.21 113.446 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.5 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 11.2 p -87.69 -161.72 0.74 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.703 0.287 . . . . 71.33 111.035 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.646 HG22 ' HE3' ' A' ' 40' ' ' LYS . 51.4 mm -85.67 -28.64 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.878 0.371 . . . . 64.34 111.087 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -91.49 -40.84 11.17 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.02 0.378 . . . . 75.43 112.02 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -127.47 96.89 4.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.444 0.64 . . . . 73.43 110.881 175.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.644 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.5 p90 -118.93 144.94 46.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.906 -0.588 . . . . 72.51 111.912 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -115.27 131.44 56.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.923 -0.58 . . . . 61.31 110.244 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -96.57 113.6 25.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.983 0.421 . . . . 74.34 111.822 -174.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.9 pt -121.1 164.64 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.406 -0.361 . . . . 64.22 111.365 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.07 29.06 11.76 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.984 0.421 . . . . 70.12 111.526 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 4.8 p -94.04 124.64 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.275 0.56 . . . . 75.3 112.218 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -113.19 155.7 24.56 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.884 -0.598 . . . . 62.15 110.758 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -104.78 139.88 38.91 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.154 -0.476 . . . . 62.21 111.202 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -138.58 146.48 41.87 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.708 0.289 . . . . 52.22 111.464 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.93 116.71 27.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.032 0.444 . . . . 54.24 111.825 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 121' ' ' ILE . 23.5 pt -106.7 105.06 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 71.44 111.15 176.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.98 132.61 51.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.281 -0.418 . . . . 61.54 111.065 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -121.51 145.78 43.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.75 0.31 . . . . 72.31 111.828 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.6 174.79 12.26 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.655 2.237 . . . . 64.22 113.001 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -80.82 135.77 36.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.015 0.436 . . . . 63.32 111.872 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.2 m -70.69 126.35 29.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.161 -0.472 . . . . 74.35 111.332 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.617 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -97.91 -35.78 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.104 0.779 . . . . 63.55 113.104 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.617 ' HG ' HG23 ' A' ' 127' ' ' VAL . 92.5 mt -125.62 120.36 30.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.726 0.298 . . . . 75.32 110.93 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.95 68.71 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 112.52 0.563 . . . . 63.34 112.52 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.98 167.52 78.41 Favored 'Cis proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.243 -1.149 . . . . 74.11 112.93 -1.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 49.2 m -75.62 133.73 40.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.857 0.361 . . . . 75.22 111.773 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.47 31.37 1.9 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.996 -0.547 . . . . 75.05 111.239 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' A' ' 123' ' ' ALA . 59.3 t -52.1 115.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.699 0.629 . . . . 71.42 112.699 -174.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.81 114.57 28.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.197 0.523 . . . . 72.11 111.733 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.1 pt -122.87 136.68 27.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.973 0.416 . . . . 61.32 112.094 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.14 135.84 14.07 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.744 2.296 . . . . 74.32 112.942 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.2 113.02 20.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.495 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -103.04 118.9 37.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.219 0.533 . . . . 71.23 112.114 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.2 mt -99.93 142.84 30.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.859 0.464 . . . . 74.44 110.692 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -102.9 144.01 31.75 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.581 0.585 . . . . 74.52 112.581 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.91 -43.27 1.92 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.971 0.749 . . . . 61.33 114.971 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.488 HD13 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -88.83 122.91 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.565 0.698 . . . . 74.12 111.993 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.6 m -82.04 154.97 25.36 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.984 -0.553 . . . . 74.21 111.205 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.585 ' HA ' HD12 ' A' ' 147' ' ' LEU . 9.0 p -57.23 -36.73 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.898 0.38 . . . . 61.5 111.733 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.6 -27.62 68.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.222 0.534 . . . . 52.01 111.208 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -94.32 0.14 55.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.243 0.461 . . . . 64.11 112.243 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.645 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.2 mt -78.73 142.1 37.33 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.101 0.477 . . . . 75.12 112.211 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.88 -56.61 0.29 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.989 -0.55 . . . . 54.04 113.129 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.496 ' HB3' HD11 ' A' ' 104' ' ' ILE . 38.7 p90 -139.33 159.3 42.48 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.323 -0.516 . . . . 71.51 112.103 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 67.4 t -134.19 96.4 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.9 -0.591 . . . . 65.32 110.415 175.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 20.4 ttm180 -93.39 112.77 24.77 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.123 -0.361 . . . . 72.51 111.969 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.63 HG21 ' SD ' ' A' ' 66' ' ' MET . 37.0 mm -89.71 138.11 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 122.205 -0.31 . . . . 74.15 111.296 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -163.58 -177.22 5.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.871 0.323 . . . . 62.23 111.871 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 65.2 20.64 11.98 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.924 0.712 . . . . 74.0 112.924 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.609 HD13 ' HA3' ' A' ' 97' ' ' GLY . 47.4 mm -69.9 103.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.393 0.616 . . . . 53.13 111.927 -177.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -136.38 153.95 76.66 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.831 -0.622 . . . . 75.42 111.149 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.79 153.81 70.16 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.635 2.224 . . . . 64.24 113.329 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.979 0.418 . . . . 50.42 111.878 179.226 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 120.998 0.428 . . . . 73.43 111.005 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -64.68 -29.94 70.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.266 -0.424 . . . . 72.52 111.331 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.05 -46.73 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.533 -0.303 . . . . 62.15 110.619 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 71.9 mmtt -63.02 -38.81 92.69 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.408 -0.36 . . . . 73.44 111.504 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.19 -48.94 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.329 0.585 . . . . 64.22 110.742 173.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.3 m -62.79 -39.47 94.34 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.932 -0.577 . . . . 74.15 110.991 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.484 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 62.8 tt0 -63.29 -45.08 93.05 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.139 -0.482 . . . . 73.04 110.919 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.3 tt0 -58.63 -50.84 72.35 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.849 0.315 . . . . 72.43 111.849 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -58.8 -43.51 90.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.86 0.362 . . . . 70.01 111.798 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -68.87 -43.49 75.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.623 0.249 . . . . 70.11 111.571 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 33' ' ' GLN . 56.3 mt -65.84 -32.84 74.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.984 0.421 . . . . 72.32 110.657 175.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -61.65 -30.64 70.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.148 -0.478 . . . . 72.13 110.556 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.29 -36.25 61.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.756 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.88 -32.81 63.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.337 0.495 . . . . 54.4 112.337 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -55.5 105.68 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.888 0.699 . . . . 73.5 112.888 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -79.6 -22.72 43.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.176 -0.466 . . . . 63.12 111.18 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB3' HH21 ' A' ' 151' ' ' ARG . 30.5 t -124.98 99.15 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 73.34 111.13 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 79.59 -143.38 25.68 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.973 -0.558 . . . . 75.44 113.916 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 28.3 m -140.52 144.96 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.993 0.425 . . . . 75.3 111.873 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 73.5 m-85 -89.89 99.1 12.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.529 -0.305 . . . . 72.0 111.172 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.4 110.08 20.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.885 0.374 . . . . 70.2 110.628 173.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.01 115.79 63.83 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 122.278 -0.264 . . . . 75.51 110.965 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 30.5 Cg_endo -64.24 -7.1 12.95 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.523 2.149 . . . . 72.34 113.281 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 -2.31 55.72 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.455 -0.403 . . . . 65.34 112.666 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.72 115.72 30.72 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.683 -0.304 . . . . 72.14 111.09 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -79.21 61.54 3.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.316 0.579 . . . . 64.4 110.659 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -155.45 151.56 22.72 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 115.798 -0.637 . . . . 73.2 111.662 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 63.6 Cg_endo -85.85 -178.61 2.98 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.128 2.552 . . . . 72.02 113.858 178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.05 138.98 18.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.873 -0.603 . . . . 63.14 110.959 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -89.14 131.74 35.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.242 0.544 . . . . 75.24 112.459 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.7 135.81 40.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.779 -0.646 . . . . 74.43 110.738 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 49.0 tt0 -93.18 128.55 39.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.947 -0.471 . . . . 63.33 111.262 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.8 p -97.13 179.81 4.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.356 -0.384 . . . . 64.11 110.58 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -83.24 -1.79 53.98 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.144 -0.348 . . . . 62.33 111.778 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.466 HG23 ' HD3' ' A' ' 157' ' ' PRO . 38.1 pt -103.94 -32.44 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.713 0.292 . . . . 74.24 110.979 171.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.23 172.9 39.17 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.52 -0.371 . . . . 51.43 112.946 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 95.6 m -78.6 138.26 38.26 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.318 -0.519 . . . . 74.45 111.402 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.91 171.73 13.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.187 0.518 . . . . 63.01 111.775 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.91 120.73 25.34 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.296 -0.411 . . . . 74.45 110.919 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.3 mtt -105.42 152.36 23.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.967 0.413 . . . . 35.5 112.094 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 84.5 p -149.29 143.29 25.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.364 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 82' ' ' LEU . 91.6 mt -96.78 100.45 11.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.934 0.397 . . . . 71.3 111.285 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.41 152.75 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.667 0.27 . . . . 74.04 111.013 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 11.4 m120 57.13 76.47 0.31 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.0 0.429 . . . . 74.21 111.166 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mt -109.36 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.513 -0.312 . . . . 72.21 111.402 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 p -129.89 152.54 80.08 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 73.11 111.714 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 165.57 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.833 2.355 . . . . 64.43 113.804 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.634 ' HB2' HG23 ' A' ' 79' ' ' THR . 33.3 t70 -139.66 170.35 16.05 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.862 -0.608 . . . . 73.23 110.673 -178.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.84 -44.63 91.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.883 0.327 . . . . 62.02 111.883 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -91.03 -31.92 16.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.183 0.438 . . . . 74.33 112.183 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.51 0.15 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.586 -0.816 . . . . 64.24 113.901 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -144.9 135.82 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.061 0.457 . . . . 75.24 111.903 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.634 HG23 ' HB2' ' A' ' 74' ' ' ASP . 46.3 p -110.24 132.88 53.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.344 -0.389 . . . . 73.2 111.167 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 2.8 pp -142.41 160.06 41.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.003 0.43 . . . . 73.2 112.052 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 m -97.96 113.44 25.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 65.12 111.469 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 68' ' ' LEU . 3.0 tm? -92.78 109.53 20.96 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.137 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 90.2 mtt180 -99.04 121.85 41.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.461 0.541 . . . . 74.24 112.461 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.6 mp -104.97 117.4 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.709 -0.678 . . . . 74.24 111.387 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -112.04 117.51 32.87 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.693 0.282 . . . . 74.15 110.415 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.14 142.64 29.71 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.254 -0.498 . . . . 54.31 113.707 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.91 -44.63 84.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.289 0.566 . . . . 74.34 109.909 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -67.88 124.26 22.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.892 -0.595 . . . . 41.45 110.858 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.421 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 21.5 m-80 -68.89 -15.8 63.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.4 . . . . 72.3 111.475 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.18 154.55 63.55 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 116.183 -0.462 . . . . 72.42 111.872 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 41.3 Cg_endo -65.4 130.85 26.32 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.022 2.481 . . . . 74.34 114.233 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.4 mt -103.43 151.61 38.66 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.046 -0.525 . . . . 73.54 111.357 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 174.93 11.94 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.514 2.143 . . . . 74.23 113.226 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.57 134.34 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.069 0.461 . . . . 23.54 112.029 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -132.32 155.48 48.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.409 0.623 . . . . 70.5 111.993 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -147.15 170.64 16.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.81 -0.632 . . . . 75.44 110.603 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -176.91 -175.17 44.0 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.252 -0.975 . . . . 44.54 113.69 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.9 m -103.05 139.09 39.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.956 0.408 . . . . 61.2 111.087 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.58 129.8 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.215 0.531 . . . . 75.25 111.787 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.801 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.2 mm-40 -90.87 139.43 30.75 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.882 -0.599 . . . . 74.03 109.692 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.479 ' CG ' HD22 ' A' ' 139' ' ' LEU . 28.5 p90 -146.04 122.96 11.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 71.25 111.695 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.79 -146.9 5.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.574 -0.739 . . . . 52.2 112.894 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.597 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 89.8 mt-30 -123.74 151.01 43.69 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.134 0.492 . . . . 60.44 111.981 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.2 133.69 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.106 -0.497 . . . . 75.41 111.252 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 11.2 pt20 -121.7 98.87 6.16 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.525 0.679 . . . . 75.21 110.982 171.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 151.21 -162.82 29.63 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.123 -0.56 . . . . 43.23 113.675 176.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.6 p -108.0 -169.86 1.59 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.068 0.547 . . . . 74.42 111.657 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.67 -47.04 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.1 0.476 . . . . 75.04 111.518 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -71.46 -48.07 51.63 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.195 0.443 . . . . 60.22 112.195 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -128.53 110.9 12.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.567 0.699 . . . . 62.22 112.627 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -140.48 154.5 46.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.735 -0.666 . . . . 73.23 111.157 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -122.86 134.37 54.39 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.135 0.493 . . . . 74.33 111.806 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -87.43 104.78 16.77 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.839 -0.619 . . . . 72.44 111.095 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.0 pt -113.93 162.67 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.18 0.192 . . . . 71.14 111.205 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 54.01 30.27 11.53 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.905 0.383 . . . . 62.55 111.973 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.84 124.34 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.313 0.578 . . . . 71.53 112.308 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -113.55 163.12 15.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.105 -0.498 . . . . 64.03 110.728 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -111.72 140.11 46.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 64.42 111.601 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -140.33 160.3 40.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.888 0.375 . . . . 61.24 111.272 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.83 136.75 41.14 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.026 -0.421 . . . . 75.41 111.712 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.27 141.05 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.578 -0.283 . . . . 74.1 110.886 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.28 115.94 17.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.806 0.336 . . . . 62.54 111.163 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 135' ' ' ILE . . . -110.49 137.2 20.63 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.019 0.377 . . . . 64.2 112.019 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.85 165.24 31.75 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.585 2.19 . . . . 42.14 113.255 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.82 24.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.843 0.683 . . . . 72.22 112.843 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 m -93.61 112.04 23.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.086 -0.507 . . . . 72.02 110.53 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.33 -48.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.072 0.463 . . . . 73.2 111.23 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.01 151.52 25.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 73.13 110.852 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.47 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -77.31 149.35 78.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.391 -0.368 . . . . 54.11 111.565 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.27 179.33 25.87 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.956 -1.268 . . . . 73.44 113.158 -0.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 49.2 m -87.59 86.75 7.24 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.465 -0.334 . . . . 74.35 111.655 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 22.2 p-10 -130.54 114.78 15.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.708 0.766 . . . . 73.54 111.567 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 134' ' ' ASP . 21.9 t -126.44 162.62 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.88 -0.6 . . . . 73.51 110.458 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 2.8 p-10 -142.53 137.24 30.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.03 0.443 . . . . 72.54 111.101 172.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 123' ' ' ALA . 20.4 pt -131.06 131.98 23.53 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 120.801 0.334 . . . . 73.02 111.722 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.64 110.28 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.129 1.886 . . . . 73.42 112.56 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -92.57 127.47 38.07 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.47 -0.786 . . . . 75.42 110.387 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -103.72 101.11 10.94 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.983 0.42 . . . . 75.11 111.546 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.479 HD22 ' CG ' ' A' ' 101' ' ' TYR . 68.1 mt -85.97 128.1 34.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.085 -0.339 . . . . 72.55 110.085 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -119.22 141.22 49.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.104 0.478 . . . . 74.4 112.059 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.16 19.31 50.89 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.183 -0.462 . . . . 72.43 113.394 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.574 HD13 HD23 ' A' ' 147' ' ' LEU . 21.2 tt -155.71 134.07 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.08 0.467 . . . . 75.21 112.06 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m -78.75 154.18 30.2 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.296 -0.411 . . . . 73.31 111.93 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.41 -46.07 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.574 0.583 . . . . 64.22 112.574 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.57 -17.28 60.1 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.198 0.523 . . . . 75.12 110.927 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.507 ' HB3' HE21 ' A' ' 103' ' ' GLN . 87.3 mm-40 -93.31 7.37 44.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.368 -0.378 . . . . 61.43 111.642 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.59 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 29.6 mt -75.95 111.53 11.42 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.207 0.527 . . . . 73.43 111.357 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -86.45 -47.74 4.78 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.225 -0.512 . . . . 71.44 112.946 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.95 151.43 25.42 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.131 0.491 . . . . 72.13 112.223 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.35 97.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.808 -0.633 . . . . 54.33 109.738 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 ttt180 -94.87 99.41 11.46 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.309 0.485 . . . . 63.03 112.309 -172.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.556 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 11.9 mm -79.78 139.97 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 64.44 111.014 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -162.17 166.58 25.41 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.824 0.676 . . . . 64.04 112.824 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.84 37.11 15.65 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.962 0.727 . . . . 73.55 112.962 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -73.11 113.5 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.405 0.621 . . . . 74.34 111.283 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.404 ' HB2' ' HD2' ' A' ' 157' ' ' PRO . 10.6 pt20 -138.69 164.0 42.82 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.506 -0.77 . . . . 73.54 111.172 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.466 ' HD3' HG23 ' A' ' 61' ' ' ILE . 29.8 Cg_endo -63.03 146.18 94.54 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.01 1.807 . . . . 73.25 112.652 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 112.494 0.553 . . . . 55.12 112.494 -178.119 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.16 0.505 . . . . 65.01 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 31' ' ' ILE . 25.2 m -69.05 -28.69 66.77 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 72.33 111.548 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.21 -44.32 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.061 0.457 . . . . 71.14 110.674 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HE3' HD23 ' A' ' 48' ' ' LEU . 48.1 tptt -63.4 -41.72 98.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.135 -0.484 . . . . 75.11 110.391 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 28' ' ' THR . 87.3 mt -56.55 -49.0 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.028 -0.533 . . . . 73.42 110.869 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 60.7 m -58.71 -42.53 88.88 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.057 -0.52 . . . . 53.23 110.944 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.776 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -57.28 -46.22 83.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.886 0.374 . . . . 64.11 110.913 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.6 tt0 -58.47 -50.02 75.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.26 0.552 . . . . 74.24 111.379 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.57 -27.33 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.852 -0.613 . . . . 73.25 112.037 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 32' ' ' THR . 99.2 mtt180 -74.31 -41.29 61.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.03 -0.419 . . . . 73.24 111.146 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.644 HD12 HD11 ' A' ' 48' ' ' LEU . 85.3 mt -65.57 -35.36 80.6 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.404 0.621 . . . . 70.32 110.469 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -59.3 -37.35 77.51 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.604 -0.725 . . . . 74.13 110.809 172.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.2 96.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.933 0.396 . . . . 65.42 111.84 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -72.32 -22.18 61.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.14 0.422 . . . . 53.22 112.14 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -92.94 139.09 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.99 0.424 . . . . 70.14 111.626 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.8 m -75.02 -83.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.669 0.618 . . . . 43.42 112.669 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.0 m -97.54 -36.18 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.113 0.412 . . . . 64.44 112.113 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.0 177.49 53.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.113 -0.565 . . . . 70.45 112.802 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 57' ' ' LEU . 27.6 m -135.83 152.19 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.535 0.683 . . . . 53.12 112.692 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.3 m-85 -98.42 102.53 14.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.667 -0.697 . . . . 74.41 110.255 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.2 mt -86.41 113.48 22.4 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.116 0.484 . . . . 74.24 111.115 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 37' ' ' LEU . 8.8 mp -89.46 114.85 62.04 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.222 -0.444 . . . . 74.23 111.145 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.679 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 36.9 Cg_endo -64.48 11.47 0.11 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.224 2.616 . . . . 73.34 114.378 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.84 -10.58 26.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.205 -0.522 . . . . 62.45 112.683 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.66 127.74 53.93 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 70.02 111.546 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -79.23 17.46 0.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.813 0.34 . . . . 73.42 111.763 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -99.95 147.06 32.94 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 112.988 0.736 . . . . 73.11 112.988 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.66 165.0 10.59 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.143 2.562 . . . . 74.23 113.25 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.6 133.94 29.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.487 -0.324 . . . . 21.54 110.984 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -97.02 122.82 40.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.381 . . . . 72.42 111.057 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 45' ' ' VAL . 3.4 pp -120.69 159.57 25.09 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.932 0.396 . . . . 61.2 111.047 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.88 106.54 18.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.047 0.451 . . . . 60.11 110.823 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.1 p -99.69 178.47 4.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.094 -0.503 . . . . 72.01 111.046 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 52.7 mt-30 -76.89 0.58 20.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.373 -0.376 . . . . 73.0 111.94 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.02 -13.91 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.926 0.393 . . . . 73.41 111.16 171.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.75 -158.89 23.49 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.473 -0.394 . . . . 72.51 113.005 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 p -76.09 129.65 37.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.372 -0.487 . . . . 65.14 112.177 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 155' ' ' ILE . 3.1 pp -140.77 138.5 34.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.586 0.708 . . . . 74.42 110.889 170.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 85' ' ' GLN . 1.6 ttp180 -98.87 115.33 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.192 -0.913 . . . . 75.4 110.951 -175.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.618 ' SD ' HG21 ' A' ' 152' ' ' ILE . 58.6 mtt -110.17 154.54 23.2 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.928 0.394 . . . . 72.33 111.608 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.1 t -159.58 155.84 26.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.415 -0.357 . . . . 75.23 111.096 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.578 HD22 HD13 ' A' ' 80' ' ' LEU . 89.0 mt -107.35 105.8 15.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.883 0.373 . . . . 74.23 111.387 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 81' ' ' THR . 31.8 m -115.97 162.76 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.573 -0.285 . . . . 62.22 111.312 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 60.62 34.14 20.22 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.121 0.486 . . . . 72.04 111.911 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.84 108.29 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.099 0.476 . . . . 71.54 111.855 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.47 150.62 74.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.129 0.418 . . . . 64.2 112.129 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.36 146.83 81.8 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.86 2.373 . . . . 64.13 113.231 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.625 ' HB2' HG23 ' A' ' 79' ' ' THR . 25.5 t70 -115.38 170.47 8.38 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.144 -0.48 . . . . 72.51 110.92 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.86 40.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.858 0.361 . . . . 22.03 111.478 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.66 -45.92 11.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.884 0.373 . . . . 64.12 111.488 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.01 -111.34 0.93 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.029 -0.605 . . . . 51.43 113.586 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -145.7 136.62 24.55 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.476 -0.426 . . . . 62.25 111.788 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.625 HG23 ' HB2' ' A' ' 74' ' ' ASP . 54.0 p -107.98 124.48 50.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.701 0.286 . . . . 62.4 111.581 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.578 HD13 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -133.66 167.84 19.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.722 0.296 . . . . 75.41 111.298 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 69' ' ' VAL . 26.4 m -113.14 116.63 30.14 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.874 0.368 . . . . 74.14 111.729 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.437 HD11 ' SD ' ' A' ' 66' ' ' MET . 3.1 tm? -93.61 110.51 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.223 -0.444 . . . . 55.24 110.236 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -100.12 115.63 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.337 0.495 . . . . 72.3 112.337 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.499 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.3 mp -95.38 147.45 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.853 0.461 . . . . 71.24 111.384 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 65' ' ' ARG . 64.9 tt0 -146.02 106.61 4.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.482 0.313 . . . . 72.23 110.335 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.34 27.54 0.84 Allowed Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.257 0.863 . . . . 53.2 115.257 -171.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 59.98 -68.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 74.15 112.097 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 m -61.87 144.66 54.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.757 0.423 . . . . 75.43 111.83 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 43.6 m-80 -74.36 -26.57 60.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.613 -0.267 . . . . 73.32 111.654 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.96 131.62 79.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 112.162 0.43 . . . . 72.24 112.162 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 26.1 Cg_endo -60.8 115.77 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.009 2.473 . . . . 74.2 113.308 -176.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.64 151.98 42.92 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.285 -0.416 . . . . 75.43 111.537 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.66 176.38 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.998 . . . . 74.23 112.536 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -68.15 163.25 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.698 0.285 . . . . 61.34 111.382 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -158.33 148.73 20.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.555 0.693 . . . . 72.4 112.282 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.3 p -127.51 168.64 14.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.417 -0.811 . . . . 74.33 110.726 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.695 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -173.04 167.6 40.44 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.214 -0.994 . . . . 72.11 114.183 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -99.26 116.88 32.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.478 0.311 . . . . 74.01 111.05 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' VAL . 34.0 m -109.79 113.08 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.436 0.636 . . . . 73.24 111.364 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.2 mt-10 -97.03 110.82 23.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.94 0.4 . . . . 75.22 111.353 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -106.74 138.45 42.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.443 -0.344 . . . . 74.32 111.134 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.15 -164.59 27.11 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.839 -0.696 . . . . 73.22 113.514 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.604 ' HB2' HG13 ' A' ' 114' ' ' ILE . 52.7 mt-30 -105.79 157.42 17.47 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.909 0.385 . . . . 73.32 110.9 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.72 142.68 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.714 0.293 . . . . 45.41 111.233 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 12.1 pt20 -138.9 103.1 4.72 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.362 0.601 . . . . 73.34 110.577 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.43 -162.79 31.27 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.197 -0.525 . . . . 72.0 113.51 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.8 p -105.82 -178.37 3.63 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.871 0.367 . . . . 63.13 111.213 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 33' ' ' GLN . 30.2 mm -62.72 -27.78 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.174 0.511 . . . . 55.43 111.013 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -81.72 -55.95 4.31 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.991 -0.55 . . . . 73.03 110.895 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -117.8 84.39 2.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.389 0.614 . . . . 71.2 112.003 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 107' ' ' THR . 31.0 p90 -107.86 123.74 49.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.079 -0.51 . . . . 72.34 110.697 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 51.2 mt-30 -94.58 117.8 30.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.982 0.42 . . . . 74.31 111.525 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.67 101.87 5.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.008 -0.542 . . . . 75.42 110.386 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 103' ' ' GLN . 36.2 pt -112.61 150.91 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.732 0.301 . . . . 64.52 111.807 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 54.38 34.49 20.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.958 0.409 . . . . 63.11 112.069 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.4 130.13 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.23 0.538 . . . . 74.5 112.13 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.55 156.8 48.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.791 -0.64 . . . . 52.2 110.269 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 8.9 p30 -103.3 153.63 20.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.46 0.911 . . . . 73.53 113.46 -171.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -133.05 150.59 52.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.296 -0.865 . . . . 71.11 109.921 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -94.84 123.13 38.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.018 0.437 . . . . 72.32 111.954 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 137' ' ' LEU . 41.6 pt -100.53 138.9 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 70.54 111.409 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.92 105.23 6.64 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.419 -0.355 . . . . 75.04 111.103 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.27 139.48 22.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.61 -0.268 . . . . 62.04 111.461 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HD2' HG11 ' A' ' 133' ' ' VAL . 38.3 Cg_exo -61.17 158.7 33.61 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.008 2.472 . . . . 64.41 113.85 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.83 130.73 41.79 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.987 -0.551 . . . . 62.11 111.703 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.1 m -91.95 101.12 13.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.87 0.366 . . . . 65.12 110.993 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 p -89.0 -21.28 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.188 0.518 . . . . 72.31 110.925 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.7 mt -101.6 165.36 11.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.181 0.515 . . . . 74.25 111.649 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -114.65 147.41 38.08 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 62.35 111.105 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 84.3 Cg_endo -83.48 169.94 54.96 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.837 -1.318 . . . . 64.33 113.529 -1.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 m -83.56 83.07 8.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.478 0.547 . . . . 71.42 112.478 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' A' ' 130' ' ' PRO . 4.6 p-10 -136.57 118.23 14.97 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.482 0.658 . . . . 72.35 111.244 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.458 HG11 ' HD2' ' A' ' 124' ' ' PRO . 46.5 t -122.23 150.74 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.0 -0.546 . . . . 74.22 111.385 -173.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -124.4 110.2 14.26 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.359 0.6 . . . . 74.44 111.557 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.0 pt -112.62 136.35 21.54 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 112.23 0.456 . . . . 73.04 112.23 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.85 146.34 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.836 2.358 . . . . 60.43 113.416 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 121' ' ' ILE . 63.0 mt -132.14 117.17 17.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.191 -0.459 . . . . 72.5 112.101 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -96.37 94.43 7.43 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.189 0.519 . . . . 74.32 110.206 171.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.7 110.05 10.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.346 0.593 . . . . 75.51 110.207 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.43 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 mtmp? -83.94 150.4 25.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.612 -0.722 . . . . 70.24 112.39 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.61 13.81 74.77 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.722 0.649 . . . . 44.12 114.722 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.5 128.43 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.03 0.915 . . . . 72.44 112.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.6 m -84.17 146.24 27.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.165 -0.47 . . . . 62.13 111.302 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.423 ' HA ' HD12 ' A' ' 147' ' ' LEU . 8.0 p -56.88 -34.77 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.524 0.564 . . . . 74.54 112.524 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.58 -32.95 70.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.161 0.505 . . . . 72.34 111.082 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HB3' HE21 ' A' ' 103' ' ' GLN . 32.0 mm-40 -97.38 5.08 50.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.317 0.488 . . . . 73.43 112.317 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.679 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 17.1 mt -69.99 96.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.266 0.555 . . . . 72.23 111.156 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.32 -41.22 11.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.863 -0.608 . . . . 73.41 113.193 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.89 157.02 23.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.186 0.517 . . . . 71.43 111.998 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.21 101.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.773 -0.649 . . . . 74.03 109.82 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 51.5 ttt180 -83.97 105.04 14.54 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.151 -0.477 . . . . 74.43 111.928 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.618 HG21 ' SD ' ' A' ' 66' ' ' MET . 21.8 mm -90.72 121.4 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 116.535 -0.302 . . . . 72.13 111.639 -177.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -159.24 178.24 10.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.322 0.49 . . . . 74.43 112.322 176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.77 18.54 11.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.883 0.697 . . . . 70.43 112.883 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.695 HD13 ' HA3' ' A' ' 97' ' ' GLY . 36.2 mm -63.19 113.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.021 0.439 . . . . 72.53 111.317 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.466 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 8.9 pt20 -136.2 153.83 76.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.007 0.523 . . . . 75.15 111.831 -173.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.87 135.05 22.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.605 2.203 . . . . 73.44 113.754 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 6.0 p . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.119 0.485 . . . . 75.24 110.942 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.061 0.458 . . . . 72.35 111.444 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.4 m -68.53 -28.23 66.8 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.248 -0.433 . . . . 73.45 111.326 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.93 -48.98 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.711 0.291 . . . . 73.42 111.164 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 14.4 mptt -59.83 -47.69 84.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.923 0.392 . . . . 65.52 111.19 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.18 -49.45 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.936 0.398 . . . . 74.32 111.382 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.7 m -57.27 -43.49 83.11 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.995 0.426 . . . . 75.54 111.136 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.705 ' HG3' HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -59.06 -44.63 91.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.27 -0.423 . . . . 74.15 111.394 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.29 -44.17 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.376 . . . . 74.1 111.256 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -63.31 -36.8 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.827 0.306 . . . . 71.52 111.827 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.99 -50.13 67.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.947 0.403 . . . . 64.31 110.914 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.62 -40.01 95.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.071 0.463 . . . . 71.33 111.32 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.29 -39.22 89.62 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.196 -0.456 . . . . 61.11 110.814 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.99 74.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.302 -0.408 . . . . 33.34 111.588 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.32 0.83 57.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.039 0.447 . . . . 71.1 111.794 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 46' ' ' TYR . 25.3 t -77.63 103.43 7.57 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.965 0.412 . . . . 74.34 111.112 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 t -88.28 -23.05 23.58 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.961 0.41 . . . . 61.45 111.743 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.4 p -131.27 104.45 7.05 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.261 -0.427 . . . . 61.12 111.054 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.93 -162.03 35.24 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.288 -0.482 . . . . 40.51 112.89 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.9 145.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.478 -0.425 . . . . 74.22 111.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.543 ' HD2' ' HB2' ' A' ' 41' ' ' SER . 46.7 m-85 -97.06 120.6 37.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.847 0.356 . . . . 75.42 111.909 176.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.55 136.08 52.51 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.991 -0.549 . . . . 62.23 109.814 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 63.8 mt -107.1 130.15 23.29 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 122.17 -0.332 . . . . 74.35 111.351 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 26.4 Cg_endo -60.3 -30.11 90.36 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.528 2.152 . . . . 64.52 112.807 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.64 -12.95 80.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.337 -0.458 . . . . 73.12 112.985 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -120.83 76.66 1.22 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.067 0.46 . . . . 41.01 111.116 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.54 80.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.292 -0.413 . . . . 72.22 111.789 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 p -136.22 152.59 75.51 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 112.091 0.404 . . . . 73.34 112.091 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.02 146.61 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.099 2.533 . . . . 73.3 114.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.81 32.96 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.83 -0.623 . . . . 53.0 110.78 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -85.9 139.93 30.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.014 0.435 . . . . 63.22 111.949 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -144.3 129.78 18.97 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.989 -0.55 . . . . 64.05 111.026 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -83.23 139.82 32.89 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.325 0.583 . . . . 72.12 110.761 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.1 p -124.32 -174.89 3.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 63.11 111.369 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.81 11.52 22.22 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 45.12 111.353 176.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.4 pt -121.67 -4.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.884 0.373 . . . . 75.33 111.179 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.34 -167.83 24.84 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.288 -0.415 . . . . 71.3 112.459 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.8 m -93.95 122.12 36.11 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.19 -0.594 . . . . 73.35 111.301 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -123.41 -176.4 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.118 0.485 . . . . 62.25 111.919 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -151.7 104.93 3.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.208 0.528 . . . . 73.24 110.709 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.629 ' HE2' HD11 ' A' ' 82' ' ' LEU . 86.5 mtp -101.33 165.67 11.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.66 0.615 . . . . 74.14 112.66 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 t -162.77 167.03 23.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.046 0.451 . . . . 63.04 111.793 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 80' ' ' LEU . 90.5 mt -117.73 123.27 45.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.062 -0.517 . . . . 62.13 111.688 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' A' ' 81' ' ' THR . 27.6 m -138.1 171.41 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 116.64 -0.255 . . . . 63.34 111.359 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 m120 56.49 33.08 21.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.614 0.598 . . . . 63.44 112.614 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.3 mt -71.79 109.17 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.023 0.44 . . . . 52.43 111.901 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -134.79 152.7 77.98 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 116.24 -0.436 . . . . 60.12 112.026 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 136.99 34.16 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.65 2.234 . . . . 41.22 112.358 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 79' ' ' THR . 33.9 t70 -113.72 156.58 23.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.737 0.303 . . . . 75.11 111.44 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.37 69.02 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.358 0.503 . . . . 55.24 112.358 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -101.15 -29.56 12.05 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.975 0.416 . . . . 74.35 111.412 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.44 -102.06 0.16 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.05 -0.595 . . . . 50.55 113.104 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.3 m -151.62 128.19 10.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.567 -0.373 . . . . 63.43 110.815 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' HG3' ' A' ' 138' ' ' GLN . 35.3 p -107.49 132.66 52.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.154 0.502 . . . . 71.05 111.824 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.571 HD13 HD22 ' A' ' 68' ' ' LEU . 3.5 pp -148.31 143.22 26.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.135 -0.484 . . . . 71.14 110.996 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 69' ' ' VAL . 56.0 m -81.54 116.49 21.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 41.14 111.358 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 ' HE2' ' A' ' 66' ' ' MET . 3.5 tm? -88.35 116.91 26.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.931 -0.577 . . . . 41.31 109.814 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -98.55 137.36 37.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.768 0.318 . . . . 73.12 111.336 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -117.93 90.53 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.887 0.375 . . . . 53.14 110.921 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 120.86 24.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 73.3 110.164 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.16 122.67 6.26 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.327 -0.94 . . . . 61.13 112.786 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -51.0 -39.83 56.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.467 0.651 . . . . 74.35 109.869 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 m -74.54 117.03 15.9 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.171 -0.922 . . . . 72.12 110.35 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -60.44 -31.68 70.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.016 0.436 . . . . 65.32 111.38 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.15 149.02 98.17 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.763 -0.653 . . . . 61.44 111.898 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 19.2 Cg_endo -58.31 124.38 15.75 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.146 2.564 . . . . 72.03 114.172 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.8 mt -84.1 149.02 54.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.518 -0.31 . . . . 72.44 111.33 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.06 173.95 13.63 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.422 2.082 . . . . 62.4 113.098 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -72.35 141.94 48.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 52.53 111.725 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.38 161.51 41.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.169 0.509 . . . . 71.52 112.291 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 81.1 p -125.09 151.69 45.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.862 -0.608 . . . . 71.14 109.992 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -144.9 154.67 26.03 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.429 -0.891 . . . . 54.34 113.904 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.2 m -97.99 106.56 18.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.414 0.285 . . . . 55.03 110.965 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 152' ' ' ILE . 15.9 m -95.58 136.07 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.975 0.416 . . . . 70.15 111.159 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.481 ' OE1' ' HD2' ' A' ' 151' ' ' ARG . 50.6 mt-10 -115.17 114.37 25.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.25 -0.432 . . . . 73.45 111.092 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -121.47 123.63 42.51 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.975 0.417 . . . . 63.44 111.645 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -165.24 -146.9 4.95 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.324 -0.465 . . . . 23.32 113.234 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.497 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 97.0 mt-30 -126.98 155.98 42.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.494 0.664 . . . . 72.33 112.333 -176.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.36 131.48 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.836 -0.62 . . . . 61.41 110.329 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -102.08 -2.9 28.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.268 0.84 . . . . 71.53 113.268 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.34 -158.99 9.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.274 -0.965 . . . . 64.12 114.619 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.5 p -99.27 -176.76 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.074 0.464 . . . . 62.24 111.831 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.705 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.4 mm -70.4 -24.92 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.188 0.518 . . . . 73.22 111.157 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.81 -43.06 14.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.346 -0.388 . . . . 72.42 111.695 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -142.81 115.91 8.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.24 0.543 . . . . 65.23 111.588 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.36 163.07 36.72 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.138 0.494 . . . . 63.51 111.978 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -132.82 129.34 38.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.978 -0.555 . . . . 73.41 110.35 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 2.4 mp0 -81.08 105.9 12.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.36 -0.382 . . . . 74.45 111.166 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.3 pt -111.11 160.37 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.292 0.478 . . . . 61.32 112.292 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.89 21.12 8.77 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.871 0.693 . . . . 52.15 112.871 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 7.4 p -84.07 137.92 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.79 0.663 . . . . 74.55 112.79 -175.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -117.92 161.13 20.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.728 -0.669 . . . . 73.55 110.804 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -110.68 151.62 27.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.349 -0.387 . . . . 63.11 111.282 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -148.15 145.07 28.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.526 -0.306 . . . . 74.32 110.403 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.72 112.07 24.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.675 0.274 . . . . 75.43 111.556 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' SER . 38.8 pt -94.56 116.94 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.089 0.471 . . . . 73.42 111.195 177.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -102.21 105.68 16.39 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.977 0.417 . . . . 72.14 111.067 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.9 146.69 35.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.488 -0.324 . . . . 42.01 111.847 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 169.79 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.947 2.431 . . . . 54.54 113.287 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -89.1 127.76 35.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.476 -0.329 . . . . 73.33 111.798 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -86.25 135.06 33.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.091 0.472 . . . . 73.11 111.388 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.59 HG23 ' HG ' ' A' ' 128' ' ' LEU . 35.9 m -117.78 4.08 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.138 -0.483 . . . . 71.21 111.871 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.59 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.3 mt -136.59 170.36 16.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.281 0.562 . . . . 74.55 111.941 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.58 145.47 47.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.97 -0.559 . . . . 55.32 111.174 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 156.08 97.49 Favored 'Cis proline' 0 C--N 1.355 0.889 0 C-N-CA 124.164 -1.181 . . . . 55.33 113.354 0.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 31.7 t -95.35 83.74 3.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.644 0.609 . . . . 72.34 112.644 -176.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -119.93 108.68 14.63 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.289 0.566 . . . . 65.25 110.179 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.47 144.07 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.413 0.524 . . . . 73.35 112.413 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.56 121.36 41.52 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.755 0.312 . . . . 71.22 111.584 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.1 pt -132.44 125.81 19.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 120.799 0.333 . . . . 65.44 111.559 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.69 115.6 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.312 2.008 . . . . 62.23 112.876 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.81 111.01 22.37 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.973 -0.558 . . . . 63.32 109.986 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.496 ' HG3' HG22 ' A' ' 79' ' ' THR . 43.6 tt0 -101.33 101.36 12.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.103 0.477 . . . . 74.21 111.365 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.3 mt -89.06 149.13 23.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.394 -0.367 . . . . 64.11 111.767 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.86 150.53 41.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.961 0.41 . . . . 74.04 111.764 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.1 29.01 73.7 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.461 0.545 . . . . 61.41 114.461 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -158.73 135.15 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 122.394 -0.474 . . . . 52.54 111.474 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.3 m -101.39 148.92 24.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.254 -0.43 . . . . 72.24 111.673 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -52.49 -51.93 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 113.317 0.858 . . . . 72.24 113.317 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.97 -17.49 62.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.157 0.503 . . . . 75.24 111.094 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -98.54 -1.65 40.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.097 -0.501 . . . . 72.03 111.739 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 1.5 tt -79.53 129.36 34.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.916 0.389 . . . . 73.03 110.486 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.66 -58.07 1.37 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.313 -0.47 . . . . 62.11 113.655 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 113' ' ' GLU . 22.6 p90 -146.39 157.52 43.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.106 0.479 . . . . 74.34 112.211 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.1 t -130.47 100.09 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.942 -0.572 . . . . 75.42 110.374 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.481 ' HD2' ' OE1' ' A' ' 100' ' ' GLU . 35.4 ttm180 -94.68 125.41 39.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.19 -0.319 . . . . 73.25 111.404 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 99' ' ' VAL . 19.0 mm -105.35 140.25 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 65.13 111.491 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -168.93 173.87 6.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.989 0.366 . . . . 73.31 111.989 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.26 40.62 17.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.62 0.6 . . . . 72.12 112.62 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 64' ' ' LEU . 42.5 mm -73.57 104.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.04 0.447 . . . . 75.42 110.221 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -123.98 146.3 50.62 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 116.277 -0.419 . . . . 74.43 111.962 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.71 141.4 37.59 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.415 2.077 . . . . 73.21 112.981 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.539 0.547 0 O-C-N 122.275 -0.265 . . . . 73.51 110.749 176.647 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.357 0.599 . . . . 72.11 110.978 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -65.88 -21.06 66.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.948 -0.569 . . . . 73.1 111.827 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.99 -47.76 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.973 0.416 . . . . 75.43 110.409 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HE2' HD23 ' A' ' 48' ' ' LEU . 17.3 tptm -63.29 -36.93 85.31 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.19 0.519 . . . . 74.5 109.958 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.2 mt -59.56 -50.41 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.172 -0.467 . . . . 61.54 111.292 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.3 m -54.42 -41.7 69.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.958 0.409 . . . . 70.23 111.082 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.696 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -61.89 -44.43 96.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.441 -0.345 . . . . 72.45 110.892 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.411 ' HG3' HD13 ' A' ' 48' ' ' LEU . 28.9 tt0 -56.85 -40.89 76.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.435 -0.348 . . . . 71.33 111.459 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.6 -50.28 73.65 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.103 0.477 . . . . 62.01 111.335 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.29 -41.72 99.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.164 -0.471 . . . . 74.34 111.325 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.895 0.378 . . . . 73.3 111.005 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.56 -29.18 70.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.088 0.471 . . . . 71.42 110.693 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.13 70.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.218 -0.446 . . . . 71.21 111.245 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -95.01 12.23 29.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.362 0.505 . . . . 75.01 112.362 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -67.35 88.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.949 0.404 . . . . 73.12 111.551 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -66.99 -56.76 8.73 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.195 0.443 . . . . 71.22 112.195 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.2 p -138.23 105.06 5.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.164 0.507 . . . . 71.41 111.226 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 92.12 142.97 11.48 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.176 -0.535 . . . . 34.44 112.956 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 27.2 m -86.35 148.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 112.472 0.545 . . . . 71.12 112.472 -173.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -95.25 114.26 26.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.007 -0.542 . . . . 65.14 112.031 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.02 103.72 13.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.895 0.378 . . . . 74.44 110.727 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.2 mp -82.37 121.96 78.76 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 122.306 -0.246 . . . . 71.13 111.035 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 52.9 Cg_exo -54.94 -32.57 78.95 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.918 2.412 . . . . 71.55 113.726 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.17 11.37 63.12 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.113 -0.565 . . . . 65.45 113.415 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.44 129.6 56.27 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.012 0.434 . . . . 73.52 111.794 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 85.8 tttt -84.85 32.32 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.487 0.661 . . . . 71.24 111.253 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -128.13 133.88 25.62 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 113.445 0.906 . . . . 73.32 113.445 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 91.5 Cg_endo -80.29 179.06 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.431 2.754 . . . . 55.41 113.066 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.76 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.062 0.458 . . . . 60.23 111.801 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -91.77 124.89 36.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.96 0.409 . . . . 72.22 111.015 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.405 HD13 HG13 ' A' ' 45' ' ' VAL . 42.8 tp -120.59 138.33 53.94 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.464 0.542 . . . . 75.34 112.464 -172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.5 117.13 22.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.945 -0.57 . . . . 72.13 110.229 172.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -118.14 173.92 6.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.935 0.398 . . . . 75.14 111.488 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 50.2 mt-30 -79.24 1.41 24.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.194 0.442 . . . . 74.45 112.194 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 157' ' ' PRO . 38.5 pt -105.37 -34.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.983 0.42 . . . . 72.53 110.693 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.46 -156.5 28.32 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.108 -0.496 . . . . 72.43 112.428 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.9 m -98.36 124.33 42.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.951 0.405 . . . . 72.33 110.994 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.99 170.75 15.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.809 0.337 . . . . 44.34 111.905 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -134.25 116.1 14.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.471 0.309 . . . . 71.54 110.526 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.747 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.1 mtt -107.4 155.32 20.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.685 0.624 . . . . 53.02 112.685 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 99.8 p -154.78 157.76 38.45 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.083 -0.508 . . . . 42.24 111.357 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.59 125.93 50.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.556 -0.293 . . . . 64.34 111.677 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.571 HG23 ' HB ' ' A' ' 81' ' ' THR . 23.9 m -137.6 169.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.65 0.262 . . . . 62.5 111.416 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.9 m120 55.54 26.72 9.37 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.543 0.571 . . . . 75.32 112.543 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 53.5 mt -60.67 111.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.819 0.342 . . . . 71.11 111.426 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 151.8 77.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.464 0.542 . . . . 72.01 112.464 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.61 118.8 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.888 2.392 . . . . 72.21 112.521 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' HB2' HG23 ' A' ' 79' ' ' THR . 28.6 t70 -100.37 164.61 11.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.398 -0.365 . . . . 73.31 111.603 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.57 92.28 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 72.12 111.828 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.85 -41.36 15.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.939 0.4 . . . . 74.54 111.404 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.21 -94.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.439 -0.886 . . . . 72.34 114.07 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.5 m -143.71 120.36 11.13 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.562 -0.375 . . . . 52.43 112.002 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 74' ' ' ASP . 8.0 p -96.83 118.71 33.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 62.31 111.127 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.1 pp -132.9 -172.47 2.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.38 -0.373 . . . . 64.44 111.261 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.571 ' HB ' HG23 ' A' ' 69' ' ' VAL . 31.2 m -130.12 111.1 12.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.88 0.371 . . . . 61.4 110.661 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.7 112.88 20.46 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 60.14 110.04 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtm180 -93.96 124.72 38.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.526 -0.306 . . . . 75.42 111.61 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -110.34 97.3 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.473 -0.33 . . . . 71.34 111.05 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.22 108.09 20.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.582 -0.525 . . . . 71.14 109.582 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.22 140.16 29.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.887 -0.673 . . . . 73.5 113.261 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.83 -21.33 57.38 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.384 0.611 . . . . 72.3 110.075 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -64.83 118.46 9.03 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.27 -0.877 . . . . 64.04 111.994 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -71.88 -14.03 61.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.202 0.525 . . . . 42.42 110.905 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.6 p-10 -97.86 149.42 35.7 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.837 -0.62 . . . . 71.44 110.913 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 16.6 Cg_exo -65.68 137.36 49.65 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.606 2.204 . . . . 72.43 113.365 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.17 158.42 31.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.418 -0.356 . . . . 72.42 111.296 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.55 -165.14 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.205 1.937 . . . . 61.21 112.43 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.92 156.13 22.51 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.278 -0.264 . . . . 34.11 110.81 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -150.19 162.86 39.63 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.585 0.707 . . . . 74.25 112.681 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 p -157.74 154.36 28.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.216 -0.902 . . . . 72.24 110.492 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.39 -175.23 35.0 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.278 -0.963 . . . . 70.2 114.039 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 m -111.23 145.43 38.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.494 0.318 . . . . 54.02 110.852 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.0 p -124.13 128.84 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.253 0.464 . . . . 75.25 112.253 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 29.8 mm-40 -98.2 110.37 22.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.248 -0.433 . . . . 73.15 110.325 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HD2' HG21 ' A' ' 142' ' ' ILE . 12.4 p90 -121.7 118.24 28.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.287 0.565 . . . . 75.12 112.064 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.18 -153.43 6.75 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.714 -0.675 . . . . 50.24 113.01 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.536 HE21 ' HB3' ' A' ' 146' ' ' GLN . 77.3 mt-30 -119.29 145.77 45.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.089 0.471 . . . . 71.4 112.27 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.96 104.69 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 75.23 110.606 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -89.36 -11.89 42.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.839 0.681 . . . . 74.32 112.839 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.11 -168.64 15.69 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.86 -0.686 . . . . 43.31 114.025 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 45.8 p -92.12 -176.66 4.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.703 0.401 . . . . 61.21 111.387 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.696 HD11 ' HG3' ' A' ' 33' ' ' GLN . 50.8 mm -74.36 -26.89 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.255 0.55 . . . . 44.54 110.622 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.9 -35.99 56.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.911 -0.586 . . . . 61.45 110.851 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.66 97.43 2.97 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.124 0.488 . . . . 75.34 111.908 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -122.64 151.27 41.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.277 0.56 . . . . 73.43 111.606 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -132.36 117.81 18.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.876 -0.602 . . . . 64.32 110.402 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.99 108.16 5.75 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.918 0.389 . . . . 71.01 111.091 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.487 HG13 ' HB2' ' A' ' 103' ' ' GLN . 34.6 pt -113.41 152.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.418 -0.356 . . . . 74.42 111.041 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 57.6 32.89 22.53 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.957 0.408 . . . . 71.02 111.297 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.96 124.72 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.375 0.607 . . . . 63.14 112.127 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -114.88 157.51 23.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.029 -0.532 . . . . 71.43 110.524 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 7.0 p30 -112.22 153.74 26.64 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.807 0.337 . . . . 72.13 111.139 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -153.39 154.05 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.691 0.282 . . . . 75.53 111.456 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -92.18 122.86 35.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.084 0.401 . . . . 73.43 112.084 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.9 pt -112.73 120.83 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.088 0.47 . . . . 73.45 111.516 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -118.03 139.73 50.77 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.259 -0.275 . . . . 72.23 111.13 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.87 149.69 73.04 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.182 0.438 . . . . 74.03 112.182 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.11 164.21 20.38 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.351 2.701 . . . . 74.03 113.988 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.35 26.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.976 -0.556 . . . . 74.44 111.979 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.2 m -83.3 55.01 2.99 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.891 0.377 . . . . 53.01 111.413 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.2 m -70.29 -2.39 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.473 0.916 . . . . 55.34 113.473 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.5 mt -131.01 124.27 30.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.164 -0.335 . . . . 72.05 111.226 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.36 56.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.651 -0.249 . . . . 62.25 111.379 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.14 156.84 94.29 Favored 'Cis proline' 0 C--N 1.355 0.901 0 C-N-CA 123.863 -1.307 . . . . 65.3 112.972 -0.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 p -80.43 57.25 2.78 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.129 0.49 . . . . 74.32 112.17 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.11 89.92 8.18 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.087 0.47 . . . . 75.13 110.084 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.66 154.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.268 -0.424 . . . . 74.23 111.714 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -142.89 144.79 32.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.791 0.329 . . . . 75.34 110.982 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.1 128.39 11.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.651 0.262 . . . . 74.12 111.705 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.71 142.06 47.15 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.286 1.991 . . . . 71.24 112.009 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.48 123.28 20.0 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.625 -0.261 . . . . 73.01 111.212 -172.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -102.1 102.91 13.44 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.121 0.486 . . . . 63.13 111.309 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 71.9 mt -83.55 128.22 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.573 -0.285 . . . . 62.33 110.267 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -103.47 142.93 33.4 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.609 0.596 . . . . 74.53 112.609 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.75 80.44 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.863 -0.608 . . . . 61.41 114.136 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.472 HG21 ' HD2' ' A' ' 101' ' ' TYR . 16.1 tt -149.51 114.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 117.485 0.643 . . . . 74.31 112.042 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 64.6 m -80.47 155.03 27.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.078 0.466 . . . . 61.41 112.214 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.05 -47.99 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 113.372 0.879 . . . . 74.43 113.372 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.91 -16.52 64.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.134 0.492 . . . . 72.34 111.341 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.536 ' HB3' HE21 ' A' ' 103' ' ' GLN . 29.7 mm-40 -108.66 11.56 26.43 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.68 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.543 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -88.94 108.18 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.071 0.462 . . . . 63.43 110.246 178.461 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.98 -55.43 3.13 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.125 -0.56 . . . . 63.33 113.661 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -145.09 152.53 40.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.973 0.416 . . . . 74.12 111.831 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.63 94.09 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.885 -0.598 . . . . 64.51 110.31 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.637 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 68.7 ttt180 -89.05 107.2 18.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.755 0.422 . . . . 62.44 111.974 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.747 HG21 ' SD ' ' A' ' 66' ' ' MET . 35.9 mm -89.12 126.44 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.468 -0.333 . . . . 74.35 111.432 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.595 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.9 p80 -154.96 177.56 11.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.156 0.428 . . . . 72.4 112.156 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 64.4 23.14 12.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.092 0.557 . . . . 72.33 112.414 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.635 HD13 ' HA3' ' A' ' 97' ' ' GLY . 51.0 mm -67.57 95.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.643 0.735 . . . . 74.13 112.073 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.455 ' HA ' ' HB2' ' A' ' 60' ' ' GLN . 9.0 pt20 -116.78 151.56 47.42 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.266 -0.879 . . . . 72.24 111.449 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 61' ' ' ILE . 58.2 Cg_endo -70.47 128.62 15.63 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 70.53 113.786 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.545 0.788 0 CA-C-O 121.849 0.833 . . . . 71.44 110.886 176.271 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 31' ' ' ILE . 40.5 tt0 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 121.236 0.541 . . . . 71.13 109.91 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.731 ' HA ' HD12 ' A' ' 31' ' ' ILE . 18.6 m -62.1 -37.51 85.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.876 -0.602 . . . . 54.04 111.389 176.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.07 -40.64 86.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.138 0.494 . . . . 74.51 110.753 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.638 ' HE3' HD13 ' A' ' 48' ' ' LEU . 43.5 tptt -64.34 -37.15 86.47 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.065 -0.516 . . . . 70.1 110.35 175.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 28' ' ' THR . 91.1 mt -57.71 -44.24 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.981 -0.554 . . . . 72.13 111.19 173.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.8 m -58.68 -43.38 89.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.204 -0.453 . . . . 51.32 110.805 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.629 ' HG3' HD11 ' A' ' 108' ' ' ILE . 55.9 tt0 -57.79 -48.49 79.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.234 -0.439 . . . . 72.41 111.14 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -51.57 -53.06 42.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.183 -0.462 . . . . 63.21 111.499 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.599 0.592 . . . . 72.53 112.599 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HD2' HG21 ' A' ' 108' ' ' ILE . 20.9 mtm180 -78.6 -38.27 40.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.068 -0.395 . . . . 63.31 111.052 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.27 -46.45 83.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.127 0.489 . . . . 72.24 110.693 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 46' ' ' TYR . 3.8 m-20 -58.36 -38.66 77.69 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.973 -0.558 . . . . 63.35 111.492 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.58 -38.1 80.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.902 0.382 . . . . 75.31 111.411 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 68.2 mttm -76.75 -32.86 58.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.936 0.347 . . . . 60.14 111.936 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -94.27 103.39 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.761 0.652 . . . . 43.15 112.761 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -96.01 27.72 3.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.381 0.61 . . . . 50.3 110.684 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -139.73 38.76 2.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.025 -0.534 . . . . 70.32 110.584 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.591 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 129.49 158.01 9.36 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.142 -0.481 . . . . 75.04 112.799 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG13 HD13 ' A' ' 57' ' ' LEU . 35.1 m -100.85 147.06 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.295 0.48 . . . . 74.14 112.295 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.454 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 31.8 m-85 -93.31 139.5 30.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.084 0.469 . . . . 75.3 110.962 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.82 119.99 29.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 62.04 109.756 172.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.638 HD13 ' HE3' ' A' ' 30' ' ' LYS . 79.0 mt -97.46 134.24 22.81 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 111.851 0.315 . . . . 72.33 111.851 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 32.0 Cg_endo -62.79 -24.64 74.56 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.577 2.184 . . . . 71.14 112.876 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.01 18.54 55.88 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.078 -0.51 . . . . 53.0 112.825 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -144.3 106.75 4.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.954 0.407 . . . . 60.22 110.915 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -74.42 11.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.623 0.601 . . . . 71.23 112.623 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -85.7 141.99 36.64 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 112.987 0.736 . . . . 53.15 112.987 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.56 -178.03 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.151 2.568 . . . . 74.53 113.516 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.18 137.03 28.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.71 -0.677 . . . . 63.13 110.785 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -82.48 97.93 8.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.023 0.439 . . . . 64.21 111.268 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.416 HD13 HG13 ' A' ' 45' ' ' VAL . 61.0 tp -104.87 122.75 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.031 0.444 . . . . 75.13 111.153 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.3 tt0 -95.86 108.55 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.11 110.543 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.9 p -96.89 -178.18 4.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.567 0.58 . . . . 71.41 112.567 -172.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.32 -4.88 44.47 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.857 -0.61 . . . . 71.03 112.02 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 92' ' ' LEU . 39.5 pt -108.48 -34.03 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.794 0.33 . . . . 73.21 111.173 175.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.69 172.27 36.1 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.234 -0.508 . . . . 44.12 112.885 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 33.8 m -77.46 124.77 28.34 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.501 -0.411 . . . . 71.3 111.327 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 155' ' ' ILE . 2.4 pp -129.98 165.03 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.49 0.662 . . . . 63.23 111.909 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -129.82 100.19 5.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.659 -0.7 . . . . 74.21 110.863 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.695 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.3 mtt -102.73 148.93 24.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.68 0.622 . . . . 70.34 112.68 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -148.42 161.03 42.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.818 0.342 . . . . 71.0 111.563 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.481 HD22 HD13 ' A' ' 80' ' ' LEU . 93.2 mt -105.44 119.32 38.8 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.797 0.332 . . . . 72.25 111.199 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 81' ' ' THR . 21.9 m -135.65 161.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.618 0.247 . . . . 75.15 111.655 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.1 m120 60.85 34.49 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.175 0.512 . . . . 75.15 111.672 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.79 114.52 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.446 . . . . 73.52 111.742 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -138.46 150.74 67.37 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.371 . . . . 73.41 111.895 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.47 155.36 70.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.809 2.339 . . . . 64.21 113.165 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.492 ' HB2' HG23 ' A' ' 79' ' ' THR . 29.0 t70 -142.05 162.99 34.09 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.476 . . . . 71.4 111.214 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.37 -43.39 97.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 64.4 111.863 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -81.91 -25.05 35.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.623 0.249 . . . . 55.52 111.615 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.73 -99.95 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.955 -0.64 . . . . 61.43 113.52 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.1 m -145.89 125.75 13.53 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.002 0.43 . . . . 73.25 111.565 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 74' ' ' ASP . 39.9 p -97.0 123.07 40.63 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.716 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.481 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -138.39 165.79 25.9 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.102 0.477 . . . . 62.32 111.712 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 69' ' ' VAL . 48.5 m -107.91 123.44 48.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.257 -0.429 . . . . 74.12 111.274 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -99.75 109.58 22.02 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.309 -0.405 . . . . 72.24 110.193 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' MET . 49.5 mtm180 -89.45 128.27 35.93 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.663 -0.244 . . . . 53.04 110.92 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 135' ' ' ILE . 3.4 mp -113.02 91.11 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.86 0.362 . . . . 71.14 110.538 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -92.75 106.49 18.45 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.84 -0.43 . . . . 71.43 109.84 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA3' ' OG ' ' A' ' 131' ' ' SER . . . -66.1 123.25 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.919 -0.658 . . . . 53.51 113.091 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.33 -25.6 66.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.513 0.673 . . . . 73.1 110.443 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -88.47 119.93 29.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.325 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.42 -22.86 63.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.949 0.404 . . . . 54.43 111.678 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -65.9 135.08 95.23 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.319 -0.4 . . . . 55.34 111.583 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.83 120.19 7.84 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.894 2.396 . . . . 72.11 113.097 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.6 mt -88.67 149.61 44.37 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.551 -0.295 . . . . 74.12 111.255 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.01 176.07 10.01 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.399 2.066 . . . . 61.34 113.167 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.24 47.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.827 0.346 . . . . 52.3 111.434 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.95 159.14 42.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.535 0.684 . . . . 75.55 112.638 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.7 p -141.38 163.94 31.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.495 -0.775 . . . . 63.21 110.141 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.648 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.31 169.68 38.48 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.278 -0.963 . . . . 53.25 114.005 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 28.2 m -99.9 129.39 45.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.699 0.4 . . . . 73.32 110.727 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 24.5 m -112.53 117.01 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.103 0.477 . . . . 72.34 111.57 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 43.7 mt-10 -92.82 103.61 15.94 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.574 -0.285 . . . . 75.41 110.787 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -112.91 137.05 51.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.009 0.433 . . . . 70.41 111.61 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.04 -145.96 4.91 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.004 -0.544 . . . . 35.44 112.957 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.474 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -130.39 145.8 51.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.995 0.426 . . . . 72.2 111.95 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.0 mt -105.4 120.99 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.478 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.08 3.36 54.9 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.402 0.89 . . . . 73.44 113.402 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.04 -162.67 9.3 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.077 -1.059 . . . . 65.22 114.724 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -88.34 -161.96 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.031 0.532 . . . . 75.31 111.585 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.629 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.5 mm -83.72 -21.97 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.409 0.624 . . . . 54.34 110.421 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.25 -37.12 12.85 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.962 -0.563 . . . . 74.33 111.337 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.47 106.6 5.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.19 0.519 . . . . 71.14 111.377 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -154.07 153.47 31.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.158 0.504 . . . . 73.14 112.235 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -125.77 146.91 49.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.965 -0.561 . . . . 74.22 110.766 173.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.32 105.62 17.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.882 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 103' ' ' GLN . 35.6 pt -110.72 157.54 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.498 -0.319 . . . . 64.22 111.446 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.6 m120 56.28 29.24 14.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.075 0.464 . . . . 72.31 111.666 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.78 131.58 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.256 0.55 . . . . 71.15 112.321 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.45 164.99 28.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.906 -0.588 . . . . 73.34 110.258 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.6 p-10 -115.01 142.09 47.11 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.956 0.724 . . . . 74.24 112.956 -173.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.42 154.91 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.666 -0.697 . . . . 65.44 110.283 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.72 122.59 42.14 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.983 0.364 . . . . 73.51 111.983 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.7 pt -102.1 143.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.503 -0.317 . . . . 75.12 111.063 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.44 119.58 19.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.972 0.415 . . . . 73.52 111.673 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.57 144.04 31.72 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 111.776 0.287 . . . . 75.34 111.776 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.28 163.3 36.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.65 2.233 . . . . 74.52 113.602 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.17 138.77 40.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.117 0.484 . . . . 75.21 112.233 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -81.55 119.1 23.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.325 -0.398 . . . . 71.33 110.772 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.626 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.9 m -93.78 -28.89 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.931 0.396 . . . . 72.35 111.228 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.626 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.0 mt -117.89 -178.5 3.51 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.987 0.423 . . . . 71.5 111.163 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -118.82 151.68 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 111.793 0.294 . . . . 62.15 111.793 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.49 -177.44 20.12 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.1 -1.209 . . . . 73.35 113.392 -2.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.476 ' OG ' ' HA3' ' A' ' 86' ' ' GLY . 53.9 p -90.2 40.62 1.01 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.101 0.477 . . . . 73.2 112.008 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -84.12 99.7 10.66 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.39 0.614 . . . . 62.13 111.423 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.36 134.11 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.215 -0.448 . . . . 65.35 111.301 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -114.78 127.09 55.54 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.241 -0.287 . . . . 64.43 111.174 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 84' ' ' ILE . 33.1 pt -131.09 146.4 61.92 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.181 0.437 . . . . 74.11 112.181 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.9 161.99 20.99 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.552 2.168 . . . . 73.13 112.496 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.93 125.37 10.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.804 0.335 . . . . 63.23 110.51 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -108.59 106.38 16.43 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.049 0.452 . . . . 65.24 111.512 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.92 135.18 33.78 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.65 -0.25 . . . . 65.35 110.772 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -109.68 149.83 29.17 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.312 0.486 . . . . 71.34 112.312 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.92 83.06 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.153 -0.476 . . . . 71.15 113.873 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 147' ' ' LEU . 17.1 tt -143.68 135.17 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.026 0.441 . . . . 75.21 111.401 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.2 m -101.71 147.52 26.35 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.61 -0.268 . . . . 54.42 111.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.61 -43.83 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.744 0.646 . . . . 55.24 112.744 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.46 -28.27 69.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.001 0.429 . . . . 70.5 111.675 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -108.11 13.13 26.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.166 -0.47 . . . . 65.11 111.664 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.633 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.4 tt -81.0 120.8 25.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 73.45 110.407 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.27 -59.0 1.32 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.971 -0.633 . . . . 53.22 113.333 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.51 153.52 35.98 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.4 . . . . 73.1 111.911 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 65.9 t -125.99 107.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.01 -0.541 . . . . 63.21 110.046 170.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 38.5 ttt180 -96.22 110.94 23.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.823 0.344 . . . . 72.24 111.683 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.695 HG21 ' SD ' ' A' ' 66' ' ' MET . 18.0 mm -90.48 124.23 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.513 -0.312 . . . . 64.32 111.331 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.591 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 1.8 p80 -159.55 -176.75 5.94 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.372 0.508 . . . . 64.01 112.372 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 98' ' ' THR . 54.4 m-20 63.15 17.87 10.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.695 0.628 . . . . 63.14 112.695 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.648 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.5 mm -61.54 103.49 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.471 0.653 . . . . 73.14 111.097 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -136.52 158.3 73.57 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.762 -0.654 . . . . 71.21 111.451 -174.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.43 132.37 23.72 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.366 2.044 . . . . 62.34 112.665 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.895 0.379 . . . . 63.34 111.783 -178.828 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 120.968 0.413 . . . . 74.3 110.4 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -65.36 -34.81 79.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.062 0.458 . . . . 75.24 110.785 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.86 -38.66 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.307 -0.406 . . . . 60.41 110.854 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -30.64 69.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.44 -0.346 . . . . 75.45 111.664 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.6 mt -61.44 -51.38 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.025 0.44 . . . . 75.22 110.496 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.4 m -58.92 -45.37 90.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.04 0.447 . . . . 74.01 110.832 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.655 HE21 HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -55.85 -45.58 78.4 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.794 -0.639 . . . . 70.44 111.256 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -63.17 -54.39 38.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.946 -0.57 . . . . 74.54 111.578 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.49 -35.86 74.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.351 -0.386 . . . . 73.35 112.033 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -64.89 -48.57 73.76 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.275 -0.265 . . . . 74.52 111.251 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.07 -41.64 88.48 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.251 0.548 . . . . 63.01 110.79 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -57.11 -43.52 82.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.661 -0.7 . . . . 72.44 111.401 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -33.69 64.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.31 0.485 . . . . 73.35 112.31 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -84.2 -7.79 59.25 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.272 0.471 . . . . 75.25 112.272 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.6 t -107.44 119.17 38.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.248 0.547 . . . . 75.4 111.946 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.6 p -83.6 -45.77 13.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.127 -0.488 . . . . 54.45 110.839 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.7 m -73.64 81.72 1.53 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.182 -0.463 . . . . 70.44 111.708 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 89.29 -171.72 38.84 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.204 -0.453 . . . . 73.23 113.848 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 57' ' ' LEU . 35.8 m -121.02 142.81 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 44.32 111.846 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.69 133.44 37.04 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.934 0.397 . . . . 74.31 111.946 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.75 138.44 52.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.854 -0.612 . . . . 53.1 110.187 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 74.8 mt -112.64 137.55 21.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 112.076 0.399 . . . . 72.21 112.076 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 16.0 Cg_exo -66.55 -30.81 42.61 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.724 2.283 . . . . 72.12 113.022 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.96 -8.04 67.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 114.314 0.486 . . . . 41.4 114.314 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.68 97.28 2.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.51 0.655 . . . . 74.52 111.901 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.87 88.88 0.11 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.847 0.832 . . . . 70.23 111.418 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -137.02 151.43 72.05 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 112.633 0.605 . . . . 73.44 112.633 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 89.2 Cg_endo -80.74 159.66 21.65 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.116 2.544 . . . . 73.25 114.06 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.19 144.8 27.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.986 -0.552 . . . . 63.33 110.632 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -83.69 119.56 24.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.943 0.401 . . . . 73.54 111.67 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.528 HD13 HG13 ' A' ' 45' ' ' VAL . 46.5 tp -113.83 119.45 37.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.335 0.588 . . . . 53.44 110.658 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.52 110.77 22.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.963 -0.562 . . . . 72.14 110.348 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.4 p -115.72 -174.32 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.505 0.669 . . . . 74.52 112.751 -170.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -72.65 -24.68 61.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.583 -0.735 . . . . 74.43 112.196 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.8 pt -91.37 -7.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.795 0.331 . . . . 72.54 111.499 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.62 -167.75 23.8 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.366 -0.445 . . . . 62.53 113.056 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 m -91.7 123.08 34.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.865 0.364 . . . . 62.44 111.069 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.45 164.2 28.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.108 0.48 . . . . 75.44 111.625 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -124.04 114.63 19.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.279 -0.419 . . . . 74.51 110.916 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.4 mtt -98.56 143.39 29.02 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.929 0.395 . . . . 44.4 111.936 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 33.3 p -141.07 142.77 34.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.128 0.49 . . . . 71.42 111.848 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 82.4 mt -97.9 122.14 40.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.16 -0.473 . . . . 73.51 111.411 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 81' ' ' THR . 23.2 m -132.68 163.06 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.647 -0.251 . . . . 74.23 110.941 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 60.28 33.55 20.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.193 0.521 . . . . 74.52 111.939 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 68' ' ' LEU . 46.5 mt -71.9 106.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.192 -0.458 . . . . 64.04 111.677 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 p -135.17 149.85 71.21 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 112.419 0.526 . . . . 62.45 112.419 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.47 148.87 55.12 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.84 2.36 . . . . 25.24 113.099 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.4 -175.44 3.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.359 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.96 -45.86 39.44 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.993 -0.442 . . . . 64.2 111.998 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 2.1 p30 -92.36 -24.31 18.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.395 0.517 . . . . 72.41 112.395 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -164.97 -118.98 0.46 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.567 -0.825 . . . . 72.53 114.047 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.1 m -139.78 132.13 28.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.607 -0.349 . . . . 75.53 111.588 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.3 p -108.59 123.44 48.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.055 0.455 . . . . 71.42 111.502 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -139.09 151.91 47.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 73.45 111.079 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.711 ' HB ' HG23 ' A' ' 69' ' ' VAL . 27.3 m -90.35 111.05 22.13 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.301 -0.249 . . . . 61.2 110.936 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.58 108.41 19.05 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.543 -0.54 . . . . 73.25 109.543 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.432 ' HE ' ' CG ' ' A' ' 134' ' ' ASP . 23.9 mtp-105 -98.64 131.58 44.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.781 0.324 . . . . 53.01 111.627 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.2 mp -114.04 96.48 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.657 -0.247 . . . . 63.53 111.051 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.4 103.73 15.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.654 0.264 . . . . 71.4 110.623 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.87 131.77 26.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.72 -0.753 . . . . 53.53 112.876 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -68.56 -25.49 64.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.234 0.54 . . . . 72.23 110.593 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.5 m -79.11 117.26 19.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.868 -0.605 . . . . 42.31 110.223 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -80.02 41.05 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.355 0.598 . . . . 75.5 112.131 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.59 154.18 80.83 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.1 0.56 . . . . 64.44 110.215 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 19.7 Cg_endo -59.14 109.0 0.47 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.492 2.128 . . . . 45.21 112.681 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.77 151.03 57.45 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.079 -0.509 . . . . 50.14 112.152 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.88 159.73 41.4 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.467 2.111 . . . . 61.23 112.841 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.55 136.76 56.79 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.983 0.421 . . . . 73.43 111.641 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -133.76 163.31 29.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.417 0.627 . . . . 74.23 112.575 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.4 p -134.73 132.94 39.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.421 -0.809 . . . . 74.53 110.564 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.783 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -133.98 166.01 24.13 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.731 -0.747 . . . . 64.15 113.195 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.4 m -108.61 124.85 51.14 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.669 -0.313 . . . . 71.1 110.917 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.5 p -106.2 118.4 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.044 0.449 . . . . 72.3 112.144 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.6 mm-40 -89.32 113.18 24.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 73.4 110.041 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -122.81 128.7 50.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.158 0.504 . . . . 63.15 111.746 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.54 4.44 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.907 -0.588 . . . . 51.01 112.636 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.645 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.3 mt-30 -128.12 156.34 43.0 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.217 0.532 . . . . 60.5 112.213 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.42 120.91 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.17 -0.468 . . . . 51.44 111.211 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -93.19 -30.99 14.93 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.538 0.57 . . . . 71.21 112.538 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -93.25 -157.67 33.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.027 -0.606 . . . . 72.03 114.175 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.7 p -92.97 -173.69 3.36 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.933 0.397 . . . . 51.51 111.425 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.655 HD11 HE21 ' A' ' 33' ' ' GLN . 36.5 mm -82.58 -3.26 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.348 0.594 . . . . 63.01 111.213 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -109.04 -39.19 5.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.233 0.54 . . . . 73.11 110.791 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -134.9 102.37 5.21 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.864 -0.607 . . . . 52.34 111.344 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 107' ' ' THR . 34.8 p90 -141.8 148.67 39.27 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.101 0.477 . . . . 75.24 111.801 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -109.44 126.03 53.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.001 -0.545 . . . . 74.22 110.703 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.8 105.28 4.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.27 -0.423 . . . . 75.01 110.91 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 pt -110.12 152.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 111.759 0.281 . . . . 43.44 111.759 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 57.68 29.6 17.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.967 0.413 . . . . 72.21 111.842 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -95.1 115.55 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.883 0.697 . . . . 73.21 112.883 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.73 170.98 8.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.985 -0.552 . . . . 64.32 110.154 170.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 22.9 p30 -123.87 162.62 22.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.341 0.867 . . . . 74.23 113.341 -171.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -144.18 152.24 40.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.313 -0.858 . . . . 74.35 110.366 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.52 117.16 28.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.892 0.377 . . . . 44.11 111.301 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 121' ' ' ILE . 30.0 pt -102.86 103.13 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.523 0.678 . . . . 51.4 111.368 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.05 114.87 29.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.115 -0.493 . . . . 70.42 111.348 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.464 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -95.05 139.37 22.05 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.543 -0.299 . . . . 71.3 111.287 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 32.5 Cg_exo -62.07 170.65 5.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.879 2.386 . . . . 75.14 113.397 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.56 10.83 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.052 0.453 . . . . 41.53 111.556 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -77.54 69.01 3.74 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.222 0.534 . . . . 62.4 111.281 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.55 -19.39 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.073 0.463 . . . . 53.01 111.734 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.7 mt -85.86 136.89 33.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.345 -0.389 . . . . 63.2 111.675 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.482 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -122.18 127.7 25.8 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.31 -0.405 . . . . 24.05 111.199 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.72 154.53 97.7 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.074 -1.219 . . . . 74.51 113.331 1.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.9 m -87.91 92.64 9.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.002 0.742 . . . . 54.31 113.002 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 8.3 p-10 -117.96 100.54 7.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.401 0.62 . . . . 62.4 110.158 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' ARG . 32.2 t -87.12 144.12 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.012 0.745 . . . . 72.32 113.012 -170.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.432 ' CG ' ' HE ' ' A' ' 83' ' ' ARG . 1.2 m-20 -115.11 115.48 26.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.887 -0.597 . . . . 75.24 110.622 175.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.8 pt -125.95 126.53 24.83 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 120.904 0.383 . . . . 63.2 111.964 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 9.9 Cg_exo -71.83 111.63 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.935 2.423 . . . . 43.34 112.274 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -103.81 115.4 30.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.267 -0.424 . . . . 54.31 110.523 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -105.92 103.28 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.3 0.571 . . . . 72.33 111.347 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.509 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 81.1 mt -78.76 138.76 38.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.17 -0.468 . . . . 55.05 109.911 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -116.23 135.76 53.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.427 0.529 . . . . 73.43 112.427 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.51 40.28 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.091 -0.504 . . . . 44.33 113.094 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.6 tt -115.19 126.86 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.202 0.525 . . . . 71.41 111.659 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.2 m -94.73 149.17 21.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.805 0.298 . . . . 71.1 111.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 p -50.37 -44.42 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.793 1.034 . . . . 73.44 113.793 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.56 -31.8 71.27 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.885 -0.509 . . . . 73.14 111.018 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -95.52 9.05 41.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.205 -0.452 . . . . 54.23 111.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.547 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.9 tt -85.45 115.84 23.41 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.097 0.475 . . . . 51.54 110.406 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -81.68 -59.55 2.33 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.326 -0.464 . . . . 72.5 113.203 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.76 149.1 31.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.086 0.47 . . . . 71.52 112.16 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.9 106.71 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.694 -0.685 . . . . 64.3 109.713 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.4 ttt180 -107.58 106.33 16.63 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.09 0.404 . . . . 75.23 112.09 -172.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.669 HG21 ' SD ' ' A' ' 66' ' ' MET . 25.6 mm -89.6 134.32 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.657 -0.247 . . . . 43.45 111.293 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.438 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.2 p80 -164.61 174.83 10.39 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.655 0.264 . . . . 73.41 111.664 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 62.72 32.75 15.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.327 0.492 . . . . 73.41 112.327 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.783 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.2 mm -66.71 99.48 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.257 -0.429 . . . . 60.41 110.804 175.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.51 151.58 67.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.264 -0.425 . . . . 62.51 111.196 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.7 149.55 89.47 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.801 2.334 . . . . 74.13 113.797 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.841 175.729 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.06 0.457 . . . . 73.31 110.594 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.5 m -59.02 -33.63 70.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.077 -0.51 . . . . 70.33 111.329 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -45.31 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.602 -0.272 . . . . 74.4 111.169 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -62.49 -44.44 96.37 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.53 0.205 . . . . 75.11 111.175 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 53' ' ' THR . 75.7 mt -54.26 -55.66 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.414 0.626 . . . . 75.22 110.831 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.533 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 89.5 m -56.0 -44.05 78.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.623 -0.717 . . . . 73.42 111.148 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.81 -44.5 90.84 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.591 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.6 -42.65 93.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.832 0.348 . . . . 74.23 111.167 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -60.95 -45.27 95.38 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.109 0.48 . . . . 72.42 111.199 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 32' ' ' THR . 70.9 mtp180 -65.19 -42.54 93.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.11 -0.495 . . . . 73.22 111.412 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.19 -37.63 86.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.885 0.374 . . . . 75.44 110.998 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.013 0.435 . . . . 74.23 110.686 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.54 66.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.292 -0.413 . . . . 50.45 111.941 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' NZ ' ' HA ' ' A' ' 109' ' ' ASP . 85.5 mttt -82.84 -18.74 39.35 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.634 0.605 . . . . 73.03 112.634 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -59.12 115.61 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.867 0.365 . . . . 73.32 111.97 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -92.07 -27.68 17.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.591 -0.277 . . . . 63.24 111.55 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.409 ' HB2' HH21 ' A' ' 151' ' ' ARG . 42.3 m -117.21 86.39 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.892 0.377 . . . . 71.51 111.374 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 83.77 -132.95 11.44 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.174 -0.536 . . . . 43.41 113.359 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.66 154.09 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.171 0.51 . . . . 63.43 111.916 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.42 101.29 10.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.067 -0.515 . . . . 75.03 111.268 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.555 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 87.1 mt -85.27 133.98 34.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 73.43 110.815 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 79.7 mt -107.15 108.55 62.08 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 120.722 0.296 . . . . 65.21 111.211 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.1 Cg_endo -57.03 -22.92 49.41 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.014 2.476 . . . . 72.25 113.654 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.75 -26.35 71.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.133 -0.556 . . . . 63.42 113.238 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.416 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -124.66 112.99 17.43 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.697 -0.296 . . . . 71.3 111.584 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HD2' HG12 ' A' ' 69' ' ' VAL . 38.8 ttpt -74.62 75.71 2.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.699 0.762 . . . . 71.31 111.019 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 31' ' ' ILE . 4.4 p -133.05 145.19 55.94 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.751 -0.659 . . . . 72.21 111.732 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 145.22 33.19 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.008 2.472 . . . . 74.11 113.711 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.86 153.02 40.18 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.885 -0.598 . . . . 64.44 110.558 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 56' ' ' ARG . 35.5 ttm105 -95.78 117.8 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.925 0.393 . . . . 74.54 111.463 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.434 HD23 ' HE3' ' A' ' 66' ' ' MET . 45.7 tp -118.3 124.69 48.41 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.296 0.569 . . . . 75.12 112.172 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.51 102.44 14.1 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.931 -0.577 . . . . 43.01 110.584 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 p -94.46 -172.71 2.84 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.222 0.534 . . . . 74.32 111.792 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.459 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 51.6 mt-30 -91.99 -2.71 56.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.109 -0.496 . . . . 61.54 111.296 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -105.72 -19.04 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.001 0.429 . . . . 64.43 110.901 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.8 160.68 9.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.101 -0.499 . . . . 64.34 112.651 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -62.53 127.57 31.94 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.152 0.476 . . . . 73.45 110.678 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.45 165.85 26.31 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.137 0.494 . . . . 64.41 111.728 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -119.15 114.79 23.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.256 -0.429 . . . . 74.45 110.763 -176.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 152' ' ' ILE . 61.7 mtt -104.01 150.9 23.83 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.987 0.422 . . . . 75.31 112.068 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.3 p -151.61 153.32 34.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.324 -0.398 . . . . 64.04 111.563 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.48 ' HB3' HD11 ' A' ' 71' ' ' ILE . 97.4 mt -103.33 112.84 25.91 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.266 -0.425 . . . . 75.31 111.352 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' A' ' 81' ' ' THR . 29.8 m -121.22 156.76 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.863 0.364 . . . . 61.31 111.646 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 59.89 37.13 21.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.123 -0.49 . . . . 70.43 111.857 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 68' ' ' LEU . 49.8 mt -69.87 101.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.903 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 18.0 p -121.23 162.95 33.02 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 115.97 -0.559 . . . . 63.35 111.574 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 57.5 Cg_endo -69.88 166.43 27.79 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.238 1.959 . . . . 53.04 113.019 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HB2' HG23 ' A' ' 79' ' ' THR . 30.4 t70 -128.22 165.57 20.21 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.116 -0.493 . . . . 74.32 110.281 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.23 69.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.049 0.452 . . . . 75.32 111.413 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.2 -47.55 3.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.204 -0.453 . . . . 61.55 111.316 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -136.55 -103.6 0.69 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.804 -0.712 . . . . 61.12 114.129 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 147' ' ' LEU . 96.0 m -143.56 130.96 20.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.245 0.461 . . . . 63.31 112.245 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 74' ' ' ASP . 40.0 p -104.36 114.22 28.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.679 0.392 . . . . 65.01 111.626 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.1 pp -137.24 149.18 46.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.89 0.376 . . . . 72.33 111.72 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.661 ' HB ' HG23 ' A' ' 69' ' ' VAL . 48.6 m -93.52 113.64 25.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.047 0.451 . . . . 64.21 111.353 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.46 112.51 24.18 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.024 -0.535 . . . . 75.3 110.132 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 32.9 mtp180 -97.27 126.6 42.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.5 107.23 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.189 -0.459 . . . . 74.11 110.62 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -106.74 106.59 17.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.727 0.299 . . . . 35.05 111.051 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.48 129.75 49.28 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.095 -0.574 . . . . 74.41 113.154 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -81.76 58.92 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.428 0.632 . . . . 72.53 111.137 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -168.49 -166.43 0.68 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.1 -0.5 . . . . 73.33 110.638 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -112.01 12.57 20.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.048 0.451 . . . . 74.24 110.628 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.66 136.1 39.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.1 -0.5 . . . . 71.5 111.975 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.39 95.43 1.04 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.242 1.961 . . . . 74.11 111.635 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.61 139.87 81.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.251 -0.432 . . . . 63.02 111.996 -176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.03 174.56 12.62 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.584 2.19 . . . . 70.33 112.901 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.47 138.69 58.52 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.123 0.487 . . . . 44.14 111.523 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -138.45 171.36 14.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.376 0.607 . . . . 61.44 112.292 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.4 p -152.92 156.73 39.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.685 -0.689 . . . . 73.44 110.746 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.579 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.5 -178.12 36.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.909 -0.662 . . . . 71.44 113.072 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.3 m -108.31 127.3 53.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.816 0.341 . . . . 62.41 111.441 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.95 123.31 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.206 0.527 . . . . 73.23 111.416 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.8 mt-10 -104.96 107.69 18.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 75.34 110.601 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -112.5 129.13 56.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 71.34 111.897 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.97 -145.78 4.53 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.964 -0.562 . . . . 74.11 112.835 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.666 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.7 mt-30 -125.71 141.14 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.031 0.443 . . . . 64.12 112.147 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.35 122.71 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.265 -0.425 . . . . 60.43 111.349 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HG3' ' HB2' ' A' ' 112' ' ' GLN . 10.7 pt20 -111.99 99.76 8.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.474 0.654 . . . . 75.31 110.39 170.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 154.15 -169.17 32.59 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.038 -0.601 . . . . 72.34 113.852 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -100.43 -165.15 1.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.098 0.475 . . . . 63.23 111.753 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -72.19 -21.38 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.182 0.515 . . . . 73.33 111.185 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.51 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 37.6 t70 -105.89 -39.63 5.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 63.42 111.874 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.49 91.77 3.59 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 75.52 111.483 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.61 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 40.0 p90 -127.93 143.45 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.964 0.412 . . . . 74.22 111.751 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 49.6 mt-30 -118.24 133.69 55.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 73.03 111.688 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -88.14 109.7 20.1 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.317 -0.401 . . . . 60.44 110.951 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 pt -123.81 162.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 111.886 0.328 . . . . 65.32 111.886 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 53.42 28.95 8.1 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.514 0.561 . . . . 72.21 112.514 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 p -90.17 138.96 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.823 0.675 . . . . 55.52 112.823 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -124.66 151.8 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.493 -0.776 . . . . 74.44 110.525 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.29 132.08 54.06 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.337 0.589 . . . . 71.25 111.75 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -129.69 156.27 44.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.035 -0.53 . . . . 61.41 110.202 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.6 mt -96.83 119.92 36.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 73.31 111.145 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.725 HG22 HD21 ' A' ' 137' ' ' LEU . 15.4 pt -99.65 100.76 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.337 0.589 . . . . 65.43 111.732 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.19 131.67 50.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.006 -0.543 . . . . 75.03 110.268 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.22 148.32 65.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.394 0.516 . . . . 71.34 112.394 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.2 175.45 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.116 2.544 . . . . 73.21 113.42 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.04 144.47 29.04 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.803 0.668 . . . . 75.12 112.803 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.6 m -87.72 102.72 14.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.203 -0.453 . . . . 72.01 110.374 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.0 m -80.6 -14.04 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.404 0.52 . . . . 71.13 112.404 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -138.81 -179.79 6.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.906 0.384 . . . . 53.45 111.233 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.95 144.52 28.75 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.533 -0.303 . . . . 72.15 111.469 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.36 170.48 53.79 Favored 'Cis proline' 0 C--N 1.352 0.724 0 C-N-CA 123.932 -1.278 . . . . 70.31 112.825 -0.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 t -86.58 85.92 7.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 63.03 111.378 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.56 122.85 48.88 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.859 -0.422 . . . . 75.02 109.859 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -135.35 112.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.12 -0.362 . . . . 73.12 111.198 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -112.81 134.79 54.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.321 0.581 . . . . 74.14 111.96 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -125.31 133.45 24.86 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.813 -0.63 . . . . 63.02 112.345 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.32 111.81 3.4 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.851 2.367 . . . . 63.54 112.439 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.725 HD21 HG22 ' A' ' 121' ' ' ILE . 23.6 mt -94.4 141.1 28.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 71.31 112.63 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.05 92.79 3.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.663 -0.699 . . . . 42.14 110.21 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.4 mt -77.13 132.16 38.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.125 -0.488 . . . . 64.33 110.775 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -96.31 145.89 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.536 0.569 . . . . 64.23 112.536 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 56.98 31.48 61.47 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.064 0.786 . . . . 64.01 115.064 172.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.1 tt -152.09 127.97 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 117.602 0.701 . . . . 75.42 111.606 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.4 m -86.83 144.24 27.11 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.306 -0.407 . . . . 50.03 111.709 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.31 -44.24 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.631 0.604 . . . . 54.21 112.631 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.56 -21.62 66.45 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.025 0.441 . . . . 75.21 111.417 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.469 ' HB3' HE21 ' A' ' 103' ' ' GLN . 81.6 mm-40 -107.1 10.63 30.13 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.084 0.401 . . . . 71.41 112.084 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.583 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.9 mt -68.84 115.26 7.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.785 0.326 . . . . 74.41 111.499 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -89.73 -49.39 3.39 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.168 -0.539 . . . . 63.12 113.298 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.16 157.37 38.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.246 0.546 . . . . 70.33 112.273 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 60.8 t -124.23 98.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.709 -0.678 . . . . 73.21 110.1 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 70.2 ttt180 -90.25 101.28 14.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.305 -0.407 . . . . 73.3 111.739 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.669 HG21 ' SD ' ' A' ' 66' ' ' MET . 33.2 mm -94.22 132.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 122.273 -0.267 . . . . 53.51 111.56 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.76 172.36 13.11 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.411 0.523 . . . . 73.32 112.411 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 65.09 22.23 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.313 0.857 . . . . 74.2 113.313 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.579 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.8 mm -63.62 101.81 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.112 0.482 . . . . 54.0 111.499 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 12.1 pt20 -129.17 159.21 70.11 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.071 -0.513 . . . . 75.35 111.174 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 156' ' ' GLN . 74.0 Cg_endo -73.01 150.96 49.51 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.157 1.905 . . . . 71.04 113.134 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.545 0.757 0 CA-C-N 116.162 -0.472 . . . . 61.24 110.889 177.797 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 25.1 tt0 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.851 0.357 . . . . 75.23 110.861 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -35.07 70.22 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.13 0.49 . . . . 71.43 110.776 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.9 -44.76 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.205 -0.452 . . . . 71.3 110.893 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -61.05 -39.84 91.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.657 0.265 . . . . 71.33 110.969 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.99 -48.19 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.081 0.467 . . . . 64.45 110.967 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.5 m -57.18 -49.5 75.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.132 0.491 . . . . 73.44 110.903 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HG3' HD12 ' A' ' 108' ' ' ILE . 63.6 tt0 -59.49 -43.73 93.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.964 -0.562 . . . . 75.15 111.337 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.39 -51.97 66.33 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.748 0.419 . . . . 70.31 111.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -58.95 -44.76 91.49 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.986 0.365 . . . . 63.23 111.986 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -63.98 -49.3 73.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.61 0.226 . . . . 75.02 111.61 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 48' ' ' LEU . 73.6 mt -60.58 -41.35 94.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.322 0.582 . . . . 54.31 110.883 176.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.37 -46.22 86.73 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.702 -0.681 . . . . 64.24 110.846 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.45 -25.6 63.26 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.046 -0.525 . . . . 74.23 111.965 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -83.37 -14.78 52.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.401 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 44.2 t -64.22 137.0 57.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.343 0.497 . . . . 73.44 112.343 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -108.93 8.89 26.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.206 -0.452 . . . . 71.05 111.047 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -160.64 117.86 2.42 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.903 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.34 -170.46 15.93 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.332 -0.461 . . . . 75.33 113.661 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.467 HG13 HD13 ' A' ' 57' ' ' LEU . 31.6 m -115.87 140.5 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.318 -0.519 . . . . 73.43 112.104 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 40.9 m-85 -89.75 118.7 29.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.313 -0.403 . . . . 63.53 111.465 175.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.9 123.4 50.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.908 0.483 . . . . 75.42 109.937 171.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 37' ' ' LEU . 68.4 mt -101.66 121.73 50.15 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.279 0.474 . . . . 63.34 112.279 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -56.66 130.7 41.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.324 2.016 . . . . 73.35 111.725 173.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . 95.18 19.68 29.98 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.832 -0.622 . . . . 44.14 112.309 -172.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . . . -142.78 100.26 3.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.461 0.305 . . . . 63.24 111.584 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.45 76.1 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.12 -0.362 . . . . 71.23 111.634 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -149.58 137.31 11.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 112.368 0.507 . . . . 75.35 112.368 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 65' ' ' ARG . 91.7 Cg_endo -78.36 145.17 21.05 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.165 2.577 . . . . 72.54 113.639 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -112.51 139.16 48.32 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 54.31 110.89 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 21.3 ttp85 -81.97 100.37 9.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.846 0.355 . . . . 73.52 111.486 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD13 HG13 ' A' ' 45' ' ' VAL . 59.7 tp -96.7 112.16 24.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.274 0.559 . . . . 74.25 111.085 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.89 92.42 9.0 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.35 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 p -100.41 -175.89 3.05 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.913 0.708 . . . . 64.12 112.913 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -69.77 -34.6 74.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.523 -0.762 . . . . 74.44 112.092 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.566 HG22 ' HB3' ' A' ' 157' ' ' PRO . 37.0 pt -76.91 -29.06 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.218 0.532 . . . . 53.22 111.183 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.24 -161.88 31.08 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.566 -0.743 . . . . 40.01 111.831 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 m -101.93 119.55 38.97 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.374 -0.486 . . . . 71.03 111.341 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.2 pp -131.61 152.71 50.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.982 0.42 . . . . 74.5 111.318 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 85.5 mtt180 -116.52 114.49 24.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.884 0.373 . . . . 54.41 111.218 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.641 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.1 mtt -99.04 142.19 30.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.277 -0.42 . . . . 71.22 111.52 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.9 p -136.16 148.32 48.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.119 0.485 . . . . 70.22 111.963 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.8 mt -99.93 112.24 24.52 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.122 -0.49 . . . . 75.04 111.671 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG23 ' HB ' ' A' ' 81' ' ' THR . 17.7 m -134.12 164.57 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 122.391 -0.193 . . . . 71.44 111.099 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.84 29.41 16.63 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.899 0.38 . . . . 55.44 111.675 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.05 110.68 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.803 0.335 . . . . 62.51 111.309 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -142.85 155.46 62.8 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.539 0.57 . . . . 75.01 112.539 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.7 157.91 21.93 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.226 2.617 . . . . 61.33 113.348 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.53 163.88 35.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.085 0.469 . . . . 65.04 111.905 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.81 70.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.139 -0.482 . . . . 41.34 111.864 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 8.8 m-20 -71.59 -43.4 66.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.079 0.466 . . . . 61.55 110.881 175.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.53 -77.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.968 -0.634 . . . . 71.12 112.911 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.8 m -149.68 138.49 20.99 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.834 0.35 . . . . 75.24 111.705 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.7 p -122.09 142.48 50.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.989 0.423 . . . . 73.24 111.401 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.25 152.75 36.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.226 -0.443 . . . . 52.3 111.549 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' HG23 ' A' ' 69' ' ' VAL . 39.0 m -84.34 103.61 13.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.743 0.306 . . . . 73.33 110.679 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.66 103.06 11.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.636 -0.505 . . . . 62.14 109.636 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HE ' HG21 ' A' ' 69' ' ' VAL . 92.8 mtt-85 -88.83 135.09 33.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.841 0.353 . . . . 64.42 111.615 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -116.67 99.46 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 74.24 110.72 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.89 109.56 21.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.957 0.408 . . . . 74.43 111.235 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.31 130.11 37.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.246 -0.502 . . . . 52.03 112.871 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -73.26 -13.72 61.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.26 0.552 . . . . 61.13 110.987 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.9 p -107.4 144.79 33.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.123 -0.489 . . . . 70.33 110.712 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.27 -17.76 51.26 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.859 0.318 . . . . 75.23 111.859 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.95 147.39 95.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.349 -0.387 . . . . 73.1 111.41 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.9 117.21 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.313 2.009 . . . . 72.31 112.936 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 126' ' ' SER . 93.0 mt -82.0 155.85 69.92 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 120.859 0.361 . . . . 73.44 111.433 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 -177.45 3.53 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.276 1.984 . . . . 72.13 112.621 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -77.99 158.44 29.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.757 0.313 . . . . 72.02 110.948 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.4 p90 -152.84 149.14 27.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.712 0.768 . . . . 72.11 112.628 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -133.64 162.76 31.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.204 -0.907 . . . . 72.43 110.238 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.92 -158.26 18.48 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.369 -0.92 . . . . 73.21 113.591 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.3 m -136.33 145.72 45.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.01 0.434 . . . . 73.12 111.324 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.68 128.34 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.045 0.45 . . . . 72.12 112.056 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.807 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 17.6 mm-40 -89.58 110.45 21.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.966 -0.561 . . . . 61.14 110.246 175.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.426 ' CG ' HD22 ' A' ' 139' ' ' LEU . 31.0 p90 -121.85 124.44 44.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.437 0.637 . . . . 63.14 111.736 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.66 -140.89 3.05 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.563 -0.744 . . . . 63.2 112.673 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.584 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 96.5 mt-30 -126.73 163.76 22.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.188 0.518 . . . . 65.32 111.872 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.77 114.79 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.227 -0.442 . . . . 72.15 111.107 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -92.48 -9.46 41.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.811 0.3 . . . . 74.13 111.811 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -91.05 178.59 42.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.09 -0.576 . . . . 32.25 113.785 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.3 p -85.76 -165.56 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.879 0.371 . . . . 70.33 111.483 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.49 HD12 ' HG3' ' A' ' 33' ' ' GLN . 41.9 mm -74.25 -31.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.908 0.385 . . . . 74.45 111.364 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.82 -43.87 8.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.782 0.325 . . . . 72.33 111.462 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -115.51 96.41 5.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.535 0.683 . . . . 71.24 111.301 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.695 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 9.3 p90 -121.41 144.1 48.86 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.852 -0.613 . . . . 75.23 111.899 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -120.09 127.01 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.661 -0.699 . . . . 72.13 111.114 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.89 99.18 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 55.24 110.611 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 pt -107.51 150.39 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.424 -0.353 . . . . 53.5 111.501 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 56.63 29.14 15.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.053 0.454 . . . . 44.02 111.851 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' A' ' 100' ' ' GLU . 6.0 p -90.57 132.35 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.483 0.549 . . . . 54.32 112.483 -176.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -116.56 154.41 30.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 73.24 110.265 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -107.56 132.73 52.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.116 0.484 . . . . 73.31 112.055 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -122.65 142.13 51.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.413 -0.358 . . . . 74.25 111.281 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.82 102.76 13.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.976 0.417 . . . . 71.25 111.721 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.59 140.21 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.219 0.533 . . . . 70.55 112.023 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -130.3 148.46 52.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.448 -0.342 . . . . 72.02 110.812 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -136.86 144.77 48.02 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 111.935 0.346 . . . . 75.43 111.935 177.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 25.7 Cg_exo -64.81 167.5 15.47 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.143 2.562 . . . . 72.11 113.648 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.14 128.9 34.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.131 -0.486 . . . . 62.25 112.11 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 66.1 m -79.69 75.73 6.35 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.164 0.507 . . . . 70.11 110.606 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.29 -30.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.239 0.543 . . . . 74.11 111.15 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.89 159.58 14.9 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.949 -0.569 . . . . 72.4 111.086 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.79 146.9 47.03 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.441 -0.345 . . . . 40.43 111.419 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.95 171.68 58.53 Favored 'Cis proline' 0 C--N 1.353 0.771 0 C-N-CA 124.331 -1.112 . . . . 73.22 112.753 -1.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 90.73 3.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.156 0.503 . . . . 72.43 111.477 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.71 84.83 2.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.268 0.556 . . . . 60.03 109.877 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.8 t -102.34 156.77 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 70.04 111.893 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 10.3 p-10 -150.13 108.71 3.82 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.192 0.52 . . . . 65.23 110.699 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.0 pt -113.32 135.27 21.81 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.119 -0.363 . . . . 52.02 111.821 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.9 119.5 5.9 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.296 1.998 . . . . 33.42 112.986 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.74 123.33 42.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.101 -0.5 . . . . 72.02 110.203 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -105.59 105.19 15.11 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.073 0.463 . . . . 64.15 111.326 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 101' ' ' TYR . 70.1 mt -91.62 130.08 37.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.383 -0.371 . . . . 75.41 111.192 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 67.3 mttm -106.64 145.13 32.33 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.122 0.415 . . . . 75.02 112.122 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.92 27.23 73.7 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.343 -0.456 . . . . 71.44 113.998 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.4 tt -155.59 122.52 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.472 0.653 . . . . 72.23 111.802 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.2 m -85.46 148.01 26.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.122 -0.49 . . . . 75.53 111.283 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.81 -34.79 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.795 0.331 . . . . 72.45 111.884 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.01 -29.08 66.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.063 0.459 . . . . 64.42 111.587 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -109.35 10.77 25.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.044 0.387 . . . . 74.02 112.044 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 3.2 mt -74.01 114.73 12.66 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 71.04 111.63 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.58 -59.2 1.65 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.241 -0.504 . . . . 31.31 112.996 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -149.77 157.58 43.34 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.385 0.612 . . . . 75.11 112.48 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 96.2 t -126.23 107.73 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.261 -0.881 . . . . 75.44 109.552 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.807 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.8 ttt180 -109.63 108.31 18.68 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.244 0.461 . . . . 74.22 112.244 -171.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.641 HG21 ' SD ' ' A' ' 66' ' ' MET . 36.0 mm -86.5 132.07 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 111.59 0.219 . . . . 53.45 111.59 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.62 178.83 8.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.745 0.307 . . . . 70.04 111.746 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 65.44 19.99 11.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.934 0.716 . . . . 70.13 112.934 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -65.56 117.74 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.279 0.562 . . . . 73.42 111.716 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -130.37 153.3 81.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.976 -0.556 . . . . 74.22 111.57 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.566 ' HB3' HG22 ' A' ' 61' ' ' ILE . 66.4 Cg_endo -73.66 117.31 5.0 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.553 2.169 . . . . 61.41 113.385 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 5.7 p . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.353 0.597 . . . . 72.22 110.997 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.0 tt0 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.87 0.367 . . . . 60.4 110.485 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.571 ' HA ' HD12 ' A' ' 31' ' ' ILE . 39.7 m -61.21 -30.38 70.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.947 0.403 . . . . 74.44 111.553 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.2 -47.6 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.788 0.327 . . . . 75.43 110.839 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -64.54 -30.09 71.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 72.21 111.335 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 28' ' ' THR . 82.6 mt -62.62 -48.31 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.249 0.547 . . . . 63.2 110.791 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -64.68 -41.35 96.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.197 0.522 . . . . 74.13 110.738 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HG3' HD12 ' A' ' 108' ' ' ILE . 57.7 tt0 -57.5 -47.59 81.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.797 -0.638 . . . . 73.24 111.102 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.4 tt0 -55.23 -47.12 75.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 72.25 111.331 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.75 -27.45 68.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.224 -0.444 . . . . 70.11 111.974 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -77.29 -36.21 54.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.076 -0.39 . . . . 65.34 111.22 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.0 -36.12 82.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.303 0.573 . . . . 55.2 110.038 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -57.17 -41.48 79.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.752 -0.658 . . . . 74.25 110.465 172.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.96 76.92 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.283 0.475 . . . . 35.41 112.283 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 109' ' ' ASP . 51.9 mttp -87.67 -9.25 54.71 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.647 0.61 . . . . 74.0 112.647 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.4 t -63.27 123.03 17.63 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.133 0.492 . . . . 74.23 112.152 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t -88.42 -30.08 19.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.104 0.478 . . . . 73.33 111.166 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -146.73 107.13 4.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.236 -0.438 . . . . 42.22 110.854 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 93.3 -143.64 16.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.084 -0.579 . . . . 74.44 113.104 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.793 HG13 HD13 ' A' ' 57' ' ' LEU . 16.4 m -143.27 153.52 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.34 0.59 . . . . 63.11 112.198 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.4 m-85 -101.25 105.46 16.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.612 -0.722 . . . . 63.14 110.964 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 98.9 mt -95.23 136.65 35.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.737 0.303 . . . . 73.12 110.904 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.2 mt -109.81 130.95 22.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.292 -0.255 . . . . 45.22 111.428 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HB3' HD13 ' A' ' 147' ' ' LEU . 33.0 Cg_endo -62.58 -27.78 76.76 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.604 2.202 . . . . 45.42 112.714 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.79 -23.54 72.14 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.139 -0.553 . . . . 32.22 112.412 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.23 73.92 1.53 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.149 0.5 . . . . 74.11 111.314 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -66.6 74.56 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.357 0.599 . . . . 54.15 110.845 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 p -148.97 159.27 37.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.771 -0.65 . . . . 42.31 112.38 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.12 149.87 28.88 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.027 2.485 . . . . 72.12 113.756 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 145.86 49.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.397 -0.365 . . . . 71.45 111.226 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -82.44 134.93 35.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.446 -0.343 . . . . 72.13 111.057 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.793 HD13 HG13 ' A' ' 45' ' ' VAL . 37.0 tp -143.53 136.56 27.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.558 0.577 . . . . 75.11 112.558 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.59 143.15 27.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.91 -0.586 . . . . 71.45 110.363 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -140.52 170.98 14.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.226 0.536 . . . . 74.5 111.673 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.511 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 50.3 mt-30 -77.51 5.76 8.37 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.074 -0.512 . . . . 71.33 112.101 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -112.0 -22.13 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.851 0.358 . . . . 62.2 110.837 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.03 -160.71 29.24 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.287 -0.415 . . . . 64.32 112.668 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.6 m -92.91 135.43 34.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.394 -0.474 . . . . 61.15 110.771 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.2 178.53 7.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.408 0.623 . . . . 32.13 112.619 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -136.29 107.06 6.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.744 -0.662 . . . . 65.04 111.013 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.725 ' SD ' HG21 ' A' ' 152' ' ' ILE . 58.3 mtt -96.04 170.17 9.47 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.049 -0.407 . . . . 75.14 111.879 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.6 p -169.08 152.74 5.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.033 0.383 . . . . 54.21 112.033 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.32 114.81 29.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.363 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.616 HG23 ' HB ' ' A' ' 81' ' ' THR . 26.9 m -128.79 164.09 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.731 0.3 . . . . 75.53 111.41 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 59.1 42.52 18.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.167 0.508 . . . . 52.11 112.036 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.9 mt -82.45 109.68 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.038 -0.528 . . . . 73.43 111.782 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 p -131.22 155.16 81.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 120.977 0.418 . . . . 63.22 112.124 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.49 136.43 33.69 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.767 2.311 . . . . 52.54 112.757 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.623 ' HB2' HG23 ' A' ' 79' ' ' THR . 32.8 t70 -115.4 164.78 13.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.841 0.456 . . . . 74.53 111.145 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.94 74.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.098 0.407 . . . . 53.11 112.098 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.88 -17.6 16.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.137 0.421 . . . . 62.45 112.137 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.3 -103.02 0.16 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.476 -0.869 . . . . 23.23 114.23 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.4 m -149.73 125.54 10.47 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.565 -0.373 . . . . 73.01 111.449 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 74' ' ' ASP . 39.4 p -101.66 124.73 47.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.806 0.336 . . . . 75.24 111.888 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 137' ' ' LEU . 3.4 pp -138.2 177.67 7.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.797 0.332 . . . . 73.11 111.252 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 69' ' ' VAL . 60.0 m -122.52 126.54 48.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.801 0.334 . . . . 64.43 111.472 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.6 114.02 25.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.89 -0.411 . . . . 73.21 109.89 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 97.2 mtt180 -104.53 110.05 22.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.287 0.477 . . . . 63.21 112.287 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -102.72 112.37 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 64.52 111.573 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 131' ' ' SER . 34.7 tt0 -98.52 141.8 30.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.568 0.223 . . . . 63.2 111.026 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.6 144.05 22.94 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.039 -0.6 . . . . 75.03 113.101 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.09 -40.67 96.62 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.974 0.416 . . . . 75.24 110.857 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.9 p -96.78 -177.66 3.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.219 0.533 . . . . 51.24 111.38 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -92.9 6.95 45.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.305 -0.407 . . . . 74.13 111.248 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.45 135.38 68.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.485 -0.325 . . . . 72.11 111.784 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 96.68 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.139 1.892 . . . . 64.42 111.801 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.75 141.3 89.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.33 0.492 . . . . 71.32 112.33 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.11 177.58 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.663 2.242 . . . . 75.43 112.929 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.3 134.4 46.75 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.013 0.435 . . . . 54.15 111.651 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.65 160.95 39.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.138 0.494 . . . . 74.54 111.954 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 92.3 p -138.71 168.8 19.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.059 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.632 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.2 165.25 37.08 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.023 -0.608 . . . . 54.2 113.337 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.6 m -98.98 107.84 20.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.91 0.386 . . . . 63.11 111.544 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 119' ' ' GLN . 3.2 p -89.83 112.97 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.202 0.525 . . . . 54.33 111.097 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 117' ' ' GLN . 47.5 mt-10 -102.6 103.56 13.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.277 0.56 . . . . 75.43 110.956 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CD1' HD22 ' A' ' 139' ' ' LEU . 19.0 p90 -104.27 137.97 41.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.814 -0.63 . . . . 74.43 111.579 -175.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.09 -145.5 4.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.697 -0.763 . . . . 52.24 113.592 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.612 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.5 mt-30 -129.44 161.35 30.59 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.885 0.374 . . . . 55.4 111.363 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 111' ' ' PHE . 51.9 mt -122.34 140.11 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.073 0.463 . . . . 73.25 112.102 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 16.0 pt20 -132.03 103.53 6.33 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.489 0.661 . . . . 65.52 110.79 169.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 157.56 -158.54 29.09 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.156 -0.545 . . . . 62.44 113.606 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 33.4 p -98.82 -170.71 1.97 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.517 -0.402 . . . . 64.25 111.073 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.495 HD12 ' HG3' ' A' ' 33' ' ' GLN . 34.0 mm -76.12 -15.41 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.31 0.576 . . . . 54.45 110.766 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.708 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 40.7 m-20 -105.2 -45.94 4.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.104 -0.498 . . . . 74.24 111.512 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -116.03 92.88 4.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.377 0.608 . . . . 73.01 111.097 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' HB2' HG23 ' A' ' 104' ' ' ILE . 38.2 p90 -127.33 132.2 50.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.131 0.491 . . . . 74.5 111.809 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.49 124.44 40.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.087 -0.506 . . . . 72.32 111.149 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.82 97.73 11.08 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.007 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.8 pt -103.53 162.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.126 -0.488 . . . . 72.41 112.043 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 53.77 22.18 3.07 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 64.42 112.61 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.57 131.77 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.366 0.603 . . . . 75.31 112.202 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 34.0 mt-30 -128.15 146.41 50.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.665 -0.698 . . . . 74.53 110.814 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.03 143.13 28.9 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.263 0.554 . . . . 53.33 112.267 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.586 ' HB3' HG13 ' A' ' 99' ' ' VAL . 49.1 tt0 -142.23 149.44 39.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.782 -0.645 . . . . 74.02 110.174 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -100.28 114.41 27.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.138 0.494 . . . . 74.31 112.231 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.92 121.94 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.113 -0.494 . . . . 65.41 111.17 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -113.46 135.65 53.65 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.902 0.382 . . . . 73.31 111.37 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.517 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -124.1 140.07 34.01 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.234 -0.439 . . . . 54.03 111.476 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.16 169.66 21.94 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.589 2.193 . . . . 72.02 113.623 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.13 134.79 34.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 55.21 111.523 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 m -77.39 124.06 27.36 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.386 -0.37 . . . . 73.24 111.419 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.28 -42.52 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.103 0.478 . . . . 73.24 110.973 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -125.81 171.58 10.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 75.15 111.83 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.11 158.79 31.07 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.263 -0.426 . . . . 71.23 111.483 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.0 160.14 57.98 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.015 -1.244 . . . . 72.25 113.129 -2.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 58.8 m -86.17 78.07 9.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.494 0.553 . . . . 54.42 112.494 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.78 79.42 2.23 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.427 -0.583 . . . . 64.35 109.427 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.529 HG12 HG23 ' A' ' 135' ' ' ILE . 40.6 t -76.68 99.78 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.402 -0.363 . . . . 75.44 111.818 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.453 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.8 p-10 -91.27 106.84 18.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.033 0.444 . . . . 52.25 110.97 174.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.529 HG23 HG12 ' A' ' 133' ' ' VAL . 26.9 pt -114.08 131.54 23.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.972 0.36 . . . . 60.33 111.972 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.58 135.69 54.35 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.722 2.281 . . . . 71.04 112.381 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.49 ' HB3' HD12 ' A' ' 80' ' ' LEU . 2.4 tt -132.42 113.33 13.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.35 -0.386 . . . . 55.14 110.424 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.61 109.76 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.058 0.456 . . . . 74.21 111.702 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 ' CD1' ' A' ' 101' ' ' TYR . 80.0 mt -88.57 140.05 29.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.143 -0.317 . . . . 63.52 110.143 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -129.4 150.69 50.65 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.888 0.375 . . . . 74.5 111.475 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.87 31.14 56.53 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.218 -0.515 . . . . 71.42 113.068 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 147' ' ' LEU . 17.8 tt -168.51 125.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.916 0.389 . . . . 75.23 111.487 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.8 m -83.53 144.71 29.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.649 0.261 . . . . 60.33 111.522 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 p -51.04 -44.77 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 112.391 0.515 . . . . 72.43 112.391 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -59.74 -38.55 82.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.211 0.529 . . . . 52.31 111.389 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -93.31 6.16 49.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.346 0.499 . . . . 70.53 112.346 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.606 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.3 tt -69.68 125.14 25.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.662 0.267 . . . . 73.55 110.402 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -95.82 -62.16 0.98 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.111 -0.566 . . . . 41.44 113.602 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -145.44 160.25 41.87 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.272 0.558 . . . . 71.02 112.008 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 75.5 t -124.86 101.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.696 -0.684 . . . . 64.31 110.406 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 31.2 ttm180 -88.31 94.37 9.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.874 0.369 . . . . 72.03 111.636 -176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.725 HG21 ' SD ' ' A' ' 66' ' ' MET . 37.1 mm -85.75 127.58 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.68 -0.237 . . . . 74.52 110.876 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -164.45 -178.3 5.34 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.405 0.521 . . . . 71.34 112.405 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 66.38 24.56 10.47 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.449 0.7 . . . . 74.31 112.293 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.632 HD13 ' HA3' ' A' ' 97' ' ' GLY . 41.9 mm -67.15 105.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.187 0.518 . . . . 73.43 111.701 -177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.511 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 7.6 pt20 -137.71 151.72 71.22 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.021 -0.536 . . . . 73.23 111.42 -175.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.8 133.25 23.27 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.406 2.071 . . . . 43.03 112.846 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.135 0.493 . . . . 51.45 111.975 -177.545 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 111.949 0.351 . . . . 73.0 111.949 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.37 -4.95 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.17 0.51 . . . . 71.41 111.437 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -73.66 79.33 1.52 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.848 -0.615 . . . . 75.14 111.038 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.04 152.12 20.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.337 -0.392 . . . . 73.03 111.31 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.9 m -75.38 69.28 2.16 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.167 0.508 . . . . 50.22 110.505 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.37 117.43 29.9 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.176 -0.465 . . . . 60.15 110.994 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.522 HG22 ' H ' ' A' ' 9' ' ' GLN . 14.9 p -101.98 148.2 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.086 0.469 . . . . 64.11 112.089 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -101.56 26.13 7.66 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.818 0.342 . . . . 63.25 111.548 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.522 ' H ' HG22 ' A' ' 7' ' ' VAL . 63.7 tt0 -53.8 110.8 0.63 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.183 -0.462 . . . . 62.14 111.613 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.0 ttm -69.3 93.14 0.61 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.046 0.451 . . . . 64.53 111.823 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 138.65 31.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.507 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -73.29 81.96 1.37 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.559 0.695 . . . . 73.1 111.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 m -148.58 126.19 11.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.792 -0.64 . . . . 73.52 110.329 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.28 131.86 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.233 0.539 . . . . 72.12 112.039 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.6 t -136.4 118.25 15.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.014 -0.539 . . . . 73.1 110.243 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.8 p -87.79 112.23 22.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.965 0.357 . . . . 71.33 111.965 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -83.31 171.14 13.86 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.869 0.366 . . . . 72.33 111.086 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -72.12 152.06 42.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.338 -0.226 . . . . 54.43 110.883 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.32 94.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.669 0.271 . . . . 72.32 111.677 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.67 135.82 56.31 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.583 -0.28 . . . . 65.53 110.438 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -72.2 177.27 4.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.801 0.667 . . . . 73.45 112.801 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -74.16 169.78 16.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.537 0.684 . . . . 63.43 112.677 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -76.55 179.24 6.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.683 -0.689 . . . . 73.21 110.8 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp -145.64 150.24 35.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.831 0.348 . . . . 70.22 111.699 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' OD1' ' HG2' ' A' ' 27' ' ' GLU . 52.4 t-20 -54.3 131.99 42.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.59 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.46 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 30.3 mm-40 -50.76 -49.03 59.02 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.316 0.487 . . . . 72.55 112.316 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 31' ' ' ILE . 14.6 pt-20 -59.68 -45.66 91.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.949 0.404 . . . . 73.32 110.842 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -60.02 -34.3 73.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.213 -0.449 . . . . 55.0 111.543 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 25' ' ' ASN . 98.1 t -62.78 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.948 0.404 . . . . 75.02 110.713 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 4.9 mptp? -62.3 -36.2 81.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 74.32 111.163 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.8 mt -62.04 -48.01 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.08 0.467 . . . . 74.24 110.798 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -60.11 -35.29 74.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.282 0.563 . . . . 74.51 110.932 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.624 ' HG3' HD11 ' A' ' 108' ' ' ILE . 35.1 tt0 -68.37 -43.35 77.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.176 -0.465 . . . . 64.11 110.653 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 -55.76 29.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.013 -0.54 . . . . 72.13 110.684 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -54.15 -47.38 71.99 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.182 0.438 . . . . 72.34 112.182 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -62.29 -48.21 80.91 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.965 0.357 . . . . 75.32 111.965 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.7 -33.57 75.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.211 0.529 . . . . 72.34 111.026 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -56.04 -48.96 75.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.856 -0.611 . . . . 71.51 110.628 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.75 -32.3 72.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.942 -0.572 . . . . 71.41 111.683 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.45 -10.46 59.41 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.007 0.373 . . . . 71.4 112.007 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.471 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 43.2 t -87.13 132.45 33.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.864 0.364 . . . . 74.34 111.871 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.0 p -103.36 -24.82 13.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 75.4 110.781 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t -100.53 93.48 5.64 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.175 -0.466 . . . . 62.34 110.918 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.64 -160.18 47.65 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.198 0.439 . . . . 70.31 114.198 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -116.6 144.92 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.3 0.481 . . . . 73.21 112.3 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.471 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 16.1 m-85 -83.3 113.75 20.92 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.407 -0.361 . . . . 72.23 111.898 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 86.9 mt -103.9 94.26 5.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.182 0.515 . . . . 72.4 110.304 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.72 120.67 82.42 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.543 -0.299 . . . . 72.41 110.818 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.629 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.7 Cg_endo -57.17 -22.2 47.01 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.827 2.352 . . . . 74.41 112.888 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.49 -21.39 60.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.34 -0.457 . . . . 61.02 113.061 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.97 -40.62 10.02 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.845 0.355 . . . . 44.13 111.164 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.9 mttm 62.88 2.48 1.0 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.69 0.626 . . . . 75.22 112.69 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 p -70.76 151.06 95.31 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 113.02 0.748 . . . . 73.52 113.02 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' A' ' 65' ' ' ARG . 73.8 Cg_endo -72.89 136.33 24.95 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.843 2.362 . . . . 72.44 112.467 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.51 140.58 51.24 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.737 0.304 . . . . 71.31 111.604 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -92.71 127.43 38.21 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.999 0.428 . . . . 75.11 111.738 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.2 tp -131.13 127.19 37.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.119 0.485 . . . . 63.32 111.369 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.02 97.7 11.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.127 0.489 . . . . 73.22 110.715 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -93.55 -177.18 4.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.275 0.56 . . . . 72.11 112.262 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -67.5 -32.41 73.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.021 -0.536 . . . . 72.23 112.032 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 pt -84.45 -30.0 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 111.883 0.327 . . . . 75.33 111.883 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.58 -177.69 37.76 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.396 -0.43 . . . . 62.22 112.895 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.5 m -85.18 109.01 17.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.039 0.447 . . . . 74.33 111.446 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.732 HD13 ' SD ' ' A' ' 66' ' ' MET . 0.6 OUTLIER -116.57 171.71 7.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.011 0.434 . . . . 73.41 111.897 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 30.6 ttm180 -140.64 114.04 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.258 -0.428 . . . . 72.13 111.101 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.732 ' SD ' HD13 ' A' ' 64' ' ' LEU . 3.2 mpp? -103.59 158.55 16.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.5 0.555 . . . . 63.31 112.5 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 p -156.67 157.85 35.93 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.793 -0.64 . . . . 70.34 111.237 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 76.3 mt -112.37 117.67 33.1 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.896 0.332 . . . . 73.33 111.896 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.74 165.06 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.657 0.265 . . . . 72.42 111.555 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 m120 57.7 40.08 26.77 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.118 0.485 . . . . 54.32 111.907 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 40.5 mt -69.86 112.18 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.2 -0.454 . . . . 73.14 111.217 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -137.23 151.31 71.39 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-O 120.772 0.32 . . . . 75.52 111.83 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.92 146.76 83.77 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.887 2.391 . . . . 60.24 113.186 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 19.6 t70 -115.02 169.86 8.78 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.258 -0.428 . . . . 73.15 111.043 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.63 72.48 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.866 0.321 . . . . 74.01 111.866 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.21 -45.68 3.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.517 -0.31 . . . . 63.23 111.465 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -130.6 -110.07 1.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.754 -0.736 . . . . 61.44 113.893 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -146.97 127.83 14.43 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.104 0.409 . . . . 54.23 112.104 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 75.7 p -98.93 120.81 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.767 0.317 . . . . 72.22 111.752 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -137.15 151.06 48.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.823 0.344 . . . . 62.13 111.197 175.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 m -83.3 113.45 20.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.006 0.431 . . . . 73.43 111.846 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.42 109.39 20.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.92 -0.582 . . . . 64.43 109.969 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 66' ' ' MET . 73.7 mtm180 -101.15 123.07 44.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.861 0.319 . . . . 63.21 111.861 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.7 mp -102.2 102.42 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.034 0.445 . . . . 73.2 110.593 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -100.9 134.51 43.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.433 -0.349 . . . . 73.52 111.188 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.56 122.52 5.81 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.075 -0.583 . . . . 62.12 113.446 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.0 -27.81 62.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.428 0.632 . . . . 65.44 110.498 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -85.89 -175.24 5.5 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.774 -0.648 . . . . 32.11 111.44 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.41 5.63 39.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.397 -0.365 . . . . 63.24 111.458 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.09 152.98 38.01 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.196 0.443 . . . . 62.0 112.196 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.678 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 73.2 Cg_endo -74.27 138.18 24.59 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.773 2.315 . . . . 74.34 112.79 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.17 122.07 55.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 O-C-N 122.142 -0.349 . . . . 70.34 111.848 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.27 170.88 14.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.607 2.205 . . . . 32.43 112.866 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.6 131.48 50.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.307 0.484 . . . . 44.44 112.307 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -146.79 154.85 41.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.261 0.553 . . . . 73.2 112.225 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.9 p -118.87 151.23 38.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.898 -0.592 . . . . 73.43 110.438 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 154' ' ' ASP . . . -141.18 150.24 21.67 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.771 -0.728 . . . . 35.44 113.83 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 154' ' ' ASP . 61.3 m -100.06 110.0 22.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.771 0.319 . . . . 70.41 110.819 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.1 p -102.28 117.88 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.433 0.531 . . . . 75.54 112.433 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 153' ' ' HIS . 32.8 mm-40 -83.98 147.26 27.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.901 -0.407 . . . . 75.42 109.901 174.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.412 ' CG ' HD22 ' A' ' 139' ' ' LEU . 32.0 p90 -155.12 133.71 11.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.066 0.46 . . . . 70.42 111.654 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.85 -147.67 5.48 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.952 -0.567 . . . . 63.22 112.951 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 87.4 mt-30 -123.36 150.71 43.33 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.333 0.587 . . . . 63.14 112.565 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.469 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.3 mt -116.26 104.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.978 -0.556 . . . . 54.43 110.657 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -89.19 -17.41 29.18 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.398 0.518 . . . . 64.02 112.398 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -90.37 -159.23 35.36 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.026 -0.607 . . . . 52.1 113.963 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 51.8 p -114.25 -178.44 3.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.806 0.443 . . . . 64.25 110.967 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.624 HD11 ' HG3' ' A' ' 33' ' ' GLN . 48.0 mm -66.81 -30.92 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 60.02 110.709 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.92 -39.28 72.8 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.097 -0.501 . . . . 74.21 111.163 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -154.59 108.87 2.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.164 -0.471 . . . . 75.15 111.191 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.613 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 36.9 p90 -125.99 139.49 53.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.89 0.376 . . . . 75.24 111.743 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -108.78 123.23 48.69 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.244 -0.434 . . . . 75.52 111.443 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -74.66 100.48 3.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.718 0.294 . . . . 64.03 110.798 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.6 pt -109.63 157.46 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 111.812 0.301 . . . . 63.22 111.812 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 56.73 31.38 19.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.18 0.514 . . . . 71.13 111.502 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -97.08 132.91 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.385 0.612 . . . . 50.15 112.583 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -142.11 178.18 7.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.723 -0.672 . . . . 70.52 109.656 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 11.3 p30 -127.85 172.91 10.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.949 1.092 . . . . 64.1 113.949 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -153.1 156.34 38.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.872 -1.058 . . . . 72.23 109.921 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.54 111.48 23.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.258 0.466 . . . . 74.11 112.258 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 121' ' ' ILE . 20.2 pt -96.11 101.17 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.325 0.583 . . . . 55.3 110.989 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.89 108.93 20.48 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.436 -0.347 . . . . 63.13 111.185 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.57 38.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.513 -0.312 . . . . 70.14 111.599 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.83 179.69 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.67 2.247 . . . . 64.54 113.553 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.89 108.09 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.023 0.439 . . . . 73.24 111.299 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 15.3 m -80.77 96.66 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 64.22 111.203 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 127' ' ' VAL . 12.2 t -86.71 7.98 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 121.081 0.467 . . . . 73.53 111.609 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.1 pt? -105.52 147.0 28.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.186 0.517 . . . . 65.44 111.925 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.39 127.37 22.44 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.098 -0.501 . . . . 72.1 111.015 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.18 155.14 91.81 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.836 -1.318 . . . . 74.3 113.086 -0.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.678 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 48.5 t -88.64 121.27 30.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.652 0.612 . . . . 70.43 112.652 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -138.79 130.72 27.95 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.085 0.469 . . . . 74.5 110.948 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.35 149.72 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.802 0.334 . . . . 54.33 111.563 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -132.76 125.38 30.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.027 0.441 . . . . 73.32 110.737 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 pt -130.74 137.88 31.77 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 120.814 0.34 . . . . 71.32 111.472 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.71 120.21 7.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.302 2.001 . . . . 75.41 112.777 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.31 97.41 8.48 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.023 -0.535 . . . . 71.11 109.782 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.456 ' HG3' HG22 ' A' ' 79' ' ' THR . 63.0 tt0 -87.83 83.36 7.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 53.45 111.297 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 101' ' ' TYR . 65.9 mt -62.86 145.75 54.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.072 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -116.81 147.57 41.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.136 0.494 . . . . 71.33 112.073 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.19 -49.98 3.88 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.066 -0.516 . . . . 71.42 114.03 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.604 HD13 HD23 ' A' ' 147' ' ' LEU . 20.9 tt -87.64 138.47 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.261 0.553 . . . . 60.13 112.24 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.6 m -92.79 149.69 21.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.183 -0.462 . . . . 72.44 111.519 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -53.25 -42.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.379 0.511 . . . . 73.14 112.379 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.75 -23.65 65.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.199 0.523 . . . . 73.33 111.289 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.441 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.1 mm-40 -103.03 7.81 38.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 74.11 112.089 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.629 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 14.0 mt -72.85 124.36 25.24 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.279 0.474 . . . . 74.33 112.279 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.67 -57.59 0.82 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.203 -0.523 . . . . 44.13 112.886 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -145.0 146.34 31.87 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.333 -0.51 . . . . 72.23 111.9 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.506 ' HB ' HD11 ' A' ' 68' ' ' LEU . 62.1 t -124.54 100.19 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.068 -0.514 . . . . 74.1 109.917 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -100.53 114.47 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.736 0.643 . . . . 75.43 112.736 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.49 123.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.797 -0.638 . . . . 51.43 110.988 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.479 ' CD2' ' HG2' ' A' ' 100' ' ' GLU . 10.2 p80 -152.88 178.44 9.66 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.574 0.226 . . . . 75.43 111.082 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.463 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 33.1 t70 54.53 73.63 0.39 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.376 0.607 . . . . 73.44 111.197 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 115.29 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.843 -0.617 . . . . 45.24 110.695 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.52 140.07 36.72 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.095 0.405 . . . . 74.42 112.095 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.91 146.77 42.68 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.635 2.224 . . . . 75.42 112.538 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.34 135.56 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.047 0.758 . . . . 75.2 113.047 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.9 ptt? 37.54 30.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.258 1.577 . . . . 64.22 115.258 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -107.12 147.85 29.53 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.592 -0.693 . . . . 74.41 111.488 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.606 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.6 pt? -80.76 148.72 29.95 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.689 0.626 . . . . 75.22 112.689 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -96.69 172.93 7.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.201 0.524 . . . . 74.44 110.979 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -106.84 123.96 48.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.497 -0.32 . . . . 63.24 110.334 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -54.27 112.53 1.0 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.946 0.403 . . . . 73.23 111.219 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -73.17 76.19 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.405 0.621 . . . . 73.42 110.591 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -74.29 88.74 2.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.908 -0.587 . . . . 72.32 111.864 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -97.41 -24.76 15.47 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.095 0.474 . . . . 63.4 111.015 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.405 -0.807 . . . . 72.54 110.899 174.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.3 mmm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 110.467 -0.197 . . . . 71.12 110.467 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.08 143.72 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.172 0.511 . . . . 71.31 112.183 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -107.18 178.51 4.53 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.038 -0.528 . . . . 75.34 110.823 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -89.15 131.58 35.22 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.274 -0.266 . . . . 73.35 111.225 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.3 p -93.94 152.9 18.52 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.11 0.481 . . . . 74.23 111.88 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.64 -168.26 2.04 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.33 111.938 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.1 173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.253 -0.43 . . . . 75.41 111.967 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -126.27 125.48 42.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.023 0.379 . . . . 73.2 112.023 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -81.0 148.25 29.83 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.141 0.496 . . . . 74.21 112.303 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.1 mmt -121.79 120.27 34.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.287 -0.415 . . . . 43.34 110.56 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -113.35 134.63 54.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.906 0.336 . . . . 72.51 111.906 -172.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -110.72 153.95 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.757 0.313 . . . . 70.1 111.125 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.5 m -101.75 164.62 11.64 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.872 0.368 . . . . 72.11 111.841 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 118.32 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.959 0.409 . . . . 72.55 111.664 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.0 p -170.86 123.14 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 111.862 0.319 . . . . 64.31 111.862 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 p -111.91 165.76 11.81 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.823 0.344 . . . . 72.1 111.365 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.36 158.32 16.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.9 0.381 . . . . 74.24 111.638 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.17 176.47 5.38 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.897 0.38 . . . . 61.11 111.719 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -105.95 153.91 21.33 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.016 0.436 . . . . 63.53 111.785 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.18 125.36 35.44 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.031 -0.531 . . . . 75.04 111.161 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -95.95 -177.7 4.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.036 0.446 . . . . 73.54 111.944 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -86.65 175.21 8.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.301 -0.409 . . . . 73.32 111.645 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.435 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 26.1 pt20 -67.98 105.38 2.0 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.551 0.691 . . . . 71.35 112.136 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.704 HD23 HG21 ' A' ' 28' ' ' THR . 19.0 tp -98.78 178.32 5.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.934 -0.576 . . . . 74.43 109.819 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.447 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 32.7 m-20 -45.96 146.17 1.31 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.135 0.493 . . . . 74.14 112.321 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -56.15 -39.81 72.86 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.443 0.905 . . . . 55.23 113.443 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -65.09 -39.69 93.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.378 -0.529 . . . . 71.42 111.067 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.704 HG21 HD23 ' A' ' 24' ' ' LEU . 94.2 m -59.62 -50.05 75.36 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.224 0.535 . . . . 63.1 111.164 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.12 -35.29 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.475 0.655 . . . . 74.31 110.657 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.615 ' HE3' HD12 ' A' ' 48' ' ' LEU . 23.7 tptt -70.3 -35.95 74.02 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.623 -0.717 . . . . 74.14 110.754 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 27' ' ' GLU . 89.2 mt -60.48 -42.91 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.412 0.625 . . . . 72.52 110.322 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -57.4 -44.76 84.81 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.838 -0.619 . . . . 71.54 110.551 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HG3' HD11 ' A' ' 108' ' ' ILE . 31.6 tt0 -60.91 -40.03 91.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.934 -0.576 . . . . 74.23 111.12 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -59.03 -55.47 34.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.938 -0.574 . . . . 70.34 111.535 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -60.71 -39.05 87.1 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 111.893 0.331 . . . . 73.34 111.893 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.08 -54.57 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.425 0.528 . . . . 74.55 112.425 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.423 HD12 HD21 ' A' ' 48' ' ' LEU . 97.9 mt -56.61 -41.64 77.39 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.064 0.459 . . . . 64.33 110.919 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.8 -46.02 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.16 -0.473 . . . . 71.01 111.343 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.81 63.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 64.22 112.561 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -94.42 -12.41 27.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.892 0.33 . . . . 75.22 111.892 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.2 t -85.7 142.47 29.0 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.669 0.271 . . . . 73.42 111.336 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.2 p -84.0 -42.32 16.34 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.099 -0.375 . . . . 72.11 111.517 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 m -148.08 87.79 1.63 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 65.43 111.377 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.4 153.35 6.08 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.244 -0.503 . . . . 42.21 112.405 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 152' ' ' ILE . 25.8 m -106.41 146.12 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.315 0.579 . . . . 60.21 112.449 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -106.22 102.9 12.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.807 -0.633 . . . . 73.22 110.884 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -92.58 116.02 28.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.897 0.379 . . . . 73.2 111.221 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.615 HD12 ' HE3' ' A' ' 30' ' ' LYS . 3.8 mm? -86.93 117.46 68.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.578 -0.283 . . . . 45.35 110.717 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 78.5 Cg_exo -51.11 -36.36 54.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.102 2.534 . . . . 73.43 113.768 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.84 99.79 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.954 -0.641 . . . . 61.1 112.548 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . . . -86.88 93.61 9.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.731 0.301 . . . . 75.14 111.487 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HE3' HD12 ' A' ' 71' ' ' ILE . 43.6 mmtm -67.52 77.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.878 0.37 . . . . 73.55 110.251 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 p -140.48 149.97 59.16 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 112.841 0.682 . . . . 75.14 112.841 -175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 92.9 Cg_endo -80.48 154.19 21.04 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.393 2.728 . . . . 64.22 113.242 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.46 137.93 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.67 0.272 . . . . 63.43 111.456 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.543 ' CZ ' HG21 ' A' ' 63' ' ' THR . 37.6 ttt85 -79.22 133.69 36.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.853 0.359 . . . . 72.3 111.901 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HB3' HD22 ' A' ' 64' ' ' LEU . 56.2 tp -138.14 120.58 16.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.497 0.554 . . . . 75.42 112.497 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.47 121.63 26.51 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.726 -0.67 . . . . 61.43 110.401 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 p -123.68 -179.33 4.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.534 . . . . 64.21 111.808 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -67.72 -19.12 65.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 72.1 112.146 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 pt -100.26 -25.71 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.971 0.415 . . . . 73.44 111.891 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.76 32.54 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.415 -0.421 . . . . 65.31 112.243 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.543 HG21 ' CZ ' ' A' ' 56' ' ' ARG . 39.0 m -94.48 127.19 40.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.176 0.513 . . . . 72.14 111.709 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.6 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.8 170.13 13.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.03 -0.532 . . . . 72.32 110.71 175.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.605 ' HG2' ' HB2' ' A' ' 54' ' ' PRO . 17.2 ttp180 -133.44 105.59 7.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.835 0.35 . . . . 74.35 110.924 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.775 ' SD ' HG21 ' A' ' 152' ' ' ILE . 66.9 mtt -95.77 148.99 21.99 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.224 0.453 . . . . 73.4 112.224 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.1 p -145.08 148.89 34.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.793 0.33 . . . . 63.03 111.742 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 80' ' ' LEU . 95.6 mt -96.68 114.0 25.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.177 -0.465 . . . . 54.13 111.557 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -134.37 162.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.625 0.232 . . . . 52.55 111.625 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.4 m120 61.96 33.89 17.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.776 0.43 . . . . 70.41 111.794 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.574 HD12 ' HE3' ' A' ' 52' ' ' LYS . 38.8 mt -71.33 106.9 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 73.03 111.421 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 21.9 p -140.67 158.72 65.01 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 111.891 0.33 . . . . 65.5 111.891 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 22.6 Cg_endo -60.17 153.76 56.59 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.73 2.287 . . . . 61.15 113.517 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.0 t70 -129.96 172.62 11.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.156 -0.475 . . . . 63.11 111.679 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -53.58 -46.63 70.38 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.306 0.484 . . . . 72.44 112.306 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -110.14 -21.39 12.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.55 0.574 . . . . 75.53 112.55 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -157.49 -103.7 0.2 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.154 -1.022 . . . . 74.04 114.144 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.2 m -150.1 129.27 12.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.711 0.291 . . . . 74.25 111.636 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.664 HG23 ' HB2' ' A' ' 74' ' ' ASP . 82.5 p -97.59 123.56 41.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.87 0.367 . . . . 54.33 111.405 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.6 pp -135.73 137.96 42.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.19 0.519 . . . . 75.41 111.352 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.0 m -83.66 107.35 16.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.155 0.502 . . . . 71.25 111.354 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -82.75 109.98 17.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.914 -0.585 . . . . 71.53 110.366 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 66' ' ' MET . 48.3 mtm180 -93.7 112.47 24.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.76 0.282 . . . . 73.34 111.76 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mp -92.18 93.94 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.04 0.448 . . . . 75.35 110.611 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -94.22 104.03 16.04 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 71.32 110.799 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.46 145.13 40.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.822 -0.704 . . . . 52.25 113.353 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.92 -45.05 95.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.418 0.628 . . . . 55.23 110.439 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 m -80.68 115.2 20.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.869 -0.605 . . . . 62.51 110.699 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -61.26 -27.22 68.3 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.89 0.376 . . . . 65.13 111.39 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 141.22 49.95 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.765 -0.652 . . . . 71.41 112.0 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.82 106.96 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.144 2.563 . . . . 72.02 113.508 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.6 148.91 63.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.238 -0.437 . . . . 72.3 111.643 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.7 179.81 4.88 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.594 2.196 . . . . 52.43 113.153 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 139.5 36.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.07 0.462 . . . . 62.01 111.687 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 42.5 p90 -141.59 176.11 9.15 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.564 0.697 . . . . 73.15 112.475 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 p -152.73 168.69 24.84 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.536 -0.757 . . . . 32.44 111.077 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.55 -177.79 44.87 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.819 -0.705 . . . . 52.14 113.605 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 m -113.13 119.06 36.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.689 0.28 . . . . 74.34 111.308 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.09 115.81 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.103 0.478 . . . . 62.24 111.235 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 53.1 mt-10 -106.56 113.64 27.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.987 0.422 . . . . 74.54 111.158 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.434 ' CE1' HD22 ' A' ' 139' ' ' LEU . 17.0 p90 -116.95 129.02 55.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.044 0.45 . . . . 74.02 111.648 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.97 -146.71 4.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.186 -0.53 . . . . 72.41 113.189 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.617 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 92.9 mt-30 -128.58 152.87 47.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.169 0.509 . . . . 55.43 111.8 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 111' ' ' PHE . 57.9 mt -114.74 126.15 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.977 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -112.7 17.23 19.27 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.862 0.319 . . . . 75.13 111.862 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -132.99 -165.0 11.05 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.915 -0.659 . . . . 65.44 113.908 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.8 p -102.82 176.01 5.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.978 0.418 . . . . 74.5 111.558 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.485 HD11 ' HG3' ' A' ' 33' ' ' GLN . 49.2 mm -58.67 -38.23 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.085 0.469 . . . . 72.02 110.613 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.28 -47.91 59.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.899 -0.591 . . . . 64.51 110.995 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.41 91.69 2.57 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 51.01 111.826 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.614 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.9 p90 -115.41 127.89 55.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.178 0.513 . . . . 73.33 112.209 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -96.96 124.39 40.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 70.12 110.827 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.91 105.59 17.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.858 -0.61 . . . . 71.12 111.195 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.28 156.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.63 -0.259 . . . . 63.13 111.652 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 56.66 39.36 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.945 0.402 . . . . 65.44 111.881 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 p -96.72 116.43 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.472 0.653 . . . . 72.01 112.454 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -105.02 147.37 27.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.98 -0.554 . . . . 62.13 110.341 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.451 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 7.4 p30 -112.68 136.47 52.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.346 0.593 . . . . 54.12 111.931 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -127.45 157.74 39.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.956 -0.565 . . . . 73.31 110.217 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.5 122.02 37.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.11 0.411 . . . . 72.34 112.11 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.856 HG22 HD21 ' A' ' 137' ' ' LEU . 20.0 pt -100.95 105.64 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.163 0.506 . . . . 64.54 111.539 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -110.38 119.14 38.27 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.338 -0.392 . . . . 55.15 110.193 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -114.28 133.29 22.45 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 111.858 0.318 . . . . 65.3 111.858 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 24.5 Cg_exo -64.28 159.99 40.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.174 2.583 . . . . 74.0 113.22 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.14 147.63 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.128 0.418 . . . . 53.25 112.128 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 t -87.39 124.54 33.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.342 -0.39 . . . . 61.2 110.541 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.4 -34.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.887 0.375 . . . . 72.0 111.722 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.09 -169.1 1.95 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.892 0.377 . . . . 71.23 111.655 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.47 149.73 53.1 Favored Pre-proline 0 N--CA 1.472 0.658 0 CA-C-N 116.508 -0.314 . . . . 33.21 111.358 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.54 147.2 63.5 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.0 -1.25 . . . . 73.33 113.306 -1.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m -65.89 82.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.356 0.598 . . . . 75.22 112.145 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.57 93.35 4.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.498 -0.774 . . . . 65.31 109.285 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.94 105.66 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.51 -0.313 . . . . 62.44 111.803 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.5 p-10 -96.97 142.9 28.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.992 0.425 . . . . 62.4 111.581 175.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 18.0 pt -135.85 135.82 22.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 116.314 -0.403 . . . . 75.13 111.346 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.0 Cg_exo -75.63 117.1 4.65 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 75.13 113.0 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.856 HD21 HG22 ' A' ' 121' ' ' ILE . 38.4 mt -97.1 112.33 24.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.185 0.439 . . . . 62.44 112.185 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -91.02 90.73 7.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.105 0.479 . . . . 62.44 110.023 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 101' ' ' TYR . 66.3 mt -76.72 137.71 39.51 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.319 -0.4 . . . . 63.44 111.252 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.8 135.82 48.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.226 0.454 . . . . 71.13 112.226 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.62 17.03 79.51 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 114.581 0.592 . . . . 61.11 114.581 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.2 tt -147.55 129.57 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 117.273 0.537 . . . . 63.1 111.628 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -92.48 156.75 16.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.975 0.416 . . . . 72.15 111.818 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.75 -33.79 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.964 -0.562 . . . . 75.24 111.727 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -31.63 72.95 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.966 0.413 . . . . 51.33 111.726 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.617 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 87.5 mm-40 -110.53 18.36 19.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.286 -0.415 . . . . 74.14 111.852 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -82.55 106.53 14.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.925 0.393 . . . . 71.03 110.832 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -83.78 -67.4 1.45 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.178 -0.534 . . . . 60.05 113.462 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -140.58 157.36 45.59 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.42 -0.459 . . . . 64.52 111.784 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.8 t -128.09 103.14 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.958 -0.565 . . . . 75.24 110.662 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -93.32 114.97 27.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.27 0.47 . . . . 71.12 112.27 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.775 HG21 ' SD ' ' A' ' 66' ' ' MET . 42.7 mm -96.14 130.78 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.105 -0.498 . . . . 73.14 111.118 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -165.39 -175.32 3.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.596 0.236 . . . . 75.45 111.632 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 64.22 24.47 13.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.117 0.567 . . . . 61.53 112.0 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.74 104.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.541 0.686 . . . . 75.34 111.538 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -132.75 142.95 46.64 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.423 -0.808 . . . . 72.34 111.159 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 95' ' ' PHE . 62.5 Cg_endo -72.07 151.53 55.8 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.296 1.997 . . . . 75.21 112.692 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.82 143.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.619 -0.264 . . . . 73.42 110.812 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.6 mtm 70.45 -10.6 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.244 0.618 . . . . 63.52 112.661 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -120.21 113.86 21.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.889 0.376 . . . . 62.53 111.095 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.97 156.87 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.223 0.535 . . . . 72.04 111.875 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.0 162.66 30.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.288 0.566 . . . . 74.42 111.856 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -52.87 127.65 24.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.381 -0.827 . . . . 73.12 112.999 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.91 143.86 41.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.133 -0.485 . . . . 73.31 110.399 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -146.34 146.62 30.74 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 42.24 111.691 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -72.96 168.62 18.61 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.872 0.367 . . . . 74.4 111.512 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 39.9 m80 69.78 92.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.056 0.761 . . . . 71.15 113.056 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.6 m170 . . . . . 0 C--O 1.255 1.394 0 CA-C-N 115.105 -0.952 . . . . 75.03 110.681 169.217 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.733 0.302 . . . . 75.51 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.88 134.15 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.921 0.391 . . . . 61.34 111.499 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -125.02 122.73 38.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.56 -0.291 . . . . 73.03 111.201 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -173.42 145.69 1.28 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.941 0.401 . . . . 75.1 111.862 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -135.14 -177.33 4.59 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.281 -0.418 . . . . 52.02 110.671 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.31 173.04 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.201 0.445 . . . . 65.24 112.201 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m -82.07 158.06 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 112.477 0.547 . . . . 64.14 112.477 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 8' ' ' ARG . 9.7 mmt85 -123.7 123.51 40.69 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.084 0.468 . . . . 72.11 111.737 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -88.19 146.5 25.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.117 0.414 . . . . 61.1 112.117 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.5 mmt -129.02 138.35 51.87 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.375 -0.375 . . . . 60.33 111.228 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.13 129.37 11.95 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.01 0.433 . . . . 65.45 111.431 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -144.05 123.0 12.76 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.506 -0.315 . . . . 54.41 111.5 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.2 m -131.53 104.02 6.73 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 72.41 111.308 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.53 145.29 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.571 -0.286 . . . . 63.51 110.931 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.7 m -111.21 97.03 6.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.918 0.39 . . . . 75.2 111.821 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.9 p -91.78 -161.27 0.81 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.439 -0.346 . . . . 70.14 111.152 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.32 176.98 9.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.232 -0.293 . . . . 74.23 110.822 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -68.17 77.9 0.24 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.85 0.834 . . . . 74.02 111.529 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -89.87 162.79 15.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.412 -0.813 . . . . 75.11 111.808 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -79.66 94.71 5.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.954 -0.566 . . . . 62.21 110.743 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.3 mmt -101.65 165.58 11.15 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.904 0.383 . . . . 73.01 111.679 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 p -61.01 -39.12 88.52 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.275 0.56 . . . . 73.15 111.336 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -109.13 151.07 26.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 63.34 110.716 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.58 141.05 57.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.319 0.581 . . . . 74.41 112.149 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -60.36 127.96 34.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.717 -0.674 . . . . 73.22 110.894 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -60.7 -30.76 70.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.655 0.264 . . . . 55.22 111.615 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.59 -47.06 85.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.392 0.615 . . . . 75.33 110.38 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 m -66.01 -31.08 71.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.829 -0.623 . . . . 72.53 111.049 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.79 -45.15 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.36 -0.382 . . . . 65.01 110.89 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.51 -48.33 77.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.142 0.496 . . . . 74.44 110.732 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -55.81 -51.22 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.904 -0.589 . . . . 72.33 111.41 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.1 m -58.36 -44.65 88.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.278 -0.419 . . . . 63.44 111.557 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.38 -44.05 96.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.447 -0.342 . . . . 74.55 111.209 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -56.79 -50.87 71.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.403 -0.362 . . . . 60.51 111.449 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -58.12 -43.8 87.4 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.859 0.361 . . . . 71.31 111.726 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -63.64 -48.23 78.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.729 0.3 . . . . 65.44 111.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.23 -33.82 76.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.333 0.587 . . . . 75.52 110.549 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.6 -41.47 98.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.834 -0.621 . . . . 71.02 110.509 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.47 65.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.048 -0.524 . . . . 65.14 111.654 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.601 ' HE3' HG22 ' A' ' 108' ' ' ILE . 66.7 mttm -82.21 -7.97 59.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.835 0.309 . . . . 51.12 111.835 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -55.97 117.57 3.83 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.648 0.61 . . . . 71.31 112.648 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 t -71.12 -36.87 72.3 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.081 -0.509 . . . . 51.24 111.691 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 m -151.99 121.54 6.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.714 0.292 . . . . 73.12 110.723 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.79 -153.59 22.08 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.221 -0.514 . . . . 42.1 112.547 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.29 148.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.14 0.47 . . . . 72.4 111.918 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -95.92 130.11 42.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.411 . . . . 72.01 112.069 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -125.06 143.89 50.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.858 -0.61 . . . . 74.42 109.868 172.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 76.5 mt -114.12 136.36 22.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.837 0.351 . . . . 63.33 111.721 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 36.8 Cg_exo -61.53 -14.0 32.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.922 2.415 . . . . 75.15 113.406 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.35 6.43 26.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.212 -0.518 . . . . 72.54 113.145 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.88 103.12 11.86 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.043 0.449 . . . . 71.3 111.125 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -80.65 60.55 4.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.513 0.673 . . . . 73.22 111.231 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 p -146.01 150.65 42.89 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-N 115.826 -0.624 . . . . 70.21 112.123 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.69 170.85 13.84 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.024 2.483 . . . . 72.42 114.396 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.38 157.03 44.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.738 -0.665 . . . . 72.42 110.076 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -113.59 119.36 37.23 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.46 0.648 . . . . 73.31 112.17 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.95 126.16 53.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.839 -0.618 . . . . 72.35 112.284 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.0 tt0 -86.78 108.33 18.66 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.741 -0.466 . . . . 61.32 109.741 172.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 82.6 p -113.04 -177.5 3.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.234 0.54 . . . . 71.13 112.338 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -67.66 -19.82 65.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.945 -0.57 . . . . 71.43 112.318 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 pt -95.19 -6.55 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.986 0.422 . . . . 72.4 111.073 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.54 -179.46 16.3 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.382 -0.437 . . . . 71.11 112.89 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 60.3 m -79.81 131.69 35.95 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.454 -0.439 . . . . 72.32 111.34 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.96 175.18 10.03 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.127 0.489 . . . . 63.32 112.246 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -124.34 123.35 40.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 74.42 110.664 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.568 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.0 mtt -118.0 156.16 29.04 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.873 0.368 . . . . 74.31 111.896 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.9 t -158.79 170.47 22.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.905 0.383 . . . . 70.2 111.908 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB3' HD11 ' A' ' 71' ' ' ILE . 99.2 mt -116.29 106.18 13.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.29 -0.414 . . . . 71.34 111.996 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 81' ' ' THR . 33.0 m -113.36 162.19 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.238 -0.288 . . . . 42.31 111.064 176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.8 m120 63.83 31.2 14.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.039 0.447 . . . . 74.33 112.095 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 68' ' ' LEU . 45.3 mt -73.08 103.93 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.17 0.433 . . . . 23.21 112.17 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 p -137.78 152.49 72.56 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 120.861 0.362 . . . . 71.51 111.562 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.11 168.88 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.737 2.291 . . . . 51.43 113.495 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.66 ' HB2' HG23 ' A' ' 79' ' ' THR . 31.5 t70 -143.82 170.54 15.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.773 -0.649 . . . . 72.53 110.749 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.25 94.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.692 0.282 . . . . 70.12 111.692 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.15 -34.27 24.09 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.525 -0.307 . . . . 61.31 111.736 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.54 -100.83 0.14 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.36 -0.924 . . . . 64.44 114.149 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -146.03 131.28 18.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.832 0.349 . . . . 73.15 111.586 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.66 HG23 ' HB2' ' A' ' 74' ' ' ASP . 79.0 p -109.56 137.7 47.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.895 0.379 . . . . 62.52 111.604 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 pp -149.41 -179.57 7.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.898 0.38 . . . . 44.24 111.272 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.691 ' HB ' HG23 ' A' ' 69' ' ' VAL . 21.7 m -124.13 117.77 25.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.894 0.378 . . . . 64.44 111.258 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.2 113.54 20.73 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.238 -0.437 . . . . 70.4 109.946 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 66' ' ' MET . 69.7 mtt180 -96.29 136.57 36.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.822 0.344 . . . . 75.42 111.09 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.536 HG12 ' HG2' ' A' ' 66' ' ' MET . 42.1 mt -131.63 133.97 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 74.14 111.529 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -142.51 124.79 15.51 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.737 -0.21 . . . . 73.15 110.689 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 92' ' ' LEU . . . -75.86 146.08 33.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.843 -0.694 . . . . 74.14 113.933 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.41 -39.48 83.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.753 0.787 . . . . 75.2 109.927 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -93.81 112.18 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 73.12 109.671 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -64.35 -7.71 10.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.46 0.541 . . . . 75.23 112.46 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.97 156.29 80.77 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.881 0.473 . . . . 64.15 111.572 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.82 123.38 11.51 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.094 2.529 . . . . 61.13 113.824 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 126' ' ' SER . 95.9 mt -100.19 147.98 34.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.099 -0.501 . . . . 73.41 111.332 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.13 172.79 15.28 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.471 2.114 . . . . 65.32 112.991 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.48 43.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 64.45 111.032 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -146.35 162.27 38.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.351 0.596 . . . . 72.33 112.282 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.4 m -146.9 151.54 37.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.932 -0.577 . . . . 53.22 110.309 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.763 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -150.25 170.61 30.22 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.411 -0.899 . . . . 55.41 113.762 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.1 m -105.32 132.04 52.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 75.13 110.999 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.75 130.39 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.955 0.407 . . . . 75.35 111.6 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 40.4 mm-40 -97.83 111.92 24.03 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 64.02 110.818 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -122.75 120.95 35.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.237 0.542 . . . . 75.35 111.844 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -161.65 -149.18 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.837 -0.62 . . . . 55.41 113.23 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -125.06 157.19 36.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.222 0.534 . . . . 61.32 112.043 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.36 121.16 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.354 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.08 5.95 32.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.872 0.367 . . . . 73.32 111.658 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -113.69 -177.89 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.233 -0.508 . . . . 73.43 113.19 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -90.44 179.41 5.87 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.611 -0.346 . . . . 52.43 111.223 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.601 HG22 ' HE3' ' A' ' 40' ' ' LYS . 48.8 mm -68.73 -27.56 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.521 . . . . 74.33 110.605 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.54 -32.34 58.16 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.384 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -150.39 90.57 1.67 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.285 0.564 . . . . 61.34 111.14 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -96.3 117.23 30.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.413 0.625 . . . . 70.31 112.05 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -86.59 111.98 21.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.081 -0.508 . . . . 71.52 110.633 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.77 104.08 11.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.951 0.405 . . . . 72.34 111.053 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.5 pt -113.39 151.65 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.475 -0.33 . . . . 63.35 111.687 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 58.14 34.44 24.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.078 0.465 . . . . 55.11 111.802 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.442 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 3.7 p -91.14 116.74 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.339 0.59 . . . . 73.41 112.331 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -99.66 171.79 7.68 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.268 -0.424 . . . . 63.44 111.011 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.12 143.47 50.87 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.14 0.495 . . . . 61.42 111.872 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -144.76 147.69 33.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.36 -0.382 . . . . 72.23 111.17 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.88 125.47 37.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.076 0.465 . . . . 74.53 112.216 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.2 pt -101.96 120.62 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.978 0.418 . . . . 72.15 111.043 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -107.32 122.31 46.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.869 0.366 . . . . 71.14 111.491 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 135' ' ' ILE . . . -119.08 138.19 25.93 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 120.732 0.301 . . . . 54.52 111.546 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 170.34 20.26 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.725 2.283 . . . . 72.51 113.396 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.53 117.59 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.161 -0.472 . . . . 43.05 112.061 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 25.1 m -79.56 63.81 4.25 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.954 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.31 -11.66 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.451 0.908 . . . . 72.0 113.451 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.45 120.67 40.91 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.034 -0.416 . . . . 73.21 111.411 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.64 139.16 31.42 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 111.733 0.272 . . . . 72.22 111.733 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.74 145.63 82.15 Favored 'Cis proline' 0 C--N 1.356 0.922 0 C-N-CA 124.116 -1.202 . . . . 74.21 113.431 0.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 p -83.86 95.53 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.991 0.737 . . . . 62.31 112.991 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.24 127.02 20.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.003 -0.544 . . . . 54.23 110.739 171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -132.59 139.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 72.54 111.712 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.47 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 18.1 p-10 -114.67 133.39 55.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.256 0.551 . . . . 64.52 110.95 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.528 HD13 ' HB2' ' A' ' 123' ' ' ALA . 25.3 pt -130.5 140.18 37.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.482 -0.327 . . . . 72.15 111.509 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.24 156.2 62.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.418 2.079 . . . . 72.51 112.439 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -145.44 116.69 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.493 -0.321 . . . . 75.02 110.158 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -103.25 96.95 7.11 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.197 0.523 . . . . 74.14 111.814 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.8 129.86 35.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.842 0.354 . . . . 74.23 110.248 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -116.11 139.45 50.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.917 0.389 . . . . 45.24 111.809 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 20.21 61.26 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.326 -0.397 . . . . 70.42 113.815 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -160.29 124.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 117.334 0.567 . . . . 73.22 112.299 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.5 m -86.45 146.69 26.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.193 -0.317 . . . . 72.02 111.602 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.92 -35.64 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.749 0.648 . . . . 74.35 112.749 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.64 -23.15 66.73 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.159 0.504 . . . . 64.03 111.481 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -109.21 8.86 26.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.062 -0.517 . . . . 75.43 111.525 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.423 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 1.1 tt -91.63 126.05 36.57 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.913 0.387 . . . . 71.12 110.894 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.19 -62.35 1.22 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.297 -0.478 . . . . 73.13 113.72 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.39 160.35 40.31 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.563 0.579 . . . . 64.34 112.563 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.92 101.48 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.644 -0.707 . . . . 51.21 110.342 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 45.2 ttp180 -98.03 116.77 30.93 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.029 -0.419 . . . . 61.35 112.055 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.568 HG21 ' SD ' ' A' ' 66' ' ' MET . 22.3 mm -85.46 130.32 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.435 -0.348 . . . . 64.4 111.191 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -158.67 179.52 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.292 -0.255 . . . . 72.34 111.585 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.43 30.92 20.17 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.763 0.653 . . . . 74.13 112.763 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.763 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.9 mm -71.79 106.43 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.365 0.602 . . . . 71.55 110.691 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 7.7 pt20 -129.71 149.39 72.83 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.711 -0.677 . . . . 73.53 111.859 -174.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 156' ' ' GLN . 9.4 Cg_exo -71.23 136.93 30.24 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.627 2.218 . . . . 74.53 112.65 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.2 153.91 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.8 0.333 . . . . 55.21 110.748 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.6 ptp -166.89 160.95 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.073 0.463 . . . . 74.01 111.971 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.75 118.15 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.333 -0.617 . . . . 75.41 109.333 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.5 tp -58.14 133.2 55.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.188 0.81 . . . . 64.13 113.188 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -118.42 -178.32 3.5 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.867 -0.606 . . . . 71.53 111.146 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -123.33 148.61 45.83 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.843 0.354 . . . . 73.13 111.574 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -147.18 134.97 21.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.489 -0.323 . . . . 74.02 111.363 -173.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -151.46 132.52 14.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.79 0.329 . . . . 71.43 111.685 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -116.83 161.64 18.97 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.821 0.343 . . . . 64.31 111.426 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -87.77 -46.72 9.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.824 0.345 . . . . 74.11 111.818 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.67 -0.681 . . . . 74.41 111.558 -179.264 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.29 0.567 . . . . 73.4 111.67 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.87 157.42 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.085 0.469 . . . . 51.11 111.502 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -138.78 119.01 13.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.162 -0.472 . . . . 44.03 110.759 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -79.3 94.62 5.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.092 0.472 . . . . 75.35 111.709 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 150.29 48.78 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.918 -0.583 . . . . 74.41 111.776 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.3 164.7 12.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.964 0.411 . . . . 71.13 111.833 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.87 136.41 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.049 0.452 . . . . 63.15 111.768 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -108.6 149.04 29.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.029 0.442 . . . . 74.13 111.63 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -108.19 104.35 13.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.099 -0.5 . . . . 75.54 110.294 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 10' ' ' MET . 3.6 mpp? -76.91 140.4 40.52 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.33 0.586 . . . . 63.4 112.195 -175.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 8.9 mmpt? -72.19 114.14 9.98 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.899 -0.591 . . . . 64.34 111.537 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -140.42 169.52 17.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.717 0.294 . . . . 72.24 111.551 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.9 p -60.23 143.0 53.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.391 -0.368 . . . . 70.35 111.291 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.33 124.19 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.147 0.499 . . . . 42.25 111.7 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 m -104.1 22.91 13.85 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.296 0.569 . . . . 73.11 110.987 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -86.55 176.99 7.53 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.942 -0.572 . . . . 52.12 112.089 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 162.21 27.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.849 0.357 . . . . 72.35 111.495 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.64 168.16 19.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.459 0.647 . . . . 74.35 112.432 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -179.2 3.88 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.946 -0.57 . . . . 74.51 111.212 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -91.74 -158.15 0.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.27 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 21' ' ' MET . 1.3 mpt? -52.46 136.79 31.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.979 0.419 . . . . 63.33 111.958 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -88.46 165.97 14.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.12 0.486 . . . . 74.4 111.778 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -76.88 -173.97 2.89 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.326 0.491 . . . . 74.34 112.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.5 tp -57.5 152.49 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.997 -0.547 . . . . 74.01 111.945 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -67.2 147.52 52.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.196 0.443 . . . . 55.44 112.196 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.316 0.487 . . . . 73.31 112.316 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 34.4 tt0 -54.99 -52.21 63.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.799 0.333 . . . . 70.12 111.522 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.0 m -56.27 -41.16 75.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.963 0.411 . . . . 51.2 111.302 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.32 -36.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 74.24 111.32 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HE3' HD13 ' A' ' 48' ' ' LEU . 52.3 tptt -66.96 -38.37 85.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.123 -0.49 . . . . 62.5 110.437 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.448 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 84.7 mt -60.22 -48.57 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.13 0.491 . . . . 63.05 110.755 174.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.6 m -56.05 -41.79 75.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.115 -0.493 . . . . 72.15 110.783 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HG3' HD11 ' A' ' 108' ' ' ILE . 34.3 tt0 -59.09 -46.37 88.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.157 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.71 -52.92 63.1 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.994 0.368 . . . . 70.42 111.994 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.69 -42.87 84.56 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.819 0.342 . . . . 75.42 111.608 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.1 -34.56 76.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.929 0.344 . . . . 60.55 111.929 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.9 mt -68.1 -37.7 81.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.929 0.395 . . . . 64.23 110.829 174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.76 -44.06 85.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.006 0.431 . . . . 53.44 110.751 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.91 81.91 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.647 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.79 -2.08 58.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.93 0.395 . . . . 74.41 111.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -78.0 150.86 33.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.075 0.464 . . . . 73.43 111.863 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 m -122.01 -31.63 3.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.821 -0.627 . . . . 74.24 110.868 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -112.19 85.47 2.16 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.194 0.521 . . . . 74.41 111.438 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 80.92 -146.25 26.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.214 -0.517 . . . . 51.24 113.833 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.502 HG13 HD13 ' A' ' 57' ' ' LEU . 33.5 m -123.74 140.6 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.472 0.545 . . . . 54.34 112.472 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 65.5 m-85 -87.04 107.63 18.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.436 -0.347 . . . . 53.44 110.895 172.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.64 128.26 44.21 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 71.32 110.499 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 72.1 mt -108.63 133.62 20.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.629 0.252 . . . . 63.52 111.471 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.41 -45.76 38.7 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.003 2.468 . . . . 72.53 113.251 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -71.38 -25.67 74.92 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.926 -0.654 . . . . 64.14 113.001 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -91.93 63.2 4.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.051 0.453 . . . . 63.13 111.429 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -64.56 75.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.409 0.623 . . . . 63.35 111.541 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -141.65 151.47 60.4 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.132 -0.486 . . . . 72.51 111.946 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.688 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 74.5 Cg_endo -73.67 128.11 12.28 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.875 2.383 . . . . 75.45 113.958 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.96 139.9 50.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.348 -0.387 . . . . 73.42 110.703 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 56' ' ' ARG . 13.0 ttp180 -89.39 133.18 34.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.063 0.458 . . . . 62.21 111.282 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.502 HD13 HG13 ' A' ' 45' ' ' VAL . 40.9 tp -132.89 129.67 38.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.132 -0.485 . . . . 62.22 111.374 -177.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.71 137.97 32.02 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.003 -0.369 . . . . 71.42 110.003 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.4 p -126.11 177.94 6.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.213 0.53 . . . . 70.34 111.287 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -78.0 0.75 23.21 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.869 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 pt -118.46 -4.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.737 0.303 . . . . 44.12 111.762 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.11 -177.94 20.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.53 -0.367 . . . . 42.04 112.993 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -88.39 132.32 34.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.207 -0.584 . . . . 73.41 111.716 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.03 -177.59 4.96 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.001 0.429 . . . . 75.12 111.706 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.688 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 66.7 ttp85 -135.41 140.77 45.2 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.477 -0.329 . . . . 74.4 111.088 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.676 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.8 mtt -129.36 152.23 49.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 61.43 111.854 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.1 p -152.38 152.65 32.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.906 0.384 . . . . 72.42 111.626 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 71.1 mt -100.81 111.06 23.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.323 -0.399 . . . . 72.14 111.349 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.639 HG21 ' HD2' ' A' ' 83' ' ' ARG . 33.7 m -128.12 159.35 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.626 0.25 . . . . 71.3 110.997 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.7 m120 51.71 69.03 0.71 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.955 0.407 . . . . 74.52 111.113 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.6 mt -100.43 102.13 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.247 -0.433 . . . . 72.42 110.732 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -121.65 144.86 41.57 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 112.672 0.619 . . . . 74.52 112.672 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.27 129.67 15.29 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.766 2.311 . . . . 73.23 112.104 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.9 t70 -110.46 164.95 12.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.159 -0.473 . . . . 54.2 111.708 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.01 76.93 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 71.11 112.489 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -96.47 -12.29 24.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.912 0.338 . . . . 71.21 111.912 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . 171.51 -102.51 0.18 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.988 -0.625 . . . . 73.32 113.48 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -147.81 130.45 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.492 -0.417 . . . . 71.21 111.775 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 39.4 p -106.78 120.41 41.93 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.831 0.348 . . . . 72.42 111.485 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -130.13 159.13 37.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.691 0.282 . . . . 65.23 110.875 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -101.92 108.21 19.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.973 0.415 . . . . 65.21 111.867 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 HD11 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -84.07 106.63 15.87 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.499 -0.556 . . . . 65.22 109.499 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' HD2' HG21 ' A' ' 69' ' ' VAL . 20.2 mtp180 -96.11 125.76 40.87 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.192 -0.318 . . . . 74.31 111.247 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.568 HD11 HD12 ' A' ' 82' ' ' LEU . 3.9 mp -115.93 103.3 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.917 0.389 . . . . 74.31 111.381 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -106.5 134.7 49.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.382 . . . . 73.34 110.722 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 142.47 32.61 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.957 -0.64 . . . . 65.01 113.324 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -62.15 -35.76 79.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.385 0.612 . . . . 62.54 110.749 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.8 m -99.82 149.83 22.97 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.794 -0.639 . . . . 60.33 110.718 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -68.71 -17.35 64.05 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.178 0.513 . . . . 74.51 111.342 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.15 136.33 58.69 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.622 -0.717 . . . . 72.41 112.052 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.75 117.01 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.456 2.104 . . . . 72.0 113.053 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -85.2 148.16 49.43 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.391 -0.368 . . . . 72.12 111.837 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.61 176.22 9.64 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.622 2.215 . . . . 64.12 113.007 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -75.14 140.46 43.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.927 0.394 . . . . 74.32 111.741 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.86 168.67 19.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.529 0.68 . . . . 72.53 112.368 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 93.8 p -146.6 145.16 29.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.522 -0.763 . . . . 55.23 110.255 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -143.49 157.12 26.88 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.556 -0.83 . . . . 72.11 113.448 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 60.9 m -99.94 104.99 16.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.981 0.42 . . . . 74.52 110.784 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 152' ' ' ILE . 20.1 m -91.06 125.3 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.007 0.432 . . . . 74.05 111.391 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.8 mt-10 -108.41 112.69 25.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.198 0.523 . . . . 70.13 110.831 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -115.97 141.28 48.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.953 -0.567 . . . . 74.42 111.641 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.27 -146.48 4.85 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.283 -0.484 . . . . 64.32 112.81 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.698 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 mt-30 -128.22 144.17 51.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.254 0.464 . . . . 70.34 112.254 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.2 mt -114.14 103.89 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.409 -0.359 . . . . 55.01 110.78 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -92.83 15.03 15.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.043 0.386 . . . . 72.45 112.043 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -123.29 -170.26 13.4 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.884 -0.674 . . . . 72.35 113.872 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 49.9 p -102.63 -178.1 3.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.804 0.441 . . . . 62.34 111.644 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.493 HD11 ' HG3' ' A' ' 33' ' ' GLN . 46.7 mm -63.42 -30.83 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.461 0.648 . . . . 70.21 110.668 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.82 -56.13 5.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.685 -0.689 . . . . 75.21 110.848 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.31 98.26 4.83 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.196 0.522 . . . . 72.15 111.567 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.543 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 32.2 p90 -113.8 132.37 55.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.082 0.468 . . . . 71.34 111.537 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -107.32 115.94 31.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.219 -0.446 . . . . 62.25 111.492 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.8 97.46 3.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.888 0.375 . . . . 63.55 110.615 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.407 HG13 ' HB2' ' A' ' 103' ' ' GLN . 36.3 pt -108.73 156.81 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.491 -0.322 . . . . 75.23 111.288 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 56.86 36.32 27.56 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.119 0.485 . . . . 73.22 111.546 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.31 116.37 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.96 0.726 . . . . 72.11 112.96 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.89 156.88 37.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.711 -0.677 . . . . 71.13 110.972 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.506 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.3 p-10 -102.42 166.9 10.29 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.361 0.875 . . . . 73.51 113.361 -172.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -152.9 152.83 31.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.413 -0.812 . . . . 74.22 110.087 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.39 133.46 35.86 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.019 0.438 . . . . 73.35 112.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.9 HG22 HD21 ' A' ' 137' ' ' LEU . 39.4 pt -109.98 106.21 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.199 0.523 . . . . 74.43 110.758 173.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.82 101.72 12.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.903 0.382 . . . . 73.2 111.031 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 140.87 21.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.073 0.398 . . . . 64.54 112.073 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.68 168.58 22.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.819 2.346 . . . . 75.25 113.216 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -82.94 139.57 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.288 -0.415 . . . . 64.02 111.856 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.8 m -78.01 93.07 4.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 75.03 110.655 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.94 -36.92 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.264 0.554 . . . . 53.14 111.034 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.15 145.11 39.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.925 -0.58 . . . . 63.45 111.148 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.73 45.54 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.483 -0.326 . . . . 63.24 110.963 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -82.33 170.85 56.71 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.007 -1.247 . . . . 73.23 113.872 1.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -79.82 74.12 6.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.324 -0.398 . . . . 75.21 112.035 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.4 103.11 12.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.262 -0.426 . . . . 65.31 111.289 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.7 t -122.38 108.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.234 0.214 . . . . 71.23 111.429 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -117.87 128.28 54.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.028 0.442 . . . . 54.04 111.701 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 pt -126.12 144.33 48.58 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.185 -0.461 . . . . 53.54 112.145 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.74 158.39 46.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.884 2.389 . . . . 72.54 112.852 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.9 HD21 HG22 ' A' ' 121' ' ' ILE . 31.7 mt -139.72 103.97 4.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.459 0.54 . . . . 75.53 112.459 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -82.78 95.11 7.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.342 0.591 . . . . 65.24 110.557 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.495 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 40.9 mt -80.19 114.79 19.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 60.41 109.803 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -95.58 134.5 38.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.006 0.431 . . . . 74.34 112.056 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.68 15.47 58.15 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.253 -0.499 . . . . 43.41 113.696 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -152.54 134.93 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 117.229 0.514 . . . . 70.13 111.528 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -94.83 156.23 16.45 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.915 0.388 . . . . 71.43 111.847 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.98 -43.76 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.874 0.694 . . . . 63.34 112.874 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.02 -13.53 62.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 63.54 111.042 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.432 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.6 mm-40 -106.18 5.82 30.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.5 . . . . 75.55 111.979 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.455 HD23 HD13 ' A' ' 142' ' ' ILE . 40.2 mt -80.14 109.6 14.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.251 0.548 . . . . 74.43 111.485 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.698 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -87.65 -45.24 5.26 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.847 -0.615 . . . . 70.31 112.904 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -156.13 151.99 27.4 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.167 0.508 . . . . 70.22 111.748 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.38 93.23 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.881 -0.599 . . . . 71.31 109.745 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 18.5 ttp85 -88.27 109.1 19.68 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.274 0.559 . . . . 75.43 112.249 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.676 HG21 ' SD ' ' A' ' 66' ' ' MET . 13.4 mm -90.51 129.69 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.748 -0.66 . . . . 72.11 111.083 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.559 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 14.8 p80 -167.25 -178.13 3.96 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.237 0.458 . . . . 61.32 112.237 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 98' ' ' THR . 8.8 t70 66.32 31.59 8.31 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.53 -0.759 . . . . 65.14 111.174 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.478 HD13 ' HA3' ' A' ' 97' ' ' GLY . 43.0 mm -68.04 94.02 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.87 -0.604 . . . . 60.14 111.154 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -112.83 145.07 32.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.813 -0.631 . . . . 73.11 111.702 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.44 140.8 37.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.487 2.125 . . . . 42.01 112.962 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.4 m -94.28 26.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.554 0.692 . . . . 61.43 111.111 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 79.0 mtp -125.82 -172.75 2.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.842 -0.617 . . . . 65.14 110.658 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -76.18 125.94 30.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.685 0.279 . . . . 53.25 111.246 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.668 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.4 pt? -127.03 143.2 51.35 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.906 0.384 . . . . 65.25 111.26 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.32 166.44 10.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.264 0.555 . . . . 74.41 112.137 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -165.56 94.65 0.61 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.671 -0.695 . . . . 74.2 110.08 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -72.62 137.76 46.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.946 0.403 . . . . 71.22 111.817 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -79.84 121.8 25.85 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.865 0.364 . . . . 73.42 111.883 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -94.98 81.12 3.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.258 0.551 . . . . 73.14 110.369 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -78.5 -18.39 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.227 -0.442 . . . . 74.43 111.725 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.2 t60 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.779 -0.629 . . . . 71.12 111.636 -178.715 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.542 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.91 0.386 . . . . 52.32 111.051 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.15 150.2 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.264 0.554 . . . . 73.11 112.138 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -106.17 137.2 44.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.968 -0.56 . . . . 72.22 111.248 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -104.55 174.05 6.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.074 0.464 . . . . 64.13 112.141 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.8 p -58.72 143.5 46.66 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.968 0.729 . . . . 60.32 112.968 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -95.31 98.04 10.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.0 -0.546 . . . . 75.13 111.377 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.21 142.08 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.926 0.393 . . . . 64.34 111.771 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.531 HH11 ' HA ' ' A' ' 10' ' ' MET . 3.5 tmt_? -141.81 112.33 7.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.398 . . . . 72.41 110.426 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.98 117.55 10.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.667 0.27 . . . . 74.53 110.808 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.531 ' HA ' HH11 ' A' ' 8' ' ' ARG . 52.6 ttm -94.19 144.1 25.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 70.3 111.834 -176.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -149.24 118.21 6.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.192 -0.458 . . . . 74.4 110.768 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -114.97 161.1 18.76 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.169 0.509 . . . . 64.41 112.167 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -103.23 -172.46 2.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.018 -0.537 . . . . 64.13 111.096 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.1 p -147.6 138.95 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.363 -0.38 . . . . 73.32 111.087 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.4 m -128.96 140.75 51.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.843 0.354 . . . . 74.22 111.538 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -101.53 168.39 9.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.856 0.36 . . . . 73.31 111.735 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -91.72 149.64 21.52 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.976 0.417 . . . . 73.24 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -98.18 129.06 44.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.854 0.359 . . . . 71.31 111.668 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -94.06 163.64 13.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.978 0.418 . . . . 55.34 111.348 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.63 149.24 44.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.064 0.459 . . . . 75.05 111.465 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.3 mmt -117.7 159.93 22.16 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.287 -0.415 . . . . 74.31 110.257 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.1 p -60.27 144.31 50.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.622 0.248 . . . . 72.54 111.069 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -51.24 106.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.203 0.525 . . . . 75.41 111.543 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.8 tp -86.09 165.0 16.97 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.94 -0.573 . . . . 73.3 111.717 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 29' ' ' VAL . 1.4 m-20 -49.76 130.66 21.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.196 -0.456 . . . . 62.43 111.506 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -53.52 -41.06 65.97 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.427 0.529 . . . . 65.2 112.427 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.8 pt-20 -58.4 -49.36 77.53 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.115 0.483 . . . . 62.42 110.726 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.464 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 7.1 m -69.01 -26.02 64.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.063 -0.517 . . . . 73.15 111.612 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 25' ' ' ASN . 98.2 t -63.15 -47.9 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.005 0.431 . . . . 72.31 110.56 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.87 -39.07 92.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.359 -0.382 . . . . 75.33 111.004 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 27' ' ' GLU . 84.4 mt -58.97 -46.43 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.994 0.426 . . . . 61.41 110.832 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -56.29 -49.54 73.98 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.246 0.546 . . . . 70.14 110.611 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.791 ' HG3' HD11 ' A' ' 108' ' ' ILE . 60.2 tt0 -54.89 -43.75 73.5 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.724 -0.671 . . . . 74.33 111.228 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 30.3 tt0 -60.53 -51.81 67.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.111 -0.495 . . . . 55.01 111.868 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -57.46 -40.4 78.45 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.19 0.441 . . . . 55.15 112.19 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -65.01 -47.67 76.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.696 0.284 . . . . 71.43 111.643 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.44 -39.35 91.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.312 0.577 . . . . 70.31 110.757 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 1.7 t30 -60.23 -38.22 82.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.583 -0.735 . . . . 53.5 111.072 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.54 -25.83 35.55 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.301 0.482 . . . . 72.1 112.301 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 55.9 mttm -69.3 -30.9 69.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.803 0.297 . . . . 74.44 111.803 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB2' ' HE1' ' A' ' 46' ' ' TYR . 48.2 t -71.4 130.19 40.71 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.358 0.503 . . . . 61.24 112.358 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.7 m -83.11 -13.86 54.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.068 -0.515 . . . . 73.32 111.686 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -160.78 102.9 1.33 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.863 0.363 . . . . 71.42 111.394 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 152' ' ' ILE . . . 116.07 137.61 6.16 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.17 -0.538 . . . . 52.33 112.896 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -89.49 138.3 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.383 0.512 . . . . 55.21 112.383 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HE1' ' HB2' ' A' ' 41' ' ' SER . 30.2 m-85 -90.01 114.11 25.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.835 -0.62 . . . . 72.43 110.783 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -108.58 133.48 52.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.493 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 74.3 mt -110.4 126.97 27.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.762 -0.199 . . . . 71.35 111.071 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -33.41 68.65 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.539 2.159 . . . . 55.45 112.727 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.29 -36.37 50.53 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.235 -0.439 . . . . 61.14 112.883 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -92.43 71.88 5.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.154 0.502 . . . . 62.43 111.187 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -66.84 77.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.159 0.504 . . . . 71.24 111.429 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -144.02 151.37 52.19 Favored Pre-proline 0 N--CA 1.47 0.546 0 CA-C-N 116.215 -0.448 . . . . 52.05 111.812 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 66' ' ' MET . 59.7 Cg_endo -70.38 152.05 65.88 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.881 2.387 . . . . 74.43 113.406 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -135.66 140.72 44.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.323 -0.399 . . . . 53.54 111.385 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HD3' HH11 ' A' ' 56' ' ' ARG . 17.1 ttm180 -83.83 132.22 34.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.83 0.347 . . . . 72.22 111.822 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.47 HD23 HD21 ' A' ' 64' ' ' LEU . 53.6 tp -130.29 129.9 43.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.8 0.44 . . . . 71.52 111.359 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.26 115.87 30.14 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.296 -0.631 . . . . 73.22 109.296 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 79.7 p -137.27 -178.9 5.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.735 0.779 . . . . 71.31 112.903 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -66.29 -20.12 66.01 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.196 -0.911 . . . . 62.43 112.563 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 95' ' ' PHE . 36.6 pt -90.68 -18.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.851 0.357 . . . . 72.44 111.247 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.43 -164.71 25.1 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.141 -0.482 . . . . 44.04 112.433 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.6 m -95.01 107.3 19.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.231 0.539 . . . . 62.04 111.34 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.817 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.6 -176.47 2.91 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.212 0.53 . . . . 75.41 111.74 -178.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 31.3 ttp180 -150.94 107.51 3.5 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.941 0.4 . . . . 72.13 110.888 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.866 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.7 mtt -104.11 161.29 14.14 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.732 0.642 . . . . 51.14 112.732 -173.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 t -153.52 158.89 41.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.101 -0.5 . . . . 52.33 111.793 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 71' ' ' ILE . 96.2 mt -106.27 110.19 22.36 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.418 -0.356 . . . . 74.14 111.71 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' HB ' ' A' ' 81' ' ' THR . 20.4 m -130.04 165.9 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.702 0.287 . . . . 71.41 111.753 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.22 29.29 18.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.988 0.515 . . . . 73.23 112.323 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' A' ' 68' ' ' LEU . 35.2 mt -68.09 107.35 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.901 0.382 . . . . 63.32 111.464 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.63 153.07 78.76 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.185 0.439 . . . . 65.14 112.185 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.28 150.34 81.37 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.824 2.35 . . . . 53.44 113.268 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -140.9 167.46 22.14 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.141 -0.482 . . . . 54.03 111.546 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.47 72.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.961 0.41 . . . . 62.15 111.911 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 6.6 m-20 -76.01 -26.77 57.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.801 0.334 . . . . 72.44 110.994 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.34 -93.32 0.1 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-N 116.022 -0.535 . . . . 63.41 112.97 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -147.84 126.5 12.54 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.549 -0.383 . . . . 73.43 111.466 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -104.77 129.89 52.94 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.705 0.288 . . . . 54.12 111.658 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 pp -141.1 152.65 44.94 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.976 0.417 . . . . 73.41 111.501 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.454 ' HB ' HG23 ' A' ' 69' ' ' VAL . 60.1 m -89.87 109.04 20.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.965 0.412 . . . . 52.3 111.113 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.423 HD12 HD11 ' A' ' 84' ' ' ILE . 2.6 tm? -86.5 109.37 19.04 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.716 -0.475 . . . . 65.14 109.716 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -99.24 130.32 45.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.811 0.339 . . . . 71.53 111.207 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.1 mp -111.62 102.85 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 73.35 111.294 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 72.43 110.695 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.74 153.43 17.54 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.006 -0.616 . . . . 70.52 112.172 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -45.33 91.56 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.349 0.575 . . . . 73.51 110.736 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -85.15 176.39 8.4 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.093 -0.503 . . . . 61.13 111.655 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -89.26 -37.11 15.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.403 -0.362 . . . . 62.11 111.67 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.93 145.71 99.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.666 0.27 . . . . 73.54 111.5 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.75 145.94 82.4 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.236 2.624 . . . . 71.23 114.99 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.42 152.92 44.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.661 -0.7 . . . . 74.24 111.393 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.23 -171.55 1.19 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.678 2.252 . . . . 73.15 113.104 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 157' ' ' PRO . . . -74.62 151.33 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.749 0.309 . . . . 33.55 111.469 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' HB3' HG21 ' A' ' 61' ' ' ILE . 36.4 p90 -154.69 149.63 26.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.599 0.714 . . . . 72.43 112.669 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 91.1 p -130.55 136.75 49.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.287 -0.869 . . . . 52.02 109.8 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.705 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -145.36 175.54 24.87 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.332 -0.937 . . . . 63.33 113.598 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.9 m -111.13 122.19 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.01 111.547 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.429 HG12 HD12 ' A' ' 152' ' ' ILE . 20.7 m -104.11 133.74 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.187 -0.461 . . . . 43.1 111.131 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 41.3 mt-10 -122.76 126.23 47.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.958 0.409 . . . . 75.34 111.024 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -134.18 133.13 40.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.803 0.335 . . . . 75.05 111.741 -171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.31 -157.43 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.242 -0.504 . . . . 72.02 113.28 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.582 ' HB2' HG13 ' A' ' 114' ' ' ILE . 87.5 mt-30 -117.39 151.43 37.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.068 0.461 . . . . 74.23 112.049 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 106' ' ' GLY . 60.7 mt -109.28 122.46 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.192 -0.458 . . . . 72.32 111.266 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -106.88 23.64 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.837 0.31 . . . . 75.45 111.837 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -146.09 -170.43 14.75 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.006 -0.616 . . . . 35.13 113.678 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 44.7 p -97.31 -173.55 2.69 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.935 0.398 . . . . 73.15 111.522 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.791 HD11 ' HG3' ' A' ' 33' ' ' GLN . 31.8 mm -67.9 -36.45 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.037 0.446 . . . . 72.1 111.397 174.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.05 -37.66 58.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.182 -0.463 . . . . 72.34 111.312 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -144.93 111.87 5.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.18 -0.464 . . . . 61.23 111.44 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.1 p90 -139.1 145.81 39.93 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.451 0.643 . . . . 73.3 112.365 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -117.01 144.73 44.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.59 -0.732 . . . . 62.31 110.495 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.19 119.57 37.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.04 0.448 . . . . 72.33 111.489 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 103' ' ' GLN . 33.6 pt -123.07 149.52 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.53 -0.305 . . . . 74.33 111.429 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.89 39.28 31.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.362 0.601 . . . . 73.2 111.445 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.05 127.19 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 55.33 112.203 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.27 167.78 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.977 -0.556 . . . . 71.4 111.058 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.7 p-10 -112.94 178.48 4.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.056 0.762 . . . . 43.11 113.056 -172.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -167.75 159.78 12.05 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.482 -0.781 . . . . 74.35 110.251 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.05 133.92 44.84 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 122.01 -0.431 . . . . 54.13 112.033 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.43 ' O ' HG13 ' A' ' 121' ' ' ILE . 28.4 pt -111.79 106.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.208 0.527 . . . . 74.01 111.165 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.51 100.84 10.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.259 -0.428 . . . . 75.15 110.635 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.72 152.48 37.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.926 0.393 . . . . 75.22 112.047 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.51 174.43 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.801 2.334 . . . . 55.45 113.0 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.83 156.82 20.4 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.218 0.532 . . . . 73.25 112.023 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.9 m -100.95 118.27 36.64 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.094 -0.503 . . . . 74.52 109.983 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.3 -51.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.851 0.358 . . . . 73.43 111.664 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -119.95 164.42 16.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.014 0.435 . . . . 50.43 111.338 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.29 91.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 116.33 -0.395 . . . . 73.1 111.973 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -91.74 166.75 26.92 Favored 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.193 -1.17 . . . . 74.21 113.344 -1.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 55.1 m -66.93 95.46 0.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.928 0.394 . . . . 74.33 111.852 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -148.47 112.71 5.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.899 -0.591 . . . . 73.44 109.946 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.86 110.15 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.648 0.261 . . . . 75.43 111.323 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.11 118.75 35.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 73.5 111.222 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.3 pt -126.41 133.1 24.63 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 120.902 0.382 . . . . 71.54 111.898 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.92 118.3 5.5 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.254 1.969 . . . . 54.33 112.144 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.35 123.54 50.51 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.064 -0.516 . . . . 62.53 110.89 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -105.39 106.59 17.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.035 0.445 . . . . 72.43 111.625 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 mt -83.17 124.21 30.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.483 -0.326 . . . . 41.41 110.535 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 35.3 mtmm -105.87 128.63 53.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.32 111.928 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.9 7.09 57.76 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.258 -0.428 . . . . 60.34 113.811 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.2 tt -145.08 137.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.173 -0.604 . . . . 74.41 111.774 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.9 m -98.3 148.99 23.08 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.459 -0.337 . . . . 73.12 111.744 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.27 -49.54 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.941 0.719 . . . . 64.14 112.941 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.79 -26.94 68.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.017 0.437 . . . . 64.44 111.803 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -100.31 14.57 30.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.273 -0.421 . . . . 64.45 111.772 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.83 121.63 34.39 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 50.33 110.708 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.22 -61.75 0.97 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.162 -0.542 . . . . 52.43 113.646 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.479 ' HE2' ' HD3' ' A' ' 151' ' ' ARG . 49.4 p90 -136.06 155.49 50.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.024 0.44 . . . . 75.44 112.096 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.32 138.4 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.888 -0.596 . . . . 64.22 110.575 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.67 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 21.3 mtp180 -123.55 113.07 18.22 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.962 0.505 . . . . 72.23 111.72 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.866 HG21 ' SD ' ' A' ' 66' ' ' MET . 9.7 mm -106.25 115.16 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 122.413 -0.179 . . . . 74.31 111.221 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -151.17 179.44 8.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.266 0.469 . . . . 74.41 112.266 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 63.12 24.98 14.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.221 0.608 . . . . 63.14 112.589 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.705 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.7 mm -63.05 105.72 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.174 0.512 . . . . 75.53 110.879 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -125.1 143.76 45.18 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.979 -0.555 . . . . 74.33 111.447 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -67.51 107.94 1.52 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.538 2.159 . . . . 74.41 113.42 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.03 111.45 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.202 0.525 . . . . 72.01 110.953 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.8 mtm -130.78 167.53 18.72 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.132 -0.355 . . . . 74.53 111.877 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -55.6 112.72 1.21 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.139 0.495 . . . . 73.13 112.099 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.76 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.0 pt? -77.2 97.01 4.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.614 0.721 . . . . 71.41 111.486 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -87.8 -66.59 0.9 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.948 -0.569 . . . . 75.13 111.752 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -130.48 137.47 49.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.419 -0.355 . . . . 70.25 111.404 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -79.15 63.48 3.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.652 0.739 . . . . 72.21 110.1 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -81.54 92.49 6.52 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.482 -0.781 . . . . 64.53 111.039 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -115.32 106.52 14.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.257 0.465 . . . . 70.44 112.257 -175.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.4 t60 74.2 -30.08 0.2 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.773 1.027 . . . . 71.01 113.773 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.898 -0.572 . . . . 61.45 111.528 -179.658 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.538 0.209 . . . . 64.15 110.798 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.9 174.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.033 0.444 . . . . 43.31 111.811 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -147.89 104.47 3.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.091 0.472 . . . . 74.32 111.162 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -105.54 100.56 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.907 0.384 . . . . 74.45 111.294 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 m -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.795 0.331 . . . . 73.23 110.637 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.09 137.79 41.42 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.869 0.366 . . . . 75.31 111.832 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -138.07 140.72 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.713 0.405 . . . . 74.42 110.466 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.585 ' H ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -117.95 141.2 48.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.947 0.403 . . . . 63.44 111.289 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -101.99 121.9 43.04 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.276 -0.42 . . . . 72.12 111.764 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.8 mmm -99.62 112.49 24.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.551 -0.295 . . . . 71.3 110.956 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -157.87 124.34 4.84 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.767 0.655 . . . . 75.04 112.767 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -166.15 98.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.599 -0.728 . . . . 75.23 110.514 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -116.26 118.66 33.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.214 0.53 . . . . 71.15 111.774 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.76 132.22 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.028 0.442 . . . . 61.4 110.743 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.1 p -131.35 101.72 5.66 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.384 0.611 . . . . 70.34 111.559 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -97.4 110.8 23.28 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.173 -0.467 . . . . 51.33 111.179 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.1 mm? -76.83 113.5 14.57 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.991 0.424 . . . . 72.42 110.981 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -80.29 142.01 34.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.229 0.537 . . . . 72.5 112.093 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 20' ' ' GLU . 26.2 mp0 -88.43 -154.34 0.28 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.902 -0.59 . . . . 74.42 111.278 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 19' ' ' GLN . 13.8 pt-20 -78.79 148.39 32.95 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.784 0.326 . . . . 63.23 111.855 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -129.7 174.65 9.5 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.109 0.481 . . . . 73.2 111.643 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.5 p -84.89 157.9 20.74 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.032 -0.531 . . . . 74.31 111.57 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.87 86.55 4.1 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.494 0.664 . . . . 70.53 112.127 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' O ' ' HB ' ' A' ' 28' ' ' THR . 55.1 tp -113.5 131.66 55.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.252 -0.431 . . . . 64.51 110.984 174.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 52.14 109.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.763 -0.653 . . . . 73.51 112.548 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -50.23 -29.46 9.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.968 0.414 . . . . 63.51 111.451 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.1 tt0 -58.88 -58.6 7.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.013 0.435 . . . . 70.35 110.733 171.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.483 ' HA ' HD12 ' A' ' 31' ' ' ILE . 89.1 m -59.58 -33.3 71.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.243 -0.435 . . . . 72.11 111.393 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.98 -45.87 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.952 0.406 . . . . 72.11 110.873 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.367 -0.379 . . . . 75.04 111.343 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 28' ' ' THR . 85.5 mt -62.09 -48.58 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.164 0.507 . . . . 74.44 110.786 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.5 m -58.5 -42.33 87.39 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.151 0.501 . . . . 72.25 110.658 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.654 HE21 HD11 ' A' ' 108' ' ' ILE . 30.8 tt0 -56.38 -50.19 72.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.615 -0.72 . . . . 64.15 111.061 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.2 -48.83 75.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.036 -0.529 . . . . 73.24 111.927 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -61.41 -46.9 88.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.891 0.33 . . . . 65.21 111.891 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.2 -36.49 84.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.005 0.372 . . . . 74.05 112.005 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.48 -38.28 89.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.07 0.462 . . . . 65.31 110.4 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.51 -33.27 75.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.925 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.46 98.87 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.927 0.394 . . . . 51.53 111.625 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HD2' ' HE1' ' A' ' 111' ' ' PHE . 61.5 mttp -74.89 -25.86 59.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.999 0.428 . . . . 54.51 111.183 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 47.8 t -69.54 125.81 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.95 0.405 . . . . 63.43 111.915 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 92.9 p -117.98 9.35 12.76 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.499 -0.319 . . . . 51.32 111.353 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 m -135.73 32.33 3.01 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.593 0.59 . . . . 65.42 112.593 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.65 -164.9 25.14 Favored Glycine 0 N--CA 1.463 0.467 0 C-N-CA 120.859 -0.686 . . . . 53.35 113.314 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 57' ' ' LEU . 27.6 m -115.69 136.33 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.085 0.469 . . . . 64.21 112.135 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 41' ' ' SER . 55.0 m-85 -89.69 103.82 16.44 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.313 -0.403 . . . . 71.14 111.242 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.12 102.14 14.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.91 0.386 . . . . 73.55 110.789 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.7 119.1 73.86 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.605 -0.27 . . . . 74.25 110.924 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -58.24 -18.97 40.04 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.263 1.975 . . . . 75.11 112.961 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.62 64.67 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.433 -0.413 . . . . 65.53 113.167 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.96 89.37 2.97 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.118 0.485 . . . . 51.11 111.117 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.39 83.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.174 0.511 . . . . 73.12 110.689 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -158.59 153.35 20.99 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 115.895 -0.593 . . . . 73.5 111.903 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.12 146.13 6.42 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.054 2.503 . . . . 73.32 112.942 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.21 136.08 53.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.796 0.332 . . . . 72.22 111.479 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 56' ' ' ARG . 14.1 ttp180 -86.75 127.21 34.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.898 0.38 . . . . 72.33 111.367 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 45' ' ' VAL . 53.5 tp -120.95 118.34 29.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.016 0.436 . . . . 62.45 111.225 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.9 100.13 12.65 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.186 0.517 . . . . 63.23 110.437 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.46 ' OG ' HG12 ' A' ' 61' ' ' ILE . 73.8 p -99.22 -167.96 1.55 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.306 0.574 . . . . 72.14 112.51 -171.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -76.0 -25.92 56.21 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.638 . . . . 74.04 111.718 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' ' 157' ' ' PRO . 33.9 pt -84.96 -24.8 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.158 0.504 . . . . 73.03 111.101 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -164.35 28.65 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.811 -0.632 . . . . 73.13 112.336 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -91.8 124.81 36.21 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.556 -0.379 . . . . 73.34 111.953 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.552 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -135.51 175.5 9.53 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.973 0.416 . . . . 71.42 111.69 176.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -131.54 119.18 21.16 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.477 -0.328 . . . . 72.24 111.298 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.581 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.3 mtt -112.16 154.99 24.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 73.54 112.315 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -160.89 169.77 21.98 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.152 -0.476 . . . . 74.33 111.234 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 80' ' ' LEU . 94.4 mt -114.66 124.32 51.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.243 0.46 . . . . 74.24 112.243 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.698 HG23 ' HB ' ' A' ' 81' ' ' THR . 29.1 m -133.04 164.53 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.413 -0.358 . . . . 72.31 111.096 174.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 62.61 28.32 16.59 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.54 0.57 . . . . 71.32 112.54 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 mt -67.94 104.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 74.12 111.416 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 p -139.1 152.69 70.43 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 112.299 0.481 . . . . 63.43 112.299 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.52 159.89 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.328 2.685 . . . . 74.22 113.873 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.558 ' HB2' HG23 ' A' ' 79' ' ' THR . 14.0 t70 -150.11 160.33 43.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.931 -0.577 . . . . 72.05 111.141 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.07 90.08 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.089 0.403 . . . . 75.23 112.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -82.49 -31.0 29.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.767 0.317 . . . . 71.13 111.552 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -174.65 -97.67 0.11 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.697 -0.763 . . . . 52.25 113.649 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.2 m -144.84 125.87 14.53 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.929 0.395 . . . . 54.12 111.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 74' ' ' ASP . 46.6 p -96.55 137.17 36.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.908 0.385 . . . . 71.1 111.825 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.423 HD13 HD22 ' A' ' 68' ' ' LEU . 3.3 pp -144.96 155.4 43.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 74.04 111.1 174.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.698 ' HB ' HG23 ' A' ' 69' ' ' VAL . 26.5 m -95.55 111.88 23.71 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.977 0.418 . . . . 60.1 111.117 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.93 109.86 18.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.547 -0.538 . . . . 72.21 109.547 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtt-85 -97.18 127.58 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.819 0.342 . . . . 73.22 111.849 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.6 mp -113.83 98.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 63.02 111.529 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.91 -178.54 6.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.952 -0.388 . . . . 73.02 109.952 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.19 135.3 5.95 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.19 -1.005 . . . . 71.31 113.973 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -59.05 -23.82 62.34 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.884 0.373 . . . . 70.02 111.559 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 88.9 p -83.47 136.26 34.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.299 0.571 . . . . 61.52 111.614 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -68.99 -37.73 78.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.524 0.678 . . . . 70.54 109.53 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.1 147.72 93.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.119 -0.946 . . . . 75.31 111.108 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 55.5 Cg_endo -67.85 162.71 38.45 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.423 2.082 . . . . 73.44 113.477 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.96 145.79 38.75 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.951 -0.568 . . . . 63.41 111.154 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.36 179.91 4.63 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.671 2.248 . . . . 54.45 112.99 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -73.09 153.89 40.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.128 0.49 . . . . 73.51 111.619 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.25 164.97 37.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.194 0.521 . . . . 71.51 111.632 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.8 m -150.88 156.07 40.47 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.16 -0.473 . . . . 23.42 110.372 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -165.25 178.9 40.04 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.271 -0.966 . . . . 74.34 113.893 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 61.3 m -104.38 135.36 45.97 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.895 0.379 . . . . 63.33 111.08 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 26.7 m -110.47 134.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 52.31 111.592 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.788 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.9 mm-40 -103.74 120.08 40.21 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.956 -0.565 . . . . 53.11 110.151 177.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.438 ' CG ' HD22 ' A' ' 139' ' ' LEU . 10.2 p90 -133.7 130.22 37.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.265 0.555 . . . . 74.03 112.149 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.41 -156.38 12.41 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.519 -0.764 . . . . 72.12 112.635 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HB2' HG13 ' A' ' 114' ' ' ILE . 10.0 mt-30 -111.02 151.3 28.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.775 0.321 . . . . 74.22 111.505 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -114.59 106.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 60.11 110.824 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -94.39 -6.74 43.48 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.832 0.679 . . . . 71.14 112.832 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -102.26 -170.04 27.03 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.949 -0.643 . . . . 75.24 113.499 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.3 p -96.31 173.26 7.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.84 0.352 . . . . 71.34 111.014 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.654 HD11 HE21 ' A' ' 33' ' ' GLN . 30.9 mm -63.79 -25.94 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.127 0.489 . . . . 74.21 111.023 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.56 -41.63 19.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.777 -0.647 . . . . 74.55 110.518 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -139.45 97.94 3.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.177 0.513 . . . . 71.24 111.53 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.683 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.0 p90 -115.99 151.07 36.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.558 0.577 . . . . 63.22 112.558 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -127.51 120.53 28.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.753 -0.658 . . . . 73.14 110.46 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.31 104.53 8.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.827 0.346 . . . . 64.12 110.8 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.487 HG13 ' HB2' ' A' ' 103' ' ' GLN . 44.6 pt -105.26 153.21 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.64 -0.254 . . . . 74.01 111.631 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.4 m120 57.32 28.29 15.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.213 0.53 . . . . 70.14 111.045 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.9 137.13 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.926 -0.579 . . . . 52.12 111.942 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.11 171.09 14.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 72.13 110.746 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 3.1 p-10 -108.5 169.96 8.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.335 0.588 . . . . 54.34 112.44 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -163.54 149.39 11.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.683 -0.69 . . . . 52.35 110.966 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -93.03 126.62 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.005 0.372 . . . . 64.04 112.005 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.9 pt -111.6 140.03 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.714 0.293 . . . . 64.13 111.427 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -124.91 131.11 53.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.596 0.236 . . . . 64.4 111.01 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -124.69 135.35 26.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 111.808 0.299 . . . . 71.52 111.808 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 15.0 Cg_exo -69.32 167.84 22.71 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.999 2.466 . . . . 65.42 113.272 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.15 130.56 34.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.15 0.426 . . . . 62.04 112.15 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 74.2 m -79.5 100.88 7.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.908 0.385 . . . . 75.0 110.717 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.67 HG13 ' HG ' ' A' ' 128' ' ' LEU . 8.5 p -71.96 -26.47 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.299 0.481 . . . . 55.33 112.299 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.67 ' HG ' HG13 ' A' ' 127' ' ' VAL . 98.4 mt -119.7 165.17 14.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.06 0.457 . . . . 72.34 112.139 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.595 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -106.28 153.64 40.25 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.042 -0.526 . . . . 72.31 111.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.75 175.15 37.27 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.241 -1.149 . . . . 70.4 113.686 0.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.7 m -75.31 97.08 3.49 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.639 0.607 . . . . 52.21 112.639 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.36 122.94 22.13 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.908 -0.587 . . . . 61.23 110.182 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 134' ' ' ASP . 26.4 t -133.96 159.61 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.395 0.278 . . . . 33.4 111.323 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.442 ' N ' HG12 ' A' ' 133' ' ' VAL . 2.7 p30 -147.14 143.11 28.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.818 0.342 . . . . 62.12 110.94 170.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 pt -140.26 147.94 52.13 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 53.11 111.729 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.7 144.24 21.96 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.704 2.269 . . . . 72.52 112.676 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.61 108.87 6.44 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.182 -0.324 . . . . 72.52 110.859 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -95.14 97.82 10.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.131 0.491 . . . . 73.23 111.625 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.438 HD22 ' CG ' ' A' ' 101' ' ' TYR . 55.4 mt -74.13 128.75 36.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.327 -0.397 . . . . 50.32 110.739 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.06 141.97 35.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.202 0.445 . . . . 62.35 112.202 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.87 34.79 88.26 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.066 -0.515 . . . . 42.25 113.878 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.96 125.96 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.07 0.462 . . . . 74.52 111.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.1 m -88.59 155.04 19.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.897 0.379 . . . . 51.42 111.358 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.49 -39.27 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.08 0.77 . . . . 65.42 113.08 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.81 -27.64 66.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.076 0.465 . . . . 54.15 111.258 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 103' ' ' GLN . 29.0 mm-40 -81.74 -4.14 55.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.273 -0.421 . . . . 71.35 111.752 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.632 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 28.5 mt -71.75 121.56 19.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.088 0.47 . . . . 75.13 112.265 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.98 -47.81 1.22 Allowed Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.098 -0.501 . . . . 62.53 112.632 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -150.97 161.69 42.25 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.75 0.31 . . . . 73.33 111.442 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.46 93.76 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.36 0.6 . . . . 62.23 110.462 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.788 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 47.2 ttp180 -86.99 107.41 18.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.952 0.406 . . . . 73.13 112.007 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.581 HG21 ' SD ' ' A' ' 66' ' ' MET . 23.3 mm -85.93 135.0 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.535 -0.302 . . . . 72.43 111.432 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.36 179.25 8.44 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.07 0.396 . . . . 74.35 112.07 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 98' ' ' THR . 75.5 m-20 64.97 22.5 12.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.193 0.597 . . . . 72.03 112.425 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.481 HD13 ' HA3' ' A' ' 97' ' ' GLY . 51.5 mm -64.53 97.33 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.42 0.629 . . . . 72.04 111.454 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -114.8 150.67 44.46 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.586 -0.734 . . . . 75.31 111.139 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.463 ' HB3' HG22 ' A' ' 61' ' ' ILE . 61.1 Cg_endo -72.69 148.32 46.75 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.324 2.016 . . . . 60.21 113.806 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 3.4 p -133.8 127.29 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.841 -0.618 . . . . 53.54 110.27 174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -152.83 -168.52 3.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.105 0.479 . . . . 73.5 112.268 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.402 ' CD ' ' H ' ' A' ' 160' ' ' GLN . 5.0 pm0 -68.58 156.41 38.13 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.151 -0.477 . . . . 73.3 111.41 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.63 115.6 15.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.478 -0.328 . . . . 73.02 111.872 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.54 138.19 53.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.151 0.501 . . . . 65.12 111.567 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -93.07 139.12 30.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.217 -0.447 . . . . 75.41 110.138 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -123.05 120.62 33.86 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.791 0.293 . . . . 62.24 111.791 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -86.16 93.67 9.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.996 0.427 . . . . 70.42 110.125 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 167' ' ' HIS . 18.3 t60 -81.14 130.04 34.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.465 -0.334 . . . . 73.32 110.451 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 166' ' ' HIS . 32.6 m80 73.94 90.29 0.09 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.235 0.614 . . . . 72.13 111.824 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.7 p80 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 116.131 -0.486 . . . . 73.35 111.5 175.732 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 111.992 0.367 . . . . 54.42 111.992 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.89 104.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.513 0.673 . . . . 64.4 112.1 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.54 78.47 4.05 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.257 0.551 . . . . 75.22 110.566 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.23 134.88 34.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.12 0.486 . . . . 64.43 111.722 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.0 p -159.57 138.31 10.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.042 -0.526 . . . . 53.13 111.122 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -101.75 151.19 22.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.851 0.358 . . . . 73.44 111.324 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.86 142.13 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.156 0.503 . . . . 75.31 111.53 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.01 102.03 14.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.206 0.527 . . . . 63.35 111.301 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -109.78 132.91 53.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.053 -0.521 . . . . 75.23 111.148 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 49.8 tpp -114.2 105.12 12.8 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 73.55 111.775 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -98.63 150.47 21.71 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.394 -0.366 . . . . 72.4 110.936 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -168.85 117.77 0.69 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.952 0.406 . . . . 72.32 111.781 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -158.31 172.68 17.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.365 -0.38 . . . . 73.45 110.538 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.14 75.81 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.983 0.897 . . . . 60.21 110.929 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.1 p -90.96 107.29 19.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.861 -0.609 . . . . 63.12 111.084 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -81.2 100.29 9.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.091 0.472 . . . . 63.42 111.67 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.909 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -95.75 158.27 15.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.415 -0.357 . . . . 73.22 110.933 176.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -104.75 -164.48 1.05 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 111.914 0.338 . . . . 73.51 111.914 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -50.05 134.78 21.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.965 0.728 . . . . 75.22 112.965 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.23 139.62 42.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.473 -0.785 . . . . 63.12 109.613 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.72 106.68 1.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.63 0.729 . . . . 74.23 111.065 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -103.74 164.97 11.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.17 -0.923 . . . . 75.13 112.675 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.42 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.689 0.996 . . . . 74.12 113.689 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD23 HG22 ' A' ' 29' ' ' VAL . 38.3 tp -148.01 137.12 22.08 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.002 -0.999 . . . . 73.23 109.134 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.4 m-80 -59.55 126.07 26.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.084 0.401 . . . . 75.05 112.084 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -53.26 -37.57 62.24 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.209 -0.45 . . . . 54.32 111.788 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . 28.6 tt0 -58.96 -54.63 44.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.969 0.414 . . . . 61.42 110.65 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -59.14 -35.4 73.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 62.12 111.471 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG22 HD23 ' A' ' 24' ' ' LEU . 89.9 t -64.54 -42.84 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.971 0.415 . . . . 74.14 110.597 174.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.573 ' HE3' HD23 ' A' ' 48' ' ' LEU . 44.5 tptt -66.61 -38.15 86.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.176 -0.466 . . . . 63.23 110.781 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.1 mt -59.74 -46.87 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.329 0.585 . . . . 61.11 110.47 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -58.89 -44.85 91.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.702 -0.681 . . . . 73.45 111.057 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.565 ' HG3' HD11 ' A' ' 108' ' ' ILE . 63.1 tt0 -59.21 -45.23 91.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.346 0.593 . . . . 75.3 110.809 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.5 -54.07 50.99 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.31 -0.859 . . . . 74.33 111.188 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -66.31 -30.8 71.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.462 0.541 . . . . 70.55 112.462 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.43 -49.66 68.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.893 0.377 . . . . 74.53 110.673 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -38.35 87.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.116 0.484 . . . . 53.54 110.732 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -56.68 -42.38 78.94 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.782 -0.645 . . . . 73.03 111.031 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -43.4 68.85 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.195 -0.457 . . . . 73.01 112.022 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.94 -7.13 53.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.03 0.381 . . . . 71.43 112.03 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 37.1 t -61.89 126.29 26.84 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.106 0.41 . . . . 73.3 112.106 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 t -93.73 -4.04 51.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.272 -0.422 . . . . 73.05 111.132 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -142.41 96.87 3.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.992 0.425 . . . . 73.21 111.364 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 66.84 -149.17 51.14 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.316 -0.469 . . . . 60.43 113.616 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG13 HD13 ' A' ' 57' ' ' LEU . 31.6 m -114.51 152.84 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.069 0.461 . . . . 63.22 112.091 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 33.6 m-85 -101.31 114.42 28.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.329 -0.396 . . . . 54.41 111.571 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.58 104.12 14.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.905 0.383 . . . . 51.43 110.749 173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.573 HD23 ' HE3' ' A' ' 30' ' ' LYS . 9.5 mp -82.18 111.83 30.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 122.312 -0.243 . . . . 74.32 110.682 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.6 Cg_endo -57.47 -23.47 56.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.848 2.365 . . . . 41.11 113.461 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.37 -17.67 59.88 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.96 -0.638 . . . . 55.04 113.16 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.67 101.09 5.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.547 0.339 . . . . 72.5 111.26 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.43 88.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.055 0.455 . . . . 52.11 110.438 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.425 HG21 HG23 ' A' ' 31' ' ' ILE . 3.3 p -135.93 148.76 66.34 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.713 0.634 . . . . 71.43 112.713 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.24 131.56 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.24 2.627 . . . . 51.22 113.24 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.04 134.0 55.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.323 -0.399 . . . . 55.25 110.679 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -84.87 109.87 18.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.192 0.52 . . . . 70.45 111.855 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 45' ' ' VAL . 44.3 tp -105.65 124.01 48.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.106 -0.497 . . . . 72.31 111.655 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -75.86 132.02 40.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.355 -0.384 . . . . 62.45 110.39 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -126.13 -178.71 4.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.337 0.589 . . . . 74.54 111.701 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.23 0.87 54.69 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.936 -0.574 . . . . 70.41 111.675 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.9 pt -111.16 -28.88 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.009 0.433 . . . . 72.41 111.016 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.26 151.1 5.83 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.16 -0.473 . . . . 73.11 112.607 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.7 m -55.28 126.47 25.08 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.955 0.378 . . . . 65.12 111.482 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.74 174.5 10.51 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.446 0.641 . . . . 62.21 112.4 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -127.61 125.67 40.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.991 -0.55 . . . . 64.02 111.087 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.806 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.3 mtt -117.14 144.1 45.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.837 0.351 . . . . 54.35 111.776 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -143.66 143.48 31.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.942 0.401 . . . . 71.34 111.413 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 82' ' ' LEU . 92.6 mt -90.17 107.01 18.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.349 -0.387 . . . . 72.12 111.429 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.61 161.48 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.186 -0.321 . . . . 73.55 111.7 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.7 m120 59.03 41.19 21.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.083 0.401 . . . . 75.24 112.083 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.414 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 57.7 mt -73.13 111.44 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.939 0.4 . . . . 73.31 111.55 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -136.82 156.5 75.96 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.413 -0.358 . . . . 61.43 111.907 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.64 151.34 52.2 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.856 2.37 . . . . 72.02 113.023 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.6 t70 -134.12 164.7 26.76 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.227 -0.442 . . . . 74.42 110.975 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -49.2 77.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 42.45 111.711 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.1 -36.41 35.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.55 -0.295 . . . . 73.02 111.628 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.41 -97.38 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.316 -0.945 . . . . 65.24 114.344 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.3 m -141.03 130.9 24.37 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.209 0.448 . . . . 53.4 112.209 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.664 HG23 ' HB2' ' A' ' 74' ' ' ASP . 30.4 p -107.04 116.87 32.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.917 0.389 . . . . 73.13 111.572 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.0 pp -137.52 147.26 45.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.864 0.364 . . . . 73.32 111.472 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -89.32 114.82 26.27 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.91 0.386 . . . . 74.02 111.188 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 68' ' ' LEU . 3.2 tm? -90.56 113.65 25.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.922 -0.399 . . . . 64.01 109.922 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 34.0 mtt-85 -102.1 114.48 28.65 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.872 0.693 . . . . 72.43 112.872 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.8 mp -92.39 147.86 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.886 -0.597 . . . . 72.21 110.716 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.1 118.45 7.86 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.296 -0.261 . . . . 62.45 110.296 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 137.75 28.56 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.99 -0.624 . . . . 72.45 113.3 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.04 68.47 4.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.421 0.629 . . . . 53.41 110.479 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -170.32 179.82 3.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.859 -0.609 . . . . 74.11 111.131 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -100.15 -3.82 30.95 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.854 0.316 . . . . 70.13 111.854 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.2 p30 -112.2 166.45 10.93 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.577 0.584 . . . . 63.32 112.577 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.663 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 72.6 Cg_endo -74.07 171.37 18.08 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.02 2.48 . . . . 75.44 114.332 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.92 152.05 76.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.066 -0.515 . . . . 71.34 111.126 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.12 172.96 15.18 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.381 2.054 . . . . 75.32 113.124 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.82 149.28 48.08 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.741 0.305 . . . . 65.11 111.662 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.72 163.04 39.53 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.613 0.721 . . . . 74.22 112.583 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.1 p -133.99 167.13 21.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.385 -0.825 . . . . 75.44 109.917 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.546 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -165.63 163.98 37.02 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.046 -1.073 . . . . 55.52 114.005 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.657 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 91.1 m -103.8 108.5 19.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.463 0.305 . . . . 61.34 110.804 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 27.9 m -98.28 130.23 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.951 0.405 . . . . 54.4 111.812 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 45.4 mt-10 -107.52 111.81 24.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.904 0.383 . . . . 75.32 111.016 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.495 ' CD1' HD22 ' A' ' 139' ' ' LEU . 40.9 p90 -115.71 140.41 49.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.714 0.292 . . . . 73.51 111.361 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -179.0 -150.34 8.84 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.141 -0.552 . . . . 72.13 113.168 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.2 mt-30 -119.9 166.14 13.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.198 0.523 . . . . 65.43 112.034 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 106' ' ' GLY . 71.0 mt -126.01 124.99 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.939 -0.573 . . . . 73.25 110.62 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -98.88 17.04 20.48 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.813 0.671 . . . . 75.14 112.813 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -145.13 -173.1 16.07 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.373 -0.918 . . . . 64.24 114.141 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 72.2 p -101.01 178.93 4.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.839 0.456 . . . . 74.33 111.667 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.565 HD11 ' HG3' ' A' ' 33' ' ' GLN . 45.1 mm -54.94 -38.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 70.35 111.845 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.64 -45.7 43.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.407 -0.361 . . . . 71.14 111.945 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -134.8 102.54 5.29 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.144 0.497 . . . . 70.5 111.57 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.1 p90 -132.25 150.57 52.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 74.43 111.898 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -134.55 130.59 36.8 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.05 -0.523 . . . . 74.11 110.856 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.38 113.95 18.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.012 -0.54 . . . . 74.44 111.197 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.0 pt -119.18 158.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.724 0.297 . . . . 61.32 111.478 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 58.75 26.79 15.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 73.14 110.826 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.36 144.67 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.538 -0.756 . . . . 62.34 112.237 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.37 161.4 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.666 -0.697 . . . . 65.45 110.5 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 2.6 p-10 -106.78 153.87 21.82 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.938 0.718 . . . . 62.22 112.938 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -139.97 148.71 42.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.704 -0.68 . . . . 55.1 110.553 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.19 119.87 29.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.8 0.333 . . . . 72.24 111.419 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.6 pt -98.09 141.66 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.465 -0.334 . . . . 62.55 110.863 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.24 114.82 18.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.863 0.364 . . . . 73.53 111.173 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.739 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -110.61 129.7 23.67 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.537 -0.301 . . . . 72.24 111.641 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.49 164.45 35.23 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.641 2.227 . . . . 73.3 113.158 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -77.49 121.88 24.45 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.304 0.483 . . . . 73.43 112.304 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.1 m -92.97 96.87 10.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.429 -0.351 . . . . 71.33 110.782 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -78.37 -21.31 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.331 0.586 . . . . 64.33 111.104 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -77.41 152.95 34.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.931 -0.577 . . . . 61.05 111.283 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.85 139.91 26.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.574 -0.285 . . . . 74.41 111.685 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.76 156.75 95.35 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.748 -1.355 . . . . 64.02 112.635 -3.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.663 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 38.7 t -72.12 99.0 2.22 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.079 0.77 . . . . 73.22 113.079 -173.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.88 143.0 44.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.716 0.293 . . . . 63.33 110.428 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.739 HG11 ' HB1' ' A' ' 123' ' ' ALA . 36.5 t -133.64 121.21 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.694 0.283 . . . . 74.42 111.03 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.35 101.72 10.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.102 0.477 . . . . 62.23 111.289 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.415 HG23 HG12 ' A' ' 133' ' ' VAL . 18.8 pt -112.5 129.06 24.74 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.369 0.507 . . . . 75.11 112.369 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.92 121.07 7.28 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.449 2.1 . . . . 53.31 112.12 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.98 107.64 15.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.108 -0.496 . . . . 63.43 111.02 -174.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.99 99.17 11.85 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.162 0.506 . . . . 75.31 111.502 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 101' ' ' TYR . 46.2 mt -77.71 123.8 27.14 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.226 -0.443 . . . . 42.24 110.506 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -99.62 148.31 24.46 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.849 0.357 . . . . 60.45 111.877 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.54 -10.09 74.71 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 114.395 0.518 . . . . 50.11 114.395 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 147' ' ' LEU . 19.4 tt -138.8 119.03 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 117.881 0.84 . . . . 75.24 112.589 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.6 m -75.01 156.58 36.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.246 -0.434 . . . . 63.24 111.286 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.76 -46.28 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.057 0.762 . . . . 73.4 113.057 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.01 -14.87 63.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.14 0.495 . . . . 74.55 111.797 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -92.21 -5.35 52.65 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.539 -0.3 . . . . 64.51 111.645 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 50.6 mt -73.39 113.33 10.36 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.743 0.645 . . . . 73.2 112.743 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.57 -36.54 6.12 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.941 -0.572 . . . . 72.11 112.68 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.98 160.51 27.8 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.8 0.333 . . . . 73.42 111.334 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.53 100.82 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.008 0.433 . . . . 75.04 110.418 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 37.6 ttm180 -86.54 119.93 27.32 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.771 0.32 . . . . 73.43 111.803 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.806 HG21 ' SD ' ' A' ' 66' ' ' MET . 20.7 mm -104.59 125.76 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.309 -0.244 . . . . 74.43 111.136 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.486 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 13.3 p80 -164.85 -175.17 3.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.955 0.354 . . . . 71.01 111.955 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.657 ' HB3' ' H ' ' A' ' 98' ' ' THR . 13.9 t70 67.29 22.38 9.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.332 0.586 . . . . 65.4 111.367 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.546 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -66.91 110.52 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.283 0.563 . . . . 75.53 112.165 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.78 144.49 53.13 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.917 -0.583 . . . . 54.13 111.106 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.82 155.73 67.8 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.411 2.074 . . . . 72.41 113.148 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.33 150.43 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.844 0.354 . . . . 75.3 110.984 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.0 ptm -163.03 -173.66 3.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.845 0.355 . . . . 74.35 111.366 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.14 163.91 16.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.244 -0.435 . . . . 73.54 111.677 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 80.1 mt -73.13 168.42 19.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.621 0.724 . . . . 63.42 112.642 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -94.2 160.55 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.436 -0.802 . . . . 64.22 111.126 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -111.72 25.07 12.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.435 0.531 . . . . 62.22 112.435 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.9 m80 63.18 69.9 0.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.11 0.481 . . . . 72.25 111.304 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -75.6 -11.13 59.95 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.55 0.574 . . . . 71.32 112.55 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.436 ' O ' ' HB2' ' A' ' 167' ' ' HIS . 55.8 t-80 57.41 57.39 4.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.429 0.529 . . . . 64.44 112.429 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 166' ' ' HIS . 44.2 t-80 178.82 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.11 0.411 . . . . 74.32 112.11 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.552 -0.737 . . . . 73.24 112.055 174.83 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.682 0.277 . . . . 74.4 111.322 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 3' ' ' GLN . 6.9 p -70.58 -56.74 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.763 -0.199 . . . . 73.21 111.111 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.495 ' H ' HG13 ' A' ' 2' ' ' VAL . 49.6 mt-30 55.95 14.58 1.44 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.379 0.881 . . . . 71.35 113.379 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 2' ' ' VAL . 51.6 mt-30 -85.25 164.08 18.26 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.098 -0.376 . . . . 65.05 110.965 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.1 p -64.8 99.23 0.32 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.882 0.327 . . . . 71.41 111.882 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.14 104.99 2.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.366 0.603 . . . . 62.52 110.078 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -86.22 160.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.272 0.558 . . . . 64.15 111.946 -175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 8' ' ' ARG . 5.0 mmp_? -100.94 118.62 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 73.03 110.538 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -59.73 144.33 48.46 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.589 0.588 . . . . 71.13 112.589 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 10' ' ' MET . 1.4 pmm? -77.86 119.57 21.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.217 0.532 . . . . 74.12 111.217 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.0 104.49 17.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.071 0.462 . . . . 70.34 110.86 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -143.47 121.5 12.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.98 0.419 . . . . 71.43 111.467 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.6 p -159.19 125.15 4.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.124 -0.489 . . . . 64.04 110.901 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -150.8 147.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.934 0.397 . . . . 40.34 111.838 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.1 m -146.2 94.63 2.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.969 0.414 . . . . 72.42 111.329 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -126.99 167.95 15.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.906 0.384 . . . . 75.22 111.525 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -82.01 95.16 7.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.993 0.425 . . . . 75.03 110.379 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -117.25 -79.36 0.59 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.788 0.328 . . . . 72.33 111.313 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -167.96 -168.22 0.95 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.995 0.426 . . . . 73.1 111.333 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.7 152.5 38.97 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.069 -0.514 . . . . 64.14 111.07 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mmt -76.99 164.25 25.94 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.264 0.554 . . . . 74.32 112.472 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.487 ' HB ' ' OE1' ' A' ' 23' ' ' GLN . 70.8 p -83.27 -165.95 1.23 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.75 -0.659 . . . . 65.33 111.689 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.487 ' OE1' ' HB ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -64.19 -175.57 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.553 0.575 . . . . 64.11 112.553 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 29' ' ' VAL . 32.4 tp -54.6 139.17 39.25 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.945 0.72 . . . . 72.33 112.945 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -122.94 165.14 17.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.971 -0.558 . . . . 72.11 110.918 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -50.1 71.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.937 0.399 . . . . 65.31 111.712 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.48 -41.67 90.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 52.31 111.451 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -60.55 -30.35 69.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.351 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG22 HD21 ' A' ' 24' ' ' LEU . 58.9 t -65.62 -47.56 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 64.22 110.364 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.08 80.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.181 -0.463 . . . . 70.12 111.274 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.686 HG23 HG21 ' A' ' 53' ' ' THR . 69.7 mt -56.85 -48.19 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.349 0.595 . . . . 71.41 111.084 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -62.0 -41.07 97.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.788 -0.642 . . . . 75.44 111.059 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.782 ' HG3' HD11 ' A' ' 108' ' ' ILE . 44.0 tt0 -65.15 -38.07 89.42 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.091 -0.504 . . . . 62.21 111.482 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.8 -57.52 12.41 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.528 -0.305 . . . . 70.34 110.566 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -52.02 -45.23 64.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.419 0.526 . . . . 41.0 112.419 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.441 ' HB2' HD12 ' A' ' 108' ' ' ILE . 99.1 mtt180 -66.51 -48.84 68.5 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.326 0.491 . . . . 71.41 112.326 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.97 -45.92 91.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.309 0.576 . . . . 64.43 110.845 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 45' ' ' VAL . 65.7 t30 -66.08 -28.89 69.17 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.884 -0.598 . . . . 70.52 111.142 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.733 0.301 . . . . 72.41 111.184 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.66 -21.93 54.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.848 0.356 . . . . 62.44 111.285 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.431 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 41.1 t -63.72 123.63 19.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.259 0.466 . . . . 64.31 112.259 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 m -108.11 -0.08 21.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.775 0.287 . . . . 73.2 111.775 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 t -148.1 77.62 1.41 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.075 0.464 . . . . 73.32 111.825 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.71 -166.89 12.21 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.512 -0.375 . . . . 65.42 112.926 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.471 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 29.1 m -130.9 149.9 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.761 0.652 . . . . 74.23 112.761 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 41' ' ' SER . 72.9 m-85 -99.95 112.1 24.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.039 -0.528 . . . . 74.43 111.42 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -104.16 106.1 16.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.075 0.464 . . . . 74.34 110.792 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 72.1 mt -83.17 128.88 63.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.619 -0.264 . . . . 52.0 111.241 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 47.8 Cg_exo -57.07 -29.17 82.08 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 122.697 2.265 . . . . 65.54 113.187 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.41 9.91 76.12 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.21 -0.519 . . . . 75.23 113.234 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.62 86.36 2.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.02 0.438 . . . . 61.14 111.651 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.47 80.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.156 0.503 . . . . 74.13 111.113 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.686 HG21 HG23 ' A' ' 31' ' ' ILE . 3.8 p -138.49 150.81 67.59 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 112.84 0.682 . . . . 54.51 112.84 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.84 127.74 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.277 2.652 . . . . 73.12 113.01 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -108.73 132.68 53.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.976 0.417 . . . . 64.1 111.293 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 56' ' ' ARG . 12.3 ttm-85 -90.97 125.89 35.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.31 -0.405 . . . . 72.3 110.771 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.99 121.11 22.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.905 0.383 . . . . 75.45 111.698 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -86.5 111.1 20.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.065 0.459 . . . . 73.43 110.1 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -112.39 -173.02 2.16 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.17 0.509 . . . . 74.54 112.343 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.452 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 47.0 mt-30 -74.25 -24.09 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.819 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.49 -29.4 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.99 0.424 . . . . 63.33 111.196 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.94 -173.22 33.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.218 -0.515 . . . . 63.43 112.955 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -82.85 112.79 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.557 -0.378 . . . . 75.22 110.712 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -119.9 171.91 8.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.521 0.677 . . . . 71.34 112.408 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -132.95 111.95 11.46 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.587 -0.733 . . . . 74.25 110.716 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.683 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.2 mtt -107.35 148.0 29.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.281 0.474 . . . . 74.43 112.281 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.2 t -154.66 157.22 37.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.948 0.404 . . . . 73.2 111.645 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 80' ' ' LEU . 95.0 mt -102.97 114.04 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.307 -0.406 . . . . 63.53 111.579 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 81' ' ' THR . 28.6 m -128.06 161.6 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.69 0.281 . . . . 65.1 111.667 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.6 m120 54.29 30.71 12.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.318 0.488 . . . . 72.12 112.318 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 68' ' ' LEU . 52.2 mt -59.22 104.13 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.007 0.432 . . . . 70.24 111.399 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -125.69 149.53 65.63 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 112.343 0.497 . . . . 71.51 112.343 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.98 129.24 14.0 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.758 2.305 . . . . 72.43 113.375 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 29.4 t70 -91.65 166.74 12.64 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.289 -0.414 . . . . 64.51 110.62 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.44 69.13 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.134 0.42 . . . . 74.35 112.134 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -115.64 -9.78 11.93 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.51 0.559 . . . . 74.03 112.51 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -167.35 -113.78 0.29 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.259 -0.972 . . . . 71.12 114.021 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -146.89 127.12 13.84 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.028 0.381 . . . . 73.24 112.028 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 41.4 p -104.6 114.83 29.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.104 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -126.81 148.46 49.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.883 0.373 . . . . 62.34 111.657 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 69' ' ' VAL . 62.2 m -92.0 107.92 19.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.123 0.487 . . . . 73.11 111.566 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.38 108.91 19.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.034 -0.53 . . . . 71.43 110.053 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 66' ' ' MET . 9.7 mtp-105 -93.66 122.96 36.65 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.3 -0.25 . . . . 74.15 111.609 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -107.16 91.29 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.535 -0.302 . . . . 73.04 110.758 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -88.19 122.79 32.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.706 0.288 . . . . 74.12 111.021 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.33 132.0 11.35 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.709 -0.757 . . . . 62.41 113.154 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -69.16 -43.56 74.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.282 0.563 . . . . 61.3 109.898 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 m -79.42 109.08 13.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.1 -0.704 . . . . 71.44 109.1 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -73.35 1.58 9.3 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.341 0.867 . . . . 73.3 113.341 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.7 p30 -74.09 156.87 87.48 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.681 0.276 . . . . 72.4 111.59 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 11.6 Cg_endo -54.03 114.24 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.021 2.481 . . . . 53.35 113.716 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.88 145.15 29.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.132 -0.485 . . . . 63.13 111.533 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.78 169.01 23.12 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.58 2.186 . . . . 72.04 112.618 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 147.9 49.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.542 -0.299 . . . . 54.04 110.949 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -144.95 160.61 41.06 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.82 0.674 . . . . 74.0 112.82 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -137.75 140.63 40.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.334 -0.848 . . . . 64.31 110.325 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -148.09 171.33 28.58 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.811 -0.709 . . . . 73.0 113.097 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 20.0 m -103.18 134.98 45.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.714 -0.286 . . . . 60.12 111.016 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 119' ' ' GLN . 7.2 p -117.36 122.67 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 74.42 112.015 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 27.5 mm-40 -90.16 105.12 17.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.871 -0.604 . . . . 74.4 110.372 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -114.99 117.81 31.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.356 0.598 . . . . 61.14 111.497 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -163.13 -149.27 5.65 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.961 -0.563 . . . . 63.21 112.866 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.414 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -121.23 157.14 30.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.076 0.465 . . . . 75.1 111.972 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -123.0 122.07 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.14 -0.482 . . . . 75.2 111.196 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 3.8 pt20 -104.34 90.71 3.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.457 0.646 . . . . 72.41 111.159 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 160.39 -152.18 22.89 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.14 113.672 175.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -120.72 -171.66 2.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.876 0.47 . . . . 64.01 111.113 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.782 HD11 ' HG3' ' A' ' 33' ' ' GLN . 29.7 mm -62.77 -34.43 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.266 0.555 . . . . 74.54 110.844 172.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.98 -49.51 8.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.664 -0.698 . . . . 71.44 112.138 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -129.65 105.53 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.08 0.467 . . . . 75.33 111.647 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.4 p90 -139.97 160.41 39.98 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.097 0.475 . . . . 73.12 112.18 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -134.51 134.76 41.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.074 -0.512 . . . . 62.54 110.768 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.19 123.12 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.484 -0.326 . . . . 63.31 110.884 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.38 154.71 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.047 0.388 . . . . 71.22 112.047 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 53.46 39.2 29.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.071 0.463 . . . . 73.13 111.751 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.483 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 5.6 p -97.6 126.18 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.318 0.58 . . . . 74.23 111.978 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -114.9 153.12 31.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.052 -0.522 . . . . 73.12 110.6 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.22 133.72 53.35 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.166 0.508 . . . . 71.15 111.85 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.52 ' O ' HG12 ' A' ' 99' ' ' VAL . 47.4 tt0 -129.03 149.26 50.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.149 -0.478 . . . . 72.45 110.02 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.8 mt -92.11 118.63 31.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.119 0.485 . . . . 71.43 111.885 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.714 HG22 HD21 ' A' ' 137' ' ' LEU . 30.4 pt -92.78 99.37 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 72.32 111.371 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -101.46 114.57 28.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.293 -0.412 . . . . 65.23 110.96 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -111.67 147.26 36.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.053 0.39 . . . . 70.05 112.053 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.98 164.91 34.19 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.886 2.391 . . . . 62.02 113.733 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.38 125.98 29.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.869 -0.605 . . . . 65.2 112.121 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 71.1 m -90.6 79.44 6.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.962 0.41 . . . . 54.41 110.614 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.37 -10.65 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.149 -0.478 . . . . 64.43 111.875 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.84 129.89 53.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.845 0.355 . . . . 74.24 111.58 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.16 139.39 23.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.359 -0.382 . . . . 72.44 111.233 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 148.48 92.25 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.103 -1.207 . . . . 73.24 113.541 2.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.9 p -89.05 125.24 34.92 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.5 0.667 . . . . 64.11 112.608 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.73 143.39 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.581 -0.736 . . . . 64.0 110.366 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.02 157.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 61.12 110.973 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.424 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.2 p30 -146.76 111.91 5.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.306 0.574 . . . . 75.12 110.866 170.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 23.5 pt -117.05 142.71 30.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.007 -0.542 . . . . 73.12 111.915 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 2.5 Cg_endo -81.24 130.92 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.907 2.405 . . . . 33.01 112.636 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 121' ' ' ILE . 62.9 mt -111.43 111.85 23.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 73.13 111.656 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -91.35 89.57 7.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.239 0.542 . . . . 71.21 110.625 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.5 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 26.2 mt -81.67 110.75 17.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 73.21 110.016 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -98.47 139.15 34.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.973 0.416 . . . . 74.03 111.76 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.98 63.72 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.079 -0.509 . . . . 61.1 113.28 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 147' ' ' LEU . 18.4 tt -134.33 123.61 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 122.401 -0.47 . . . . 72.14 111.774 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -85.41 147.53 26.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.094 0.405 . . . . 74.14 112.094 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -47.66 -51.4 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 113.192 0.812 . . . . 55.2 113.192 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.2 -38.13 82.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.094 0.473 . . . . 74.14 111.61 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -87.54 7.64 28.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.194 0.442 . . . . 71.32 112.194 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.517 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.2 tt -82.35 126.86 32.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.749 0.309 . . . . 73.43 110.257 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.42 -58.51 1.36 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.09 -0.576 . . . . 53.21 113.452 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -147.34 148.83 31.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.369 -0.489 . . . . 74.4 112.305 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.6 t -116.79 99.33 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.72 -0.673 . . . . 60.51 109.833 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -102.55 114.1 28.03 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.091 0.472 . . . . 75.22 111.74 -171.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.683 HG21 ' SD ' ' A' ' 66' ' ' MET . 38.2 mm -90.59 140.19 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.842 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -165.67 179.33 6.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 111.908 0.336 . . . . 75.42 111.908 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 98' ' ' THR . 73.2 m-20 61.87 22.57 13.13 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.417 0.895 . . . . 42.22 113.417 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.8 mm -63.86 94.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.313 0.578 . . . . 74.52 111.741 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 8.0 pt20 -125.66 144.8 49.31 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.556 -0.747 . . . . 72.32 111.179 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 146.27 51.14 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.49 2.127 . . . . 70.42 113.654 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.83 146.33 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.261 -0.427 . . . . 64.31 110.451 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -136.16 152.95 51.35 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.115 0.413 . . . . 75.11 112.115 -175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -75.75 -13.0 60.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.124 -0.489 . . . . 73.4 111.248 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.67 149.19 32.89 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.381 -0.372 . . . . 74.03 110.551 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.29 -81.45 0.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.853 0.686 . . . . 74.22 112.853 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -129.57 141.46 50.96 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.535 0.569 . . . . 74.02 112.535 -174.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -80.24 148.11 30.95 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.038 -0.528 . . . . 74.22 111.44 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -97.64 178.69 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.083 -0.386 . . . . 73.35 111.629 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 65.19 87.69 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.093 0.473 . . . . 74.44 110.994 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -155.63 39.66 0.39 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.469 -0.332 . . . . 75.14 111.838 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.037 0 N-CA-C 112.605 0.594 . . . . 75.44 112.605 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.7 mtm . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.77 0.319 . . . . 61.12 111.658 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -167.61 151.2 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.624 0.25 . . . . 61.52 110.951 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.89 151.37 39.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.009 0.433 . . . . 74.24 111.747 176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -134.53 101.99 5.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.453 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 t -114.49 93.44 4.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.131 0.491 . . . . 74.31 110.918 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -95.34 93.81 7.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.988 0.423 . . . . 54.52 110.914 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.73 133.81 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.422 0.629 . . . . 72.13 112.355 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.3 OUTLIER -138.12 112.27 8.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.941 -0.572 . . . . 75.44 110.965 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -81.96 102.92 11.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.916 0.389 . . . . 63.43 111.339 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -153.95 119.44 5.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.397 0.517 . . . . 73.33 112.397 -177.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -143.52 149.81 38.02 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.235 -0.439 . . . . 73.15 111.117 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -91.02 -10.08 43.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.993 0.368 . . . . 64.32 111.993 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -85.9 112.41 21.13 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.856 0.36 . . . . 64.53 111.335 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.81 119.42 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.397 0.618 . . . . 42.01 112.147 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.8 t -134.88 154.64 51.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.955 -0.566 . . . . 61.33 110.638 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -137.38 140.43 41.38 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.216 0.531 . . . . 74.03 112.154 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.8 mm? -106.93 164.65 11.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.281 -0.637 . . . . 63.44 109.281 170.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -51.64 128.12 22.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 121.12 -0.232 . . . . 75.33 110.924 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -40.06 135.4 1.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.588 0.958 . . . . 74.35 113.588 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.85 -175.61 0.31 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.587 0.958 . . . . 65.32 113.587 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.6 mtp -96.51 -172.23 2.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.092 -0.958 . . . . 74.1 111.632 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 p -95.11 140.92 29.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.191 0.52 . . . . 65.05 111.804 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -96.44 128.88 43.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.165 -0.47 . . . . 71.4 110.479 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp -47.82 137.03 10.18 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.361 0.504 . . . . 64.42 112.361 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.75 137.95 58.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.095 -0.502 . . . . 71.35 111.714 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.92 -30.87 70.46 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.313 -0.403 . . . . 75.54 111.267 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.64 -53.93 52.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.906 0.384 . . . . 73.21 110.797 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -56.55 -37.14 70.11 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.141 -0.481 . . . . 72.43 111.044 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.16 -47.14 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.356 -0.384 . . . . 65.12 111.065 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.636 ' HE2' ' HB3' ' A' ' 48' ' ' LEU . 21.0 tptm -62.24 -43.3 99.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.98 0.419 . . . . 65.41 111.176 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -49.31 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.031 0.443 . . . . 63.0 111.185 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -56.55 -38.78 72.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.965 0.412 . . . . 43.5 110.906 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -59.71 -42.04 92.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.024 -0.534 . . . . 72.42 111.073 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -62.52 -52.42 63.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.479 -0.328 . . . . 75.42 111.072 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -52.99 -42.96 66.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.88 0.371 . . . . 75.02 111.209 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -57.29 -45.92 83.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.994 0.426 . . . . 65.33 111.567 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.47 -31.18 72.11 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.833 0.349 . . . . 71.02 111.26 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -67.8 -30.48 69.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.938 0.399 . . . . 73.1 110.971 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.89 66.48 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.14 0.495 . . . . 74.24 111.083 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.43 1.05 47.22 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.284 -0.416 . . . . 54.32 111.788 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 t -65.77 120.48 13.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.274 0.472 . . . . 75.3 112.274 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -126.48 -13.97 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.37 -0.377 . . . . 72.31 111.695 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.3 p -129.39 25.51 5.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.377 0.51 . . . . 63.22 112.377 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.39 161.75 11.35 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.048 -0.596 . . . . 71.4 112.763 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.78 135.34 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.542 0.687 . . . . 64.25 112.823 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.96 109.41 20.75 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.453 -0.794 . . . . 72.41 110.746 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.3 131.98 47.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.793 0.33 . . . . 64.12 110.676 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.636 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 84.8 mt -117.17 120.29 33.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 111.903 0.334 . . . . 72.4 111.903 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HG3' HD22 ' A' ' 147' ' ' LEU . 11.5 Cg_endo -55.42 139.23 81.72 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.339 2.026 . . . . 73.15 111.666 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.82 -36.67 3.82 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.9 -0.667 . . . . 72.4 111.923 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.7 93.47 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.096 0.474 . . . . 74.45 110.057 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -79.61 27.29 0.28 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.265 0.555 . . . . 63.52 111.959 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 p -97.35 142.59 24.78 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 121.129 0.49 . . . . 64.45 112.132 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HB2' ' HG3' ' A' ' 65' ' ' ARG . 73.9 Cg_endo -73.57 163.8 36.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.116 2.544 . . . . 62.53 113.597 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.86 140.66 45.99 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.094 -0.503 . . . . 73.33 111.117 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -86.78 123.53 32.03 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.115 0.483 . . . . 72.55 112.046 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.3 tp -125.45 123.28 38.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.187 -0.46 . . . . 74.5 111.187 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -85.11 96.91 9.59 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 61.24 110.21 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.7 p -86.58 -174.85 5.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.265 0.555 . . . . 63.34 111.737 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -83.56 -4.71 58.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.998 -0.546 . . . . 74.32 111.605 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 92' ' ' LEU . 31.0 pt -106.59 -28.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.92 0.391 . . . . 73.23 111.253 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.62 175.54 31.74 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.128 -0.558 . . . . 61.32 113.188 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.4 m -72.76 112.05 8.45 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.056 0.455 . . . . 71.24 111.119 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 pp -121.84 155.95 34.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.329 0.585 . . . . 64.32 112.076 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 32.4 ttt180 -118.17 107.05 13.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.6 -0.727 . . . . 64.55 110.854 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.755 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.5 mtt -104.41 156.06 18.26 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.079 0.466 . . . . 55.41 112.09 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.1 t -158.07 160.82 37.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.779 0.324 . . . . 74.4 111.582 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 80' ' ' LEU . 79.3 mt -105.29 113.13 26.53 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.275 -0.421 . . . . 75.44 111.478 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.501 HG21 ' HD2' ' A' ' 83' ' ' ARG . 27.2 m -130.58 166.27 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.327 -0.233 . . . . 73.54 111.194 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.6 m120 61.16 28.1 17.79 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.012 0.434 . . . . 61.34 111.618 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 HG23 ' A' ' 144' ' ' VAL . 51.8 mt -64.03 96.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.141 0.496 . . . . 74.02 111.319 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 p -131.26 150.88 77.73 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.102 -0.499 . . . . 74.02 112.089 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.66 156.97 61.1 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.737 2.291 . . . . 72.23 113.568 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.473 ' HB2' HG23 ' A' ' 79' ' ' THR . 22.9 t70 -133.36 168.8 17.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.875 -0.602 . . . . 74.42 110.65 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.83 68.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 71.41 111.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.56 -31.9 32.44 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.184 0.438 . . . . 74.43 112.184 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.96 -99.1 0.13 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.233 -0.984 . . . . 63.32 113.759 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -147.2 134.01 20.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.834 0.35 . . . . 51.31 111.539 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 36.2 p -110.72 127.55 55.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.569 -0.287 . . . . 72.54 111.627 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -134.35 145.16 48.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.018 0.437 . . . . 53.25 111.208 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.5 m -84.37 101.78 12.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.11 0.481 . . . . 61.42 111.405 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.1 107.28 12.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.031 -0.531 . . . . 73.42 109.971 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HD2' HG21 ' A' ' 69' ' ' VAL . 14.9 mtp180 -95.66 113.13 24.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.791 0.329 . . . . 54.1 111.614 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.571 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.2 mp -88.53 88.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.133 0.492 . . . . 70.22 110.09 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 63.2 tt0 -94.03 95.18 8.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.133 0.492 . . . . 73.43 110.78 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.45 131.51 41.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.401 -0.428 . . . . 43.43 113.462 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.19 -5.98 58.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.112 0.482 . . . . 70.22 111.352 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.5 p -91.65 147.84 22.7 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.136 -0.484 . . . . 63.4 110.872 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.452 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 28.1 t-20 -79.5 -24.77 42.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.957 0.408 . . . . 70.33 110.639 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.3 134.46 95.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.289 -0.414 . . . . 74.32 111.802 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.57 102.74 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.648 2.232 . . . . 61.34 112.576 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.7 mt -68.88 141.87 92.85 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 112.251 0.463 . . . . 72.02 112.251 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.93 177.07 6.8 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.665 2.243 . . . . 74.31 113.33 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -63.19 135.01 56.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.939 0.4 . . . . 65.54 111.339 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.94 154.28 46.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.43 0.633 . . . . 75.53 112.56 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 90.1 p -131.04 -179.93 5.62 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.626 -0.716 . . . . 51.55 110.498 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . 179.66 175.12 46.21 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.727 -0.749 . . . . 52.44 113.095 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.9 m -111.61 131.96 54.9 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.239 0.216 . . . . 74.32 110.5 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 m -118.79 133.93 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.199 0.523 . . . . 64.15 111.987 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 8.6 mm-40 -99.13 106.65 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.851 -0.613 . . . . 71.41 110.557 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.466 ' HE1' ' HB2' ' A' ' 119' ' ' GLN . 48.5 p90 -116.65 122.56 44.92 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.391 0.615 . . . . 70.53 111.831 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.54 -144.71 4.36 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.68 -0.691 . . . . 61.12 112.811 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.483 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.9 mt-30 -127.03 158.42 37.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.104 0.478 . . . . 63.24 111.687 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.8 mt -119.17 117.07 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.347 -0.388 . . . . 71.24 111.332 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.25 41.81 1.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.086 0.47 . . . . 65.22 111.167 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.496 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -162.35 -158.95 9.91 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.975 -0.631 . . . . 51.02 113.676 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.5 p -125.78 -175.92 3.48 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.911 0.386 . . . . 71.52 111.59 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.493 HD11 ' HG3' ' A' ' 33' ' ' GLN . 45.9 mm -56.75 -38.57 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.031 0.443 . . . . 73.44 111.454 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.63 -42.63 77.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.263 -0.426 . . . . 71.33 111.234 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -139.32 87.59 2.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.293 0.568 . . . . 72.24 111.996 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -98.0 129.86 44.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.079 0.466 . . . . 74.42 111.065 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -123.68 120.17 31.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.059 -0.519 . . . . 63.11 110.838 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.08 118.71 19.11 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.976 0.417 . . . . 74.54 111.937 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.5 pt -130.57 155.11 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.444 -0.343 . . . . 72.2 110.96 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 54.67 32.08 16.55 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.463 0.649 . . . . 70.53 111.279 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.41 117.77 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.752 -0.658 . . . . 70.13 112.226 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -102.42 145.77 29.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.035 -0.529 . . . . 73.14 110.178 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -103.72 117.73 35.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.003 0.43 . . . . 71.42 111.324 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.466 ' HB2' ' HE1' ' A' ' 101' ' ' TYR . 52.1 tt0 -109.68 147.57 32.89 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 75.34 110.889 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.02 115.16 29.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.848 0.356 . . . . 73.43 111.05 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 121' ' ' ILE . 46.7 pt -94.8 116.38 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.108 0.48 . . . . 64.42 111.756 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -109.74 109.4 20.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.984 -0.376 . . . . 72.14 109.984 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.84 147.63 34.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 112.201 0.445 . . . . 41.53 112.201 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.45 151.46 84.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.826 2.35 . . . . 43.02 113.168 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -67.7 140.0 56.75 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.033 0.444 . . . . 74.31 112.041 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -83.7 77.37 9.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.118 -0.326 . . . . 73.35 110.118 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.433 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -67.94 -21.71 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.066 0.46 . . . . 73.53 111.925 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.433 ' HG ' HG23 ' A' ' 127' ' ' VAL . 93.1 mt -105.1 152.42 22.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 75.2 111.039 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 89' ' ' ASN . . . -115.15 140.05 25.18 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.525 -0.307 . . . . 50.12 111.644 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.74 173.83 56.15 Favored 'Cis proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.78 -1.342 . . . . 53.35 113.496 0.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -73.67 111.09 8.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.327 0.491 . . . . 73.25 112.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -141.94 115.57 9.09 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.326 0.584 . . . . 72.32 111.056 172.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.82 155.34 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 116.403 -0.362 . . . . 71.14 110.932 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 9.0 p-10 -143.97 121.34 11.64 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.142 0.496 . . . . 73.2 111.303 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.1 pt -119.91 138.52 27.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 112.182 0.438 . . . . 72.22 112.182 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.8 Cg_exo -78.14 123.33 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.015 2.477 . . . . 74.34 112.819 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' THR . 76.1 mt -100.89 106.46 17.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.89 0.376 . . . . 64.04 111.945 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.479 ' HA ' HG22 ' A' ' 79' ' ' THR . 35.4 tt0 -84.05 88.37 7.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.401 0.62 . . . . 71.12 110.228 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -81.44 116.74 21.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 71.24 110.013 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -99.68 141.82 31.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 73.41 112.055 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.2 41.29 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.297 -0.478 . . . . 44.14 113.154 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 147' ' ' LEU . 16.9 tt -161.51 127.12 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.039 0.447 . . . . 63.11 111.191 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.4 m -84.65 145.78 27.81 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.007 0.373 . . . . 71.2 112.007 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 71' ' ' ILE . 7.2 p -56.84 -43.03 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.741 0.645 . . . . 73.24 112.741 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.54 -30.3 64.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.096 0.474 . . . . 74.14 111.471 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.469 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 29.7 mm-40 -90.88 -4.16 56.77 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.079 0.4 . . . . 55.5 112.079 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.486 HD22 ' HG3' ' A' ' 49' ' ' PRO . 1.6 tt -61.26 117.94 6.25 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.859 0.361 . . . . 72.15 110.304 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.98 -62.45 1.36 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.278 -0.487 . . . . 41.21 113.457 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.436 ' HD2' ' HG3' ' A' ' 151' ' ' ARG . 37.4 p90 -142.63 155.55 44.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.383 0.512 . . . . 72.1 112.383 -174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.9 t -131.49 104.02 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.196 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.597 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 77.5 mtp180 -96.09 115.28 27.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.933 0.397 . . . . 65.53 112.01 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.755 HG21 ' SD ' ' A' ' 66' ' ' MET . 21.4 mm -93.69 121.91 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.071 -0.513 . . . . 73.24 110.741 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -154.34 172.94 16.88 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.245 0.461 . . . . 52.14 112.245 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 63.6 23.8 13.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.889 0.7 . . . . 73.14 112.889 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.409 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.3 mm -64.23 109.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.18 0.514 . . . . 73.24 111.293 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -133.86 147.11 62.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.84 -0.618 . . . . 74.44 111.9 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.527 ' HB2' ' HG2' ' A' ' 159' ' ' MET . 60.6 Cg_endo -72.44 124.1 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.253 1.968 . . . . 54.05 112.339 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.24 8.9 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 112.424 0.527 . . . . 75.31 112.424 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.527 ' HG2' ' HB2' ' A' ' 157' ' ' PRO . 25.3 ptt? -80.0 108.29 13.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.202 0.525 . . . . 55.25 111.447 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -88.05 8.2 27.76 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.312 0.577 . . . . 71.42 110.936 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.73 9.79 41.7 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.097 0.406 . . . . 71.44 112.097 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.36 156.73 25.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.31 0.576 . . . . 72.32 112.331 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -126.11 37.25 4.37 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.102 -0.499 . . . . 74.21 111.386 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -58.74 -47.86 83.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.235 0.457 . . . . 61.42 112.235 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -63.82 129.04 38.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.629 0.252 . . . . 73.5 111.173 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -98.74 97.61 8.83 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.212 0.529 . . . . 72.24 112.392 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -158.53 79.52 0.8 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.36 0.6 . . . . 64.42 110.612 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 55.0 t60 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.503 -0.771 . . . . 73.02 110.85 179.518 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.96 0.41 . . . . 72.41 111.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.35 156.96 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.086 0.469 . . . . 41.0 111.596 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -111.38 151.45 28.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.335 -0.393 . . . . 75.04 111.071 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -63.99 93.81 0.09 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.68 0.753 . . . . 65.12 110.773 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.9 m -89.77 132.01 35.44 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.952 -0.567 . . . . 63.14 112.183 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.93 -175.89 3.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.35 -0.386 . . . . 72.32 111.366 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.01 155.34 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.577 . . . . 73.44 111.792 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.54 148.95 24.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.092 -0.504 . . . . 64.32 110.566 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.2 86.51 1.42 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.553 0.692 . . . . 73.44 111.441 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 mmt -72.67 147.3 45.85 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.579 -0.737 . . . . 71.52 110.978 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.601 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 3.2 mptp? -87.99 83.7 7.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.913 0.387 . . . . 75.23 111.548 -171.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -143.28 115.74 8.57 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.573 -0.285 . . . . 72.25 111.022 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -179.48 -170.99 0.18 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.963 0.411 . . . . 74.53 111.006 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.73 105.57 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.886 0.375 . . . . 74.44 110.956 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -74.0 99.04 3.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.903 0.383 . . . . 55.11 111.818 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.6 p -98.38 126.61 43.97 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.01 0.433 . . . . 74.51 111.329 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -107.23 142.77 36.44 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.888 0.375 . . . . 73.34 111.701 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -65.22 143.72 57.65 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.288 -0.415 . . . . 61.23 111.652 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -95.03 -177.31 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.6 0.714 . . . . 72.41 112.697 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.13 124.42 24.4 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.312 -0.858 . . . . 75.44 111.95 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.1 ttm -84.72 157.31 21.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.435 -0.348 . . . . 71.23 110.843 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -75.5 -167.87 0.74 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -50.43 141.65 11.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.474 0.546 . . . . 75.31 112.474 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -126.64 145.58 50.51 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.959 0.409 . . . . 73.52 111.693 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 86.2 m-20 -91.89 147.91 22.61 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.602 -0.272 . . . . 73.32 111.375 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -60.3 -39.58 87.48 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.756 0.312 . . . . 73.11 111.704 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 31' ' ' ILE . 42.8 tt0 -58.79 -48.46 81.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.004 0.431 . . . . 75.5 110.149 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 25' ' ' ASN . 3.9 m -61.32 -33.2 73.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.151 -0.477 . . . . 72.12 111.212 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.66 -54.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.322 0.582 . . . . 73.42 110.973 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -64.72 -34.69 78.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.59 -0.732 . . . . 73.41 111.777 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 27' ' ' GLU . 77.1 mt -64.9 -46.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.871 0.367 . . . . 74.35 111.314 174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.4 m -64.56 -38.97 92.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.781 0.324 . . . . 72.44 111.201 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -60.16 -45.33 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.825 0.345 . . . . 70.4 110.489 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -57.24 10.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.073 -0.512 . . . . 62.31 110.573 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -55.17 -46.27 75.76 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.459 0.54 . . . . 63.11 112.459 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.71 -48.6 76.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.132 0.419 . . . . 73.52 112.132 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.173 0.511 . . . . 60.33 110.8 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -59.25 -44.01 92.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.78 -0.645 . . . . 74.25 110.386 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.6 97.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.034 -0.53 . . . . 71.02 111.945 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HE3' HG22 ' A' ' 108' ' ' ILE . 68.7 mttm -68.81 -23.24 64.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.832 0.349 . . . . 72.33 111.855 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -63.87 115.47 4.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.88 0.371 . . . . 74.45 111.75 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 m -64.42 -47.72 78.08 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.174 0.511 . . . . 62.13 111.4 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.2 p -129.64 117.75 20.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.176 -0.465 . . . . 71.53 111.143 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 99.85 169.51 29.81 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.154 -0.546 . . . . 44.31 113.727 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 57' ' ' LEU . 31.1 m -113.19 153.99 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.113 0.483 . . . . 71.32 111.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -101.95 126.8 48.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.258 -0.428 . . . . 71.31 111.421 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.83 112.28 19.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.397 -0.365 . . . . 74.53 110.749 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 9.6 mp -91.88 135.01 27.92 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.718 -0.219 . . . . 73.31 111.265 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 38.5 Cg_exo -56.62 -32.5 90.64 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.685 2.257 . . . . 63.43 113.274 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.73 15.23 61.01 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.256 -0.497 . . . . 64.31 113.131 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.03 84.2 2.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.164 0.506 . . . . 73.02 111.607 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.75 81.98 0.44 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.45 0.643 . . . . 71.23 111.301 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 p -137.43 152.07 72.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.98 -0.555 . . . . 51.05 112.246 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HB3' HH11 ' A' ' 65' ' ' ARG . 92.8 Cg_endo -81.5 132.4 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.959 2.439 . . . . 62.5 112.717 171.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.11 130.16 55.58 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.813 0.34 . . . . 71.42 111.14 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.715 ' HD3' HG23 ' A' ' 63' ' ' THR . 1.6 tmm_? -86.28 108.52 18.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.96 0.409 . . . . 74.24 110.137 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.422 HD13 HG13 ' A' ' 45' ' ' VAL . 40.2 tp -101.77 131.42 48.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.454 0.645 . . . . 54.41 112.595 -174.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.32 106.21 15.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.277 -0.874 . . . . 73.12 109.817 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -110.41 -178.71 3.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.168 0.509 . . . . 72.43 111.927 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 47.7 mt-30 -87.64 -2.96 58.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.075 -0.512 . . . . 74.34 111.747 177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 157' ' ' PRO . 31.8 pt -104.18 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.839 0.352 . . . . 75.43 111.175 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -162.43 29.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.425 -0.417 . . . . 33.14 113.318 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.715 HG23 ' HD3' ' A' ' 56' ' ' ARG . 77.8 m -87.46 118.72 27.11 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.58 -0.365 . . . . 45.21 111.012 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.45 169.36 17.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.63 0.604 . . . . 74.12 112.63 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.678 HH11 ' HB3' ' A' ' 54' ' ' PRO . 35.1 ttp85 -118.09 136.42 53.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.704 -0.68 . . . . 74.05 110.844 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.639 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.2 mtt -130.39 157.4 42.69 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.768 0.318 . . . . 63.44 111.545 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -164.5 165.11 21.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.905 0.383 . . . . 64.13 111.682 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 80' ' ' LEU . 94.4 mt -109.5 117.69 34.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 61.42 111.588 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 81' ' ' THR . 35.3 m -128.01 162.99 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 72.31 111.51 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.7 m120 58.41 29.58 18.43 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.463 0.542 . . . . 72.33 112.463 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.28 106.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.915 0.388 . . . . 73.11 110.935 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -138.22 151.25 69.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.183 -0.462 . . . . 75.44 112.122 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.06 162.3 38.84 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.9 2.4 . . . . 72.33 113.147 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 79' ' ' THR . 20.5 t70 -147.16 158.46 43.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.246 -0.433 . . . . 75.21 111.478 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.58 84.34 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.17 0.433 . . . . 71.12 112.17 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -88.26 -32.85 18.3 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.707 0.289 . . . . 71.42 111.269 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -172.43 -96.19 0.1 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.692 -0.766 . . . . 74.04 113.763 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -150.72 129.35 12.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.562 -0.375 . . . . 65.43 111.498 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.566 HG23 ' HB2' ' A' ' 74' ' ' ASP . 60.3 p -104.36 125.76 50.87 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.187 -0.321 . . . . 71.24 111.525 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.45 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -138.61 151.37 47.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.038 0.447 . . . . 75.44 111.44 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.496 ' HB ' HG23 ' A' ' 69' ' ' VAL . 32.7 m -94.79 110.02 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 71.33 111.422 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.36 111.58 19.56 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.663 -0.495 . . . . 72.14 109.663 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HE ' ' HB3' ' A' ' 134' ' ' ASP . 38.0 mtp180 -105.28 126.51 52.18 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.239 0.459 . . . . 75.35 112.239 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.2 mp -110.96 141.13 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.824 -0.626 . . . . 75.4 110.201 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -139.64 148.05 41.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 65.14 111.055 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.15 124.61 6.5 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.884 -0.674 . . . . 71.12 113.567 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 63' ' ' THR . 19.3 mm-40 -70.76 -3.32 18.19 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.966 0.413 . . . . 64.43 111.264 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -116.34 161.93 18.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.305 -0.407 . . . . 54.43 110.826 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -81.6 24.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.723 0.297 . . . . 55.12 111.741 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.86 146.74 34.42 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.704 0.402 . . . . 62.33 111.293 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 59.9 Cg_endo -72.64 112.06 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.633 2.222 . . . . 54.41 112.988 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.46 143.38 98.19 Favored Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 112.529 0.566 . . . . 63.24 112.529 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.89 -165.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.793 2.329 . . . . 71.42 112.675 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 138.39 31.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.937 0.399 . . . . 71.22 111.502 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.86 162.88 38.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.144 0.497 . . . . 74.33 112.148 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 95.5 p -140.76 151.0 44.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.973 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.689 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -153.01 170.64 32.02 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.527 -0.844 . . . . 74.21 113.839 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -100.93 124.34 46.48 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.744 0.307 . . . . 61.13 111.388 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.47 130.75 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 75.41 111.194 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.04 126.36 52.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.977 0.418 . . . . 64.15 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 139' ' ' LEU . 10.4 p90 -127.95 121.14 29.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 63.14 111.193 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.92 -159.29 9.57 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.092 -0.575 . . . . 62.03 113.085 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB2' HG13 ' A' ' 114' ' ' ILE . 77.2 mt-30 -119.22 156.53 29.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.007 0.432 . . . . 45.22 111.896 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.2 mt -112.96 129.39 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.125 -0.489 . . . . 73.24 110.998 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -114.14 30.09 7.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.055 0.391 . . . . 74.53 112.055 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -151.83 -157.86 8.12 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.652 -0.785 . . . . 73.35 113.461 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.3 p -105.77 -164.47 1.02 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.529 0.332 . . . . 73.13 111.613 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.416 HG22 ' HE3' ' A' ' 40' ' ' LYS . 50.0 mm -66.18 -40.57 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.877 0.695 . . . . 72.45 112.877 -175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -94.09 -42.7 8.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.311 0.486 . . . . 73.41 112.311 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.76 99.81 7.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.332 0.587 . . . . 73.41 111.807 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.89 148.11 26.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.902 -0.59 . . . . 72.34 111.493 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -113.69 136.9 52.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.907 0.384 . . . . 63.24 110.912 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.49 103.91 13.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.194 0.521 . . . . 74.44 111.189 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.473 HG13 ' HB2' ' A' ' 103' ' ' GLN . 45.2 pt -109.28 155.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 116.447 -0.342 . . . . 50.14 111.889 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 51.89 39.32 25.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.187 0.517 . . . . 72.23 111.837 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.32 123.66 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.175 0.512 . . . . 74.2 111.904 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.15 160.31 17.69 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.087 -0.506 . . . . 65.21 110.442 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.31 145.01 51.19 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.251 0.463 . . . . 64.12 112.251 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -140.91 166.32 25.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.959 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -107.64 121.79 45.38 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.814 0.34 . . . . 73.25 111.791 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.559 HG22 HD21 ' A' ' 137' ' ' LEU . 32.2 pt -95.05 107.58 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.203 0.525 . . . . 73.34 111.369 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.53 101.88 13.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.881 0.372 . . . . 73.42 111.004 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.11 140.73 21.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.862 0.319 . . . . 54.5 111.862 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.41 168.47 21.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.832 2.355 . . . . 75.51 113.466 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.29 146.11 31.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.225 0.454 . . . . 61.44 112.225 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.0 m -93.34 155.81 17.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.138 0.495 . . . . 74.32 112.02 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.0 t -105.51 -47.45 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.958 -0.565 . . . . 44.41 111.682 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.35 173.5 6.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.352 0.596 . . . . 72.35 112.165 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.96 142.34 45.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.741 -0.663 . . . . 74.33 111.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.87 162.93 90.34 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 123.809 -1.33 . . . . 74.51 112.931 -1.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 38.6 m -100.59 108.39 20.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.181 0.438 . . . . 74.4 112.181 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.78 93.09 4.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.579 0.351 . . . . 72.31 110.209 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.57 111.28 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.354 0.261 . . . . 71.33 111.341 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.501 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -117.01 143.69 45.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.287 0.565 . . . . 74.34 112.047 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.7 pt -137.63 136.35 20.11 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.707 -0.679 . . . . 73.34 111.608 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.97 137.28 19.45 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.694 2.263 . . . . 65.14 113.382 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.559 HD21 HG22 ' A' ' 121' ' ' ILE . 20.4 mt -120.54 114.83 22.33 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.125 0.417 . . . . 73.32 112.125 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -91.66 93.73 9.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.963 0.411 . . . . 74.05 110.245 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 46.7 mt -74.33 120.89 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 63.11 110.053 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.2 mtmt -102.33 141.47 35.11 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.396 0.517 . . . . 64.32 112.396 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.29 10.43 86.01 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.211 -0.519 . . . . 61.43 113.885 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.5 tt -143.63 122.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.346 0.593 . . . . 71.0 111.847 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -76.77 155.54 33.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.395 -0.366 . . . . 73.34 111.416 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.4 -40.1 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.117 0.484 . . . . 73.24 111.407 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.53 -23.39 66.86 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.057 0.456 . . . . 72.51 111.47 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -89.47 1.13 56.29 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.226 0.454 . . . . 53.12 112.226 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.3 mt -81.43 125.83 30.91 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.237 0.541 . . . . 74.31 111.872 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.82 -54.28 0.68 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.652 -0.704 . . . . 70.12 112.284 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.13 150.02 37.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.752 0.31 . . . . 70.4 111.332 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.8 102.97 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.1 110.546 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -91.53 116.31 28.75 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.004 0.372 . . . . 61.2 112.004 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.639 HG21 ' SD ' ' A' ' 66' ' ' MET . 11.2 mm -100.48 119.63 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 110.045 -0.354 . . . . 73.52 110.045 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.513 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 15.5 p80 -143.78 177.94 8.17 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.729 1.011 . . . . 74.13 113.729 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 74.64 -74.66 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.771 -1.104 . . . . 71.31 111.769 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.689 HD13 ' HA3' ' A' ' 97' ' ' GLY . 46.7 mm 39.83 82.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.602 0.715 . . . . 70.1 112.376 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.431 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.6 pt20 -110.09 150.54 41.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.451 -0.795 . . . . 60.22 111.557 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.504 ' HG3' HG22 ' A' ' 61' ' ' ILE . 8.4 Cg_exo -71.23 128.19 14.38 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.51 2.14 . . . . 43.24 112.715 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.65 2.95 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.808 0.813 . . . . 72.53 111.081 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 59.5 mtt -100.98 152.9 20.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.784 -1.098 . . . . 43.3 110.189 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -69.58 96.38 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.179 0.514 . . . . 73.33 111.78 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.4 pt? -71.07 140.13 50.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 74.04 111.044 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.11 -175.18 5.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.823 0.344 . . . . 63.35 111.251 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -127.17 160.42 31.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.127 0.489 . . . . 73.52 111.827 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -134.21 160.76 36.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.212 -0.449 . . . . 73.12 111.426 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -137.02 152.7 50.42 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.904 0.335 . . . . 73.51 111.904 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -153.95 139.76 18.09 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.126 0.417 . . . . 74.24 112.126 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -81.77 -55.25 4.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.378 0.608 . . . . 74.32 109.907 170.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.57 -0.728 . . . . 70.54 110.95 176.491 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.652 0.263 . . . . 75.35 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -81.24 129.3 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.009 0.433 . . . . 74.45 111.701 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -104.5 84.03 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.085 0.469 . . . . 54.05 110.916 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -91.46 -176.32 4.49 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.146 0.498 . . . . 63.42 111.94 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -76.21 104.79 6.9 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.031 0.443 . . . . 74.45 112.124 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -117.58 120.04 36.85 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.232 -0.44 . . . . 64.21 110.671 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.16 150.53 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.363 0.602 . . . . 62.54 112.525 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 8' ' ' ARG . 40.3 mtt180 -118.56 -170.65 1.94 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.055 -0.521 . . . . 73.43 111.161 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.69 159.79 33.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.175 0.512 . . . . 74.2 111.64 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.5 mmt -95.46 140.9 29.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.993 0.425 . . . . 74.52 111.509 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -111.43 -174.57 2.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.927 0.394 . . . . 61.0 111.09 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -163.21 154.62 17.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.553 -0.294 . . . . 72.12 111.194 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 t -83.26 -174.72 5.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.814 0.34 . . . . 64.24 111.321 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.64 118.93 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 121.201 0.524 . . . . 74.11 111.424 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -100.94 121.18 41.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.337 -0.392 . . . . 74.4 111.497 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.0 p -136.42 102.35 4.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.594 0.358 . . . . 70.02 110.836 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.4 mt -78.59 168.61 19.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.072 0.463 . . . . 71.01 112.113 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -118.24 168.56 10.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.043 0.449 . . . . 74.54 111.47 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -123.65 135.15 53.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.205 -0.452 . . . . 61.35 111.155 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.97 121.73 20.56 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.782 0.325 . . . . 72.11 110.791 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.09 176.96 8.08 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.521 0.563 . . . . 72.51 112.521 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.0 p -100.29 -158.0 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.879 -0.6 . . . . 54.34 111.802 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -73.73 -177.89 2.95 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.641 0.734 . . . . 73.22 112.817 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.12 144.15 33.32 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.495 -0.775 . . . . 61.22 111.017 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.498 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.8 m-80 -122.23 160.42 25.26 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.74 -0.209 . . . . 63.4 110.747 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 16.1 mm100 -57.72 -44.09 85.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.724 0.297 . . . . 65.43 111.496 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -58.85 -45.36 90.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.015 0.436 . . . . 73.33 110.711 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.3 m -59.85 -31.96 70.24 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.082 -0.508 . . . . 72.24 110.982 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 25' ' ' ASN . 87.8 t -64.54 -50.35 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.709 -0.223 . . . . 74.14 110.935 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 4.7 mptp? -55.47 -47.24 76.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.017 0.437 . . . . 62.3 110.854 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 53' ' ' THR . 73.7 mt -55.17 -53.64 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.131 -0.486 . . . . 75.45 111.337 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.7 m -56.65 -47.82 78.91 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.258 -0.428 . . . . 73.33 111.625 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -58.83 -39.92 82.64 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.984 -0.553 . . . . 70.2 111.363 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.89 -47.66 85.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.722 0.296 . . . . 74.31 111.181 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -57.87 -41.69 82.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.931 0.396 . . . . 70.41 111.148 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.4 mmp_? -60.57 -54.55 44.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.949 0.404 . . . . 74.33 111.568 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.88 -36.05 83.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.991 0.424 . . . . 73.24 111.683 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -63.95 -35.18 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.843 0.354 . . . . 73.44 111.043 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.05 60.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.949 0.404 . . . . 71.23 111.362 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HE3' HG22 ' A' ' 108' ' ' ILE . 62.5 mttm -90.69 -3.9 57.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 73.03 111.572 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 108.63 4.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.145 0.498 . . . . 55.41 112.061 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.5 p -91.98 -1.33 57.31 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.162 -0.472 . . . . 73.22 111.696 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.6 p -153.71 102.9 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.783 0.325 . . . . 75.32 111.23 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 -145.47 28.0 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.941 -0.647 . . . . 64.34 112.692 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 57' ' ' LEU . 17.9 m -134.29 139.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.336 -0.508 . . . . 72.31 112.333 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.55 106.91 18.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.924 -0.58 . . . . 71.43 111.455 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.54 148.78 23.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.989 -0.375 . . . . 63.1 109.989 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.78 130.79 23.48 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.369 . . . . 63.41 111.466 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.645 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 66.2 Cg_endo -72.2 28.36 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.208 2.605 . . . . 54.44 113.805 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.35 12.93 2.05 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.493 -0.384 . . . . 70.33 112.3 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.13 115.72 18.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 73.14 111.551 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -69.07 8.66 0.52 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.675 0.621 . . . . 72.12 112.675 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.435 HG21 HG23 ' A' ' 31' ' ' ILE . 1.5 p -90.81 145.25 31.62 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.584 0.587 . . . . 72.14 112.584 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 75.1 Cg_endo -81.97 -178.28 4.03 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.168 2.578 . . . . 45.42 114.029 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.31 145.64 29.42 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.811 -0.631 . . . . 72.52 111.389 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -80.83 112.25 18.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.415 -0.357 . . . . 71.45 111.185 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.495 HD13 HG13 ' A' ' 45' ' ' VAL . 56.1 tp -117.95 120.64 38.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.296 0.569 . . . . 73.2 111.534 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -83.85 115.09 22.09 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.615 . . . . 72.34 110.701 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -114.08 179.14 4.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.124 0.487 . . . . 64.35 111.512 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -79.19 0.12 29.66 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.197 0.443 . . . . 73.53 112.197 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 92' ' ' LEU . 37.5 pt -109.61 5.27 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.231 0.539 . . . . 62.24 110.551 171.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.13 -171.35 13.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.99 -0.55 . . . . 62.22 112.731 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -77.87 134.33 37.97 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.485 -0.421 . . . . 43.45 111.257 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.48 152.96 48.76 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.333 0.587 . . . . 65.31 111.427 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HD2' ' OE1' ' A' ' 85' ' ' GLN . 39.8 ttm180 -109.63 107.1 17.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.957 -0.565 . . . . 74.13 111.325 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.0 mtt -98.96 138.07 36.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.76 0.314 . . . . 63.51 111.785 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 42.3 t -139.15 161.77 36.59 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.392 -0.367 . . . . 70.0 111.614 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 80' ' ' LEU . 89.8 mt -113.79 108.95 17.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.951 0.405 . . . . 75.41 111.768 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 81' ' ' THR . 35.6 m -117.25 161.53 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.7 0.286 . . . . 74.51 111.284 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 65.14 22.76 12.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.488 0.551 . . . . 74.33 112.488 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 49' ' ' PRO . 51.4 mt -61.84 114.78 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 111.948 0.351 . . . . 73.04 111.948 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -145.09 154.49 54.49 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 112.32 0.489 . . . . 74.34 112.32 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.68 136.62 33.67 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.503 2.135 . . . . 72.5 112.67 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.499 ' HB2' HG23 ' A' ' 79' ' ' THR . 34.7 t70 -107.69 159.06 16.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.826 0.346 . . . . 72.21 111.123 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.93 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.068 0.461 . . . . 53.33 111.647 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -86.95 -55.06 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.297 0.57 . . . . 72.12 110.131 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.21 -94.42 0.16 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.116 -0.564 . . . . 54.51 113.343 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -149.21 136.19 19.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.375 -0.486 . . . . 51.14 111.702 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 74' ' ' ASP . 32.4 p -116.08 129.97 56.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.288 0.566 . . . . 74.22 111.939 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.666 HD13 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -142.34 150.75 41.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.006 -0.543 . . . . 72.53 111.236 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.596 ' HB ' HG23 ' A' ' 69' ' ' VAL . 30.9 m -92.89 112.16 24.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.871 0.367 . . . . 71.42 111.687 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.3 112.97 22.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.773 -0.454 . . . . 64.51 109.773 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' MET . 83.6 mtt180 -110.64 133.82 52.98 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.144 0.424 . . . . 73.03 112.144 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.457 HG13 ' HG2' ' A' ' 66' ' ' MET . 4.0 mp -113.66 109.36 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.072 -0.513 . . . . 75.5 111.175 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 97.6 mt-30 -93.25 143.61 26.1 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.927 0.394 . . . . 63.01 111.193 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.13 146.85 23.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.28 -0.486 . . . . 75.31 114.013 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.8 -46.02 59.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.664 0.386 . . . . 72.14 111.969 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -102.45 179.9 4.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.307 0.575 . . . . 71.14 112.222 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -84.87 10.19 12.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.789 -0.641 . . . . 73.12 111.223 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.96 145.75 31.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.078 -0.51 . . . . 74.51 110.864 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.73 131.54 14.75 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.461 2.107 . . . . 72.3 112.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.479 ' HB3' HD12 ' A' ' 61' ' ' ILE . 94.3 mt -79.75 147.63 67.26 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.681 0.277 . . . . 62.31 111.534 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 16.3 Cg_exo -69.83 -178.13 2.22 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.891 2.394 . . . . 72.43 113.07 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -78.14 132.34 37.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.568 -0.287 . . . . 72.11 111.412 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.56 170.24 16.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 75.24 112.342 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.3 p -153.65 157.02 38.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.041 -0.527 . . . . 74.5 110.516 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.609 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -161.64 -173.67 30.58 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.717 -0.754 . . . . 75.04 113.787 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -120.59 142.94 48.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.76 0.315 . . . . 53.53 110.806 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.0 128.83 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.053 0.454 . . . . 54.1 112.034 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 11.1 mm-40 -95.82 113.04 24.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.011 -0.54 . . . . 75.24 110.039 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 44.6 p90 -124.31 127.9 48.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.874 -0.516 . . . . 53.3 111.965 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.59 -154.26 9.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.075 -0.583 . . . . 70.43 113.263 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -113.31 152.12 30.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.202 0.525 . . . . 74.22 111.944 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.565 HG23 ' HB2' ' A' ' 111' ' ' PHE . 66.3 mt -108.45 106.82 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.008 -0.542 . . . . 73.33 111.037 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -92.64 22.53 4.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.039 0.385 . . . . 75.31 112.039 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -136.66 -165.38 10.49 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.894 -0.67 . . . . 63.21 113.446 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.5 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 11.2 p -87.69 -161.72 0.74 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.703 0.287 . . . . 71.33 111.035 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.646 HG22 ' HE3' ' A' ' 40' ' ' LYS . 51.4 mm -85.67 -28.64 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.878 0.371 . . . . 64.34 111.087 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -91.49 -40.84 11.17 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.02 0.378 . . . . 75.43 112.02 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -127.47 96.89 4.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.444 0.64 . . . . 73.43 110.881 175.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.644 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.5 p90 -118.93 144.94 46.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.906 -0.588 . . . . 72.51 111.912 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -115.27 131.44 56.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.923 -0.58 . . . . 61.31 110.244 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -96.57 113.6 25.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.983 0.421 . . . . 74.34 111.822 -174.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.9 pt -121.1 164.64 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.406 -0.361 . . . . 64.22 111.365 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.07 29.06 11.76 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.984 0.421 . . . . 70.12 111.526 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 4.8 p -94.04 124.64 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.275 0.56 . . . . 75.3 112.218 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -113.19 155.7 24.56 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.884 -0.598 . . . . 62.15 110.758 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -104.78 139.88 38.91 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.154 -0.476 . . . . 62.21 111.202 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -138.58 146.48 41.87 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.708 0.289 . . . . 52.22 111.464 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.93 116.71 27.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.032 0.444 . . . . 54.24 111.825 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 121' ' ' ILE . 23.5 pt -106.7 105.06 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 71.44 111.15 176.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.98 132.61 51.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.281 -0.418 . . . . 61.54 111.065 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -121.51 145.78 43.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.75 0.31 . . . . 72.31 111.828 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.6 174.79 12.26 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.655 2.237 . . . . 64.22 113.001 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -80.82 135.77 36.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.015 0.436 . . . . 63.32 111.872 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.2 m -70.69 126.35 29.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.161 -0.472 . . . . 74.35 111.332 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.617 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -97.91 -35.78 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.104 0.779 . . . . 63.55 113.104 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.617 ' HG ' HG23 ' A' ' 127' ' ' VAL . 92.5 mt -125.62 120.36 30.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.726 0.298 . . . . 75.32 110.93 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.95 68.71 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 112.52 0.563 . . . . 63.34 112.52 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.98 167.52 78.41 Favored 'Cis proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.243 -1.149 . . . . 74.11 112.93 -1.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 49.2 m -75.62 133.73 40.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.857 0.361 . . . . 75.22 111.773 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.47 31.37 1.9 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.996 -0.547 . . . . 75.05 111.239 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' A' ' 123' ' ' ALA . 59.3 t -52.1 115.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.699 0.629 . . . . 71.42 112.699 -174.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.81 114.57 28.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.197 0.523 . . . . 72.11 111.733 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.1 pt -122.87 136.68 27.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.973 0.416 . . . . 61.32 112.094 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.14 135.84 14.07 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.744 2.296 . . . . 74.32 112.942 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.2 113.02 20.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.495 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -103.04 118.9 37.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.219 0.533 . . . . 71.23 112.114 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.2 mt -99.93 142.84 30.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.859 0.464 . . . . 74.44 110.692 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -102.9 144.01 31.75 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.581 0.585 . . . . 74.52 112.581 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.91 -43.27 1.92 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.971 0.749 . . . . 61.33 114.971 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.488 HD13 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -88.83 122.91 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.565 0.698 . . . . 74.12 111.993 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.6 m -82.04 154.97 25.36 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.984 -0.553 . . . . 74.21 111.205 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.585 ' HA ' HD12 ' A' ' 147' ' ' LEU . 9.0 p -57.23 -36.73 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.898 0.38 . . . . 61.5 111.733 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.6 -27.62 68.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.222 0.534 . . . . 52.01 111.208 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -94.32 0.14 55.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.243 0.461 . . . . 64.11 112.243 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.645 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.2 mt -78.73 142.1 37.33 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.101 0.477 . . . . 75.12 112.211 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.88 -56.61 0.29 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.989 -0.55 . . . . 54.04 113.129 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.496 ' HB3' HD11 ' A' ' 104' ' ' ILE . 38.7 p90 -139.33 159.3 42.48 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.323 -0.516 . . . . 71.51 112.103 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 67.4 t -134.19 96.4 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.9 -0.591 . . . . 65.32 110.415 175.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 20.4 ttm180 -93.39 112.77 24.77 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.123 -0.361 . . . . 72.51 111.969 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.63 HG21 ' SD ' ' A' ' 66' ' ' MET . 37.0 mm -89.71 138.11 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 122.205 -0.31 . . . . 74.15 111.296 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -163.58 -177.22 5.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.871 0.323 . . . . 62.23 111.871 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 65.2 20.64 11.98 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.924 0.712 . . . . 74.0 112.924 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.609 HD13 ' HA3' ' A' ' 97' ' ' GLY . 47.4 mm -69.9 103.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.393 0.616 . . . . 53.13 111.927 -177.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -136.38 153.95 76.66 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.831 -0.622 . . . . 75.42 111.149 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.79 153.81 70.16 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.635 2.224 . . . . 64.24 113.329 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.79 -171.56 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.979 0.418 . . . . 50.42 111.878 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.498 ' N ' ' SD ' ' A' ' 159' ' ' MET . 3.3 mpp? -73.21 83.15 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.081 0.467 . . . . 73.13 111.455 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -94.79 129.96 41.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 74.25 110.203 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 161' ' ' LEU . 7.0 mp -75.93 106.9 7.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.941 0.4 . . . . 61.41 111.931 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.49 -173.43 2.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.402 -0.363 . . . . 54.04 110.807 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -125.31 121.44 34.0 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.033 0.444 . . . . 44.22 110.941 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -83.64 157.32 22.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.584 0.587 . . . . 74.43 112.584 -170.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -161.08 140.14 10.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.205 -0.452 . . . . 73.33 111.652 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -103.02 161.84 13.43 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.833 0.349 . . . . 75.33 110.604 171.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -137.62 13.17 2.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.869 0.322 . . . . 74.05 111.869 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 122.834 0.454 . . . . 73.13 111.985 -176.338 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.714 0.292 . . . . 71.2 111.503 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.24 147.41 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.652 0.263 . . . . 74.22 110.786 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.58 161.15 26.82 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.159 0.504 . . . . 72.21 112.122 -174.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.91 134.13 35.67 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.076 -0.511 . . . . 70.44 110.712 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 p -96.68 97.95 9.77 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.356 0.598 . . . . 74.3 111.56 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.57 104.74 17.19 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.209 -0.451 . . . . 72.1 111.103 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.16 176.24 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.384 0.611 . . . . 44.42 112.57 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -119.02 149.88 40.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.902 -0.59 . . . . 73.31 110.936 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -142.12 134.39 27.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.808 0.337 . . . . 71.21 111.682 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 62.1 mtt -110.42 -172.85 2.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.817 0.341 . . . . 65.2 111.299 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -99.5 167.61 10.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.22 0.533 . . . . 65.21 111.967 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -139.15 157.62 45.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.224 -0.444 . . . . 72.42 111.229 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.8 p -130.87 140.95 50.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.796 0.331 . . . . 63.42 111.376 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.77 139.81 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 54.24 111.327 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -132.41 141.56 48.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.324 -0.398 . . . . 65.33 110.903 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -97.35 101.34 12.86 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 75.53 111.192 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.62 111.09 22.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.925 0.393 . . . . 71.41 111.042 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.74 113.72 8.1 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.332 0.587 . . . . 72.42 111.304 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -140.94 171.92 13.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.753 -0.658 . . . . 51.25 111.308 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.08 142.14 39.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.102 0.477 . . . . 74.21 110.992 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.2 ttp -125.21 155.65 39.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 72.41 110.464 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -58.89 140.23 55.6 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.252 -0.277 . . . . 73.13 110.252 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -53.68 111.48 0.74 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.28 0.562 . . . . 72.1 111.725 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -60.22 146.16 44.64 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.408 -0.814 . . . . 75.44 112.163 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 29' ' ' VAL . 36.4 m-80 -47.17 125.02 7.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.192 -0.458 . . . . 52.51 111.338 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -53.89 -33.63 57.07 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.049 0.452 . . . . 74.32 111.137 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.62 -53.11 62.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.953 -0.567 . . . . 73.43 111.005 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -64.68 -29.94 70.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.266 -0.424 . . . . 72.52 111.331 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 25' ' ' ASN . 99.0 t -64.05 -46.73 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.533 -0.303 . . . . 62.15 110.619 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 71.9 mmtt -63.02 -38.81 92.69 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.408 -0.36 . . . . 73.44 111.504 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.19 -48.94 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.329 0.585 . . . . 64.22 110.742 173.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.3 m -62.79 -39.47 94.34 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.932 -0.577 . . . . 74.15 110.991 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.484 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 62.8 tt0 -63.29 -45.08 93.05 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.139 -0.482 . . . . 73.04 110.919 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.3 tt0 -58.63 -50.84 72.35 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.849 0.315 . . . . 72.43 111.849 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -58.8 -43.51 90.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.86 0.362 . . . . 70.01 111.798 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -68.87 -43.49 75.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.623 0.249 . . . . 70.11 111.571 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 33' ' ' GLN . 56.3 mt -65.84 -32.84 74.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.984 0.421 . . . . 72.32 110.657 175.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -61.65 -30.64 70.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.148 -0.478 . . . . 72.13 110.556 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.29 -36.25 61.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.756 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.88 -32.81 63.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.337 0.495 . . . . 54.4 112.337 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -55.5 105.68 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.888 0.699 . . . . 73.5 112.888 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -79.6 -22.72 43.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.176 -0.466 . . . . 63.12 111.18 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB3' HH21 ' A' ' 151' ' ' ARG . 30.5 t -124.98 99.15 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 73.34 111.13 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 79.59 -143.38 25.68 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.973 -0.558 . . . . 75.44 113.916 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 28.3 m -140.52 144.96 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.993 0.425 . . . . 75.3 111.873 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 73.5 m-85 -89.89 99.1 12.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.529 -0.305 . . . . 72.0 111.172 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.4 110.08 20.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.885 0.374 . . . . 70.2 110.628 173.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.01 115.79 63.83 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 122.278 -0.264 . . . . 75.51 110.965 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 30.5 Cg_endo -64.24 -7.1 12.95 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.523 2.149 . . . . 72.34 113.281 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 -2.31 55.72 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.455 -0.403 . . . . 65.34 112.666 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.72 115.72 30.72 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.683 -0.304 . . . . 72.14 111.09 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -79.21 61.54 3.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.316 0.579 . . . . 64.4 110.659 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -155.45 151.56 22.72 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 115.798 -0.637 . . . . 73.2 111.662 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 63.6 Cg_endo -85.85 -178.61 2.98 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.128 2.552 . . . . 72.02 113.858 178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.05 138.98 18.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.873 -0.603 . . . . 63.14 110.959 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -89.14 131.74 35.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.242 0.544 . . . . 75.24 112.459 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.7 135.81 40.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.779 -0.646 . . . . 74.43 110.738 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 49.0 tt0 -93.18 128.55 39.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.947 -0.471 . . . . 63.33 111.262 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.8 p -97.13 179.81 4.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.356 -0.384 . . . . 64.11 110.58 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.718 HE21 ' HB3' ' A' ' 156' ' ' GLN . 38.2 mt-30 -83.24 -1.79 53.98 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.144 -0.348 . . . . 62.33 111.778 178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.466 HG23 ' HD3' ' A' ' 157' ' ' PRO . 38.1 pt -103.94 -32.44 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.713 0.292 . . . . 74.24 110.979 171.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.23 172.9 39.17 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.52 -0.371 . . . . 51.43 112.946 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 95.6 m -78.6 138.26 38.26 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.318 -0.519 . . . . 74.45 111.402 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.91 171.73 13.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.187 0.518 . . . . 63.01 111.775 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.91 120.73 25.34 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.296 -0.411 . . . . 74.45 110.919 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.3 mtt -105.42 152.36 23.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.967 0.413 . . . . 35.5 112.094 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 84.5 p -149.29 143.29 25.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.364 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 82' ' ' LEU . 91.6 mt -96.78 100.45 11.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.934 0.397 . . . . 71.3 111.285 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.41 152.75 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.667 0.27 . . . . 74.04 111.013 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 11.4 m120 57.13 76.47 0.31 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.0 0.429 . . . . 74.21 111.166 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mt -109.36 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.513 -0.312 . . . . 72.21 111.402 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 p -129.89 152.54 80.08 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 73.11 111.714 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 165.57 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.833 2.355 . . . . 64.43 113.804 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.634 ' HB2' HG23 ' A' ' 79' ' ' THR . 33.3 t70 -139.66 170.35 16.05 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.862 -0.608 . . . . 73.23 110.673 -178.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.84 -44.63 91.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.883 0.327 . . . . 62.02 111.883 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -91.03 -31.92 16.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.183 0.438 . . . . 74.33 112.183 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.51 0.15 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.586 -0.816 . . . . 64.24 113.901 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -144.9 135.82 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.061 0.457 . . . . 75.24 111.903 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.634 HG23 ' HB2' ' A' ' 74' ' ' ASP . 46.3 p -110.24 132.88 53.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.344 -0.389 . . . . 73.2 111.167 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 2.8 pp -142.41 160.06 41.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.003 0.43 . . . . 73.2 112.052 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 m -97.96 113.44 25.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 65.12 111.469 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 68' ' ' LEU . 3.0 tm? -92.78 109.53 20.96 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.137 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 90.2 mtt180 -99.04 121.85 41.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.461 0.541 . . . . 74.24 112.461 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.6 mp -104.97 117.4 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.709 -0.678 . . . . 74.24 111.387 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -112.04 117.51 32.87 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.693 0.282 . . . . 74.15 110.415 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.14 142.64 29.71 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.254 -0.498 . . . . 54.31 113.707 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.91 -44.63 84.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.289 0.566 . . . . 74.34 109.909 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -67.88 124.26 22.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.892 -0.595 . . . . 41.45 110.858 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.421 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 21.5 m-80 -68.89 -15.8 63.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.4 . . . . 72.3 111.475 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.18 154.55 63.55 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 116.183 -0.462 . . . . 72.42 111.872 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 41.3 Cg_endo -65.4 130.85 26.32 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.022 2.481 . . . . 74.34 114.233 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.4 mt -103.43 151.61 38.66 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.046 -0.525 . . . . 73.54 111.357 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 174.93 11.94 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.514 2.143 . . . . 74.23 113.226 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.57 134.34 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.069 0.461 . . . . 23.54 112.029 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -132.32 155.48 48.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.409 0.623 . . . . 70.5 111.993 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -147.15 170.64 16.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.81 -0.632 . . . . 75.44 110.603 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -176.91 -175.17 44.0 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.252 -0.975 . . . . 44.54 113.69 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.9 m -103.05 139.09 39.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.956 0.408 . . . . 61.2 111.087 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.58 129.8 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.215 0.531 . . . . 75.25 111.787 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.801 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.2 mm-40 -90.87 139.43 30.75 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.882 -0.599 . . . . 74.03 109.692 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.479 ' CG ' HD22 ' A' ' 139' ' ' LEU . 28.5 p90 -146.04 122.96 11.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 71.25 111.695 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.79 -146.9 5.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.574 -0.739 . . . . 52.2 112.894 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.597 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 89.8 mt-30 -123.74 151.01 43.69 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.134 0.492 . . . . 60.44 111.981 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.2 133.69 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.106 -0.497 . . . . 75.41 111.252 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 11.2 pt20 -121.7 98.87 6.16 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.525 0.679 . . . . 75.21 110.982 171.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 151.21 -162.82 29.63 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.123 -0.56 . . . . 43.23 113.675 176.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.6 p -108.0 -169.86 1.59 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.068 0.547 . . . . 74.42 111.657 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.67 -47.04 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.1 0.476 . . . . 75.04 111.518 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -71.46 -48.07 51.63 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.195 0.443 . . . . 60.22 112.195 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -128.53 110.9 12.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.567 0.699 . . . . 62.22 112.627 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -140.48 154.5 46.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.735 -0.666 . . . . 73.23 111.157 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -122.86 134.37 54.39 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.135 0.493 . . . . 74.33 111.806 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -87.43 104.78 16.77 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.839 -0.619 . . . . 72.44 111.095 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.0 pt -113.93 162.67 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.18 0.192 . . . . 71.14 111.205 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 54.01 30.27 11.53 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.905 0.383 . . . . 62.55 111.973 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.84 124.34 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.313 0.578 . . . . 71.53 112.308 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -113.55 163.12 15.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.105 -0.498 . . . . 64.03 110.728 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -111.72 140.11 46.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 64.42 111.601 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -140.33 160.3 40.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.888 0.375 . . . . 61.24 111.272 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.83 136.75 41.14 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.026 -0.421 . . . . 75.41 111.712 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.27 141.05 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.578 -0.283 . . . . 74.1 110.886 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.28 115.94 17.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.806 0.336 . . . . 62.54 111.163 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 135' ' ' ILE . . . -110.49 137.2 20.63 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.019 0.377 . . . . 64.2 112.019 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.85 165.24 31.75 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.585 2.19 . . . . 42.14 113.255 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.82 24.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.843 0.683 . . . . 72.22 112.843 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 m -93.61 112.04 23.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.086 -0.507 . . . . 72.02 110.53 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.33 -48.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.072 0.463 . . . . 73.2 111.23 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.01 151.52 25.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 73.13 110.852 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.47 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -77.31 149.35 78.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.391 -0.368 . . . . 54.11 111.565 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.27 179.33 25.87 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.956 -1.268 . . . . 73.44 113.158 -0.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 49.2 m -87.59 86.75 7.24 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.465 -0.334 . . . . 74.35 111.655 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 22.2 p-10 -130.54 114.78 15.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.708 0.766 . . . . 73.54 111.567 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 134' ' ' ASP . 21.9 t -126.44 162.62 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.88 -0.6 . . . . 73.51 110.458 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 2.8 p-10 -142.53 137.24 30.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.03 0.443 . . . . 72.54 111.101 172.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 123' ' ' ALA . 20.4 pt -131.06 131.98 23.53 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 120.801 0.334 . . . . 73.02 111.722 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.64 110.28 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.129 1.886 . . . . 73.42 112.56 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -92.57 127.47 38.07 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.47 -0.786 . . . . 75.42 110.387 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -103.72 101.11 10.94 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.983 0.42 . . . . 75.11 111.546 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.479 HD22 ' CG ' ' A' ' 101' ' ' TYR . 68.1 mt -85.97 128.1 34.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.085 -0.339 . . . . 72.55 110.085 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -119.22 141.22 49.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.104 0.478 . . . . 74.4 112.059 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.16 19.31 50.89 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.183 -0.462 . . . . 72.43 113.394 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.574 HD13 HD23 ' A' ' 147' ' ' LEU . 21.2 tt -155.71 134.07 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.08 0.467 . . . . 75.21 112.06 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m -78.75 154.18 30.2 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.296 -0.411 . . . . 73.31 111.93 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.41 -46.07 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.574 0.583 . . . . 64.22 112.574 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.57 -17.28 60.1 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.198 0.523 . . . . 75.12 110.927 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.507 ' HB3' HE21 ' A' ' 103' ' ' GLN . 87.3 mm-40 -93.31 7.37 44.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.368 -0.378 . . . . 61.43 111.642 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.59 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 29.6 mt -75.95 111.53 11.42 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.207 0.527 . . . . 73.43 111.357 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -86.45 -47.74 4.78 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.225 -0.512 . . . . 71.44 112.946 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.95 151.43 25.42 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.131 0.491 . . . . 72.13 112.223 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.35 97.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.808 -0.633 . . . . 54.33 109.738 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 ttt180 -94.87 99.41 11.46 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.309 0.485 . . . . 63.03 112.309 -172.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.556 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 11.9 mm -79.78 139.97 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 64.44 111.014 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -162.17 166.58 25.41 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.824 0.676 . . . . 64.04 112.824 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.84 37.11 15.65 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.962 0.727 . . . . 73.55 112.962 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -73.11 113.5 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.405 0.621 . . . . 74.34 111.283 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.718 ' HB3' HE21 ' A' ' 60' ' ' GLN . 10.6 pt20 -138.69 164.0 42.82 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.506 -0.77 . . . . 73.54 111.172 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.466 ' HD3' HG23 ' A' ' 61' ' ' ILE . 29.8 Cg_endo -63.03 146.18 94.54 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.01 1.807 . . . . 73.25 112.652 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.13 19.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 112.494 0.553 . . . . 55.12 112.494 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 21.6 ptp -145.97 -167.8 2.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.257 0.551 . . . . 75.31 112.287 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.582 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 10.6 pt20 -71.1 -169.97 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.532 -0.758 . . . . 74.12 111.731 174.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.582 ' HG ' ' HG3' ' A' ' 160' ' ' GLN . 81.0 mt 63.14 28.82 16.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.211 -0.449 . . . . 72.42 112.122 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.35 147.37 53.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.089 0.471 . . . . 65.54 111.62 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -161.63 114.03 1.81 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.992 -0.549 . . . . 65.44 110.711 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -72.88 148.35 44.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.99 -0.55 . . . . 75.42 112.051 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -90.05 -79.51 0.34 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.436 0.532 . . . . 64.21 112.436 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -128.68 -171.98 2.6 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.467 0.543 . . . . 65.44 112.467 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 71.0 70.84 0.18 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.36 0.664 . . . . 73.11 109.834 -169.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 . . . . . 0 C--O 1.255 1.371 0 CA-C-N 115.795 -0.639 . . . . 70.24 111.605 -178.618 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 tpp . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.973 0.416 . . . . 73.45 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 125.65 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.029 0.443 . . . . 72.21 110.896 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.63 137.58 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.075 0.464 . . . . 61.14 111.567 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.32 176.14 9.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.136 -0.484 . . . . 61.13 111.207 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 t -171.33 120.92 0.51 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.923 0.392 . . . . 71.25 111.953 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -127.68 -176.21 3.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.123 0.487 . . . . 63.43 111.63 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.52 166.49 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.351 0.596 . . . . 65.24 112.408 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -107.47 121.97 45.68 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 72.11 110.517 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -82.25 165.1 20.71 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.734 0.642 . . . . 64.25 112.734 -174.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.29 -178.83 4.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.852 -0.613 . . . . 64.52 111.303 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -140.17 153.83 46.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.39 0.515 . . . . 61.24 112.39 -176.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -125.53 143.51 50.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.121 -0.491 . . . . 72.24 110.55 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -72.0 -176.18 1.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.156 0.503 . . . . 60.13 112.202 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.2 p -118.13 146.13 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.977 0.418 . . . . 61.3 111.658 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -84.86 127.47 34.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.902 0.382 . . . . 72.23 111.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -95.64 118.32 32.11 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.537 -0.302 . . . . 73.44 111.773 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.87 153.09 43.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.864 0.364 . . . . 71.05 111.393 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.45 118.85 25.23 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.263 0.554 . . . . 72.51 112.447 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -110.04 168.67 9.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.037 -0.529 . . . . 73.04 111.082 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -53.42 107.2 0.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.2 0.524 . . . . 74.15 111.965 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.5 ptp -79.9 169.71 17.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.309 0.576 . . . . 64.35 112.265 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -95.91 -162.37 0.95 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.92 -0.582 . . . . 65.54 111.765 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -70.01 -164.98 0.08 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.244 0.545 . . . . 74.3 112.328 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 tp -58.43 137.53 57.24 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.209 -0.451 . . . . 72.54 111.431 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.2 m-80 -111.67 154.9 24.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.612 -0.267 . . . . 73.15 111.122 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -54.01 -38.61 65.29 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.327 0.491 . . . . 54.14 112.327 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.54 -52.8 60.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.16 0.505 . . . . 65.01 110.93 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 31' ' ' ILE . 25.2 m -69.05 -28.69 66.77 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 72.33 111.548 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 25' ' ' ASN . 97.7 t -61.21 -44.32 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.061 0.457 . . . . 71.14 110.674 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HE3' HD23 ' A' ' 48' ' ' LEU . 48.1 tptt -63.4 -41.72 98.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.135 -0.484 . . . . 75.11 110.391 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 28' ' ' THR . 87.3 mt -56.55 -49.0 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.028 -0.533 . . . . 73.42 110.869 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 60.7 m -58.71 -42.53 88.88 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.057 -0.52 . . . . 53.23 110.944 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.776 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -57.28 -46.22 83.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.886 0.374 . . . . 64.11 110.913 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.6 tt0 -58.47 -50.02 75.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.26 0.552 . . . . 74.24 111.379 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.57 -27.33 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.852 -0.613 . . . . 73.25 112.037 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 32' ' ' THR . 99.2 mtt180 -74.31 -41.29 61.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.03 -0.419 . . . . 73.24 111.146 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.644 HD12 HD11 ' A' ' 48' ' ' LEU . 85.3 mt -65.57 -35.36 80.6 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.404 0.621 . . . . 70.32 110.469 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -59.3 -37.35 77.51 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.604 -0.725 . . . . 74.13 110.809 172.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.2 96.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.933 0.396 . . . . 65.42 111.84 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -72.32 -22.18 61.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.14 0.422 . . . . 53.22 112.14 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -92.94 139.09 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.99 0.424 . . . . 70.14 111.626 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.8 m -75.02 -83.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.669 0.618 . . . . 43.42 112.669 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.0 m -97.54 -36.18 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.113 0.412 . . . . 64.44 112.113 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.0 177.49 53.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.113 -0.565 . . . . 70.45 112.802 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 57' ' ' LEU . 27.6 m -135.83 152.19 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.535 0.683 . . . . 53.12 112.692 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.3 m-85 -98.42 102.53 14.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.667 -0.697 . . . . 74.41 110.255 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.2 mt -86.41 113.48 22.4 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.116 0.484 . . . . 74.24 111.115 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 37' ' ' LEU . 8.8 mp -89.46 114.85 62.04 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.222 -0.444 . . . . 74.23 111.145 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.679 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 36.9 Cg_endo -64.48 11.47 0.11 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.224 2.616 . . . . 73.34 114.378 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.84 -10.58 26.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.205 -0.522 . . . . 62.45 112.683 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.66 127.74 53.93 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 70.02 111.546 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -79.23 17.46 0.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.813 0.34 . . . . 73.42 111.763 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -99.95 147.06 32.94 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 112.988 0.736 . . . . 73.11 112.988 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.66 165.0 10.59 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.143 2.562 . . . . 74.23 113.25 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.6 133.94 29.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.487 -0.324 . . . . 21.54 110.984 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -97.02 122.82 40.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.381 . . . . 72.42 111.057 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 45' ' ' VAL . 3.4 pp -120.69 159.57 25.09 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.932 0.396 . . . . 61.2 111.047 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.88 106.54 18.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.047 0.451 . . . . 60.11 110.823 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.1 p -99.69 178.47 4.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.094 -0.503 . . . . 72.01 111.046 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 52.7 mt-30 -76.89 0.58 20.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.373 -0.376 . . . . 73.0 111.94 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.02 -13.91 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.926 0.393 . . . . 73.41 111.16 171.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.75 -158.89 23.49 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.473 -0.394 . . . . 72.51 113.005 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 p -76.09 129.65 37.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.372 -0.487 . . . . 65.14 112.177 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 155' ' ' ILE . 3.1 pp -140.77 138.5 34.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.586 0.708 . . . . 74.42 110.889 170.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 85' ' ' GLN . 1.6 ttp180 -98.87 115.33 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.192 -0.913 . . . . 75.4 110.951 -175.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.618 ' SD ' HG21 ' A' ' 152' ' ' ILE . 58.6 mtt -110.17 154.54 23.2 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.928 0.394 . . . . 72.33 111.608 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.1 t -159.58 155.84 26.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.415 -0.357 . . . . 75.23 111.096 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.578 HD22 HD13 ' A' ' 80' ' ' LEU . 89.0 mt -107.35 105.8 15.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.883 0.373 . . . . 74.23 111.387 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 81' ' ' THR . 31.8 m -115.97 162.76 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.573 -0.285 . . . . 62.22 111.312 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 60.62 34.14 20.22 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.121 0.486 . . . . 72.04 111.911 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.84 108.29 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.099 0.476 . . . . 71.54 111.855 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.47 150.62 74.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.129 0.418 . . . . 64.2 112.129 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.36 146.83 81.8 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.86 2.373 . . . . 64.13 113.231 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.625 ' HB2' HG23 ' A' ' 79' ' ' THR . 25.5 t70 -115.38 170.47 8.38 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.144 -0.48 . . . . 72.51 110.92 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.86 40.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.858 0.361 . . . . 22.03 111.478 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.66 -45.92 11.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.884 0.373 . . . . 64.12 111.488 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.01 -111.34 0.93 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.029 -0.605 . . . . 51.43 113.586 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -145.7 136.62 24.55 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.476 -0.426 . . . . 62.25 111.788 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.625 HG23 ' HB2' ' A' ' 74' ' ' ASP . 54.0 p -107.98 124.48 50.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.701 0.286 . . . . 62.4 111.581 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.578 HD13 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -133.66 167.84 19.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.722 0.296 . . . . 75.41 111.298 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 69' ' ' VAL . 26.4 m -113.14 116.63 30.14 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.874 0.368 . . . . 74.14 111.729 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.437 HD11 ' SD ' ' A' ' 66' ' ' MET . 3.1 tm? -93.61 110.51 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.223 -0.444 . . . . 55.24 110.236 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -100.12 115.63 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.337 0.495 . . . . 72.3 112.337 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.499 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.3 mp -95.38 147.45 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.853 0.461 . . . . 71.24 111.384 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 65' ' ' ARG . 64.9 tt0 -146.02 106.61 4.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.482 0.313 . . . . 72.23 110.335 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.34 27.54 0.84 Allowed Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.257 0.863 . . . . 53.2 115.257 -171.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 59.98 -68.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 74.15 112.097 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 m -61.87 144.66 54.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.757 0.423 . . . . 75.43 111.83 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 43.6 m-80 -74.36 -26.57 60.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.613 -0.267 . . . . 73.32 111.654 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.96 131.62 79.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 112.162 0.43 . . . . 72.24 112.162 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 26.1 Cg_endo -60.8 115.77 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.009 2.473 . . . . 74.2 113.308 -176.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.64 151.98 42.92 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.285 -0.416 . . . . 75.43 111.537 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.66 176.38 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.998 . . . . 74.23 112.536 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -68.15 163.25 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.698 0.285 . . . . 61.34 111.382 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -158.33 148.73 20.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.555 0.693 . . . . 72.4 112.282 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.3 p -127.51 168.64 14.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.417 -0.811 . . . . 74.33 110.726 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.695 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -173.04 167.6 40.44 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.214 -0.994 . . . . 72.11 114.183 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -99.26 116.88 32.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.478 0.311 . . . . 74.01 111.05 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' VAL . 34.0 m -109.79 113.08 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.436 0.636 . . . . 73.24 111.364 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.2 mt-10 -97.03 110.82 23.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.94 0.4 . . . . 75.22 111.353 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -106.74 138.45 42.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.443 -0.344 . . . . 74.32 111.134 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.15 -164.59 27.11 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.839 -0.696 . . . . 73.22 113.514 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.604 ' HB2' HG13 ' A' ' 114' ' ' ILE . 52.7 mt-30 -105.79 157.42 17.47 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.909 0.385 . . . . 73.32 110.9 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.72 142.68 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.714 0.293 . . . . 45.41 111.233 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 12.1 pt20 -138.9 103.1 4.72 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.362 0.601 . . . . 73.34 110.577 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.43 -162.79 31.27 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.197 -0.525 . . . . 72.0 113.51 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.8 p -105.82 -178.37 3.63 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.871 0.367 . . . . 63.13 111.213 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 33' ' ' GLN . 30.2 mm -62.72 -27.78 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.174 0.511 . . . . 55.43 111.013 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -81.72 -55.95 4.31 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.991 -0.55 . . . . 73.03 110.895 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -117.8 84.39 2.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.389 0.614 . . . . 71.2 112.003 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 107' ' ' THR . 31.0 p90 -107.86 123.74 49.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.079 -0.51 . . . . 72.34 110.697 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 51.2 mt-30 -94.58 117.8 30.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.982 0.42 . . . . 74.31 111.525 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.67 101.87 5.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.008 -0.542 . . . . 75.42 110.386 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 103' ' ' GLN . 36.2 pt -112.61 150.91 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.732 0.301 . . . . 64.52 111.807 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 54.38 34.49 20.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.958 0.409 . . . . 63.11 112.069 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.4 130.13 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.23 0.538 . . . . 74.5 112.13 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.55 156.8 48.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.791 -0.64 . . . . 52.2 110.269 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 8.9 p30 -103.3 153.63 20.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.46 0.911 . . . . 73.53 113.46 -171.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -133.05 150.59 52.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.296 -0.865 . . . . 71.11 109.921 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -94.84 123.13 38.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.018 0.437 . . . . 72.32 111.954 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 137' ' ' LEU . 41.6 pt -100.53 138.9 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 70.54 111.409 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.92 105.23 6.64 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.419 -0.355 . . . . 75.04 111.103 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.27 139.48 22.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.61 -0.268 . . . . 62.04 111.461 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HD2' HG11 ' A' ' 133' ' ' VAL . 38.3 Cg_exo -61.17 158.7 33.61 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.008 2.472 . . . . 64.41 113.85 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.83 130.73 41.79 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.987 -0.551 . . . . 62.11 111.703 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.1 m -91.95 101.12 13.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.87 0.366 . . . . 65.12 110.993 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 p -89.0 -21.28 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.188 0.518 . . . . 72.31 110.925 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.7 mt -101.6 165.36 11.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.181 0.515 . . . . 74.25 111.649 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -114.65 147.41 38.08 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 62.35 111.105 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 84.3 Cg_endo -83.48 169.94 54.96 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.837 -1.318 . . . . 64.33 113.529 -1.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 m -83.56 83.07 8.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.478 0.547 . . . . 71.42 112.478 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' A' ' 130' ' ' PRO . 4.6 p-10 -136.57 118.23 14.97 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.482 0.658 . . . . 72.35 111.244 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.458 HG11 ' HD2' ' A' ' 124' ' ' PRO . 46.5 t -122.23 150.74 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.0 -0.546 . . . . 74.22 111.385 -173.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -124.4 110.2 14.26 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.359 0.6 . . . . 74.44 111.557 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.0 pt -112.62 136.35 21.54 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 112.23 0.456 . . . . 73.04 112.23 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.85 146.34 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.836 2.358 . . . . 60.43 113.416 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 121' ' ' ILE . 63.0 mt -132.14 117.17 17.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.191 -0.459 . . . . 72.5 112.101 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -96.37 94.43 7.43 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.189 0.519 . . . . 74.32 110.206 171.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.7 110.05 10.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.346 0.593 . . . . 75.51 110.207 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.43 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 mtmp? -83.94 150.4 25.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.612 -0.722 . . . . 70.24 112.39 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.61 13.81 74.77 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.722 0.649 . . . . 44.12 114.722 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.5 128.43 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.03 0.915 . . . . 72.44 112.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.6 m -84.17 146.24 27.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.165 -0.47 . . . . 62.13 111.302 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.423 ' HA ' HD12 ' A' ' 147' ' ' LEU . 8.0 p -56.88 -34.77 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.524 0.564 . . . . 74.54 112.524 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.58 -32.95 70.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.161 0.505 . . . . 72.34 111.082 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HB3' HE21 ' A' ' 103' ' ' GLN . 32.0 mm-40 -97.38 5.08 50.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.317 0.488 . . . . 73.43 112.317 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.679 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 17.1 mt -69.99 96.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.266 0.555 . . . . 72.23 111.156 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.32 -41.22 11.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.863 -0.608 . . . . 73.41 113.193 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.89 157.02 23.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.186 0.517 . . . . 71.43 111.998 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.21 101.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.773 -0.649 . . . . 74.03 109.82 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 51.5 ttt180 -83.97 105.04 14.54 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.151 -0.477 . . . . 74.43 111.928 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.618 HG21 ' SD ' ' A' ' 66' ' ' MET . 21.8 mm -90.72 121.4 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 116.535 -0.302 . . . . 72.13 111.639 -177.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -159.24 178.24 10.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.322 0.49 . . . . 74.43 112.322 176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.77 18.54 11.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.883 0.697 . . . . 70.43 112.883 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.695 HD13 ' HA3' ' A' ' 97' ' ' GLY . 36.2 mm -63.19 113.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.021 0.439 . . . . 72.53 111.317 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.466 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 8.9 pt20 -136.2 153.83 76.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.007 0.523 . . . . 75.15 111.831 -173.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.87 135.05 22.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.605 2.203 . . . . 73.44 113.754 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 6.0 p -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.119 0.485 . . . . 75.24 110.942 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptp -152.54 -165.8 2.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.539 -0.3 . . . . 64.24 110.751 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -69.2 158.58 34.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.959 0.409 . . . . 71.03 111.136 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 161' ' ' LEU . 7.2 mp -67.4 108.48 2.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.778 -0.452 . . . . 63.42 109.778 173.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.02 147.69 12.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.404 0.621 . . . . 41.54 112.017 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -87.41 59.51 5.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.183 -0.462 . . . . 63.22 111.828 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.2 p80 39.85 59.08 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.67 . . . . 73.51 112.645 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -84.45 -25.46 28.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.815 -0.629 . . . . 72.42 111.917 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -56.37 102.55 0.08 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.081 0.467 . . . . 74.43 112.256 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 61.36 84.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.837 -0.619 . . . . 75.32 111.739 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.797 -0.62 . . . . 75.31 111.855 177.088 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.81 0.338 . . . . 73.12 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.62 113.78 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.7 0.286 . . . . 75.23 111.288 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -95.49 124.32 39.46 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.846 0.355 . . . . 73.44 110.44 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.14 119.04 19.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.196 0.522 . . . . 74.43 112.251 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 p -104.46 86.03 2.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.407 0.622 . . . . 64.21 110.533 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -79.13 72.81 5.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.921 -0.582 . . . . 64.1 111.836 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.35 157.79 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.934 -0.575 . . . . 74.34 111.968 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -125.75 110.51 13.82 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.909 0.337 . . . . 71.33 111.909 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -94.08 140.53 29.62 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.202 -0.295 . . . . 75.41 110.202 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -131.14 128.51 40.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 75.54 111.842 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -152.04 146.62 25.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.269 -0.423 . . . . 74.54 111.022 174.058 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -78.32 113.37 16.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 65.53 111.326 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 t -60.8 123.75 18.44 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.395 -0.366 . . . . 73.14 111.683 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.1 140.97 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.182 0.515 . . . . 71.43 112.315 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.5 t -109.35 132.66 53.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.118 -0.492 . . . . 34.33 110.425 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -134.59 155.62 50.14 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 112.561 0.578 . . . . 72.11 112.561 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.89 146.52 41.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.055 -0.52 . . . . 42.22 111.516 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 14.9 m120 -86.01 100.99 12.53 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.015 0.436 . . . . 74.34 111.497 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -82.91 23.84 0.8 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.904 0.383 . . . . 74.23 111.426 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 13.1 pt-20 -96.95 179.13 5.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.412 0.523 . . . . 75.2 112.412 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.23 -169.99 1.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.041 -0.527 . . . . 73.01 111.914 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -83.46 -163.63 0.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.662 0.615 . . . . 63.34 112.662 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -42.54 143.26 0.69 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.288 0.847 . . . . 65.54 113.288 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.6 tp -123.42 145.31 48.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 72.24 111.425 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -62.5 133.48 55.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.86 0.362 . . . . 73.32 111.683 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -47.32 -39.53 15.0 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.758 0.651 . . . . 72.44 112.758 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -51.77 -56.3 14.68 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.061 0.458 . . . . 72.35 111.444 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.4 m -68.53 -28.23 66.8 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.248 -0.433 . . . . 73.45 111.326 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.93 -48.98 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.711 0.291 . . . . 73.42 111.164 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 14.4 mptt -59.83 -47.69 84.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.923 0.392 . . . . 65.52 111.19 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.18 -49.45 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.936 0.398 . . . . 74.32 111.382 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.7 m -57.27 -43.49 83.11 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.995 0.426 . . . . 75.54 111.136 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.705 ' HG3' HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -59.06 -44.63 91.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.27 -0.423 . . . . 74.15 111.394 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.29 -44.17 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.376 . . . . 74.1 111.256 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -63.31 -36.8 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.827 0.306 . . . . 71.52 111.827 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.99 -50.13 67.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.947 0.403 . . . . 64.31 110.914 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.62 -40.01 95.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.071 0.463 . . . . 71.33 111.32 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.29 -39.22 89.62 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.196 -0.456 . . . . 61.11 110.814 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.99 74.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.302 -0.408 . . . . 33.34 111.588 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.32 0.83 57.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.039 0.447 . . . . 71.1 111.794 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 46' ' ' TYR . 25.3 t -77.63 103.43 7.57 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.965 0.412 . . . . 74.34 111.112 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 t -88.28 -23.05 23.58 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.961 0.41 . . . . 61.45 111.743 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.4 p -131.27 104.45 7.05 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.261 -0.427 . . . . 61.12 111.054 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.93 -162.03 35.24 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.288 -0.482 . . . . 40.51 112.89 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.9 145.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.478 -0.425 . . . . 74.22 111.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.543 ' HD2' ' HB2' ' A' ' 41' ' ' SER . 46.7 m-85 -97.06 120.6 37.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.847 0.356 . . . . 75.42 111.909 176.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.55 136.08 52.51 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.991 -0.549 . . . . 62.23 109.814 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 63.8 mt -107.1 130.15 23.29 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 122.17 -0.332 . . . . 74.35 111.351 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 26.4 Cg_endo -60.3 -30.11 90.36 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.528 2.152 . . . . 64.52 112.807 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.64 -12.95 80.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.337 -0.458 . . . . 73.12 112.985 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -120.83 76.66 1.22 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.067 0.46 . . . . 41.01 111.116 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.54 80.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.292 -0.413 . . . . 72.22 111.789 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 p -136.22 152.59 75.51 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 112.091 0.404 . . . . 73.34 112.091 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.02 146.61 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.099 2.533 . . . . 73.3 114.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.81 32.96 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.83 -0.623 . . . . 53.0 110.78 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -85.9 139.93 30.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.014 0.435 . . . . 63.22 111.949 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -144.3 129.78 18.97 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.989 -0.55 . . . . 64.05 111.026 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -83.23 139.82 32.89 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.325 0.583 . . . . 72.12 110.761 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.1 p -124.32 -174.89 3.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 63.11 111.369 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.81 11.52 22.22 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 45.12 111.353 176.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.4 pt -121.67 -4.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.884 0.373 . . . . 75.33 111.179 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.34 -167.83 24.84 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.288 -0.415 . . . . 71.3 112.459 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.8 m -93.95 122.12 36.11 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.19 -0.594 . . . . 73.35 111.301 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -123.41 -176.4 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.118 0.485 . . . . 62.25 111.919 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -151.7 104.93 3.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.208 0.528 . . . . 73.24 110.709 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.629 ' HE2' HD11 ' A' ' 82' ' ' LEU . 86.5 mtp -101.33 165.67 11.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.66 0.615 . . . . 74.14 112.66 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 t -162.77 167.03 23.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.046 0.451 . . . . 63.04 111.793 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 80' ' ' LEU . 90.5 mt -117.73 123.27 45.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.062 -0.517 . . . . 62.13 111.688 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' A' ' 81' ' ' THR . 27.6 m -138.1 171.41 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 116.64 -0.255 . . . . 63.34 111.359 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 m120 56.49 33.08 21.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.614 0.598 . . . . 63.44 112.614 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.3 mt -71.79 109.17 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.023 0.44 . . . . 52.43 111.901 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -134.79 152.7 77.98 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 116.24 -0.436 . . . . 60.12 112.026 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 136.99 34.16 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.65 2.234 . . . . 41.22 112.358 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 79' ' ' THR . 33.9 t70 -113.72 156.58 23.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.737 0.303 . . . . 75.11 111.44 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.37 69.02 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.358 0.503 . . . . 55.24 112.358 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -101.15 -29.56 12.05 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.975 0.416 . . . . 74.35 111.412 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.44 -102.06 0.16 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.05 -0.595 . . . . 50.55 113.104 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.3 m -151.62 128.19 10.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.567 -0.373 . . . . 63.43 110.815 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' HG3' ' A' ' 138' ' ' GLN . 35.3 p -107.49 132.66 52.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.154 0.502 . . . . 71.05 111.824 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.571 HD13 HD22 ' A' ' 68' ' ' LEU . 3.5 pp -148.31 143.22 26.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.135 -0.484 . . . . 71.14 110.996 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 69' ' ' VAL . 56.0 m -81.54 116.49 21.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 41.14 111.358 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 ' HE2' ' A' ' 66' ' ' MET . 3.5 tm? -88.35 116.91 26.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.931 -0.577 . . . . 41.31 109.814 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -98.55 137.36 37.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.768 0.318 . . . . 73.12 111.336 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -117.93 90.53 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.887 0.375 . . . . 53.14 110.921 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 120.86 24.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 73.3 110.164 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.16 122.67 6.26 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.327 -0.94 . . . . 61.13 112.786 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -51.0 -39.83 56.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.467 0.651 . . . . 74.35 109.869 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 m -74.54 117.03 15.9 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.171 -0.922 . . . . 72.12 110.35 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -60.44 -31.68 70.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.016 0.436 . . . . 65.32 111.38 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.15 149.02 98.17 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.763 -0.653 . . . . 61.44 111.898 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 19.2 Cg_endo -58.31 124.38 15.75 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.146 2.564 . . . . 72.03 114.172 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.8 mt -84.1 149.02 54.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.518 -0.31 . . . . 72.44 111.33 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.06 173.95 13.63 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.422 2.082 . . . . 62.4 113.098 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -72.35 141.94 48.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 52.53 111.725 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.38 161.51 41.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.169 0.509 . . . . 71.52 112.291 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 81.1 p -125.09 151.69 45.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.862 -0.608 . . . . 71.14 109.992 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -144.9 154.67 26.03 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.429 -0.891 . . . . 54.34 113.904 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.2 m -97.99 106.56 18.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.414 0.285 . . . . 55.03 110.965 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 152' ' ' ILE . 15.9 m -95.58 136.07 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.975 0.416 . . . . 70.15 111.159 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.481 ' OE1' ' HD2' ' A' ' 151' ' ' ARG . 50.6 mt-10 -115.17 114.37 25.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.25 -0.432 . . . . 73.45 111.092 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -121.47 123.63 42.51 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.975 0.417 . . . . 63.44 111.645 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -165.24 -146.9 4.95 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.324 -0.465 . . . . 23.32 113.234 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.497 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 97.0 mt-30 -126.98 155.98 42.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.494 0.664 . . . . 72.33 112.333 -176.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.36 131.48 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.836 -0.62 . . . . 61.41 110.329 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -102.08 -2.9 28.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.268 0.84 . . . . 71.53 113.268 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.34 -158.99 9.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.274 -0.965 . . . . 64.12 114.619 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.5 p -99.27 -176.76 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.074 0.464 . . . . 62.24 111.831 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.705 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.4 mm -70.4 -24.92 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.188 0.518 . . . . 73.22 111.157 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.81 -43.06 14.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.346 -0.388 . . . . 72.42 111.695 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -142.81 115.91 8.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.24 0.543 . . . . 65.23 111.588 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.36 163.07 36.72 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.138 0.494 . . . . 63.51 111.978 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -132.82 129.34 38.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.978 -0.555 . . . . 73.41 110.35 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 2.4 mp0 -81.08 105.9 12.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.36 -0.382 . . . . 74.45 111.166 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.3 pt -111.11 160.37 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.292 0.478 . . . . 61.32 112.292 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.89 21.12 8.77 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.871 0.693 . . . . 52.15 112.871 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 7.4 p -84.07 137.92 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.79 0.663 . . . . 74.55 112.79 -175.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -117.92 161.13 20.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.728 -0.669 . . . . 73.55 110.804 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -110.68 151.62 27.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.349 -0.387 . . . . 63.11 111.282 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -148.15 145.07 28.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.526 -0.306 . . . . 74.32 110.403 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.72 112.07 24.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.675 0.274 . . . . 75.43 111.556 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' SER . 38.8 pt -94.56 116.94 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.089 0.471 . . . . 73.42 111.195 177.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -102.21 105.68 16.39 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.977 0.417 . . . . 72.14 111.067 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.9 146.69 35.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.488 -0.324 . . . . 42.01 111.847 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 169.79 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.947 2.431 . . . . 54.54 113.287 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -89.1 127.76 35.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.476 -0.329 . . . . 73.33 111.798 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -86.25 135.06 33.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.091 0.472 . . . . 73.11 111.388 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.59 HG23 ' HG ' ' A' ' 128' ' ' LEU . 35.9 m -117.78 4.08 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.138 -0.483 . . . . 71.21 111.871 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.59 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.3 mt -136.59 170.36 16.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.281 0.562 . . . . 74.55 111.941 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.58 145.47 47.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.97 -0.559 . . . . 55.32 111.174 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 156.08 97.49 Favored 'Cis proline' 0 C--N 1.355 0.889 0 C-N-CA 124.164 -1.181 . . . . 55.33 113.354 0.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 31.7 t -95.35 83.74 3.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.644 0.609 . . . . 72.34 112.644 -176.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -119.93 108.68 14.63 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.289 0.566 . . . . 65.25 110.179 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.47 144.07 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.413 0.524 . . . . 73.35 112.413 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.56 121.36 41.52 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.755 0.312 . . . . 71.22 111.584 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.1 pt -132.44 125.81 19.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 120.799 0.333 . . . . 65.44 111.559 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.69 115.6 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.312 2.008 . . . . 62.23 112.876 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.81 111.01 22.37 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.973 -0.558 . . . . 63.32 109.986 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.496 ' HG3' HG22 ' A' ' 79' ' ' THR . 43.6 tt0 -101.33 101.36 12.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.103 0.477 . . . . 74.21 111.365 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.3 mt -89.06 149.13 23.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.394 -0.367 . . . . 64.11 111.767 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.86 150.53 41.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.961 0.41 . . . . 74.04 111.764 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.1 29.01 73.7 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.461 0.545 . . . . 61.41 114.461 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -158.73 135.15 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 122.394 -0.474 . . . . 52.54 111.474 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.3 m -101.39 148.92 24.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.254 -0.43 . . . . 72.24 111.673 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -52.49 -51.93 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 113.317 0.858 . . . . 72.24 113.317 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.97 -17.49 62.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.157 0.503 . . . . 75.24 111.094 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -98.54 -1.65 40.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.097 -0.501 . . . . 72.03 111.739 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 1.5 tt -79.53 129.36 34.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.916 0.389 . . . . 73.03 110.486 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.66 -58.07 1.37 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.313 -0.47 . . . . 62.11 113.655 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 113' ' ' GLU . 22.6 p90 -146.39 157.52 43.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.106 0.479 . . . . 74.34 112.211 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.1 t -130.47 100.09 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.942 -0.572 . . . . 75.42 110.374 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.481 ' HD2' ' OE1' ' A' ' 100' ' ' GLU . 35.4 ttm180 -94.68 125.41 39.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.19 -0.319 . . . . 73.25 111.404 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 99' ' ' VAL . 19.0 mm -105.35 140.25 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 65.13 111.491 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -168.93 173.87 6.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.989 0.366 . . . . 73.31 111.989 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.26 40.62 17.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.62 0.6 . . . . 72.12 112.62 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 64' ' ' LEU . 42.5 mm -73.57 104.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.04 0.447 . . . . 75.42 110.221 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -123.98 146.3 50.62 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 116.277 -0.419 . . . . 74.43 111.962 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.71 141.4 37.59 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.415 2.077 . . . . 73.21 112.981 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.41 161.41 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.275 -0.265 . . . . 73.51 110.749 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.8 mtp 61.85 25.12 15.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.221 0.534 . . . . 62.32 111.086 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.23 149.6 42.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.227 0.537 . . . . 55.3 111.957 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.11 156.86 29.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.434 -0.348 . . . . 51.34 110.635 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.57 136.98 58.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.253 0.549 . . . . 71.44 112.345 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -139.79 86.89 2.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.275 0.56 . . . . 74.03 110.512 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -81.15 132.49 35.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.882 -0.599 . . . . 74.32 111.256 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.62 126.84 55.72 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.941 0.401 . . . . 63.4 111.269 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -102.57 139.97 37.47 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.325 -0.398 . . . . 74.12 111.628 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -76.15 7.93 3.74 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.49 0.552 . . . . 61.43 112.49 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 29.1 p80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.641 -0.695 . . . . 72.53 110.928 173.431 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.705 0.288 . . . . 74.44 110.602 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.21 140.51 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.267 0.556 . . . . 74.25 112.312 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -116.17 137.88 51.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 70.44 110.84 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -78.4 152.8 32.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.238 0.542 . . . . 75.33 112.137 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -139.32 143.24 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.038 -0.528 . . . . 21.42 110.257 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.45 84.89 7.49 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.261 0.553 . . . . 64.22 111.88 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -91.93 146.58 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.279 -0.419 . . . . 74.14 110.505 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -90.9 144.92 25.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.978 0.418 . . . . 74.41 111.657 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -171.43 3.45 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.094 0.473 . . . . 71.44 112.07 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -142.85 177.65 8.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.066 0.46 . . . . 61.25 111.803 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.03 177.08 11.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.166 -0.47 . . . . 62.54 110.787 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -65.51 154.41 38.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.948 0.404 . . . . 74.2 111.741 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -77.55 155.9 31.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.033 0.444 . . . . 63.53 111.594 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.01 110.48 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.363 -0.38 . . . . 64.14 110.698 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 t -71.91 93.9 1.39 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.855 0.36 . . . . 74.43 110.766 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.8 p -86.02 139.93 30.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.925 0.393 . . . . 74.11 111.893 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.44 139.05 49.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.889 0.376 . . . . 60.1 110.915 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -75.23 105.2 6.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.382 0.61 . . . . 70.33 112.495 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -105.88 87.85 2.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.245 0.545 . . . . 71.44 111.567 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.32 124.99 37.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.737 -0.665 . . . . 63.53 109.357 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -97.4 105.19 17.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.805 1.039 . . . . 52.53 113.805 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p 49.78 -166.97 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.535 1.309 . . . . 73.3 114.535 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -83.83 164.06 19.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.73 -0.668 . . . . 72.32 111.648 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -139.21 163.3 32.82 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 54.41 110.728 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' O ' HG23 ' A' ' 29' ' ' VAL . 2.0 m-20 -49.17 121.73 5.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.262 0.225 . . . . 65.55 111.137 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -45.26 -47.69 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.84 0.682 . . . . 73.04 112.84 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.15 -55.05 35.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.357 0.599 . . . . 72.11 110.978 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -65.88 -21.06 66.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.948 -0.569 . . . . 73.1 111.827 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 25' ' ' ASN . 73.7 t -67.99 -47.76 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.973 0.416 . . . . 75.43 110.409 173.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HE2' HD23 ' A' ' 48' ' ' LEU . 17.3 tptm -63.29 -36.93 85.31 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.19 0.519 . . . . 74.5 109.958 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.2 mt -59.56 -50.41 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.172 -0.467 . . . . 61.54 111.292 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.3 m -54.42 -41.7 69.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.958 0.409 . . . . 70.23 111.082 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.696 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -61.89 -44.43 96.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.441 -0.345 . . . . 72.45 110.892 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.411 ' HG3' HD13 ' A' ' 48' ' ' LEU . 28.9 tt0 -56.85 -40.89 76.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.435 -0.348 . . . . 71.33 111.459 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.6 -50.28 73.65 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.103 0.477 . . . . 62.01 111.335 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.29 -41.72 99.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.164 -0.471 . . . . 74.34 111.325 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.895 0.378 . . . . 73.3 111.005 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.56 -29.18 70.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.088 0.471 . . . . 71.42 110.693 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.13 70.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.218 -0.446 . . . . 71.21 111.245 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -95.01 12.23 29.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.362 0.505 . . . . 75.01 112.362 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -67.35 88.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.949 0.404 . . . . 73.12 111.551 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -66.99 -56.76 8.73 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.195 0.443 . . . . 71.22 112.195 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.2 p -138.23 105.06 5.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.164 0.507 . . . . 71.41 111.226 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 92.12 142.97 11.48 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.176 -0.535 . . . . 34.44 112.956 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 27.2 m -86.35 148.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 112.472 0.545 . . . . 71.12 112.472 -173.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -95.25 114.26 26.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.007 -0.542 . . . . 65.14 112.031 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.02 103.72 13.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.895 0.378 . . . . 74.44 110.727 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.2 mp -82.37 121.96 78.76 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 122.306 -0.246 . . . . 71.13 111.035 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 52.9 Cg_exo -54.94 -32.57 78.95 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.918 2.412 . . . . 71.55 113.726 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.17 11.37 63.12 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.113 -0.565 . . . . 65.45 113.415 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.44 129.6 56.27 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.012 0.434 . . . . 73.52 111.794 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 85.8 tttt -84.85 32.32 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.487 0.661 . . . . 71.24 111.253 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -128.13 133.88 25.62 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 113.445 0.906 . . . . 73.32 113.445 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 91.5 Cg_endo -80.29 179.06 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.431 2.754 . . . . 55.41 113.066 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.76 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.062 0.458 . . . . 60.23 111.801 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -91.77 124.89 36.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.96 0.409 . . . . 72.22 111.015 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD13 HG13 ' A' ' 45' ' ' VAL . 42.8 tp -120.59 138.33 53.94 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.464 0.542 . . . . 75.34 112.464 -172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.5 117.13 22.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.945 -0.57 . . . . 72.13 110.229 172.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -118.14 173.92 6.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.935 0.398 . . . . 75.14 111.488 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 50.2 mt-30 -79.24 1.41 24.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.194 0.442 . . . . 74.45 112.194 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 157' ' ' PRO . 38.5 pt -105.37 -34.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.983 0.42 . . . . 72.53 110.693 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.46 -156.5 28.32 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.108 -0.496 . . . . 72.43 112.428 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.9 m -98.36 124.33 42.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.951 0.405 . . . . 72.33 110.994 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.99 170.75 15.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.809 0.337 . . . . 44.34 111.905 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -134.25 116.1 14.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.471 0.309 . . . . 71.54 110.526 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.747 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.1 mtt -107.4 155.32 20.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.685 0.624 . . . . 53.02 112.685 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 99.8 p -154.78 157.76 38.45 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.083 -0.508 . . . . 42.24 111.357 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.59 125.93 50.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.556 -0.293 . . . . 64.34 111.677 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.571 HG23 ' HB ' ' A' ' 81' ' ' THR . 23.9 m -137.6 169.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.65 0.262 . . . . 62.5 111.416 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.9 m120 55.54 26.72 9.37 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.543 0.571 . . . . 75.32 112.543 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 53.5 mt -60.67 111.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.819 0.342 . . . . 71.11 111.426 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 151.8 77.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.464 0.542 . . . . 72.01 112.464 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.61 118.8 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.888 2.392 . . . . 72.21 112.521 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' HB2' HG23 ' A' ' 79' ' ' THR . 28.6 t70 -100.37 164.61 11.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.398 -0.365 . . . . 73.31 111.603 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.57 92.28 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 72.12 111.828 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.85 -41.36 15.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.939 0.4 . . . . 74.54 111.404 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.21 -94.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.439 -0.886 . . . . 72.34 114.07 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.5 m -143.71 120.36 11.13 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.562 -0.375 . . . . 52.43 112.002 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 74' ' ' ASP . 8.0 p -96.83 118.71 33.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 62.31 111.127 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.1 pp -132.9 -172.47 2.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.38 -0.373 . . . . 64.44 111.261 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.571 ' HB ' HG23 ' A' ' 69' ' ' VAL . 31.2 m -130.12 111.1 12.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.88 0.371 . . . . 61.4 110.661 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.7 112.88 20.46 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 60.14 110.04 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtm180 -93.96 124.72 38.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.526 -0.306 . . . . 75.42 111.61 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -110.34 97.3 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.473 -0.33 . . . . 71.34 111.05 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.22 108.09 20.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.582 -0.525 . . . . 71.14 109.582 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.22 140.16 29.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.887 -0.673 . . . . 73.5 113.261 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.83 -21.33 57.38 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.384 0.611 . . . . 72.3 110.075 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -64.83 118.46 9.03 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.27 -0.877 . . . . 64.04 111.994 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -71.88 -14.03 61.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.202 0.525 . . . . 42.42 110.905 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.6 p-10 -97.86 149.42 35.7 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.837 -0.62 . . . . 71.44 110.913 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 16.6 Cg_exo -65.68 137.36 49.65 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.606 2.204 . . . . 72.43 113.365 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.17 158.42 31.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.418 -0.356 . . . . 72.42 111.296 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.55 -165.14 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.205 1.937 . . . . 61.21 112.43 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.92 156.13 22.51 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.278 -0.264 . . . . 34.11 110.81 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -150.19 162.86 39.63 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.585 0.707 . . . . 74.25 112.681 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 p -157.74 154.36 28.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.216 -0.902 . . . . 72.24 110.492 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.39 -175.23 35.0 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.278 -0.963 . . . . 70.2 114.039 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 m -111.23 145.43 38.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.494 0.318 . . . . 54.02 110.852 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.0 p -124.13 128.84 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.253 0.464 . . . . 75.25 112.253 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 29.8 mm-40 -98.2 110.37 22.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.248 -0.433 . . . . 73.15 110.325 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HD2' HG21 ' A' ' 142' ' ' ILE . 12.4 p90 -121.7 118.24 28.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.287 0.565 . . . . 75.12 112.064 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.18 -153.43 6.75 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.714 -0.675 . . . . 50.24 113.01 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.536 HE21 ' HB3' ' A' ' 146' ' ' GLN . 77.3 mt-30 -119.29 145.77 45.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.089 0.471 . . . . 71.4 112.27 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.96 104.69 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 75.23 110.606 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -89.36 -11.89 42.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.839 0.681 . . . . 74.32 112.839 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.11 -168.64 15.69 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.86 -0.686 . . . . 43.31 114.025 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 45.8 p -92.12 -176.66 4.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.703 0.401 . . . . 61.21 111.387 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.696 HD11 ' HG3' ' A' ' 33' ' ' GLN . 50.8 mm -74.36 -26.89 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.255 0.55 . . . . 44.54 110.622 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.9 -35.99 56.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.911 -0.586 . . . . 61.45 110.851 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.66 97.43 2.97 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.124 0.488 . . . . 75.34 111.908 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -122.64 151.27 41.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.277 0.56 . . . . 73.43 111.606 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -132.36 117.81 18.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.876 -0.602 . . . . 64.32 110.402 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.99 108.16 5.75 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.918 0.389 . . . . 71.01 111.091 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.487 HG13 ' HB2' ' A' ' 103' ' ' GLN . 34.6 pt -113.41 152.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.418 -0.356 . . . . 74.42 111.041 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 57.6 32.89 22.53 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.957 0.408 . . . . 71.02 111.297 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.96 124.72 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.375 0.607 . . . . 63.14 112.127 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -114.88 157.51 23.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.029 -0.532 . . . . 71.43 110.524 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 7.0 p30 -112.22 153.74 26.64 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.807 0.337 . . . . 72.13 111.139 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -153.39 154.05 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.691 0.282 . . . . 75.53 111.456 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -92.18 122.86 35.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.084 0.401 . . . . 73.43 112.084 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.9 pt -112.73 120.83 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.088 0.47 . . . . 73.45 111.516 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -118.03 139.73 50.77 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.259 -0.275 . . . . 72.23 111.13 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.87 149.69 73.04 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.182 0.438 . . . . 74.03 112.182 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.11 164.21 20.38 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.351 2.701 . . . . 74.03 113.988 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.35 26.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.976 -0.556 . . . . 74.44 111.979 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.2 m -83.3 55.01 2.99 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.891 0.377 . . . . 53.01 111.413 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.2 m -70.29 -2.39 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.473 0.916 . . . . 55.34 113.473 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.5 mt -131.01 124.27 30.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.164 -0.335 . . . . 72.05 111.226 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.36 56.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.651 -0.249 . . . . 62.25 111.379 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.14 156.84 94.29 Favored 'Cis proline' 0 C--N 1.355 0.901 0 C-N-CA 123.863 -1.307 . . . . 65.3 112.972 -0.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 p -80.43 57.25 2.78 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.129 0.49 . . . . 74.32 112.17 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.11 89.92 8.18 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.087 0.47 . . . . 75.13 110.084 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.66 154.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.268 -0.424 . . . . 74.23 111.714 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -142.89 144.79 32.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.791 0.329 . . . . 75.34 110.982 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.1 128.39 11.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.651 0.262 . . . . 74.12 111.705 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.71 142.06 47.15 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.286 1.991 . . . . 71.24 112.009 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.48 123.28 20.0 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.625 -0.261 . . . . 73.01 111.212 -172.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -102.1 102.91 13.44 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.121 0.486 . . . . 63.13 111.309 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 71.9 mt -83.55 128.22 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.573 -0.285 . . . . 62.33 110.267 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -103.47 142.93 33.4 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.609 0.596 . . . . 74.53 112.609 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.75 80.44 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.863 -0.608 . . . . 61.41 114.136 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.472 HG21 ' HD2' ' A' ' 101' ' ' TYR . 16.1 tt -149.51 114.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 117.485 0.643 . . . . 74.31 112.042 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 64.6 m -80.47 155.03 27.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.078 0.466 . . . . 61.41 112.214 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.05 -47.99 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 113.372 0.879 . . . . 74.43 113.372 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.91 -16.52 64.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.134 0.492 . . . . 72.34 111.341 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.536 ' HB3' HE21 ' A' ' 103' ' ' GLN . 29.7 mm-40 -108.66 11.56 26.43 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.68 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.543 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -88.94 108.18 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.071 0.462 . . . . 63.43 110.246 178.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.98 -55.43 3.13 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.125 -0.56 . . . . 63.33 113.661 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -145.09 152.53 40.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.973 0.416 . . . . 74.12 111.831 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.63 94.09 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.885 -0.598 . . . . 64.51 110.31 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.637 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 68.7 ttt180 -89.05 107.2 18.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.755 0.422 . . . . 62.44 111.974 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG21 ' SD ' ' A' ' 66' ' ' MET . 35.9 mm -89.12 126.44 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.468 -0.333 . . . . 74.35 111.432 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.595 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.9 p80 -154.96 177.56 11.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.156 0.428 . . . . 72.4 112.156 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 64.4 23.14 12.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.092 0.557 . . . . 72.33 112.414 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.635 HD13 ' HA3' ' A' ' 97' ' ' GLY . 51.0 mm -67.57 95.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.643 0.735 . . . . 74.13 112.073 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.455 ' HA ' ' HB2' ' A' ' 60' ' ' GLN . 9.0 pt20 -116.78 151.56 47.42 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.266 -0.879 . . . . 72.24 111.449 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 61' ' ' ILE . 58.2 Cg_endo -70.47 128.62 15.63 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 70.53 113.786 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.28 95.41 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.849 0.833 . . . . 71.44 110.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 57.8 mtm -106.74 -162.23 0.84 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.524 -0.762 . . . . 60.24 111.52 -174.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -103.37 -167.92 1.44 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.244 0.461 . . . . 70.32 112.244 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.41 87.29 1.16 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.12 0.785 . . . . 61.24 113.12 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.35 149.84 22.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.601 -0.518 . . . . 64.03 109.601 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -147.14 101.92 3.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.503 0.668 . . . . 71.23 112.8 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -106.92 105.86 16.1 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.701 -0.682 . . . . 73.52 110.263 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -91.72 155.12 18.51 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.344 0.592 . . . . 72.04 112.233 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -58.79 103.42 0.16 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.71 -0.677 . . . . 60.41 111.726 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -97.09 -39.15 9.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.85 0.357 . . . . 62.0 111.251 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.885 -0.579 . . . . 64.13 111.451 179.116 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.766 0.317 . . . . 72.05 111.375 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t -129.95 122.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.965 0.412 . . . . 61.44 111.228 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -137.62 122.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.332 -0.395 . . . . 62.12 110.133 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -149.75 150.22 31.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.098 0.475 . . . . 74.05 111.946 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.1 t -92.51 145.78 24.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.168 -0.469 . . . . 55.3 112.104 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.24 147.81 26.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.975 0.417 . . . . 42.54 111.386 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.6 t -108.93 125.37 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.299 -0.409 . . . . 54.42 110.6 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -137.79 134.77 35.61 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.826 0.346 . . . . 73.22 111.646 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.57 178.72 4.77 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.363 -0.381 . . . . 64.2 111.378 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -132.14 148.52 52.48 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.311 -0.404 . . . . 61.21 111.031 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 5.1 ttmp? -80.0 108.66 13.76 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.885 0.374 . . . . 74.04 111.596 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -73.02 136.11 45.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.439 -0.346 . . . . 72.52 110.972 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 t -83.02 114.58 21.37 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.412 -0.358 . . . . 33.15 111.328 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -100.22 173.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.131 0.491 . . . . 51.44 112.262 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -164.1 103.41 0.87 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.117 -0.492 . . . . 70.04 111.202 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.3 p -110.27 -176.9 3.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.952 0.406 . . . . 71.42 111.755 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -145.51 174.09 11.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.437 -0.347 . . . . 64.53 111.425 -178.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -65.32 109.69 2.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.493 0.553 . . . . 44.35 112.493 -175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' HG3' HD22 ' A' ' 17' ' ' LEU . 98.1 mt-30 -132.39 179.53 6.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.121 -0.49 . . . . 75.52 110.835 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -68.84 129.17 39.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.731 0.301 . . . . 74.43 111.074 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 tpt -70.04 137.09 51.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.727 0.299 . . . . 64.1 110.457 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -87.22 -160.92 0.64 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.071 0.397 . . . . 64.53 112.071 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -51.63 161.27 0.53 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.212 0.819 . . . . 70.13 113.212 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 tp -51.56 136.46 26.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.752 -0.658 . . . . 72.4 112.456 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' VAL . 4.4 m-20 -94.02 146.85 23.65 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.908 -0.587 . . . . 70.34 111.905 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.29 -31.01 72.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 72.1 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 31' ' ' ILE . 40.5 tt0 -60.38 -45.73 92.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.236 0.541 . . . . 71.13 109.91 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.731 ' HA ' HD12 ' A' ' 31' ' ' ILE . 18.6 m -62.1 -37.51 85.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.876 -0.602 . . . . 54.04 111.389 176.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 25' ' ' ASN . 76.3 t -61.07 -40.64 86.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.138 0.494 . . . . 74.51 110.753 174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.638 ' HE3' HD13 ' A' ' 48' ' ' LEU . 43.5 tptt -64.34 -37.15 86.47 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.065 -0.516 . . . . 70.1 110.35 175.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 28' ' ' THR . 91.1 mt -57.71 -44.24 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.981 -0.554 . . . . 72.13 111.19 173.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.8 m -58.68 -43.38 89.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.204 -0.453 . . . . 51.32 110.805 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.629 ' HG3' HD11 ' A' ' 108' ' ' ILE . 55.9 tt0 -57.79 -48.49 79.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.234 -0.439 . . . . 72.41 111.14 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -51.57 -53.06 42.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.183 -0.462 . . . . 63.21 111.499 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.599 0.592 . . . . 72.53 112.599 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HD2' HG21 ' A' ' 108' ' ' ILE . 20.9 mtm180 -78.6 -38.27 40.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.068 -0.395 . . . . 63.31 111.052 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.27 -46.45 83.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.127 0.489 . . . . 72.24 110.693 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 46' ' ' TYR . 3.8 m-20 -58.36 -38.66 77.69 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.973 -0.558 . . . . 63.35 111.492 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.58 -38.1 80.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.902 0.382 . . . . 75.31 111.411 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 68.2 mttm -76.75 -32.86 58.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.936 0.347 . . . . 60.14 111.936 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -94.27 103.39 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.761 0.652 . . . . 43.15 112.761 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -96.01 27.72 3.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.381 0.61 . . . . 50.3 110.684 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -139.73 38.76 2.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.025 -0.534 . . . . 70.32 110.584 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.591 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 129.49 158.01 9.36 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.142 -0.481 . . . . 75.04 112.799 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG13 HD13 ' A' ' 57' ' ' LEU . 35.1 m -100.85 147.06 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.295 0.48 . . . . 74.14 112.295 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.454 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 31.8 m-85 -93.31 139.5 30.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.084 0.469 . . . . 75.3 110.962 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.82 119.99 29.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 62.04 109.756 172.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.638 HD13 ' HE3' ' A' ' 30' ' ' LYS . 79.0 mt -97.46 134.24 22.81 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 111.851 0.315 . . . . 72.33 111.851 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 32.0 Cg_endo -62.79 -24.64 74.56 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.577 2.184 . . . . 71.14 112.876 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.01 18.54 55.88 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.078 -0.51 . . . . 53.0 112.825 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -144.3 106.75 4.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.954 0.407 . . . . 60.22 110.915 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -74.42 11.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.623 0.601 . . . . 71.23 112.623 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -85.7 141.99 36.64 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 112.987 0.736 . . . . 53.15 112.987 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.56 -178.03 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.151 2.568 . . . . 74.53 113.516 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.18 137.03 28.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.71 -0.677 . . . . 63.13 110.785 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -82.48 97.93 8.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.023 0.439 . . . . 64.21 111.268 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.416 HD13 HG13 ' A' ' 45' ' ' VAL . 61.0 tp -104.87 122.75 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.031 0.444 . . . . 75.13 111.153 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.3 tt0 -95.86 108.55 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.11 110.543 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.9 p -96.89 -178.18 4.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.567 0.58 . . . . 71.41 112.567 -172.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.32 -4.88 44.47 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.857 -0.61 . . . . 71.03 112.02 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 92' ' ' LEU . 39.5 pt -108.48 -34.03 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.794 0.33 . . . . 73.21 111.173 175.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.69 172.27 36.1 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.234 -0.508 . . . . 44.12 112.885 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 33.8 m -77.46 124.77 28.34 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.501 -0.411 . . . . 71.3 111.327 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 155' ' ' ILE . 2.4 pp -129.98 165.03 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.49 0.662 . . . . 63.23 111.909 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -129.82 100.19 5.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.659 -0.7 . . . . 74.21 110.863 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.695 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.3 mtt -102.73 148.93 24.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.68 0.622 . . . . 70.34 112.68 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -148.42 161.03 42.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.818 0.342 . . . . 71.0 111.563 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.481 HD22 HD13 ' A' ' 80' ' ' LEU . 93.2 mt -105.44 119.32 38.8 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.797 0.332 . . . . 72.25 111.199 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 81' ' ' THR . 21.9 m -135.65 161.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.618 0.247 . . . . 75.15 111.655 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.1 m120 60.85 34.49 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.175 0.512 . . . . 75.15 111.672 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.79 114.52 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.446 . . . . 73.52 111.742 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -138.46 150.74 67.37 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.371 . . . . 73.41 111.895 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.47 155.36 70.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.809 2.339 . . . . 64.21 113.165 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.492 ' HB2' HG23 ' A' ' 79' ' ' THR . 29.0 t70 -142.05 162.99 34.09 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.476 . . . . 71.4 111.214 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.37 -43.39 97.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 64.4 111.863 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -81.91 -25.05 35.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.623 0.249 . . . . 55.52 111.615 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.73 -99.95 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.955 -0.64 . . . . 61.43 113.52 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.1 m -145.89 125.75 13.53 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.002 0.43 . . . . 73.25 111.565 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 74' ' ' ASP . 39.9 p -97.0 123.07 40.63 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.716 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -138.39 165.79 25.9 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.102 0.477 . . . . 62.32 111.712 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 69' ' ' VAL . 48.5 m -107.91 123.44 48.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.257 -0.429 . . . . 74.12 111.274 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -99.75 109.58 22.02 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.309 -0.405 . . . . 72.24 110.193 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' MET . 49.5 mtm180 -89.45 128.27 35.93 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.663 -0.244 . . . . 53.04 110.92 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 135' ' ' ILE . 3.4 mp -113.02 91.11 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.86 0.362 . . . . 71.14 110.538 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -92.75 106.49 18.45 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.84 -0.43 . . . . 71.43 109.84 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA3' ' OG ' ' A' ' 131' ' ' SER . . . -66.1 123.25 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.919 -0.658 . . . . 53.51 113.091 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.33 -25.6 66.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.513 0.673 . . . . 73.1 110.443 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -88.47 119.93 29.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.325 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.42 -22.86 63.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.949 0.404 . . . . 54.43 111.678 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -65.9 135.08 95.23 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.319 -0.4 . . . . 55.34 111.583 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.83 120.19 7.84 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.894 2.396 . . . . 72.11 113.097 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.6 mt -88.67 149.61 44.37 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.551 -0.295 . . . . 74.12 111.255 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.01 176.07 10.01 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.399 2.066 . . . . 61.34 113.167 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.24 47.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.827 0.346 . . . . 52.3 111.434 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.95 159.14 42.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.535 0.684 . . . . 75.55 112.638 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.7 p -141.38 163.94 31.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.495 -0.775 . . . . 63.21 110.141 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.648 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.31 169.68 38.48 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.278 -0.963 . . . . 53.25 114.005 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 28.2 m -99.9 129.39 45.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.699 0.4 . . . . 73.32 110.727 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 24.5 m -112.53 117.01 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.103 0.477 . . . . 72.34 111.57 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 43.7 mt-10 -92.82 103.61 15.94 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.574 -0.285 . . . . 75.41 110.787 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -112.91 137.05 51.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.009 0.433 . . . . 70.41 111.61 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.04 -145.96 4.91 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.004 -0.544 . . . . 35.44 112.957 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.474 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -130.39 145.8 51.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.995 0.426 . . . . 72.2 111.95 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.0 mt -105.4 120.99 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.478 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.08 3.36 54.9 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.402 0.89 . . . . 73.44 113.402 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.04 -162.67 9.3 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.077 -1.059 . . . . 65.22 114.724 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -88.34 -161.96 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.031 0.532 . . . . 75.31 111.585 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.629 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.5 mm -83.72 -21.97 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.409 0.624 . . . . 54.34 110.421 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.25 -37.12 12.85 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.962 -0.563 . . . . 74.33 111.337 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.47 106.6 5.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.19 0.519 . . . . 71.14 111.377 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -154.07 153.47 31.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.158 0.504 . . . . 73.14 112.235 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -125.77 146.91 49.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.965 -0.561 . . . . 74.22 110.766 173.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.32 105.62 17.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.882 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 103' ' ' GLN . 35.6 pt -110.72 157.54 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.498 -0.319 . . . . 64.22 111.446 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.6 m120 56.28 29.24 14.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.075 0.464 . . . . 72.31 111.666 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.78 131.58 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.256 0.55 . . . . 71.15 112.321 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.45 164.99 28.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.906 -0.588 . . . . 73.34 110.258 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.6 p-10 -115.01 142.09 47.11 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.956 0.724 . . . . 74.24 112.956 -173.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.42 154.91 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.666 -0.697 . . . . 65.44 110.283 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.72 122.59 42.14 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.983 0.364 . . . . 73.51 111.983 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.7 pt -102.1 143.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.503 -0.317 . . . . 75.12 111.063 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.44 119.58 19.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.972 0.415 . . . . 73.52 111.673 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.57 144.04 31.72 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 111.776 0.287 . . . . 75.34 111.776 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.28 163.3 36.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.65 2.233 . . . . 74.52 113.602 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.17 138.77 40.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.117 0.484 . . . . 75.21 112.233 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -81.55 119.1 23.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.325 -0.398 . . . . 71.33 110.772 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.626 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.9 m -93.78 -28.89 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.931 0.396 . . . . 72.35 111.228 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.626 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.0 mt -117.89 -178.5 3.51 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.987 0.423 . . . . 71.5 111.163 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -118.82 151.68 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 111.793 0.294 . . . . 62.15 111.793 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.49 -177.44 20.12 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.1 -1.209 . . . . 73.35 113.392 -2.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.476 ' OG ' ' HA3' ' A' ' 86' ' ' GLY . 53.9 p -90.2 40.62 1.01 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.101 0.477 . . . . 73.2 112.008 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -84.12 99.7 10.66 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.39 0.614 . . . . 62.13 111.423 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.36 134.11 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.215 -0.448 . . . . 65.35 111.301 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -114.78 127.09 55.54 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.241 -0.287 . . . . 64.43 111.174 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 84' ' ' ILE . 33.1 pt -131.09 146.4 61.92 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.181 0.437 . . . . 74.11 112.181 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.9 161.99 20.99 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.552 2.168 . . . . 73.13 112.496 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.93 125.37 10.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.804 0.335 . . . . 63.23 110.51 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -108.59 106.38 16.43 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.049 0.452 . . . . 65.24 111.512 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.92 135.18 33.78 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.65 -0.25 . . . . 65.35 110.772 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -109.68 149.83 29.17 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.312 0.486 . . . . 71.34 112.312 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.92 83.06 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.153 -0.476 . . . . 71.15 113.873 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 147' ' ' LEU . 17.1 tt -143.68 135.17 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.026 0.441 . . . . 75.21 111.401 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.2 m -101.71 147.52 26.35 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.61 -0.268 . . . . 54.42 111.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.61 -43.83 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.744 0.646 . . . . 55.24 112.744 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.46 -28.27 69.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.001 0.429 . . . . 70.5 111.675 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -108.11 13.13 26.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.166 -0.47 . . . . 65.11 111.664 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.633 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.4 tt -81.0 120.8 25.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 73.45 110.407 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.27 -59.0 1.32 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.971 -0.633 . . . . 53.22 113.333 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.51 153.52 35.98 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.4 . . . . 73.1 111.911 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 65.9 t -125.99 107.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.01 -0.541 . . . . 63.21 110.046 170.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 38.5 ttt180 -96.22 110.94 23.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.823 0.344 . . . . 72.24 111.683 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.695 HG21 ' SD ' ' A' ' 66' ' ' MET . 18.0 mm -90.48 124.23 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.513 -0.312 . . . . 64.32 111.331 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.591 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 1.8 p80 -159.55 -176.75 5.94 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.372 0.508 . . . . 64.01 112.372 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 98' ' ' THR . 54.4 m-20 63.15 17.87 10.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.695 0.628 . . . . 63.14 112.695 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.648 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.5 mm -61.54 103.49 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.471 0.653 . . . . 73.14 111.097 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -136.52 158.3 73.57 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.762 -0.654 . . . . 71.21 111.451 -174.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.43 132.37 23.72 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.366 2.044 . . . . 62.34 112.665 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.56 170.11 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.895 0.379 . . . . 63.34 111.783 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mtm 63.1 23.12 13.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.166 -0.47 . . . . 74.23 112.016 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 157.8 37.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.199 0.523 . . . . 71.14 111.696 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 161' ' ' LEU . 4.9 mp -97.67 144.04 27.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.136 -0.484 . . . . 63.42 111.155 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.17 113.42 20.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.865 0.364 . . . . 75.22 111.527 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -79.99 75.28 6.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.357 0.598 . . . . 72.23 110.277 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -61.43 133.47 55.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.631 -0.713 . . . . 72.21 112.237 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -145.26 172.4 13.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.194 -0.457 . . . . 54.51 111.036 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -113.93 115.42 27.65 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.365 0.876 . . . . 70.55 113.365 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 70.19 92.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.278 0.631 . . . . 74.03 112.647 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 119.01 -0.519 . . . . 71.21 110.93 170.877 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.453 0.168 . . . . 63.2 110.783 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t -131.24 110.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.651 0.262 . . . . 63.5 111.256 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.38 177.96 5.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.876 0.369 . . . . 73.54 111.551 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.24 162.59 36.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.955 0.407 . . . . 71.35 111.322 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.4 p -133.02 142.64 48.92 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.995 0.426 . . . . 72.45 111.284 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -90.4 -174.42 4.14 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.433 0.635 . . . . 74.41 112.304 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.21 95.65 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.585 -0.734 . . . . 63.42 110.093 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -91.33 -170.18 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.898 -0.592 . . . . 64.31 111.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.46 85.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.136 0.493 . . . . 72.33 111.95 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.6 mtp -109.22 135.45 50.3 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.221 -0.445 . . . . 63.12 110.848 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.93 102.1 1.51 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.12 0.415 . . . . 72.03 112.12 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -101.18 86.06 2.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.718 0.294 . . . . 74.43 110.673 174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.8 t 55.4 75.28 0.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.306 -0.406 . . . . 70.43 111.289 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.65 113.06 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.191 0.52 . . . . 44.14 112.369 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.4 m -145.47 108.54 4.57 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.754 -0.657 . . . . 72.51 109.557 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -144.43 174.59 10.79 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.246 0.546 . . . . 72.32 112.345 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.3 mm? -95.96 -169.22 1.89 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.919 -0.582 . . . . 72.53 111.392 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -74.8 90.37 2.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.149 0.5 . . . . 60.3 110.636 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -110.02 -166.31 1.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.226 -0.443 . . . . 50.23 111.828 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -49.8 152.17 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.186 0.439 . . . . 72.42 112.186 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.5 mtt -51.35 126.92 18.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.15 -0.477 . . . . 75.23 112.166 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -77.08 -175.32 3.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.13 0.491 . . . . 73.22 111.855 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -69.94 164.66 23.38 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 63.33 112.013 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.12 142.33 31.32 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.27 -0.423 . . . . 70.4 111.429 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.03 140.37 50.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.805 0.336 . . . . 75.43 111.354 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -60.71 -31.63 70.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.778 0.659 . . . . 55.52 112.778 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.14 -44.98 96.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.968 0.413 . . . . 74.3 110.4 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -65.36 -34.81 79.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.062 0.458 . . . . 75.24 110.785 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.86 -38.66 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.307 -0.406 . . . . 60.41 110.854 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -30.64 69.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.44 -0.346 . . . . 75.45 111.664 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.6 mt -61.44 -51.38 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.025 0.44 . . . . 75.22 110.496 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.4 m -58.92 -45.37 90.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.04 0.447 . . . . 74.01 110.832 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.655 HE21 HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -55.85 -45.58 78.4 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.794 -0.639 . . . . 70.44 111.256 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -63.17 -54.39 38.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.946 -0.57 . . . . 74.54 111.578 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.49 -35.86 74.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.351 -0.386 . . . . 73.35 112.033 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -64.89 -48.57 73.76 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.275 -0.265 . . . . 74.52 111.251 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.07 -41.64 88.48 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.251 0.548 . . . . 63.01 110.79 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -57.11 -43.52 82.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.661 -0.7 . . . . 72.44 111.401 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -33.69 64.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.31 0.485 . . . . 73.35 112.31 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -84.2 -7.79 59.25 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.272 0.471 . . . . 75.25 112.272 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.6 t -107.44 119.17 38.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.248 0.547 . . . . 75.4 111.946 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.6 p -83.6 -45.77 13.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.127 -0.488 . . . . 54.45 110.839 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.7 m -73.64 81.72 1.53 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.182 -0.463 . . . . 70.44 111.708 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 89.29 -171.72 38.84 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.204 -0.453 . . . . 73.23 113.848 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 57' ' ' LEU . 35.8 m -121.02 142.81 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 44.32 111.846 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.69 133.44 37.04 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.934 0.397 . . . . 74.31 111.946 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.75 138.44 52.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.854 -0.612 . . . . 53.1 110.187 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 74.8 mt -112.64 137.55 21.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 112.076 0.399 . . . . 72.21 112.076 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 16.0 Cg_exo -66.55 -30.81 42.61 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.724 2.283 . . . . 72.12 113.022 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.96 -8.04 67.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 114.314 0.486 . . . . 41.4 114.314 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.68 97.28 2.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.51 0.655 . . . . 74.52 111.901 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.87 88.88 0.11 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.847 0.832 . . . . 70.23 111.418 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -137.02 151.43 72.05 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 112.633 0.605 . . . . 73.44 112.633 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 89.2 Cg_endo -80.74 159.66 21.65 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.116 2.544 . . . . 73.25 114.06 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.19 144.8 27.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.986 -0.552 . . . . 63.33 110.632 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -83.69 119.56 24.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.943 0.401 . . . . 73.54 111.67 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.528 HD13 HG13 ' A' ' 45' ' ' VAL . 46.5 tp -113.83 119.45 37.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.335 0.588 . . . . 53.44 110.658 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.52 110.77 22.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.963 -0.562 . . . . 72.14 110.348 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.4 p -115.72 -174.32 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.505 0.669 . . . . 74.52 112.751 -170.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -72.65 -24.68 61.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.583 -0.735 . . . . 74.43 112.196 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.8 pt -91.37 -7.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.795 0.331 . . . . 72.54 111.499 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.62 -167.75 23.8 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.366 -0.445 . . . . 62.53 113.056 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 m -91.7 123.08 34.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.865 0.364 . . . . 62.44 111.069 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.45 164.2 28.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.108 0.48 . . . . 75.44 111.625 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -124.04 114.63 19.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.279 -0.419 . . . . 74.51 110.916 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.4 mtt -98.56 143.39 29.02 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.929 0.395 . . . . 44.4 111.936 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 33.3 p -141.07 142.77 34.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.128 0.49 . . . . 71.42 111.848 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 82.4 mt -97.9 122.14 40.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.16 -0.473 . . . . 73.51 111.411 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 81' ' ' THR . 23.2 m -132.68 163.06 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.647 -0.251 . . . . 74.23 110.941 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 60.28 33.55 20.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.193 0.521 . . . . 74.52 111.939 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 68' ' ' LEU . 46.5 mt -71.9 106.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.192 -0.458 . . . . 64.04 111.677 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 p -135.17 149.85 71.21 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 112.419 0.526 . . . . 62.45 112.419 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.47 148.87 55.12 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.84 2.36 . . . . 25.24 113.099 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.4 -175.44 3.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.359 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.96 -45.86 39.44 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.993 -0.442 . . . . 64.2 111.998 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 2.1 p30 -92.36 -24.31 18.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.395 0.517 . . . . 72.41 112.395 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -164.97 -118.98 0.46 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.567 -0.825 . . . . 72.53 114.047 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.1 m -139.78 132.13 28.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.607 -0.349 . . . . 75.53 111.588 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.3 p -108.59 123.44 48.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.055 0.455 . . . . 71.42 111.502 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -139.09 151.91 47.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 73.45 111.079 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.711 ' HB ' HG23 ' A' ' 69' ' ' VAL . 27.3 m -90.35 111.05 22.13 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.301 -0.249 . . . . 61.2 110.936 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.58 108.41 19.05 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.543 -0.54 . . . . 73.25 109.543 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.432 ' HE ' ' CG ' ' A' ' 134' ' ' ASP . 23.9 mtp-105 -98.64 131.58 44.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.781 0.324 . . . . 53.01 111.627 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.2 mp -114.04 96.48 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.657 -0.247 . . . . 63.53 111.051 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.4 103.73 15.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.654 0.264 . . . . 71.4 110.623 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.87 131.77 26.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.72 -0.753 . . . . 53.53 112.876 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -68.56 -25.49 64.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.234 0.54 . . . . 72.23 110.593 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.5 m -79.11 117.26 19.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.868 -0.605 . . . . 42.31 110.223 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -80.02 41.05 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.355 0.598 . . . . 75.5 112.131 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.59 154.18 80.83 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.1 0.56 . . . . 64.44 110.215 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 19.7 Cg_endo -59.14 109.0 0.47 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.492 2.128 . . . . 45.21 112.681 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.77 151.03 57.45 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.079 -0.509 . . . . 50.14 112.152 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.88 159.73 41.4 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.467 2.111 . . . . 61.23 112.841 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.55 136.76 56.79 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.983 0.421 . . . . 73.43 111.641 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -133.76 163.31 29.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.417 0.627 . . . . 74.23 112.575 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.4 p -134.73 132.94 39.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.421 -0.809 . . . . 74.53 110.564 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.783 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -133.98 166.01 24.13 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.731 -0.747 . . . . 64.15 113.195 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.4 m -108.61 124.85 51.14 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.669 -0.313 . . . . 71.1 110.917 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.5 p -106.2 118.4 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.044 0.449 . . . . 72.3 112.144 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.6 mm-40 -89.32 113.18 24.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 73.4 110.041 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -122.81 128.7 50.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.158 0.504 . . . . 63.15 111.746 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.54 4.44 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.907 -0.588 . . . . 51.01 112.636 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.645 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.3 mt-30 -128.12 156.34 43.0 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.217 0.532 . . . . 60.5 112.213 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.42 120.91 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.17 -0.468 . . . . 51.44 111.211 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -93.19 -30.99 14.93 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.538 0.57 . . . . 71.21 112.538 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -93.25 -157.67 33.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.027 -0.606 . . . . 72.03 114.175 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.7 p -92.97 -173.69 3.36 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.933 0.397 . . . . 51.51 111.425 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.655 HD11 HE21 ' A' ' 33' ' ' GLN . 36.5 mm -82.58 -3.26 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.348 0.594 . . . . 63.01 111.213 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -109.04 -39.19 5.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.233 0.54 . . . . 73.11 110.791 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -134.9 102.37 5.21 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.864 -0.607 . . . . 52.34 111.344 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 107' ' ' THR . 34.8 p90 -141.8 148.67 39.27 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.101 0.477 . . . . 75.24 111.801 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -109.44 126.03 53.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.001 -0.545 . . . . 74.22 110.703 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.8 105.28 4.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.27 -0.423 . . . . 75.01 110.91 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 pt -110.12 152.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 111.759 0.281 . . . . 43.44 111.759 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 57.68 29.6 17.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.967 0.413 . . . . 72.21 111.842 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -95.1 115.55 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.883 0.697 . . . . 73.21 112.883 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.73 170.98 8.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.985 -0.552 . . . . 64.32 110.154 170.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 22.9 p30 -123.87 162.62 22.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.341 0.867 . . . . 74.23 113.341 -171.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -144.18 152.24 40.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.313 -0.858 . . . . 74.35 110.366 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.52 117.16 28.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.892 0.377 . . . . 44.11 111.301 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 121' ' ' ILE . 30.0 pt -102.86 103.13 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.523 0.678 . . . . 51.4 111.368 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.05 114.87 29.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.115 -0.493 . . . . 70.42 111.348 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.464 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -95.05 139.37 22.05 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.543 -0.299 . . . . 71.3 111.287 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 32.5 Cg_exo -62.07 170.65 5.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.879 2.386 . . . . 75.14 113.397 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.56 10.83 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.052 0.453 . . . . 41.53 111.556 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -77.54 69.01 3.74 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.222 0.534 . . . . 62.4 111.281 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.55 -19.39 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.073 0.463 . . . . 53.01 111.734 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.7 mt -85.86 136.89 33.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.345 -0.389 . . . . 63.2 111.675 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.482 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -122.18 127.7 25.8 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.31 -0.405 . . . . 24.05 111.199 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.72 154.53 97.7 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.074 -1.219 . . . . 74.51 113.331 1.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.9 m -87.91 92.64 9.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.002 0.742 . . . . 54.31 113.002 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 8.3 p-10 -117.96 100.54 7.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.401 0.62 . . . . 62.4 110.158 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' ARG . 32.2 t -87.12 144.12 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.012 0.745 . . . . 72.32 113.012 -170.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.432 ' CG ' ' HE ' ' A' ' 83' ' ' ARG . 1.2 m-20 -115.11 115.48 26.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.887 -0.597 . . . . 75.24 110.622 175.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.8 pt -125.95 126.53 24.83 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 120.904 0.383 . . . . 63.2 111.964 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 9.9 Cg_exo -71.83 111.63 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.935 2.423 . . . . 43.34 112.274 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -103.81 115.4 30.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.267 -0.424 . . . . 54.31 110.523 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -105.92 103.28 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.3 0.571 . . . . 72.33 111.347 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.509 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 81.1 mt -78.76 138.76 38.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.17 -0.468 . . . . 55.05 109.911 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -116.23 135.76 53.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.427 0.529 . . . . 73.43 112.427 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.51 40.28 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.091 -0.504 . . . . 44.33 113.094 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.6 tt -115.19 126.86 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.202 0.525 . . . . 71.41 111.659 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.2 m -94.73 149.17 21.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.805 0.298 . . . . 71.1 111.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 p -50.37 -44.42 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.793 1.034 . . . . 73.44 113.793 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.56 -31.8 71.27 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.885 -0.509 . . . . 73.14 111.018 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -95.52 9.05 41.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.205 -0.452 . . . . 54.23 111.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.547 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.9 tt -85.45 115.84 23.41 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.097 0.475 . . . . 51.54 110.406 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -81.68 -59.55 2.33 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.326 -0.464 . . . . 72.5 113.203 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.76 149.1 31.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.086 0.47 . . . . 71.52 112.16 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.9 106.71 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.694 -0.685 . . . . 64.3 109.713 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.4 ttt180 -107.58 106.33 16.63 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.09 0.404 . . . . 75.23 112.09 -172.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.669 HG21 ' SD ' ' A' ' 66' ' ' MET . 25.6 mm -89.6 134.32 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.657 -0.247 . . . . 43.45 111.293 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.438 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.2 p80 -164.61 174.83 10.39 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.655 0.264 . . . . 73.41 111.664 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 62.72 32.75 15.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.327 0.492 . . . . 73.41 112.327 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.783 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.2 mm -66.71 99.48 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.257 -0.429 . . . . 60.41 110.804 175.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.51 151.58 67.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.264 -0.425 . . . . 62.51 111.196 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.7 149.55 89.47 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.801 2.334 . . . . 74.13 113.797 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.63 -155.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.841 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.2 ptp -46.23 103.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.66 0.615 . . . . 73.54 112.66 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -130.2 117.36 19.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 70.43 111.193 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 161' ' ' LEU . 6.4 mp -100.78 120.16 39.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.954 0.407 . . . . 62.33 110.698 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.08 163.19 31.37 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.515 -0.311 . . . . 74.13 111.221 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -52.71 115.55 1.86 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 74.3 111.437 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -73.74 122.61 22.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.373 -0.376 . . . . 65.34 111.707 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -100.67 148.71 24.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.423 -0.353 . . . . 73.4 110.868 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -73.24 171.75 12.43 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.9 0.704 . . . . 74.23 112.9 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -136.8 -42.41 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.437 -0.801 . . . . 75.42 110.054 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.862 -0.608 . . . . 71.52 111.07 175.076 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.964 0.412 . . . . 64.41 111.262 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.76 129.85 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.845 0.355 . . . . 74.02 111.583 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.37 137.66 47.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.466 -0.334 . . . . 62.43 110.752 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.55 158.93 27.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.375 0.607 . . . . 74.32 112.432 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -165.16 142.15 5.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.573 -0.74 . . . . 43.31 110.299 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.47 177.37 10.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.954 0.406 . . . . 55.53 111.951 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -159.23 157.33 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 116.117 -0.492 . . . . 73.01 110.611 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -161.76 129.68 4.14 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.305 -0.247 . . . . 74.12 110.801 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -128.9 167.19 17.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.467 0.651 . . . . 72.05 112.467 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.9 156.36 43.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.314 -0.857 . . . . 73.43 109.679 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -147.38 100.64 3.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.823 0.675 . . . . 71.14 112.823 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -150.08 133.32 16.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.65 -0.704 . . . . 74.44 110.277 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.5 p -96.12 105.96 18.08 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.011 0.434 . . . . 73.31 111.235 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.47 118.57 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.974 0.416 . . . . 70.13 111.495 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.3 m -115.78 18.62 15.62 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.479 -0.328 . . . . 55.22 111.377 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -61.32 143.46 55.66 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.547 0.573 . . . . 75.0 112.547 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.8 mt -93.63 135.0 35.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.166 -0.47 . . . . 74.52 112.179 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -138.17 -91.29 0.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.132 -0.485 . . . . 74.41 110.294 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -138.67 164.73 28.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.043 0.449 . . . . 64.21 110.929 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -145.81 123.56 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.313 -0.403 . . . . 74.51 110.189 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -92.53 177.76 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.289 0.566 . . . . 70.34 112.356 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -83.02 -176.29 6.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.818 -0.628 . . . . 70.32 111.875 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -105.22 168.95 8.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.2 -0.455 . . . . 71.54 111.905 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.66 152.83 51.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.283 -0.417 . . . . 73.01 111.09 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.531 ' O ' HG23 ' A' ' 29' ' ' VAL . 25.8 t-20 -61.65 131.29 49.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.602 0.239 . . . . 74.43 111.2 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 1.6 mp0 -56.86 -44.57 82.3 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.269 0.47 . . . . 55.54 112.269 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 39.4 tt0 -58.35 -47.31 84.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.06 0.457 . . . . 73.31 110.594 176.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.5 m -59.02 -33.63 70.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.077 -0.51 . . . . 70.33 111.329 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 25' ' ' ASN . 89.6 t -64.49 -45.31 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.602 -0.272 . . . . 74.4 111.169 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 1.3 mptm? -62.49 -44.44 96.37 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.53 0.205 . . . . 75.11 111.175 176.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 53' ' ' THR . 75.7 mt -54.26 -55.66 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.414 0.626 . . . . 75.22 110.831 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.533 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 89.5 m -56.0 -44.05 78.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.623 -0.717 . . . . 73.42 111.148 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.81 -44.5 90.84 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.591 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.6 -42.65 93.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.832 0.348 . . . . 74.23 111.167 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -60.95 -45.27 95.38 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.109 0.48 . . . . 72.42 111.199 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 32' ' ' THR . 70.9 mtp180 -65.19 -42.54 93.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.11 -0.495 . . . . 73.22 111.412 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.19 -37.63 86.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.885 0.374 . . . . 75.44 110.998 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.013 0.435 . . . . 74.23 110.686 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.54 66.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.292 -0.413 . . . . 50.45 111.941 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' NZ ' ' HA ' ' A' ' 109' ' ' ASP . 85.5 mttt -82.84 -18.74 39.35 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.634 0.605 . . . . 73.03 112.634 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -59.12 115.61 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.867 0.365 . . . . 73.32 111.97 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -92.07 -27.68 17.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.591 -0.277 . . . . 63.24 111.55 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.409 ' HB2' HH21 ' A' ' 151' ' ' ARG . 42.3 m -117.21 86.39 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.892 0.377 . . . . 71.51 111.374 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 83.77 -132.95 11.44 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.174 -0.536 . . . . 43.41 113.359 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.66 154.09 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.171 0.51 . . . . 63.43 111.916 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.42 101.29 10.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.067 -0.515 . . . . 75.03 111.268 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.555 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 87.1 mt -85.27 133.98 34.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 73.43 110.815 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 79.7 mt -107.15 108.55 62.08 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 120.722 0.296 . . . . 65.21 111.211 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.1 Cg_endo -57.03 -22.92 49.41 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.014 2.476 . . . . 72.25 113.654 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.75 -26.35 71.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.133 -0.556 . . . . 63.42 113.238 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.416 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -124.66 112.99 17.43 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.697 -0.296 . . . . 71.3 111.584 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HD2' HG12 ' A' ' 69' ' ' VAL . 38.8 ttpt -74.62 75.71 2.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.699 0.762 . . . . 71.31 111.019 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 31' ' ' ILE . 4.4 p -133.05 145.19 55.94 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.751 -0.659 . . . . 72.21 111.732 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 145.22 33.19 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.008 2.472 . . . . 74.11 113.711 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.86 153.02 40.18 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.885 -0.598 . . . . 64.44 110.558 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 56' ' ' ARG . 35.5 ttm105 -95.78 117.8 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.925 0.393 . . . . 74.54 111.463 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.434 HD23 ' HE3' ' A' ' 66' ' ' MET . 45.7 tp -118.3 124.69 48.41 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.296 0.569 . . . . 75.12 112.172 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.51 102.44 14.1 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.931 -0.577 . . . . 43.01 110.584 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 p -94.46 -172.71 2.84 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.222 0.534 . . . . 74.32 111.792 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.459 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 51.6 mt-30 -91.99 -2.71 56.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.109 -0.496 . . . . 61.54 111.296 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -105.72 -19.04 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.001 0.429 . . . . 64.43 110.901 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.8 160.68 9.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.101 -0.499 . . . . 64.34 112.651 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -62.53 127.57 31.94 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.152 0.476 . . . . 73.45 110.678 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.45 165.85 26.31 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.137 0.494 . . . . 64.41 111.728 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -119.15 114.79 23.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.256 -0.429 . . . . 74.45 110.763 -176.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 152' ' ' ILE . 61.7 mtt -104.01 150.9 23.83 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.987 0.422 . . . . 75.31 112.068 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.3 p -151.61 153.32 34.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.324 -0.398 . . . . 64.04 111.563 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.48 ' HB3' HD11 ' A' ' 71' ' ' ILE . 97.4 mt -103.33 112.84 25.91 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.266 -0.425 . . . . 75.31 111.352 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' A' ' 81' ' ' THR . 29.8 m -121.22 156.76 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.863 0.364 . . . . 61.31 111.646 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 59.89 37.13 21.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.123 -0.49 . . . . 70.43 111.857 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 68' ' ' LEU . 49.8 mt -69.87 101.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.903 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 18.0 p -121.23 162.95 33.02 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 115.97 -0.559 . . . . 63.35 111.574 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 57.5 Cg_endo -69.88 166.43 27.79 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.238 1.959 . . . . 53.04 113.019 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HB2' HG23 ' A' ' 79' ' ' THR . 30.4 t70 -128.22 165.57 20.21 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.116 -0.493 . . . . 74.32 110.281 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.23 69.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.049 0.452 . . . . 75.32 111.413 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.2 -47.55 3.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.204 -0.453 . . . . 61.55 111.316 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -136.55 -103.6 0.69 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.804 -0.712 . . . . 61.12 114.129 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 147' ' ' LEU . 96.0 m -143.56 130.96 20.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.245 0.461 . . . . 63.31 112.245 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 74' ' ' ASP . 40.0 p -104.36 114.22 28.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.679 0.392 . . . . 65.01 111.626 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.1 pp -137.24 149.18 46.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.89 0.376 . . . . 72.33 111.72 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.661 ' HB ' HG23 ' A' ' 69' ' ' VAL . 48.6 m -93.52 113.64 25.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.047 0.451 . . . . 64.21 111.353 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.46 112.51 24.18 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.024 -0.535 . . . . 75.3 110.132 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 32.9 mtp180 -97.27 126.6 42.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.5 107.23 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.189 -0.459 . . . . 74.11 110.62 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -106.74 106.59 17.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.727 0.299 . . . . 35.05 111.051 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.48 129.75 49.28 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.095 -0.574 . . . . 74.41 113.154 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -81.76 58.92 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.428 0.632 . . . . 72.53 111.137 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -168.49 -166.43 0.68 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.1 -0.5 . . . . 73.33 110.638 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -112.01 12.57 20.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.048 0.451 . . . . 74.24 110.628 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.66 136.1 39.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.1 -0.5 . . . . 71.5 111.975 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.39 95.43 1.04 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.242 1.961 . . . . 74.11 111.635 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.61 139.87 81.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.251 -0.432 . . . . 63.02 111.996 -176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.03 174.56 12.62 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.584 2.19 . . . . 70.33 112.901 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.47 138.69 58.52 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.123 0.487 . . . . 44.14 111.523 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -138.45 171.36 14.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.376 0.607 . . . . 61.44 112.292 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.4 p -152.92 156.73 39.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.685 -0.689 . . . . 73.44 110.746 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.5 -178.12 36.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.909 -0.662 . . . . 71.44 113.072 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.3 m -108.31 127.3 53.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.816 0.341 . . . . 62.41 111.441 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.95 123.31 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.206 0.527 . . . . 73.23 111.416 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.8 mt-10 -104.96 107.69 18.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 75.34 110.601 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -112.5 129.13 56.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 71.34 111.897 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.97 -145.78 4.53 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.964 -0.562 . . . . 74.11 112.835 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.666 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.7 mt-30 -125.71 141.14 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.031 0.443 . . . . 64.12 112.147 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.35 122.71 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.265 -0.425 . . . . 60.43 111.349 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HG3' ' HB2' ' A' ' 112' ' ' GLN . 10.7 pt20 -111.99 99.76 8.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.474 0.654 . . . . 75.31 110.39 170.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 154.15 -169.17 32.59 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.038 -0.601 . . . . 72.34 113.852 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -100.43 -165.15 1.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.098 0.475 . . . . 63.23 111.753 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -72.19 -21.38 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.182 0.515 . . . . 73.33 111.185 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.51 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 37.6 t70 -105.89 -39.63 5.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 63.42 111.874 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.49 91.77 3.59 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 75.52 111.483 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.61 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 40.0 p90 -127.93 143.45 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.964 0.412 . . . . 74.22 111.751 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 49.6 mt-30 -118.24 133.69 55.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 73.03 111.688 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -88.14 109.7 20.1 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.317 -0.401 . . . . 60.44 110.951 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.9 pt -123.81 162.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 111.886 0.328 . . . . 65.32 111.886 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 53.42 28.95 8.1 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.514 0.561 . . . . 72.21 112.514 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 p -90.17 138.96 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.823 0.675 . . . . 55.52 112.823 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -124.66 151.8 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.493 -0.776 . . . . 74.44 110.525 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.29 132.08 54.06 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.337 0.589 . . . . 71.25 111.75 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -129.69 156.27 44.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.035 -0.53 . . . . 61.41 110.202 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.6 mt -96.83 119.92 36.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 73.31 111.145 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.725 HG22 HD21 ' A' ' 137' ' ' LEU . 15.4 pt -99.65 100.76 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.337 0.589 . . . . 65.43 111.732 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.19 131.67 50.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.006 -0.543 . . . . 75.03 110.268 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.22 148.32 65.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.394 0.516 . . . . 71.34 112.394 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.2 175.45 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.116 2.544 . . . . 73.21 113.42 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.04 144.47 29.04 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.803 0.668 . . . . 75.12 112.803 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.6 m -87.72 102.72 14.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.203 -0.453 . . . . 72.01 110.374 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.0 m -80.6 -14.04 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.404 0.52 . . . . 71.13 112.404 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -138.81 -179.79 6.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.906 0.384 . . . . 53.45 111.233 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.95 144.52 28.75 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.533 -0.303 . . . . 72.15 111.469 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.36 170.48 53.79 Favored 'Cis proline' 0 C--N 1.352 0.724 0 C-N-CA 123.932 -1.278 . . . . 70.31 112.825 -0.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 t -86.58 85.92 7.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 63.03 111.378 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.56 122.85 48.88 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.859 -0.422 . . . . 75.02 109.859 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -135.35 112.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.12 -0.362 . . . . 73.12 111.198 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -112.81 134.79 54.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.321 0.581 . . . . 74.14 111.96 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -125.31 133.45 24.86 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.813 -0.63 . . . . 63.02 112.345 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.32 111.81 3.4 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.851 2.367 . . . . 63.54 112.439 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.725 HD21 HG22 ' A' ' 121' ' ' ILE . 23.6 mt -94.4 141.1 28.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 71.31 112.63 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.05 92.79 3.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.663 -0.699 . . . . 42.14 110.21 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.4 mt -77.13 132.16 38.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.125 -0.488 . . . . 64.33 110.775 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -96.31 145.89 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.536 0.569 . . . . 64.23 112.536 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 56.98 31.48 61.47 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.064 0.786 . . . . 64.01 115.064 172.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.1 tt -152.09 127.97 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 117.602 0.701 . . . . 75.42 111.606 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.4 m -86.83 144.24 27.11 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.306 -0.407 . . . . 50.03 111.709 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.31 -44.24 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.631 0.604 . . . . 54.21 112.631 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.56 -21.62 66.45 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.025 0.441 . . . . 75.21 111.417 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.469 ' HB3' HE21 ' A' ' 103' ' ' GLN . 81.6 mm-40 -107.1 10.63 30.13 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.084 0.401 . . . . 71.41 112.084 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.583 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.9 mt -68.84 115.26 7.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.785 0.326 . . . . 74.41 111.499 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -89.73 -49.39 3.39 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.168 -0.539 . . . . 63.12 113.298 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.16 157.37 38.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.246 0.546 . . . . 70.33 112.273 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 60.8 t -124.23 98.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.709 -0.678 . . . . 73.21 110.1 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 70.2 ttt180 -90.25 101.28 14.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.305 -0.407 . . . . 73.3 111.739 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.669 HG21 ' SD ' ' A' ' 66' ' ' MET . 33.2 mm -94.22 132.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 122.273 -0.267 . . . . 53.51 111.56 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.76 172.36 13.11 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.411 0.523 . . . . 73.32 112.411 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 65.09 22.23 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.313 0.857 . . . . 74.2 113.313 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.579 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.8 mm -63.62 101.81 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.112 0.482 . . . . 54.0 111.499 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 12.1 pt20 -129.17 159.21 70.11 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.071 -0.513 . . . . 75.35 111.174 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 156' ' ' GLN . 74.0 Cg_endo -73.01 150.96 49.51 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.157 1.905 . . . . 71.04 113.134 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.46 -153.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 116.162 -0.472 . . . . 61.24 110.889 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -50.87 94.17 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.466 0.65 . . . . 63.11 111.732 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.74 153.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.022 -0.536 . . . . 74.35 111.255 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 161' ' ' LEU . 3.1 mm? -71.83 132.48 44.49 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.984 0.421 . . . . 72.51 111.847 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.78 142.65 57.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.161 0.505 . . . . 62.5 112.161 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -116.75 82.42 1.79 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.322 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -85.23 115.7 23.16 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.842 0.682 . . . . 71.35 112.842 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -115.67 140.52 49.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.044 -0.525 . . . . 73.01 110.531 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -66.21 90.61 0.15 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.862 0.69 . . . . 52.15 112.862 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -126.01 28.21 6.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.056 -0.52 . . . . 72.1 110.525 170.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.919 -0.562 . . . . 55.31 111.461 177.689 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.889 0.376 . . . . 74.02 111.149 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.05 106.06 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.333 -0.394 . . . . 64.24 110.776 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -108.75 170.43 8.04 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.734 0.302 . . . . 74.41 110.844 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.88 163.98 39.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.066 0.46 . . . . 63.45 111.979 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -140.35 133.71 29.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.271 -0.422 . . . . 72.43 110.987 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -136.64 159.54 41.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.705 0.288 . . . . 64.14 111.04 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.94 125.43 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.263 0.554 . . . . 72.54 111.659 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -81.34 142.31 33.17 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.218 -0.446 . . . . 73.21 111.33 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -56.73 148.78 19.42 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.237 0.541 . . . . 64.34 112.257 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 10' ' ' MET . 1.3 mpt? -65.17 171.38 3.76 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.336 0.865 . . . . 72.15 113.336 -173.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -73.11 95.38 2.05 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.379 -0.828 . . . . 72.21 111.323 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -67.79 139.04 56.6 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.189 -0.459 . . . . 63.44 111.374 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.6 p -70.24 149.16 47.75 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.972 0.415 . . . . 73.45 111.485 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.67 -178.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.276 0.56 . . . . 73.14 112.488 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.4 t -134.81 176.42 8.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.907 -0.588 . . . . 73.22 110.203 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 t -161.08 149.47 15.99 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.978 0.732 . . . . 74.44 112.978 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt -119.4 116.2 25.67 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.822 -0.626 . . . . 73.1 109.721 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -81.07 178.69 8.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.477 0.547 . . . . 73.12 112.477 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -85.03 -172.07 3.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.322 -0.399 . . . . 73.11 111.91 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 21' ' ' MET . 31.5 tt0 -70.43 159.73 33.67 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.919 0.39 . . . . 71.33 111.655 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.479 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 83.3 mtp -56.12 158.05 4.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.735 0.642 . . . . 74.43 112.735 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -143.35 -175.28 4.48 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.056 -0.52 . . . . 70.41 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -71.02 167.43 19.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.248 0.547 . . . . 75.13 112.392 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.36 139.76 35.14 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.99 -0.55 . . . . 71.31 112.341 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -109.16 149.71 28.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.128 -0.487 . . . . 72.23 110.694 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -59.09 -34.87 72.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.078 0.466 . . . . 74.24 110.714 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 25.1 tt0 -63.05 -43.22 99.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.088 -0.506 . . . . 75.23 110.861 173.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -35.07 70.22 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.13 0.49 . . . . 71.43 110.776 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.9 -44.76 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.205 -0.452 . . . . 71.3 110.893 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -61.05 -39.84 91.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.657 0.265 . . . . 71.33 110.969 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.99 -48.19 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.081 0.467 . . . . 64.45 110.967 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.5 m -57.18 -49.5 75.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.132 0.491 . . . . 73.44 110.903 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HG3' HD12 ' A' ' 108' ' ' ILE . 63.6 tt0 -59.49 -43.73 93.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.964 -0.562 . . . . 75.15 111.337 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.39 -51.97 66.33 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.748 0.419 . . . . 70.31 111.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -58.95 -44.76 91.49 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.986 0.365 . . . . 63.23 111.986 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -63.98 -49.3 73.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.61 0.226 . . . . 75.02 111.61 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 48' ' ' LEU . 73.6 mt -60.58 -41.35 94.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.322 0.582 . . . . 54.31 110.883 176.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.37 -46.22 86.73 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.702 -0.681 . . . . 64.24 110.846 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.45 -25.6 63.26 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.046 -0.525 . . . . 74.23 111.965 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -83.37 -14.78 52.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.401 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 44.2 t -64.22 137.0 57.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.343 0.497 . . . . 73.44 112.343 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -108.93 8.89 26.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.206 -0.452 . . . . 71.05 111.047 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -160.64 117.86 2.42 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.903 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.34 -170.46 15.93 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.332 -0.461 . . . . 75.33 113.661 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.467 HG13 HD13 ' A' ' 57' ' ' LEU . 31.6 m -115.87 140.5 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.318 -0.519 . . . . 73.43 112.104 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 40.9 m-85 -89.75 118.7 29.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.313 -0.403 . . . . 63.53 111.465 175.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.9 123.4 50.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.908 0.483 . . . . 75.42 109.937 171.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 37' ' ' LEU . 68.4 mt -101.66 121.73 50.15 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.279 0.474 . . . . 63.34 112.279 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -56.66 130.7 41.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.324 2.016 . . . . 73.35 111.725 173.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . 95.18 19.68 29.98 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.832 -0.622 . . . . 44.14 112.309 -172.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . . . -142.78 100.26 3.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.461 0.305 . . . . 63.24 111.584 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.45 76.1 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.12 -0.362 . . . . 71.23 111.634 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -149.58 137.31 11.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 112.368 0.507 . . . . 75.35 112.368 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 65' ' ' ARG . 91.7 Cg_endo -78.36 145.17 21.05 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.165 2.577 . . . . 72.54 113.639 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -112.51 139.16 48.32 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 54.31 110.89 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 21.3 ttp85 -81.97 100.37 9.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.846 0.355 . . . . 73.52 111.486 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD13 HG13 ' A' ' 45' ' ' VAL . 59.7 tp -96.7 112.16 24.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.274 0.559 . . . . 74.25 111.085 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.89 92.42 9.0 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.35 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 p -100.41 -175.89 3.05 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.913 0.708 . . . . 64.12 112.913 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -69.77 -34.6 74.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.523 -0.762 . . . . 74.44 112.092 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.566 HG22 ' HB3' ' A' ' 157' ' ' PRO . 37.0 pt -76.91 -29.06 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.218 0.532 . . . . 53.22 111.183 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.24 -161.88 31.08 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.566 -0.743 . . . . 40.01 111.831 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 m -101.93 119.55 38.97 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.374 -0.486 . . . . 71.03 111.341 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.2 pp -131.61 152.71 50.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.982 0.42 . . . . 74.5 111.318 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 85.5 mtt180 -116.52 114.49 24.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.884 0.373 . . . . 54.41 111.218 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.641 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.1 mtt -99.04 142.19 30.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.277 -0.42 . . . . 71.22 111.52 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.9 p -136.16 148.32 48.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.119 0.485 . . . . 70.22 111.963 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.8 mt -99.93 112.24 24.52 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.122 -0.49 . . . . 75.04 111.671 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG23 ' HB ' ' A' ' 81' ' ' THR . 17.7 m -134.12 164.57 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 122.391 -0.193 . . . . 71.44 111.099 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.84 29.41 16.63 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.899 0.38 . . . . 55.44 111.675 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.05 110.68 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.803 0.335 . . . . 62.51 111.309 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -142.85 155.46 62.8 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.539 0.57 . . . . 75.01 112.539 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.7 157.91 21.93 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.226 2.617 . . . . 61.33 113.348 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.53 163.88 35.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.085 0.469 . . . . 65.04 111.905 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.81 70.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.139 -0.482 . . . . 41.34 111.864 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 8.8 m-20 -71.59 -43.4 66.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.079 0.466 . . . . 61.55 110.881 175.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.53 -77.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.968 -0.634 . . . . 71.12 112.911 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.8 m -149.68 138.49 20.99 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.834 0.35 . . . . 75.24 111.705 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.7 p -122.09 142.48 50.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.989 0.423 . . . . 73.24 111.401 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.25 152.75 36.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.226 -0.443 . . . . 52.3 111.549 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' HG23 ' A' ' 69' ' ' VAL . 39.0 m -84.34 103.61 13.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.743 0.306 . . . . 73.33 110.679 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.66 103.06 11.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.636 -0.505 . . . . 62.14 109.636 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HE ' HG21 ' A' ' 69' ' ' VAL . 92.8 mtt-85 -88.83 135.09 33.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.841 0.353 . . . . 64.42 111.615 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -116.67 99.46 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 74.24 110.72 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.89 109.56 21.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.957 0.408 . . . . 74.43 111.235 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.31 130.11 37.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.246 -0.502 . . . . 52.03 112.871 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -73.26 -13.72 61.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.26 0.552 . . . . 61.13 110.987 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.9 p -107.4 144.79 33.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.123 -0.489 . . . . 70.33 110.712 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.27 -17.76 51.26 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.859 0.318 . . . . 75.23 111.859 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.95 147.39 95.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.349 -0.387 . . . . 73.1 111.41 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.9 117.21 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.313 2.009 . . . . 72.31 112.936 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 126' ' ' SER . 93.0 mt -82.0 155.85 69.92 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 120.859 0.361 . . . . 73.44 111.433 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 -177.45 3.53 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.276 1.984 . . . . 72.13 112.621 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -77.99 158.44 29.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.757 0.313 . . . . 72.02 110.948 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.4 p90 -152.84 149.14 27.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.712 0.768 . . . . 72.11 112.628 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -133.64 162.76 31.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.204 -0.907 . . . . 72.43 110.238 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.92 -158.26 18.48 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.369 -0.92 . . . . 73.21 113.591 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.3 m -136.33 145.72 45.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.01 0.434 . . . . 73.12 111.324 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.68 128.34 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.045 0.45 . . . . 72.12 112.056 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.807 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 17.6 mm-40 -89.58 110.45 21.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.966 -0.561 . . . . 61.14 110.246 175.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.426 ' CG ' HD22 ' A' ' 139' ' ' LEU . 31.0 p90 -121.85 124.44 44.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.437 0.637 . . . . 63.14 111.736 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.66 -140.89 3.05 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.563 -0.744 . . . . 63.2 112.673 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.584 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 96.5 mt-30 -126.73 163.76 22.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.188 0.518 . . . . 65.32 111.872 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.77 114.79 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.227 -0.442 . . . . 72.15 111.107 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -92.48 -9.46 41.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.811 0.3 . . . . 74.13 111.811 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -91.05 178.59 42.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.09 -0.576 . . . . 32.25 113.785 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.3 p -85.76 -165.56 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.879 0.371 . . . . 70.33 111.483 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.49 HD12 ' HG3' ' A' ' 33' ' ' GLN . 41.9 mm -74.25 -31.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.908 0.385 . . . . 74.45 111.364 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.82 -43.87 8.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.782 0.325 . . . . 72.33 111.462 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -115.51 96.41 5.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.535 0.683 . . . . 71.24 111.301 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.695 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 9.3 p90 -121.41 144.1 48.86 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.852 -0.613 . . . . 75.23 111.899 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -120.09 127.01 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.661 -0.699 . . . . 72.13 111.114 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.89 99.18 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 55.24 110.611 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 pt -107.51 150.39 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.424 -0.353 . . . . 53.5 111.501 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 56.63 29.14 15.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.053 0.454 . . . . 44.02 111.851 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' A' ' 100' ' ' GLU . 6.0 p -90.57 132.35 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.483 0.549 . . . . 54.32 112.483 -176.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -116.56 154.41 30.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 73.24 110.265 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -107.56 132.73 52.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.116 0.484 . . . . 73.31 112.055 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -122.65 142.13 51.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.413 -0.358 . . . . 74.25 111.281 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.82 102.76 13.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.976 0.417 . . . . 71.25 111.721 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.59 140.21 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.219 0.533 . . . . 70.55 112.023 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -130.3 148.46 52.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.448 -0.342 . . . . 72.02 110.812 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -136.86 144.77 48.02 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 111.935 0.346 . . . . 75.43 111.935 177.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 25.7 Cg_exo -64.81 167.5 15.47 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.143 2.562 . . . . 72.11 113.648 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.14 128.9 34.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.131 -0.486 . . . . 62.25 112.11 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 66.1 m -79.69 75.73 6.35 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.164 0.507 . . . . 70.11 110.606 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.29 -30.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.239 0.543 . . . . 74.11 111.15 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.89 159.58 14.9 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.949 -0.569 . . . . 72.4 111.086 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.79 146.9 47.03 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.441 -0.345 . . . . 40.43 111.419 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.95 171.68 58.53 Favored 'Cis proline' 0 C--N 1.353 0.771 0 C-N-CA 124.331 -1.112 . . . . 73.22 112.753 -1.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 90.73 3.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.156 0.503 . . . . 72.43 111.477 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.71 84.83 2.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.268 0.556 . . . . 60.03 109.877 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.8 t -102.34 156.77 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 70.04 111.893 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 10.3 p-10 -150.13 108.71 3.82 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.192 0.52 . . . . 65.23 110.699 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.0 pt -113.32 135.27 21.81 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.119 -0.363 . . . . 52.02 111.821 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.9 119.5 5.9 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.296 1.998 . . . . 33.42 112.986 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.74 123.33 42.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.101 -0.5 . . . . 72.02 110.203 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -105.59 105.19 15.11 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.073 0.463 . . . . 64.15 111.326 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 101' ' ' TYR . 70.1 mt -91.62 130.08 37.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.383 -0.371 . . . . 75.41 111.192 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 67.3 mttm -106.64 145.13 32.33 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.122 0.415 . . . . 75.02 112.122 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.92 27.23 73.7 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.343 -0.456 . . . . 71.44 113.998 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.4 tt -155.59 122.52 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.472 0.653 . . . . 72.23 111.802 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.2 m -85.46 148.01 26.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.122 -0.49 . . . . 75.53 111.283 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.81 -34.79 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.795 0.331 . . . . 72.45 111.884 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.01 -29.08 66.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.063 0.459 . . . . 64.42 111.587 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -109.35 10.77 25.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.044 0.387 . . . . 74.02 112.044 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 3.2 mt -74.01 114.73 12.66 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 71.04 111.63 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.58 -59.2 1.65 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.241 -0.504 . . . . 31.31 112.996 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -149.77 157.58 43.34 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.385 0.612 . . . . 75.11 112.48 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 96.2 t -126.23 107.73 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.261 -0.881 . . . . 75.44 109.552 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.807 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.8 ttt180 -109.63 108.31 18.68 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.244 0.461 . . . . 74.22 112.244 -171.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.641 HG21 ' SD ' ' A' ' 66' ' ' MET . 36.0 mm -86.5 132.07 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 111.59 0.219 . . . . 53.45 111.59 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.62 178.83 8.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.745 0.307 . . . . 70.04 111.746 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 65.44 19.99 11.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.934 0.716 . . . . 70.13 112.934 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -65.56 117.74 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.279 0.562 . . . . 73.42 111.716 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -130.37 153.3 81.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.976 -0.556 . . . . 74.22 111.57 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.566 ' HB3' HG22 ' A' ' 61' ' ' ILE . 66.4 Cg_endo -73.66 117.31 5.0 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.553 2.169 . . . . 61.41 113.385 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 5.7 p -110.55 122.16 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.353 0.597 . . . . 72.22 110.997 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 21.1 ptp -161.44 177.7 9.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 51.01 111.358 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -60.49 131.02 49.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.985 0.422 . . . . 73.23 110.715 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 161' ' ' LEU . 6.7 mp -72.62 87.34 1.22 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.651 0.611 . . . . 74.11 112.651 -173.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.01 127.13 32.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.653 -0.499 . . . . 63.31 109.653 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -56.9 115.89 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.178 0.513 . . . . 75.14 111.649 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -72.18 130.32 40.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.746 -0.661 . . . . 55.33 111.847 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -105.84 92.72 4.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 72.13 111.902 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -79.33 126.72 31.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.341 -0.391 . . . . 73.14 110.11 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 68.41 87.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.992 0.425 . . . . 74.14 110.913 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.728 -0.653 . . . . 71.12 111.964 176.378 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.86 0.362 . . . . 64.44 111.174 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -102.97 154.62 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.865 0.364 . . . . 42.22 111.613 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -153.65 90.91 1.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.209 0.528 . . . . 74.24 110.718 175.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.1 154.37 20.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.055 -0.52 . . . . 73.03 111.106 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -148.34 161.52 41.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.963 0.411 . . . . 61.14 111.729 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.63 133.66 53.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.202 -0.454 . . . . 62.21 111.432 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.5 m -100.3 126.91 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.988 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -131.28 151.1 51.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.181 0.515 . . . . 72.23 112.059 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -78.95 163.65 25.06 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.732 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.4 mmt -120.33 -175.16 2.94 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.33 0.586 . . . . 71.53 112.35 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -85.81 156.18 20.68 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.889 -0.596 . . . . 72.12 112.424 -171.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -133.04 143.71 49.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.015 0.436 . . . . 71.04 111.467 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -92.12 176.5 6.47 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.155 -0.475 . . . . 45.22 112.176 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.59 119.13 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.165 0.507 . . . . 72.33 111.118 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -86.91 141.67 28.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.39 -0.368 . . . . 74.13 111.718 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.0 p -126.5 179.02 5.52 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.149 0.5 . . . . 75.11 112.046 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.33 117.91 9.97 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.224 -0.444 . . . . 73.33 112.003 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -89.06 148.75 23.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.134 0.492 . . . . 74.42 111.274 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -99.97 -165.23 1.2 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.908 -0.587 . . . . 72.25 111.628 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.08 92.17 0.17 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.949 0.404 . . . . 75.23 110.659 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.7 mtt -128.34 -168.16 1.87 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.965 0.412 . . . . 63.32 111.633 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 p -77.44 -172.65 2.59 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.159 0.504 . . . . 73.5 112.036 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.3 126.85 29.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.207 -0.451 . . . . 75.14 111.056 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -133.32 163.03 30.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.784 0.326 . . . . 55.44 111.004 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -50.02 124.71 10.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.218 -0.446 . . . . 54.32 110.863 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.46 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 29.9 mm-40 -60.81 -18.24 54.33 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.393 0.516 . . . . 75.54 112.393 -175.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.0 tt0 -58.08 -63.55 1.22 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.87 0.367 . . . . 60.4 110.485 171.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.571 ' HA ' HD12 ' A' ' 31' ' ' ILE . 39.7 m -61.21 -30.38 70.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.947 0.403 . . . . 74.44 111.553 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.2 -47.6 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.788 0.327 . . . . 75.43 110.839 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 6.0 mptp? -64.54 -30.09 71.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 72.21 111.335 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 28' ' ' THR . 82.6 mt -62.62 -48.31 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.249 0.547 . . . . 63.2 110.791 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -64.68 -41.35 96.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.197 0.522 . . . . 74.13 110.738 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HG3' HD12 ' A' ' 108' ' ' ILE . 57.7 tt0 -57.5 -47.59 81.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.797 -0.638 . . . . 73.24 111.102 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.4 tt0 -55.23 -47.12 75.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 72.25 111.331 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.75 -27.45 68.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.224 -0.444 . . . . 70.11 111.974 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -77.29 -36.21 54.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.076 -0.39 . . . . 65.34 111.22 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.0 -36.12 82.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.303 0.573 . . . . 55.2 110.038 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -57.17 -41.48 79.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.752 -0.658 . . . . 74.25 110.465 172.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.96 76.92 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.283 0.475 . . . . 35.41 112.283 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 109' ' ' ASP . 51.9 mttp -87.67 -9.25 54.71 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.647 0.61 . . . . 74.0 112.647 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.4 t -63.27 123.03 17.63 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.133 0.492 . . . . 74.23 112.152 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t -88.42 -30.08 19.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.104 0.478 . . . . 73.33 111.166 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -146.73 107.13 4.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.236 -0.438 . . . . 42.22 110.854 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 93.3 -143.64 16.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.084 -0.579 . . . . 74.44 113.104 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.793 HG13 HD13 ' A' ' 57' ' ' LEU . 16.4 m -143.27 153.52 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.34 0.59 . . . . 63.11 112.198 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.4 m-85 -101.25 105.46 16.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.612 -0.722 . . . . 63.14 110.964 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 98.9 mt -95.23 136.65 35.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.737 0.303 . . . . 73.12 110.904 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.2 mt -109.81 130.95 22.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.292 -0.255 . . . . 45.22 111.428 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HB3' HD13 ' A' ' 147' ' ' LEU . 33.0 Cg_endo -62.58 -27.78 76.76 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.604 2.202 . . . . 45.42 112.714 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.79 -23.54 72.14 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.139 -0.553 . . . . 32.22 112.412 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.23 73.92 1.53 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.149 0.5 . . . . 74.11 111.314 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -66.6 74.56 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.357 0.599 . . . . 54.15 110.845 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 p -148.97 159.27 37.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.771 -0.65 . . . . 42.31 112.38 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.12 149.87 28.88 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.027 2.485 . . . . 72.12 113.756 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 145.86 49.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.397 -0.365 . . . . 71.45 111.226 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -82.44 134.93 35.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.446 -0.343 . . . . 72.13 111.057 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.793 HD13 HG13 ' A' ' 45' ' ' VAL . 37.0 tp -143.53 136.56 27.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.558 0.577 . . . . 75.11 112.558 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.59 143.15 27.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.91 -0.586 . . . . 71.45 110.363 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -140.52 170.98 14.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.226 0.536 . . . . 74.5 111.673 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.511 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 50.3 mt-30 -77.51 5.76 8.37 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.074 -0.512 . . . . 71.33 112.101 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -112.0 -22.13 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.851 0.358 . . . . 62.2 110.837 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.03 -160.71 29.24 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.287 -0.415 . . . . 64.32 112.668 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.6 m -92.91 135.43 34.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.394 -0.474 . . . . 61.15 110.771 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.2 178.53 7.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.408 0.623 . . . . 32.13 112.619 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -136.29 107.06 6.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.744 -0.662 . . . . 65.04 111.013 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.725 ' SD ' HG21 ' A' ' 152' ' ' ILE . 58.3 mtt -96.04 170.17 9.47 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.049 -0.407 . . . . 75.14 111.879 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.6 p -169.08 152.74 5.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.033 0.383 . . . . 54.21 112.033 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.32 114.81 29.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.363 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.616 HG23 ' HB ' ' A' ' 81' ' ' THR . 26.9 m -128.79 164.09 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.731 0.3 . . . . 75.53 111.41 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 59.1 42.52 18.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.167 0.508 . . . . 52.11 112.036 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.9 mt -82.45 109.68 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.038 -0.528 . . . . 73.43 111.782 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 p -131.22 155.16 81.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 120.977 0.418 . . . . 63.22 112.124 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.49 136.43 33.69 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.767 2.311 . . . . 52.54 112.757 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.623 ' HB2' HG23 ' A' ' 79' ' ' THR . 32.8 t70 -115.4 164.78 13.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.841 0.456 . . . . 74.53 111.145 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.94 74.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.098 0.407 . . . . 53.11 112.098 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.88 -17.6 16.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.137 0.421 . . . . 62.45 112.137 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.3 -103.02 0.16 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.476 -0.869 . . . . 23.23 114.23 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.4 m -149.73 125.54 10.47 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.565 -0.373 . . . . 73.01 111.449 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 74' ' ' ASP . 39.4 p -101.66 124.73 47.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.806 0.336 . . . . 75.24 111.888 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 137' ' ' LEU . 3.4 pp -138.2 177.67 7.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.797 0.332 . . . . 73.11 111.252 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 69' ' ' VAL . 60.0 m -122.52 126.54 48.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.801 0.334 . . . . 64.43 111.472 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.6 114.02 25.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.89 -0.411 . . . . 73.21 109.89 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 97.2 mtt180 -104.53 110.05 22.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.287 0.477 . . . . 63.21 112.287 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -102.72 112.37 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 64.52 111.573 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 131' ' ' SER . 34.7 tt0 -98.52 141.8 30.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.568 0.223 . . . . 63.2 111.026 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.6 144.05 22.94 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.039 -0.6 . . . . 75.03 113.101 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.09 -40.67 96.62 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.974 0.416 . . . . 75.24 110.857 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.9 p -96.78 -177.66 3.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.219 0.533 . . . . 51.24 111.38 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -92.9 6.95 45.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.305 -0.407 . . . . 74.13 111.248 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.45 135.38 68.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.485 -0.325 . . . . 72.11 111.784 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 96.68 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.139 1.892 . . . . 64.42 111.801 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.75 141.3 89.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.33 0.492 . . . . 71.32 112.33 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.11 177.58 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.663 2.242 . . . . 75.43 112.929 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.3 134.4 46.75 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.013 0.435 . . . . 54.15 111.651 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.65 160.95 39.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.138 0.494 . . . . 74.54 111.954 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 92.3 p -138.71 168.8 19.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.059 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.632 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.2 165.25 37.08 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.023 -0.608 . . . . 54.2 113.337 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.6 m -98.98 107.84 20.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.91 0.386 . . . . 63.11 111.544 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 119' ' ' GLN . 3.2 p -89.83 112.97 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.202 0.525 . . . . 54.33 111.097 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 117' ' ' GLN . 47.5 mt-10 -102.6 103.56 13.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.277 0.56 . . . . 75.43 110.956 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CD1' HD22 ' A' ' 139' ' ' LEU . 19.0 p90 -104.27 137.97 41.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.814 -0.63 . . . . 74.43 111.579 -175.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.09 -145.5 4.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.697 -0.763 . . . . 52.24 113.592 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.612 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.5 mt-30 -129.44 161.35 30.59 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.885 0.374 . . . . 55.4 111.363 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 111' ' ' PHE . 51.9 mt -122.34 140.11 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.073 0.463 . . . . 73.25 112.102 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 16.0 pt20 -132.03 103.53 6.33 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.489 0.661 . . . . 65.52 110.79 169.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 157.56 -158.54 29.09 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.156 -0.545 . . . . 62.44 113.606 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 33.4 p -98.82 -170.71 1.97 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.517 -0.402 . . . . 64.25 111.073 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.495 HD12 ' HG3' ' A' ' 33' ' ' GLN . 34.0 mm -76.12 -15.41 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.31 0.576 . . . . 54.45 110.766 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.708 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 40.7 m-20 -105.2 -45.94 4.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.104 -0.498 . . . . 74.24 111.512 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -116.03 92.88 4.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.377 0.608 . . . . 73.01 111.097 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' HB2' HG23 ' A' ' 104' ' ' ILE . 38.2 p90 -127.33 132.2 50.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.131 0.491 . . . . 74.5 111.809 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.49 124.44 40.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.087 -0.506 . . . . 72.32 111.149 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.82 97.73 11.08 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.007 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.8 pt -103.53 162.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.126 -0.488 . . . . 72.41 112.043 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 53.77 22.18 3.07 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 64.42 112.61 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.57 131.77 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.366 0.603 . . . . 75.31 112.202 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 34.0 mt-30 -128.15 146.41 50.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.665 -0.698 . . . . 74.53 110.814 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.03 143.13 28.9 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.263 0.554 . . . . 53.33 112.267 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.586 ' HB3' HG13 ' A' ' 99' ' ' VAL . 49.1 tt0 -142.23 149.44 39.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.782 -0.645 . . . . 74.02 110.174 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -100.28 114.41 27.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.138 0.494 . . . . 74.31 112.231 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.92 121.94 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.113 -0.494 . . . . 65.41 111.17 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -113.46 135.65 53.65 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.902 0.382 . . . . 73.31 111.37 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.517 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -124.1 140.07 34.01 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.234 -0.439 . . . . 54.03 111.476 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.16 169.66 21.94 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.589 2.193 . . . . 72.02 113.623 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.13 134.79 34.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 55.21 111.523 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 m -77.39 124.06 27.36 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.386 -0.37 . . . . 73.24 111.419 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.28 -42.52 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.103 0.478 . . . . 73.24 110.973 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -125.81 171.58 10.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 75.15 111.83 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.11 158.79 31.07 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.263 -0.426 . . . . 71.23 111.483 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.0 160.14 57.98 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.015 -1.244 . . . . 72.25 113.129 -2.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 58.8 m -86.17 78.07 9.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.494 0.553 . . . . 54.42 112.494 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.78 79.42 2.23 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.427 -0.583 . . . . 64.35 109.427 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.529 HG12 HG23 ' A' ' 135' ' ' ILE . 40.6 t -76.68 99.78 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.402 -0.363 . . . . 75.44 111.818 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.453 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.8 p-10 -91.27 106.84 18.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.033 0.444 . . . . 52.25 110.97 174.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.529 HG23 HG12 ' A' ' 133' ' ' VAL . 26.9 pt -114.08 131.54 23.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.972 0.36 . . . . 60.33 111.972 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.58 135.69 54.35 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.722 2.281 . . . . 71.04 112.381 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.49 ' HB3' HD12 ' A' ' 80' ' ' LEU . 2.4 tt -132.42 113.33 13.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.35 -0.386 . . . . 55.14 110.424 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.61 109.76 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.058 0.456 . . . . 74.21 111.702 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 ' CD1' ' A' ' 101' ' ' TYR . 80.0 mt -88.57 140.05 29.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.143 -0.317 . . . . 63.52 110.143 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -129.4 150.69 50.65 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.888 0.375 . . . . 74.5 111.475 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.87 31.14 56.53 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.218 -0.515 . . . . 71.42 113.068 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 147' ' ' LEU . 17.8 tt -168.51 125.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.916 0.389 . . . . 75.23 111.487 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.8 m -83.53 144.71 29.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.649 0.261 . . . . 60.33 111.522 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 p -51.04 -44.77 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 112.391 0.515 . . . . 72.43 112.391 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -59.74 -38.55 82.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.211 0.529 . . . . 52.31 111.389 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -93.31 6.16 49.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.346 0.499 . . . . 70.53 112.346 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.606 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.3 tt -69.68 125.14 25.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.662 0.267 . . . . 73.55 110.402 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -95.82 -62.16 0.98 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.111 -0.566 . . . . 41.44 113.602 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -145.44 160.25 41.87 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.272 0.558 . . . . 71.02 112.008 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 75.5 t -124.86 101.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.696 -0.684 . . . . 64.31 110.406 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 31.2 ttm180 -88.31 94.37 9.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.874 0.369 . . . . 72.03 111.636 -176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.725 HG21 ' SD ' ' A' ' 66' ' ' MET . 37.1 mm -85.75 127.58 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.68 -0.237 . . . . 74.52 110.876 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -164.45 -178.3 5.34 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.405 0.521 . . . . 71.34 112.405 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 66.38 24.56 10.47 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.449 0.7 . . . . 74.31 112.293 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.632 HD13 ' HA3' ' A' ' 97' ' ' GLY . 41.9 mm -67.15 105.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.187 0.518 . . . . 73.43 111.701 -177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.511 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 7.6 pt20 -137.71 151.72 71.22 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.021 -0.536 . . . . 73.23 111.42 -175.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.666 ' HG2' HD11 ' A' ' 161' ' ' LEU . 57.9 Cg_endo -70.8 133.25 23.27 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.406 2.071 . . . . 43.03 112.846 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.1 m -85.87 28.92 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.135 0.493 . . . . 51.45 111.975 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -122.84 -175.02 3.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.924 0.392 . . . . 74.21 111.362 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -80.09 121.37 25.45 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.948 0.404 . . . . 71.55 111.835 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.666 HD11 ' HG2' ' A' ' 157' ' ' PRO . 6.5 mp -100.35 148.15 25.02 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.884 0.373 . . . . 63.22 111.065 176.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.45 153.46 50.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.033 0.444 . . . . 72.31 111.446 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -158.5 154.66 27.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.031 -0.532 . . . . 72.11 110.867 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -137.76 121.85 17.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.28 0.474 . . . . 70.22 112.28 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -96.19 -173.9 2.93 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.221 0.534 . . . . 75.41 111.244 175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -133.68 -174.46 3.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.295 -0.412 . . . . 71.23 110.501 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -75.32 -32.38 60.93 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.148 0.499 . . . . 44.22 109.818 170.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.747 -0.644 . . . . 74.24 110.831 174.913 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 31' ' ' ILE . 14.6 pt-20 . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 120.949 0.404 . . . . 73.32 110.842 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -60.02 -34.3 73.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.213 -0.449 . . . . 55.0 111.543 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.78 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.948 0.404 . . . . 75.02 110.713 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -62.3 -36.2 81.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 74.32 111.163 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.8 mt -62.04 -48.01 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.08 0.467 . . . . 74.24 110.798 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -60.11 -35.29 74.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.282 0.563 . . . . 74.51 110.932 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.624 ' HG3' HD11 ' A' ' 108' ' ' ILE . 35.1 tt0 -68.37 -43.35 77.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.176 -0.465 . . . . 64.11 110.653 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 -55.76 29.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.013 -0.54 . . . . 72.13 110.684 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -54.15 -47.38 71.99 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.182 0.438 . . . . 72.34 112.182 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -62.29 -48.21 80.91 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.965 0.357 . . . . 75.32 111.965 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.7 -33.57 75.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.211 0.529 . . . . 72.34 111.026 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -56.04 -48.96 75.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.856 -0.611 . . . . 71.51 110.628 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.75 -32.3 72.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.942 -0.572 . . . . 71.41 111.683 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.45 -10.46 59.41 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.007 0.373 . . . . 71.4 112.007 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.471 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 43.2 t -87.13 132.45 33.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.864 0.364 . . . . 74.34 111.871 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.0 p -103.36 -24.82 13.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 75.4 110.781 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t -100.53 93.48 5.64 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.175 -0.466 . . . . 62.34 110.918 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.64 -160.18 47.65 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.198 0.439 . . . . 70.31 114.198 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -116.6 144.92 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.3 0.481 . . . . 73.21 112.3 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.471 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 16.1 m-85 -83.3 113.75 20.92 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.407 -0.361 . . . . 72.23 111.898 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 86.9 mt -103.9 94.26 5.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.182 0.515 . . . . 72.4 110.304 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.72 120.67 82.42 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.543 -0.299 . . . . 72.41 110.818 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.629 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.7 Cg_endo -57.17 -22.2 47.01 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.827 2.352 . . . . 74.41 112.888 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.49 -21.39 60.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.34 -0.457 . . . . 61.02 113.061 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.97 -40.62 10.02 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.845 0.355 . . . . 44.13 111.164 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.9 mttm 62.88 2.48 1.0 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.69 0.626 . . . . 75.22 112.69 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 p -70.76 151.06 95.31 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 113.02 0.748 . . . . 73.52 113.02 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' A' ' 65' ' ' ARG . 73.8 Cg_endo -72.89 136.33 24.95 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.843 2.362 . . . . 72.44 112.467 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.51 140.58 51.24 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.737 0.304 . . . . 71.31 111.604 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -92.71 127.43 38.21 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.999 0.428 . . . . 75.11 111.738 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.2 tp -131.13 127.19 37.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.119 0.485 . . . . 63.32 111.369 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.02 97.7 11.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.127 0.489 . . . . 73.22 110.715 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -93.55 -177.18 4.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.275 0.56 . . . . 72.11 112.262 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -67.5 -32.41 73.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.021 -0.536 . . . . 72.23 112.032 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 pt -84.45 -30.0 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 111.883 0.327 . . . . 75.33 111.883 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.58 -177.69 37.76 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.396 -0.43 . . . . 62.22 112.895 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.5 m -85.18 109.01 17.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.039 0.447 . . . . 74.33 111.446 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.732 HD13 ' SD ' ' A' ' 66' ' ' MET . 0.6 OUTLIER -116.57 171.71 7.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.011 0.434 . . . . 73.41 111.897 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 30.6 ttm180 -140.64 114.04 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.258 -0.428 . . . . 72.13 111.101 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.732 ' SD ' HD13 ' A' ' 64' ' ' LEU . 3.2 mpp? -103.59 158.55 16.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.5 0.555 . . . . 63.31 112.5 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 p -156.67 157.85 35.93 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.793 -0.64 . . . . 70.34 111.237 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 76.3 mt -112.37 117.67 33.1 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.896 0.332 . . . . 73.33 111.896 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.488 HG23 HD22 ' A' ' 70' ' ' ASN . 22.5 m -135.74 165.06 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.657 0.265 . . . . 72.42 111.555 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.488 HD22 HG23 ' A' ' 69' ' ' VAL . 44.4 m-80 57.7 40.08 26.77 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.118 0.485 . . . . 54.32 111.907 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 40.5 mt -69.86 112.18 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.2 -0.454 . . . . 73.14 111.217 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -137.23 151.31 71.39 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-O 120.772 0.32 . . . . 75.52 111.83 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.92 146.76 83.77 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.887 2.391 . . . . 60.24 113.186 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 19.6 t70 -115.02 169.86 8.78 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.258 -0.428 . . . . 73.15 111.043 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.63 72.48 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.866 0.321 . . . . 74.01 111.866 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.21 -45.68 3.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.517 -0.31 . . . . 63.23 111.465 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -130.6 -110.07 1.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.754 -0.736 . . . . 61.44 113.893 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -146.97 127.83 14.43 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.104 0.409 . . . . 54.23 112.104 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 75.7 p -98.93 120.81 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.767 0.317 . . . . 72.22 111.752 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -137.15 151.06 48.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.823 0.344 . . . . 62.13 111.197 175.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 m -83.3 113.45 20.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.006 0.431 . . . . 73.43 111.846 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.42 109.39 20.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.92 -0.582 . . . . 64.43 109.969 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 66' ' ' MET . 73.7 mtm180 -101.15 123.07 44.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.861 0.319 . . . . 63.21 111.861 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.7 mp -102.2 102.42 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.034 0.445 . . . . 73.2 110.593 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -100.9 134.51 43.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.433 -0.349 . . . . 73.52 111.188 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.56 122.52 5.81 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.075 -0.583 . . . . 62.12 113.446 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.0 -27.81 62.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.428 0.632 . . . . 65.44 110.498 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -85.89 -175.24 5.5 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.774 -0.648 . . . . 32.11 111.44 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.41 5.63 39.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.397 -0.365 . . . . 63.24 111.458 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.09 152.98 38.01 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.196 0.443 . . . . 62.0 112.196 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.678 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 73.2 Cg_endo -74.27 138.18 24.59 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.773 2.315 . . . . 74.34 112.79 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.17 122.07 55.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 O-C-N 122.142 -0.349 . . . . 70.34 111.848 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.27 170.88 14.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.607 2.205 . . . . 32.43 112.866 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.6 131.48 50.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.307 0.484 . . . . 44.44 112.307 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -146.79 154.85 41.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.261 0.553 . . . . 73.2 112.225 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.9 p -118.87 151.23 38.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.898 -0.592 . . . . 73.43 110.438 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 154' ' ' ASP . . . -141.18 150.24 21.67 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.771 -0.728 . . . . 35.44 113.83 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 154' ' ' ASP . 61.3 m -100.06 110.0 22.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.771 0.319 . . . . 70.41 110.819 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.1 p -102.28 117.88 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.433 0.531 . . . . 75.54 112.433 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 153' ' ' HIS . 32.8 mm-40 -83.98 147.26 27.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.901 -0.407 . . . . 75.42 109.901 174.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.412 ' CG ' HD22 ' A' ' 139' ' ' LEU . 32.0 p90 -155.12 133.71 11.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.066 0.46 . . . . 70.42 111.654 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.85 -147.67 5.48 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.952 -0.567 . . . . 63.22 112.951 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 87.4 mt-30 -123.36 150.71 43.33 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.333 0.587 . . . . 63.14 112.565 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.469 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.3 mt -116.26 104.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.978 -0.556 . . . . 54.43 110.657 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.505 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.0 pt20 -89.19 -17.41 29.18 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.398 0.518 . . . . 64.02 112.398 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -90.37 -159.23 35.36 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.026 -0.607 . . . . 52.1 113.963 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 51.8 p -114.25 -178.44 3.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.806 0.443 . . . . 64.25 110.967 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.624 HD11 ' HG3' ' A' ' 33' ' ' GLN . 48.0 mm -66.81 -30.92 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 60.02 110.709 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.92 -39.28 72.8 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.097 -0.501 . . . . 74.21 111.163 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.59 108.87 2.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.164 -0.471 . . . . 75.15 111.191 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.613 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 36.9 p90 -125.99 139.49 53.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.89 0.376 . . . . 75.24 111.743 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -108.78 123.23 48.69 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.244 -0.434 . . . . 75.52 111.443 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -74.66 100.48 3.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.718 0.294 . . . . 64.03 110.798 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.505 HD13 ' NE2' ' A' ' 105' ' ' GLN . 50.6 pt -109.63 157.46 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 111.812 0.301 . . . . 63.22 111.812 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 56.73 31.38 19.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.18 0.514 . . . . 71.13 111.502 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -97.08 132.91 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.385 0.612 . . . . 50.15 112.583 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -142.11 178.18 7.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.723 -0.672 . . . . 70.52 109.656 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 11.3 p30 -127.85 172.91 10.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.949 1.092 . . . . 64.1 113.949 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -153.1 156.34 38.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.872 -1.058 . . . . 72.23 109.921 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.54 111.48 23.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.258 0.466 . . . . 74.11 112.258 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 121' ' ' ILE . 20.2 pt -96.11 101.17 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.325 0.583 . . . . 55.3 110.989 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.89 108.93 20.48 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.436 -0.347 . . . . 63.13 111.185 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.57 38.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.513 -0.312 . . . . 70.14 111.599 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.83 179.69 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.67 2.247 . . . . 64.54 113.553 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.89 108.09 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.023 0.439 . . . . 73.24 111.299 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 15.3 m -80.77 96.66 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 64.22 111.203 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 127' ' ' VAL . 12.2 t -86.71 7.98 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 121.081 0.467 . . . . 73.53 111.609 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.1 pt? -105.52 147.0 28.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.186 0.517 . . . . 65.44 111.925 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.39 127.37 22.44 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.098 -0.501 . . . . 72.1 111.015 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.18 155.14 91.81 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.836 -1.318 . . . . 74.3 113.086 -0.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.678 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 48.5 t -88.64 121.27 30.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.652 0.612 . . . . 70.43 112.652 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -138.79 130.72 27.95 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.085 0.469 . . . . 74.5 110.948 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.35 149.72 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.802 0.334 . . . . 54.33 111.563 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -132.76 125.38 30.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.027 0.441 . . . . 73.32 110.737 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 pt -130.74 137.88 31.77 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 120.814 0.34 . . . . 71.32 111.472 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.71 120.21 7.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.302 2.001 . . . . 75.41 112.777 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.31 97.41 8.48 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.023 -0.535 . . . . 71.11 109.782 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.456 ' HG3' HG22 ' A' ' 79' ' ' THR . 63.0 tt0 -87.83 83.36 7.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 53.45 111.297 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 101' ' ' TYR . 65.9 mt -62.86 145.75 54.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.072 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -116.81 147.57 41.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.136 0.494 . . . . 71.33 112.073 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.19 -49.98 3.88 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.066 -0.516 . . . . 71.42 114.03 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.604 HD13 HD23 ' A' ' 147' ' ' LEU . 20.9 tt -87.64 138.47 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.261 0.553 . . . . 60.13 112.24 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.6 m -92.79 149.69 21.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.183 -0.462 . . . . 72.44 111.519 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -53.25 -42.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.379 0.511 . . . . 73.14 112.379 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.75 -23.65 65.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.199 0.523 . . . . 73.33 111.289 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.441 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.1 mm-40 -103.03 7.81 38.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 74.11 112.089 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.629 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 14.0 mt -72.85 124.36 25.24 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.279 0.474 . . . . 74.33 112.279 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.67 -57.59 0.82 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.203 -0.523 . . . . 44.13 112.886 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -145.0 146.34 31.87 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.333 -0.51 . . . . 72.23 111.9 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.506 ' HB ' HD11 ' A' ' 68' ' ' LEU . 62.1 t -124.54 100.19 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.068 -0.514 . . . . 74.1 109.917 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -100.53 114.47 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.736 0.643 . . . . 75.43 112.736 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.49 123.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.797 -0.638 . . . . 51.43 110.988 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.479 ' CD2' ' HG2' ' A' ' 100' ' ' GLU . 10.2 p80 -152.88 178.44 9.66 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.574 0.226 . . . . 75.43 111.082 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.463 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 33.1 t70 54.53 73.63 0.39 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.376 0.607 . . . . 73.44 111.197 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 115.29 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.843 -0.617 . . . . 45.24 110.695 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.52 140.07 36.72 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.095 0.405 . . . . 74.42 112.095 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.91 146.77 42.68 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.635 2.224 . . . . 75.42 112.538 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 113.047 0.758 . . . . 75.2 113.047 -176.056 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.571 0.224 . . . . 71.42 111.067 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.2 m -59.62 -50.05 75.36 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.224 0.535 . . . . 63.1 111.164 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.12 -35.29 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.475 0.655 . . . . 74.31 110.657 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.615 ' HE3' HD12 ' A' ' 48' ' ' LEU . 23.7 tptt -70.3 -35.95 74.02 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.623 -0.717 . . . . 74.14 110.754 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 27' ' ' GLU . 89.2 mt -60.48 -42.91 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.412 0.625 . . . . 72.52 110.322 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -57.4 -44.76 84.81 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.838 -0.619 . . . . 71.54 110.551 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HG3' HD11 ' A' ' 108' ' ' ILE . 31.6 tt0 -60.91 -40.03 91.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.934 -0.576 . . . . 74.23 111.12 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -59.03 -55.47 34.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.938 -0.574 . . . . 70.34 111.535 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -60.71 -39.05 87.1 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 111.893 0.331 . . . . 73.34 111.893 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.08 -54.57 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.425 0.528 . . . . 74.55 112.425 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.423 HD12 HD21 ' A' ' 48' ' ' LEU . 97.9 mt -56.61 -41.64 77.39 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.064 0.459 . . . . 64.33 110.919 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.8 -46.02 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.16 -0.473 . . . . 71.01 111.343 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.81 63.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 64.22 112.561 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -94.42 -12.41 27.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.892 0.33 . . . . 75.22 111.892 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.2 t -85.7 142.47 29.0 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.669 0.271 . . . . 73.42 111.336 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.2 p -84.0 -42.32 16.34 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.099 -0.375 . . . . 72.11 111.517 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 m -148.08 87.79 1.63 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 65.43 111.377 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.4 153.35 6.08 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.244 -0.503 . . . . 42.21 112.405 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 152' ' ' ILE . 25.8 m -106.41 146.12 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.315 0.579 . . . . 60.21 112.449 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -106.22 102.9 12.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.807 -0.633 . . . . 73.22 110.884 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -92.58 116.02 28.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.897 0.379 . . . . 73.2 111.221 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.615 HD12 ' HE3' ' A' ' 30' ' ' LYS . 3.8 mm? -86.93 117.46 68.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.578 -0.283 . . . . 45.35 110.717 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 78.5 Cg_exo -51.11 -36.36 54.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.102 2.534 . . . . 73.43 113.768 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.84 99.79 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.954 -0.641 . . . . 61.1 112.548 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . . . -86.88 93.61 9.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.731 0.301 . . . . 75.14 111.487 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HE3' HD12 ' A' ' 71' ' ' ILE . 43.6 mmtm -67.52 77.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.878 0.37 . . . . 73.55 110.251 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 p -140.48 149.97 59.16 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 112.841 0.682 . . . . 75.14 112.841 -175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 92.9 Cg_endo -80.48 154.19 21.04 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.393 2.728 . . . . 64.22 113.242 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.46 137.93 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.67 0.272 . . . . 63.43 111.456 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.543 ' CZ ' HG21 ' A' ' 63' ' ' THR . 37.6 ttt85 -79.22 133.69 36.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.853 0.359 . . . . 72.3 111.901 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HB3' HD22 ' A' ' 64' ' ' LEU . 56.2 tp -138.14 120.58 16.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.497 0.554 . . . . 75.42 112.497 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.47 121.63 26.51 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.726 -0.67 . . . . 61.43 110.401 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 p -123.68 -179.33 4.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.534 . . . . 64.21 111.808 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.555 HE22 ' HB3' ' A' ' 156' ' ' GLN . 46.3 mt-30 -67.72 -19.12 65.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 72.1 112.146 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 pt -100.26 -25.71 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.971 0.415 . . . . 73.44 111.891 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.76 32.54 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.415 -0.421 . . . . 65.31 112.243 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.543 HG21 ' CZ ' ' A' ' 56' ' ' ARG . 39.0 m -94.48 127.19 40.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.176 0.513 . . . . 72.14 111.709 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.6 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.8 170.13 13.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.03 -0.532 . . . . 72.32 110.71 175.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.605 ' HG2' ' HB2' ' A' ' 54' ' ' PRO . 17.2 ttp180 -133.44 105.59 7.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.835 0.35 . . . . 74.35 110.924 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.775 ' SD ' HG21 ' A' ' 152' ' ' ILE . 66.9 mtt -95.77 148.99 21.99 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.224 0.453 . . . . 73.4 112.224 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.1 p -145.08 148.89 34.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.793 0.33 . . . . 63.03 111.742 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 80' ' ' LEU . 95.6 mt -96.68 114.0 25.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.177 -0.465 . . . . 54.13 111.557 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.699 HG23 HD22 ' A' ' 70' ' ' ASN . 28.3 m -134.37 162.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.625 0.232 . . . . 52.55 111.625 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.699 HD22 HG23 ' A' ' 69' ' ' VAL . 44.5 m-80 61.96 33.89 17.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.776 0.43 . . . . 70.41 111.794 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.574 HD12 ' HE3' ' A' ' 52' ' ' LYS . 38.8 mt -71.33 106.9 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 73.03 111.421 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 21.9 p -140.67 158.72 65.01 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 111.891 0.33 . . . . 65.5 111.891 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 22.6 Cg_endo -60.17 153.76 56.59 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.73 2.287 . . . . 61.15 113.517 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.0 t70 -129.96 172.62 11.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.156 -0.475 . . . . 63.11 111.679 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -53.58 -46.63 70.38 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.306 0.484 . . . . 72.44 112.306 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -110.14 -21.39 12.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.55 0.574 . . . . 75.53 112.55 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -157.49 -103.7 0.2 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.154 -1.022 . . . . 74.04 114.144 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.2 m -150.1 129.27 12.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.711 0.291 . . . . 74.25 111.636 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.664 HG23 ' HB2' ' A' ' 74' ' ' ASP . 82.5 p -97.59 123.56 41.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.87 0.367 . . . . 54.33 111.405 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.6 pp -135.73 137.96 42.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.19 0.519 . . . . 75.41 111.352 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.0 m -83.66 107.35 16.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.155 0.502 . . . . 71.25 111.354 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -82.75 109.98 17.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.914 -0.585 . . . . 71.53 110.366 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 66' ' ' MET . 48.3 mtm180 -93.7 112.47 24.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.76 0.282 . . . . 73.34 111.76 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mp -92.18 93.94 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.04 0.448 . . . . 75.35 110.611 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -94.22 104.03 16.04 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 71.32 110.799 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.46 145.13 40.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.822 -0.704 . . . . 52.25 113.353 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.92 -45.05 95.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.418 0.628 . . . . 55.23 110.439 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 m -80.68 115.2 20.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.869 -0.605 . . . . 62.51 110.699 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -61.26 -27.22 68.3 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.89 0.376 . . . . 65.13 111.39 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 141.22 49.95 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.765 -0.652 . . . . 71.41 112.0 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.82 106.96 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.144 2.563 . . . . 72.02 113.508 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.6 148.91 63.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.238 -0.437 . . . . 72.3 111.643 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.7 179.81 4.88 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.594 2.196 . . . . 52.43 113.153 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 139.5 36.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.07 0.462 . . . . 62.01 111.687 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 42.5 p90 -141.59 176.11 9.15 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.564 0.697 . . . . 73.15 112.475 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 p -152.73 168.69 24.84 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.536 -0.757 . . . . 32.44 111.077 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.55 -177.79 44.87 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.819 -0.705 . . . . 52.14 113.605 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 m -113.13 119.06 36.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.689 0.28 . . . . 74.34 111.308 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.09 115.81 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.103 0.478 . . . . 62.24 111.235 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 53.1 mt-10 -106.56 113.64 27.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.987 0.422 . . . . 74.54 111.158 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.434 ' CE1' HD22 ' A' ' 139' ' ' LEU . 17.0 p90 -116.95 129.02 55.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.044 0.45 . . . . 74.02 111.648 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.97 -146.71 4.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.186 -0.53 . . . . 72.41 113.189 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.617 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 92.9 mt-30 -128.58 152.87 47.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.169 0.509 . . . . 55.43 111.8 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 111' ' ' PHE . 57.9 mt -114.74 126.15 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.977 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -112.7 17.23 19.27 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.862 0.319 . . . . 75.13 111.862 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -132.99 -165.0 11.05 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.915 -0.659 . . . . 65.44 113.908 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.8 p -102.82 176.01 5.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.978 0.418 . . . . 74.5 111.558 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.485 HD11 ' HG3' ' A' ' 33' ' ' GLN . 49.2 mm -58.67 -38.23 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.085 0.469 . . . . 72.02 110.613 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.28 -47.91 59.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.899 -0.591 . . . . 64.51 110.995 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.41 91.69 2.57 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 51.01 111.826 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.614 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.9 p90 -115.41 127.89 55.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.178 0.513 . . . . 73.33 112.209 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.96 124.39 40.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 70.12 110.827 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.91 105.59 17.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.858 -0.61 . . . . 71.12 111.195 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.452 HD13 ' NE2' ' A' ' 105' ' ' GLN . 41.0 pt -109.28 156.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.63 -0.259 . . . . 63.13 111.652 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 56.66 39.36 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.945 0.402 . . . . 65.44 111.881 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 p -96.72 116.43 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.472 0.653 . . . . 72.01 112.454 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.02 147.37 27.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.98 -0.554 . . . . 62.13 110.341 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.451 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 7.4 p30 -112.68 136.47 52.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.346 0.593 . . . . 54.12 111.931 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.403 ' NE2' HD23 ' A' ' 139' ' ' LEU . 8.8 tt0 -127.45 157.74 39.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.956 -0.565 . . . . 73.31 110.217 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.5 122.02 37.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.11 0.411 . . . . 72.34 112.11 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.856 HG22 HD21 ' A' ' 137' ' ' LEU . 20.0 pt -100.95 105.64 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.163 0.506 . . . . 64.54 111.539 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -110.38 119.14 38.27 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.338 -0.392 . . . . 55.15 110.193 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -114.28 133.29 22.45 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 111.858 0.318 . . . . 65.3 111.858 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 24.5 Cg_exo -64.28 159.99 40.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.174 2.583 . . . . 74.0 113.22 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.14 147.63 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.128 0.418 . . . . 53.25 112.128 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 t -87.39 124.54 33.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.342 -0.39 . . . . 61.2 110.541 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.4 -34.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.887 0.375 . . . . 72.0 111.722 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.09 -169.1 1.95 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.892 0.377 . . . . 71.23 111.655 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.47 149.73 53.1 Favored Pre-proline 0 N--CA 1.472 0.658 0 CA-C-N 116.508 -0.314 . . . . 33.21 111.358 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.54 147.2 63.5 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.0 -1.25 . . . . 73.33 113.306 -1.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m -65.89 82.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.356 0.598 . . . . 75.22 112.145 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.57 93.35 4.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.498 -0.774 . . . . 65.31 109.285 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.94 105.66 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.51 -0.313 . . . . 62.44 111.803 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.5 p-10 -96.97 142.9 28.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.992 0.425 . . . . 62.4 111.581 175.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 18.0 pt -135.85 135.82 22.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 116.314 -0.403 . . . . 75.13 111.346 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.0 Cg_exo -75.63 117.1 4.65 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 75.13 113.0 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.856 HD21 HG22 ' A' ' 121' ' ' ILE . 38.4 mt -97.1 112.33 24.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.185 0.439 . . . . 62.44 112.185 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -91.02 90.73 7.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.105 0.479 . . . . 62.44 110.023 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 101' ' ' TYR . 66.3 mt -76.72 137.71 39.51 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.319 -0.4 . . . . 63.44 111.252 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.8 135.82 48.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.226 0.454 . . . . 71.13 112.226 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.62 17.03 79.51 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 114.581 0.592 . . . . 61.11 114.581 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.2 tt -147.55 129.57 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 117.273 0.537 . . . . 63.1 111.628 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -92.48 156.75 16.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.975 0.416 . . . . 72.15 111.818 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.75 -33.79 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.964 -0.562 . . . . 75.24 111.727 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -31.63 72.95 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.966 0.413 . . . . 51.33 111.726 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.617 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 87.5 mm-40 -110.53 18.36 19.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.286 -0.415 . . . . 74.14 111.852 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -82.55 106.53 14.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.925 0.393 . . . . 71.03 110.832 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -83.78 -67.4 1.45 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.178 -0.534 . . . . 60.05 113.462 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -140.58 157.36 45.59 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.42 -0.459 . . . . 64.52 111.784 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.8 t -128.09 103.14 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.958 -0.565 . . . . 75.24 110.662 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -93.32 114.97 27.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.27 0.47 . . . . 71.12 112.27 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.775 HG21 ' SD ' ' A' ' 66' ' ' MET . 42.7 mm -96.14 130.78 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.105 -0.498 . . . . 73.14 111.118 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -165.39 -175.32 3.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.596 0.236 . . . . 75.45 111.632 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 64.22 24.47 13.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.117 0.567 . . . . 61.53 112.0 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.74 104.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.541 0.686 . . . . 75.34 111.538 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.555 ' HB3' HE22 ' A' ' 60' ' ' GLN . 8.0 pt20 -132.75 142.95 46.64 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.423 -0.808 . . . . 72.34 111.159 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 95' ' ' PHE . 62.5 Cg_endo -72.07 151.53 55.8 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.296 1.997 . . . . 75.21 112.692 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.619 -0.264 . . . . 73.42 110.812 178.132 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.392 0.615 . . . . 75.33 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 m -66.01 -31.08 71.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.829 -0.623 . . . . 72.53 111.049 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.79 -45.15 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.36 -0.382 . . . . 65.01 110.89 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.51 -48.33 77.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.142 0.496 . . . . 74.44 110.732 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -55.81 -51.22 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.904 -0.589 . . . . 72.33 111.41 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.1 m -58.36 -44.65 88.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.278 -0.419 . . . . 63.44 111.557 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.38 -44.05 96.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.447 -0.342 . . . . 74.55 111.209 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -56.79 -50.87 71.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.403 -0.362 . . . . 60.51 111.449 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -58.12 -43.8 87.4 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.859 0.361 . . . . 71.31 111.726 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -63.64 -48.23 78.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.729 0.3 . . . . 65.44 111.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.23 -33.82 76.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.333 0.587 . . . . 75.52 110.549 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.491 HD21 ' HB ' ' A' ' 45' ' ' VAL . 6.9 t-20 -63.6 -41.47 98.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.834 -0.621 . . . . 71.02 110.509 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.47 65.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.048 -0.524 . . . . 65.14 111.654 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.601 ' HE3' HG22 ' A' ' 108' ' ' ILE . 66.7 mttm -82.21 -7.97 59.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.835 0.309 . . . . 51.12 111.835 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -55.97 117.57 3.83 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.648 0.61 . . . . 71.31 112.648 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 t -71.12 -36.87 72.3 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.081 -0.509 . . . . 51.24 111.691 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 m -151.99 121.54 6.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.714 0.292 . . . . 73.12 110.723 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.79 -153.59 22.08 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.221 -0.514 . . . . 42.1 112.547 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.491 ' HB ' HD21 ' A' ' 38' ' ' ASN . 17.7 m -136.29 148.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.14 0.47 . . . . 72.4 111.918 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -95.92 130.11 42.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.411 . . . . 72.01 112.069 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -125.06 143.89 50.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.858 -0.61 . . . . 74.42 109.868 172.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 76.5 mt -114.12 136.36 22.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.837 0.351 . . . . 63.33 111.721 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 36.8 Cg_exo -61.53 -14.0 32.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.922 2.415 . . . . 75.15 113.406 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.35 6.43 26.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.212 -0.518 . . . . 72.54 113.145 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.88 103.12 11.86 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.043 0.449 . . . . 71.3 111.125 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -80.65 60.55 4.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.513 0.673 . . . . 73.22 111.231 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 p -146.01 150.65 42.89 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-N 115.826 -0.624 . . . . 70.21 112.123 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.69 170.85 13.84 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.024 2.483 . . . . 72.42 114.396 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 38' ' ' ASN . . . -143.38 157.03 44.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.738 -0.665 . . . . 72.42 110.076 174.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -113.59 119.36 37.23 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.46 0.648 . . . . 73.31 112.17 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.95 126.16 53.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.839 -0.618 . . . . 72.35 112.284 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.0 tt0 -86.78 108.33 18.66 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.741 -0.466 . . . . 61.32 109.741 172.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 82.6 p -113.04 -177.5 3.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.234 0.54 . . . . 71.13 112.338 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 50.1 mt-30 -67.66 -19.82 65.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.945 -0.57 . . . . 71.43 112.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 pt -95.19 -6.55 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.986 0.422 . . . . 72.4 111.073 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.54 -179.46 16.3 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.382 -0.437 . . . . 71.11 112.89 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 60.3 m -79.81 131.69 35.95 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.454 -0.439 . . . . 72.32 111.34 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.96 175.18 10.03 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.127 0.489 . . . . 63.32 112.246 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -124.34 123.35 40.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 74.42 110.664 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.568 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.0 mtt -118.0 156.16 29.04 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.873 0.368 . . . . 74.31 111.896 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.9 t -158.79 170.47 22.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.905 0.383 . . . . 70.2 111.908 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB3' HD11 ' A' ' 71' ' ' ILE . 99.2 mt -116.29 106.18 13.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.29 -0.414 . . . . 71.34 111.996 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 81' ' ' THR . 33.0 m -113.36 162.19 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.238 -0.288 . . . . 42.31 111.064 176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 63.83 31.2 14.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.039 0.447 . . . . 74.33 112.095 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 68' ' ' LEU . 45.3 mt -73.08 103.93 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.17 0.433 . . . . 23.21 112.17 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 p -137.78 152.49 72.56 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 120.861 0.362 . . . . 71.51 111.562 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.11 168.88 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.737 2.291 . . . . 51.43 113.495 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.66 ' HB2' HG23 ' A' ' 79' ' ' THR . 31.5 t70 -143.82 170.54 15.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.773 -0.649 . . . . 72.53 110.749 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.25 94.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.692 0.282 . . . . 70.12 111.692 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.15 -34.27 24.09 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.525 -0.307 . . . . 61.31 111.736 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.54 -100.83 0.14 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.36 -0.924 . . . . 64.44 114.149 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -146.03 131.28 18.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.832 0.349 . . . . 73.15 111.586 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.66 HG23 ' HB2' ' A' ' 74' ' ' ASP . 79.0 p -109.56 137.7 47.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.895 0.379 . . . . 62.52 111.604 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 pp -149.41 -179.57 7.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.898 0.38 . . . . 44.24 111.272 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.691 ' HB ' HG23 ' A' ' 69' ' ' VAL . 21.7 m -124.13 117.77 25.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.894 0.378 . . . . 64.44 111.258 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.2 113.54 20.73 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.238 -0.437 . . . . 70.4 109.946 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 66' ' ' MET . 69.7 mtt180 -96.29 136.57 36.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.822 0.344 . . . . 75.42 111.09 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.536 HG12 ' HG2' ' A' ' 66' ' ' MET . 42.1 mt -131.63 133.97 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 74.14 111.529 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -142.51 124.79 15.51 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.737 -0.21 . . . . 73.15 110.689 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 92' ' ' LEU . . . -75.86 146.08 33.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.843 -0.694 . . . . 74.14 113.933 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.41 -39.48 83.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.753 0.787 . . . . 75.2 109.927 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -93.81 112.18 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 73.12 109.671 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -64.35 -7.71 10.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.46 0.541 . . . . 75.23 112.46 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.97 156.29 80.77 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.881 0.473 . . . . 64.15 111.572 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.82 123.38 11.51 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.094 2.529 . . . . 61.13 113.824 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 126' ' ' SER . 95.9 mt -100.19 147.98 34.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.099 -0.501 . . . . 73.41 111.332 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.13 172.79 15.28 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.471 2.114 . . . . 65.32 112.991 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.48 43.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 64.45 111.032 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -146.35 162.27 38.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.351 0.596 . . . . 72.33 112.282 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.4 m -146.9 151.54 37.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.932 -0.577 . . . . 53.22 110.309 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.763 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -150.25 170.61 30.22 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.411 -0.899 . . . . 55.41 113.762 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.1 m -105.32 132.04 52.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 75.13 110.999 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.75 130.39 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.955 0.407 . . . . 75.35 111.6 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 40.4 mm-40 -97.83 111.92 24.03 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 64.02 110.818 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -122.75 120.95 35.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.237 0.542 . . . . 75.35 111.844 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -161.65 -149.18 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.837 -0.62 . . . . 55.41 113.23 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -125.06 157.19 36.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.222 0.534 . . . . 61.32 112.043 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.36 121.16 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.354 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.441 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -105.08 5.95 32.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.872 0.367 . . . . 73.32 111.658 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -113.69 -177.89 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.233 -0.508 . . . . 73.43 113.19 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -90.44 179.41 5.87 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.611 -0.346 . . . . 52.43 111.223 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.601 HG22 ' HE3' ' A' ' 40' ' ' LYS . 48.8 mm -68.73 -27.56 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.521 . . . . 74.33 110.605 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.54 -32.34 58.16 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.384 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.39 90.57 1.67 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.285 0.564 . . . . 61.34 111.14 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -96.3 117.23 30.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.413 0.625 . . . . 70.31 112.05 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -86.59 111.98 21.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.081 -0.508 . . . . 71.52 110.633 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.77 104.08 11.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.951 0.405 . . . . 72.34 111.053 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.441 HD13 ' NE2' ' A' ' 105' ' ' GLN . 41.5 pt -113.39 151.65 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.475 -0.33 . . . . 63.35 111.687 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 58.14 34.44 24.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.078 0.465 . . . . 55.11 111.802 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.442 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 3.7 p -91.14 116.74 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.339 0.59 . . . . 73.41 112.331 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.66 171.79 7.68 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.268 -0.424 . . . . 63.44 111.011 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.12 143.47 50.87 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.14 0.495 . . . . 61.42 111.872 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -144.76 147.69 33.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.36 -0.382 . . . . 72.23 111.17 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.88 125.47 37.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.076 0.465 . . . . 74.53 112.216 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.2 pt -101.96 120.62 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.978 0.418 . . . . 72.15 111.043 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.32 122.31 46.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.869 0.366 . . . . 71.14 111.491 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 135' ' ' ILE . . . -119.08 138.19 25.93 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 120.732 0.301 . . . . 54.52 111.546 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 170.34 20.26 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.725 2.283 . . . . 72.51 113.396 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.53 117.59 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.161 -0.472 . . . . 43.05 112.061 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 25.1 m -79.56 63.81 4.25 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.954 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.31 -11.66 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.451 0.908 . . . . 72.0 113.451 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.45 120.67 40.91 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.034 -0.416 . . . . 73.21 111.411 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.64 139.16 31.42 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 111.733 0.272 . . . . 72.22 111.733 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.74 145.63 82.15 Favored 'Cis proline' 0 C--N 1.356 0.922 0 C-N-CA 124.116 -1.202 . . . . 74.21 113.431 0.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 p -83.86 95.53 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.991 0.737 . . . . 62.31 112.991 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.24 127.02 20.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.003 -0.544 . . . . 54.23 110.739 171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -132.59 139.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 72.54 111.712 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.47 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 18.1 p-10 -114.67 133.39 55.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.256 0.551 . . . . 64.52 110.95 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.528 HD13 ' HB2' ' A' ' 123' ' ' ALA . 25.3 pt -130.5 140.18 37.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.482 -0.327 . . . . 72.15 111.509 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.24 156.2 62.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.418 2.079 . . . . 72.51 112.439 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -145.44 116.69 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.493 -0.321 . . . . 75.02 110.158 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -103.25 96.95 7.11 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.197 0.523 . . . . 74.14 111.814 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.8 129.86 35.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.842 0.354 . . . . 74.23 110.248 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -116.11 139.45 50.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.917 0.389 . . . . 45.24 111.809 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 20.21 61.26 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.326 -0.397 . . . . 70.42 113.815 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -160.29 124.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 117.334 0.567 . . . . 73.22 112.299 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.5 m -86.45 146.69 26.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.193 -0.317 . . . . 72.02 111.602 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.92 -35.64 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.749 0.648 . . . . 74.35 112.749 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.64 -23.15 66.73 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.159 0.504 . . . . 64.03 111.481 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -109.21 8.86 26.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.062 -0.517 . . . . 75.43 111.525 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.423 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 1.1 tt -91.63 126.05 36.57 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.913 0.387 . . . . 71.12 110.894 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.19 -62.35 1.22 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.297 -0.478 . . . . 73.13 113.72 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.39 160.35 40.31 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.563 0.579 . . . . 64.34 112.563 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.92 101.48 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.644 -0.707 . . . . 51.21 110.342 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 45.2 ttp180 -98.03 116.77 30.93 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.029 -0.419 . . . . 61.35 112.055 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.568 HG21 ' SD ' ' A' ' 66' ' ' MET . 22.3 mm -85.46 130.32 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.435 -0.348 . . . . 64.4 111.191 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -158.67 179.52 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.292 -0.255 . . . . 72.34 111.585 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.43 30.92 20.17 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.763 0.653 . . . . 74.13 112.763 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.763 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.9 mm -71.79 106.43 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.365 0.602 . . . . 71.55 110.691 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.471 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.7 pt20 -129.71 149.39 72.83 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.711 -0.677 . . . . 73.53 111.859 -174.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 156' ' ' GLN . 9.4 Cg_exo -71.23 136.93 30.24 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.627 2.218 . . . . 74.53 112.65 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 120.8 0.333 . . . . 55.21 110.748 177.154 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 34.4 tt0 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.799 0.333 . . . . 70.12 111.522 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.0 m -56.27 -41.16 75.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.963 0.411 . . . . 51.2 111.302 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.32 -36.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 74.24 111.32 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HE3' HD13 ' A' ' 48' ' ' LEU . 52.3 tptt -66.96 -38.37 85.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.123 -0.49 . . . . 62.5 110.437 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.448 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 84.7 mt -60.22 -48.57 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.13 0.491 . . . . 63.05 110.755 174.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.6 m -56.05 -41.79 75.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.115 -0.493 . . . . 72.15 110.783 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HG3' HD11 ' A' ' 108' ' ' ILE . 34.3 tt0 -59.09 -46.37 88.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.157 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.71 -52.92 63.1 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.994 0.368 . . . . 70.42 111.994 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.69 -42.87 84.56 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.819 0.342 . . . . 75.42 111.608 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.1 -34.56 76.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.929 0.344 . . . . 60.55 111.929 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.9 mt -68.1 -37.7 81.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.929 0.395 . . . . 64.23 110.829 174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.434 HD21 HG12 ' A' ' 45' ' ' VAL . 26.9 t-20 -57.76 -44.06 85.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.006 0.431 . . . . 53.44 110.751 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.91 81.91 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.647 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.79 -2.08 58.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.93 0.395 . . . . 74.41 111.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -78.0 150.86 33.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.075 0.464 . . . . 73.43 111.863 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 m -122.01 -31.63 3.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.821 -0.627 . . . . 74.24 110.868 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -112.19 85.47 2.16 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.194 0.521 . . . . 74.41 111.438 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 80.92 -146.25 26.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.214 -0.517 . . . . 51.24 113.833 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.502 HG13 HD13 ' A' ' 57' ' ' LEU . 33.5 m -123.74 140.6 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.472 0.545 . . . . 54.34 112.472 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 65.5 m-85 -87.04 107.63 18.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.436 -0.347 . . . . 53.44 110.895 172.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.64 128.26 44.21 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 71.32 110.499 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 72.1 mt -108.63 133.62 20.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.629 0.252 . . . . 63.52 111.471 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.41 -45.76 38.7 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.003 2.468 . . . . 72.53 113.251 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -71.38 -25.67 74.92 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.926 -0.654 . . . . 64.14 113.001 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -91.93 63.2 4.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.051 0.453 . . . . 63.13 111.429 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -64.56 75.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.409 0.623 . . . . 63.35 111.541 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -141.65 151.47 60.4 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.132 -0.486 . . . . 72.51 111.946 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.688 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 74.5 Cg_endo -73.67 128.11 12.28 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.875 2.383 . . . . 75.45 113.958 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.96 139.9 50.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.348 -0.387 . . . . 73.42 110.703 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 56' ' ' ARG . 13.0 ttp180 -89.39 133.18 34.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.063 0.458 . . . . 62.21 111.282 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.502 HD13 HG13 ' A' ' 45' ' ' VAL . 40.9 tp -132.89 129.67 38.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.132 -0.485 . . . . 62.22 111.374 -177.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.71 137.97 32.02 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.003 -0.369 . . . . 71.42 110.003 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.4 p -126.11 177.94 6.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.213 0.53 . . . . 70.34 111.287 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.0 0.75 23.21 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.869 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 pt -118.46 -4.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.737 0.303 . . . . 44.12 111.762 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.11 -177.94 20.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.53 -0.367 . . . . 42.04 112.993 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -88.39 132.32 34.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.207 -0.584 . . . . 73.41 111.716 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.03 -177.59 4.96 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.001 0.429 . . . . 75.12 111.706 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.688 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 66.7 ttp85 -135.41 140.77 45.2 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.477 -0.329 . . . . 74.4 111.088 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.676 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.8 mtt -129.36 152.23 49.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 61.43 111.854 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.1 p -152.38 152.65 32.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.906 0.384 . . . . 72.42 111.626 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 71.1 mt -100.81 111.06 23.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.323 -0.399 . . . . 72.14 111.349 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.639 HG21 ' HD2' ' A' ' 83' ' ' ARG . 33.7 m -128.12 159.35 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.626 0.25 . . . . 71.3 110.997 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.567 HD22 HG23 ' A' ' 69' ' ' VAL . 28.7 m-80 51.71 69.03 0.71 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.955 0.407 . . . . 74.52 111.113 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.6 mt -100.43 102.13 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.247 -0.433 . . . . 72.42 110.732 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -121.65 144.86 41.57 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 112.672 0.619 . . . . 74.52 112.672 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.27 129.67 15.29 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.766 2.311 . . . . 73.23 112.104 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.9 t70 -110.46 164.95 12.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.159 -0.473 . . . . 54.2 111.708 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.01 76.93 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 71.11 112.489 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -96.47 -12.29 24.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.912 0.338 . . . . 71.21 111.912 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . 171.51 -102.51 0.18 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.988 -0.625 . . . . 73.32 113.48 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -147.81 130.45 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.492 -0.417 . . . . 71.21 111.775 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 39.4 p -106.78 120.41 41.93 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.831 0.348 . . . . 72.42 111.485 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -130.13 159.13 37.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.691 0.282 . . . . 65.23 110.875 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -101.92 108.21 19.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.973 0.415 . . . . 65.21 111.867 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 HD11 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -84.07 106.63 15.87 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.499 -0.556 . . . . 65.22 109.499 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' HD2' HG21 ' A' ' 69' ' ' VAL . 20.2 mtp180 -96.11 125.76 40.87 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.192 -0.318 . . . . 74.31 111.247 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.568 HD11 HD12 ' A' ' 82' ' ' LEU . 3.9 mp -115.93 103.3 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.917 0.389 . . . . 74.31 111.381 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -106.5 134.7 49.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.382 . . . . 73.34 110.722 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 142.47 32.61 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.957 -0.64 . . . . 65.01 113.324 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -62.15 -35.76 79.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.385 0.612 . . . . 62.54 110.749 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.8 m -99.82 149.83 22.97 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.794 -0.639 . . . . 60.33 110.718 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.71 -17.35 64.05 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.178 0.513 . . . . 74.51 111.342 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.15 136.33 58.69 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.622 -0.717 . . . . 72.41 112.052 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.75 117.01 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.456 2.104 . . . . 72.0 113.053 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -85.2 148.16 49.43 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.391 -0.368 . . . . 72.12 111.837 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.61 176.22 9.64 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.622 2.215 . . . . 64.12 113.007 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -75.14 140.46 43.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.927 0.394 . . . . 74.32 111.741 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.86 168.67 19.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.529 0.68 . . . . 72.53 112.368 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 93.8 p -146.6 145.16 29.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.522 -0.763 . . . . 55.23 110.255 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -143.49 157.12 26.88 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.556 -0.83 . . . . 72.11 113.448 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 60.9 m -99.94 104.99 16.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.981 0.42 . . . . 74.52 110.784 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 152' ' ' ILE . 20.1 m -91.06 125.3 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.007 0.432 . . . . 74.05 111.391 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.8 mt-10 -108.41 112.69 25.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.198 0.523 . . . . 70.13 110.831 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -115.97 141.28 48.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.953 -0.567 . . . . 74.42 111.641 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.27 -146.48 4.85 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.283 -0.484 . . . . 64.32 112.81 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.698 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 mt-30 -128.22 144.17 51.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.254 0.464 . . . . 70.34 112.254 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.2 mt -114.14 103.89 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.409 -0.359 . . . . 55.01 110.78 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.444 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -92.83 15.03 15.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.043 0.386 . . . . 72.45 112.043 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -123.29 -170.26 13.4 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.884 -0.674 . . . . 72.35 113.872 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 49.9 p -102.63 -178.1 3.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.804 0.441 . . . . 62.34 111.644 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.493 HD11 ' HG3' ' A' ' 33' ' ' GLN . 46.7 mm -63.42 -30.83 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.461 0.648 . . . . 70.21 110.668 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.82 -56.13 5.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.685 -0.689 . . . . 75.21 110.848 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.31 98.26 4.83 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.196 0.522 . . . . 72.15 111.567 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.543 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 32.2 p90 -113.8 132.37 55.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.082 0.468 . . . . 71.34 111.537 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -107.32 115.94 31.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.219 -0.446 . . . . 62.25 111.492 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.8 97.46 3.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.888 0.375 . . . . 63.55 110.615 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.444 HD13 ' NE2' ' A' ' 105' ' ' GLN . 36.3 pt -108.73 156.81 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.491 -0.322 . . . . 75.23 111.288 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 56.86 36.32 27.56 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.119 0.485 . . . . 73.22 111.546 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.31 116.37 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.96 0.726 . . . . 72.11 112.96 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.572 ' H ' ' NE2' ' A' ' 117' ' ' GLN . 0.8 OUTLIER -124.89 156.88 37.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.711 -0.677 . . . . 71.13 110.972 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.506 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.3 p-10 -102.42 166.9 10.29 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.361 0.875 . . . . 73.51 113.361 -172.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.425 ' NE2' HD23 ' A' ' 139' ' ' LEU . 8.4 tt0 -152.9 152.83 31.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.413 -0.812 . . . . 74.22 110.087 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.39 133.46 35.86 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.019 0.438 . . . . 73.35 112.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.9 HG22 HD21 ' A' ' 137' ' ' LEU . 39.4 pt -109.98 106.21 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.199 0.523 . . . . 74.43 110.758 173.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.82 101.72 12.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.903 0.382 . . . . 73.2 111.031 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 140.87 21.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.073 0.398 . . . . 64.54 112.073 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.68 168.58 22.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.819 2.346 . . . . 75.25 113.216 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -82.94 139.57 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.288 -0.415 . . . . 64.02 111.856 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.8 m -78.01 93.07 4.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 75.03 110.655 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.94 -36.92 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.264 0.554 . . . . 53.14 111.034 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.15 145.11 39.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.925 -0.58 . . . . 63.45 111.148 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.73 45.54 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.483 -0.326 . . . . 63.24 110.963 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -82.33 170.85 56.71 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.007 -1.247 . . . . 73.23 113.872 1.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -79.82 74.12 6.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.324 -0.398 . . . . 75.21 112.035 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.4 103.11 12.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.262 -0.426 . . . . 65.31 111.289 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.7 t -122.38 108.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.234 0.214 . . . . 71.23 111.429 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -117.87 128.28 54.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.028 0.442 . . . . 54.04 111.701 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 pt -126.12 144.33 48.58 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.185 -0.461 . . . . 53.54 112.145 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.74 158.39 46.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.884 2.389 . . . . 72.54 112.852 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.9 HD21 HG22 ' A' ' 121' ' ' ILE . 31.7 mt -139.72 103.97 4.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.459 0.54 . . . . 75.53 112.459 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -82.78 95.11 7.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.342 0.591 . . . . 65.24 110.557 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.495 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 40.9 mt -80.19 114.79 19.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 60.41 109.803 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -95.58 134.5 38.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.006 0.431 . . . . 74.34 112.056 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.68 15.47 58.15 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.253 -0.499 . . . . 43.41 113.696 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -152.54 134.93 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 117.229 0.514 . . . . 70.13 111.528 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -94.83 156.23 16.45 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.915 0.388 . . . . 71.43 111.847 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.98 -43.76 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.874 0.694 . . . . 63.34 112.874 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.02 -13.53 62.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 63.54 111.042 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.432 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.6 mm-40 -106.18 5.82 30.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.5 . . . . 75.55 111.979 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.455 HD23 HD13 ' A' ' 142' ' ' ILE . 40.2 mt -80.14 109.6 14.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.251 0.548 . . . . 74.43 111.485 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.698 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -87.65 -45.24 5.26 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.847 -0.615 . . . . 70.31 112.904 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -156.13 151.99 27.4 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.167 0.508 . . . . 70.22 111.748 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.38 93.23 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.881 -0.599 . . . . 71.31 109.745 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 18.5 ttp85 -88.27 109.1 19.68 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.274 0.559 . . . . 75.43 112.249 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.676 HG21 ' SD ' ' A' ' 66' ' ' MET . 13.4 mm -90.51 129.69 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.748 -0.66 . . . . 72.11 111.083 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.559 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 14.8 p80 -167.25 -178.13 3.96 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.237 0.458 . . . . 61.32 112.237 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 98' ' ' THR . 8.8 t70 66.32 31.59 8.31 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.53 -0.759 . . . . 65.14 111.174 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.478 HD13 ' HA3' ' A' ' 97' ' ' GLY . 43.0 mm -68.04 94.02 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.87 -0.604 . . . . 60.14 111.154 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -112.83 145.07 32.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.813 -0.631 . . . . 73.11 111.702 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.44 140.8 37.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.487 2.125 . . . . 42.01 112.962 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.554 0.692 . . . . 61.43 111.111 177.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.8 pt-20 . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.115 0.483 . . . . 62.42 110.726 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.464 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 7.1 m -69.01 -26.02 64.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.063 -0.517 . . . . 73.15 111.612 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.15 -47.9 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.005 0.431 . . . . 72.31 110.56 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.87 -39.07 92.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.359 -0.382 . . . . 75.33 111.004 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 27' ' ' GLU . 84.4 mt -58.97 -46.43 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.994 0.426 . . . . 61.41 110.832 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -56.29 -49.54 73.98 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.246 0.546 . . . . 70.14 110.611 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.791 ' HG3' HD11 ' A' ' 108' ' ' ILE . 60.2 tt0 -54.89 -43.75 73.5 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.724 -0.671 . . . . 74.33 111.228 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 30.3 tt0 -60.53 -51.81 67.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.111 -0.495 . . . . 55.01 111.868 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -57.46 -40.4 78.45 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.19 0.441 . . . . 55.15 112.19 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -65.01 -47.67 76.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.696 0.284 . . . . 71.43 111.643 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.44 -39.35 91.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.312 0.577 . . . . 70.31 110.757 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.541 HD21 ' HB ' ' A' ' 45' ' ' VAL . 3.3 t-20 -60.23 -38.22 82.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.583 -0.735 . . . . 53.5 111.072 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.54 -25.83 35.55 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.301 0.482 . . . . 72.1 112.301 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 55.9 mttm -69.3 -30.9 69.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.803 0.297 . . . . 74.44 111.803 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB2' ' HE1' ' A' ' 46' ' ' TYR . 48.2 t -71.4 130.19 40.71 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.358 0.503 . . . . 61.24 112.358 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.7 m -83.11 -13.86 54.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.068 -0.515 . . . . 73.32 111.686 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -160.78 102.9 1.33 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.863 0.363 . . . . 71.42 111.394 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 152' ' ' ILE . . . 116.07 137.61 6.16 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.17 -0.538 . . . . 52.33 112.896 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.541 ' HB ' HD21 ' A' ' 38' ' ' ASN . 27.4 m -89.49 138.3 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.383 0.512 . . . . 55.21 112.383 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HE1' ' HB2' ' A' ' 41' ' ' SER . 30.2 m-85 -90.01 114.11 25.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.835 -0.62 . . . . 72.43 110.783 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -108.58 133.48 52.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.493 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 74.3 mt -110.4 126.97 27.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.762 -0.199 . . . . 71.35 111.071 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -33.41 68.65 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.539 2.159 . . . . 55.45 112.727 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.29 -36.37 50.53 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.235 -0.439 . . . . 61.14 112.883 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -92.43 71.88 5.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.154 0.502 . . . . 62.43 111.187 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -66.84 77.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.159 0.504 . . . . 71.24 111.429 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -144.02 151.37 52.19 Favored Pre-proline 0 N--CA 1.47 0.546 0 CA-C-N 116.215 -0.448 . . . . 52.05 111.812 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 66' ' ' MET . 59.7 Cg_endo -70.38 152.05 65.88 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.881 2.387 . . . . 74.43 113.406 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -135.66 140.72 44.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.323 -0.399 . . . . 53.54 111.385 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HD3' HH11 ' A' ' 56' ' ' ARG . 17.1 ttm180 -83.83 132.22 34.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.83 0.347 . . . . 72.22 111.822 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.47 HD23 HD21 ' A' ' 64' ' ' LEU . 53.6 tp -130.29 129.9 43.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.8 0.44 . . . . 71.52 111.359 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.26 115.87 30.14 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.296 -0.631 . . . . 73.22 109.296 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 79.7 p -137.27 -178.9 5.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.735 0.779 . . . . 71.31 112.903 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -66.29 -20.12 66.01 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.196 -0.911 . . . . 62.43 112.563 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 95' ' ' PHE . 36.6 pt -90.68 -18.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.851 0.357 . . . . 72.44 111.247 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.43 -164.71 25.1 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.141 -0.482 . . . . 44.04 112.433 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.6 m -95.01 107.3 19.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.231 0.539 . . . . 62.04 111.34 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.817 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.6 -176.47 2.91 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.212 0.53 . . . . 75.41 111.74 -178.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 31.3 ttp180 -150.94 107.51 3.5 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.941 0.4 . . . . 72.13 110.888 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.866 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.7 mtt -104.11 161.29 14.14 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.732 0.642 . . . . 51.14 112.732 -173.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 t -153.52 158.89 41.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.101 -0.5 . . . . 52.33 111.793 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 71' ' ' ILE . 96.2 mt -106.27 110.19 22.36 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.418 -0.356 . . . . 74.14 111.71 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.613 HG23 HD22 ' A' ' 70' ' ' ASN . 20.4 m -130.04 165.9 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.702 0.287 . . . . 71.41 111.753 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.613 HD22 HG23 ' A' ' 69' ' ' VAL . 37.7 m-80 59.22 29.29 18.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.988 0.515 . . . . 73.23 112.323 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' A' ' 68' ' ' LEU . 35.2 mt -68.09 107.35 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.901 0.382 . . . . 63.32 111.464 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.63 153.07 78.76 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.185 0.439 . . . . 65.14 112.185 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.28 150.34 81.37 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.824 2.35 . . . . 53.44 113.268 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -140.9 167.46 22.14 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.141 -0.482 . . . . 54.03 111.546 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.47 72.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.961 0.41 . . . . 62.15 111.911 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 6.6 m-20 -76.01 -26.77 57.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.801 0.334 . . . . 72.44 110.994 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.34 -93.32 0.1 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-N 116.022 -0.535 . . . . 63.41 112.97 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -147.84 126.5 12.54 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.549 -0.383 . . . . 73.43 111.466 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -104.77 129.89 52.94 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.705 0.288 . . . . 54.12 111.658 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 pp -141.1 152.65 44.94 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.976 0.417 . . . . 73.41 111.501 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.454 ' HB ' HG23 ' A' ' 69' ' ' VAL . 60.1 m -89.87 109.04 20.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.965 0.412 . . . . 52.3 111.113 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD12 HD11 ' A' ' 84' ' ' ILE . 2.6 tm? -86.5 109.37 19.04 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.716 -0.475 . . . . 65.14 109.716 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -99.24 130.32 45.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.811 0.339 . . . . 71.53 111.207 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.1 mp -111.62 102.85 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 73.35 111.294 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 72.43 110.695 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.74 153.43 17.54 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.006 -0.616 . . . . 70.52 112.172 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -45.33 91.56 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.349 0.575 . . . . 73.51 110.736 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -85.15 176.39 8.4 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.093 -0.503 . . . . 61.13 111.655 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.539 HD22 ' N ' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -89.26 -37.11 15.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.403 -0.362 . . . . 62.11 111.67 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.93 145.71 99.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.666 0.27 . . . . 73.54 111.5 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.75 145.94 82.4 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.236 2.624 . . . . 71.23 114.99 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.42 152.92 44.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.661 -0.7 . . . . 74.24 111.393 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.23 -171.55 1.19 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.678 2.252 . . . . 73.15 113.104 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 157' ' ' PRO . . . -74.62 151.33 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.749 0.309 . . . . 33.55 111.469 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' HB3' HG21 ' A' ' 61' ' ' ILE . 36.4 p90 -154.69 149.63 26.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.599 0.714 . . . . 72.43 112.669 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 91.1 p -130.55 136.75 49.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.287 -0.869 . . . . 52.02 109.8 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.705 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -145.36 175.54 24.87 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.332 -0.937 . . . . 63.33 113.598 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.9 m -111.13 122.19 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.01 111.547 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.429 HG12 HD12 ' A' ' 152' ' ' ILE . 20.7 m -104.11 133.74 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.187 -0.461 . . . . 43.1 111.131 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 41.3 mt-10 -122.76 126.23 47.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.958 0.409 . . . . 75.34 111.024 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -134.18 133.13 40.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.803 0.335 . . . . 75.05 111.741 -171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.31 -157.43 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.242 -0.504 . . . . 72.02 113.28 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.582 ' HB2' HG13 ' A' ' 114' ' ' ILE . 87.5 mt-30 -117.39 151.43 37.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.068 0.461 . . . . 74.23 112.049 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 106' ' ' GLY . 60.7 mt -109.28 122.46 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.192 -0.458 . . . . 72.32 111.266 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -106.88 23.64 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.837 0.31 . . . . 75.45 111.837 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -146.09 -170.43 14.75 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.006 -0.616 . . . . 35.13 113.678 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 44.7 p -97.31 -173.55 2.69 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.935 0.398 . . . . 73.15 111.522 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.791 HD11 ' HG3' ' A' ' 33' ' ' GLN . 31.8 mm -67.9 -36.45 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.037 0.446 . . . . 72.1 111.397 174.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.05 -37.66 58.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.182 -0.463 . . . . 72.34 111.312 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -144.93 111.87 5.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.18 -0.464 . . . . 61.23 111.44 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.1 p90 -139.1 145.81 39.93 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.451 0.643 . . . . 73.3 112.365 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -117.01 144.73 44.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.59 -0.732 . . . . 62.31 110.495 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.19 119.57 37.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.04 0.448 . . . . 72.33 111.489 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 103' ' ' GLN . 33.6 pt -123.07 149.52 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.53 -0.305 . . . . 74.33 111.429 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.89 39.28 31.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.362 0.601 . . . . 73.2 111.445 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.05 127.19 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 55.33 112.203 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.27 167.78 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.977 -0.556 . . . . 71.4 111.058 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.7 p-10 -112.94 178.48 4.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.056 0.762 . . . . 43.11 113.056 -172.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -167.75 159.78 12.05 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.482 -0.781 . . . . 74.35 110.251 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.05 133.92 44.84 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 122.01 -0.431 . . . . 54.13 112.033 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.43 ' O ' HG13 ' A' ' 121' ' ' ILE . 28.4 pt -111.79 106.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.208 0.527 . . . . 74.01 111.165 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.51 100.84 10.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.259 -0.428 . . . . 75.15 110.635 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.72 152.48 37.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.926 0.393 . . . . 75.22 112.047 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.51 174.43 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.801 2.334 . . . . 55.45 113.0 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.83 156.82 20.4 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.218 0.532 . . . . 73.25 112.023 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.9 m -100.95 118.27 36.64 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.094 -0.503 . . . . 74.52 109.983 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.3 -51.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.851 0.358 . . . . 73.43 111.664 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -119.95 164.42 16.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.014 0.435 . . . . 50.43 111.338 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.29 91.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 116.33 -0.395 . . . . 73.1 111.973 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -91.74 166.75 26.92 Favored 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.193 -1.17 . . . . 74.21 113.344 -1.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 55.1 m -66.93 95.46 0.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.928 0.394 . . . . 74.33 111.852 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -148.47 112.71 5.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.899 -0.591 . . . . 73.44 109.946 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.86 110.15 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.648 0.261 . . . . 75.43 111.323 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.11 118.75 35.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 73.5 111.222 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.3 pt -126.41 133.1 24.63 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 120.902 0.382 . . . . 71.54 111.898 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.92 118.3 5.5 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.254 1.969 . . . . 54.33 112.144 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.35 123.54 50.51 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.064 -0.516 . . . . 62.53 110.89 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -105.39 106.59 17.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.035 0.445 . . . . 72.43 111.625 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 mt -83.17 124.21 30.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.483 -0.326 . . . . 41.41 110.535 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 35.3 mtmm -105.87 128.63 53.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.32 111.928 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.9 7.09 57.76 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.258 -0.428 . . . . 60.34 113.811 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.2 tt -145.08 137.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.173 -0.604 . . . . 74.41 111.774 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.9 m -98.3 148.99 23.08 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.459 -0.337 . . . . 73.12 111.744 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.27 -49.54 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.941 0.719 . . . . 64.14 112.941 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.79 -26.94 68.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.017 0.437 . . . . 64.44 111.803 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -100.31 14.57 30.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.273 -0.421 . . . . 64.45 111.772 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.83 121.63 34.39 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 50.33 110.708 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.22 -61.75 0.97 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.162 -0.542 . . . . 52.43 113.646 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.479 ' HE2' ' HD3' ' A' ' 151' ' ' ARG . 49.4 p90 -136.06 155.49 50.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.024 0.44 . . . . 75.44 112.096 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.32 138.4 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.888 -0.596 . . . . 64.22 110.575 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.67 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 21.3 mtp180 -123.55 113.07 18.22 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.962 0.505 . . . . 72.23 111.72 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.866 HG21 ' SD ' ' A' ' 66' ' ' MET . 9.7 mm -106.25 115.16 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 122.413 -0.179 . . . . 74.31 111.221 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -151.17 179.44 8.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.266 0.469 . . . . 74.41 112.266 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 63.12 24.98 14.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.221 0.608 . . . . 63.14 112.589 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.705 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.7 mm -63.05 105.72 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.174 0.512 . . . . 75.53 110.879 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -125.1 143.76 45.18 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.979 -0.555 . . . . 74.33 111.447 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -67.51 107.94 1.52 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.538 2.159 . . . . 74.41 113.42 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 121.202 0.525 . . . . 72.01 110.953 177.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.1 tt0 . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.013 0.435 . . . . 70.35 110.733 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.483 ' HA ' HD12 ' A' ' 31' ' ' ILE . 89.1 m -59.58 -33.3 71.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.243 -0.435 . . . . 72.11 111.393 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.98 -45.87 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.952 0.406 . . . . 72.11 110.873 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.367 -0.379 . . . . 75.04 111.343 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 28' ' ' THR . 85.5 mt -62.09 -48.58 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.164 0.507 . . . . 74.44 110.786 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.5 m -58.5 -42.33 87.39 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.151 0.501 . . . . 72.25 110.658 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.654 HE21 HD11 ' A' ' 108' ' ' ILE . 30.8 tt0 -56.38 -50.19 72.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.615 -0.72 . . . . 64.15 111.061 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.2 -48.83 75.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.036 -0.529 . . . . 73.24 111.927 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -61.41 -46.9 88.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.891 0.33 . . . . 65.21 111.891 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.2 -36.49 84.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.005 0.372 . . . . 74.05 112.005 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.48 -38.28 89.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.07 0.462 . . . . 65.31 110.4 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.51 -33.27 75.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.925 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.46 98.87 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.927 0.394 . . . . 51.53 111.625 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HD2' ' HE1' ' A' ' 111' ' ' PHE . 61.5 mttp -74.89 -25.86 59.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.999 0.428 . . . . 54.51 111.183 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 47.8 t -69.54 125.81 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.95 0.405 . . . . 63.43 111.915 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 92.9 p -117.98 9.35 12.76 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.499 -0.319 . . . . 51.32 111.353 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 m -135.73 32.33 3.01 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.593 0.59 . . . . 65.42 112.593 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.65 -164.9 25.14 Favored Glycine 0 N--CA 1.463 0.467 0 C-N-CA 120.859 -0.686 . . . . 53.35 113.314 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 57' ' ' LEU . 27.6 m -115.69 136.33 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.085 0.469 . . . . 64.21 112.135 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 41' ' ' SER . 55.0 m-85 -89.69 103.82 16.44 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.313 -0.403 . . . . 71.14 111.242 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.12 102.14 14.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.91 0.386 . . . . 73.55 110.789 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.7 119.1 73.86 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.605 -0.27 . . . . 74.25 110.924 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -58.24 -18.97 40.04 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.263 1.975 . . . . 75.11 112.961 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.62 64.67 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.433 -0.413 . . . . 65.53 113.167 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.96 89.37 2.97 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.118 0.485 . . . . 51.11 111.117 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.39 83.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.174 0.511 . . . . 73.12 110.689 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -158.59 153.35 20.99 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 115.895 -0.593 . . . . 73.5 111.903 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.12 146.13 6.42 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.054 2.503 . . . . 73.32 112.942 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.21 136.08 53.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.796 0.332 . . . . 72.22 111.479 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 56' ' ' ARG . 14.1 ttp180 -86.75 127.21 34.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.898 0.38 . . . . 72.33 111.367 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 45' ' ' VAL . 53.5 tp -120.95 118.34 29.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.016 0.436 . . . . 62.45 111.225 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.9 100.13 12.65 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.186 0.517 . . . . 63.23 110.437 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.46 ' OG ' HG12 ' A' ' 61' ' ' ILE . 73.8 p -99.22 -167.96 1.55 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.306 0.574 . . . . 72.14 112.51 -171.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -76.0 -25.92 56.21 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.638 . . . . 74.04 111.718 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' ' 157' ' ' PRO . 33.9 pt -84.96 -24.8 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.158 0.504 . . . . 73.03 111.101 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -164.35 28.65 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.811 -0.632 . . . . 73.13 112.336 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -91.8 124.81 36.21 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.556 -0.379 . . . . 73.34 111.953 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.552 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -135.51 175.5 9.53 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.973 0.416 . . . . 71.42 111.69 176.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -131.54 119.18 21.16 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.477 -0.328 . . . . 72.24 111.298 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.581 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.3 mtt -112.16 154.99 24.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 73.54 112.315 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -160.89 169.77 21.98 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.152 -0.476 . . . . 74.33 111.234 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 80' ' ' LEU . 94.4 mt -114.66 124.32 51.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.243 0.46 . . . . 74.24 112.243 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.698 HG23 ' HB ' ' A' ' 81' ' ' THR . 29.1 m -133.04 164.53 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.413 -0.358 . . . . 72.31 111.096 174.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 62.61 28.32 16.59 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.54 0.57 . . . . 71.32 112.54 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 mt -67.94 104.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 74.12 111.416 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 p -139.1 152.69 70.43 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 112.299 0.481 . . . . 63.43 112.299 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.52 159.89 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.328 2.685 . . . . 74.22 113.873 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.558 ' HB2' HG23 ' A' ' 79' ' ' THR . 14.0 t70 -150.11 160.33 43.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.931 -0.577 . . . . 72.05 111.141 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.07 90.08 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.089 0.403 . . . . 75.23 112.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -82.49 -31.0 29.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.767 0.317 . . . . 71.13 111.552 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -174.65 -97.67 0.11 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.697 -0.763 . . . . 52.25 113.649 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.2 m -144.84 125.87 14.53 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.929 0.395 . . . . 54.12 111.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 74' ' ' ASP . 46.6 p -96.55 137.17 36.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.908 0.385 . . . . 71.1 111.825 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.423 HD13 HD22 ' A' ' 68' ' ' LEU . 3.3 pp -144.96 155.4 43.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 74.04 111.1 174.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.698 ' HB ' HG23 ' A' ' 69' ' ' VAL . 26.5 m -95.55 111.88 23.71 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.977 0.418 . . . . 60.1 111.117 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.93 109.86 18.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.547 -0.538 . . . . 72.21 109.547 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtt-85 -97.18 127.58 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.819 0.342 . . . . 73.22 111.849 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.6 mp -113.83 98.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 63.02 111.529 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.91 -178.54 6.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.952 -0.388 . . . . 73.02 109.952 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.19 135.3 5.95 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.19 -1.005 . . . . 71.31 113.973 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -59.05 -23.82 62.34 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.884 0.373 . . . . 70.02 111.559 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 88.9 p -83.47 136.26 34.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.299 0.571 . . . . 61.52 111.614 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -68.99 -37.73 78.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.524 0.678 . . . . 70.54 109.53 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.1 147.72 93.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.119 -0.946 . . . . 75.31 111.108 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 55.5 Cg_endo -67.85 162.71 38.45 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.423 2.082 . . . . 73.44 113.477 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.96 145.79 38.75 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.951 -0.568 . . . . 63.41 111.154 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.36 179.91 4.63 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.671 2.248 . . . . 54.45 112.99 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -73.09 153.89 40.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.128 0.49 . . . . 73.51 111.619 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.25 164.97 37.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.194 0.521 . . . . 71.51 111.632 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.8 m -150.88 156.07 40.47 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.16 -0.473 . . . . 23.42 110.372 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -165.25 178.9 40.04 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.271 -0.966 . . . . 74.34 113.893 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 61.3 m -104.38 135.36 45.97 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.895 0.379 . . . . 63.33 111.08 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 26.7 m -110.47 134.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 52.31 111.592 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.788 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.9 mm-40 -103.74 120.08 40.21 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.956 -0.565 . . . . 53.11 110.151 177.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.438 ' CG ' HD22 ' A' ' 139' ' ' LEU . 10.2 p90 -133.7 130.22 37.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.265 0.555 . . . . 74.03 112.149 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.41 -156.38 12.41 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.519 -0.764 . . . . 72.12 112.635 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.522 HE21 ' HB3' ' A' ' 146' ' ' GLN . 52.9 mt-30 -111.02 151.3 28.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.775 0.321 . . . . 74.22 111.505 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -114.59 106.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 60.11 110.824 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.503 ' NE2' HD13 ' A' ' 114' ' ' ILE . 3.6 pt20 -94.39 -6.74 43.48 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.832 0.679 . . . . 71.14 112.832 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -102.26 -170.04 27.03 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.949 -0.643 . . . . 75.24 113.499 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.3 p -96.31 173.26 7.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.84 0.352 . . . . 71.34 111.014 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.654 HD11 HE21 ' A' ' 33' ' ' GLN . 30.9 mm -63.79 -25.94 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.127 0.489 . . . . 74.21 111.023 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.56 -41.63 19.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.777 -0.647 . . . . 74.55 110.518 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -139.45 97.94 3.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.177 0.513 . . . . 71.24 111.53 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.683 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.0 p90 -115.99 151.07 36.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.558 0.577 . . . . 63.22 112.558 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -127.51 120.53 28.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.753 -0.658 . . . . 73.14 110.46 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.31 104.53 8.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.827 0.346 . . . . 64.12 110.8 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.503 HD13 ' NE2' ' A' ' 105' ' ' GLN . 44.6 pt -105.26 153.21 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.64 -0.254 . . . . 74.01 111.631 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 57.32 28.29 15.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.213 0.53 . . . . 70.14 111.045 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.9 137.13 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.926 -0.579 . . . . 52.12 111.942 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.11 171.09 14.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 72.13 110.746 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 3.1 p-10 -108.5 169.96 8.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.335 0.588 . . . . 54.34 112.44 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.437 HE22 ' HA ' ' A' ' 139' ' ' LEU . 8.8 tt0 -163.54 149.39 11.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.683 -0.69 . . . . 52.35 110.966 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -93.03 126.62 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.005 0.372 . . . . 64.04 112.005 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.9 pt -111.6 140.03 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.714 0.293 . . . . 64.13 111.427 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -124.91 131.11 53.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.596 0.236 . . . . 64.4 111.01 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -124.69 135.35 26.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 111.808 0.299 . . . . 71.52 111.808 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 15.0 Cg_exo -69.32 167.84 22.71 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.999 2.466 . . . . 65.42 113.272 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.15 130.56 34.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.15 0.426 . . . . 62.04 112.15 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 74.2 m -79.5 100.88 7.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.908 0.385 . . . . 75.0 110.717 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.67 HG13 ' HG ' ' A' ' 128' ' ' LEU . 8.5 p -71.96 -26.47 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.299 0.481 . . . . 55.33 112.299 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.67 ' HG ' HG13 ' A' ' 127' ' ' VAL . 98.4 mt -119.7 165.17 14.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.06 0.457 . . . . 72.34 112.139 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.595 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -106.28 153.64 40.25 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.042 -0.526 . . . . 72.31 111.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.75 175.15 37.27 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.241 -1.149 . . . . 70.4 113.686 0.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.7 m -75.31 97.08 3.49 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.639 0.607 . . . . 52.21 112.639 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.36 122.94 22.13 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.908 -0.587 . . . . 61.23 110.182 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 134' ' ' ASP . 26.4 t -133.96 159.61 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.395 0.278 . . . . 33.4 111.323 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.442 ' N ' HG12 ' A' ' 133' ' ' VAL . 2.7 p30 -147.14 143.11 28.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.818 0.342 . . . . 62.12 110.94 170.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 pt -140.26 147.94 52.13 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 53.11 111.729 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.7 144.24 21.96 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.704 2.269 . . . . 72.52 112.676 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.61 108.87 6.44 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.182 -0.324 . . . . 72.52 110.859 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -95.14 97.82 10.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.131 0.491 . . . . 73.23 111.625 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.438 HD22 ' CG ' ' A' ' 101' ' ' TYR . 55.4 mt -74.13 128.75 36.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.327 -0.397 . . . . 50.32 110.739 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.06 141.97 35.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.202 0.445 . . . . 62.35 112.202 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.87 34.79 88.26 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.066 -0.515 . . . . 42.25 113.878 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.96 125.96 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.07 0.462 . . . . 74.52 111.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.1 m -88.59 155.04 19.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.897 0.379 . . . . 51.42 111.358 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.49 -39.27 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.08 0.77 . . . . 65.42 113.08 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.81 -27.64 66.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.076 0.465 . . . . 54.15 111.258 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.522 ' HB3' HE21 ' A' ' 103' ' ' GLN . 15.3 mm100 -81.74 -4.14 55.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.273 -0.421 . . . . 71.35 111.752 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.632 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 28.5 mt -71.75 121.56 19.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.088 0.47 . . . . 75.13 112.265 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.98 -47.81 1.22 Allowed Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.098 -0.501 . . . . 62.53 112.632 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -150.97 161.69 42.25 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.75 0.31 . . . . 73.33 111.442 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.46 93.76 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.36 0.6 . . . . 62.23 110.462 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.788 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 47.2 ttp180 -86.99 107.41 18.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.952 0.406 . . . . 73.13 112.007 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.581 HG21 ' SD ' ' A' ' 66' ' ' MET . 23.3 mm -85.93 135.0 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.535 -0.302 . . . . 72.43 111.432 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.36 179.25 8.44 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.07 0.396 . . . . 74.35 112.07 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 98' ' ' THR . 75.5 m-20 64.97 22.5 12.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.193 0.597 . . . . 72.03 112.425 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.481 HD13 ' HA3' ' A' ' 97' ' ' GLY . 51.5 mm -64.53 97.33 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.42 0.629 . . . . 72.04 111.454 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -114.8 150.67 44.46 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.586 -0.734 . . . . 75.31 111.139 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.463 ' HB3' HG22 ' A' ' 61' ' ' ILE . 61.1 Cg_endo -72.69 148.32 46.75 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.324 2.016 . . . . 60.21 113.806 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 3.4 p . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 115.841 -0.618 . . . . 53.54 110.27 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . 28.6 tt0 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.969 0.414 . . . . 61.42 110.65 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -59.14 -35.4 73.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 62.12 111.471 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.54 -42.84 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.971 0.415 . . . . 74.14 110.597 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.573 ' HE3' HD23 ' A' ' 48' ' ' LEU . 44.5 tptt -66.61 -38.15 86.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.176 -0.466 . . . . 63.23 110.781 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.1 mt -59.74 -46.87 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.329 0.585 . . . . 61.11 110.47 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -58.89 -44.85 91.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.702 -0.681 . . . . 73.45 111.057 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.565 ' HG3' HD11 ' A' ' 108' ' ' ILE . 63.1 tt0 -59.21 -45.23 91.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.346 0.593 . . . . 75.3 110.809 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.5 -54.07 50.99 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.31 -0.859 . . . . 74.33 111.188 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -66.31 -30.8 71.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.462 0.541 . . . . 70.55 112.462 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.43 -49.66 68.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.893 0.377 . . . . 74.53 110.673 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -38.35 87.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.116 0.484 . . . . 53.54 110.732 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.504 HD21 ' HB ' ' A' ' 45' ' ' VAL . 2.4 t-20 -56.68 -42.38 78.94 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.782 -0.645 . . . . 73.03 111.031 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -43.4 68.85 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.195 -0.457 . . . . 73.01 112.022 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.94 -7.13 53.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.03 0.381 . . . . 71.43 112.03 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 37.1 t -61.89 126.29 26.84 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.106 0.41 . . . . 73.3 112.106 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 t -93.73 -4.04 51.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.272 -0.422 . . . . 73.05 111.132 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -142.41 96.87 3.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.992 0.425 . . . . 73.21 111.364 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 66.84 -149.17 51.14 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.316 -0.469 . . . . 60.43 113.616 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 38' ' ' ASN . 31.6 m -114.51 152.84 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.069 0.461 . . . . 63.22 112.091 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 33.6 m-85 -101.31 114.42 28.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.329 -0.396 . . . . 54.41 111.571 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.58 104.12 14.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.905 0.383 . . . . 51.43 110.749 173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.573 HD23 ' HE3' ' A' ' 30' ' ' LYS . 9.5 mp -82.18 111.83 30.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 122.312 -0.243 . . . . 74.32 110.682 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.6 Cg_endo -57.47 -23.47 56.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.848 2.365 . . . . 41.11 113.461 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.37 -17.67 59.88 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.96 -0.638 . . . . 55.04 113.16 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.67 101.09 5.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.547 0.339 . . . . 72.5 111.26 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.43 88.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.055 0.455 . . . . 52.11 110.438 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.425 HG21 HG23 ' A' ' 31' ' ' ILE . 3.3 p -135.93 148.76 66.34 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.713 0.634 . . . . 71.43 112.713 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.24 131.56 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.24 2.627 . . . . 51.22 113.24 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.04 134.0 55.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.323 -0.399 . . . . 55.25 110.679 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -84.87 109.87 18.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.192 0.52 . . . . 70.45 111.855 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 45' ' ' VAL . 44.3 tp -105.65 124.01 48.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.106 -0.497 . . . . 72.31 111.655 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -75.86 132.02 40.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.355 -0.384 . . . . 62.45 110.39 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -126.13 -178.71 4.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.337 0.589 . . . . 74.54 111.701 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.23 0.87 54.69 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.936 -0.574 . . . . 70.41 111.675 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.9 pt -111.16 -28.88 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.009 0.433 . . . . 72.41 111.016 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.26 151.1 5.83 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.16 -0.473 . . . . 73.11 112.607 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.7 m -55.28 126.47 25.08 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.955 0.378 . . . . 65.12 111.482 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.74 174.5 10.51 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.446 0.641 . . . . 62.21 112.4 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -127.61 125.67 40.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.991 -0.55 . . . . 64.02 111.087 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.806 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.3 mtt -117.14 144.1 45.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.837 0.351 . . . . 54.35 111.776 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -143.66 143.48 31.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.942 0.401 . . . . 71.34 111.413 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 82' ' ' LEU . 92.6 mt -90.17 107.01 18.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.349 -0.387 . . . . 72.12 111.429 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.632 HG23 HD22 ' A' ' 70' ' ' ASN . 27.5 m -122.61 161.48 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.186 -0.321 . . . . 73.55 111.7 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.632 HD22 HG23 ' A' ' 69' ' ' VAL . 35.5 m-80 59.03 41.19 21.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.083 0.401 . . . . 75.24 112.083 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.414 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 57.7 mt -73.13 111.44 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.939 0.4 . . . . 73.31 111.55 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -136.82 156.5 75.96 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.413 -0.358 . . . . 61.43 111.907 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.64 151.34 52.2 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.856 2.37 . . . . 72.02 113.023 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.6 t70 -134.12 164.7 26.76 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.227 -0.442 . . . . 74.42 110.975 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -49.2 77.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 42.45 111.711 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.1 -36.41 35.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.55 -0.295 . . . . 73.02 111.628 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.41 -97.38 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.316 -0.945 . . . . 65.24 114.344 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.3 m -141.03 130.9 24.37 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.209 0.448 . . . . 53.4 112.209 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.664 HG23 ' HB2' ' A' ' 74' ' ' ASP . 30.4 p -107.04 116.87 32.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.917 0.389 . . . . 73.13 111.572 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.0 pp -137.52 147.26 45.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.864 0.364 . . . . 73.32 111.472 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -89.32 114.82 26.27 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.91 0.386 . . . . 74.02 111.188 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 68' ' ' LEU . 3.2 tm? -90.56 113.65 25.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.922 -0.399 . . . . 64.01 109.922 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 34.0 mtt-85 -102.1 114.48 28.65 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.872 0.693 . . . . 72.43 112.872 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.8 mp -92.39 147.86 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.886 -0.597 . . . . 72.21 110.716 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.1 118.45 7.86 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.296 -0.261 . . . . 62.45 110.296 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 137.75 28.56 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.99 -0.624 . . . . 72.45 113.3 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.04 68.47 4.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.421 0.629 . . . . 53.41 110.479 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -170.32 179.82 3.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.859 -0.609 . . . . 74.11 111.131 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -100.15 -3.82 30.95 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.854 0.316 . . . . 70.13 111.854 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.2 p30 -112.2 166.45 10.93 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.577 0.584 . . . . 63.32 112.577 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.663 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 72.6 Cg_endo -74.07 171.37 18.08 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.02 2.48 . . . . 75.44 114.332 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.92 152.05 76.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.066 -0.515 . . . . 71.34 111.126 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.12 172.96 15.18 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.381 2.054 . . . . 75.32 113.124 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.82 149.28 48.08 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.741 0.305 . . . . 65.11 111.662 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.72 163.04 39.53 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.613 0.721 . . . . 74.22 112.583 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.1 p -133.99 167.13 21.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.385 -0.825 . . . . 75.44 109.917 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.546 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -165.63 163.98 37.02 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.046 -1.073 . . . . 55.52 114.005 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.657 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 91.1 m -103.8 108.5 19.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.463 0.305 . . . . 61.34 110.804 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 27.9 m -98.28 130.23 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.951 0.405 . . . . 54.4 111.812 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 45.4 mt-10 -107.52 111.81 24.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.904 0.383 . . . . 75.32 111.016 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.495 ' CD1' HD22 ' A' ' 139' ' ' LEU . 40.9 p90 -115.71 140.41 49.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.714 0.292 . . . . 73.51 111.361 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -179.0 -150.34 8.84 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.141 -0.552 . . . . 72.13 113.168 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.2 mt-30 -119.9 166.14 13.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.198 0.523 . . . . 65.43 112.034 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 106' ' ' GLY . 71.0 mt -126.01 124.99 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.939 -0.573 . . . . 73.25 110.62 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.596 HE21 HG21 ' A' ' 114' ' ' ILE . 6.3 pt20 -98.88 17.04 20.48 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.813 0.671 . . . . 75.14 112.813 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -145.13 -173.1 16.07 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.373 -0.918 . . . . 64.24 114.141 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 72.2 p -101.01 178.93 4.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.839 0.456 . . . . 74.33 111.667 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.565 HD11 ' HG3' ' A' ' 33' ' ' GLN . 45.1 mm -54.94 -38.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 70.35 111.845 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.64 -45.7 43.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.407 -0.361 . . . . 71.14 111.945 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -134.8 102.54 5.29 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.144 0.497 . . . . 70.5 111.57 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.1 p90 -132.25 150.57 52.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 74.43 111.898 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -134.55 130.59 36.8 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.05 -0.523 . . . . 74.11 110.856 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.38 113.95 18.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.012 -0.54 . . . . 74.44 111.197 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.596 HG21 HE21 ' A' ' 105' ' ' GLN . 36.0 pt -119.18 158.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.724 0.297 . . . . 61.32 111.478 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 58.75 26.79 15.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 73.14 110.826 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.36 144.67 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.538 -0.756 . . . . 62.34 112.237 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.37 161.4 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.666 -0.697 . . . . 65.45 110.5 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 2.6 p-10 -106.78 153.87 21.82 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.938 0.718 . . . . 62.22 112.938 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -139.97 148.71 42.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.704 -0.68 . . . . 55.1 110.553 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.19 119.87 29.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.8 0.333 . . . . 72.24 111.419 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.6 pt -98.09 141.66 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.465 -0.334 . . . . 62.55 110.863 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.24 114.82 18.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.863 0.364 . . . . 73.53 111.173 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.739 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -110.61 129.7 23.67 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.537 -0.301 . . . . 72.24 111.641 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.49 164.45 35.23 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.641 2.227 . . . . 73.3 113.158 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -77.49 121.88 24.45 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.304 0.483 . . . . 73.43 112.304 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.1 m -92.97 96.87 10.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.429 -0.351 . . . . 71.33 110.782 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -78.37 -21.31 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.331 0.586 . . . . 64.33 111.104 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -77.41 152.95 34.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.931 -0.577 . . . . 61.05 111.283 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.85 139.91 26.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.574 -0.285 . . . . 74.41 111.685 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.76 156.75 95.35 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.748 -1.355 . . . . 64.02 112.635 -3.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.663 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 38.7 t -72.12 99.0 2.22 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.079 0.77 . . . . 73.22 113.079 -173.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.88 143.0 44.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.716 0.293 . . . . 63.33 110.428 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.739 HG11 ' HB1' ' A' ' 123' ' ' ALA . 36.5 t -133.64 121.21 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.694 0.283 . . . . 74.42 111.03 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.35 101.72 10.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.102 0.477 . . . . 62.23 111.289 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.415 HG23 HG12 ' A' ' 133' ' ' VAL . 18.8 pt -112.5 129.06 24.74 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.369 0.507 . . . . 75.11 112.369 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.92 121.07 7.28 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.449 2.1 . . . . 53.31 112.12 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.98 107.64 15.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.108 -0.496 . . . . 63.43 111.02 -174.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.99 99.17 11.85 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.162 0.506 . . . . 75.31 111.502 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 101' ' ' TYR . 46.2 mt -77.71 123.8 27.14 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.226 -0.443 . . . . 42.24 110.506 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -99.62 148.31 24.46 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.849 0.357 . . . . 60.45 111.877 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.54 -10.09 74.71 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 114.395 0.518 . . . . 50.11 114.395 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 147' ' ' LEU . 19.4 tt -138.8 119.03 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 117.881 0.84 . . . . 75.24 112.589 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.6 m -75.01 156.58 36.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.246 -0.434 . . . . 63.24 111.286 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.76 -46.28 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.057 0.762 . . . . 73.4 113.057 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.01 -14.87 63.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.14 0.495 . . . . 74.55 111.797 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -92.21 -5.35 52.65 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.539 -0.3 . . . . 64.51 111.645 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 50.6 mt -73.39 113.33 10.36 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.743 0.645 . . . . 73.2 112.743 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.57 -36.54 6.12 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.941 -0.572 . . . . 72.11 112.68 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.98 160.51 27.8 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.8 0.333 . . . . 73.42 111.334 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.53 100.82 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.008 0.433 . . . . 75.04 110.418 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 37.6 ttm180 -86.54 119.93 27.32 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.771 0.32 . . . . 73.43 111.803 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.806 HG21 ' SD ' ' A' ' 66' ' ' MET . 20.7 mm -104.59 125.76 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.309 -0.244 . . . . 74.43 111.136 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.486 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 13.3 p80 -164.85 -175.17 3.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.955 0.354 . . . . 71.01 111.955 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.657 ' HB3' ' H ' ' A' ' 98' ' ' THR . 13.9 t70 67.29 22.38 9.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.332 0.586 . . . . 65.4 111.367 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.546 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -66.91 110.52 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.283 0.563 . . . . 75.53 112.165 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.78 144.49 53.13 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.917 -0.583 . . . . 54.13 111.106 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.82 155.73 67.8 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.411 2.074 . . . . 72.41 113.148 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.844 0.354 . . . . 75.3 110.984 177.242 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 52.31 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -60.55 -30.35 69.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.351 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.62 -47.56 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 64.22 110.364 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.08 80.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.181 -0.463 . . . . 70.12 111.274 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.686 HG23 HG21 ' A' ' 53' ' ' THR . 69.7 mt -56.85 -48.19 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.349 0.595 . . . . 71.41 111.084 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -62.0 -41.07 97.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.788 -0.642 . . . . 75.44 111.059 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.782 ' HG3' HD11 ' A' ' 108' ' ' ILE . 44.0 tt0 -65.15 -38.07 89.42 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.091 -0.504 . . . . 62.21 111.482 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.8 -57.52 12.41 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.528 -0.305 . . . . 70.34 110.566 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -52.02 -45.23 64.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.419 0.526 . . . . 41.0 112.419 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.441 ' HB2' HD12 ' A' ' 108' ' ' ILE . 99.1 mtt180 -66.51 -48.84 68.5 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.326 0.491 . . . . 71.41 112.326 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.97 -45.92 91.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.309 0.576 . . . . 64.43 110.845 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 45' ' ' VAL . 65.7 t30 -66.08 -28.89 69.17 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.884 -0.598 . . . . 70.52 111.142 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.733 0.301 . . . . 72.41 111.184 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.66 -21.93 54.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.848 0.356 . . . . 62.44 111.285 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.431 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 41.1 t -63.72 123.63 19.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.259 0.466 . . . . 64.31 112.259 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 m -108.11 -0.08 21.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.775 0.287 . . . . 73.2 111.775 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 t -148.1 77.62 1.41 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.075 0.464 . . . . 73.32 111.825 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.71 -166.89 12.21 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.512 -0.375 . . . . 65.42 112.926 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.471 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 29.1 m -130.9 149.9 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.761 0.652 . . . . 74.23 112.761 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 41' ' ' SER . 72.9 m-85 -99.95 112.1 24.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.039 -0.528 . . . . 74.43 111.42 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -104.16 106.1 16.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.075 0.464 . . . . 74.34 110.792 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 72.1 mt -83.17 128.88 63.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.619 -0.264 . . . . 52.0 111.241 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 47.8 Cg_exo -57.07 -29.17 82.08 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 122.697 2.265 . . . . 65.54 113.187 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.41 9.91 76.12 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.21 -0.519 . . . . 75.23 113.234 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.62 86.36 2.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.02 0.438 . . . . 61.14 111.651 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.47 80.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.156 0.503 . . . . 74.13 111.113 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.686 HG21 HG23 ' A' ' 31' ' ' ILE . 3.8 p -138.49 150.81 67.59 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 112.84 0.682 . . . . 54.51 112.84 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.84 127.74 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.277 2.652 . . . . 73.12 113.01 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -108.73 132.68 53.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.976 0.417 . . . . 64.1 111.293 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 56' ' ' ARG . 12.3 ttm-85 -90.97 125.89 35.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.31 -0.405 . . . . 72.3 110.771 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.99 121.11 22.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.905 0.383 . . . . 75.45 111.698 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -86.5 111.1 20.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.065 0.459 . . . . 73.43 110.1 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -112.39 -173.02 2.16 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.17 0.509 . . . . 74.54 112.343 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.452 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 47.0 mt-30 -74.25 -24.09 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.819 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.49 -29.4 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.99 0.424 . . . . 63.33 111.196 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.94 -173.22 33.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.218 -0.515 . . . . 63.43 112.955 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -82.85 112.79 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.557 -0.378 . . . . 75.22 110.712 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -119.9 171.91 8.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.521 0.677 . . . . 71.34 112.408 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -132.95 111.95 11.46 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.587 -0.733 . . . . 74.25 110.716 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.683 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.2 mtt -107.35 148.0 29.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.281 0.474 . . . . 74.43 112.281 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.2 t -154.66 157.22 37.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.948 0.404 . . . . 73.2 111.645 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 80' ' ' LEU . 95.0 mt -102.97 114.04 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.307 -0.406 . . . . 63.53 111.579 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 81' ' ' THR . 28.6 m -128.06 161.6 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.69 0.281 . . . . 65.1 111.667 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.462 HD22 HG23 ' A' ' 69' ' ' VAL . 47.5 m-80 54.29 30.71 12.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.318 0.488 . . . . 72.12 112.318 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 68' ' ' LEU . 52.2 mt -59.22 104.13 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.007 0.432 . . . . 70.24 111.399 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -125.69 149.53 65.63 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 112.343 0.497 . . . . 71.51 112.343 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.98 129.24 14.0 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.758 2.305 . . . . 72.43 113.375 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 29.4 t70 -91.65 166.74 12.64 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.289 -0.414 . . . . 64.51 110.62 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.44 69.13 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.134 0.42 . . . . 74.35 112.134 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -115.64 -9.78 11.93 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.51 0.559 . . . . 74.03 112.51 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -167.35 -113.78 0.29 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.259 -0.972 . . . . 71.12 114.021 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -146.89 127.12 13.84 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.028 0.381 . . . . 73.24 112.028 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 41.4 p -104.6 114.83 29.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.104 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -126.81 148.46 49.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.883 0.373 . . . . 62.34 111.657 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 69' ' ' VAL . 62.2 m -92.0 107.92 19.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.123 0.487 . . . . 73.11 111.566 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.38 108.91 19.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.034 -0.53 . . . . 71.43 110.053 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 66' ' ' MET . 9.7 mtp-105 -93.66 122.96 36.65 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.3 -0.25 . . . . 74.15 111.609 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -107.16 91.29 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.535 -0.302 . . . . 73.04 110.758 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -88.19 122.79 32.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.706 0.288 . . . . 74.12 111.021 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.33 132.0 11.35 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.709 -0.757 . . . . 62.41 113.154 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -69.16 -43.56 74.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.282 0.563 . . . . 61.3 109.898 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 m -79.42 109.08 13.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.1 -0.704 . . . . 71.44 109.1 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -73.35 1.58 9.3 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.341 0.867 . . . . 73.3 113.341 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.7 p30 -74.09 156.87 87.48 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.681 0.276 . . . . 72.4 111.59 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 11.6 Cg_endo -54.03 114.24 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.021 2.481 . . . . 53.35 113.716 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.88 145.15 29.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.132 -0.485 . . . . 63.13 111.533 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.78 169.01 23.12 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.58 2.186 . . . . 72.04 112.618 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 147.9 49.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.542 -0.299 . . . . 54.04 110.949 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -144.95 160.61 41.06 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.82 0.674 . . . . 74.0 112.82 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -137.75 140.63 40.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.334 -0.848 . . . . 64.31 110.325 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -148.09 171.33 28.58 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.811 -0.709 . . . . 73.0 113.097 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 20.0 m -103.18 134.98 45.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.714 -0.286 . . . . 60.12 111.016 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 119' ' ' GLN . 7.2 p -117.36 122.67 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 74.42 112.015 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 27.5 mm-40 -90.16 105.12 17.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.871 -0.604 . . . . 74.4 110.372 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -114.99 117.81 31.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.356 0.598 . . . . 61.14 111.497 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -163.13 -149.27 5.65 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.961 -0.563 . . . . 63.21 112.866 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.414 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -121.23 157.14 30.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.076 0.465 . . . . 75.1 111.972 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -123.0 122.07 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.14 -0.482 . . . . 75.2 111.196 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 3.8 pt20 -104.34 90.71 3.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.457 0.646 . . . . 72.41 111.159 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 160.39 -152.18 22.89 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.14 113.672 175.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -120.72 -171.66 2.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.876 0.47 . . . . 64.01 111.113 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.782 HD11 ' HG3' ' A' ' 33' ' ' GLN . 29.7 mm -62.77 -34.43 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.266 0.555 . . . . 74.54 110.844 172.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.98 -49.51 8.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.664 -0.698 . . . . 71.44 112.138 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -129.65 105.53 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.08 0.467 . . . . 75.33 111.647 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.518 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.4 p90 -139.97 160.41 39.98 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.097 0.475 . . . . 73.12 112.18 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -134.51 134.76 41.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.074 -0.512 . . . . 62.54 110.768 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.19 123.12 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.484 -0.326 . . . . 63.31 110.884 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.38 154.71 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.047 0.388 . . . . 71.22 112.047 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 53.46 39.2 29.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.071 0.463 . . . . 73.13 111.751 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.483 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 5.6 p -97.6 126.18 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.318 0.58 . . . . 74.23 111.978 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -114.9 153.12 31.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.052 -0.522 . . . . 73.12 110.6 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.22 133.72 53.35 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.166 0.508 . . . . 71.15 111.85 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.52 ' O ' HG12 ' A' ' 99' ' ' VAL . 8.8 tt0 -129.03 149.26 50.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.149 -0.478 . . . . 72.45 110.02 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.8 mt -92.11 118.63 31.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.119 0.485 . . . . 71.43 111.885 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.714 HG22 HD21 ' A' ' 137' ' ' LEU . 30.4 pt -92.78 99.37 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 72.32 111.371 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -101.46 114.57 28.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.293 -0.412 . . . . 65.23 110.96 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -111.67 147.26 36.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.053 0.39 . . . . 70.05 112.053 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.98 164.91 34.19 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.886 2.391 . . . . 62.02 113.733 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.38 125.98 29.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.869 -0.605 . . . . 65.2 112.121 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 71.1 m -90.6 79.44 6.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.962 0.41 . . . . 54.41 110.614 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.37 -10.65 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.149 -0.478 . . . . 64.43 111.875 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.84 129.89 53.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.845 0.355 . . . . 74.24 111.58 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.16 139.39 23.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.359 -0.382 . . . . 72.44 111.233 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 148.48 92.25 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.103 -1.207 . . . . 73.24 113.541 2.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.9 p -89.05 125.24 34.92 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.5 0.667 . . . . 64.11 112.608 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.73 143.39 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.581 -0.736 . . . . 64.0 110.366 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.02 157.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 61.12 110.973 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.424 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.2 p30 -146.76 111.91 5.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.306 0.574 . . . . 75.12 110.866 170.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 23.5 pt -117.05 142.71 30.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.007 -0.542 . . . . 73.12 111.915 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 2.5 Cg_endo -81.24 130.92 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.907 2.405 . . . . 33.01 112.636 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 121' ' ' ILE . 62.9 mt -111.43 111.85 23.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 73.13 111.656 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -91.35 89.57 7.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.239 0.542 . . . . 71.21 110.625 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.513 HD23 HE22 ' A' ' 119' ' ' GLN . 26.2 mt -81.67 110.75 17.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 73.21 110.016 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -98.47 139.15 34.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.973 0.416 . . . . 74.03 111.76 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.98 63.72 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.079 -0.509 . . . . 61.1 113.28 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 147' ' ' LEU . 18.4 tt -134.33 123.61 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 122.401 -0.47 . . . . 72.14 111.774 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -85.41 147.53 26.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.094 0.405 . . . . 74.14 112.094 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -47.66 -51.4 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 113.192 0.812 . . . . 55.2 113.192 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.2 -38.13 82.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.094 0.473 . . . . 74.14 111.61 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -87.54 7.64 28.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.194 0.442 . . . . 71.32 112.194 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.517 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.2 tt -82.35 126.86 32.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.749 0.309 . . . . 73.43 110.257 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.42 -58.51 1.36 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.09 -0.576 . . . . 53.21 113.452 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -147.34 148.83 31.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.369 -0.489 . . . . 74.4 112.305 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.6 t -116.79 99.33 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.72 -0.673 . . . . 60.51 109.833 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -102.55 114.1 28.03 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.091 0.472 . . . . 75.22 111.74 -171.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.683 HG21 ' SD ' ' A' ' 66' ' ' MET . 38.2 mm -90.59 140.19 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.842 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -165.67 179.33 6.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 111.908 0.336 . . . . 75.42 111.908 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 98' ' ' THR . 73.2 m-20 61.87 22.57 13.13 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.417 0.895 . . . . 42.22 113.417 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.8 mm -63.86 94.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.313 0.578 . . . . 74.52 111.741 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 8.0 pt20 -125.66 144.8 49.31 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.556 -0.747 . . . . 72.32 111.179 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 146.27 51.14 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.49 2.127 . . . . 70.42 113.654 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 116.261 -0.427 . . . . 64.31 110.451 175.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.906 0.384 . . . . 73.21 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -56.55 -37.14 70.11 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.141 -0.481 . . . . 72.43 111.044 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.16 -47.14 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.356 -0.384 . . . . 65.12 111.065 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.636 ' HE2' ' HB3' ' A' ' 48' ' ' LEU . 21.0 tptm -62.24 -43.3 99.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.98 0.419 . . . . 65.41 111.176 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -49.31 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.031 0.443 . . . . 63.0 111.185 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -56.55 -38.78 72.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.965 0.412 . . . . 43.5 110.906 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -59.71 -42.04 92.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.024 -0.534 . . . . 72.42 111.073 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -62.52 -52.42 63.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.479 -0.328 . . . . 75.42 111.072 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -52.99 -42.96 66.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.88 0.371 . . . . 75.02 111.209 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -57.29 -45.92 83.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.994 0.426 . . . . 65.33 111.567 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.47 -31.18 72.11 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.833 0.349 . . . . 71.02 111.26 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -67.8 -30.48 69.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.938 0.399 . . . . 73.1 110.971 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.89 66.48 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.14 0.495 . . . . 74.24 111.083 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.43 1.05 47.22 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.284 -0.416 . . . . 54.32 111.788 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 t -65.77 120.48 13.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.274 0.472 . . . . 75.3 112.274 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -126.48 -13.97 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.37 -0.377 . . . . 72.31 111.695 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.3 p -129.39 25.51 5.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.377 0.51 . . . . 63.22 112.377 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.39 161.75 11.35 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.048 -0.596 . . . . 71.4 112.763 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.78 135.34 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.542 0.687 . . . . 64.25 112.823 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.96 109.41 20.75 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.453 -0.794 . . . . 72.41 110.746 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.3 131.98 47.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.793 0.33 . . . . 64.12 110.676 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.636 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 84.8 mt -117.17 120.29 33.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 111.903 0.334 . . . . 72.4 111.903 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HG3' HD22 ' A' ' 147' ' ' LEU . 11.5 Cg_endo -55.42 139.23 81.72 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.339 2.026 . . . . 73.15 111.666 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.82 -36.67 3.82 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.9 -0.667 . . . . 72.4 111.923 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.7 93.47 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.096 0.474 . . . . 74.45 110.057 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -79.61 27.29 0.28 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.265 0.555 . . . . 63.52 111.959 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 p -97.35 142.59 24.78 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 121.129 0.49 . . . . 64.45 112.132 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HB2' ' HG3' ' A' ' 65' ' ' ARG . 73.9 Cg_endo -73.57 163.8 36.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.116 2.544 . . . . 62.53 113.597 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.86 140.66 45.99 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.094 -0.503 . . . . 73.33 111.117 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -86.78 123.53 32.03 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.115 0.483 . . . . 72.55 112.046 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.3 tp -125.45 123.28 38.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.187 -0.46 . . . . 74.5 111.187 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -85.11 96.91 9.59 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 61.24 110.21 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.7 p -86.58 -174.85 5.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.265 0.555 . . . . 63.34 111.737 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 43.4 mt-30 -83.56 -4.71 58.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.998 -0.546 . . . . 74.32 111.605 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 92' ' ' LEU . 31.0 pt -106.59 -28.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.92 0.391 . . . . 73.23 111.253 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.62 175.54 31.74 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.128 -0.558 . . . . 61.32 113.188 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.4 m -72.76 112.05 8.45 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.056 0.455 . . . . 71.24 111.119 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 pp -121.84 155.95 34.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.329 0.585 . . . . 64.32 112.076 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 32.4 ttt180 -118.17 107.05 13.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.6 -0.727 . . . . 64.55 110.854 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.755 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.5 mtt -104.41 156.06 18.26 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.079 0.466 . . . . 55.41 112.09 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.1 t -158.07 160.82 37.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.779 0.324 . . . . 74.4 111.582 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 80' ' ' LEU . 79.3 mt -105.29 113.13 26.53 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.275 -0.421 . . . . 75.44 111.478 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.696 HG23 HD22 ' A' ' 70' ' ' ASN . 27.2 m -130.58 166.27 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.327 -0.233 . . . . 73.54 111.194 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.696 HD22 HG23 ' A' ' 69' ' ' VAL . 45.5 m-80 61.16 28.1 17.79 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.012 0.434 . . . . 61.34 111.618 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 HG23 ' A' ' 144' ' ' VAL . 51.8 mt -64.03 96.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.141 0.496 . . . . 74.02 111.319 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 p -131.26 150.88 77.73 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.102 -0.499 . . . . 74.02 112.089 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.66 156.97 61.1 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.737 2.291 . . . . 72.23 113.568 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.473 ' HB2' HG23 ' A' ' 79' ' ' THR . 22.9 t70 -133.36 168.8 17.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.875 -0.602 . . . . 74.42 110.65 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.83 68.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 71.41 111.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.56 -31.9 32.44 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.184 0.438 . . . . 74.43 112.184 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.96 -99.1 0.13 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.233 -0.984 . . . . 63.32 113.759 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -147.2 134.01 20.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.834 0.35 . . . . 51.31 111.539 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 36.2 p -110.72 127.55 55.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.569 -0.287 . . . . 72.54 111.627 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -134.35 145.16 48.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.018 0.437 . . . . 53.25 111.208 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.5 m -84.37 101.78 12.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.11 0.481 . . . . 61.42 111.405 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.1 107.28 12.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.031 -0.531 . . . . 73.42 109.971 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HD2' HG21 ' A' ' 69' ' ' VAL . 14.9 mtp180 -95.66 113.13 24.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.791 0.329 . . . . 54.1 111.614 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.571 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.2 mp -88.53 88.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.133 0.492 . . . . 70.22 110.09 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 63.2 tt0 -94.03 95.18 8.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.133 0.492 . . . . 73.43 110.78 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.45 131.51 41.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.401 -0.428 . . . . 43.43 113.462 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.19 -5.98 58.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.112 0.482 . . . . 70.22 111.352 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.5 p -91.65 147.84 22.7 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.136 -0.484 . . . . 63.4 110.872 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.452 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 28.1 t-20 -79.5 -24.77 42.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.957 0.408 . . . . 70.33 110.639 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.3 134.46 95.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.289 -0.414 . . . . 74.32 111.802 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.57 102.74 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.648 2.232 . . . . 61.34 112.576 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.7 mt -68.88 141.87 92.85 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 112.251 0.463 . . . . 72.02 112.251 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.93 177.07 6.8 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.665 2.243 . . . . 74.31 113.33 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -63.19 135.01 56.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.939 0.4 . . . . 65.54 111.339 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.94 154.28 46.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.43 0.633 . . . . 75.53 112.56 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 90.1 p -131.04 -179.93 5.62 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.626 -0.716 . . . . 51.55 110.498 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . 179.66 175.12 46.21 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.727 -0.749 . . . . 52.44 113.095 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.9 m -111.61 131.96 54.9 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.239 0.216 . . . . 74.32 110.5 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 m -118.79 133.93 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.199 0.523 . . . . 64.15 111.987 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 8.6 mm-40 -99.13 106.65 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.851 -0.613 . . . . 71.41 110.557 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.466 ' HE1' ' HB2' ' A' ' 119' ' ' GLN . 48.5 p90 -116.65 122.56 44.92 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.391 0.615 . . . . 70.53 111.831 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.54 -144.71 4.36 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.68 -0.691 . . . . 61.12 112.811 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.483 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.9 mt-30 -127.03 158.42 37.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.104 0.478 . . . . 63.24 111.687 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.8 mt -119.17 117.07 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.347 -0.388 . . . . 71.24 111.332 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -92.25 41.81 1.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.086 0.47 . . . . 65.22 111.167 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.496 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -162.35 -158.95 9.91 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.975 -0.631 . . . . 51.02 113.676 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.5 p -125.78 -175.92 3.48 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.911 0.386 . . . . 71.52 111.59 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.493 HD11 ' HG3' ' A' ' 33' ' ' GLN . 45.9 mm -56.75 -38.57 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.031 0.443 . . . . 73.44 111.454 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.63 -42.63 77.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.263 -0.426 . . . . 71.33 111.234 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -139.32 87.59 2.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.293 0.568 . . . . 72.24 111.996 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -98.0 129.86 44.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.079 0.466 . . . . 74.42 111.065 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -123.68 120.17 31.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.059 -0.519 . . . . 63.11 110.838 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.08 118.71 19.11 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.976 0.417 . . . . 74.54 111.937 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.5 pt -130.57 155.11 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.444 -0.343 . . . . 72.2 110.96 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 54.67 32.08 16.55 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.463 0.649 . . . . 70.53 111.279 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.41 117.77 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.752 -0.658 . . . . 70.13 112.226 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -102.42 145.77 29.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.035 -0.529 . . . . 73.14 110.178 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -103.72 117.73 35.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.003 0.43 . . . . 71.42 111.324 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.466 ' HB2' ' HE1' ' A' ' 101' ' ' TYR . 8.9 tt0 -109.68 147.57 32.89 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 75.34 110.889 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.02 115.16 29.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.848 0.356 . . . . 73.43 111.05 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 121' ' ' ILE . 46.7 pt -94.8 116.38 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.108 0.48 . . . . 64.42 111.756 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.9 OUTLIER -109.74 109.4 20.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.984 -0.376 . . . . 72.14 109.984 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.84 147.63 34.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 112.201 0.445 . . . . 41.53 112.201 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.45 151.46 84.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.826 2.35 . . . . 43.02 113.168 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -67.7 140.0 56.75 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.033 0.444 . . . . 74.31 112.041 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -83.7 77.37 9.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.118 -0.326 . . . . 73.35 110.118 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.433 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -67.94 -21.71 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.066 0.46 . . . . 73.53 111.925 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.433 ' HG ' HG23 ' A' ' 127' ' ' VAL . 93.1 mt -105.1 152.42 22.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 75.2 111.039 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 89' ' ' ASN . . . -115.15 140.05 25.18 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.525 -0.307 . . . . 50.12 111.644 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.74 173.83 56.15 Favored 'Cis proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.78 -1.342 . . . . 53.35 113.496 0.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -73.67 111.09 8.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.327 0.491 . . . . 73.25 112.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -141.94 115.57 9.09 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.326 0.584 . . . . 72.32 111.056 172.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.82 155.34 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 116.403 -0.362 . . . . 71.14 110.932 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 9.0 p-10 -143.97 121.34 11.64 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.142 0.496 . . . . 73.2 111.303 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.1 pt -119.91 138.52 27.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 112.182 0.438 . . . . 72.22 112.182 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.8 Cg_exo -78.14 123.33 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.015 2.477 . . . . 74.34 112.819 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' THR . 76.1 mt -100.89 106.46 17.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.89 0.376 . . . . 64.04 111.945 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.479 ' HA ' HG22 ' A' ' 79' ' ' THR . 35.4 tt0 -84.05 88.37 7.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.401 0.62 . . . . 71.12 110.228 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.409 HD23 ' NE2' ' A' ' 119' ' ' GLN . 29.4 mt -81.44 116.74 21.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 71.24 110.013 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -99.68 141.82 31.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 73.41 112.055 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.2 41.29 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.297 -0.478 . . . . 44.14 113.154 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 147' ' ' LEU . 16.9 tt -161.51 127.12 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.039 0.447 . . . . 63.11 111.191 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.4 m -84.65 145.78 27.81 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.007 0.373 . . . . 71.2 112.007 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 71' ' ' ILE . 7.2 p -56.84 -43.03 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.741 0.645 . . . . 73.24 112.741 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.54 -30.3 64.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.096 0.474 . . . . 74.14 111.471 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.469 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 29.7 mm-40 -90.88 -4.16 56.77 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.079 0.4 . . . . 55.5 112.079 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.486 HD22 ' HG3' ' A' ' 49' ' ' PRO . 1.6 tt -61.26 117.94 6.25 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.859 0.361 . . . . 72.15 110.304 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.98 -62.45 1.36 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.278 -0.487 . . . . 41.21 113.457 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.436 ' HD2' ' HG3' ' A' ' 151' ' ' ARG . 37.4 p90 -142.63 155.55 44.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.383 0.512 . . . . 72.1 112.383 -174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.9 t -131.49 104.02 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.196 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.597 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 77.5 mtp180 -96.09 115.28 27.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.933 0.397 . . . . 65.53 112.01 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.755 HG21 ' SD ' ' A' ' 66' ' ' MET . 21.4 mm -93.69 121.91 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.071 -0.513 . . . . 73.24 110.741 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -154.34 172.94 16.88 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.245 0.461 . . . . 52.14 112.245 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 63.6 23.8 13.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.889 0.7 . . . . 73.14 112.889 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.409 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.3 mm -64.23 109.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.18 0.514 . . . . 73.24 111.293 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.464 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.2 pt20 -133.86 147.11 62.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.84 -0.618 . . . . 74.44 111.9 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.44 124.1 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.253 1.968 . . . . 54.05 112.339 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 112.424 0.527 . . . . 75.31 112.424 -177.026 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 31' ' ' ILE . 42.8 tt0 . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.004 0.431 . . . . 75.5 110.149 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.9 m -61.32 -33.2 73.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.151 -0.477 . . . . 72.12 111.212 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.66 -54.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.322 0.582 . . . . 73.42 110.973 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -64.72 -34.69 78.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.59 -0.732 . . . . 73.41 111.777 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 27' ' ' GLU . 77.1 mt -64.9 -46.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.871 0.367 . . . . 74.35 111.314 174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.4 m -64.56 -38.97 92.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.781 0.324 . . . . 72.44 111.201 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -60.16 -45.33 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.825 0.345 . . . . 70.4 110.489 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -57.24 10.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.073 -0.512 . . . . 62.31 110.573 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -55.17 -46.27 75.76 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.459 0.54 . . . . 63.11 112.459 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.71 -48.6 76.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.132 0.419 . . . . 73.52 112.132 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.173 0.511 . . . . 60.33 110.8 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -59.25 -44.01 92.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.78 -0.645 . . . . 74.25 110.386 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.6 97.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.034 -0.53 . . . . 71.02 111.945 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HE3' HG22 ' A' ' 108' ' ' ILE . 68.7 mttm -68.81 -23.24 64.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.832 0.349 . . . . 72.33 111.855 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -63.87 115.47 4.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.88 0.371 . . . . 74.45 111.75 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 m -64.42 -47.72 78.08 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.174 0.511 . . . . 62.13 111.4 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.2 p -129.64 117.75 20.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.176 -0.465 . . . . 71.53 111.143 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 99.85 169.51 29.81 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.154 -0.546 . . . . 44.31 113.727 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 57' ' ' LEU . 31.1 m -113.19 153.99 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.113 0.483 . . . . 71.32 111.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -101.95 126.8 48.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.258 -0.428 . . . . 71.31 111.421 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.83 112.28 19.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.397 -0.365 . . . . 74.53 110.749 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 9.6 mp -91.88 135.01 27.92 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.718 -0.219 . . . . 73.31 111.265 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 38.5 Cg_exo -56.62 -32.5 90.64 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.685 2.257 . . . . 63.43 113.274 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.73 15.23 61.01 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.256 -0.497 . . . . 64.31 113.131 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.03 84.2 2.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.164 0.506 . . . . 73.02 111.607 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.75 81.98 0.44 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.45 0.643 . . . . 71.23 111.301 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 p -137.43 152.07 72.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.98 -0.555 . . . . 51.05 112.246 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HB3' HH11 ' A' ' 65' ' ' ARG . 92.8 Cg_endo -81.5 132.4 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.959 2.439 . . . . 62.5 112.717 171.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.11 130.16 55.58 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.813 0.34 . . . . 71.42 111.14 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.715 ' HD3' HG23 ' A' ' 63' ' ' THR . 1.6 tmm_? -86.28 108.52 18.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.96 0.409 . . . . 74.24 110.137 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.422 HD13 HG13 ' A' ' 45' ' ' VAL . 40.2 tp -101.77 131.42 48.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.454 0.645 . . . . 54.41 112.595 -174.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.32 106.21 15.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.277 -0.874 . . . . 73.12 109.817 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -110.41 -178.71 3.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.168 0.509 . . . . 72.43 111.927 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 47.7 mt-30 -87.64 -2.96 58.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.075 -0.512 . . . . 74.34 111.747 177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 157' ' ' PRO . 31.8 pt -104.18 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.839 0.352 . . . . 75.43 111.175 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -162.43 29.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.425 -0.417 . . . . 33.14 113.318 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.715 HG23 ' HD3' ' A' ' 56' ' ' ARG . 77.8 m -87.46 118.72 27.11 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.58 -0.365 . . . . 45.21 111.012 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.45 169.36 17.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.63 0.604 . . . . 74.12 112.63 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.678 HH11 ' HB3' ' A' ' 54' ' ' PRO . 35.1 ttp85 -118.09 136.42 53.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.704 -0.68 . . . . 74.05 110.844 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.639 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.2 mtt -130.39 157.4 42.69 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.768 0.318 . . . . 63.44 111.545 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -164.5 165.11 21.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.905 0.383 . . . . 64.13 111.682 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 80' ' ' LEU . 94.4 mt -109.5 117.69 34.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 61.42 111.588 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.615 HG23 HD22 ' A' ' 70' ' ' ASN . 35.3 m -128.01 162.99 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 72.31 111.51 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.615 HD22 HG23 ' A' ' 69' ' ' VAL . 51.1 m-80 58.41 29.58 18.43 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.463 0.542 . . . . 72.33 112.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.28 106.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.915 0.388 . . . . 73.11 110.935 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -138.22 151.25 69.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.183 -0.462 . . . . 75.44 112.122 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.06 162.3 38.84 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.9 2.4 . . . . 72.33 113.147 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 79' ' ' THR . 20.5 t70 -147.16 158.46 43.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.246 -0.433 . . . . 75.21 111.478 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.58 84.34 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.17 0.433 . . . . 71.12 112.17 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -88.26 -32.85 18.3 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.707 0.289 . . . . 71.42 111.269 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -172.43 -96.19 0.1 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.692 -0.766 . . . . 74.04 113.763 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -150.72 129.35 12.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.562 -0.375 . . . . 65.43 111.498 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.566 HG23 ' HB2' ' A' ' 74' ' ' ASP . 60.3 p -104.36 125.76 50.87 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.187 -0.321 . . . . 71.24 111.525 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.45 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -138.61 151.37 47.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.038 0.447 . . . . 75.44 111.44 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.496 ' HB ' HG23 ' A' ' 69' ' ' VAL . 32.7 m -94.79 110.02 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 71.33 111.422 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.36 111.58 19.56 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.663 -0.495 . . . . 72.14 109.663 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HE ' ' HB3' ' A' ' 134' ' ' ASP . 38.0 mtp180 -105.28 126.51 52.18 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.239 0.459 . . . . 75.35 112.239 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.2 mp -110.96 141.13 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.824 -0.626 . . . . 75.4 110.201 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -139.64 148.05 41.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 65.14 111.055 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.15 124.61 6.5 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.884 -0.674 . . . . 71.12 113.567 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 63' ' ' THR . 19.3 mm-40 -70.76 -3.32 18.19 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.966 0.413 . . . . 64.43 111.264 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -116.34 161.93 18.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.305 -0.407 . . . . 54.43 110.826 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -81.6 24.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.723 0.297 . . . . 55.12 111.741 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.86 146.74 34.42 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.704 0.402 . . . . 62.33 111.293 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 59.9 Cg_endo -72.64 112.06 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.633 2.222 . . . . 54.41 112.988 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.46 143.38 98.19 Favored Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 112.529 0.566 . . . . 63.24 112.529 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.89 -165.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.793 2.329 . . . . 71.42 112.675 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 138.39 31.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.937 0.399 . . . . 71.22 111.502 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.86 162.88 38.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.144 0.497 . . . . 74.33 112.148 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 95.5 p -140.76 151.0 44.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.973 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.689 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -153.01 170.64 32.02 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.527 -0.844 . . . . 74.21 113.839 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -100.93 124.34 46.48 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.744 0.307 . . . . 61.13 111.388 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.47 130.75 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 75.41 111.194 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.04 126.36 52.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.977 0.418 . . . . 64.15 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 139' ' ' LEU . 10.4 p90 -127.95 121.14 29.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 63.14 111.193 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.92 -159.29 9.57 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.092 -0.575 . . . . 62.03 113.085 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB2' HG13 ' A' ' 114' ' ' ILE . 77.2 mt-30 -119.22 156.53 29.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.007 0.432 . . . . 45.22 111.896 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.2 mt -112.96 129.39 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.125 -0.489 . . . . 73.24 110.998 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.541 HE21 HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -114.14 30.09 7.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.055 0.391 . . . . 74.53 112.055 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -151.83 -157.86 8.12 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.652 -0.785 . . . . 73.35 113.461 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.3 p -105.77 -164.47 1.02 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.529 0.332 . . . . 73.13 111.613 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.416 HG22 ' HE3' ' A' ' 40' ' ' LYS . 50.0 mm -66.18 -40.57 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.877 0.695 . . . . 72.45 112.877 -175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -94.09 -42.7 8.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.311 0.486 . . . . 73.41 112.311 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.76 99.81 7.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.332 0.587 . . . . 73.41 111.807 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.89 148.11 26.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.902 -0.59 . . . . 72.34 111.493 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -113.69 136.9 52.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.907 0.384 . . . . 63.24 110.912 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.49 103.91 13.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.194 0.521 . . . . 74.44 111.189 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.541 HD13 HE21 ' A' ' 105' ' ' GLN . 45.2 pt -109.28 155.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 116.447 -0.342 . . . . 50.14 111.889 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 51.89 39.32 25.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.187 0.517 . . . . 72.23 111.837 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.32 123.66 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.175 0.512 . . . . 74.2 111.904 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -112.15 160.31 17.69 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.087 -0.506 . . . . 65.21 110.442 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.31 145.01 51.19 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.251 0.463 . . . . 64.12 112.251 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -140.91 166.32 25.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.959 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -107.64 121.79 45.38 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.814 0.34 . . . . 73.25 111.791 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.559 HG22 HD21 ' A' ' 137' ' ' LEU . 32.2 pt -95.05 107.58 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.203 0.525 . . . . 73.34 111.369 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.53 101.88 13.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.881 0.372 . . . . 73.42 111.004 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.11 140.73 21.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.862 0.319 . . . . 54.5 111.862 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.41 168.47 21.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.832 2.355 . . . . 75.51 113.466 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.29 146.11 31.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.225 0.454 . . . . 61.44 112.225 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.0 m -93.34 155.81 17.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.138 0.495 . . . . 74.32 112.02 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.0 t -105.51 -47.45 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.958 -0.565 . . . . 44.41 111.682 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.35 173.5 6.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.352 0.596 . . . . 72.35 112.165 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.96 142.34 45.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.741 -0.663 . . . . 74.33 111.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.87 162.93 90.34 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 123.809 -1.33 . . . . 74.51 112.931 -1.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 38.6 m -100.59 108.39 20.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.181 0.438 . . . . 74.4 112.181 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.78 93.09 4.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.579 0.351 . . . . 72.31 110.209 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.57 111.28 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.354 0.261 . . . . 71.33 111.341 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.501 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -117.01 143.69 45.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.287 0.565 . . . . 74.34 112.047 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.7 pt -137.63 136.35 20.11 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.707 -0.679 . . . . 73.34 111.608 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.97 137.28 19.45 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.694 2.263 . . . . 65.14 113.382 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.559 HD21 HG22 ' A' ' 121' ' ' ILE . 20.4 mt -120.54 114.83 22.33 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.125 0.417 . . . . 73.32 112.125 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -91.66 93.73 9.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.963 0.411 . . . . 74.05 110.245 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 46.7 mt -74.33 120.89 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 63.11 110.053 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.2 mtmt -102.33 141.47 35.11 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.396 0.517 . . . . 64.32 112.396 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.29 10.43 86.01 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.211 -0.519 . . . . 61.43 113.885 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.5 tt -143.63 122.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.346 0.593 . . . . 71.0 111.847 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -76.77 155.54 33.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.395 -0.366 . . . . 73.34 111.416 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.4 -40.1 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.117 0.484 . . . . 73.24 111.407 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.53 -23.39 66.86 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.057 0.456 . . . . 72.51 111.47 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -89.47 1.13 56.29 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.226 0.454 . . . . 53.12 112.226 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.3 mt -81.43 125.83 30.91 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.237 0.541 . . . . 74.31 111.872 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.82 -54.28 0.68 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.652 -0.704 . . . . 70.12 112.284 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.13 150.02 37.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.752 0.31 . . . . 70.4 111.332 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.8 102.97 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.1 110.546 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -91.53 116.31 28.75 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.004 0.372 . . . . 61.2 112.004 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.639 HG21 ' SD ' ' A' ' 66' ' ' MET . 11.2 mm -100.48 119.63 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 110.045 -0.354 . . . . 73.52 110.045 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.513 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 15.5 p80 -143.78 177.94 8.17 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.729 1.011 . . . . 74.13 113.729 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 74.64 -74.66 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.771 -1.104 . . . . 71.31 111.769 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.689 HD13 ' HA3' ' A' ' 97' ' ' GLY . 46.7 mm 39.83 82.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.602 0.715 . . . . 70.1 112.376 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.431 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.6 pt20 -110.09 150.54 41.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.451 -0.795 . . . . 60.22 111.557 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.504 ' HG3' HG22 ' A' ' 61' ' ' ILE . 8.4 Cg_exo -71.23 128.19 14.38 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.51 2.14 . . . . 43.24 112.715 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.808 0.813 . . . . 72.53 111.081 176.369 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.015 0.436 . . . . 73.33 110.711 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.3 m -59.85 -31.96 70.24 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.082 -0.508 . . . . 72.24 110.982 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.54 -50.35 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.709 -0.223 . . . . 74.14 110.935 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -55.47 -47.24 76.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.017 0.437 . . . . 62.3 110.854 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 53' ' ' THR . 73.7 mt -55.17 -53.64 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.131 -0.486 . . . . 75.45 111.337 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.7 m -56.65 -47.82 78.91 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.258 -0.428 . . . . 73.33 111.625 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -58.83 -39.92 82.64 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.984 -0.553 . . . . 70.2 111.363 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.89 -47.66 85.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.722 0.296 . . . . 74.31 111.181 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -57.87 -41.69 82.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.931 0.396 . . . . 70.41 111.148 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.4 mmp_? -60.57 -54.55 44.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.949 0.404 . . . . 74.33 111.568 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.88 -36.05 83.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.991 0.424 . . . . 73.24 111.683 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' ND2' ' HB1' ' A' ' 55' ' ' ALA . 20.0 t-20 -63.95 -35.18 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.843 0.354 . . . . 73.44 111.043 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.05 60.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.949 0.404 . . . . 71.23 111.362 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HE3' HG22 ' A' ' 108' ' ' ILE . 62.5 mttm -90.69 -3.9 57.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 73.03 111.572 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 108.63 4.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.145 0.498 . . . . 55.41 112.061 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.5 p -91.98 -1.33 57.31 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.162 -0.472 . . . . 73.22 111.696 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.6 p -153.71 102.9 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.783 0.325 . . . . 75.32 111.23 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 -145.47 28.0 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.941 -0.647 . . . . 64.34 112.692 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 57' ' ' LEU . 17.9 m -134.29 139.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.336 -0.508 . . . . 72.31 112.333 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.55 106.91 18.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.924 -0.58 . . . . 71.43 111.455 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.54 148.78 23.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.989 -0.375 . . . . 63.1 109.989 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.78 130.79 23.48 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.369 . . . . 63.41 111.466 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.645 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 66.2 Cg_endo -72.2 28.36 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.208 2.605 . . . . 54.44 113.805 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.35 12.93 2.05 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.493 -0.384 . . . . 70.33 112.3 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.13 115.72 18.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 73.14 111.551 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -69.07 8.66 0.52 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.675 0.621 . . . . 72.12 112.675 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.435 HG21 HG23 ' A' ' 31' ' ' ILE . 1.5 p -90.81 145.25 31.62 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.584 0.587 . . . . 72.14 112.584 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 75.1 Cg_endo -81.97 -178.28 4.03 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.168 2.578 . . . . 45.42 114.029 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.433 ' HB1' ' ND2' ' A' ' 38' ' ' ASN . . . -147.31 145.64 29.42 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.811 -0.631 . . . . 72.52 111.389 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -80.83 112.25 18.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.415 -0.357 . . . . 71.45 111.185 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.495 HD13 HG13 ' A' ' 45' ' ' VAL . 56.1 tp -117.95 120.64 38.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.296 0.569 . . . . 73.2 111.534 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -83.85 115.09 22.09 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.615 . . . . 72.34 110.701 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -114.08 179.14 4.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.124 0.487 . . . . 64.35 111.512 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.19 0.12 29.66 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.197 0.443 . . . . 73.53 112.197 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 92' ' ' LEU . 37.5 pt -109.61 5.27 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.231 0.539 . . . . 62.24 110.551 171.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.13 -171.35 13.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.99 -0.55 . . . . 62.22 112.731 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -77.87 134.33 37.97 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.485 -0.421 . . . . 43.45 111.257 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.48 152.96 48.76 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.333 0.587 . . . . 65.31 111.427 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HD2' ' OE1' ' A' ' 85' ' ' GLN . 39.8 ttm180 -109.63 107.1 17.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.957 -0.565 . . . . 74.13 111.325 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.0 mtt -98.96 138.07 36.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.76 0.314 . . . . 63.51 111.785 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 42.3 t -139.15 161.77 36.59 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.392 -0.367 . . . . 70.0 111.614 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 80' ' ' LEU . 89.8 mt -113.79 108.95 17.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.951 0.405 . . . . 75.41 111.768 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 81' ' ' THR . 35.6 m -117.25 161.53 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.7 0.286 . . . . 74.51 111.284 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 65.14 22.76 12.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.488 0.551 . . . . 74.33 112.488 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 49' ' ' PRO . 51.4 mt -61.84 114.78 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 111.948 0.351 . . . . 73.04 111.948 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -145.09 154.49 54.49 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 112.32 0.489 . . . . 74.34 112.32 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.68 136.62 33.67 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.503 2.135 . . . . 72.5 112.67 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.499 ' HB2' HG23 ' A' ' 79' ' ' THR . 34.7 t70 -107.69 159.06 16.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.826 0.346 . . . . 72.21 111.123 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.93 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.068 0.461 . . . . 53.33 111.647 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -86.95 -55.06 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.297 0.57 . . . . 72.12 110.131 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.21 -94.42 0.16 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.116 -0.564 . . . . 54.51 113.343 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -149.21 136.19 19.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.375 -0.486 . . . . 51.14 111.702 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 74' ' ' ASP . 32.4 p -116.08 129.97 56.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.288 0.566 . . . . 74.22 111.939 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.666 HD13 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -142.34 150.75 41.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.006 -0.543 . . . . 72.53 111.236 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.596 ' HB ' HG23 ' A' ' 69' ' ' VAL . 30.9 m -92.89 112.16 24.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.871 0.367 . . . . 71.42 111.687 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.3 112.97 22.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.773 -0.454 . . . . 64.51 109.773 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' MET . 83.6 mtt180 -110.64 133.82 52.98 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.144 0.424 . . . . 73.03 112.144 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.457 HG13 ' HG2' ' A' ' 66' ' ' MET . 4.0 mp -113.66 109.36 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.072 -0.513 . . . . 75.5 111.175 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 97.6 mt-30 -93.25 143.61 26.1 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.927 0.394 . . . . 63.01 111.193 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.13 146.85 23.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.28 -0.486 . . . . 75.31 114.013 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.8 -46.02 59.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.664 0.386 . . . . 72.14 111.969 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -102.45 179.9 4.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.307 0.575 . . . . 71.14 112.222 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.87 10.19 12.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.789 -0.641 . . . . 73.12 111.223 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.96 145.75 31.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.078 -0.51 . . . . 74.51 110.864 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.73 131.54 14.75 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.461 2.107 . . . . 72.3 112.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.479 ' HB3' HD12 ' A' ' 61' ' ' ILE . 94.3 mt -79.75 147.63 67.26 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.681 0.277 . . . . 62.31 111.534 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 16.3 Cg_exo -69.83 -178.13 2.22 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.891 2.394 . . . . 72.43 113.07 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -78.14 132.34 37.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.568 -0.287 . . . . 72.11 111.412 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.56 170.24 16.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 75.24 112.342 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.3 p -153.65 157.02 38.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.041 -0.527 . . . . 74.5 110.516 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.609 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -161.64 -173.67 30.58 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.717 -0.754 . . . . 75.04 113.787 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -120.59 142.94 48.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.76 0.315 . . . . 53.53 110.806 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.0 128.83 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.053 0.454 . . . . 54.1 112.034 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 11.1 mm-40 -95.82 113.04 24.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.011 -0.54 . . . . 75.24 110.039 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 44.6 p90 -124.31 127.9 48.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.874 -0.516 . . . . 53.3 111.965 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.59 -154.26 9.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.075 -0.583 . . . . 70.43 113.263 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -113.31 152.12 30.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.202 0.525 . . . . 74.22 111.944 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.565 HG23 ' HB2' ' A' ' 111' ' ' PHE . 66.3 mt -108.45 106.82 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.008 -0.542 . . . . 73.33 111.037 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -92.64 22.53 4.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.039 0.385 . . . . 75.31 112.039 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -136.66 -165.38 10.49 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.894 -0.67 . . . . 63.21 113.446 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.5 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 11.2 p -87.69 -161.72 0.74 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.703 0.287 . . . . 71.33 111.035 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.646 HG22 ' HE3' ' A' ' 40' ' ' LYS . 51.4 mm -85.67 -28.64 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.878 0.371 . . . . 64.34 111.087 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -91.49 -40.84 11.17 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.02 0.378 . . . . 75.43 112.02 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -127.47 96.89 4.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.444 0.64 . . . . 73.43 110.881 175.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.644 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.5 p90 -118.93 144.94 46.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.906 -0.588 . . . . 72.51 111.912 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -115.27 131.44 56.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.923 -0.58 . . . . 61.31 110.244 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -96.57 113.6 25.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.983 0.421 . . . . 74.34 111.822 -174.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.9 pt -121.1 164.64 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.406 -0.361 . . . . 64.22 111.365 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.07 29.06 11.76 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.984 0.421 . . . . 70.12 111.526 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 4.8 p -94.04 124.64 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.275 0.56 . . . . 75.3 112.218 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.19 155.7 24.56 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.884 -0.598 . . . . 62.15 110.758 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -104.78 139.88 38.91 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.154 -0.476 . . . . 62.21 111.202 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -138.58 146.48 41.87 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.708 0.289 . . . . 52.22 111.464 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.93 116.71 27.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.032 0.444 . . . . 54.24 111.825 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 121' ' ' ILE . 23.5 pt -106.7 105.06 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 71.44 111.15 176.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.98 132.61 51.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.281 -0.418 . . . . 61.54 111.065 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -121.51 145.78 43.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.75 0.31 . . . . 72.31 111.828 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.6 174.79 12.26 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.655 2.237 . . . . 64.22 113.001 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -80.82 135.77 36.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.015 0.436 . . . . 63.32 111.872 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.2 m -70.69 126.35 29.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.161 -0.472 . . . . 74.35 111.332 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.617 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -97.91 -35.78 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.104 0.779 . . . . 63.55 113.104 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.617 ' HG ' HG23 ' A' ' 127' ' ' VAL . 92.5 mt -125.62 120.36 30.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.726 0.298 . . . . 75.32 110.93 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.95 68.71 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 112.52 0.563 . . . . 63.34 112.52 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.98 167.52 78.41 Favored 'Cis proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.243 -1.149 . . . . 74.11 112.93 -1.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 49.2 m -75.62 133.73 40.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.857 0.361 . . . . 75.22 111.773 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.47 31.37 1.9 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.996 -0.547 . . . . 75.05 111.239 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' A' ' 123' ' ' ALA . 59.3 t -52.1 115.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.699 0.629 . . . . 71.42 112.699 -174.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.81 114.57 28.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.197 0.523 . . . . 72.11 111.733 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.1 pt -122.87 136.68 27.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.973 0.416 . . . . 61.32 112.094 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.14 135.84 14.07 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.744 2.296 . . . . 74.32 112.942 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.2 113.02 20.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.495 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -103.04 118.9 37.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.219 0.533 . . . . 71.23 112.114 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.2 mt -99.93 142.84 30.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.859 0.464 . . . . 74.44 110.692 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -102.9 144.01 31.75 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.581 0.585 . . . . 74.52 112.581 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.91 -43.27 1.92 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.971 0.749 . . . . 61.33 114.971 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.488 HD13 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -88.83 122.91 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.565 0.698 . . . . 74.12 111.993 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.6 m -82.04 154.97 25.36 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.984 -0.553 . . . . 74.21 111.205 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.585 ' HA ' HD12 ' A' ' 147' ' ' LEU . 9.0 p -57.23 -36.73 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.898 0.38 . . . . 61.5 111.733 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.6 -27.62 68.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.222 0.534 . . . . 52.01 111.208 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -94.32 0.14 55.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.243 0.461 . . . . 64.11 112.243 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.645 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.2 mt -78.73 142.1 37.33 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.101 0.477 . . . . 75.12 112.211 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.88 -56.61 0.29 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.989 -0.55 . . . . 54.04 113.129 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.496 ' HB3' HD11 ' A' ' 104' ' ' ILE . 38.7 p90 -139.33 159.3 42.48 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.323 -0.516 . . . . 71.51 112.103 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 67.4 t -134.19 96.4 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.9 -0.591 . . . . 65.32 110.415 175.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 20.4 ttm180 -93.39 112.77 24.77 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.123 -0.361 . . . . 72.51 111.969 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.63 HG21 ' SD ' ' A' ' 66' ' ' MET . 37.0 mm -89.71 138.11 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 122.205 -0.31 . . . . 74.15 111.296 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -163.58 -177.22 5.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.871 0.323 . . . . 62.23 111.871 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 65.2 20.64 11.98 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.924 0.712 . . . . 74.0 112.924 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.609 HD13 ' HA3' ' A' ' 97' ' ' GLY . 47.4 mm -69.9 103.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.393 0.616 . . . . 53.13 111.927 -177.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -136.38 153.95 76.66 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.831 -0.622 . . . . 75.42 111.149 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.79 153.81 70.16 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.635 2.224 . . . . 64.24 113.329 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.979 0.418 . . . . 50.42 111.878 179.226 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 120.998 0.428 . . . . 73.43 111.005 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -64.68 -29.94 70.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.266 -0.424 . . . . 72.52 111.331 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.05 -46.73 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.533 -0.303 . . . . 62.15 110.619 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 71.9 mmtt -63.02 -38.81 92.69 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.408 -0.36 . . . . 73.44 111.504 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.19 -48.94 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.329 0.585 . . . . 64.22 110.742 173.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.3 m -62.79 -39.47 94.34 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.932 -0.577 . . . . 74.15 110.991 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.484 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 62.8 tt0 -63.29 -45.08 93.05 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.139 -0.482 . . . . 73.04 110.919 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.3 tt0 -58.63 -50.84 72.35 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.849 0.315 . . . . 72.43 111.849 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -58.8 -43.51 90.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.86 0.362 . . . . 70.01 111.798 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -68.87 -43.49 75.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.623 0.249 . . . . 70.11 111.571 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 33' ' ' GLN . 56.3 mt -65.84 -32.84 74.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.984 0.421 . . . . 72.32 110.657 175.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.437 ' ND2' HG12 ' A' ' 45' ' ' VAL . 3.3 t-20 -61.65 -30.64 70.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.148 -0.478 . . . . 72.13 110.556 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.29 -36.25 61.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.756 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.88 -32.81 63.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.337 0.495 . . . . 54.4 112.337 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -55.5 105.68 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.888 0.699 . . . . 73.5 112.888 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -79.6 -22.72 43.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.176 -0.466 . . . . 63.12 111.18 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB3' HH21 ' A' ' 151' ' ' ARG . 30.5 t -124.98 99.15 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 73.34 111.13 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 79.59 -143.38 25.68 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.973 -0.558 . . . . 75.44 113.916 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 28.3 m -140.52 144.96 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.993 0.425 . . . . 75.3 111.873 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 73.5 m-85 -89.89 99.1 12.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.529 -0.305 . . . . 72.0 111.172 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.4 110.08 20.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.885 0.374 . . . . 70.2 110.628 173.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.01 115.79 63.83 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 122.278 -0.264 . . . . 75.51 110.965 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 30.5 Cg_endo -64.24 -7.1 12.95 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.523 2.149 . . . . 72.34 113.281 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 -2.31 55.72 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.455 -0.403 . . . . 65.34 112.666 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.72 115.72 30.72 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.683 -0.304 . . . . 72.14 111.09 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -79.21 61.54 3.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.316 0.579 . . . . 64.4 110.659 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -155.45 151.56 22.72 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 115.798 -0.637 . . . . 73.2 111.662 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 63.6 Cg_endo -85.85 -178.61 2.98 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.128 2.552 . . . . 72.02 113.858 178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.05 138.98 18.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.873 -0.603 . . . . 63.14 110.959 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -89.14 131.74 35.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.242 0.544 . . . . 75.24 112.459 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.7 135.81 40.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.779 -0.646 . . . . 74.43 110.738 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 49.0 tt0 -93.18 128.55 39.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.947 -0.471 . . . . 63.33 111.262 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.8 p -97.13 179.81 4.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.356 -0.384 . . . . 64.11 110.58 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.718 HE21 ' HB3' ' A' ' 156' ' ' GLN . 38.2 mt-30 -83.24 -1.79 53.98 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.144 -0.348 . . . . 62.33 111.778 178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.466 HG23 ' HD3' ' A' ' 157' ' ' PRO . 38.1 pt -103.94 -32.44 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.713 0.292 . . . . 74.24 110.979 171.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.23 172.9 39.17 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.52 -0.371 . . . . 51.43 112.946 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 95.6 m -78.6 138.26 38.26 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.318 -0.519 . . . . 74.45 111.402 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.91 171.73 13.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.187 0.518 . . . . 63.01 111.775 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.91 120.73 25.34 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.296 -0.411 . . . . 74.45 110.919 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.3 mtt -105.42 152.36 23.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.967 0.413 . . . . 35.5 112.094 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 84.5 p -149.29 143.29 25.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.364 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 82' ' ' LEU . 91.6 mt -96.78 100.45 11.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.934 0.397 . . . . 71.3 111.285 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.448 HG23 HD22 ' A' ' 70' ' ' ASN . 27.5 m -120.41 152.75 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.667 0.27 . . . . 74.04 111.013 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 19.2 m-80 57.13 76.47 0.31 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.0 0.429 . . . . 74.21 111.166 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mt -109.36 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.513 -0.312 . . . . 72.21 111.402 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 p -129.89 152.54 80.08 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 73.11 111.714 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 165.57 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.833 2.355 . . . . 64.43 113.804 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.634 ' HB2' HG23 ' A' ' 79' ' ' THR . 33.3 t70 -139.66 170.35 16.05 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.862 -0.608 . . . . 73.23 110.673 -178.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.84 -44.63 91.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.883 0.327 . . . . 62.02 111.883 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -91.03 -31.92 16.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.183 0.438 . . . . 74.33 112.183 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.51 0.15 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.586 -0.816 . . . . 64.24 113.901 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -144.9 135.82 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.061 0.457 . . . . 75.24 111.903 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.634 HG23 ' HB2' ' A' ' 74' ' ' ASP . 46.3 p -110.24 132.88 53.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.344 -0.389 . . . . 73.2 111.167 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 2.8 pp -142.41 160.06 41.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.003 0.43 . . . . 73.2 112.052 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 m -97.96 113.44 25.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 65.12 111.469 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 68' ' ' LEU . 3.0 tm? -92.78 109.53 20.96 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.137 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 90.2 mtt180 -99.04 121.85 41.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.461 0.541 . . . . 74.24 112.461 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.6 mp -104.97 117.4 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.709 -0.678 . . . . 74.24 111.387 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -112.04 117.51 32.87 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.693 0.282 . . . . 74.15 110.415 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.14 142.64 29.71 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.254 -0.498 . . . . 54.31 113.707 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.91 -44.63 84.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.289 0.566 . . . . 74.34 109.909 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -67.88 124.26 22.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.892 -0.595 . . . . 41.45 110.858 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.421 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 21.5 m-80 -68.89 -15.8 63.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.4 . . . . 72.3 111.475 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.18 154.55 63.55 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 116.183 -0.462 . . . . 72.42 111.872 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 41.3 Cg_endo -65.4 130.85 26.32 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.022 2.481 . . . . 74.34 114.233 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.4 mt -103.43 151.61 38.66 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.046 -0.525 . . . . 73.54 111.357 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 174.93 11.94 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.514 2.143 . . . . 74.23 113.226 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.57 134.34 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.069 0.461 . . . . 23.54 112.029 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -132.32 155.48 48.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.409 0.623 . . . . 70.5 111.993 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -147.15 170.64 16.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.81 -0.632 . . . . 75.44 110.603 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -176.91 -175.17 44.0 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.252 -0.975 . . . . 44.54 113.69 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.9 m -103.05 139.09 39.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.956 0.408 . . . . 61.2 111.087 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.58 129.8 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.215 0.531 . . . . 75.25 111.787 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.801 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.2 mm-40 -90.87 139.43 30.75 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.882 -0.599 . . . . 74.03 109.692 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.479 ' CG ' HD22 ' A' ' 139' ' ' LEU . 28.5 p90 -146.04 122.96 11.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 71.25 111.695 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.79 -146.9 5.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.574 -0.739 . . . . 52.2 112.894 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.597 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 89.8 mt-30 -123.74 151.01 43.69 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.134 0.492 . . . . 60.44 111.981 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.2 133.69 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.106 -0.497 . . . . 75.41 111.252 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 4.0 pt20 -121.7 98.87 6.16 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.525 0.679 . . . . 75.21 110.982 171.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 151.21 -162.82 29.63 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.123 -0.56 . . . . 43.23 113.675 176.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.6 p -108.0 -169.86 1.59 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.068 0.547 . . . . 74.42 111.657 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.67 -47.04 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.1 0.476 . . . . 75.04 111.518 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -71.46 -48.07 51.63 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.195 0.443 . . . . 60.22 112.195 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.53 110.9 12.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.567 0.699 . . . . 62.22 112.627 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -140.48 154.5 46.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.735 -0.666 . . . . 73.23 111.157 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -122.86 134.37 54.39 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.135 0.493 . . . . 74.33 111.806 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -87.43 104.78 16.77 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.839 -0.619 . . . . 72.44 111.095 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.0 pt -113.93 162.67 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.18 0.192 . . . . 71.14 111.205 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 54.01 30.27 11.53 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.905 0.383 . . . . 62.55 111.973 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.84 124.34 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.313 0.578 . . . . 71.53 112.308 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -113.55 163.12 15.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.105 -0.498 . . . . 64.03 110.728 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -111.72 140.11 46.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 64.42 111.601 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.426 HE22 ' HA ' ' A' ' 139' ' ' LEU . 8.7 tt0 -140.33 160.3 40.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.888 0.375 . . . . 61.24 111.272 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.83 136.75 41.14 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.026 -0.421 . . . . 75.41 111.712 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.27 141.05 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.578 -0.283 . . . . 74.1 110.886 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.28 115.94 17.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.806 0.336 . . . . 62.54 111.163 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 135' ' ' ILE . . . -110.49 137.2 20.63 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.019 0.377 . . . . 64.2 112.019 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.85 165.24 31.75 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.585 2.19 . . . . 42.14 113.255 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.82 24.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.843 0.683 . . . . 72.22 112.843 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 m -93.61 112.04 23.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.086 -0.507 . . . . 72.02 110.53 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.33 -48.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.072 0.463 . . . . 73.2 111.23 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.01 151.52 25.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 73.13 110.852 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.47 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -77.31 149.35 78.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.391 -0.368 . . . . 54.11 111.565 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.27 179.33 25.87 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.956 -1.268 . . . . 73.44 113.158 -0.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 49.2 m -87.59 86.75 7.24 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.465 -0.334 . . . . 74.35 111.655 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 22.2 p-10 -130.54 114.78 15.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.708 0.766 . . . . 73.54 111.567 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 134' ' ' ASP . 21.9 t -126.44 162.62 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.88 -0.6 . . . . 73.51 110.458 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 2.8 p-10 -142.53 137.24 30.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.03 0.443 . . . . 72.54 111.101 172.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 123' ' ' ALA . 20.4 pt -131.06 131.98 23.53 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 120.801 0.334 . . . . 73.02 111.722 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.64 110.28 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.129 1.886 . . . . 73.42 112.56 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -92.57 127.47 38.07 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.47 -0.786 . . . . 75.42 110.387 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -103.72 101.11 10.94 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.983 0.42 . . . . 75.11 111.546 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.479 HD22 ' CG ' ' A' ' 101' ' ' TYR . 68.1 mt -85.97 128.1 34.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.085 -0.339 . . . . 72.55 110.085 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -119.22 141.22 49.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.104 0.478 . . . . 74.4 112.059 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.16 19.31 50.89 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.183 -0.462 . . . . 72.43 113.394 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.574 HD13 HD23 ' A' ' 147' ' ' LEU . 21.2 tt -155.71 134.07 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.08 0.467 . . . . 75.21 112.06 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m -78.75 154.18 30.2 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.296 -0.411 . . . . 73.31 111.93 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.41 -46.07 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.574 0.583 . . . . 64.22 112.574 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.57 -17.28 60.1 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.198 0.523 . . . . 75.12 110.927 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.507 ' HB3' HE21 ' A' ' 103' ' ' GLN . 87.3 mm-40 -93.31 7.37 44.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.368 -0.378 . . . . 61.43 111.642 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.59 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 29.6 mt -75.95 111.53 11.42 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.207 0.527 . . . . 73.43 111.357 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -86.45 -47.74 4.78 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.225 -0.512 . . . . 71.44 112.946 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.95 151.43 25.42 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.131 0.491 . . . . 72.13 112.223 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.35 97.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.808 -0.633 . . . . 54.33 109.738 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 ttt180 -94.87 99.41 11.46 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.309 0.485 . . . . 63.03 112.309 -172.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.556 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 11.9 mm -79.78 139.97 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 64.44 111.014 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -162.17 166.58 25.41 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.824 0.676 . . . . 64.04 112.824 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.84 37.11 15.65 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.962 0.727 . . . . 73.55 112.962 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -73.11 113.5 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.405 0.621 . . . . 74.34 111.283 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.718 ' HB3' HE21 ' A' ' 60' ' ' GLN . 10.6 pt20 -138.69 164.0 42.82 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.506 -0.77 . . . . 73.54 111.172 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.466 ' HD3' HG23 ' A' ' 61' ' ' ILE . 29.8 Cg_endo -63.03 146.18 94.54 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.01 1.807 . . . . 73.25 112.652 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 112.494 0.553 . . . . 55.12 112.494 -178.119 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.16 0.505 . . . . 65.01 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 31' ' ' ILE . 25.2 m -69.05 -28.69 66.77 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 72.33 111.548 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.21 -44.32 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.061 0.457 . . . . 71.14 110.674 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HE3' HD23 ' A' ' 48' ' ' LEU . 48.1 tptt -63.4 -41.72 98.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.135 -0.484 . . . . 75.11 110.391 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 28' ' ' THR . 87.3 mt -56.55 -49.0 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.028 -0.533 . . . . 73.42 110.869 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 60.7 m -58.71 -42.53 88.88 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.057 -0.52 . . . . 53.23 110.944 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.776 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -57.28 -46.22 83.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.886 0.374 . . . . 64.11 110.913 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.6 tt0 -58.47 -50.02 75.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.26 0.552 . . . . 74.24 111.379 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.57 -27.33 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.852 -0.613 . . . . 73.25 112.037 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 32' ' ' THR . 99.2 mtt180 -74.31 -41.29 61.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.03 -0.419 . . . . 73.24 111.146 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.644 HD12 HD11 ' A' ' 48' ' ' LEU . 85.3 mt -65.57 -35.36 80.6 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.404 0.621 . . . . 70.32 110.469 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.518 ' ND2' HG12 ' A' ' 45' ' ' VAL . 26.2 t-20 -59.3 -37.35 77.51 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.604 -0.725 . . . . 74.13 110.809 172.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.2 96.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.933 0.396 . . . . 65.42 111.84 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -72.32 -22.18 61.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.14 0.422 . . . . 53.22 112.14 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -92.94 139.09 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.99 0.424 . . . . 70.14 111.626 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.8 m -75.02 -83.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.669 0.618 . . . . 43.42 112.669 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.0 m -97.54 -36.18 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.113 0.412 . . . . 64.44 112.113 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.0 177.49 53.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.113 -0.565 . . . . 70.45 112.802 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.518 HG12 ' ND2' ' A' ' 38' ' ' ASN . 27.6 m -135.83 152.19 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.535 0.683 . . . . 53.12 112.692 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.3 m-85 -98.42 102.53 14.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.667 -0.697 . . . . 74.41 110.255 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.2 mt -86.41 113.48 22.4 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.116 0.484 . . . . 74.24 111.115 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 37' ' ' LEU . 8.8 mp -89.46 114.85 62.04 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.222 -0.444 . . . . 74.23 111.145 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.679 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 36.9 Cg_endo -64.48 11.47 0.11 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.224 2.616 . . . . 73.34 114.378 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.84 -10.58 26.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.205 -0.522 . . . . 62.45 112.683 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.66 127.74 53.93 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 70.02 111.546 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -79.23 17.46 0.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.813 0.34 . . . . 73.42 111.763 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -99.95 147.06 32.94 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 112.988 0.736 . . . . 73.11 112.988 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.66 165.0 10.59 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.143 2.562 . . . . 74.23 113.25 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.6 133.94 29.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.487 -0.324 . . . . 21.54 110.984 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -97.02 122.82 40.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.381 . . . . 72.42 111.057 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 45' ' ' VAL . 3.4 pp -120.69 159.57 25.09 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.932 0.396 . . . . 61.2 111.047 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.88 106.54 18.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.047 0.451 . . . . 60.11 110.823 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.1 p -99.69 178.47 4.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.094 -0.503 . . . . 72.01 111.046 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 50.2 mt-30 -76.89 0.58 20.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.373 -0.376 . . . . 73.0 111.94 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.02 -13.91 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.926 0.393 . . . . 73.41 111.16 171.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.75 -158.89 23.49 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.473 -0.394 . . . . 72.51 113.005 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 p -76.09 129.65 37.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.372 -0.487 . . . . 65.14 112.177 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 155' ' ' ILE . 3.1 pp -140.77 138.5 34.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.586 0.708 . . . . 74.42 110.889 170.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 85' ' ' GLN . 1.6 ttp180 -98.87 115.33 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.192 -0.913 . . . . 75.4 110.951 -175.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.618 ' SD ' HG21 ' A' ' 152' ' ' ILE . 58.6 mtt -110.17 154.54 23.2 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.928 0.394 . . . . 72.33 111.608 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.1 t -159.58 155.84 26.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.415 -0.357 . . . . 75.23 111.096 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.578 HD22 HD13 ' A' ' 80' ' ' LEU . 89.0 mt -107.35 105.8 15.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.883 0.373 . . . . 74.23 111.387 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 81' ' ' THR . 31.8 m -115.97 162.76 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.573 -0.285 . . . . 62.22 111.312 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 60.62 34.14 20.22 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.121 0.486 . . . . 72.04 111.911 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.84 108.29 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.099 0.476 . . . . 71.54 111.855 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.47 150.62 74.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.129 0.418 . . . . 64.2 112.129 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.36 146.83 81.8 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.86 2.373 . . . . 64.13 113.231 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.625 ' HB2' HG23 ' A' ' 79' ' ' THR . 25.5 t70 -115.38 170.47 8.38 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.144 -0.48 . . . . 72.51 110.92 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.86 40.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.858 0.361 . . . . 22.03 111.478 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.66 -45.92 11.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.884 0.373 . . . . 64.12 111.488 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.01 -111.34 0.93 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.029 -0.605 . . . . 51.43 113.586 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -145.7 136.62 24.55 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.476 -0.426 . . . . 62.25 111.788 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.625 HG23 ' HB2' ' A' ' 74' ' ' ASP . 54.0 p -107.98 124.48 50.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.701 0.286 . . . . 62.4 111.581 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.578 HD13 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -133.66 167.84 19.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.722 0.296 . . . . 75.41 111.298 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 69' ' ' VAL . 26.4 m -113.14 116.63 30.14 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.874 0.368 . . . . 74.14 111.729 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.437 HD11 ' SD ' ' A' ' 66' ' ' MET . 3.1 tm? -93.61 110.51 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.223 -0.444 . . . . 55.24 110.236 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -100.12 115.63 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.337 0.495 . . . . 72.3 112.337 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.499 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.3 mp -95.38 147.45 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.853 0.461 . . . . 71.24 111.384 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 65' ' ' ARG . 64.9 tt0 -146.02 106.61 4.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.482 0.313 . . . . 72.23 110.335 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.34 27.54 0.84 Allowed Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.257 0.863 . . . . 53.2 115.257 -171.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 59.98 -68.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 74.15 112.097 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 m -61.87 144.66 54.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.757 0.423 . . . . 75.43 111.83 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 43.6 m-80 -74.36 -26.57 60.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.613 -0.267 . . . . 73.32 111.654 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.96 131.62 79.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 112.162 0.43 . . . . 72.24 112.162 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 26.1 Cg_endo -60.8 115.77 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.009 2.473 . . . . 74.2 113.308 -176.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.64 151.98 42.92 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.285 -0.416 . . . . 75.43 111.537 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.66 176.38 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.998 . . . . 74.23 112.536 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -68.15 163.25 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.698 0.285 . . . . 61.34 111.382 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -158.33 148.73 20.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.555 0.693 . . . . 72.4 112.282 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.3 p -127.51 168.64 14.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.417 -0.811 . . . . 74.33 110.726 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.695 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -173.04 167.6 40.44 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.214 -0.994 . . . . 72.11 114.183 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -99.26 116.88 32.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.478 0.311 . . . . 74.01 111.05 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' VAL . 34.0 m -109.79 113.08 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.436 0.636 . . . . 73.24 111.364 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.2 mt-10 -97.03 110.82 23.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.94 0.4 . . . . 75.22 111.353 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -106.74 138.45 42.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.443 -0.344 . . . . 74.32 111.134 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.15 -164.59 27.11 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.839 -0.696 . . . . 73.22 113.514 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.604 ' HB2' HG13 ' A' ' 114' ' ' ILE . 52.7 mt-30 -105.79 157.42 17.47 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.909 0.385 . . . . 73.32 110.9 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.72 142.68 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.714 0.293 . . . . 45.41 111.233 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 4.1 pt20 -138.9 103.1 4.72 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.362 0.601 . . . . 73.34 110.577 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.43 -162.79 31.27 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.197 -0.525 . . . . 72.0 113.51 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.8 p -105.82 -178.37 3.63 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.871 0.367 . . . . 63.13 111.213 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 33' ' ' GLN . 30.2 mm -62.72 -27.78 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.174 0.511 . . . . 55.43 111.013 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -81.72 -55.95 4.31 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.991 -0.55 . . . . 73.03 110.895 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -117.8 84.39 2.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.389 0.614 . . . . 71.2 112.003 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 107' ' ' THR . 31.0 p90 -107.86 123.74 49.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.079 -0.51 . . . . 72.34 110.697 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 51.2 mt-30 -94.58 117.8 30.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.982 0.42 . . . . 74.31 111.525 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.67 101.87 5.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.008 -0.542 . . . . 75.42 110.386 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 103' ' ' GLN . 36.2 pt -112.61 150.91 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.732 0.301 . . . . 64.52 111.807 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 54.38 34.49 20.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.958 0.409 . . . . 63.11 112.069 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.4 130.13 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.23 0.538 . . . . 74.5 112.13 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.55 156.8 48.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.791 -0.64 . . . . 52.2 110.269 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 8.9 p30 -103.3 153.63 20.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.46 0.911 . . . . 73.53 113.46 -171.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.407 ' NE2' HD23 ' A' ' 139' ' ' LEU . 8.4 tt0 -133.05 150.59 52.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.296 -0.865 . . . . 71.11 109.921 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -94.84 123.13 38.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.018 0.437 . . . . 72.32 111.954 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 137' ' ' LEU . 41.6 pt -100.53 138.9 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 70.54 111.409 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.92 105.23 6.64 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.419 -0.355 . . . . 75.04 111.103 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.27 139.48 22.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.61 -0.268 . . . . 62.04 111.461 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HD2' HG11 ' A' ' 133' ' ' VAL . 38.3 Cg_exo -61.17 158.7 33.61 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.008 2.472 . . . . 64.41 113.85 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.83 130.73 41.79 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.987 -0.551 . . . . 62.11 111.703 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.1 m -91.95 101.12 13.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.87 0.366 . . . . 65.12 110.993 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 p -89.0 -21.28 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.188 0.518 . . . . 72.31 110.925 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.7 mt -101.6 165.36 11.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.181 0.515 . . . . 74.25 111.649 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -114.65 147.41 38.08 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 62.35 111.105 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 84.3 Cg_endo -83.48 169.94 54.96 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.837 -1.318 . . . . 64.33 113.529 -1.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 m -83.56 83.07 8.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.478 0.547 . . . . 71.42 112.478 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' A' ' 130' ' ' PRO . 4.6 p-10 -136.57 118.23 14.97 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.482 0.658 . . . . 72.35 111.244 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.458 HG11 ' HD2' ' A' ' 124' ' ' PRO . 46.5 t -122.23 150.74 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.0 -0.546 . . . . 74.22 111.385 -173.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -124.4 110.2 14.26 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.359 0.6 . . . . 74.44 111.557 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.0 pt -112.62 136.35 21.54 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 112.23 0.456 . . . . 73.04 112.23 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.85 146.34 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.836 2.358 . . . . 60.43 113.416 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 121' ' ' ILE . 63.0 mt -132.14 117.17 17.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.191 -0.459 . . . . 72.5 112.101 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -96.37 94.43 7.43 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.189 0.519 . . . . 74.32 110.206 171.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.407 HD23 ' NE2' ' A' ' 119' ' ' GLN . 50.7 mt -76.7 110.05 10.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.346 0.593 . . . . 75.51 110.207 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.43 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 mtmp? -83.94 150.4 25.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.612 -0.722 . . . . 70.24 112.39 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.61 13.81 74.77 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.722 0.649 . . . . 44.12 114.722 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.5 128.43 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.03 0.915 . . . . 72.44 112.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.6 m -84.17 146.24 27.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.165 -0.47 . . . . 62.13 111.302 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.423 ' HA ' HD12 ' A' ' 147' ' ' LEU . 8.0 p -56.88 -34.77 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.524 0.564 . . . . 74.54 112.524 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.58 -32.95 70.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.161 0.505 . . . . 72.34 111.082 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HB3' HE21 ' A' ' 103' ' ' GLN . 32.0 mm-40 -97.38 5.08 50.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.317 0.488 . . . . 73.43 112.317 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.679 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 17.1 mt -69.99 96.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.266 0.555 . . . . 72.23 111.156 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.32 -41.22 11.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.863 -0.608 . . . . 73.41 113.193 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.89 157.02 23.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.186 0.517 . . . . 71.43 111.998 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.21 101.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.773 -0.649 . . . . 74.03 109.82 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 51.5 ttt180 -83.97 105.04 14.54 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.151 -0.477 . . . . 74.43 111.928 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.618 HG21 ' SD ' ' A' ' 66' ' ' MET . 21.8 mm -90.72 121.4 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 116.535 -0.302 . . . . 72.13 111.639 -177.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -159.24 178.24 10.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.322 0.49 . . . . 74.43 112.322 176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.77 18.54 11.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.883 0.697 . . . . 70.43 112.883 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.695 HD13 ' HA3' ' A' ' 97' ' ' GLY . 36.2 mm -63.19 113.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.021 0.439 . . . . 72.53 111.317 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.603 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 8.9 pt20 -136.2 153.83 76.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.007 0.523 . . . . 75.15 111.831 -173.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.87 135.05 22.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.605 2.203 . . . . 73.44 113.754 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 6.0 p . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.119 0.485 . . . . 75.24 110.942 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.061 0.458 . . . . 72.35 111.444 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.4 m -68.53 -28.23 66.8 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.248 -0.433 . . . . 73.45 111.326 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.93 -48.98 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.711 0.291 . . . . 73.42 111.164 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 14.4 mptt -59.83 -47.69 84.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.923 0.392 . . . . 65.52 111.19 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.18 -49.45 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.936 0.398 . . . . 74.32 111.382 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.7 m -57.27 -43.49 83.11 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.995 0.426 . . . . 75.54 111.136 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.705 ' HG3' HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -59.06 -44.63 91.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.27 -0.423 . . . . 74.15 111.394 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.29 -44.17 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.376 . . . . 74.1 111.256 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -63.31 -36.8 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.827 0.306 . . . . 71.52 111.827 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.99 -50.13 67.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.947 0.403 . . . . 64.31 110.914 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.62 -40.01 95.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.071 0.463 . . . . 71.33 111.32 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.29 -39.22 89.62 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.196 -0.456 . . . . 61.11 110.814 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.99 74.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.302 -0.408 . . . . 33.34 111.588 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.32 0.83 57.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.039 0.447 . . . . 71.1 111.794 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 46' ' ' TYR . 25.3 t -77.63 103.43 7.57 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.965 0.412 . . . . 74.34 111.112 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 t -88.28 -23.05 23.58 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.961 0.41 . . . . 61.45 111.743 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.4 p -131.27 104.45 7.05 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.261 -0.427 . . . . 61.12 111.054 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.93 -162.03 35.24 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.288 -0.482 . . . . 40.51 112.89 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.9 145.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.478 -0.425 . . . . 74.22 111.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.543 ' HD2' ' HB2' ' A' ' 41' ' ' SER . 46.7 m-85 -97.06 120.6 37.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.847 0.356 . . . . 75.42 111.909 176.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.55 136.08 52.51 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.991 -0.549 . . . . 62.23 109.814 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 63.8 mt -107.1 130.15 23.29 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 122.17 -0.332 . . . . 74.35 111.351 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 26.4 Cg_endo -60.3 -30.11 90.36 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.528 2.152 . . . . 64.52 112.807 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.64 -12.95 80.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.337 -0.458 . . . . 73.12 112.985 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -120.83 76.66 1.22 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.067 0.46 . . . . 41.01 111.116 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.54 80.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.292 -0.413 . . . . 72.22 111.789 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 p -136.22 152.59 75.51 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 112.091 0.404 . . . . 73.34 112.091 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.02 146.61 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.099 2.533 . . . . 73.3 114.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.81 32.96 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.83 -0.623 . . . . 53.0 110.78 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -85.9 139.93 30.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.014 0.435 . . . . 63.22 111.949 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -144.3 129.78 18.97 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.989 -0.55 . . . . 64.05 111.026 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -83.23 139.82 32.89 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.325 0.583 . . . . 72.12 110.761 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.1 p -124.32 -174.89 3.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 63.11 111.369 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.3 mt-30 -90.81 11.52 22.22 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 45.12 111.353 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.4 pt -121.67 -4.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.884 0.373 . . . . 75.33 111.179 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.34 -167.83 24.84 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.288 -0.415 . . . . 71.3 112.459 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.8 m -93.95 122.12 36.11 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.19 -0.594 . . . . 73.35 111.301 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -123.41 -176.4 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.118 0.485 . . . . 62.25 111.919 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -151.7 104.93 3.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.208 0.528 . . . . 73.24 110.709 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.629 ' HE2' HD11 ' A' ' 82' ' ' LEU . 86.5 mtp -101.33 165.67 11.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.66 0.615 . . . . 74.14 112.66 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 t -162.77 167.03 23.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.046 0.451 . . . . 63.04 111.793 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 80' ' ' LEU . 90.5 mt -117.73 123.27 45.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.062 -0.517 . . . . 62.13 111.688 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.763 HG23 HD22 ' A' ' 70' ' ' ASN . 27.6 m -138.1 171.41 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 116.64 -0.255 . . . . 63.34 111.359 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.763 HD22 HG23 ' A' ' 69' ' ' VAL . 46.7 m-80 56.49 33.08 21.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.614 0.598 . . . . 63.44 112.614 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.3 mt -71.79 109.17 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.023 0.44 . . . . 52.43 111.901 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -134.79 152.7 77.98 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 116.24 -0.436 . . . . 60.12 112.026 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 136.99 34.16 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.65 2.234 . . . . 41.22 112.358 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 79' ' ' THR . 33.9 t70 -113.72 156.58 23.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.737 0.303 . . . . 75.11 111.44 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.37 69.02 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.358 0.503 . . . . 55.24 112.358 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -101.15 -29.56 12.05 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.975 0.416 . . . . 74.35 111.412 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.44 -102.06 0.16 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.05 -0.595 . . . . 50.55 113.104 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.3 m -151.62 128.19 10.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.567 -0.373 . . . . 63.43 110.815 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' HG3' ' A' ' 138' ' ' GLN . 35.3 p -107.49 132.66 52.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.154 0.502 . . . . 71.05 111.824 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.571 HD13 HD22 ' A' ' 68' ' ' LEU . 3.5 pp -148.31 143.22 26.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.135 -0.484 . . . . 71.14 110.996 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 69' ' ' VAL . 56.0 m -81.54 116.49 21.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 41.14 111.358 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 ' HE2' ' A' ' 66' ' ' MET . 3.5 tm? -88.35 116.91 26.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.931 -0.577 . . . . 41.31 109.814 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -98.55 137.36 37.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.768 0.318 . . . . 73.12 111.336 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -117.93 90.53 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.887 0.375 . . . . 53.14 110.921 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 120.86 24.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 73.3 110.164 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.16 122.67 6.26 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.327 -0.94 . . . . 61.13 112.786 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -51.0 -39.83 56.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.467 0.651 . . . . 74.35 109.869 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 m -74.54 117.03 15.9 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.171 -0.922 . . . . 72.12 110.35 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -60.44 -31.68 70.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.016 0.436 . . . . 65.32 111.38 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.15 149.02 98.17 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.763 -0.653 . . . . 61.44 111.898 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 19.2 Cg_endo -58.31 124.38 15.75 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.146 2.564 . . . . 72.03 114.172 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.8 mt -84.1 149.02 54.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.518 -0.31 . . . . 72.44 111.33 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.06 173.95 13.63 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.422 2.082 . . . . 62.4 113.098 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -72.35 141.94 48.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 52.53 111.725 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.38 161.51 41.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.169 0.509 . . . . 71.52 112.291 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 81.1 p -125.09 151.69 45.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.862 -0.608 . . . . 71.14 109.992 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -144.9 154.67 26.03 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.429 -0.891 . . . . 54.34 113.904 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.2 m -97.99 106.56 18.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.414 0.285 . . . . 55.03 110.965 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 152' ' ' ILE . 15.9 m -95.58 136.07 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.975 0.416 . . . . 70.15 111.159 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.481 ' OE1' ' HD2' ' A' ' 151' ' ' ARG . 50.6 mt-10 -115.17 114.37 25.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.25 -0.432 . . . . 73.45 111.092 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -121.47 123.63 42.51 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.975 0.417 . . . . 63.44 111.645 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -165.24 -146.9 4.95 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.324 -0.465 . . . . 23.32 113.234 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.497 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 97.0 mt-30 -126.98 155.98 42.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.494 0.664 . . . . 72.33 112.333 -176.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.36 131.48 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.836 -0.62 . . . . 61.41 110.329 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -102.08 -2.9 28.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.268 0.84 . . . . 71.53 113.268 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.34 -158.99 9.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.274 -0.965 . . . . 64.12 114.619 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.5 p -99.27 -176.76 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.074 0.464 . . . . 62.24 111.831 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.705 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.4 mm -70.4 -24.92 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.188 0.518 . . . . 73.22 111.157 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.81 -43.06 14.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.346 -0.388 . . . . 72.42 111.695 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.81 115.91 8.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.24 0.543 . . . . 65.23 111.588 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.36 163.07 36.72 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.138 0.494 . . . . 63.51 111.978 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -132.82 129.34 38.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.978 -0.555 . . . . 73.41 110.35 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 2.4 mp0 -81.08 105.9 12.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.36 -0.382 . . . . 74.45 111.166 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.3 pt -111.11 160.37 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.292 0.478 . . . . 61.32 112.292 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.89 21.12 8.77 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.871 0.693 . . . . 52.15 112.871 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 7.4 p -84.07 137.92 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.79 0.663 . . . . 74.55 112.79 -175.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -117.92 161.13 20.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.728 -0.669 . . . . 73.55 110.804 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -110.68 151.62 27.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.349 -0.387 . . . . 63.11 111.282 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.15 145.07 28.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.526 -0.306 . . . . 74.32 110.403 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.72 112.07 24.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.675 0.274 . . . . 75.43 111.556 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' SER . 38.8 pt -94.56 116.94 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.089 0.471 . . . . 73.42 111.195 177.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.21 105.68 16.39 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.977 0.417 . . . . 72.14 111.067 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.9 146.69 35.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.488 -0.324 . . . . 42.01 111.847 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 169.79 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.947 2.431 . . . . 54.54 113.287 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -89.1 127.76 35.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.476 -0.329 . . . . 73.33 111.798 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -86.25 135.06 33.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.091 0.472 . . . . 73.11 111.388 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.59 HG23 ' HG ' ' A' ' 128' ' ' LEU . 35.9 m -117.78 4.08 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.138 -0.483 . . . . 71.21 111.871 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.59 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.3 mt -136.59 170.36 16.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.281 0.562 . . . . 74.55 111.941 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.58 145.47 47.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.97 -0.559 . . . . 55.32 111.174 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 156.08 97.49 Favored 'Cis proline' 0 C--N 1.355 0.889 0 C-N-CA 124.164 -1.181 . . . . 55.33 113.354 0.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 31.7 t -95.35 83.74 3.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.644 0.609 . . . . 72.34 112.644 -176.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -119.93 108.68 14.63 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.289 0.566 . . . . 65.25 110.179 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.47 144.07 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.413 0.524 . . . . 73.35 112.413 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.56 121.36 41.52 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.755 0.312 . . . . 71.22 111.584 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.1 pt -132.44 125.81 19.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 120.799 0.333 . . . . 65.44 111.559 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.69 115.6 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.312 2.008 . . . . 62.23 112.876 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.81 111.01 22.37 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.973 -0.558 . . . . 63.32 109.986 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.496 ' HG3' HG22 ' A' ' 79' ' ' THR . 7.6 tt0 -101.33 101.36 12.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.103 0.477 . . . . 74.21 111.365 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.3 mt -89.06 149.13 23.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.394 -0.367 . . . . 64.11 111.767 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.86 150.53 41.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.961 0.41 . . . . 74.04 111.764 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.1 29.01 73.7 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.461 0.545 . . . . 61.41 114.461 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -158.73 135.15 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 122.394 -0.474 . . . . 52.54 111.474 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.3 m -101.39 148.92 24.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.254 -0.43 . . . . 72.24 111.673 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -52.49 -51.93 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 113.317 0.858 . . . . 72.24 113.317 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.97 -17.49 62.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.157 0.503 . . . . 75.24 111.094 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -98.54 -1.65 40.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.097 -0.501 . . . . 72.03 111.739 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 1.5 tt -79.53 129.36 34.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.916 0.389 . . . . 73.03 110.486 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.66 -58.07 1.37 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.313 -0.47 . . . . 62.11 113.655 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 113' ' ' GLU . 22.6 p90 -146.39 157.52 43.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.106 0.479 . . . . 74.34 112.211 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.1 t -130.47 100.09 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.942 -0.572 . . . . 75.42 110.374 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.481 ' HD2' ' OE1' ' A' ' 100' ' ' GLU . 35.4 ttm180 -94.68 125.41 39.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.19 -0.319 . . . . 73.25 111.404 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 99' ' ' VAL . 19.0 mm -105.35 140.25 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 65.13 111.491 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -168.93 173.87 6.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.989 0.366 . . . . 73.31 111.989 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.26 40.62 17.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.62 0.6 . . . . 72.12 112.62 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 64' ' ' LEU . 42.5 mm -73.57 104.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.04 0.447 . . . . 75.42 110.221 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.546 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.0 pt20 -123.98 146.3 50.62 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 116.277 -0.419 . . . . 74.43 111.962 -171.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.71 141.4 37.59 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.415 2.077 . . . . 73.21 112.981 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.539 0.547 0 O-C-N 122.275 -0.265 . . . . 73.51 110.749 176.647 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.357 0.599 . . . . 72.11 110.978 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -65.88 -21.06 66.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.948 -0.569 . . . . 73.1 111.827 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.99 -47.76 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.973 0.416 . . . . 75.43 110.409 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HE2' HD23 ' A' ' 48' ' ' LEU . 17.3 tptm -63.29 -36.93 85.31 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.19 0.519 . . . . 74.5 109.958 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.2 mt -59.56 -50.41 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.172 -0.467 . . . . 61.54 111.292 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.3 m -54.42 -41.7 69.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.958 0.409 . . . . 70.23 111.082 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.696 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -61.89 -44.43 96.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.441 -0.345 . . . . 72.45 110.892 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.411 ' HG3' HD13 ' A' ' 48' ' ' LEU . 28.9 tt0 -56.85 -40.89 76.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.435 -0.348 . . . . 71.33 111.459 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.6 -50.28 73.65 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.103 0.477 . . . . 62.01 111.335 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.29 -41.72 99.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.164 -0.471 . . . . 74.34 111.325 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.895 0.378 . . . . 73.3 111.005 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.56 -29.18 70.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.088 0.471 . . . . 71.42 110.693 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.13 70.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.218 -0.446 . . . . 71.21 111.245 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -95.01 12.23 29.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.362 0.505 . . . . 75.01 112.362 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -67.35 88.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.949 0.404 . . . . 73.12 111.551 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -66.99 -56.76 8.73 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.195 0.443 . . . . 71.22 112.195 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.2 p -138.23 105.06 5.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.164 0.507 . . . . 71.41 111.226 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 92.12 142.97 11.48 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.176 -0.535 . . . . 34.44 112.956 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 27.2 m -86.35 148.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 112.472 0.545 . . . . 71.12 112.472 -173.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -95.25 114.26 26.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.007 -0.542 . . . . 65.14 112.031 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.02 103.72 13.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.895 0.378 . . . . 74.44 110.727 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.2 mp -82.37 121.96 78.76 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 122.306 -0.246 . . . . 71.13 111.035 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 52.9 Cg_exo -54.94 -32.57 78.95 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.918 2.412 . . . . 71.55 113.726 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.17 11.37 63.12 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.113 -0.565 . . . . 65.45 113.415 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.44 129.6 56.27 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.012 0.434 . . . . 73.52 111.794 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 85.8 tttt -84.85 32.32 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.487 0.661 . . . . 71.24 111.253 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -128.13 133.88 25.62 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 113.445 0.906 . . . . 73.32 113.445 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 91.5 Cg_endo -80.29 179.06 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.431 2.754 . . . . 55.41 113.066 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.76 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.062 0.458 . . . . 60.23 111.801 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -91.77 124.89 36.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.96 0.409 . . . . 72.22 111.015 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.405 HD13 HG13 ' A' ' 45' ' ' VAL . 42.8 tp -120.59 138.33 53.94 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.464 0.542 . . . . 75.34 112.464 -172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.5 117.13 22.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.945 -0.57 . . . . 72.13 110.229 172.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -118.14 173.92 6.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.935 0.398 . . . . 75.14 111.488 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 48.0 mt-30 -79.24 1.41 24.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.194 0.442 . . . . 74.45 112.194 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 157' ' ' PRO . 38.5 pt -105.37 -34.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.983 0.42 . . . . 72.53 110.693 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.46 -156.5 28.32 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.108 -0.496 . . . . 72.43 112.428 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.9 m -98.36 124.33 42.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.951 0.405 . . . . 72.33 110.994 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.99 170.75 15.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.809 0.337 . . . . 44.34 111.905 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -134.25 116.1 14.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.471 0.309 . . . . 71.54 110.526 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.747 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.1 mtt -107.4 155.32 20.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.685 0.624 . . . . 53.02 112.685 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 99.8 p -154.78 157.76 38.45 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.083 -0.508 . . . . 42.24 111.357 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.59 125.93 50.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.556 -0.293 . . . . 64.34 111.677 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.641 HG23 HD22 ' A' ' 70' ' ' ASN . 23.9 m -137.6 169.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.65 0.262 . . . . 62.5 111.416 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.641 HD22 HG23 ' A' ' 69' ' ' VAL . 40.9 m-80 55.54 26.72 9.37 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.543 0.571 . . . . 75.32 112.543 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 53.5 mt -60.67 111.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.819 0.342 . . . . 71.11 111.426 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 151.8 77.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.464 0.542 . . . . 72.01 112.464 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.61 118.8 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.888 2.392 . . . . 72.21 112.521 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' HB2' HG23 ' A' ' 79' ' ' THR . 28.6 t70 -100.37 164.61 11.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.398 -0.365 . . . . 73.31 111.603 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.57 92.28 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 72.12 111.828 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.85 -41.36 15.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.939 0.4 . . . . 74.54 111.404 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.21 -94.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.439 -0.886 . . . . 72.34 114.07 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.5 m -143.71 120.36 11.13 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.562 -0.375 . . . . 52.43 112.002 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 74' ' ' ASP . 8.0 p -96.83 118.71 33.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 62.31 111.127 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.1 pp -132.9 -172.47 2.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.38 -0.373 . . . . 64.44 111.261 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.571 ' HB ' HG23 ' A' ' 69' ' ' VAL . 31.2 m -130.12 111.1 12.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.88 0.371 . . . . 61.4 110.661 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.7 112.88 20.46 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 60.14 110.04 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtm180 -93.96 124.72 38.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.526 -0.306 . . . . 75.42 111.61 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -110.34 97.3 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.473 -0.33 . . . . 71.34 111.05 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.22 108.09 20.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.582 -0.525 . . . . 71.14 109.582 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.22 140.16 29.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.887 -0.673 . . . . 73.5 113.261 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.83 -21.33 57.38 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.384 0.611 . . . . 72.3 110.075 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -64.83 118.46 9.03 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.27 -0.877 . . . . 64.04 111.994 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -71.88 -14.03 61.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.202 0.525 . . . . 42.42 110.905 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.6 p-10 -97.86 149.42 35.7 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.837 -0.62 . . . . 71.44 110.913 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 16.6 Cg_exo -65.68 137.36 49.65 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.606 2.204 . . . . 72.43 113.365 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.17 158.42 31.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.418 -0.356 . . . . 72.42 111.296 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.55 -165.14 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.205 1.937 . . . . 61.21 112.43 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.92 156.13 22.51 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.278 -0.264 . . . . 34.11 110.81 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -150.19 162.86 39.63 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.585 0.707 . . . . 74.25 112.681 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 p -157.74 154.36 28.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.216 -0.902 . . . . 72.24 110.492 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.39 -175.23 35.0 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.278 -0.963 . . . . 70.2 114.039 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 m -111.23 145.43 38.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.494 0.318 . . . . 54.02 110.852 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.0 p -124.13 128.84 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.253 0.464 . . . . 75.25 112.253 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 29.8 mm-40 -98.2 110.37 22.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.248 -0.433 . . . . 73.15 110.325 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HD2' HG21 ' A' ' 142' ' ' ILE . 12.4 p90 -121.7 118.24 28.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.287 0.565 . . . . 75.12 112.064 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.18 -153.43 6.75 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.714 -0.675 . . . . 50.24 113.01 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.536 HE21 ' HB3' ' A' ' 146' ' ' GLN . 77.3 mt-30 -119.29 145.77 45.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.089 0.471 . . . . 71.4 112.27 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.96 104.69 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 75.23 110.606 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.613 HE21 HD13 ' A' ' 114' ' ' ILE . 8.8 pt20 -89.36 -11.89 42.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.839 0.681 . . . . 74.32 112.839 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.11 -168.64 15.69 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.86 -0.686 . . . . 43.31 114.025 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 45.8 p -92.12 -176.66 4.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.703 0.401 . . . . 61.21 111.387 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.696 HD11 ' HG3' ' A' ' 33' ' ' GLN . 50.8 mm -74.36 -26.89 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.255 0.55 . . . . 44.54 110.622 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.9 -35.99 56.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.911 -0.586 . . . . 61.45 110.851 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.66 97.43 2.97 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.124 0.488 . . . . 75.34 111.908 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -122.64 151.27 41.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.277 0.56 . . . . 73.43 111.606 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -132.36 117.81 18.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.876 -0.602 . . . . 64.32 110.402 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.99 108.16 5.75 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.918 0.389 . . . . 71.01 111.091 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.613 HD13 HE21 ' A' ' 105' ' ' GLN . 34.6 pt -113.41 152.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.418 -0.356 . . . . 74.42 111.041 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 57.6 32.89 22.53 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.957 0.408 . . . . 71.02 111.297 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.96 124.72 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.375 0.607 . . . . 63.14 112.127 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -114.88 157.51 23.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.029 -0.532 . . . . 71.43 110.524 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 7.0 p30 -112.22 153.74 26.64 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.807 0.337 . . . . 72.13 111.139 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -153.39 154.05 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.691 0.282 . . . . 75.53 111.456 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -92.18 122.86 35.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.084 0.401 . . . . 73.43 112.084 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.9 pt -112.73 120.83 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.088 0.47 . . . . 73.45 111.516 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -118.03 139.73 50.77 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.259 -0.275 . . . . 72.23 111.13 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.87 149.69 73.04 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.182 0.438 . . . . 74.03 112.182 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.11 164.21 20.38 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.351 2.701 . . . . 74.03 113.988 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.35 26.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.976 -0.556 . . . . 74.44 111.979 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.2 m -83.3 55.01 2.99 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.891 0.377 . . . . 53.01 111.413 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.2 m -70.29 -2.39 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.473 0.916 . . . . 55.34 113.473 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.5 mt -131.01 124.27 30.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.164 -0.335 . . . . 72.05 111.226 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.36 56.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.651 -0.249 . . . . 62.25 111.379 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.14 156.84 94.29 Favored 'Cis proline' 0 C--N 1.355 0.901 0 C-N-CA 123.863 -1.307 . . . . 65.3 112.972 -0.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 p -80.43 57.25 2.78 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.129 0.49 . . . . 74.32 112.17 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.11 89.92 8.18 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.087 0.47 . . . . 75.13 110.084 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.66 154.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.268 -0.424 . . . . 74.23 111.714 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -142.89 144.79 32.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.791 0.329 . . . . 75.34 110.982 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.1 128.39 11.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.651 0.262 . . . . 74.12 111.705 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.71 142.06 47.15 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.286 1.991 . . . . 71.24 112.009 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.48 123.28 20.0 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.625 -0.261 . . . . 73.01 111.212 -172.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -102.1 102.91 13.44 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.121 0.486 . . . . 63.13 111.309 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 71.9 mt -83.55 128.22 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.573 -0.285 . . . . 62.33 110.267 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -103.47 142.93 33.4 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.609 0.596 . . . . 74.53 112.609 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.75 80.44 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.863 -0.608 . . . . 61.41 114.136 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.472 HG21 ' HD2' ' A' ' 101' ' ' TYR . 16.1 tt -149.51 114.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 117.485 0.643 . . . . 74.31 112.042 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 64.6 m -80.47 155.03 27.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.078 0.466 . . . . 61.41 112.214 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.05 -47.99 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 113.372 0.879 . . . . 74.43 113.372 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.91 -16.52 64.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.134 0.492 . . . . 72.34 111.341 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.536 ' HB3' HE21 ' A' ' 103' ' ' GLN . 29.7 mm-40 -108.66 11.56 26.43 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.68 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.543 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -88.94 108.18 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.071 0.462 . . . . 63.43 110.246 178.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.98 -55.43 3.13 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.125 -0.56 . . . . 63.33 113.661 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -145.09 152.53 40.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.973 0.416 . . . . 74.12 111.831 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.63 94.09 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.885 -0.598 . . . . 64.51 110.31 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.637 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 68.7 ttt180 -89.05 107.2 18.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.755 0.422 . . . . 62.44 111.974 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.747 HG21 ' SD ' ' A' ' 66' ' ' MET . 35.9 mm -89.12 126.44 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.468 -0.333 . . . . 74.35 111.432 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.595 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.9 p80 -154.96 177.56 11.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.156 0.428 . . . . 72.4 112.156 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 64.4 23.14 12.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.092 0.557 . . . . 72.33 112.414 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.635 HD13 ' HA3' ' A' ' 97' ' ' GLY . 51.0 mm -67.57 95.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.643 0.735 . . . . 74.13 112.073 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.455 ' HA ' ' HB2' ' A' ' 60' ' ' GLN . 9.0 pt20 -116.78 151.56 47.42 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.266 -0.879 . . . . 72.24 111.449 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 61' ' ' ILE . 58.2 Cg_endo -70.47 128.62 15.63 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 70.53 113.786 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.545 0.788 0 CA-C-O 121.849 0.833 . . . . 71.44 110.886 176.271 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 31' ' ' ILE . 40.5 tt0 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 121.236 0.541 . . . . 71.13 109.91 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.731 ' HA ' HD12 ' A' ' 31' ' ' ILE . 18.6 m -62.1 -37.51 85.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.876 -0.602 . . . . 54.04 111.389 176.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.07 -40.64 86.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.138 0.494 . . . . 74.51 110.753 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.638 ' HE3' HD13 ' A' ' 48' ' ' LEU . 43.5 tptt -64.34 -37.15 86.47 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.065 -0.516 . . . . 70.1 110.35 175.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 28' ' ' THR . 91.1 mt -57.71 -44.24 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.981 -0.554 . . . . 72.13 111.19 173.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.8 m -58.68 -43.38 89.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.204 -0.453 . . . . 51.32 110.805 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.629 ' HG3' HD11 ' A' ' 108' ' ' ILE . 55.9 tt0 -57.79 -48.49 79.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.234 -0.439 . . . . 72.41 111.14 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -51.57 -53.06 42.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.183 -0.462 . . . . 63.21 111.499 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.599 0.592 . . . . 72.53 112.599 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HD2' HG21 ' A' ' 108' ' ' ILE . 20.9 mtm180 -78.6 -38.27 40.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.068 -0.395 . . . . 63.31 111.052 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.27 -46.45 83.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.127 0.489 . . . . 72.24 110.693 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 46' ' ' TYR . 3.8 m-20 -58.36 -38.66 77.69 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.973 -0.558 . . . . 63.35 111.492 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.58 -38.1 80.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.902 0.382 . . . . 75.31 111.411 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 68.2 mttm -76.75 -32.86 58.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.936 0.347 . . . . 60.14 111.936 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -94.27 103.39 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.761 0.652 . . . . 43.15 112.761 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -96.01 27.72 3.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.381 0.61 . . . . 50.3 110.684 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -139.73 38.76 2.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.025 -0.534 . . . . 70.32 110.584 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.591 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 129.49 158.01 9.36 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.142 -0.481 . . . . 75.04 112.799 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG13 HD13 ' A' ' 57' ' ' LEU . 35.1 m -100.85 147.06 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.295 0.48 . . . . 74.14 112.295 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.454 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 31.8 m-85 -93.31 139.5 30.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.084 0.469 . . . . 75.3 110.962 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.82 119.99 29.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 62.04 109.756 172.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.638 HD13 ' HE3' ' A' ' 30' ' ' LYS . 79.0 mt -97.46 134.24 22.81 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 111.851 0.315 . . . . 72.33 111.851 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 32.0 Cg_endo -62.79 -24.64 74.56 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.577 2.184 . . . . 71.14 112.876 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.01 18.54 55.88 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.078 -0.51 . . . . 53.0 112.825 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -144.3 106.75 4.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.954 0.407 . . . . 60.22 110.915 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -74.42 11.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.623 0.601 . . . . 71.23 112.623 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -85.7 141.99 36.64 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 112.987 0.736 . . . . 53.15 112.987 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.56 -178.03 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.151 2.568 . . . . 74.53 113.516 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.18 137.03 28.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.71 -0.677 . . . . 63.13 110.785 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -82.48 97.93 8.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.023 0.439 . . . . 64.21 111.268 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.416 HD13 HG13 ' A' ' 45' ' ' VAL . 61.0 tp -104.87 122.75 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.031 0.444 . . . . 75.13 111.153 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.3 tt0 -95.86 108.55 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.11 110.543 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.9 p -96.89 -178.18 4.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.567 0.58 . . . . 71.41 112.567 -172.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.9 mt-30 -76.32 -4.88 44.47 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.857 -0.61 . . . . 71.03 112.02 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 92' ' ' LEU . 39.5 pt -108.48 -34.03 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.794 0.33 . . . . 73.21 111.173 175.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.69 172.27 36.1 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.234 -0.508 . . . . 44.12 112.885 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 33.8 m -77.46 124.77 28.34 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.501 -0.411 . . . . 71.3 111.327 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 155' ' ' ILE . 2.4 pp -129.98 165.03 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.49 0.662 . . . . 63.23 111.909 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -129.82 100.19 5.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.659 -0.7 . . . . 74.21 110.863 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.695 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.3 mtt -102.73 148.93 24.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.68 0.622 . . . . 70.34 112.68 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -148.42 161.03 42.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.818 0.342 . . . . 71.0 111.563 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.481 HD22 HD13 ' A' ' 80' ' ' LEU . 93.2 mt -105.44 119.32 38.8 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.797 0.332 . . . . 72.25 111.199 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.636 HG23 HD22 ' A' ' 70' ' ' ASN . 21.9 m -135.65 161.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.618 0.247 . . . . 75.15 111.655 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.636 HD22 HG23 ' A' ' 69' ' ' VAL . 31.4 m-80 60.85 34.49 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.175 0.512 . . . . 75.15 111.672 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.79 114.52 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.446 . . . . 73.52 111.742 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -138.46 150.74 67.37 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.371 . . . . 73.41 111.895 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.47 155.36 70.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.809 2.339 . . . . 64.21 113.165 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.492 ' HB2' HG23 ' A' ' 79' ' ' THR . 29.0 t70 -142.05 162.99 34.09 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.476 . . . . 71.4 111.214 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.37 -43.39 97.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 64.4 111.863 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -81.91 -25.05 35.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.623 0.249 . . . . 55.52 111.615 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.73 -99.95 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.955 -0.64 . . . . 61.43 113.52 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.1 m -145.89 125.75 13.53 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.002 0.43 . . . . 73.25 111.565 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 74' ' ' ASP . 39.9 p -97.0 123.07 40.63 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.716 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.481 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -138.39 165.79 25.9 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.102 0.477 . . . . 62.32 111.712 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 69' ' ' VAL . 48.5 m -107.91 123.44 48.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.257 -0.429 . . . . 74.12 111.274 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -99.75 109.58 22.02 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.309 -0.405 . . . . 72.24 110.193 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' MET . 49.5 mtm180 -89.45 128.27 35.93 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.663 -0.244 . . . . 53.04 110.92 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 135' ' ' ILE . 3.4 mp -113.02 91.11 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.86 0.362 . . . . 71.14 110.538 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -92.75 106.49 18.45 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.84 -0.43 . . . . 71.43 109.84 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA3' ' OG ' ' A' ' 131' ' ' SER . . . -66.1 123.25 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.919 -0.658 . . . . 53.51 113.091 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.33 -25.6 66.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.513 0.673 . . . . 73.1 110.443 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -88.47 119.93 29.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.325 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.42 -22.86 63.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.949 0.404 . . . . 54.43 111.678 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -65.9 135.08 95.23 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.319 -0.4 . . . . 55.34 111.583 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.83 120.19 7.84 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.894 2.396 . . . . 72.11 113.097 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.6 mt -88.67 149.61 44.37 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.551 -0.295 . . . . 74.12 111.255 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.01 176.07 10.01 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.399 2.066 . . . . 61.34 113.167 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.24 47.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.827 0.346 . . . . 52.3 111.434 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.95 159.14 42.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.535 0.684 . . . . 75.55 112.638 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.7 p -141.38 163.94 31.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.495 -0.775 . . . . 63.21 110.141 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.648 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.31 169.68 38.48 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.278 -0.963 . . . . 53.25 114.005 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 28.2 m -99.9 129.39 45.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.699 0.4 . . . . 73.32 110.727 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 24.5 m -112.53 117.01 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.103 0.477 . . . . 72.34 111.57 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 43.7 mt-10 -92.82 103.61 15.94 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.574 -0.285 . . . . 75.41 110.787 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -112.91 137.05 51.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.009 0.433 . . . . 70.41 111.61 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.04 -145.96 4.91 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.004 -0.544 . . . . 35.44 112.957 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.474 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -130.39 145.8 51.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.995 0.426 . . . . 72.2 111.95 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.0 mt -105.4 120.99 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.478 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.08 3.36 54.9 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.402 0.89 . . . . 73.44 113.402 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.04 -162.67 9.3 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.077 -1.059 . . . . 65.22 114.724 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -88.34 -161.96 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.031 0.532 . . . . 75.31 111.585 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.629 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.5 mm -83.72 -21.97 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.409 0.624 . . . . 54.34 110.421 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.25 -37.12 12.85 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.962 -0.563 . . . . 74.33 111.337 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.47 106.6 5.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.19 0.519 . . . . 71.14 111.377 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -154.07 153.47 31.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.158 0.504 . . . . 73.14 112.235 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -125.77 146.91 49.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.965 -0.561 . . . . 74.22 110.766 173.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.32 105.62 17.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.882 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 103' ' ' GLN . 35.6 pt -110.72 157.54 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.498 -0.319 . . . . 64.22 111.446 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 56.28 29.24 14.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.075 0.464 . . . . 72.31 111.666 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.78 131.58 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.256 0.55 . . . . 71.15 112.321 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.45 164.99 28.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.906 -0.588 . . . . 73.34 110.258 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.6 p-10 -115.01 142.09 47.11 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.956 0.724 . . . . 74.24 112.956 -173.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.42 154.91 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.666 -0.697 . . . . 65.44 110.283 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.72 122.59 42.14 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.983 0.364 . . . . 73.51 111.983 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.7 pt -102.1 143.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.503 -0.317 . . . . 75.12 111.063 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.44 119.58 19.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.972 0.415 . . . . 73.52 111.673 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.57 144.04 31.72 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 111.776 0.287 . . . . 75.34 111.776 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.28 163.3 36.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.65 2.233 . . . . 74.52 113.602 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.17 138.77 40.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.117 0.484 . . . . 75.21 112.233 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -81.55 119.1 23.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.325 -0.398 . . . . 71.33 110.772 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.626 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.9 m -93.78 -28.89 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.931 0.396 . . . . 72.35 111.228 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.626 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.0 mt -117.89 -178.5 3.51 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.987 0.423 . . . . 71.5 111.163 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -118.82 151.68 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 111.793 0.294 . . . . 62.15 111.793 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.49 -177.44 20.12 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.1 -1.209 . . . . 73.35 113.392 -2.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.476 ' OG ' ' HA3' ' A' ' 86' ' ' GLY . 53.9 p -90.2 40.62 1.01 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.101 0.477 . . . . 73.2 112.008 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -84.12 99.7 10.66 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.39 0.614 . . . . 62.13 111.423 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.36 134.11 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.215 -0.448 . . . . 65.35 111.301 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -114.78 127.09 55.54 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.241 -0.287 . . . . 64.43 111.174 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 84' ' ' ILE . 33.1 pt -131.09 146.4 61.92 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.181 0.437 . . . . 74.11 112.181 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.9 161.99 20.99 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.552 2.168 . . . . 73.13 112.496 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.93 125.37 10.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.804 0.335 . . . . 63.23 110.51 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -108.59 106.38 16.43 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.049 0.452 . . . . 65.24 111.512 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.92 135.18 33.78 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.65 -0.25 . . . . 65.35 110.772 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -109.68 149.83 29.17 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.312 0.486 . . . . 71.34 112.312 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.92 83.06 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.153 -0.476 . . . . 71.15 113.873 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 147' ' ' LEU . 17.1 tt -143.68 135.17 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.026 0.441 . . . . 75.21 111.401 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.2 m -101.71 147.52 26.35 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.61 -0.268 . . . . 54.42 111.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.61 -43.83 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.744 0.646 . . . . 55.24 112.744 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.46 -28.27 69.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.001 0.429 . . . . 70.5 111.675 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -108.11 13.13 26.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.166 -0.47 . . . . 65.11 111.664 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.633 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.4 tt -81.0 120.8 25.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 73.45 110.407 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.27 -59.0 1.32 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.971 -0.633 . . . . 53.22 113.333 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.51 153.52 35.98 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.4 . . . . 73.1 111.911 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 65.9 t -125.99 107.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.01 -0.541 . . . . 63.21 110.046 170.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 38.5 ttt180 -96.22 110.94 23.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.823 0.344 . . . . 72.24 111.683 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.695 HG21 ' SD ' ' A' ' 66' ' ' MET . 18.0 mm -90.48 124.23 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.513 -0.312 . . . . 64.32 111.331 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.591 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 1.8 p80 -159.55 -176.75 5.94 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.372 0.508 . . . . 64.01 112.372 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 98' ' ' THR . 54.4 m-20 63.15 17.87 10.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.695 0.628 . . . . 63.14 112.695 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.648 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.5 mm -61.54 103.49 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.471 0.653 . . . . 73.14 111.097 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.416 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.2 pt20 -136.52 158.3 73.57 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.762 -0.654 . . . . 71.21 111.451 -174.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.43 132.37 23.72 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.366 2.044 . . . . 62.34 112.665 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.895 0.379 . . . . 63.34 111.783 -178.828 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 120.968 0.413 . . . . 74.3 110.4 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -65.36 -34.81 79.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.062 0.458 . . . . 75.24 110.785 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.86 -38.66 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.307 -0.406 . . . . 60.41 110.854 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -30.64 69.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.44 -0.346 . . . . 75.45 111.664 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.6 mt -61.44 -51.38 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.025 0.44 . . . . 75.22 110.496 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.4 m -58.92 -45.37 90.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.04 0.447 . . . . 74.01 110.832 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.655 HE21 HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -55.85 -45.58 78.4 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.794 -0.639 . . . . 70.44 111.256 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -63.17 -54.39 38.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.946 -0.57 . . . . 74.54 111.578 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.49 -35.86 74.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.351 -0.386 . . . . 73.35 112.033 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -64.89 -48.57 73.76 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.275 -0.265 . . . . 74.52 111.251 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.07 -41.64 88.48 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.251 0.548 . . . . 63.01 110.79 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.11 -43.52 82.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.661 -0.7 . . . . 72.44 111.401 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -33.69 64.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.31 0.485 . . . . 73.35 112.31 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -84.2 -7.79 59.25 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.272 0.471 . . . . 75.25 112.272 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.6 t -107.44 119.17 38.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.248 0.547 . . . . 75.4 111.946 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.6 p -83.6 -45.77 13.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.127 -0.488 . . . . 54.45 110.839 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.7 m -73.64 81.72 1.53 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.182 -0.463 . . . . 70.44 111.708 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 89.29 -171.72 38.84 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.204 -0.453 . . . . 73.23 113.848 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 57' ' ' LEU . 35.8 m -121.02 142.81 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 44.32 111.846 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.69 133.44 37.04 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.934 0.397 . . . . 74.31 111.946 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.75 138.44 52.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.854 -0.612 . . . . 53.1 110.187 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 74.8 mt -112.64 137.55 21.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 112.076 0.399 . . . . 72.21 112.076 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 16.0 Cg_exo -66.55 -30.81 42.61 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.724 2.283 . . . . 72.12 113.022 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.96 -8.04 67.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 114.314 0.486 . . . . 41.4 114.314 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.68 97.28 2.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.51 0.655 . . . . 74.52 111.901 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.87 88.88 0.11 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.847 0.832 . . . . 70.23 111.418 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -137.02 151.43 72.05 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 112.633 0.605 . . . . 73.44 112.633 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 89.2 Cg_endo -80.74 159.66 21.65 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.116 2.544 . . . . 73.25 114.06 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.19 144.8 27.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.986 -0.552 . . . . 63.33 110.632 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -83.69 119.56 24.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.943 0.401 . . . . 73.54 111.67 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.528 HD13 HG13 ' A' ' 45' ' ' VAL . 46.5 tp -113.83 119.45 37.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.335 0.588 . . . . 53.44 110.658 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.52 110.77 22.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.963 -0.562 . . . . 72.14 110.348 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.4 p -115.72 -174.32 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.505 0.669 . . . . 74.52 112.751 -170.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -72.65 -24.68 61.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.583 -0.735 . . . . 74.43 112.196 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.8 pt -91.37 -7.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.795 0.331 . . . . 72.54 111.499 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.62 -167.75 23.8 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.366 -0.445 . . . . 62.53 113.056 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 m -91.7 123.08 34.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.865 0.364 . . . . 62.44 111.069 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.45 164.2 28.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.108 0.48 . . . . 75.44 111.625 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -124.04 114.63 19.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.279 -0.419 . . . . 74.51 110.916 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.4 mtt -98.56 143.39 29.02 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.929 0.395 . . . . 44.4 111.936 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 33.3 p -141.07 142.77 34.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.128 0.49 . . . . 71.42 111.848 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 82.4 mt -97.9 122.14 40.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.16 -0.473 . . . . 73.51 111.411 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 81' ' ' THR . 23.2 m -132.68 163.06 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.647 -0.251 . . . . 74.23 110.941 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 60.28 33.55 20.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.193 0.521 . . . . 74.52 111.939 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 68' ' ' LEU . 46.5 mt -71.9 106.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.192 -0.458 . . . . 64.04 111.677 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 p -135.17 149.85 71.21 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 112.419 0.526 . . . . 62.45 112.419 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.47 148.87 55.12 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.84 2.36 . . . . 25.24 113.099 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.4 -175.44 3.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.359 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.96 -45.86 39.44 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.993 -0.442 . . . . 64.2 111.998 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 2.1 p30 -92.36 -24.31 18.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.395 0.517 . . . . 72.41 112.395 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -164.97 -118.98 0.46 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.567 -0.825 . . . . 72.53 114.047 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.1 m -139.78 132.13 28.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.607 -0.349 . . . . 75.53 111.588 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.3 p -108.59 123.44 48.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.055 0.455 . . . . 71.42 111.502 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -139.09 151.91 47.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 73.45 111.079 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.711 ' HB ' HG23 ' A' ' 69' ' ' VAL . 27.3 m -90.35 111.05 22.13 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.301 -0.249 . . . . 61.2 110.936 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.58 108.41 19.05 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.543 -0.54 . . . . 73.25 109.543 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.432 ' HE ' ' CG ' ' A' ' 134' ' ' ASP . 23.9 mtp-105 -98.64 131.58 44.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.781 0.324 . . . . 53.01 111.627 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.2 mp -114.04 96.48 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.657 -0.247 . . . . 63.53 111.051 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.4 103.73 15.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.654 0.264 . . . . 71.4 110.623 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.87 131.77 26.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.72 -0.753 . . . . 53.53 112.876 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -68.56 -25.49 64.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.234 0.54 . . . . 72.23 110.593 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.5 m -79.11 117.26 19.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.868 -0.605 . . . . 42.31 110.223 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -80.02 41.05 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.355 0.598 . . . . 75.5 112.131 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.59 154.18 80.83 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.1 0.56 . . . . 64.44 110.215 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 19.7 Cg_endo -59.14 109.0 0.47 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.492 2.128 . . . . 45.21 112.681 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.77 151.03 57.45 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.079 -0.509 . . . . 50.14 112.152 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.88 159.73 41.4 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.467 2.111 . . . . 61.23 112.841 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.55 136.76 56.79 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.983 0.421 . . . . 73.43 111.641 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -133.76 163.31 29.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.417 0.627 . . . . 74.23 112.575 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.4 p -134.73 132.94 39.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.421 -0.809 . . . . 74.53 110.564 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.783 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -133.98 166.01 24.13 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.731 -0.747 . . . . 64.15 113.195 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.4 m -108.61 124.85 51.14 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.669 -0.313 . . . . 71.1 110.917 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.5 p -106.2 118.4 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.044 0.449 . . . . 72.3 112.144 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.6 mm-40 -89.32 113.18 24.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 73.4 110.041 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -122.81 128.7 50.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.158 0.504 . . . . 63.15 111.746 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.54 4.44 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.907 -0.588 . . . . 51.01 112.636 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.645 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.3 mt-30 -128.12 156.34 43.0 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.217 0.532 . . . . 60.5 112.213 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.42 120.91 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.17 -0.468 . . . . 51.44 111.211 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -93.19 -30.99 14.93 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.538 0.57 . . . . 71.21 112.538 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -93.25 -157.67 33.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.027 -0.606 . . . . 72.03 114.175 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.7 p -92.97 -173.69 3.36 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.933 0.397 . . . . 51.51 111.425 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.655 HD11 HE21 ' A' ' 33' ' ' GLN . 36.5 mm -82.58 -3.26 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.348 0.594 . . . . 63.01 111.213 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -109.04 -39.19 5.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.233 0.54 . . . . 73.11 110.791 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -134.9 102.37 5.21 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.864 -0.607 . . . . 52.34 111.344 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 107' ' ' THR . 34.8 p90 -141.8 148.67 39.27 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.101 0.477 . . . . 75.24 111.801 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -109.44 126.03 53.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.001 -0.545 . . . . 74.22 110.703 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.8 105.28 4.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.27 -0.423 . . . . 75.01 110.91 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 pt -110.12 152.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 111.759 0.281 . . . . 43.44 111.759 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 57.68 29.6 17.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.967 0.413 . . . . 72.21 111.842 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -95.1 115.55 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.883 0.697 . . . . 73.21 112.883 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.58 ' H ' ' NE2' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -117.73 170.98 8.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.985 -0.552 . . . . 64.32 110.154 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 22.9 p30 -123.87 162.62 22.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.341 0.867 . . . . 74.23 113.341 -171.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -144.18 152.24 40.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.313 -0.858 . . . . 74.35 110.366 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.52 117.16 28.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.892 0.377 . . . . 44.11 111.301 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 121' ' ' ILE . 30.0 pt -102.86 103.13 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.523 0.678 . . . . 51.4 111.368 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.05 114.87 29.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.115 -0.493 . . . . 70.42 111.348 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.464 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -95.05 139.37 22.05 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.543 -0.299 . . . . 71.3 111.287 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 32.5 Cg_exo -62.07 170.65 5.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.879 2.386 . . . . 75.14 113.397 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.56 10.83 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.052 0.453 . . . . 41.53 111.556 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -77.54 69.01 3.74 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.222 0.534 . . . . 62.4 111.281 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.55 -19.39 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.073 0.463 . . . . 53.01 111.734 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.7 mt -85.86 136.89 33.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.345 -0.389 . . . . 63.2 111.675 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.482 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -122.18 127.7 25.8 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.31 -0.405 . . . . 24.05 111.199 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.72 154.53 97.7 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.074 -1.219 . . . . 74.51 113.331 1.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.9 m -87.91 92.64 9.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.002 0.742 . . . . 54.31 113.002 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 8.3 p-10 -117.96 100.54 7.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.401 0.62 . . . . 62.4 110.158 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' ARG . 32.2 t -87.12 144.12 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.012 0.745 . . . . 72.32 113.012 -170.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.432 ' CG ' ' HE ' ' A' ' 83' ' ' ARG . 1.2 m-20 -115.11 115.48 26.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.887 -0.597 . . . . 75.24 110.622 175.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.8 pt -125.95 126.53 24.83 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 120.904 0.383 . . . . 63.2 111.964 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 9.9 Cg_exo -71.83 111.63 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.935 2.423 . . . . 43.34 112.274 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -103.81 115.4 30.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.267 -0.424 . . . . 54.31 110.523 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -105.92 103.28 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.3 0.571 . . . . 72.33 111.347 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.509 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 81.1 mt -78.76 138.76 38.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.17 -0.468 . . . . 55.05 109.911 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -116.23 135.76 53.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.427 0.529 . . . . 73.43 112.427 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.51 40.28 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.091 -0.504 . . . . 44.33 113.094 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.6 tt -115.19 126.86 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.202 0.525 . . . . 71.41 111.659 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.2 m -94.73 149.17 21.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.805 0.298 . . . . 71.1 111.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 p -50.37 -44.42 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.793 1.034 . . . . 73.44 113.793 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.56 -31.8 71.27 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.885 -0.509 . . . . 73.14 111.018 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -95.52 9.05 41.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.205 -0.452 . . . . 54.23 111.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.547 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.9 tt -85.45 115.84 23.41 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.097 0.475 . . . . 51.54 110.406 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -81.68 -59.55 2.33 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.326 -0.464 . . . . 72.5 113.203 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.76 149.1 31.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.086 0.47 . . . . 71.52 112.16 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.9 106.71 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.694 -0.685 . . . . 64.3 109.713 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.4 ttt180 -107.58 106.33 16.63 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.09 0.404 . . . . 75.23 112.09 -172.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.669 HG21 ' SD ' ' A' ' 66' ' ' MET . 25.6 mm -89.6 134.32 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.657 -0.247 . . . . 43.45 111.293 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.438 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.2 p80 -164.61 174.83 10.39 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.655 0.264 . . . . 73.41 111.664 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 62.72 32.75 15.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.327 0.492 . . . . 73.41 112.327 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.783 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.2 mm -66.71 99.48 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.257 -0.429 . . . . 60.41 110.804 175.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.51 151.58 67.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.264 -0.425 . . . . 62.51 111.196 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.7 149.55 89.47 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.801 2.334 . . . . 74.13 113.797 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.841 175.729 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.06 0.457 . . . . 73.31 110.594 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.5 m -59.02 -33.63 70.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.077 -0.51 . . . . 70.33 111.329 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -45.31 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.602 -0.272 . . . . 74.4 111.169 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -62.49 -44.44 96.37 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.53 0.205 . . . . 75.11 111.175 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 53' ' ' THR . 75.7 mt -54.26 -55.66 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.414 0.626 . . . . 75.22 110.831 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.533 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 89.5 m -56.0 -44.05 78.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.623 -0.717 . . . . 73.42 111.148 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.81 -44.5 90.84 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.591 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.6 -42.65 93.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.832 0.348 . . . . 74.23 111.167 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -60.95 -45.27 95.38 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.109 0.48 . . . . 72.42 111.199 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 32' ' ' THR . 70.9 mtp180 -65.19 -42.54 93.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.11 -0.495 . . . . 73.22 111.412 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.19 -37.63 86.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.885 0.374 . . . . 75.44 110.998 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.013 0.435 . . . . 74.23 110.686 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.54 66.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.292 -0.413 . . . . 50.45 111.941 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' NZ ' ' HA ' ' A' ' 109' ' ' ASP . 85.5 mttt -82.84 -18.74 39.35 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.634 0.605 . . . . 73.03 112.634 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -59.12 115.61 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.867 0.365 . . . . 73.32 111.97 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -92.07 -27.68 17.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.591 -0.277 . . . . 63.24 111.55 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.409 ' HB2' HH21 ' A' ' 151' ' ' ARG . 42.3 m -117.21 86.39 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.892 0.377 . . . . 71.51 111.374 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 83.77 -132.95 11.44 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.174 -0.536 . . . . 43.41 113.359 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.66 154.09 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.171 0.51 . . . . 63.43 111.916 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.42 101.29 10.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.067 -0.515 . . . . 75.03 111.268 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.555 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 87.1 mt -85.27 133.98 34.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 73.43 110.815 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 79.7 mt -107.15 108.55 62.08 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 120.722 0.296 . . . . 65.21 111.211 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.1 Cg_endo -57.03 -22.92 49.41 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.014 2.476 . . . . 72.25 113.654 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.75 -26.35 71.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.133 -0.556 . . . . 63.42 113.238 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.416 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -124.66 112.99 17.43 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.697 -0.296 . . . . 71.3 111.584 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HD2' HG12 ' A' ' 69' ' ' VAL . 38.8 ttpt -74.62 75.71 2.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.699 0.762 . . . . 71.31 111.019 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 31' ' ' ILE . 4.4 p -133.05 145.19 55.94 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.751 -0.659 . . . . 72.21 111.732 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 145.22 33.19 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.008 2.472 . . . . 74.11 113.711 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.86 153.02 40.18 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.885 -0.598 . . . . 64.44 110.558 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 56' ' ' ARG . 35.5 ttm105 -95.78 117.8 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.925 0.393 . . . . 74.54 111.463 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.434 HD23 ' HE3' ' A' ' 66' ' ' MET . 45.7 tp -118.3 124.69 48.41 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.296 0.569 . . . . 75.12 112.172 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.51 102.44 14.1 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.931 -0.577 . . . . 43.01 110.584 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 p -94.46 -172.71 2.84 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.222 0.534 . . . . 74.32 111.792 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.605 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.2 mt-30 -91.99 -2.71 56.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.109 -0.496 . . . . 61.54 111.296 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -105.72 -19.04 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.001 0.429 . . . . 64.43 110.901 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.8 160.68 9.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.101 -0.499 . . . . 64.34 112.651 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -62.53 127.57 31.94 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.152 0.476 . . . . 73.45 110.678 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.45 165.85 26.31 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.137 0.494 . . . . 64.41 111.728 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -119.15 114.79 23.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.256 -0.429 . . . . 74.45 110.763 -176.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 152' ' ' ILE . 61.7 mtt -104.01 150.9 23.83 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.987 0.422 . . . . 75.31 112.068 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.3 p -151.61 153.32 34.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.324 -0.398 . . . . 64.04 111.563 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.48 ' HB3' HD11 ' A' ' 71' ' ' ILE . 97.4 mt -103.33 112.84 25.91 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.266 -0.425 . . . . 75.31 111.352 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' A' ' 81' ' ' THR . 29.8 m -121.22 156.76 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.863 0.364 . . . . 61.31 111.646 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 59.89 37.13 21.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.123 -0.49 . . . . 70.43 111.857 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 68' ' ' LEU . 49.8 mt -69.87 101.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.903 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 18.0 p -121.23 162.95 33.02 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 115.97 -0.559 . . . . 63.35 111.574 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 57.5 Cg_endo -69.88 166.43 27.79 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.238 1.959 . . . . 53.04 113.019 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HB2' HG23 ' A' ' 79' ' ' THR . 30.4 t70 -128.22 165.57 20.21 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.116 -0.493 . . . . 74.32 110.281 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.23 69.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.049 0.452 . . . . 75.32 111.413 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.2 -47.55 3.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.204 -0.453 . . . . 61.55 111.316 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -136.55 -103.6 0.69 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.804 -0.712 . . . . 61.12 114.129 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 147' ' ' LEU . 96.0 m -143.56 130.96 20.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.245 0.461 . . . . 63.31 112.245 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 74' ' ' ASP . 40.0 p -104.36 114.22 28.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.679 0.392 . . . . 65.01 111.626 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.1 pp -137.24 149.18 46.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.89 0.376 . . . . 72.33 111.72 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.661 ' HB ' HG23 ' A' ' 69' ' ' VAL . 48.6 m -93.52 113.64 25.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.047 0.451 . . . . 64.21 111.353 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.46 112.51 24.18 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.024 -0.535 . . . . 75.3 110.132 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 32.9 mtp180 -97.27 126.6 42.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.5 107.23 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.189 -0.459 . . . . 74.11 110.62 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -106.74 106.59 17.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.727 0.299 . . . . 35.05 111.051 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.48 129.75 49.28 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.095 -0.574 . . . . 74.41 113.154 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -81.76 58.92 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.428 0.632 . . . . 72.53 111.137 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -168.49 -166.43 0.68 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.1 -0.5 . . . . 73.33 110.638 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -112.01 12.57 20.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.048 0.451 . . . . 74.24 110.628 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.66 136.1 39.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.1 -0.5 . . . . 71.5 111.975 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.39 95.43 1.04 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.242 1.961 . . . . 74.11 111.635 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.61 139.87 81.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.251 -0.432 . . . . 63.02 111.996 -176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.03 174.56 12.62 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.584 2.19 . . . . 70.33 112.901 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.47 138.69 58.52 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.123 0.487 . . . . 44.14 111.523 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -138.45 171.36 14.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.376 0.607 . . . . 61.44 112.292 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.4 p -152.92 156.73 39.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.685 -0.689 . . . . 73.44 110.746 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.579 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.5 -178.12 36.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.909 -0.662 . . . . 71.44 113.072 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.3 m -108.31 127.3 53.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.816 0.341 . . . . 62.41 111.441 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.95 123.31 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.206 0.527 . . . . 73.23 111.416 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.8 mt-10 -104.96 107.69 18.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 75.34 110.601 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -112.5 129.13 56.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 71.34 111.897 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.97 -145.78 4.53 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.964 -0.562 . . . . 74.11 112.835 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.666 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.7 mt-30 -125.71 141.14 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.031 0.443 . . . . 64.12 112.147 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.35 122.71 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.265 -0.425 . . . . 60.43 111.349 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HG3' ' HB2' ' A' ' 112' ' ' GLN . 3.9 pt20 -111.99 99.76 8.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.474 0.654 . . . . 75.31 110.39 170.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 154.15 -169.17 32.59 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.038 -0.601 . . . . 72.34 113.852 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -100.43 -165.15 1.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.098 0.475 . . . . 63.23 111.753 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -72.19 -21.38 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.182 0.515 . . . . 73.33 111.185 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.51 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 37.6 t70 -105.89 -39.63 5.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 63.42 111.874 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.49 91.77 3.59 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 75.52 111.483 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.61 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 40.0 p90 -127.93 143.45 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.964 0.412 . . . . 74.22 111.751 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 49.6 mt-30 -118.24 133.69 55.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 73.03 111.688 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -88.14 109.7 20.1 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.317 -0.401 . . . . 60.44 110.951 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.405 HD13 ' NE2' ' A' ' 105' ' ' GLN . 39.9 pt -123.81 162.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 111.886 0.328 . . . . 65.32 111.886 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 53.42 28.95 8.1 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.514 0.561 . . . . 72.21 112.514 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 p -90.17 138.96 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.823 0.675 . . . . 55.52 112.823 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -124.66 151.8 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.493 -0.776 . . . . 74.44 110.525 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.29 132.08 54.06 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.337 0.589 . . . . 71.25 111.75 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -129.69 156.27 44.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.035 -0.53 . . . . 61.41 110.202 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.6 mt -96.83 119.92 36.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 73.31 111.145 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.725 HG22 HD21 ' A' ' 137' ' ' LEU . 15.4 pt -99.65 100.76 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.337 0.589 . . . . 65.43 111.732 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.19 131.67 50.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.006 -0.543 . . . . 75.03 110.268 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.22 148.32 65.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.394 0.516 . . . . 71.34 112.394 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.2 175.45 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.116 2.544 . . . . 73.21 113.42 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.04 144.47 29.04 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.803 0.668 . . . . 75.12 112.803 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.6 m -87.72 102.72 14.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.203 -0.453 . . . . 72.01 110.374 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.0 m -80.6 -14.04 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.404 0.52 . . . . 71.13 112.404 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -138.81 -179.79 6.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.906 0.384 . . . . 53.45 111.233 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.95 144.52 28.75 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.533 -0.303 . . . . 72.15 111.469 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.36 170.48 53.79 Favored 'Cis proline' 0 C--N 1.352 0.724 0 C-N-CA 123.932 -1.278 . . . . 70.31 112.825 -0.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 t -86.58 85.92 7.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 63.03 111.378 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.56 122.85 48.88 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.859 -0.422 . . . . 75.02 109.859 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -135.35 112.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.12 -0.362 . . . . 73.12 111.198 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -112.81 134.79 54.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.321 0.581 . . . . 74.14 111.96 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -125.31 133.45 24.86 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.813 -0.63 . . . . 63.02 112.345 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.32 111.81 3.4 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.851 2.367 . . . . 63.54 112.439 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.725 HD21 HG22 ' A' ' 121' ' ' ILE . 23.6 mt -94.4 141.1 28.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 71.31 112.63 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.05 92.79 3.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.663 -0.699 . . . . 42.14 110.21 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.4 mt -77.13 132.16 38.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.125 -0.488 . . . . 64.33 110.775 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -96.31 145.89 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.536 0.569 . . . . 64.23 112.536 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 56.98 31.48 61.47 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.064 0.786 . . . . 64.01 115.064 172.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.1 tt -152.09 127.97 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 117.602 0.701 . . . . 75.42 111.606 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.4 m -86.83 144.24 27.11 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.306 -0.407 . . . . 50.03 111.709 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.31 -44.24 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.631 0.604 . . . . 54.21 112.631 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.56 -21.62 66.45 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.025 0.441 . . . . 75.21 111.417 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.469 ' HB3' HE21 ' A' ' 103' ' ' GLN . 81.6 mm-40 -107.1 10.63 30.13 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.084 0.401 . . . . 71.41 112.084 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.583 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.9 mt -68.84 115.26 7.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.785 0.326 . . . . 74.41 111.499 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -89.73 -49.39 3.39 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.168 -0.539 . . . . 63.12 113.298 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.16 157.37 38.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.246 0.546 . . . . 70.33 112.273 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 60.8 t -124.23 98.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.709 -0.678 . . . . 73.21 110.1 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 70.2 ttt180 -90.25 101.28 14.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.305 -0.407 . . . . 73.3 111.739 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.669 HG21 ' SD ' ' A' ' 66' ' ' MET . 33.2 mm -94.22 132.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 122.273 -0.267 . . . . 53.51 111.56 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.76 172.36 13.11 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.411 0.523 . . . . 73.32 112.411 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 65.09 22.23 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.313 0.857 . . . . 74.2 113.313 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.579 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.8 mm -63.62 101.81 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.112 0.482 . . . . 54.0 111.499 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.605 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 12.1 pt20 -129.17 159.21 70.11 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.071 -0.513 . . . . 75.35 111.174 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 156' ' ' GLN . 74.0 Cg_endo -73.01 150.96 49.51 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.157 1.905 . . . . 71.04 113.134 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.545 0.757 0 CA-C-N 116.162 -0.472 . . . . 61.24 110.889 177.797 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 25.1 tt0 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.851 0.357 . . . . 75.23 110.861 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -35.07 70.22 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.13 0.49 . . . . 71.43 110.776 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.9 -44.76 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.205 -0.452 . . . . 71.3 110.893 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -61.05 -39.84 91.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.657 0.265 . . . . 71.33 110.969 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.99 -48.19 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.081 0.467 . . . . 64.45 110.967 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.5 m -57.18 -49.5 75.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.132 0.491 . . . . 73.44 110.903 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HG3' HD12 ' A' ' 108' ' ' ILE . 63.6 tt0 -59.49 -43.73 93.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.964 -0.562 . . . . 75.15 111.337 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.39 -51.97 66.33 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.748 0.419 . . . . 70.31 111.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -58.95 -44.76 91.49 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.986 0.365 . . . . 63.23 111.986 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -63.98 -49.3 73.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.61 0.226 . . . . 75.02 111.61 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 48' ' ' LEU . 73.6 mt -60.58 -41.35 94.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.322 0.582 . . . . 54.31 110.883 176.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.497 HD21 ' HB ' ' A' ' 45' ' ' VAL . 11.8 t-20 -58.37 -46.22 86.73 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.702 -0.681 . . . . 64.24 110.846 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.45 -25.6 63.26 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.046 -0.525 . . . . 74.23 111.965 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -83.37 -14.78 52.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.401 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 44.2 t -64.22 137.0 57.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.343 0.497 . . . . 73.44 112.343 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -108.93 8.89 26.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.206 -0.452 . . . . 71.05 111.047 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -160.64 117.86 2.42 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.903 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.34 -170.46 15.93 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.332 -0.461 . . . . 75.33 113.661 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 38' ' ' ASN . 31.6 m -115.87 140.5 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.318 -0.519 . . . . 73.43 112.104 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 40.9 m-85 -89.75 118.7 29.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.313 -0.403 . . . . 63.53 111.465 175.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.9 123.4 50.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.908 0.483 . . . . 75.42 109.937 171.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 37' ' ' LEU . 68.4 mt -101.66 121.73 50.15 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.279 0.474 . . . . 63.34 112.279 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -56.66 130.7 41.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.324 2.016 . . . . 73.35 111.725 173.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . 95.18 19.68 29.98 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.832 -0.622 . . . . 44.14 112.309 -172.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . . . -142.78 100.26 3.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.461 0.305 . . . . 63.24 111.584 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.45 76.1 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.12 -0.362 . . . . 71.23 111.634 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -149.58 137.31 11.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 112.368 0.507 . . . . 75.35 112.368 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 65' ' ' ARG . 91.7 Cg_endo -78.36 145.17 21.05 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.165 2.577 . . . . 72.54 113.639 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -112.51 139.16 48.32 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 54.31 110.89 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 21.3 ttp85 -81.97 100.37 9.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.846 0.355 . . . . 73.52 111.486 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD13 HG13 ' A' ' 45' ' ' VAL . 59.7 tp -96.7 112.16 24.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.274 0.559 . . . . 74.25 111.085 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.89 92.42 9.0 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.35 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 p -100.41 -175.89 3.05 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.913 0.708 . . . . 64.12 112.913 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -69.77 -34.6 74.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.523 -0.762 . . . . 74.44 112.092 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.566 HG22 ' HB3' ' A' ' 157' ' ' PRO . 37.0 pt -76.91 -29.06 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.218 0.532 . . . . 53.22 111.183 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.24 -161.88 31.08 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.566 -0.743 . . . . 40.01 111.831 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 m -101.93 119.55 38.97 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.374 -0.486 . . . . 71.03 111.341 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.2 pp -131.61 152.71 50.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.982 0.42 . . . . 74.5 111.318 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 85.5 mtt180 -116.52 114.49 24.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.884 0.373 . . . . 54.41 111.218 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.641 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.1 mtt -99.04 142.19 30.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.277 -0.42 . . . . 71.22 111.52 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.9 p -136.16 148.32 48.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.119 0.485 . . . . 70.22 111.963 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.8 mt -99.93 112.24 24.52 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.122 -0.49 . . . . 75.04 111.671 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG23 ' HB ' ' A' ' 81' ' ' THR . 17.7 m -134.12 164.57 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 122.391 -0.193 . . . . 71.44 111.099 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.598 HD22 HG23 ' A' ' 69' ' ' VAL . 40.4 m-80 62.84 29.41 16.63 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.899 0.38 . . . . 55.44 111.675 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.05 110.68 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.803 0.335 . . . . 62.51 111.309 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -142.85 155.46 62.8 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.539 0.57 . . . . 75.01 112.539 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.7 157.91 21.93 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.226 2.617 . . . . 61.33 113.348 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.53 163.88 35.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.085 0.469 . . . . 65.04 111.905 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.81 70.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.139 -0.482 . . . . 41.34 111.864 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 8.8 m-20 -71.59 -43.4 66.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.079 0.466 . . . . 61.55 110.881 175.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.53 -77.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.968 -0.634 . . . . 71.12 112.911 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.8 m -149.68 138.49 20.99 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.834 0.35 . . . . 75.24 111.705 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.7 p -122.09 142.48 50.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.989 0.423 . . . . 73.24 111.401 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.25 152.75 36.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.226 -0.443 . . . . 52.3 111.549 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' HG23 ' A' ' 69' ' ' VAL . 39.0 m -84.34 103.61 13.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.743 0.306 . . . . 73.33 110.679 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.66 103.06 11.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.636 -0.505 . . . . 62.14 109.636 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.63 ' HB3' HE22 ' A' ' 85' ' ' GLN . 92.8 mtt-85 -88.83 135.09 33.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.841 0.353 . . . . 64.42 111.615 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -116.67 99.46 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 74.24 110.72 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.63 HE22 ' HB3' ' A' ' 83' ' ' ARG . 22.8 mp0 -93.89 109.56 21.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.957 0.408 . . . . 74.43 111.235 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.31 130.11 37.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.246 -0.502 . . . . 52.03 112.871 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -73.26 -13.72 61.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.26 0.552 . . . . 61.13 110.987 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.9 p -107.4 144.79 33.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.123 -0.489 . . . . 70.33 110.712 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.27 -17.76 51.26 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.859 0.318 . . . . 75.23 111.859 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.95 147.39 95.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.349 -0.387 . . . . 73.1 111.41 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.9 117.21 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.313 2.009 . . . . 72.31 112.936 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 126' ' ' SER . 93.0 mt -82.0 155.85 69.92 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 120.859 0.361 . . . . 73.44 111.433 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 -177.45 3.53 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.276 1.984 . . . . 72.13 112.621 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -77.99 158.44 29.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.757 0.313 . . . . 72.02 110.948 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.4 p90 -152.84 149.14 27.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.712 0.768 . . . . 72.11 112.628 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -133.64 162.76 31.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.204 -0.907 . . . . 72.43 110.238 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.92 -158.26 18.48 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.369 -0.92 . . . . 73.21 113.591 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.3 m -136.33 145.72 45.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.01 0.434 . . . . 73.12 111.324 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.68 128.34 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.045 0.45 . . . . 72.12 112.056 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.807 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 17.6 mm-40 -89.58 110.45 21.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.966 -0.561 . . . . 61.14 110.246 175.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.426 ' CG ' HD22 ' A' ' 139' ' ' LEU . 31.0 p90 -121.85 124.44 44.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.437 0.637 . . . . 63.14 111.736 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.66 -140.89 3.05 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.563 -0.744 . . . . 63.2 112.673 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.584 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 96.5 mt-30 -126.73 163.76 22.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.188 0.518 . . . . 65.32 111.872 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.77 114.79 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.227 -0.442 . . . . 72.15 111.107 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -92.48 -9.46 41.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.811 0.3 . . . . 74.13 111.811 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -91.05 178.59 42.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.09 -0.576 . . . . 32.25 113.785 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.3 p -85.76 -165.56 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.879 0.371 . . . . 70.33 111.483 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.49 HD12 ' HG3' ' A' ' 33' ' ' GLN . 41.9 mm -74.25 -31.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.908 0.385 . . . . 74.45 111.364 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.82 -43.87 8.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.782 0.325 . . . . 72.33 111.462 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -115.51 96.41 5.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.535 0.683 . . . . 71.24 111.301 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.695 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 9.3 p90 -121.41 144.1 48.86 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.852 -0.613 . . . . 75.23 111.899 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -120.09 127.01 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.661 -0.699 . . . . 72.13 111.114 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.89 99.18 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 55.24 110.611 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 pt -107.51 150.39 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.424 -0.353 . . . . 53.5 111.501 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 56.63 29.14 15.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.053 0.454 . . . . 44.02 111.851 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' A' ' 100' ' ' GLU . 6.0 p -90.57 132.35 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.483 0.549 . . . . 54.32 112.483 -176.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -116.56 154.41 30.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 73.24 110.265 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -107.56 132.73 52.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.116 0.484 . . . . 73.31 112.055 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -122.65 142.13 51.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.413 -0.358 . . . . 74.25 111.281 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.82 102.76 13.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.976 0.417 . . . . 71.25 111.721 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.59 140.21 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.219 0.533 . . . . 70.55 112.023 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -130.3 148.46 52.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.448 -0.342 . . . . 72.02 110.812 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -136.86 144.77 48.02 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 111.935 0.346 . . . . 75.43 111.935 177.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 25.7 Cg_exo -64.81 167.5 15.47 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.143 2.562 . . . . 72.11 113.648 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.14 128.9 34.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.131 -0.486 . . . . 62.25 112.11 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 66.1 m -79.69 75.73 6.35 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.164 0.507 . . . . 70.11 110.606 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.29 -30.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.239 0.543 . . . . 74.11 111.15 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.89 159.58 14.9 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.949 -0.569 . . . . 72.4 111.086 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.79 146.9 47.03 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.441 -0.345 . . . . 40.43 111.419 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.95 171.68 58.53 Favored 'Cis proline' 0 C--N 1.353 0.771 0 C-N-CA 124.331 -1.112 . . . . 73.22 112.753 -1.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 90.73 3.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.156 0.503 . . . . 72.43 111.477 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.71 84.83 2.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.268 0.556 . . . . 60.03 109.877 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.8 t -102.34 156.77 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 70.04 111.893 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 10.3 p-10 -150.13 108.71 3.82 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.192 0.52 . . . . 65.23 110.699 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.0 pt -113.32 135.27 21.81 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.119 -0.363 . . . . 52.02 111.821 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.9 119.5 5.9 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.296 1.998 . . . . 33.42 112.986 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.74 123.33 42.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.101 -0.5 . . . . 72.02 110.203 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -105.59 105.19 15.11 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.073 0.463 . . . . 64.15 111.326 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 101' ' ' TYR . 70.1 mt -91.62 130.08 37.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.383 -0.371 . . . . 75.41 111.192 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 67.3 mttm -106.64 145.13 32.33 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.122 0.415 . . . . 75.02 112.122 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.92 27.23 73.7 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.343 -0.456 . . . . 71.44 113.998 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.4 tt -155.59 122.52 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.472 0.653 . . . . 72.23 111.802 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.2 m -85.46 148.01 26.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.122 -0.49 . . . . 75.53 111.283 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.81 -34.79 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.795 0.331 . . . . 72.45 111.884 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.01 -29.08 66.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.063 0.459 . . . . 64.42 111.587 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -109.35 10.77 25.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.044 0.387 . . . . 74.02 112.044 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 3.2 mt -74.01 114.73 12.66 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 71.04 111.63 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.58 -59.2 1.65 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.241 -0.504 . . . . 31.31 112.996 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -149.77 157.58 43.34 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.385 0.612 . . . . 75.11 112.48 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 96.2 t -126.23 107.73 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.261 -0.881 . . . . 75.44 109.552 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.807 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.8 ttt180 -109.63 108.31 18.68 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.244 0.461 . . . . 74.22 112.244 -171.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.641 HG21 ' SD ' ' A' ' 66' ' ' MET . 36.0 mm -86.5 132.07 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 111.59 0.219 . . . . 53.45 111.59 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.62 178.83 8.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.745 0.307 . . . . 70.04 111.746 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 65.44 19.99 11.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.934 0.716 . . . . 70.13 112.934 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -65.56 117.74 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.279 0.562 . . . . 73.42 111.716 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -130.37 153.3 81.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.976 -0.556 . . . . 74.22 111.57 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.566 ' HB3' HG22 ' A' ' 61' ' ' ILE . 66.4 Cg_endo -73.66 117.31 5.0 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.553 2.169 . . . . 61.41 113.385 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 5.7 p . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.353 0.597 . . . . 72.22 110.997 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.0 tt0 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.87 0.367 . . . . 60.4 110.485 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.571 ' HA ' HD12 ' A' ' 31' ' ' ILE . 39.7 m -61.21 -30.38 70.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.947 0.403 . . . . 74.44 111.553 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.2 -47.6 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.788 0.327 . . . . 75.43 110.839 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -64.54 -30.09 71.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 72.21 111.335 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 28' ' ' THR . 82.6 mt -62.62 -48.31 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.249 0.547 . . . . 63.2 110.791 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -64.68 -41.35 96.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.197 0.522 . . . . 74.13 110.738 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HG3' HD12 ' A' ' 108' ' ' ILE . 57.7 tt0 -57.5 -47.59 81.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.797 -0.638 . . . . 73.24 111.102 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.4 tt0 -55.23 -47.12 75.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 72.25 111.331 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.75 -27.45 68.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.224 -0.444 . . . . 70.11 111.974 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -77.29 -36.21 54.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.076 -0.39 . . . . 65.34 111.22 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.0 -36.12 82.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.303 0.573 . . . . 55.2 110.038 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -57.17 -41.48 79.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.752 -0.658 . . . . 74.25 110.465 172.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.96 76.92 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.283 0.475 . . . . 35.41 112.283 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 109' ' ' ASP . 51.9 mttp -87.67 -9.25 54.71 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.647 0.61 . . . . 74.0 112.647 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.4 t -63.27 123.03 17.63 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.133 0.492 . . . . 74.23 112.152 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t -88.42 -30.08 19.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.104 0.478 . . . . 73.33 111.166 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -146.73 107.13 4.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.236 -0.438 . . . . 42.22 110.854 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 93.3 -143.64 16.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.084 -0.579 . . . . 74.44 113.104 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.793 HG13 HD13 ' A' ' 57' ' ' LEU . 16.4 m -143.27 153.52 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.34 0.59 . . . . 63.11 112.198 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.4 m-85 -101.25 105.46 16.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.612 -0.722 . . . . 63.14 110.964 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 98.9 mt -95.23 136.65 35.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.737 0.303 . . . . 73.12 110.904 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.2 mt -109.81 130.95 22.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.292 -0.255 . . . . 45.22 111.428 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HB3' HD13 ' A' ' 147' ' ' LEU . 33.0 Cg_endo -62.58 -27.78 76.76 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.604 2.202 . . . . 45.42 112.714 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.79 -23.54 72.14 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.139 -0.553 . . . . 32.22 112.412 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.23 73.92 1.53 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.149 0.5 . . . . 74.11 111.314 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -66.6 74.56 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.357 0.599 . . . . 54.15 110.845 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 p -148.97 159.27 37.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.771 -0.65 . . . . 42.31 112.38 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.12 149.87 28.88 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.027 2.485 . . . . 72.12 113.756 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 145.86 49.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.397 -0.365 . . . . 71.45 111.226 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -82.44 134.93 35.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.446 -0.343 . . . . 72.13 111.057 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.793 HD13 HG13 ' A' ' 45' ' ' VAL . 37.0 tp -143.53 136.56 27.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.558 0.577 . . . . 75.11 112.558 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.59 143.15 27.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.91 -0.586 . . . . 71.45 110.363 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -140.52 170.98 14.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.226 0.536 . . . . 74.5 111.673 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.652 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.0 mt-30 -77.51 5.76 8.37 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.074 -0.512 . . . . 71.33 112.101 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -112.0 -22.13 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.851 0.358 . . . . 62.2 110.837 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.03 -160.71 29.24 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.287 -0.415 . . . . 64.32 112.668 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.6 m -92.91 135.43 34.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.394 -0.474 . . . . 61.15 110.771 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.2 178.53 7.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.408 0.623 . . . . 32.13 112.619 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -136.29 107.06 6.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.744 -0.662 . . . . 65.04 111.013 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.725 ' SD ' HG21 ' A' ' 152' ' ' ILE . 58.3 mtt -96.04 170.17 9.47 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.049 -0.407 . . . . 75.14 111.879 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.6 p -169.08 152.74 5.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.033 0.383 . . . . 54.21 112.033 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.32 114.81 29.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.363 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.616 HG23 ' HB ' ' A' ' 81' ' ' THR . 26.9 m -128.79 164.09 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.731 0.3 . . . . 75.53 111.41 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 59.1 42.52 18.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.167 0.508 . . . . 52.11 112.036 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.9 mt -82.45 109.68 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.038 -0.528 . . . . 73.43 111.782 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 p -131.22 155.16 81.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 120.977 0.418 . . . . 63.22 112.124 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.49 136.43 33.69 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.767 2.311 . . . . 52.54 112.757 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.623 ' HB2' HG23 ' A' ' 79' ' ' THR . 32.8 t70 -115.4 164.78 13.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.841 0.456 . . . . 74.53 111.145 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.94 74.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.098 0.407 . . . . 53.11 112.098 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.88 -17.6 16.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.137 0.421 . . . . 62.45 112.137 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.3 -103.02 0.16 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.476 -0.869 . . . . 23.23 114.23 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.4 m -149.73 125.54 10.47 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.565 -0.373 . . . . 73.01 111.449 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 74' ' ' ASP . 39.4 p -101.66 124.73 47.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.806 0.336 . . . . 75.24 111.888 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 137' ' ' LEU . 3.4 pp -138.2 177.67 7.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.797 0.332 . . . . 73.11 111.252 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 69' ' ' VAL . 60.0 m -122.52 126.54 48.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.801 0.334 . . . . 64.43 111.472 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.6 114.02 25.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.89 -0.411 . . . . 73.21 109.89 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 97.2 mtt180 -104.53 110.05 22.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.287 0.477 . . . . 63.21 112.287 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -102.72 112.37 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 64.52 111.573 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 131' ' ' SER . 34.7 tt0 -98.52 141.8 30.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.568 0.223 . . . . 63.2 111.026 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.6 144.05 22.94 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.039 -0.6 . . . . 75.03 113.101 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.09 -40.67 96.62 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.974 0.416 . . . . 75.24 110.857 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.9 p -96.78 -177.66 3.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.219 0.533 . . . . 51.24 111.38 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -92.9 6.95 45.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.305 -0.407 . . . . 74.13 111.248 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.45 135.38 68.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.485 -0.325 . . . . 72.11 111.784 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 96.68 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.139 1.892 . . . . 64.42 111.801 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.75 141.3 89.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.33 0.492 . . . . 71.32 112.33 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.11 177.58 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.663 2.242 . . . . 75.43 112.929 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.3 134.4 46.75 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.013 0.435 . . . . 54.15 111.651 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.65 160.95 39.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.138 0.494 . . . . 74.54 111.954 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 92.3 p -138.71 168.8 19.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.059 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.632 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.2 165.25 37.08 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.023 -0.608 . . . . 54.2 113.337 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.6 m -98.98 107.84 20.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.91 0.386 . . . . 63.11 111.544 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 119' ' ' GLN . 3.2 p -89.83 112.97 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.202 0.525 . . . . 54.33 111.097 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 117' ' ' GLN . 47.5 mt-10 -102.6 103.56 13.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.277 0.56 . . . . 75.43 110.956 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CD1' HD22 ' A' ' 139' ' ' LEU . 19.0 p90 -104.27 137.97 41.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.814 -0.63 . . . . 74.43 111.579 -175.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.09 -145.5 4.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.697 -0.763 . . . . 52.24 113.592 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.612 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.5 mt-30 -129.44 161.35 30.59 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.885 0.374 . . . . 55.4 111.363 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 111' ' ' PHE . 51.9 mt -122.34 140.11 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.073 0.463 . . . . 73.25 112.102 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.802 HE21 HD13 ' A' ' 114' ' ' ILE . 10.9 pt20 -132.03 103.53 6.33 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.489 0.661 . . . . 65.52 110.79 169.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 157.56 -158.54 29.09 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.156 -0.545 . . . . 62.44 113.606 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 33.4 p -98.82 -170.71 1.97 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.517 -0.402 . . . . 64.25 111.073 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.495 HD12 ' HG3' ' A' ' 33' ' ' GLN . 34.0 mm -76.12 -15.41 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.31 0.576 . . . . 54.45 110.766 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.708 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 40.7 m-20 -105.2 -45.94 4.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.104 -0.498 . . . . 74.24 111.512 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -116.03 92.88 4.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.377 0.608 . . . . 73.01 111.097 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' HB2' HG23 ' A' ' 104' ' ' ILE . 38.2 p90 -127.33 132.2 50.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.131 0.491 . . . . 74.5 111.809 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -96.49 124.44 40.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.087 -0.506 . . . . 72.32 111.149 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.82 97.73 11.08 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.007 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.802 HD13 HE21 ' A' ' 105' ' ' GLN . 36.8 pt -103.53 162.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.126 -0.488 . . . . 72.41 112.043 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 53.77 22.18 3.07 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 64.42 112.61 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.57 131.77 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.366 0.603 . . . . 75.31 112.202 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 34.0 mt-30 -128.15 146.41 50.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.665 -0.698 . . . . 74.53 110.814 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.03 143.13 28.9 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.263 0.554 . . . . 53.33 112.267 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.586 ' HB3' HG13 ' A' ' 99' ' ' VAL . 8.4 tt0 -142.23 149.44 39.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.782 -0.645 . . . . 74.02 110.174 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -100.28 114.41 27.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.138 0.494 . . . . 74.31 112.231 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.92 121.94 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.113 -0.494 . . . . 65.41 111.17 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -113.46 135.65 53.65 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.902 0.382 . . . . 73.31 111.37 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.517 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -124.1 140.07 34.01 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.234 -0.439 . . . . 54.03 111.476 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.16 169.66 21.94 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.589 2.193 . . . . 72.02 113.623 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.13 134.79 34.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 55.21 111.523 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 m -77.39 124.06 27.36 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.386 -0.37 . . . . 73.24 111.419 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.28 -42.52 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.103 0.478 . . . . 73.24 110.973 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -125.81 171.58 10.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 75.15 111.83 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.11 158.79 31.07 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.263 -0.426 . . . . 71.23 111.483 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.0 160.14 57.98 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.015 -1.244 . . . . 72.25 113.129 -2.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 58.8 m -86.17 78.07 9.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.494 0.553 . . . . 54.42 112.494 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.78 79.42 2.23 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.427 -0.583 . . . . 64.35 109.427 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.529 HG12 HG23 ' A' ' 135' ' ' ILE . 40.6 t -76.68 99.78 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.402 -0.363 . . . . 75.44 111.818 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.453 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.8 p-10 -91.27 106.84 18.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.033 0.444 . . . . 52.25 110.97 174.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.529 HG23 HG12 ' A' ' 133' ' ' VAL . 26.9 pt -114.08 131.54 23.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.972 0.36 . . . . 60.33 111.972 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.58 135.69 54.35 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.722 2.281 . . . . 71.04 112.381 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.49 ' HB3' HD12 ' A' ' 80' ' ' LEU . 2.4 tt -132.42 113.33 13.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.35 -0.386 . . . . 55.14 110.424 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.61 109.76 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.058 0.456 . . . . 74.21 111.702 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 ' CD1' ' A' ' 101' ' ' TYR . 80.0 mt -88.57 140.05 29.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.143 -0.317 . . . . 63.52 110.143 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -129.4 150.69 50.65 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.888 0.375 . . . . 74.5 111.475 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.87 31.14 56.53 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.218 -0.515 . . . . 71.42 113.068 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 147' ' ' LEU . 17.8 tt -168.51 125.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.916 0.389 . . . . 75.23 111.487 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.8 m -83.53 144.71 29.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.649 0.261 . . . . 60.33 111.522 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 p -51.04 -44.77 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 112.391 0.515 . . . . 72.43 112.391 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -59.74 -38.55 82.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.211 0.529 . . . . 52.31 111.389 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -93.31 6.16 49.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.346 0.499 . . . . 70.53 112.346 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.606 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.3 tt -69.68 125.14 25.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.662 0.267 . . . . 73.55 110.402 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -95.82 -62.16 0.98 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.111 -0.566 . . . . 41.44 113.602 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -145.44 160.25 41.87 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.272 0.558 . . . . 71.02 112.008 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 75.5 t -124.86 101.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.696 -0.684 . . . . 64.31 110.406 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 31.2 ttm180 -88.31 94.37 9.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.874 0.369 . . . . 72.03 111.636 -176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.725 HG21 ' SD ' ' A' ' 66' ' ' MET . 37.1 mm -85.75 127.58 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.68 -0.237 . . . . 74.52 110.876 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -164.45 -178.3 5.34 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.405 0.521 . . . . 71.34 112.405 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 66.38 24.56 10.47 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.449 0.7 . . . . 74.31 112.293 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.632 HD13 ' HA3' ' A' ' 97' ' ' GLY . 41.9 mm -67.15 105.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.187 0.518 . . . . 73.43 111.701 -177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.652 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.6 pt20 -137.71 151.72 71.22 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.021 -0.536 . . . . 73.23 111.42 -175.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.8 133.25 23.27 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.406 2.071 . . . . 43.03 112.846 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.135 0.493 . . . . 51.45 111.975 -177.545 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 111.949 0.351 . . . . 73.0 111.949 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m -82.37 -4.95 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.17 0.51 . . . . 71.41 111.437 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -73.66 79.33 1.52 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.848 -0.615 . . . . 75.14 111.038 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.04 152.12 20.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.337 -0.392 . . . . 73.03 111.31 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.9 m -75.38 69.28 2.16 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.167 0.508 . . . . 50.22 110.505 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.37 117.43 29.9 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.176 -0.465 . . . . 60.15 110.994 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.522 HG22 ' H ' ' A' ' 9' ' ' GLN . 14.9 p -101.98 148.2 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.086 0.469 . . . . 64.11 112.089 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -101.56 26.13 7.66 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.818 0.342 . . . . 63.25 111.548 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.522 ' H ' HG22 ' A' ' 7' ' ' VAL . 63.7 tt0 -53.8 110.8 0.63 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.183 -0.462 . . . . 62.14 111.613 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.0 ttm -69.3 93.14 0.61 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.046 0.451 . . . . 64.53 111.823 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 138.65 31.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.507 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -73.29 81.96 1.37 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.559 0.695 . . . . 73.1 111.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 m -148.58 126.19 11.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.792 -0.64 . . . . 73.52 110.329 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.28 131.86 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.233 0.539 . . . . 72.12 112.039 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.6 t -136.4 118.25 15.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.014 -0.539 . . . . 73.1 110.243 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.8 p -87.79 112.23 22.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.965 0.357 . . . . 71.33 111.965 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -83.31 171.14 13.86 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.869 0.366 . . . . 72.33 111.086 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.12 152.06 42.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.338 -0.226 . . . . 54.43 110.883 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.32 94.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.669 0.271 . . . . 72.32 111.677 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.67 135.82 56.31 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.583 -0.28 . . . . 65.53 110.438 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -72.2 177.27 4.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.801 0.667 . . . . 73.45 112.801 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -74.16 169.78 16.86 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.537 0.684 . . . . 63.43 112.677 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -76.55 179.24 6.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.683 -0.689 . . . . 73.21 110.8 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp -145.64 150.24 35.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.831 0.348 . . . . 70.22 111.699 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' OD1' ' HG2' ' A' ' 27' ' ' GLU . 52.4 t-20 -54.3 131.99 42.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.59 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.46 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 30.3 mm-40 -50.76 -49.03 59.02 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.316 0.487 . . . . 72.55 112.316 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 31' ' ' ILE . 14.6 pt-20 -59.68 -45.66 91.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.949 0.404 . . . . 73.32 110.842 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -60.02 -34.3 73.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.213 -0.449 . . . . 55.0 111.543 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 25' ' ' ASN . 98.1 t -62.78 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.948 0.404 . . . . 75.02 110.713 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 4.9 mptp? -62.3 -36.2 81.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 74.32 111.163 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.8 mt -62.04 -48.01 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.08 0.467 . . . . 74.24 110.798 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -60.11 -35.29 74.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.282 0.563 . . . . 74.51 110.932 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.624 ' HG3' HD11 ' A' ' 108' ' ' ILE . 35.1 tt0 -68.37 -43.35 77.57 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.176 -0.465 . . . . 64.11 110.653 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 -55.76 29.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.013 -0.54 . . . . 72.13 110.684 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -54.15 -47.38 71.99 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.182 0.438 . . . . 72.34 112.182 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -62.29 -48.21 80.91 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.965 0.357 . . . . 75.32 111.965 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.7 -33.57 75.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.211 0.529 . . . . 72.34 111.026 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -56.04 -48.96 75.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.856 -0.611 . . . . 71.51 110.628 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.75 -32.3 72.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.942 -0.572 . . . . 71.41 111.683 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.45 -10.46 59.41 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.007 0.373 . . . . 71.4 112.007 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.471 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 43.2 t -87.13 132.45 33.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.864 0.364 . . . . 74.34 111.871 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 82.0 p -103.36 -24.82 13.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.108 0.48 . . . . 75.4 110.781 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t -100.53 93.48 5.64 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.175 -0.466 . . . . 62.34 110.918 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.64 -160.18 47.65 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.198 0.439 . . . . 70.31 114.198 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -116.6 144.92 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.3 0.481 . . . . 73.21 112.3 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.471 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 16.1 m-85 -83.3 113.75 20.92 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.407 -0.361 . . . . 72.23 111.898 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 86.9 mt -103.9 94.26 5.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.182 0.515 . . . . 72.4 110.304 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.72 120.67 82.42 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.543 -0.299 . . . . 72.41 110.818 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.629 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.7 Cg_endo -57.17 -22.2 47.01 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.827 2.352 . . . . 74.41 112.888 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.49 -21.39 60.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.34 -0.457 . . . . 61.02 113.061 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.97 -40.62 10.02 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.845 0.355 . . . . 44.13 111.164 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.9 mttm 62.88 2.48 1.0 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.69 0.626 . . . . 75.22 112.69 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 p -70.76 151.06 95.31 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 113.02 0.748 . . . . 73.52 113.02 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' A' ' 65' ' ' ARG . 73.8 Cg_endo -72.89 136.33 24.95 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.843 2.362 . . . . 72.44 112.467 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.51 140.58 51.24 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.737 0.304 . . . . 71.31 111.604 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -92.71 127.43 38.21 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.999 0.428 . . . . 75.11 111.738 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.2 tp -131.13 127.19 37.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.119 0.485 . . . . 63.32 111.369 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.02 97.7 11.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.127 0.489 . . . . 73.22 110.715 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -93.55 -177.18 4.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.275 0.56 . . . . 72.11 112.262 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -67.5 -32.41 73.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.021 -0.536 . . . . 72.23 112.032 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 pt -84.45 -30.0 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 111.883 0.327 . . . . 75.33 111.883 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.58 -177.69 37.76 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.396 -0.43 . . . . 62.22 112.895 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.5 m -85.18 109.01 17.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.039 0.447 . . . . 74.33 111.446 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.732 HD13 ' SD ' ' A' ' 66' ' ' MET . 0.6 OUTLIER -116.57 171.71 7.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.011 0.434 . . . . 73.41 111.897 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 30.6 ttm180 -140.64 114.04 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.258 -0.428 . . . . 72.13 111.101 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.732 ' SD ' HD13 ' A' ' 64' ' ' LEU . 3.2 mpp? -103.59 158.55 16.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.5 0.555 . . . . 63.31 112.5 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 p -156.67 157.85 35.93 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.793 -0.64 . . . . 70.34 111.237 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 76.3 mt -112.37 117.67 33.1 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.896 0.332 . . . . 73.33 111.896 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.488 HG23 HD22 ' A' ' 70' ' ' ASN . 22.5 m -135.74 165.06 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.657 0.265 . . . . 72.42 111.555 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.488 HD22 HG23 ' A' ' 69' ' ' VAL . 44.4 m-80 57.7 40.08 26.77 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.118 0.485 . . . . 54.32 111.907 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 40.5 mt -69.86 112.18 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.2 -0.454 . . . . 73.14 111.217 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -137.23 151.31 71.39 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-O 120.772 0.32 . . . . 75.52 111.83 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.92 146.76 83.77 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.887 2.391 . . . . 60.24 113.186 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 19.6 t70 -115.02 169.86 8.78 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.258 -0.428 . . . . 73.15 111.043 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.65 -40.63 72.48 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.866 0.321 . . . . 74.01 111.866 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.21 -45.68 3.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.517 -0.31 . . . . 63.23 111.465 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -130.6 -110.07 1.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.754 -0.736 . . . . 61.44 113.893 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -146.97 127.83 14.43 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.104 0.409 . . . . 54.23 112.104 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 75.7 p -98.93 120.81 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.767 0.317 . . . . 72.22 111.752 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -137.15 151.06 48.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.823 0.344 . . . . 62.13 111.197 175.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.3 m -83.3 113.45 20.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.006 0.431 . . . . 73.43 111.846 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.42 109.39 20.78 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.92 -0.582 . . . . 64.43 109.969 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 66' ' ' MET . 73.7 mtm180 -101.15 123.07 44.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.861 0.319 . . . . 63.21 111.861 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.7 mp -102.2 102.42 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.034 0.445 . . . . 73.2 110.593 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -100.9 134.51 43.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.433 -0.349 . . . . 73.52 111.188 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.56 122.52 5.81 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.075 -0.583 . . . . 62.12 113.446 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.0 -27.81 62.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.428 0.632 . . . . 65.44 110.498 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -85.89 -175.24 5.5 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.774 -0.648 . . . . 32.11 111.44 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.41 5.63 39.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.397 -0.365 . . . . 63.24 111.458 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.09 152.98 38.01 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.196 0.443 . . . . 62.0 112.196 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.678 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 73.2 Cg_endo -74.27 138.18 24.59 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.773 2.315 . . . . 74.34 112.79 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.17 122.07 55.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 O-C-N 122.142 -0.349 . . . . 70.34 111.848 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.607 ' HB2' HE22 ' A' ' 160' ' ' GLN . 57.8 Cg_endo -69.27 170.88 14.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.607 2.205 . . . . 32.43 112.866 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.6 131.48 50.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.307 0.484 . . . . 44.44 112.307 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -146.79 154.85 41.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.261 0.553 . . . . 73.2 112.225 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.9 p -118.87 151.23 38.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.898 -0.592 . . . . 73.43 110.438 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 154' ' ' ASP . . . -141.18 150.24 21.67 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.771 -0.728 . . . . 35.44 113.83 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 154' ' ' ASP . 61.3 m -100.06 110.0 22.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.771 0.319 . . . . 70.41 110.819 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.1 p -102.28 117.88 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.433 0.531 . . . . 75.54 112.433 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 153' ' ' HIS . 32.8 mm-40 -83.98 147.26 27.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.901 -0.407 . . . . 75.42 109.901 174.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.412 ' CG ' HD22 ' A' ' 139' ' ' LEU . 32.0 p90 -155.12 133.71 11.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.066 0.46 . . . . 70.42 111.654 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.85 -147.67 5.48 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.952 -0.567 . . . . 63.22 112.951 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 87.4 mt-30 -123.36 150.71 43.33 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.333 0.587 . . . . 63.14 112.565 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.469 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.3 mt -116.26 104.09 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.978 -0.556 . . . . 54.43 110.657 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.505 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.0 pt20 -89.19 -17.41 29.18 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.398 0.518 . . . . 64.02 112.398 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -90.37 -159.23 35.36 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.026 -0.607 . . . . 52.1 113.963 -175.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 51.8 p -114.25 -178.44 3.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.806 0.443 . . . . 64.25 110.967 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.624 HD11 ' HG3' ' A' ' 33' ' ' GLN . 48.0 mm -66.81 -30.92 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.188 0.518 . . . . 60.02 110.709 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.92 -39.28 72.8 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.097 -0.501 . . . . 74.21 111.163 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -154.59 108.87 2.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.164 -0.471 . . . . 75.15 111.191 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.613 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 36.9 p90 -125.99 139.49 53.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.89 0.376 . . . . 75.24 111.743 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -108.78 123.23 48.69 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.244 -0.434 . . . . 75.52 111.443 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -74.66 100.48 3.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.718 0.294 . . . . 64.03 110.798 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.505 HD13 ' NE2' ' A' ' 105' ' ' GLN . 50.6 pt -109.63 157.46 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 111.812 0.301 . . . . 63.22 111.812 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 56.73 31.38 19.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.18 0.514 . . . . 71.13 111.502 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -97.08 132.91 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.385 0.612 . . . . 50.15 112.583 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -142.11 178.18 7.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.723 -0.672 . . . . 70.52 109.656 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 11.3 p30 -127.85 172.91 10.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.949 1.092 . . . . 64.1 113.949 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -153.1 156.34 38.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.872 -1.058 . . . . 72.23 109.921 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.54 111.48 23.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.258 0.466 . . . . 74.11 112.258 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 121' ' ' ILE . 20.2 pt -96.11 101.17 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.325 0.583 . . . . 55.3 110.989 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.89 108.93 20.48 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.436 -0.347 . . . . 63.13 111.185 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.57 38.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.513 -0.312 . . . . 70.14 111.599 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.83 179.69 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.67 2.247 . . . . 64.54 113.553 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.89 108.09 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.023 0.439 . . . . 73.24 111.299 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 15.3 m -80.77 96.66 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 64.22 111.203 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 127' ' ' VAL . 12.2 t -86.71 7.98 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 121.081 0.467 . . . . 73.53 111.609 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.1 pt? -105.52 147.0 28.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.186 0.517 . . . . 65.44 111.925 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.39 127.37 22.44 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.098 -0.501 . . . . 72.1 111.015 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.18 155.14 91.81 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.836 -1.318 . . . . 74.3 113.086 -0.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.678 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 48.5 t -88.64 121.27 30.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.652 0.612 . . . . 70.43 112.652 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -138.79 130.72 27.95 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.085 0.469 . . . . 74.5 110.948 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.35 149.72 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.802 0.334 . . . . 54.33 111.563 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -132.76 125.38 30.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.027 0.441 . . . . 73.32 110.737 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 pt -130.74 137.88 31.77 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 120.814 0.34 . . . . 71.32 111.472 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.71 120.21 7.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.302 2.001 . . . . 75.41 112.777 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.31 97.41 8.48 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.023 -0.535 . . . . 71.11 109.782 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.456 ' HG3' HG22 ' A' ' 79' ' ' THR . 63.0 tt0 -87.83 83.36 7.13 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.139 0.495 . . . . 53.45 111.297 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 101' ' ' TYR . 65.9 mt -62.86 145.75 54.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.072 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -116.81 147.57 41.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.136 0.494 . . . . 71.33 112.073 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.19 -49.98 3.88 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.066 -0.516 . . . . 71.42 114.03 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.604 HD13 HD23 ' A' ' 147' ' ' LEU . 20.9 tt -87.64 138.47 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.261 0.553 . . . . 60.13 112.24 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.6 m -92.79 149.69 21.13 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.183 -0.462 . . . . 72.44 111.519 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -53.25 -42.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.379 0.511 . . . . 73.14 112.379 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -67.75 -23.65 65.26 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.199 0.523 . . . . 73.33 111.289 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.441 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.1 mm-40 -103.03 7.81 38.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.139 -0.482 . . . . 74.11 112.089 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.629 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 14.0 mt -72.85 124.36 25.24 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.279 0.474 . . . . 74.33 112.279 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.67 -57.59 0.82 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.203 -0.523 . . . . 44.13 112.886 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -145.0 146.34 31.87 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.333 -0.51 . . . . 72.23 111.9 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.506 ' HB ' HD11 ' A' ' 68' ' ' LEU . 62.1 t -124.54 100.19 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.068 -0.514 . . . . 74.1 109.917 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -100.53 114.47 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.736 0.643 . . . . 75.43 112.736 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.49 123.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.797 -0.638 . . . . 51.43 110.988 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.479 ' CD2' ' HG2' ' A' ' 100' ' ' GLU . 10.2 p80 -152.88 178.44 9.66 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.574 0.226 . . . . 75.43 111.082 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.463 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 33.1 t70 54.53 73.63 0.39 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.376 0.607 . . . . 73.44 111.197 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 115.29 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.843 -0.617 . . . . 45.24 110.695 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.52 140.07 36.72 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.095 0.405 . . . . 74.42 112.095 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.91 146.77 42.68 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.635 2.224 . . . . 75.42 112.538 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.0 m -110.34 135.56 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.047 0.758 . . . . 75.2 113.047 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.9 ptt? 37.54 30.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.258 1.577 . . . . 64.22 115.258 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.607 HE22 ' HB2' ' A' ' 93' ' ' PRO . 2.3 pt20 -107.12 147.85 29.53 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.592 -0.693 . . . . 74.41 111.488 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.606 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.6 pt? -80.76 148.72 29.95 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.689 0.626 . . . . 75.22 112.689 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -96.69 172.93 7.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.201 0.524 . . . . 74.44 110.979 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -106.84 123.96 48.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.497 -0.32 . . . . 63.24 110.334 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -54.27 112.53 1.0 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.946 0.403 . . . . 73.23 111.219 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -73.17 76.19 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.405 0.621 . . . . 73.42 110.591 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -74.29 88.74 2.03 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.908 -0.587 . . . . 72.32 111.864 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -97.41 -24.76 15.47 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.095 0.474 . . . . 63.4 111.015 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.405 -0.807 . . . . 72.54 110.899 174.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.3 mmm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 110.467 -0.197 . . . . 71.12 110.467 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.08 143.72 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.172 0.511 . . . . 71.31 112.183 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -107.18 178.51 4.53 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.038 -0.528 . . . . 75.34 110.823 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -89.15 131.58 35.22 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.274 -0.266 . . . . 73.35 111.225 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.3 p -93.94 152.9 18.52 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.11 0.481 . . . . 74.23 111.88 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.64 -168.26 2.04 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.33 111.938 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.1 173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.253 -0.43 . . . . 75.41 111.967 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -126.27 125.48 42.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.023 0.379 . . . . 73.2 112.023 -175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -81.0 148.25 29.83 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.141 0.496 . . . . 74.21 112.303 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.1 mmt -121.79 120.27 34.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.287 -0.415 . . . . 43.34 110.56 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -113.35 134.63 54.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.906 0.336 . . . . 72.51 111.906 -172.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -110.72 153.95 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.757 0.313 . . . . 70.1 111.125 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.5 m -101.75 164.62 11.64 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.872 0.368 . . . . 72.11 111.841 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 118.32 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.959 0.409 . . . . 72.55 111.664 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.0 p -170.86 123.14 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 111.862 0.319 . . . . 64.31 111.862 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 p -111.91 165.76 11.81 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.823 0.344 . . . . 72.1 111.365 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.36 158.32 16.28 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.9 0.381 . . . . 74.24 111.638 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.17 176.47 5.38 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.897 0.38 . . . . 61.11 111.719 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -105.95 153.91 21.33 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.016 0.436 . . . . 63.53 111.785 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.18 125.36 35.44 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.031 -0.531 . . . . 75.04 111.161 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -95.95 -177.7 4.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.036 0.446 . . . . 73.54 111.944 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.4 p -86.65 175.21 8.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.301 -0.409 . . . . 73.32 111.645 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.435 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 26.1 pt20 -67.98 105.38 2.0 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.551 0.691 . . . . 71.35 112.136 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.704 HD23 HG21 ' A' ' 28' ' ' THR . 19.0 tp -98.78 178.32 5.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.934 -0.576 . . . . 74.43 109.819 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.447 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 32.7 m-20 -45.96 146.17 1.31 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.135 0.493 . . . . 74.14 112.321 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -56.15 -39.81 72.86 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.443 0.905 . . . . 55.23 113.443 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -65.09 -39.69 93.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.378 -0.529 . . . . 71.42 111.067 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.704 HG21 HD23 ' A' ' 24' ' ' LEU . 94.2 m -59.62 -50.05 75.36 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.224 0.535 . . . . 63.1 111.164 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.12 -35.29 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.475 0.655 . . . . 74.31 110.657 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.615 ' HE3' HD12 ' A' ' 48' ' ' LEU . 23.7 tptt -70.3 -35.95 74.02 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.623 -0.717 . . . . 74.14 110.754 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 27' ' ' GLU . 89.2 mt -60.48 -42.91 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 121.412 0.625 . . . . 72.52 110.322 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -57.4 -44.76 84.81 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.838 -0.619 . . . . 71.54 110.551 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HG3' HD11 ' A' ' 108' ' ' ILE . 31.6 tt0 -60.91 -40.03 91.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.934 -0.576 . . . . 74.23 111.12 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -59.03 -55.47 34.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.938 -0.574 . . . . 70.34 111.535 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -60.71 -39.05 87.1 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 111.893 0.331 . . . . 73.34 111.893 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -66.08 -54.57 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.425 0.528 . . . . 74.55 112.425 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.423 HD12 HD21 ' A' ' 48' ' ' LEU . 97.9 mt -56.61 -41.64 77.39 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.064 0.459 . . . . 64.33 110.919 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.8 -46.02 70.95 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.16 -0.473 . . . . 71.01 111.343 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.81 63.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 64.22 112.561 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -94.42 -12.41 27.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.892 0.33 . . . . 75.22 111.892 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.2 t -85.7 142.47 29.0 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.669 0.271 . . . . 73.42 111.336 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.2 p -84.0 -42.32 16.34 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.099 -0.375 . . . . 72.11 111.517 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 m -148.08 87.79 1.63 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 65.43 111.377 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.4 153.35 6.08 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.244 -0.503 . . . . 42.21 112.405 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 152' ' ' ILE . 25.8 m -106.41 146.12 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.315 0.579 . . . . 60.21 112.449 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -106.22 102.9 12.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.807 -0.633 . . . . 73.22 110.884 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -92.58 116.02 28.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.897 0.379 . . . . 73.2 111.221 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.615 HD12 ' HE3' ' A' ' 30' ' ' LYS . 3.8 mm? -86.93 117.46 68.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.578 -0.283 . . . . 45.35 110.717 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 78.5 Cg_exo -51.11 -36.36 54.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.102 2.534 . . . . 73.43 113.768 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.84 99.79 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.954 -0.641 . . . . 61.1 112.548 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . . . -86.88 93.61 9.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.731 0.301 . . . . 75.14 111.487 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HE3' HD12 ' A' ' 71' ' ' ILE . 43.6 mmtm -67.52 77.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.878 0.37 . . . . 73.55 110.251 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 p -140.48 149.97 59.16 Favored Pre-proline 0 N--CA 1.47 0.562 0 N-CA-C 112.841 0.682 . . . . 75.14 112.841 -175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 92.9 Cg_endo -80.48 154.19 21.04 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.393 2.728 . . . . 64.22 113.242 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.46 137.93 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.67 0.272 . . . . 63.43 111.456 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.543 ' CZ ' HG21 ' A' ' 63' ' ' THR . 37.6 ttt85 -79.22 133.69 36.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.853 0.359 . . . . 72.3 111.901 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HB3' HD22 ' A' ' 64' ' ' LEU . 56.2 tp -138.14 120.58 16.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.497 0.554 . . . . 75.42 112.497 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.47 121.63 26.51 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.726 -0.67 . . . . 61.43 110.401 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 p -123.68 -179.33 4.32 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.534 . . . . 64.21 111.808 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.555 HE22 ' HB3' ' A' ' 156' ' ' GLN . 46.3 mt-30 -67.72 -19.12 65.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 72.1 112.146 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 pt -100.26 -25.71 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.971 0.415 . . . . 73.44 111.891 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.76 32.54 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.415 -0.421 . . . . 65.31 112.243 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.543 HG21 ' CZ ' ' A' ' 56' ' ' ARG . 39.0 m -94.48 127.19 40.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.176 0.513 . . . . 72.14 111.709 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.6 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.8 170.13 13.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.03 -0.532 . . . . 72.32 110.71 175.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.605 ' HG2' ' HB2' ' A' ' 54' ' ' PRO . 17.2 ttp180 -133.44 105.59 7.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.835 0.35 . . . . 74.35 110.924 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.775 ' SD ' HG21 ' A' ' 152' ' ' ILE . 66.9 mtt -95.77 148.99 21.99 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.224 0.453 . . . . 73.4 112.224 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.1 p -145.08 148.89 34.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.793 0.33 . . . . 63.03 111.742 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 80' ' ' LEU . 95.6 mt -96.68 114.0 25.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.177 -0.465 . . . . 54.13 111.557 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.699 HG23 HD22 ' A' ' 70' ' ' ASN . 28.3 m -134.37 162.95 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.625 0.232 . . . . 52.55 111.625 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.699 HD22 HG23 ' A' ' 69' ' ' VAL . 44.5 m-80 61.96 33.89 17.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.776 0.43 . . . . 70.41 111.794 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.574 HD12 ' HE3' ' A' ' 52' ' ' LYS . 38.8 mt -71.33 106.9 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 73.03 111.421 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 21.9 p -140.67 158.72 65.01 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 111.891 0.33 . . . . 65.5 111.891 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 22.6 Cg_endo -60.17 153.76 56.59 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.73 2.287 . . . . 61.15 113.517 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.0 t70 -129.96 172.62 11.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.156 -0.475 . . . . 63.11 111.679 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -53.58 -46.63 70.38 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.306 0.484 . . . . 72.44 112.306 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -110.14 -21.39 12.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.55 0.574 . . . . 75.53 112.55 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -157.49 -103.7 0.2 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.154 -1.022 . . . . 74.04 114.144 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.2 m -150.1 129.27 12.76 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.711 0.291 . . . . 74.25 111.636 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.664 HG23 ' HB2' ' A' ' 74' ' ' ASP . 82.5 p -97.59 123.56 41.52 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.87 0.367 . . . . 54.33 111.405 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.6 pp -135.73 137.96 42.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.19 0.519 . . . . 75.41 111.352 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.0 m -83.66 107.35 16.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.155 0.502 . . . . 71.25 111.354 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -82.75 109.98 17.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.914 -0.585 . . . . 71.53 110.366 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 66' ' ' MET . 48.3 mtm180 -93.7 112.47 24.35 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.76 0.282 . . . . 73.34 111.76 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mp -92.18 93.94 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.04 0.448 . . . . 75.35 110.611 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -94.22 104.03 16.04 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 71.32 110.799 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.46 145.13 40.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.822 -0.704 . . . . 52.25 113.353 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.92 -45.05 95.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.418 0.628 . . . . 55.23 110.439 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 m -80.68 115.2 20.06 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.869 -0.605 . . . . 62.51 110.699 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -61.26 -27.22 68.3 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.89 0.376 . . . . 65.13 111.39 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 141.22 49.95 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.765 -0.652 . . . . 71.41 112.0 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.82 106.96 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.144 2.563 . . . . 72.02 113.508 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.6 148.91 63.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.238 -0.437 . . . . 72.3 111.643 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.7 179.81 4.88 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.594 2.196 . . . . 52.43 113.153 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 139.5 36.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.07 0.462 . . . . 62.01 111.687 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 157' ' ' PRO . 42.5 p90 -141.59 176.11 9.15 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.564 0.697 . . . . 73.15 112.475 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 p -152.73 168.69 24.84 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.536 -0.757 . . . . 32.44 111.077 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.55 -177.79 44.87 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.819 -0.705 . . . . 52.14 113.605 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 m -113.13 119.06 36.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.689 0.28 . . . . 74.34 111.308 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.09 115.81 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.103 0.478 . . . . 62.24 111.235 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 53.1 mt-10 -106.56 113.64 27.27 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.987 0.422 . . . . 74.54 111.158 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.434 ' CE1' HD22 ' A' ' 139' ' ' LEU . 17.0 p90 -116.95 129.02 55.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.044 0.45 . . . . 74.02 111.648 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.97 -146.71 4.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.186 -0.53 . . . . 72.41 113.189 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.617 ' NE2' ' HB3' ' A' ' 146' ' ' GLN . 92.9 mt-30 -128.58 152.87 47.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.169 0.509 . . . . 55.43 111.8 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 111' ' ' PHE . 57.9 mt -114.74 126.15 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.977 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -112.7 17.23 19.27 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.862 0.319 . . . . 75.13 111.862 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -132.99 -165.0 11.05 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.915 -0.659 . . . . 65.44 113.908 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.8 p -102.82 176.01 5.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.978 0.418 . . . . 74.5 111.558 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.485 HD11 ' HG3' ' A' ' 33' ' ' GLN . 49.2 mm -58.67 -38.23 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.085 0.469 . . . . 72.02 110.613 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.28 -47.91 59.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.899 -0.591 . . . . 64.51 110.995 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.41 91.69 2.57 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 51.01 111.826 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.614 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.9 p90 -115.41 127.89 55.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.178 0.513 . . . . 73.33 112.209 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.96 124.39 40.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 70.12 110.827 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.91 105.59 17.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.858 -0.61 . . . . 71.12 111.195 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.452 HD13 ' NE2' ' A' ' 105' ' ' GLN . 41.0 pt -109.28 156.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.63 -0.259 . . . . 63.13 111.652 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 56.66 39.36 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.945 0.402 . . . . 65.44 111.881 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 p -96.72 116.43 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.472 0.653 . . . . 72.01 112.454 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -105.02 147.37 27.9 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.98 -0.554 . . . . 62.13 110.341 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.451 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 7.4 p30 -112.68 136.47 52.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.346 0.593 . . . . 54.12 111.931 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.403 ' NE2' HD23 ' A' ' 139' ' ' LEU . 8.8 tt0 -127.45 157.74 39.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.956 -0.565 . . . . 73.31 110.217 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.5 122.02 37.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.11 0.411 . . . . 72.34 112.11 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.856 HG22 HD21 ' A' ' 137' ' ' LEU . 20.0 pt -100.95 105.64 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.163 0.506 . . . . 64.54 111.539 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -110.38 119.14 38.27 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.338 -0.392 . . . . 55.15 110.193 176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -114.28 133.29 22.45 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 111.858 0.318 . . . . 65.3 111.858 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 24.5 Cg_exo -64.28 159.99 40.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.174 2.583 . . . . 74.0 113.22 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.14 147.63 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.128 0.418 . . . . 53.25 112.128 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 t -87.39 124.54 33.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.342 -0.39 . . . . 61.2 110.541 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.4 -34.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.887 0.375 . . . . 72.0 111.722 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.09 -169.1 1.95 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.892 0.377 . . . . 71.23 111.655 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.47 149.73 53.1 Favored Pre-proline 0 N--CA 1.472 0.658 0 CA-C-N 116.508 -0.314 . . . . 33.21 111.358 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.54 147.2 63.5 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.0 -1.25 . . . . 73.33 113.306 -1.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m -65.89 82.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.356 0.598 . . . . 75.22 112.145 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.57 93.35 4.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.498 -0.774 . . . . 65.31 109.285 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.94 105.66 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.51 -0.313 . . . . 62.44 111.803 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.5 p-10 -96.97 142.9 28.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.992 0.425 . . . . 62.4 111.581 175.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 18.0 pt -135.85 135.82 22.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 116.314 -0.403 . . . . 75.13 111.346 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.0 Cg_exo -75.63 117.1 4.65 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 75.13 113.0 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.856 HD21 HG22 ' A' ' 121' ' ' ILE . 38.4 mt -97.1 112.33 24.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.185 0.439 . . . . 62.44 112.185 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -91.02 90.73 7.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.105 0.479 . . . . 62.44 110.023 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 101' ' ' TYR . 66.3 mt -76.72 137.71 39.51 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.319 -0.4 . . . . 63.44 111.252 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.8 135.82 48.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.226 0.454 . . . . 71.13 112.226 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.62 17.03 79.51 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 114.581 0.592 . . . . 61.11 114.581 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.2 tt -147.55 129.57 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 117.273 0.537 . . . . 63.1 111.628 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -92.48 156.75 16.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.975 0.416 . . . . 72.15 111.818 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.75 -33.79 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.964 -0.562 . . . . 75.24 111.727 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -31.63 72.95 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.966 0.413 . . . . 51.33 111.726 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.617 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 87.5 mm-40 -110.53 18.36 19.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.286 -0.415 . . . . 74.14 111.852 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -82.55 106.53 14.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.925 0.393 . . . . 71.03 110.832 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -83.78 -67.4 1.45 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.178 -0.534 . . . . 60.05 113.462 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -140.58 157.36 45.59 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.42 -0.459 . . . . 64.52 111.784 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.8 t -128.09 103.14 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.958 -0.565 . . . . 75.24 110.662 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -93.32 114.97 27.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.27 0.47 . . . . 71.12 112.27 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.775 HG21 ' SD ' ' A' ' 66' ' ' MET . 42.7 mm -96.14 130.78 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.105 -0.498 . . . . 73.14 111.118 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -165.39 -175.32 3.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.596 0.236 . . . . 75.45 111.632 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 64.22 24.47 13.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.117 0.567 . . . . 61.53 112.0 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.74 104.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.541 0.686 . . . . 75.34 111.538 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.555 ' HB3' HE22 ' A' ' 60' ' ' GLN . 8.0 pt20 -132.75 142.95 46.64 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.423 -0.808 . . . . 72.34 111.159 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 95' ' ' PHE . 62.5 Cg_endo -72.07 151.53 55.8 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.296 1.997 . . . . 75.21 112.692 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.82 143.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.619 -0.264 . . . . 73.42 110.812 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.6 mtm 70.45 -10.6 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.244 0.618 . . . . 63.52 112.661 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.21 113.86 21.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.889 0.376 . . . . 62.53 111.095 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.97 156.87 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.223 0.535 . . . . 72.04 111.875 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.0 162.66 30.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.288 0.566 . . . . 74.42 111.856 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -52.87 127.65 24.27 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.381 -0.827 . . . . 73.12 112.999 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.91 143.86 41.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.133 -0.485 . . . . 73.31 110.399 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -146.34 146.62 30.74 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 42.24 111.691 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -72.96 168.62 18.61 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.872 0.367 . . . . 74.4 111.512 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 39.9 m80 69.78 92.62 0.08 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.056 0.761 . . . . 71.15 113.056 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.6 m170 . . . . . 0 C--O 1.255 1.394 0 CA-C-N 115.105 -0.952 . . . . 75.03 110.681 169.217 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.733 0.302 . . . . 75.51 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.88 134.15 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.921 0.391 . . . . 61.34 111.499 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -125.02 122.73 38.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.56 -0.291 . . . . 73.03 111.201 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -173.42 145.69 1.28 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.941 0.401 . . . . 75.1 111.862 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -135.14 -177.33 4.59 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.281 -0.418 . . . . 52.02 110.671 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.31 173.04 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.201 0.445 . . . . 65.24 112.201 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m -82.07 158.06 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 112.477 0.547 . . . . 64.14 112.477 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 8' ' ' ARG . 9.7 mmt85 -123.7 123.51 40.69 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.084 0.468 . . . . 72.11 111.737 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -88.19 146.5 25.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.117 0.414 . . . . 61.1 112.117 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.5 mmt -129.02 138.35 51.87 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.375 -0.375 . . . . 60.33 111.228 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.13 129.37 11.95 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.01 0.433 . . . . 65.45 111.431 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -144.05 123.0 12.76 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.506 -0.315 . . . . 54.41 111.5 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.2 m -131.53 104.02 6.73 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 72.41 111.308 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.53 145.29 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.571 -0.286 . . . . 63.51 110.931 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.7 m -111.21 97.03 6.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.918 0.39 . . . . 75.2 111.821 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.9 p -91.78 -161.27 0.81 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.439 -0.346 . . . . 70.14 111.152 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.32 176.98 9.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.232 -0.293 . . . . 74.23 110.822 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -68.17 77.9 0.24 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.85 0.834 . . . . 74.02 111.529 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -89.87 162.79 15.29 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.412 -0.813 . . . . 75.11 111.808 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -79.66 94.71 5.75 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.954 -0.566 . . . . 62.21 110.743 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.3 mmt -101.65 165.58 11.15 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.904 0.383 . . . . 73.01 111.679 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 p -61.01 -39.12 88.52 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.275 0.56 . . . . 73.15 111.336 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -109.13 151.07 26.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 63.34 110.716 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.58 141.05 57.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.319 0.581 . . . . 74.41 112.149 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -60.36 127.96 34.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.717 -0.674 . . . . 73.22 110.894 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -60.7 -30.76 70.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.655 0.264 . . . . 55.22 111.615 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.59 -47.06 85.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.392 0.615 . . . . 75.33 110.38 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 m -66.01 -31.08 71.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.829 -0.623 . . . . 72.53 111.049 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.79 -45.15 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.36 -0.382 . . . . 65.01 110.89 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.51 -48.33 77.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.142 0.496 . . . . 74.44 110.732 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.6 mt -55.81 -51.22 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.904 -0.589 . . . . 72.33 111.41 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.1 m -58.36 -44.65 88.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.278 -0.419 . . . . 63.44 111.557 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.38 -44.05 96.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.447 -0.342 . . . . 74.55 111.209 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -56.79 -50.87 71.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.403 -0.362 . . . . 60.51 111.449 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -58.12 -43.8 87.4 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.859 0.361 . . . . 71.31 111.726 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -63.64 -48.23 78.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.729 0.3 . . . . 65.44 111.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.23 -33.82 76.32 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.333 0.587 . . . . 75.52 110.549 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.491 HD21 ' HB ' ' A' ' 45' ' ' VAL . 6.9 t-20 -63.6 -41.47 98.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.834 -0.621 . . . . 71.02 110.509 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.47 65.22 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.048 -0.524 . . . . 65.14 111.654 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.601 ' HE3' HG22 ' A' ' 108' ' ' ILE . 66.7 mttm -82.21 -7.97 59.64 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.835 0.309 . . . . 51.12 111.835 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -55.97 117.57 3.83 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.648 0.61 . . . . 71.31 112.648 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 t -71.12 -36.87 72.3 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.081 -0.509 . . . . 51.24 111.691 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 m -151.99 121.54 6.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.714 0.292 . . . . 73.12 110.723 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.79 -153.59 22.08 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.221 -0.514 . . . . 42.1 112.547 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.491 ' HB ' HD21 ' A' ' 38' ' ' ASN . 17.7 m -136.29 148.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.14 0.47 . . . . 72.4 111.918 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -95.92 130.11 42.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.297 -0.411 . . . . 72.01 112.069 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -125.06 143.89 50.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.858 -0.61 . . . . 74.42 109.868 172.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 76.5 mt -114.12 136.36 22.2 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.837 0.351 . . . . 63.33 111.721 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 36.8 Cg_exo -61.53 -14.0 32.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.922 2.415 . . . . 75.15 113.406 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.35 6.43 26.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.212 -0.518 . . . . 72.54 113.145 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.88 103.12 11.86 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.043 0.449 . . . . 71.3 111.125 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -80.65 60.55 4.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.513 0.673 . . . . 73.22 111.231 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 p -146.01 150.65 42.89 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-N 115.826 -0.624 . . . . 70.21 112.123 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -81.69 170.85 13.84 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.024 2.483 . . . . 72.42 114.396 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 38' ' ' ASN . . . -143.38 157.03 44.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.738 -0.665 . . . . 72.42 110.076 174.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -113.59 119.36 37.23 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.46 0.648 . . . . 73.31 112.17 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.95 126.16 53.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.839 -0.618 . . . . 72.35 112.284 -175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.0 tt0 -86.78 108.33 18.66 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.741 -0.466 . . . . 61.32 109.741 172.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 82.6 p -113.04 -177.5 3.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.234 0.54 . . . . 71.13 112.338 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 50.1 mt-30 -67.66 -19.82 65.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.945 -0.57 . . . . 71.43 112.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 pt -95.19 -6.55 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.986 0.422 . . . . 72.4 111.073 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.54 -179.46 16.3 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.382 -0.437 . . . . 71.11 112.89 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 60.3 m -79.81 131.69 35.95 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.454 -0.439 . . . . 72.32 111.34 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.96 175.18 10.03 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.127 0.489 . . . . 63.32 112.246 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -124.34 123.35 40.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.106 -0.497 . . . . 74.42 110.664 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.568 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.0 mtt -118.0 156.16 29.04 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.873 0.368 . . . . 74.31 111.896 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.9 t -158.79 170.47 22.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.905 0.383 . . . . 70.2 111.908 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB3' HD11 ' A' ' 71' ' ' ILE . 99.2 mt -116.29 106.18 13.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.29 -0.414 . . . . 71.34 111.996 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 81' ' ' THR . 33.0 m -113.36 162.19 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.238 -0.288 . . . . 42.31 111.064 176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 63.83 31.2 14.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.039 0.447 . . . . 74.33 112.095 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 68' ' ' LEU . 45.3 mt -73.08 103.93 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.17 0.433 . . . . 23.21 112.17 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 p -137.78 152.49 72.56 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 120.861 0.362 . . . . 71.51 111.562 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.11 168.88 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.737 2.291 . . . . 51.43 113.495 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.66 ' HB2' HG23 ' A' ' 79' ' ' THR . 31.5 t70 -143.82 170.54 15.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.773 -0.649 . . . . 72.53 110.749 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.25 94.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.692 0.282 . . . . 70.12 111.692 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -84.15 -34.27 24.09 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.525 -0.307 . . . . 61.31 111.736 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.54 -100.83 0.14 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.36 -0.924 . . . . 64.44 114.149 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -146.03 131.28 18.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.832 0.349 . . . . 73.15 111.586 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.66 HG23 ' HB2' ' A' ' 74' ' ' ASP . 79.0 p -109.56 137.7 47.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.895 0.379 . . . . 62.52 111.604 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 pp -149.41 -179.57 7.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.898 0.38 . . . . 44.24 111.272 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.691 ' HB ' HG23 ' A' ' 69' ' ' VAL . 21.7 m -124.13 117.77 25.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.894 0.378 . . . . 64.44 111.258 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.2 113.54 20.73 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.238 -0.437 . . . . 70.4 109.946 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 66' ' ' MET . 69.7 mtt180 -96.29 136.57 36.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.822 0.344 . . . . 75.42 111.09 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.536 HG12 ' HG2' ' A' ' 66' ' ' MET . 42.1 mt -131.63 133.97 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.02 -0.536 . . . . 74.14 111.529 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -142.51 124.79 15.51 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.737 -0.21 . . . . 73.15 110.689 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 92' ' ' LEU . . . -75.86 146.08 33.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.843 -0.694 . . . . 74.14 113.933 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -59.41 -39.48 83.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.753 0.787 . . . . 75.2 109.927 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -93.81 112.18 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 73.12 109.671 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -64.35 -7.71 10.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.46 0.541 . . . . 75.23 112.46 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.97 156.29 80.77 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 122.881 0.473 . . . . 64.15 111.572 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.82 123.38 11.51 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.094 2.529 . . . . 61.13 113.824 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 126' ' ' SER . 95.9 mt -100.19 147.98 34.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.099 -0.501 . . . . 73.41 111.332 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.13 172.79 15.28 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.471 2.114 . . . . 65.32 112.991 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.48 43.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 64.45 111.032 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -146.35 162.27 38.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.351 0.596 . . . . 72.33 112.282 -173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.4 m -146.9 151.54 37.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.932 -0.577 . . . . 53.22 110.309 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.763 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -150.25 170.61 30.22 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.411 -0.899 . . . . 55.41 113.762 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.1 m -105.32 132.04 52.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 75.13 110.999 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.75 130.39 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.955 0.407 . . . . 75.35 111.6 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 40.4 mm-40 -97.83 111.92 24.03 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 64.02 110.818 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -122.75 120.95 35.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.237 0.542 . . . . 75.35 111.844 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -161.65 -149.18 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.837 -0.62 . . . . 55.41 113.23 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -125.06 157.19 36.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.222 0.534 . . . . 61.32 112.043 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.36 121.16 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.354 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.441 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -105.08 5.95 32.85 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.872 0.367 . . . . 73.32 111.658 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -113.69 -177.89 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.233 -0.508 . . . . 73.43 113.19 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -90.44 179.41 5.87 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.611 -0.346 . . . . 52.43 111.223 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.601 HG22 ' HE3' ' A' ' 40' ' ' LYS . 48.8 mm -68.73 -27.56 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.521 . . . . 74.33 110.605 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.54 -32.34 58.16 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.384 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.39 90.57 1.67 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.285 0.564 . . . . 61.34 111.14 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -96.3 117.23 30.39 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.413 0.625 . . . . 70.31 112.05 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -86.59 111.98 21.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.081 -0.508 . . . . 71.52 110.633 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.77 104.08 11.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.951 0.405 . . . . 72.34 111.053 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.441 HD13 ' NE2' ' A' ' 105' ' ' GLN . 41.5 pt -113.39 151.65 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.475 -0.33 . . . . 63.35 111.687 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 58.14 34.44 24.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.078 0.465 . . . . 55.11 111.802 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.442 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 3.7 p -91.14 116.74 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.339 0.59 . . . . 73.41 112.331 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.66 171.79 7.68 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.268 -0.424 . . . . 63.44 111.011 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.12 143.47 50.87 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.14 0.495 . . . . 61.42 111.872 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -144.76 147.69 33.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.36 -0.382 . . . . 72.23 111.17 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.88 125.47 37.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.076 0.465 . . . . 74.53 112.216 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.2 pt -101.96 120.62 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.978 0.418 . . . . 72.15 111.043 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -107.32 122.31 46.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.869 0.366 . . . . 71.14 111.491 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 135' ' ' ILE . . . -119.08 138.19 25.93 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 120.732 0.301 . . . . 54.52 111.546 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 170.34 20.26 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.725 2.283 . . . . 72.51 113.396 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.53 117.59 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.161 -0.472 . . . . 43.05 112.061 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 25.1 m -79.56 63.81 4.25 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.954 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.31 -11.66 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 113.451 0.908 . . . . 72.0 113.451 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -102.45 120.67 40.91 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.034 -0.416 . . . . 73.21 111.411 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.64 139.16 31.42 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 111.733 0.272 . . . . 72.22 111.733 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.74 145.63 82.15 Favored 'Cis proline' 0 C--N 1.356 0.922 0 C-N-CA 124.116 -1.202 . . . . 74.21 113.431 0.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.8 p -83.86 95.53 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.991 0.737 . . . . 62.31 112.991 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.24 127.02 20.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.003 -0.544 . . . . 54.23 110.739 171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -132.59 139.45 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.323 -0.399 . . . . 72.54 111.712 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.47 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 18.1 p-10 -114.67 133.39 55.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.256 0.551 . . . . 64.52 110.95 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.528 HD13 ' HB2' ' A' ' 123' ' ' ALA . 25.3 pt -130.5 140.18 37.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.482 -0.327 . . . . 72.15 111.509 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.24 156.2 62.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.418 2.079 . . . . 72.51 112.439 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -145.44 116.69 7.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.493 -0.321 . . . . 75.02 110.158 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -103.25 96.95 7.11 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.197 0.523 . . . . 74.14 111.814 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.8 129.86 35.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.842 0.354 . . . . 74.23 110.248 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -116.11 139.45 50.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.917 0.389 . . . . 45.24 111.809 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.12 20.21 61.26 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.326 -0.397 . . . . 70.42 113.815 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -160.29 124.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 117.334 0.567 . . . . 73.22 112.299 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.5 m -86.45 146.69 26.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.193 -0.317 . . . . 72.02 111.602 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.92 -35.64 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 112.749 0.648 . . . . 74.35 112.749 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.64 -23.15 66.73 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.159 0.504 . . . . 64.03 111.481 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -109.21 8.86 26.0 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.062 -0.517 . . . . 75.43 111.525 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.423 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 1.1 tt -91.63 126.05 36.57 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.913 0.387 . . . . 71.12 110.894 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.19 -62.35 1.22 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.297 -0.478 . . . . 73.13 113.72 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.39 160.35 40.31 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.563 0.579 . . . . 64.34 112.563 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.92 101.48 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.644 -0.707 . . . . 51.21 110.342 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 45.2 ttp180 -98.03 116.77 30.93 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.029 -0.419 . . . . 61.35 112.055 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.568 HG21 ' SD ' ' A' ' 66' ' ' MET . 22.3 mm -85.46 130.32 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.435 -0.348 . . . . 64.4 111.191 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -158.67 179.52 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.292 -0.255 . . . . 72.34 111.585 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.43 30.92 20.17 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.763 0.653 . . . . 74.13 112.763 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.763 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.9 mm -71.79 106.43 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.365 0.602 . . . . 71.55 110.691 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.471 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.7 pt20 -129.71 149.39 72.83 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.711 -0.677 . . . . 73.53 111.859 -174.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 156' ' ' GLN . 9.4 Cg_exo -71.23 136.93 30.24 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.627 2.218 . . . . 74.53 112.65 177.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.2 153.91 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.8 0.333 . . . . 55.21 110.748 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.6 ptp -166.89 160.95 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.073 0.463 . . . . 74.01 111.971 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.75 118.15 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.333 -0.617 . . . . 75.41 109.333 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 44.5 tp -58.14 133.2 55.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.188 0.81 . . . . 64.13 113.188 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -118.42 -178.32 3.5 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.867 -0.606 . . . . 71.53 111.146 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -123.33 148.61 45.83 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.843 0.354 . . . . 73.13 111.574 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -147.18 134.97 21.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.489 -0.323 . . . . 74.02 111.363 -173.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -151.46 132.52 14.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.79 0.329 . . . . 71.43 111.685 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -116.83 161.64 18.97 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.821 0.343 . . . . 64.31 111.426 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -87.77 -46.72 9.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.824 0.345 . . . . 74.11 111.818 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.67 -0.681 . . . . 74.41 111.558 -179.264 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.29 0.567 . . . . 73.4 111.67 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.87 157.42 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.085 0.469 . . . . 51.11 111.502 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -138.78 119.01 13.57 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.162 -0.472 . . . . 44.03 110.759 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -79.3 94.62 5.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.092 0.472 . . . . 75.35 111.709 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 150.29 48.78 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.918 -0.583 . . . . 74.41 111.776 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.3 164.7 12.02 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.964 0.411 . . . . 71.13 111.833 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.87 136.41 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.049 0.452 . . . . 63.15 111.768 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -108.6 149.04 29.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.029 0.442 . . . . 74.13 111.63 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -108.19 104.35 13.74 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.099 -0.5 . . . . 75.54 110.294 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 10' ' ' MET . 3.6 mpp? -76.91 140.4 40.52 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.33 0.586 . . . . 63.4 112.195 -175.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 8.9 mmpt? -72.19 114.14 9.98 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.899 -0.591 . . . . 64.34 111.537 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -140.42 169.52 17.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.717 0.294 . . . . 72.24 111.551 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.9 p -60.23 143.0 53.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.391 -0.368 . . . . 70.35 111.291 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.33 124.19 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.147 0.499 . . . . 42.25 111.7 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 m -104.1 22.91 13.85 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.296 0.569 . . . . 73.11 110.987 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -86.55 176.99 7.53 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.942 -0.572 . . . . 52.12 112.089 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.18 162.21 27.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.849 0.357 . . . . 72.35 111.495 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.64 168.16 19.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.459 0.647 . . . . 74.35 112.432 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -179.2 3.88 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.946 -0.57 . . . . 74.51 111.212 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -91.74 -158.15 0.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.27 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 21' ' ' MET . 1.3 mpt? -52.46 136.79 31.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.979 0.419 . . . . 63.33 111.958 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.7 p -88.46 165.97 14.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.12 0.486 . . . . 74.4 111.778 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -76.88 -173.97 2.89 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.326 0.491 . . . . 74.34 112.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.5 tp -57.5 152.49 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.997 -0.547 . . . . 74.01 111.945 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -67.2 147.52 52.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.196 0.443 . . . . 55.44 112.196 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.316 0.487 . . . . 73.31 112.316 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 34.4 tt0 -54.99 -52.21 63.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.799 0.333 . . . . 70.12 111.522 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.0 m -56.27 -41.16 75.38 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.963 0.411 . . . . 51.2 111.302 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.32 -36.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 74.24 111.32 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HE3' HD13 ' A' ' 48' ' ' LEU . 52.3 tptt -66.96 -38.37 85.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.123 -0.49 . . . . 62.5 110.437 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.448 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 84.7 mt -60.22 -48.57 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.13 0.491 . . . . 63.05 110.755 174.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.6 m -56.05 -41.79 75.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.115 -0.493 . . . . 72.15 110.783 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HG3' HD11 ' A' ' 108' ' ' ILE . 34.3 tt0 -59.09 -46.37 88.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.157 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.71 -52.92 63.1 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.994 0.368 . . . . 70.42 111.994 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.69 -42.87 84.56 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.819 0.342 . . . . 75.42 111.608 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.1 -34.56 76.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.929 0.344 . . . . 60.55 111.929 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.9 mt -68.1 -37.7 81.47 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.929 0.395 . . . . 64.23 110.829 174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.434 HD21 HG12 ' A' ' 45' ' ' VAL . 26.9 t-20 -57.76 -44.06 85.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.006 0.431 . . . . 53.44 110.751 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.91 81.91 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.647 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.79 -2.08 58.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.93 0.395 . . . . 74.41 111.817 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -78.0 150.86 33.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.075 0.464 . . . . 73.43 111.863 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 m -122.01 -31.63 3.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.821 -0.627 . . . . 74.24 110.868 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -112.19 85.47 2.16 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.194 0.521 . . . . 74.41 111.438 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 80.92 -146.25 26.61 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.214 -0.517 . . . . 51.24 113.833 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.502 HG13 HD13 ' A' ' 57' ' ' LEU . 33.5 m -123.74 140.6 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.472 0.545 . . . . 54.34 112.472 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 65.5 m-85 -87.04 107.63 18.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.436 -0.347 . . . . 53.44 110.895 172.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.64 128.26 44.21 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 71.32 110.499 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 72.1 mt -108.63 133.62 20.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.629 0.252 . . . . 63.52 111.471 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.41 -45.76 38.7 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.003 2.468 . . . . 72.53 113.251 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -71.38 -25.67 74.92 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.926 -0.654 . . . . 64.14 113.001 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -91.93 63.2 4.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.051 0.453 . . . . 63.13 111.429 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -64.56 75.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.409 0.623 . . . . 63.35 111.541 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 p -141.65 151.47 60.4 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.132 -0.486 . . . . 72.51 111.946 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.688 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 74.5 Cg_endo -73.67 128.11 12.28 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.875 2.383 . . . . 75.45 113.958 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.96 139.9 50.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.348 -0.387 . . . . 73.42 110.703 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 56' ' ' ARG . 13.0 ttp180 -89.39 133.18 34.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.063 0.458 . . . . 62.21 111.282 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.502 HD13 HG13 ' A' ' 45' ' ' VAL . 40.9 tp -132.89 129.67 38.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.132 -0.485 . . . . 62.22 111.374 -177.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.71 137.97 32.02 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.003 -0.369 . . . . 71.42 110.003 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.4 p -126.11 177.94 6.07 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.213 0.53 . . . . 70.34 111.287 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.0 0.75 23.21 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.869 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 pt -118.46 -4.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.737 0.303 . . . . 44.12 111.762 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.11 -177.94 20.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.53 -0.367 . . . . 42.04 112.993 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -88.39 132.32 34.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.207 -0.584 . . . . 73.41 111.716 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.03 -177.59 4.96 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.001 0.429 . . . . 75.12 111.706 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.688 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 66.7 ttp85 -135.41 140.77 45.2 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.477 -0.329 . . . . 74.4 111.088 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.676 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.8 mtt -129.36 152.23 49.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 61.43 111.854 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.1 p -152.38 152.65 32.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.906 0.384 . . . . 72.42 111.626 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 71.1 mt -100.81 111.06 23.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.323 -0.399 . . . . 72.14 111.349 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.639 HG21 ' HD2' ' A' ' 83' ' ' ARG . 33.7 m -128.12 159.35 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.626 0.25 . . . . 71.3 110.997 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.567 HD22 HG23 ' A' ' 69' ' ' VAL . 28.7 m-80 51.71 69.03 0.71 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.955 0.407 . . . . 74.52 111.113 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.6 mt -100.43 102.13 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.247 -0.433 . . . . 72.42 110.732 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -121.65 144.86 41.57 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 112.672 0.619 . . . . 74.52 112.672 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.27 129.67 15.29 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.766 2.311 . . . . 73.23 112.104 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.9 t70 -110.46 164.95 12.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.159 -0.473 . . . . 54.2 111.708 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.01 76.93 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.489 0.551 . . . . 71.11 112.489 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -96.47 -12.29 24.39 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.912 0.338 . . . . 71.21 111.912 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . 171.51 -102.51 0.18 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.988 -0.625 . . . . 73.32 113.48 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -147.81 130.45 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.492 -0.417 . . . . 71.21 111.775 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 39.4 p -106.78 120.41 41.93 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.831 0.348 . . . . 72.42 111.485 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -130.13 159.13 37.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.691 0.282 . . . . 65.23 110.875 176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -101.92 108.21 19.6 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.973 0.415 . . . . 65.21 111.867 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 HD11 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -84.07 106.63 15.87 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.499 -0.556 . . . . 65.22 109.499 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' HD2' HG21 ' A' ' 69' ' ' VAL . 20.2 mtp180 -96.11 125.76 40.87 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.192 -0.318 . . . . 74.31 111.247 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.568 HD11 HD12 ' A' ' 82' ' ' LEU . 3.9 mp -115.93 103.3 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.917 0.389 . . . . 74.31 111.381 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -106.5 134.7 49.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.382 . . . . 73.34 110.722 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 142.47 32.61 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.957 -0.64 . . . . 65.01 113.324 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -62.15 -35.76 79.77 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.385 0.612 . . . . 62.54 110.749 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.8 m -99.82 149.83 22.97 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.794 -0.639 . . . . 60.33 110.718 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.71 -17.35 64.05 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.178 0.513 . . . . 74.51 111.342 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.15 136.33 58.69 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.622 -0.717 . . . . 72.41 112.052 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.75 117.01 4.42 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.456 2.104 . . . . 72.0 113.053 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -85.2 148.16 49.43 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.391 -0.368 . . . . 72.12 111.837 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.61 176.22 9.64 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.622 2.215 . . . . 64.12 113.007 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -75.14 140.46 43.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.927 0.394 . . . . 74.32 111.741 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.86 168.67 19.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.529 0.68 . . . . 72.53 112.368 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 93.8 p -146.6 145.16 29.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.522 -0.763 . . . . 55.23 110.255 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -143.49 157.12 26.88 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.556 -0.83 . . . . 72.11 113.448 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 60.9 m -99.94 104.99 16.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.981 0.42 . . . . 74.52 110.784 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 152' ' ' ILE . 20.1 m -91.06 125.3 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.007 0.432 . . . . 74.05 111.391 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.8 mt-10 -108.41 112.69 25.24 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.198 0.523 . . . . 70.13 110.831 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -115.97 141.28 48.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.953 -0.567 . . . . 74.42 111.641 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.27 -146.48 4.85 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.283 -0.484 . . . . 64.32 112.81 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.698 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 mt-30 -128.22 144.17 51.1 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.254 0.464 . . . . 70.34 112.254 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 111' ' ' PHE . 68.2 mt -114.14 103.89 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.409 -0.359 . . . . 55.01 110.78 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.444 ' NE2' HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -92.83 15.03 15.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.043 0.386 . . . . 72.45 112.043 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -123.29 -170.26 13.4 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.884 -0.674 . . . . 72.35 113.872 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 49.9 p -102.63 -178.1 3.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.804 0.441 . . . . 62.34 111.644 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.493 HD11 ' HG3' ' A' ' 33' ' ' GLN . 46.7 mm -63.42 -30.83 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.461 0.648 . . . . 70.21 110.668 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.82 -56.13 5.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.685 -0.689 . . . . 75.21 110.848 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -129.31 98.26 4.83 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.196 0.522 . . . . 72.15 111.567 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.543 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 32.2 p90 -113.8 132.37 55.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.082 0.468 . . . . 71.34 111.537 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -107.32 115.94 31.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.219 -0.446 . . . . 62.25 111.492 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.8 97.46 3.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.888 0.375 . . . . 63.55 110.615 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.444 HD13 ' NE2' ' A' ' 105' ' ' GLN . 36.3 pt -108.73 156.81 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.491 -0.322 . . . . 75.23 111.288 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 56.86 36.32 27.56 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.119 0.485 . . . . 73.22 111.546 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.31 116.37 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.96 0.726 . . . . 72.11 112.96 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.572 ' H ' ' NE2' ' A' ' 117' ' ' GLN . 0.8 OUTLIER -124.89 156.88 37.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.711 -0.677 . . . . 71.13 110.972 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.506 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.3 p-10 -102.42 166.9 10.29 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.361 0.875 . . . . 73.51 113.361 -172.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.425 ' NE2' HD23 ' A' ' 139' ' ' LEU . 8.4 tt0 -152.9 152.83 31.95 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.413 -0.812 . . . . 74.22 110.087 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.39 133.46 35.86 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.019 0.438 . . . . 73.35 112.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.9 HG22 HD21 ' A' ' 137' ' ' LEU . 39.4 pt -109.98 106.21 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.199 0.523 . . . . 74.43 110.758 173.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.82 101.72 12.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.903 0.382 . . . . 73.2 111.031 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 140.87 21.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.073 0.398 . . . . 64.54 112.073 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.68 168.58 22.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.819 2.346 . . . . 75.25 113.216 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -82.94 139.57 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.288 -0.415 . . . . 64.02 111.856 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.8 m -78.01 93.07 4.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 75.03 110.655 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.94 -36.92 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.264 0.554 . . . . 53.14 111.034 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -111.15 145.11 39.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.925 -0.58 . . . . 63.45 111.148 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.73 45.54 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.483 -0.326 . . . . 63.24 110.963 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -82.33 170.85 56.71 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.007 -1.247 . . . . 73.23 113.872 1.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -79.82 74.12 6.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.324 -0.398 . . . . 75.21 112.035 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.4 103.11 12.38 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.262 -0.426 . . . . 65.31 111.289 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.7 t -122.38 108.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.234 0.214 . . . . 71.23 111.429 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -117.87 128.28 54.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.028 0.442 . . . . 54.04 111.701 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 pt -126.12 144.33 48.58 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.185 -0.461 . . . . 53.54 112.145 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.74 158.39 46.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.884 2.389 . . . . 72.54 112.852 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.9 HD21 HG22 ' A' ' 121' ' ' ILE . 31.7 mt -139.72 103.97 4.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.459 0.54 . . . . 75.53 112.459 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -82.78 95.11 7.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.342 0.591 . . . . 65.24 110.557 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.495 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 40.9 mt -80.19 114.79 19.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 60.41 109.803 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -95.58 134.5 38.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.006 0.431 . . . . 74.34 112.056 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.68 15.47 58.15 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.253 -0.499 . . . . 43.41 113.696 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -152.54 134.93 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 117.229 0.514 . . . . 70.13 111.528 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -94.83 156.23 16.45 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.915 0.388 . . . . 71.43 111.847 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.98 -43.76 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.874 0.694 . . . . 63.34 112.874 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.02 -13.53 62.01 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 63.54 111.042 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.432 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 31.6 mm-40 -106.18 5.82 30.3 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.099 -0.5 . . . . 75.55 111.979 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.455 HD23 HD13 ' A' ' 142' ' ' ILE . 40.2 mt -80.14 109.6 14.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.251 0.548 . . . . 74.43 111.485 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.698 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -87.65 -45.24 5.26 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.847 -0.615 . . . . 70.31 112.904 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -156.13 151.99 27.4 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.167 0.508 . . . . 70.22 111.748 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.38 93.23 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.881 -0.599 . . . . 71.31 109.745 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 18.5 ttp85 -88.27 109.1 19.68 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.274 0.559 . . . . 75.43 112.249 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.676 HG21 ' SD ' ' A' ' 66' ' ' MET . 13.4 mm -90.51 129.69 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.748 -0.66 . . . . 72.11 111.083 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.559 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 14.8 p80 -167.25 -178.13 3.96 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.237 0.458 . . . . 61.32 112.237 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 98' ' ' THR . 8.8 t70 66.32 31.59 8.31 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.53 -0.759 . . . . 65.14 111.174 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.478 HD13 ' HA3' ' A' ' 97' ' ' GLY . 43.0 mm -68.04 94.02 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.87 -0.604 . . . . 60.14 111.154 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -112.83 145.07 32.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.813 -0.631 . . . . 73.11 111.702 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.44 140.8 37.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.487 2.125 . . . . 42.01 112.962 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.4 m -94.28 26.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.554 0.692 . . . . 61.43 111.111 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 79.0 mtp -125.82 -172.75 2.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.842 -0.617 . . . . 65.14 110.658 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -76.18 125.94 30.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.685 0.279 . . . . 53.25 111.246 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.668 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.4 pt? -127.03 143.2 51.35 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.906 0.384 . . . . 65.25 111.26 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.32 166.44 10.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.264 0.555 . . . . 74.41 112.137 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -165.56 94.65 0.61 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.671 -0.695 . . . . 74.2 110.08 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -72.62 137.76 46.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.946 0.403 . . . . 71.22 111.817 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -79.84 121.8 25.85 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.865 0.364 . . . . 73.42 111.883 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -94.98 81.12 3.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.258 0.551 . . . . 73.14 110.369 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -78.5 -18.39 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.227 -0.442 . . . . 74.43 111.725 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 72.2 t60 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.779 -0.629 . . . . 71.12 111.636 -178.715 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.542 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.91 0.386 . . . . 52.32 111.051 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -82.15 150.2 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.264 0.554 . . . . 73.11 112.138 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -106.17 137.2 44.53 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.968 -0.56 . . . . 72.22 111.248 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -104.55 174.05 6.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.074 0.464 . . . . 64.13 112.141 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.8 p -58.72 143.5 46.66 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.968 0.729 . . . . 60.32 112.968 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -95.31 98.04 10.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.0 -0.546 . . . . 75.13 111.377 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.21 142.08 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.926 0.393 . . . . 64.34 111.771 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.531 HH11 ' HA ' ' A' ' 10' ' ' MET . 3.5 tmt_? -141.81 112.33 7.11 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.323 -0.398 . . . . 72.41 110.426 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.98 117.55 10.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.667 0.27 . . . . 74.53 110.808 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.531 ' HA ' HH11 ' A' ' 8' ' ' ARG . 52.6 ttm -94.19 144.1 25.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 70.3 111.834 -176.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -149.24 118.21 6.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.192 -0.458 . . . . 74.4 110.768 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -114.97 161.1 18.76 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.169 0.509 . . . . 64.41 112.167 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -103.23 -172.46 2.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.018 -0.537 . . . . 64.13 111.096 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.1 p -147.6 138.95 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.363 -0.38 . . . . 73.32 111.087 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.4 m -128.96 140.75 51.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.843 0.354 . . . . 74.22 111.538 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -101.53 168.39 9.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.856 0.36 . . . . 73.31 111.735 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -91.72 149.64 21.52 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.976 0.417 . . . . 73.24 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -98.18 129.06 44.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.854 0.359 . . . . 71.31 111.668 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -94.06 163.64 13.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.978 0.418 . . . . 55.34 111.348 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.63 149.24 44.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.064 0.459 . . . . 75.05 111.465 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.3 mmt -117.7 159.93 22.16 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.287 -0.415 . . . . 74.31 110.257 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.1 p -60.27 144.31 50.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.622 0.248 . . . . 72.54 111.069 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -51.24 106.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.203 0.525 . . . . 75.41 111.543 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.8 tp -86.09 165.0 16.97 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.94 -0.573 . . . . 73.3 111.717 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 29' ' ' VAL . 1.4 m-20 -49.76 130.66 21.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.196 -0.456 . . . . 62.43 111.506 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -53.52 -41.06 65.97 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.427 0.529 . . . . 65.2 112.427 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.8 pt-20 -58.4 -49.36 77.53 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.115 0.483 . . . . 62.42 110.726 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.464 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 7.1 m -69.01 -26.02 64.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.063 -0.517 . . . . 73.15 111.612 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 25' ' ' ASN . 98.2 t -63.15 -47.9 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.005 0.431 . . . . 72.31 110.56 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.87 -39.07 92.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.359 -0.382 . . . . 75.33 111.004 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 27' ' ' GLU . 84.4 mt -58.97 -46.43 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.994 0.426 . . . . 61.41 110.832 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -56.29 -49.54 73.98 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.246 0.546 . . . . 70.14 110.611 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.791 ' HG3' HD11 ' A' ' 108' ' ' ILE . 60.2 tt0 -54.89 -43.75 73.5 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.724 -0.671 . . . . 74.33 111.228 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 30.3 tt0 -60.53 -51.81 67.87 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.111 -0.495 . . . . 55.01 111.868 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -57.46 -40.4 78.45 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.19 0.441 . . . . 55.15 112.19 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -65.01 -47.67 76.68 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.696 0.284 . . . . 71.43 111.643 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.44 -39.35 91.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.312 0.577 . . . . 70.31 110.757 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.541 HD21 ' HB ' ' A' ' 45' ' ' VAL . 3.3 t-20 -60.23 -38.22 82.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.583 -0.735 . . . . 53.5 111.072 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.54 -25.83 35.55 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.301 0.482 . . . . 72.1 112.301 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 55.9 mttm -69.3 -30.9 69.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.803 0.297 . . . . 74.44 111.803 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB2' ' HE1' ' A' ' 46' ' ' TYR . 48.2 t -71.4 130.19 40.71 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.358 0.503 . . . . 61.24 112.358 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.7 m -83.11 -13.86 54.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.068 -0.515 . . . . 73.32 111.686 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -160.78 102.9 1.33 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.863 0.363 . . . . 71.42 111.394 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 152' ' ' ILE . . . 116.07 137.61 6.16 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.17 -0.538 . . . . 52.33 112.896 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.541 ' HB ' HD21 ' A' ' 38' ' ' ASN . 27.4 m -89.49 138.3 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.383 0.512 . . . . 55.21 112.383 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HE1' ' HB2' ' A' ' 41' ' ' SER . 30.2 m-85 -90.01 114.11 25.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.835 -0.62 . . . . 72.43 110.783 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -108.58 133.48 52.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.493 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 74.3 mt -110.4 126.97 27.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.762 -0.199 . . . . 71.35 111.071 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -33.41 68.65 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.539 2.159 . . . . 55.45 112.727 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.29 -36.37 50.53 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.235 -0.439 . . . . 61.14 112.883 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -92.43 71.88 5.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.154 0.502 . . . . 62.43 111.187 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -66.84 77.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.159 0.504 . . . . 71.24 111.429 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -144.02 151.37 52.19 Favored Pre-proline 0 N--CA 1.47 0.546 0 CA-C-N 116.215 -0.448 . . . . 52.05 111.812 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 66' ' ' MET . 59.7 Cg_endo -70.38 152.05 65.88 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.881 2.387 . . . . 74.43 113.406 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -135.66 140.72 44.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.323 -0.399 . . . . 53.54 111.385 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HD3' HH11 ' A' ' 56' ' ' ARG . 17.1 ttm180 -83.83 132.22 34.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.83 0.347 . . . . 72.22 111.822 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.47 HD23 HD21 ' A' ' 64' ' ' LEU . 53.6 tp -130.29 129.9 43.83 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.8 0.44 . . . . 71.52 111.359 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.26 115.87 30.14 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.296 -0.631 . . . . 73.22 109.296 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 79.7 p -137.27 -178.9 5.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.735 0.779 . . . . 71.31 112.903 -171.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -66.29 -20.12 66.01 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.196 -0.911 . . . . 62.43 112.563 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 95' ' ' PHE . 36.6 pt -90.68 -18.62 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.851 0.357 . . . . 72.44 111.247 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.43 -164.71 25.1 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.141 -0.482 . . . . 44.04 112.433 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 93.6 m -95.01 107.3 19.34 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.231 0.539 . . . . 62.04 111.34 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.817 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.6 -176.47 2.91 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.212 0.53 . . . . 75.41 111.74 -178.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 31.3 ttp180 -150.94 107.51 3.5 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.941 0.4 . . . . 72.13 110.888 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.866 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.7 mtt -104.11 161.29 14.14 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.732 0.642 . . . . 51.14 112.732 -173.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 t -153.52 158.89 41.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.101 -0.5 . . . . 52.33 111.793 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 71' ' ' ILE . 96.2 mt -106.27 110.19 22.36 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.418 -0.356 . . . . 74.14 111.71 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.613 HG23 HD22 ' A' ' 70' ' ' ASN . 20.4 m -130.04 165.9 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.702 0.287 . . . . 71.41 111.753 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.613 HD22 HG23 ' A' ' 69' ' ' VAL . 37.7 m-80 59.22 29.29 18.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.988 0.515 . . . . 73.23 112.323 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' A' ' 68' ' ' LEU . 35.2 mt -68.09 107.35 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.901 0.382 . . . . 63.32 111.464 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.63 153.07 78.76 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.185 0.439 . . . . 65.14 112.185 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.28 150.34 81.37 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.824 2.35 . . . . 53.44 113.268 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -140.9 167.46 22.14 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.141 -0.482 . . . . 54.03 111.546 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.47 72.97 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.961 0.41 . . . . 62.15 111.911 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 6.6 m-20 -76.01 -26.77 57.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.801 0.334 . . . . 72.44 110.994 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.34 -93.32 0.1 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-N 116.022 -0.535 . . . . 63.41 112.97 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -147.84 126.5 12.54 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.549 -0.383 . . . . 73.43 111.466 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -104.77 129.89 52.94 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.705 0.288 . . . . 54.12 111.658 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 pp -141.1 152.65 44.94 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.976 0.417 . . . . 73.41 111.501 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.454 ' HB ' HG23 ' A' ' 69' ' ' VAL . 60.1 m -89.87 109.04 20.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.965 0.412 . . . . 52.3 111.113 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.423 HD12 HD11 ' A' ' 84' ' ' ILE . 2.6 tm? -86.5 109.37 19.04 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.716 -0.475 . . . . 65.14 109.716 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -99.24 130.32 45.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.811 0.339 . . . . 71.53 111.207 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.1 mp -111.62 102.85 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 73.35 111.294 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.846 0.355 . . . . 72.43 110.695 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.74 153.43 17.54 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.006 -0.616 . . . . 70.52 112.172 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -45.33 91.56 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.349 0.575 . . . . 73.51 110.736 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.4 t -85.15 176.39 8.4 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.093 -0.503 . . . . 61.13 111.655 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.539 HD22 ' N ' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -89.26 -37.11 15.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.403 -0.362 . . . . 62.11 111.67 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.93 145.71 99.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.666 0.27 . . . . 73.54 111.5 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.75 145.94 82.4 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.236 2.624 . . . . 71.23 114.99 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.42 152.92 44.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.661 -0.7 . . . . 74.24 111.393 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.23 -171.55 1.19 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.678 2.252 . . . . 73.15 113.104 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 157' ' ' PRO . . . -74.62 151.33 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.749 0.309 . . . . 33.55 111.469 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' HB3' HG21 ' A' ' 61' ' ' ILE . 36.4 p90 -154.69 149.63 26.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.599 0.714 . . . . 72.43 112.669 -174.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 91.1 p -130.55 136.75 49.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.287 -0.869 . . . . 52.02 109.8 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.705 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -145.36 175.54 24.87 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.332 -0.937 . . . . 63.33 113.598 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.9 m -111.13 122.19 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.01 111.547 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.429 HG12 HD12 ' A' ' 152' ' ' ILE . 20.7 m -104.11 133.74 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.187 -0.461 . . . . 43.1 111.131 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 41.3 mt-10 -122.76 126.23 47.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.958 0.409 . . . . 75.34 111.024 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -134.18 133.13 40.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.803 0.335 . . . . 75.05 111.741 -171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.31 -157.43 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.242 -0.504 . . . . 72.02 113.28 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.582 ' HB2' HG13 ' A' ' 114' ' ' ILE . 87.5 mt-30 -117.39 151.43 37.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.068 0.461 . . . . 74.23 112.049 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 106' ' ' GLY . 60.7 mt -109.28 122.46 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.192 -0.458 . . . . 72.32 111.266 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -106.88 23.64 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 111.837 0.31 . . . . 75.45 111.837 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -146.09 -170.43 14.75 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.006 -0.616 . . . . 35.13 113.678 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 44.7 p -97.31 -173.55 2.69 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.935 0.398 . . . . 73.15 111.522 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.791 HD11 ' HG3' ' A' ' 33' ' ' GLN . 31.8 mm -67.9 -36.45 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.037 0.446 . . . . 72.1 111.397 174.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.05 -37.66 58.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.182 -0.463 . . . . 72.34 111.312 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -144.93 111.87 5.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.18 -0.464 . . . . 61.23 111.44 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.1 p90 -139.1 145.81 39.93 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.451 0.643 . . . . 73.3 112.365 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -117.01 144.73 44.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.59 -0.732 . . . . 62.31 110.495 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.19 119.57 37.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.04 0.448 . . . . 72.33 111.489 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 103' ' ' GLN . 33.6 pt -123.07 149.52 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.53 -0.305 . . . . 74.33 111.429 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.89 39.28 31.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.362 0.601 . . . . 73.2 111.445 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.05 127.19 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.932 -0.576 . . . . 55.33 112.203 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.27 167.78 21.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.977 -0.556 . . . . 71.4 111.058 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 2.7 p-10 -112.94 178.48 4.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.056 0.762 . . . . 43.11 113.056 -172.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -167.75 159.78 12.05 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.482 -0.781 . . . . 74.35 110.251 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.05 133.92 44.84 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 122.01 -0.431 . . . . 54.13 112.033 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.43 ' O ' HG13 ' A' ' 121' ' ' ILE . 28.4 pt -111.79 106.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.208 0.527 . . . . 74.01 111.165 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.51 100.84 10.71 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.259 -0.428 . . . . 75.15 110.635 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.72 152.48 37.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.926 0.393 . . . . 75.22 112.047 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.51 174.43 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.801 2.334 . . . . 55.45 113.0 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.83 156.82 20.4 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.218 0.532 . . . . 73.25 112.023 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.9 m -100.95 118.27 36.64 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.094 -0.503 . . . . 74.52 109.983 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.3 -51.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.851 0.358 . . . . 73.43 111.664 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -119.95 164.42 16.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.014 0.435 . . . . 50.43 111.338 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.29 91.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 116.33 -0.395 . . . . 73.1 111.973 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -91.74 166.75 26.92 Favored 'Cis proline' 0 C--N 1.355 0.898 0 C-N-CA 124.193 -1.17 . . . . 74.21 113.344 -1.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 55.1 m -66.93 95.46 0.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.928 0.394 . . . . 74.33 111.852 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -148.47 112.71 5.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.899 -0.591 . . . . 73.44 109.946 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.86 110.15 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.648 0.261 . . . . 75.43 111.323 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.11 118.75 35.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 73.5 111.222 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.3 pt -126.41 133.1 24.63 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 120.902 0.382 . . . . 71.54 111.898 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.92 118.3 5.5 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.254 1.969 . . . . 54.33 112.144 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.35 123.54 50.51 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.064 -0.516 . . . . 62.53 110.89 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -105.39 106.59 17.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.035 0.445 . . . . 72.43 111.625 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 mt -83.17 124.21 30.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.483 -0.326 . . . . 41.41 110.535 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 35.3 mtmm -105.87 128.63 53.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.32 111.928 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.9 7.09 57.76 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.258 -0.428 . . . . 60.34 113.811 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.2 tt -145.08 137.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.173 -0.604 . . . . 74.41 111.774 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.9 m -98.3 148.99 23.08 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.459 -0.337 . . . . 73.12 111.744 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.27 -49.54 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.941 0.719 . . . . 64.14 112.941 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.79 -26.94 68.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.017 0.437 . . . . 64.44 111.803 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -100.31 14.57 30.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.273 -0.421 . . . . 64.45 111.772 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.83 121.63 34.39 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 50.33 110.708 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.22 -61.75 0.97 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.162 -0.542 . . . . 52.43 113.646 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.479 ' HE2' ' HD3' ' A' ' 151' ' ' ARG . 49.4 p90 -136.06 155.49 50.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.024 0.44 . . . . 75.44 112.096 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.32 138.4 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.888 -0.596 . . . . 64.22 110.575 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.67 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 21.3 mtp180 -123.55 113.07 18.22 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.962 0.505 . . . . 72.23 111.72 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.866 HG21 ' SD ' ' A' ' 66' ' ' MET . 9.7 mm -106.25 115.16 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 122.413 -0.179 . . . . 74.31 111.221 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -151.17 179.44 8.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.266 0.469 . . . . 74.41 112.266 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 63.12 24.98 14.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.221 0.608 . . . . 63.14 112.589 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.705 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.7 mm -63.05 105.72 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.174 0.512 . . . . 75.53 110.879 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -125.1 143.76 45.18 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.979 -0.555 . . . . 74.33 111.447 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 46.9 Cg_endo -67.51 107.94 1.52 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.538 2.159 . . . . 74.41 113.42 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.03 111.45 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.202 0.525 . . . . 72.01 110.953 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.8 mtm -130.78 167.53 18.72 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.132 -0.355 . . . . 74.53 111.877 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -55.6 112.72 1.21 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.139 0.495 . . . . 73.13 112.099 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.76 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.0 pt? -77.2 97.01 4.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.614 0.721 . . . . 71.41 111.486 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -87.8 -66.59 0.9 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.948 -0.569 . . . . 75.13 111.752 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -130.48 137.47 49.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.419 -0.355 . . . . 70.25 111.404 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -79.15 63.48 3.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.652 0.739 . . . . 72.21 110.1 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -81.54 92.49 6.52 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.482 -0.781 . . . . 64.53 111.039 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -115.32 106.52 14.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.257 0.465 . . . . 70.44 112.257 -175.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.4 t60 74.2 -30.08 0.2 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.773 1.027 . . . . 71.01 113.773 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.898 -0.572 . . . . 61.45 111.528 -179.658 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.538 0.209 . . . . 64.15 110.798 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.9 174.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.033 0.444 . . . . 43.31 111.811 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -147.89 104.47 3.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.091 0.472 . . . . 74.32 111.162 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -105.54 100.56 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.907 0.384 . . . . 74.45 111.294 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 m -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.795 0.331 . . . . 73.23 110.637 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.09 137.79 41.42 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.869 0.366 . . . . 75.31 111.832 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.9 t -138.07 140.72 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.713 0.405 . . . . 74.42 110.466 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.585 ' H ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -117.95 141.2 48.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.947 0.403 . . . . 63.44 111.289 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -101.99 121.9 43.04 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.276 -0.42 . . . . 72.12 111.764 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.8 mmm -99.62 112.49 24.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.551 -0.295 . . . . 71.3 110.956 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -157.87 124.34 4.84 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.767 0.655 . . . . 75.04 112.767 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -166.15 98.26 0.62 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.599 -0.728 . . . . 75.23 110.514 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -116.26 118.66 33.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.214 0.53 . . . . 71.15 111.774 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.76 132.22 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.028 0.442 . . . . 61.4 110.743 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.1 p -131.35 101.72 5.66 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.384 0.611 . . . . 70.34 111.559 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -97.4 110.8 23.28 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.173 -0.467 . . . . 51.33 111.179 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.1 mm? -76.83 113.5 14.57 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.991 0.424 . . . . 72.42 110.981 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -80.29 142.01 34.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.229 0.537 . . . . 72.5 112.093 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 20' ' ' GLU . 26.2 mp0 -88.43 -154.34 0.28 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.902 -0.59 . . . . 74.42 111.278 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 19' ' ' GLN . 13.8 pt-20 -78.79 148.39 32.95 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.784 0.326 . . . . 63.23 111.855 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -129.7 174.65 9.5 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.109 0.481 . . . . 73.2 111.643 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.5 p -84.89 157.9 20.74 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.032 -0.531 . . . . 74.31 111.57 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.87 86.55 4.1 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.494 0.664 . . . . 70.53 112.127 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' O ' ' HB ' ' A' ' 28' ' ' THR . 55.1 tp -113.5 131.66 55.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.252 -0.431 . . . . 64.51 110.984 174.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 52.14 109.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.763 -0.653 . . . . 73.51 112.548 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -50.23 -29.46 9.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.968 0.414 . . . . 63.51 111.451 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.1 tt0 -58.88 -58.6 7.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.013 0.435 . . . . 70.35 110.733 171.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.483 ' HA ' HD12 ' A' ' 31' ' ' ILE . 89.1 m -59.58 -33.3 71.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.243 -0.435 . . . . 72.11 111.393 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.98 -45.87 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.952 0.406 . . . . 72.11 110.873 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.367 -0.379 . . . . 75.04 111.343 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 28' ' ' THR . 85.5 mt -62.09 -48.58 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.164 0.507 . . . . 74.44 110.786 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.5 m -58.5 -42.33 87.39 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.151 0.501 . . . . 72.25 110.658 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.654 HE21 HD11 ' A' ' 108' ' ' ILE . 30.8 tt0 -56.38 -50.19 72.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.615 -0.72 . . . . 64.15 111.061 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.0 tt0 -56.2 -48.83 75.65 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.036 -0.529 . . . . 73.24 111.927 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -61.41 -46.9 88.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.891 0.33 . . . . 65.21 111.891 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -65.2 -36.49 84.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.005 0.372 . . . . 74.05 112.005 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.48 -38.28 89.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.07 0.462 . . . . 65.31 110.4 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.51 -33.27 75.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.925 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.46 98.87 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.927 0.394 . . . . 51.53 111.625 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HD2' ' HE1' ' A' ' 111' ' ' PHE . 61.5 mttp -74.89 -25.86 59.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.999 0.428 . . . . 54.51 111.183 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 47.8 t -69.54 125.81 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.95 0.405 . . . . 63.43 111.915 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 92.9 p -117.98 9.35 12.76 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.499 -0.319 . . . . 51.32 111.353 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 m -135.73 32.33 3.01 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.593 0.59 . . . . 65.42 112.593 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.65 -164.9 25.14 Favored Glycine 0 N--CA 1.463 0.467 0 C-N-CA 120.859 -0.686 . . . . 53.35 113.314 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 57' ' ' LEU . 27.6 m -115.69 136.33 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.085 0.469 . . . . 64.21 112.135 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 41' ' ' SER . 55.0 m-85 -89.69 103.82 16.44 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.313 -0.403 . . . . 71.14 111.242 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.12 102.14 14.85 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.91 0.386 . . . . 73.55 110.789 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.7 119.1 73.86 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.605 -0.27 . . . . 74.25 110.924 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -58.24 -18.97 40.04 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.263 1.975 . . . . 75.11 112.961 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.01 -8.62 64.67 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.433 -0.413 . . . . 65.53 113.167 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.96 89.37 2.97 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.118 0.485 . . . . 51.11 111.117 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.39 83.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.174 0.511 . . . . 73.12 110.689 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -158.59 153.35 20.99 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 115.895 -0.593 . . . . 73.5 111.903 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.12 146.13 6.42 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.054 2.503 . . . . 73.32 112.942 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.21 136.08 53.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.796 0.332 . . . . 72.22 111.479 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 56' ' ' ARG . 14.1 ttp180 -86.75 127.21 34.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.898 0.38 . . . . 72.33 111.367 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 45' ' ' VAL . 53.5 tp -120.95 118.34 29.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.016 0.436 . . . . 62.45 111.225 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.9 100.13 12.65 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.186 0.517 . . . . 63.23 110.437 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.46 ' OG ' HG12 ' A' ' 61' ' ' ILE . 73.8 p -99.22 -167.96 1.55 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.306 0.574 . . . . 72.14 112.51 -171.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -76.0 -25.92 56.21 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.638 . . . . 74.04 111.718 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' ' 157' ' ' PRO . 33.9 pt -84.96 -24.8 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.158 0.504 . . . . 73.03 111.101 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -164.35 28.65 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.811 -0.632 . . . . 73.13 112.336 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -91.8 124.81 36.21 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.556 -0.379 . . . . 73.34 111.953 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.552 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -135.51 175.5 9.53 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.973 0.416 . . . . 71.42 111.69 176.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -131.54 119.18 21.16 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.477 -0.328 . . . . 72.24 111.298 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.581 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.3 mtt -112.16 154.99 24.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 73.54 112.315 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -160.89 169.77 21.98 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.152 -0.476 . . . . 74.33 111.234 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 80' ' ' LEU . 94.4 mt -114.66 124.32 51.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.243 0.46 . . . . 74.24 112.243 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.698 HG23 ' HB ' ' A' ' 81' ' ' THR . 29.1 m -133.04 164.53 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.413 -0.358 . . . . 72.31 111.096 174.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 62.61 28.32 16.59 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.54 0.57 . . . . 71.32 112.54 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 mt -67.94 104.52 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 74.12 111.416 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 p -139.1 152.69 70.43 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 112.299 0.481 . . . . 63.43 112.299 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.52 159.89 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.328 2.685 . . . . 74.22 113.873 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.558 ' HB2' HG23 ' A' ' 79' ' ' THR . 14.0 t70 -150.11 160.33 43.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.931 -0.577 . . . . 72.05 111.141 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.07 90.08 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.089 0.403 . . . . 75.23 112.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -82.49 -31.0 29.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.767 0.317 . . . . 71.13 111.552 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -174.65 -97.67 0.11 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.697 -0.763 . . . . 52.25 113.649 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.2 m -144.84 125.87 14.53 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.929 0.395 . . . . 54.12 111.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 74' ' ' ASP . 46.6 p -96.55 137.17 36.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.908 0.385 . . . . 71.1 111.825 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.423 HD13 HD22 ' A' ' 68' ' ' LEU . 3.3 pp -144.96 155.4 43.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 74.04 111.1 174.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.698 ' HB ' HG23 ' A' ' 69' ' ' VAL . 26.5 m -95.55 111.88 23.71 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.977 0.418 . . . . 60.1 111.117 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.93 109.86 18.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.547 -0.538 . . . . 72.21 109.547 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtt-85 -97.18 127.58 43.27 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.819 0.342 . . . . 73.22 111.849 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.6 mp -113.83 98.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 63.02 111.529 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.91 -178.54 6.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.952 -0.388 . . . . 73.02 109.952 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.19 135.3 5.95 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.19 -1.005 . . . . 71.31 113.973 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -59.05 -23.82 62.34 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.884 0.373 . . . . 70.02 111.559 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 88.9 p -83.47 136.26 34.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.299 0.571 . . . . 61.52 111.614 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -68.99 -37.73 78.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.524 0.678 . . . . 70.54 109.53 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.1 147.72 93.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.119 -0.946 . . . . 75.31 111.108 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 55.5 Cg_endo -67.85 162.71 38.45 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.423 2.082 . . . . 73.44 113.477 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.96 145.79 38.75 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.951 -0.568 . . . . 63.41 111.154 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.36 179.91 4.63 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.671 2.248 . . . . 54.45 112.99 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -73.09 153.89 40.63 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.128 0.49 . . . . 73.51 111.619 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.25 164.97 37.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.194 0.521 . . . . 71.51 111.632 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.8 m -150.88 156.07 40.47 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.16 -0.473 . . . . 23.42 110.372 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -165.25 178.9 40.04 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.271 -0.966 . . . . 74.34 113.893 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 61.3 m -104.38 135.36 45.97 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.895 0.379 . . . . 63.33 111.08 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 26.7 m -110.47 134.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 52.31 111.592 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.788 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.9 mm-40 -103.74 120.08 40.21 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.956 -0.565 . . . . 53.11 110.151 177.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.438 ' CG ' HD22 ' A' ' 139' ' ' LEU . 10.2 p90 -133.7 130.22 37.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.265 0.555 . . . . 74.03 112.149 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.41 -156.38 12.41 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.519 -0.764 . . . . 72.12 112.635 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.522 HE21 ' HB3' ' A' ' 146' ' ' GLN . 52.9 mt-30 -111.02 151.3 28.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.775 0.321 . . . . 74.22 111.505 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -114.59 106.79 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 60.11 110.824 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.503 ' NE2' HD13 ' A' ' 114' ' ' ILE . 3.6 pt20 -94.39 -6.74 43.48 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.832 0.679 . . . . 71.14 112.832 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -102.26 -170.04 27.03 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.949 -0.643 . . . . 75.24 113.499 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.3 p -96.31 173.26 7.47 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.84 0.352 . . . . 71.34 111.014 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.654 HD11 HE21 ' A' ' 33' ' ' GLN . 30.9 mm -63.79 -25.94 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.127 0.489 . . . . 74.21 111.023 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.56 -41.63 19.36 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.777 -0.647 . . . . 74.55 110.518 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -139.45 97.94 3.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.177 0.513 . . . . 71.24 111.53 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.683 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.0 p90 -115.99 151.07 36.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.558 0.577 . . . . 63.22 112.558 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -127.51 120.53 28.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.753 -0.658 . . . . 73.14 110.46 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.31 104.53 8.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.827 0.346 . . . . 64.12 110.8 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.503 HD13 ' NE2' ' A' ' 105' ' ' GLN . 44.6 pt -105.26 153.21 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.64 -0.254 . . . . 74.01 111.631 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 57.32 28.29 15.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.213 0.53 . . . . 70.14 111.045 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.9 137.13 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.926 -0.579 . . . . 52.12 111.942 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.11 171.09 14.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 72.13 110.746 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 3.1 p-10 -108.5 169.96 8.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.335 0.588 . . . . 54.34 112.44 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.437 HE22 ' HA ' ' A' ' 139' ' ' LEU . 8.8 tt0 -163.54 149.39 11.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.683 -0.69 . . . . 52.35 110.966 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -93.03 126.62 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.005 0.372 . . . . 64.04 112.005 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.9 pt -111.6 140.03 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.714 0.293 . . . . 64.13 111.427 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -124.91 131.11 53.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.596 0.236 . . . . 64.4 111.01 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -124.69 135.35 26.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 111.808 0.299 . . . . 71.52 111.808 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 15.0 Cg_exo -69.32 167.84 22.71 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.999 2.466 . . . . 65.42 113.272 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.15 130.56 34.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.15 0.426 . . . . 62.04 112.15 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 91' ' ' PRO . 74.2 m -79.5 100.88 7.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.908 0.385 . . . . 75.0 110.717 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.67 HG13 ' HG ' ' A' ' 128' ' ' LEU . 8.5 p -71.96 -26.47 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.299 0.481 . . . . 55.33 112.299 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.67 ' HG ' HG13 ' A' ' 127' ' ' VAL . 98.4 mt -119.7 165.17 14.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.06 0.457 . . . . 72.34 112.139 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.595 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -106.28 153.64 40.25 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.042 -0.526 . . . . 72.31 111.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.75 175.15 37.27 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.241 -1.149 . . . . 70.4 113.686 0.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.7 m -75.31 97.08 3.49 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.639 0.607 . . . . 52.21 112.639 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -135.36 122.94 22.13 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.908 -0.587 . . . . 61.23 110.182 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 134' ' ' ASP . 26.4 t -133.96 159.61 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.395 0.278 . . . . 33.4 111.323 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.442 ' N ' HG12 ' A' ' 133' ' ' VAL . 2.7 p30 -147.14 143.11 28.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.818 0.342 . . . . 62.12 110.94 170.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 pt -140.26 147.94 52.13 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 53.11 111.729 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.7 144.24 21.96 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.704 2.269 . . . . 72.52 112.676 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.61 108.87 6.44 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.182 -0.324 . . . . 72.52 110.859 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -95.14 97.82 10.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.131 0.491 . . . . 73.23 111.625 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.438 HD22 ' CG ' ' A' ' 101' ' ' TYR . 55.4 mt -74.13 128.75 36.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.327 -0.397 . . . . 50.32 110.739 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.06 141.97 35.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.202 0.445 . . . . 62.35 112.202 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.87 34.79 88.26 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.066 -0.515 . . . . 42.25 113.878 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.96 125.96 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.07 0.462 . . . . 74.52 111.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.1 m -88.59 155.04 19.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.897 0.379 . . . . 51.42 111.358 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.49 -39.27 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.08 0.77 . . . . 65.42 113.08 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.81 -27.64 66.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.076 0.465 . . . . 54.15 111.258 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.522 ' HB3' HE21 ' A' ' 103' ' ' GLN . 15.3 mm100 -81.74 -4.14 55.55 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.273 -0.421 . . . . 71.35 111.752 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.632 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 28.5 mt -71.75 121.56 19.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.088 0.47 . . . . 75.13 112.265 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.98 -47.81 1.22 Allowed Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.098 -0.501 . . . . 62.53 112.632 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -150.97 161.69 42.25 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.75 0.31 . . . . 73.33 111.442 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.46 93.76 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.36 0.6 . . . . 62.23 110.462 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.788 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 47.2 ttp180 -86.99 107.41 18.39 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.952 0.406 . . . . 73.13 112.007 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.581 HG21 ' SD ' ' A' ' 66' ' ' MET . 23.3 mm -85.93 135.0 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.535 -0.302 . . . . 72.43 111.432 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.36 179.25 8.44 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.07 0.396 . . . . 74.35 112.07 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 98' ' ' THR . 75.5 m-20 64.97 22.5 12.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.193 0.597 . . . . 72.03 112.425 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.481 HD13 ' HA3' ' A' ' 97' ' ' GLY . 51.5 mm -64.53 97.33 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.42 0.629 . . . . 72.04 111.454 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -114.8 150.67 44.46 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.586 -0.734 . . . . 75.31 111.139 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.463 ' HB3' HG22 ' A' ' 61' ' ' ILE . 61.1 Cg_endo -72.69 148.32 46.75 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.324 2.016 . . . . 60.21 113.806 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 3.4 p -133.8 127.29 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.841 -0.618 . . . . 53.54 110.27 174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -152.83 -168.52 3.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.105 0.479 . . . . 73.5 112.268 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.545 ' H ' ' NE2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -68.58 156.41 38.13 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.151 -0.477 . . . . 73.3 111.41 176.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.63 115.6 15.48 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.478 -0.328 . . . . 73.02 111.872 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.54 138.19 53.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.151 0.501 . . . . 65.12 111.567 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -93.07 139.12 30.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.217 -0.447 . . . . 75.41 110.138 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -123.05 120.62 33.86 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.791 0.293 . . . . 62.24 111.791 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -86.16 93.67 9.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.996 0.427 . . . . 70.42 110.125 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 167' ' ' HIS . 18.3 t60 -81.14 130.04 34.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.465 -0.334 . . . . 73.32 110.451 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 166' ' ' HIS . 32.6 m80 73.94 90.29 0.09 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.235 0.614 . . . . 72.13 111.824 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.7 p80 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 116.131 -0.486 . . . . 73.35 111.5 175.732 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 111.992 0.367 . . . . 54.42 111.992 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.89 104.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.513 0.673 . . . . 64.4 112.1 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.54 78.47 4.05 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.257 0.551 . . . . 75.22 110.566 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.23 134.88 34.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.12 0.486 . . . . 64.43 111.722 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.0 p -159.57 138.31 10.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.042 -0.526 . . . . 53.13 111.122 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -101.75 151.19 22.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.851 0.358 . . . . 73.44 111.324 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.86 142.13 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.156 0.503 . . . . 75.31 111.53 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.01 102.03 14.68 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.206 0.527 . . . . 63.35 111.301 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -109.78 132.91 53.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.053 -0.521 . . . . 75.23 111.148 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 49.8 tpp -114.2 105.12 12.8 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 73.55 111.775 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -98.63 150.47 21.71 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.394 -0.366 . . . . 72.4 110.936 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -168.85 117.77 0.69 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.952 0.406 . . . . 72.32 111.781 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -158.31 172.68 17.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.365 -0.38 . . . . 73.45 110.538 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.14 75.81 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.983 0.897 . . . . 60.21 110.929 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.1 p -90.96 107.29 19.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.861 -0.609 . . . . 63.12 111.084 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -81.2 100.29 9.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.091 0.472 . . . . 63.42 111.67 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.909 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -95.75 158.27 15.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.415 -0.357 . . . . 73.22 110.933 176.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -104.75 -164.48 1.05 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 111.914 0.338 . . . . 73.51 111.914 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -50.05 134.78 21.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.965 0.728 . . . . 75.22 112.965 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.23 139.62 42.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.473 -0.785 . . . . 63.12 109.613 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.72 106.68 1.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.63 0.729 . . . . 74.23 111.065 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 p -103.74 164.97 11.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.17 -0.923 . . . . 75.13 112.675 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.42 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.689 0.996 . . . . 74.12 113.689 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD23 HG22 ' A' ' 29' ' ' VAL . 38.3 tp -148.01 137.12 22.08 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.002 -0.999 . . . . 73.23 109.134 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.4 m-80 -59.55 126.07 26.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.084 0.401 . . . . 75.05 112.084 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -53.26 -37.57 62.24 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.209 -0.45 . . . . 54.32 111.788 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . 28.6 tt0 -58.96 -54.63 44.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.969 0.414 . . . . 61.42 110.65 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.2 m -59.14 -35.4 73.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.025 0.44 . . . . 62.12 111.471 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG22 HD23 ' A' ' 24' ' ' LEU . 89.9 t -64.54 -42.84 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.971 0.415 . . . . 74.14 110.597 174.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.573 ' HE3' HD23 ' A' ' 48' ' ' LEU . 44.5 tptt -66.61 -38.15 86.36 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.176 -0.466 . . . . 63.23 110.781 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 27' ' ' GLU . 72.1 mt -59.74 -46.87 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.329 0.585 . . . . 61.11 110.47 174.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -58.89 -44.85 91.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.702 -0.681 . . . . 73.45 111.057 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.565 ' HG3' HD11 ' A' ' 108' ' ' ILE . 63.1 tt0 -59.21 -45.23 91.67 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.346 0.593 . . . . 75.3 110.809 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.5 -54.07 50.99 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.31 -0.859 . . . . 74.33 111.188 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -66.31 -30.8 71.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.462 0.541 . . . . 70.55 112.462 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.43 -49.66 68.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.893 0.377 . . . . 74.53 110.673 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -38.35 87.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.116 0.484 . . . . 53.54 110.732 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.504 HD21 ' HB ' ' A' ' 45' ' ' VAL . 2.4 t-20 -56.68 -42.38 78.94 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.782 -0.645 . . . . 73.03 111.031 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -43.4 68.85 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.195 -0.457 . . . . 73.01 112.022 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.94 -7.13 53.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.03 0.381 . . . . 71.43 112.03 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 37.1 t -61.89 126.29 26.84 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.106 0.41 . . . . 73.3 112.106 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 t -93.73 -4.04 51.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.272 -0.422 . . . . 73.05 111.132 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -142.41 96.87 3.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.992 0.425 . . . . 73.21 111.364 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 66.84 -149.17 51.14 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.316 -0.469 . . . . 60.43 113.616 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 38' ' ' ASN . 31.6 m -114.51 152.84 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.069 0.461 . . . . 63.22 112.091 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 33.6 m-85 -101.31 114.42 28.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.329 -0.396 . . . . 54.41 111.571 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.58 104.12 14.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.905 0.383 . . . . 51.43 110.749 173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.573 HD23 ' HE3' ' A' ' 30' ' ' LYS . 9.5 mp -82.18 111.83 30.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 122.312 -0.243 . . . . 74.32 110.682 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.6 Cg_endo -57.47 -23.47 56.08 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.848 2.365 . . . . 41.11 113.461 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.37 -17.67 59.88 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.96 -0.638 . . . . 55.04 113.16 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.67 101.09 5.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.547 0.339 . . . . 72.5 111.26 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.43 88.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.055 0.455 . . . . 52.11 110.438 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.425 HG21 HG23 ' A' ' 31' ' ' ILE . 3.3 p -135.93 148.76 66.34 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.713 0.634 . . . . 71.43 112.713 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.24 131.56 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.24 2.627 . . . . 51.22 113.24 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.04 134.0 55.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.323 -0.399 . . . . 55.25 110.679 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -84.87 109.87 18.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.192 0.52 . . . . 70.45 111.855 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 45' ' ' VAL . 44.3 tp -105.65 124.01 48.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.106 -0.497 . . . . 72.31 111.655 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -75.86 132.02 40.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.355 -0.384 . . . . 62.45 110.39 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -126.13 -178.71 4.41 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.337 0.589 . . . . 74.54 111.701 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.23 0.87 54.69 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.936 -0.574 . . . . 70.41 111.675 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.9 pt -111.16 -28.88 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.009 0.433 . . . . 72.41 111.016 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.26 151.1 5.83 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.16 -0.473 . . . . 73.11 112.607 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.7 m -55.28 126.47 25.08 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.955 0.378 . . . . 65.12 111.482 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.74 174.5 10.51 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.446 0.641 . . . . 62.21 112.4 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -127.61 125.67 40.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.991 -0.55 . . . . 64.02 111.087 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.806 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.3 mtt -117.14 144.1 45.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.837 0.351 . . . . 54.35 111.776 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -143.66 143.48 31.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.942 0.401 . . . . 71.34 111.413 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 82' ' ' LEU . 92.6 mt -90.17 107.01 18.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.349 -0.387 . . . . 72.12 111.429 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.632 HG23 HD22 ' A' ' 70' ' ' ASN . 27.5 m -122.61 161.48 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.186 -0.321 . . . . 73.55 111.7 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.632 HD22 HG23 ' A' ' 69' ' ' VAL . 35.5 m-80 59.03 41.19 21.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.083 0.401 . . . . 75.24 112.083 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.414 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 57.7 mt -73.13 111.44 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.939 0.4 . . . . 73.31 111.55 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -136.82 156.5 75.96 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.413 -0.358 . . . . 61.43 111.907 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.64 151.34 52.2 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.856 2.37 . . . . 72.02 113.023 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB2' HG23 ' A' ' 79' ' ' THR . 26.6 t70 -134.12 164.7 26.76 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.227 -0.442 . . . . 74.42 110.975 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -49.2 77.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 42.45 111.711 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -80.1 -36.41 35.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.55 -0.295 . . . . 73.02 111.628 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.41 -97.38 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.316 -0.945 . . . . 65.24 114.344 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.3 m -141.03 130.9 24.37 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.209 0.448 . . . . 53.4 112.209 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.664 HG23 ' HB2' ' A' ' 74' ' ' ASP . 30.4 p -107.04 116.87 32.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.917 0.389 . . . . 73.13 111.572 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.0 pp -137.52 147.26 45.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.864 0.364 . . . . 73.32 111.472 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -89.32 114.82 26.27 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.91 0.386 . . . . 74.02 111.188 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 68' ' ' LEU . 3.2 tm? -90.56 113.65 25.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.922 -0.399 . . . . 64.01 109.922 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 34.0 mtt-85 -102.1 114.48 28.65 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.872 0.693 . . . . 72.43 112.872 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.8 mp -92.39 147.86 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.886 -0.597 . . . . 72.21 110.716 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.1 118.45 7.86 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.296 -0.261 . . . . 62.45 110.296 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 137.75 28.56 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.99 -0.624 . . . . 72.45 113.3 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.04 68.47 4.99 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.421 0.629 . . . . 53.41 110.479 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -170.32 179.82 3.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.859 -0.609 . . . . 74.11 111.131 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -100.15 -3.82 30.95 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.854 0.316 . . . . 70.13 111.854 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 1.2 p30 -112.2 166.45 10.93 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.577 0.584 . . . . 63.32 112.577 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.663 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 72.6 Cg_endo -74.07 171.37 18.08 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.02 2.48 . . . . 75.44 114.332 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.92 152.05 76.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.066 -0.515 . . . . 71.34 111.126 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.12 172.96 15.18 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.381 2.054 . . . . 75.32 113.124 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.82 149.28 48.08 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.741 0.305 . . . . 65.11 111.662 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.72 163.04 39.53 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.613 0.721 . . . . 74.22 112.583 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.1 p -133.99 167.13 21.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.385 -0.825 . . . . 75.44 109.917 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.546 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -165.63 163.98 37.02 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.046 -1.073 . . . . 55.52 114.005 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.657 ' H ' ' HB3' ' A' ' 154' ' ' ASP . 91.1 m -103.8 108.5 19.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.463 0.305 . . . . 61.34 110.804 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 27.9 m -98.28 130.23 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.951 0.405 . . . . 54.4 111.812 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 45.4 mt-10 -107.52 111.81 24.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.904 0.383 . . . . 75.32 111.016 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.495 ' CD1' HD22 ' A' ' 139' ' ' LEU . 40.9 p90 -115.71 140.41 49.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.714 0.292 . . . . 73.51 111.361 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -179.0 -150.34 8.84 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.141 -0.552 . . . . 72.13 113.168 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.2 mt-30 -119.9 166.14 13.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.198 0.523 . . . . 65.43 112.034 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 106' ' ' GLY . 71.0 mt -126.01 124.99 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.939 -0.573 . . . . 73.25 110.62 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.596 HE21 HG21 ' A' ' 114' ' ' ILE . 6.3 pt20 -98.88 17.04 20.48 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.813 0.671 . . . . 75.14 112.813 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -145.13 -173.1 16.07 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.373 -0.918 . . . . 64.24 114.141 -174.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 72.2 p -101.01 178.93 4.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.839 0.456 . . . . 74.33 111.667 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.565 HD11 ' HG3' ' A' ' 33' ' ' GLN . 45.1 mm -54.94 -38.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 70.35 111.845 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.64 -45.7 43.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.407 -0.361 . . . . 71.14 111.945 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -134.8 102.54 5.29 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.144 0.497 . . . . 70.5 111.57 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 44.1 p90 -132.25 150.57 52.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 74.43 111.898 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -134.55 130.59 36.8 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.05 -0.523 . . . . 74.11 110.856 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.38 113.95 18.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.012 -0.54 . . . . 74.44 111.197 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.596 HG21 HE21 ' A' ' 105' ' ' GLN . 36.0 pt -119.18 158.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.724 0.297 . . . . 61.32 111.478 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 58.75 26.79 15.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 73.14 110.826 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.36 144.67 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.538 -0.756 . . . . 62.34 112.237 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.37 161.4 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.666 -0.697 . . . . 65.45 110.5 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 2.6 p-10 -106.78 153.87 21.82 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.938 0.718 . . . . 62.22 112.938 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -139.97 148.71 42.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.704 -0.68 . . . . 55.1 110.553 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.19 119.87 29.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.8 0.333 . . . . 72.24 111.419 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.6 pt -98.09 141.66 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.465 -0.334 . . . . 62.55 110.863 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.24 114.82 18.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.863 0.364 . . . . 73.53 111.173 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.739 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -110.61 129.7 23.67 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.537 -0.301 . . . . 72.24 111.641 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.49 164.45 35.23 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.641 2.227 . . . . 73.3 113.158 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -77.49 121.88 24.45 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.304 0.483 . . . . 73.43 112.304 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.1 m -92.97 96.87 10.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.429 -0.351 . . . . 71.33 110.782 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -78.37 -21.31 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.331 0.586 . . . . 64.33 111.104 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -77.41 152.95 34.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.931 -0.577 . . . . 61.05 111.283 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.85 139.91 26.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.574 -0.285 . . . . 74.41 111.685 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.76 156.75 95.35 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.748 -1.355 . . . . 64.02 112.635 -3.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.663 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 38.7 t -72.12 99.0 2.22 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.079 0.77 . . . . 73.22 113.079 -173.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.88 143.0 44.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.716 0.293 . . . . 63.33 110.428 170.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.739 HG11 ' HB1' ' A' ' 123' ' ' ALA . 36.5 t -133.64 121.21 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.694 0.283 . . . . 74.42 111.03 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -110.35 101.72 10.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.102 0.477 . . . . 62.23 111.289 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.415 HG23 HG12 ' A' ' 133' ' ' VAL . 18.8 pt -112.5 129.06 24.74 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.369 0.507 . . . . 75.11 112.369 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.92 121.07 7.28 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.449 2.1 . . . . 53.31 112.12 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.98 107.64 15.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.108 -0.496 . . . . 63.43 111.02 -174.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.99 99.17 11.85 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.162 0.506 . . . . 75.31 111.502 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 101' ' ' TYR . 46.2 mt -77.71 123.8 27.14 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.226 -0.443 . . . . 42.24 110.506 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -99.62 148.31 24.46 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.849 0.357 . . . . 60.45 111.877 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.54 -10.09 74.71 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 114.395 0.518 . . . . 50.11 114.395 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 147' ' ' LEU . 19.4 tt -138.8 119.03 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 117.881 0.84 . . . . 75.24 112.589 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.6 m -75.01 156.58 36.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.246 -0.434 . . . . 63.24 111.286 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.76 -46.28 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.057 0.762 . . . . 73.4 113.057 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.01 -14.87 63.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.14 0.495 . . . . 74.55 111.797 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -92.21 -5.35 52.65 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.539 -0.3 . . . . 64.51 111.645 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 50.6 mt -73.39 113.33 10.36 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.743 0.645 . . . . 73.2 112.743 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.57 -36.54 6.12 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.941 -0.572 . . . . 72.11 112.68 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.98 160.51 27.8 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.8 0.333 . . . . 73.42 111.334 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -130.53 100.82 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.008 0.433 . . . . 75.04 110.418 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 37.6 ttm180 -86.54 119.93 27.32 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.771 0.32 . . . . 73.43 111.803 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.806 HG21 ' SD ' ' A' ' 66' ' ' MET . 20.7 mm -104.59 125.76 59.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.309 -0.244 . . . . 74.43 111.136 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.486 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 13.3 p80 -164.85 -175.17 3.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.955 0.354 . . . . 71.01 111.955 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.657 ' HB3' ' H ' ' A' ' 98' ' ' THR . 13.9 t70 67.29 22.38 9.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.332 0.586 . . . . 65.4 111.367 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.546 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -66.91 110.52 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.283 0.563 . . . . 75.53 112.165 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.78 144.49 53.13 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.917 -0.583 . . . . 54.13 111.106 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.82 155.73 67.8 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.411 2.074 . . . . 72.41 113.148 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.33 150.43 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.844 0.354 . . . . 75.3 110.984 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.0 ptm -163.03 -173.66 3.54 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.845 0.355 . . . . 74.35 111.366 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.14 163.91 16.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.244 -0.435 . . . . 73.54 111.677 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 80.1 mt -73.13 168.42 19.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.621 0.724 . . . . 63.42 112.642 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -94.2 160.55 14.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.436 -0.802 . . . . 64.22 111.126 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -111.72 25.07 12.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.435 0.531 . . . . 62.22 112.435 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.9 m80 63.18 69.9 0.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.11 0.481 . . . . 72.25 111.304 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -75.6 -11.13 59.95 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.55 0.574 . . . . 71.32 112.55 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.436 ' O ' ' HB2' ' A' ' 167' ' ' HIS . 55.8 t-80 57.41 57.39 4.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.429 0.529 . . . . 64.44 112.429 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 166' ' ' HIS . 44.2 t-80 178.82 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.11 0.411 . . . . 74.32 112.11 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.552 -0.737 . . . . 73.24 112.055 174.83 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.682 0.277 . . . . 74.4 111.322 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 3' ' ' GLN . 6.9 p -70.58 -56.74 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.763 -0.199 . . . . 73.21 111.111 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.495 ' H ' HG13 ' A' ' 2' ' ' VAL . 49.6 mt-30 55.95 14.58 1.44 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.379 0.881 . . . . 71.35 113.379 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 2' ' ' VAL . 51.6 mt-30 -85.25 164.08 18.26 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.098 -0.376 . . . . 65.05 110.965 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.1 p -64.8 99.23 0.32 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.882 0.327 . . . . 71.41 111.882 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.14 104.99 2.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.366 0.603 . . . . 62.52 110.078 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.2 m -86.22 160.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.272 0.558 . . . . 64.15 111.946 -175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 8' ' ' ARG . 5.0 mmp_? -100.94 118.62 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 73.03 110.538 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -59.73 144.33 48.46 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.589 0.588 . . . . 71.13 112.589 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 10' ' ' MET . 1.4 pmm? -77.86 119.57 21.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.217 0.532 . . . . 74.12 111.217 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.0 104.49 17.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.071 0.462 . . . . 70.34 110.86 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -143.47 121.5 12.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.98 0.419 . . . . 71.43 111.467 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.6 p -159.19 125.15 4.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.124 -0.489 . . . . 64.04 110.901 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -150.8 147.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.934 0.397 . . . . 40.34 111.838 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.1 m -146.2 94.63 2.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.969 0.414 . . . . 72.42 111.329 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -126.99 167.95 15.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.906 0.384 . . . . 75.22 111.525 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -82.01 95.16 7.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.993 0.425 . . . . 75.03 110.379 176.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -117.25 -79.36 0.59 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.788 0.328 . . . . 72.33 111.313 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -167.96 -168.22 0.95 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.995 0.426 . . . . 73.1 111.333 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.7 152.5 38.97 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.069 -0.514 . . . . 64.14 111.07 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 mmt -76.99 164.25 25.94 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.264 0.554 . . . . 74.32 112.472 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.487 ' HB ' ' OE1' ' A' ' 23' ' ' GLN . 70.8 p -83.27 -165.95 1.23 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.75 -0.659 . . . . 65.33 111.689 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.487 ' OE1' ' HB ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -64.19 -175.57 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.553 0.575 . . . . 64.11 112.553 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 29' ' ' VAL . 32.4 tp -54.6 139.17 39.25 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.945 0.72 . . . . 72.33 112.945 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -122.94 165.14 17.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.971 -0.558 . . . . 72.11 110.918 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -50.1 71.18 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.937 0.399 . . . . 65.31 111.712 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.48 -41.67 90.34 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.134 0.492 . . . . 52.31 111.451 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -60.55 -30.35 69.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.351 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG22 HD21 ' A' ' 24' ' ' LEU . 58.9 t -65.62 -47.56 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 64.22 110.364 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.08 80.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.181 -0.463 . . . . 70.12 111.274 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.686 HG23 HG21 ' A' ' 53' ' ' THR . 69.7 mt -56.85 -48.19 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.349 0.595 . . . . 71.41 111.084 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -62.0 -41.07 97.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.788 -0.642 . . . . 75.44 111.059 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.782 ' HG3' HD11 ' A' ' 108' ' ' ILE . 44.0 tt0 -65.15 -38.07 89.42 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.091 -0.504 . . . . 62.21 111.482 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.8 -57.52 12.41 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.528 -0.305 . . . . 70.34 110.566 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -52.02 -45.23 64.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.419 0.526 . . . . 41.0 112.419 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.441 ' HB2' HD12 ' A' ' 108' ' ' ILE . 99.1 mtt180 -66.51 -48.84 68.5 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.326 0.491 . . . . 71.41 112.326 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.97 -45.92 91.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.309 0.576 . . . . 64.43 110.845 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 45' ' ' VAL . 65.7 t30 -66.08 -28.89 69.17 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.884 -0.598 . . . . 70.52 111.142 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.733 0.301 . . . . 72.41 111.184 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.66 -21.93 54.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.848 0.356 . . . . 62.44 111.285 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.431 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 41.1 t -63.72 123.63 19.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.259 0.466 . . . . 64.31 112.259 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 m -108.11 -0.08 21.32 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.775 0.287 . . . . 73.2 111.775 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 t -148.1 77.62 1.41 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.075 0.464 . . . . 73.32 111.825 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.71 -166.89 12.21 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.512 -0.375 . . . . 65.42 112.926 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.471 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 29.1 m -130.9 149.9 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.761 0.652 . . . . 74.23 112.761 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 41' ' ' SER . 72.9 m-85 -99.95 112.1 24.39 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.039 -0.528 . . . . 74.43 111.42 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -104.16 106.1 16.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.075 0.464 . . . . 74.34 110.792 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 72.1 mt -83.17 128.88 63.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.619 -0.264 . . . . 52.0 111.241 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 47.8 Cg_exo -57.07 -29.17 82.08 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 122.697 2.265 . . . . 65.54 113.187 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.41 9.91 76.12 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.21 -0.519 . . . . 75.23 113.234 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.62 86.36 2.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.02 0.438 . . . . 61.14 111.651 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.47 80.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.156 0.503 . . . . 74.13 111.113 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.686 HG21 HG23 ' A' ' 31' ' ' ILE . 3.8 p -138.49 150.81 67.59 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 112.84 0.682 . . . . 54.51 112.84 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.84 127.74 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.277 2.652 . . . . 73.12 113.01 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -108.73 132.68 53.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.976 0.417 . . . . 64.1 111.293 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 56' ' ' ARG . 12.3 ttm-85 -90.97 125.89 35.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.31 -0.405 . . . . 72.3 110.771 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.99 121.11 22.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.905 0.383 . . . . 75.45 111.698 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -86.5 111.1 20.25 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.065 0.459 . . . . 73.43 110.1 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -112.39 -173.02 2.16 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.17 0.509 . . . . 74.54 112.343 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.452 ' OE1' ' HB3' ' A' ' 156' ' ' GLN . 47.0 mt-30 -74.25 -24.09 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.819 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.49 -29.4 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.99 0.424 . . . . 63.33 111.196 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.94 -173.22 33.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.218 -0.515 . . . . 63.43 112.955 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -82.85 112.79 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.557 -0.378 . . . . 75.22 110.712 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -119.9 171.91 8.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.521 0.677 . . . . 71.34 112.408 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -132.95 111.95 11.46 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.587 -0.733 . . . . 74.25 110.716 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.683 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.2 mtt -107.35 148.0 29.6 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.281 0.474 . . . . 74.43 112.281 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.2 t -154.66 157.22 37.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.948 0.404 . . . . 73.2 111.645 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 80' ' ' LEU . 95.0 mt -102.97 114.04 28.0 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.307 -0.406 . . . . 63.53 111.579 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 81' ' ' THR . 28.6 m -128.06 161.6 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.69 0.281 . . . . 65.1 111.667 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.462 HD22 HG23 ' A' ' 69' ' ' VAL . 47.5 m-80 54.29 30.71 12.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.318 0.488 . . . . 72.12 112.318 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 68' ' ' LEU . 52.2 mt -59.22 104.13 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.007 0.432 . . . . 70.24 111.399 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -125.69 149.53 65.63 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 112.343 0.497 . . . . 71.51 112.343 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.98 129.24 14.0 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.758 2.305 . . . . 72.43 113.375 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.737 ' HB2' HG23 ' A' ' 79' ' ' THR . 29.4 t70 -91.65 166.74 12.64 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.289 -0.414 . . . . 64.51 110.62 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.44 69.13 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.134 0.42 . . . . 74.35 112.134 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -115.64 -9.78 11.93 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.51 0.559 . . . . 74.03 112.51 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -167.35 -113.78 0.29 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.259 -0.972 . . . . 71.12 114.021 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -146.89 127.12 13.84 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.028 0.381 . . . . 73.24 112.028 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 74' ' ' ASP . 41.4 p -104.6 114.83 29.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.104 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -126.81 148.46 49.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.883 0.373 . . . . 62.34 111.657 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 69' ' ' VAL . 62.2 m -92.0 107.92 19.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.123 0.487 . . . . 73.11 111.566 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.38 108.91 19.2 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.034 -0.53 . . . . 71.43 110.053 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 66' ' ' MET . 9.7 mtp-105 -93.66 122.96 36.65 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.3 -0.25 . . . . 74.15 111.609 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -107.16 91.29 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.535 -0.302 . . . . 73.04 110.758 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -88.19 122.79 32.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.706 0.288 . . . . 74.12 111.021 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.33 132.0 11.35 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.709 -0.757 . . . . 62.41 113.154 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -69.16 -43.56 74.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.282 0.563 . . . . 61.3 109.898 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 m -79.42 109.08 13.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.1 -0.704 . . . . 71.44 109.1 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -73.35 1.58 9.3 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.341 0.867 . . . . 73.3 113.341 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 3.7 p30 -74.09 156.87 87.48 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.681 0.276 . . . . 72.4 111.59 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 11.6 Cg_endo -54.03 114.24 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.021 2.481 . . . . 53.35 113.716 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.88 145.15 29.06 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.132 -0.485 . . . . 63.13 111.533 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.78 169.01 23.12 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.58 2.186 . . . . 72.04 112.618 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 147.9 49.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.542 -0.299 . . . . 54.04 110.949 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -144.95 160.61 41.06 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.82 0.674 . . . . 74.0 112.82 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -137.75 140.63 40.75 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.334 -0.848 . . . . 64.31 110.325 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -148.09 171.33 28.58 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.811 -0.709 . . . . 73.0 113.097 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 20.0 m -103.18 134.98 45.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.714 -0.286 . . . . 60.12 111.016 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 119' ' ' GLN . 7.2 p -117.36 122.67 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 74.42 112.015 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 27.5 mm-40 -90.16 105.12 17.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.871 -0.604 . . . . 74.4 110.372 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -114.99 117.81 31.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.356 0.598 . . . . 61.14 111.497 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -163.13 -149.27 5.65 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.961 -0.563 . . . . 63.21 112.866 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.414 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -121.23 157.14 30.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.076 0.465 . . . . 75.1 111.972 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -123.0 122.07 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.14 -0.482 . . . . 75.2 111.196 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 3.8 pt20 -104.34 90.71 3.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.457 0.646 . . . . 72.41 111.159 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 160.39 -152.18 22.89 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.14 113.672 175.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -120.72 -171.66 2.23 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.876 0.47 . . . . 64.01 111.113 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.782 HD11 ' HG3' ' A' ' 33' ' ' GLN . 29.7 mm -62.77 -34.43 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.266 0.555 . . . . 74.54 110.844 172.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.98 -49.51 8.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.664 -0.698 . . . . 71.44 112.138 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -129.65 105.53 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.08 0.467 . . . . 75.33 111.647 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 39.4 p90 -139.97 160.41 39.98 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.097 0.475 . . . . 73.12 112.18 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -134.51 134.76 41.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.074 -0.512 . . . . 62.54 110.768 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.19 123.12 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.484 -0.326 . . . . 63.31 110.884 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.3 pt -134.38 154.71 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.047 0.388 . . . . 71.22 112.047 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 53.46 39.2 29.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.071 0.463 . . . . 73.13 111.751 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.483 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 5.6 p -97.6 126.18 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.318 0.58 . . . . 74.23 111.978 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -114.9 153.12 31.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.052 -0.522 . . . . 73.12 110.6 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.22 133.72 53.35 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.166 0.508 . . . . 71.15 111.85 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.52 ' O ' HG12 ' A' ' 99' ' ' VAL . 8.8 tt0 -129.03 149.26 50.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.149 -0.478 . . . . 72.45 110.02 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.8 mt -92.11 118.63 31.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.119 0.485 . . . . 71.43 111.885 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.714 HG22 HD21 ' A' ' 137' ' ' LEU . 30.4 pt -92.78 99.37 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 72.32 111.371 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -101.46 114.57 28.7 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.293 -0.412 . . . . 65.23 110.96 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -111.67 147.26 36.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.053 0.39 . . . . 70.05 112.053 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.98 164.91 34.19 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.886 2.391 . . . . 62.02 113.733 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.38 125.98 29.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.869 -0.605 . . . . 65.2 112.121 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 71.1 m -90.6 79.44 6.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.962 0.41 . . . . 54.41 110.614 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.37 -10.65 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.149 -0.478 . . . . 64.43 111.875 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.84 129.89 53.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.845 0.355 . . . . 74.24 111.58 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.16 139.39 23.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.359 -0.382 . . . . 72.44 111.233 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 148.48 92.25 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.103 -1.207 . . . . 73.24 113.541 2.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.9 p -89.05 125.24 34.92 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.5 0.667 . . . . 64.11 112.608 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.73 143.39 5.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.581 -0.736 . . . . 64.0 110.366 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.02 157.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.791 0.329 . . . . 61.12 110.973 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.424 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.2 p30 -146.76 111.91 5.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.306 0.574 . . . . 75.12 110.866 170.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 23.5 pt -117.05 142.71 30.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.007 -0.542 . . . . 73.12 111.915 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 2.5 Cg_endo -81.24 130.92 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.907 2.405 . . . . 33.01 112.636 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 121' ' ' ILE . 62.9 mt -111.43 111.85 23.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 73.13 111.656 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -91.35 89.57 7.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.239 0.542 . . . . 71.21 110.625 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.513 HD23 HE22 ' A' ' 119' ' ' GLN . 26.2 mt -81.67 110.75 17.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 73.21 110.016 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -98.47 139.15 34.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.973 0.416 . . . . 74.03 111.76 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.98 63.72 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.079 -0.509 . . . . 61.1 113.28 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 147' ' ' LEU . 18.4 tt -134.33 123.61 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 O-C-N 122.401 -0.47 . . . . 72.14 111.774 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -85.41 147.53 26.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.094 0.405 . . . . 74.14 112.094 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -47.66 -51.4 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 113.192 0.812 . . . . 55.2 113.192 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.2 -38.13 82.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.094 0.473 . . . . 74.14 111.61 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -87.54 7.64 28.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.194 0.442 . . . . 71.32 112.194 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.517 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.2 tt -82.35 126.86 32.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.749 0.309 . . . . 73.43 110.257 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.42 -58.51 1.36 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.09 -0.576 . . . . 53.21 113.452 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -147.34 148.83 31.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.369 -0.489 . . . . 74.4 112.305 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 90.6 t -116.79 99.33 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.72 -0.673 . . . . 60.51 109.833 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -102.55 114.1 28.03 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.091 0.472 . . . . 75.22 111.74 -171.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.683 HG21 ' SD ' ' A' ' 66' ' ' MET . 38.2 mm -90.59 140.19 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.842 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -165.67 179.33 6.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 111.908 0.336 . . . . 75.42 111.908 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 98' ' ' THR . 73.2 m-20 61.87 22.57 13.13 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.417 0.895 . . . . 42.22 113.417 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.8 mm -63.86 94.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.313 0.578 . . . . 74.52 111.741 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 8.0 pt20 -125.66 144.8 49.31 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.556 -0.747 . . . . 72.32 111.179 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 146.27 51.14 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.49 2.127 . . . . 70.42 113.654 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.83 146.33 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.261 -0.427 . . . . 64.31 110.451 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -136.16 152.95 51.35 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.115 0.413 . . . . 75.11 112.115 -175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -75.75 -13.0 60.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.124 -0.489 . . . . 73.4 111.248 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.67 149.19 32.89 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.381 -0.372 . . . . 74.03 110.551 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.29 -81.45 0.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.853 0.686 . . . . 74.22 112.853 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -129.57 141.46 50.96 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.535 0.569 . . . . 74.02 112.535 -174.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -80.24 148.11 30.95 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.038 -0.528 . . . . 74.22 111.44 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -97.64 178.69 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.083 -0.386 . . . . 73.35 111.629 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 65.19 87.69 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.093 0.473 . . . . 74.44 110.994 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -155.63 39.66 0.39 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.469 -0.332 . . . . 75.14 111.838 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.037 0 N-CA-C 112.605 0.594 . . . . 75.44 112.605 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.7 mtm . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.77 0.319 . . . . 61.12 111.658 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -167.61 151.2 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.624 0.25 . . . . 61.52 110.951 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.89 151.37 39.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.009 0.433 . . . . 74.24 111.747 176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -134.53 101.99 5.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.453 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 t -114.49 93.44 4.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.131 0.491 . . . . 74.31 110.918 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -95.34 93.81 7.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.988 0.423 . . . . 54.52 110.914 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.73 133.81 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.422 0.629 . . . . 72.13 112.355 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.3 OUTLIER -138.12 112.27 8.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.941 -0.572 . . . . 75.44 110.965 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -81.96 102.92 11.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.916 0.389 . . . . 63.43 111.339 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -153.95 119.44 5.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.397 0.517 . . . . 73.33 112.397 -177.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -143.52 149.81 38.02 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.235 -0.439 . . . . 73.15 111.117 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -91.02 -10.08 43.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.993 0.368 . . . . 64.32 111.993 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -85.9 112.41 21.13 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.856 0.36 . . . . 64.53 111.335 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.81 119.42 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.397 0.618 . . . . 42.01 112.147 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.8 t -134.88 154.64 51.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.955 -0.566 . . . . 61.33 110.638 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -137.38 140.43 41.38 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.216 0.531 . . . . 74.03 112.154 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.8 mm? -106.93 164.65 11.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.281 -0.637 . . . . 63.44 109.281 170.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -51.64 128.12 22.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 121.12 -0.232 . . . . 75.33 110.924 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -40.06 135.4 1.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.588 0.958 . . . . 74.35 113.588 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.85 -175.61 0.31 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.587 0.958 . . . . 65.32 113.587 -174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.6 mtp -96.51 -172.23 2.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.092 -0.958 . . . . 74.1 111.632 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 p -95.11 140.92 29.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.191 0.52 . . . . 65.05 111.804 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -96.44 128.88 43.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.165 -0.47 . . . . 71.4 110.479 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp -47.82 137.03 10.18 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.361 0.504 . . . . 64.42 112.361 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.75 137.95 58.28 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.095 -0.502 . . . . 71.35 111.714 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.92 -30.87 70.46 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.313 -0.403 . . . . 75.54 111.267 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.64 -53.93 52.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.906 0.384 . . . . 73.21 110.797 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -56.55 -37.14 70.11 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.141 -0.481 . . . . 72.43 111.044 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.16 -47.14 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.356 -0.384 . . . . 65.12 111.065 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.636 ' HE2' ' HB3' ' A' ' 48' ' ' LEU . 21.0 tptm -62.24 -43.3 99.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.98 0.419 . . . . 65.41 111.176 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -49.31 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.031 0.443 . . . . 63.0 111.185 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -56.55 -38.78 72.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.965 0.412 . . . . 43.5 110.906 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -59.71 -42.04 92.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.024 -0.534 . . . . 72.42 111.073 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -62.52 -52.42 63.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.479 -0.328 . . . . 75.42 111.072 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -52.99 -42.96 66.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.88 0.371 . . . . 75.02 111.209 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -57.29 -45.92 83.65 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.994 0.426 . . . . 65.33 111.567 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.47 -31.18 72.11 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.833 0.349 . . . . 71.02 111.26 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -67.8 -30.48 69.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.938 0.399 . . . . 73.1 110.971 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.89 66.48 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.14 0.495 . . . . 74.24 111.083 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.43 1.05 47.22 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.284 -0.416 . . . . 54.32 111.788 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 t -65.77 120.48 13.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.274 0.472 . . . . 75.3 112.274 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -126.48 -13.97 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.37 -0.377 . . . . 72.31 111.695 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.3 p -129.39 25.51 5.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.377 0.51 . . . . 63.22 112.377 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.39 161.75 11.35 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.048 -0.596 . . . . 71.4 112.763 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -76.78 135.34 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.542 0.687 . . . . 64.25 112.823 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.96 109.41 20.75 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.453 -0.794 . . . . 72.41 110.746 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.3 131.98 47.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.793 0.33 . . . . 64.12 110.676 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.636 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 84.8 mt -117.17 120.29 33.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 111.903 0.334 . . . . 72.4 111.903 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HG3' HD22 ' A' ' 147' ' ' LEU . 11.5 Cg_endo -55.42 139.23 81.72 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.339 2.026 . . . . 73.15 111.666 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.82 -36.67 3.82 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.9 -0.667 . . . . 72.4 111.923 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.7 93.47 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.096 0.474 . . . . 74.45 110.057 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -79.61 27.29 0.28 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.265 0.555 . . . . 63.52 111.959 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 p -97.35 142.59 24.78 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 121.129 0.49 . . . . 64.45 112.132 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HB2' ' HG3' ' A' ' 65' ' ' ARG . 73.9 Cg_endo -73.57 163.8 36.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.116 2.544 . . . . 62.53 113.597 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.86 140.66 45.99 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.094 -0.503 . . . . 73.33 111.117 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -86.78 123.53 32.03 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.115 0.483 . . . . 72.55 112.046 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.3 tp -125.45 123.28 38.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.187 -0.46 . . . . 74.5 111.187 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -85.11 96.91 9.59 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 61.24 110.21 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.7 p -86.58 -174.85 5.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.265 0.555 . . . . 63.34 111.737 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 43.4 mt-30 -83.56 -4.71 58.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.998 -0.546 . . . . 74.32 111.605 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 92' ' ' LEU . 31.0 pt -106.59 -28.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.92 0.391 . . . . 73.23 111.253 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.62 175.54 31.74 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.128 -0.558 . . . . 61.32 113.188 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.4 m -72.76 112.05 8.45 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.056 0.455 . . . . 71.24 111.119 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 pp -121.84 155.95 34.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.329 0.585 . . . . 64.32 112.076 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 32.4 ttt180 -118.17 107.05 13.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.6 -0.727 . . . . 64.55 110.854 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.755 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.5 mtt -104.41 156.06 18.26 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.079 0.466 . . . . 55.41 112.09 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.1 t -158.07 160.82 37.78 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.779 0.324 . . . . 74.4 111.582 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 80' ' ' LEU . 79.3 mt -105.29 113.13 26.53 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.275 -0.421 . . . . 75.44 111.478 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.696 HG23 HD22 ' A' ' 70' ' ' ASN . 27.2 m -130.58 166.27 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.327 -0.233 . . . . 73.54 111.194 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.696 HD22 HG23 ' A' ' 69' ' ' VAL . 45.5 m-80 61.16 28.1 17.79 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.012 0.434 . . . . 61.34 111.618 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 HG23 ' A' ' 144' ' ' VAL . 51.8 mt -64.03 96.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.141 0.496 . . . . 74.02 111.319 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 p -131.26 150.88 77.73 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.102 -0.499 . . . . 74.02 112.089 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.66 156.97 61.1 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.737 2.291 . . . . 72.23 113.568 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.473 ' HB2' HG23 ' A' ' 79' ' ' THR . 22.9 t70 -133.36 168.8 17.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.875 -0.602 . . . . 74.42 110.65 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.83 68.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 71.41 111.644 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.56 -31.9 32.44 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.184 0.438 . . . . 74.43 112.184 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.96 -99.1 0.13 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.233 -0.984 . . . . 63.32 113.759 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -147.2 134.01 20.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.834 0.35 . . . . 51.31 111.539 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 36.2 p -110.72 127.55 55.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.569 -0.287 . . . . 72.54 111.627 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 68' ' ' LEU . 2.9 pp -134.35 145.16 48.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.018 0.437 . . . . 53.25 111.208 176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.5 m -84.37 101.78 12.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.11 0.481 . . . . 61.42 111.405 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.1 107.28 12.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.031 -0.531 . . . . 73.42 109.971 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HD2' HG21 ' A' ' 69' ' ' VAL . 14.9 mtp180 -95.66 113.13 24.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.791 0.329 . . . . 54.1 111.614 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.571 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.2 mp -88.53 88.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.133 0.492 . . . . 70.22 110.09 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 63.2 tt0 -94.03 95.18 8.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.133 0.492 . . . . 73.43 110.78 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.45 131.51 41.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.401 -0.428 . . . . 43.43 113.462 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.19 -5.98 58.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.112 0.482 . . . . 70.22 111.352 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.5 p -91.65 147.84 22.7 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.136 -0.484 . . . . 63.4 110.872 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.452 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 28.1 t-20 -79.5 -24.77 42.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.957 0.408 . . . . 70.33 110.639 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.3 134.46 95.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.289 -0.414 . . . . 74.32 111.802 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.57 102.74 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.648 2.232 . . . . 61.34 112.576 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.7 mt -68.88 141.87 92.85 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 112.251 0.463 . . . . 72.02 112.251 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.93 177.07 6.8 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.665 2.243 . . . . 74.31 113.33 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -63.19 135.01 56.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.939 0.4 . . . . 65.54 111.339 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.94 154.28 46.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.43 0.633 . . . . 75.53 112.56 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 90.1 p -131.04 -179.93 5.62 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.626 -0.716 . . . . 51.55 110.498 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . 179.66 175.12 46.21 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.727 -0.749 . . . . 52.44 113.095 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.9 m -111.61 131.96 54.9 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.239 0.216 . . . . 74.32 110.5 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 m -118.79 133.93 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.199 0.523 . . . . 64.15 111.987 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 8.6 mm-40 -99.13 106.65 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.851 -0.613 . . . . 71.41 110.557 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.466 ' HE1' ' HB2' ' A' ' 119' ' ' GLN . 48.5 p90 -116.65 122.56 44.92 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.391 0.615 . . . . 70.53 111.831 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.54 -144.71 4.36 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.68 -0.691 . . . . 61.12 112.811 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.483 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.9 mt-30 -127.03 158.42 37.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.104 0.478 . . . . 63.24 111.687 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.8 mt -119.17 117.07 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.347 -0.388 . . . . 71.24 111.332 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -92.25 41.81 1.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.086 0.47 . . . . 65.22 111.167 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.496 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -162.35 -158.95 9.91 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.975 -0.631 . . . . 51.02 113.676 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.5 p -125.78 -175.92 3.48 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.911 0.386 . . . . 71.52 111.59 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.493 HD11 ' HG3' ' A' ' 33' ' ' GLN . 45.9 mm -56.75 -38.57 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.031 0.443 . . . . 73.44 111.454 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.63 -42.63 77.78 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.263 -0.426 . . . . 71.33 111.234 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -139.32 87.59 2.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.293 0.568 . . . . 72.24 111.996 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -98.0 129.86 44.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.079 0.466 . . . . 74.42 111.065 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -123.68 120.17 31.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.059 -0.519 . . . . 63.11 110.838 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.08 118.71 19.11 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.976 0.417 . . . . 74.54 111.937 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.5 pt -130.57 155.11 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.444 -0.343 . . . . 72.2 110.96 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 54.67 32.08 16.55 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.463 0.649 . . . . 70.53 111.279 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.41 117.77 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.752 -0.658 . . . . 70.13 112.226 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -102.42 145.77 29.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.035 -0.529 . . . . 73.14 110.178 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -103.72 117.73 35.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.003 0.43 . . . . 71.42 111.324 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.466 ' HB2' ' HE1' ' A' ' 101' ' ' TYR . 8.9 tt0 -109.68 147.57 32.89 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 75.34 110.889 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.02 115.16 29.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.848 0.356 . . . . 73.43 111.05 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 121' ' ' ILE . 46.7 pt -94.8 116.38 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.108 0.48 . . . . 64.42 111.756 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.9 OUTLIER -109.74 109.4 20.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.984 -0.376 . . . . 72.14 109.984 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.84 147.63 34.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 112.201 0.445 . . . . 41.53 112.201 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.45 151.46 84.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.826 2.35 . . . . 43.02 113.168 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -67.7 140.0 56.75 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.033 0.444 . . . . 74.31 112.041 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -83.7 77.37 9.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 110.118 -0.326 . . . . 73.35 110.118 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.433 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -67.94 -21.71 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.066 0.46 . . . . 73.53 111.925 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.433 ' HG ' HG23 ' A' ' 127' ' ' VAL . 93.1 mt -105.1 152.42 22.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 75.2 111.039 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 89' ' ' ASN . . . -115.15 140.05 25.18 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.525 -0.307 . . . . 50.12 111.644 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.74 173.83 56.15 Favored 'Cis proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.78 -1.342 . . . . 53.35 113.496 0.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -73.67 111.09 8.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.327 0.491 . . . . 73.25 112.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -141.94 115.57 9.09 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.326 0.584 . . . . 72.32 111.056 172.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.82 155.34 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 116.403 -0.362 . . . . 71.14 110.932 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 9.0 p-10 -143.97 121.34 11.64 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.142 0.496 . . . . 73.2 111.303 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.1 pt -119.91 138.52 27.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 112.182 0.438 . . . . 72.22 112.182 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 4.8 Cg_exo -78.14 123.33 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.015 2.477 . . . . 74.34 112.819 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' THR . 76.1 mt -100.89 106.46 17.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.89 0.376 . . . . 64.04 111.945 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.479 ' HA ' HG22 ' A' ' 79' ' ' THR . 35.4 tt0 -84.05 88.37 7.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.401 0.62 . . . . 71.12 110.228 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.409 HD23 ' NE2' ' A' ' 119' ' ' GLN . 29.4 mt -81.44 116.74 21.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 71.24 110.013 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -99.68 141.82 31.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 73.41 112.055 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.2 41.29 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.297 -0.478 . . . . 44.14 113.154 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 147' ' ' LEU . 16.9 tt -161.51 127.12 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.039 0.447 . . . . 63.11 111.191 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.4 m -84.65 145.78 27.81 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.007 0.373 . . . . 71.2 112.007 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 71' ' ' ILE . 7.2 p -56.84 -43.03 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.741 0.645 . . . . 73.24 112.741 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.54 -30.3 64.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.096 0.474 . . . . 74.14 111.471 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.469 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 29.7 mm-40 -90.88 -4.16 56.77 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.079 0.4 . . . . 55.5 112.079 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.486 HD22 ' HG3' ' A' ' 49' ' ' PRO . 1.6 tt -61.26 117.94 6.25 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.859 0.361 . . . . 72.15 110.304 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.98 -62.45 1.36 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.278 -0.487 . . . . 41.21 113.457 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.436 ' HD2' ' HG3' ' A' ' 151' ' ' ARG . 37.4 p90 -142.63 155.55 44.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.383 0.512 . . . . 72.1 112.383 -174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.9 t -131.49 104.02 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.196 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.597 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 77.5 mtp180 -96.09 115.28 27.19 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.933 0.397 . . . . 65.53 112.01 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.755 HG21 ' SD ' ' A' ' 66' ' ' MET . 21.4 mm -93.69 121.91 44.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.071 -0.513 . . . . 73.24 110.741 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -154.34 172.94 16.88 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.245 0.461 . . . . 52.14 112.245 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 63.6 23.8 13.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.889 0.7 . . . . 73.14 112.889 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.409 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.3 mm -64.23 109.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.18 0.514 . . . . 73.24 111.293 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.464 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.2 pt20 -133.86 147.11 62.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.84 -0.618 . . . . 74.44 111.9 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.527 ' HB2' ' HG2' ' A' ' 159' ' ' MET . 60.6 Cg_endo -72.44 124.1 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.253 1.968 . . . . 54.05 112.339 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.7 m -81.24 8.9 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 112.424 0.527 . . . . 75.31 112.424 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.527 ' HG2' ' HB2' ' A' ' 157' ' ' PRO . 25.3 ptt? -80.0 108.29 13.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.202 0.525 . . . . 55.25 111.447 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -88.05 8.2 27.76 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.312 0.577 . . . . 71.42 110.936 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.73 9.79 41.7 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.097 0.406 . . . . 71.44 112.097 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.36 156.73 25.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.31 0.576 . . . . 72.32 112.331 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -126.11 37.25 4.37 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.102 -0.499 . . . . 74.21 111.386 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -58.74 -47.86 83.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.235 0.457 . . . . 61.42 112.235 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -63.82 129.04 38.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.629 0.252 . . . . 73.5 111.173 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -98.74 97.61 8.83 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.212 0.529 . . . . 72.24 112.392 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -158.53 79.52 0.8 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.36 0.6 . . . . 64.42 110.612 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 55.0 t60 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.503 -0.771 . . . . 73.02 110.85 179.518 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.96 0.41 . . . . 72.41 111.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.35 156.96 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.086 0.469 . . . . 41.0 111.596 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -111.38 151.45 28.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.335 -0.393 . . . . 75.04 111.071 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -63.99 93.81 0.09 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.68 0.753 . . . . 65.12 110.773 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.9 m -89.77 132.01 35.44 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.952 -0.567 . . . . 63.14 112.183 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.93 -175.89 3.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.35 -0.386 . . . . 72.32 111.366 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.01 155.34 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.577 . . . . 73.44 111.792 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.54 148.95 24.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.092 -0.504 . . . . 64.32 110.566 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.2 86.51 1.42 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.553 0.692 . . . . 73.44 111.441 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.8 mmt -72.67 147.3 45.85 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.579 -0.737 . . . . 71.52 110.978 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.601 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 3.2 mptp? -87.99 83.7 7.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.913 0.387 . . . . 75.23 111.548 -171.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -143.28 115.74 8.57 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.573 -0.285 . . . . 72.25 111.022 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -179.48 -170.99 0.18 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.963 0.411 . . . . 74.53 111.006 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.73 105.57 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.886 0.375 . . . . 74.44 110.956 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -74.0 99.04 3.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.903 0.383 . . . . 55.11 111.818 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.6 p -98.38 126.61 43.97 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.01 0.433 . . . . 74.51 111.329 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -107.23 142.77 36.44 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.888 0.375 . . . . 73.34 111.701 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -65.22 143.72 57.65 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.288 -0.415 . . . . 61.23 111.652 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -95.03 -177.31 4.11 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.6 0.714 . . . . 72.41 112.697 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -71.13 124.42 24.4 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.312 -0.858 . . . . 75.44 111.95 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.1 ttm -84.72 157.31 21.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.435 -0.348 . . . . 71.23 110.843 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -75.5 -167.87 0.74 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -50.43 141.65 11.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.474 0.546 . . . . 75.31 112.474 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.6 tp -126.64 145.58 50.51 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.959 0.409 . . . . 73.52 111.693 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 86.2 m-20 -91.89 147.91 22.61 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.602 -0.272 . . . . 73.32 111.375 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -60.3 -39.58 87.48 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.756 0.312 . . . . 73.11 111.704 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 31' ' ' ILE . 42.8 tt0 -58.79 -48.46 81.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.004 0.431 . . . . 75.5 110.149 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 25' ' ' ASN . 3.9 m -61.32 -33.2 73.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.151 -0.477 . . . . 72.12 111.212 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.66 -54.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.322 0.582 . . . . 73.42 110.973 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -64.72 -34.69 78.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.59 -0.732 . . . . 73.41 111.777 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 27' ' ' GLU . 77.1 mt -64.9 -46.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.871 0.367 . . . . 74.35 111.314 174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.4 m -64.56 -38.97 92.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.781 0.324 . . . . 72.44 111.201 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -60.16 -45.33 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.825 0.345 . . . . 70.4 110.489 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -57.24 10.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.073 -0.512 . . . . 62.31 110.573 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -55.17 -46.27 75.76 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.459 0.54 . . . . 63.11 112.459 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.71 -48.6 76.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.132 0.419 . . . . 73.52 112.132 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.173 0.511 . . . . 60.33 110.8 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -59.25 -44.01 92.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.78 -0.645 . . . . 74.25 110.386 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.6 97.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.034 -0.53 . . . . 71.02 111.945 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HE3' HG22 ' A' ' 108' ' ' ILE . 68.7 mttm -68.81 -23.24 64.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.832 0.349 . . . . 72.33 111.855 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -63.87 115.47 4.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.88 0.371 . . . . 74.45 111.75 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 m -64.42 -47.72 78.08 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.174 0.511 . . . . 62.13 111.4 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.2 p -129.64 117.75 20.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.176 -0.465 . . . . 71.53 111.143 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 99.85 169.51 29.81 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.154 -0.546 . . . . 44.31 113.727 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 57' ' ' LEU . 31.1 m -113.19 153.99 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.113 0.483 . . . . 71.32 111.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -101.95 126.8 48.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.258 -0.428 . . . . 71.31 111.421 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.83 112.28 19.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.397 -0.365 . . . . 74.53 110.749 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 9.6 mp -91.88 135.01 27.92 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.718 -0.219 . . . . 73.31 111.265 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 48' ' ' LEU . 38.5 Cg_exo -56.62 -32.5 90.64 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.685 2.257 . . . . 63.43 113.274 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.73 15.23 61.01 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.256 -0.497 . . . . 64.31 113.131 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.03 84.2 2.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.164 0.506 . . . . 73.02 111.607 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.75 81.98 0.44 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.45 0.643 . . . . 71.23 111.301 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 p -137.43 152.07 72.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.98 -0.555 . . . . 51.05 112.246 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HB3' HH11 ' A' ' 65' ' ' ARG . 92.8 Cg_endo -81.5 132.4 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.959 2.439 . . . . 62.5 112.717 171.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.11 130.16 55.58 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.813 0.34 . . . . 71.42 111.14 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.715 ' HD3' HG23 ' A' ' 63' ' ' THR . 1.6 tmm_? -86.28 108.52 18.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.96 0.409 . . . . 74.24 110.137 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.422 HD13 HG13 ' A' ' 45' ' ' VAL . 40.2 tp -101.77 131.42 48.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.454 0.645 . . . . 54.41 112.595 -174.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.32 106.21 15.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.277 -0.874 . . . . 73.12 109.817 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -110.41 -178.71 3.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.168 0.509 . . . . 72.43 111.927 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 47.7 mt-30 -87.64 -2.96 58.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.075 -0.512 . . . . 74.34 111.747 177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 157' ' ' PRO . 31.8 pt -104.18 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.839 0.352 . . . . 75.43 111.175 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -162.43 29.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.425 -0.417 . . . . 33.14 113.318 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.715 HG23 ' HD3' ' A' ' 56' ' ' ARG . 77.8 m -87.46 118.72 27.11 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.58 -0.365 . . . . 45.21 111.012 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.45 169.36 17.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.63 0.604 . . . . 74.12 112.63 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.678 HH11 ' HB3' ' A' ' 54' ' ' PRO . 35.1 ttp85 -118.09 136.42 53.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.704 -0.68 . . . . 74.05 110.844 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.639 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.2 mtt -130.39 157.4 42.69 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.768 0.318 . . . . 63.44 111.545 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 t -164.5 165.11 21.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.905 0.383 . . . . 64.13 111.682 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 80' ' ' LEU . 94.4 mt -109.5 117.69 34.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 61.42 111.588 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.615 HG23 HD22 ' A' ' 70' ' ' ASN . 35.3 m -128.01 162.99 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 72.31 111.51 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.615 HD22 HG23 ' A' ' 69' ' ' VAL . 51.1 m-80 58.41 29.58 18.43 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.463 0.542 . . . . 72.33 112.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 56.9 mt -62.28 106.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.915 0.388 . . . . 73.11 110.935 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -138.22 151.25 69.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.183 -0.462 . . . . 75.44 112.122 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.06 162.3 38.84 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.9 2.4 . . . . 72.33 113.147 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 79' ' ' THR . 20.5 t70 -147.16 158.46 43.95 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.246 -0.433 . . . . 75.21 111.478 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.58 84.34 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.17 0.433 . . . . 71.12 112.17 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -88.26 -32.85 18.3 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.707 0.289 . . . . 71.42 111.269 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -172.43 -96.19 0.1 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.692 -0.766 . . . . 74.04 113.763 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -150.72 129.35 12.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.562 -0.375 . . . . 65.43 111.498 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.566 HG23 ' HB2' ' A' ' 74' ' ' ASP . 60.3 p -104.36 125.76 50.87 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.187 -0.321 . . . . 71.24 111.525 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.45 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -138.61 151.37 47.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.038 0.447 . . . . 75.44 111.44 176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.496 ' HB ' HG23 ' A' ' 69' ' ' VAL . 32.7 m -94.79 110.02 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 71.33 111.422 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.36 111.58 19.56 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.663 -0.495 . . . . 72.14 109.663 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.501 ' HE ' ' HB3' ' A' ' 134' ' ' ASP . 38.0 mtp180 -105.28 126.51 52.18 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.239 0.459 . . . . 75.35 112.239 -177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.2 mp -110.96 141.13 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.824 -0.626 . . . . 75.4 110.201 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -139.64 148.05 41.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 65.14 111.055 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.15 124.61 6.5 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.884 -0.674 . . . . 71.12 113.567 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 63' ' ' THR . 19.3 mm-40 -70.76 -3.32 18.19 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.966 0.413 . . . . 64.43 111.264 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -116.34 161.93 18.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.305 -0.407 . . . . 54.43 110.826 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -81.6 24.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.723 0.297 . . . . 55.12 111.741 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.86 146.74 34.42 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.704 0.402 . . . . 62.33 111.293 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 59.9 Cg_endo -72.64 112.06 3.39 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.633 2.222 . . . . 54.41 112.988 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.46 143.38 98.19 Favored Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 112.529 0.566 . . . . 63.24 112.529 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.89 -165.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.793 2.329 . . . . 71.42 112.675 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 138.39 31.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.937 0.399 . . . . 71.22 111.502 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.86 162.88 38.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.144 0.497 . . . . 74.33 112.148 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 95.5 p -140.76 151.0 44.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.973 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.689 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -153.01 170.64 32.02 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.527 -0.844 . . . . 74.21 113.839 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -100.93 124.34 46.48 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.744 0.307 . . . . 61.13 111.388 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -107.47 130.75 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.085 0.469 . . . . 75.41 111.194 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.04 126.36 52.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.977 0.418 . . . . 64.15 110.919 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 139' ' ' LEU . 10.4 p90 -127.95 121.14 29.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 63.14 111.193 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.92 -159.29 9.57 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.092 -0.575 . . . . 62.03 113.085 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB2' HG13 ' A' ' 114' ' ' ILE . 77.2 mt-30 -119.22 156.53 29.73 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.007 0.432 . . . . 45.22 111.896 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 106' ' ' GLY . 67.2 mt -112.96 129.39 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.125 -0.489 . . . . 73.24 110.998 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.541 HE21 HD13 ' A' ' 114' ' ' ILE . 4.1 pt20 -114.14 30.09 7.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.055 0.391 . . . . 74.53 112.055 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 104' ' ' ILE . . . -151.83 -157.86 8.12 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.652 -0.785 . . . . 73.35 113.461 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.3 p -105.77 -164.47 1.02 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.529 0.332 . . . . 73.13 111.613 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.416 HG22 ' HE3' ' A' ' 40' ' ' LYS . 50.0 mm -66.18 -40.57 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.877 0.695 . . . . 72.45 112.877 -175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -94.09 -42.7 8.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.311 0.486 . . . . 73.41 112.311 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.76 99.81 7.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.332 0.587 . . . . 73.41 111.807 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -152.89 148.11 26.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.902 -0.59 . . . . 72.34 111.493 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -113.69 136.9 52.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.907 0.384 . . . . 63.24 110.912 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.49 103.91 13.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.194 0.521 . . . . 74.44 111.189 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.541 HD13 HE21 ' A' ' 105' ' ' GLN . 45.2 pt -109.28 155.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 116.447 -0.342 . . . . 50.14 111.889 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 51.89 39.32 25.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.187 0.517 . . . . 72.23 111.837 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.32 123.66 50.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.175 0.512 . . . . 74.2 111.904 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -112.15 160.31 17.69 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.087 -0.506 . . . . 65.21 110.442 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.31 145.01 51.19 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.251 0.463 . . . . 64.12 112.251 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -140.91 166.32 25.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.959 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -107.64 121.79 45.38 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.814 0.34 . . . . 73.25 111.791 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.559 HG22 HD21 ' A' ' 137' ' ' LEU . 32.2 pt -95.05 107.58 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.203 0.525 . . . . 73.34 111.369 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.53 101.88 13.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.881 0.372 . . . . 73.42 111.004 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.11 140.73 21.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.862 0.319 . . . . 54.5 111.862 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.41 168.47 21.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.832 2.355 . . . . 75.51 113.466 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.29 146.11 31.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.225 0.454 . . . . 61.44 112.225 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.0 m -93.34 155.81 17.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.138 0.495 . . . . 74.32 112.02 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.0 t -105.51 -47.45 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.958 -0.565 . . . . 44.41 111.682 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.35 173.5 6.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.352 0.596 . . . . 72.35 112.165 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.96 142.34 45.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 115.741 -0.663 . . . . 74.33 111.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.87 162.93 90.34 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 123.809 -1.33 . . . . 74.51 112.931 -1.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 38.6 m -100.59 108.39 20.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.181 0.438 . . . . 74.4 112.181 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -103.78 93.09 4.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.579 0.351 . . . . 72.31 110.209 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.57 111.28 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.354 0.261 . . . . 71.33 111.341 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.501 ' HB3' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -117.01 143.69 45.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.287 0.565 . . . . 74.34 112.047 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.7 pt -137.63 136.35 20.11 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.707 -0.679 . . . . 73.34 111.608 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.97 137.28 19.45 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.694 2.263 . . . . 65.14 113.382 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.559 HD21 HG22 ' A' ' 121' ' ' ILE . 20.4 mt -120.54 114.83 22.33 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.125 0.417 . . . . 73.32 112.125 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -91.66 93.73 9.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.963 0.411 . . . . 74.05 110.245 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 46.7 mt -74.33 120.89 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 63.11 110.053 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 46.2 mtmt -102.33 141.47 35.11 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.396 0.517 . . . . 64.32 112.396 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.29 10.43 86.01 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.211 -0.519 . . . . 61.43 113.885 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.5 tt -143.63 122.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.346 0.593 . . . . 71.0 111.847 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -76.77 155.54 33.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.395 -0.366 . . . . 73.34 111.416 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.4 -40.1 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.117 0.484 . . . . 73.24 111.407 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.53 -23.39 66.86 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.057 0.456 . . . . 72.51 111.47 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -89.47 1.13 56.29 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.226 0.454 . . . . 53.12 112.226 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.3 mt -81.43 125.83 30.91 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.237 0.541 . . . . 74.31 111.872 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.82 -54.28 0.68 Allowed Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.652 -0.704 . . . . 70.12 112.284 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.13 150.02 37.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.752 0.31 . . . . 70.4 111.332 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.8 102.97 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.1 110.546 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -91.53 116.31 28.75 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.004 0.372 . . . . 61.2 112.004 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.639 HG21 ' SD ' ' A' ' 66' ' ' MET . 11.2 mm -100.48 119.63 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 110.045 -0.354 . . . . 73.52 110.045 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.513 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 15.5 p80 -143.78 177.94 8.17 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.729 1.011 . . . . 74.13 113.729 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 74.64 -74.66 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.771 -1.104 . . . . 71.31 111.769 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.689 HD13 ' HA3' ' A' ' 97' ' ' GLY . 46.7 mm 39.83 82.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.602 0.715 . . . . 70.1 112.376 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.431 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.6 pt20 -110.09 150.54 41.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.451 -0.795 . . . . 60.22 111.557 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.504 ' HG3' HG22 ' A' ' 61' ' ' ILE . 8.4 Cg_exo -71.23 128.19 14.38 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.51 2.14 . . . . 43.24 112.715 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.65 2.95 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.808 0.813 . . . . 72.53 111.081 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 59.5 mtt -100.98 152.9 20.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.784 -1.098 . . . . 43.3 110.189 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -69.58 96.38 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.179 0.514 . . . . 73.33 111.78 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.4 pt? -71.07 140.13 50.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 74.04 111.044 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.11 -175.18 5.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.823 0.344 . . . . 63.35 111.251 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -127.17 160.42 31.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.127 0.489 . . . . 73.52 111.827 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -134.21 160.76 36.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.212 -0.449 . . . . 73.12 111.426 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -137.02 152.7 50.42 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.904 0.335 . . . . 73.51 111.904 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -153.95 139.76 18.09 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.126 0.417 . . . . 74.24 112.126 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -81.77 -55.25 4.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.378 0.608 . . . . 74.32 109.907 170.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.57 -0.728 . . . . 70.54 110.95 176.491 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.652 0.263 . . . . 75.35 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -81.24 129.3 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.009 0.433 . . . . 74.45 111.701 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -104.5 84.03 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.085 0.469 . . . . 54.05 110.916 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -91.46 -176.32 4.49 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.146 0.498 . . . . 63.42 111.94 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -76.21 104.79 6.9 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.031 0.443 . . . . 74.45 112.124 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -117.58 120.04 36.85 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.232 -0.44 . . . . 64.21 110.671 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.16 150.53 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.363 0.602 . . . . 62.54 112.525 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 8' ' ' ARG . 40.3 mtt180 -118.56 -170.65 1.94 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.055 -0.521 . . . . 73.43 111.161 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.69 159.79 33.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.175 0.512 . . . . 74.2 111.64 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.5 mmt -95.46 140.9 29.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.993 0.425 . . . . 74.52 111.509 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -111.43 -174.57 2.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.927 0.394 . . . . 61.0 111.09 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -163.21 154.62 17.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.553 -0.294 . . . . 72.12 111.194 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 t -83.26 -174.72 5.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.814 0.34 . . . . 64.24 111.321 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.64 118.93 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 121.201 0.524 . . . . 74.11 111.424 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -100.94 121.18 41.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.337 -0.392 . . . . 74.4 111.497 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.0 p -136.42 102.35 4.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.594 0.358 . . . . 70.02 110.836 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.4 mt -78.59 168.61 19.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.072 0.463 . . . . 71.01 112.113 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -118.24 168.56 10.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.043 0.449 . . . . 74.54 111.47 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -123.65 135.15 53.76 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.205 -0.452 . . . . 61.35 111.155 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.97 121.73 20.56 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.782 0.325 . . . . 72.11 110.791 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.09 176.96 8.08 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.521 0.563 . . . . 72.51 112.521 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.0 p -100.29 -158.0 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.879 -0.6 . . . . 54.34 111.802 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -73.73 -177.89 2.95 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.641 0.734 . . . . 73.22 112.817 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.12 144.15 33.32 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.495 -0.775 . . . . 61.22 111.017 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.498 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.8 m-80 -122.23 160.42 25.26 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.74 -0.209 . . . . 63.4 110.747 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 16.1 mm100 -57.72 -44.09 85.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.724 0.297 . . . . 65.43 111.496 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -58.85 -45.36 90.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.015 0.436 . . . . 73.33 110.711 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.3 m -59.85 -31.96 70.24 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.082 -0.508 . . . . 72.24 110.982 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 25' ' ' ASN . 87.8 t -64.54 -50.35 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.709 -0.223 . . . . 74.14 110.935 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 4.7 mptp? -55.47 -47.24 76.42 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.017 0.437 . . . . 62.3 110.854 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 53' ' ' THR . 73.7 mt -55.17 -53.64 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.131 -0.486 . . . . 75.45 111.337 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.7 m -56.65 -47.82 78.91 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.258 -0.428 . . . . 73.33 111.625 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -58.83 -39.92 82.64 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.984 -0.553 . . . . 70.2 111.363 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.89 -47.66 85.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.722 0.296 . . . . 74.31 111.181 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -57.87 -41.69 82.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.931 0.396 . . . . 70.41 111.148 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.4 mmp_? -60.57 -54.55 44.04 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.949 0.404 . . . . 74.33 111.568 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.88 -36.05 83.1 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.991 0.424 . . . . 73.24 111.683 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' ND2' ' HB1' ' A' ' 55' ' ' ALA . 20.0 t-20 -63.95 -35.18 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.843 0.354 . . . . 73.44 111.043 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.05 60.5 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.949 0.404 . . . . 71.23 111.362 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HE3' HG22 ' A' ' 108' ' ' ILE . 62.5 mttm -90.69 -3.9 57.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 73.03 111.572 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 108.63 4.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.145 0.498 . . . . 55.41 112.061 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.5 p -91.98 -1.33 57.31 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.162 -0.472 . . . . 73.22 111.696 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.6 p -153.71 102.9 2.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.783 0.325 . . . . 75.32 111.23 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 -145.47 28.0 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.941 -0.647 . . . . 64.34 112.692 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 57' ' ' LEU . 17.9 m -134.29 139.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.336 -0.508 . . . . 72.31 112.333 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.55 106.91 18.82 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.924 -0.58 . . . . 71.43 111.455 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.54 148.78 23.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.989 -0.375 . . . . 63.1 109.989 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 mt -113.78 130.79 23.48 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.369 . . . . 63.41 111.466 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.645 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 66.2 Cg_endo -72.2 28.36 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.208 2.605 . . . . 54.44 113.805 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.35 12.93 2.05 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.493 -0.384 . . . . 70.33 112.3 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.13 115.72 18.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.993 0.425 . . . . 73.14 111.551 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -69.07 8.66 0.52 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.675 0.621 . . . . 72.12 112.675 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.435 HG21 HG23 ' A' ' 31' ' ' ILE . 1.5 p -90.81 145.25 31.62 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.584 0.587 . . . . 72.14 112.584 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 75.1 Cg_endo -81.97 -178.28 4.03 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.168 2.578 . . . . 45.42 114.029 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.433 ' HB1' ' ND2' ' A' ' 38' ' ' ASN . . . -147.31 145.64 29.42 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.811 -0.631 . . . . 72.52 111.389 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -80.83 112.25 18.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.415 -0.357 . . . . 71.45 111.185 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.495 HD13 HG13 ' A' ' 45' ' ' VAL . 56.1 tp -117.95 120.64 38.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.296 0.569 . . . . 73.2 111.534 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -83.85 115.09 22.09 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.846 -0.615 . . . . 72.34 110.701 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -114.08 179.14 4.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.124 0.487 . . . . 64.35 111.512 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.19 0.12 29.66 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.197 0.443 . . . . 73.53 112.197 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 92' ' ' LEU . 37.5 pt -109.61 5.27 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.231 0.539 . . . . 62.24 110.551 171.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.13 -171.35 13.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.99 -0.55 . . . . 62.22 112.731 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -77.87 134.33 37.97 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.485 -0.421 . . . . 43.45 111.257 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.48 152.96 48.76 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.333 0.587 . . . . 65.31 111.427 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HD2' ' OE1' ' A' ' 85' ' ' GLN . 39.8 ttm180 -109.63 107.1 17.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.957 -0.565 . . . . 74.13 111.325 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.0 mtt -98.96 138.07 36.6 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.76 0.314 . . . . 63.51 111.785 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 42.3 t -139.15 161.77 36.59 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.392 -0.367 . . . . 70.0 111.614 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 80' ' ' LEU . 89.8 mt -113.79 108.95 17.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.951 0.405 . . . . 75.41 111.768 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.596 HG23 ' HB ' ' A' ' 81' ' ' THR . 35.6 m -117.25 161.53 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.7 0.286 . . . . 74.51 111.284 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 65.14 22.76 12.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.488 0.551 . . . . 74.33 112.488 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 49' ' ' PRO . 51.4 mt -61.84 114.78 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 111.948 0.351 . . . . 73.04 111.948 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 p -145.09 154.49 54.49 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 112.32 0.489 . . . . 74.34 112.32 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.68 136.62 33.67 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.503 2.135 . . . . 72.5 112.67 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.499 ' HB2' HG23 ' A' ' 79' ' ' THR . 34.7 t70 -107.69 159.06 16.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.826 0.346 . . . . 72.21 111.123 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.93 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.068 0.461 . . . . 53.33 111.647 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -86.95 -55.06 4.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.297 0.57 . . . . 72.12 110.131 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.21 -94.42 0.16 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.116 -0.564 . . . . 54.51 113.343 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -149.21 136.19 19.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 122.375 -0.486 . . . . 51.14 111.702 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 74' ' ' ASP . 32.4 p -116.08 129.97 56.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.288 0.566 . . . . 74.22 111.939 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.666 HD13 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -142.34 150.75 41.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.006 -0.543 . . . . 72.53 111.236 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.596 ' HB ' HG23 ' A' ' 69' ' ' VAL . 30.9 m -92.89 112.16 24.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.871 0.367 . . . . 71.42 111.687 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.3 112.97 22.6 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.773 -0.454 . . . . 64.51 109.773 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' MET . 83.6 mtt180 -110.64 133.82 52.98 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.144 0.424 . . . . 73.03 112.144 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.457 HG13 ' HG2' ' A' ' 66' ' ' MET . 4.0 mp -113.66 109.36 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.072 -0.513 . . . . 75.5 111.175 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 97.6 mt-30 -93.25 143.61 26.1 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.927 0.394 . . . . 63.01 111.193 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.13 146.85 23.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.28 -0.486 . . . . 75.31 114.013 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.8 -46.02 59.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.664 0.386 . . . . 72.14 111.969 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.2 t -102.45 179.9 4.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.307 0.575 . . . . 71.14 112.222 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.87 10.19 12.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.789 -0.641 . . . . 73.12 111.223 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.96 145.75 31.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.078 -0.51 . . . . 74.51 110.864 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.73 131.54 14.75 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.461 2.107 . . . . 72.3 112.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.479 ' HB3' HD12 ' A' ' 61' ' ' ILE . 94.3 mt -79.75 147.63 67.26 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.681 0.277 . . . . 62.31 111.534 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 16.3 Cg_exo -69.83 -178.13 2.22 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.891 2.394 . . . . 72.43 113.07 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -78.14 132.34 37.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.568 -0.287 . . . . 72.11 111.412 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -137.56 170.24 16.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 75.24 112.342 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.3 p -153.65 157.02 38.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.041 -0.527 . . . . 74.5 110.516 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.609 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -161.64 -173.67 30.58 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.717 -0.754 . . . . 75.04 113.787 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -120.59 142.94 48.92 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.76 0.315 . . . . 53.53 110.806 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.0 128.83 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.053 0.454 . . . . 54.1 112.034 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 11.1 mm-40 -95.82 113.04 24.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.011 -0.54 . . . . 75.24 110.039 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 44.6 p90 -124.31 127.9 48.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.874 -0.516 . . . . 53.3 111.965 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.59 -154.26 9.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.075 -0.583 . . . . 70.43 113.263 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -113.31 152.12 30.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.202 0.525 . . . . 74.22 111.944 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.565 HG23 ' HB2' ' A' ' 111' ' ' PHE . 66.3 mt -108.45 106.82 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 116.008 -0.542 . . . . 73.33 111.037 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -92.64 22.53 4.65 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.039 0.385 . . . . 75.31 112.039 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -136.66 -165.38 10.49 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.894 -0.67 . . . . 63.21 113.446 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.5 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 11.2 p -87.69 -161.72 0.74 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.703 0.287 . . . . 71.33 111.035 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.646 HG22 ' HE3' ' A' ' 40' ' ' LYS . 51.4 mm -85.67 -28.64 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.878 0.371 . . . . 64.34 111.087 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -91.49 -40.84 11.17 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.02 0.378 . . . . 75.43 112.02 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -127.47 96.89 4.69 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.444 0.64 . . . . 73.43 110.881 175.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.644 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 30.5 p90 -118.93 144.94 46.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.906 -0.588 . . . . 72.51 111.912 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -115.27 131.44 56.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.923 -0.58 . . . . 61.31 110.244 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -96.57 113.6 25.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.983 0.421 . . . . 74.34 111.822 -174.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.9 pt -121.1 164.64 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.406 -0.361 . . . . 64.22 111.365 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.07 29.06 11.76 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.984 0.421 . . . . 70.12 111.526 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 4.8 p -94.04 124.64 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.275 0.56 . . . . 75.3 112.218 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.19 155.7 24.56 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.884 -0.598 . . . . 62.15 110.758 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -104.78 139.88 38.91 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.154 -0.476 . . . . 62.21 111.202 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -138.58 146.48 41.87 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.708 0.289 . . . . 52.22 111.464 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.93 116.71 27.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.032 0.444 . . . . 54.24 111.825 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 121' ' ' ILE . 23.5 pt -106.7 105.06 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 71.44 111.15 176.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.98 132.61 51.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.281 -0.418 . . . . 61.54 111.065 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -121.51 145.78 43.56 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.75 0.31 . . . . 72.31 111.828 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.6 174.79 12.26 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.655 2.237 . . . . 64.22 113.001 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -80.82 135.77 36.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.015 0.436 . . . . 63.32 111.872 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.2 m -70.69 126.35 29.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.161 -0.472 . . . . 74.35 111.332 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.617 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.4 m -97.91 -35.78 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.104 0.779 . . . . 63.55 113.104 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.617 ' HG ' HG23 ' A' ' 127' ' ' VAL . 92.5 mt -125.62 120.36 30.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.726 0.298 . . . . 75.32 110.93 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.95 68.71 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 112.52 0.563 . . . . 63.34 112.52 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.98 167.52 78.41 Favored 'Cis proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.243 -1.149 . . . . 74.11 112.93 -1.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 49.2 m -75.62 133.73 40.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.857 0.361 . . . . 75.22 111.773 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.47 31.37 1.9 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.996 -0.547 . . . . 75.05 111.239 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' A' ' 123' ' ' ALA . 59.3 t -52.1 115.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 112.699 0.629 . . . . 71.42 112.699 -174.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.81 114.57 28.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.197 0.523 . . . . 72.11 111.733 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 27.1 pt -122.87 136.68 27.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.973 0.416 . . . . 61.32 112.094 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.14 135.84 14.07 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.744 2.296 . . . . 74.32 112.942 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.2 113.02 20.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.383 -0.371 . . . . 74.31 110.495 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -103.04 118.9 37.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.219 0.533 . . . . 71.23 112.114 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.2 mt -99.93 142.84 30.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.859 0.464 . . . . 74.44 110.692 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -102.9 144.01 31.75 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.581 0.585 . . . . 74.52 112.581 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 76.91 -43.27 1.92 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 114.971 0.749 . . . . 61.33 114.971 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.488 HD13 HD23 ' A' ' 147' ' ' LEU . 20.7 tt -88.83 122.91 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.565 0.698 . . . . 74.12 111.993 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.6 m -82.04 154.97 25.36 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.984 -0.553 . . . . 74.21 111.205 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.585 ' HA ' HD12 ' A' ' 147' ' ' LEU . 9.0 p -57.23 -36.73 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.898 0.38 . . . . 61.5 111.733 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.6 -27.62 68.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.222 0.534 . . . . 52.01 111.208 174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -94.32 0.14 55.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.243 0.461 . . . . 64.11 112.243 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.645 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.2 mt -78.73 142.1 37.33 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.101 0.477 . . . . 75.12 112.211 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.88 -56.61 0.29 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.989 -0.55 . . . . 54.04 113.129 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.496 ' HB3' HD11 ' A' ' 104' ' ' ILE . 38.7 p90 -139.33 159.3 42.48 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.323 -0.516 . . . . 71.51 112.103 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 67.4 t -134.19 96.4 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.9 -0.591 . . . . 65.32 110.415 175.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 20.4 ttm180 -93.39 112.77 24.77 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.123 -0.361 . . . . 72.51 111.969 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.63 HG21 ' SD ' ' A' ' 66' ' ' MET . 37.0 mm -89.71 138.11 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 122.205 -0.31 . . . . 74.15 111.296 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -163.58 -177.22 5.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.871 0.323 . . . . 62.23 111.871 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 65.2 20.64 11.98 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.924 0.712 . . . . 74.0 112.924 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.609 HD13 ' HA3' ' A' ' 97' ' ' GLY . 47.4 mm -69.9 103.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.393 0.616 . . . . 53.13 111.927 -177.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -136.38 153.95 76.66 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.831 -0.622 . . . . 75.42 111.149 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.79 153.81 70.16 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.635 2.224 . . . . 64.24 113.329 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.79 -171.56 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.979 0.418 . . . . 50.42 111.878 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.498 ' N ' ' SD ' ' A' ' 159' ' ' MET . 3.3 mpp? -73.21 83.15 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.081 0.467 . . . . 73.13 111.455 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -94.79 129.96 41.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 74.25 110.203 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 161' ' ' LEU . 7.0 mp -75.93 106.9 7.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.941 0.4 . . . . 61.41 111.931 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.49 -173.43 2.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.402 -0.363 . . . . 54.04 110.807 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -125.31 121.44 34.0 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.033 0.444 . . . . 44.22 110.941 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -83.64 157.32 22.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.584 0.587 . . . . 74.43 112.584 -170.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -161.08 140.14 10.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.205 -0.452 . . . . 73.33 111.652 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -103.02 161.84 13.43 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.833 0.349 . . . . 75.33 110.604 171.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -137.62 13.17 2.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.869 0.322 . . . . 74.05 111.869 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 122.834 0.454 . . . . 73.13 111.985 -176.338 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.714 0.292 . . . . 71.2 111.503 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.24 147.41 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.652 0.263 . . . . 74.22 110.786 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.58 161.15 26.82 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.159 0.504 . . . . 72.21 112.122 -174.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.91 134.13 35.67 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.076 -0.511 . . . . 70.44 110.712 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 p -96.68 97.95 9.77 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.356 0.598 . . . . 74.3 111.56 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.57 104.74 17.19 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.209 -0.451 . . . . 72.1 111.103 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.16 176.24 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.384 0.611 . . . . 44.42 112.57 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -119.02 149.88 40.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.902 -0.59 . . . . 73.31 110.936 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -142.12 134.39 27.75 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.808 0.337 . . . . 71.21 111.682 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 62.1 mtt -110.42 -172.85 2.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.817 0.341 . . . . 65.2 111.299 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -99.5 167.61 10.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.22 0.533 . . . . 65.21 111.967 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -139.15 157.62 45.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.224 -0.444 . . . . 72.42 111.229 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.8 p -130.87 140.95 50.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.796 0.331 . . . . 63.42 111.376 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.77 139.81 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 54.24 111.327 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.7 m -132.41 141.56 48.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.324 -0.398 . . . . 65.33 110.903 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -97.35 101.34 12.86 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 75.53 111.192 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.62 111.09 22.7 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.925 0.393 . . . . 71.41 111.042 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.74 113.72 8.1 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.332 0.587 . . . . 72.42 111.304 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -140.94 171.92 13.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.753 -0.658 . . . . 51.25 111.308 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.08 142.14 39.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.102 0.477 . . . . 74.21 110.992 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.2 ttp -125.21 155.65 39.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 72.41 110.464 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -58.89 140.23 55.6 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.252 -0.277 . . . . 73.13 110.252 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -53.68 111.48 0.74 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.28 0.562 . . . . 72.1 111.725 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -60.22 146.16 44.64 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.408 -0.814 . . . . 75.44 112.163 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 29' ' ' VAL . 36.4 m-80 -47.17 125.02 7.21 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.192 -0.458 . . . . 52.51 111.338 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -53.89 -33.63 57.07 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.049 0.452 . . . . 74.32 111.137 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.62 -53.11 62.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.953 -0.567 . . . . 73.43 111.005 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -64.68 -29.94 70.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.266 -0.424 . . . . 72.52 111.331 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 25' ' ' ASN . 99.0 t -64.05 -46.73 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.533 -0.303 . . . . 62.15 110.619 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 71.9 mmtt -63.02 -38.81 92.69 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.408 -0.36 . . . . 73.44 111.504 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.19 -48.94 81.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.329 0.585 . . . . 64.22 110.742 173.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.3 m -62.79 -39.47 94.34 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.932 -0.577 . . . . 74.15 110.991 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.484 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 62.8 tt0 -63.29 -45.08 93.05 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.139 -0.482 . . . . 73.04 110.919 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 30.3 tt0 -58.63 -50.84 72.35 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.849 0.315 . . . . 72.43 111.849 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -58.8 -43.51 90.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.86 0.362 . . . . 70.01 111.798 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -68.87 -43.49 75.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.623 0.249 . . . . 70.11 111.571 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 33' ' ' GLN . 56.3 mt -65.84 -32.84 74.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.984 0.421 . . . . 72.32 110.657 175.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.437 ' ND2' HG12 ' A' ' 45' ' ' VAL . 3.3 t-20 -61.65 -30.64 70.85 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.148 -0.478 . . . . 72.13 110.556 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.29 -36.25 61.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.756 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.88 -32.81 63.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.337 0.495 . . . . 54.4 112.337 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -55.5 105.68 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.888 0.699 . . . . 73.5 112.888 -173.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -79.6 -22.72 43.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.176 -0.466 . . . . 63.12 111.18 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.544 ' HB3' HH21 ' A' ' 151' ' ' ARG . 30.5 t -124.98 99.15 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.124 -0.489 . . . . 73.34 111.13 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 79.59 -143.38 25.68 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.973 -0.558 . . . . 75.44 113.916 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 28.3 m -140.52 144.96 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.993 0.425 . . . . 75.3 111.873 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 73.5 m-85 -89.89 99.1 12.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.529 -0.305 . . . . 72.0 111.172 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.4 110.08 20.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.885 0.374 . . . . 70.2 110.628 173.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.01 115.79 63.83 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 122.278 -0.264 . . . . 75.51 110.965 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 30.5 Cg_endo -64.24 -7.1 12.95 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.523 2.149 . . . . 72.34 113.281 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 -2.31 55.72 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.455 -0.403 . . . . 65.34 112.666 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.72 115.72 30.72 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 122.683 -0.304 . . . . 72.14 111.09 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -79.21 61.54 3.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.316 0.579 . . . . 64.4 110.659 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -155.45 151.56 22.72 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 115.798 -0.637 . . . . 73.2 111.662 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 63.6 Cg_endo -85.85 -178.61 2.98 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.128 2.552 . . . . 72.02 113.858 178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.05 138.98 18.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.873 -0.603 . . . . 63.14 110.959 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -89.14 131.74 35.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.242 0.544 . . . . 75.24 112.459 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.7 135.81 40.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.779 -0.646 . . . . 74.43 110.738 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 49.0 tt0 -93.18 128.55 39.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.947 -0.471 . . . . 63.33 111.262 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.8 p -97.13 179.81 4.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.356 -0.384 . . . . 64.11 110.58 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.718 HE21 ' HB3' ' A' ' 156' ' ' GLN . 38.2 mt-30 -83.24 -1.79 53.98 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.144 -0.348 . . . . 62.33 111.778 178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.466 HG23 ' HD3' ' A' ' 157' ' ' PRO . 38.1 pt -103.94 -32.44 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.713 0.292 . . . . 74.24 110.979 171.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.23 172.9 39.17 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.52 -0.371 . . . . 51.43 112.946 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 95.6 m -78.6 138.26 38.26 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.318 -0.519 . . . . 74.45 111.402 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.91 171.73 13.66 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.187 0.518 . . . . 63.01 111.775 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.91 120.73 25.34 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.296 -0.411 . . . . 74.45 110.919 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 152' ' ' ILE . 62.3 mtt -105.42 152.36 23.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.967 0.413 . . . . 35.5 112.094 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 84.5 p -149.29 143.29 25.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.364 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 82' ' ' LEU . 91.6 mt -96.78 100.45 11.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.934 0.397 . . . . 71.3 111.285 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.448 HG23 HD22 ' A' ' 70' ' ' ASN . 27.5 m -120.41 152.75 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.667 0.27 . . . . 74.04 111.013 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 19.2 m-80 57.13 76.47 0.31 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.0 0.429 . . . . 74.21 111.166 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mt -109.36 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.513 -0.312 . . . . 72.21 111.402 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 p -129.89 152.54 80.08 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 73.11 111.714 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 165.57 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.833 2.355 . . . . 64.43 113.804 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.634 ' HB2' HG23 ' A' ' 79' ' ' THR . 33.3 t70 -139.66 170.35 16.05 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.862 -0.608 . . . . 73.23 110.673 -178.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.84 -44.63 91.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.883 0.327 . . . . 62.02 111.883 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -91.03 -31.92 16.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.183 0.438 . . . . 74.33 112.183 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.51 0.15 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.586 -0.816 . . . . 64.24 113.901 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -144.9 135.82 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.061 0.457 . . . . 75.24 111.903 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.634 HG23 ' HB2' ' A' ' 74' ' ' ASP . 46.3 p -110.24 132.88 53.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.344 -0.389 . . . . 73.2 111.167 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 2.8 pp -142.41 160.06 41.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.003 0.43 . . . . 73.2 112.052 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 m -97.96 113.44 25.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.045 0.45 . . . . 65.12 111.469 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 68' ' ' LEU . 3.0 tm? -92.78 109.53 20.96 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.137 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 90.2 mtt180 -99.04 121.85 41.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.461 0.541 . . . . 74.24 112.461 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.6 mp -104.97 117.4 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.709 -0.678 . . . . 74.24 111.387 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -112.04 117.51 32.87 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.693 0.282 . . . . 74.15 110.415 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.14 142.64 29.71 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.254 -0.498 . . . . 54.31 113.707 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.91 -44.63 84.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.289 0.566 . . . . 74.34 109.909 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -67.88 124.26 22.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.892 -0.595 . . . . 41.45 110.858 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.421 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 21.5 m-80 -68.89 -15.8 63.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.4 . . . . 72.3 111.475 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.18 154.55 63.55 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 116.183 -0.462 . . . . 72.42 111.872 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 41.3 Cg_endo -65.4 130.85 26.32 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 123.022 2.481 . . . . 74.34 114.233 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.4 mt -103.43 151.61 38.66 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.046 -0.525 . . . . 73.54 111.357 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 174.93 11.94 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.514 2.143 . . . . 74.23 113.226 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.57 134.34 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.069 0.461 . . . . 23.54 112.029 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -132.32 155.48 48.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.409 0.623 . . . . 70.5 111.993 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -147.15 170.64 16.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.81 -0.632 . . . . 75.44 110.603 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -176.91 -175.17 44.0 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.252 -0.975 . . . . 44.54 113.69 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.9 m -103.05 139.09 39.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.956 0.408 . . . . 61.2 111.087 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.58 129.8 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.215 0.531 . . . . 75.25 111.787 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.801 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 5.2 mm-40 -90.87 139.43 30.75 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.882 -0.599 . . . . 74.03 109.692 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.479 ' CG ' HD22 ' A' ' 139' ' ' LEU . 28.5 p90 -146.04 122.96 11.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 71.25 111.695 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.79 -146.9 5.11 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.574 -0.739 . . . . 52.2 112.894 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.597 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 89.8 mt-30 -123.74 151.01 43.69 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.134 0.492 . . . . 60.44 111.981 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.2 133.69 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.106 -0.497 . . . . 75.41 111.252 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 4.0 pt20 -121.7 98.87 6.16 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.525 0.679 . . . . 75.21 110.982 171.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 151.21 -162.82 29.63 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.123 -0.56 . . . . 43.23 113.675 176.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.6 p -108.0 -169.86 1.59 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.068 0.547 . . . . 74.42 111.657 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.67 -47.04 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.1 0.476 . . . . 75.04 111.518 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -71.46 -48.07 51.63 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.195 0.443 . . . . 60.22 112.195 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.53 110.9 12.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.567 0.699 . . . . 62.22 112.627 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -140.48 154.5 46.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.735 -0.666 . . . . 73.23 111.157 177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -122.86 134.37 54.39 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.135 0.493 . . . . 74.33 111.806 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -87.43 104.78 16.77 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.839 -0.619 . . . . 72.44 111.095 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.0 pt -113.93 162.67 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 122.18 0.192 . . . . 71.14 111.205 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 54.01 30.27 11.53 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.905 0.383 . . . . 62.55 111.973 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.84 124.34 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.313 0.578 . . . . 71.53 112.308 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -113.55 163.12 15.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.105 -0.498 . . . . 64.03 110.728 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -111.72 140.11 46.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.848 0.356 . . . . 64.42 111.601 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.426 HE22 ' HA ' ' A' ' 139' ' ' LEU . 8.7 tt0 -140.33 160.3 40.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.888 0.375 . . . . 61.24 111.272 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.83 136.75 41.14 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.026 -0.421 . . . . 75.41 111.712 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.27 141.05 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.578 -0.283 . . . . 74.1 110.886 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.28 115.94 17.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.806 0.336 . . . . 62.54 111.163 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 135' ' ' ILE . . . -110.49 137.2 20.63 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.019 0.377 . . . . 64.2 112.019 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.85 165.24 31.75 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.585 2.19 . . . . 42.14 113.255 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.82 24.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.843 0.683 . . . . 72.22 112.843 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 m -93.61 112.04 23.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.086 -0.507 . . . . 72.02 110.53 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.33 -48.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.072 0.463 . . . . 73.2 111.23 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.01 151.52 25.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 73.13 110.852 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.47 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -77.31 149.35 78.87 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.391 -0.368 . . . . 54.11 111.565 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.27 179.33 25.87 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.956 -1.268 . . . . 73.44 113.158 -0.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.4 ' OG ' ' HA ' ' A' ' 91' ' ' PRO . 49.2 m -87.59 86.75 7.24 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.465 -0.334 . . . . 74.35 111.655 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 22.2 p-10 -130.54 114.78 15.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.708 0.766 . . . . 73.54 111.567 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 134' ' ' ASP . 21.9 t -126.44 162.62 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.88 -0.6 . . . . 73.51 110.458 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 2.8 p-10 -142.53 137.24 30.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.03 0.443 . . . . 72.54 111.101 172.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 123' ' ' ALA . 20.4 pt -131.06 131.98 23.53 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 120.801 0.334 . . . . 73.02 111.722 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.64 110.28 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.129 1.886 . . . . 73.42 112.56 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tt -92.57 127.47 38.07 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.47 -0.786 . . . . 75.42 110.387 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -103.72 101.11 10.94 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.983 0.42 . . . . 75.11 111.546 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.479 HD22 ' CG ' ' A' ' 101' ' ' TYR . 68.1 mt -85.97 128.1 34.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.085 -0.339 . . . . 72.55 110.085 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -119.22 141.22 49.09 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.104 0.478 . . . . 74.4 112.059 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.16 19.31 50.89 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 116.183 -0.462 . . . . 72.43 113.394 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.574 HD13 HD23 ' A' ' 147' ' ' LEU . 21.2 tt -155.71 134.07 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.08 0.467 . . . . 75.21 112.06 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m -78.75 154.18 30.2 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.296 -0.411 . . . . 73.31 111.93 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.41 -46.07 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.574 0.583 . . . . 64.22 112.574 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.57 -17.28 60.1 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.198 0.523 . . . . 75.12 110.927 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.507 ' HB3' HE21 ' A' ' 103' ' ' GLN . 87.3 mm-40 -93.31 7.37 44.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.368 -0.378 . . . . 61.43 111.642 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.59 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 29.6 mt -75.95 111.53 11.42 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.207 0.527 . . . . 73.43 111.357 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -86.45 -47.74 4.78 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.225 -0.512 . . . . 71.44 112.946 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.95 151.43 25.42 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.131 0.491 . . . . 72.13 112.223 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.35 97.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.808 -0.633 . . . . 54.33 109.738 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 ttt180 -94.87 99.41 11.46 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.309 0.485 . . . . 63.03 112.309 -172.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.556 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 11.9 mm -79.78 139.97 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 64.44 111.014 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -162.17 166.58 25.41 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.824 0.676 . . . . 64.04 112.824 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.84 37.11 15.65 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.962 0.727 . . . . 73.55 112.962 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.7 mm -73.11 113.5 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.405 0.621 . . . . 74.34 111.283 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.718 ' HB3' HE21 ' A' ' 60' ' ' GLN . 10.6 pt20 -138.69 164.0 42.82 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.506 -0.77 . . . . 73.54 111.172 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.466 ' HD3' HG23 ' A' ' 61' ' ' ILE . 29.8 Cg_endo -63.03 146.18 94.54 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.01 1.807 . . . . 73.25 112.652 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.13 19.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 112.494 0.553 . . . . 55.12 112.494 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 21.6 ptp -145.97 -167.8 2.82 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.257 0.551 . . . . 75.31 112.287 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.582 ' HG3' ' HG ' ' A' ' 161' ' ' LEU . 10.6 pt20 -71.1 -169.97 0.42 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.532 -0.758 . . . . 74.12 111.731 174.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.582 ' HG ' ' HG3' ' A' ' 160' ' ' GLN . 81.0 mt 63.14 28.82 16.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.211 -0.449 . . . . 72.42 112.122 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.35 147.37 53.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.089 0.471 . . . . 65.54 111.62 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -161.63 114.03 1.81 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.992 -0.549 . . . . 65.44 110.711 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -72.88 148.35 44.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.99 -0.55 . . . . 75.42 112.051 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -90.05 -79.51 0.34 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.436 0.532 . . . . 64.21 112.436 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -128.68 -171.98 2.6 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.467 0.543 . . . . 65.44 112.467 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 71.0 70.84 0.18 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.36 0.664 . . . . 73.11 109.834 -169.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 . . . . . 0 C--O 1.255 1.371 0 CA-C-N 115.795 -0.639 . . . . 70.24 111.605 -178.618 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 tpp . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.973 0.416 . . . . 73.45 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 125.65 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.029 0.443 . . . . 72.21 110.896 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.63 137.58 51.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.075 0.464 . . . . 61.14 111.567 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.32 176.14 9.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.136 -0.484 . . . . 61.13 111.207 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 t -171.33 120.92 0.51 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.923 0.392 . . . . 71.25 111.953 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -127.68 -176.21 3.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.123 0.487 . . . . 63.43 111.63 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.52 166.49 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.351 0.596 . . . . 65.24 112.408 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -107.47 121.97 45.68 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.829 -0.623 . . . . 72.11 110.517 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -82.25 165.1 20.71 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.734 0.642 . . . . 64.25 112.734 -174.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.29 -178.83 4.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.852 -0.613 . . . . 64.52 111.303 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -140.17 153.83 46.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.39 0.515 . . . . 61.24 112.39 -176.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -125.53 143.51 50.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.121 -0.491 . . . . 72.24 110.55 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -72.0 -176.18 1.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.156 0.503 . . . . 60.13 112.202 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.2 p -118.13 146.13 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.977 0.418 . . . . 61.3 111.658 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 99.0 p -84.86 127.47 34.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.902 0.382 . . . . 72.23 111.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -95.64 118.32 32.11 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.537 -0.302 . . . . 73.44 111.773 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.87 153.09 43.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.864 0.364 . . . . 71.05 111.393 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.45 118.85 25.23 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.263 0.554 . . . . 72.51 112.447 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -110.04 168.67 9.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.037 -0.529 . . . . 73.04 111.082 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -53.42 107.2 0.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.2 0.524 . . . . 74.15 111.965 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.5 ptp -79.9 169.71 17.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.309 0.576 . . . . 64.35 112.265 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -95.91 -162.37 0.95 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.92 -0.582 . . . . 65.54 111.765 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -70.01 -164.98 0.08 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.244 0.545 . . . . 74.3 112.328 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.5 tp -58.43 137.53 57.24 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.209 -0.451 . . . . 72.54 111.431 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.2 m-80 -111.67 154.9 24.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.612 -0.267 . . . . 73.15 111.122 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -54.01 -38.61 65.29 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.327 0.491 . . . . 54.14 112.327 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.54 -52.8 60.91 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.16 0.505 . . . . 65.01 110.93 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 31' ' ' ILE . 25.2 m -69.05 -28.69 66.77 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 72.33 111.548 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 25' ' ' ASN . 97.7 t -61.21 -44.32 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.061 0.457 . . . . 71.14 110.674 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HE3' HD23 ' A' ' 48' ' ' LEU . 48.1 tptt -63.4 -41.72 98.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.135 -0.484 . . . . 75.11 110.391 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 28' ' ' THR . 87.3 mt -56.55 -49.0 79.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.028 -0.533 . . . . 73.42 110.869 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 60.7 m -58.71 -42.53 88.88 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.057 -0.52 . . . . 53.23 110.944 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.776 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -57.28 -46.22 83.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.886 0.374 . . . . 64.11 110.913 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.6 tt0 -58.47 -50.02 75.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.26 0.552 . . . . 74.24 111.379 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.57 -27.33 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.852 -0.613 . . . . 73.25 112.037 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 32' ' ' THR . 99.2 mtt180 -74.31 -41.29 61.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.03 -0.419 . . . . 73.24 111.146 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.644 HD12 HD11 ' A' ' 48' ' ' LEU . 85.3 mt -65.57 -35.36 80.6 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.404 0.621 . . . . 70.32 110.469 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.518 ' ND2' HG12 ' A' ' 45' ' ' VAL . 26.2 t-20 -59.3 -37.35 77.51 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.604 -0.725 . . . . 74.13 110.809 172.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.2 96.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.933 0.396 . . . . 65.42 111.84 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -72.32 -22.18 61.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.14 0.422 . . . . 53.22 112.14 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 t -92.94 139.09 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.99 0.424 . . . . 70.14 111.626 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.8 m -75.02 -83.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.669 0.618 . . . . 43.42 112.669 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.0 m -97.54 -36.18 10.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.113 0.412 . . . . 64.44 112.113 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.0 177.49 53.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.113 -0.565 . . . . 70.45 112.802 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.518 HG12 ' ND2' ' A' ' 38' ' ' ASN . 27.6 m -135.83 152.19 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.535 0.683 . . . . 53.12 112.692 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.3 m-85 -98.42 102.53 14.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.667 -0.697 . . . . 74.41 110.255 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.2 mt -86.41 113.48 22.4 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.116 0.484 . . . . 74.24 111.115 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 37' ' ' LEU . 8.8 mp -89.46 114.85 62.04 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.222 -0.444 . . . . 74.23 111.145 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.679 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 36.9 Cg_endo -64.48 11.47 0.11 Allowed 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.224 2.616 . . . . 73.34 114.378 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.84 -10.58 26.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.205 -0.522 . . . . 62.45 112.683 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.66 127.74 53.93 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 70.02 111.546 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -79.23 17.46 0.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.813 0.34 . . . . 73.42 111.763 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 p -99.95 147.06 32.94 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 112.988 0.736 . . . . 73.11 112.988 -174.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.66 165.0 10.59 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.143 2.562 . . . . 74.23 113.25 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.6 133.94 29.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.487 -0.324 . . . . 21.54 110.984 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -97.02 122.82 40.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.381 . . . . 72.42 111.057 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 45' ' ' VAL . 3.4 pp -120.69 159.57 25.09 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.932 0.396 . . . . 61.2 111.047 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.88 106.54 18.87 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.047 0.451 . . . . 60.11 110.823 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.1 p -99.69 178.47 4.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.094 -0.503 . . . . 72.01 111.046 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 50.2 mt-30 -76.89 0.58 20.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.373 -0.376 . . . . 73.0 111.94 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.02 -13.91 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.926 0.393 . . . . 73.41 111.16 171.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.75 -158.89 23.49 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.473 -0.394 . . . . 72.51 113.005 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 p -76.09 129.65 37.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.372 -0.487 . . . . 65.14 112.177 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 155' ' ' ILE . 3.1 pp -140.77 138.5 34.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.586 0.708 . . . . 74.42 110.889 170.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 85' ' ' GLN . 1.6 ttp180 -98.87 115.33 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.192 -0.913 . . . . 75.4 110.951 -175.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.618 ' SD ' HG21 ' A' ' 152' ' ' ILE . 58.6 mtt -110.17 154.54 23.2 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.928 0.394 . . . . 72.33 111.608 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.1 t -159.58 155.84 26.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.415 -0.357 . . . . 75.23 111.096 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.578 HD22 HD13 ' A' ' 80' ' ' LEU . 89.0 mt -107.35 105.8 15.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.883 0.373 . . . . 74.23 111.387 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 81' ' ' THR . 31.8 m -115.97 162.76 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.573 -0.285 . . . . 62.22 111.312 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 60.62 34.14 20.22 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.121 0.486 . . . . 72.04 111.911 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.84 108.29 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.099 0.476 . . . . 71.54 111.855 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -134.47 150.62 74.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.129 0.418 . . . . 64.2 112.129 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.36 146.83 81.8 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.86 2.373 . . . . 64.13 113.231 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.625 ' HB2' HG23 ' A' ' 79' ' ' THR . 25.5 t70 -115.38 170.47 8.38 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.144 -0.48 . . . . 72.51 110.92 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.86 40.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.858 0.361 . . . . 22.03 111.478 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.66 -45.92 11.24 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.884 0.373 . . . . 64.12 111.488 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.01 -111.34 0.93 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.029 -0.605 . . . . 51.43 113.586 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -145.7 136.62 24.55 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.476 -0.426 . . . . 62.25 111.788 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.625 HG23 ' HB2' ' A' ' 74' ' ' ASP . 54.0 p -107.98 124.48 50.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.701 0.286 . . . . 62.4 111.581 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.578 HD13 HD22 ' A' ' 68' ' ' LEU . 3.2 pp -133.66 167.84 19.77 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.722 0.296 . . . . 75.41 111.298 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 69' ' ' VAL . 26.4 m -113.14 116.63 30.14 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.874 0.368 . . . . 74.14 111.729 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.437 HD11 ' SD ' ' A' ' 66' ' ' MET . 3.1 tm? -93.61 110.51 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.223 -0.444 . . . . 55.24 110.236 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -100.12 115.63 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.337 0.495 . . . . 72.3 112.337 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.499 HD12 ' H ' ' A' ' 84' ' ' ILE . 3.3 mp -95.38 147.45 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 122.853 0.461 . . . . 71.24 111.384 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 65' ' ' ARG . 64.9 tt0 -146.02 106.61 4.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.482 0.313 . . . . 72.23 110.335 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.34 27.54 0.84 Allowed Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.257 0.863 . . . . 53.2 115.257 -171.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 59.98 -68.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.7 0.8 . . . . 74.15 112.097 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 m -61.87 144.66 54.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.757 0.423 . . . . 75.43 111.83 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 43.6 m-80 -74.36 -26.57 60.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.613 -0.267 . . . . 73.32 111.654 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.96 131.62 79.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 112.162 0.43 . . . . 72.24 112.162 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 26.1 Cg_endo -60.8 115.77 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.009 2.473 . . . . 74.2 113.308 -176.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.64 151.98 42.92 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.285 -0.416 . . . . 75.43 111.537 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.66 176.38 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.998 . . . . 74.23 112.536 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -68.15 163.25 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.698 0.285 . . . . 61.34 111.382 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -158.33 148.73 20.21 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.555 0.693 . . . . 72.4 112.282 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.3 p -127.51 168.64 14.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.417 -0.811 . . . . 74.33 110.726 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.695 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -173.04 167.6 40.44 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.214 -0.994 . . . . 72.11 114.183 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -99.26 116.88 32.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.478 0.311 . . . . 74.01 111.05 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' VAL . 34.0 m -109.79 113.08 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.436 0.636 . . . . 73.24 111.364 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' ' 118' ' ' ASN . 49.2 mt-10 -97.03 110.82 23.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.94 0.4 . . . . 75.22 111.353 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -106.74 138.45 42.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.443 -0.344 . . . . 74.32 111.134 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.15 -164.59 27.11 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.839 -0.696 . . . . 73.22 113.514 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.604 ' HB2' HG13 ' A' ' 114' ' ' ILE . 52.7 mt-30 -105.79 157.42 17.47 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.909 0.385 . . . . 73.32 110.9 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.72 142.68 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.714 0.293 . . . . 45.41 111.233 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 4.1 pt20 -138.9 103.1 4.72 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.362 0.601 . . . . 73.34 110.577 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.43 -162.79 31.27 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.197 -0.525 . . . . 72.0 113.51 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 40.8 p -105.82 -178.37 3.63 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.871 0.367 . . . . 63.13 111.213 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 33' ' ' GLN . 30.2 mm -62.72 -27.78 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.174 0.511 . . . . 55.43 111.013 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -81.72 -55.95 4.31 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.991 -0.55 . . . . 73.03 110.895 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -117.8 84.39 2.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.389 0.614 . . . . 71.2 112.003 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 107' ' ' THR . 31.0 p90 -107.86 123.74 49.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.079 -0.51 . . . . 72.34 110.697 176.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 51.2 mt-30 -94.58 117.8 30.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.982 0.42 . . . . 74.31 111.525 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.67 101.87 5.94 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.008 -0.542 . . . . 75.42 110.386 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 103' ' ' GLN . 36.2 pt -112.61 150.91 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.732 0.301 . . . . 64.52 111.807 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 54.38 34.49 20.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.958 0.409 . . . . 63.11 112.069 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.4 130.13 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.23 0.538 . . . . 74.5 112.13 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.55 156.8 48.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.791 -0.64 . . . . 52.2 110.269 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 100' ' ' GLU . 8.9 p30 -103.3 153.63 20.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.46 0.911 . . . . 73.53 113.46 -171.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.407 ' NE2' HD23 ' A' ' 139' ' ' LEU . 8.4 tt0 -133.05 150.59 52.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.296 -0.865 . . . . 71.11 109.921 173.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -94.84 123.13 38.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.018 0.437 . . . . 72.32 111.954 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 137' ' ' LEU . 41.6 pt -100.53 138.9 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.973 0.416 . . . . 70.54 111.409 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.92 105.23 6.64 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.419 -0.355 . . . . 75.04 111.103 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.27 139.48 22.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.61 -0.268 . . . . 62.04 111.461 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HD2' HG11 ' A' ' 133' ' ' VAL . 38.3 Cg_exo -61.17 158.7 33.61 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.008 2.472 . . . . 64.41 113.85 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.83 130.73 41.79 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.987 -0.551 . . . . 62.11 111.703 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.1 m -91.95 101.12 13.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.87 0.366 . . . . 65.12 110.993 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 p -89.0 -21.28 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.188 0.518 . . . . 72.31 110.925 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.7 mt -101.6 165.36 11.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.181 0.515 . . . . 74.25 111.649 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.44 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -114.65 147.41 38.08 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 62.35 111.105 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 84.3 Cg_endo -83.48 169.94 54.96 Favored 'Cis proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.837 -1.318 . . . . 64.33 113.529 -1.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 m -83.56 83.07 8.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.478 0.547 . . . . 71.42 112.478 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' A' ' 130' ' ' PRO . 4.6 p-10 -136.57 118.23 14.97 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.482 0.658 . . . . 72.35 111.244 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.458 HG11 ' HD2' ' A' ' 124' ' ' PRO . 46.5 t -122.23 150.74 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.0 -0.546 . . . . 74.22 111.385 -173.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -124.4 110.2 14.26 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.359 0.6 . . . . 74.44 111.557 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.0 pt -112.62 136.35 21.54 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 112.23 0.456 . . . . 73.04 112.23 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.85 146.34 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.836 2.358 . . . . 60.43 113.416 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 121' ' ' ILE . 63.0 mt -132.14 117.17 17.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.191 -0.459 . . . . 72.5 112.101 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -96.37 94.43 7.43 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.189 0.519 . . . . 74.32 110.206 171.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.407 HD23 ' NE2' ' A' ' 119' ' ' GLN . 50.7 mt -76.7 110.05 10.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.346 0.593 . . . . 75.51 110.207 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.43 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 mtmp? -83.94 150.4 25.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.612 -0.722 . . . . 70.24 112.39 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.61 13.81 74.77 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.722 0.649 . . . . 44.12 114.722 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.5 128.43 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.03 0.915 . . . . 72.44 112.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.6 m -84.17 146.24 27.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.165 -0.47 . . . . 62.13 111.302 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.423 ' HA ' HD12 ' A' ' 147' ' ' LEU . 8.0 p -56.88 -34.77 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.524 0.564 . . . . 74.54 112.524 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.58 -32.95 70.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.161 0.505 . . . . 72.34 111.082 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HB3' HE21 ' A' ' 103' ' ' GLN . 32.0 mm-40 -97.38 5.08 50.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.317 0.488 . . . . 73.43 112.317 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.679 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 17.1 mt -69.99 96.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.266 0.555 . . . . 72.23 111.156 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.32 -41.22 11.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.863 -0.608 . . . . 73.41 113.193 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.89 157.02 23.27 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.186 0.517 . . . . 71.43 111.998 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.21 101.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.773 -0.649 . . . . 74.03 109.82 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 51.5 ttt180 -83.97 105.04 14.54 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.151 -0.477 . . . . 74.43 111.928 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.618 HG21 ' SD ' ' A' ' 66' ' ' MET . 21.8 mm -90.72 121.4 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 116.535 -0.302 . . . . 72.13 111.639 -177.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -159.24 178.24 10.19 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.322 0.49 . . . . 74.43 112.322 176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 64.77 18.54 11.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.883 0.697 . . . . 70.43 112.883 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.695 HD13 ' HA3' ' A' ' 97' ' ' GLY . 36.2 mm -63.19 113.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.021 0.439 . . . . 72.53 111.317 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.603 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 8.9 pt20 -136.2 153.83 76.87 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.007 0.523 . . . . 75.15 111.831 -173.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.87 135.05 22.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.605 2.203 . . . . 73.44 113.754 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 6.0 p -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.119 0.485 . . . . 75.24 110.942 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptp -152.54 -165.8 2.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.539 -0.3 . . . . 64.24 110.751 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -69.2 158.58 34.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.959 0.409 . . . . 71.03 111.136 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 161' ' ' LEU . 7.2 mp -67.4 108.48 2.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.778 -0.452 . . . . 63.42 109.778 173.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.02 147.69 12.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.404 0.621 . . . . 41.54 112.017 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -87.41 59.51 5.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.183 -0.462 . . . . 63.22 111.828 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.2 p80 39.85 59.08 1.98 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.67 . . . . 73.51 112.645 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -84.45 -25.46 28.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.815 -0.629 . . . . 72.42 111.917 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -56.37 102.55 0.08 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.081 0.467 . . . . 74.43 112.256 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 61.36 84.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.837 -0.619 . . . . 75.32 111.739 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.3 p80 . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.797 -0.62 . . . . 75.31 111.855 177.088 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.81 0.338 . . . . 73.12 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.62 113.78 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.7 0.286 . . . . 75.23 111.288 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -95.49 124.32 39.46 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.846 0.355 . . . . 73.44 110.44 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.14 119.04 19.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.196 0.522 . . . . 74.43 112.251 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 p -104.46 86.03 2.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.407 0.622 . . . . 64.21 110.533 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -79.13 72.81 5.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.921 -0.582 . . . . 64.1 111.836 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.35 157.79 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.934 -0.575 . . . . 74.34 111.968 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -125.75 110.51 13.82 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.909 0.337 . . . . 71.33 111.909 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -94.08 140.53 29.62 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 110.202 -0.295 . . . . 75.41 110.202 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -131.14 128.51 40.24 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 75.54 111.842 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -152.04 146.62 25.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.269 -0.423 . . . . 74.54 111.022 174.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -78.32 113.37 16.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 65.53 111.326 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 t -60.8 123.75 18.44 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.395 -0.366 . . . . 73.14 111.683 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.1 140.97 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.182 0.515 . . . . 71.43 112.315 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.5 t -109.35 132.66 53.91 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.118 -0.492 . . . . 34.33 110.425 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -134.59 155.62 50.14 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 112.561 0.578 . . . . 72.11 112.561 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.89 146.52 41.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.055 -0.52 . . . . 42.22 111.516 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 14.9 m120 -86.01 100.99 12.53 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.015 0.436 . . . . 74.34 111.497 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -82.91 23.84 0.8 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.904 0.383 . . . . 74.23 111.426 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 13.1 pt-20 -96.95 179.13 5.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.412 0.523 . . . . 75.2 112.412 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.5 mmt -109.23 -169.99 1.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.041 -0.527 . . . . 73.01 111.914 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -83.46 -163.63 0.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.662 0.615 . . . . 63.34 112.662 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -42.54 143.26 0.69 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.288 0.847 . . . . 65.54 113.288 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.6 tp -123.42 145.31 48.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.937 -0.574 . . . . 72.24 111.425 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -62.5 133.48 55.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.86 0.362 . . . . 73.32 111.683 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -47.32 -39.53 15.0 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.758 0.651 . . . . 72.44 112.758 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -51.77 -56.3 14.68 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.061 0.458 . . . . 72.35 111.444 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.4 m -68.53 -28.23 66.8 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.248 -0.433 . . . . 73.45 111.326 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.93 -48.98 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.711 0.291 . . . . 73.42 111.164 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 14.4 mptt -59.83 -47.69 84.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.923 0.392 . . . . 65.52 111.19 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.18 -49.45 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.936 0.398 . . . . 74.32 111.382 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.7 m -57.27 -43.49 83.11 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.995 0.426 . . . . 75.54 111.136 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.705 ' HG3' HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -59.06 -44.63 91.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.27 -0.423 . . . . 74.15 111.394 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.29 -44.17 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.376 . . . . 74.1 111.256 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -63.31 -36.8 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.827 0.306 . . . . 71.52 111.827 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.99 -50.13 67.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.947 0.403 . . . . 64.31 110.914 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.62 -40.01 95.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.071 0.463 . . . . 71.33 111.32 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.29 -39.22 89.62 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.196 -0.456 . . . . 61.11 110.814 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.99 74.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.302 -0.408 . . . . 33.34 111.588 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.32 0.83 57.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.039 0.447 . . . . 71.1 111.794 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 46' ' ' TYR . 25.3 t -77.63 103.43 7.57 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.965 0.412 . . . . 74.34 111.112 176.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 t -88.28 -23.05 23.58 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.961 0.41 . . . . 61.45 111.743 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.4 p -131.27 104.45 7.05 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.261 -0.427 . . . . 61.12 111.054 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.93 -162.03 35.24 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.288 -0.482 . . . . 40.51 112.89 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.9 145.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 122.478 -0.425 . . . . 74.22 111.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.543 ' HD2' ' HB2' ' A' ' 41' ' ' SER . 46.7 m-85 -97.06 120.6 37.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.847 0.356 . . . . 75.42 111.909 176.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.55 136.08 52.51 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.991 -0.549 . . . . 62.23 109.814 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 63.8 mt -107.1 130.15 23.29 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 122.17 -0.332 . . . . 74.35 111.351 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 26.4 Cg_endo -60.3 -30.11 90.36 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.528 2.152 . . . . 64.52 112.807 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.64 -12.95 80.93 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.337 -0.458 . . . . 73.12 112.985 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -120.83 76.66 1.22 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.067 0.46 . . . . 41.01 111.116 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -68.54 80.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.292 -0.413 . . . . 72.22 111.789 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 p -136.22 152.59 75.51 Favored Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 112.091 0.404 . . . . 73.34 112.091 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.02 146.61 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.099 2.533 . . . . 73.3 114.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.81 32.96 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.83 -0.623 . . . . 53.0 110.78 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -85.9 139.93 30.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.014 0.435 . . . . 63.22 111.949 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -144.3 129.78 18.97 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.989 -0.55 . . . . 64.05 111.026 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -83.23 139.82 32.89 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.325 0.583 . . . . 72.12 110.761 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.1 p -124.32 -174.89 3.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 63.11 111.369 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.3 mt-30 -90.81 11.52 22.22 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 45.12 111.353 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.4 pt -121.67 -4.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.884 0.373 . . . . 75.33 111.179 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.34 -167.83 24.84 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.288 -0.415 . . . . 71.3 112.459 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.8 m -93.95 122.12 36.11 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.19 -0.594 . . . . 73.35 111.301 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 155' ' ' ILE . 3.3 pp -123.41 -176.4 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.118 0.485 . . . . 62.25 111.919 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -151.7 104.93 3.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.208 0.528 . . . . 73.24 110.709 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.629 ' HE2' HD11 ' A' ' 82' ' ' LEU . 86.5 mtp -101.33 165.67 11.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.66 0.615 . . . . 74.14 112.66 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 t -162.77 167.03 23.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.046 0.451 . . . . 63.04 111.793 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 80' ' ' LEU . 90.5 mt -117.73 123.27 45.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.062 -0.517 . . . . 62.13 111.688 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.763 HG23 HD22 ' A' ' 70' ' ' ASN . 27.6 m -138.1 171.41 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 116.64 -0.255 . . . . 63.34 111.359 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.763 HD22 HG23 ' A' ' 69' ' ' VAL . 46.7 m-80 56.49 33.08 21.92 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.614 0.598 . . . . 63.44 112.614 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.3 mt -71.79 109.17 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.023 0.44 . . . . 52.43 111.901 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -134.79 152.7 77.98 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 116.24 -0.436 . . . . 60.12 112.026 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 136.99 34.16 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.65 2.234 . . . . 41.22 112.358 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 79' ' ' THR . 33.9 t70 -113.72 156.58 23.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.737 0.303 . . . . 75.11 111.44 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.19 -27.37 69.02 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.358 0.503 . . . . 55.24 112.358 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -101.15 -29.56 12.05 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.975 0.416 . . . . 74.35 111.412 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.44 -102.06 0.16 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.05 -0.595 . . . . 50.55 113.104 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.3 m -151.62 128.19 10.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.567 -0.373 . . . . 63.43 110.815 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' HG3' ' A' ' 138' ' ' GLN . 35.3 p -107.49 132.66 52.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.154 0.502 . . . . 71.05 111.824 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.571 HD13 HD22 ' A' ' 68' ' ' LEU . 3.5 pp -148.31 143.22 26.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.135 -0.484 . . . . 71.14 110.996 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 69' ' ' VAL . 56.0 m -81.54 116.49 21.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 41.14 111.358 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 ' HE2' ' A' ' 66' ' ' MET . 3.5 tm? -88.35 116.91 26.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.931 -0.577 . . . . 41.31 109.814 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -98.55 137.36 37.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.768 0.318 . . . . 73.12 111.336 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -117.93 90.53 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.887 0.375 . . . . 53.14 110.921 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 120.86 24.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 73.3 110.164 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.16 122.67 6.26 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.327 -0.94 . . . . 61.13 112.786 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -51.0 -39.83 56.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.467 0.651 . . . . 74.35 109.869 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 m -74.54 117.03 15.9 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.171 -0.922 . . . . 72.12 110.35 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -60.44 -31.68 70.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.016 0.436 . . . . 65.32 111.38 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.15 149.02 98.17 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.763 -0.653 . . . . 61.44 111.898 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' A' ' 131' ' ' SER . 19.2 Cg_endo -58.31 124.38 15.75 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.146 2.564 . . . . 72.03 114.172 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.8 mt -84.1 149.02 54.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.518 -0.31 . . . . 72.44 111.33 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.06 173.95 13.63 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.422 2.082 . . . . 62.4 113.098 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -72.35 141.94 48.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 52.53 111.725 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.38 161.51 41.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.169 0.509 . . . . 71.52 112.291 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 81.1 p -125.09 151.69 45.35 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.862 -0.608 . . . . 71.14 109.992 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -144.9 154.67 26.03 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.429 -0.891 . . . . 54.34 113.904 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 55.2 m -97.99 106.56 18.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.414 0.285 . . . . 55.03 110.965 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 152' ' ' ILE . 15.9 m -95.58 136.07 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.975 0.416 . . . . 70.15 111.159 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.481 ' OE1' ' HD2' ' A' ' 151' ' ' ARG . 50.6 mt-10 -115.17 114.37 25.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.25 -0.432 . . . . 73.45 111.092 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -121.47 123.63 42.51 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.975 0.417 . . . . 63.44 111.645 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 116' ' ' VAL . . . -165.24 -146.9 4.95 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.324 -0.465 . . . . 23.32 113.234 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.497 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 97.0 mt-30 -126.98 155.98 42.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.494 0.664 . . . . 72.33 112.333 -176.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.36 131.48 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.836 -0.62 . . . . 61.41 110.329 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -102.08 -2.9 28.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.268 0.84 . . . . 71.53 113.268 -175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.34 -158.99 9.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.274 -0.965 . . . . 64.12 114.619 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.5 p -99.27 -176.76 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.074 0.464 . . . . 62.24 111.831 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.705 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.4 mm -70.4 -24.92 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.188 0.518 . . . . 73.22 111.157 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.81 -43.06 14.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.346 -0.388 . . . . 72.42 111.695 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.81 115.91 8.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.24 0.543 . . . . 65.23 111.588 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.36 163.07 36.72 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.138 0.494 . . . . 63.51 111.978 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -132.82 129.34 38.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.978 -0.555 . . . . 73.41 110.35 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 2.4 mp0 -81.08 105.9 12.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.36 -0.382 . . . . 74.45 111.166 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.3 pt -111.11 160.37 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.292 0.478 . . . . 61.32 112.292 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.89 21.12 8.77 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.871 0.693 . . . . 52.15 112.871 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 7.4 p -84.07 137.92 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.79 0.663 . . . . 74.55 112.79 -175.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -117.92 161.13 20.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.728 -0.669 . . . . 73.55 110.804 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -110.68 151.62 27.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.349 -0.387 . . . . 63.11 111.282 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.15 145.07 28.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.526 -0.306 . . . . 74.32 110.403 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.72 112.07 24.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.675 0.274 . . . . 75.43 111.556 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' SER . 38.8 pt -94.56 116.94 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.089 0.471 . . . . 73.42 111.195 177.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.21 105.68 16.39 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.977 0.417 . . . . 72.14 111.067 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.9 146.69 35.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.488 -0.324 . . . . 42.01 111.847 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 169.79 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.947 2.431 . . . . 54.54 113.287 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . . . -89.1 127.76 35.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.476 -0.329 . . . . 73.33 111.798 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -86.25 135.06 33.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.091 0.472 . . . . 73.11 111.388 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.59 HG23 ' HG ' ' A' ' 128' ' ' LEU . 35.9 m -117.78 4.08 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.138 -0.483 . . . . 71.21 111.871 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.59 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.3 mt -136.59 170.36 16.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.281 0.562 . . . . 74.55 111.941 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.58 145.47 47.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.97 -0.559 . . . . 55.32 111.174 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 156.08 97.49 Favored 'Cis proline' 0 C--N 1.355 0.889 0 C-N-CA 124.164 -1.181 . . . . 55.33 113.354 0.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 31.7 t -95.35 83.74 3.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.644 0.609 . . . . 72.34 112.644 -176.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -119.93 108.68 14.63 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.289 0.566 . . . . 65.25 110.179 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.47 144.07 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.413 0.524 . . . . 73.35 112.413 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.56 121.36 41.52 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.755 0.312 . . . . 71.22 111.584 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.1 pt -132.44 125.81 19.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 120.799 0.333 . . . . 65.44 111.559 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.69 115.6 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.312 2.008 . . . . 62.23 112.876 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.81 111.01 22.37 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.973 -0.558 . . . . 63.32 109.986 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.496 ' HG3' HG22 ' A' ' 79' ' ' THR . 7.6 tt0 -101.33 101.36 12.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.103 0.477 . . . . 74.21 111.365 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.3 mt -89.06 149.13 23.36 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.394 -0.367 . . . . 64.11 111.767 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.86 150.53 41.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.961 0.41 . . . . 74.04 111.764 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.1 29.01 73.7 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.461 0.545 . . . . 61.41 114.461 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.9 tt -158.73 135.15 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 122.394 -0.474 . . . . 52.54 111.474 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.3 m -101.39 148.92 24.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.254 -0.43 . . . . 72.24 111.673 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -52.49 -51.93 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 113.317 0.858 . . . . 72.24 113.317 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.97 -17.49 62.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.157 0.503 . . . . 75.24 111.094 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -98.54 -1.65 40.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.097 -0.501 . . . . 72.03 111.739 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 1.5 tt -79.53 129.36 34.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.916 0.389 . . . . 73.03 110.486 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.66 -58.07 1.37 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.313 -0.47 . . . . 62.11 113.655 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 113' ' ' GLU . 22.6 p90 -146.39 157.52 43.78 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.106 0.479 . . . . 74.34 112.211 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.1 t -130.47 100.09 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.942 -0.572 . . . . 75.42 110.374 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.481 ' HD2' ' OE1' ' A' ' 100' ' ' GLU . 35.4 ttm180 -94.68 125.41 39.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.19 -0.319 . . . . 73.25 111.404 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 99' ' ' VAL . 19.0 mm -105.35 140.25 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 65.13 111.491 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -168.93 173.87 6.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 111.989 0.366 . . . . 73.31 111.989 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.26 40.62 17.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.62 0.6 . . . . 72.12 112.62 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 64' ' ' LEU . 42.5 mm -73.57 104.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.04 0.447 . . . . 75.42 110.221 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.546 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.0 pt20 -123.98 146.3 50.62 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 116.277 -0.419 . . . . 74.43 111.962 -171.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.71 141.4 37.59 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.415 2.077 . . . . 73.21 112.981 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.41 161.41 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 122.275 -0.265 . . . . 73.51 110.749 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 81.8 mtp 61.85 25.12 15.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.221 0.534 . . . . 62.32 111.086 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.23 149.6 42.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.227 0.537 . . . . 55.3 111.957 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.11 156.86 29.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.434 -0.348 . . . . 51.34 110.635 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.57 136.98 58.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.253 0.549 . . . . 71.44 112.345 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -139.79 86.89 2.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.275 0.56 . . . . 74.03 110.512 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -81.15 132.49 35.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.882 -0.599 . . . . 74.32 111.256 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -113.62 126.84 55.72 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.941 0.401 . . . . 63.4 111.269 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -102.57 139.97 37.47 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.325 -0.398 . . . . 74.12 111.628 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -76.15 7.93 3.74 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.49 0.552 . . . . 61.43 112.49 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 29.1 p80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.641 -0.695 . . . . 72.53 110.928 173.431 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.705 0.288 . . . . 74.44 110.602 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.21 140.51 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.267 0.556 . . . . 74.25 112.312 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -116.17 137.88 51.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 70.44 110.84 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -78.4 152.8 32.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.238 0.542 . . . . 75.33 112.137 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -139.32 143.24 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.038 -0.528 . . . . 21.42 110.257 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.45 84.89 7.49 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.261 0.553 . . . . 64.22 111.88 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -91.93 146.58 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.279 -0.419 . . . . 74.14 110.505 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -90.9 144.92 25.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.978 0.418 . . . . 74.41 111.657 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -171.43 3.45 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.094 0.473 . . . . 71.44 112.07 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -142.85 177.65 8.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.066 0.46 . . . . 61.25 111.803 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.03 177.08 11.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.166 -0.47 . . . . 62.54 110.787 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -65.51 154.41 38.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.948 0.404 . . . . 74.2 111.741 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -77.55 155.9 31.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.033 0.444 . . . . 63.53 111.594 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.01 110.48 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.363 -0.38 . . . . 64.14 110.698 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 t -71.91 93.9 1.39 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.855 0.36 . . . . 74.43 110.766 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.8 p -86.02 139.93 30.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.925 0.393 . . . . 74.11 111.893 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.44 139.05 49.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.889 0.376 . . . . 60.1 110.915 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -75.23 105.2 6.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.382 0.61 . . . . 70.33 112.495 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -105.88 87.85 2.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.245 0.545 . . . . 71.44 111.567 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.32 124.99 37.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.737 -0.665 . . . . 63.53 109.357 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -97.4 105.19 17.29 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.805 1.039 . . . . 52.53 113.805 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p 49.78 -166.97 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.535 1.309 . . . . 73.3 114.535 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -83.83 164.06 19.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.73 -0.668 . . . . 72.32 111.648 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.7 tp -139.21 163.3 32.82 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.208 -0.451 . . . . 54.41 110.728 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' O ' HG23 ' A' ' 29' ' ' VAL . 2.0 m-20 -49.17 121.73 5.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.262 0.225 . . . . 65.55 111.137 176.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -45.26 -47.69 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.84 0.682 . . . . 73.04 112.84 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.15 -55.05 35.57 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.357 0.599 . . . . 72.11 110.978 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -65.88 -21.06 66.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.948 -0.569 . . . . 73.1 111.827 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 25' ' ' ASN . 73.7 t -67.99 -47.76 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.973 0.416 . . . . 75.43 110.409 173.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HE2' HD23 ' A' ' 48' ' ' LEU . 17.3 tptm -63.29 -36.93 85.31 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.19 0.519 . . . . 74.5 109.958 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.2 mt -59.56 -50.41 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.172 -0.467 . . . . 61.54 111.292 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.3 m -54.42 -41.7 69.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.958 0.409 . . . . 70.23 111.082 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.696 ' HG3' HD11 ' A' ' 108' ' ' ILE . 62.8 tt0 -61.89 -44.43 96.81 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.441 -0.345 . . . . 72.45 110.892 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.411 ' HG3' HD13 ' A' ' 48' ' ' LEU . 28.9 tt0 -56.85 -40.89 76.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.435 -0.348 . . . . 71.33 111.459 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.6 -50.28 73.65 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.103 0.477 . . . . 62.01 111.335 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.29 -41.72 99.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.164 -0.471 . . . . 74.34 111.325 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.895 0.378 . . . . 73.3 111.005 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.56 -29.18 70.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.088 0.471 . . . . 71.42 110.693 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.13 70.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.218 -0.446 . . . . 71.21 111.245 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -95.01 12.23 29.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.362 0.505 . . . . 75.01 112.362 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 t -67.35 88.5 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.949 0.404 . . . . 73.12 111.551 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -66.99 -56.76 8.73 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.195 0.443 . . . . 71.22 112.195 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.2 p -138.23 105.06 5.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.164 0.507 . . . . 71.41 111.226 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 92.12 142.97 11.48 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.176 -0.535 . . . . 34.44 112.956 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 151' ' ' ARG . 27.2 m -86.35 148.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 112.472 0.545 . . . . 71.12 112.472 -173.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -95.25 114.26 26.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.007 -0.542 . . . . 65.14 112.031 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.02 103.72 13.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.895 0.378 . . . . 74.44 110.727 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.2 mp -82.37 121.96 78.76 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 122.306 -0.246 . . . . 71.13 111.035 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 52.9 Cg_exo -54.94 -32.57 78.95 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.918 2.412 . . . . 71.55 113.726 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.17 11.37 63.12 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.113 -0.565 . . . . 65.45 113.415 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.44 129.6 56.27 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.012 0.434 . . . . 73.52 111.794 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 85.8 tttt -84.85 32.32 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.487 0.661 . . . . 71.24 111.253 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 p -128.13 133.88 25.62 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 113.445 0.906 . . . . 73.32 113.445 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 91.5 Cg_endo -80.29 179.06 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.431 2.754 . . . . 55.41 113.066 175.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.76 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.062 0.458 . . . . 60.23 111.801 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -91.77 124.89 36.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.96 0.409 . . . . 72.22 111.015 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD13 HG13 ' A' ' 45' ' ' VAL . 42.8 tp -120.59 138.33 53.94 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.464 0.542 . . . . 75.34 112.464 -172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -82.5 117.13 22.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.945 -0.57 . . . . 72.13 110.229 172.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -118.14 173.92 6.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.935 0.398 . . . . 75.14 111.488 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 48.0 mt-30 -79.24 1.41 24.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.194 0.442 . . . . 74.45 112.194 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 157' ' ' PRO . 38.5 pt -105.37 -34.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.983 0.42 . . . . 72.53 110.693 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.46 -156.5 28.32 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.108 -0.496 . . . . 72.43 112.428 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.9 m -98.36 124.33 42.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.951 0.405 . . . . 72.33 110.994 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.99 170.75 15.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.809 0.337 . . . . 44.34 111.905 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -134.25 116.1 14.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.471 0.309 . . . . 71.54 110.526 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.747 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.1 mtt -107.4 155.32 20.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.685 0.624 . . . . 53.02 112.685 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 99.8 p -154.78 157.76 38.45 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.083 -0.508 . . . . 42.24 111.357 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.59 125.93 50.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.556 -0.293 . . . . 64.34 111.677 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.641 HG23 HD22 ' A' ' 70' ' ' ASN . 23.9 m -137.6 169.09 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 120.65 0.262 . . . . 62.5 111.416 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.641 HD22 HG23 ' A' ' 69' ' ' VAL . 40.9 m-80 55.54 26.72 9.37 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.543 0.571 . . . . 75.32 112.543 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 53.5 mt -60.67 111.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.819 0.342 . . . . 71.11 111.426 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -133.75 151.8 77.68 Favored Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.464 0.542 . . . . 72.01 112.464 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.61 118.8 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.888 2.392 . . . . 72.21 112.521 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' HB2' HG23 ' A' ' 79' ' ' THR . 28.6 t70 -100.37 164.61 11.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.398 -0.365 . . . . 73.31 111.603 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.57 92.28 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 72.12 111.828 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -85.85 -41.36 15.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.939 0.4 . . . . 74.54 111.404 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -160.21 -94.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.439 -0.886 . . . . 72.34 114.07 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.5 m -143.71 120.36 11.13 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.562 -0.375 . . . . 52.43 112.002 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 74' ' ' ASP . 8.0 p -96.83 118.71 33.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 62.31 111.127 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 3.1 pp -132.9 -172.47 2.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.38 -0.373 . . . . 64.44 111.261 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.571 ' HB ' HG23 ' A' ' 69' ' ' VAL . 31.2 m -130.12 111.1 12.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.88 0.371 . . . . 61.4 110.661 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.7 112.88 20.46 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 60.14 110.04 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 66' ' ' MET . 81.9 mtm180 -93.96 124.72 38.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.526 -0.306 . . . . 75.42 111.61 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.9 mp -110.34 97.3 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.473 -0.33 . . . . 71.34 111.05 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.22 108.09 20.22 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.582 -0.525 . . . . 71.14 109.582 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.22 140.16 29.26 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.887 -0.673 . . . . 73.5 113.261 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.83 -21.33 57.38 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.384 0.611 . . . . 72.3 110.075 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -64.83 118.46 9.03 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.27 -0.877 . . . . 64.04 111.994 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -71.88 -14.03 61.83 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.202 0.525 . . . . 42.42 110.905 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.6 p-10 -97.86 149.42 35.7 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.837 -0.62 . . . . 71.44 110.913 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 16.6 Cg_exo -65.68 137.36 49.65 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.606 2.204 . . . . 72.43 113.365 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.17 158.42 31.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.418 -0.356 . . . . 72.42 111.296 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.55 -165.14 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.205 1.937 . . . . 61.21 112.43 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.92 156.13 22.51 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.278 -0.264 . . . . 34.11 110.81 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -150.19 162.86 39.63 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.585 0.707 . . . . 74.25 112.681 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 p -157.74 154.36 28.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.216 -0.902 . . . . 72.24 110.492 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.39 -175.23 35.0 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.278 -0.963 . . . . 70.2 114.039 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 m -111.23 145.43 38.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.494 0.318 . . . . 54.02 110.852 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.0 p -124.13 128.84 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.253 0.464 . . . . 75.25 112.253 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 29.8 mm-40 -98.2 110.37 22.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.248 -0.433 . . . . 73.15 110.325 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HD2' HG21 ' A' ' 142' ' ' ILE . 12.4 p90 -121.7 118.24 28.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.287 0.565 . . . . 75.12 112.064 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.18 -153.43 6.75 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.714 -0.675 . . . . 50.24 113.01 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.536 HE21 ' HB3' ' A' ' 146' ' ' GLN . 77.3 mt-30 -119.29 145.77 45.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.089 0.471 . . . . 71.4 112.27 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -110.96 104.69 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 75.23 110.606 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.613 HE21 HD13 ' A' ' 114' ' ' ILE . 8.8 pt20 -89.36 -11.89 42.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.839 0.681 . . . . 74.32 112.839 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.11 -168.64 15.69 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.86 -0.686 . . . . 43.31 114.025 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 45.8 p -92.12 -176.66 4.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.703 0.401 . . . . 61.21 111.387 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.696 HD11 ' HG3' ' A' ' 33' ' ' GLN . 50.8 mm -74.36 -26.89 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.255 0.55 . . . . 44.54 110.622 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.9 -35.99 56.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.911 -0.586 . . . . 61.45 110.851 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.66 97.43 2.97 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.124 0.488 . . . . 75.34 111.908 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 107' ' ' THR . 36.8 p90 -122.64 151.27 41.65 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.277 0.56 . . . . 73.43 111.606 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -132.36 117.81 18.6 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.876 -0.602 . . . . 64.32 110.402 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.99 108.16 5.75 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.918 0.389 . . . . 71.01 111.091 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.613 HD13 HE21 ' A' ' 105' ' ' GLN . 34.6 pt -113.41 152.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.418 -0.356 . . . . 74.42 111.041 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 57.6 32.89 22.53 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.957 0.408 . . . . 71.02 111.297 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.96 124.72 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.375 0.607 . . . . 63.14 112.127 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -114.88 157.51 23.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.029 -0.532 . . . . 71.43 110.524 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 7.0 p30 -112.22 153.74 26.64 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.807 0.337 . . . . 72.13 111.139 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -153.39 154.05 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.691 0.282 . . . . 75.53 111.456 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -92.18 122.86 35.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.084 0.401 . . . . 73.43 112.084 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.9 pt -112.73 120.83 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.088 0.47 . . . . 73.45 111.516 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -118.03 139.73 50.77 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.259 -0.275 . . . . 72.23 111.13 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.87 149.69 73.04 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.182 0.438 . . . . 74.03 112.182 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.11 164.21 20.38 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.351 2.701 . . . . 74.03 113.988 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.35 26.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.976 -0.556 . . . . 74.44 111.979 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.2 m -83.3 55.01 2.99 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.891 0.377 . . . . 53.01 111.413 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.2 m -70.29 -2.39 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.473 0.916 . . . . 55.34 113.473 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.5 mt -131.01 124.27 30.55 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.164 -0.335 . . . . 72.05 111.226 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.36 56.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.651 -0.249 . . . . 62.25 111.379 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.14 156.84 94.29 Favored 'Cis proline' 0 C--N 1.355 0.901 0 C-N-CA 123.863 -1.307 . . . . 65.3 112.972 -0.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 p -80.43 57.25 2.78 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.129 0.49 . . . . 74.32 112.17 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.11 89.92 8.18 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.087 0.47 . . . . 75.13 110.084 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.66 154.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.268 -0.424 . . . . 74.23 111.714 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -142.89 144.79 32.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.791 0.329 . . . . 75.34 110.982 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.1 128.39 11.92 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.651 0.262 . . . . 74.12 111.705 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.71 142.06 47.15 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.286 1.991 . . . . 71.24 112.009 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.48 123.28 20.0 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.625 -0.261 . . . . 73.01 111.212 -172.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -102.1 102.91 13.44 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.121 0.486 . . . . 63.13 111.309 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 71.9 mt -83.55 128.22 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.573 -0.285 . . . . 62.33 110.267 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -103.47 142.93 33.4 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.609 0.596 . . . . 74.53 112.609 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.75 80.44 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.863 -0.608 . . . . 61.41 114.136 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.472 HG21 ' HD2' ' A' ' 101' ' ' TYR . 16.1 tt -149.51 114.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 117.485 0.643 . . . . 74.31 112.042 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 64.6 m -80.47 155.03 27.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.078 0.466 . . . . 61.41 112.214 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.05 -47.99 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 113.372 0.879 . . . . 74.43 113.372 -174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.91 -16.52 64.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.134 0.492 . . . . 72.34 111.341 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.536 ' HB3' HE21 ' A' ' 103' ' ' GLN . 29.7 mm-40 -108.66 11.56 26.43 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.68 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.543 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -88.94 108.18 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.071 0.462 . . . . 63.43 110.246 178.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.98 -55.43 3.13 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.125 -0.56 . . . . 63.33 113.661 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -145.09 152.53 40.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.973 0.416 . . . . 74.12 111.831 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.63 94.09 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.885 -0.598 . . . . 64.51 110.31 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.637 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 68.7 ttt180 -89.05 107.2 18.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.755 0.422 . . . . 62.44 111.974 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG21 ' SD ' ' A' ' 66' ' ' MET . 35.9 mm -89.12 126.44 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.468 -0.333 . . . . 74.35 111.432 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.595 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.9 p80 -154.96 177.56 11.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.156 0.428 . . . . 72.4 112.156 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 64.4 23.14 12.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.092 0.557 . . . . 72.33 112.414 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.635 HD13 ' HA3' ' A' ' 97' ' ' GLY . 51.0 mm -67.57 95.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.643 0.735 . . . . 74.13 112.073 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.455 ' HA ' ' HB2' ' A' ' 60' ' ' GLN . 9.0 pt20 -116.78 151.56 47.42 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.266 -0.879 . . . . 72.24 111.449 -178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 61' ' ' ILE . 58.2 Cg_endo -70.47 128.62 15.63 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 70.53 113.786 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.28 95.41 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.849 0.833 . . . . 71.44 110.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 57.8 mtm -106.74 -162.23 0.84 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.524 -0.762 . . . . 60.24 111.52 -174.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -103.37 -167.92 1.44 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.244 0.461 . . . . 70.32 112.244 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.41 87.29 1.16 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.12 0.785 . . . . 61.24 113.12 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.35 149.84 22.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.601 -0.518 . . . . 64.03 109.601 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -147.14 101.92 3.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.503 0.668 . . . . 71.23 112.8 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -106.92 105.86 16.1 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.701 -0.682 . . . . 73.52 110.263 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -91.72 155.12 18.51 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.344 0.592 . . . . 72.04 112.233 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -58.79 103.42 0.16 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.71 -0.677 . . . . 60.41 111.726 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -97.09 -39.15 9.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.85 0.357 . . . . 62.0 111.251 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.885 -0.579 . . . . 64.13 111.451 179.116 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.766 0.317 . . . . 72.05 111.375 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t -129.95 122.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.965 0.412 . . . . 61.44 111.228 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -137.62 122.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.332 -0.395 . . . . 62.12 110.133 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -149.75 150.22 31.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.098 0.475 . . . . 74.05 111.946 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.1 t -92.51 145.78 24.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.168 -0.469 . . . . 55.3 112.104 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.24 147.81 26.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.975 0.417 . . . . 42.54 111.386 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.6 t -108.93 125.37 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.299 -0.409 . . . . 54.42 110.6 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -137.79 134.77 35.61 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.826 0.346 . . . . 73.22 111.646 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.411 ' NE2' ' H ' ' A' ' 9' ' ' GLN . 0.5 OUTLIER -99.57 178.72 4.77 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.363 -0.381 . . . . 64.2 111.378 178.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -132.14 148.52 52.48 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.311 -0.404 . . . . 61.21 111.031 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' NZ ' ' HB2' ' A' ' 11' ' ' LYS . 5.1 ttmp? -80.0 108.66 13.76 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.885 0.374 . . . . 74.04 111.596 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -73.02 136.11 45.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.439 -0.346 . . . . 72.52 110.972 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 t -83.02 114.58 21.37 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.412 -0.358 . . . . 33.15 111.328 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -100.22 173.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.131 0.491 . . . . 51.44 112.262 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -164.1 103.41 0.87 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.117 -0.492 . . . . 70.04 111.202 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.3 p -110.27 -176.9 3.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.952 0.406 . . . . 71.42 111.755 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -145.51 174.09 11.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.437 -0.347 . . . . 64.53 111.425 -178.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -65.32 109.69 2.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.493 0.553 . . . . 44.35 112.493 -175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' HG3' HD22 ' A' ' 17' ' ' LEU . 98.1 mt-30 -132.39 179.53 6.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.121 -0.49 . . . . 75.52 110.835 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -68.84 129.17 39.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.731 0.301 . . . . 74.43 111.074 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 tpt -70.04 137.09 51.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.727 0.299 . . . . 64.1 110.457 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.3 p -87.22 -160.92 0.64 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.071 0.397 . . . . 64.53 112.071 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -51.63 161.27 0.53 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.212 0.819 . . . . 70.13 113.212 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 tp -51.56 136.46 26.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.752 -0.658 . . . . 72.4 112.456 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.48 HD22 ' N ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -94.02 146.85 23.65 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.908 -0.587 . . . . 70.34 111.905 -177.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -64.29 -31.01 72.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 72.1 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 31' ' ' ILE . 40.5 tt0 -60.38 -45.73 92.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.236 0.541 . . . . 71.13 109.91 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.731 ' HA ' HD12 ' A' ' 31' ' ' ILE . 18.6 m -62.1 -37.51 85.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.876 -0.602 . . . . 54.04 111.389 176.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 25' ' ' ASN . 76.3 t -61.07 -40.64 86.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.138 0.494 . . . . 74.51 110.753 174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.638 ' HE3' HD13 ' A' ' 48' ' ' LEU . 43.5 tptt -64.34 -37.15 86.47 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.065 -0.516 . . . . 70.1 110.35 175.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 28' ' ' THR . 91.1 mt -57.71 -44.24 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.981 -0.554 . . . . 72.13 111.19 173.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.8 m -58.68 -43.38 89.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.204 -0.453 . . . . 51.32 110.805 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.629 ' HG3' HD11 ' A' ' 108' ' ' ILE . 55.9 tt0 -57.79 -48.49 79.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.234 -0.439 . . . . 72.41 111.14 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -51.57 -53.06 42.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.183 -0.462 . . . . 63.21 111.499 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.599 0.592 . . . . 72.53 112.599 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HD2' HG21 ' A' ' 108' ' ' ILE . 20.9 mtm180 -78.6 -38.27 40.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.068 -0.395 . . . . 63.31 111.052 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.27 -46.45 83.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.127 0.489 . . . . 72.24 110.693 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 46' ' ' TYR . 3.8 m-20 -58.36 -38.66 77.69 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.973 -0.558 . . . . 63.35 111.492 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.58 -38.1 80.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.902 0.382 . . . . 75.31 111.411 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 108' ' ' ILE . 68.2 mttm -76.75 -32.86 58.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.936 0.347 . . . . 60.14 111.936 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.2 t -94.27 103.39 15.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.761 0.652 . . . . 43.15 112.761 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -96.01 27.72 3.48 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.381 0.61 . . . . 50.3 110.684 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -139.73 38.76 2.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.025 -0.534 . . . . 70.32 110.584 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.591 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 129.49 158.01 9.36 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.142 -0.481 . . . . 75.04 112.799 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG13 HD13 ' A' ' 57' ' ' LEU . 35.1 m -100.85 147.06 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.295 0.48 . . . . 74.14 112.295 -175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.454 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . 31.8 m-85 -93.31 139.5 30.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.084 0.469 . . . . 75.3 110.962 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.82 119.99 29.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.962 -0.563 . . . . 62.04 109.756 172.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.638 HD13 ' HE3' ' A' ' 30' ' ' LYS . 79.0 mt -97.46 134.24 22.81 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 111.851 0.315 . . . . 72.33 111.851 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 32.0 Cg_endo -62.79 -24.64 74.56 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.577 2.184 . . . . 71.14 112.876 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.01 18.54 55.88 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.078 -0.51 . . . . 53.0 112.825 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -144.3 106.75 4.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.954 0.407 . . . . 60.22 110.915 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -74.42 11.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.623 0.601 . . . . 71.23 112.623 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -85.7 141.99 36.64 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 112.987 0.736 . . . . 53.15 112.987 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.56 -178.03 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.151 2.568 . . . . 74.53 113.516 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.18 137.03 28.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.71 -0.677 . . . . 63.13 110.785 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -82.48 97.93 8.66 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.023 0.439 . . . . 64.21 111.268 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.416 HD13 HG13 ' A' ' 45' ' ' VAL . 61.0 tp -104.87 122.75 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.031 0.444 . . . . 75.13 111.153 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 43.3 tt0 -95.86 108.55 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.11 110.543 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.9 p -96.89 -178.18 4.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.567 0.58 . . . . 71.41 112.567 -172.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.9 mt-30 -76.32 -4.88 44.47 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.857 -0.61 . . . . 71.03 112.02 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 92' ' ' LEU . 39.5 pt -108.48 -34.03 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.794 0.33 . . . . 73.21 111.173 175.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.69 172.27 36.1 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.234 -0.508 . . . . 44.12 112.885 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 33.8 m -77.46 124.77 28.34 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.501 -0.411 . . . . 71.3 111.327 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 155' ' ' ILE . 2.4 pp -129.98 165.03 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.49 0.662 . . . . 63.23 111.909 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -129.82 100.19 5.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.659 -0.7 . . . . 74.21 110.863 -173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.695 ' SD ' HG21 ' A' ' 152' ' ' ILE . 65.3 mtt -102.73 148.93 24.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.68 0.622 . . . . 70.34 112.68 -173.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -148.42 161.03 42.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.818 0.342 . . . . 71.0 111.563 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.481 HD22 HD13 ' A' ' 80' ' ' LEU . 93.2 mt -105.44 119.32 38.8 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.797 0.332 . . . . 72.25 111.199 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.636 HG23 HD22 ' A' ' 70' ' ' ASN . 21.9 m -135.65 161.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.618 0.247 . . . . 75.15 111.655 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.636 HD22 HG23 ' A' ' 69' ' ' VAL . 31.4 m-80 60.85 34.49 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.175 0.512 . . . . 75.15 111.672 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.79 114.52 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.446 . . . . 73.52 111.742 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -138.46 150.74 67.37 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.371 . . . . 73.41 111.895 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.47 155.36 70.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.809 2.339 . . . . 64.21 113.165 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.492 ' HB2' HG23 ' A' ' 79' ' ' THR . 29.0 t70 -142.05 162.99 34.09 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.152 -0.476 . . . . 71.4 111.214 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.37 -43.39 97.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 64.4 111.863 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -81.91 -25.05 35.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.623 0.249 . . . . 55.52 111.615 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.73 -99.95 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 120.955 -0.64 . . . . 61.43 113.52 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.1 m -145.89 125.75 13.53 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.002 0.43 . . . . 73.25 111.565 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 74' ' ' ASP . 39.9 p -97.0 123.07 40.63 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.716 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD13 HD22 ' A' ' 68' ' ' LEU . 3.1 pp -138.39 165.79 25.9 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.102 0.477 . . . . 62.32 111.712 177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 69' ' ' VAL . 48.5 m -107.91 123.44 48.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.257 -0.429 . . . . 74.12 111.274 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -99.75 109.58 22.02 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.309 -0.405 . . . . 72.24 110.193 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' MET . 49.5 mtm180 -89.45 128.27 35.93 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.663 -0.244 . . . . 53.04 110.92 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 135' ' ' ILE . 3.4 mp -113.02 91.11 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.86 0.362 . . . . 71.14 110.538 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -92.75 106.49 18.45 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.84 -0.43 . . . . 71.43 109.84 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA3' ' OG ' ' A' ' 131' ' ' SER . . . -66.1 123.25 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.919 -0.658 . . . . 53.51 113.091 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.33 -25.6 66.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.513 0.673 . . . . 73.1 110.443 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -88.47 119.93 29.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.325 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.42 -22.86 63.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.949 0.404 . . . . 54.43 111.678 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -65.9 135.08 95.23 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.319 -0.4 . . . . 55.34 111.583 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.83 120.19 7.84 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.894 2.396 . . . . 72.11 113.097 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HB3' HD12 ' A' ' 61' ' ' ILE . 92.6 mt -88.67 149.61 44.37 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.551 -0.295 . . . . 74.12 111.255 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.01 176.07 10.01 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.399 2.066 . . . . 61.34 113.167 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.24 47.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.827 0.346 . . . . 52.3 111.434 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.95 159.14 42.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.535 0.684 . . . . 75.55 112.638 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.7 p -141.38 163.94 31.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.495 -0.775 . . . . 63.21 110.141 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.648 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.31 169.68 38.48 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.278 -0.963 . . . . 53.25 114.005 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 28.2 m -99.9 129.39 45.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.699 0.4 . . . . 73.32 110.727 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 24.5 m -112.53 117.01 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.103 0.477 . . . . 72.34 111.57 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 43.7 mt-10 -92.82 103.61 15.94 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.574 -0.285 . . . . 75.41 110.787 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -112.91 137.05 51.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.009 0.433 . . . . 70.41 111.61 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -170.04 -145.96 4.91 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.004 -0.544 . . . . 35.44 112.957 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.474 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.1 mt-30 -130.39 145.8 51.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.995 0.426 . . . . 72.2 111.95 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.0 mt -105.4 120.99 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.478 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.08 3.36 54.9 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.402 0.89 . . . . 73.44 113.402 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.04 -162.67 9.3 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.077 -1.059 . . . . 65.22 114.724 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -88.34 -161.96 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.031 0.532 . . . . 75.31 111.585 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.629 HD11 ' HG3' ' A' ' 33' ' ' GLN . 44.5 mm -83.72 -21.97 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.409 0.624 . . . . 54.34 110.421 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.25 -37.12 12.85 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.962 -0.563 . . . . 74.33 111.337 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.47 106.6 5.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.19 0.519 . . . . 71.14 111.377 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -154.07 153.47 31.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.158 0.504 . . . . 73.14 112.235 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -125.77 146.91 49.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.965 -0.561 . . . . 74.22 110.766 173.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.32 105.62 17.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.882 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 103' ' ' GLN . 35.6 pt -110.72 157.54 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.498 -0.319 . . . . 64.22 111.446 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 56.28 29.24 14.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.075 0.464 . . . . 72.31 111.666 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.78 131.58 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.256 0.55 . . . . 71.15 112.321 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.45 164.99 28.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.906 -0.588 . . . . 73.34 110.258 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.6 p-10 -115.01 142.09 47.11 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.956 0.724 . . . . 74.24 112.956 -173.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.42 154.91 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.666 -0.697 . . . . 65.44 110.283 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.72 122.59 42.14 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.983 0.364 . . . . 73.51 111.983 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.7 pt -102.1 143.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.503 -0.317 . . . . 75.12 111.063 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.44 119.58 19.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.972 0.415 . . . . 73.52 111.673 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.57 144.04 31.72 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 111.776 0.287 . . . . 75.34 111.776 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.28 163.3 36.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.65 2.233 . . . . 74.52 113.602 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.17 138.77 40.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.117 0.484 . . . . 75.21 112.233 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -81.55 119.1 23.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.325 -0.398 . . . . 71.33 110.772 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.626 HG23 ' HG ' ' A' ' 128' ' ' LEU . 34.9 m -93.78 -28.89 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.931 0.396 . . . . 72.35 111.228 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.626 ' HG ' HG23 ' A' ' 127' ' ' VAL . 96.0 mt -117.89 -178.5 3.51 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.987 0.423 . . . . 71.5 111.163 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -118.82 151.68 50.5 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 111.793 0.294 . . . . 62.15 111.793 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.49 -177.44 20.12 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.1 -1.209 . . . . 73.35 113.392 -2.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.476 ' OG ' ' HA3' ' A' ' 86' ' ' GLY . 53.9 p -90.2 40.62 1.01 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.101 0.477 . . . . 73.2 112.008 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -84.12 99.7 10.66 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.39 0.614 . . . . 62.13 111.423 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.36 134.11 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.215 -0.448 . . . . 65.35 111.301 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -114.78 127.09 55.54 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.241 -0.287 . . . . 64.43 111.174 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 84' ' ' ILE . 33.1 pt -131.09 146.4 61.92 Favored Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.181 0.437 . . . . 74.11 112.181 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.9 161.99 20.99 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.552 2.168 . . . . 73.13 112.496 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.93 125.37 10.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.804 0.335 . . . . 63.23 110.51 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -108.59 106.38 16.43 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.049 0.452 . . . . 65.24 111.512 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.92 135.18 33.78 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.65 -0.25 . . . . 65.35 110.772 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -109.68 149.83 29.17 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.312 0.486 . . . . 71.34 112.312 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.81 6.92 83.06 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.153 -0.476 . . . . 71.15 113.873 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 147' ' ' LEU . 17.1 tt -143.68 135.17 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.026 0.441 . . . . 75.21 111.401 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.2 m -101.71 147.52 26.35 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.61 -0.268 . . . . 54.42 111.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.61 -43.83 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.744 0.646 . . . . 55.24 112.744 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.46 -28.27 69.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.001 0.429 . . . . 70.5 111.675 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -108.11 13.13 26.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.166 -0.47 . . . . 65.11 111.664 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.633 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.4 tt -81.0 120.8 25.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 73.45 110.407 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -92.27 -59.0 1.32 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.971 -0.633 . . . . 53.22 113.333 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.51 153.52 35.98 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.4 . . . . 73.1 111.911 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 65.9 t -125.99 107.32 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.01 -0.541 . . . . 63.21 110.046 170.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 38.5 ttt180 -96.22 110.94 23.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.823 0.344 . . . . 72.24 111.683 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.695 HG21 ' SD ' ' A' ' 66' ' ' MET . 18.0 mm -90.48 124.23 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.513 -0.312 . . . . 64.32 111.331 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.591 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 1.8 p80 -159.55 -176.75 5.94 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.372 0.508 . . . . 64.01 112.372 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 98' ' ' THR . 54.4 m-20 63.15 17.87 10.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.695 0.628 . . . . 63.14 112.695 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.648 HD13 ' HA3' ' A' ' 97' ' ' GLY . 50.5 mm -61.54 103.49 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.471 0.653 . . . . 73.14 111.097 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.416 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 9.2 pt20 -136.52 158.3 73.57 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.762 -0.654 . . . . 71.21 111.451 -174.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.43 132.37 23.72 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.366 2.044 . . . . 62.34 112.665 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.56 170.11 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.895 0.379 . . . . 63.34 111.783 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 42.6 mtm 63.1 23.12 13.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.166 -0.47 . . . . 74.23 112.016 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 157.8 37.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.199 0.523 . . . . 71.14 111.696 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 161' ' ' LEU . 4.9 mp -97.67 144.04 27.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.136 -0.484 . . . . 63.42 111.155 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.17 113.42 20.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.865 0.364 . . . . 75.22 111.527 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -79.99 75.28 6.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.357 0.598 . . . . 72.23 110.277 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -61.43 133.47 55.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.631 -0.713 . . . . 72.21 112.237 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -145.26 172.4 13.19 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.194 -0.457 . . . . 54.51 111.036 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -113.93 115.42 27.65 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.365 0.876 . . . . 70.55 113.365 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 70.19 92.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.278 0.631 . . . . 74.03 112.647 169.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 119.01 -0.519 . . . . 71.21 110.93 170.877 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.453 0.168 . . . . 63.2 110.783 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t -131.24 110.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.651 0.262 . . . . 63.5 111.256 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.38 177.96 5.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.876 0.369 . . . . 73.54 111.551 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.24 162.59 36.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.955 0.407 . . . . 71.35 111.322 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.4 p -133.02 142.64 48.92 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.995 0.426 . . . . 72.45 111.284 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -90.4 -174.42 4.14 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.433 0.635 . . . . 74.41 112.304 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.21 95.65 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.585 -0.734 . . . . 63.42 110.093 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -91.33 -170.18 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.898 -0.592 . . . . 64.31 111.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.46 85.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.136 0.493 . . . . 72.33 111.95 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.6 mtp -109.22 135.45 50.3 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.221 -0.445 . . . . 63.12 110.848 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.93 102.1 1.51 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.12 0.415 . . . . 72.03 112.12 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -101.18 86.06 2.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.718 0.294 . . . . 74.43 110.673 174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.8 t 55.4 75.28 0.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.306 -0.406 . . . . 70.43 111.289 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.65 113.06 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.191 0.52 . . . . 44.14 112.369 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.4 m -145.47 108.54 4.57 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.754 -0.657 . . . . 72.51 109.557 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -144.43 174.59 10.79 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.246 0.546 . . . . 72.32 112.345 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.3 mm? -95.96 -169.22 1.89 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.919 -0.582 . . . . 72.53 111.392 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -74.8 90.37 2.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.149 0.5 . . . . 60.3 110.636 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -110.02 -166.31 1.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.226 -0.443 . . . . 50.23 111.828 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -49.8 152.17 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.186 0.439 . . . . 72.42 112.186 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.5 mtt -51.35 126.92 18.31 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.15 -0.477 . . . . 75.23 112.166 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -77.08 -175.32 3.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.13 0.491 . . . . 73.22 111.855 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -69.94 164.66 23.38 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 63.33 112.013 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -83.12 142.33 31.32 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.27 -0.423 . . . . 70.4 111.429 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.03 140.37 50.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.805 0.336 . . . . 75.43 111.354 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -60.71 -31.63 70.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.778 0.659 . . . . 55.52 112.778 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.14 -44.98 96.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.968 0.413 . . . . 74.3 110.4 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -65.36 -34.81 79.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.062 0.458 . . . . 75.24 110.785 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.86 -38.66 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.307 -0.406 . . . . 60.41 110.854 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -30.64 69.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.44 -0.346 . . . . 75.45 111.664 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.6 mt -61.44 -51.38 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.025 0.44 . . . . 75.22 110.496 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.4 m -58.92 -45.37 90.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.04 0.447 . . . . 74.01 110.832 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.655 HE21 HD11 ' A' ' 108' ' ' ILE . 63.8 tt0 -55.85 -45.58 78.4 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.794 -0.639 . . . . 70.44 111.256 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -63.17 -54.39 38.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.946 -0.57 . . . . 74.54 111.578 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.49 -35.86 74.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.351 -0.386 . . . . 73.35 112.033 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -64.89 -48.57 73.76 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.275 -0.265 . . . . 74.52 111.251 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.07 -41.64 88.48 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.251 0.548 . . . . 63.01 110.79 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.11 -43.52 82.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.661 -0.7 . . . . 72.44 111.401 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -33.69 64.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.31 0.485 . . . . 73.35 112.31 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -84.2 -7.79 59.25 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.272 0.471 . . . . 75.25 112.272 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.6 t -107.44 119.17 38.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.248 0.547 . . . . 75.4 111.946 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.6 p -83.6 -45.77 13.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.127 -0.488 . . . . 54.45 110.839 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.7 m -73.64 81.72 1.53 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.182 -0.463 . . . . 70.44 111.708 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 153' ' ' HIS . . . 89.29 -171.72 38.84 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.204 -0.453 . . . . 73.23 113.848 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 57' ' ' LEU . 35.8 m -121.02 142.81 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 44.32 111.846 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -93.69 133.44 37.04 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.934 0.397 . . . . 74.31 111.946 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.75 138.44 52.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.854 -0.612 . . . . 53.1 110.187 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 74.8 mt -112.64 137.55 21.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 112.076 0.399 . . . . 72.21 112.076 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HG2' ' HB3' ' A' ' 147' ' ' LEU . 16.0 Cg_exo -66.55 -30.81 42.61 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.724 2.283 . . . . 72.12 113.022 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.96 -8.04 67.88 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 114.314 0.486 . . . . 41.4 114.314 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.68 97.28 2.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.51 0.655 . . . . 74.52 111.901 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.87 88.88 0.11 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.847 0.832 . . . . 70.23 111.418 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -137.02 151.43 72.05 Favored Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 112.633 0.605 . . . . 73.44 112.633 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 89.2 Cg_endo -80.74 159.66 21.65 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.116 2.544 . . . . 73.25 114.06 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.19 144.8 27.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.986 -0.552 . . . . 63.33 110.632 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -83.69 119.56 24.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.943 0.401 . . . . 73.54 111.67 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.528 HD13 HG13 ' A' ' 45' ' ' VAL . 46.5 tp -113.83 119.45 37.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.335 0.588 . . . . 53.44 110.658 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.52 110.77 22.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.963 -0.562 . . . . 72.14 110.348 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.4 p -115.72 -174.32 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.505 0.669 . . . . 74.52 112.751 -170.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -72.65 -24.68 61.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.583 -0.735 . . . . 74.43 112.196 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.8 pt -91.37 -7.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.795 0.331 . . . . 72.54 111.499 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.62 -167.75 23.8 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.366 -0.445 . . . . 62.53 113.056 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 m -91.7 123.08 34.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.865 0.364 . . . . 62.44 111.069 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.45 164.2 28.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.108 0.48 . . . . 75.44 111.625 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -124.04 114.63 19.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.279 -0.419 . . . . 74.51 110.916 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 152' ' ' ILE . 63.4 mtt -98.56 143.39 29.02 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.929 0.395 . . . . 44.4 111.936 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 33.3 p -141.07 142.77 34.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.128 0.49 . . . . 71.42 111.848 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 80' ' ' LEU . 82.4 mt -97.9 122.14 40.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.16 -0.473 . . . . 73.51 111.411 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 81' ' ' THR . 23.2 m -132.68 163.06 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.647 -0.251 . . . . 74.23 110.941 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 60.28 33.55 20.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.193 0.521 . . . . 74.52 111.939 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 68' ' ' LEU . 46.5 mt -71.9 106.25 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.192 -0.458 . . . . 64.04 111.677 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 p -135.17 149.85 71.21 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 112.419 0.526 . . . . 62.45 112.419 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.47 148.87 55.12 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.84 2.36 . . . . 25.24 113.099 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.4 -175.44 3.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.359 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.96 -45.86 39.44 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.993 -0.442 . . . . 64.2 111.998 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 2.1 p30 -92.36 -24.31 18.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.395 0.517 . . . . 72.41 112.395 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 139' ' ' LEU . . . -164.97 -118.98 0.46 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.567 -0.825 . . . . 72.53 114.047 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.1 m -139.78 132.13 28.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.607 -0.349 . . . . 75.53 111.588 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.3 p -108.59 123.44 48.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.055 0.455 . . . . 71.42 111.502 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 68' ' ' LEU . 3.4 pp -139.09 151.91 47.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 73.45 111.079 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.711 ' HB ' HG23 ' A' ' 69' ' ' VAL . 27.3 m -90.35 111.05 22.13 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.301 -0.249 . . . . 61.2 110.936 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.58 108.41 19.05 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.543 -0.54 . . . . 73.25 109.543 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.432 ' HE ' ' CG ' ' A' ' 134' ' ' ASP . 23.9 mtp-105 -98.64 131.58 44.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.781 0.324 . . . . 53.01 111.627 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.2 mp -114.04 96.48 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.657 -0.247 . . . . 63.53 111.051 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.4 103.73 15.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.654 0.264 . . . . 71.4 110.623 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.87 131.77 26.0 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.72 -0.753 . . . . 53.53 112.876 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -68.56 -25.49 64.93 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.234 0.54 . . . . 72.23 110.593 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.5 m -79.11 117.26 19.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.868 -0.605 . . . . 42.31 110.223 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -80.02 41.05 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.355 0.598 . . . . 75.5 112.131 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.59 154.18 80.83 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.1 0.56 . . . . 64.44 110.215 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 129' ' ' ALA . 19.7 Cg_endo -59.14 109.0 0.47 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.492 2.128 . . . . 45.21 112.681 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.77 151.03 57.45 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.079 -0.509 . . . . 50.14 112.152 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.88 159.73 41.4 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.467 2.111 . . . . 61.23 112.841 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.55 136.76 56.79 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.983 0.421 . . . . 73.43 111.641 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -133.76 163.31 29.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.417 0.627 . . . . 74.23 112.575 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.4 p -134.73 132.94 39.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.421 -0.809 . . . . 74.53 110.564 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.783 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -133.98 166.01 24.13 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.731 -0.747 . . . . 64.15 113.195 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.4 m -108.61 124.85 51.14 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.669 -0.313 . . . . 71.1 110.917 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.5 p -106.2 118.4 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.044 0.449 . . . . 72.3 112.144 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.6 mm-40 -89.32 113.18 24.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.28 -0.418 . . . . 73.4 110.041 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -122.81 128.7 50.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.158 0.504 . . . . 63.15 111.746 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.54 4.44 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.907 -0.588 . . . . 51.01 112.636 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.645 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.3 mt-30 -128.12 156.34 43.0 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.217 0.532 . . . . 60.5 112.213 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.9 mt -116.42 120.91 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.17 -0.468 . . . . 51.44 111.211 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -93.19 -30.99 14.93 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.538 0.57 . . . . 71.21 112.538 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -93.25 -157.67 33.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.027 -0.606 . . . . 72.03 114.175 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 30.7 p -92.97 -173.69 3.36 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.933 0.397 . . . . 51.51 111.425 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.655 HD11 HE21 ' A' ' 33' ' ' GLN . 36.5 mm -82.58 -3.26 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.348 0.594 . . . . 63.01 111.213 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -109.04 -39.19 5.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.233 0.54 . . . . 73.11 110.791 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -134.9 102.37 5.21 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.864 -0.607 . . . . 52.34 111.344 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 107' ' ' THR . 34.8 p90 -141.8 148.67 39.27 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.101 0.477 . . . . 75.24 111.801 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -109.44 126.03 53.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.001 -0.545 . . . . 74.22 110.703 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.8 105.28 4.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.27 -0.423 . . . . 75.01 110.91 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 pt -110.12 152.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 111.759 0.281 . . . . 43.44 111.759 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 57.68 29.6 17.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.967 0.413 . . . . 72.21 111.842 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -95.1 115.55 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 112.883 0.697 . . . . 73.21 112.883 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.58 ' H ' ' NE2' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -117.73 170.98 8.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.985 -0.552 . . . . 64.32 110.154 170.309 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 22.9 p30 -123.87 162.62 22.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.341 0.867 . . . . 74.23 113.341 -171.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -144.18 152.24 40.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.313 -0.858 . . . . 74.35 110.366 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.52 117.16 28.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.892 0.377 . . . . 44.11 111.301 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 121' ' ' ILE . 30.0 pt -102.86 103.13 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.523 0.678 . . . . 51.4 111.368 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -106.05 114.87 29.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.115 -0.493 . . . . 70.42 111.348 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.464 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -95.05 139.37 22.05 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.543 -0.299 . . . . 71.3 111.287 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 32.5 Cg_exo -62.07 170.65 5.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.879 2.386 . . . . 75.14 113.397 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.6 120.56 10.83 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.052 0.453 . . . . 41.53 111.556 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.7 m -77.54 69.01 3.74 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.222 0.534 . . . . 62.4 111.281 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.55 -19.39 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.073 0.463 . . . . 53.01 111.734 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.7 mt -85.86 136.89 33.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.345 -0.389 . . . . 63.2 111.675 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.482 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . . . -122.18 127.7 25.8 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.31 -0.405 . . . . 24.05 111.199 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.72 154.53 97.7 Favored 'Cis proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.074 -1.219 . . . . 74.51 113.331 1.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.9 m -87.91 92.64 9.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.002 0.742 . . . . 54.31 113.002 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 8.3 p-10 -117.96 100.54 7.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.401 0.62 . . . . 62.4 110.158 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' ARG . 32.2 t -87.12 144.12 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.012 0.745 . . . . 72.32 113.012 -170.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.432 ' CG ' ' HE ' ' A' ' 83' ' ' ARG . 1.2 m-20 -115.11 115.48 26.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.887 -0.597 . . . . 75.24 110.622 175.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 24.8 pt -125.95 126.53 24.83 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 120.904 0.383 . . . . 63.2 111.964 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 135' ' ' ILE . 9.9 Cg_exo -71.83 111.63 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.935 2.423 . . . . 43.34 112.274 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -103.81 115.4 30.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.267 -0.424 . . . . 54.31 110.523 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -105.92 103.28 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.3 0.571 . . . . 72.33 111.347 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.509 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 81.1 mt -78.76 138.76 38.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.17 -0.468 . . . . 55.05 109.911 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -116.23 135.76 53.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.427 0.529 . . . . 73.43 112.427 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.51 40.28 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.091 -0.504 . . . . 44.33 113.094 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 147' ' ' LEU . 20.6 tt -115.19 126.86 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.202 0.525 . . . . 71.41 111.659 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.2 m -94.73 149.17 21.52 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.805 0.298 . . . . 71.1 111.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 p -50.37 -44.42 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 113.793 1.034 . . . . 73.44 113.793 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.56 -31.8 71.27 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.885 -0.509 . . . . 73.14 111.018 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -95.52 9.05 41.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.205 -0.452 . . . . 54.23 111.361 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.547 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.9 tt -85.45 115.84 23.41 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.097 0.475 . . . . 51.54 110.406 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -81.68 -59.55 2.33 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.326 -0.464 . . . . 72.5 113.203 -177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.76 149.1 31.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.086 0.47 . . . . 71.52 112.16 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.9 106.71 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.694 -0.685 . . . . 64.3 109.713 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.4 ttt180 -107.58 106.33 16.63 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.09 0.404 . . . . 75.23 112.09 -172.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.669 HG21 ' SD ' ' A' ' 66' ' ' MET . 25.6 mm -89.6 134.32 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 116.657 -0.247 . . . . 43.45 111.293 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.438 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 7.2 p80 -164.61 174.83 10.39 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.655 0.264 . . . . 73.41 111.664 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 62.72 32.75 15.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.327 0.492 . . . . 73.41 112.327 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.783 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.2 mm -66.71 99.48 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.257 -0.429 . . . . 60.41 110.804 175.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -124.51 151.58 67.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.264 -0.425 . . . . 62.51 111.196 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.7 149.55 89.47 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.801 2.334 . . . . 74.13 113.797 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.63 -155.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.841 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 19.2 ptp -46.23 103.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.66 0.615 . . . . 73.54 112.66 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -130.2 117.36 19.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 70.43 111.193 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 161' ' ' LEU . 6.4 mp -100.78 120.16 39.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.954 0.407 . . . . 62.33 110.698 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.08 163.19 31.37 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.515 -0.311 . . . . 74.13 111.221 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -52.71 115.55 1.86 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 74.3 111.437 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -73.74 122.61 22.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.373 -0.376 . . . . 65.34 111.707 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -100.67 148.71 24.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.423 -0.353 . . . . 73.4 110.868 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -73.24 171.75 12.43 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.9 0.704 . . . . 74.23 112.9 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -136.8 -42.41 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.437 -0.801 . . . . 75.42 110.054 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.862 -0.608 . . . . 71.52 111.07 175.076 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.964 0.412 . . . . 64.41 111.262 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.76 129.85 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.845 0.355 . . . . 74.02 111.583 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.37 137.66 47.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.466 -0.334 . . . . 62.43 110.752 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.55 158.93 27.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.375 0.607 . . . . 74.32 112.432 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -165.16 142.15 5.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.573 -0.74 . . . . 43.31 110.299 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.47 177.37 10.07 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.954 0.406 . . . . 55.53 111.951 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -159.23 157.33 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 116.117 -0.492 . . . . 73.01 110.611 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -161.76 129.68 4.14 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.305 -0.247 . . . . 74.12 110.801 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -128.9 167.19 17.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.467 0.651 . . . . 72.05 112.467 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.9 156.36 43.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.314 -0.857 . . . . 73.43 109.679 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -147.38 100.64 3.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.823 0.675 . . . . 71.14 112.823 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -150.08 133.32 16.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.65 -0.704 . . . . 74.44 110.277 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.5 p -96.12 105.96 18.08 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.011 0.434 . . . . 73.31 111.235 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.47 118.57 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.974 0.416 . . . . 70.13 111.495 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.3 m -115.78 18.62 15.62 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.479 -0.328 . . . . 55.22 111.377 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -61.32 143.46 55.66 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.547 0.573 . . . . 75.0 112.547 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.8 mt -93.63 135.0 35.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.166 -0.47 . . . . 74.52 112.179 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -138.17 -91.29 0.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.132 -0.485 . . . . 74.41 110.294 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -138.67 164.73 28.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.043 0.449 . . . . 64.21 110.929 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -145.81 123.56 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.313 -0.403 . . . . 74.51 110.189 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -92.53 177.76 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.289 0.566 . . . . 70.34 112.356 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -83.02 -176.29 6.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.818 -0.628 . . . . 70.32 111.875 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -105.22 168.95 8.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.2 -0.455 . . . . 71.54 111.905 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 tp -132.66 152.83 51.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.283 -0.417 . . . . 73.01 111.09 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.531 ' O ' HG23 ' A' ' 29' ' ' VAL . 25.8 t-20 -61.65 131.29 49.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.602 0.239 . . . . 74.43 111.2 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 1.6 mp0 -56.86 -44.57 82.3 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.269 0.47 . . . . 55.54 112.269 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . 39.4 tt0 -58.35 -47.31 84.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.06 0.457 . . . . 73.31 110.594 176.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.5 m -59.02 -33.63 70.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.077 -0.51 . . . . 70.33 111.329 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 25' ' ' ASN . 89.6 t -64.49 -45.31 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.602 -0.272 . . . . 74.4 111.169 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 1.3 mptm? -62.49 -44.44 96.37 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.53 0.205 . . . . 75.11 111.175 176.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 53' ' ' THR . 75.7 mt -54.26 -55.66 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.414 0.626 . . . . 75.22 110.831 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.533 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 89.5 m -56.0 -44.05 78.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.623 -0.717 . . . . 73.42 111.148 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.81 -44.5 90.84 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.591 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.6 -42.65 93.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.832 0.348 . . . . 74.23 111.167 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -60.95 -45.27 95.38 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.109 0.48 . . . . 72.42 111.199 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 32' ' ' THR . 70.9 mtp180 -65.19 -42.54 93.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.11 -0.495 . . . . 73.22 111.412 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.19 -37.63 86.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.885 0.374 . . . . 75.44 110.998 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.013 0.435 . . . . 74.23 110.686 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.77 -39.54 66.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.292 -0.413 . . . . 50.45 111.941 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' NZ ' ' HA ' ' A' ' 109' ' ' ASP . 85.5 mttt -82.84 -18.74 39.35 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.634 0.605 . . . . 73.03 112.634 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -59.12 115.61 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.867 0.365 . . . . 73.32 111.97 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -92.07 -27.68 17.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.591 -0.277 . . . . 63.24 111.55 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.409 ' HB2' HH21 ' A' ' 151' ' ' ARG . 42.3 m -117.21 86.39 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.892 0.377 . . . . 71.51 111.374 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 83.77 -132.95 11.44 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.174 -0.536 . . . . 43.41 113.359 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.66 154.09 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.171 0.51 . . . . 63.43 111.916 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.42 101.29 10.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.067 -0.515 . . . . 75.03 111.268 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.555 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 87.1 mt -85.27 133.98 34.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 73.43 110.815 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 79.7 mt -107.15 108.55 62.08 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 120.722 0.296 . . . . 65.21 111.211 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 14.1 Cg_endo -57.03 -22.92 49.41 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.014 2.476 . . . . 72.25 113.654 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.75 -26.35 71.04 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.133 -0.556 . . . . 63.42 113.238 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.416 ' HB1' HG12 ' A' ' 31' ' ' ILE . . . -124.66 112.99 17.43 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.697 -0.296 . . . . 71.3 111.584 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HD2' HG12 ' A' ' 69' ' ' VAL . 38.8 ttpt -74.62 75.71 2.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.699 0.762 . . . . 71.31 111.019 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 31' ' ' ILE . 4.4 p -133.05 145.19 55.94 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.751 -0.659 . . . . 72.21 111.732 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 145.22 33.19 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.008 2.472 . . . . 74.11 113.711 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.86 153.02 40.18 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.885 -0.598 . . . . 64.44 110.558 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 56' ' ' ARG . 35.5 ttm105 -95.78 117.8 31.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.925 0.393 . . . . 74.54 111.463 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.434 HD23 ' HE3' ' A' ' 66' ' ' MET . 45.7 tp -118.3 124.69 48.41 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.296 0.569 . . . . 75.12 112.172 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.51 102.44 14.1 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.931 -0.577 . . . . 43.01 110.584 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 p -94.46 -172.71 2.84 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.222 0.534 . . . . 74.32 111.792 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.605 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.2 mt-30 -91.99 -2.71 56.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.109 -0.496 . . . . 61.54 111.296 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -105.72 -19.04 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.001 0.429 . . . . 64.43 110.901 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.8 160.68 9.22 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.101 -0.499 . . . . 64.34 112.651 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -62.53 127.57 31.94 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.152 0.476 . . . . 73.45 110.678 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.45 165.85 26.31 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.137 0.494 . . . . 64.41 111.728 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -119.15 114.79 23.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.256 -0.429 . . . . 74.45 110.763 -176.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.669 ' SD ' HG21 ' A' ' 152' ' ' ILE . 61.7 mtt -104.01 150.9 23.83 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.987 0.422 . . . . 75.31 112.068 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.3 p -151.61 153.32 34.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.324 -0.398 . . . . 64.04 111.563 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.48 ' HB3' HD11 ' A' ' 71' ' ' ILE . 97.4 mt -103.33 112.84 25.91 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.266 -0.425 . . . . 75.31 111.352 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' A' ' 81' ' ' THR . 29.8 m -121.22 156.76 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.863 0.364 . . . . 61.31 111.646 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 59.89 37.13 21.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.123 -0.49 . . . . 70.43 111.857 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 68' ' ' LEU . 49.8 mt -69.87 101.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.903 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 73' ' ' PRO . 18.0 p -121.23 162.95 33.02 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 115.97 -0.559 . . . . 63.35 111.574 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 72' ' ' THR . 57.5 Cg_endo -69.88 166.43 27.79 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.238 1.959 . . . . 53.04 113.019 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HB2' HG23 ' A' ' 79' ' ' THR . 30.4 t70 -128.22 165.57 20.21 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.116 -0.493 . . . . 74.32 110.281 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.23 69.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.049 0.452 . . . . 75.32 111.413 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.2 -47.55 3.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.204 -0.453 . . . . 61.55 111.316 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' C ' ' HB3' ' A' ' 74' ' ' ASP . . . -136.55 -103.6 0.69 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.804 -0.712 . . . . 61.12 114.129 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 147' ' ' LEU . 96.0 m -143.56 130.96 20.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.245 0.461 . . . . 63.31 112.245 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 74' ' ' ASP . 40.0 p -104.36 114.22 28.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.679 0.392 . . . . 65.01 111.626 177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.1 pp -137.24 149.18 46.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.89 0.376 . . . . 72.33 111.72 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.661 ' HB ' HG23 ' A' ' 69' ' ' VAL . 48.6 m -93.52 113.64 25.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.047 0.451 . . . . 64.21 111.353 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.46 112.51 24.18 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.024 -0.535 . . . . 75.3 110.132 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 32.9 mtp180 -97.27 126.6 42.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.5 107.23 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.189 -0.459 . . . . 74.11 110.62 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -106.74 106.59 17.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.727 0.299 . . . . 35.05 111.051 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.48 129.75 49.28 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.095 -0.574 . . . . 74.41 113.154 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -81.76 58.92 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.428 0.632 . . . . 72.53 111.137 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -168.49 -166.43 0.68 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.1 -0.5 . . . . 73.33 110.638 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -112.01 12.57 20.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.048 0.451 . . . . 74.24 110.628 172.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.66 136.1 39.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.1 -0.5 . . . . 71.5 111.975 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.39 95.43 1.04 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.242 1.961 . . . . 74.11 111.635 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.61 139.87 81.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.251 -0.432 . . . . 63.02 111.996 -176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.03 174.56 12.62 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.584 2.19 . . . . 70.33 112.901 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.47 138.69 58.52 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.123 0.487 . . . . 44.14 111.523 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -138.45 171.36 14.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.376 0.607 . . . . 61.44 112.292 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 86.4 p -152.92 156.73 39.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.685 -0.689 . . . . 73.44 110.746 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -163.5 -178.12 36.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.909 -0.662 . . . . 71.44 113.072 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.3 m -108.31 127.3 53.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.816 0.341 . . . . 62.41 111.441 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.95 123.31 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.206 0.527 . . . . 73.23 111.416 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 39.8 mt-10 -104.96 107.69 18.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 75.34 110.601 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -112.5 129.13 56.45 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 71.34 111.897 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.97 -145.78 4.53 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.964 -0.562 . . . . 74.11 112.835 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.666 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 95.7 mt-30 -125.71 141.14 52.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.031 0.443 . . . . 64.12 112.147 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.35 122.71 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.265 -0.425 . . . . 60.43 111.349 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HG3' ' HB2' ' A' ' 112' ' ' GLN . 3.9 pt20 -111.99 99.76 8.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.474 0.654 . . . . 75.31 110.39 170.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 154.15 -169.17 32.59 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.038 -0.601 . . . . 72.34 113.852 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -100.43 -165.15 1.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.098 0.475 . . . . 63.23 111.753 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -72.19 -21.38 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.182 0.515 . . . . 73.33 111.185 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.51 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 37.6 t70 -105.89 -39.63 5.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.795 0.331 . . . . 63.42 111.874 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -121.49 91.77 3.59 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 75.52 111.483 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.61 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 40.0 p90 -127.93 143.45 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.964 0.412 . . . . 74.22 111.751 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 105' ' ' GLN . 49.6 mt-30 -118.24 133.69 55.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.367 -0.379 . . . . 73.03 111.688 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -88.14 109.7 20.1 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.317 -0.401 . . . . 60.44 110.951 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.405 HD13 ' NE2' ' A' ' 105' ' ' GLN . 39.9 pt -123.81 162.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 111.886 0.328 . . . . 65.32 111.886 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 53.42 28.95 8.1 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.514 0.561 . . . . 72.21 112.514 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 p -90.17 138.96 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.823 0.675 . . . . 55.52 112.823 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -124.66 151.8 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.493 -0.776 . . . . 74.44 110.525 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.29 132.08 54.06 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.337 0.589 . . . . 71.25 111.75 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -129.69 156.27 44.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.035 -0.53 . . . . 61.41 110.202 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.6 mt -96.83 119.92 36.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 73.31 111.145 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.725 HG22 HD21 ' A' ' 137' ' ' LEU . 15.4 pt -99.65 100.76 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.337 0.589 . . . . 65.43 111.732 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.19 131.67 50.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.006 -0.543 . . . . 75.03 110.268 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.22 148.32 65.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.394 0.516 . . . . 71.34 112.394 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.2 175.45 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.116 2.544 . . . . 73.21 113.42 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.04 144.47 29.04 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.803 0.668 . . . . 75.12 112.803 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.6 m -87.72 102.72 14.92 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.203 -0.453 . . . . 72.01 110.374 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.0 m -80.6 -14.04 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.404 0.52 . . . . 71.13 112.404 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -138.81 -179.79 6.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.906 0.384 . . . . 53.45 111.233 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.95 144.52 28.75 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.533 -0.303 . . . . 72.15 111.469 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.36 170.48 53.79 Favored 'Cis proline' 0 C--N 1.352 0.724 0 C-N-CA 123.932 -1.278 . . . . 70.31 112.825 -0.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 t -86.58 85.92 7.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 63.03 111.378 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.56 122.85 48.88 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.859 -0.422 . . . . 75.02 109.859 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -135.35 112.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 122.12 -0.362 . . . . 73.12 111.198 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -112.81 134.79 54.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.321 0.581 . . . . 74.14 111.96 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.6 pt -125.31 133.45 24.86 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.813 -0.63 . . . . 63.02 112.345 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.32 111.81 3.4 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.851 2.367 . . . . 63.54 112.439 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.725 HD21 HG22 ' A' ' 121' ' ' ILE . 23.6 mt -94.4 141.1 28.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.63 0.604 . . . . 71.31 112.63 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.05 92.79 3.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.663 -0.699 . . . . 42.14 110.21 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.4 mt -77.13 132.16 38.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.125 -0.488 . . . . 64.33 110.775 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -96.31 145.89 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.536 0.569 . . . . 64.23 112.536 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 56.98 31.48 61.47 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.064 0.786 . . . . 64.01 115.064 172.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.1 tt -152.09 127.97 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 117.602 0.701 . . . . 75.42 111.606 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 44.4 m -86.83 144.24 27.11 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.306 -0.407 . . . . 50.03 111.709 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.31 -44.24 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.631 0.604 . . . . 54.21 112.631 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.56 -21.62 66.45 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.025 0.441 . . . . 75.21 111.417 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.469 ' HB3' HE21 ' A' ' 103' ' ' GLN . 81.6 mm-40 -107.1 10.63 30.13 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.084 0.401 . . . . 71.41 112.084 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.583 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 20.9 mt -68.84 115.26 7.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.785 0.326 . . . . 74.41 111.499 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -89.73 -49.39 3.39 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.168 -0.539 . . . . 63.12 113.298 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.16 157.37 38.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.246 0.546 . . . . 70.33 112.273 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 60.8 t -124.23 98.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.709 -0.678 . . . . 73.21 110.1 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 70.2 ttt180 -90.25 101.28 14.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.305 -0.407 . . . . 73.3 111.739 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.669 HG21 ' SD ' ' A' ' 66' ' ' MET . 33.2 mm -94.22 132.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 122.273 -0.267 . . . . 53.51 111.56 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.76 172.36 13.11 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.411 0.523 . . . . 73.32 112.411 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 65.09 22.23 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.313 0.857 . . . . 74.2 113.313 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.579 HD13 ' HA3' ' A' ' 97' ' ' GLY . 49.8 mm -63.62 101.81 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.112 0.482 . . . . 54.0 111.499 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.605 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 12.1 pt20 -129.17 159.21 70.11 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.071 -0.513 . . . . 75.35 111.174 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 156' ' ' GLN . 74.0 Cg_endo -73.01 150.96 49.51 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.157 1.905 . . . . 71.04 113.134 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.46 -153.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 116.162 -0.472 . . . . 61.24 110.889 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -50.87 94.17 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.466 0.65 . . . . 63.11 111.732 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.74 153.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.022 -0.536 . . . . 74.35 111.255 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 161' ' ' LEU . 3.1 mm? -71.83 132.48 44.49 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.984 0.421 . . . . 72.51 111.847 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.78 142.65 57.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.161 0.505 . . . . 62.5 112.161 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -116.75 82.42 1.79 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.322 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -85.23 115.7 23.16 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.842 0.682 . . . . 71.35 112.842 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -115.67 140.52 49.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.044 -0.525 . . . . 73.01 110.531 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -66.21 90.61 0.15 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.862 0.69 . . . . 52.15 112.862 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -126.01 28.21 6.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.056 -0.52 . . . . 72.1 110.525 170.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.919 -0.562 . . . . 55.31 111.461 177.689 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.889 0.376 . . . . 74.02 111.149 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.05 106.06 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.333 -0.394 . . . . 64.24 110.776 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -108.75 170.43 8.04 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.734 0.302 . . . . 74.41 110.844 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.88 163.98 39.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.066 0.46 . . . . 63.45 111.979 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -140.35 133.71 29.86 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.271 -0.422 . . . . 72.43 110.987 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -136.64 159.54 41.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.705 0.288 . . . . 64.14 111.04 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.94 125.43 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.263 0.554 . . . . 72.54 111.659 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -81.34 142.31 33.17 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.218 -0.446 . . . . 73.21 111.33 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -56.73 148.78 19.42 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.237 0.541 . . . . 64.34 112.257 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 10' ' ' MET . 1.3 mpt? -65.17 171.38 3.76 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.336 0.865 . . . . 72.15 113.336 -173.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -73.11 95.38 2.05 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.379 -0.828 . . . . 72.21 111.323 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -67.79 139.04 56.6 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.189 -0.459 . . . . 63.44 111.374 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.6 p -70.24 149.16 47.75 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.972 0.415 . . . . 73.45 111.485 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.67 -178.41 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.276 0.56 . . . . 73.14 112.488 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.4 t -134.81 176.42 8.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.907 -0.588 . . . . 73.22 110.203 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 t -161.08 149.47 15.99 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.978 0.732 . . . . 74.44 112.978 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt -119.4 116.2 25.67 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.822 -0.626 . . . . 73.1 109.721 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -81.07 178.69 8.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.477 0.547 . . . . 73.12 112.477 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -85.03 -172.07 3.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.322 -0.399 . . . . 73.11 111.91 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 21' ' ' MET . 31.5 tt0 -70.43 159.73 33.67 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.919 0.39 . . . . 71.33 111.655 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.479 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 83.3 mtp -56.12 158.05 4.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.735 0.642 . . . . 74.43 112.735 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -143.35 -175.28 4.48 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.056 -0.52 . . . . 70.41 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -71.02 167.43 19.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.248 0.547 . . . . 75.13 112.392 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.3 tp -81.36 139.76 35.14 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.99 -0.55 . . . . 71.31 112.341 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -109.16 149.71 28.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.128 -0.487 . . . . 72.23 110.694 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -59.09 -34.87 72.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.078 0.466 . . . . 74.24 110.714 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 50' ' ' GLY . 25.1 tt0 -63.05 -43.22 99.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.088 -0.506 . . . . 75.23 110.861 173.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -35.07 70.22 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.13 0.49 . . . . 71.43 110.776 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.9 -44.76 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.205 -0.452 . . . . 71.3 110.893 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -61.05 -39.84 91.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.657 0.265 . . . . 71.33 110.969 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.99 -48.19 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.081 0.467 . . . . 64.45 110.967 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.5 m -57.18 -49.5 75.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.132 0.491 . . . . 73.44 110.903 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HG3' HD12 ' A' ' 108' ' ' ILE . 63.6 tt0 -59.49 -43.73 93.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.964 -0.562 . . . . 75.15 111.337 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.39 -51.97 66.33 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.748 0.419 . . . . 70.31 111.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -58.95 -44.76 91.49 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.986 0.365 . . . . 63.23 111.986 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -63.98 -49.3 73.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.61 0.226 . . . . 75.02 111.61 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 48' ' ' LEU . 73.6 mt -60.58 -41.35 94.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.322 0.582 . . . . 54.31 110.883 176.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.497 HD21 ' HB ' ' A' ' 45' ' ' VAL . 11.8 t-20 -58.37 -46.22 86.73 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.702 -0.681 . . . . 64.24 110.846 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.45 -25.6 63.26 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.046 -0.525 . . . . 74.23 111.965 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -83.37 -14.78 52.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.401 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 44.2 t -64.22 137.0 57.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.343 0.497 . . . . 73.44 112.343 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -108.93 8.89 26.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.206 -0.452 . . . . 71.05 111.047 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.7 t -160.64 117.86 2.42 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.903 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.34 -170.46 15.93 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.332 -0.461 . . . . 75.33 113.661 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 38' ' ' ASN . 31.6 m -115.87 140.5 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.318 -0.519 . . . . 73.43 112.104 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 41' ' ' SER . 40.9 m-85 -89.75 118.7 29.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.313 -0.403 . . . . 63.53 111.465 175.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.9 123.4 50.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.908 0.483 . . . . 75.42 109.937 171.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 37' ' ' LEU . 68.4 mt -101.66 121.73 50.15 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.279 0.474 . . . . 63.34 112.279 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HG3' ' HB3' ' A' ' 147' ' ' LEU . 12.0 Cg_endo -56.66 130.7 41.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.324 2.016 . . . . 73.35 111.725 173.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . 95.18 19.68 29.98 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.832 -0.622 . . . . 44.14 112.309 -172.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . . . -142.78 100.26 3.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.461 0.305 . . . . 63.24 111.584 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -75.45 76.1 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.12 -0.362 . . . . 71.23 111.634 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -149.58 137.31 11.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 112.368 0.507 . . . . 75.35 112.368 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 65' ' ' ARG . 91.7 Cg_endo -78.36 145.17 21.05 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.165 2.577 . . . . 72.54 113.639 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' ARG . . . -112.51 139.16 48.32 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.406 -0.361 . . . . 54.31 110.89 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 21.3 ttp85 -81.97 100.37 9.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.846 0.355 . . . . 73.52 111.486 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD13 HG13 ' A' ' 45' ' ' VAL . 59.7 tp -96.7 112.16 24.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.274 0.559 . . . . 74.25 111.085 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.89 92.42 9.0 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.35 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 p -100.41 -175.89 3.05 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.913 0.708 . . . . 64.12 112.913 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -69.77 -34.6 74.0 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.523 -0.762 . . . . 74.44 112.092 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.566 HG22 ' HB3' ' A' ' 157' ' ' PRO . 37.0 pt -76.91 -29.06 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.218 0.532 . . . . 53.22 111.183 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.24 -161.88 31.08 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.566 -0.743 . . . . 40.01 111.831 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 m -101.93 119.55 38.97 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.374 -0.486 . . . . 71.03 111.341 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.2 pp -131.61 152.71 50.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.982 0.42 . . . . 74.5 111.318 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 85.5 mtt180 -116.52 114.49 24.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.884 0.373 . . . . 54.41 111.218 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.641 ' SD ' HG21 ' A' ' 152' ' ' ILE . 64.1 mtt -99.04 142.19 30.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.277 -0.42 . . . . 71.22 111.52 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.9 p -136.16 148.32 48.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.119 0.485 . . . . 70.22 111.963 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.8 mt -99.93 112.24 24.52 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.122 -0.49 . . . . 75.04 111.671 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG23 ' HB ' ' A' ' 81' ' ' THR . 17.7 m -134.12 164.57 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 122.391 -0.193 . . . . 71.44 111.099 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.598 HD22 HG23 ' A' ' 69' ' ' VAL . 40.4 m-80 62.84 29.41 16.63 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.899 0.38 . . . . 55.44 111.675 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.05 110.68 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.803 0.335 . . . . 62.51 111.309 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -142.85 155.46 62.8 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 112.539 0.57 . . . . 75.01 112.539 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.7 157.91 21.93 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.226 2.617 . . . . 61.33 113.348 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.53 163.88 35.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.085 0.469 . . . . 65.04 111.905 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.81 70.41 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.139 -0.482 . . . . 41.34 111.864 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 140' ' ' LYS . 8.8 m-20 -71.59 -43.4 66.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.079 0.466 . . . . 61.55 110.881 175.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.53 -77.22 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.968 -0.634 . . . . 71.12 112.911 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.8 m -149.68 138.49 20.99 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.834 0.35 . . . . 75.24 111.705 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.7 p -122.09 142.48 50.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.989 0.423 . . . . 73.24 111.401 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.25 152.75 36.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.226 -0.443 . . . . 52.3 111.549 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.602 ' HB ' HG23 ' A' ' 69' ' ' VAL . 39.0 m -84.34 103.61 13.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.743 0.306 . . . . 73.33 110.679 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.66 103.06 11.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.636 -0.505 . . . . 62.14 109.636 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.63 ' HB3' HE22 ' A' ' 85' ' ' GLN . 92.8 mtt-85 -88.83 135.09 33.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.841 0.353 . . . . 64.42 111.615 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.5 mp -116.67 99.46 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 74.24 110.72 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.63 HE22 ' HB3' ' A' ' 83' ' ' ARG . 22.8 mp0 -93.89 109.56 21.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.957 0.408 . . . . 74.43 111.235 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.31 130.11 37.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.246 -0.502 . . . . 52.03 112.871 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -73.26 -13.72 61.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.26 0.552 . . . . 61.13 110.987 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.9 p -107.4 144.79 33.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.123 -0.489 . . . . 70.33 110.712 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.27 -17.76 51.26 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.859 0.318 . . . . 75.23 111.859 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.95 147.39 95.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.349 -0.387 . . . . 73.1 111.41 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.9 117.21 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.313 2.009 . . . . 72.31 112.936 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 126' ' ' SER . 93.0 mt -82.0 155.85 69.92 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 120.859 0.361 . . . . 73.44 111.433 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.27 -177.45 3.53 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.276 1.984 . . . . 72.13 112.621 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 158' ' ' VAL . . . -77.99 158.44 29.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.757 0.313 . . . . 72.02 110.948 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB3' HD13 ' A' ' 61' ' ' ILE . 37.4 p90 -152.84 149.14 27.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.712 0.768 . . . . 72.11 112.628 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.9 p -133.64 162.76 31.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.204 -0.907 . . . . 72.43 110.238 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.92 -158.26 18.48 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.369 -0.92 . . . . 73.21 113.591 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.3 m -136.33 145.72 45.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.01 0.434 . . . . 73.12 111.324 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.68 128.34 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.045 0.45 . . . . 72.12 112.056 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.807 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 17.6 mm-40 -89.58 110.45 21.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.966 -0.561 . . . . 61.14 110.246 175.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.426 ' CG ' HD22 ' A' ' 139' ' ' LEU . 31.0 p90 -121.85 124.44 44.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.437 0.637 . . . . 63.14 111.736 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.66 -140.89 3.05 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.563 -0.744 . . . . 63.2 112.673 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.584 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 96.5 mt-30 -126.73 163.76 22.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.188 0.518 . . . . 65.32 111.872 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.77 114.79 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 116.227 -0.442 . . . . 72.15 111.107 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -92.48 -9.46 41.36 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.811 0.3 . . . . 74.13 111.811 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . -91.05 178.59 42.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.09 -0.576 . . . . 32.25 113.785 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.3 p -85.76 -165.56 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.879 0.371 . . . . 70.33 111.483 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.49 HD12 ' HG3' ' A' ' 33' ' ' GLN . 41.9 mm -74.25 -31.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.908 0.385 . . . . 74.45 111.364 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.82 -43.87 8.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.782 0.325 . . . . 72.33 111.462 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -115.51 96.41 5.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.535 0.683 . . . . 71.24 111.301 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.695 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 9.3 p90 -121.41 144.1 48.86 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.852 -0.613 . . . . 75.23 111.899 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -120.09 127.01 52.14 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.661 -0.699 . . . . 72.13 111.114 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.89 99.18 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 55.24 110.611 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 pt -107.51 150.39 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.424 -0.353 . . . . 53.5 111.501 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 56.63 29.14 15.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.053 0.454 . . . . 44.02 111.851 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' A' ' 100' ' ' GLU . 6.0 p -90.57 132.35 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.483 0.549 . . . . 54.32 112.483 -176.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -116.56 154.41 30.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.085 -0.507 . . . . 73.24 110.265 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -107.56 132.73 52.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.116 0.484 . . . . 73.31 112.055 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -122.65 142.13 51.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.413 -0.358 . . . . 74.25 111.281 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.82 102.76 13.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.976 0.417 . . . . 71.25 111.721 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.59 140.21 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.219 0.533 . . . . 70.55 112.023 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -130.3 148.46 52.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.448 -0.342 . . . . 72.02 110.812 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . . . -136.86 144.77 48.02 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 111.935 0.346 . . . . 75.43 111.935 177.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 25.7 Cg_exo -64.81 167.5 15.47 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.143 2.562 . . . . 72.11 113.648 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.14 128.9 34.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.131 -0.486 . . . . 62.25 112.11 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 66.1 m -79.69 75.73 6.35 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.164 0.507 . . . . 70.11 110.606 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.29 -30.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.239 0.543 . . . . 74.11 111.15 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 83.2 mt -95.89 159.58 14.9 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.949 -0.569 . . . . 72.4 111.086 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.79 146.9 47.03 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.441 -0.345 . . . . 40.43 111.419 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.95 171.68 58.53 Favored 'Cis proline' 0 C--N 1.353 0.771 0 C-N-CA 124.331 -1.112 . . . . 73.22 112.753 -1.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 90.73 3.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.156 0.503 . . . . 72.43 111.477 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.71 84.83 2.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.268 0.556 . . . . 60.03 109.877 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.8 t -102.34 156.77 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 70.04 111.893 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 10.3 p-10 -150.13 108.71 3.82 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.192 0.52 . . . . 65.23 110.699 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.0 pt -113.32 135.27 21.81 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.119 -0.363 . . . . 52.02 111.821 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.9 119.5 5.9 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.296 1.998 . . . . 33.42 112.986 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.6 tt -98.74 123.33 42.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.101 -0.5 . . . . 72.02 110.203 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -105.59 105.19 15.11 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.073 0.463 . . . . 64.15 111.326 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 101' ' ' TYR . 70.1 mt -91.62 130.08 37.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.383 -0.371 . . . . 75.41 111.192 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 67.3 mttm -106.64 145.13 32.33 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.122 0.415 . . . . 75.02 112.122 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.92 27.23 73.7 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.343 -0.456 . . . . 71.44 113.998 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.4 tt -155.59 122.52 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.472 0.653 . . . . 72.23 111.802 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.2 m -85.46 148.01 26.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.122 -0.49 . . . . 75.53 111.283 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.81 -34.79 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.795 0.331 . . . . 72.45 111.884 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.01 -29.08 66.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.063 0.459 . . . . 64.42 111.587 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -109.35 10.77 25.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.044 0.387 . . . . 74.02 112.044 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . 3.2 mt -74.01 114.73 12.66 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 71.04 111.63 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -88.58 -59.2 1.65 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.241 -0.504 . . . . 31.31 112.996 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -149.77 157.58 43.34 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.385 0.612 . . . . 75.11 112.48 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 96.2 t -126.23 107.73 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.261 -0.881 . . . . 75.44 109.552 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.807 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 60.8 ttt180 -109.63 108.31 18.68 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.244 0.461 . . . . 74.22 112.244 -171.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.641 HG21 ' SD ' ' A' ' 66' ' ' MET . 36.0 mm -86.5 132.07 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 111.59 0.219 . . . . 53.45 111.59 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.62 178.83 8.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.745 0.307 . . . . 70.04 111.746 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 65.44 19.99 11.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.934 0.716 . . . . 70.13 112.934 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 48.3 mm -65.56 117.74 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.279 0.562 . . . . 73.42 111.716 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -130.37 153.3 81.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.976 -0.556 . . . . 74.22 111.57 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.566 ' HB3' HG22 ' A' ' 61' ' ' ILE . 66.4 Cg_endo -73.66 117.31 5.0 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.553 2.169 . . . . 61.41 113.385 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 5.7 p -110.55 122.16 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.353 0.597 . . . . 72.22 110.997 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 21.1 ptp -161.44 177.7 9.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 51.01 111.358 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -60.49 131.02 49.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.985 0.422 . . . . 73.23 110.715 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 161' ' ' LEU . 6.7 mp -72.62 87.34 1.22 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.651 0.611 . . . . 74.11 112.651 -173.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -81.01 127.13 32.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.653 -0.499 . . . . 63.31 109.653 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -56.9 115.89 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.178 0.513 . . . . 75.14 111.649 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -72.18 130.32 40.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.746 -0.661 . . . . 55.33 111.847 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -105.84 92.72 4.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 72.13 111.902 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -79.33 126.72 31.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.341 -0.391 . . . . 73.14 110.11 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 68.41 87.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.992 0.425 . . . . 74.14 110.913 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.728 -0.653 . . . . 71.12 111.964 176.378 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.86 0.362 . . . . 64.44 111.174 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -102.97 154.62 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.865 0.364 . . . . 42.22 111.613 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -153.65 90.91 1.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.209 0.528 . . . . 74.24 110.718 175.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.1 154.37 20.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.055 -0.52 . . . . 73.03 111.106 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -148.34 161.52 41.38 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.963 0.411 . . . . 61.14 111.729 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.63 133.66 53.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.202 -0.454 . . . . 62.21 111.432 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.5 m -100.3 126.91 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.988 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -131.28 151.1 51.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.181 0.515 . . . . 72.23 112.059 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -78.95 163.65 25.06 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.732 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.4 mmt -120.33 -175.16 2.94 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.33 0.586 . . . . 71.53 112.35 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -85.81 156.18 20.68 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.889 -0.596 . . . . 72.12 112.424 -171.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -133.04 143.71 49.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.015 0.436 . . . . 71.04 111.467 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -92.12 176.5 6.47 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.155 -0.475 . . . . 45.22 112.176 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.59 119.13 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.165 0.507 . . . . 72.33 111.118 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -86.91 141.67 28.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.39 -0.368 . . . . 74.13 111.718 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.0 p -126.5 179.02 5.52 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.149 0.5 . . . . 75.11 112.046 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.33 117.91 9.97 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.224 -0.444 . . . . 73.33 112.003 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.539 HD22 ' N ' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -89.06 148.75 23.55 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.134 0.492 . . . . 74.42 111.274 176.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -99.97 -165.23 1.2 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.908 -0.587 . . . . 72.25 111.628 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.08 92.17 0.17 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.949 0.404 . . . . 75.23 110.659 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.7 mtt -128.34 -168.16 1.87 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.965 0.412 . . . . 63.32 111.633 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 p -77.44 -172.65 2.59 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.159 0.504 . . . . 73.5 112.036 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.3 126.85 29.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.207 -0.451 . . . . 75.14 111.056 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -133.32 163.03 30.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.784 0.326 . . . . 55.44 111.004 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -50.02 124.71 10.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.218 -0.446 . . . . 54.32 110.863 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.46 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 29.9 mm-40 -60.81 -18.24 54.33 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.393 0.516 . . . . 75.54 112.393 -175.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' O ' HG13 ' A' ' 31' ' ' ILE . 38.0 tt0 -58.08 -63.55 1.22 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.87 0.367 . . . . 60.4 110.485 171.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.571 ' HA ' HD12 ' A' ' 31' ' ' ILE . 39.7 m -61.21 -30.38 70.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.947 0.403 . . . . 74.44 111.553 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.2 -47.6 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.788 0.327 . . . . 75.43 110.839 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 26' ' ' GLN . 6.0 mptp? -64.54 -30.09 71.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 72.21 111.335 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 28' ' ' THR . 82.6 mt -62.62 -48.31 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.249 0.547 . . . . 63.2 110.791 174.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.3 m -64.68 -41.35 96.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.197 0.522 . . . . 74.13 110.738 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HG3' HD12 ' A' ' 108' ' ' ILE . 57.7 tt0 -57.5 -47.59 81.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.797 -0.638 . . . . 73.24 111.102 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 46' ' ' TYR . 29.4 tt0 -55.23 -47.12 75.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.078 0.466 . . . . 72.25 111.331 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.75 -27.45 68.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.224 -0.444 . . . . 70.11 111.974 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -77.29 -36.21 54.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.076 -0.39 . . . . 65.34 111.22 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.0 -36.12 82.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.303 0.573 . . . . 55.2 110.038 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -57.17 -41.48 79.3 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.752 -0.658 . . . . 74.25 110.465 172.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.96 76.92 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.283 0.475 . . . . 35.41 112.283 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 109' ' ' ASP . 51.9 mttp -87.67 -9.25 54.71 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.647 0.61 . . . . 74.0 112.647 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.4 t -63.27 123.03 17.63 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.133 0.492 . . . . 74.23 112.152 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.4 t -88.42 -30.08 19.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.104 0.478 . . . . 73.33 111.166 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t -146.73 107.13 4.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.236 -0.438 . . . . 42.22 110.854 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 152' ' ' ILE . . . 93.3 -143.64 16.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.084 -0.579 . . . . 74.44 113.104 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.793 HG13 HD13 ' A' ' 57' ' ' LEU . 16.4 m -143.27 153.52 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.34 0.59 . . . . 63.11 112.198 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 16.4 m-85 -101.25 105.46 16.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.612 -0.722 . . . . 63.14 110.964 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 98.9 mt -95.23 136.65 35.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.737 0.303 . . . . 73.12 110.904 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.2 mt -109.81 130.95 22.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.292 -0.255 . . . . 45.22 111.428 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HB3' HD13 ' A' ' 147' ' ' LEU . 33.0 Cg_endo -62.58 -27.78 76.76 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.604 2.202 . . . . 45.42 112.714 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.79 -23.54 72.14 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.139 -0.553 . . . . 32.22 112.412 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.23 73.92 1.53 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.149 0.5 . . . . 74.11 111.314 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -66.6 74.56 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.357 0.599 . . . . 54.15 110.845 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 p -148.97 159.27 37.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.771 -0.65 . . . . 42.31 112.38 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.12 149.87 28.88 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.027 2.485 . . . . 72.12 113.756 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 145.86 49.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.397 -0.365 . . . . 71.45 111.226 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -82.44 134.93 35.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.446 -0.343 . . . . 72.13 111.057 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.793 HD13 HG13 ' A' ' 45' ' ' VAL . 37.0 tp -143.53 136.56 27.72 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.558 0.577 . . . . 75.11 112.558 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.59 143.15 27.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.91 -0.586 . . . . 71.45 110.363 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -140.52 170.98 14.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.226 0.536 . . . . 74.5 111.673 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.652 ' NE2' ' HB3' ' A' ' 156' ' ' GLN . 49.0 mt-30 -77.51 5.76 8.37 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.074 -0.512 . . . . 71.33 112.101 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -112.0 -22.13 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 120.851 0.358 . . . . 62.2 110.837 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.03 -160.71 29.24 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.287 -0.415 . . . . 64.32 112.668 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.6 m -92.91 135.43 34.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.394 -0.474 . . . . 61.15 110.771 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.2 178.53 7.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.408 0.623 . . . . 32.13 112.619 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -136.29 107.06 6.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.744 -0.662 . . . . 65.04 111.013 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.725 ' SD ' HG21 ' A' ' 152' ' ' ILE . 58.3 mtt -96.04 170.17 9.47 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.049 -0.407 . . . . 75.14 111.879 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.6 p -169.08 152.74 5.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.033 0.383 . . . . 54.21 112.033 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.32 114.81 29.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.363 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.616 HG23 ' HB ' ' A' ' 81' ' ' THR . 26.9 m -128.79 164.09 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.731 0.3 . . . . 75.53 111.41 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 59.1 42.52 18.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.167 0.508 . . . . 52.11 112.036 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.9 mt -82.45 109.68 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.038 -0.528 . . . . 73.43 111.782 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 p -131.22 155.16 81.9 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 120.977 0.418 . . . . 63.22 112.124 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.49 136.43 33.69 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.767 2.311 . . . . 52.54 112.757 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.623 ' HB2' HG23 ' A' ' 79' ' ' THR . 32.8 t70 -115.4 164.78 13.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.841 0.456 . . . . 74.53 111.145 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.94 74.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.098 0.407 . . . . 53.11 112.098 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.88 -17.6 16.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.137 0.421 . . . . 62.45 112.137 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.3 -103.02 0.16 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.476 -0.869 . . . . 23.23 114.23 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.4 m -149.73 125.54 10.47 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.565 -0.373 . . . . 73.01 111.449 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 74' ' ' ASP . 39.4 p -101.66 124.73 47.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.806 0.336 . . . . 75.24 111.888 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 137' ' ' LEU . 3.4 pp -138.2 177.67 7.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.797 0.332 . . . . 73.11 111.252 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 69' ' ' VAL . 60.0 m -122.52 126.54 48.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.801 0.334 . . . . 64.43 111.472 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.6 114.02 25.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.89 -0.411 . . . . 73.21 109.89 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 97.2 mtt180 -104.53 110.05 22.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.287 0.477 . . . . 63.21 112.287 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -102.72 112.37 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.108 -0.496 . . . . 64.52 111.573 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 131' ' ' SER . 34.7 tt0 -98.52 141.8 30.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.568 0.223 . . . . 63.2 111.026 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.6 144.05 22.94 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.039 -0.6 . . . . 75.03 113.101 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.09 -40.67 96.62 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.974 0.416 . . . . 75.24 110.857 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.9 p -96.78 -177.66 3.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.219 0.533 . . . . 51.24 111.38 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -92.9 6.95 45.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.305 -0.407 . . . . 74.13 111.248 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.45 135.38 68.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.485 -0.325 . . . . 72.11 111.784 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 96.68 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.139 1.892 . . . . 64.42 111.801 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.75 141.3 89.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.33 0.492 . . . . 71.32 112.33 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.11 177.58 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.663 2.242 . . . . 75.43 112.929 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.3 134.4 46.75 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.013 0.435 . . . . 54.15 111.651 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.65 160.95 39.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.138 0.494 . . . . 74.54 111.954 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 92.3 p -138.71 168.8 19.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.059 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.632 ' HA3' HD13 ' A' ' 155' ' ' ILE . . . -164.2 165.25 37.08 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.023 -0.608 . . . . 54.2 113.337 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.6 m -98.98 107.84 20.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.91 0.386 . . . . 63.11 111.544 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 119' ' ' GLN . 3.2 p -89.83 112.97 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.202 0.525 . . . . 54.33 111.097 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 117' ' ' GLN . 47.5 mt-10 -102.6 103.56 13.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.277 0.56 . . . . 75.43 110.956 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CD1' HD22 ' A' ' 139' ' ' LEU . 19.0 p90 -104.27 137.97 41.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.814 -0.63 . . . . 74.43 111.579 -175.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.09 -145.5 4.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.697 -0.763 . . . . 52.24 113.592 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.612 ' HA ' ' HA3' ' A' ' 148' ' ' GLY . 93.5 mt-30 -129.44 161.35 30.59 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.885 0.374 . . . . 55.4 111.363 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 111' ' ' PHE . 51.9 mt -122.34 140.11 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.073 0.463 . . . . 73.25 112.102 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.802 HE21 HD13 ' A' ' 114' ' ' ILE . 10.9 pt20 -132.03 103.53 6.33 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.489 0.661 . . . . 65.52 110.79 169.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 111' ' ' PHE . . . 157.56 -158.54 29.09 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.156 -0.545 . . . . 62.44 113.606 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 33.4 p -98.82 -170.71 1.97 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 122.517 -0.402 . . . . 64.25 111.073 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.495 HD12 ' HG3' ' A' ' 33' ' ' GLN . 34.0 mm -76.12 -15.41 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.31 0.576 . . . . 54.45 110.766 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.708 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 40.7 m-20 -105.2 -45.94 4.37 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.104 -0.498 . . . . 74.24 111.512 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -116.03 92.88 4.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.377 0.608 . . . . 73.01 111.097 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' HB2' HG23 ' A' ' 104' ' ' ILE . 38.2 p90 -127.33 132.2 50.28 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.131 0.491 . . . . 74.5 111.809 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -96.49 124.44 40.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.087 -0.506 . . . . 72.32 111.149 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.82 97.73 11.08 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.007 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.802 HD13 HE21 ' A' ' 105' ' ' GLN . 36.8 pt -103.53 162.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.126 -0.488 . . . . 72.41 112.043 -175.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 53.77 22.18 3.07 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 64.42 112.61 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.57 131.77 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.366 0.603 . . . . 75.31 112.202 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 34.0 mt-30 -128.15 146.41 50.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.665 -0.698 . . . . 74.53 110.814 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -98.03 143.13 28.9 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.263 0.554 . . . . 53.33 112.267 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.586 ' HB3' HG13 ' A' ' 99' ' ' VAL . 8.4 tt0 -142.23 149.44 39.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.782 -0.645 . . . . 74.02 110.174 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -100.28 114.41 27.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.138 0.494 . . . . 74.31 112.231 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.92 121.94 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.113 -0.494 . . . . 65.41 111.17 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -113.46 135.65 53.65 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.902 0.382 . . . . 73.31 111.37 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.517 ' HB1' HG11 ' A' ' 133' ' ' VAL . . . -124.1 140.07 34.01 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.234 -0.439 . . . . 54.03 111.476 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.16 169.66 21.94 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.589 2.193 . . . . 72.02 113.623 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.13 134.79 34.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 55.21 111.523 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 m -77.39 124.06 27.36 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.386 -0.37 . . . . 73.24 111.419 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.28 -42.52 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.103 0.478 . . . . 73.24 110.973 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -125.81 171.58 10.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.036 -0.529 . . . . 75.15 111.83 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.11 158.79 31.07 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.263 -0.426 . . . . 71.23 111.483 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.0 160.14 57.98 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.015 -1.244 . . . . 72.25 113.129 -2.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 58.8 m -86.17 78.07 9.45 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.494 0.553 . . . . 54.42 112.494 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.78 79.42 2.23 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.427 -0.583 . . . . 64.35 109.427 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.529 HG12 HG23 ' A' ' 135' ' ' ILE . 40.6 t -76.68 99.78 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.402 -0.363 . . . . 75.44 111.818 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.453 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . 5.8 p-10 -91.27 106.84 18.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.033 0.444 . . . . 52.25 110.97 174.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.529 HG23 HG12 ' A' ' 133' ' ' VAL . 26.9 pt -114.08 131.54 23.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 111.972 0.36 . . . . 60.33 111.972 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.58 135.69 54.35 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.722 2.281 . . . . 71.04 112.381 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.49 ' HB3' HD12 ' A' ' 80' ' ' LEU . 2.4 tt -132.42 113.33 13.02 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.35 -0.386 . . . . 55.14 110.424 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.61 109.76 22.24 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.058 0.456 . . . . 74.21 111.702 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 ' CD1' ' A' ' 101' ' ' TYR . 80.0 mt -88.57 140.05 29.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.143 -0.317 . . . . 63.52 110.143 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -129.4 150.69 50.65 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.888 0.375 . . . . 74.5 111.475 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.87 31.14 56.53 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.218 -0.515 . . . . 71.42 113.068 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 147' ' ' LEU . 17.8 tt -168.51 125.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.916 0.389 . . . . 75.23 111.487 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.8 m -83.53 144.71 29.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.649 0.261 . . . . 60.33 111.522 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 p -51.04 -44.77 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 112.391 0.515 . . . . 72.43 112.391 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -59.74 -38.55 82.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.211 0.529 . . . . 52.31 111.389 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -93.31 6.16 49.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.346 0.499 . . . . 70.53 112.346 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.606 ' HA ' HD11 ' A' ' 142' ' ' ILE . 1.3 tt -69.68 125.14 25.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.662 0.267 . . . . 73.55 110.402 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 103' ' ' GLN . . . -95.82 -62.16 0.98 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.111 -0.566 . . . . 41.44 113.602 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -145.44 160.25 41.87 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.272 0.558 . . . . 71.02 112.008 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 75.5 t -124.86 101.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.696 -0.684 . . . . 64.31 110.406 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . 31.2 ttm180 -88.31 94.37 9.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.874 0.369 . . . . 72.03 111.636 -176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.725 HG21 ' SD ' ' A' ' 66' ' ' MET . 37.1 mm -85.75 127.58 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.68 -0.237 . . . . 74.52 110.876 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -164.45 -178.3 5.34 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.405 0.521 . . . . 71.34 112.405 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 66.38 24.56 10.47 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.449 0.7 . . . . 74.31 112.293 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.632 HD13 ' HA3' ' A' ' 97' ' ' GLY . 41.9 mm -67.15 105.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.187 0.518 . . . . 73.43 111.701 -177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.652 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 7.6 pt20 -137.71 151.72 71.22 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.021 -0.536 . . . . 73.23 111.42 -175.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.666 ' HG2' HD11 ' A' ' 161' ' ' LEU . 57.9 Cg_endo -70.8 133.25 23.27 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.406 2.071 . . . . 43.03 112.846 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.1 m -85.87 28.92 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.135 0.493 . . . . 51.45 111.975 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -122.84 -175.02 3.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.924 0.392 . . . . 74.21 111.362 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -80.09 121.37 25.45 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.948 0.404 . . . . 71.55 111.835 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.666 HD11 ' HG2' ' A' ' 157' ' ' PRO . 6.5 mp -100.35 148.15 25.02 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.884 0.373 . . . . 63.22 111.065 176.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.45 153.46 50.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.033 0.444 . . . . 72.31 111.446 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -158.5 154.66 27.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.031 -0.532 . . . . 72.11 110.867 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -137.76 121.85 17.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.28 0.474 . . . . 70.22 112.28 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -96.19 -173.9 2.93 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.221 0.534 . . . . 75.41 111.244 175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -133.68 -174.46 3.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.295 -0.412 . . . . 71.23 110.501 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -75.32 -32.38 60.93 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.148 0.499 . . . . 44.22 109.818 170.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.747 -0.644 . . . . 74.24 110.831 174.913 . . . . . . . . 0 0 . 1 stop_ save_